Citrus Sinensis ID: 018487

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-----
Protein Sequence
MVSTSQKNLHSLLTTKLKKLTITPPSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLIIFHCLFVNSLELLSHFPENCPASH
Secondary Structure (PSIPRED)
cccccccccccccHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHccHHHHHHccccccccccccEEEEEEcccccEEEEEEEccccccccccEEEEEEccHHHHHHHHHHHHHHHHHHHHHHccccEEEcccEEEcccccEEEEEEEccccHHHHHHHHccccccccHHHHHHHHHHHHHHHHcccccccccccccccccccccEEEEccccccccccccccccccccccccccHHcccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHccccccccccHHHHHHHHcccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccccccccccccccccccccccccccccccccccccccHcccHHHHHccccccccccccccccccccccccccccccccccccccccccccccHHHEEEccccccHHEEEEEEccccccccccEEEEEEEEHHHHHHcccHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEccccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEccccccEccccccHHHccHHHHccccEccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHccccccccccHHHHHHHHHHHccccccc
Coil and Loop (DISEMBL)
mvstsqknLHSLLTTKLkkltitppsasspdfdftevfgpltpcrhnnqspastsaslgdpqvihnrshsfvgpspryalssslplqIQELEHENDaeleaeserkigpgdfeIFRVVGQGAFGKVFQVKkkgvddgdsdgIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYrqgifredqaRFYTAEIVSAVSHLHkcgivhrdlkpenilmdsdghvmltdfglakeidessrsnsmcgtteymapeillskghnkdadwWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLIIFHCLFVNSLellshfpencpash
Flexible Loop (DISEMBL)
mvstsqknLHSLLTTKLKKLTITPPSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKvfqvkkkgvddgdsdgiyamkvmrkdtiikknHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLIIFHCLFVNSLELLSHFpencpash
Low Complexity Region (SEG)
MVSTSQKNLHSllttklkkltITPPSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFgkvfqvkkkgvddgdsdgIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLIIFHCLFVNSLELLSHFPENCPASH
Disordered region (IsUnstruct)
************************************VF***********************************************************************GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK***********CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLIIFHCLFVNSLELLSHF********
Disordered Region (DISOPRED)
**************************************************************************************************************DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLIIFHCLFVNSLELLS***EN*****
Disordered Region (DISEMBL)
*********HSLLTTKLKKLTITPPSASSPDFDFTEVFGPLTPCRHNN**********GDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI*********CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLIIFHCLFVNSLELLSHFPENCPASH
Disordered Region (DISPRO)
**********************************************************************************************************IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLIIFHCLFVNSLELLSHFPEN*****
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MVSTSQKNLHSLLTTKLKKLTITPPSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLIIFHCLFVNSLELLSHFPENCPASH
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	355	2.2.26 [Sep-21-2011]
Q39030	471	Serine/threonine-protein	yes	no	0.839	0.632	0.572	1e-99
P42818	465	Serine/threonine-protein	no	no	0.797	0.608	0.560	1e-95
P28178	479	Protein kinase 2 OS=Dicty	yes	no	0.549	0.407	0.585	6e-68
P51812	740	Ribosomal protein S6 kina	yes	no	0.628	0.301	0.515	6e-64
P18654	740	Ribosomal protein S6 kina	yes	no	0.628	0.301	0.515	6e-64
Q9UBS0	482	Ribosomal protein S6 kina	no	no	0.619	0.456	0.534	8e-64
P54644	444	RAC family serine/threoni	no	no	0.580	0.463	0.511	1e-62
Q9Z1M4	485	Ribosomal protein S6 kina	no	no	0.619	0.453	0.530	1e-62
P18652	752	Ribosomal protein S6 kina	no	no	0.628	0.296	0.502	3e-62
P67999	525	Ribosomal protein S6 kina	no	no	0.571	0.386	0.555	4e-62

>sp|Q39030|KPK2_ARATH Serine/threonine-protein kinase AtPK2/AtPK19 OS=Arabidopsis thaliana GN=ATPK2 PE=1 SV=2

 Score =  363 bits (932), Expect = e-99,   Method: Compositional matrix adjust.
 Identities = 194/339 (57%), Positives = 236/339 (69%), Gaps = 41/339 (12%)

Query: 3   STSQKNLHSLLTTKLKKLTITPPSASSPD---FDFTEVFGPLTPCRHNNQSPASTSASLG 59
           S + KN       K   L+I+PP +   D     F++VFGP+        S  +   +  
Sbjct: 7   SVANKNQTGKPFQKHLSLSISPPKSVLGDNLELQFSDVFGPMPEA----NSEEACDVAYD 62

Query: 60  DPQVIHNRSHSFVGPSPRYALSSSLP---LQIQELE--------------HEND---AEL 99
           +P V+++RSHS VGPS    +S SL    L ++E E               END      
Sbjct: 63  EPAVVYSRSHSLVGPS--LVVSHSLKMNKLTLRETEDSVDLVECVEGESIKENDEFSGND 120

Query: 100 EAESERK-------IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDT 152
           + +SE+        +G  DFE+ +VVGQGAFGKV+QV+KK     D+  IYAMKVMRKD 
Sbjct: 121 DTDSEKSPEEVSGVVGIEDFEVLKVVGQGAFGKVYQVRKK-----DTSEIYAMKVMRKDK 175

Query: 153 IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
           I++KNH +YMKAERDILTK+ HPFIVQL+YSFQT+ +LYL+LDFINGGHLFF LY QG+F
Sbjct: 176 IVEKNHAEYMKAERDILTKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHQGLF 235

Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN 272
           RED AR YTAEIVSAVSHLH+ GI+HRDLKPENILMD DGHVMLTDFGLAKE +E++RSN
Sbjct: 236 REDLARVYTAEIVSAVSHLHEKGIMHRDLKPENILMDVDGHVMLTDFGLAKEFEENTRSN 295

Query: 273 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           SMCGTTEYMAPEI+  KGH+K ADWWSVGILLYEMLTG+
Sbjct: 296 SMCGTTEYMAPEIVRGKGHDKAADWWSVGILLYEMLTGK 334

Downstream effector of TOR signaling pathway. May be involved in adaptation of plant to cold or high-salt conditions.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|P42818|KPK1_ARATH Serine/threonine-protein kinase AtPK1/AtPK6 OS=Arabidopsis thaliana GN=ATPK1 PE=1 SV=1

 Score =  350 bits (897), Expect = 1e-95,   Method: Compositional matrix adjust.
 Identities = 184/328 (56%), Positives = 232/328 (70%), Gaps = 45/328 (13%)

Query: 16  KLKKLTITPPSASSPD---FDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFV 72
           K + L+I+P ++   D    +F++VFGPL P   N+        +  +P V+++RSHS V
Sbjct: 14  KQQYLSISPSNSVLKDDVELEFSDVFGPL-PEEAND-------IAYDEPAVVYSRSHSLV 65

Query: 73  GPSPRYALSSSLP----------------LQIQELEHENDAELEAESERK---------- 106
           GP    + S  L                 L+ + L+  +D     +S+ +          
Sbjct: 66  GPCSLDSHSLKLTKLTLLETEDSIDLVECLEGESLKENDDFSGNDDSDNEKALEGDLVKV 125

Query: 107 ---IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK 163
              +G  DFE+ +VVG+GAFGKV+QV+KK     ++  IYAMKVMRKD I++KNH +YMK
Sbjct: 126 SGVVGIDDFEVMKVVGKGAFGKVYQVRKK-----ETSEIYAMKVMRKDHIMEKNHAEYMK 180

Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
           AERDILTK+ HPFIVQL+YSFQT+ +LYL+LDFINGGHLFF LY QG+FRED AR YTAE
Sbjct: 181 AERDILTKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHQGLFREDLARVYTAE 240

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           IVSAVSHLH+ GI+HRDLKPENILMD+DGHVMLTDFGLAKE +E++RSNSMCGTTEYMAP
Sbjct: 241 IVSAVSHLHEKGIMHRDLKPENILMDTDGHVMLTDFGLAKEFEENTRSNSMCGTTEYMAP 300

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQ 311
           EI+  KGH+K ADWWSVGILLYEMLTG+
Sbjct: 301 EIVRGKGHDKAADWWSVGILLYEMLTGK 328

Downstream effector of TOR signaling pathway involved in osmotic stress response. Could be involved in the control of plant growth and development. Phosphorylates the ribosomal proteins P14, P16 and S6.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P28178|PK2_DICDI Protein kinase 2 OS=Dictyostelium discoideum GN=pkgB PE=1 SV=2

 Score =  258 bits (658), Expect = 6e-68,   Method: Compositional matrix adjust.
 Identities = 117/200 (58%), Positives = 153/200 (76%), Gaps = 5/200 (2%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE+  V+G+G+FGKV QVKKKG      D I+AMKV+RKD II +  V++ K+E+ IL 
Sbjct: 152 DFELLNVIGKGSFGKVMQVKKKG-----EDKIFAMKVLRKDAIIARKQVNHTKSEKTILQ 206

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            ++HPFIV L Y+FQT+ KLY++LDF+NGG LFFHL R+G F E + + Y AEIVSA+ H
Sbjct: 207 CISHPFIVNLHYAFQTKDKLYMVLDFVNGGELFFHLKREGRFSEPRVKIYAAEIVSALDH 266

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
           LHK  IV+RDLKPENIL+DS+GH+ +TDFGL+K+I+ +  + + CGT EY+APE+L   G
Sbjct: 267 LHKQDIVYRDLKPENILLDSEGHICITDFGLSKKIETTDGTFTFCGTPEYLAPEVLNGHG 326

Query: 291 HNKDADWWSVGILLYEMLTG 310
           H    DWWS+G LLYEMLTG
Sbjct: 327 HGCAVDWWSLGTLLYEMLTG 346

Required for morphogenesis during multicellular development. Phosphorylates talB, gefN, gefS, PI4P 5-kinase and gacQ.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51812|KS6A3_HUMAN Ribosomal protein S6 kinase alpha-3 OS=Homo sapiens GN=RPS6KA3 PE=1 SV=1

 Score =  244 bits (624), Expect = 6e-64,   Method: Compositional matrix adjust.
 Identities = 117/227 (51%), Positives = 158/227 (69%), Gaps = 4/227 (1%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
           E   K  P  FE+ +V+GQG+FGKVF VKK  +   D+  +YAMKV++K T+  ++ V  
Sbjct: 58  EGHEKADPSQFELLKVLGQGSFGKVFLVKK--ISGSDARQLYAMKVLKKATLKVRDRV-R 114

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
            K ERDIL +V HPFIV+L Y+FQT  KLYLILDF+ GG LF  L ++ +F E+  +FY 
Sbjct: 115 TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 174

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEY 280
           AE+  A+ HLH  GI++RDLKPENIL+D +GH+ LTDFGL+KE ID   ++ S CGT EY
Sbjct: 175 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 234

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLL 327
           MAPE++  +GH + ADWWS G+L++EMLTG +  +        TM+L
Sbjct: 235 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL 281

Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1. In fibroblast, is required for EGF-stimulated phosphorylation of CREB1 and histone H3 at 'Ser-10', which results in the subsequent transcriptional activation of several immediate-early genes. In response to mitogenic stimulation (EGF and PMA), phosphorylates and activates NR4A1/NUR77 and ETV1/ER81 transcription factors and the cofactor CREBBP. Upon insulin-derived signal, acts indirectly on the transcription regulation of several genes by phosphorylating GSK3B at 'Ser-9' and inhibiting its activity. Phosphorylates RPS6 in response to serum or EGF via an mTOR-independent mechanism and promotes translation initiation by facilitating assembly of the preinitiation complex. In response to insulin, phosphorylates EIF4B, enhancing EIF4B affinity for the EIF3 complex and stimulating cap-dependent translation. Is involved in the mTOR nutrient-sensing pathway by directly phosphorylating TSC2 at 'Ser-1798', which potently inhibits TSC2 ability to suppress mTOR signaling, and mediates phosphorylation of RPTOR, which regulates mTORC1 activity and may promote rapamycin-sensitive signaling independently of the PI3K/AKT pathway. Mediates cell survival by phosphorylating the pro-apoptotic proteins BAD and DAPK1 and suppressing their pro-apoptotic function. Promotes the survival of hepatic stellate cells by phosphorylating CEBPB in response to the hepatotoxin carbon tetrachloride (CCl4). Is involved in cell cycle regulation by phosphorylating the CDK inhibitor CDKN1B, which promotes CDKN1B association with 14-3-3 proteins and prevents its translocation to the nucleus and inhibition of G1 progression. In LPS-stimulated dendritic cells, is involved in TLR4-induced macropinocytosis, and in myeloma cells, acts as effector of FGFR3-mediated transformation signaling, after direct phosphorylation at Thr-529 by FGFR3. Phosphorylates DAPK1.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P18654|KS6A3_MOUSE Ribosomal protein S6 kinase alpha-3 OS=Mus musculus GN=Rps6ka3 PE=1 SV=2

 Score =  244 bits (624), Expect = 6e-64,   Method: Compositional matrix adjust.
 Identities = 117/227 (51%), Positives = 158/227 (69%), Gaps = 4/227 (1%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
           E   K  P  FE+ +V+GQG+FGKVF VKK  +   D+  +YAMKV++K T+  ++ V  
Sbjct: 58  EGHEKADPSQFELLKVLGQGSFGKVFLVKK--ISGSDARQLYAMKVLKKATLKVRDRV-R 114

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
            K ERDIL +V HPFIV+L Y+FQT  KLYLILDF+ GG LF  L ++ +F E+  +FY 
Sbjct: 115 TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 174

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEY 280
           AE+  A+ HLH  GI++RDLKPENIL+D +GH+ LTDFGL+KE ID   ++ S CGT EY
Sbjct: 175 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 234

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLL 327
           MAPE++  +GH + ADWWS G+L++EMLTG +  +        TM+L
Sbjct: 235 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL 281

Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1. In fibroblast, is required for EGF-stimulated phosphorylation of CREB1 and histone H3 at 'Ser-10', which results in the subsequent transcriptional activation of several immediate-early genes. In response to mitogenic stimulation (EGF and PMA), phosphorylates and activates NR4A1/NUR77 and ETV1/ER81 transcription factors and the cofactor CREBBP. Upon insulin-derived signal, acts indirectly on the transcription regulation of several genes by phosphorylating GSK3B at 'Ser-9' and inhibiting its activity. Phosphorylates RPS6 in response to serum or EGF via an mTOR-independent mechanism and promotes translation initiation by facilitating assembly of the preinitiation complex. In response to insulin, phosphorylates EIF4B, enhancing EIF4B affinity for the EIF3 complex and stimulating cap-dependent translation. Is involved in the mTOR nutrient-sensing pathway by directly phosphorylating TSC2 at 'Ser-1798', which potently inhibits TSC2 ability to suppress mTOR signaling, and mediates phosphorylation of RPTOR, which regulates mTORC1 activity and may promote rapamycin-sensitive signaling independently of the PI3K/AKT pathway. Mediates cell survival by phosphorylating the pro-apoptotic proteins BAD and DAPK1 and suppressing their pro-apoptotic function. Promotes the survival of hepatic stellate cells by phosphorylating CEBPB in response to the hepatotoxin carbon tetrachloride (CCl4). Is involved in cell cycle regulation by phosphorylating the CDK inhibitor CDKN1B, which promotes CDKN1B association with 14-3-3 proteins and prevents its translocation to the nucleus and inhibition of G1 progression. In LPS-stimulated dendritic cells, is involved in TLR4-induced macropinocytosis, and in myeloma cells, acts as effector of FGFR3-mediated transformation signaling, after direct phosphorylation at Thr-529 by FGFR3. Phosphorylates DAPK1.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9UBS0|KS6B2_HUMAN Ribosomal protein S6 kinase beta-2 OS=Homo sapiens GN=RPS6KB2 PE=1 SV=2

 Score =  244 bits (622), Expect = 8e-64,   Method: Compositional matrix adjust.
 Identities = 123/230 (53%), Positives = 162/230 (70%), Gaps = 10/230 (4%)

Query: 88  IQELEHENDAELEAES----ERKIGPGDFEIFRVVGQGAFGKVFQVKK-KGVDDGDSDGI 142
           ++ + H  + EL   S      +IGP  FE+ RV+G+G +GKVFQV+K +G + G    I
Sbjct: 39  LEPVGHYEEVELTETSVNVGPERIGPHCFELLRVLGKGGYGKVFQVRKVQGTNLGK---I 95

Query: 143 YAMKVMRKDTIIKK-NHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           YAMKV+RK  I++      + +AER+IL  V HPFIV+L Y+FQT  KLYLIL+ ++GG 
Sbjct: 96  YAMKVLRKAKIVRNAKDTAHTRAERNILESVKHPFIVELAYAFQTGGKLYLILECLSGGE 155

Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           LF HL R+GIF ED A FY AEI  A+ HLH  GI++RDLKPENI++ S GH+ LTDFGL
Sbjct: 156 LFTHLEREGIFLEDTACFYLAEITLALGHLHSQGIIYRDLKPENIMLSSQGHIKLTDFGL 215

Query: 262 AKE-IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            KE I E + +++ CGT EYMAPEIL+  GHN+  DWWS+G L+Y+MLTG
Sbjct: 216 CKESIHEGAVTHTFCGTIEYMAPEILVRSGHNRAVDWWSLGALMYDMLTG 265

Phosphorylates specifically ribosomal protein S6.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P54644|KRAC_DICDI RAC family serine/threonine-protein kinase homolog OS=Dictyostelium discoideum GN=pkbA PE=1 SV=1

 Score =  240 bits (613), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 109/213 (51%), Positives = 152/213 (71%), Gaps = 7/213 (3%)

Query: 100 EAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV 159
           + +   K+G  DFE+  +VG+G+FGKV QV+KK     D+  +YAMKV+ K  I++ N V
Sbjct: 108 QPKKSEKVGVADFELLNLVGKGSFGKVIQVRKK-----DTGEVYAMKVLSKKHIVEHNEV 162

Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           ++  +ER+IL K+ HPF+V L YSFQT  KLY ILD++NGG LF+HL +   F ED+ R+
Sbjct: 163 EHTLSERNILQKINHPFLVNLNYSFQTEDKLYFILDYVNGGELFYHLQKDKKFTEDRVRY 222

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE--IDESSRSNSMCGT 277
           Y AEIV A+ HLH  G+++RDLKPEN+L+ ++GH+ +TDFGL KE  +  + ++ + CGT
Sbjct: 223 YGAEIVLALEHLHLSGVIYRDLKPENLLLTNEGHICMTDFGLCKEGLLTPTDKTGTFCGT 282

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            EY+APE+L   G+ K  DWWS G LLYEMLTG
Sbjct: 283 PEYLAPEVLQGNGYGKQVDWWSFGSLLYEMLTG 315

Predominantly involved during the aggregation to control cell polarity and chemotaxis. Phosphorylates talB, gefN, gefS, PI4P 5-kinase and gacQ.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9Z1M4|KS6B2_MOUSE Ribosomal protein S6 kinase beta-2 OS=Mus musculus GN=Rps6kb2 PE=1 SV=1

 Score =  240 bits (612), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 122/230 (53%), Positives = 160/230 (69%), Gaps = 10/230 (4%)

Query: 88  IQELEHENDAELEAES----ERKIGPGDFEIFRVVGQGAFGKVFQVKK-KGVDDGDSDGI 142
           ++ + H  + EL   S      +IGP  FE+  V+G+G +GKVFQV+K +G + G    I
Sbjct: 39  LETVGHYEEVELTESSVNLGPERIGPHCFELLSVLGKGGYGKVFQVRKVQGTNLGK---I 95

Query: 143 YAMKVMRKDTII-KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           YAMKV+RK  I+       + +AER+IL  V HPFIV+L Y+FQT  KLYLIL+ ++GG 
Sbjct: 96  YAMKVLRKAKIVCSAKDTAHTRAERNILESVKHPFIVELAYAFQTGGKLYLILECLSGGE 155

Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           LF HL R+GIF ED A FY AEI  A+ HLH  GI++RDLKPENI++ S GH+ LTDFGL
Sbjct: 156 LFTHLEREGIFLEDTACFYLAEITLALGHLHSHGIIYRDLKPENIMLSSQGHIKLTDFGL 215

Query: 262 AKE-IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            KE I E + +++ CGT EYMAPEIL+  GHN+  DWWS+G L+Y+MLTG
Sbjct: 216 CKESIHEGAITHTFCGTIEYMAPEILVRTGHNRAVDWWSLGALMYDMLTG 265

Phosphorylates specifically ribosomal protein S6.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P18652|KS6AA_CHICK Ribosomal protein S6 kinase 2 alpha OS=Gallus gallus GN=RPS6KA PE=2 SV=1

 Score =  239 bits (609), Expect = 3e-62,   Method: Compositional matrix adjust.
 Identities = 114/227 (50%), Positives = 157/227 (69%), Gaps = 4/227 (1%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
           E   K  P  FE+ +V+GQG+FGKVF V+K  +   DS+ +YAMKV++K T+  ++ V  
Sbjct: 70  EGSEKADPSQFELLKVLGQGSFGKVFLVRK--ITPPDSNHLYAMKVLKKATLKVRDRV-R 126

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
            K ERDIL  V HPF+V+L Y+FQT  KLYLILDF+ GG LF  L ++ +F E+  +FY 
Sbjct: 127 TKIERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 186

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEY 280
           AE+   + HLH  GI++RDLKPENIL+D +GH+ LTDFGL+KE ID   ++ S CGT EY
Sbjct: 187 AELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEY 246

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLL 327
           MAPE++  +GH+  ADWWS G+L++EMLTG +  +        T++L
Sbjct: 247 MAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLIL 293

Serine/threonine kinase that may play a role in mediating the growth-factor and stress induced activation of transcription.

Gallus gallus (taxid: 9031)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P67999|KS6B1_RAT Ribosomal protein S6 kinase beta-1 OS=Rattus norvegicus GN=Rps6kb1 PE=1 SV=1

 Score =  238 bits (608), Expect = 4e-62,   Method: Compositional matrix adjust.
 Identities = 115/207 (55%), Positives = 153/207 (73%), Gaps = 4/207 (1%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-NHVDYMKA 164
           KI P  FE+ RV+G+G +GKVFQV+K  V   ++  I+AMKV++K  I++      + KA
Sbjct: 85  KIRPECFELLRVLGKGGYGKVFQVRK--VTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA 142

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  L R+GIF ED A FY AEI
Sbjct: 143 ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 202

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAP 283
             A+ HLH+ GI++RDLKPENI+++  GHV LTDFGL KE I + + +++ CGT EYMAP
Sbjct: 203 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 262

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTG 310
           EIL+  GHN+  DWWS+G L+Y+MLTG
Sbjct: 263 EILMRSGHNRAVDWWSLGALMYDMLTG 289

Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation. The active form then phosphorylates and activates several substrates in the preinitiation complex, including the EIF2B complex and the cap-binding complex component EIF4B. Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis. Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR. In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2. Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling. Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function. Phosphorylates mitochondrial RMP leading to dissociation of a RMP:PPP1CC complex. The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at 'Thr-412', which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function. Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1. In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B. May be involved in cytoskeletal rearrangement through binding to neurabin.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	355
225457176	452	PREDICTED: serine/threonine-protein kina	0.853	0.670	0.727	1e-125
147817142	463	hypothetical protein VITISV_040765 [Viti	0.853	0.654	0.724	1e-124
224119194	470	predicted protein [Populus trichocarpa]	0.861	0.651	0.720	1e-124
449440730	483	PREDICTED: serine/threonine-protein kina	0.847	0.623	0.665	1e-119
449527582	486	PREDICTED: serine/threonine-protein kina	0.847	0.619	0.660	1e-119
62183960	466	putative ribosomal-protein S6 kinase-lik	0.850	0.648	0.653	1e-111
358248554	415	uncharacterized protein LOC100798259 [Gl	0.704	0.602	0.787	1e-107
168036479	470	predicted protein [Physcomitrella patens	0.785	0.593	0.617	1e-102
167999486	452	predicted protein [Physcomitrella patens	0.777	0.610	0.607	1e-101
363545243	505	putative ribosomal S6 kinase [Physcomitr	0.785	0.552	0.578	1e-100

>gi|225457176|ref|XP_002280523.1| PREDICTED: serine/threonine-protein kinase AtPK2/AtPK19-like [Vitis vinifera]

 Score =  454 bits (1169), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 232/319 (72%), Positives = 261/319 (81%), Gaps = 16/319 (5%)

Query: 6   QKNLHSLLTTKLKKLTITPPSASSPD-FDFTEVFGPLTPCRHN------NQSPASTSASL 58
           +K LHS+L +KLK   +T PS SSPD  DF++VFGPLTP  H       + S +S   +L
Sbjct: 8   KKTLHSILASKLK---LTIPSPSSPDSLDFSDVFGPLTPHHHKASPSSSSPSSSSPCVAL 64

Query: 59  GDPQVIHNRSHSFVGPSPRYALSSSL-PLQIQELEHENDAELEAE---SERKIGPGDFEI 114
           GDPQVIHNRSHS +GPSPR+A+++ L P +   +     ++ E      E ++GPGDFEI
Sbjct: 65  GDPQVIHNRSHSLLGPSPRFAVTAPLLPFKEDMVFQSEGSDKEGGDEVGEGRVGPGDFEI 124

Query: 115 FRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV 172
            RVVG+GAFGKVFQV+KKG  +  GDSDGI+AMKVMRKDTII KNH+DYMKAERDIL KV
Sbjct: 125 MRVVGKGAFGKVFQVRKKGGPEISGDSDGIFAMKVMRKDTIISKNHMDYMKAERDILIKV 184

Query: 173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
            HPFIV LR SFQT SKLYLI+DF+NGGHLFFHLYRQGIF EDQAR Y AEIVSAVSHLH
Sbjct: 185 EHPFIVSLRCSFQTNSKLYLIMDFVNGGHLFFHLYRQGIFSEDQARVYIAEIVSAVSHLH 244

Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN 292
           K GIVHRDLKPENILMD+DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN
Sbjct: 245 KSGIVHRDLKPENILMDADGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN 304

Query: 293 KDADWWSVGILLYEMLTGQ 311
           KDADWWS+GILLYEMLTGQ
Sbjct: 305 KDADWWSIGILLYEMLTGQ 323

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147817142|emb|CAN77683.1| hypothetical protein VITISV_040765 [Vitis vinifera]

 Score =  451 bits (1161), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 231/319 (72%), Positives = 260/319 (81%), Gaps = 16/319 (5%)

Query: 6   QKNLHSLLTTKLKKLTITPPSASSPD-FDFTEVFGPLTPCRHN------NQSPASTSASL 58
           +K LHS+L +KLK   +T PS SSPD  DF++VFGPLTP  H       + S +S   +L
Sbjct: 8   KKTLHSILASKLK---LTIPSPSSPDSLDFSDVFGPLTPHHHKASPSSSSPSSSSPCVAL 64

Query: 59  GDPQVIHNRSHSFVGPSPRYALSSSL-PLQIQELEHENDAELEAE---SERKIGPGDFEI 114
           GDPQVIHNRSHS +GPSPR+A+++ L P +   +     ++ E      E ++GPGDFEI
Sbjct: 65  GDPQVIHNRSHSLLGPSPRFAVTAPLLPFKEDMVFQSEGSDKEGGDEVGEGRVGPGDFEI 124

Query: 115 FRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV 172
            RVVG+GAFGKVFQV+KKG  +  GDSDGI+AMKVMRKDTII KNH+DYMKAERDIL KV
Sbjct: 125 MRVVGKGAFGKVFQVRKKGGPEISGDSDGIFAMKVMRKDTIISKNHMDYMKAERDILIKV 184

Query: 173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
            HPFIV LR  FQT SKLYLI+DF+NGGHLFFHLYRQGIF EDQAR Y AEIVSAVSHLH
Sbjct: 185 EHPFIVSLRCFFQTNSKLYLIMDFVNGGHLFFHLYRQGIFSEDQARVYIAEIVSAVSHLH 244

Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN 292
           K GIVHRDLKPENILMD+DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN
Sbjct: 245 KSGIVHRDLKPENILMDADGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN 304

Query: 293 KDADWWSVGILLYEMLTGQ 311
           KDADWWS+GILLYEMLTGQ
Sbjct: 305 KDADWWSIGILLYEMLTGQ 323

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224119194|ref|XP_002318010.1| predicted protein [Populus trichocarpa] gi|222858683|gb|EEE96230.1| predicted protein [Populus trichocarpa]

 Score =  451 bits (1160), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 245/340 (72%), Positives = 269/340 (79%), Gaps = 34/340 (10%)

Query: 1   MVSTSQKN-LHSLLTTKLKKLTITPPSASSPDFDFTEVFGPL-TPCRHNNQSPASTSASL 58
           +VSTSQK  L SLL+  LKKLTITPP+    D +F++VFGP  TP   N+    STS+S+
Sbjct: 6   LVSTSQKKTLLSLLSINLKKLTITPPN----DLEFSDVFGPSSTPHDPNHSHSPSTSSSV 61

Query: 59  GDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAES--------------- 103
            DP VIHNRSHSFVGPSPRY L SS PL    ++ +++A +E ES               
Sbjct: 62  LDPPVIHNRSHSFVGPSPRYPLPSS-PLPFHHIQEDDEAVIENESCDNEKGKSEDDEGQV 120

Query: 104 -----ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-------IYAMKVMRKD 151
                  KIGP DFEI RVVG+GAFGKVFQV+KK  D  +  G       IYAMKVMRKD
Sbjct: 121 GSCGNNNKIGPADFEILRVVGKGAFGKVFQVRKKTGDGKEKGGGGGSGDGIYAMKVMRKD 180

Query: 152 TIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI 211
           TIIKK HVDYMKAERDILTKV HPFIVQLRYSFQT+SKLYLILDF+NGGHLFFHLYRQGI
Sbjct: 181 TIIKKKHVDYMKAERDILTKVVHPFIVQLRYSFQTKSKLYLILDFMNGGHLFFHLYRQGI 240

Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS 271
           F EDQARFYTAEIVSAV+HLHKCGIVHRDLKPENIL+D+DGHV+LTDFGLAKEIDESSRS
Sbjct: 241 FSEDQARFYTAEIVSAVAHLHKCGIVHRDLKPENILLDADGHVLLTDFGLAKEIDESSRS 300

Query: 272 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ
Sbjct: 301 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 340

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449440730|ref|XP_004138137.1| PREDICTED: serine/threonine-protein kinase AtPK2/AtPK19-like [Cucumis sativus]

 Score =  435 bits (1119), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 241/362 (66%), Positives = 264/362 (72%), Gaps = 61/362 (16%)

Query: 1   MVSTS-QKNLHSLLTTKLKKLTITPPSASSP---------DFDFTEVFGPLTPCRHNNQS 50
           MVS S QKN+HSLL   L KLTI   S+SS          DFDF +VFGP  P       
Sbjct: 1   MVSASIQKNMHSLLVANLTKLTIPSSSSSSSPSASAAAVHDFDFNDVFGPTNP------- 53

Query: 51  PASTSASLGDPQ--------VIHNRSHSFVGPSPRYALSSSLPLQIQELEHE-------- 94
             S S+  GDPQ        VIHNRSHSFVGPSPR    +SLP   +E++ +        
Sbjct: 54  --SPSSFHGDPQHHEQQQPVVIHNRSHSFVGPSPRLTPPASLPF-FREVDSQSEGEEEEE 110

Query: 95  --NDAEL------EAESER--------------KIGPGDFEIFRVVGQGAFGKVFQVKKK 132
             ND E+      + E +R              KIG GDF+I RVVG+GAFGKVF V+KK
Sbjct: 111 EENDLEISTRDGAQEEEKRVGETENCSGENVQGKIGVGDFDILRVVGKGAFGKVFLVRKK 170

Query: 133 GVDDG---DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189
           G   G   D+D IYAMKVMRKDTIIKKNHVDYMKAERDILTKV HPFIVQLRYSFQT+SK
Sbjct: 171 GNCKGNGSDNDEIYAMKVMRKDTIIKKNHVDYMKAERDILTKVAHPFIVQLRYSFQTKSK 230

Query: 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD 249
           LYLILDFINGGHLF+HLYRQGIF EDQAR Y AEIVSAVSHLH CGIVHRDLKPENILMD
Sbjct: 231 LYLILDFINGGHLFYHLYRQGIFSEDQARVYAAEIVSAVSHLHNCGIVHRDLKPENILMD 290

Query: 250 SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           +DGHV+LTDFGLAKEIDESSRSNS+CGTTEYMAPEILLS+GHNKDADWWSVGILLYEML+
Sbjct: 291 ADGHVVLTDFGLAKEIDESSRSNSLCGTTEYMAPEILLSRGHNKDADWWSVGILLYEMLS 350

Query: 310 GQ 311
           GQ
Sbjct: 351 GQ 352

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449527582|ref|XP_004170789.1| PREDICTED: serine/threonine-protein kinase AtPK2/AtPK19-like [Cucumis sativus]

 Score =  434 bits (1116), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 241/365 (66%), Positives = 264/365 (72%), Gaps = 64/365 (17%)

Query: 1   MVSTS-QKNLHSLLTTKLKKLTITPPSASSP------------DFDFTEVFGPLTPCRHN 47
           MVS S QKN+HSLL   L KLTI   S+SS             DFDF +VFGP  P    
Sbjct: 1   MVSASIQKNMHSLLVANLTKLTIPSSSSSSSPSASAAAAAAVHDFDFNDVFGPTNP---- 56

Query: 48  NQSPASTSASLGDPQ--------VIHNRSHSFVGPSPRYALSSSLPLQIQELEHE----- 94
                S S+  GDPQ        VIHNRSHSFVGPSPR    +SLP   +E++ +     
Sbjct: 57  -----SPSSFHGDPQHHEQQQPVVIHNRSHSFVGPSPRLTPPASLPF-FREVDSQSEGEE 110

Query: 95  -----NDAEL------EAESER--------------KIGPGDFEIFRVVGQGAFGKVFQV 129
                ND E+      + E +R              KIG GDF+I RVVG+GAFGKVF V
Sbjct: 111 EEEEENDLEISTRDGAQEEEKRVGETENCSGENVQGKIGVGDFDILRVVGKGAFGKVFLV 170

Query: 130 KKKGVDDG---DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186
           +KKG   G   D+D IYAMKVMRKDTIIKKNHVDYMKAERDILTKV HPFIVQLRYSFQT
Sbjct: 171 RKKGNCKGNGSDNDEIYAMKVMRKDTIIKKNHVDYMKAERDILTKVAHPFIVQLRYSFQT 230

Query: 187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI 246
           +SKLYLILDFINGGHLF+HLYRQGIF EDQAR Y AEIVSAVSHLH CGIVHRDLKPENI
Sbjct: 231 KSKLYLILDFINGGHLFYHLYRQGIFSEDQARVYAAEIVSAVSHLHNCGIVHRDLKPENI 290

Query: 247 LMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYE 306
           LMD+DGHV+LTDFGLAKEIDESSRSNS+CGTTEYMAPEILLS+GHNKDADWWSVGILLYE
Sbjct: 291 LMDADGHVVLTDFGLAKEIDESSRSNSLCGTTEYMAPEILLSRGHNKDADWWSVGILLYE 350

Query: 307 MLTGQ 311
           ML+GQ
Sbjct: 351 MLSGQ 355

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|62183960|gb|AAX73301.1| putative ribosomal-protein S6 kinase-like protein [Solanum lycopersicum]

 Score =  407 bits (1046), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 223/341 (65%), Positives = 254/341 (74%), Gaps = 39/341 (11%)

Query: 2   VSTSQKNLHSLLTTKLKKLTITPPSASSPD------FDFTEVFGPLTPCRHNNQSPASTS 55
            +  +K +HS+L  KL  L I   S+SS        FDF++VFG  T       SP+S+S
Sbjct: 4   AAQQKKAIHSMLANKLTHLKIPDSSSSSSPPPTDPDFDFSDVFGAPT-------SPSSSS 56

Query: 56  ASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAEL---------------- 99
           + L DPQ+IH+RSHSFVGPSPR  LS  LP   QE++ E +++                 
Sbjct: 57  SFLTDPQIIHSRSHSFVGPSPRITLSKPLPFH-QEVDSEGESDSDKVNTHVGTHQTECSD 115

Query: 100 --------EAESERKIGPGDFEIFRVVGQGAFGKVFQVK-KKGVDDGDSDGIYAMKVMRK 150
                   E  +  K GPGDFEI R++G+G+FGKVFQVK K    +G+ DGI AMKVMRK
Sbjct: 116 GIEEISGDEGSAVTKFGPGDFEILRMIGKGSFGKVFQVKMKGYGGEGEGDGILAMKVMRK 175

Query: 151 DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG 210
           DT+IK NHVDYM+AERDILTKV HPFIVQLRYSFQT+SKLYLILDFINGGHLF+HLYRQG
Sbjct: 176 DTVIKNNHVDYMRAERDILTKVEHPFIVQLRYSFQTKSKLYLILDFINGGHLFYHLYRQG 235

Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR 270
           IF EDQAR Y AEIVSAVSHLH+ GIVHRDLKPENILMD DGHVMLTDFGLAKEIDESSR
Sbjct: 236 IFSEDQARIYAAEIVSAVSHLHQRGIVHRDLKPENILMDGDGHVMLTDFGLAKEIDESSR 295

Query: 271 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           SNSMCGT EYMAPEI+ SKGHNKDADWWSVG+LLYEMLTGQ
Sbjct: 296 SNSMCGTMEYMAPEIIQSKGHNKDADWWSVGVLLYEMLTGQ 336

Source: Solanum lycopersicum

Species: Solanum lycopersicum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|358248554|ref|NP_001239901.1| uncharacterized protein LOC100798259 [Glycine max] gi|255634893|gb|ACU17805.1| unknown [Glycine max]

 Score =  392 bits (1008), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 200/254 (78%), Positives = 215/254 (84%), Gaps = 4/254 (1%)

Query: 62  QVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELE---AESERKIGPGDFEIFRVV 118
            VI +RSHSFVGPSPR+ + SS PL   E E E + E E        KIGP DF I RVV
Sbjct: 31  HVIFSRSHSFVGPSPRF-VPSSTPLFFLEEEEEEEEEEELPFGPDPPKIGPSDFHILRVV 89

Query: 119 GQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIV 178
           GQGAFGKVF V+KKG    D+DG++AMKVMRKDTIIKKNHVDYMKAERDILTKV HPFIV
Sbjct: 90  GQGAFGKVFLVRKKGDCFDDADGVFAMKVMRKDTIIKKNHVDYMKAERDILTKVLHPFIV 149

Query: 179 QLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVH 238
           QLRYSFQT+SKLYL+LDFINGGHLFF LYRQGIF EDQAR YTAEIVSAVSHLHK GIVH
Sbjct: 150 QLRYSFQTKSKLYLVLDFINGGHLFFQLYRQGIFSEDQARLYTAEIVSAVSHLHKNGIVH 209

Query: 239 RDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           RDLKPENILMD+DGHVMLTDFGL+KEI+E  RSNS CGT EYMAPEILL+KGHNKDADWW
Sbjct: 210 RDLKPENILMDADGHVMLTDFGLSKEINELGRSNSFCGTVEYMAPEILLAKGHNKDADWW 269

Query: 299 SVGILLYEMLTGQV 312
           SVGILLYEMLTG+ 
Sbjct: 270 SVGILLYEMLTGKA 283

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|168036479|ref|XP_001770734.1| predicted protein [Physcomitrella patens subsp. patens] gi|162677952|gb|EDQ64416.1| predicted protein [Physcomitrella patens subsp. patens]

 Score =  376 bits (966), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 195/316 (61%), Positives = 228/316 (72%), Gaps = 37/316 (11%)

Query: 25  PSASSPDFDFTEVFGPLTPCRHNNQSPASTSAS-----------LGDPQVIHNRSHSFVG 73
           P   + ++DF++VFG + P   +N  P    A            L DP V+++RSHS VG
Sbjct: 28  PDQLNEEYDFSDVFGHVQP---HNTPPLLVVAEDVDTIEWGPELLQDPVVVYSRSHSLVG 84

Query: 74  PSPRYAL-------------SSSLPLQIQELEHENDAELEAESER-----KIGPGDFEIF 115
           PSP+ +L             SSS   +    E E D  L  E E+     K+GP DFE+ 
Sbjct: 85  PSPKLSLTRSHNKSACDEQGSSSAIEEAISFERECDEHLPKELEKGNGVEKLGPQDFELL 144

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           RVVGQGAFGKVFQV+KKG  +     IYAMKVMRK+ II++NH DYMKAERDILTKV HP
Sbjct: 145 RVVGQGAFGKVFQVQKKGTSE-----IYAMKVMRKEKIIERNHGDYMKAERDILTKVVHP 199

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
           FIVQL+YSFQT+SKLYL+LDFINGGHLFF L+RQG F ED AR YTAEIV AV+HLH+ G
Sbjct: 200 FIVQLQYSFQTKSKLYLVLDFINGGHLFFQLFRQGTFNEDLARMYTAEIVLAVAHLHENG 259

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDA 295
           I+HRDLKPENIL+D+DGHVMLTDFGLAKE+ E S SNS+CGT EYMAPEI+LSKGH K A
Sbjct: 260 IIHRDLKPENILLDADGHVMLTDFGLAKEVKEDSHSNSLCGTIEYMAPEIILSKGHGKAA 319

Query: 296 DWWSVGILLYEMLTGQ 311
           DWWSVGILLYEMLTGQ
Sbjct: 320 DWWSVGILLYEMLTGQ 335

Source: Physcomitrella patens subsp. patens

Species: Physcomitrella patens

Genus: Physcomitrella

Family: Funariaceae

Order: Funariales

Class: Bryopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|167999486|ref|XP_001752448.1| predicted protein [Physcomitrella patens subsp. patens] gi|162696348|gb|EDQ82687.1| predicted protein [Physcomitrella patens subsp. patens]

 Score =  375 bits (963), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 195/321 (60%), Positives = 229/321 (71%), Gaps = 45/321 (14%)

Query: 25  PSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLG-----------DPQVIHNRSHSFVG 73
           P   + +FDF++VFGP+ P   +  SP    A  G           DP V+++RSHS VG
Sbjct: 8   PDQCNEEFDFSDVFGPVPP---HPTSPLPAVAEDGETIDWSLELRQDPVVVYSRSHSLVG 64

Query: 74  PSPRYALSSSLPLQIQELEHENDA-----------------ELEAE------SERKIGPG 110
           PSP+ +L+    LQ + +  E D+                 EL ++         K+GP 
Sbjct: 65  PSPKPSLTR---LQSKPVWDEQDSLSLVRVASDSPTVHEVGELTSKDFVNGIGTEKLGPQ 121

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE+ RVVGQGAFGKVFQV+KKG  +     IYAMKVMRK+ II++NH DYMKAERDILT
Sbjct: 122 DFELLRVVGQGAFGKVFQVQKKGTSE-----IYAMKVMRKEKIIERNHGDYMKAERDILT 176

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           KV HPFIVQL+YSFQT+SKLYL+LDFINGGHLFF LYRQG F ED AR YTAEIV AV+H
Sbjct: 177 KVVHPFIVQLQYSFQTQSKLYLVLDFINGGHLFFQLYRQGTFNEDLARMYTAEIVLAVAH 236

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
           LHK GI+HRDLKPENIL+D DG+VMLTDFGLAKE+ E S SNS+CGT EYMAPEI+LSKG
Sbjct: 237 LHKNGIIHRDLKPENILLDGDGYVMLTDFGLAKEVKEDSHSNSLCGTMEYMAPEIILSKG 296

Query: 291 HNKDADWWSVGILLYEMLTGQ 311
           H K ADWWSVGILLYEMLTGQ
Sbjct: 297 HGKPADWWSVGILLYEMLTGQ 317

Source: Physcomitrella patens subsp. patens

Species: Physcomitrella patens

Genus: Physcomitrella

Family: Funariaceae

Order: Funariales

Class: Bryopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|363545243|gb|AEW26787.1| putative ribosomal S6 kinase [Physcomitrella patens]

 Score =  370 bits (950), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 198/342 (57%), Positives = 231/342 (67%), Gaps = 63/342 (18%)

Query: 25  PSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLG-----------DPQVIHNRSHSFVG 73
           P   + +FDF++VFGP+ P   +  SP    A  G           DP V+++RSHS VG
Sbjct: 37  PDQCNEEFDFSDVFGPVPP---HPTSPLPAVAEDGETIDWSLELRQDPVVVYSRSHSLVG 93

Query: 74  PSPRYALS-----------SSLPL-----------QIQEL-----------------EHE 94
           PSP+ +L+            SL L           ++ EL                 E E
Sbjct: 94  PSPKPSLTRLQSKPVWDEQDSLSLVRVASDSPTVHEVGELTSKVTEQALSDSGGSGSELE 153

Query: 95  NDAELEAE-----SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR 149
            D  L+ +        K+GP DFE+ RVVGQGAFGKVFQV+KKG  +     IYAMKVMR
Sbjct: 154 GDNHLQKDFVNGIGTEKLGPQDFELLRVVGQGAFGKVFQVQKKGTSE-----IYAMKVMR 208

Query: 150 KDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ 209
           K+ II++NH DYMKAERDILTKV HPFIVQL+YSFQT+SKLYL+LDFINGGHLFF LYRQ
Sbjct: 209 KEKIIERNHGDYMKAERDILTKVVHPFIVQLQYSFQTQSKLYLVLDFINGGHLFFQLYRQ 268

Query: 210 GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS 269
           G F ED AR YTAEIV AV+HLHK GI+HRDLKPENIL+D DG+VMLTDFGLAKE+ E S
Sbjct: 269 GTFNEDLARMYTAEIVLAVAHLHKNGIIHRDLKPENILLDGDGYVMLTDFGLAKEVKEDS 328

Query: 270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
            SNS+CGT EYMAPEI+LSKGH K ADWWSVGILLYEMLTGQ
Sbjct: 329 HSNSLCGTMEYMAPEIILSKGHGKPADWWSVGILLYEMLTGQ 370

Source: Physcomitrella patens

Species: Physcomitrella patens

Genus: Physcomitrella

Family: Funariaceae

Order: Funariales

Class: Bryopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	355
TAIR|locus:2077873	465	PK1 "protein-serine kinase 1"	0.605	0.462	0.681	1.3e-84
TAIR|locus:2077843	471	S6K2 "serine/threonine protein	0.777	0.585	0.572	6.8e-79
DICTYBASE|DDB_G0290157	479	pkgB "SGK family protein kinas	0.602	0.446	0.5	3.3e-56
UNIPROTKB|J9NU84	482	RPS6KB2 "Uncharacterized prote	0.690	0.508	0.480	1.4e-55
UNIPROTKB|E1BZK5	364	SGK2 "Uncharacterized protein"	0.554	0.541	0.495	1.6e-55
ZFIN|ZDB-GENE-070209-74	739	rps6ka3b "ribosomal protein S6	0.681	0.327	0.465	1.8e-55
UNIPROTKB|F1NLJ3	697	RPS6KA3 "Uncharacterized prote	0.628	0.319	0.484	1.8e-55
UNIPROTKB|E2RP04	712	RPS6KA3 "Uncharacterized prote	0.628	0.313	0.480	4.8e-55
UNIPROTKB|B4DG22	711	RPS6KA3 "cDNA FLJ56618, highly	0.628	0.313	0.480	4.8e-55
UNIPROTKB|B7ZB17	712	RPS6KA3 "cDNA, FLJ79381, highl	0.628	0.313	0.480	4.8e-55

TAIR|locus:2077873 PK1 "protein-serine kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 788 (282.4 bits), Expect = 1.3e-84, Sum P(2) = 1.3e-84
 Identities = 152/223 (68%), Positives = 179/223 (80%)

Query:    92 EHENDAELEAESERK---IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVM 148
             + +N+  LE +  +    +G  DFE+ +VVG+GAF                  IYAMKVM
Sbjct:   111 DSDNEKALEGDLVKVSGVVGIDDFEVMKVVGKGAFGKVYQVRKKETSE-----IYAMKVM 165

Query:   149 RKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR 208
             RKD I++KNH +YMKAERDILTK+ HPFIVQL+YSFQT+ +LYL+LDFINGGHLFF LY 
Sbjct:   166 RKDHIMEKNHAEYMKAERDILTKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHLFFQLYH 225

Query:   209 QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES 268
             QG+FRED AR YTAEIVSAVSHLH+ GI+HRDLKPENILMD+DGHVMLTDFGLAKE +E+
Sbjct:   226 QGLFREDLARVYTAEIVSAVSHLHEKGIMHRDLKPENILMDTDGHVMLTDFGLAKEFEEN 285

Query:   269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
             +RSNSMCGTTEYMAPEI+  KGH+K ADWWSVGILLYEMLTG+
Sbjct:   286 TRSNSMCGTTEYMAPEIVRGKGHDKAADWWSVGILLYEMLTGK 328

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005737 "cytoplasm" evidence=IDA

GO:0006970 "response to osmotic stress" evidence=IMP;IDA

GO:0045727 "positive regulation of translation" evidence=RCA;TAS

GO:0009409 "response to cold" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

TAIR|locus:2077843 S6K2 "serine/threonine protein kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 793 (284.2 bits), Expect = 6.8e-79, P = 6.8e-79
 Identities = 173/302 (57%), Positives = 206/302 (68%)

Query:    31 DFDFTEVFGPLTP------CRHNNQSPA---STSASLGDPQVIHNRSHSFVGPSPRYALS 81
             +  F++VFGP+        C      PA   S S SL  P ++ + S      + R    
Sbjct:    38 ELQFSDVFGPMPEANSEEACDVAYDEPAVVYSRSHSLVGPSLVVSHSLKMNKLTLRETED 97

Query:    82 SSLPLQIQELEH--END---AELEAESERK-------IGPGDFEIFRVVGQGAFXXXXXX 129
             S   ++  E E   END      + +SE+        +G  DFE+ +VVGQGAF      
Sbjct:    98 SVDLVECVEGESIKENDEFSGNDDTDSEKSPEEVSGVVGIEDFEVLKVVGQGAFGKVYQV 157

Query:   130 XXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189
                         IYAMKVMRKD I++KNH +YMKAERDILTK+ HPFIVQL+YSFQT+ +
Sbjct:   158 RKKDTSE-----IYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFIVQLKYSFQTKYR 212

Query:   190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD 249
             LYL+LDFINGGHLFF LY QG+FRED AR YTAEIVSAVSHLH+ GI+HRDLKPENILMD
Sbjct:   213 LYLVLDFINGGHLFFQLYHQGLFREDLARVYTAEIVSAVSHLHEKGIMHRDLKPENILMD 272

Query:   250 SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
              DGHVMLTDFGLAKE +E++RSNSMCGTTEYMAPEI+  KGH+K ADWWSVGILLYEMLT
Sbjct:   273 VDGHVMLTDFGLAKEFEENTRSNSMCGTTEYMAPEIVRGKGHDKAADWWSVGILLYEMLT 332

Query:   310 GQ 311
             G+
Sbjct:   333 GK 334

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0045727 "positive regulation of translation" evidence=RCA;TAS

GO:0009409 "response to cold" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0009408 "response to heat" evidence=IEP

DICTYBASE|DDB_G0290157 pkgB "SGK family protein kinase PkgB" [Dictyostelium discoideum (taxid:44689)]

 Score = 579 (208.9 bits), Expect = 3.3e-56, P = 3.3e-56
 Identities = 110/220 (50%), Positives = 152/220 (69%)

Query:    92 EHENDAE-LEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRK 150
             E E   E + +++++     DFE+  V+G+G+F                  I+AMKV+RK
Sbjct:   132 EDEGPEEVIFSKNKQSATKDDFELLNVIGKGSFGKVMQVKKKGEDK-----IFAMKVLRK 186

Query:   151 DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG 210
             D II +  V++ K+E+ IL  ++HPFIV L Y+FQT+ KLY++LDF+NGG LFFHL R+G
Sbjct:   187 DAIIARKQVNHTKSEKTILQCISHPFIVNLHYAFQTKDKLYMVLDFVNGGELFFHLKREG 246

Query:   211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR 270
              F E + + Y AEIVSA+ HLHK  IV+RDLKPENIL+DS+GH+ +TDFGL+K+I+ +  
Sbjct:   247 RFSEPRVKIYAAEIVSALDHLHKQDIVYRDLKPENILLDSEGHICITDFGLSKKIETTDG 306

Query:   271 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
             + + CGT EY+APE+L   GH    DWWS+G LLYEMLTG
Sbjct:   307 TFTFCGTPEYLAPEVLNGHGHGCAVDWWSLGTLLYEMLTG 346

GO:0006468 "protein phosphorylation" evidence=IEA;IGI;IDA

GO:0043327 "chemotaxis to cAMP" evidence=IGI

GO:0031288 "sorocarp morphogenesis" evidence=IMP

GO:0005886 "plasma membrane" evidence=IEA;IDA

GO:0004691 "cAMP-dependent protein kinase activity" evidence=IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0006935 "chemotaxis" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0044351 "macropinocytosis" evidence=RCA

UNIPROTKB|J9NU84 RPS6KB2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 573 (206.8 bits), Expect = 1.4e-55, P = 1.4e-55
 Identities = 124/258 (48%), Positives = 163/258 (63%)

Query:    57 SLGDPQVIHNRSHSFVGPSPRYALSSSLPL-QIQELE-HENDAELEAESERKIGPGDFEI 114
             S G+P+     S S  GP P      + P+   +E+E  E    L  E   +IGP  FE+
Sbjct:    15 SEGEPEF----SPSVSGPPPPLTSCINRPVGHCEEVELTETSVNLGPE---RIGPHCFEL 67

Query:   115 FRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKK-NHVDYMKAERDILTKVT 173
              RV+G+G +                  IYAMKV+RK  I++      + +AER+IL  V 
Sbjct:    68 LRVLGKGGYGKVFQVRKVQGTNLGK--IYAMKVLRKAKIVRNAKDTAHTRAERNILESVK 125

Query:   174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
             HPFIV+L Y+FQT  KLYLIL+ ++GG LF HL R+GIF ED A FY AEI  A+ HLH 
Sbjct:   126 HPFIVELAYAFQTGGKLYLILECLSGGELFTHLEREGIFLEDTACFYLAEITLALGHLHS 185

Query:   234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHN 292
              GI++RDLKPENI+++S GH+ LTDFGL KE I E + +++ CGT EYMAPEIL+  GHN
Sbjct:   186 QGIIYRDLKPENIMLNSQGHIKLTDFGLCKESIHEGAVTHTFCGTIEYMAPEILVRSGHN 245

Query:   293 KDADWWSVGILLYEMLTG 310
             +  DWWS+G L+Y+MLTG
Sbjct:   246 RAVDWWSLGALMYDMLTG 263

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

UNIPROTKB|E1BZK5 SGK2 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 546 (197.3 bits), Expect = 1.6e-55, Sum P(2) = 1.6e-55
 Identities = 101/204 (49%), Positives = 140/204 (68%)

Query:   109 PGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDI 168
             P DF+  +V+G+G+F                   YA+KV+ K TI+KK   +++ AER++
Sbjct:    32 PTDFDFLKVIGKGSFGKVLLAKRKSDGT-----FYAVKVLHKKTILKKKEQNHIMAERNV 86

Query:   169 LTK-VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
             L K V HPF+V L YSFQT  KLY +LD++NGG LFFHL R+  FRE +ARFY AE+ SA
Sbjct:    87 LLKNVKHPFLVGLHYSFQTSEKLYFVLDYVNGGELFFHLQRERCFREPRARFYAAEVASA 146

Query:   228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEIL 286
             + +LH   I++RDLKPENIL+D  GHV+LTDFGL KE ++E   +++ CGT EY+APE+L
Sbjct:   147 IGYLHSLNIIYRDLKPENILLDCQGHVVLTDFGLCKEGMEEEETTSTFCGTPEYLAPEVL 206

Query:   287 LSKGHNKDADWWSVGILLYEMLTG 310
               + +++  DWW +G +LYEML G
Sbjct:   207 KKQPYDRTVDWWCLGAVLYEMLFG 230

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0015459 "potassium channel regulator activity" evidence=IEA

ZFIN|ZDB-GENE-070209-74 rps6ka3b "ribosomal protein S6 kinase, polypeptide 3b" [Danio rerio (taxid:7955)]

 Score = 572 (206.4 bits), Expect = 1.8e-55, P = 1.8e-55
 Identities = 116/249 (46%), Positives = 157/249 (63%)

Query:    80 LSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXX 139
             LS    + ++E+   N   L  E   K  P  FE+ +V+GQG+F                
Sbjct:    38 LSCQEEVSVKEI---NITHLVKEGSEKADPQQFELRKVLGQGSFGKVFLVKKTTGPDAGQ 94

Query:   140 XXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
               +YAMKV++K T+  ++ V   K ERDIL +V HPFIV+L Y+FQT  KLYLILDF+ G
Sbjct:    95 --LYAMKVLKKATLKVRDQVR-TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRG 151

Query:   200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF 259
             G LF  L ++ +F E+  +FY AE+  A+ HLH  GI++RDLKPENIL+D DGH+ LTDF
Sbjct:   152 GDLFTRLSKEVMFTEEDVKFYLAELALALDHLHGLGIIYRDLKPENILLDEDGHIKLTDF 211

Query:   260 GLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQ 318
             GL+KE ID  +++ S CGT EYMAPE++  +GH   ADWWS G+L+YEMLTG +  +   
Sbjct:   212 GLSKESIDHENKAYSFCGTVEYMAPEVVNRRGHTYSADWWSYGVLMYEMLTGTLPFQGKD 271

Query:   319 VIACNTMLL 327
                  TM+L
Sbjct:   272 RKETMTMIL 280

GO:0000287 "magnesium ion binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007243 "intracellular protein kinase cascade" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

UNIPROTKB|F1NLJ3 RPS6KA3 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 572 (206.4 bits), Expect = 1.8e-55, P = 1.8e-55
 Identities = 110/227 (48%), Positives = 148/227 (65%)

Query:   102 ESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDY 161
             E   K  P  FE+ +V+GQG+F                  +YAMKV++K T+  ++ V  
Sbjct:    15 EGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQ--LYAMKVLKKATLKVRDRVR- 71

Query:   162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
              K ERDIL +V HPFIV+L Y+FQT  KLYLILDF+ GG LF  L ++ +F ED  +FY 
Sbjct:    72 TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEDDVKFYL 131

Query:   222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEY 280
             AE+  A+ HLH  GI++RDLKPENIL+D +GH+ LTDFGL+KE ID   ++ S CGT EY
Sbjct:   132 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 191

Query:   281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLL 327
             MAPE++  +GH + ADWWS G+L++EMLTG +  +        TM+L
Sbjct:   192 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL 238

GO:0000287 "magnesium ion binding" evidence=IEA

GO:0007243 "intracellular protein kinase cascade" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0002224 "toll-like receptor signaling pathway" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0019901 "protein kinase binding" evidence=IEA

GO:0032496 "response to lipopolysaccharide" evidence=IEA

GO:0043027 "cysteine-type endopeptidase inhibitor activity involved in apoptotic process" evidence=IEA

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IEA

UNIPROTKB|E2RP04 RPS6KA3 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 568 (205.0 bits), Expect = 4.8e-55, P = 4.8e-55
 Identities = 109/227 (48%), Positives = 148/227 (65%)

Query:   102 ESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDY 161
             E   K  P  FE+ +V+GQG+F                  +YAMKV++K T+  ++ V  
Sbjct:    30 EGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQ--LYAMKVLKKATLKVRDRVR- 86

Query:   162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
              K ERDIL +V HPFIV+L Y+FQT  KLYLILDF+ GG LF  L ++ +F E+  +FY 
Sbjct:    87 TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 146

Query:   222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEY 280
             AE+  A+ HLH  GI++RDLKPENIL+D +GH+ LTDFGL+KE ID   ++ S CGT EY
Sbjct:   147 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 206

Query:   281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLL 327
             MAPE++  +GH + ADWWS G+L++EMLTG +  +        TM+L
Sbjct:   207 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL 253

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IEA

GO:0043027 "cysteine-type endopeptidase inhibitor activity involved in apoptotic process" evidence=IEA

GO:0032496 "response to lipopolysaccharide" evidence=IEA

GO:0019901 "protein kinase binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0002224 "toll-like receptor signaling pathway" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0007243 "intracellular protein kinase cascade" evidence=IEA

GO:0000287 "magnesium ion binding" evidence=IEA

UNIPROTKB|B4DG22 RPS6KA3 "cDNA FLJ56618, highly similar to Ribosomal protein S6 kinase alpha-3 (EC 2.7.11.1)" [Homo sapiens (taxid:9606)]

 Score = 568 (205.0 bits), Expect = 4.8e-55, P = 4.8e-55
 Identities = 109/227 (48%), Positives = 148/227 (65%)

Query:   102 ESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDY 161
             E   K  P  FE+ +V+GQG+F                  +YAMKV++K T+  ++ V  
Sbjct:    30 EGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQ--LYAMKVLKKATLKVRDRVR- 86

Query:   162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
              K ERDIL +V HPFIV+L Y+FQT  KLYLILDF+ GG LF  L ++ +F E+  +FY 
Sbjct:    87 TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 146

Query:   222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEY 280
             AE+  A+ HLH  GI++RDLKPENIL+D +GH+ LTDFGL+KE ID   ++ S CGT EY
Sbjct:   147 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 206

Query:   281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLL 327
             MAPE++  +GH + ADWWS G+L++EMLTG +  +        TM+L
Sbjct:   207 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL 253

GO:0000287 "magnesium ion binding" evidence=IEA

GO:0007243 "intracellular protein kinase cascade" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005840 "ribosome" evidence=IEA

UNIPROTKB|B7ZB17 RPS6KA3 "cDNA, FLJ79381, highly similar to Ribosomal protein S6 kinase alpha-3 (EC 2.7.11.1)" [Homo sapiens (taxid:9606)]

 Score = 568 (205.0 bits), Expect = 4.8e-55, P = 4.8e-55
 Identities = 109/227 (48%), Positives = 148/227 (65%)

Query:   102 ESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDY 161
             E   K  P  FE+ +V+GQG+F                  +YAMKV++K T+  ++ V  
Sbjct:    30 EGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQ--LYAMKVLKKATLKVRDRVR- 86

Query:   162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
              K ERDIL +V HPFIV+L Y+FQT  KLYLILDF+ GG LF  L ++ +F E+  +FY 
Sbjct:    87 TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 146

Query:   222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEY 280
             AE+  A+ HLH  GI++RDLKPENIL+D +GH+ LTDFGL+KE ID   ++ S CGT EY
Sbjct:   147 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 206

Query:   281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLL 327
             MAPE++  +GH + ADWWS G+L++EMLTG +  +        TM+L
Sbjct:   207 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL 253

GO:0000287 "magnesium ion binding" evidence=IEA

GO:0007243 "intracellular protein kinase cascade" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005840 "ribosome" evidence=IEA

GO:0002224 "toll-like receptor signaling pathway" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0019901 "protein kinase binding" evidence=IEA

GO:0032496 "response to lipopolysaccharide" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q39030	KPK2_ARATH	2, ., 7, ., 1, 1, ., 1	0.5722	0.8394	0.6326	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.914
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	355
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-115
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-94
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-91
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-89
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-84
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-82
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-81
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-81
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	6e-80
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-80
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	9e-79
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-77
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-76
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-73
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-73
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-73
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-73
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-72
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	9e-72
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-71
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-70
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-70
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	8e-70
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	9e-69
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-68
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	6e-68
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-66
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-66
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-64
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-63
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	7e-63
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	7e-62
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-61
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-61
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-60
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-59
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	7e-59
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	6e-58
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	9e-58
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-57
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	7e-57
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-56
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-56
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-56
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-56
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-56
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	5e-56
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-56
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-55
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-55
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-55
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	8e-55
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-54
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-54
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-54
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-54
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-54
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-54
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-51
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-50
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-50
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-50
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-49
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-48
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-48
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-47
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-46
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-46
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	7e-46
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	9e-46
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-43
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-42
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-41
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-41
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-41
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-38
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-37
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-37
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-36
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	5e-36
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	5e-35
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-34
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-34
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-34
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-34
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	4e-34
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-33
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-33
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-33
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-32
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	9e-32
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-31
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-31
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	6e-31
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	8e-31
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-30
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-30
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-30
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-30
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	8e-30
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	8e-30
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-29
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-28
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-28
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-28
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	6e-28
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	7e-28
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	9e-28
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-27
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-27
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-27
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-27
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-27
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	5e-27
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-27
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-26
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-26
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	8e-26
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	9e-26
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-25
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-25
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-25
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-25
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-24
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-24
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-24
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-24
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-24
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	9e-24
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-23
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-23
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-23
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-23
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-23
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-23
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-23
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	7e-23
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-22
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-22
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-22
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	7e-22
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-21
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-21
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-21
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-21
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-21
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-21
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-21
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-21
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	9e-21
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-20
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-20
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-20
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-20
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	6e-20
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	7e-20
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-19
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-19
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-19
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-19
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-19
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-19
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-19
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	7e-19
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	7e-19
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	9e-19
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-18
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-18
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-18
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-18
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-18
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	6e-18
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	7e-18
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	9e-18
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-17
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-17
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-17
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-17
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-17
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-17
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-17
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-17
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-17
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	6e-17
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	7e-17
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	9e-17
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-16
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-16
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-16
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-16
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-16
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-16
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-16
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-16
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-16
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-16
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	6e-16
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	6e-16
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-16
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	7e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	7e-16
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	8e-16
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	8e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-15
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-15
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-15
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-15
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-15
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-15
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-15
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-15
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-15
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-15
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-15
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	7e-15
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	8e-15
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	9e-15
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-14
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-14
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-14
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-14
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-14
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-14
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-14
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-14
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-14
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-14
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-14
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-14
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	6e-14
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	8e-14
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-13
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-13
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-13
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-13
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-13
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-13
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-13
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-13
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-13
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-13
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	6e-13
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	7e-13
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-12
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-12
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-12
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-12
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-12
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-12
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-12
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	6e-12
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-12
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-11
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-11
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-11
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-11
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-11
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-11
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	3e-11
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-11
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-11
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	9e-11
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-10
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-10
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-10
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-10
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-10
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-10
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-10
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	8e-10
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-09
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-09
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	9e-09
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-08
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-08
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	5e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	7e-08
PRK09188	365	PRK09188, PRK09188, serine/threonine protein kinas	1e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-07
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-07
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-06
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	2e-06
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-06
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	6e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	1e-05
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-05
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	8e-05
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	1e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-04
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	3e-04
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	5e-04
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	5e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	0.001
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.001
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	0.001
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	0.002
cd05144	198	cd05144, RIO2_C, RIO kinase family; RIO2, C-termin	0.002
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	0.002
cd05119	187	cd05119, RIO, RIO kinase family, catalytic domain	0.002
cd05151	170	cd05151, ChoK, Choline Kinase (ChoK)	0.003
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	0.004
TIGR01982	437	TIGR01982, UbiB, 2-polyprenylphenol 6-hydroxylase	0.004

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  333 bits (856), Expect = e-115
 Identities = 113/195 (57%), Positives = 152/195 (77%), Gaps = 6/195 (3%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G+FGKV  V+KK     D+  +YAMKV++K  IIK+  V++   ER+IL+++ HPFI
Sbjct: 1   LGKGSFGKVLLVRKK-----DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFI 55

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
           V+L Y+FQT  KLYL+L++  GG LF HL ++G F E++ARFY AEIV A+ +LH  GI+
Sbjct: 56  VKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGII 115

Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNKDAD 296
           +RDLKPENIL+D+DGH+ LTDFGLAKE   E SR+N+ CGT EY+APE+LL KG+ K  D
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVD 175

Query: 297 WWSVGILLYEMLTGQ 311
           WWS+G+LLYEMLTG+
Sbjct: 176 WWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  281 bits (722), Expect = 4e-94
 Identities = 97/200 (48%), Positives = 138/200 (69%), Gaps = 7/200 (3%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE  + +G G+FG+V  V+ K      S   YA+K++ K  I+K   V+++  E+ IL 
Sbjct: 2   DFEFIKTLGTGSFGRVMLVRHK-----GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQ 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HPF+V L  SFQ  S LYL+++++ GG LF HL + G F E  ARFY A++V A+ +
Sbjct: 57  SIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEY 116

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
           LH   IV+RDLKPEN+L+DSDG++ +TDFG AK +    R+ ++CGT EY+APEI+LSKG
Sbjct: 117 LHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG--RTYTLCGTPEYLAPEIILSKG 174

Query: 291 HNKDADWWSVGILLYEMLTG 310
           + K  DWW++GIL+YEML G
Sbjct: 175 YGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  273 bits (701), Expect = 2e-91
 Identities = 94/200 (47%), Positives = 134/200 (67%), Gaps = 7/200 (3%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +EI   +G+G+FGKV+  + K      +  + A+KV++K  I K    + +  E  IL K
Sbjct: 1   YEILEKLGEGSFGKVYLARDK-----KTGKLVAIKVIKKKKIKKD--RERILREIKILKK 53

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP IV+L   F+   KLYL++++  GG LF  L ++G   ED+ARFY  +I+SA+ +L
Sbjct: 54  LKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYL 113

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGH 291
           H  GIVHRDLKPENIL+D DGHV L DFGLA+++D   +  +  GT EYMAPE+LL KG+
Sbjct: 114 HSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGY 173

Query: 292 NKDADWWSVGILLYEMLTGQ 311
            K  D WS+G++LYE+LTG+
Sbjct: 174 GKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  270 bits (691), Expect = 5e-89
 Identities = 116/199 (58%), Positives = 150/199 (75%), Gaps = 6/199 (3%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD--YMKAERDILTKVT 173
           +V+G+G +GKVFQV+K  V   D+  I+AMKV++K TI++ N  D  + KAER+IL  V 
Sbjct: 2   KVLGKGGYGKVFQVRK--VTGADTGKIFAMKVLKKATIVR-NQKDTAHTKAERNILEAVK 58

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
           HPFIV L Y+FQT  KLYLIL++++GG LF HL R+GIF ED A FY +EI  A+ HLH+
Sbjct: 59  HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQ 118

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHN 292
            GI++RDLKPENIL+D+ GHV LTDFGL KE I E + +++ CGT EYMAPEIL+  GH 
Sbjct: 119 QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHG 178

Query: 293 KDADWWSVGILLYEMLTGQ 311
           K  DWWS+G L+Y+MLTG 
Sbjct: 179 KAVDWWSLGALMYDMLTGA 197

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  257 bits (659), Expect = 1e-84
 Identities = 109/206 (52%), Positives = 151/206 (73%), Gaps = 8/206 (3%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV-DYMKAERDIL 169
           +FE+ RV+G GA+GKVF V+K G    D+  +YAMKV++K TI++K    ++ + ER +L
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVG--GHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVL 58

Query: 170 TKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
             V   PF+V L Y+FQT +KL+LILD++NGG LF HLY++  F E + R Y AEIV A+
Sbjct: 59  EAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLAL 118

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYMAPEIL 286
            HLH+ GI++RD+K ENIL+DS+GHV+LTDFGL+KE   +E  R+ S CGT EYMAPE++
Sbjct: 119 DHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178

Query: 287 LSK--GHNKDADWWSVGILLYEMLTG 310
                GH+K  DWWS+G+L +E+LTG
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  253 bits (647), Expect = 2e-82
 Identities = 108/196 (55%), Positives = 146/196 (74%), Gaps = 4/196 (2%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +V+GQG+FGKVF V+K  +   D+  +YAMKV++K T+  ++ V   K ERDIL +V HP
Sbjct: 2   KVLGQGSFGKVFLVRK--ITGPDAGQLYAMKVLKKATLKVRDRVR-TKMERDILAEVNHP 58

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
           FIV+L Y+FQT  KLYLILDF+ GG LF  L ++ +F E+  +FY AE+  A+ HLH  G
Sbjct: 59  FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNKD 294
           I++RDLKPENIL+D +GH+ LTDFGL+KE ID   ++ S CGT EYMAPE++  +GH + 
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 178

Query: 295 ADWWSVGILLYEMLTG 310
           ADWWS G+L++EMLTG
Sbjct: 179 ADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  251 bits (643), Expect = 2e-81
 Identities = 97/232 (41%), Positives = 146/232 (62%), Gaps = 35/232 (15%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            DFE+ +V+G+GAFG+V+ V+ K     D+  +YAMKV+RK  +IK+N + +++AERDIL
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDK-----DTGQVYAMKVLRKSDMIKRNQIAHVRAERDIL 55

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
                P+IV+L YSFQ    LYL+++++ GG L   L R+ +F E+ ARFY AE+V A+ 
Sbjct: 56  ADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALD 115

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-------------------- 269
            +HK G +HRD+KP+NIL+D+DGH+ L DFGL K+++++                     
Sbjct: 116 SVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175

Query: 270 ----------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
                     R+NS  GT +Y+APE+L    +  + DWWS+G++LYEML G 
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  250 bits (639), Expect = 3e-81
 Identities = 104/197 (52%), Positives = 140/197 (71%), Gaps = 7/197 (3%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTH 174
           +V+G+G+FGKV   K K          YA+KV++K  I+KK    ++ AER++L K V H
Sbjct: 1   KVIGKGSFGKVLLAKHK-----ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+V L YSFQT  KLY +LD++NGG LFFHL R+  F E +ARFY AEI SA+ +LH  
Sbjct: 56  PFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
            I++RDLKPENIL+DS GHV+LTDFGL KE I+ S  +++ CGT EY+APE+L  + +++
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDR 175

Query: 294 DADWWSVGILLYEMLTG 310
             DWW +G +LYEML G
Sbjct: 176 TVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  244 bits (625), Expect = 6e-80
 Identities = 89/199 (44%), Positives = 131/199 (65%), Gaps = 5/199 (2%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           FE+ RV+G+GAFGKV  V+K+     D+  ++AMK M K   ++K  V  +  ER IL +
Sbjct: 2   FELLRVIGKGAFGKVCIVQKR-----DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQE 56

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HPF+V L YSFQ    +YL++D + GG L +HL ++  F E+Q +F+  EIV A+ +L
Sbjct: 57  LNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYL 116

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGH 291
           H  GI+HRD+KP+NIL+D  GHV +TDF +A ++   + + S  GT  YMAPE+L  +G+
Sbjct: 117 HSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGY 176

Query: 292 NKDADWWSVGILLYEMLTG 310
           +   DWWS+G+  YE L G
Sbjct: 177 SVAVDWWSLGVTAYECLRG 195

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  244 bits (626), Expect = 6e-80
 Identities = 95/202 (47%), Positives = 134/202 (66%), Gaps = 14/202 (6%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           + +GA+G+VF  KKK   D     IYA+KV++K  +I+KN VD +  ERDIL++   P++
Sbjct: 1   ISKGAYGRVFLAKKKSTGD-----IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYV 55

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
           V+L YSFQ +  LYL+++++ GG L   L   G   ED AR Y AEIV A+ +LH  GI+
Sbjct: 56  VKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGII 115

Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKE---------IDESSRSNSMCGTTEYMAPEILLS 288
           HRDLKP+NIL+DS+GH+ LTDFGL+K           D+      + GT +Y+APE++L 
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175

Query: 289 KGHNKDADWWSVGILLYEMLTG 310
           +GH+K  DWWS+G +LYE L G
Sbjct: 176 QGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  244 bits (623), Expect = 9e-79
 Identities = 110/205 (53%), Positives = 155/205 (75%), Gaps = 7/205 (3%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH-VDYMKAERDIL 169
           +FE+ +V+G GA+GKVF V+K  V   D+  +YAMKV++K  +++K   V++ + ER++L
Sbjct: 1   NFELLKVLGTGAYGKVFLVRK--VTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVL 58

Query: 170 TKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
             V   PF+V L Y+FQT +KL+LILD+++GG +F HLY++  F ED+ RFY+ EI+ A+
Sbjct: 59  EHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILAL 118

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYMAPEIL 286
            HLHK GIV+RD+K ENIL+DS+GHV+LTDFGL+KE   +E  R+ S CGT EYMAPEI+
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178

Query: 287 LSK-GHNKDADWWSVGILLYEMLTG 310
             K GH K  DWWS+GIL++E+LTG
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  238 bits (609), Expect = 6e-77
 Identities = 102/194 (52%), Positives = 142/194 (73%), Gaps = 6/194 (3%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G+FGKV QV+K+     D+  IYA+K +RK  I+ ++ V +  AER +L +V  PFI
Sbjct: 1   IGKGSFGKVMQVRKR-----DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFI 55

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
           V L++SFQ+  KLYL+L FINGG LF HL R+G F   +ARFYTAE++ A+ +LHK  ++
Sbjct: 56  VPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVI 115

Query: 238 HRDLKPENILMDSDGHVMLTDFGLAK-EIDESSRSNSMCGTTEYMAPEILLSKGHNKDAD 296
           +RDLKPENIL+D  GH+ L DFGL K  + +  ++N+ CGT EY+APE+LL  G+ K  D
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVD 175

Query: 297 WWSVGILLYEMLTG 310
           WW++G+LLYEMLTG
Sbjct: 176 WWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  235 bits (602), Expect = 4e-76
 Identities = 85/223 (38%), Positives = 134/223 (60%), Gaps = 27/223 (12%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F  V   K+K     +++  YA+K++ K  +IK+  V Y+K E+++LT
Sbjct: 2   DFKFGKIIGEGSFSTVVLAKEK-----ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLT 56

Query: 171 KVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           ++  HP I++L Y+FQ    LY +L++   G L  ++ + G   E   RFY AEI+ A+ 
Sbjct: 57  RLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALE 116

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-------------------- 269
           +LH  GI+HRDLKPENIL+D D H+ +TDFG AK +D +S                    
Sbjct: 117 YLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176

Query: 270 -RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
            R  S  GT EY++PE+L  K   K +D W++G ++Y+MLTG+
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  228 bits (584), Expect = 1e-73
 Identities = 86/221 (38%), Positives = 133/221 (60%), Gaps = 13/221 (5%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +E+ R +G G+FG V++ K KG        I A+K+++K +   K      + E  IL +
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGK-----IVAVKILKKRSEKSKKDQ-TARREIRILRR 54

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           ++HP IV+L  +F+ +  LYL++++  GG LF +L R G   ED+A+    +I+  + +L
Sbjct: 55  LSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYL 114

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-NSMCGTTEYMAPEILL-SK 289
           H  GI+HRDLKPENIL+D +G V + DFGLAK++ +SS S  +  GT  YMAPE+LL   
Sbjct: 115 HSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGN 174

Query: 290 GHNKDADWWSVGILLYEMLTGQV-----NIKSMQVIACNTM 325
           G+    D WS+G++LYE+LTG+      NI     +    +
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRIL 215

Length = 260

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  229 bits (585), Expect = 1e-73
 Identities = 109/206 (52%), Positives = 152/206 (73%), Gaps = 8/206 (3%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-NHVDYMKAERDIL 169
           +FE+ +V+G GA+GKVF V+K  V   DS  +YAMKV++K TI++K    ++ + ER +L
Sbjct: 1   NFELLKVLGTGAYGKVFLVRK--VSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 58

Query: 170 TKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
             +   PF+V L Y+FQT +KL+LILD+INGG LF HL ++  F+E + + Y+ EIV A+
Sbjct: 59  EHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLAL 118

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYMAPEIL 286
            HLHK GI++RD+K ENIL+DS+GHV+LTDFGL+KE   DE  R+ S CGT EYMAP+I+
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178

Query: 287 L--SKGHNKDADWWSVGILLYEMLTG 310
                GH+K  DWWS+G+L+YE+LTG
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  229 bits (586), Expect = 3e-73
 Identities = 92/200 (46%), Positives = 137/200 (68%), Gaps = 7/200 (3%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE+   +G G+FG+V   K KG  +      YA+K ++K  I+K   V ++  E+ IL 
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGE-----YYAIKCLKKREILKMKQVQHVAQEKSILM 73

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +++HPFIV +  SFQ  +++Y +L+F+ GG LF HL + G F  D A+FY AE+V A  +
Sbjct: 74  ELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEY 133

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
           LH   I++RDLKPEN+L+D+ GHV +TDFG AK++ +  R+ ++CGT EY+APE++ SKG
Sbjct: 134 LHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD--RTFTLCGTPEYLAPEVIQSKG 191

Query: 291 HNKDADWWSVGILLYEMLTG 310
           H K  DWW++G+LLYE + G
Sbjct: 192 HGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  229 bits (584), Expect = 5e-73
 Identities = 104/198 (52%), Positives = 145/198 (73%), Gaps = 9/198 (4%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDILTK-VT 173
           +V+G+G+FGKV   K+K      SDG  YA+KV++K TI+KK   +++ AER++L K + 
Sbjct: 1   KVIGKGSFGKVLLAKRK------SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK 54

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
           HPF+V L YSFQT  KLY +LD++NGG LFFHL R+  F E +ARFY AE+ SA+ +LH 
Sbjct: 55  HPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHS 114

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHN 292
             I++RDLKPENIL+DS GHV+LTDFGL KE ++    +++ CGT EY+APE+L  + ++
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174

Query: 293 KDADWWSVGILLYEMLTG 310
           +  DWW +G +LYEML G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  227 bits (581), Expect = 2e-72
 Identities = 93/201 (46%), Positives = 129/201 (64%), Gaps = 7/201 (3%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            DF+I   VGQG +G+VF  KKK     D+  I A+K M+K  + K N V ++  ERDIL
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKK-----DTGEIVALKRMKKSLLFKLNEVRHVLTERDIL 55

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           T     ++V+L Y+FQ    LYL ++++ GG     L   G+  ED ARFY AE+  AV 
Sbjct: 56  TTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVD 115

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
            LH+ G +HRDLKPEN L+D+ GH+ LTDFGL+K I   + +NS+ G+ +YMAPE+L  K
Sbjct: 116 ALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI--VTYANSVVGSPDYMAPEVLRGK 173

Query: 290 GHNKDADWWSVGILLYEMLTG 310
           G++   D+WS+G +LYE L G
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  226 bits (577), Expect = 9e-72
 Identities = 102/198 (51%), Positives = 144/198 (72%), Gaps = 10/198 (5%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH--- 174
           +G+G FG+V+QV+KK     D+  IYAMKV+ K  I+ K  V +   ER+IL +      
Sbjct: 1   IGKGTFGQVYQVRKK-----DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDES 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PFIV L++SFQT S LYL+ D+++GG LF+HL ++G F ED+A+FY AE+V A+ HLHK 
Sbjct: 56  PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAK-EIDESSRSNSMCGTTEYMAPEILL-SKGHN 292
            IV+RDLKPENIL+D+ GH+ L DFGL+K  + ++  +N+ CGTTEY+APE+LL  KG+ 
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYT 175

Query: 293 KDADWWSVGILLYEMLTG 310
           K  D+WS+G+L++EM  G
Sbjct: 176 KHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  224 bits (573), Expect = 3e-71
 Identities = 88/198 (44%), Positives = 136/198 (68%), Gaps = 7/198 (3%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-H 174
           +V+G+G+FGKV   + KG D+     +YA+KV++KD I++ + V+    E+ +L     H
Sbjct: 1   KVLGKGSFGKVLLAELKGTDE-----LYAVKVLKKDVILQDDDVECTMTEKRVLALAGKH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+ QL   FQT+ +L+ +++++NGG L FH+ R G F E +ARFY AEIV  +  LH+ 
Sbjct: 56  PFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
           GI++RDLK +N+L+DS+GH+ + DFG+ KE I     +++ CGT +Y+APEIL  + +  
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGP 175

Query: 294 DADWWSVGILLYEMLTGQ 311
             DWW++G+LLYEML GQ
Sbjct: 176 AVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  219 bits (561), Expect = 3e-70
 Identities = 83/195 (42%), Positives = 134/195 (68%), Gaps = 5/195 (2%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G G FG+V  VK K       +  +A+K ++K  I++    +++ +E++IL +  HPFI
Sbjct: 1   LGVGGFGRVELVKVKS-----KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFI 55

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
           V+L  +F+ +  +Y+++++  GG L+  L  +G+F E  ARFY A +V A  +LH  GI+
Sbjct: 56  VKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGII 115

Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADW 297
           +RDLKPEN+L+DS+G+V L DFG AK++    ++ + CGT EY+APEI+L+KG++   D+
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDY 175

Query: 298 WSVGILLYEMLTGQV 312
           WS+GILLYE+LTG+ 
Sbjct: 176 WSLGILLYELLTGRP 190

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  220 bits (562), Expect = 5e-70
 Identities = 88/200 (44%), Positives = 132/200 (66%), Gaps = 7/200 (3%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D E  + VG G FG+V  V+ +      S+  YA+KVM    +I+     ++  E+ +L 
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRI-----SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLK 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +V+HPFI++L ++   +  LY++++++ GG LF +L   G F      FY +EIV A+ +
Sbjct: 57  EVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEY 116

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
           LH   IV+RDLKPENIL+D +GH+ LTDFG AK++    R+ ++CGT EY+APE++ SKG
Sbjct: 117 LHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL--RDRTWTLCGTPEYLAPEVIQSKG 174

Query: 291 HNKDADWWSVGILLYEMLTG 310
           HNK  DWW++GIL+YEML G
Sbjct: 175 HNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  220 bits (563), Expect = 8e-70
 Identities = 90/198 (45%), Positives = 137/198 (69%), Gaps = 6/198 (3%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +++G+G FGKV  V++K      +   YAMK+++K+ II K+ V +   E  +L    HP
Sbjct: 1   KLLGKGTFGKVILVREKA-----TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHP 55

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
           F+  L+YSFQT  +L  ++++ NGG LFFHL R+ +F ED+ARFY AEIVSA+ +LH C 
Sbjct: 56  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD 115

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNKD 294
           +V+RDLK EN+++D DGH+ +TDFGL KE I + +   + CGT EY+APE+L    + + 
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 295 ADWWSVGILLYEMLTGQV 312
            DWW +G+++YEM+ G++
Sbjct: 176 VDWWGLGVVMYEMMCGRL 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  219 bits (560), Expect = 9e-69
 Identities = 92/239 (38%), Positives = 143/239 (59%), Gaps = 44/239 (18%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE  +V+G+GAFG+V  V+KK     D+  IYAMK +RK  +++K  V +++AERDIL 
Sbjct: 2   DFESIKVIGRGAFGEVRLVQKK-----DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILA 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +  +P++V+L YSFQ  + LYLI++++ GG +   L ++  F E++ RFY AE + A+  
Sbjct: 57  EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDS 116

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN------------------ 272
           +HK G +HRD+KP+N+L+D+ GH+ L+DFGL   + +S R+                   
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS 176

Query: 273 ---------------------SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
                                S  GT +Y+APE+ L  G+NK+ DWWS+G+++YEML G
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  217 bits (555), Expect = 1e-68
 Identities = 104/197 (52%), Positives = 140/197 (71%), Gaps = 7/197 (3%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTH 174
           +V+G+G+FGKV   K+K   DG     YA+KV++K  ++ +    ++ AER++L K V H
Sbjct: 1   KVIGKGSFGKVLLAKRK--LDGK---CYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+V L YSFQT  KLY +LDF+NGG LFFHL R+  F E +ARFY AEI SA+ +LH  
Sbjct: 56  PFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
            IV+RDLKPENIL+DS GHV+LTDFGL KE I +S  + + CGT EY+APE++  + ++ 
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175

Query: 294 DADWWSVGILLYEMLTG 310
             DWW +G +LYEML G
Sbjct: 176 TVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  216 bits (551), Expect = 6e-68
 Identities = 100/197 (50%), Positives = 141/197 (71%), Gaps = 7/197 (3%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTH 174
           +V+G+G+FGKV   + K       +  YA+KV++K  I+KK    ++ +ER++L K V H
Sbjct: 1   KVIGKGSFGKVLLARHKA-----EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+V L +SFQT  KLY +LD+INGG LF+HL R+  F E +ARFY AEI SA+ +LH  
Sbjct: 56  PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
            IV+RDLKPENIL+DS GH++LTDFGL KE I+ +  +++ CGT EY+APE+L  + +++
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175

Query: 294 DADWWSVGILLYEMLTG 310
             DWW +G +LYEML G
Sbjct: 176 TVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  212 bits (541), Expect = 2e-66
 Identities = 95/232 (40%), Positives = 134/232 (57%), Gaps = 37/232 (15%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            F+  +++G+G  G+VF V+ KG     +  ++A+KV+ K  +IK+N V  +  E++IL 
Sbjct: 2   HFKKIKLLGKGDVGRVFLVRLKG-----TGKLFALKVLDKKEMIKRNKVKRVLTEQEILA 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAV 228
            + HPF+  L  SFQT + L L++D+  GG LF  L RQ      E+ ARFY AE++ A+
Sbjct: 57  TLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLAL 116

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE--------------------- 267
            +LH  GIV+RDLKPENIL+   GH+ML+DF L+K+ D                      
Sbjct: 117 EYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176

Query: 268 ---------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
                    S RSNS  GT EY+APE++   GH    DWW++GILLYEML G
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  213 bits (544), Expect = 3e-66
 Identities = 97/245 (39%), Positives = 138/245 (56%), Gaps = 49/245 (20%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F   + +G GAFG+V  V+K      D++ +YAMK +RK  ++ +N   ++KAERDIL +
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKV-----DTNALYAMKTLRKADVLMRNQAAHVKAERDILAE 57

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
             + ++V+L YSFQ +  LY ++D+I GG +   L R GIF ED ARFY AE+  A+  +
Sbjct: 58  ADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESV 117

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLA--------------------------KEI 265
           HK G +HRD+KP+NIL+D DGH+ LTDFGL                           +E 
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEW 177

Query: 266 DESSR------------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
            E  R                  ++S+ GT  Y+APE+LL  G+ +  DWWSVG++LYEM
Sbjct: 178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237

Query: 308 LTGQV 312
           L GQ 
Sbjct: 238 LVGQP 242

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  206 bits (525), Expect = 3e-64
 Identities = 87/198 (43%), Positives = 136/198 (68%), Gaps = 6/198 (3%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +++G+G FGKV  V++K      +   YAMK++RK+ II K+ V +   E  +L    HP
Sbjct: 1   KLLGKGTFGKVILVREKA-----TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 55

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
           F+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIVSA+ +LH   
Sbjct: 56  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 115

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNKD 294
           +V+RD+K EN+++D DGH+ +TDFGL KE I + +   + CGT EY+APE+L    + + 
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 295 ADWWSVGILLYEMLTGQV 312
            DWW +G+++YEM+ G++
Sbjct: 176 VDWWGLGVVMYEMMCGRL 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  203 bits (518), Expect = 4e-63
 Identities = 90/198 (45%), Positives = 138/198 (69%), Gaps = 6/198 (3%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +++G+G FGKV  V++K      S   YAMK+++K+ II K+ V +   E  +L    HP
Sbjct: 1   KLLGKGTFGKVILVREKA-----SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHP 55

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
           F+  L+YSFQT+ +L  +++++NGG LFFHL R+ +F ED+ RFY AEIVSA+ +LH   
Sbjct: 56  FLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK 115

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNKD 294
           IV+RDLK EN+++D DGH+ +TDFGL KE I +++   + CGT EY+APE+L    + + 
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 295 ADWWSVGILLYEMLTGQV 312
            DWW +G+++YEM+ G++
Sbjct: 176 VDWWGLGVVMYEMMCGRL 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  203 bits (517), Expect = 7e-63
 Identities = 84/203 (41%), Positives = 132/203 (65%), Gaps = 7/203 (3%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF    V+G+G+FGKV   ++KG     +D +YA+K+++KD II+ + V+    E+ +L 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKG-----TDELYAIKILKKDVIIQDDDVECTMVEKRVLA 55

Query: 171 KVTHP-FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
               P F+ QL   FQT  +LY +++++NGG L +H+ + G F+E  A FY AEI   + 
Sbjct: 56  LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLF 115

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLS 288
            LH  GI++RDLK +N+++D++GH+ + DFG+ KE I     + + CGT +Y+APEI+  
Sbjct: 116 FLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAY 175

Query: 289 KGHNKDADWWSVGILLYEMLTGQ 311
           + + K  DWW+ G+LLYEML GQ
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  200 bits (510), Expect = 7e-62
 Identities = 83/198 (41%), Positives = 130/198 (65%), Gaps = 7/198 (3%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT-KVTH 174
           +V+G+G+FGKV   + KG D+     +YA+KV++KD I++ + VD    E+ IL     H
Sbjct: 1   KVLGKGSFGKVMLAELKGTDE-----VYAIKVLKKDVILQDDDVDCTMTEKRILALAAKH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+  L   FQT+ +L+ +++++NGG L F + R   F E ++RFY AE+  A+  LH+ 
Sbjct: 56  PFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
           G+++RDLK +NIL+D++GH  L DFG+ KE I     + + CGT +Y+APEIL    +  
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGP 175

Query: 294 DADWWSVGILLYEMLTGQ 311
             DWW++G+L+YEM+ GQ
Sbjct: 176 SVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  198 bits (505), Expect = 3e-61
 Identities = 84/198 (42%), Positives = 134/198 (67%), Gaps = 7/198 (3%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-H 174
           +V+G+G+FGKV   + KG ++      +A+K ++KD +++ + V+    ER +L     H
Sbjct: 1   KVLGKGSFGKVMLAELKGTNE-----FFAIKALKKDVVLEDDDVECTMVERRVLALAWEH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+  L  +FQT+  L+ +++++NGG L FH+   G F E +ARFY AEI+  +  LHK 
Sbjct: 56  PFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
           GI++RDLK +N+L+D DGH+ + DFG+ KE ++   ++++ CGT +Y+APEIL  + +N+
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNE 175

Query: 294 DADWWSVGILLYEMLTGQ 311
             DWWS G+LLYEML GQ
Sbjct: 176 SVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  198 bits (504), Expect = 5e-61
 Identities = 88/198 (44%), Positives = 130/198 (65%), Gaps = 7/198 (3%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-TH 174
           RV+G+G+FGKV   + K     +S  +YA+KV++KD I++ + V+    E+ IL+    H
Sbjct: 1   RVLGKGSFGKVMLARLK-----ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+ QL   FQT  +L+ +++F+NGG L FH+ +   F E +ARFY AEI SA+  LH  
Sbjct: 56  PFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
           GI++RDLK +N+L+D +GH  L DFG+ KE I     +++ CGT +Y+APEIL    +  
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGP 175

Query: 294 DADWWSVGILLYEMLTGQ 311
             DWW++G+LLYEML G 
Sbjct: 176 SVDWWAMGVLLYEMLCGH 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  197 bits (502), Expect = 1e-60
 Identities = 89/199 (44%), Positives = 137/199 (68%), Gaps = 7/199 (3%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +++G+G FGKV  VK+K      +   YAMK+++K+ I+ K+ V +   E  +L    HP
Sbjct: 1   KLLGKGTFGKVILVKEKA-----TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 55

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH-KC 234
           F+  L+YSFQT  +L  ++++ NGG LFFHL R+ +F ED+ARFY AEIVSA+ +LH + 
Sbjct: 56  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
            +V+RDLK EN+++D DGH+ +TDFGL KE I + +   + CGT EY+APE+L    + +
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175

Query: 294 DADWWSVGILLYEMLTGQV 312
             DWW +G+++YEM+ G++
Sbjct: 176 AVDWWGLGVVMYEMMCGRL 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  192 bits (490), Expect = 2e-59
 Identities = 76/196 (38%), Positives = 117/196 (59%), Gaps = 7/196 (3%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G FG+V   + K      +  +YA K + K  + K+        E+ IL KV+  FI
Sbjct: 1   LGKGGFGEVCACQVK-----ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFI 55

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCG 235
           V L Y+F+T+  L L++  +NGG L +H+Y  G   F E +A FY A+I+  + HLH+  
Sbjct: 56  VSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR 115

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDA 295
           IV+RDLKPEN+L+D  G+V ++D GLA E+    +     GT  YMAPE+L  + ++   
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSV 175

Query: 296 DWWSVGILLYEMLTGQ 311
           DW+++G  LYEM+ G+
Sbjct: 176 DWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  192 bits (490), Expect = 7e-59
 Identities = 89/210 (42%), Positives = 133/210 (63%), Gaps = 14/210 (6%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF++  +VG+G FG+V  V++K   D     IYAMKVM+K  ++ +  V + + ERDIL+
Sbjct: 2   DFDVKSLVGRGHFGEVQVVREKATGD-----IYAMKVMKKSVLLAQETVSFFEEERDILS 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVS 229
               P+I QL+Y+FQ +  LYL++++  GG L   L R +  F ED A+FY AE+V A+ 
Sbjct: 57  ISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIH 116

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM--CGTTEYMAPEILL 287
            +H+ G VHRD+KPEN+L+D  GH+ L DFG A  +  +   NS    GT +Y+APE+L 
Sbjct: 117 SVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176

Query: 288 -----SKG-HNKDADWWSVGILLYEMLTGQ 311
                 KG +  + DWWS+G++ YEM+ G+
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  190 bits (484), Expect = 6e-58
 Identities = 82/198 (41%), Positives = 135/198 (68%), Gaps = 7/198 (3%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL-TKVTH 174
           RV+G+G++ KV  V+ K      +  IYAMKV++K+ +     +D+++ E+ +  T   H
Sbjct: 1   RVIGRGSYAKVLLVELK-----KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+V L   FQT S+L+ +++F++GG L FH+ RQ    E+ ARFY+AEI  A++ LH+ 
Sbjct: 56  PFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
           GI++RDLK +N+L+D++GH+ LTD+G+ KE I     +++ CGT  Y+APEIL  + +  
Sbjct: 116 GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGF 175

Query: 294 DADWWSVGILLYEMLTGQ 311
             DWW++G+L++EM+ G+
Sbjct: 176 SVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  190 bits (484), Expect = 9e-58
 Identities = 96/217 (44%), Positives = 135/217 (62%), Gaps = 6/217 (2%)

Query: 94  ENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI 153
           ++D+  E + + K+   DF   R +G G+FG+V     K   + D   + A+K   K  I
Sbjct: 14  DSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYK---NEDFPPV-AIKRFEKSKI 69

Query: 154 IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFR 213
           IK+  VD++ +ER IL  + HPF V L  SF+  S LYL+L+F+ GG  F  L R   F 
Sbjct: 70  IKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFP 129

Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
            D   FY A+IV    +L    IV+RDLKPEN+L+D DG + +TDFG AK +D  +R+ +
Sbjct: 130 NDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD--TRTYT 187

Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           +CGT EY+APEILL+ GH K ADWW++GI +YE+L G
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  190 bits (484), Expect = 2e-57
 Identities = 84/206 (40%), Positives = 131/206 (63%), Gaps = 12/206 (5%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF++ +V+G+GAFG+V  V+ K      S  +YAMK++ K  +IK++   +   ERDI+ 
Sbjct: 44  DFDVIKVIGRGAFGEVQLVRHK-----SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
                +IVQL Y+FQ    LY++++++ GG L   +    I  E  ARFYTAE+V A+  
Sbjct: 99  HANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDI-PEKWARFYTAEVVLALDA 157

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILLS 288
           +H  G +HRD+KP+N+L+D  GH+ L DFG   ++D +   R ++  GT +Y++PE+L S
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKS 217

Query: 289 KGHN----KDADWWSVGILLYEMLTG 310
           +G +    ++ DWWSVG+ LYEML G
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  185 bits (472), Expect = 7e-57
 Identities = 81/194 (41%), Positives = 125/194 (64%), Gaps = 9/194 (4%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL-TKVTHPF 176
           + +GAFG V+  KK+   D      +A+KV++K  +I KN V  +KAER I+  +   P+
Sbjct: 4   ISKGAFGSVYLAKKRSTGD-----YFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPY 58

Query: 177 IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGI 236
           + +L YSFQ++  LYL+++++NGG     +   G   ED A+ Y AE+V  V  LH+ GI
Sbjct: 59  VAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGI 118

Query: 237 VHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDAD 296
           +HRD+KPEN+L+D  GH+ LTDFGL++   E+ +     GT +Y+APE +L  G +K +D
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK---FVGTPDYLAPETILGVGDDKMSD 175

Query: 297 WWSVGILLYEMLTG 310
           WWS+G +++E L G
Sbjct: 176 WWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  186 bits (475), Expect = 1e-56
 Identities = 75/204 (36%), Positives = 122/204 (59%), Gaps = 10/204 (4%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL-- 169
           F    V+G+G FGKV   + K      +  +YA+K ++K  II ++ V+ +  E+ I   
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKK-----TGELYAIKALKKGDIIARDEVESLMCEKRIFET 55

Query: 170 -TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
                HPF+V L   FQT   +  ++++  GG L  H++   +F E +A FY A +V  +
Sbjct: 56  ANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGL 114

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILL 287
            +LH+  IV+RDLK +N+L+D++G V + DFGL KE +    R+++ CGT E++APE+L 
Sbjct: 115 QYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT 174

Query: 288 SKGHNKDADWWSVGILLYEMLTGQ 311
              + +  DWW +G+L+YEML G+
Sbjct: 175 ETSYTRAVDWWGLGVLIYEMLVGE 198

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  184 bits (469), Expect = 2e-56
 Identities = 69/207 (33%), Positives = 123/207 (59%), Gaps = 13/207 (6%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            +EI + +G+G+FGKV+ V++K      SDG +Y +K +    + +K   D +  E  IL
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRK------SDGKLYVLKEIDLSNMSEKEREDALN-EVKIL 53

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI----FREDQARFYTAEIV 225
            K+ HP I++   SF+ + KL +++++ +GG L   + +Q      F E+Q   +  ++ 
Sbjct: 54  KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLC 113

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-NSMCGTTEYMAPE 284
            A+ +LH   I+HRD+KP+NI + S+G V L DFG++K +  +     ++ GT  Y++PE
Sbjct: 114 LALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPE 173

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQ 311
           +  +K +N  +D WS+G +LYE+ T +
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLK 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  187 bits (477), Expect = 2e-56
 Identities = 92/248 (37%), Positives = 131/248 (52%), Gaps = 53/248 (21%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF   +V+G+GAFG+V  V+KK  D G    IYAMK + K  + KK+ + ++KAERD+L 
Sbjct: 2   DFHTVKVIGKGAFGEVRLVQKK--DTGK---IYAMKTLLKSEMFKKDQLAHVKAERDVLA 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +   P++V L YSFQ    LYLI++F+ GG L   L +   F ED  RFY AE V A+  
Sbjct: 57  ESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEA 116

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN------------------ 272
           +HK G +HRD+KP+NIL+D  GH+ L+DFGL+    +   S                   
Sbjct: 117 VHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176

Query: 273 ------------------------------SMCGTTEYMAPEILLSKGHNKDADWWSVGI 302
                                         S  GT +Y+APEI L +G+ ++ DWWS+G 
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236

Query: 303 LLYEMLTG 310
           +++E L G
Sbjct: 237 IMFECLIG 244

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  185 bits (471), Expect = 4e-56
 Identities = 84/203 (41%), Positives = 135/203 (66%), Gaps = 7/203 (3%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF    V+G+G+FGKV   ++KG D+     +YA+K+++KD +I+ + V+    E+ +L 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDE-----LYAIKILKKDVVIQDDDVECTMVEKRVLA 55

Query: 171 KVTHP-FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
               P F+ QL   FQT  +LY +++++NGG L +H+ + G F+E QA FY AEI   + 
Sbjct: 56  LQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLF 115

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLS 288
            LH+ GI++RDLK +N+++DS+GH+ + DFG+ KE + +   + + CGT +Y+APEI+  
Sbjct: 116 FLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAY 175

Query: 289 KGHNKDADWWSVGILLYEMLTGQ 311
           + + K  DWW+ G+LLYEML GQ
Sbjct: 176 QPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score =  187 bits (475), Expect = 4e-56
 Identities = 96/248 (38%), Positives = 137/248 (55%), Gaps = 53/248 (21%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F   + +G GAFG+V   +K      D+  +YAMK +RK  ++ +N V ++KAERDIL +
Sbjct: 3   FVKIKTLGIGAFGEVCLARKV-----DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAE 57

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
             + ++V+L YSFQ +  LY ++D+I GG +   L R GIF ED ARFY AE+  AV  +
Sbjct: 58  ADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESV 117

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGL--------------------------AKEI 265
           HK G +HRD+KP+NIL+D DGH+ LTDFGL                          + E 
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177

Query: 266 DESSR----------------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
            + +                       ++S+ GT  Y+APE+LL  G+ +  DWWSVG++
Sbjct: 178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237

Query: 304 LYEMLTGQ 311
           LYEML GQ
Sbjct: 238 LYEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  185 bits (470), Expect = 5e-56
 Identities = 82/204 (40%), Positives = 132/204 (64%), Gaps = 7/204 (3%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF    V+G+G+FGKV   ++KG D+     +YA+K+++KD +I+ + V+    E+ +L 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDE-----LYAIKILKKDVVIQDDDVECTMVEKRVLA 55

Query: 171 -KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
                PF+ QL   FQT  +LY +++++NGG L + + + G F+E  A FY AEI   + 
Sbjct: 56  LSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLF 115

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLS 288
            LH  GI++RDLK +N+++DS+GH+ + DFG+ KE + +   + + CGT +Y+APEI+  
Sbjct: 116 FLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAY 175

Query: 289 KGHNKDADWWSVGILLYEMLTGQV 312
           + + K  DWW+ G+LLYEML GQ 
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQA 199

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  184 bits (469), Expect = 6e-56
 Identities = 87/219 (39%), Positives = 131/219 (59%), Gaps = 21/219 (9%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            DFE  +++  GA+G V+ V+ K     ++   +AMK + K  +I +N +  +  ERDIL
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHK-----ETRQRFAMKKINKQNLILRNQIQQVFVERDIL 55

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           T   +PF+V +  SF+T+  L ++++++ GG     L   G    D AR Y AE V A+ 
Sbjct: 56  TFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALE 115

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK-------------EIDESSRS---NS 273
           +LH  GIVHRDLKP+N+L+ S GH+ LTDFGL+K              I++ +R      
Sbjct: 116 YLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175

Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
           +CGT EY+APE++L +G+ K  DWW++GI+LYE L G V
Sbjct: 176 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCV 214

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  182 bits (464), Expect = 1e-55
 Identities = 69/201 (34%), Positives = 115/201 (57%), Gaps = 11/201 (5%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
            ++G+G+FG V+      +D  D+  + A+K +      ++  ++ ++ E  IL+ + HP
Sbjct: 6   ELLGRGSFGSVYL----ALDK-DTGELMAVKSVELSGDSEE-ELEALEREIRILSSLQHP 59

Query: 176 FIVQLRYSFQTRSK--LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
            IV+   S +   K  L + L++++GG L   L + G   E   R YT +I+  +++LH 
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE---SSRSNSMCGTTEYMAPEILLSKG 290
            GIVHRD+K  NIL+DSDG V L DFG AK + +      + S+ GT  +MAPE++  + 
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179

Query: 291 HNKDADWWSVGILLYEMLTGQ 311
           + + AD WS+G  + EM TG+
Sbjct: 180 YGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  183 bits (466), Expect = 2e-55
 Identities = 81/198 (40%), Positives = 138/198 (69%), Gaps = 7/198 (3%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-H 174
           RV+G+G++ KV  V+ K      ++ IYAMKV++K+ +     +D+++ E+ +  + + H
Sbjct: 1   RVIGRGSYAKVLLVRLK-----KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+V L   FQT S+L+ +++++NGG L FH+ RQ    E+ ARFY+AEI  A+++LH+ 
Sbjct: 56  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
           GI++RDLK +N+L+DS+GH+ LTD+G+ KE +     +++ CGT  Y+APEIL  + +  
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 175

Query: 294 DADWWSVGILLYEMLTGQ 311
             DWW++G+L++EM+ G+
Sbjct: 176 SVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  183 bits (465), Expect = 3e-55
 Identities = 82/198 (41%), Positives = 137/198 (69%), Gaps = 7/198 (3%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-TH 174
           RV+G+G++ KV  V+ K      +D IYAMKV++K+ +     +D+++ E+ +  +  ++
Sbjct: 1   RVIGRGSYAKVLLVRLK-----KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSN 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+V L   FQT S+L+L+++++NGG L FH+ RQ    E+ ARFY AEI  A++ LH+ 
Sbjct: 56  PFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
           GI++RDLK +N+L+D+DGH+ LTD+G+ KE +     +++ CGT  Y+APEIL  + +  
Sbjct: 116 GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGF 175

Query: 294 DADWWSVGILLYEMLTGQ 311
             DWW++G+L++EM+ G+
Sbjct: 176 SVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  183 bits (465), Expect = 8e-55
 Identities = 88/236 (37%), Positives = 139/236 (58%), Gaps = 41/236 (17%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE  +V+G+GAFG+V  V+KK     D+  IYAMK++RK  +++K  V +++AERDIL 
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKK-----DTGHIYAMKILRKADMLEKEQVAHIRAERDILV 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +    ++V++ YSFQ +  LYLI++F+ GG +   L ++    E+  +FY AE V A+  
Sbjct: 57  EADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDA 116

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN------------------ 272
           +H+ G +HRD+KP+N+L+D+ GHV L+DFGL   + ++ R+                   
Sbjct: 117 IHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176

Query: 273 ------------------SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
                             S  GT +Y+APE+ +  G+NK  DWWS+G+++YEML G
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  180 bits (459), Expect = 2e-54
 Identities = 82/198 (41%), Positives = 131/198 (66%), Gaps = 7/198 (3%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-TH 174
           +++G+G+FGKVF  + KG     ++  +A+K ++KD ++  + V+    E+ +L+    H
Sbjct: 1   KMLGKGSFGKVFLAELKG-----TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+  L  +FQT+  L+ +++++NGG L FH+     F   +A FY AEI+  +  LH  
Sbjct: 56  PFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
           GIV+RDLK +NIL+D+DGH+ + DFG+ KE +   +++ + CGT +Y+APEILL + +N 
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNT 175

Query: 294 DADWWSVGILLYEMLTGQ 311
             DWWS G+LLYEML GQ
Sbjct: 176 SVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  179 bits (456), Expect = 3e-54
 Identities = 87/205 (42%), Positives = 122/205 (59%), Gaps = 13/205 (6%)

Query: 112 FEIFRVVGQGAFGKVF--QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA-ERDI 168
           F  +RV+G+G FG+V   QV+  G        +YA K + K  I KK   + M   E+ I
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATG-------KMYACKKLEKKRI-KKRKGEAMALNEKQI 53

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVS 226
           L KV   F+V L Y+++T+  L L+L  +NGG L FH+Y  G   F E++A FY AEI  
Sbjct: 54  LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITC 113

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEIL 286
            +  LH+  IV+RDLKPENIL+D  GH+ ++D GLA EI E        GT  YMAPE++
Sbjct: 114 GLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV 173

Query: 287 LSKGHNKDADWWSVGILLYEMLTGQ 311
            ++ +    DWW +G L+YEM+ G+
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  181 bits (461), Expect = 3e-54
 Identities = 88/236 (37%), Positives = 140/236 (59%), Gaps = 41/236 (17%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE  +V+G+GAFG+V  V+KK     D+  +YAMK++RK  +++K  V +++AERDIL 
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKK-----DTGHVYAMKILRKADMLEKEQVGHIRAERDILV 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +    ++V++ YSFQ +  LYLI++F+ GG +   L ++    E++ +FY AE V A+  
Sbjct: 57  EADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDS 116

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN------------------ 272
           +H+ G +HRD+KP+N+L+DS GHV L+DFGL   + ++ R+                   
Sbjct: 117 IHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176

Query: 273 ------------------SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
                             S  GT +Y+APE+ +  G+NK  DWWS+G+++YEML G
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  177 bits (450), Expect = 4e-54
 Identities = 73/194 (37%), Positives = 116/194 (59%), Gaps = 11/194 (5%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G FG V+  +     D  +    A+K+++K+     + ++ +  E +IL K+ HP I
Sbjct: 1   LGEGGFGTVYLAR-----DKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNI 53

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGI 236
           V+L   F+  + LYL++++  GG L   L    G   ED+      +I+  + +LH  GI
Sbjct: 54  VKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGI 113

Query: 237 VHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSR-SNSMCGTTEYMAPEILLSKGH-NK 293
           +HRDLKPENIL+DSD G V L DFGL+K +        ++ GT  YMAPE+LL KG+ ++
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173

Query: 294 DADWWSVGILLYEM 307
            +D WS+G++LYE+
Sbjct: 174 KSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score =  182 bits (462), Expect = 4e-54
 Identities = 92/248 (37%), Positives = 134/248 (54%), Gaps = 53/248 (21%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F   + +G GAFG+V    K      D+  +YAMK +RK  ++ +N V ++KAERDIL +
Sbjct: 3   FVKIKTLGIGAFGEVCLACKV-----DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAE 57

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
             + ++V+L YSFQ +  LY ++D+I GG +   L R  +F E  ARFY AE+  A+  +
Sbjct: 58  ADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESV 117

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGL------------------------------ 261
           HK G +HRD+KP+NIL+D DGH+ LTDFGL                              
Sbjct: 118 HKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177

Query: 262 ------------------AKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
                             A +  +   ++S+ GT  Y+APE+LL KG+ +  DWWSVG++
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237

Query: 304 LYEMLTGQ 311
           L+EML GQ
Sbjct: 238 LFEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  180 bits (458), Expect = 5e-54
 Identities = 87/209 (41%), Positives = 128/209 (61%), Gaps = 13/209 (6%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI +V+G+GAFG+V  VK K         +YAMK++ K  ++K+      + ERD+L 
Sbjct: 2   DFEILKVIGRGAFGEVAVVKMKNTGQ-----VYAMKILNKWEMLKRAETACFREERDVLV 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVS 229
                +I  L Y+FQ  + LYL++D+  GG L   L + +    ED ARFY AE+V A+ 
Sbjct: 57  NGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAID 116

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFG--LAKEIDESSRSNSMCGTTEYMAPEILL 287
            +H+ G VHRD+KP+N+L+D +GH+ L DFG  L    D + +SN   GT +Y++PEIL 
Sbjct: 117 SVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQ 176

Query: 288 S----KGH-NKDADWWSVGILLYEMLTGQ 311
           +    KG    + DWWS+G+ +YEML G+
Sbjct: 177 AMEDGKGRYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  171 bits (435), Expect = 3e-51
 Identities = 84/204 (41%), Positives = 120/204 (58%), Gaps = 11/204 (5%)

Query: 112 FEIFRVVGQGAFGKVF--QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           F  +RV+G+G FG+V   QV+  G        +YA K + K  I K+        E+ IL
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATG-------KMYACKRLEKKRIKKRKGESMALNEKQIL 54

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSA 227
            KV   F+V L Y+++T+  L L+L  +NGG L FH+Y  G   F E++A FY AEI+  
Sbjct: 55  EKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG 114

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           +  LH+   V+RDLKPENIL+D  GH+ ++D GLA +I E        GT  YMAPE+L 
Sbjct: 115 LEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLN 174

Query: 288 SKGHNKDADWWSVGILLYEMLTGQ 311
           ++ +    D+W +G L+YEM+ GQ
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  170 bits (433), Expect = 1e-50
 Identities = 80/198 (40%), Positives = 127/198 (64%), Gaps = 7/198 (3%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-TH 174
           +V+G+G+FGKV   + KG  +      +A+K ++KD ++  + V+    E+ +L     +
Sbjct: 1   KVLGKGSFGKVLLAELKGKGE-----YFAVKALKKDVVLIDDDVECTMVEKRVLALAWEN 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+  L  +FQT+  L+ +++F+NGG L FH+  +G F   +A FY AEIV  +  LH  
Sbjct: 56  PFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
           GI++RDLK +N+++D DGH+ + DFG+ KE +   +R+++ CGT +Y+APEIL    +  
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTF 175

Query: 294 DADWWSVGILLYEMLTGQ 311
             DWWS G+LLYEML GQ
Sbjct: 176 SVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  169 bits (428), Expect = 4e-50
 Identities = 85/204 (41%), Positives = 119/204 (58%), Gaps = 11/204 (5%)

Query: 112 FEIFRVVGQGAFGKVF--QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           F  +RV+G+G FG+V   QV+  G        +YA K + K  I K+        E+ IL
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATG-------KMYACKKLEKKRIKKRKGESMALNEKQIL 54

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSA 227
            KV   F+V L Y+++T+  L L+L  +NGG L FH+Y  G   F E +A FY AEI   
Sbjct: 55  EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG 114

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           +  LH+  IV+RDLKPENIL+D  GH+ ++D GLA  + E        GT  YMAPE++ 
Sbjct: 115 LEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK 174

Query: 288 SKGHNKDADWWSVGILLYEMLTGQ 311
           ++ +    DWW++G LLYEM+ GQ
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  166 bits (424), Expect = 7e-50
 Identities = 69/208 (33%), Positives = 114/208 (54%), Gaps = 21/208 (10%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            FEI   +G+G FG+V++ + K        G   A+KV++ ++  KK  +     E  IL
Sbjct: 1   LFEILEKIGKGGFGEVYKARHK------RTGKEVAIKVIKLESKEKKEKI---INEIQIL 51

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ------GIFREDQARFYTAE 223
            K  HP IV+   S+  + +L+++++F +GG L     +           E Q  +   E
Sbjct: 52  KKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSL-----KDLLKSTNQTLTESQIAYVCKE 106

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           ++  + +LH  GI+HRD+K  NIL+ SDG V L DFGL+ ++ ++   N+M GT  +MAP
Sbjct: 107 LLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAP 166

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQ 311
           E++  K ++  AD WS+GI   E+  G+
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score =  166 bits (421), Expect = 3e-49
 Identities = 83/204 (40%), Positives = 118/204 (57%), Gaps = 11/204 (5%)

Query: 112 FEIFRVVGQGAFGKVF--QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           F  +RV+G+G FG+V   QV+  G        +YA K + K  I K+        E+ IL
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATG-------KMYACKKLEKKRIKKRKGEAMALNEKRIL 54

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSA 227
            KV   F+V L Y+++T+  L L+L  +NGG L FH+Y  G   F E +A FY AE+   
Sbjct: 55  EKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCG 114

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           +  L +  IV+RDLKPENIL+D  GH+ ++D GLA +I E        GT  YMAPE++ 
Sbjct: 115 LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVIN 174

Query: 288 SKGHNKDADWWSVGILLYEMLTGQ 311
           ++ +    DWW +G L+YEM+ GQ
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  166 bits (421), Expect = 3e-48
 Identities = 82/206 (39%), Positives = 132/206 (64%), Gaps = 12/206 (5%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+E+ +V+G+GAFG+V  V+ K      +  +YAMK++ K  +IK++   +   ERDI+ 
Sbjct: 44  DYEVVKVIGRGAFGEVQLVRHKS-----TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
               P++VQL Y+FQ    LY++++++ GG L  +L       E  ARFYTAE+V A+  
Sbjct: 99  FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDA 157

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILLS 288
           +H  G +HRD+KP+N+L+D  GH+ L DFG   ++++    R ++  GT +Y++PE+L S
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 217

Query: 289 KG----HNKDADWWSVGILLYEMLTG 310
           +G    + ++ DWWSVG+ LYEML G
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  165 bits (420), Expect = 4e-48
 Identities = 81/206 (39%), Positives = 133/206 (64%), Gaps = 12/206 (5%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ +V+G+GAFG+V  V+ K      S  +YAMK++ K  +IK++   +   ERDI+ 
Sbjct: 44  DYDVVKVIGRGAFGEVQLVRHKS-----SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
               P++VQL  +FQ    LY++++++ GG L  +L       E  A+FYTAE+V A+  
Sbjct: 99  FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLV-NLMSNYDVPEKWAKFYTAEVVLALDA 157

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILLS 288
           +H  G++HRD+KP+N+L+D  GH+ L DFG   ++DE+   R ++  GT +Y++PE+L S
Sbjct: 158 IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKS 217

Query: 289 KG----HNKDADWWSVGILLYEMLTG 310
           +G    + ++ DWWSVG+ L+EML G
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score =  162 bits (411), Expect = 4e-47
 Identities = 86/209 (41%), Positives = 133/209 (63%), Gaps = 13/209 (6%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI +V+G+GAFG+V  VK K     ++D ++AMK++ K  ++K+      + ERD+L 
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLK-----NADKVFAMKILNKWEMLKRAETACFREERDVLV 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVS 229
              + +I  L Y+FQ  + LYL++D+  GG L   L + +    ED ARFY AE+V A+ 
Sbjct: 57  NGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAID 116

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYMAPEILL 287
            +H+   VHRD+KP+NILMD +GH+ L DFG   ++  D + +S+   GT +Y++PEIL 
Sbjct: 117 SVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176

Query: 288 S----KG-HNKDADWWSVGILLYEMLTGQ 311
           +    KG +  + DWWS+G+ +YEML G+
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  159 bits (403), Expect = 1e-46
 Identities = 83/200 (41%), Positives = 122/200 (61%), Gaps = 12/200 (6%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-- 174
           ++G+G FG+V+  +K      D+  +YAMK + K  I  K        ER +L+ V+   
Sbjct: 1   IIGRGGFGEVYGCRK-----ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 55

Query: 175 -PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
            PFIV + Y+F T  KL  ILD +NGG L +HL + G+F E + RFY AEI+  + H+H 
Sbjct: 56  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHN 115

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG--H 291
             +V+RDLKP NIL+D  GHV ++D GLA +  +     S+ GT  YMAPE+ L KG  +
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEV-LQKGVAY 173

Query: 292 NKDADWWSVGILLYEMLTGQ 311
           +  ADW+S+G +L+++L G 
Sbjct: 174 DSSADWFSLGCMLFKLLRGH 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score =  158 bits (402), Expect = 2e-46
 Identities = 77/202 (38%), Positives = 117/202 (57%), Gaps = 11/202 (5%)

Query: 118 VGQGAFGKV--FQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +G+G FG+V   QVK  G        +YA K + K  + KK+       E++IL KV  P
Sbjct: 1   LGKGGFGEVCAVQVKNTG-------KMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSP 53

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR--FYTAEIVSAVSHLHK 233
           FIV L Y+F++++ L L++  +NGG L +H+Y  G    +  R   Y+A+I   + HLH 
Sbjct: 54  FIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS 113

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNK 293
             IV+RD+KPEN+L+D  G+  L+D GLA E+ +        GT  YMAPEIL  + ++ 
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSY 173

Query: 294 DADWWSVGILLYEMLTGQVNIK 315
             DW+++G  +YEM+ G+   K
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFK 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  159 bits (402), Expect = 7e-46
 Identities = 85/209 (40%), Positives = 129/209 (61%), Gaps = 13/209 (6%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI +V+G+GAFG+V  VK K      ++ IYAMK++ K  ++K+      + ER++L 
Sbjct: 2   DFEIIKVIGRGAFGEVAVVKMK-----HTERIYAMKILNKWEMLKRAETACFREERNVLV 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVS 229
                +I  L Y+FQ  + LYL++D+  GG L   L + +    ED ARFY AE+V A+ 
Sbjct: 57  NGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIH 116

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFG--LAKEIDESSRSNSMCGTTEYMAPEIL- 286
            +H+   VHRD+KP+N+L+D +GH+ L DFG  L    D + +S+   GT +Y++PEIL 
Sbjct: 117 SIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQ 176

Query: 287 -LSKGHNK---DADWWSVGILLYEMLTGQ 311
            +  G  K   + DWWS+G+ +YEML G+
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  157 bits (398), Expect = 9e-46
 Identities = 76/196 (38%), Positives = 123/196 (62%), Gaps = 10/196 (5%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G FG+V   + +      +  +YA K + K  + K+   +    E+ IL KV   FI
Sbjct: 1   LGKGGFGEVSACQMRA-----TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFI 55

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLY----RQGIFREDQARFYTAEIVSAVSHLHK 233
           V L Y+FQT++ L L++  +NGG L +H+Y        F E +A FYTA+I+S + HLH+
Sbjct: 56  VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ 115

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPEILLSKGHN 292
             I++RDLKPEN+L+D+DG+V ++D GLA E+ D  S++    GT  +MAPE+L  + ++
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYD 175

Query: 293 KDADWWSVGILLYEML 308
              D++++G+ LYEM+
Sbjct: 176 FSVDYFALGVTLYEMI 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  150 bits (381), Expect = 2e-43
 Identities = 81/200 (40%), Positives = 122/200 (61%), Gaps = 12/200 (6%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-- 174
           ++G+G FG+V+  +K      D+  +YAMK + K  I  K        ER +L+ V+   
Sbjct: 1   IIGRGGFGEVYGCRK-----ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 55

Query: 175 -PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
            PFIV + Y+F T  KL  ILD +NGG L +HL + G+F E + RFY  EI+  + H+H 
Sbjct: 56  CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHN 115

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG--H 291
             +V+RDLKP NIL+D  GHV ++D GLA +  +  + ++  GT  YMAPE+ L KG  +
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEV-LQKGTAY 173

Query: 292 NKDADWWSVGILLYEMLTGQ 311
           +  ADW+S+G +L+++L G 
Sbjct: 174 DSSADWFSLGCMLFKLLRGH 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  152 bits (383), Expect = 1e-42
 Identities = 82/216 (37%), Positives = 121/216 (56%), Gaps = 23/216 (10%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            + I R +G+G+FG+V+  + +         + A+KV+ K    K   V+    E  IL 
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRK--------LVALKVLAKKLESKSKEVERFLREIQILA 52

Query: 171 KVTHP-FIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQGIFREDQARFYTAEIVS 226
            + HP  IV+L   FQ    LYL++++++GG    L   + R+G   E +A F  A+I+S
Sbjct: 53  SLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGH-VMLTDFGLAKEIDESS-------RSNSMCGTT 278
           A+ +LH  GI+HRD+KPENIL+D DG  V L DFGLAK + +           ++  GT 
Sbjct: 113 ALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172

Query: 279 EYMAPEILLSKGH---NKDADWWSVGILLYEMLTGQ 311
            YMAPE+LL       +  +D WS+GI LYE+LTG 
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208

Length = 384

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  145 bits (368), Expect = 1e-41
 Identities = 70/199 (35%), Positives = 113/199 (56%), Gaps = 8/199 (4%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR--KDTIIKKNHVDYMKAERDILTKVT 173
            ++G G+FG V++    G++  D    +A+K +    D    +  V  ++ E  +L+K+ 
Sbjct: 6   ELLGSGSFGSVYE----GLN-LDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
           HP IVQ   + +    LY+ L+ + GG L   L + G F E   R YT +I+  + +LH 
Sbjct: 61  HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG-HN 292
              VHRD+K  NIL+D++G V L DFG+AK++ E S + S  G+  +MAPE++  +G + 
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYG 180

Query: 293 KDADWWSVGILLYEMLTGQ 311
             AD WS+G  + EM TG+
Sbjct: 181 LAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score =  152 bits (386), Expect = 3e-41
 Identities = 66/155 (42%), Positives = 105/155 (67%), Gaps = 9/155 (5%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F I + + +GAFGKV+  +KK     ++  +YA+KV++K  +I KN V  ++AERD L 
Sbjct: 5   EFVIVKPISRGAFGKVYLGRKK-----NNSKLYAVKVVKKADMINKNMVHQVQAERDALA 59

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAV 228
               PFIV L YS Q+ + +YL+++++ GG +    H+Y  G F E+ A  Y +E+  A+
Sbjct: 60  LSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALAL 117

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK 263
            +LH+ GI+HRDLKP+N+L+ ++GH+ LTDFGL+K
Sbjct: 118 DYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  143 bits (363), Expect = 8e-41
 Identities = 66/202 (32%), Positives = 117/202 (57%), Gaps = 7/202 (3%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           ++++  ++G+GAFG V+    KG++  ++    A+K +  + I ++     M  E D+L 
Sbjct: 1   NYQLGDLIGRGAFGVVY----KGLN-LETGDFVAIKQISLEKIKEEALKSIM-QEIDLLK 54

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP IV+   S +T   LY+IL++   G L   + + G F E     Y  +++  +++
Sbjct: 55  NLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAY 114

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR-SNSMCGTTEYMAPEILLSK 289
           LH+ G++HRD+K  NIL   DG V L DFG+A ++++ S+   S+ GT  +MAPE++   
Sbjct: 115 LHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS 174

Query: 290 GHNKDADWWSVGILLYEMLTGQ 311
           G +  +D WS+G  + E+LTG 
Sbjct: 175 GASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  137 bits (347), Expect = 2e-38
 Identities = 68/204 (33%), Positives = 110/204 (53%), Gaps = 16/204 (7%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G G FGKV+        + D+  + A+K +R      K     +  E  +L  + HP +
Sbjct: 8   IGGGTFGKVYTAV-----NLDTGELMAVKEIRIQDNDPKTI-KEIADEMKVLELLKHPNL 61

Query: 178 VQLRYSFQT-RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGI 236
           V+  Y  +  R K+Y+ +++ +GG L   L    I  E   R YT +++  +++LH  GI
Sbjct: 62  VKY-YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGI 120

Query: 237 VHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-----NSMCGTTEYMAPEILL---S 288
           VHRD+KP NI +D +G + L DFG A ++  ++ +      S+ GT  YMAPE++     
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180

Query: 289 KGHNKDADWWSVGILLYEMLTGQV 312
           KGH + AD WS+G ++ EM TG+ 
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  135 bits (343), Expect = 2e-37
 Identities = 66/222 (29%), Positives = 118/222 (53%), Gaps = 15/222 (6%)

Query: 96  DAELEAESERKIGPGD----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD 151
           + EL+A  +  +  GD    ++    +G+GA G+V++   +    G      A+K MR  
Sbjct: 1   EEELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRA--TGKE---VAIKKMR-- 53

Query: 152 TIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QG 210
             ++K + + +  E  I+    HP IV    S+    +L++++++++GG L   + +   
Sbjct: 54  --LRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFV 111

Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESS 269
              E Q  +   E++  + +LH   ++HRD+K +NIL+  DG V L DFG A ++  E S
Sbjct: 112 RMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171

Query: 270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           + NS+ GT  +MAPE++  K +    D WS+GI+  EM  G+
Sbjct: 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  134 bits (339), Expect = 3e-37
 Identities = 61/203 (30%), Positives = 110/203 (54%), Gaps = 9/203 (4%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D E  +V+GQG+ G V++V+ K    G    IYA+K +  D   +      +  E   L 
Sbjct: 2   DLERVKVLGQGSSGVVYKVRHKP--TGK---IYALKKIHVDGDEEFRKQ--LLRELKTLR 54

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
               P++V+   +F    ++ ++L++++GG L   L + G   E    +   +I+  + +
Sbjct: 55  SCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDY 114

Query: 231 LHKC-GIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-RSNSMCGTTEYMAPEILLS 288
           LH    I+HRD+KP N+L++S G V + DFG++K ++ +  + N+  GT  YM+PE +  
Sbjct: 115 LHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQG 174

Query: 289 KGHNKDADWWSVGILLYEMLTGQ 311
           + ++  AD WS+G+ L E   G+
Sbjct: 175 ESYSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  131 bits (333), Expect = 4e-36
 Identities = 61/200 (30%), Positives = 112/200 (56%), Gaps = 9/200 (4%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F +   +G+G+FG+V+    K +D   +  + A+KV+  +    ++ ++ ++ E   L++
Sbjct: 3   FTLLECIGKGSFGEVY----KAIDKRTNQ-VVAIKVIDLEE--AEDEIEDIQQEIQFLSQ 55

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
              P+I +   SF   SKL++I+++  GG     L + G   E    F   E++  + +L
Sbjct: 56  CRSPYITKYYGSFLKGSKLWIIMEYCGGGSCL-DLLKPGKLDETYIAFILREVLLGLEYL 114

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPEILLSKG 290
           H+ G +HRD+K  NIL+  +G V L DFG++ ++    S+ N+  GT  +MAPE++   G
Sbjct: 115 HEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG 174

Query: 291 HNKDADWWSVGILLYEMLTG 310
           +++ AD WS+GI   E+  G
Sbjct: 175 YDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  131 bits (331), Expect = 5e-36
 Identities = 67/205 (32%), Positives = 105/205 (51%), Gaps = 7/205 (3%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           P ++   +++GQGAFG+V+      VD G    +  +         K   V+ ++ E  +
Sbjct: 1   PTNWRRGKLLGQGAFGRVYLCYD--VDTGRELAVKQVPFDPDSPETK-KEVNALECEIQL 57

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           L  + H  IVQ     +    L + ++++ GG +   L   G   E   R YT +I+  V
Sbjct: 58  LKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGV 117

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID----ESSRSNSMCGTTEYMAPE 284
            +LH   IVHRD+K  NIL DS G+V L DFG +K +       +   S+ GT  +M+PE
Sbjct: 118 EYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177

Query: 285 ILLSKGHNKDADWWSVGILLYEMLT 309
           ++  +G+ + AD WSVG  + EMLT
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  128 bits (323), Expect = 5e-35
 Identities = 66/195 (33%), Positives = 111/195 (56%), Gaps = 9/195 (4%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G+FGK   VK K  +DG    I  + + +    +     +  + E  +L+ + HP I
Sbjct: 8   IGEGSFGKAILVKSK--EDGKQYVIKEINISK----MSPKEREESRKEVAVLSNMKHPNI 61

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GI-FREDQARFYTAEIVSAVSHLHKCG 235
           VQ + SF+    LY+++D+  GG L+  +  Q G+ F EDQ   +  +I  A+ H+H   
Sbjct: 62  VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK 121

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMC-GTTEYMAPEILLSKGHNKD 294
           I+HRD+K +NI +  DG + L DFG+A+ ++ +      C GT  Y++PEI  ++ +N  
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNK 181

Query: 295 ADWWSVGILLYEMLT 309
           +D W++G +LYEM T
Sbjct: 182 SDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  126 bits (319), Expect = 2e-34
 Identities = 66/208 (31%), Positives = 121/208 (58%), Gaps = 17/208 (8%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMK---VMRKDTIIKKNHVDYMKAERD 167
           DFEI   +G+G+FG VF+V +K   D     +YAMK   + + +   ++  +D    E  
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRK--ADKR---VYAMKQIDLSKMNRREREEAID----EAR 51

Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG--HLFFHLYRQGIFREDQA-RFYTAEI 224
           +L K+   +I++   SF  + KL +++++   G  H    + R     EDQ  RF+  +I
Sbjct: 52  VLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QI 110

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR-SNSMCGTTEYMAP 283
           +  ++HLH   I+HRD+K  N+ +D+  +V + D G+AK + +++  +N++ GT  Y++P
Sbjct: 111 LLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSP 170

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQ 311
           E+   K +N+ +D W++G++LYE  TG+
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  126 bits (319), Expect = 2e-34
 Identities = 56/215 (26%), Positives = 113/215 (52%), Gaps = 15/215 (6%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            F+I   +G+G++G V++   K     ++  + A+KV+  +  +++     +  E  IL 
Sbjct: 4   VFDILEKLGEGSYGSVYKAIHK-----ETGQVVAIKVVPVEEDLQE-----IIKEISILK 53

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEIVSAVS 229
           +   P+IV+   S+   + L++++++   G +   +        E++      + +  + 
Sbjct: 54  QCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLE 113

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPEILLS 288
           +LH    +HRD+K  NIL++ +G   L DFG++ ++ D  ++ N++ GT  +MAPE++  
Sbjct: 114 YLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE 173

Query: 289 KGHNKDADWWSVGILLYEMLTGQ---VNIKSMQVI 320
            G+N  AD WS+GI   EM  G+    +I  M+ I
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI 208

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  126 bits (319), Expect = 2e-34
 Identities = 69/213 (32%), Positives = 113/213 (53%), Gaps = 17/213 (7%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMK-------VMRKDTIIKKNHVDYMKA 164
           + +   +G GAFG V++V+KK     +   + A+K          KD   +   +  + +
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKN----NGQNLLALKEINVHNPAFGKDKRERDKSIGDIVS 57

Query: 165 ERDILTK-VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY----RQGIFREDQARF 219
           E  I+ + + HP IV+   +F    +LY+++D I G  L  H      ++  F E++   
Sbjct: 58  EVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117

Query: 220 YTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
              ++V A+ +LHK   IVHRDL P NI++  D  V +TDFGLAK+    S+  S+ GT 
Sbjct: 118 IFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTI 177

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
            Y  PEI+ ++ + + AD W+ G +LY+M T Q
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQ 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  127 bits (321), Expect = 3e-34
 Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 19/208 (9%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--L 169
           +E+  VVG+GA+G V + + K    G+   I   K    D  +KK       A R++  L
Sbjct: 3   YEVLGVVGEGAYGVVLKCRNK--ATGEIVAIKKFKESEDDEDVKK------TALREVKVL 54

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL---YRQGIFREDQARFYTAEIVS 226
            ++ H  IV L+ +F+ + +LYL+ +++        L      G+   D  R Y  +++ 
Sbjct: 55  RQLRHENIVNLKEAFRRKGRLYLVFEYV--ERTLLELLEASPGGL-PPDAVRSYIWQLLQ 111

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN--SMCGTTEYMAPE 284
           A+++ H   I+HRD+KPENIL+   G + L DFG A+ +     S       T  Y APE
Sbjct: 112 AIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPE 171

Query: 285 ILLSKG-HNKDADWWSVGILLYEMLTGQ 311
           +L+    + K  D W++G ++ E+L G+
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  126 bits (319), Expect = 4e-34
 Identities = 61/204 (29%), Positives = 107/204 (52%), Gaps = 12/204 (5%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--L 169
           ++    +G+G +G V++ +     D  +  I A+K ++      ++      A R+I  L
Sbjct: 1   YQKLGKIGEGTYGVVYKAR-----DKLTGEIVAIKKIKLRF---ESEGIPKTALREIKLL 52

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
            ++ HP I++L   F+ +  LYL+ +F++         RQ    E   + Y  +++  ++
Sbjct: 53  KELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA 112

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-NSMCGTTEYMAPEILL- 287
             H  GI+HRDLKPEN+L++++G + L DFGLA+      R       T  Y APE+LL 
Sbjct: 113 FCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLG 172

Query: 288 SKGHNKDADWWSVGILLYEMLTGQ 311
            KG++   D WSVG +  E+L+ +
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  123 bits (311), Expect = 3e-33
 Identities = 67/201 (33%), Positives = 113/201 (56%), Gaps = 9/201 (4%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +   RV+G+GAFG+    ++      + D +   K +    + +K   D +  E  IL+ 
Sbjct: 2   YIPIRVLGKGAFGEATLYRRT-----EDDSLVVWKEVNLTRLSEKERRDALN-EIVILSL 55

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVS 229
           + HP I+     F   + L + +++ NGG L+  + RQ   +F E+   +Y  +IVSAVS
Sbjct: 56  LQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVS 115

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPEILLS 288
           ++HK GI+HRD+K  NI +   G + L DFG++K +  E S + ++ GT  YM+PE+   
Sbjct: 116 YIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQG 175

Query: 289 KGHNKDADWWSVGILLYEMLT 309
             +N  +D W++G +LYE+LT
Sbjct: 176 VKYNFKSDIWALGCVLYELLT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  123 bits (311), Expect = 4e-33
 Identities = 64/214 (29%), Positives = 112/214 (52%), Gaps = 20/214 (9%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           D+E+   +G+G+FG V +V++K      SDG I   K +    + +K     + +E +IL
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRK------SDGKILVWKEIDYGNMTEKEK-QQLVSEVNIL 53

Query: 170 TKVTHPFIVQL--RYSFQTRSKLYLILDFINGGHL--FFHLYRQ--GIFREDQARFYTAE 223
            ++ HP IV+   R   ++   LY+++++  GG L       ++      E+       +
Sbjct: 54  RELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQ 113

Query: 224 IVSAVSHLHKCG-----IVHRDLKPENILMDSDGHVMLTDFGLAKEIDE-SSRSNSMCGT 277
           ++ A+   H        ++HRDLKP NI +D++ +V L DFGLAK +   SS + +  GT
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGT 173

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
             YM+PE L    +++ +D WS+G L+YE+    
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  123 bits (312), Expect = 4e-33
 Identities = 57/220 (25%), Positives = 109/220 (49%), Gaps = 43/220 (19%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD---- 167
           +E    +G+G +G+V++ + K   +     + A+K +R +             E++    
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGE-----LVALKKIRMEN------------EKEGFPI 43

Query: 168 -------ILTKVTHPFIVQLR--YSFQTRSKLYLILDFI----NGGHLFFHLYRQGIFRE 214
                  +L K+ HP IV+L+   + + +  +Y++ +++     G         +  F E
Sbjct: 44  TAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG----LLDSPEVKFTE 99

Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR---S 271
            Q + Y  +++  + +LH  GI+HRD+K  NIL+++DG + L DFGLA+   + +    +
Sbjct: 100 SQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159

Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTG 310
           N +  T  Y  PE+LL +  +  + D WSVG +L E+  G
Sbjct: 160 NRVI-TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  121 bits (304), Expect = 3e-32
 Identities = 67/202 (33%), Positives = 114/202 (56%), Gaps = 10/202 (4%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +EI + +G+G+FGK++  K K     DS+     ++      +K+      K E  +L K
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKS----DSEHCVIKEIDLTKMPVKEKEAS--KKEVILLAK 55

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVS 229
           + HP IV    SFQ   +L++++++ +GG L   + RQ   +F EDQ   +  +I   + 
Sbjct: 56  MKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMC-GTTEYMAPEILL 287
           H+H   I+HRD+K +NI +  +G V  L DFG+A+++++S      C GT  Y++PEI  
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQ 175

Query: 288 SKGHNKDADWWSVGILLYEMLT 309
           ++ +N   D WS+G +LYE+ T
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  119 bits (301), Expect = 9e-32
 Identities = 63/215 (29%), Positives = 117/215 (54%), Gaps = 15/215 (6%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           DF++ + +G+G++G V++VK+       SD   YA+K +   ++ +K   D +   R IL
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKR------LSDNQFYALKEVDLGSMSQKEREDAVNEIR-IL 53

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEIV 225
             V HP I+  + +F   +KL +++++   G L   + ++     +  E +      +++
Sbjct: 54  ASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEI 285
             +  LH+  I+HRDLK  NIL+ ++  V + D G++K + + + + +  GT  YMAPE+
Sbjct: 114 RGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISK-VLKKNMAKTQIGTPHYMAPEV 172

Query: 286 LLSKGHNKDADWWSVGILLYEMLTGQV--NIKSMQ 318
              + ++  +D WS+G LLYEM T       +SMQ
Sbjct: 173 WKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ 207

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  119 bits (302), Expect = 1e-31
 Identities = 66/219 (30%), Positives = 105/219 (47%), Gaps = 42/219 (19%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD--------TIIKKNHVDYMK 163
           +E    +G+G +G V++ + K      +  I A+K +R D        T ++        
Sbjct: 1   YEKLEKLGEGTYGVVYKARDK-----KTGEIVALKKIRLDNEEEGIPSTALR-------- 47

Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-----RQGIFREDQAR 218
            E  +L ++ HP IV+L     T  KLYL+ ++ +       L      R G    +  +
Sbjct: 48  -EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-----MDLKKYLDKRPGPLSPNLIK 101

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
               +++  +++ H   I+HRDLKP+NIL++ DG + L DFGLA+             T 
Sbjct: 102 SIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAF----GIPLRTYTH 157

Query: 279 E-----YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
           E     Y APEILL SK ++   D WSVG +  EM+TG+
Sbjct: 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  118 bits (298), Expect = 3e-31
 Identities = 60/219 (27%), Positives = 117/219 (53%), Gaps = 18/219 (8%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+E+ + +G G +G V++ +     D  +  + A+KV++ +     +  + ++ E  +L 
Sbjct: 4   DYELIQRIGSGTYGDVYKAR-----DIATGELVAIKVIKLE---PGDDFEIIQQEISMLK 55

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAV 228
           +  HP IV    S+  R KL++++++  GG L   + + R G   E Q  +   E +  +
Sbjct: 56  ECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGL 114

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEYMAPEILL 287
           ++LH+ G +HRD+K  NIL+  DG V L DFG++ ++  + ++  S  GT  +MAPE+  
Sbjct: 115 AYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAA 174

Query: 288 SK---GHNKDADWWSVGILLYEMLTGQ---VNIKSMQVI 320
            +   G++   D W++GI   E+   Q    ++  M+ +
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  117 bits (296), Expect = 6e-31
 Identities = 61/214 (28%), Positives = 106/214 (49%), Gaps = 20/214 (9%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR---KDTIIKKNHVDYMKAER 166
            D E    +G G  G V +V  +      +  I A+K +R    + I K+     +  E 
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRP-----TGKIMAVKTIRLEINEAIQKQ-----ILREL 50

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEI 224
           DIL K   P+IV    +F     + + +++++GG L       +  I  E         +
Sbjct: 51  DILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRI-PERILGKIAVAV 109

Query: 225 VSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMA 282
           +  +++LH K  I+HRD+KP NIL++S G + L DFG++ + ++  S + +  GT+ YMA
Sbjct: 110 LKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN--SLAKTFVGTSSYMA 167

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQVNIKS 316
           PE +    ++  +D WS+G+ L E+ TG+     
Sbjct: 168 PERIQGNDYSVKSDIWSLGLSLIELATGRFPYPP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  117 bits (294), Expect = 8e-31
 Identities = 67/203 (33%), Positives = 113/203 (55%), Gaps = 12/203 (5%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH-VDYMKAERDIL 169
            + + RVVG+G+FG+   V+       +SD  YAMK +R   + K +  V+  + E  +L
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHV-----NSDQKYAMKEIR---LPKSSSAVEDSRKEAVLL 52

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF--FHLYRQGIFREDQARFYTAEIVSA 227
            K+ HP IV  + SF+    LY+++++ +GG L     L R  +F ED    +  ++   
Sbjct: 53  AKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLG 112

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEYMAPEIL 286
           V H+H+  ++HRD+K +NI +  +G V L DFG A+ +    + + +  GT  Y+ PEI 
Sbjct: 113 VQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIW 172

Query: 287 LSKGHNKDADWWSVGILLYEMLT 309
            +  +N  +D WS+G +LYE+ T
Sbjct: 173 ENMPYNNKSDIWSLGCILYELCT 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  116 bits (293), Expect = 1e-30
 Identities = 64/209 (30%), Positives = 115/209 (55%), Gaps = 25/209 (11%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM-KAER---- 166
           +E  RVVG+GAFG V   ++K                +K  IIK+  V+ M K ER    
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKAD--------------QKLVIIKQIPVEQMTKDERLAAQ 47

Query: 167 ---DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYT 221
               +L  ++HP I++   +F     L +++++  GG L  ++ ++   +  ED    + 
Sbjct: 48  NECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFF 107

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCGTTEY 280
            +I+ A+ H+H   I+HRDLK +NIL+D    V+ + DFG++K +   S++ ++ GT  Y
Sbjct: 108 VQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCY 167

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT 309
           ++PE+   K +N+ +D W++G +LYE+ +
Sbjct: 168 ISPELCEGKPYNQKSDIWALGCVLYELAS 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  117 bits (294), Expect = 1e-30
 Identities = 64/204 (31%), Positives = 116/204 (56%), Gaps = 13/204 (6%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           ++   ++G+GA+G V+  + K V  G    + A+K++  DT    + V  ++ E  +L++
Sbjct: 3   YQRLELIGRGAYGAVY--RGKHVPTGR---VVALKIINLDT--PDDDVSDIQREVALLSQ 55

Query: 172 VTH---PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           +     P I +   S+    +L++I+++  GG +   L + G   E        E++ A+
Sbjct: 56  LRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVR-TLMKAGPIAEKYISVIIREVLVAL 114

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMAPEILL 287
            ++HK G++HRD+K  NIL+ + G+V L DFG+A  ++++S   S   GT  +MAPE++ 
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVIT 174

Query: 288 S-KGHNKDADWWSVGILLYEMLTG 310
             K ++  AD WS+GI +YEM TG
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  117 bits (294), Expect = 1e-30
 Identities = 63/214 (29%), Positives = 120/214 (56%), Gaps = 11/214 (5%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR----KDTIIKKNHVDYMKAERDILTKV 172
           ++G+G +G+V+      V  G+   +  +++      +    +K+ V  +++E + L  +
Sbjct: 8   LIGKGTYGRVYLALN--VTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
            H  IVQ      T   L + L+++ GG +   L   G F E   RF+T +++  +++LH
Sbjct: 66  DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125

Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE---SSRSNSMCGTTEYMAPEILLS- 288
             GI+HRDLK +N+L+D+DG   ++DFG++K+ D+   + ++ SM G+  +MAPE++ S 
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185

Query: 289 -KGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA 321
            +G++   D WS+G ++ EM  G+      + IA
Sbjct: 186 SQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  116 bits (294), Expect = 2e-30
 Identities = 63/207 (30%), Positives = 107/207 (51%), Gaps = 18/207 (8%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--L 169
           +++ + +G G FG V+  + K     ++  + A+K M+K      +  + M   R++  L
Sbjct: 1   YKVIKQLGDGTFGSVYLARNK-----ETGELVAIKKMKKKF---YSWEECMN-LREVKSL 51

Query: 170 TKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ---GIFREDQARFYTAEIV 225
            K+  HP IV+L+  F+   +LY + +++ G    + L +      F E   R    +I+
Sbjct: 52  RKLNEHPNIVKLKEVFRENDELYFVFEYMEGN--LYQLMKDRKGKPFSESVIRSIIYQIL 109

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEI 285
             ++H+HK G  HRDLKPEN+L+     V + DFGLA+EI           T  Y APEI
Sbjct: 110 QGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEI 169

Query: 286 LL-SKGHNKDADWWSVGILLYEMLTGQ 311
           LL S  ++   D W++G ++ E+ T +
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  115 bits (289), Expect = 8e-30
 Identities = 69/207 (33%), Positives = 112/207 (54%), Gaps = 16/207 (7%)

Query: 109 PGDF-EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD 167
           P D  EI   +G GAFGKV++ + K     ++    A K++      ++   D+M  E D
Sbjct: 3   PNDIWEIIGELGDGAFGKVYKAQHK-----ETGLFAAAKII--QIESEEELEDFM-VEID 54

Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIVS 226
           IL++  HP IV L  ++   +KL+++++F +GG L    L  +    E Q R+   +++ 
Sbjct: 55  ILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLE 114

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL-AKEIDESSRSNSMCGTTEYMAPEI 285
           A++ LH   ++HRDLK  NIL+  DG V L DFG+ AK      + ++  GT  +MAPE+
Sbjct: 115 ALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEV 174

Query: 286 LL-----SKGHNKDADWWSVGILLYEM 307
           +         ++  AD WS+GI L E+
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  115 bits (289), Expect = 8e-30
 Identities = 74/214 (34%), Positives = 118/214 (55%), Gaps = 20/214 (9%)

Query: 104 ERKIGPGD-FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
            R + P + +EI   +G GAFGKV++ K K     ++  + A KV+  +T  ++   DYM
Sbjct: 5   RRDLDPNEVWEIIGELGDGAFGKVYKAKNK-----ETGALAAAKVI--ETKSEEELEDYM 57

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH---LFFHLYRQGIFREDQARF 219
             E +IL    HP+IV+L  +F    KL+++++F  GG    +   L R     E Q + 
Sbjct: 58  -VEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQV 114

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL-AKEIDESSRSNSMCGTT 278
              +++ A+ +LH   I+HRDLK  N+L+  DG + L DFG+ AK +    R +S  GT 
Sbjct: 115 ICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTP 174

Query: 279 EYMAPEILLSKG-----HNKDADWWSVGILLYEM 307
            +MAPE+++ +      ++  AD WS+GI L EM
Sbjct: 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  112 bits (283), Expect = 4e-29
 Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 32/217 (14%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-IKKNHVDYMKAERDIL 169
           D+E+  V+G GA   V+                A+ +   + + IK+  ++  +   D L
Sbjct: 2   DYELIEVIGVGATAVVYA---------------AICLPNNEKVAIKRIDLEKCQTSVDEL 46

Query: 170 TK-------VTHPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQGIFREDQARF 219
            K         HP +V+   SF    +L+L++ +++GG    +    Y +G   E     
Sbjct: 47  RKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIAT 106

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG----LAKEIDESSRS-NSM 274
              E++  + +LH  G +HRD+K  NIL+  DG V + DFG    LA   D + +   + 
Sbjct: 107 VLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF 166

Query: 275 CGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTG 310
            GT  +MAPE++    G++  AD WS GI   E+ TG
Sbjct: 167 VGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATG 203

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  111 bits (279), Expect = 2e-28
 Identities = 76/211 (36%), Positives = 115/211 (54%), Gaps = 20/211 (9%)

Query: 107 IGPGDF-EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           + P +F EI   +G GAFGKV++ + K     ++  + A KV+  DT  ++   DYM  E
Sbjct: 1   LNPEEFWEIIGELGDGAFGKVYKAQNK-----ETGVLAAAKVI--DTKSEEELEDYM-VE 52

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL---FFHLYRQGIFREDQARFYTA 222
            DIL    HP IV+L  +F   + L+++++F  GG +      L R     E Q R    
Sbjct: 53  IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTEPQIRVVCK 110

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL-AKEIDESSRSNSMCGTTEYM 281
           + + A+++LH+  I+HRDLK  NIL   DG + L DFG+ AK      R +S  GT  +M
Sbjct: 111 QTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWM 170

Query: 282 APEILL-----SKGHNKDADWWSVGILLYEM 307
           APE+++      + ++  AD WS+GI L EM
Sbjct: 171 APEVVMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  110 bits (276), Expect = 3e-28
 Identities = 66/225 (29%), Positives = 116/225 (51%), Gaps = 31/225 (13%)

Query: 117 VVGQGAFGKVF-----------QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           ++G G+FG V+            VK+  +    +          KD   K++ +D +  E
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASS--------KDR--KRSMLDALARE 56

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L ++ H  IVQ   S      L + L+++ GG +   L   G F E   R +  +I+
Sbjct: 57  IALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL 116

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN-------SMCGTT 278
             +++LH  GI+HRD+K  NIL+D+ G + ++DFG++K+++ +S S        S+ G+ 
Sbjct: 117 KGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ---VNIKSMQVI 320
            +MAPE++    + + AD WS+G L+ EMLTG+    +   +Q I
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI 221

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  109 bits (275), Expect = 6e-28
 Identities = 62/224 (27%), Positives = 110/224 (49%), Gaps = 24/224 (10%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G+GAFG+V++ K KG D   ++   A+K +++D   ++   D++K E  ++ K+ HP
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEV--AVKTLKEDASEEE-RKDFLK-EARVMKKLGHP 56

Query: 176 FIVQLR-YSFQTRSKLYLILDFINGGHL----------FFHLYRQGIFREDQARFYTAEI 224
            +V+L          LYL+L+++ GG L          F    +  +  +D   F   +I
Sbjct: 57  NVVRLLGVCT-EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSF-AIQI 114

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE---YM 281
              + +L     VHRDL   N L+  D  V ++DFGL++++ +        G      +M
Sbjct: 115 AKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM 174

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT-GQV---NIKSMQVIA 321
           APE L        +D WS G+LL+E+ T G      + + +V+ 
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLE 218

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  110 bits (276), Expect = 6e-28
 Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 25/212 (11%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMK---VMRKDTIIKKNHVDYMKAERD 167
            ++I   +G+GA G VF+ K +      +    A+K   + R +  I    +  +KA   
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRE-----TGETVALKKVALRRLEGGIPNQALREIKA--- 52

Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-----RQGIFREDQARFYTA 222
            L    HP++V+L   F   S   L+++++        L       +    E Q + Y  
Sbjct: 53  -LQACQHPYVVKLLDVFPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQVKSYMR 106

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNS-MCGTTEY 280
            ++  V+++H  GI+HRDLKP N+L+ +DG + + DFGLA+    E  R  S    T  Y
Sbjct: 107 MLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWY 166

Query: 281 MAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
            APE+L  ++ ++   D W+VG +  E+L G 
Sbjct: 167 RAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  109 bits (275), Expect = 7e-28
 Identities = 64/221 (28%), Positives = 116/221 (52%), Gaps = 28/221 (12%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
            G FE+  V+G+G +GKV++ + K      +  + A+K+M     I ++  + +K E +I
Sbjct: 5   TGIFELVEVIGEGTYGKVYKARHK-----KTGQLVAIKIMD----IIEDEEEEIKEEYNI 55

Query: 169 LTKVT-HPFIVQLRYSFQTRS------KLYLILDFINGG---HLFFHLYRQG-IFREDQA 217
           L K + HP I     +F  ++      +L+L+++   GG    L   L ++G   +E+  
Sbjct: 56  LRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWI 115

Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCG 276
            +   E +  +++LH+  ++HRD+K +NIL+  +  V L DFG++ ++D    R N+  G
Sbjct: 116 AYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIG 175

Query: 277 TTEYMAPEILLSKGHNKDA------DWWSVGILLYEMLTGQ 311
           T  +MAPE++       DA      D WS+GI   E+  G+
Sbjct: 176 TPYWMAPEVIACD-EQPDASYDARSDVWSLGITAIELADGK 215

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  109 bits (274), Expect = 9e-28
 Identities = 56/199 (28%), Positives = 99/199 (49%), Gaps = 7/199 (3%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G+GAFG+V++   KG  +G  +   A+K +++    ++   ++++ E  I+ K++HP
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGT-ETKVAVKTLKEGAS-EEEREEFLE-EASIMKKLSHP 61

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSHLHKC 234
            IV+L         LY++ +++ GG L   L + G             +I   + +L   
Sbjct: 62  NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK 121

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE---YMAPEILLSKGH 291
             VHRDL   N L+  +  V ++DFGL+++I E        G      +MAPE L     
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKF 181

Query: 292 NKDADWWSVGILLYEMLTG 310
              +D WS G+LL+E+ T 
Sbjct: 182 TSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score =  108 bits (273), Expect = 1e-27
 Identities = 70/201 (34%), Positives = 99/201 (49%), Gaps = 34/201 (16%)

Query: 121 GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN------HV-DYMKAERDILTKVT 173
           G FGKV  +K K             K+  +  I  KN       V   MK          
Sbjct: 27  GKFGKVSVLKHKPTQ----------KLFVQKIIKAKNFNAIEPMVHQLMK---------D 67

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
           +P  ++L YS  T     LI+D+I  G LF  L ++G   E + +    ++V A++ LHK
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127

Query: 234 CGIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN 292
             I+H D+K EN+L D +   + L D+GL K I   S      GT +Y +PE +  KGHN
Sbjct: 128 HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS---CYDGTLDYFSPEKI--KGHN 182

Query: 293 KDA--DWWSVGILLYEMLTGQ 311
            D   DWW+VG+L YE+LTG+
Sbjct: 183 YDVSFDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  109 bits (276), Expect = 2e-27
 Identities = 68/219 (31%), Positives = 111/219 (50%), Gaps = 36/219 (16%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK------NHVDYMKAE 165
           +EI + +G+GA+G V+    K +D          +  ++   +KK      N  D  +  
Sbjct: 9   YEILQKLGKGAYGIVW----KAID----------RRTKEVVALKKIFDAFRNATDAQRTF 54

Query: 166 RDI--LTKVT-HPFIVQLR--YSFQTRSKLYLILDFINGGHLFFH-LYRQGIFREDQARF 219
           R+I  L ++  HP IV+L      +    +YL+ +++       H + R  I  +   R+
Sbjct: 55  REIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETD---LHAVIRANILEDVHKRY 111

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
              +++ A+ ++H   ++HRDLKP NIL++SD  V L DFGLA+ + E   +      T+
Sbjct: 112 IMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD 171

Query: 280 YMA------PEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
           Y+A      PEILL S  + K  D WSVG +L EML G+
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score =  107 bits (269), Expect = 2e-27
 Identities = 56/168 (33%), Positives = 87/168 (51%), Gaps = 4/168 (2%)

Query: 145 MKVMRKDTIIKKNHVDYMKAERDILTKVTH--PFIVQLRYSFQTRSKLYLILDFINGGHL 202
           M    + T I K      +  R+ LT + H  P +V L     +   ++L+L    GG L
Sbjct: 13  MDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKL 72

Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           + H+ +     E+  + + AE+V A+  LH+ GIV RDL P NIL+D  GH+ LT F   
Sbjct: 73  WSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRW 132

Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            E+++S    ++     Y APE+       +  DWWS+G +L+E+LTG
Sbjct: 133 SEVEDSCDGEAV--ENMYCAPEVGGISEETEACDWWSLGAILFELLTG 178

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  108 bits (270), Expect = 4e-27
 Identities = 66/202 (32%), Positives = 106/202 (52%), Gaps = 8/202 (3%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           FE+  VVG+GA+G V + + K     ++  I A+K   KD+   +   +    E  +L  
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHK-----ETKEIVAIKKF-KDSEENEEVKETTLRELKMLRT 56

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           +    IV+L+ +F+ R KLYL+ +++    L            ++ R Y  +++ A+   
Sbjct: 57  LKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWC 116

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN--SMCGTTEYMAPEILLSK 289
           HK  IVHRD+KPEN+L+  +  + L DFG A+ + E S +N      T  Y +PE+LL  
Sbjct: 117 HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176

Query: 290 GHNKDADWWSVGILLYEMLTGQ 311
            + K  D WSVG +L E+  GQ
Sbjct: 177 PYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  107 bits (268), Expect = 4e-27
 Identities = 70/209 (33%), Positives = 112/209 (53%), Gaps = 13/209 (6%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN--HVDYMKAER 166
           P ++ + +++G+GAFG+V+        D D+    A+K +  D   ++    V+ ++ E 
Sbjct: 1   PVNWRLGKLLGRGAFGEVYLCY-----DADTGRELAVKQVPFDPDSQETSKEVNALECEI 55

Query: 167 DILTKVTHPFIVQLRYSFQ--TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
            +L  + H  IVQ     +     KL + ++++ GG +   L   G   E+  R YT +I
Sbjct: 56  QLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI 115

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS----NSMCGTTEY 280
           +  VS+LH   IVHRD+K  NIL DS G+V L DFG +K I     S     S+ GT  +
Sbjct: 116 LQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT 309
           M+PE++  +G+ + AD WSV   + EMLT
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  107 bits (268), Expect = 5e-27
 Identities = 67/231 (29%), Positives = 114/231 (49%), Gaps = 34/231 (14%)

Query: 117 VVGQGAFGKVF----------QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           V+G+GA+G V+           VK+  +D  +     A K   K           ++ E 
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLA--AEKEYEK-----------LQEEV 53

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVS 226
           D+L  + H  IVQ   +    + + + ++F+ GG +   L R G   E     YT +I+ 
Sbjct: 54  DLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD 113

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-------DESSRSNSMCGTTE 279
            V++LH   +VHRD+K  N+++  +G + L DFG A+ +         S+   SM GT  
Sbjct: 114 GVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173

Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYL 330
           +MAPE++   G+ + +D WS+G  ++EM TG+  + SM  +A     +FY+
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA----MFYI 220

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  106 bits (268), Expect = 6e-27
 Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 13/201 (6%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIY---AMKVMRKDTIIKKNHVDYMKAERDILTKV 172
           + +G+GAFG+V+    KG   G  DG     A+K +++D   +   ++    E  I+ K+
Sbjct: 5   KKLGEGAFGEVY----KGTLKGKGDGKEVEVAVKTLKEDASEQ--QIEEFLREARIMRKL 58

Query: 173 THPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAVSH 230
            HP IV+L         L ++++++ GG L  +    R           +  +I   + +
Sbjct: 59  DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG--TTEYMAPEILLS 288
           L     +HRDL   N L+  +  V ++DFGL++++ +        G     +MAPE L  
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178

Query: 289 KGHNKDADWWSVGILLYEMLT 309
                 +D WS G+LL+E+ T
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFT 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  106 bits (266), Expect = 1e-26
 Identities = 60/195 (30%), Positives = 111/195 (56%), Gaps = 9/195 (4%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G+FG+VF    KG+D+  +  + A+K++  D    ++ ++ ++ E  +L++   P++
Sbjct: 12  IGKGSFGEVF----KGIDN-RTQQVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
            +   S+   +KL++I++++ GG     L R G F E Q      EI+  + +LH    +
Sbjct: 65  TKYYGSYLKGTKLWIIMEYLGGGSAL-DLLRAGPFDEFQIATMLKEILKGLDYLHSEKKI 123

Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPEILLSKGHNKDAD 296
           HRD+K  N+L+   G V L DFG+A ++ D   + N+  GT  +MAPE++    ++  AD
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKAD 183

Query: 297 WWSVGILLYEMLTGQ 311
            WS+GI   E+  G+
Sbjct: 184 IWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  105 bits (263), Expect = 2e-26
 Identities = 70/210 (33%), Positives = 111/210 (52%), Gaps = 15/210 (7%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR--KDTIIKKNHVDYMKAER 166
           P ++ + +++GQGAFG+V+        D D+    A+K ++   ++      V+ ++ E 
Sbjct: 1   PTNWRLGKLLGQGAFGRVYLCY-----DADTGRELAVKQVQFDPESPETSKEVNALECEI 55

Query: 167 DILTKVTHPFIVQLRYSF---QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            +L  + H  IVQ  Y          L + ++ + GG +   L   G   E+  R YT +
Sbjct: 56  QLLKNLLHERIVQY-YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQ 114

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN----SMCGTTE 279
           I+  VS+LH   IVHRD+K  NIL DS G+V L DFG +K +     S     S+ GT  
Sbjct: 115 ILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174

Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           +M+PE++  +G+ + AD WSVG  + EMLT
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  104 bits (260), Expect = 8e-26
 Identities = 61/204 (29%), Positives = 111/204 (54%), Gaps = 12/204 (5%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRK-DTIIKKNHVDYMKAERDI 168
           G+F+I + +G+G F  V++             + A+K ++  + +  K   D +K E D+
Sbjct: 2   GNFKIEKKIGKGQFSVVYKAICL-----LDGRVVALKKVQIFEMMDAKARQDCLK-EIDL 55

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQG-IFREDQARFYTAEI 224
           L ++ HP +++   SF   ++L ++L+  + G    +  H  +Q  +  E     Y  ++
Sbjct: 56  LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAP 283
            SA+ H+H   I+HRD+KP N+ + + G V L D GL +    +++ ++S+ GT  YM+P
Sbjct: 116 CSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 284 EILLSKGHNKDADWWSVGILLYEM 307
           E +   G+N  +D WS+G LLYEM
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  104 bits (261), Expect = 9e-26
 Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 29/212 (13%)

Query: 112 FEIFRVVGQGAFGKVFQVK----------KKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
           +E    +G+GA+G V++ +          KK       +GI  +  +R+  ++K+     
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGI-PLSTLREIALLKQ----- 54

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRS-----KLYLILDFINGG-HLFFHLYRQGIFRED 215
                  L    HP IV+L             KL L+ + ++     +     +     +
Sbjct: 55  -------LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPE 107

Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMC 275
             +    +++  V  LH   IVHRDLKP+NIL+ SDG V + DFGLA+         S+ 
Sbjct: 108 TIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVV 167

Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
            T  Y APE+LL   +    D WSVG +  E+
Sbjct: 168 VTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  102 bits (257), Expect = 2e-25
 Identities = 52/200 (26%), Positives = 95/200 (47%), Gaps = 12/200 (6%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIY---AMKVMRKDTIIKKNHVDYMKAERDILTKV 172
           + +G+GAFG+V+    KG   G         A+K +++D   +   ++    E  I+ K+
Sbjct: 5   KKLGEGAFGEVY----KGKLKGKGGKKKVEVAVKTLKEDASEQ--QIEEFLREARIMRKL 58

Query: 173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEIVSAVSHL 231
            HP +V+L         LY++++++ GG L  +L   +          +  +I   + +L
Sbjct: 59  DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILLSK 289
                +HRDL   N L+  +  V ++DFGL++++ +    R         +MAPE L   
Sbjct: 119 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEG 178

Query: 290 GHNKDADWWSVGILLYEMLT 309
                +D WS G+LL+E+ T
Sbjct: 179 KFTSKSDVWSFGVLLWEIFT 198

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  102 bits (255), Expect = 3e-25
 Identities = 67/202 (33%), Positives = 108/202 (53%), Gaps = 13/202 (6%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR--KDTIIKKNHVDYMKAERDILTKVT 173
           +++GQGAFG+V+        D D+    A K ++   ++      V  ++ E  +L  + 
Sbjct: 8   KLLGQGAFGRVYLCY-----DVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 174 HPFIVQLRYSFQTRSK--LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           H  IVQ     + R++  L + ++++ GG +   L   G   E   R YT +I+  +S+L
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYL 122

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN----SMCGTTEYMAPEILL 287
           H   IVHRD+K  NIL DS G+V L DFG +K +     S     S+ GT  +M+PE++ 
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182

Query: 288 SKGHNKDADWWSVGILLYEMLT 309
            +G+ + AD WS+G  + EMLT
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  102 bits (255), Expect = 3e-25
 Identities = 59/201 (29%), Positives = 110/201 (54%), Gaps = 9/201 (4%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F     +G+G+FG+VF    KG+D+  +  + A+K++  D    ++ ++ ++ E  +L++
Sbjct: 6   FTKLEKIGKGSFGEVF----KGIDN-RTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQ 58

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
              P++ +   S+   +KL++I++++ GG     L   G   E Q      EI+  + +L
Sbjct: 59  CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYL 117

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPEILLSKG 290
           H    +HRD+K  N+L+   G V L DFG+A ++ D   + N+  GT  +MAPE++    
Sbjct: 118 HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177

Query: 291 HNKDADWWSVGILLYEMLTGQ 311
           ++  AD WS+GI   E+  G+
Sbjct: 178 YDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  102 bits (254), Expect = 4e-25
 Identities = 62/201 (30%), Positives = 107/201 (53%), Gaps = 12/201 (5%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE+ + +G G +G V+  K + V+ G+   + A+KV++ +          ++ E  ++ 
Sbjct: 10  DFELIQRIGSGTYGDVY--KARNVNTGE---LAAIKVIKLE---PGEDFAVVQQEIIMMK 61

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
              H  IV    S+  R KL++ ++F  GG L    +  G   E Q  + + E +  + +
Sbjct: 62  DCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYY 121

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEYMAPEILLSK 289
           LH  G +HRD+K  NIL+  +GHV L DFG++ +I  + ++  S  GT  +MAPE+   +
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVE 181

Query: 290 ---GHNKDADWWSVGILLYEM 307
              G+N+  D W+VGI   E+
Sbjct: 182 RKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  100 bits (251), Expect = 2e-24
 Identities = 69/219 (31%), Positives = 113/219 (51%), Gaps = 22/219 (10%)

Query: 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM---RKDTIIKKNHVDYMKAERDILTK 171
           F  +GQGA G V+      V  G    I  M +    +K+ II  N +  M+  +     
Sbjct: 24  FEKIGQGASGTVYTAID--VATGQEVAIKQMNLQQQPKKELII--NEILVMRENK----- 74

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
             HP IV    S+    +L+++++++ GG L   +  +    E Q      E + A+  L
Sbjct: 75  --HPNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQALEFL 131

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEILLSKG 290
           H   ++HRD+K +NIL+  DG V LTDFG   +I  E S+ ++M GT  +MAPE++  K 
Sbjct: 132 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191

Query: 291 HNKDADWWSVGILLYEMLTGQ---VN---IKSMQVIACN 323
           +    D WS+GI+  EM+ G+   +N   ++++ +IA N
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN 230

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 99.7 bits (248), Expect = 3e-24
 Identities = 57/195 (29%), Positives = 109/195 (55%), Gaps = 9/195 (4%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G+FG+V+    KG+D+  +  + A+K++  D    ++ ++ ++ E  +L++   P+I
Sbjct: 12  IGKGSFGEVY----KGIDN-RTKEVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPYI 64

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
            +   S+   +KL++I++++ GG     L + G   E        EI+  + +LH    +
Sbjct: 65  TRYYGSYLKGTKLWIIMEYLGGGSAL-DLLKPGPLEETYIATILREILKGLDYLHSERKI 123

Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPEILLSKGHNKDAD 296
           HRD+K  N+L+   G V L DFG+A ++ D   + N+  GT  +MAPE++    ++  AD
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKAD 183

Query: 297 WWSVGILLYEMLTGQ 311
            WS+GI   E+  G+
Sbjct: 184 IWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 99.8 bits (249), Expect = 4e-24
 Identities = 60/204 (29%), Positives = 106/204 (51%), Gaps = 10/204 (4%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
               + F  +G+G+ G V     K      +    A+K M    + K+   + +  E  I
Sbjct: 18  RSYLDNFVKIGEGSTGIVCIATDK-----STGRQVAVKKM---DLRKQQRRELLFNEVVI 69

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           +    HP IV++  S+    +L+++++F+ GG L   +       E+Q       ++ A+
Sbjct: 70  MRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT-DIVTHTRMNEEQIATVCLAVLKAL 128

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPEILL 287
           S LH  G++HRD+K ++IL+ SDG V L+DFG   ++  E  R  S+ GT  +MAPE++ 
Sbjct: 129 SFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVIS 188

Query: 288 SKGHNKDADWWSVGILLYEMLTGQ 311
              +  + D WS+GI++ EM+ G+
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 99.2 bits (247), Expect = 4e-24
 Identities = 55/202 (27%), Positives = 105/202 (51%), Gaps = 8/202 (3%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G GAF   +Q +   V  G    +  +  +R  +  ++  V+ ++ E  ++ ++ HP
Sbjct: 6   QQLGTGAFSSCYQARD--VKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHP 63

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
            I+++  +    S   L ++++ GG +   L + G F+E     YT +++  +S+LH+  
Sbjct: 64  HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ 123

Query: 236 IVHRDLKPENILMDSDGH-VMLTDFGLAKEIDESSR-----SNSMCGTTEYMAPEILLSK 289
           I+HRD+K  N+L+DS G  + + DFG A  +             + GT  +MAPE+L  +
Sbjct: 124 IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE 183

Query: 290 GHNKDADWWSVGILLYEMLTGQ 311
            + +  D WSVG ++ EM T +
Sbjct: 184 QYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 99.6 bits (249), Expect = 5e-24
 Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 23/208 (11%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--L 169
           +E  + +G+G +  V++ +     D ++  I A+K ++     +        A R+I  L
Sbjct: 2   YEKGKKLGEGTYAVVYKAR-----DKETGRIVAIKKIKLGERKEAKDGINFTALREIKLL 56

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVS--- 226
            ++ HP I+ L   F  +S + L+ +F+    L      + + ++       A+I S   
Sbjct: 57  QELKHPNIIGLLDVFGHKSNINLVFEFM-ETDL------EKVIKDKSIVLTPADIKSYML 109

Query: 227 ----AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYM 281
                + +LH   I+HRDLKP N+L+ SDG + L DFGLA+     + +      T  Y 
Sbjct: 110 MTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYR 169

Query: 282 APEILL-SKGHNKDADWWSVGILLYEML 308
           APE+L  ++ +    D WSVG +  E+L
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELL 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 98.9 bits (246), Expect = 9e-24
 Identities = 66/217 (30%), Positives = 113/217 (52%), Gaps = 26/217 (11%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G FE+  VVG G +G+V+  K + V  G    + A+KVM     + ++  + +K E ++L
Sbjct: 16  GIFELVEVVGNGTYGQVY--KGRHVKTGQ---LAAIKVMD----VTEDEEEEIKLEINML 66

Query: 170 TKVTHPFIVQLRY-SFQTRS------KLYLILDFINGGHL--FFHLYRQGIFREDQARFY 220
            K +H   +   Y +F  +S      +L+L+++F   G +       +    +ED   + 
Sbjct: 67  KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYI 126

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTE 279
             EI+  ++HLH   ++HRD+K +N+L+  +  V L DFG++ ++D +  R N+  GT  
Sbjct: 127 CREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 186

Query: 280 YMAPEILLSKGHNKDA------DWWSVGILLYEMLTG 310
           +MAPE++     N DA      D WS+GI   EM  G
Sbjct: 187 WMAPEVIACD-ENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 99.1 bits (248), Expect = 1e-23
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 29/215 (13%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--L 169
           +E+ + +G GA+G V         D  +    A+K +     +  + +D  +  R+I  L
Sbjct: 2   YELLKPIGSGAYGVVCSAV-----DKRTGRKVAIKKISN---VFDDLIDAKRILREIKLL 53

Query: 170 TKVTHPFIVQLRYSFQTRSK-----LYLILDFINGGHLFFH--LYRQGIFREDQARFYTA 222
             + H  I+ L    +  S      +Y++ + +       H  +       +D  +++  
Sbjct: 54  RHLRHENIIGLLDILRPPSPEDFNDVYIVTELM---ETDLHKVIKSPQPLTDDHIQYFLY 110

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYM- 281
           +I+  + +LH   ++HRDLKP NIL++S+  + + DFGLA+ +D           TEY+ 
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF--LTEYVV 168

Query: 282 -----APEILLS-KGHNKDADWWSVGILLYEMLTG 310
                APE+LLS   + K  D WSVG +  E+LT 
Sbjct: 169 TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 98.6 bits (245), Expect = 1e-23
 Identities = 64/201 (31%), Positives = 103/201 (51%), Gaps = 16/201 (7%)

Query: 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM---RKDTIIKKNHVDYMKAERDILTK 171
           F  +GQGA G V+      V  G    I  M +    +K+ II  N +  M+  ++    
Sbjct: 25  FEKIGQGASGTVYTAMD--VATGQEVAIRQMNLQQQPKKELII--NEILVMRENKN---- 76

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
              P IV    S+    +L+++++++ GG L   +  +    E Q      E + A+  L
Sbjct: 77  ---PNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQALEFL 132

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEILLSKG 290
           H   ++HRD+K +NIL+  DG V LTDFG   +I  E S+ ++M GT  +MAPE++  K 
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192

Query: 291 HNKDADWWSVGILLYEMLTGQ 311
           +    D WS+GI+  EM+ G+
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 98.0 bits (244), Expect = 2e-23
 Identities = 59/201 (29%), Positives = 105/201 (52%), Gaps = 9/201 (4%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F+    +G+G +G V++ + K      +  + A+K +R DT  +      ++ E  +L +
Sbjct: 2   FQKVEKIGEGTYGVVYKARNK-----LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKE 55

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           + HP IV+L     T +KLYL+ +F++     F              + Y  +++  ++ 
Sbjct: 56  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM-CGTTEYMAPEILL-S 288
            H   ++HRDLKP+N+L++++G + L DFGLA+      R+ +    T  Y APEILL  
Sbjct: 116 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 175

Query: 289 KGHNKDADWWSVGILLYEMLT 309
           K ++   D WS+G +  EM+T
Sbjct: 176 KYYSTAVDIWSLGCIFAEMVT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 97.0 bits (241), Expect = 2e-23
 Identities = 60/200 (30%), Positives = 114/200 (57%), Gaps = 14/200 (7%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--ILTKVT 173
           RVVG+G++G+V  V+ +      +DG     V++K  +   +  +   AE++  +L+++ 
Sbjct: 6   RVVGKGSYGEVSLVRHR------TDG--KQYVIKKLNLRNASRRERKAAEQEAQLLSQLK 57

Query: 174 HPFIVQLRYSFQTRS-KLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSH 230
           HP IV  R S++     LY+++ F  GG L+  L  Q   +  E+Q   +  +I  A+ +
Sbjct: 58  HPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQY 117

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEILLSK 289
           LH+  I+HRDLK +N+ +     + + D G+A+ ++ +   ++++ GT  YM+PE+  +K
Sbjct: 118 LHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNK 177

Query: 290 GHNKDADWWSVGILLYEMLT 309
            +N  +D W++G  +YEM T
Sbjct: 178 PYNYKSDVWALGCCVYEMAT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 97.4 bits (242), Expect = 2e-23
 Identities = 62/207 (29%), Positives = 112/207 (54%), Gaps = 10/207 (4%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            +F I + +G+G F +V+  +   + DG    +  +++   D +  K   D +K E D+L
Sbjct: 2   ANFRIEKKIGRGQFSEVY--RATCLLDGVPVALKKVQIF--DLMDAKARADCIK-EIDLL 56

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL---FFHLYRQG-IFREDQARFYTAEIV 225
            ++ HP +++   SF   ++L ++L+  + G L     H  +Q  +  E     Y  ++ 
Sbjct: 57  KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC 116

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPE 284
           SA+ H+H   ++HRD+KP N+ + + G V L D GL +    +++ ++S+ GT  YM+PE
Sbjct: 117 SALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQ 311
            +   G+N  +D WS+G LLYEM   Q
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQ 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 97.9 bits (243), Expect = 3e-23
 Identities = 63/201 (31%), Positives = 103/201 (51%), Gaps = 16/201 (7%)

Query: 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM---RKDTIIKKNHVDYMKAERDILTK 171
           F  +GQGA G V+      +  G    I  M +    +K+ II  N +  M+  ++    
Sbjct: 24  FEKIGQGASGTVYTAID--IATGQEVAIKQMNLQQQPKKELII--NEILVMRENKN---- 75

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
              P IV    S+    +L+++++++ GG L   +  +    E Q      E + A+  L
Sbjct: 76  ---PNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQALDFL 131

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEILLSKG 290
           H   ++HRD+K +NIL+  DG V LTDFG   +I  E S+ ++M GT  +MAPE++  K 
Sbjct: 132 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191

Query: 291 HNKDADWWSVGILLYEMLTGQ 311
           +    D WS+GI+  EM+ G+
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 97.0 bits (241), Expect = 3e-23
 Identities = 61/202 (30%), Positives = 109/202 (53%), Gaps = 10/202 (4%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F+I + +G+G F +V+    +     D   +   KV   + +  K   D +K E D+L 
Sbjct: 3   NFQIEKKIGRGQFSEVY----RATCLLDRKPVALKKVQIFEMMDAKARQDCVK-EIDLLK 57

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHL---FFHLYRQG-IFREDQARFYTAEIVS 226
           ++ HP +++   SF   ++L ++L+  + G L     +  +Q  +  E     Y  ++ S
Sbjct: 58  QLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPEI 285
           AV H+H   ++HRD+KP N+ + + G V L D GL +    +++ ++S+ GT  YM+PE 
Sbjct: 118 AVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177

Query: 286 LLSKGHNKDADWWSVGILLYEM 307
           +   G+N  +D WS+G LLYEM
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 98.8 bits (246), Expect = 7e-23
 Identities = 79/238 (33%), Positives = 116/238 (48%), Gaps = 44/238 (18%)

Query: 96  DAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK 155
           D     E  +K     + I RV+G GA G V   K+  V DG+    +A+KV+  + +  
Sbjct: 23  DEATAKEQAKK-----YWISRVLGSGATGTVLCAKR--VSDGEP---FAVKVVDMEGM-- 70

Query: 156 KNHVDYMKA--ERDILTKVTHPFIVQLRYSFQTR--------SKLYLILDFINGGHLFFH 205
            +  D  +A  E   L       IV+    F  +          + L+LD+ N G L   
Sbjct: 71  -SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDL--- 126

Query: 206 LYRQGI---------FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
             RQ I         FRE +A     +++ AV H+H   ++HRD+K  NIL+ S+G V L
Sbjct: 127 --RQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL 184

Query: 257 TDFGLAKEI-----DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            DFG +K       D+  R  + CGT  Y+APEI   K ++K AD +S+G+LLYE+LT
Sbjct: 185 GDFGFSKMYAATVSDDVGR--TFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLT 240

Length = 496

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 95.0 bits (236), Expect = 2e-22
 Identities = 57/197 (28%), Positives = 104/197 (52%), Gaps = 13/197 (6%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI--IKKNHVDYMKAERDILTKVTHP 175
           +G+G+FG V+ VK K     +      +KV+++  +  +  N       E  +L+K+ HP
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEER-----LKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHL--YRQG--IFREDQARFYTAEIVSAVSHL 231
            IV+   SF  R    +I ++  G  L   L   +       E+Q   +  +++  V ++
Sbjct: 63  AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEYMAPEILLSKG 290
           H+  I+HRDLK +NI + ++  + + DFG+++ +  S   + +  GT  YM+PE L  +G
Sbjct: 123 HQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQG 181

Query: 291 HNKDADWWSVGILLYEM 307
           ++  +D WS+G +LYEM
Sbjct: 182 YDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 95.2 bits (236), Expect = 2e-22
 Identities = 63/199 (31%), Positives = 102/199 (51%), Gaps = 12/199 (6%)

Query: 115 FRVVGQGAFGKVFQVKKKGVDDGDS-DGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT 173
           +  +GQGA G VF           +   I   K  +K+ II  N +  MK       ++ 
Sbjct: 24  YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELII--NEILVMK-------ELK 74

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
           +P IV    SF    +L+++++++ GG L   +  +    E Q      E + A+  LH 
Sbjct: 75  NPNIVNFLDSFLVGDELFVVMEYLAGGSLT-DVVTETCMDEAQIAAVCRECLQALEFLHA 133

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEILLSKGHN 292
             ++HRD+K +N+L+  DG V LTDFG   +I  E S+ ++M GT  +MAPE++  K + 
Sbjct: 134 NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 193

Query: 293 KDADWWSVGILLYEMLTGQ 311
              D WS+GI+  EM+ G+
Sbjct: 194 PKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 95.4 bits (238), Expect = 4e-22
 Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 29/217 (13%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY-AMKVMRK--DTIIKKNHVDYMKAE 165
           P  ++    VG GA+G+V              G   A+K + +   + I   H      E
Sbjct: 14  PDRYQNLSPVGSGAYGQVCSAFDTKT------GRKVAIKKLSRPFQSAI---HAKRTYRE 64

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKL------YLILDFINGGHLFFHLYRQGIFREDQARF 219
             +L  + H  ++ L   F   S L      YL+   +  G    ++ +     +D  +F
Sbjct: 65  LRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIVKCQKLSDDHIQF 122

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG--- 276
              +I+  + ++H  GI+HRDLKP NI ++ D  + + DFGLA+  D+      M G   
Sbjct: 123 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD-----EMTGYVA 177

Query: 277 TTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQV 312
           T  Y APEI+L+  H N+  D WSVG ++ E+LTG+ 
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 93.9 bits (233), Expect = 7e-22
 Identities = 59/210 (28%), Positives = 111/210 (52%), Gaps = 14/210 (6%)

Query: 107 IGPGD----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           +  GD     E +  +G+G+ G V   ++K      S    A+K+M    + K+   + +
Sbjct: 14  VDQGDPRSLLENYIKIGEGSTGIVCIAREK-----HSGRQVAVKMM---DLRKQQRRELL 65

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
             E  I+    H  +V++  S+    +L+++++F+ GG L   +  Q    E+Q      
Sbjct: 66  FNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT-DIVSQTRLNEEQIATVCE 124

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEYM 281
            ++ A+ +LH  G++HRD+K ++IL+  DG V L+DFG   +I +   +  S+ GT  +M
Sbjct: 125 SVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWM 184

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           APE++    +  + D WS+GI++ EM+ G+
Sbjct: 185 APEVISRTPYGTEVDIWSLGIMVIEMVDGE 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 92.8 bits (230), Expect = 1e-21
 Identities = 60/212 (28%), Positives = 109/212 (51%), Gaps = 16/212 (7%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
           +  R+    D+E+ + VG G +G V++ +   +  G+   +  +K+   D        D+
Sbjct: 1   DILRRNPQHDYELIQRVGSGTYGDVYKARN--LHTGELAAVKIIKLEPGD--------DF 50

Query: 162 MKAERDI--LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
              +++I  + +  H  IV    S+ +R KL++ +++  GG L    +  G   E Q  +
Sbjct: 51  SLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY 110

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTT 278
              E +  +++LH  G +HRD+K  NIL+  +G V L DFG+A +I  + ++  S  GT 
Sbjct: 111 VCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTP 170

Query: 279 EYMAPEILLSK---GHNKDADWWSVGILLYEM 307
            +MAPE+   +   G+N+  D W+VGI   E+
Sbjct: 171 YWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 92.8 bits (231), Expect = 1e-21
 Identities = 67/208 (32%), Positives = 106/208 (50%), Gaps = 20/208 (9%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM---RKDTIIKKNHVDYMKAERDI 168
           +E   +VG+G++G V + K K     ++  I A+K       D ++KK       A R+I
Sbjct: 3   YENLGLVGEGSYGMVMKCKHK-----ETGQIVAIKKFLESEDDKMVKK------IAMREI 51

Query: 169 --LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIV 225
             L ++ H  +V L   F+ + +LYL+ +F++   L     Y  G+  E + R Y  +I+
Sbjct: 52  RMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGL-DESRVRKYLFQIL 110

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-NSMCGTTEYMAPE 284
             +   H   I+HRD+KPENIL+   G V L DFG A+ +            T  Y APE
Sbjct: 111 RGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPE 170

Query: 285 ILLSK-GHNKDADWWSVGILLYEMLTGQ 311
           +L+    + +  D W+VG L+ EMLTG+
Sbjct: 171 LLVGDTKYGRAVDIWAVGCLVTEMLTGE 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 92.8 bits (231), Expect = 1e-21
 Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 35/210 (16%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD--------TIIKKNHVDYMKAERDIL 169
           +G+G +G V++ + K   +     I A+K +R +        T I+         E  +L
Sbjct: 7   IGEGTYGVVYKARDKLTGE-----IVALKKIRLETEDEGVPSTAIR---------EISLL 52

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGG--HLFFHLYRQGIFREDQARFYTAEIVSA 227
            ++ HP IV+L     + +KLYL+ +F++             G+      + Y  +++  
Sbjct: 53  KELNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDP-PLIKSYLYQLLQG 111

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE-----YMA 282
           +++ H   ++HRDLKP+N+L+D +G + L DFGLA+      R+     T E     Y A
Sbjct: 112 IAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY----THEVVTLWYRA 167

Query: 283 PEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
           PEILL S+ ++   D WS+G +  EM+  +
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 92.5 bits (229), Expect = 1e-21
 Identities = 64/217 (29%), Positives = 113/217 (52%), Gaps = 26/217 (11%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G FE+  +VG G +G+V+  K + V  G    + A+KVM     +  +  + +K E ++L
Sbjct: 6   GIFELVELVGNGTYGQVY--KGRHVKTGQ---LAAIKVMD----VTGDEEEEIKQEINML 56

Query: 170 TKVTHPFIVQLRY-SFQTRS------KLYLILDFINGGHL--FFHLYRQGIFREDQARFY 220
            K +H   +   Y +F  ++      +L+L+++F   G +       +    +E+   + 
Sbjct: 57  KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI 116

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTE 279
             EI+  +SHLH+  ++HRD+K +N+L+  +  V L DFG++ ++D +  R N+  GT  
Sbjct: 117 CREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 176

Query: 280 YMAPEILLSKGHNKDA------DWWSVGILLYEMLTG 310
           +MAPE++     N DA      D WS+GI   EM  G
Sbjct: 177 WMAPEVIACD-ENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 92.9 bits (231), Expect = 1e-21
 Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 30/212 (14%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA---ER 166
                   +G+GA G V + + K      +  I+A+K     TI    + D  K    E 
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKN-----TGMIFALK-----TITTDPNPDLQKQILREL 50

Query: 167 DILTKVTHPFIVQLRYSF--QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE- 223
           +I      P+IV+   +F  ++ S + + +++  GG L   +Y++   ++   R    E 
Sbjct: 51  EINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLD-SIYKK--VKKRGGR--IGEK 105

Query: 224 --------IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMC 275
                   ++  +S+LH   I+HRD+KP NIL+   G V L DFG++ E+  S    +  
Sbjct: 106 VLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAG-TFT 164

Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           GT+ YMAPE +  K ++  +D WS+G+ L E+
Sbjct: 165 GTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 93.7 bits (233), Expect = 1e-21
 Identities = 81/285 (28%), Positives = 128/285 (44%), Gaps = 39/285 (13%)

Query: 48  NQSPASTSASLGDPQVIHNRSH---SFVGPSPRY--ALSSSLPLQIQELEHENDAELEAE 102
            Q P              +R         P P+   +L+  LPL        + +   A 
Sbjct: 4   IQPPPGVPLPSTARHTTKSRPRRRPDLTLPLPQRDPSLAVPLPLPPPSSSSSSSSSSSAS 63

Query: 103 SERKIGPGDF-EIFRV--VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV 159
                      E+ RV  +G GA G V++V  +      +  +YA+KV      I  NH 
Sbjct: 64  GSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRP-----TGRLYALKV------IYGNHE 112

Query: 160 DYMK----AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED 215
           D ++     E +IL  V HP +V+    F    ++ ++L+F++GG L         F  D
Sbjct: 113 DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD 172

Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG----LAKEIDESSRS 271
            AR    +I+S +++LH+  IVHRD+KP N+L++S  +V + DFG    LA+ +D     
Sbjct: 173 VAR----QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP---C 225

Query: 272 NSMCGTTEYMAPEIL---LSKG--HNKDADWWSVGILLYEMLTGQ 311
           NS  GT  YM+PE +   L+ G       D WS+G+ + E   G+
Sbjct: 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 92.4 bits (229), Expect = 2e-21
 Identities = 62/226 (27%), Positives = 116/226 (51%), Gaps = 17/226 (7%)

Query: 91  LEHENDAELEAESERKIGPGD----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMK 146
           + HE   +  A  +  + PGD     + F  +G+G+ G V    +K      +    A+K
Sbjct: 2   VSHE---QFRAALQLVVSPGDPREYLDSFIKIGEGSTGIVCIATEK-----HTGKQVAVK 53

Query: 147 VMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
            M    + K+   + +  E  I+    H  +V +  S+    +L+++++F+ GG L   +
Sbjct: 54  KM---DLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT-DI 109

Query: 207 YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID 266
                  E+Q       ++ A+S+LH  G++HRD+K ++IL+ SDG + L+DFG   ++ 
Sbjct: 110 VTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169

Query: 267 -ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
            E  +  S+ GT  +MAPE++    +  + D WS+GI++ EM+ G+
Sbjct: 170 KEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 92.0 bits (228), Expect = 3e-21
 Identities = 61/221 (27%), Positives = 112/221 (50%), Gaps = 18/221 (8%)

Query: 98  ELEAESERKIGPGD----FEIFRVVGQGAFGKV--FQVKKKGVDDGDSDGIYAMKVMRKD 151
           +  A  +  + PGD     + F  +G+G+ G V    VK  G           +  ++K 
Sbjct: 4   QFRAALQMVVDPGDPRTYLDNFIKIGEGSTGIVCIATVKSSG----------KLVAVKKM 53

Query: 152 TIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI 211
            + K+   + +  E  I+    H  +V++  S+    +L+++++F+ GG L   +     
Sbjct: 54  DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIVTHTR 112

Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSR 270
             E+Q       ++ A+S LH  G++HRD+K ++IL+  DG V L+DFG   ++  E  R
Sbjct: 113 MNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 172

Query: 271 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
             S+ GT  +MAPE++    +  + D WS+GI++ EM+ G+
Sbjct: 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 93.9 bits (233), Expect = 3e-21
 Identities = 68/208 (32%), Positives = 104/208 (50%), Gaps = 30/208 (14%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF 176
           +VG+      F V  +G D    + + A  VM  D    +    Y ++E   L    H  
Sbjct: 74  LVGRNPTTAAF-VATRGSDP--KEKVVAKFVMLND----ERQAAYARSELHCLAACDHFG 126

Query: 177 IVQLRYSFQTRSKLYLILDFINGG------------HLFFHLYRQGIFREDQARFYTAEI 224
           IV+    F++  KL LI+++ +GG            HL F  Y  G+       FY  +I
Sbjct: 127 IVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL------FY--QI 178

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYM 281
           V A+  +H   ++HRDLK  NI +   G + L DFG +K+  +S     ++S CGT  Y+
Sbjct: 179 VLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYL 238

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT 309
           APE+   K ++K AD WS+G++LYE+LT
Sbjct: 239 APELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 90.5 bits (225), Expect = 9e-21
 Identities = 68/216 (31%), Positives = 108/216 (50%), Gaps = 19/216 (8%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
                 D E    +G G  G+V++++ K      +  + A+K MR+    ++N    M  
Sbjct: 10  YPADLNDLENLGEIGSGTCGQVYKMRFK-----KTGHVMAVKQMRRTGNKEENKRILM-- 62

Query: 165 ERDILTKVTH--PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR--QGIFREDQARFY 220
           + D++ K +H  P+IV+    F T S +++ ++ +        L +  QG   ED     
Sbjct: 63  DLDVVLK-SHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKM 119

Query: 221 TAEIVSAVSHL-HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
           T  IV A+ +L  K G++HRD+KP NIL+D+ G+V L DFG++  + +S       G   
Sbjct: 120 TVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAA 179

Query: 280 YMAPEILLSKGHNKD----ADWWSVGILLYEMLTGQ 311
           YMAPE +     N      AD WS+GI L E+ TGQ
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 23/210 (10%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRK---DTIIKKNHVDYMKAERDI 168
           ++    +G GA+G V       +D      +   K+       T+ K+        E  I
Sbjct: 7   YKPIENIGSGAYGVVC----SAIDTRSGKKVAIKKIPHAFDVPTLAKRTL-----RELKI 57

Query: 169 LTKVTHPFIVQLRYSFQTRSKL----YLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           L    H  I+ +R   +         Y+++D +    L   ++      E+  R++  ++
Sbjct: 58  LRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQL 116

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM-----CGTTE 279
           +  + ++H   ++HRDLKP N+L++ D  + + DFG+A+ +  S   +         T  
Sbjct: 117 LRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176

Query: 280 YMAPEILLS-KGHNKDADWWSVGILLYEML 308
           Y APE+LLS   +    D WSVG +  EML
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 89.3 bits (222), Expect = 2e-20
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 34/206 (16%)

Query: 119 GQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--LTKVT-HP 175
           G+G F +V   K +    G     YA+K M+K        ++ +   R+I  L +++ HP
Sbjct: 8   GEGTFSEVL--KAQSRKTGKY---YAIKCMKK----HFKSLEQVNNLREIQALRRLSPHP 58

Query: 176 FIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGI----------FREDQARFYTAEI 224
            I++L         + ++ D   G   L F L    +            E + + Y  ++
Sbjct: 59  NILRL---------IEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQL 109

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
           + ++ H+H+ GI HRD+KPENIL+  D  + L DFG  + I           T  Y APE
Sbjct: 110 LKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTRWYRAPE 168

Query: 285 ILLSKG-HNKDADWWSVGILLYEMLT 309
            LL+ G +    D W+VG + +E+L+
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 87.8 bits (218), Expect = 4e-20
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 27/209 (12%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY-----AMKVMRKDTIIKKNHVDY 161
           I   + ++   +G+G FG V              G Y     A+K ++ D+         
Sbjct: 3   INSKELKLGATIGKGEFGDVML------------GDYRGQKVAVKCLKDDS----TAAQA 46

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY---RQGIFREDQAR 218
             AE  ++T + HP +VQL       + LY++ +++  G L  +L    R  I    Q  
Sbjct: 47  FLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLG 106

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
           F   ++   + +L +   VHRDL   N+L+  D    ++DFGLAKE  +   S  +    
Sbjct: 107 F-ALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL--PV 163

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEM 307
           ++ APE L  K  +  +D WS GILL+E+
Sbjct: 164 KWTAPEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 88.3 bits (219), Expect = 4e-20
 Identities = 57/206 (27%), Positives = 109/206 (52%), Gaps = 29/206 (14%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-------TIIKKNHVDYMKAERDILT 170
           +G+G +  V++ + +   +     I A+K +  D       T I+         E  ++ 
Sbjct: 8   LGEGTYATVYKGRNRTTGE-----IVALKEIHLDAEEGTPSTAIR---------EISLMK 53

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQGIFREDQARFYTAEIVSA 227
           ++ H  IV+L     T +KL L+ ++++     ++  H  R G    +  + +T +++  
Sbjct: 54  ELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVR-GALDPNTVKSFTYQLLKG 112

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE--IDESSRSNSMCGTTEYMAPEI 285
           ++  H+  ++HRDLKP+N+L++  G + L DFGLA+   I  ++ SN +  T  Y AP++
Sbjct: 113 IAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDV 171

Query: 286 LL-SKGHNKDADWWSVGILLYEMLTG 310
           LL S+ ++   D WSVG ++ EM+TG
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITG 197

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 88.9 bits (221), Expect = 6e-20
 Identities = 60/223 (26%), Positives = 106/223 (47%), Gaps = 38/223 (17%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK----NHVDY- 161
           +GP  ++    +G+GA+G V                  +KV      IKK     H  + 
Sbjct: 3   VGP-RYQNLSYIGEGAYGMVCSAT---------HKPTGVKVA-----IKKISPFEHQTFC 47

Query: 162 MKAERDI--LTKVTHPFIVQLR-----YSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
            +  R+I  L +  H  I+ +       SF++ + +Y++ + +      + L +      
Sbjct: 48  QRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETD--LYKLIKTQHLSN 105

Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM 274
           D  +++  +I+  + ++H   ++HRDLKP N+L++++  + + DFGLA+  D        
Sbjct: 106 DHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGF 165

Query: 275 CGTTEYM------APEILL-SKGHNKDADWWSVGILLYEMLTG 310
              TEY+      APEI+L SKG+ K  D WSVG +L EML+ 
Sbjct: 166 --LTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 91.1 bits (226), Expect = 7e-20
 Identities = 50/181 (27%), Positives = 90/181 (49%), Gaps = 12/181 (6%)

Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-SKLYLILDFINGGHL 202
           A+K++R D   +++     + E  +  ++ HP IV L  S +     L+ + +++ G  L
Sbjct: 7   AIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTL 66

Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVMLTDF 259
              L   G     +      +++ A++  H  GIVHRDLKP+NI++   G   H  + DF
Sbjct: 67  REVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDF 126

Query: 260 GL------AKEIDES--SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           G+       ++ D +  +R+  + GT  Y APE L  +    ++D ++ G++  E LTGQ
Sbjct: 127 GIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186

Query: 312 V 312
            
Sbjct: 187 R 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 87.5 bits (217), Expect = 1e-19
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 23/213 (10%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA-- 164
           +   D E    +G G  G V +VK           I    VM K  +    H+    +  
Sbjct: 2   LRNEDLETISDLGAGNGGSVSKVKH----------IPTGTVMAKKVV----HIGAKSSVR 47

Query: 165 -----ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
                E  I+ +   P+IV    +F   + + + ++F++ G L     + G    +    
Sbjct: 48  KQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK 107

Query: 220 YTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
               +V  +++L+    I+HRD+KP NIL++S G + L DFG++ E+  +S +++  GT+
Sbjct: 108 IAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL-INSIADTFVGTS 166

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
            YM+PE +    +   +D WS+GI + E+  G+
Sbjct: 167 TYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 87.6 bits (217), Expect = 1e-19
 Identities = 59/210 (28%), Positives = 106/210 (50%), Gaps = 18/210 (8%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           + E+   +G+G +G V++V  +      +    AMK +R +  + ++  + +  E DIL 
Sbjct: 2   EIEVLDELGKGNYGSVYKVLHR-----PTGVTMAMKEIRLE--LDESKFNQIIMELDILH 54

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQGIFREDQARFYTAEIVSA 227
           K   P+IV    +F     +Y+ +++++ G    L+          ED  R  T  +V  
Sbjct: 55  KAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKG 114

Query: 228 VSHL-HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEIL 286
           +  L  +  I+HRD+KP N+L++ +G V L DFG++  +  +S + +  G   YMAPE +
Sbjct: 115 LKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL-VASLAKTNIGCQSYMAPERI 173

Query: 287 LSKGHNK------DADWWSVGILLYEMLTG 310
            S G N+       +D WS+G+ + EM  G
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALG 203

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 87.8 bits (217), Expect = 1e-19
 Identities = 64/205 (31%), Positives = 108/205 (52%), Gaps = 9/205 (4%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE    +G G  G VF+V  K      S  I A K++  +  IK    + +  E  +L 
Sbjct: 6   DFEKISELGAGNGGVVFKVSHK-----PSGLIMARKLIHLE--IKPAIRNQIIRELQVLH 58

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  ++  +++
Sbjct: 59  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 118

Query: 231 L-HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           L  K  I+HRD+KP NIL++S G + L DFG++ ++ + S +NS  GT  YM+PE L   
Sbjct: 119 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGT 177

Query: 290 GHNKDADWWSVGILLYEMLTGQVNI 314
            ++  +D WS+G+ L EM  G+  I
Sbjct: 178 HYSVQSDIWSMGLSLVEMAIGRYPI 202

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 85.7 bits (212), Expect = 2e-19
 Identities = 57/215 (26%), Positives = 103/215 (47%), Gaps = 31/215 (14%)

Query: 107 IGPGDFEIFRVVGQGAFGKV--------FQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH 158
           I P +    + +G G FG V         +V  K +++G          M ++  I+   
Sbjct: 1   INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG---------AMSEEDFIE--- 48

Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQ 216
                 E  ++ K++HP +VQL Y   T+ K LY++ +F+  G L  +L  RQG   +D 
Sbjct: 49  ------EAKVMMKLSHPKLVQL-YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDM 101

Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSM 274
                 ++   + +L +   +HRDL   N L+ S G V ++DFG+ + +  DE + S+  
Sbjct: 102 LLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGA 161

Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
               ++  PE+     ++  +D WS G+L++E+ T
Sbjct: 162 KFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 86.3 bits (214), Expect = 4e-19
 Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 36/218 (16%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--- 167
           +FE    +G+G +G V++ +     D  S  I A+K +R            M  ERD   
Sbjct: 8   EFEKLNRIGEGTYGIVYRAR-----DTTSGEIVALKKVR------------MDNERDGIP 50

Query: 168 --------ILTKVTHPFIVQLRYSFQTRS--KLYLILDFING--GHLFFHLYRQGIFRED 215
                   +L  + HP IV+L+     +    ++L++++       L  ++     F E 
Sbjct: 51  ISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSES 108

Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMC 275
           Q +    +++  + +LH+  I+HRDLK  N+L+   G + + DFGLA+     ++  +  
Sbjct: 109 QVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPK 168

Query: 276 GTT-EYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
             T  Y APE+LL    +    D W+VG +L E+L  +
Sbjct: 169 VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 85.5 bits (212), Expect = 5e-19
 Identities = 53/223 (23%), Positives = 94/223 (42%), Gaps = 37/223 (16%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
              + R +GQG+FG V++   KGV  G+ +   A+K + ++  +++      +A   ++ 
Sbjct: 7   KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEA--SVMK 64

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY---------- 220
           +     +V+L     T     ++++ +  G L  +L R      +               
Sbjct: 65  EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL-RSRRPEAENNPGLGPPTLQKFIQ 123

Query: 221 -TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
             AEI   +++L     VHRDL   N ++  D  V + DFG+ ++I E          T+
Sbjct: 124 MAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE----------TD 173

Query: 280 Y-------------MAPEILLSKGHNKDADWWSVGILLYEMLT 309
           Y             MAPE L        +D WS G++L+EM T
Sbjct: 174 YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 5e-19
 Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 30/219 (13%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD--YMKAERDI- 168
           +EI   +G+G +G+V++ K+K   +G     YA+K  + D    K         A R+I 
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRK---NGKDGKEYAIKKFKGD----KEQYTGISQSACREIA 54

Query: 169 -LTKVTHPFIVQLRYSFQTRS--KLYLILDFINGGHLFFHL---YRQGIFREDQARFY-- 220
            L ++ H  +V L   F   +   +YL+ D+    H  + +   +RQ             
Sbjct: 55  LLRELKHENVVSLVEVFLEHADKSVYLLFDYAE--HDLWQIIKFHRQAKRVSIPPSMVKS 112

Query: 221 -TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----VMLTDFGLAKEIDESSRS---- 271
              +I++ V +LH   ++HRDLKP NIL+  +G     V + D GLA+  +   +     
Sbjct: 113 LLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172

Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLT 309
           + +  T  Y APE+LL ++ + K  D W++G +  E+LT
Sbjct: 173 DPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 86.4 bits (214), Expect = 7e-19
 Identities = 59/190 (31%), Positives = 100/190 (52%), Gaps = 13/190 (6%)

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E DIL  ++H  I+ L ++++ +S + +++       LF ++ R G    +QA      +
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRL 194

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMC----GTTEY 280
           + A+++LH  GI+HRD+K ENI +D   + +L DFG A ++D    +   C    GT E 
Sbjct: 195 LEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT-PQCYGWSGTLET 253

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLIIFHCLFVNS 340
            +PE+L    +    D WS G++L+EM    V +   QV + ++ L     I  C+ V+ 
Sbjct: 254 NSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQL---RSIIRCMQVHP 310

Query: 341 LELLSHFPEN 350
           LE    FP+N
Sbjct: 311 LE----FPQN 316

Length = 392

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 85.1 bits (210), Expect = 7e-19
 Identities = 71/228 (31%), Positives = 115/228 (50%), Gaps = 31/228 (13%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             +EI   +G+G +GKV++V  K   DG    + A+K++  D I   +  + ++AE +IL
Sbjct: 22  DTWEIIETIGKGTYGKVYKVTNK--KDGS---LAAVKIL--DPI--SDVDEEIEAEYNIL 72

Query: 170 TKVT-HPFIVQLRYSFQTRSK-----LYLILDFINGG---HLFFHLYRQGIFREDQAR-- 218
             +  HP +V+    F    K     L+L+L+  NGG    L   L   G  R D+A   
Sbjct: 73  QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ-RLDEAMIS 131

Query: 219 --FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-RSNSMC 275
              Y A +   + HLH   I+HRD+K  NIL+ ++G V L DFG++ ++  +  R N+  
Sbjct: 132 YILYGALL--GLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV 189

Query: 276 GTTEYMAPEILLSK-----GHNKDADWWSVGILLYEMLTGQVNIKSMQ 318
           GT  +MAPE++  +      ++   D WS+GI   E+  G   +  M 
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 85.1 bits (210), Expect = 9e-19
 Identities = 65/219 (29%), Positives = 110/219 (50%), Gaps = 26/219 (11%)

Query: 109 PGD-FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD 167
           P D +EI   +G+G +GKVF+V  K   +G      A+K++     I +     ++AE +
Sbjct: 16  PSDTWEIIETIGKGTYGKVFKVLNK--KNGSKA---AVKILDPIHDIDEE----IEAEYN 66

Query: 168 ILTKVT-HPFIVQL-----RYSFQTRSKLYLILDFINGGHLF----FHLYRQGIFREDQA 217
           IL  ++ HP +V+      +   +   +L+L+L+  NGG +       L R     E   
Sbjct: 67  ILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPII 126

Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-RSNSMCG 276
            +   E +  + HLH    +HRD+K  NIL+ ++G V L DFG++ ++  +  R N+  G
Sbjct: 127 AYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVG 186

Query: 277 TTEYMAPEIL-----LSKGHNKDADWWSVGILLYEMLTG 310
           T  +MAPE++     L   ++   D WS+GI   E+  G
Sbjct: 187 TPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 84.2 bits (208), Expect = 2e-18
 Identities = 55/186 (29%), Positives = 100/186 (53%), Gaps = 7/186 (3%)

Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           I A+KV+  D  ++      + +E +IL K   P+I+    +F   +++ +  +F++GG 
Sbjct: 28  ILAVKVIPLDITVELQK--QIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGS 85

Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L   +YR+ I      R   A +V  +++L    I+HRD+KP N+L+++ G V L DFG+
Sbjct: 86  L--DVYRK-IPEHVLGRIAVA-VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGV 141

Query: 262 AKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA 321
           + ++  +S + +  GT  YMAPE +  + +   +D WS+GI   E+  G+     +Q   
Sbjct: 142 STQL-VNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQ 200

Query: 322 CNTMLL 327
            + M L
Sbjct: 201 GSLMPL 206

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 64/206 (31%), Positives = 107/206 (51%), Gaps = 11/206 (5%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE    +G G  G V +V  +      S  I A K++  +  IK    + +  E  +L 
Sbjct: 2   DFEKLGELGAGNGGVVTKVLHR-----PSGLIMARKLIHLE--IKPAIRNQIIRELKVLH 54

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +   P+IV    +F +  ++ + ++ ++GG L   L + G   E+     +  ++  +++
Sbjct: 55  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTY 114

Query: 231 LH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLS 288
           L  K  I+HRD+KP NIL++S G + L DFG++ + ID  S +NS  GT  YM+PE L  
Sbjct: 115 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMSPERLQG 172

Query: 289 KGHNKDADWWSVGILLYEMLTGQVNI 314
             +   +D WS+G+ L EM  G+  I
Sbjct: 173 THYTVQSDIWSLGLSLVEMAIGRYPI 198

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 83.2 bits (206), Expect = 4e-18
 Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 46/221 (20%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD--------TIIKKNHVDYM 162
           D+     +G+G +G V++ + K      +  I AMK +R +        T I+       
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNK-----KTGQIVAMKKIRLESEEEGVPSTAIR------- 48

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFIN------------GGHLFFHLYRQG 210
             E  +L ++ HP IV L+      S+LYLI +F++            G ++   L +  
Sbjct: 49  --EISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKS- 105

Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR 270
                    Y  +I+  +   H   ++HRDLKP+N+L+D+ G + L DFGLA+      R
Sbjct: 106 ---------YLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156

Query: 271 SNSM-CGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLT 309
             +    T  Y APE+LL S  ++   D WS+G +  EM T
Sbjct: 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 82.8 bits (205), Expect = 4e-18
 Identities = 61/250 (24%), Positives = 110/250 (44%), Gaps = 18/250 (7%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G+G FGKV   +   + D   + + A+K +      ++ H    + E +IL  + H 
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQV-AVKSLNHSG--EEQHRSDFEREIEILRTLDHE 66

Query: 176 FIVQLRY--SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHL 231
            IV+ +          L LI++++  G L  +L R    + +  R   ++++I   + +L
Sbjct: 67  NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYL 125

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGT-TEYMAPEILL 287
                +HRDL   NIL++S+  V ++DFGLAK + E            +   + APE L 
Sbjct: 126 GSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185

Query: 288 SKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACNTMLLFYLIIFHCLFVNSL---EL 343
           +   +  +D WS G+ LYE+ T G  +           + +    +     +  L   E 
Sbjct: 186 TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFL-RMIGIAQGQMIVTRLLELLKEGER 244

Query: 344 LSHFPENCPA 353
           L   P +CP 
Sbjct: 245 LPR-PPSCPD 253

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 82.1 bits (203), Expect = 5e-18
 Identities = 53/208 (25%), Positives = 106/208 (50%), Gaps = 15/208 (7%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I P +    + +G G FG V   K +G  D       A+K++R+  +   +  D+++ E 
Sbjct: 1   IDPSELTFLKELGSGQFGVVHLGKWRGKID------VAIKMIREGAM---SEDDFIE-EA 50

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEI 224
            ++ K++HP +VQL Y   T+ + ++++ +++  G L  +L  + G    +      +++
Sbjct: 51  KVMMKLSHPNLVQL-YGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDV 109

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYMA 282
             A+ +L   G +HRDL   N L+  D  V ++DFGLA+ +  D+ + S       ++  
Sbjct: 110 CEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAP 169

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTG 310
           PE+      +  +D WS G+L++E+ + 
Sbjct: 170 PEVFDYSRFSSKSDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 82.5 bits (204), Expect = 6e-18
 Identities = 62/213 (29%), Positives = 108/213 (50%), Gaps = 26/213 (12%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGV--DDGDSDGI-YAMKVMRKDTIIKKNHVDYMKAER 166
            + E  +V+G GAFG V+    KGV   +G+   I  A+KV+R++T   K + + +  E 
Sbjct: 7   TELEKIKVLGSGAFGTVY----KGVWIPEGEKVKIPVAIKVLREETS-PKANKEILD-EA 60

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF------- 219
            ++  V HP +V+L       S++ LI   +  G L  ++      R  +          
Sbjct: 61  YVMASVDHPHVVRL-LGICLSSQVQLITQLMPLGCLLDYV------RNHKDNIGSQYLLN 113

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG--- 276
           +  +I   +S+L +  +VHRDL   N+L+ +  HV +TDFGLAK +D   +     G   
Sbjct: 114 WCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV 173

Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             ++MA E +L + +   +D WS G+ ++E++T
Sbjct: 174 PIKWMALESILHRIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 82.5 bits (204), Expect = 7e-18
 Identities = 62/221 (28%), Positives = 106/221 (47%), Gaps = 39/221 (17%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD--------TIIKKNHVDYMK 163
           F+I   +G+G +G+V++ +     D D+  + A+K +R D        T I+        
Sbjct: 9   FDIIGQIGEGTYGQVYKAR-----DKDTGELVALKKVRLDNEKEGFPITAIR-------- 55

Query: 164 AERDILTKVTHPFIVQLR---------YSFQTRSK-LYLILDFINGGHLFFHLYRQGI-- 211
            E  IL ++ H  IV L+           F+      YL+ ++++  H    L   G+  
Sbjct: 56  -EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD--HDLMGLLESGLVH 112

Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESS 269
           F ED  + +  +++  +++ HK   +HRD+K  NIL+++ G + L DFGLA+    +ES 
Sbjct: 113 FSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172

Query: 270 RSNSMCGTTEYMAPEILLSKGHNKDA-DWWSVGILLYEMLT 309
              +   T  Y  PE+LL +     A D WS G +L E+ T
Sbjct: 173 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 82.0 bits (203), Expect = 9e-18
 Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 24/204 (11%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM---RKDTIIKKNHVDYMKAERDI--LTKV 172
           +G+G++G VF+ + +     ++  I A+K       D +IKK       A R+I  L ++
Sbjct: 9   IGEGSYGVVFKCRNR-----ETGQIVAIKKFVESEDDPVIKK------IALREIRMLKQL 57

Query: 173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFH---LYRQGIFREDQARFYTAEIVSAVS 229
            HP +V L   F+ + KL+L+ ++ +  H   +      +G+  E   +    + + AV+
Sbjct: 58  KHPNLVNLIEVFRRKRKLHLVFEYCD--HTVLNELEKNPRGV-PEHLIKKIIWQTLQAVN 114

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE-YMAPEILLS 288
             HK   +HRD+KPENIL+   G + L DFG A+ +       +    T  Y APE+L+ 
Sbjct: 115 FCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVG 174

Query: 289 K-GHNKDADWWSVGILLYEMLTGQ 311
              +    D W++G +  E+LTGQ
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 82.3 bits (203), Expect = 2e-17
 Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 44/218 (20%)

Query: 118 VGQGAFGKVF---------QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           VG GA+G V          +V  K +       I+A +  R+ T++K    + +    D+
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDF-------INGGHLFFHLYRQGIFREDQARFYT 221
            T            S       YL++ +       I G              ED+ ++  
Sbjct: 83  FTSAV---------SGDEFQDFYLVMPYMQTDLQKIMGHP----------LSEDKVQYLV 123

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG---TT 278
            +++  + ++H  GI+HRDLKP N+ ++ D  + + DFGLA+  D       M G   T 
Sbjct: 124 YQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTR 178

Query: 279 EYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQVNIK 315
            Y APE++L+  H N+  D WSVG ++ EMLTG+   K
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK 216

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 81.4 bits (201), Expect = 2e-17
 Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 41/224 (18%)

Query: 112 FEIFRVVGQGAFGKVFQVK----------KKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
           +E    +G+G +GKV++ +          KK   + D +GI         T ++      
Sbjct: 3   YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGI-------PPTALR------ 49

Query: 162 MKAERDILTKVTH-PFIVQLRYSFQTRSK-----LYLILDFINGG-HLFFHLYRQGIFR- 213
              E  +L  ++   +IV+L        K     LYL+ ++++     F     +G  R 
Sbjct: 50  ---EISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRP 106

Query: 214 --EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAK--EIDES 268
                 + +  +++  V+H HK G++HRDLKP+N+L+D    ++ + D GL +   I   
Sbjct: 107 LPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK 166

Query: 269 SRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
           S ++ +  T  Y APE+LL   H +   D WSVG +  EM   Q
Sbjct: 167 SYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 80.8 bits (199), Expect = 2e-17
 Identities = 61/205 (29%), Positives = 108/205 (52%), Gaps = 22/205 (10%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGI-YAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
           +V+G GAFG V+  K   + DG++  I  A+KV+R++T  K N    +  E  ++  V  
Sbjct: 13  KVLGSGAFGTVY--KGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGS 68

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-------YTAEIVSA 227
           P++ +L       S + L+   +  G L  ++      RE++ R        +  +I   
Sbjct: 69  PYVCRL-LGICLTSTVQLVTQLMPYGCLLDYV------RENKDRIGSQDLLNWCVQIAKG 121

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESS-RSNSMCGTTEYMAPE 284
           +S+L +  +VHRDL   N+L+ S  HV +TDFGLA+  +IDE+   ++      ++MA E
Sbjct: 122 MSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 181

Query: 285 ILLSKGHNKDADWWSVGILLYEMLT 309
            +L +     +D WS G+ ++E++T
Sbjct: 182 SILHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 80.3 bits (198), Expect = 2e-17
 Identities = 53/212 (25%), Positives = 105/212 (49%), Gaps = 25/212 (11%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I P D    + +G G FG V   K +G  D       A+K++++ ++ +   ++    E 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYD------VAIKMIKEGSMSEDEFIE----EA 50

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVS 226
            ++ K++H  +VQL      +  +Y++ ++++ G L  +L      RE   RF  ++++ 
Sbjct: 51  KVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL------REHGKRFQPSQLLE 104

Query: 227 -------AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT 277
                   +++L     +HRDL   N L+D  G V ++DFGL++ +  DE + S      
Sbjct: 105 MCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFP 164

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             +  PE+LL    +  +D W+ G+L++E+ +
Sbjct: 165 VRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 81.3 bits (201), Expect = 3e-17
 Identities = 48/154 (31%), Positives = 79/154 (51%), Gaps = 15/154 (9%)

Query: 168 ILTKVTHPFIVQL------RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE-DQAR-- 218
           ++  V H  I+ L      + S +    +YL+++ ++          Q I  + D  R  
Sbjct: 68  LMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD------ANLCQVIQMDLDHERMS 121

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
           +   +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+    S        T 
Sbjct: 122 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 181

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            Y APE++L  G+ ++ D WSVG ++ EM+ G V
Sbjct: 182 YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTV 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 81.2 bits (200), Expect = 3e-17
 Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 25/214 (11%)

Query: 109 PGDFEIFRVVGQGAFGKV---------FQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV 159
           P  ++    VG GA+G V          +V  K +       I+A +  R+  ++K    
Sbjct: 16  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK---- 71

Query: 160 DYMKAERDI-LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
            +MK E  I L  V  P       S +  + +YL+   +  G    ++ +     +D  +
Sbjct: 72  -HMKHENVIGLLDVFTP-----ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQ 123

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
           F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+         T 
Sbjct: 124 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATR 181

Query: 279 EYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
            Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 182 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 81.1 bits (200), Expect = 3e-17
 Identities = 53/197 (26%), Positives = 93/197 (47%), Gaps = 14/197 (7%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           + + + +  G+ G+VF   K     G  D +  +K+ +K T +          E  +L  
Sbjct: 68  YTVIKTLTPGSEGRVFVATK----PGQPDPV-VLKIGQKGTTL---------IEAMLLQN 113

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           V HP +++++ +  + +   ++L   +     +   R      DQA     +I+  + +L
Sbjct: 114 VNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYL 173

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGH 291
           H   I+HRD+K ENI ++    V + D G A+    +     + GT E  APE+L    +
Sbjct: 174 HAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKY 233

Query: 292 NKDADWWSVGILLYEML 308
           N  AD WS GI+L+EML
Sbjct: 234 NSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 79.5 bits (196), Expect = 5e-17
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 30/216 (13%)

Query: 116 RVVGQGAFGKVFQVKKKGVD-DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
             +G GAFG+V++     +   G      A+K +RK    ++   +++K E  +++   H
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFLK-EAHLMSNFNH 58

Query: 175 PFIV-QLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA----------- 222
           P IV  L          Y+I++ + GG L  +L    +      RF              
Sbjct: 59  PNIVKLLGVCLLNEP-QYIIMELMEGGDLLSYLRDARV-----ERFGPPLLTLKELLDIC 112

Query: 223 -EIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----VMLTDFGLAKEI---DESSRSNS 273
            ++     +L +   +HRDL   N L+   G+     V + DFGLA++I   D   +   
Sbjct: 113 LDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGE 172

Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
                 +MAPE LL       +D WS G+L++E+LT
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 80.9 bits (199), Expect = 5e-17
 Identities = 37/90 (41%), Positives = 55/90 (61%)

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+    S        T  Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQV 312
           PE++L  G+ ++ D WSVG ++ EM+ G V
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGV 223

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 80.5 bits (198), Expect = 6e-17
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 14/210 (6%)

Query: 156 KNHVDYMKAERDI--LTKVTHPFIVQL------RYSFQTRSKLYLILDFINGGHL-FFHL 206
           +N     +A R++  L  V H  I+ L      + S +    +YL+++ ++       H+
Sbjct: 59  QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM 118

Query: 207 YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID 266
                   ++  +   +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+   
Sbjct: 119 E----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174

Query: 267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTML 326
            +        T  Y APE++L  G+ ++ D WSVG ++ E++ G V  +    I     +
Sbjct: 175 TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKV 234

Query: 327 LFYLIIFHCLFVNSL-ELLSHFPENCPASH 355
           +  L      F+N L   + ++ EN P   
Sbjct: 235 IEQLGTPSAEFMNRLQPTVRNYVENRPQYP 264

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 78.9 bits (194), Expect = 7e-17
 Identities = 54/200 (27%), Positives = 98/200 (49%), Gaps = 17/200 (8%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           + ++ + +G+G FG V     +G          A+K ++ D   +        AE  ++T
Sbjct: 7   ELKLLQTIGKGEFGDVMLGDYRGNK-------VAVKCIKNDATAQA-----FLAEASVMT 54

Query: 171 KVTHPFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSA 227
           ++ H  +VQL     + +  LY++ +++  G L  +L  +G  +   D    ++ ++  A
Sbjct: 55  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 114

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + +L     VHRDL   N+L+  D    ++DFGL KE   SS  ++     ++ APE L 
Sbjct: 115 MEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA--SSTQDTGKLPVKWTAPEALR 172

Query: 288 SKGHNKDADWWSVGILLYEM 307
            K  +  +D WS GILL+E+
Sbjct: 173 EKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 80.1 bits (197), Expect = 9e-17
 Identities = 58/219 (26%), Positives = 105/219 (47%), Gaps = 33/219 (15%)

Query: 109 PGDFEIFRVVGQGAFGKVF---------QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV 159
           P  ++    VG GA+G V          +V  K +       I+A +  R+  ++K    
Sbjct: 14  PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLK---- 69

Query: 160 DYMKAER-----DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
            +MK E      D+ T  T         S +  +++YL+ + +  G    ++ +     +
Sbjct: 70  -HMKHENVIGLLDVFTPAT---------SIENFNEVYLVTNLM--GADLNNIVKCQKLSD 117

Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM 274
           +  +F   +++  + ++H  GI+HRDLKP N+ ++ D  + + DFGLA++ D+       
Sbjct: 118 EHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD--EMTGY 175

Query: 275 CGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQV 312
             T  Y APEI+L+  H N+  D WSVG ++ E+L G+ 
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKA 214

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 80.0 bits (197), Expect = 1e-16
 Identities = 64/235 (27%), Positives = 95/235 (40%), Gaps = 39/235 (16%)

Query: 92  EHENDAE----LEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKV 147
           E E+DA+    L AE+   I    F I      GA G  F                    
Sbjct: 70  EDESDADASLALCAEARAGIEKAGFSILETFTPGAEGFAFACIDNKT------------- 116

Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
             +  +IK         E  IL  + HP I+QL+ +F       LIL            Y
Sbjct: 117 -CEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP----------RY 165

Query: 208 RQGIF--REDQARFYTAEIVS-------AVSHLHKCGIVHRDLKPENILMDSDGHVMLTD 258
           +  ++     +      +I++       A+ +LH+  I+HRD+K ENI ++  G V L D
Sbjct: 166 KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGD 225

Query: 259 FGLA-KEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           FG A   +D  +++     GT    APE+L    +    D WS GI+L+EM T  
Sbjct: 226 FGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 79.7 bits (196), Expect = 1e-16
 Identities = 61/205 (29%), Positives = 107/205 (52%), Gaps = 9/205 (4%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE    +G G  G V +V+ K      S  I A K++  +  IK    + +  E  +L 
Sbjct: 6   DFERISELGAGNGGVVTKVQHK-----PSGLIMARKLIHLE--IKPAIRNQIIRELQVLH 58

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +   P+IV    +F +  ++ + ++ ++GG L   L       E+     +  ++  +++
Sbjct: 59  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAY 118

Query: 231 L-HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           L  K  I+HRD+KP NIL++S G + L DFG++ ++ + S +NS  GT  YM+PE L   
Sbjct: 119 LREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGT 177

Query: 290 GHNKDADWWSVGILLYEMLTGQVNI 314
            ++  +D WS+G+ L E+  G+  I
Sbjct: 178 HYSVQSDIWSMGLSLVELAIGRYPI 202

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 42/217 (19%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +GQG FG+VF+ + K         I A+K +  +   +   +  ++ E  IL  + H  +
Sbjct: 20  IGQGTFGEVFKARHKKTKQ-----IVALKKVLMENEKEGFPITALR-EIKILQLLKHENV 73

Query: 178 VQL------------RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI- 224
           V L            RY    +   YL+ +F    H        G+      +F  +EI 
Sbjct: 74  VNLIEICRTKATPYNRY----KGSFYLVFEFCE--HDL-----AGLLSNKNVKFTLSEIK 122

Query: 225 ------VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
                 ++ + ++H+  I+HRD+K  NIL+  DG + L DFGLA+    S  S     T 
Sbjct: 123 KVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTN 182

Query: 279 E-----YMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
                 Y  PE+LL  + +    D W  G ++ EM T
Sbjct: 183 RVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 80.1 bits (197), Expect = 2e-16
 Identities = 69/272 (25%), Positives = 121/272 (44%), Gaps = 48/272 (17%)

Query: 65  HNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFR-------- 116
           H  +    G        +   L  +E  H N+A  + + E+ I   D +I R        
Sbjct: 18  HKANKGGSGKFEM----NDKKLDEEERSHNNNAGEDEDEEKMI---DNDINRSPNKSYKL 70

Query: 117 --VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
             ++G G+FG V++     +    S+ +   KV++           Y   E  I+  + H
Sbjct: 71  GNIIGNGSFGVVYE----AICIDTSEKVAIKKVLQDP--------QYKNRELLIMKNLNH 118

Query: 175 PFIVQLRYSFQTRSK--------LYLILDFINGGHLFFHLYRQGIFREDQA------RFY 220
             I+ L+  + T           L ++++FI       H Y +   R + A      + Y
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQT---VHKYMKHYARNNHALPLFLVKLY 175

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCGTTE 279
           + ++  A++++H   I HRDLKP+N+L+D + H + L DFG AK +    RS S   +  
Sbjct: 176 SYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF 235

Query: 280 YMAPEILL-SKGHNKDADWWSVGILLYEMLTG 310
           Y APE++L +  +    D WS+G ++ EM+ G
Sbjct: 236 YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 79.0 bits (194), Expect = 2e-16
 Identities = 53/180 (29%), Positives = 89/180 (49%), Gaps = 17/180 (9%)

Query: 147 VMRKDTIIKK------NHVDYMKAERD-ILTK-VTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R+ +L K V H  I+ L   F  +  L      YL
Sbjct: 40  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYL 99

Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 100 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 156

Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+  ++
Sbjct: 157 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 61/234 (26%), Positives = 110/234 (47%), Gaps = 43/234 (18%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-IKKNHVDYMKAERDI 168
             ++I R++G+G  G+V+       D   S  + A+K +R+D          +++ E  I
Sbjct: 2   QRYDIIRLIGKGGMGEVYL----AYDPVCSRRV-ALKKIREDLSENPLLKKRFLR-EAKI 55

Query: 169 LTKVTHPFIVQLRYSFQTRSKL-YLILDFING---GHLFFHLYRQGIFREDQAR------ 218
              + HP IV + YS  +     Y  + +I G     L   ++++    ++ A       
Sbjct: 56  AADLIHPGIVPV-YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGA 114

Query: 219 ----FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--------EID 266
               F+   I + + ++H  G++HRDLKP+NIL+   G V++ D+G A          +D
Sbjct: 115 FLSIFHK--ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172

Query: 267 ESSRSNSMC-----------GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
                 ++C           GT +YMAPE LL    ++  D +++G++LY+MLT
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 78.0 bits (192), Expect = 2e-16
 Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 10/200 (5%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           RV+G+G FGKV        +DG  + + A+K ++++    + +    K E +IL  + H 
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGE-MVAVKTLKREC--GQQNTSGWKKEINILKTLYHE 66

Query: 176 FIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
            IV+ +   S Q    L LI++++  G L  +L +  +    Q   +  +I   +++LH 
Sbjct: 67  NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKL-NLAQLLLFAQQICEGMAYLHS 125

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSK 289
              +HRDL   N+L+D+D  V + DFGLAK + E      +    +    + A E L   
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN 185

Query: 290 GHNKDADWWSVGILLYEMLT 309
             +  +D WS G+ LYE+LT
Sbjct: 186 KFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 78.2 bits (192), Expect = 2e-16
 Identities = 57/214 (26%), Positives = 106/214 (49%), Gaps = 15/214 (7%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--IL 169
           +E    +G+G++  V++ K K      +  + A+KV+R    +++       A R+  +L
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKV-----NGKLVALKVIR----LQEEEGTPFTAIREASLL 57

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + H  IV L     T+  L L+ ++++     +     G    +  + +  +++  +S
Sbjct: 58  KGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLS 117

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGL--AKEIDESSRSNSMCGTTEYMAPEILL 287
           ++H+  I+HRDLKP+N+L+   G + L DFGL  AK +   + SN +  T  Y  P++LL
Sbjct: 118 YIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLL 176

Query: 288 -SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVI 320
            S  ++   D W VG +  EM+ G      M+ I
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI 210

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 79.8 bits (196), Expect = 3e-16
 Identities = 60/233 (25%), Positives = 117/233 (50%), Gaps = 38/233 (16%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           ++E+ + +G G FG+VF VK K   +      +  K +    + K+     +  E +++ 
Sbjct: 14  EYEVIKKIGNGRFGEVFLVKHKRTQE-----FFCWKAISYRGL-KEREKSQLVIEVNVMR 67

Query: 171 KVTHPFIVQL--RYSFQTRSKLYLILDFINGGHLFFHL---YRQ-GIFREDQARFYTAEI 224
           ++ H  IV+   R+  +   KLY++++F + G L  ++   Y+  G   E      T ++
Sbjct: 68  ELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQL 127

Query: 225 VSAVSHLHKCG-------IVHRDLKPENILMDSD----GHVM-------------LTDFG 260
           + A+++ H          ++HRDLKP+NI + +     G +              + DFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187

Query: 261 LAKEIDESSRSNSMCGTTEYMAPEILL--SKGHNKDADWWSVGILLYEMLTGQ 311
           L+K I   S ++S  GT  Y +PE+LL  +K ++  +D W++G ++YE+ +G+
Sbjct: 188 LSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Length = 1021

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 77.7 bits (192), Expect = 4e-16
 Identities = 61/228 (26%), Positives = 107/228 (46%), Gaps = 39/228 (17%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM--KAERD 167
            D+EI   +G+G FG+V++ ++       +  + A+K      I+  N  D     A R+
Sbjct: 8   RDYEILGKLGEGTFGEVYKARQI-----KTGRVVALK-----KILMHNEKDGFPITALRE 57

Query: 168 I--LTKVTHPFIVQL------RYSFQTRSK--LYLILDFINGGH-LFFHLYRQGI-FRED 215
           I  L K+ HP +V L      R     R +  +Y++  +++  H L   L    +   E 
Sbjct: 58  IKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD--HDLSGLLENPSVKLTES 115

Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN--- 272
           Q + Y  +++  +++LH+  I+HRD+K  NIL+D+ G + + DFGLA+  D    +    
Sbjct: 116 QIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175

Query: 273 ---------SMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTG 310
                    ++  T  Y  PE+LL  + +    D W +G +  EM T 
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 77.7 bits (191), Expect = 5e-16
 Identities = 43/123 (34%), Positives = 70/123 (56%), Gaps = 5/123 (4%)

Query: 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD 249
            YL++ F+  G     L +     ED+ +F   +++  + ++H  GI+HRDLKP N+ ++
Sbjct: 95  FYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN 152

Query: 250 SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEML 308
            D  + + DFGLA++ D  S       T  Y APE++L+  H  +  D WSVG ++ EML
Sbjct: 153 EDCELKILDFGLARQTD--SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEML 210

Query: 309 TGQ 311
           TG+
Sbjct: 211 TGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 77.2 bits (190), Expect = 6e-16
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 19/203 (9%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR---KDTIIKKNHVDYMKAERDI 168
           F   R +G G+FG V+  +     D  ++ + A+K M    K +  K    D +K E   
Sbjct: 17  FTDLREIGHGSFGAVYFAR-----DVRTNEVVAIKKMSYSGKQSNEKWQ--DIIK-EVRF 68

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDF-INGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           L ++ HP  ++ +  +      +L++++ +        ++++ + +E +        +  
Sbjct: 69  LQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPL-QEVEIAAICHGALQG 127

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           +++LH    +HRD+K  NIL+   G V L DFG A  +     +NS  GT  +MAPE++L
Sbjct: 128 LAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP---ANSFVGTPYWMAPEVIL 184

Query: 288 S--KGHNKD-ADWWSVGILLYEM 307
           +  +G      D WS+GI   E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 77.5 bits (191), Expect = 6e-16
 Identities = 39/101 (38%), Positives = 59/101 (58%), Gaps = 3/101 (2%)

Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRSN 272
           D  + +  +I+  + +LH  GI+HRD+KP N+L++S+  + + DFGLA+  E DES    
Sbjct: 103 DHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT 162

Query: 273 SMCGTTEYMAPEILLSKGHNKDA-DWWSVGILLYEMLTGQV 312
               T  Y APEIL+   H   A D WSVG +  E+L  ++
Sbjct: 163 QEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRI 203

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 76.4 bits (188), Expect = 7e-16
 Identities = 38/103 (36%), Positives = 63/103 (61%), Gaps = 4/103 (3%)

Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKEIDE-SSR 270
            E    FYT +I+  + +LH   IVHRD+K +N+L+++  G V ++DFG +K +   +  
Sbjct: 106 NEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC 165

Query: 271 SNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQ 311
           + +  GT +YMAPE++    +G+   AD WS+G  + EM TG+
Sbjct: 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 77.1 bits (190), Expect = 7e-16
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 44/224 (19%)

Query: 115 FRVVGQGAFGKVFQ-----------VKKKGVDDGDS--DGIYAMKVMRK---DTIIKKNH 158
            R +G G+ G VF            VKK  + D  S    +  +K++R+   D I+K   
Sbjct: 10  LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYE 69

Query: 159 VDYMKAERD-----ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFR 213
           V              LT++   +IVQ           Y+  D  N       +  QG   
Sbjct: 70  VLGPSGSDLTEDVGSLTELNSVYIVQE----------YMETDLAN-------VLEQGPLS 112

Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEID-ESSRS 271
           E+ AR +  +++  + ++H   ++HRDLKP N+ ++++  V+ + DFGLA+ +D   S  
Sbjct: 113 EEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHK 172

Query: 272 N--SMCGTTE-YMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              S    T+ Y +P +LLS  +  K  D W+ G +  EMLTG+
Sbjct: 173 GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 76.6 bits (189), Expect = 7e-16
 Identities = 37/112 (33%), Positives = 63/112 (56%), Gaps = 4/112 (3%)

Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGL 261
           + +   + +  E+         V A+++L +   I+HRD+KP NIL+D +G++ L DFG+
Sbjct: 95  YVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGI 154

Query: 262 AKEIDESSRSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTG 310
           + ++ +S       G   YMAPE +      G++  +D WS+GI LYE+ TG
Sbjct: 155 SGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 76.5 bits (189), Expect = 8e-16
 Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 24/211 (11%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           ++E    + +G +G V++ + K      +  I A+K ++ +   +   +  ++ E +IL 
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDK-----KTGEIVALKKLKMEKEKEGFPITSLR-EINILL 59

Query: 171 KVTHPFIVQLRYSF--QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI---- 224
           K+ HP IV ++         K+Y++++++       H  +  +    Q  F  +E+    
Sbjct: 60  KLQHPNIVTVKEVVVGSNLDKIYMVMEYVE------HDLKSLMETMKQ-PFLQSEVKCLM 112

Query: 225 ---VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-NSMCGTTEY 280
              +S V+HLH   I+HRDLK  N+L+++ G + + DFGLA+E     +    +  T  Y
Sbjct: 113 LQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWY 172

Query: 281 MAPEILLSKGHNKDA-DWWSVGILLYEMLTG 310
            APE+LL       A D WSVG +  E+LT 
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 76.3 bits (188), Expect = 8e-16
 Identities = 57/209 (27%), Positives = 103/209 (49%), Gaps = 16/209 (7%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D E+   +G+GA+G V +++        +  I A+K +R     ++     M  + DI  
Sbjct: 2   DLEVIEELGRGAYGVVDKMRHV-----PTGTIMAVKRIRATVNSQEQKRLLM--DLDISM 54

Query: 171 KVTH-PFIVQLRYSFQTRSKLYLILDFINGG--HLFFHLYRQGIF-REDQARFYTAEIVS 226
           +    P+ V    +      +++ ++ ++      +  +Y +G+   ED        IV 
Sbjct: 55  RSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVK 114

Query: 227 AVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE- 284
           A+ +LH K  ++HRD+KP N+L++ +G V L DFG++  + +S       G   YMAPE 
Sbjct: 115 ALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPER 174

Query: 285 ---ILLSKGHNKDADWWSVGILLYEMLTG 310
               L  KG++  +D WS+GI + E+ TG
Sbjct: 175 INPELNQKGYDVKSDVWSLGITMIELATG 203

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 56/212 (26%), Positives = 103/212 (48%), Gaps = 26/212 (12%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGI---YAMKVMRKDTIIKKNHVDYMKAERD 167
           +F+  +V+G GAFG V+    KG+   + + +    A+K +R+ T  K N    +  E  
Sbjct: 8   EFKKIKVLGSGAFGTVY----KGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAY 61

Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-------Y 220
           ++  V +P + +L       S + LI   +  G L  ++      RE +          +
Sbjct: 62  VMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYV------REHKDNIGSQYLLNW 114

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG---T 277
             +I   +++L +  +VHRDL   N+L+ +  HV +TDFGLAK +    +     G    
Sbjct: 115 CVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            ++MA E +L + +   +D WS G+ ++E++T
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 38/222 (17%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +E+ + +GQGA+G V   +     + ++  I      +K T +             IL K
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAI------KKITNVFSK---------KILAK 46

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDF-------INGGHLFFHLYR---QGIFREDQA---- 217
                +  LR+ F+    +  + D         N  +L+  L       I R  Q     
Sbjct: 47  RALRELKLLRH-FRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDA 105

Query: 218 --RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-- 273
             + +  +I+  + ++H   ++HRDLKP N+L+++D  + + DFGLA+   E+   N+  
Sbjct: 106 HFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF 165

Query: 274 ---MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQ 311
                 T  Y APEI+LS + + K  D WSVG +L E+L  +
Sbjct: 166 MTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 51/194 (26%), Positives = 95/194 (48%), Gaps = 12/194 (6%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHP 175
           +G+G +G VF+ K +     ++  I A+K +R D     +      A R+I  L ++ H 
Sbjct: 8   IGEGTYGTVFKAKNR-----ETHEIVALKRVRLD---DDDEGVPSSALREICLLKELKHK 59

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
            IV+L     +  KL L+ ++ +     +     G    +  + +  +++  ++  H   
Sbjct: 60  NIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN 119

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM-CGTTEYMAPEILL-SKGHNK 293
           ++HRDLKP+N+L++ +G + L DFGLA+      R  S    T  Y  P++L  +K ++ 
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 179

Query: 294 DADWWSVGILLYEM 307
             D WS G +  E+
Sbjct: 180 SIDMWSAGCIFAEL 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 75.2 bits (185), Expect = 2e-15
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 23/213 (10%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           R +G+GAFGKVF  +   ++  +   + A+K + K+T       D+ + E ++LT   H 
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFER-EAELLTNFQHE 68

Query: 176 FIVQLRYSFQTR-SKLYLILDFINGGHLFFHLYRQG-----IFREDQARF---------Y 220
            IV+  Y   T      ++ +++  G L   L   G     +   D              
Sbjct: 69  NIVKF-YGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT-- 278
             +I S + +L     VHRDL   N L+  D  V + DFG+++++  ++    + G T  
Sbjct: 128 AVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV-YTTDYYRVGGHTML 186

Query: 279 --EYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
              +M PE ++ +    ++D WS G++L+E+ T
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 33/221 (14%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA-----------ER 166
           +G+G +GKV +       D  +  I A+K ++   I      D               E 
Sbjct: 17  LGEGTYGKVEKAY-----DTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLREL 71

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVS 226
            I+ ++ H  I+ L   +     + L++D +    L   + R+    E Q +    +I++
Sbjct: 72  KIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILN 130

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE------IDESSRSNSMCGTTE- 279
            ++ LHK   +HRDL P NI ++S G   + DFGLA+        D  S+  +M    E 
Sbjct: 131 GLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190

Query: 280 --------YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
                   Y APE+L+ ++ ++   D WSVG +  E+LTG+
Sbjct: 191 TSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 74.3 bits (182), Expect = 3e-15
 Identities = 57/205 (27%), Positives = 102/205 (49%), Gaps = 16/205 (7%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +GQG FG+V+     G  +G +    A+K ++  T+  +  +     E  ++ K+ H  +
Sbjct: 14  LGQGCFGEVW----MGTWNGTTR--VAIKTLKPGTMSPEAFLQ----EAQVMKKLRHEKL 63

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCG 235
           VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A+I S ++++ +  
Sbjct: 64  VQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 122

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEILLSKGHNK 293
            VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++ APE  L      
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 294 DADWWSVGILLYEMLT-GQVNIKSM 317
            +D WS GILL E+ T G+V    M
Sbjct: 183 KSDVWSFGILLTELTTKGRVPYPGM 207

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 73.8 bits (181), Expect = 4e-15
 Identities = 51/195 (26%), Positives = 95/195 (48%), Gaps = 17/195 (8%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF 176
           ++G+G FG V Q +  G          A+K ++ D   +         E  ++TK+ H  
Sbjct: 13  IIGEGEFGAVLQGEYTGQK-------VAVKNIKCDVTAQA-----FLEETAVMTKLHHKN 60

Query: 177 IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKC 234
           +V+L       + LY++++ ++ G+L   L  +G       +   ++ ++   + +L   
Sbjct: 61  LVRL-LGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK 119

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKD 294
            +VHRDL   NIL+  DG   ++DFGLA+    S   ++     ++ APE L  K  +  
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLPVKWTAPEALKHKKFSSK 177

Query: 295 ADWWSVGILLYEMLT 309
           +D WS G+LL+E+ +
Sbjct: 178 SDVWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 74.7 bits (183), Expect = 4e-15
 Identities = 62/219 (28%), Positives = 106/219 (48%), Gaps = 39/219 (17%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHP 175
           VG+G +G V++ K+K   DG  D  YA+K +    I        M A R+I  L ++ HP
Sbjct: 9   VGRGTYGHVYKAKRK---DGKDDRDYALKQIEGTGI-------SMSACREIALLRELKHP 58

Query: 176 FIVQLRYSFQTRS--KLYLILDFINGGHLFFHLYRQGIFREDQA------------RFYT 221
            ++ L+  F + +  K++L+ D+    H  +H+ +    R  +A            +   
Sbjct: 59  NVISLQKVFLSHADRKVWLLFDYAE--HDLWHIIK--FHRASKANKKPVQLPRGMVKSLL 114

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSD----GHVMLTDFGLAKEIDESSRS----NS 273
            +I+  + +LH   ++HRDLKP NIL+  +    G V + D G A+  +   +     + 
Sbjct: 115 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174

Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
           +  T  Y APE+LL   H  K  D W++G +  E+LT +
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 74.3 bits (182), Expect = 4e-15
 Identities = 57/204 (27%), Positives = 100/204 (49%), Gaps = 25/204 (12%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-------TIIKKNHVDYMKAERDILT 170
           +G+G +  VF+ + K  ++     + A+K +R +       T I+         E  +L 
Sbjct: 13  LGEGTYATVFKGRSKLTEN-----LVALKEIRLEHEEGAPCTAIR---------EVSLLK 58

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + H  IV L     T   L L+ ++++     +      +      + +  +++  +S+
Sbjct: 59  NLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSY 118

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGL--AKEIDESSRSNSMCGTTEYMAPEILL- 287
            HK  I+HRDLKP+N+L++  G + L DFGL  AK +   + SN +  T  Y  P++LL 
Sbjct: 119 CHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLG 177

Query: 288 SKGHNKDADWWSVGILLYEMLTGQ 311
           S  ++   D W VG +LYEM TG+
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 74.2 bits (182), Expect = 4e-15
 Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 12/202 (5%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
           R +G+G FGKV   +     +GD+ G   A+K ++ ++    NH+  +K E +IL  + H
Sbjct: 10  RDLGEGHFGKVELCRYD--PEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYH 65

Query: 175 PFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHL 231
             IV+ +   +    + + LI++F+  G L  +L R +      Q   Y  +I   + +L
Sbjct: 66  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL 125

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR----SNSMCGTTEYMAPEILL 287
                VHRDL   N+L++S+  V + DFGL K I+         + +     + APE L+
Sbjct: 126 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185

Query: 288 SKGHNKDADWWSVGILLYEMLT 309
                  +D WS G+ LYE+LT
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 73.6 bits (181), Expect = 5e-15
 Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 27/213 (12%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F + R +G G FG+V++   K           A+K+++ D        D+ K E   L 
Sbjct: 7   EFTLERKLGSGYFGEVWEGLWKNRVR------VAIKILKSDD--LLKQQDFQK-EVQALK 57

Query: 171 KVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYT-------- 221
           ++ H  ++ L ++  +  + +Y+I + +  G L   L      R  + +           
Sbjct: 58  RLRHKHLISL-FAVCSVGEPVYIITELMEKGSLLAFL------RSPEGQVLPVASLIDMA 110

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT-TEY 280
            ++   +++L +   +HRDL   NIL+  D    + DFGLA+ I E    +S      ++
Sbjct: 111 CQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKW 170

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQV 312
            APE       +  +D WS GILLYEM T GQV
Sbjct: 171 TAPEAASHGTFSTKSDVWSFGILLYEMFTYGQV 203

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 74.3 bits (182), Expect = 5e-15
 Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 27/205 (13%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-------TIIKKNHVDYMKAERDILT 170
           +G+G +  V++ + K  D+     + A+K +R +       T I+         E  +L 
Sbjct: 14  LGEGTYATVYKGRSKLTDN-----LVALKEIRLEHEEGAPCTAIR---------EVSLLK 59

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVS 229
            + H  IV L     T   L L+ ++++   L  +L   G        + +  +++  ++
Sbjct: 60  DLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLN 118

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGL--AKEIDESSRSNSMCGTTEYMAPEILL 287
           + H+  ++HRDLKP+N+L++  G + L DFGL  AK I   + SN +  T  Y  P+ILL
Sbjct: 119 YCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILL 177

Query: 288 -SKGHNKDADWWSVGILLYEMLTGQ 311
            S  ++   D W VG + YEM TG+
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 73.6 bits (181), Expect = 7e-15
 Identities = 58/237 (24%), Positives = 107/237 (45%), Gaps = 26/237 (10%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           ++      + R +G GAFG+V++   +G D    +   A+K + +    +++  D++  E
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLM-E 59

Query: 166 RDILTKVTHPFIVQL-RYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQAR---- 218
             I++K  H  IV+L   SF+   + +++L+ + GG L  F    R    R         
Sbjct: 60  ALIMSKFNHQNIVRLIGVSFERLPR-FILLELMAGGDLKSFLRENRPRPERPSSLTMKDL 118

Query: 219 -FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESS--RSN 272
            F   ++     +L +   +HRD+   N L+   G      + DFG+A++I  +S  R  
Sbjct: 119 LFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178

Query: 273 --SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML-------TGQVNIKSMQVI 320
             +M    ++M PE  L        D WS G+LL+E+         G+ N + M+ +
Sbjct: 179 GRAML-PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV 234

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 73.2 bits (180), Expect = 8e-15
 Identities = 56/203 (27%), Positives = 102/203 (50%), Gaps = 18/203 (8%)

Query: 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV 172
           ++ R +G G FG+V++    G+ +  +    A+K ++  T+  K+ +    AE  I+ K+
Sbjct: 9   QLLRKLGAGQFGEVWE----GLWNNTTP--VAVKTLKPGTMDPKDFL----AEAQIMKKL 58

Query: 173 THPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVS 229
            HP ++QL Y+  T  + +Y++ + +  G L  +L        +  Q     A++ S ++
Sbjct: 59  RHPKLIQL-YAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMA 117

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEYMAPEIL 286
           +L     +HRDL   N+L+  +    + DFGLA+ I E     +  G     ++ APE  
Sbjct: 118 YLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI-YEAREGAKFPIKWTAPEAA 176

Query: 287 LSKGHNKDADWWSVGILLYEMLT 309
           L    +  +D WS GILL E++T
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 73.7 bits (181), Expect = 9e-15
 Identities = 36/100 (36%), Positives = 60/100 (60%), Gaps = 4/100 (4%)

Query: 214 EDQ-ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN 272
           E Q  +++  +I+  + ++H  G+VHRDLKP NIL++ +  + + DFGLA+  D   +  
Sbjct: 106 EKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD--PQMT 163

Query: 273 SMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQ 311
               T  Y APEI+L+ + ++ + D WS G +  EML G+
Sbjct: 164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 73.3 bits (180), Expect = 1e-14
 Identities = 70/259 (27%), Positives = 119/259 (45%), Gaps = 40/259 (15%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF 176
           +G+G FG V   +   +   D+ G + A+K ++  T     H+   + E +IL  + H  
Sbjct: 12  LGKGNFGSVELCRYDPL--QDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDN 66

Query: 177 IVQLR---YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHL 231
           IV+ +   YS   R  L L+++++  G L  +L +    R D  +   Y ++I   + +L
Sbjct: 67  IVKYKGVCYS-AGRRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYL 124

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE----YMAPEILL 287
                VHRDL   NIL++S+  V + DFGL K + +      +    E    + APE L 
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184

Query: 288 SKGHNKDADWWSVGILLYEMLTGQVNIKS-----MQVIACN---TMLLFYLIIFHCLFVN 339
               +  +D WS G++LYE+ T      S     M+++  +    M++++LI        
Sbjct: 185 ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI-------- 236

Query: 340 SLELLSH-----FPENCPA 353
             ELL +      P  CPA
Sbjct: 237 --ELLKNNGRLPAPPGCPA 253

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 16/207 (7%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK--AERDIL 169
           +E    +G+GA+GKVF+ +    D  +     A+K +R  T  +   +  ++  A    L
Sbjct: 3   YECVAEIGEGAYGKVFKAR----DLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 58

Query: 170 TKVTHPFIVQL----RYSFQTR-SKLYLILDFINGGHLFFHLYR---QGIFREDQARFYT 221
               HP +V+L      S   R +KL L+ + ++   L  +L +    G+  E   +   
Sbjct: 59  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTE-TIKDMM 116

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYM 281
            +++  +  LH   +VHRDLKP+NIL+ S G + L DFGLA+         S+  T  Y 
Sbjct: 117 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYR 176

Query: 282 APEILLSKGHNKDADWWSVGILLYEML 308
           APE+LL   +    D WSVG +  EM 
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMF 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 72.4 bits (178), Expect = 1e-14
 Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 29/214 (13%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           R +G G FG+V+     G  +G +    A+K ++  T+  +    +++ E  I+ K+ H 
Sbjct: 12  RKLGAGQFGEVW----MGTWNGTTK--VAVKTLKPGTMSPE---AFLQ-EAQIMKKLRHD 61

Query: 176 FIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARF--------YTAEIVS 226
            +VQL Y+  +  + +Y++ ++++ G L   L      +  + +           A+I  
Sbjct: 62  KLVQL-YAVCSEEEPIYIVTEYMSKGSLLDFL------KSGEGKKLRLPQLVDMAAQIAE 114

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRSNSMCGTTEYMAPE 284
            +++L     +HRDL   NIL+  +    + DFGLA+  E DE +         ++ APE
Sbjct: 115 GMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPE 174

Query: 285 ILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSM 317
                     +D WS GILL E++T G+V    M
Sbjct: 175 AANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM 208

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 74.0 bits (181), Expect = 2e-14
 Identities = 74/320 (23%), Positives = 131/320 (40%), Gaps = 48/320 (15%)

Query: 18  KKLTITPPSASSPDFDFTEV-----FGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFV 72
           +K++I  P  + P      +      G L   R N    AS        +        F 
Sbjct: 64  EKVSIMAPERADPTGAHRALEDAAPAGELLVPRSNADLFASAGDGPSGAEDSDASHLDFD 123

Query: 73  GPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVG---QGAFGKVF-- 127
              P  A    +PL   +L+H+++                  FRV+     GAFGK+F  
Sbjct: 124 EAPPDAA--GPVPLAQAKLKHDDEF--------------LAHFRVIDDLPAGAFGKIFIC 167

Query: 128 --------QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQ 179
                      ++GV+  +       +++ K           ++ E   L ++ H  I++
Sbjct: 168 ALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227

Query: 180 LRYSFQTRSKLYLI---LDFINGGHLFFHLYRQGIFRED-----QARFYTAEIVSAVSHL 231
           +    ++ +  Y+I    DF     L+  +Y +    +D     Q R    +++ AV ++
Sbjct: 228 IEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYI 283

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRSNSMCGTTEYMAPEILLSK 289
           H   ++HRD+K ENI ++ DG ++L DFG A   E +  +      GT    +PEIL   
Sbjct: 284 HDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD 343

Query: 290 GHNKDADWWSVGILLYEMLT 309
           G+ +  D WS G++L +ML+
Sbjct: 344 GYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 57/211 (27%), Positives = 106/211 (50%), Gaps = 28/211 (13%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD--------TIIKKNHVDYMK 163
           +E    +G+G +G V++ + +  ++       A+K +R +        T I+        
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNE-----TIALKKIRLEQEDEGVPSTAIR-------- 50

Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQ--ARFYT 221
            E  +L ++ H  IV+L+    +  +LYL+ ++++   L  H+     F ++    + Y 
Sbjct: 51  -EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYL 108

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDESSRSNSM-CGTTE 279
            +I+  +++ H   ++HRDLKP+N+L+D     + L DFGLA+      R+ +    T  
Sbjct: 109 YQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLW 168

Query: 280 YMAPEILL-SKGHNKDADWWSVGILLYEMLT 309
           Y APEILL S+ ++   D WSVG +  EM+ 
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199

Length = 294

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 62/219 (28%), Positives = 106/219 (48%), Gaps = 39/219 (17%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHP 175
           VG+G +G V++ K+K   DG  +  YA+K +    I        M A R+I  L ++ HP
Sbjct: 9   VGRGTYGHVYKAKRK---DGKDEKEYALKQIEGTGI-------SMSACREIALLRELKHP 58

Query: 176 FIVQLRYSFQTRS--KLYLILDFINGGHLFFHLYRQGIFREDQA------------RFYT 221
            ++ L+  F + S  K++L+ D+    H  +H+ +    R  +A            +   
Sbjct: 59  NVIALQKVFLSHSDRKVWLLFDYAE--HDLWHIIK--FHRASKANKKPMQLPRSMVKSLL 114

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSD----GHVMLTDFGLAKEIDESSRS----NS 273
            +I+  + +LH   ++HRDLKP NIL+  +    G V + D G A+  +   +     + 
Sbjct: 115 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174

Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
           +  T  Y APE+LL   H  K  D W++G +  E+LT +
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 72.0 bits (176), Expect = 2e-14
 Identities = 54/212 (25%), Positives = 107/212 (50%), Gaps = 18/212 (8%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
            ++ + +G G FG+V+     G  +G++    A+K ++  T+  ++ ++    E  I+ K
Sbjct: 8   LQLIKKLGNGQFGEVWM----GTWNGNTK--VAVKTLKPGTMSPESFLE----EAQIMKK 57

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE---DQARFYTAEIVSAV 228
           + H  +VQL Y+  +   +Y++ ++++ G L   L + G  R           A++ + +
Sbjct: 58  LRHDKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGM 115

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEIL 286
           +++ +   +HRDL+  NIL+       + DFGLA+ I+++  +         ++ APE  
Sbjct: 116 AYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175

Query: 287 LSKGHNKDADWWSVGILLYEMLT-GQVNIKSM 317
           L       +D WS GILL E++T G+V    M
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 71.9 bits (176), Expect = 3e-14
 Identities = 43/150 (28%), Positives = 75/150 (50%), Gaps = 4/150 (2%)

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L  + H  IV L     T+  L  + ++++     + +   G       R +  ++
Sbjct: 53  EASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQL 112

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA--KEIDESSRSNSMCGTTEYMA 282
           +  ++++H   I+HRDLKP+N+L+   G + L DFGLA  K I   + S+ +  T  Y  
Sbjct: 113 LRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRP 171

Query: 283 PEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
           P++LL +  ++   D W  G +  EML GQ
Sbjct: 172 PDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 55/213 (25%), Positives = 105/213 (49%), Gaps = 22/213 (10%)

Query: 118 VGQGAFGKVFQVKKKGVD-DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THP 175
           +G+G FG+V   +  G+D D   + +     M KD   +K+  D + +E +++  +  H 
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGKHK 81

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHL---------YRQGIFR--EDQARFY---- 220
            I+ L  +      LY+I+++ + G+L  +L         Y   I R  ++Q  F     
Sbjct: 82  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141

Query: 221 -TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE---IDESSRSNSMCG 276
            T ++   + +L     +HRDL   N+L+  +  + + DFGLA++   ID   ++ +   
Sbjct: 142 CTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRL 201

Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             ++MAPE L  + +   +D WS G+L++E+ T
Sbjct: 202 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 57/219 (26%), Positives = 103/219 (47%), Gaps = 28/219 (12%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY---AMKVMRKDTIIKKNHVDYMKAERD 167
           D +   V+G+G FG+V + + K       DG+    A+K M K+   K +H D+   E +
Sbjct: 8   DIKFQDVIGEGNFGQVLKARIK------KDGLRMDAAIKRM-KEYASKDDHRDF-AGELE 59

Query: 168 ILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED----------- 215
           +L K+  HP I+ L  + + R  LYL +++   G+L   L +  +   D           
Sbjct: 60  VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 119

Query: 216 -----QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR 270
                Q   + A++   + +L +   +HRDL   NIL+  +    + DFGL++  +   +
Sbjct: 120 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 179

Query: 271 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
                    +MA E L    +  ++D WS G+LL+E+++
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 71.9 bits (176), Expect = 4e-14
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 25/204 (12%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-------TIIKKNHVDYMKAERDILT 170
           +G+G +  VF+ + K  ++     + A+K +R +       T I+         E  +L 
Sbjct: 14  LGEGTYATVFKGRSKLTEN-----LVALKEIRLEHEEGAPCTAIR---------EVSLLK 59

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + H  IV L     T   L L+ ++++     +      I      + +  +I+  +++
Sbjct: 60  DLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAY 119

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGL--AKEIDESSRSNSMCGTTEYMAPEILL- 287
            H+  ++HRDLKP+N+L++  G + L DFGL  AK +   + SN +  T  Y  P++LL 
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLG 178

Query: 288 SKGHNKDADWWSVGILLYEMLTGQ 311
           S  ++   D W VG + +EM +G+
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 71.6 bits (175), Expect = 4e-14
 Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 11/199 (5%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F   R +G G+FG V+  +     D  +  + A+K M             +  E   L K
Sbjct: 17  FSDLREIGHGSFGAVYFAR-----DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP  +Q R  +      +L++++  G         +   +E +    T   +  +++L
Sbjct: 72  LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG- 290
           H   ++HRD+K  NIL+   G V L DFG A  +   + +N   GT  +MAPE++L+   
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANXFVGTPYWMAPEVILAMDE 188

Query: 291 --HNKDADWWSVGILLYEM 307
             ++   D WS+GI   E+
Sbjct: 189 GQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 71.7 bits (175), Expect = 5e-14
 Identities = 51/199 (25%), Positives = 91/199 (45%), Gaps = 11/199 (5%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F   R +G G+FG V+  +     D  ++ + A+K M             +  E   L +
Sbjct: 27  FTDLREIGHGSFGAVYFAR-----DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQR 81

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP  ++ +  +      +L++++  G         +   +E +    T   +  +++L
Sbjct: 82  IKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYL 141

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG- 290
           H   ++HRD+K  NIL+   G V L DFG A      S +NS  GT  +MAPE++L+   
Sbjct: 142 HSHNMIHRDIKAGNILLTEPGQVKLADFGSASIA---SPANSFVGTPYWMAPEVILAMDE 198

Query: 291 --HNKDADWWSVGILLYEM 307
             ++   D WS+GI   E+
Sbjct: 199 GQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 71.1 bits (174), Expect = 6e-14
 Identities = 55/227 (24%), Positives = 102/227 (44%), Gaps = 41/227 (18%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGI--YAMKVMRKDTIIKKNHVDYMK--AERDILTK 171
           + +G+G FGKV  VK          G    A+K+++++     +  +     +E ++L +
Sbjct: 6   KTLGEGEFGKV--VKATAFRLKGRAGYTTVAVKMLKENA----SSSELRDLLSEFNLLKQ 59

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQ--------GIFREDQARF-- 219
           V HP +++L  +      L LI+++   G L  F    R+           R        
Sbjct: 60  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119

Query: 220 ------------YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEID 266
                       +  +I   + +L +  +VHRDL   N+L+ ++G  M ++DFGL++++ 
Sbjct: 120 DERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV-AEGRKMKISDFGLSRDVY 178

Query: 267 ES----SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           E      RS       ++MA E L    +   +D WS G+LL+E++T
Sbjct: 179 EEDSYVKRSKGRI-PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 71.1 bits (174), Expect = 6e-14
 Identities = 37/86 (43%), Positives = 46/86 (53%)

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           + +  +  LH   IVHRDLKPENIL+ S G V L DFGLA+          +  T  Y A
Sbjct: 116 QFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRA 175

Query: 283 PEILLSKGHNKDADWWSVGILLYEML 308
           PE+LL   +    D WSVG +  EM 
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 70.9 bits (173), Expect = 8e-14
 Identities = 57/200 (28%), Positives = 104/200 (52%), Gaps = 12/200 (6%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGI-YAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
           +V+G GAFG V+  K   V +G++  I  A+K++ + T  K N V++M  E  I+  + H
Sbjct: 13  KVLGSGAFGTVY--KGIWVPEGETVKIPVAIKILNETTGPKAN-VEFMD-EALIMASMDH 68

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
           P +V+L         + L+   +  G L  + H ++  I  +     +  +I   + +L 
Sbjct: 69  PHLVRL-LGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLN-WCVQIAKGMMYLE 126

Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG---TTEYMAPEILLSK 289
           +  +VHRDL   N+L+ S  HV +TDFGLA+ ++   +  +  G     ++MA E +  +
Sbjct: 127 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 186

Query: 290 GHNKDADWWSVGILLYEMLT 309
                +D WS G+ ++E++T
Sbjct: 187 KFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 69.6 bits (170), Expect = 1e-13
 Identities = 50/196 (25%), Positives = 101/196 (51%), Gaps = 11/196 (5%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF 176
           ++G+G FG+VF   K  + D       A+K  ++D + ++  + ++   R IL +  HP 
Sbjct: 2   LLGKGNFGEVF---KGTLKDKTP---VAVKTCKED-LPQELKIKFLSEAR-ILKQYDHPN 53

Query: 177 IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSHLHKCG 235
           IV+L      R  +Y++++ + GG     L ++    +  Q   +  +  + +++L    
Sbjct: 54  IVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN 113

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEILLSKGHNK 293
            +HRDL   N L+  +  + ++DFG++++ D+   S+S       ++ APE L    ++ 
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS 173

Query: 294 DADWWSVGILLYEMLT 309
           ++D WS GILL+E  +
Sbjct: 174 ESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 70.0 bits (171), Expect = 1e-13
 Identities = 57/216 (26%), Positives = 108/216 (50%), Gaps = 30/216 (13%)

Query: 118 VGQGAFG----KVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT 173
           +G G FG     V++++KK +D        A+KV++ +   +K+  D M  E +I+ ++ 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQID-------VAIKVLKNEN--EKSVRDEMMREAEIMHQLD 53

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGG--HLFFHLYRQGIFREDQARFYTAEIVSAVS-- 229
           +P+IV++    +  + L L+++  +GG  + F    +  I   +       E++  VS  
Sbjct: 54  NPYIVRMIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSN-----VVELMHQVSMG 107

Query: 230 --HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT--TEYMAP 283
             +L     VHRDL   N+L+ +  +  ++DFGL+K +  D+S       G    ++ AP
Sbjct: 108 MKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAP 167

Query: 284 EILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQ 318
           E +  +  +  +D WS GI ++E  + GQ   K M+
Sbjct: 168 ECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK 203

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 69.7 bits (171), Expect = 1e-13
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 25/205 (12%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-------TIIKKNHVDYMKAERDIL 169
            +G+G++  V++ + K         + A+K +R +       T I+         E  +L
Sbjct: 12  KLGEGSYATVYKGRSKLTGQ-----LVALKEIRLEHEEGAPFTAIR---------EASLL 57

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + H  IV L     T+  L L+ ++++     +     G       R +  +++  ++
Sbjct: 58  KDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLA 117

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGL--AKEIDESSRSNSMCGTTEYMAPEILL 287
           + H+  ++HRDLKP+N+L+   G + L DFGL  AK +   + SN +  T  Y  P++LL
Sbjct: 118 YCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-TLWYRPPDVLL 176

Query: 288 -SKGHNKDADWWSVGILLYEMLTGQ 311
            S  ++   D W VG + YEM TG+
Sbjct: 177 GSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 69.8 bits (171), Expect = 1e-13
 Identities = 50/206 (24%), Positives = 97/206 (47%), Gaps = 17/206 (8%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV--DYMKAERDILTKVTH 174
            +G+G FG+VF  K KG+++   + +  +K ++K    K  ++  ++ + E D+  K++H
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK---TKDENLQSEFRR-ELDMFRKLSH 67

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAV---- 228
             +V+L    +     Y+IL++ + G L  F    +    +       T + V+      
Sbjct: 68  KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127

Query: 229 ---SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYMAP 283
               HL     VHRDL   N L+ S   V ++   L+K++   E  +  +      ++AP
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAP 187

Query: 284 EILLSKGHNKDADWWSVGILLYEMLT 309
           E +     +  +D WS G+L++E+ T
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 68.8 bits (168), Expect = 2e-13
 Identities = 50/210 (23%), Positives = 103/210 (49%), Gaps = 21/210 (10%)

Query: 107 IGPGDFEIFRVVGQGAFGKVF----QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           I P +  + + +G G FG V+      K+K           A+K +R+  + +++     
Sbjct: 1   IHPSELTLVQEIGSGQFGLVWLGYWLEKRK----------VAIKTIREGAMSEED----F 46

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYT 221
             E  ++ K++HP +VQL      RS + L+ +F+  G L  +L  Q G F ++      
Sbjct: 47  IEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMC 106

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTE 279
            ++   +++L    ++HRDL   N L+  +  V ++DFG+ + +  D+ + S       +
Sbjct: 107 LDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK 166

Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           + +PE+     ++  +D WS G+L++E+ +
Sbjct: 167 WSSPEVFSFSKYSSKSDVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 68.6 bits (168), Expect = 3e-13
 Identities = 49/204 (24%), Positives = 92/204 (45%), Gaps = 22/204 (10%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA----ERDILTK 171
             +G+G FG V++   KG      +   A+K  R            +K     E +IL +
Sbjct: 1   EKIGKGNFGDVYKGVLKG------NTEVAVKTCRSTL------PPDLKRKFLQEAEILKQ 48

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSH 230
             HP IV+L      +  +Y++++ + GG L   L ++       +    + +  + + +
Sbjct: 49  YDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEY 108

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE----YMAPEIL 286
           L     +HRDL   N L+  +  + ++DFG+++E +    + S  G  +    + APE L
Sbjct: 109 LESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS-DGLKQIPIKWTAPEAL 167

Query: 287 LSKGHNKDADWWSVGILLYEMLTG 310
               +  ++D WS GILL+E  + 
Sbjct: 168 NYGRYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 68.9 bits (168), Expect = 3e-13
 Identities = 59/243 (24%), Positives = 112/243 (46%), Gaps = 28/243 (11%)

Query: 88  IQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKV 147
           + E E   D   E   +R +      + + +G+G FG+V   +  G+D    + +  + V
Sbjct: 2   VSEYELPEDPRWEVPRDRLV------LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAV 55

Query: 148 -MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFH 205
            M K    +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +
Sbjct: 56  KMLKSDATEKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 114

Query: 206 L-----------YRQGIFREDQARFY-----TAEIVSAVSHLHKCGIVHRDLKPENILMD 249
           L           Y      E+Q  F        ++   + +L     +HRDL   N+L+ 
Sbjct: 115 LRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 174

Query: 250 SDGHVMLTDFGLAKEI---DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYE 306
            D  + + DFGLA++I   D   ++ +     ++MAPE L  + +   +D WS G+LL+E
Sbjct: 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 234

Query: 307 MLT 309
           + T
Sbjct: 235 IFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 68.7 bits (168), Expect = 4e-13
 Identities = 53/225 (23%), Positives = 97/225 (43%), Gaps = 27/225 (12%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            + E  R +GQGAFG+VFQ +  G+   +   + A+K M K+        D+ + E  ++
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVK-MLKEEASADMQADFQR-EAALM 62

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-------QGIFREDQARFYT- 221
            +  HP IV+L         + L+ +++  G L   L                 AR    
Sbjct: 63  AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122

Query: 222 --------------AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-- 265
                          ++ + +++L +   VHRDL   N L+  +  V + DFGL++ I  
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 182

Query: 266 -DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            D    S +      +M PE +    +  ++D W+ G++L+E+ +
Sbjct: 183 ADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 68.1 bits (167), Expect = 4e-13
 Identities = 59/216 (27%), Positives = 109/216 (50%), Gaps = 26/216 (12%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQ--VKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
           I P    I +V+G G FG+V +  +K  G  + D     A+K   K     K  +D++  
Sbjct: 1   IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEID----VAIK-TLKAGSSDKQRLDFL-T 54

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
           E  I+ +  HP I++L     T+S+ + +I +++  G L   L      RE+  +F   +
Sbjct: 55  EASIMGQFDHPNIIRL-EGVVTKSRPVMIITEYMENGSLDKFL------RENDGKFTVGQ 107

Query: 224 IV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-NSMC 275
           +V       S + +L +   VHRDL   NIL++S+    ++DFGL++ +++S  +  +  
Sbjct: 108 LVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKG 167

Query: 276 GTT--EYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           G     + APE +  +     +D WS GI+++E+++
Sbjct: 168 GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 68.0 bits (166), Expect = 5e-13
 Identities = 57/215 (26%), Positives = 104/215 (48%), Gaps = 23/215 (10%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I     +I +V+G G FG+V   + K    G  +   A+K + K    +K   D++ +E 
Sbjct: 1   IDASCIKIEKVIGAGEFGEVCSGRLK--LPGKREIPVAIKTL-KAGYTEKQRRDFL-SEA 56

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
            I+ +  HP I+ L     T+SK + ++ +++  G L          R+   +F   ++V
Sbjct: 57  SIMGQFDHPNIIHLE-GVVTKSKPVMIVTEYMENGSL------DAFLRKHDGQFTVIQLV 109

Query: 226 -------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRSNSMCG 276
                  S + +L   G VHRDL   NIL++S+    ++DFGL++  E D  +   +  G
Sbjct: 110 GMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 169

Query: 277 T--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
                + APE +  +     +D WS GI+++E+++
Sbjct: 170 KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 68.3 bits (167), Expect = 5e-13
 Identities = 53/204 (25%), Positives = 97/204 (47%), Gaps = 16/204 (7%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKV---MRKDTIIKKNHVDYMKAERDILTKV 172
           + +G GAFGKV +    G+   D+     MKV   M K T    +  + + +E  I++ +
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDA----VMKVAVKMLKPTA-HSSEREALMSELKIMSHL 95

Query: 173 -THPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAVS 229
             H  IV L  +      + +I ++   G L  F    R+     +    ++ ++   ++
Sbjct: 96  GNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMA 155

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCGT---TEYMAPEI 285
            L     +HRDL   N+L+ + G ++ + DFGLA++I   S            ++MAPE 
Sbjct: 156 FLASKNCIHRDLAARNVLL-THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPES 214

Query: 286 LLSKGHNKDADWWSVGILLYEMLT 309
           + +  +  ++D WS GILL+E+ +
Sbjct: 215 IFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 68.0 bits (166), Expect = 6e-13
 Identities = 55/200 (27%), Positives = 99/200 (49%), Gaps = 21/200 (10%)

Query: 118 VGQGAFGKVFQ-VKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF 176
           +G G +G+V++ V KK           A+K +++DT+     V+    E  ++ ++ HP 
Sbjct: 14  LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPN 63

Query: 177 IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQ---ARFYTA-EIVSAVSHLH 232
           +VQL          Y+I +F+  G+L  +L      R++       Y A +I SA+ +L 
Sbjct: 64  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLE 121

Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT---EYMAPEILLSK 289
           K   +HRDL   N L+  +  V + DFGL++ +   + + +  G     ++ APE L   
Sbjct: 122 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYN 180

Query: 290 GHNKDADWWSVGILLYEMLT 309
             +  +D W+ G+LL+E+ T
Sbjct: 181 KFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 67.8 bits (166), Expect = 7e-13
 Identities = 46/211 (21%), Positives = 100/211 (47%), Gaps = 27/211 (12%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF 176
           ++ +G FG++F         G  + ++   V    + I+   V  +  E  +L  ++H  
Sbjct: 13  LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ---VTLLLQESCLLYGLSHQN 69

Query: 177 IVQ-LRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA--------EIVSA 227
           I+  L    +     +++  ++N G+L   L +  +   +  +  +         +I   
Sbjct: 70  ILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACG 129

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---------DESSRSNSMCGTT 278
           +S+LHK G++H+D+   N ++D +  V +TD  L++++         D  +R        
Sbjct: 130 MSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP------V 183

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           ++MA E L++K ++  +D WS G+LL+E++T
Sbjct: 184 KWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 67.0 bits (163), Expect = 1e-12
 Identities = 56/206 (27%), Positives = 103/206 (50%), Gaps = 18/206 (8%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +GQG FG+V+     G  +G +    A+K ++  T++ +  +     E  I+ K+ H  +
Sbjct: 14  LGQGCFGEVWM----GTWNGTTK--VAIKTLKPGTMMPEAFLQ----EAQIMKKLRHDKL 63

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHKC 234
           V L Y+  +   +Y++ +F+  G L   L ++G     +  Q     A+I   ++++ + 
Sbjct: 64  VPL-YAVVSEEPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIERM 121

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEILLSKGHN 292
             +HRDL+  NIL+  +    + DFGLA+ I+++  +         ++ APE  L     
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 293 KDADWWSVGILLYEMLT-GQVNIKSM 317
             +D WS GILL E++T G+V    M
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGM 207

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 56/219 (25%), Positives = 102/219 (46%), Gaps = 24/219 (10%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D  + R +G+GAFGKVF  +   +       + A+K ++  T+  +   D+ + E ++LT
Sbjct: 6   DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK--DFQR-EAELLT 62

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAE--- 223
            + H  IV+          L ++ +++  G L   L   G    I  + Q R    E   
Sbjct: 63  NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122

Query: 224 ---------IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM 274
                    I S + +L     VHRDL   N L+ ++  V + DFG+++++  S+    +
Sbjct: 123 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV-YSTDYYRV 181

Query: 275 CGTT----EYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            G T     +M PE ++ +    ++D WS G++L+E+ T
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 49/195 (25%), Positives = 95/195 (48%), Gaps = 15/195 (7%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHP 175
           +G G+FG V+        +  ++ + A+K M      K+ +  +    +++  L ++ HP
Sbjct: 29  IGHGSFGAVYFAT-----NSHTNEVVAVKKMSYSG--KQTNEKWQDIIKEVKFLQQLKHP 81

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
             ++ +  +      +L++++  G         +   +E +    T   +  +++LH   
Sbjct: 82  NTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 141

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG---HN 292
           ++HRD+K  NIL+   G V L DFG A    +SS +NS  GT  +MAPE++L+     ++
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSAS---KSSPANSFVGTPYWMAPEVILAMDEGQYD 198

Query: 293 KDADWWSVGILLYEM 307
              D WS+GI   E+
Sbjct: 199 GKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 66.5 bits (162), Expect = 2e-12
 Identities = 56/213 (26%), Positives = 101/213 (47%), Gaps = 22/213 (10%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKV-MRKDTIIKKNHVDYMKAERDILTKV-THP 175
           +G+G FG+V + +  G+D    D    + V M KD    K+  D + +E +++  +  H 
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLI-SEMELMKLIGKHK 78

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHL---------YRQGIFREDQARFYTAEIVS 226
            I+ L         LY+I+++   G+L   L         Y   I +  + +    ++VS
Sbjct: 79  NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138

Query: 227 AV-------SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK---EIDESSRSNSMCG 276
                     +L     +HRDL   N+L+  D  + + DFGLA+   +ID   ++++   
Sbjct: 139 CAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRL 198

Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             ++MAPE L  + +   +D WS GIL++E+ T
Sbjct: 199 PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 65.9 bits (161), Expect = 2e-12
 Identities = 56/218 (25%), Positives = 90/218 (41%), Gaps = 38/218 (17%)

Query: 106 KIGPGDFEIFRVVGQGAF----GKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
           K+G G F    VV +G +    GKV  V              A+K ++ D +      D+
Sbjct: 2   KLGDGSF---GVVRRGEWSTSGGKVIPV--------------AVKCLKSDKL-SDIMDDF 43

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF--FHLYRQGIFREDQARF 219
           +K E  I+  + H  +++L Y       L ++ +    G L         G F       
Sbjct: 44  LK-EAAIMHSLDHENLIRL-YGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCD 101

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
           Y  +I + + +L     +HRDL   NIL+ SD  V + DFGL + + +    N      E
Sbjct: 102 YAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQ----NEDHYVME 157

Query: 280 --------YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
                   + APE L ++  +  +D W  G+ L+EM T
Sbjct: 158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 65.7 bits (160), Expect = 3e-12
 Identities = 57/217 (26%), Positives = 109/217 (50%), Gaps = 21/217 (9%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F + R++G+G FG V + + K  +DG    + A+K+++ D     +  ++++ E   + +
Sbjct: 1   FTLGRMLGKGEFGSVREAQLK-SEDGSFQKV-AVKMLKADIFSSSDIEEFLR-EAACMKE 57

Query: 172 VTHPFIVQL-RYSFQTRSKLYL-----ILDFINGG--HLFFHLYRQG-----IFREDQAR 218
             HP +++L   S ++R+K  L     IL F+  G  H F  + R G     +  +   R
Sbjct: 58  FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT- 277
           F   +I S + +L     +HRDL   N +++ +  V + DFGL+K+I         C + 
Sbjct: 118 FMI-DIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176

Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQ 311
              +++A E L    +   +D W+ G+ ++E++T GQ
Sbjct: 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 65.9 bits (161), Expect = 3e-12
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 26/214 (12%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPF 176
           +G+GAFG+V + +  G+D+ +     A+K M KD   +K+  D + +E +++  +  H  
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVK-MLKDDATEKDLSDLV-SEMEMMKMIGKHKN 77

Query: 177 IVQLRYSFQTRSKLYLILDFINGGHLFFHL---------YRQGIFREDQARFYTAEIVS- 226
           I+ L         LY+++++   G+L   L               R  +      ++VS 
Sbjct: 78  IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137

Query: 227 ------AVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDE----SSRSNSMC 275
                  +  L     +HRDL   N+L+ ++ HVM + DFGLA++I         +N   
Sbjct: 138 AYQVARGMEFLASKKCIHRDLAARNVLV-TEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196

Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
              ++MAPE L  + +   +D WS G+LL+E+ T
Sbjct: 197 -PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 64.9 bits (158), Expect = 5e-12
 Identities = 54/211 (25%), Positives = 108/211 (51%), Gaps = 25/211 (11%)

Query: 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV 172
           +I  V+G G FG+V + + K    G  +   A+K + K    +K   D++ +E  I+ + 
Sbjct: 7   KIEEVIGAGEFGEVCRGRLKLP--GKREIFVAIKTL-KSGYTEKQRRDFL-SEASIMGQF 62

Query: 173 THPFIVQLRYSFQTRSKLYLIL-DFINGGHLFFHLYRQGIFREDQARFYTAEIV------ 225
            HP I+ L     T+S+  +I+ +F+  G L          R++  +F   ++V      
Sbjct: 63  DHPNIIHLE-GVVTKSRPVMIITEFMENGAL------DSFLRQNDGQFTVIQLVGMLRGI 115

Query: 226 -SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR----SNSMCGT--T 278
            + + +L +   VHRDL   NIL++S+    ++DFGL++ +++ +     ++S+ G    
Sbjct: 116 AAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPI 175

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            + APE +  +     +D WS GI+++E+++
Sbjct: 176 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 65.5 bits (160), Expect = 6e-12
 Identities = 32/105 (30%), Positives = 61/105 (58%), Gaps = 12/105 (11%)

Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +++  +++  + ++H   ++HRDLKP N+L++++  + + DFGLA+    S + + 
Sbjct: 107 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDF 164

Query: 274 MCGTTEYM------APEILLS-KGHNKDADWWSVGILLYEMLTGQ 311
           M   TEY+      APE+LL+   +    D WSVG +  E+L  +
Sbjct: 165 M---TEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 64.3 bits (156), Expect = 7e-12
 Identities = 50/203 (24%), Positives = 95/203 (46%), Gaps = 25/203 (12%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G FG+VF  + +       +   A+K  R +T+       +++  R IL + +HP I
Sbjct: 3   IGRGNFGEVFSGRLRA-----DNTPVAVKSCR-ETLPPDLKAKFLQEAR-ILKQYSHPNI 55

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV-------SAVSH 230
           V+L      +  +Y++++ + GG            R +  R    E++       + + +
Sbjct: 56  VRLIGVCTQKQPIYIVMELVQGGDF------LTFLRTEGPRLKVKELIQMVENAAAGMEY 109

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE----YMAPEIL 286
           L     +HRDL   N L+     + ++DFG+++E +E     S  G  +    + APE L
Sbjct: 110 LESKHCIHRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEAL 168

Query: 287 LSKGHNKDADWWSVGILLYEMLT 309
               ++ ++D WS GILL+E  +
Sbjct: 169 NYGRYSSESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 18/214 (8%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGV--DDGDSDGI-YAMKVMRKDTIIKKNH--V 159
           R +   +    +++G G FG V     KG+   +GDS  I  A+K ++  +  +      
Sbjct: 2   RILKETELRKLKLLGSGVFGTV----HKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEIT 57

Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQAR 218
           D+M A    +  + H +IV+L       + L L+      G L  H+   +      +  
Sbjct: 58  DHMLA----MGSLDHAYIVRL-LGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLL 112

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMC 275
            +  +I   + +L +  +VHR+L   NIL+ SD  V + DFG+A  +   D+    +   
Sbjct: 113 NWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHK 172

Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
              ++MA E +L   +   +D WS G+ ++EM++
Sbjct: 173 TPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 53/213 (24%), Positives = 102/213 (47%), Gaps = 22/213 (10%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKV-MRKDTIIKKNHVDYMKAERDILTKV-THP 175
           +G+G FG+V   +  G+D    +    + V M KD    K+  D + +E +++  +  H 
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSD-LVSEMEMMKMIGKHK 78

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHL---------YRQGIFREDQARFYTAEIVS 226
            I+ L  +      LY+++++ + G+L  +L         Y     +  + +    ++VS
Sbjct: 79  NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138

Query: 227 -------AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE---IDESSRSNSMCG 276
                   + +L     +HRDL   N+L+  D  + + DFGLA++   ID   ++ +   
Sbjct: 139 CAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRL 198

Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             ++MAPE L  + +   +D WS G+LL+E+ T
Sbjct: 199 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 63.8 bits (155), Expect = 1e-11
 Identities = 54/209 (25%), Positives = 100/209 (47%), Gaps = 9/209 (4%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           +I P      +V+G G FG+VF+   K    G  +   A+K + K    +K   D++ +E
Sbjct: 1   EIHPSHITKQKVIGAGEFGEVFRGILK--MPGRKEVAVAIKTL-KPGYTEKQRQDFL-SE 56

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEI 224
             I+ + +H  I++L           +I +++  G L  +L    G F   Q       I
Sbjct: 57  ASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGI 116

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCG---TTEY 280
            + + +L     VHRDL   NIL++S+    ++DFGL++ + D+   + +  G      +
Sbjct: 117 AAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW 176

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT 309
            APE +  +     +D WS GI+++E+++
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 63.9 bits (155), Expect = 1e-11
 Identities = 55/213 (25%), Positives = 99/213 (46%), Gaps = 28/213 (13%)

Query: 117 VVGQGAFGKVFQ--VKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
           V+G+G FG+V +  +KK G+       + A     K+   K +H D+   E ++L K+ H
Sbjct: 2   VIGEGNFGQVLKARIKKDGLR------MDAAIKRMKEYASKDDHRDF-AGELEVLCKLGH 54

Query: 175 -PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA---------------- 217
            P I+ L  + + R  LYL +++   G+L   L +  +   D A                
Sbjct: 55  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114

Query: 218 -RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
             F  A++   + +L +   +HRDL   NIL+  +    + DFGL++  +   +      
Sbjct: 115 LHF-AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 173

Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
              +MA E L    +  ++D WS G+LL+E+++
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 52/218 (23%), Positives = 101/218 (46%), Gaps = 26/218 (11%)

Query: 111 DFEIFRVVGQGAFGKVFQ--VKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           D +   V+G+G FG+V +  +KK      D   + A   M K+   + +H D+   E ++
Sbjct: 3   DIKFEDVIGEGNFGQVIRAMIKK------DGLKMNAAIKMLKEFASENDHRDF-AGELEV 55

Query: 169 LTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED------------ 215
           L K+  HP I+ L  + + R  LY+ +++   G+L   L +  +   D            
Sbjct: 56  LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST 115

Query: 216 ----QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS 271
               Q   + +++ + + +L +   +HRDL   N+L+  +    + DFGL++  +   + 
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK 175

Query: 272 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
                   +MA E L    +   +D WS G+LL+E+++
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 63.6 bits (155), Expect = 2e-11
 Identities = 60/270 (22%), Positives = 110/270 (40%), Gaps = 61/270 (22%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+GAFGKV++ +  G ++  S    A+K ++++   K       + E ++++ + HP I
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQ--QEFRQEAELMSDLQHPNI 70

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYR----------------QGIFREDQARFYT 221
           V L           ++ +++  G L   L R                +            
Sbjct: 71  VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS----RSNSMCGT 277
            +I + + +L     VHRDL   N L+     V ++DFGL+++I  +     +S S+   
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL-P 189

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-------GQVN------IKSMQVIACNT 324
             +M PE +L      ++D WS G++L+E+ +       G  N      I+S Q++ C  
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPC-- 247

Query: 325 MLLFYLIIFHCLFVNSLELLSHFPENCPAS 354
                                  PE+CPA 
Sbjct: 248 -----------------------PEDCPAR 254

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 78/339 (23%), Positives = 137/339 (40%), Gaps = 51/339 (15%)

Query: 2   VSTSQKNLHSLLTTKLKKLTITPPSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLGDP 61
              S K  +S  T +    +      S    D        +    +++  A+T  +   P
Sbjct: 28  SGNSPKANNSASTGQTTSRSTNSARRSGSKRDRETATSTDSGRTKSHEGAATTKQATTTP 87

Query: 62  QVIHNRSHSFVGPSP-RYALSSSLPLQIQELEHEN---DAELEAESERKIGPGDFEIFRV 117
                 ++  V P P +  ++ +LP Q +E  H       +++  ++R      F+I  +
Sbjct: 88  T-----TNVEVAPPPKKKKVTYALPNQSREEGHFYVVLGEDIDVSTQR------FKILSL 136

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR---KDTIIKKNHVDYMKAERDILTKVTH 174
           +G+G FGKV +       D       A+K++R   K T   K  + +M+  R        
Sbjct: 137 LGEGTFGKVVEAW-----DRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRF 191

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV----SAVSH 230
           P +   RY FQ  +    I+    G  L   + + G F       + A+I+     A+ +
Sbjct: 192 PLMKIQRY-FQNETGHMCIVMPKYGPCLLDWIMKHGPFSHR----HLAQIIFQTGVALDY 246

Query: 231 LH-KCGIVHRDLKPENILMDSDG----------------HVMLTDFGLAKEIDESSRSNS 273
            H +  ++H DLKPENILM++                   V + D G     DE     +
Sbjct: 247 FHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC--CDERHSRTA 304

Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
           +  T  Y +PE++L  G     D WS+G ++YE+ TG++
Sbjct: 305 IVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKL 343

Length = 467

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 62.4 bits (152), Expect = 3e-11
 Identities = 60/257 (23%), Positives = 103/257 (40%), Gaps = 53/257 (20%)

Query: 118 VGQGAFGKVFQVKKKGV---DDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
           +G G FG V     KGV     G    + A+K ++++ I           E  ++ ++ H
Sbjct: 3   LGHGNFGSV----VKGVYLMKSGKEVEV-AVKTLKQEHI--AAGKKEFLREASVMAQLDH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           P IV+L    +    L L+++    G L  +L ++        +    ++   +++L   
Sbjct: 56  PCIVRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK 114

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY------------MA 282
             VHRDL   N+L+ +     ++DFG+++ +          G+  Y             A
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALG--------AGSDYYRATTAGRWPLKWYA 166

Query: 283 PE-ILLSKGHNKDADWWSVGILLYEMLT-GQV---NIKSMQVIACNTMLLFYLIIFHCLF 337
           PE I   K  +K +D WS G+ L+E  + G      +K  +VIA                
Sbjct: 167 PECINYGKFSSK-SDVWSYGVTLWEAFSYGAKPYGEMKGAEVIA---------------M 210

Query: 338 VNSLELLSHFPENCPAS 354
           + S E L   PE CP  
Sbjct: 211 LESGERLPR-PEECPQE 226

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 62.3 bits (151), Expect = 4e-11
 Identities = 49/198 (24%), Positives = 96/198 (48%), Gaps = 15/198 (7%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G G FG+V+          +     A+K M+  ++     V+   AE +++  + H 
Sbjct: 12  KKLGAGQFGEVWMATY------NKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHD 61

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHK 233
            +V+L ++  T+  +Y+I +F+  G L   L      ++   +   ++A+I   ++ + +
Sbjct: 62  KLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 120

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRSNSMCGTTEYMAPEILLSKGH 291
              +HRDL+  NIL+ +     + DFGLA+  E +E +         ++ APE +     
Sbjct: 121 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 180

Query: 292 NKDADWWSVGILLYEMLT 309
              +D WS GILL E++T
Sbjct: 181 TIKSDVWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 62.2 bits (151), Expect = 4e-11
 Identities = 52/201 (25%), Positives = 103/201 (51%), Gaps = 15/201 (7%)

Query: 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV 172
           ++ + +G G FG+V+     G  +G +    A+K +++ ++      +   AE +++ ++
Sbjct: 9   KLVKKLGAGQFGEVWM----GYYNGHTK--VAIKSLKQGSM----SPEAFLAEANLMKQL 58

Query: 173 THPFIVQLRYSFQTRSKLYLILDFI-NGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSH 230
            HP +V+L Y+  T+  +Y+I +++ NG  + F    +GI    ++     A+I   ++ 
Sbjct: 59  QHPRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAF 117

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRSNSMCGTTEYMAPEILLS 288
           + +   +HRDL+  NIL+       + DFGLA+  E +E +         ++ APE +  
Sbjct: 118 IERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 177

Query: 289 KGHNKDADWWSVGILLYEMLT 309
                 +D WS GILL E++T
Sbjct: 178 GTFTIKSDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 61.9 bits (150), Expect = 9e-11
 Identities = 65/261 (24%), Positives = 102/261 (39%), Gaps = 69/261 (26%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-TH 174
           +V+G GAFGKV +    G+D   S    A+K M K+      H   M +E  IL  +  H
Sbjct: 13  KVLGHGAFGKVVEASAFGIDKKSSCNTVAVK-MLKEGATASEHKALM-SELKILIHIGNH 70

Query: 175 PFIVQLRYS-FQTRSKLYLILDFINGGHL---------FFHLYRQ--------------- 209
             +V L  +  +    L +I++F   G+L         FF  YR+               
Sbjct: 71  LNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQ 130

Query: 210 ---------GIFREDQARF-----------------------------YTAEIVSAVSHL 231
                    G      +RF                             Y+ ++   +  L
Sbjct: 131 SRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL 190

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCGTTEYMAPEILLS 288
                +HRDL   NIL+  +  V + DFGLA++I    +  R  S     ++MAPE +  
Sbjct: 191 ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFD 250

Query: 289 KGHNKDADWWSVGILLYEMLT 309
           K +   +D WS G+LL+E+ +
Sbjct: 251 KVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 54/212 (25%), Positives = 99/212 (46%), Gaps = 25/212 (11%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+GAFGKVF  +   +       + A+K +++ +  +    D+ + E ++LT + H  I
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQR-EAELLTVLQHQHI 69

Query: 178 VQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQG----IFREDQAR-----------FYT 221
           V+  Y   T  + L ++ +++  G L   L   G    I    +                
Sbjct: 70  VRF-YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT--- 278
           ++I S + +L     VHRDL   N L+     V + DFG++++I  S+    + G T   
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI-YSTDYYRVGGRTMLP 187

Query: 279 -EYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             +M PE +L +    ++D WS G++L+E+ T
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 60.8 bits (147), Expect = 1e-10
 Identities = 50/208 (24%), Positives = 98/208 (47%), Gaps = 28/208 (13%)

Query: 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY------AMKVMRKDTIIKKNHVDYMKAER 166
           ++ + +G G FG+V+             G Y      A+K ++  T+     V     E 
Sbjct: 9   KLVKKLGAGQFGEVWM------------GYYNNSTKVAVKTLKPGTM----SVQAFLEEA 52

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARF--YTAE 223
           +++  + H  +V+L Y+  T+ + +Y+I +++  G L   L      +    +   ++A+
Sbjct: 53  NLMKTLQHDKLVRL-YAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ 111

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYM 281
           I   ++++ +   +HRDL+  N+L+       + DFGLA+ I  +E +         ++ 
Sbjct: 112 IAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWT 171

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT 309
           APE +        +D WS GILLYE++T
Sbjct: 172 APEAINFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 30/88 (34%), Positives = 50/88 (56%), Gaps = 5/88 (5%)

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN----SMCGTT 278
           +++SA+ ++H  GI+HRD+K EN+L++    + L DFG A      S S      + GT 
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFA-RGSWSTPFHYGIAGTV 326

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYE 306
           +  APE+L    +    D WS G++++E
Sbjct: 327 DTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 29/215 (13%)

Query: 118 VGQGAFGKVFQ--VKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +G+ AFGK+++  +   G+D      + A+K ++   I         + E  ++ ++ HP
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQ---LVAIKTLKD--INNPQQWGEFQQEASLMAELHHP 67

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQ------------GIFRE--DQARFY 220
            IV L         + ++ +++N G L  F + R             G  +   D   F 
Sbjct: 68  NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127

Query: 221 --TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS----RSNSM 274
               +I + + +L     VH+DL   NIL+    HV ++D GL++EI  +     +  S+
Sbjct: 128 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
                +M PE ++    + D+D WS G++L+E+ +
Sbjct: 188 L-PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 59.7 bits (145), Expect = 4e-10
 Identities = 51/203 (25%), Positives = 100/203 (49%), Gaps = 12/203 (5%)

Query: 111 DFEIFRVVGQGAFGKVFQ-VKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           D  + R +G+G FG V+Q V     ++  +  +   K     ++ +K        E  I+
Sbjct: 7   DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-----FLQEAYIM 61

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF--YTAEIVSA 227
            +  HP IV+L     T + ++++++    G L  +L +   +  D A    Y+ ++ +A
Sbjct: 62  RQFDHPHIVKL-IGVITENPVWIVMELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTA 119

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEI 285
           +++L     VHRD+   N+L+ S   V L DFGL++ +++ S   +  G    ++MAPE 
Sbjct: 120 LAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPES 179

Query: 286 LLSKGHNKDADWWSVGILLYEML 308
           +  +     +D W  G+ ++E+L
Sbjct: 180 INFRRFTSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 59.7 bits (144), Expect = 4e-10
 Identities = 52/213 (24%), Positives = 95/213 (44%), Gaps = 25/213 (11%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR--KDTIIKKNHVDYMKAERDILTKVT 173
           R +G+GAFGKVF  +   +       + A+K ++   D   K  H      E ++LT + 
Sbjct: 11  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFH-----REAELLTNLQ 65

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-------------FREDQARFY 220
           H  IV+          L ++ +++  G L   L   G                + Q    
Sbjct: 66  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT-- 278
             +I + + +L     VHRDL   N L+  +  V + DFG+++++  S+    + G T  
Sbjct: 126 AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDV-YSTDYYRVGGHTML 184

Query: 279 --EYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
              +M PE ++ +    ++D WS+G++L+E+ T
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 59.7 bits (145), Expect = 4e-10
 Identities = 45/187 (24%), Positives = 89/187 (47%), Gaps = 16/187 (8%)

Query: 147 VMRKDTIIKKNHVDYMKAERDILT--KVTHPFIVQLRYSFQTRSKLYLILDFINGGH--- 201
            ++K  +   +  D    +++I+T  ++ HP I+    SF   S+LY++   +  G    
Sbjct: 29  AVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED 88

Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L    + +G   E    F   ++++A+ ++H  G +HR +K  +IL+  DG V+L+    
Sbjct: 89  LLKTHFPEG-LPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRY 147

Query: 262 AKEIDESS-RSNSMCGTTEY-------MAPEILLS--KGHNKDADWWSVGILLYEMLTGQ 311
           +  + +   R   +    +        ++PE+L    +G+N+ +D +SVGI   E+  G 
Sbjct: 148 SVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGH 207

Query: 312 VNIKSMQ 318
           V  K M 
Sbjct: 208 VPFKDMP 214

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 58.5 bits (141), Expect = 8e-10
 Identities = 48/209 (22%), Positives = 96/209 (45%), Gaps = 19/209 (9%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           R +GQG+FG V++   KGV   + +   A+K + +   +++  ++++  E  ++ +    
Sbjct: 12  RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRE-RIEFLN-EASVMKEFNCH 69

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA------------E 223
            +V+L           +I++ +  G L  +L  + +  E +     A            E
Sbjct: 70  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVQAPPSLKKMIQMAGE 127

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEY 280
           I   +++L+    VHRDL   N ++  D  V + DFG+ ++I E+    +         +
Sbjct: 128 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT 309
           M+PE L        +D WS G++L+E+ T
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 54/214 (25%), Positives = 103/214 (48%), Gaps = 24/214 (11%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--L 169
           ++I  V+G+G++G V         D  +    A+K   K   + ++  D  +  R+I  L
Sbjct: 2   YKIQEVIGKGSYGVVCSAI-----DTHTGEKVAIK---KINDVFEHVSDATRILREIKLL 53

Query: 170 TKVTHPFIVQLRY-----SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
             + HP IV++++     S +    +Y++ + +    L   +        +  +F+  ++
Sbjct: 54  RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQL 112

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS----NSMCGTTEY 280
           + A+ ++H   + HRDLKP+NIL ++D  + + DFGLA+     + +         T  Y
Sbjct: 113 LRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 172

Query: 281 MAPEI---LLSKGHNKDADWWSVGILLYEMLTGQ 311
            APE+     SK +    D WS+G +  E+LTG+
Sbjct: 173 RAPELCGSFFSK-YTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 51/214 (23%), Positives = 90/214 (42%), Gaps = 23/214 (10%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +++G+G FG V + +    DDG S    A+K M+ D        +++  E   +    HP
Sbjct: 5   KILGEGEFGSVMEGQLSQ-DDG-SQLKVAVKTMKLDIHTYSEIEEFLS-EAACMKDFDHP 61

Query: 176 FIVQL-RYSFQTRS-----KLYLILDFINGGHLFFHLYRQGIFREDQARFYT-------- 221
            +++L    F+  S     K  +IL F+  G L   L    +                  
Sbjct: 62  NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRL--GGLPEKLPLQTLLKFM 119

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---T 278
            +I   + +L     +HRDL   N ++  D  V + DFGL+K+I                
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQ 311
           +++A E L  + +   +D W+ G+ ++E+ T GQ
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQ 213

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 49/216 (22%), Positives = 95/216 (43%), Gaps = 26/216 (12%)

Query: 118 VGQGAFGKVFQVKKKGVDD---------GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           +G+G FG+V   + +G+ +              + A+K++R D + K    D++K E  I
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLK-EIKI 70

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE------------DQ 216
           ++++ +P I++L     +   L +I +++  G L   L ++ I                 
Sbjct: 71  MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130

Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNS 273
             +   +I S + +L     VHRDL   N L+ +   + + DFG+++ +   D       
Sbjct: 131 LLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGR 190

Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
                 +MA E +L       +D W+ G+ L+EM T
Sbjct: 191 AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 29/80 (36%), Positives = 45/80 (56%), Gaps = 5/80 (6%)

Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSK 289
           KC  +HRDL   NIL+  +  V + DFGLA++I +     R        ++MAPE +  K
Sbjct: 193 KC--IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDK 250

Query: 290 GHNKDADWWSVGILLYEMLT 309
            +   +D WS G+LL+E+ +
Sbjct: 251 VYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 55.4 bits (133), Expect = 9e-09
 Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 26/214 (12%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK--KNHV------DYMKAERDIL 169
           +G G FG V    KKG+        Y MK   K   +K  KN        D +  E +++
Sbjct: 3   LGSGNFGTV----KKGM--------YKMKKSEKTVAVKILKNDNNDPALKDELLREANVM 50

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
            ++ +P+IV++    +  S   L+++    G L   L +     E        ++   + 
Sbjct: 51  QQLDNPYIVRMIGICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMK 109

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT--TEYMAPEI 285
           +L +   VHRDL   N+L+ +  +  ++DFGL+K +  DE+       G    ++ APE 
Sbjct: 110 YLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPEC 169

Query: 286 LLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQ 318
           +     +  +D WS G+L++E  + GQ   K M+
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK 203

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 47/212 (22%), Positives = 97/212 (45%), Gaps = 21/212 (9%)

Query: 114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT 173
           + R +GQG+FG V++   + +  G+++   A+K + +   +++  ++++  E  ++   T
Sbjct: 10  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE-RIEFLN-EASVMKGFT 67

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED----QARF---------Y 220
              +V+L           ++++ +  G L  +L      R +      R           
Sbjct: 68  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS---LRPEAENNPGRPPPTLQEMIQM 124

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGT 277
            AEI   +++L+    VHRDL   N ++  D  V + DFG+ ++I E+    +       
Sbjct: 125 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             +MAPE L        +D WS G++L+E+ +
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 28/93 (30%), Positives = 49/93 (52%), Gaps = 3/93 (3%)

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+  +  V + DFGLA++I    +  R      
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243

Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             ++MAPE +  + +   +D WS G+LL+E+ +
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 54.3 bits (130), Expect = 4e-08
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 3/93 (3%)

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT-- 277
           +T ++   +  L     VHRDL   N+L+     V + DFGLA++I   S   S   T  
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301

Query: 278 -TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             ++MAPE +    +   +D WS GILL+E+ +
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 53.4 bits (128), Expect = 4e-08
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 22/208 (10%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G G FGKV   +      G S     +K +R  +      + +++ E     ++ HP +
Sbjct: 3   IGNGWFGKVLLGE---AHRGMSKARVVVKELR-ASATPDEQLLFLQ-EVQPYRELNHPNV 57

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFRED-----QARFYTAEIVSAVSHL 231
           +Q            L+L+F   G L  +L   +G+  +        R    E+ S +  L
Sbjct: 58  LQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM-ACEVASGLLWL 116

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCGTTEYMAPEI--- 285
           H+   +H DL   N  + +D  V + D+GLA E    D     +       ++APE+   
Sbjct: 117 HQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176

Query: 286 ----LLSKGHNKDADWWSVGILLYEMLT 309
               LL K   K ++ WS+G+ ++E+ T
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 54.5 bits (131), Expect = 5e-08
 Identities = 19/35 (54%), Positives = 26/35 (74%)

Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           GT +Y+APE+LL K H    DWW++G+ L+E LTG
Sbjct: 542 GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTG 576

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 53.1 bits (127), Expect = 5e-08
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 28/216 (12%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G+G FG V + +   ++  DS    A+K M K  I  ++ ++   +E   + +  HP
Sbjct: 5   KTLGEGEFGSVMEGQ---LNQDDSILKVAVKTM-KIAICTRSEMEDFLSEAVCMKEFDHP 60

Query: 176 FIVQL-RYSFQ-TRSKLY----LILDFINGG--HLFFHLYRQGIFREDQARF-------- 219
            +++L     Q   S+ Y    +IL F+  G  H F    R G    D  ++        
Sbjct: 61  NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLG----DCPQYLPTQMLVK 116

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCG 276
           +  +I S + +L     +HRDL   N +++ + +V + DFGL+K+I   D   +      
Sbjct: 117 FMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176

Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQ 311
             +++A E L  + +   +D WS G+ ++E+ T GQ
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQ 212

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 53.9 bits (129), Expect = 5e-08
 Identities = 26/67 (38%), Positives = 41/67 (61%), Gaps = 2/67 (2%)

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE--Y 280
           ++++ +  LH+ GIVHRD+KPEN+L+  DG V + DFG A ++      N + G  +  Y
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRY 376

Query: 281 MAPEILL 287
             PE L+
Sbjct: 377 SPPEELV 383

Length = 507

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 53.4 bits (128), Expect = 5e-08
 Identities = 55/219 (25%), Positives = 99/219 (45%), Gaps = 31/219 (14%)

Query: 118 VGQGAFGKVFQVKKKGVDD-----------GDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +G+G FG+V   + +G++            G+   + A+K++R+D   K    D++K E 
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN-KNARNDFLK-EI 70

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA--------- 217
            I++++  P I++L     T   L +I +++  G L   L R    +E            
Sbjct: 71  KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHE-PQEAAEKADVVTISY 129

Query: 218 ---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRS 271
               F   +I S + +L     VHRDL   N L+  +  + + DFG+++ +   D     
Sbjct: 130 STLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189

Query: 272 NSMCGTTEYMAPE-ILLSKGHNKDADWWSVGILLYEMLT 309
                   +M+ E ILL K     +D W+ G+ L+E+LT
Sbjct: 190 GRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.5 bits (128), Expect = 7e-08
 Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 3/93 (3%)

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT-- 277
           ++ ++ + +  L     VHRDL   N+L+     V + DFGLA++I   S   S   T  
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303

Query: 278 -TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             ++MAPE + +  +   +D WS GILL+E+ T
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|236400 PRK09188, PRK09188, serine/threonine protein kinase; Provisional

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 29/80 (36%), Positives = 36/80 (45%), Gaps = 8/80 (10%)

Query: 192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDL-KPENILMDS 250
           L+  +  G  L  HL R      D A F +A    A+  LH+ GI H DL KP+N LM  
Sbjct: 95  LVRGWTEGVPL--HLARP---HGDPAWFRSAH--RALRDLHRAGITHNDLAKPQNWLMGP 147

Query: 251 DGHVMLTDFGLAKEIDESSR 270
           DG   + DF LA        
Sbjct: 148 DGEAAVIDFQLASVFRRRGA 167

Length = 365

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 32/101 (31%), Positives = 56/101 (55%), Gaps = 8/101 (7%)

Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESS--- 269
           +D  RF ++++   +  L     +HRD+   N+L+ +DG V  + DFGLA++I   S   
Sbjct: 212 DDLLRF-SSQVAQGMDFLASKNCIHRDVAARNVLL-TDGRVAKICDFGLARDIMNDSNYV 269

Query: 270 -RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            + N+     ++MAPE +    +   +D WS GILL+E+ +
Sbjct: 270 VKGNARL-PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 55/237 (23%), Positives = 102/237 (43%), Gaps = 34/237 (14%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+  FGKV++    G   G+     A+K ++          +  K E  + +++ HP I
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLR--EEFKHEAMMRSRLQHPNI 70

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQ-----GIFREDQ--------ARFY--T 221
           V L         L +I  + +   L  F + R      G   +D+        A F    
Sbjct: 71  VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---T 278
            +I + +  L    +VH+DL   N+L+    +V ++D GL +E+  +     M  +    
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPI 190

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLT-------GQVN------IKSMQVIAC 322
            +M+PE ++    + D+D WS G++L+E+ +       G  N      I++ QV+ C
Sbjct: 191 RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPC 247

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 50.5 bits (121), Expect = 3e-07
 Identities = 27/78 (34%), Positives = 39/78 (50%), Gaps = 5/78 (6%)

Query: 237 VHRDLKPENILMDSDGHVMLTDFGLA-----KEIDESSRSNSMCGTTEYMAPEILLSKGH 291
           VHRDL   N ++D    V + DFGLA     KE              ++MA E L ++  
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKF 179

Query: 292 NKDADWWSVGILLYEMLT 309
              +D WS G+LL+E++T
Sbjct: 180 TTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 37/150 (24%), Positives = 67/150 (44%), Gaps = 16/150 (10%)

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED----QARFYTAEIVSAVS 229
           HP I+Q            L+ ++   G L  +L ++   R +      +    EI + V+
Sbjct: 54  HPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVT 113

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA----KEIDESSRSNSMCGTTEYMAPEI 285
           H+HK   +H DL   N  + SD  V + D+G+     KE D     +  C    ++APE+
Sbjct: 114 HMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE-DYIETEDDKCVPLRWLAPEL 172

Query: 286 -------LLSKGHNKDADWWSVGILLYEML 308
                  L++    K ++ W++G+ L+E+ 
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 29/94 (30%), Positives = 51/94 (54%), Gaps = 5/94 (5%)

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS----RSNSMC 275
           ++ ++   +S L     +HRDL   NIL+       + DFGLA++I   S    + N+  
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL 278

Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
              ++MAPE + +  +  ++D WS GILL+E+ +
Sbjct: 279 -PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 44/172 (25%), Positives = 79/172 (45%), Gaps = 14/172 (8%)

Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH---LFFHLYRQGIFRED 215
           V +++ E  +     HP IV  R +F   ++L+++  F+  G    L    +  G+  E 
Sbjct: 43  VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGM-SEL 101

Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF-GLAKEIDESSRSNSM 274
              +    ++ A+ ++H  G VHR +K  +IL+  DG V L+        I+   R   +
Sbjct: 102 AIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV 161

Query: 275 CGTTEY-------MAPEILLS--KGHNKDADWWSVGILLYEMLTGQVNIKSM 317
               +Y       ++PE+L    +G++  +D +SVGI   E+  G V  K M
Sbjct: 162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 43/187 (22%), Positives = 77/187 (41%), Gaps = 24/187 (12%)

Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K++R D   K    D++K E  IL+++  P I++L         L +I +++  G L 
Sbjct: 50  AVKILRPDAN-KNARNDFLK-EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107

Query: 204 FHLYR------------------QGIFREDQARFYTA-EIVSAVSHLHKCGIVHRDLKPE 244
             L                            +  + A +I S + +L     VHRDL   
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATR 167

Query: 245 NILMDSDGHVMLTDFGLAKEI---DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVG 301
           N L+  +  + + DFG+++ +   D             +MA E +L       +D W+ G
Sbjct: 168 NCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFG 227

Query: 302 ILLYEML 308
           + L+E+L
Sbjct: 228 VTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 41/157 (26%), Positives = 72/157 (45%), Gaps = 14/157 (8%)

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           HP I+     F T S L++I  F+  G    L    + +G+  E          +  +++
Sbjct: 58  HPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGM-SEALIGNILFGALRGLNY 116

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFG-LAKEIDESSRS-------NSMCGTTEYMA 282
           LH+ G +HR++K  +IL+  DG V L+    L   +    ++               +++
Sbjct: 117 LHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLS 176

Query: 283 PEILLSK--GHNKDADWWSVGILLYEMLTGQVNIKSM 317
           PE+L     G+N  +D +SVGI   E+ TG+V  + M
Sbjct: 177 PELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 46.9 bits (111), Expect = 6e-06
 Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 12/97 (12%)

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA----KEIDESSRSNSMCGTT 278
           EI   + HLHK   +H DL   N L+ +D  V + D+GL+    KE D     + +    
Sbjct: 108 EIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE-DYYVTPDQLWVPL 166

Query: 279 EYMAPEI-------LLSKGHNKDADWWSVGILLYEML 308
            ++APE+       LL     K+++ WS+G+ ++E+ 
Sbjct: 167 RWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 18/41 (43%), Positives = 25/41 (60%), Gaps = 1/41 (2%)

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDFGLA 262
           +I+ A+  LH  GIVHRD+KP+NI+     G   + D G A
Sbjct: 263 QILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 49/219 (22%), Positives = 94/219 (42%), Gaps = 23/219 (10%)

Query: 98  ELEAES---ERKIGPGDF-EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI 153
           EL+ +S   ER +G G F E+ R   +    +   V    +  G SD             
Sbjct: 1   ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD------------- 47

Query: 154 IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIF 212
             K    ++ AE   L +  H  IV+L       + + ++ ++++ G L   L + +G  
Sbjct: 48  --KQRRGFL-AEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQL 104

Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN 272
              Q       + S + +L + G VH+ L    +L++SD    ++ F   +E    +   
Sbjct: 105 VAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYT 164

Query: 273 SMCGTTE--YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           +M G +   + APE +     +  +D WS GI+++E+++
Sbjct: 165 TMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 43.0 bits (102), Expect = 8e-05
 Identities = 17/41 (41%), Positives = 22/41 (53%), Gaps = 1/41 (2%)

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK 263
           E+   V  LHK GIVH DL   NI++     +   DFGL +
Sbjct: 100 EVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGE 139

Length = 204

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 42.6 bits (101), Expect = 1e-04
 Identities = 16/33 (48%), Positives = 22/33 (66%), Gaps = 1/33 (3%)

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK 263
           LH  GI+H DL   N+++ S G + L DFGLA+
Sbjct: 111 LHSAGIIHGDLTTSNMIL-SGGKIYLIDFGLAE 142

Length = 211

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 40.9 bits (96), Expect = 2e-04
 Identities = 31/141 (21%), Positives = 61/141 (43%), Gaps = 16/141 (11%)

Query: 131 KKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY----MKAERDILTKV-THPFIV-QLRYSF 184
            K +  G ++ +Y +    +D ++K N         + E  IL  +      V ++  S 
Sbjct: 3   IKLLKGGLTNRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASG 62

Query: 185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC---GIVHRDL 241
           ++    YL++++I G  L      +   +ED A     ++   ++ LH+     + H DL
Sbjct: 63  ESDGWSYLLMEWIEGETLDEVSEEE---KEDIAE----QLAELLAKLHQLPLLVLCHGDL 115

Query: 242 KPENILMDSDGHVMLTDFGLA 262
            P NIL+D    + + D+  A
Sbjct: 116 HPGNILVDDGKILGIIDWEYA 136

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 40.8 bits (96), Expect = 3e-04
 Identities = 29/107 (27%), Positives = 50/107 (46%), Gaps = 13/107 (12%)

Query: 206 LYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI 265
           +  + +  E++     A  +  +  L +    HR  K  NIL+  DG + L      K  
Sbjct: 9   VRGRPL-NEEEI---WAVCLQCLGALREL---HRQAKSGNILLTWDGLLKLDGSVAFKT- 60

Query: 266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            E SR +       +MAPE++  + + + AD +S+GI LYE L  ++
Sbjct: 61  PEQSRPDPY-----FMAPEVIQGQSYTEKADIYSLGITLYEALDYEL 102

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 41.4 bits (98), Expect = 5e-04
 Identities = 21/52 (40%), Positives = 25/52 (48%), Gaps = 5/52 (9%)

Query: 220 YTAEIVSAVSH----LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE 267
              E+V  V      LHK GIVH DL   N ++  D  + L DFGL K  D 
Sbjct: 429 GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DDRLYLIDFGLGKYSDL 479

Length = 535

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 40.3 bits (95), Expect = 5e-04
 Identities = 19/37 (51%), Positives = 22/37 (59%), Gaps = 1/37 (2%)

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK 263
            V  LHK GIVH DL   NI++  D  + L DFGL K
Sbjct: 102 LVGKLHKAGIVHGDLTTSNIIVRDDK-LYLIDFGLGK 137

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 41.0 bits (96), Expect = 0.001
 Identities = 43/148 (29%), Positives = 74/148 (50%), Gaps = 14/148 (9%)

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           + K+ HP IV+L    ++    YLI ++I G +L   L  + +  E + +     I  A+
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL--RNLSWERRRKIAIG-IAKAL 793

Query: 229 SHLH-KCG--IVHRDLKPENILMD--SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
             LH +C   +V  +L PE I++D   + H+ L+  GL    D     +S      Y+AP
Sbjct: 794 RFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLC-TDTKCFISS-----AYVAP 847

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQ 311
           E   +K   + +D +  G++L E+LTG+
Sbjct: 848 ETRETKDITEKSDIYGFGLILIELLTGK 875

Length = 968

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 14/42 (33%), Positives = 29/42 (69%)

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
             ++++ + ++H+ GI H D+KPENI++D +    + D+G+A
Sbjct: 132 MKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIA 173

Length = 294

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 40.0 bits (94), Expect = 0.001
 Identities = 47/195 (24%), Positives = 87/195 (44%), Gaps = 22/195 (11%)

Query: 132 KGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY 191
              D+ D+  + A+KV+R D        D++K E  IL++++ P I +L         L 
Sbjct: 38  AENDNADAPVLVAVKVLRPDAS-DNAREDFLK-EVKILSRLSDPNIARLLGVCTVDPPLC 95

Query: 192 LILDFINGGHLFFHLYRQGIFREDQARFYT------------AEIVSAVSHLHKCGIVHR 239
           +I++++  G L   L +  +         +             +I S + +L     VHR
Sbjct: 96  MIMEYMENGDLNQFLQKH-VAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHR 154

Query: 240 DLKPENILMDSDGHVMLTDFGLAKEIDESS----RSNSMCGTTEYMAPE-ILLSKGHNKD 294
           DL   N L+  +  + + DFG+++ +  S     +  +      +MA E +LL K     
Sbjct: 155 DLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPL-PIRWMAWESVLLGK-FTTK 212

Query: 295 ADWWSVGILLYEMLT 309
           +D W+ G+ L+E+LT
Sbjct: 213 SDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 39.4 bits (92), Expect = 0.002
 Identities = 43/211 (20%), Positives = 95/211 (45%), Gaps = 30/211 (14%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA---ERDILTKVTH 174
           +GQG F K+F+  ++ V  GD   ++  +V+ K  ++ K+H +Y ++      ++++++H
Sbjct: 3   LGQGTFTKIFKGIRREV--GDYGELHKTEVLLK--VLDKSHRNYSESFFEAASMMSQLSH 58

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA-EIVSAVSHLHK 233
             +V          +  ++ +++  G L  +L +         +   A ++  A+  L  
Sbjct: 59  KHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED 118

Query: 234 CGIVHRDLKPENILMDSDGH--------VMLTDFG-----LAKEIDESSRSNSMCGTTEY 280
            G+ H ++  +N+L+  +          + L+D G     L KEI        +     +
Sbjct: 119 KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI--------LLERIPW 170

Query: 281 MAPEILL-SKGHNKDADWWSVGILLYEMLTG 310
           + PE +   +  +  AD WS G  L+E+ +G
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|240167 cd05144, RIO2_C, RIO kinase family; RIO2, C-terminal catalytic domain

 Score = 38.7 bits (91), Expect = 0.002
 Identities = 14/37 (37%), Positives = 22/37 (59%)

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF 259
           EI+  +   +K GI+H DL   NIL+D D  + + D+
Sbjct: 133 EILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDW 169

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH domains may be involved in RNA recognition. RIO2 is essential for survival and is necessary for rRNA cleavage during 40S ribosomal subunit maturation. The biological substrates of RIO2 are still unknown. Length = 198

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 39.0 bits (91), Expect = 0.002
 Identities = 45/230 (19%), Positives = 97/230 (42%), Gaps = 33/230 (14%)

Query: 119 GQGAFGKVFQ--VKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER--DILTKVTH 174
           GQG F  +++  ++ +   D    G     V++   ++  +H D +       ++++++H
Sbjct: 4   GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLK---VLGSDHRDSLAFFETASLMSQLSH 60

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA-EIVSAVSHLHK 233
             +V+L Y    R +  ++ +++  G L   L+R+        +   A ++ SA+ +L  
Sbjct: 61  KHLVKL-YGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED 119

Query: 234 CGIVHRDLKPENILMDSDGH-------VMLTDFG-----LAKEIDESSRSNSMCGTTEYM 281
             +VH ++  +NIL+   G        + L+D G     L++E               ++
Sbjct: 120 KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER--------IPWI 171

Query: 282 APEIL--LSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFY 329
           APE +          AD WS G  L E+ +     + +  ++ +    FY
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSN--GEEPLSTLSSSEKERFY 219

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|240158 cd05119, RIO, RIO kinase family, catalytic domain

 Score = 38.2 bits (90), Expect = 0.002
 Identities = 26/76 (34%), Positives = 38/76 (50%), Gaps = 3/76 (3%)

Query: 192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL-HKCGIVHRDLKPENILMDS 250
           L+++FI G  +     +     ED    Y  +I+  +  L  + G+VH DL   NIL+D 
Sbjct: 92  LVMEFIGGDGIPAPRLKDVRLLEDPEELY-DQILELMRKLYREAGLVHGDLSEYNILVD- 149

Query: 251 DGHVMLTDFGLAKEID 266
           DG V + D   A EID
Sbjct: 150 DGKVYIIDVPQAVEID 165

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They function as non-ribosomal factors necessary for late 18S rRNA processing. RIO1 is also required for proper cell cycle progression and chromosome maintenance. The biological substrates for RIO kinases are still unknown. Length = 187

>gnl|CDD|240172 cd05151, ChoK, Choline Kinase (ChoK)

 Score = 37.6 bits (88), Expect = 0.003
 Identities = 26/119 (21%), Positives = 40/119 (33%), Gaps = 18/119 (15%)

Query: 147 VMRKDTIIKKNHVDYMKAERDILTKVTHPFIV-QLRYSFQTRSKLYLILDFINGGHLFFH 205
           V+R      +  ++  + E +         I  +L Y         LI +FI G  L   
Sbjct: 25  VVRIPGNGTELLIN-RENEAENSKLAAEAGIGPKLYYFDPETG--VLITEFIEGSELLTE 81

Query: 206 LYRQGIFREDQARFYTAEIVSAVSHLHKCGIV-----HRDLKPENILMDSDGHVMLTDF 259
            +      E        +I   +  LH   +      H DL P N L   DG + L D+
Sbjct: 82  DFSDPENLE--------KIAKLLKKLHSSPLPDLVPCHNDLLPGNFL-LDDGRLWLIDW 131

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate and displays negligible activity towards N-methylated derivatives of Etn. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Length = 170

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 38.0 bits (88), Expect = 0.004
 Identities = 53/214 (24%), Positives = 100/214 (46%), Gaps = 21/214 (9%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGI---YAMKVMRKDTIIKKNHVDYMKA---ERDILTK 171
           +G+G   +++       DD + DG      +KV+ K  ++  +H D   A      ++ +
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILK--VLDPSHRDISLAFFETASMMRQ 60

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA-EIVSAVSH 230
           V+H  IV L        +  ++ +F+  G L   ++R+        +F  A ++ SA+S+
Sbjct: 61  VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSY 120

Query: 231 LHKCGIVHRDLKPENILMDSDG-------HVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           L    +VH ++  +NIL+  +G        + L+D G+   I   SR   +     ++AP
Sbjct: 121 LEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP--ITVLSRQECV-ERIPWIAP 177

Query: 284 EILL-SKGHNKDADWWSVGILLYEM-LTGQVNIK 315
           E +  SK  +  AD WS G  L+E+   G++ +K
Sbjct: 178 ECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLK 211

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|233667 TIGR01982, UbiB, 2-polyprenylphenol 6-hydroxylase

 Score = 38.4 bits (90), Expect = 0.004
 Identities = 14/36 (38%), Positives = 19/36 (52%)

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR 270
           G  H DL P NI +  DG ++  DFG+   + E  R
Sbjct: 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSEEDR 312

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol -> 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species [Biosynthesis of cofactors, prosthetic groups, and carriers, Menaquinone and ubiquinone]. Length = 437

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	355
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.98
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.94
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.93
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.93
PRK12274	218	serine/threonine protein kinase; Provisional	99.92
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.92
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.91
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.91
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.9
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.89
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.87
PRK10345	210	hypothetical protein; Provisional	99.87
smart00090	237	RIO RIO-like kinase.	99.87
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.86
PRK14879	211	serine/threonine protein kinase; Provisional	99.84
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.84
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.84
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.83
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.82
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.82
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.78
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.78
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.77
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.74
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.7
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.64
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.61
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.6
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.57
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.55
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.52
KOG1243	690	consensus Protein kinase [General function predict	99.51
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.51
KOG3087	229	consensus Serine/threonine protein kinase [General	99.47
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.42
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.41
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.35
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.32
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.23
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.22
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.14
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.06
COG4248	637	Uncharacterized protein with protein kinase and he	99.05
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.02
PRK09902	216	hypothetical protein; Provisional	98.99
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.92
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.87
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.75
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.73
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.7
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.66
PF01636	239	APH: Phosphotransferase enzyme family This family	98.65
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.53
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.5
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.48
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.41
PLN02876	822	acyl-CoA dehydrogenase	98.36
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.26
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.25
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.14
PRK10593	297	hypothetical protein; Provisional	98.13
KOG2268	465	consensus Serine/threonine protein kinase [Signal	98.1
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.09
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.08
KOG2270	520	consensus Serine/threonine protein kinase involved	97.98
PRK05231	319	homoserine kinase; Provisional	97.95
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.91
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.9
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.84
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.77
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.74
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.71
PLN02236	344	choline kinase	97.48
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.47
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.41
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.32
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.26
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.17
PLN02756	418	S-methyl-5-thioribose kinase	97.15
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.13
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.06
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.87
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.81
COG2334	331	Putative homoserine kinase type II (protein kinase	96.8
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.72
PRK12396	409	5-methylribose kinase; Reviewed	96.64
PTZ00384	383	choline kinase; Provisional	96.63
PRK11768	325	serine/threonine protein kinase; Provisional	96.45
PRK06148	1013	hypothetical protein; Provisional	96.18
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.09
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	95.98
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.46

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-54  Score=383.23  Aligned_cols=233  Identities=56%  Similarity=0.942  Sum_probs=208.0

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +.+++|++++.||+|+||+||.|+.+     ++++.+|+|++++.........+...+|..+|.+++||.||+++..|++
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~-----dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt   96 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKK-----DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT   96 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEc-----ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc
Confidence            45678999999999999999999987     6789999999999988888888889999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc-
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-  265 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~-  265 (355)
                      ...+|+|+||+.||.|+.+|.+++.|+|..++.++.+|+.||.|||++|||||||||+|||||.+|.++|+|||+++.. 
T Consensus        97 ~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~  176 (357)
T KOG0598|consen   97 EEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL  176 (357)
T ss_pred             CCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999999954 


Q ss_pred             CcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhhhhH--------------HHHHh
Q 018487          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTML--------------LFYLI  331 (355)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~~~~--------------~~~~~  331 (355)
                      .......++|||+.|||||++.+..|+..+|+||||+++|||++|..||...+.......+              .-+++
T Consensus       177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardl  256 (357)
T KOG0598|consen  177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDL  256 (357)
T ss_pred             cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHH
Confidence            4445566789999999999999999999999999999999999999999987643322111              22455


Q ss_pred             hhheeeecCCCcC
Q 018487          332 IFHCLFVNSLELL  344 (355)
Q Consensus       332 i~~~l~~~~~e~~  344 (355)
                      +.+-|.++|..++
T Consensus       257 l~~LL~rdp~~RL  269 (357)
T KOG0598|consen  257 LKKLLKRDPRQRL  269 (357)
T ss_pred             HHHHhccCHHHhc
Confidence            5566666666654

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-53  Score=380.88  Aligned_cols=203  Identities=35%  Similarity=0.661  Sum_probs=190.5

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|.+.++||+|+||+||+|+++     .++..||||.+.+... .+..++.+..|+.+|+.++|||||.+++++...+
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~-----~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~   82 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHK-----KSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD   82 (429)
T ss_pred             cccceehhhccCcceEEEEEeEec-----cCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC
Confidence            468999999999999999999988     5668899999987764 5666777889999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCC------CcEEEEecCCc
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD------GHVMLTDFGLA  262 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~------~~~kl~Dfg~a  262 (355)
                      .+|+|||||.||+|.+++..++.+++..++.++.||+.||++||+++||||||||.||||+.+      -.+||+|||+|
T Consensus        83 ~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   83 FIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             eEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            999999999999999999999999999999999999999999999999999999999999765      45899999999


Q ss_pred             cccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      +.+.......+.||++.|||||++..+.|+.|+|+||+|+++|+|++|+.||+..
T Consensus       163 R~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~  217 (429)
T KOG0595|consen  163 RFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE  217 (429)
T ss_pred             hhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence            9999888888999999999999999999999999999999999999999999954

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-52  Score=370.65  Aligned_cols=231  Identities=29%  Similarity=0.472  Sum_probs=205.4

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +..++++.++.||+|..|+||+|+++     .+++.+|+|++...  .+....+++.+|+++++.++|||||.+|++|..
T Consensus        76 i~~~dle~~~~lG~G~gG~V~kv~Hk-----~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~  148 (364)
T KOG0581|consen   76 ISLSDLERLGVLGSGNGGTVYKVRHK-----PTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYS  148 (364)
T ss_pred             cCHHHhhhhhhcccCCCcEEEEEEEc-----CCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence            44457888899999999999999998     57899999999543  356667789999999999999999999999999


Q ss_pred             CC-eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          187 RS-KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       187 ~~-~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      ++ .++|+||||++|+|++.+...+.++|..+..++.++++||.|||+ ++||||||||+|||++..|+|||||||.++.
T Consensus       149 ~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~  228 (364)
T KOG0581|consen  149 NGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGI  228 (364)
T ss_pred             CCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHH
Confidence            98 599999999999999999999999999999999999999999995 9999999999999999999999999999998


Q ss_pred             cCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCc-----hhhhhh---------------h
Q 018487          265 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSM-----QVIACN---------------T  324 (355)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~-----~~~~~~---------------~  324 (355)
                      +... ...+++||..|||||.+.+..|+.++||||||++++||.+|+.||...     +....-               .
T Consensus       229 lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~f  307 (364)
T KOG0581|consen  229 LVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEF  307 (364)
T ss_pred             hhhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccC
Confidence            8766 567889999999999999999999999999999999999999999874     111100               1


Q ss_pred             hHHHHHhhhheeeecCCCcCC
Q 018487          325 MLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       325 ~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ..-|..+|..||+++|.++..
T Consensus       308 S~ef~~FV~~CL~Kdp~~R~s  328 (364)
T KOG0581|consen  308 SPEFRSFVSCCLRKDPSERPS  328 (364)
T ss_pred             CHHHHHHHHHHhcCCcccCCC
Confidence            223788999999999998753

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-52  Score=389.29  Aligned_cols=230  Identities=30%  Similarity=0.543  Sum_probs=209.1

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      .+|+..+.||+|||++||.+++.     .+++.||+|++.+.........+.+.+|++|.+.|+|||||+++++|++.++
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~-----~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDL-----DTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEc-----CCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCc
Confidence            47999999999999999999975     5788999999999888888888899999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC-
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-  268 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~-  268 (355)
                      +|||+|+|..++|..++++++.++|.+++.+++||+.||.|||+++|||||||..|+||+++.+|||+|||+|..+... 
T Consensus        93 VYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             eEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999998754 


Q ss_pred             CCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhhhhHHH-------------HHhhhhe
Q 018487          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLF-------------YLIIFHC  335 (355)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~~~~~~-------------~~~i~~~  335 (355)
                      .+..+.||||.|.|||++....++..+||||+||+||.||+|+.||+..++...-..+..             .+.|.+-
T Consensus       173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~l  252 (592)
T KOG0575|consen  173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKL  252 (592)
T ss_pred             cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHH
Confidence            667889999999999999999999999999999999999999999999876654444432             2455566


Q ss_pred             eeecCCCcC
Q 018487          336 LFVNSLELL  344 (355)
Q Consensus       336 l~~~~~e~~  344 (355)
                      |.++|.+++
T Consensus       253 L~~~P~~Rp  261 (592)
T KOG0575|consen  253 LRPNPSERP  261 (592)
T ss_pred             hcCCcccCC
Confidence            666666654

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.3e-52  Score=371.07  Aligned_cols=205  Identities=35%  Similarity=0.595  Sum_probs=186.2

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccch----hHHHHHHHHHHHHHhcCCCcceeccee
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK----NHVDYMKAERDILTKVTHPFIVQLRYS  183 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~  183 (355)
                      ..+.|.+.+.||+|+||.|-+|..+     .+++.||||++.++.....    .......+|+++|++++|||||+++++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~-----~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~  244 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEK-----KTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF  244 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEc-----ccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee
Confidence            3467999999999999999999977     6789999999988765442    233346799999999999999999999


Q ss_pred             eecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCC---CcEEEEecC
Q 018487          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---GHVMLTDFG  260 (355)
Q Consensus       184 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~---~~~kl~Dfg  260 (355)
                      |...+..|||||||+||+|++.+..++.+.+...+.+++||+.|+.|||++||+||||||+|||+..+   ..+||+|||
T Consensus       245 f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFG  324 (475)
T KOG0615|consen  245 FEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFG  324 (475)
T ss_pred             eecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999766   679999999


Q ss_pred             CccccCcCCCCCcccccCccccchhhccCCC---CCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGH---NKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       261 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      +|+..+......+.|||+.|.|||++.++.+   ..++||||+||+||.+|+|..||.+.
T Consensus       325 lAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~  384 (475)
T KOG0615|consen  325 LAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEE  384 (475)
T ss_pred             hhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccc
Confidence            9999998888999999999999999987643   34789999999999999999999764

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-49  Score=342.30  Aligned_cols=207  Identities=45%  Similarity=0.841  Sum_probs=195.9

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      ..-++|++++.||.|+||+|.+++.+     .++..+|+|++.++.......++...+|..+|+.+.||+++++++.|.+
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k-----~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d  115 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREK-----HSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD  115 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEc-----cCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence            44568999999999999999999987     6788999999999988888888899999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                      .+.+||||||++||.|+.++++.++|++..++.++.||+.||+|||.++|++|||||+|||||.+|.+||+|||+|+.+.
T Consensus       116 ~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~  195 (355)
T KOG0616|consen  116 NSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS  195 (355)
T ss_pred             CCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhh
Q 018487          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVI  320 (355)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~  320 (355)
                      ..  .-+.||||.|+|||++..++|+.++|.|||||++|||+.|..||...+.+
T Consensus       196 ~r--T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~  247 (355)
T KOG0616|consen  196 GR--TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI  247 (355)
T ss_pred             Cc--EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH
Confidence            54  56789999999999999999999999999999999999999999987653

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3e-49  Score=363.67  Aligned_cols=208  Identities=41%  Similarity=0.758  Sum_probs=193.3

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~  184 (355)
                      .....+|.+++.||+|+|++||+|+.+     .+++.||||++.++-+..+..++.+..|-..|.+| .||.|++|+..|
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~-----~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF  143 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREK-----ATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF  143 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeec-----CCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe
Confidence            455679999999999999999999977     57899999999998888888888899999999999 799999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      ++...+|+|+||+++|+|.+++.+.+.|++..++.++.||+.||+|||++|||||||||+|||||.++++||+|||.|+.
T Consensus       144 QD~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  144 QDEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             ecccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeecccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999987


Q ss_pred             cCcCCC--------------CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          265 IDESSR--------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       265 ~~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      +.....              ...++||..|.+||++.+...+..+|||+|||+||+|+.|+.||++.+
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N  291 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN  291 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc
Confidence            643211              145899999999999999999999999999999999999999999864

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=5.6e-49  Score=361.88  Aligned_cols=213  Identities=46%  Similarity=0.868  Sum_probs=195.4

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      .+..++|++++.||+|+||.||+|+.+     .++..+|+|++++......+.++.++.|.++|...+++.||+|+.+|+
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk-----~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQ  211 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKK-----DTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQ  211 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEc-----cCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEec
Confidence            466789999999999999999999988     678999999999999889999999999999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      +..++||||||++||++..+|.+.+.|++..++.++.+++.|++.||+.|+|||||||+|+|||..|.+||+|||++..+
T Consensus       212 D~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  212 DKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             CCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999998533


Q ss_pred             Cc-------------------------CC----C-------------------CCcccccCccccchhhccCCCCCcccH
Q 018487          266 DE-------------------------SS----R-------------------SNSMCGTTEYMAPEILLSKGHNKDADW  297 (355)
Q Consensus       266 ~~-------------------------~~----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di  297 (355)
                      ..                         ..    .                   ....+|||.|||||++.++.|+..+|+
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw  371 (550)
T KOG0605|consen  292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW  371 (550)
T ss_pred             hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence            11                         00    0                   012479999999999999999999999


Q ss_pred             HHHHHHHHHHHcCCCCCCCchhhhhh
Q 018487          298 WSVGILLYEMLTGQVNIKSMQVIACN  323 (355)
Q Consensus       298 wSlG~~l~elltg~~pf~~~~~~~~~  323 (355)
                      |||||||||||.|-.||.+.+....-
T Consensus       372 WSLG~ImyEmLvGyPPF~s~tp~~T~  397 (550)
T KOG0605|consen  372 WSLGCIMYEMLVGYPPFCSETPQETY  397 (550)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999999999999999998765533

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-50  Score=345.47  Aligned_cols=231  Identities=27%  Similarity=0.476  Sum_probs=196.0

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecce-eeecCC
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY-SFQTRS  188 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~-~~~~~~  188 (355)
                      .+|+++++||+|+||+||+|...     .+++.||.|.+..+. .+....+.+..|+.+|++|+|||||++++ .|..+.
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~-----~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~   92 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCL-----LDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN   92 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeec-----cCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence            36999999999999999999977     578899999998554 34555667888999999999999999998 566555


Q ss_pred             e-EEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH--CC--CeeccCCCCcEEecCCCcEEEEec
Q 018487          189 K-LYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHK--CG--IVHRDLKPENILMDSDGHVMLTDF  259 (355)
Q Consensus       189 ~-~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~L~~LH~--~~--iiHrDlkp~NILl~~~~~~kl~Df  259 (355)
                      . ++||||||.+|+|...++.    +..++|..+|.++.|++.||..+|.  ..  |+||||||.||+|+.+|.+||+||
T Consensus        93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf  172 (375)
T KOG0591|consen   93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF  172 (375)
T ss_pred             hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence            5 8999999999999888763    3569999999999999999999998  44  999999999999999999999999


Q ss_pred             CCccccCcCCC-CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhhhhH------------
Q 018487          260 GLAKEIDESSR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTML------------  326 (355)
Q Consensus       260 g~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~~~~------------  326 (355)
                      |+++.+..... ..+.+|||+||+||.+.+.+|+.++||||+||++|||+.-+.||.+.+.......+            
T Consensus       173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~  252 (375)
T KOG0591|consen  173 GLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEH  252 (375)
T ss_pred             hhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHH
Confidence            99998865543 46789999999999999999999999999999999999999999997544322111            


Q ss_pred             ---HHHHhhhheeeecCCCcCCC
Q 018487          327 ---LFYLIIFHCLFVNSLELLSH  346 (355)
Q Consensus       327 ---~~~~~i~~~l~~~~~e~~~~  346 (355)
                         .+..+|.-|+..++..++..
T Consensus       253 YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  253 YSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             hhhHHHHHHHHHccCCcccCCCc
Confidence               34566777887777666543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-48  Score=359.04  Aligned_cols=232  Identities=29%  Similarity=0.505  Sum_probs=198.7

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +...++.+.+.||+|+||+||++.|++..      .||+|++......... .+.|.+|+.+|.+++|||||+++|++..
T Consensus        38 i~~~~l~~~~~iG~G~~g~V~~~~~~g~~------~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~  110 (362)
T KOG0192|consen   38 IDPDELPIEEVLGSGSFGTVYKGKWRGTD------VVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTS  110 (362)
T ss_pred             cChHHhhhhhhcccCCceeEEEEEeCCce------eEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            33445666677999999999999998432      2999999876654444 7789999999999999999999999998


Q ss_pred             CC-eEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-CeeccCCCCcEEecCCC-cEEEEecCC
Q 018487          187 RS-KLYLILDFINGGHLFFHLYR--QGIFREDQARFYTAEIVSAVSHLHKCG-IVHRDLKPENILMDSDG-HVMLTDFGL  261 (355)
Q Consensus       187 ~~-~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~ql~~~L~~LH~~~-iiHrDlkp~NILl~~~~-~~kl~Dfg~  261 (355)
                      .. .+++|||||++|+|..++..  ...++...+..|+.||++||.|||+++ ||||||||+|||++.++ .+||+|||+
T Consensus       111 ~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGl  190 (362)
T KOG0192|consen  111 PPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGL  190 (362)
T ss_pred             CCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcc
Confidence            87 79999999999999999988  577999999999999999999999999 99999999999999998 999999999


Q ss_pred             ccccCcC-CCCCcccccCccccchhhc--cCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh---------------
Q 018487          262 AKEIDES-SRSNSMCGTTEYMAPEILL--SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN---------------  323 (355)
Q Consensus       262 a~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~---------------  323 (355)
                      ++..... .......||+.|||||++.  ...|+.++||||||++||||+||+.||.....+...               
T Consensus       191 sr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~  270 (362)
T KOG0192|consen  191 SREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKE  270 (362)
T ss_pred             ceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCcc
Confidence            9876654 3344478999999999999  568999999999999999999999999998643211               


Q ss_pred             hhHHHHHhhhheeeecCCCcCC
Q 018487          324 TMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       324 ~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ....+..++.+||..+|..++.
T Consensus       271 ~~~~l~~l~~~CW~~dp~~RP~  292 (362)
T KOG0192|consen  271 CPPHLSSLMERCWLVDPSRRPS  292 (362)
T ss_pred             CCHHHHHHHHHhCCCCCCcCCC
Confidence            2224567788899888887654

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=8.2e-49  Score=337.60  Aligned_cols=206  Identities=27%  Similarity=0.432  Sum_probs=182.1

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      +.|+.+.++|+|+||+||+|+++     .+++.||||.+.... .++...+-..+|+++|++++|+|+|.++++|.....
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk-----~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrk   75 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNK-----DTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRK   75 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccC-----CcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcce
Confidence            46889999999999999999987     789999999997654 344455556789999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC-cC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ES  268 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~-~~  268 (355)
                      +++|+|||+..-|.+.-....-+++..+..+++|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+.+. ..
T Consensus        76 lhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg  155 (396)
T KOG0593|consen   76 LHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG  155 (396)
T ss_pred             eEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence            99999999985554444444558999999999999999999999999999999999999999999999999999887 44


Q ss_pred             CCCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh
Q 018487          269 SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA  321 (355)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~  321 (355)
                      ...+..+.|.+|+|||.+.| ..|+..+||||+||++.||++|...|++...+.
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiD  209 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDID  209 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHH
Confidence            44566789999999999987 789999999999999999999999999976543

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-47  Score=358.86  Aligned_cols=235  Identities=36%  Similarity=0.709  Sum_probs=206.4

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceeccee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYS  183 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~  183 (355)
                      ..+..++|.++++||+|+||+|++|..+     .+++.+|||+++++.+...+.++..+.|.+++.... ||.+++++..
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k-----~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~  437 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELK-----GTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC  437 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEc-----CCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc
Confidence            3456679999999999999999999998     456789999999999999999999999999988776 9999999999


Q ss_pred             eecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       184 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      |+..+++|+||||+.||++ .++...+.|++..++.++..|+.||.|||++||||||||.+|||||.+|.+||+|||+++
T Consensus       438 fQT~~~l~fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  438 FQTKEHLFFVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             cccCCeEEEEEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccc
Confidence            9999999999999999994 444455789999999999999999999999999999999999999999999999999999


Q ss_pred             ccC-cCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhhhhH-------------HHH
Q 018487          264 EID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTML-------------LFY  329 (355)
Q Consensus       264 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~~~~-------------~~~  329 (355)
                      ..- ......++|||+.|||||++.+..|+.++|.|||||+|||||.|+.||.+.+....-..+             -..
T Consensus       517 e~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~  596 (694)
T KOG0694|consen  517 EGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAI  596 (694)
T ss_pred             ccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHH
Confidence            753 555678899999999999999999999999999999999999999999987554422222             124


Q ss_pred             HhhhheeeecCCCcCC
Q 018487          330 LIIFHCLFVNSLELLS  345 (355)
Q Consensus       330 ~~i~~~l~~~~~e~~~  345 (355)
                      .++.+-|.++|..++=
T Consensus       597 ~il~~ll~k~p~kRLG  612 (694)
T KOG0694|consen  597 AIMRRLLRKNPEKRLG  612 (694)
T ss_pred             HHHHHHhccCcccccC
Confidence            5666777888877663

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-47  Score=353.17  Aligned_cols=207  Identities=38%  Similarity=0.702  Sum_probs=187.0

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccc--hhHHHHHHHHHHHHHhcC-CCcceeccee
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK--KNHVDYMKAERDILTKVT-HPFIVQLRYS  183 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~l~~~  183 (355)
                      ...++|.+.+.||+|+||+|++|.+.     .+++.||+|++.+.....  ....+.+.+|+.+++.++ ||||++++++
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~-----~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev   88 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHR-----LTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEV   88 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeec-----cCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEE
Confidence            34578999999999999999999977     456889999877653221  134456778999999999 9999999999


Q ss_pred             eecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCC-CcEEEEecCCc
Q 018487          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLA  262 (355)
Q Consensus       184 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~-~~~kl~Dfg~a  262 (355)
                      +.....+|+||||+.||+|++++...+++.|.+++.+++|++.|++|||++||+||||||+|||++.+ +++||+|||++
T Consensus        89 ~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   89 FATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999 99999999999


Q ss_pred             ccc-CcCCCCCcccccCccccchhhccCC-CC-CcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          263 KEI-DESSRSNSMCGTTEYMAPEILLSKG-HN-KDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       263 ~~~-~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      ... .......+.|||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+
T Consensus       169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~  227 (370)
T KOG0583|consen  169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN  227 (370)
T ss_pred             cccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence            988 4556678899999999999999877 85 78999999999999999999999854

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=8.8e-48  Score=354.80  Aligned_cols=229  Identities=30%  Similarity=0.559  Sum_probs=200.1

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|.+.+.||+|+||+||+|+.+     .+.+.||+|.+.+... .+..++.+.+|++|++.++|||||.++++|+...+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK-----~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~   75 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRK-----YTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAH   75 (808)
T ss_pred             cchhHHHHhcCCccceeeecccc-----cceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccce
Confidence            47899999999999999999977     5678999999987764 34456778999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      +|+|+||+.| +|+.++...+.++|++++.++.|++.||.|||+.+|+|||+||.|||++.+|.+|+||||+|+......
T Consensus        76 ~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t  154 (808)
T KOG0597|consen   76 LWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT  154 (808)
T ss_pred             EEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence            9999999988 999999999999999999999999999999999999999999999999999999999999999876544


Q ss_pred             C-CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhhh-------------hHHHHHhhhhe
Q 018487          270 R-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNT-------------MLLFYLIIFHC  335 (355)
Q Consensus       270 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~~-------------~~~~~~~i~~~  335 (355)
                      . .....|||.|||||++.++.|+..+|+||+||++|||++|+.||........-.             ...|.+++..-
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gL  234 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGL  234 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHH
Confidence            3 356789999999999999999999999999999999999999999865433222             22445566666


Q ss_pred             eeecCCCcCC
Q 018487          336 LFVNSLELLS  345 (355)
Q Consensus       336 l~~~~~e~~~  345 (355)
                      |+++|..++.
T Consensus       235 L~kdP~~Rlt  244 (808)
T KOG0597|consen  235 LIKDPAQRLT  244 (808)
T ss_pred             hhcChhhccc
Confidence            6777666543

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-46  Score=346.17  Aligned_cols=227  Identities=29%  Similarity=0.473  Sum_probs=198.8

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      ...|....+||+|+.|.||.|...     ..++.||||.+.....   ...+.+.+|+.+|+..+|+|||++++.|...+
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~-----~~~~~VaiK~m~l~~Q---~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d  343 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKI-----STKQEVAIKRMDLRKQ---PKKELLLNEILVMRDLHHPNIVNFLDSYLVGD  343 (550)
T ss_pred             hhhhcchhhhccccccceeeeeec-----cCCceEEEEEEEeccC---CchhhhHHHHHHHHhccchHHHHHHHHhcccc
Confidence            356999999999999999999976     4567799999976543   33456789999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      .+|+|||||+||+|.+.+... .++|.++..|++++++||+|||.+||+|||||.+|||++.+|.+||+|||+|..+...
T Consensus       344 eLWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~  422 (550)
T KOG0578|consen  344 ELWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE  422 (550)
T ss_pred             eeEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence            999999999999997777544 5899999999999999999999999999999999999999999999999999988655


Q ss_pred             C-CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhhh----------------hHHHHHh
Q 018487          269 S-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNT----------------MLLFYLI  331 (355)
Q Consensus       269 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~~----------------~~~~~~~  331 (355)
                      . ...+.+||++|||||++..+.|++++||||||++++||+-|+.||-..+.+..--                --.|+++
T Consensus       423 ~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdF  502 (550)
T KOG0578|consen  423 QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDF  502 (550)
T ss_pred             cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHH
Confidence            4 5667899999999999999999999999999999999999999998654443221                1267899


Q ss_pred             hhheeeecCCCcC
Q 018487          332 IFHCLFVNSLELL  344 (355)
Q Consensus       332 i~~~l~~~~~e~~  344 (355)
                      +.+||+.+++.+.
T Consensus       503 L~~cL~~dv~~Ra  515 (550)
T KOG0578|consen  503 LDRCLVVDVEQRA  515 (550)
T ss_pred             HHHHhhcchhcCC
Confidence            9999998877653

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-47  Score=347.85  Aligned_cols=207  Identities=29%  Similarity=0.509  Sum_probs=183.0

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC-
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-  187 (355)
                      .+.|+.+++||+|.||.||+|++.     .+++.||+|.++.+.. +.+....+.+||.||++|+||||++|.+..... 
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~-----~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~  189 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDL-----ETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL  189 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeec-----ccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecC
Confidence            457999999999999999999966     7899999999998764 455666778899999999999999999988766 


Q ss_pred             -CeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          188 -SKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       188 -~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                       +.+|||+|||+. +|.-++...+ .|++.+++.+++||+.||+|||.+||+|||||.+|||||.+|.+||+|||+|+.+
T Consensus       190 ~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  190 SGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             CceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeec
Confidence             689999999987 6766666543 5999999999999999999999999999999999999999999999999999977


Q ss_pred             CcCC--CCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh
Q 018487          266 DESS--RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC  322 (355)
Q Consensus       266 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~  322 (355)
                      ....  ..+..+-|.+|+|||+++| ..|+.++|+||.||||.||++|+..|.+.+.+..
T Consensus       269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ  328 (560)
T KOG0600|consen  269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ  328 (560)
T ss_pred             cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH
Confidence            5544  3566788999999999997 4799999999999999999999999999865543

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.4e-47  Score=337.58  Aligned_cols=231  Identities=30%  Similarity=0.521  Sum_probs=208.5

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      ..+|++.+.||+|.||.|-+|...     ..++.||||.++++.+.+++.+-.+++|++||..|+||||+.++++|+..+
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~-----~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkd  126 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEH-----KSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD  126 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhc-----cCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc
Confidence            357999999999999999999854     678999999999999988888888999999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      .+.|||||..+|.|++|+...+.+++.+++.|++||+.|+.|+|.++++|||||.+|||+|.++++||+|||++..+...
T Consensus       127 KIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  127 KIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK  206 (668)
T ss_pred             eEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999888


Q ss_pred             CCCCcccccCccccchhhccCCC-CCcccHHHHHHHHHHHHcCCCCCCCchhhhhhhhHH------------HHHhhhhe
Q 018487          269 SRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLL------------FYLIIFHC  335 (355)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~~~~~------------~~~~i~~~  335 (355)
                      ....++||++-|.+||++.|.+| .+.+|-|||||+||.|+.|..||++.+....-.++.            -.-.|++.
T Consensus       207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PSdA~gLIRwm  286 (668)
T KOG0611|consen  207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPSDASGLIRWM  286 (668)
T ss_pred             cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCchHHHHHHHH
Confidence            88899999999999999999988 678999999999999999999999987654332221            12345566


Q ss_pred             eeecCCCcC
Q 018487          336 LFVNSLELL  344 (355)
Q Consensus       336 l~~~~~e~~  344 (355)
                      |-.||.++.
T Consensus       287 LmVNP~RRA  295 (668)
T KOG0611|consen  287 LMVNPERRA  295 (668)
T ss_pred             HhcCcccch
Confidence            666665543

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-45  Score=331.67  Aligned_cols=234  Identities=29%  Similarity=0.470  Sum_probs=200.3

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      +....++|++.++||.|..++||+|+...     .++.||||++..+....  .++.+++|+..|+.++||||++++..|
T Consensus        21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p-----~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~HPNIv~~~~sF   93 (516)
T KOG0582|consen   21 FPLNAKDYELQEVIGVGASAVVYLARCIP-----TNEVVAIKIINLEKCNN--DLDALRKEVQTMSLIDHPNIVTYHCSF   93 (516)
T ss_pred             CCCCccceeEEEEEeccceeEeeeeeecc-----cCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcCCCCcceEEEEE
Confidence            44556799999999999999999999883     45789999998876433  378899999999999999999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                      ..+..+|+||.||.+|++.+++...-  -+.|..+..|++++++||.|||++|.||||||+.||||+.+|.|||+|||.+
T Consensus        94 vv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvs  173 (516)
T KOG0582|consen   94 VVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVS  173 (516)
T ss_pred             EecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceee
Confidence            99999999999999999999998653  3899999999999999999999999999999999999999999999999987


Q ss_pred             cccCcCCC-----CCcccccCccccchhhcc--CCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh--------------
Q 018487          263 KEIDESSR-----SNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA--------------  321 (355)
Q Consensus       263 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~--------------  321 (355)
                      ..+.....     ...++||++|||||++..  ..|+.|+||||||++..||.+|..||..+-...              
T Consensus       174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~  253 (516)
T KOG0582|consen  174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL  253 (516)
T ss_pred             eeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc
Confidence            65533221     156789999999999653  579999999999999999999999998864221              


Q ss_pred             ---------hhhhHHHHHhhhheeeecCCCcCC
Q 018487          322 ---------CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 ---------~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                               ......|...|..||+++|..++.
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRpt  286 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPT  286 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCCC
Confidence                     001115678899999999888654

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-46  Score=344.66  Aligned_cols=232  Identities=25%  Similarity=0.371  Sum_probs=196.1

Q ss_pred             hhcCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecce
Q 018487          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (355)
Q Consensus       103 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~  182 (355)
                      .+|.+..++..+...||+|.||+||+|+|.|.        ||||++..+.. ..+..+.|++|+..+++-+|.||+-+.|
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd--------VAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFMG  455 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD--------VAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFMG  455 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccccc--------eEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeeeh
Confidence            45677788899999999999999999998753        99999988765 4558899999999999999999999999


Q ss_pred             eeecCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCC
Q 018487          183 SFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (355)
Q Consensus       183 ~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~  261 (355)
                      ++..... .||+.||+|.+|+.+++.. ..|.....+.|++|+++|+.|||.++|||||||..|||+.++++|||+|||+
T Consensus       456 ~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGL  534 (678)
T KOG0193|consen  456 ACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGL  534 (678)
T ss_pred             hhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccc
Confidence            9998877 9999999999999999765 4588999999999999999999999999999999999999999999999999


Q ss_pred             ccccC---cCCCCCcccccCccccchhhcc---CCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh--------------
Q 018487          262 AKEID---ESSRSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA--------------  321 (355)
Q Consensus       262 a~~~~---~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~--------------  321 (355)
                      +..-.   .........|...|||||++..   .+|+..+||||||+|+|||+||.+||.......              
T Consensus       535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~  614 (678)
T KOG0193|consen  535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDL  614 (678)
T ss_pred             eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccc
Confidence            87432   2222344568899999999974   468999999999999999999999998321111              


Q ss_pred             ----hhhhHHHHHhhhheeeecCCCcC
Q 018487          322 ----CNTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       322 ----~~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                          .+..--++++...|+...+.|++
T Consensus       615 s~~~s~~pk~mk~Ll~~C~~~~~~eRP  641 (678)
T KOG0193|consen  615 SKIRSNCPKAMKRLLSDCWKFDREERP  641 (678)
T ss_pred             hhhhccCHHHHHHHHHHHHhcCcccCc
Confidence                12222457788889987777754

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.5e-47  Score=315.18  Aligned_cols=234  Identities=33%  Similarity=0.560  Sum_probs=209.0

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      .+..++|++.+.||+|.||.||+|+.+     .+...||+|++.+...........+.+|+.+-..|+||||+++|++|.
T Consensus        18 ~~~l~dfeigr~LgkgkFG~vYlarek-----ks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh   92 (281)
T KOG0580|consen   18 TWTLDDFEIGRPLGKGKFGNVYLAREK-----KSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH   92 (281)
T ss_pred             ccchhhccccccccCCccccEeEeeec-----cCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhee
Confidence            345578999999999999999999977     678899999999988877777888999999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          186 TRSKLYLILDFINGGHLFFHLY--RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~--~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      +...+|+++||...|+|+..|.  ....+++..++.+++|++.||.|+|..+||||||||+|+|++.+|.+||+|||.+.
T Consensus        93 d~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV  172 (281)
T KOG0580|consen   93 DSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSV  172 (281)
T ss_pred             ccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCcee
Confidence            9999999999999999999998  56779999999999999999999999999999999999999999999999999987


Q ss_pred             ccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhhhhH-------------HHHH
Q 018487          264 EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTML-------------LFYL  330 (355)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~~~~-------------~~~~  330 (355)
                      .-. .....+.|||..|.+||+..+..++..+|+|++|++.||++.|..||++......-..+             --.+
T Consensus       173 ~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~d  251 (281)
T KOG0580|consen  173 HAP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAAD  251 (281)
T ss_pred             ecC-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHH
Confidence            654 55677889999999999999999999999999999999999999999987533322211             1256


Q ss_pred             hhhheeeecCCCcCC
Q 018487          331 IIFHCLFVNSLELLS  345 (355)
Q Consensus       331 ~i~~~l~~~~~e~~~  345 (355)
                      .|..|+.++|.+++.
T Consensus       252 lI~~ll~~~p~~r~~  266 (281)
T KOG0580|consen  252 LISRLLVKNPIERLA  266 (281)
T ss_pred             HHHHHhccCcccccc
Confidence            777888888888764

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.8e-45  Score=339.29  Aligned_cols=231  Identities=40%  Similarity=0.711  Sum_probs=202.7

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ..++|++.+.||+|+||.||+|+++     .+++.||+|++...........+.+.+|+.++++++||||+++++++..+
T Consensus        16 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   90 (329)
T PTZ00263         16 KLSDFEMGETLGTGSFGRVRIAKHK-----GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE   90 (329)
T ss_pred             CchheEEEEEEEecCCeEEEEEEEC-----CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC
Confidence            3468999999999999999999977     45778999999876544445567788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      +.+|+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        91 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         91 NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             CEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            99999999999999999999888899999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHHhhhh
Q 018487          268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYLIIFH  334 (355)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~~i~~  334 (355)
                      .  ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.....             ....+.++|.+
T Consensus       171 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  248 (329)
T PTZ00263        171 R--TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKG  248 (329)
T ss_pred             C--cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHH
Confidence            3  23457999999999999999999999999999999999999999875432211             12346788999


Q ss_pred             eeeecCCCcCC
Q 018487          335 CLFVNSLELLS  345 (355)
Q Consensus       335 ~l~~~~~e~~~  345 (355)
                      ||+.+|.+++.
T Consensus       249 ~L~~dP~~R~~  259 (329)
T PTZ00263        249 LLQTDHTKRLG  259 (329)
T ss_pred             HhhcCHHHcCC
Confidence            99999998864

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-45  Score=332.70  Aligned_cols=229  Identities=40%  Similarity=0.724  Sum_probs=199.2

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++.+.||+|+||.||+|.++     .+++.||+|++...........+.+.+|+.+++.++||||+++++++.+...
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   75 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDR-----ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRF   75 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEc-----CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCe
Confidence            47999999999999999999976     4578899999976544344445668889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      +|+||||+++++|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-  154 (291)
T cd05612          76 LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-  154 (291)
T ss_pred             EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence            9999999999999999998888999999999999999999999999999999999999999999999999999876432 


Q ss_pred             CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-------------hhhHHHHHhhhhee
Q 018487          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-------------NTMLLFYLIIFHCL  336 (355)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-------------~~~~~~~~~i~~~l  336 (355)
                       ....+|++.|+|||++.+..++.++|||||||++|+|++|+.||...+....             .....+.++|.+||
T Consensus       155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l  233 (291)
T cd05612         155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLL  233 (291)
T ss_pred             -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHc
Confidence             2345799999999999999999999999999999999999999987643221             11235578888999


Q ss_pred             eecCCCcCC
Q 018487          337 FVNSLELLS  345 (355)
Q Consensus       337 ~~~~~e~~~  345 (355)
                      ..+|.+++.
T Consensus       234 ~~dp~~R~~  242 (291)
T cd05612         234 VVDRTRRLG  242 (291)
T ss_pred             CCCHHHccC
Confidence            998888763

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7e-46  Score=333.11  Aligned_cols=227  Identities=30%  Similarity=0.491  Sum_probs=189.8

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC-
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-  188 (355)
                      .+|...+.||+|+||.||++.++     .+++..|||.+.....   ...+.+.+|+.+|++++|||||++++...... 
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~-----~~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~   88 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNK-----KTGELMAVKSVELEDS---PTSESLEREIRILSRLNHPNIVQYYGSSSSREN   88 (313)
T ss_pred             chhhhhccccCccceEEEEEEec-----CCCcceeeeeeecccc---hhHHHHHHHHHHHHhCCCCCEEeeCCccccccC
Confidence            46788899999999999999977     3478899999876522   11667889999999999999999999754444 


Q ss_pred             -eEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC-CCcEEEEecCCcccc
Q 018487          189 -KLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKEI  265 (355)
Q Consensus       189 -~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~-~~~~kl~Dfg~a~~~  265 (355)
                       .+++.|||+++|+|.+++.+.+ .+++..++.+.+|+++||+|||++||+||||||+|||++. ++.+||+|||++...
T Consensus        89 ~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~  168 (313)
T KOG0198|consen   89 DEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKL  168 (313)
T ss_pred             eeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence             6999999999999999999887 7999999999999999999999999999999999999999 799999999999877


Q ss_pred             Cc----CCCCCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCc-hhhh---------------hhh
Q 018487          266 DE----SSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSM-QVIA---------------CNT  324 (355)
Q Consensus       266 ~~----~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~-~~~~---------------~~~  324 (355)
                      ..    ........||+.|||||++.++ ....++|||||||++.||+||+.||... ....               ...
T Consensus       169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~l  248 (313)
T KOG0198|consen  169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSL  248 (313)
T ss_pred             ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCccc
Confidence            63    2223457899999999999853 3345999999999999999999999972 1111               111


Q ss_pred             hHHHHHhhhheeeecCCCcC
Q 018487          325 MLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       325 ~~~~~~~i~~~l~~~~~e~~  344 (355)
                      ...-++++.+||.++|.+++
T Consensus       249 s~~a~~Fl~~C~~~~p~~Rp  268 (313)
T KOG0198|consen  249 SDEAKDFLRKCFKRDPEKRP  268 (313)
T ss_pred             CHHHHHHHHHHhhcCcccCc
Confidence            12457889999999987765

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-47  Score=339.55  Aligned_cols=229  Identities=25%  Similarity=0.465  Sum_probs=205.8

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ..|..+++||+|+||.||+|.+.     .+++.||+|++..+.  .+..++.+++|+.+|.+++++||.++|+.|..+..
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~-----~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~   85 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDN-----KTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK   85 (467)
T ss_pred             cccccchhccccccceeeeeeec-----cccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc
Confidence            46888899999999999999966     778899999998765  35566788999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      +|++||||.||++.+.+.....+.+.++..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+..+....
T Consensus        86 LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   86 LWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             HHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999998775443


Q ss_pred             -CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh--------------hhhHHHHHhhhh
Q 018487          270 -RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC--------------NTMLLFYLIIFH  334 (355)
Q Consensus       270 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~--------------~~~~~~~~~i~~  334 (355)
                       ...+++||+.|||||++.+..|+.++||||||++.+||++|..|+......+.              +..--|+++++.
T Consensus       166 ~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~  245 (467)
T KOG0201|consen  166 KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEA  245 (467)
T ss_pred             hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHH
Confidence             34788999999999999988999999999999999999999999988765442              222357999999


Q ss_pred             eeeecCCCcCC
Q 018487          335 CLFVNSLELLS  345 (355)
Q Consensus       335 ~l~~~~~e~~~  345 (355)
                      ||.++|.+++.
T Consensus       246 CL~k~P~~Rps  256 (467)
T KOG0201|consen  246 CLDKNPEFRPS  256 (467)
T ss_pred             HhhcCcccCcC
Confidence            99999988764

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=6.3e-45  Score=336.96  Aligned_cols=225  Identities=40%  Similarity=0.759  Sum_probs=194.9

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEEEe
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  195 (355)
                      +.||+|+||.||+|+++     .+++.||+|+++............+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREK-----ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEe
Confidence            46999999999999976     5678899999987654445555667789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC-cCCCCCcc
Q 018487          196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSM  274 (355)
Q Consensus       196 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~-~~~~~~~~  274 (355)
                      |+++++|..++...+.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... ........
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  155 (323)
T cd05571          76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccce
Confidence            99999999999988899999999999999999999999999999999999999999999999999987542 22233456


Q ss_pred             cccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHHhhhheeeecCC
Q 018487          275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYLIIFHCLFVNSL  341 (355)
Q Consensus       275 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~~i~~~l~~~~~  341 (355)
                      +||+.|+|||++.+..++.++|||||||++|||++|+.||...+.....             ....+..+|.+||.++|.
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~  235 (323)
T cd05571         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPK  235 (323)
T ss_pred             ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHH
Confidence            7999999999999999999999999999999999999999876433211             122457788899999998


Q ss_pred             CcCC
Q 018487          342 ELLS  345 (355)
Q Consensus       342 e~~~  345 (355)
                      +++.
T Consensus       236 ~R~~  239 (323)
T cd05571         236 QRLG  239 (323)
T ss_pred             HcCC
Confidence            8873

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.1e-45  Score=325.70  Aligned_cols=234  Identities=38%  Similarity=0.656  Sum_probs=199.5

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      .+..+.|+++++||.|.-|+||+|+.++     +...+|+|++.+........+.+.+.|..||+.++||.++.||..|+
T Consensus        73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~-----t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fe  147 (459)
T KOG0610|consen   73 SLGLRHFRLLKRLGCGDIGTVYLVELRG-----TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFE  147 (459)
T ss_pred             ccCHHHHHHHHHcCCCCceeEEEEEecC-----CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheee
Confidence            4556789999999999999999999884     45789999999988887888888999999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      .+...|+|||||+||+|...++++  +.|++..++.++.+++.||+|||..|||+|||||+||||-++|.|.|+||.++.
T Consensus       148 t~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~  227 (459)
T KOG0610|consen  148 TDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSL  227 (459)
T ss_pred             ccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccc
Confidence            999999999999999998888876  459999999999999999999999999999999999999999999999999875


Q ss_pred             ccCc-----------------------------------C----------------------CCCCcccccCccccchhh
Q 018487          264 EIDE-----------------------------------S----------------------SRSNSMCGTTEYMAPEIL  286 (355)
Q Consensus       264 ~~~~-----------------------------------~----------------------~~~~~~~gt~~y~aPE~~  286 (355)
                      ....                                   .                      .+...++||-.|.|||++
T Consensus       228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI  307 (459)
T KOG0610|consen  228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI  307 (459)
T ss_pred             cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence            3210                                   0                      011346899999999999


Q ss_pred             ccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh---------------hhHHHHHhhhheeeecCCCcC
Q 018487          287 LSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN---------------TMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       287 ~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~---------------~~~~~~~~i~~~l~~~~~e~~  344 (355)
                      .|...+.++|+|+|||++||||.|..||++.+-...-               .....++.|++-|.++|..++
T Consensus       308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRl  380 (459)
T KOG0610|consen  308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRL  380 (459)
T ss_pred             ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhh
Confidence            9999999999999999999999999999997433211               112335666666666665544

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.7e-45  Score=309.89  Aligned_cols=205  Identities=26%  Similarity=0.440  Sum_probs=179.1

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      .+|..+++||+|.||+||+|++.     .+++.||||.++.....+.-.. ...+|++.|+.++|+||+.++++|...+.
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~-----~t~~~VAIKKIkl~~~kdGi~~-talREIK~Lqel~h~nIi~LiD~F~~~~~   75 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDT-----ETGKRVAIKKIKLGNAKDGINR-TALREIKLLQELKHPNIIELIDVFPHKSN   75 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEec-----CCCcEEEEEEeeccccccCccH-HHHHHHHHHHHccCcchhhhhhhccCCCc
Confidence            47888999999999999999966     6788999999988754433333 35679999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          190 LYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      +.+|+|||+. +|...++... .++..+++.|+.++++||+|||++.|+||||||.|+|++.+|.+||+|||+|+.+...
T Consensus        76 l~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   76 LSLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             eEEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            9999999987 7888887654 5899999999999999999999999999999999999999999999999999988654


Q ss_pred             CCC-CcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh
Q 018487          269 SRS-NSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA  321 (355)
Q Consensus       269 ~~~-~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~  321 (355)
                      ... ...+-|.+|+|||.+.| +.|+..+||||.||++.||+-|..-|.+...+.
T Consensus       155 ~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid  209 (318)
T KOG0659|consen  155 NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID  209 (318)
T ss_pred             CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH
Confidence            443 33478999999999987 579999999999999999998888788765443

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.2e-44  Score=340.31  Aligned_cols=204  Identities=43%  Similarity=0.838  Sum_probs=182.9

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++++.||+|+||+||+|.++     .+++.||+|++++...........+.+|+.+++.++|+||+++++.+.+...
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~   75 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKK-----DTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLN   75 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEEC-----CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCe
Confidence            47999999999999999999976     4678899999987654455556678889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      +|+||||++||+|.+++...+.+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            99999999999999999988899999999999999999999999999999999999999999999999999987543211


Q ss_pred             ------------------------------------CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCC
Q 018487          270 ------------------------------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVN  313 (355)
Q Consensus       270 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~p  313 (355)
                                                          .....+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence                                                01235799999999999999999999999999999999999999


Q ss_pred             CCCch
Q 018487          314 IKSMQ  318 (355)
Q Consensus       314 f~~~~  318 (355)
                      |...+
T Consensus       236 f~~~~  240 (363)
T cd05628         236 FCSET  240 (363)
T ss_pred             CCCCC
Confidence            98754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-45  Score=346.54  Aligned_cols=204  Identities=30%  Similarity=0.577  Sum_probs=190.1

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      |-|++.+-||.|+.|.|-+|++.     .+|+.+|||++.+...........+.+|+.+|+-+.||||+++|++|....+
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~-----~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~   86 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHA-----ETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQH   86 (786)
T ss_pred             cceeccccccCCCCceehhhhcc-----cccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCce
Confidence            56999999999999999999976     7899999999988754555556678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      +|+|.||++||.|++++.+++.+++.+++.+++||+.|+.|||..+|+||||||+|+|||.++++||+|||+|..-....
T Consensus        87 lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk  166 (786)
T KOG0588|consen   87 LYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK  166 (786)
T ss_pred             EEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999998877777


Q ss_pred             CCCcccccCccccchhhccCCC-CCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          270 RSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      ...+-||++.|+|||++.|..| +.++||||.|||||.||||++||++.+
T Consensus       167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN  216 (786)
T KOG0588|consen  167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN  216 (786)
T ss_pred             cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc
Confidence            7788899999999999999988 578999999999999999999999653

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-44  Score=335.62  Aligned_cols=227  Identities=42%  Similarity=0.688  Sum_probs=197.3

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|+++++||+|+||.||+|.++     .+++.||+|++.............+.+|+.+++.++||||+++++++...+.
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~   75 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKK-----DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEY   75 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEEC-----CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCE
Confidence            47999999999999999999976     4577899999987654444556678889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      +|+||||+++++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....  
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--  153 (333)
T cd05600          76 LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--  153 (333)
T ss_pred             EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence            999999999999999998888899999999999999999999999999999999999999999999999999986544  


Q ss_pred             CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh---------------------hhhHHH
Q 018487          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC---------------------NTMLLF  328 (355)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~---------------------~~~~~~  328 (355)
                      .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+....                     .....+
T Consensus       154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~  233 (333)
T cd05600         154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEA  233 (333)
T ss_pred             ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHH
Confidence            23456799999999999999999999999999999999999999987543221                     112345


Q ss_pred             HHhhhheeeecCCCc
Q 018487          329 YLIIFHCLFVNSLEL  343 (355)
Q Consensus       329 ~~~i~~~l~~~~~e~  343 (355)
                      +.+|.+||..++.++
T Consensus       234 ~~li~~~l~~~~~rr  248 (333)
T cd05600         234 WDLITKLINDPSRRF  248 (333)
T ss_pred             HHHHHHHhhChhhhc
Confidence            678888887666654

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.5e-44  Score=336.42  Aligned_cols=232  Identities=40%  Similarity=0.657  Sum_probs=200.7

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +..++|++.+.||+|+||.||+|.++.    .....||+|++...........+.+.+|+.+++.++||||+++++++..
T Consensus        27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~  102 (340)
T PTZ00426         27 MKYEDFNFIRTLGTGSFGRVILATYKN----EDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD  102 (340)
T ss_pred             CChhhcEEEEEEeecCCeEEEEEEEEC----CCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe
Confidence            445689999999999999999998763    2346799999976654445556678889999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                      .+.+|+||||+++|+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       103 ~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        103 ESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            99999999999999999999988899999999999999999999999999999999999999999999999999998764


Q ss_pred             cCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHHhhh
Q 018487          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYLIIF  333 (355)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~~i~  333 (355)
                      ..  ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.....             ......+.|.
T Consensus       183 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  260 (340)
T PTZ00426        183 TR--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMK  260 (340)
T ss_pred             CC--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence            32  34567999999999999888999999999999999999999999876442211             1224567888


Q ss_pred             heeeecCCCcC
Q 018487          334 HCLFVNSLELL  344 (355)
Q Consensus       334 ~~l~~~~~e~~  344 (355)
                      +||..+|.+++
T Consensus       261 ~~l~~dp~~R~  271 (340)
T PTZ00426        261 KLLSHDLTKRY  271 (340)
T ss_pred             HHcccCHHHcC
Confidence            99999988875

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4e-46  Score=343.91  Aligned_cols=222  Identities=30%  Similarity=0.476  Sum_probs=192.8

Q ss_pred             hhcCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecce
Q 018487          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (355)
Q Consensus       103 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~  182 (355)
                      ..|.+..+....++-||.|+.|.||+++.+       ++.||||.++.-.          ..+++-|++|+|+||+.|.+
T Consensus       117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~-------netVAVKKV~elk----------ETdIKHLRkLkH~NII~FkG  179 (904)
T KOG4721|consen  117 ELWEIPFEEISELEWLGSGAQGAVFLGRLH-------NETVAVKKVRELK----------ETDIKHLRKLKHPNIITFKG  179 (904)
T ss_pred             hhccCCHHHhhhhhhhccCcccceeeeecc-------CceehhHHHhhhh----------hhhHHHHHhccCcceeeEee
Confidence            344555566667788999999999999976       5679999875321          24788899999999999999


Q ss_pred             eeecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       183 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                      +|.....+|||||||..|-|+..|+....+.......|..+|+.||.|||.++|||||||.-||||..+..|||+|||.+
T Consensus       180 VCtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS  259 (904)
T KOG4721|consen  180 VCTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTS  259 (904)
T ss_pred             eecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccch
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhhhhHHHHHhhhheeeecCCC
Q 018487          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLIIFHCLFVNSLE  342 (355)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~~~~~~~~~i~~~l~~~~~e  342 (355)
                      +........-.++||..|||||++.+.+.+.|+|||||||||||||||..||++.+..+          |...+..|.+.
T Consensus       260 ~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----------IIwGVGsNsL~  329 (904)
T KOG4721|consen  260 KELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----------IIWGVGSNSLH  329 (904)
T ss_pred             HhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----------eEEeccCCccc
Confidence            98877777778999999999999999999999999999999999999999999876533          33445555555


Q ss_pred             cCCCCCCCCCC
Q 018487          343 LLSHFPENCPA  353 (355)
Q Consensus       343 ~~~~~p~~~p~  353 (355)
                      |+  +|..||.
T Consensus       330 Lp--vPstcP~  338 (904)
T KOG4721|consen  330 LP--VPSTCPD  338 (904)
T ss_pred             cc--CcccCch
Confidence            44  5555553

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.7e-44  Score=333.42  Aligned_cols=224  Identities=41%  Similarity=0.749  Sum_probs=194.3

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEEEe
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  195 (355)
                      +.||+|+||.||+|+++     .+++.||+|++.+...........+.+|+.+++.++||||+++++.+...+.+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREK-----ASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEe
Confidence            46999999999999976     5678899999987655455556677889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc-CCCCCcc
Q 018487          196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE-SSRSNSM  274 (355)
Q Consensus       196 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~-~~~~~~~  274 (355)
                      |+++++|..++.....+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......
T Consensus        76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~  155 (328)
T cd05593          76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF  155 (328)
T ss_pred             CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccc
Confidence            999999999998888899999999999999999999999999999999999999999999999999875422 2223456


Q ss_pred             cccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHHhhhheeeecCC
Q 018487          275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYLIIFHCLFVNSL  341 (355)
Q Consensus       275 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~~i~~~l~~~~~  341 (355)
                      +||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.....             ....+..+|.+||.++|.
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~  235 (328)
T cd05593         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPN  235 (328)
T ss_pred             cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHH
Confidence            7999999999999889999999999999999999999999765432211             113467888999999998


Q ss_pred             CcC
Q 018487          342 ELL  344 (355)
Q Consensus       342 e~~  344 (355)
                      +++
T Consensus       236 ~R~  238 (328)
T cd05593         236 KRL  238 (328)
T ss_pred             HcC
Confidence            876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.4e-44  Score=326.28  Aligned_cols=230  Identities=37%  Similarity=0.609  Sum_probs=195.6

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      .|++.+.||+|+||.||+|.++     .+++.||+|.+.............+.+|+.+++.++|+||+++++++...+.+
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~   75 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEe-----cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeE
Confidence            3889999999999999999976     46788999998765544344445677899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      ++||||+++|+|..++...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus        76 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05631          76 CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG  155 (285)
T ss_pred             EEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence            9999999999998877643  35899999999999999999999999999999999999999999999999999876544


Q ss_pred             CCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhh------h-----------hhhhHHHHHh
Q 018487          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVI------A-----------CNTMLLFYLI  331 (355)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~------~-----------~~~~~~~~~~  331 (355)
                      .......||..|+|||++.+..++.++|||||||++|+|++|+.||...+..      .           ......+..+
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (285)
T cd05631         156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSI  235 (285)
T ss_pred             CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHH
Confidence            4444567999999999999999999999999999999999999999864221      0           0112245778


Q ss_pred             hhheeeecCCCcCC
Q 018487          332 IFHCLFVNSLELLS  345 (355)
Q Consensus       332 i~~~l~~~~~e~~~  345 (355)
                      |.+||..+|.+++.
T Consensus       236 i~~~l~~~P~~R~~  249 (285)
T cd05631         236 CRMLLTKNPKERLG  249 (285)
T ss_pred             HHHHhhcCHHHhcC
Confidence            88999999988763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-44  Score=340.68  Aligned_cols=204  Identities=45%  Similarity=0.818  Sum_probs=181.1

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|+++++||+|+||.||+|.++     .+++.||||++.+.........+.+.+|+++++.++||||++++++|.+...
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~   75 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKK-----DTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQY   75 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEEC-----CCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCe
Confidence            37999999999999999999976     5678899999977554455566778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      +|+||||+++|+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          76 LYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             eEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            99999999999999999888889999999999999999999999999999999999999999999999999986431100


Q ss_pred             ------------------------------------------------CCCcccccCccccchhhccCCCCCcccHHHHH
Q 018487          270 ------------------------------------------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVG  301 (355)
Q Consensus       270 ------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  301 (355)
                                                                      .....+||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  235 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence                                                            00124699999999999999999999999999


Q ss_pred             HHHHHHHcCCCCCCCch
Q 018487          302 ILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       302 ~~l~elltg~~pf~~~~  318 (355)
                      |++|||++|+.||...+
T Consensus       236 vil~elltG~~Pf~~~~  252 (377)
T cd05629         236 AIMFECLIGWPPFCSEN  252 (377)
T ss_pred             hhhhhhhcCCCCCCCCC
Confidence            99999999999997654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.2e-44  Score=332.21  Aligned_cols=224  Identities=39%  Similarity=0.738  Sum_probs=193.5

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEEEe
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  195 (355)
                      +.||+|+||.||+|+++     .+++.||+|+++............+.+|+.+++.++||||++++++|...+.+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREK-----ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEEC-----CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEe
Confidence            46999999999999976     4678899999987654445556667789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC-cCCCCCcc
Q 018487          196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSM  274 (355)
Q Consensus       196 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~-~~~~~~~~  274 (355)
                      |+++++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ........
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~  155 (323)
T cd05595          76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccc
Confidence            99999999999888889999999999999999999999999999999999999999999999999987542 22223456


Q ss_pred             cccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHHhhhheeeecCC
Q 018487          275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYLIIFHCLFVNSL  341 (355)
Q Consensus       275 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~~i~~~l~~~~~  341 (355)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.||...+.....             ....+..+|.+||..+|.
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~  235 (323)
T cd05595         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPK  235 (323)
T ss_pred             cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHH
Confidence            7999999999999999999999999999999999999999776433211             123456788899999988


Q ss_pred             CcC
Q 018487          342 ELL  344 (355)
Q Consensus       342 e~~  344 (355)
                      +++
T Consensus       236 ~R~  238 (323)
T cd05595         236 QRL  238 (323)
T ss_pred             HhC
Confidence            876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-45  Score=338.72  Aligned_cols=230  Identities=26%  Similarity=0.407  Sum_probs=193.2

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      +.+....++++++||+|.||.||++.+++..      .||+|.++.....    .+.|.+|+++|++|+|+|||++++++
T Consensus       201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~------~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~  270 (468)
T KOG0197|consen  201 WEIPREELKLIRELGSGQFGEVWLGKWNGST------KVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVC  270 (468)
T ss_pred             eeecHHHHHHHHHhcCCccceEEEEEEcCCC------cccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEE
Confidence            3344455677899999999999999998543      3899998765432    24566899999999999999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYR--QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                      ..++.+|||||||+.|+|.++|..  ...+...+...++.||++||+||+++++|||||..+||||++++.+||+|||+|
T Consensus       271 ~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLA  350 (468)
T KOG0197|consen  271 TKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLA  350 (468)
T ss_pred             ecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccc
Confidence            998899999999999999999997  456999999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCCCCc--ccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhhh--------------hh
Q 018487          263 KEIDESSRSNS--MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACN--------------TM  325 (355)
Q Consensus       263 ~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~~--------------~~  325 (355)
                      +...++.....  ..-...|.|||.+....++.++|||||||+||||+| |+.|+..+.....-              ..
T Consensus       351 r~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP  430 (468)
T KOG0197|consen  351 RLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCP  430 (468)
T ss_pred             cccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCC
Confidence            96554443222  223567999999999999999999999999999999 99999988543322              22


Q ss_pred             HHHHHhhhheeeecCCCcC
Q 018487          326 LLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~  344 (355)
                      ..++.++..|+...|.+++
T Consensus       431 ~~vY~lM~~CW~~~P~~RP  449 (468)
T KOG0197|consen  431 DEVYELMKSCWHEDPEDRP  449 (468)
T ss_pred             HHHHHHHHHHhhCCcccCC
Confidence            2557777888888877765

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-46  Score=335.83  Aligned_cols=205  Identities=29%  Similarity=0.525  Sum_probs=182.4

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecceeeecC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTR  187 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~  187 (355)
                      .++|.++++||.|.||.||+|+.+     ++++.||||.+++....-++ .. -.+|+..|++++ |||||++.+++.+.
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~-----~~~~~VAIK~MK~Kf~s~ee-~~-nLREvksL~kln~hpniikL~Evi~d~   81 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSK-----ETGELVAIKKMKKKFYSWEE-CM-NLREVKSLRKLNPHPNIIKLKEVIRDN   81 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeec-----CCCceeeHHHHHhhhccHHH-HH-HHHHHHHHHhcCCCCcchhhHHHhhcc
Confidence            468999999999999999999977     67788999999876543222 22 346999999999 99999999999988


Q ss_pred             C-eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          188 S-KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       188 ~-~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      + .+|+|||||+. .|+++++.+ ..|++..++.|+.||++||+|+|++|++|||+||+|||+..+..+||+|||+|+.+
T Consensus        82 ~~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   82 DRILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             CceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccc
Confidence            8 99999999987 788888766 45999999999999999999999999999999999999998999999999999998


Q ss_pred             CcCCCCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh
Q 018487          266 DESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA  321 (355)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~  321 (355)
                      ......+..+.|.+|+|||++.. ..|+.+.||||+|||++|+.+-+..|.+.+.++
T Consensus       161 ~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D  217 (538)
T KOG0661|consen  161 RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID  217 (538)
T ss_pred             ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH
Confidence            87777788899999999999874 678999999999999999999999999976554

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-44  Score=338.02  Aligned_cols=204  Identities=45%  Similarity=0.876  Sum_probs=182.2

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++++.||+|+||+||+|+++     .+++.||||++.............+.+|+.+++.++|+||++++++|..++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~   75 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKK-----DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENY   75 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCe
Confidence            47999999999999999999976     4678899999987654445556678889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      +|+||||+++|+|.+++...+.+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus        76 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          76 LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             EEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            99999999999999999988889999999999999999999999999999999999999999999999999987542211


Q ss_pred             ---------------------------------------CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcC
Q 018487          270 ---------------------------------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG  310 (355)
Q Consensus       270 ---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg  310 (355)
                                                             .....+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence                                                   01134699999999999999999999999999999999999


Q ss_pred             CCCCCCch
Q 018487          311 QVNIKSMQ  318 (355)
Q Consensus       311 ~~pf~~~~  318 (355)
                      +.||...+
T Consensus       236 ~~Pf~~~~  243 (364)
T cd05599         236 YPPFCSDN  243 (364)
T ss_pred             CCCCCCCC
Confidence            99998754

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=5.8e-44  Score=337.82  Aligned_cols=203  Identities=45%  Similarity=0.816  Sum_probs=181.6

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      .|+++++||+|+||+||+|+++     .+++.||+|++...........+.+.+|+.+++.++|+||+++++++.+.+.+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~-----~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKV-----DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEEC-----CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEE
Confidence            6899999999999999999976     46788999999876555556667788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC-
Q 018487          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-  269 (355)
                      |+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.... 
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            9999999999999999988889999999999999999999999999999999999999999999999999976431100 


Q ss_pred             -----------------------------------------------CCCcccccCccccchhhccCCCCCcccHHHHHH
Q 018487          270 -----------------------------------------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGI  302 (355)
Q Consensus       270 -----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~  302 (355)
                                                                     .....+||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~  236 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV  236 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence                                                           012357999999999999989999999999999


Q ss_pred             HHHHHHcCCCCCCCch
Q 018487          303 LLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       303 ~l~elltg~~pf~~~~  318 (355)
                      ++|||+||+.||...+
T Consensus       237 il~elltG~~Pf~~~~  252 (381)
T cd05626         237 ILFEMLVGQPPFLAPT  252 (381)
T ss_pred             HHHHHHhCCCCCcCCC
Confidence            9999999999998754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.2e-45  Score=317.02  Aligned_cols=210  Identities=28%  Similarity=0.443  Sum_probs=181.9

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec-
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-  186 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-  186 (355)
                      ..++|+.+.+|++|.||.||+|+++     .++++||+|.++.+.....--+ .-.+|+.+|.+++|||||.+-.+... 
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk-----~t~eIVALKr~kmekek~GFPI-tsLREIniLl~~~H~NIV~vkEVVvG~  147 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDK-----KTDEIVALKRLKMEKEKEGFPI-TSLREINILLKARHPNIVEVKEVVVGS  147 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccC-----CcceeEEeeecccccccCCCcc-hhHHHHHHHHhcCCCCeeeeEEEEecc
Confidence            3457999999999999999999976     6788999999987763333223 34579999999999999999877653 


Q ss_pred             -CCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          187 -RSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       187 -~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                       .+.+|||||||+. +|...+...+ +|...+++.++.|+++|++|||.+.|+|||||++|+|+++.|.+||+|||+|+.
T Consensus       148 ~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~  226 (419)
T KOG0663|consen  148 NMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLARE  226 (419)
T ss_pred             ccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhh
Confidence             4579999999987 7888888765 799999999999999999999999999999999999999999999999999998


Q ss_pred             cCcCC-CCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhhh
Q 018487          265 IDESS-RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNT  324 (355)
Q Consensus       265 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~~  324 (355)
                      +.... ..+..+-|.+|+|||.+.+ ..|+++.|+||+|||+.||++++..|.+...+..-.
T Consensus       227 ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~  288 (419)
T KOG0663|consen  227 YGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLD  288 (419)
T ss_pred             hcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHH
Confidence            86553 3566788999999999987 469999999999999999999999999986555433

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=7.9e-44  Score=331.55  Aligned_cols=239  Identities=26%  Similarity=0.412  Sum_probs=194.1

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceeccee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~  183 (355)
                      +.+..++|++.++||+|+||.||+|.+.+..+...++.||+|+++...  .....+.+.+|+.+++.+ +||||++++++
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~   79 (338)
T cd05102           2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGA   79 (338)
T ss_pred             cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence            346678999999999999999999997765555667889999987542  233445688899999999 89999999998


Q ss_pred             eecC-CeEEEEEeccCCCChHHHHHhc-----------------------------------------------------
Q 018487          184 FQTR-SKLYLILDFINGGHLFFHLYRQ-----------------------------------------------------  209 (355)
Q Consensus       184 ~~~~-~~~~lv~e~~~~gsL~~~l~~~-----------------------------------------------------  209 (355)
                      +... +.+++||||+++|+|.+++...                                                     
T Consensus        80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (338)
T cd05102          80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP  159 (338)
T ss_pred             ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence            8754 4689999999999999888653                                                     


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCC---CCccccc
Q 018487          210 ---------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGT  277 (355)
Q Consensus       210 ---------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt  277 (355)
                               ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......   .....++
T Consensus       160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence                     2377788899999999999999999999999999999999999999999999986532211   1223456


Q ss_pred             CccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh---------------hhhhHHHHHhhhheeeecCC
Q 018487          278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA---------------CNTMLLFYLIIFHCLFVNSL  341 (355)
Q Consensus       278 ~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~---------------~~~~~~~~~~i~~~l~~~~~  341 (355)
                      ..|+|||++.+..++.++|||||||++|||++ |..||...+...               ......+..++.+||..+|.
T Consensus       240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~  319 (338)
T cd05102         240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPK  319 (338)
T ss_pred             ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence            78999999999999999999999999999997 999998743211               01123467788889888888


Q ss_pred             CcCC
Q 018487          342 ELLS  345 (355)
Q Consensus       342 e~~~  345 (355)
                      +++.
T Consensus       320 ~RPs  323 (338)
T cd05102         320 ERPT  323 (338)
T ss_pred             hCcC
Confidence            7653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-44  Score=328.92  Aligned_cols=222  Identities=47%  Similarity=0.817  Sum_probs=192.2

Q ss_pred             eccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEEEecc
Q 018487          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI  197 (355)
Q Consensus       118 lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  197 (355)
                      ||+|+||.||+|.++     .+++.||+|++.............+.+|+.++++++||||+++++++...+..|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~-----~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKR-----DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCC
Confidence            799999999999976     457789999997654444555667788999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc-CCCCCcccc
Q 018487          198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE-SSRSNSMCG  276 (355)
Q Consensus       198 ~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~-~~~~~~~~g  276 (355)
                      ++|+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.... .......+|
T Consensus        76 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  155 (312)
T cd05585          76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG  155 (312)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccC
Confidence            9999999999888899999999999999999999999999999999999999999999999999875422 222345679


Q ss_pred             cCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-------------hhhHHHHHhhhheeeecCCCc
Q 018487          277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-------------NTMLLFYLIIFHCLFVNSLEL  343 (355)
Q Consensus       277 t~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-------------~~~~~~~~~i~~~l~~~~~e~  343 (355)
                      |+.|+|||++.+..++.++|||||||++|+|++|+.||...+....             .....+.+.|.+||..+|.++
T Consensus       156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  235 (312)
T cd05585         156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRR  235 (312)
T ss_pred             CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHc
Confidence            9999999999999999999999999999999999999987543221             112245778889999998887


Q ss_pred             C
Q 018487          344 L  344 (355)
Q Consensus       344 ~  344 (355)
                      +
T Consensus       236 ~  236 (312)
T cd05585         236 L  236 (312)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.5e-43  Score=327.78  Aligned_cols=230  Identities=36%  Similarity=0.695  Sum_probs=196.1

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceeeecCCe
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSK  189 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~  189 (355)
                      +|++.+.||+|+||.||+|+++     .+++.||+|++.+.........+.+..|..++..+ +|++|+++++++...+.
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERK-----GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCE
Confidence            5899999999999999999976     45778999999876544444455566788888777 58999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc-C
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE-S  268 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~-~  268 (355)
                      +|+||||+++|+|..++...+.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~  155 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG  155 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence            999999999999999998888899999999999999999999999999999999999999999999999999975432 2


Q ss_pred             CCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-------------hhhHHHHHhhhhe
Q 018487          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-------------NTMLLFYLIIFHC  335 (355)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-------------~~~~~~~~~i~~~  335 (355)
                      ......+||+.|+|||++.+..++.++|||||||++|||+||+.||...+....             .......+++.+|
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  235 (323)
T cd05616         156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGL  235 (323)
T ss_pred             CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHH
Confidence            233456799999999999999999999999999999999999999987643221             1223456788899


Q ss_pred             eeecCCCcCC
Q 018487          336 LFVNSLELLS  345 (355)
Q Consensus       336 l~~~~~e~~~  345 (355)
                      |+++|.++..
T Consensus       236 l~~~p~~R~~  245 (323)
T cd05616         236 MTKHPGKRLG  245 (323)
T ss_pred             cccCHHhcCC
Confidence            9999888764

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=7.4e-44  Score=337.27  Aligned_cols=203  Identities=47%  Similarity=0.856  Sum_probs=181.0

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      .|+++++||+|+||+||+|+++     .+++.||+|++.+.........+.+.+|+.+++.++|+||+++++.|..++.+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~-----~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKV-----DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEEC-----CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEE
Confidence            6999999999999999999976     46788999999876544555667788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC--
Q 018487          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES--  268 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~--  268 (355)
                      |+||||+++|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...  
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence            999999999999999988888999999999999999999999999999999999999999999999999997533100  


Q ss_pred             ----------------------------------------------CCCCcccccCccccchhhccCCCCCcccHHHHHH
Q 018487          269 ----------------------------------------------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGI  302 (355)
Q Consensus       269 ----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~  302 (355)
                                                                    ......+||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv  236 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  236 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence                                                          0012347999999999999999999999999999


Q ss_pred             HHHHHHcCCCCCCCch
Q 018487          303 LLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       303 ~l~elltg~~pf~~~~  318 (355)
                      ++|||++|+.||...+
T Consensus       237 il~elltG~~Pf~~~~  252 (382)
T cd05625         237 ILYEMLVGQPPFLAQT  252 (382)
T ss_pred             HHHHHHhCCCCCCCCC
Confidence            9999999999998754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.5e-43  Score=327.97  Aligned_cols=230  Identities=37%  Similarity=0.706  Sum_probs=195.5

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCC-cceecceeeecCCe
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP-FIVQLRYSFQTRSK  189 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~  189 (355)
                      +|++++.||+|+||.||+|.++     .+++.||+|++.+.........+.+..|..++..+.|+ +|+++++++...+.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERK-----GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCE
Confidence            5899999999999999999976     45678999999876544445556677899999999765 58889999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC-cC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ES  268 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~-~~  268 (355)
                      +|+||||+++|+|..++.....+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ..
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG  155 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence            99999999999999999888889999999999999999999999999999999999999999999999999987532 22


Q ss_pred             CCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-------------hhhHHHHHhhhhe
Q 018487          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-------------NTMLLFYLIIFHC  335 (355)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-------------~~~~~~~~~i~~~  335 (355)
                      ......+||+.|+|||++.+..++.++|||||||++|+|+||+.||...+....             .......+++.+|
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  235 (324)
T cd05587         156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGL  235 (324)
T ss_pred             CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            223456799999999999999999999999999999999999999987543221             1122446788899


Q ss_pred             eeecCCCcCC
Q 018487          336 LFVNSLELLS  345 (355)
Q Consensus       336 l~~~~~e~~~  345 (355)
                      |.++|.++..
T Consensus       236 l~~~P~~R~~  245 (324)
T cd05587         236 LTKHPAKRLG  245 (324)
T ss_pred             hhcCHHHcCC
Confidence            9999888763

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-44  Score=324.79  Aligned_cols=231  Identities=28%  Similarity=0.466  Sum_probs=185.7

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccc-----------hhHHHHHHHHHHHHHhcCCC
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-----------KNHVDYMKAERDILTKVTHP  175 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~  175 (355)
                      ...++|++++.||+|.||.|-+|+..     ..++.||||++.+.....           ...++...+|+.+|++++||
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~-----~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~  168 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDE-----VDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHP  168 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeec-----CCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCc
Confidence            33468999999999999999999965     578899999997644322           12345788999999999999


Q ss_pred             cceecceeeec--CCeEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC
Q 018487          176 FIVQLRYSFQT--RSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG  252 (355)
Q Consensus       176 nIv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~-l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~  252 (355)
                      |||+|+++..+  .+.+|||+|||..|.+ .+....+. +++.+++.++++++.||+|||.+|||||||||+|+||+++|
T Consensus       169 nVV~LiEvLDDP~s~~~YlVley~s~G~v-~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  169 NVVKLIEVLDDPESDKLYLVLEYCSKGEV-KWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             CeeEEEEeecCcccCceEEEEEeccCCcc-ccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC
Confidence            99999999875  4689999999999987 34444455 99999999999999999999999999999999999999999


Q ss_pred             cEEEEecCCccccCcC------CCCCcccccCccccchhhccCC----CCCcccHHHHHHHHHHHHcCCCCCCCchhhhh
Q 018487          253 HVMLTDFGLAKEIDES------SRSNSMCGTTEYMAPEILLSKG----HNKDADWWSVGILLYEMLTGQVNIKSMQVIAC  322 (355)
Q Consensus       253 ~~kl~Dfg~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~  322 (355)
                      .+||+|||.+..+...      ......+|||.|+|||.+.++.    .+.+.||||+||+||.|+.|+.||-+......
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l  327 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL  327 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence            9999999998866222      1123478999999999998632    25678999999999999999999988643332


Q ss_pred             hh---------------hHHHHHhhhheeeecCCCc
Q 018487          323 NT---------------MLLFYLIIFHCLFVNSLEL  343 (355)
Q Consensus       323 ~~---------------~~~~~~~i~~~l~~~~~e~  343 (355)
                      -.               ...++++|.+-|.++|..+
T Consensus       328 ~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~R  363 (576)
T KOG0585|consen  328 FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQR  363 (576)
T ss_pred             HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhhe
Confidence            11               2234566666666666544

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=6.6e-44  Score=336.91  Aligned_cols=205  Identities=46%  Similarity=0.848  Sum_probs=181.0

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++++.||+|+||.||+|+++     .+++.||+|++.+...........+.+|+.+|+.++|+||+++++.|..++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~   75 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKV-----DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDN   75 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEEC-----CCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCE
Confidence            47999999999999999999976     4578899999976544344455668889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC-
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-  268 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~-  268 (355)
                      +|+||||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+... 
T Consensus        76 ~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            9999999999999999998888999999999999999999999999999999999999999999999999997533110 


Q ss_pred             -------------------------------------------CCCCcccccCccccchhhccCCCCCcccHHHHHHHHH
Q 018487          269 -------------------------------------------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLY  305 (355)
Q Consensus       269 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~  305 (355)
                                                                 ......+||+.|||||++.+..++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence                                                       0012357999999999999999999999999999999


Q ss_pred             HHHcCCCCCCCchh
Q 018487          306 EMLTGQVNIKSMQV  319 (355)
Q Consensus       306 elltg~~pf~~~~~  319 (355)
                      ||++|+.||...+.
T Consensus       236 ell~G~~Pf~~~~~  249 (376)
T cd05598         236 EMLVGQPPFLADTP  249 (376)
T ss_pred             ehhhCCCCCCCCCH
Confidence            99999999987643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-44  Score=332.76  Aligned_cols=230  Identities=44%  Similarity=0.814  Sum_probs=197.2

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++.+.||+|+||+||+|.++     .+++.||+|++.............+.+|+.+++.++|+||+++++++.+++.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   75 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDK-----DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEH   75 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEEC-----CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCe
Confidence            47999999999999999999976     4678899999987655454566778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      +|+||||+++++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          76 LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence            99999999999999999988889999999999999999999999999999999999999999999999999998764433


Q ss_pred             ------------------------------CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchh
Q 018487          270 ------------------------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQV  319 (355)
Q Consensus       270 ------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~  319 (355)
                                                    ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence                                          22345789999999999999999999999999999999999999987643


Q ss_pred             hhhhh-----------------hHHHHHhhhheeeecCCCcCC
Q 018487          320 IACNT-----------------MLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       320 ~~~~~-----------------~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      .....                 ...+..+|..|+. +|.+++.
T Consensus       236 ~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~  277 (350)
T cd05573         236 QETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLG  277 (350)
T ss_pred             HHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCC
Confidence            22110                 2234566777775 6665554

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=8.5e-44  Score=329.68  Aligned_cols=224  Identities=40%  Similarity=0.739  Sum_probs=192.7

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEEEe
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  195 (355)
                      +.||+|+||.||+|.++     .+++.||+|++.+...........+.+|+++++.++||||+++++++...+.+|+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~-----~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEK-----ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEe
Confidence            46999999999999976     4678899999987654445555667789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEecCCCcEEEEecCCccccC-cCCCCCc
Q 018487          196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNS  273 (355)
Q Consensus       196 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~-~~~~~~~  273 (355)
                      |+++++|..++.....+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++... .......
T Consensus        76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (325)
T cd05594          76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT  155 (325)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence            99999999999888889999999999999999999997 799999999999999999999999999987542 2222345


Q ss_pred             ccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHHhhhheeeecC
Q 018487          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYLIIFHCLFVNS  340 (355)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~~i~~~l~~~~  340 (355)
                      .+||+.|+|||++.+..++.++|||||||++|+|+||+.||...+.....             ....+..++.+||..+|
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP  235 (325)
T cd05594         156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDP  235 (325)
T ss_pred             ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence            67999999999999999999999999999999999999999775432211             12245678889999999


Q ss_pred             CCcC
Q 018487          341 LELL  344 (355)
Q Consensus       341 ~e~~  344 (355)
                      .+++
T Consensus       236 ~~R~  239 (325)
T cd05594         236 KQRL  239 (325)
T ss_pred             HHhC
Confidence            8886

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-44  Score=332.45  Aligned_cols=229  Identities=31%  Similarity=0.513  Sum_probs=199.5

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|..++++|+|+||.+++++++     ...+.+++|.+.......+.. +...+|+.++++++|||||.+.+.|..++.
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk-----~~~~~~vlK~I~l~~~t~~~r-~~A~~E~~lis~~~hP~iv~y~ds~~~~~~   77 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHK-----SDDKLYVLKKINLEKLTEPER-RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQ   77 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhc-----cCCceEEEEEEeccccCchhh-HHHHHHHHHHHhccCCCeeeeccchhcCCc
Confidence            57999999999999999999988     455689999998776544433 356779999999999999999999999888


Q ss_pred             -EEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          190 -LYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       190 -~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                       ++|||+||+||+|.+.+.+++  .++++.+..|+.|++.|+.|||++.|+|||||+.|||++.++.|||+|||+|+.+.
T Consensus        78 ~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~  157 (426)
T KOG0589|consen   78 LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN  157 (426)
T ss_pred             eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence             999999999999999988765  58999999999999999999999999999999999999999999999999999987


Q ss_pred             cCC-CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhhhhH--------------HHHHh
Q 018487          267 ESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTML--------------LFYLI  331 (355)
Q Consensus       267 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~~~~--------------~~~~~  331 (355)
                      ... ...+.+||+.||+||.+.+.+|+.|+|||||||++|||++-+.+|++.+....-..+              -+...
T Consensus       158 ~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~l  237 (426)
T KOG0589|consen  158 PEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSL  237 (426)
T ss_pred             CchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHH
Confidence            776 677889999999999999999999999999999999999999999997665533222              23455


Q ss_pred             hhheeeecCCCcC
Q 018487          332 IFHCLFVNSLELL  344 (355)
Q Consensus       332 i~~~l~~~~~e~~  344 (355)
                      |..|++++|..++
T Consensus       238 v~~~l~~~P~~RP  250 (426)
T KOG0589|consen  238 VKSMLRKNPEHRP  250 (426)
T ss_pred             HHHHhhcCCccCC
Confidence            6666666666544

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-45  Score=316.19  Aligned_cols=210  Identities=44%  Similarity=0.872  Sum_probs=196.6

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      .++-.++|..+++||+|.||.|-+|+.+     .+++.||+|+++++....++.+..-..|-++|+.++||.+..+...|
T Consensus       163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEK-----at~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF  237 (516)
T KOG0690|consen  163 NKVTMEDFDFLKVLGKGTFGKVILCREK-----ATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF  237 (516)
T ss_pred             ceeccchhhHHHHhcCCccceEEEEeec-----ccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh
Confidence            3456678999999999999999999977     67899999999999988888888888899999999999999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      +..+.+|+||||..||.|+.+|.+...+++..++.+...|+.||.|||+++||+||||.+|+|+|.+|.+||+|||+++.
T Consensus       238 Qt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE  317 (516)
T KOG0690|consen  238 QTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKE  317 (516)
T ss_pred             ccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999985


Q ss_pred             -cCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchh
Q 018487          265 -IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQV  319 (355)
Q Consensus       265 -~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~  319 (355)
                       +.......++||||.|+|||++....|+..+|.|.+||+||||++|+.||.+.+.
T Consensus       318 ~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh  373 (516)
T KOG0690|consen  318 EIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH  373 (516)
T ss_pred             cccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch
Confidence             3555567889999999999999999999999999999999999999999998654

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3e-43  Score=325.71  Aligned_cols=229  Identities=50%  Similarity=0.828  Sum_probs=193.5

Q ss_pred             EeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeeccccc-chhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEE
Q 018487          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLI  193 (355)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  193 (355)
                      +++||+|+||.||+|+....  ...++.||+|++...... .......+.+|+.+++.++||||+++++.|..++.+|+|
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv   78 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTG--ADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLI   78 (323)
T ss_pred             CceeeecCCeEEEEEEEccc--CCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEE
Confidence            36899999999999986432  246788999999765432 223344567899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc-CCCCC
Q 018487          194 LDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE-SSRSN  272 (355)
Q Consensus       194 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~-~~~~~  272 (355)
                      |||+++++|.+++...+.+.+..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.... .....
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  158 (323)
T cd05584          79 LEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH  158 (323)
T ss_pred             EeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccc
Confidence            99999999999999888899999999999999999999999999999999999999999999999999875432 22234


Q ss_pred             cccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-------------hhhHHHHHhhhheeeec
Q 018487          273 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-------------NTMLLFYLIIFHCLFVN  339 (355)
Q Consensus       273 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-------------~~~~~~~~~i~~~l~~~  339 (355)
                      ..+||+.|+|||++.+..++.++|||||||++|||++|+.||...+....             .....+.++|.+||.++
T Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  238 (323)
T cd05584         159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRN  238 (323)
T ss_pred             ccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccC
Confidence            46799999999999988899999999999999999999999987643221             11235678899999999


Q ss_pred             CCCcCC
Q 018487          340 SLELLS  345 (355)
Q Consensus       340 ~~e~~~  345 (355)
                      |.+++.
T Consensus       239 p~~R~~  244 (323)
T cd05584         239 PSSRLG  244 (323)
T ss_pred             HhHcCC
Confidence            998873

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.3e-43  Score=325.01  Aligned_cols=226  Identities=40%  Similarity=0.709  Sum_probs=192.7

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceeeecCCeEEEEE
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~  194 (355)
                      +.||+|+||+||+|+++     .+++.||+|++.+.........+.+..|..++..+ +||||+++++++...+.+|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLK-----ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEc-----CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEE
Confidence            46999999999999976     46788999999876544445556677788888876 6999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC-cCCCCCc
Q 018487          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNS  273 (355)
Q Consensus       195 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~-~~~~~~~  273 (355)
                      ||+++|+|..++.....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.... .......
T Consensus        76 Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (320)
T cd05590          76 EFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST  155 (320)
T ss_pred             cCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccc
Confidence            999999999999888889999999999999999999999999999999999999999999999999987542 2222345


Q ss_pred             ccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHHhhhheeeecC
Q 018487          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYLIIFHCLFVNS  340 (355)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~~i~~~l~~~~  340 (355)
                      .+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.....             ....+.+++.+||.++|
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP  235 (320)
T cd05590         156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNP  235 (320)
T ss_pred             cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCH
Confidence            67999999999999889999999999999999999999999876433211             12245678899999998


Q ss_pred             CCcCCC
Q 018487          341 LELLSH  346 (355)
Q Consensus       341 ~e~~~~  346 (355)
                      .+++..
T Consensus       236 ~~R~~~  241 (320)
T cd05590         236 TMRLGS  241 (320)
T ss_pred             HHCCCC
Confidence            887754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.4e-43  Score=324.35  Aligned_cols=225  Identities=37%  Similarity=0.719  Sum_probs=189.0

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHh-cCCCcceecceeeecCCeEEEEE
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTHPFIVQLRYSFQTRSKLYLIL  194 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~lv~  194 (355)
                      +.||+|+||.||+|.++     .+++.||+|+++..........+.+..|..++.. .+||||+++++++..++.+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELK-----GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEE
Confidence            46999999999999976     4577899999987654344444555567777665 47999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc-CCCCCc
Q 018487          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE-SSRSNS  273 (355)
Q Consensus       195 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~-~~~~~~  273 (355)
                      ||++||+|..++...+.+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ......
T Consensus        76 e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  155 (316)
T cd05592          76 EYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST  155 (316)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccc
Confidence            9999999999998888899999999999999999999999999999999999999999999999999976432 223345


Q ss_pred             ccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHHhhhheeeecC
Q 018487          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYLIIFHCLFVNS  340 (355)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~~i~~~l~~~~  340 (355)
                      .+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.....             ....+..++.+||.++|
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P  235 (316)
T cd05592         156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDP  235 (316)
T ss_pred             ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCH
Confidence            67999999999999989999999999999999999999999876432211             12245678889999888


Q ss_pred             CCcCC
Q 018487          341 LELLS  345 (355)
Q Consensus       341 ~e~~~  345 (355)
                      .+++.
T Consensus       236 ~~R~~  240 (316)
T cd05592         236 TKRLG  240 (316)
T ss_pred             HHcCC
Confidence            77753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=5e-43  Score=324.41  Aligned_cols=227  Identities=35%  Similarity=0.641  Sum_probs=191.4

Q ss_pred             eEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHH---HhcCCCcceecceeeecCC
Q 018487          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL---TKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~nIv~l~~~~~~~~  188 (355)
                      |++++.||+|+||.||+|.++     .+++.||||++++.........+.+.+|++++   +.++||||+++++++...+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYK-----KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC
Confidence            788999999999999999976     46788999999876544444555666676655   5667999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc-
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE-  267 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~-  267 (355)
                      .+|+||||+++++|..++.. +.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... 
T Consensus        76 ~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence            99999999999999877754 5689999999999999999999999999999999999999999999999999875422 


Q ss_pred             CCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-------------hhhHHHHHhhhh
Q 018487          268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-------------NTMLLFYLIIFH  334 (355)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-------------~~~~~~~~~i~~  334 (355)
                      .......+|++.|+|||++.+..++.++|||||||++|+|++|+.||...+....             .....+..+|.+
T Consensus       155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  234 (324)
T cd05589         155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRR  234 (324)
T ss_pred             CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            2223456799999999999999999999999999999999999999987543221             112345778999


Q ss_pred             eeeecCCCcC
Q 018487          335 CLFVNSLELL  344 (355)
Q Consensus       335 ~l~~~~~e~~  344 (355)
                      ||..+|.+++
T Consensus       235 ~L~~dP~~R~  244 (324)
T cd05589         235 LLRRNPERRL  244 (324)
T ss_pred             HhhcCHhHcC
Confidence            9999998886

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.8e-43  Score=326.70  Aligned_cols=225  Identities=37%  Similarity=0.735  Sum_probs=191.9

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceeeecCCeEEEEE
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~  194 (355)
                      +.||+|+||.||+|+++     .+++.||+|++++.........+.+..|..+++.+ +||||++++++|...+.+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~-----~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELK-----KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEE
Confidence            46999999999999976     46788999999876554555566788899999988 6999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc-CcCCCCCc
Q 018487          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNS  273 (355)
Q Consensus       195 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~-~~~~~~~~  273 (355)
                      ||+++|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.. ........
T Consensus        76 e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (329)
T cd05588          76 EFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST  155 (329)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccc
Confidence            99999999999988888999999999999999999999999999999999999999999999999998753 22233345


Q ss_pred             ccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh----------------------hhhhHHHHHh
Q 018487          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA----------------------CNTMLLFYLI  331 (355)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~----------------------~~~~~~~~~~  331 (355)
                      .+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......                      ......+..+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l  235 (329)
T cd05588         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSV  235 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            689999999999999999999999999999999999999996321100                      0111235678


Q ss_pred             hhheeeecCCCcCC
Q 018487          332 IFHCLFVNSLELLS  345 (355)
Q Consensus       332 i~~~l~~~~~e~~~  345 (355)
                      |.+||..+|.+++.
T Consensus       236 i~~~L~~dP~~R~~  249 (329)
T cd05588         236 LKGFLNKDPKERLG  249 (329)
T ss_pred             HHHHhccCHHHcCC
Confidence            88999999888864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.3e-43  Score=324.42  Aligned_cols=225  Identities=46%  Similarity=0.811  Sum_probs=189.3

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHH-HHHHhcCCCcceecceeeecCCeEEEEE
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER-DILTKVTHPFIVQLRYSFQTRSKLYLIL  194 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~nIv~l~~~~~~~~~~~lv~  194 (355)
                      +.||+|+||.||+|+++     ..++.||+|++.+...........+..|+ .+++.++||||+++++.+...+..|+||
T Consensus         1 ~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRK-----SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEEC-----CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEE
Confidence            46999999999999976     46788999999765443333344454555 4678899999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc-CcCCCCCc
Q 018487          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNS  273 (355)
Q Consensus       195 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~-~~~~~~~~  273 (355)
                      ||+++++|..++.....+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.. ........
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05603          76 DYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST  155 (321)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccc
Confidence            99999999999988888999999999999999999999999999999999999999999999999998753 22223345


Q ss_pred             ccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-------------hhhHHHHHhhhheeeecC
Q 018487          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-------------NTMLLFYLIIFHCLFVNS  340 (355)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-------------~~~~~~~~~i~~~l~~~~  340 (355)
                      .+||+.|+|||++.+..++.++|||||||++|||++|+.||...+....             .....+.++|.+||+++|
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p  235 (321)
T cd05603         156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQ  235 (321)
T ss_pred             ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCH
Confidence            6799999999999988999999999999999999999999987643221             122245678899999998


Q ss_pred             CCcCC
Q 018487          341 LELLS  345 (355)
Q Consensus       341 ~e~~~  345 (355)
                      .+++.
T Consensus       236 ~~R~~  240 (321)
T cd05603         236 RRRLG  240 (321)
T ss_pred             hhcCC
Confidence            88764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=6.3e-43  Score=323.58  Aligned_cols=230  Identities=37%  Similarity=0.706  Sum_probs=195.3

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecceeeecCCe
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSK  189 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~  189 (355)
                      +|++.+.||+|+||+||+|+++     .+++.||+|++.+.........+.+..|..+++.+. |++|+++++++...+.
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERK-----GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDR   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCE
Confidence            4788999999999999999976     467889999998765444445566777888888886 5778889999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC-
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-  268 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~-  268 (355)
                      +|+||||+++|+|..++...+.+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..... 
T Consensus        76 ~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~  155 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG  155 (323)
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence            9999999999999999988888999999999999999999999999999999999999999999999999998764322 


Q ss_pred             CCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-------------hhhHHHHHhhhhe
Q 018487          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-------------NTMLLFYLIIFHC  335 (355)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-------------~~~~~~~~~i~~~  335 (355)
                      ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....             .......+++.+|
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~  235 (323)
T cd05615         156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGL  235 (323)
T ss_pred             ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHH
Confidence            223445799999999999998999999999999999999999999987643221             1122346788899


Q ss_pred             eeecCCCcCC
Q 018487          336 LFVNSLELLS  345 (355)
Q Consensus       336 l~~~~~e~~~  345 (355)
                      |.++|.+++.
T Consensus       236 l~~~p~~R~~  245 (323)
T cd05615         236 MTKHPSKRLG  245 (323)
T ss_pred             cccCHhhCCC
Confidence            9999888764

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.1e-42  Score=316.40  Aligned_cols=203  Identities=31%  Similarity=0.528  Sum_probs=177.5

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++.+.||+|+||.||+|+++     .+++.||+|++..... .....+.+.+|+.+++.++|+||+++++++...+.
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHK-----ETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGK   74 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEEC-----CCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCE
Confidence            47999999999999999999976     4677899999876532 23344567789999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      +|+||||++++.+..+......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus        75 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          75 LYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            99999999998776655555679999999999999999999999999999999999999999999999999998764322


Q ss_pred             --CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          270 --RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       270 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                        ......|++.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~  205 (287)
T cd07848         155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES  205 (287)
T ss_pred             cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence              2234578999999999998899999999999999999999999998653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.2e-43  Score=331.39  Aligned_cols=205  Identities=43%  Similarity=0.835  Sum_probs=183.1

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++++.||+|+||.||+|..+     .+++.||+|+++............+.+|+.++..++|+||+++++.+...+.
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   75 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKK-----DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRN   75 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEEC-----CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            47999999999999999999976     4678899999986554455566778889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      +|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          76 LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            99999999999999999888889999999999999999999999999999999999999999999999999987542211


Q ss_pred             ------------------------------------CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCC
Q 018487          270 ------------------------------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVN  313 (355)
Q Consensus       270 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~p  313 (355)
                                                          .....+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence                                                01235799999999999999999999999999999999999999


Q ss_pred             CCCchh
Q 018487          314 IKSMQV  319 (355)
Q Consensus       314 f~~~~~  319 (355)
                      |...+.
T Consensus       236 f~~~~~  241 (360)
T cd05627         236 FCSETP  241 (360)
T ss_pred             CCCCCH
Confidence            987643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.2e-43  Score=325.53  Aligned_cols=225  Identities=37%  Similarity=0.736  Sum_probs=190.6

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceeeecCCeEEEEE
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~  194 (355)
                      +.||+|+||.||+|.++     .+++.||+|++++.........+.+.+|+.++.++ +||||+++++++...+.+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLK-----KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEEC-----CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEE
Confidence            46999999999999976     46778999999876544555566778898888776 7999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC-cCCCCCc
Q 018487          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNS  273 (355)
Q Consensus       195 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~-~~~~~~~  273 (355)
                      ||+++++|..++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++... .......
T Consensus        76 E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (329)
T cd05618          76 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST  155 (329)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccc
Confidence            999999999999888889999999999999999999999999999999999999999999999999987542 2222345


Q ss_pred             ccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhh----------------------hhhhhHHHHHh
Q 018487          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVI----------------------ACNTMLLFYLI  331 (355)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~----------------------~~~~~~~~~~~  331 (355)
                      .+||+.|+|||++.+..++.++|||||||++|+|++|+.||......                      .......+..+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l  235 (329)
T cd05618         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASV  235 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence            67999999999999999999999999999999999999999531100                      00112244678


Q ss_pred             hhheeeecCCCcCC
Q 018487          332 IFHCLFVNSLELLS  345 (355)
Q Consensus       332 i~~~l~~~~~e~~~  345 (355)
                      +.+||..+|.+++.
T Consensus       236 l~~~L~~dP~~R~~  249 (329)
T cd05618         236 LKSFLNKDPKERLG  249 (329)
T ss_pred             HHHHhcCCHHHcCC
Confidence            88999999888864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=8.4e-43  Score=323.89  Aligned_cols=232  Identities=47%  Similarity=0.815  Sum_probs=193.5

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeeccccc-chhHHHHHHHHHHHHHhcC-CCcceecceeeecCC
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-KKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRS  188 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~  188 (355)
                      +|+++++||+|+||+||+|+....  ..+++.||+|++.+.... .....+.+.+|+.+++.++ |+||+++++++...+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTG--HDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA   78 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEccc--CCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC
Confidence            589999999999999999986532  246788999999764332 2333456778999999995 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      .+|+||||+++|+|.+++..+..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus        79 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~  158 (332)
T cd05614          79 KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE  158 (332)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999999865332


Q ss_pred             C--CCCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCchhhh------h-----------hhhHHH
Q 018487          269 S--RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSMQVIA------C-----------NTMLLF  328 (355)
Q Consensus       269 ~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~------~-----------~~~~~~  328 (355)
                      .  .....+||+.|+|||++.+. .++.++|||||||++|||+||+.||.......      .           .....+
T Consensus       159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (332)
T cd05614         159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEA  238 (332)
T ss_pred             CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHH
Confidence            2  23346799999999999865 47889999999999999999999996421110      0           112245


Q ss_pred             HHhhhheeeecCCCcC
Q 018487          329 YLIIFHCLFVNSLELL  344 (355)
Q Consensus       329 ~~~i~~~l~~~~~e~~  344 (355)
                      .+++.+||..+|.+++
T Consensus       239 ~~li~~~l~~dp~~R~  254 (332)
T cd05614         239 QDLLHKLLRKDPKKRL  254 (332)
T ss_pred             HHHHHHHcCCCHHHcC
Confidence            7788899999998887

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=5.8e-43  Score=323.53  Aligned_cols=224  Identities=38%  Similarity=0.709  Sum_probs=191.6

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceeeecCCeEEEEE
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~  194 (355)
                      +.||+|+||.||+|+++     .+++.||+|++.+.........+.+..|..++..+ +||||+++++++...+.+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELK-----GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEEC-----CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEE
Confidence            46999999999999976     45778999999876544455556677788888866 7999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc-CCCCCc
Q 018487          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE-SSRSNS  273 (355)
Q Consensus       195 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~-~~~~~~  273 (355)
                      ||+++++|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ......
T Consensus        76 E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05591          76 EYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT  155 (321)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccc
Confidence            9999999999998888899999999999999999999999999999999999999999999999999875422 222345


Q ss_pred             ccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHHhhhheeeecC
Q 018487          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYLIIFHCLFVNS  340 (355)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~~i~~~l~~~~  340 (355)
                      .+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.....             ....+.+++.+||.++|
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp  235 (321)
T cd05591         156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNP  235 (321)
T ss_pred             cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCH
Confidence            67999999999999889999999999999999999999999876432211             12345678889999998


Q ss_pred             CCcC
Q 018487          341 LELL  344 (355)
Q Consensus       341 ~e~~  344 (355)
                      .+++
T Consensus       236 ~~R~  239 (321)
T cd05591         236 NKRL  239 (321)
T ss_pred             HHcC
Confidence            8876

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=5.3e-43  Score=324.09  Aligned_cols=226  Identities=47%  Similarity=0.792  Sum_probs=189.7

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHH-HHHhcCCCcceecceeeecCCeEEEEE
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD-ILTKVTHPFIVQLRYSFQTRSKLYLIL  194 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~  194 (355)
                      +.||+|+||+||+|.++     .+++.||+|++.+...........+.+|.. +++.++||||+++++.+...+.+|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHK-----ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEEC-----CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEE
Confidence            46999999999999976     567889999997654433333344445544 568899999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC-cCCCCCc
Q 018487          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNS  273 (355)
Q Consensus       195 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~-~~~~~~~  273 (355)
                      ||+++++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... .......
T Consensus        76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (323)
T cd05575          76 DYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST  155 (323)
T ss_pred             cCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccc
Confidence            999999999999988889999999999999999999999999999999999999999999999999987542 2223345


Q ss_pred             ccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-------------hhhHHHHHhhhheeeecC
Q 018487          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-------------NTMLLFYLIIFHCLFVNS  340 (355)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-------------~~~~~~~~~i~~~l~~~~  340 (355)
                      .+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....             .....+..+|.+||+++|
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p  235 (323)
T cd05575         156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDR  235 (323)
T ss_pred             ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence            6799999999999999999999999999999999999999987643221             122345778889999888


Q ss_pred             CCcCCC
Q 018487          341 LELLSH  346 (355)
Q Consensus       341 ~e~~~~  346 (355)
                      .+++..
T Consensus       236 ~~R~~~  241 (323)
T cd05575         236 TKRLGA  241 (323)
T ss_pred             HhCCCC
Confidence            887643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=6.7e-43  Score=328.97  Aligned_cols=209  Identities=38%  Similarity=0.764  Sum_probs=182.3

Q ss_pred             hcCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceeccee
Q 018487          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (355)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~  183 (355)
                      ......++|++.+.||+|+||.||+|+++     .+++.||+|++.+.........+.+.+|+.+++.++||||++++++
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~  111 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHK-----SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCA  111 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            34456689999999999999999999977     4678899999976544444445567889999999999999999999


Q ss_pred             eecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       184 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      +..+..+|+||||+++|+|.+++... .+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus       112 ~~~~~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~  190 (370)
T cd05621         112 FQDDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCM  190 (370)
T ss_pred             EEcCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccce
Confidence            99999999999999999999988654 58999999999999999999999999999999999999999999999999998


Q ss_pred             ccCcCCC--CCcccccCccccchhhccCC----CCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          264 EIDESSR--SNSMCGTTEYMAPEILLSKG----HNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       264 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      .......  ....+||+.|+|||++.+..    ++.++|||||||++|+|++|+.||...+
T Consensus       191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~  251 (370)
T cd05621         191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS  251 (370)
T ss_pred             ecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence            7643322  23567999999999997643    7889999999999999999999998764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.3e-42  Score=319.87  Aligned_cols=202  Identities=29%  Similarity=0.456  Sum_probs=180.6

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ..++|++.++||+|+||.||+|+++     .++..||+|++....  .....+.+.+|++++++++||||+++++++..+
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   75 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHK-----PSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD   75 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEEC-----CCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC
Confidence            3578999999999999999999976     467789999987542  234456788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~-~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                      +.+++||||+++++|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..+.
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  155 (331)
T cd06649          76 GEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (331)
T ss_pred             CEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence            99999999999999999998888899999999999999999999986 69999999999999999999999999998664


Q ss_pred             cCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      ... .....|++.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus       156 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~  205 (331)
T cd06649         156 DSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP  205 (331)
T ss_pred             ccc-cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            332 34457899999999999989999999999999999999999999754

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=7e-43  Score=323.56  Aligned_cols=225  Identities=45%  Similarity=0.778  Sum_probs=188.3

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHH-HHHHhcCCCcceecceeeecCCeEEEEE
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER-DILTKVTHPFIVQLRYSFQTRSKLYLIL  194 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~nIv~l~~~~~~~~~~~lv~  194 (355)
                      +.||+|+||+||+|+++     .+++.||+|++.+...........+..|. .+++.++|+||+++++++...+.+|+||
T Consensus         1 ~~lg~G~fg~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHK-----AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEEC-----CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEE
Confidence            46999999999999976     45778999999765433333333344444 4578899999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC-cCCCCCc
Q 018487          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNS  273 (355)
Q Consensus       195 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~-~~~~~~~  273 (355)
                      ||+++++|..++...+.+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... .......
T Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~  155 (325)
T cd05602          76 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST  155 (325)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccc
Confidence            999999999999888889999999999999999999999999999999999999999999999999987542 2223445


Q ss_pred             ccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-------------hhhHHHHHhhhheeeecC
Q 018487          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-------------NTMLLFYLIIFHCLFVNS  340 (355)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-------------~~~~~~~~~i~~~l~~~~  340 (355)
                      .+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....             +....+..+|.+||+++|
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p  235 (325)
T cd05602         156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDR  235 (325)
T ss_pred             ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCH
Confidence            6799999999999999999999999999999999999999987543221             122355778889999998


Q ss_pred             CCcCC
Q 018487          341 LELLS  345 (355)
Q Consensus       341 ~e~~~  345 (355)
                      .+++.
T Consensus       236 ~~R~~  240 (325)
T cd05602         236 TKRLG  240 (325)
T ss_pred             HHCCC
Confidence            88764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.1e-42  Score=321.01  Aligned_cols=225  Identities=36%  Similarity=0.664  Sum_probs=189.3

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceeeecCCeEEEEE
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~  194 (355)
                      +.||+|+||.||+|+++     .+++.||+|+++..........+.+..|..++... +||||+++++++...+.+|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELK-----GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEE
Confidence            46999999999999977     45778999999875433333445566677777754 8999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc-CCCCCc
Q 018487          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE-SSRSNS  273 (355)
Q Consensus       195 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~-~~~~~~  273 (355)
                      ||+++++|..++...+.+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.... ......
T Consensus        76 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05620          76 EFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST  155 (316)
T ss_pred             CCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceec
Confidence            9999999999998888899999999999999999999999999999999999999999999999999875322 222345


Q ss_pred             ccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHHhhhheeeecC
Q 018487          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYLIIFHCLFVNS  340 (355)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~~i~~~l~~~~  340 (355)
                      .+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.....             ....+.++|.+||..+|
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  235 (316)
T cd05620         156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDP  235 (316)
T ss_pred             cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCH
Confidence            67999999999999999999999999999999999999999875432211             11245678889999998


Q ss_pred             CCcCC
Q 018487          341 LELLS  345 (355)
Q Consensus       341 ~e~~~  345 (355)
                      .+++.
T Consensus       236 ~~R~~  240 (316)
T cd05620         236 TRRLG  240 (316)
T ss_pred             HHcCC
Confidence            88764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.3e-42  Score=327.27  Aligned_cols=233  Identities=36%  Similarity=0.687  Sum_probs=193.7

Q ss_pred             hcCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceeccee
Q 018487          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (355)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~  183 (355)
                      ......++|++.++||+|+||.||+|+++     .+++.||+|++.+.........+.+.+|+.+++.++||||++++++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~  111 (370)
T cd05596          37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHK-----SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYA  111 (370)
T ss_pred             cCCCCHHHcEEEEEEeeCCCEEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            34456678999999999999999999976     4678899999976544444445567789999999999999999999


Q ss_pred             eecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       184 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      +..+..+|+||||++||+|..++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus       112 ~~~~~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~  190 (370)
T cd05596         112 FQDDKYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (370)
T ss_pred             EecCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEecccee
Confidence            9999999999999999999988765 458999999999999999999999999999999999999999999999999998


Q ss_pred             ccCcCC--CCCcccccCccccchhhccC----CCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh--------------
Q 018487          264 EIDESS--RSNSMCGTTEYMAPEILLSK----GHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN--------------  323 (355)
Q Consensus       264 ~~~~~~--~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~--------------  323 (355)
                      ......  .....+||+.|+|||++.+.    .++.++|||||||++|||++|+.||...+.....              
T Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~  270 (370)
T cd05596         191 KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPD  270 (370)
T ss_pred             eccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCC
Confidence            764332  22346799999999998753    4788999999999999999999999876432210              


Q ss_pred             ---hhHHHHHhhhheeeecCCC
Q 018487          324 ---TMLLFYLIIFHCLFVNSLE  342 (355)
Q Consensus       324 ---~~~~~~~~i~~~l~~~~~e  342 (355)
                         .......+|.+||..+|.+
T Consensus       271 ~~~~s~~~~~li~~~L~~~p~r  292 (370)
T cd05596         271 DIEISKQAKDLICAFLTDREVR  292 (370)
T ss_pred             cCCCCHHHHHHHHHHccChhhc
Confidence               1224466777888766654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-42  Score=323.17  Aligned_cols=230  Identities=33%  Similarity=0.549  Sum_probs=202.4

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecceeeecC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTR  187 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~  187 (355)
                      ...|++.+.||+|.||.||+|..+     .+++.+|+|++.+.........+.+.+|+.+|+++. |||||.+++.|+..
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~-----~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~  108 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREK-----STGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP  108 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEec-----CCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence            457999999999999999999987     458889999999887666556678899999999999 99999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCC----CcEEEEecCCcc
Q 018487          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD----GHVMLTDFGLAK  263 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~----~~~kl~Dfg~a~  263 (355)
                      ..+++|||++.||.|++.+... .+++..+..++.|++.++.|||+.||+||||||+|+|+...    +.+|++|||++.
T Consensus       109 ~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  109 DSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             CeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            9999999999999999999887 49999999999999999999999999999999999999643    479999999999


Q ss_pred             ccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhhhhH-----------------
Q 018487          264 EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTML-----------------  326 (355)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~~~~-----------------  326 (355)
                      ...........+||+.|+|||++....|+..+||||+||++|.|++|..||...+........                 
T Consensus       188 ~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~  267 (382)
T KOG0032|consen  188 FIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE  267 (382)
T ss_pred             EccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence            987766677889999999999999999999999999999999999999999998643322211                 


Q ss_pred             HHHHhhhheeeecCCCcC
Q 018487          327 LFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       327 ~~~~~i~~~l~~~~~e~~  344 (355)
                      ..++.|..++..+|..++
T Consensus       268 ~akd~i~~ll~~dp~~R~  285 (382)
T KOG0032|consen  268 SAKDFIRKLLEFDPRKRL  285 (382)
T ss_pred             HHHHHHHHhcccCcccCC
Confidence            336667777777776554

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.6e-42  Score=326.61  Aligned_cols=212  Identities=38%  Similarity=0.772  Sum_probs=183.5

Q ss_pred             hhhcCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecc
Q 018487          102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR  181 (355)
Q Consensus       102 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~  181 (355)
                      ........++|++.+.||+|+||.||+|+++     .+++.||+|++.+...........+.+|+.+++.++||||++++
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~-----~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~  109 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHK-----STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF  109 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEEC-----CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            3345566789999999999999999999977     56788999998765444444455677899999999999999999


Q ss_pred             eeeecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCC
Q 018487          182 YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (355)
Q Consensus       182 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~  261 (355)
                      +.+..++.+|+||||+++|+|..++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus       110 ~~~~~~~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~  188 (371)
T cd05622         110 YAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT  188 (371)
T ss_pred             EEEEcCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence            9999999999999999999998888654 589999999999999999999999999999999999999999999999999


Q ss_pred             ccccCcCC--CCCcccccCccccchhhccCC----CCCcccHHHHHHHHHHHHcCCCCCCCchh
Q 018487          262 AKEIDESS--RSNSMCGTTEYMAPEILLSKG----HNKDADWWSVGILLYEMLTGQVNIKSMQV  319 (355)
Q Consensus       262 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~~l~elltg~~pf~~~~~  319 (355)
                      +.......  .....+||+.|+|||++.+..    ++.++|||||||++|||++|+.||...+.
T Consensus       189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~  252 (371)
T cd05622         189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL  252 (371)
T ss_pred             eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH
Confidence            98764332  223567999999999997543    78899999999999999999999987644

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=8.8e-43  Score=323.12  Aligned_cols=225  Identities=38%  Similarity=0.727  Sum_probs=191.9

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceeeecCCeEEEEE
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~  194 (355)
                      +.||+|+||.||+|..+     ..++.||+|++++.........+.+.+|+.++.++ +|+||+++++++...+.+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLK-----KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEE
Confidence            46999999999999976     46788999999876554555667788899999888 5999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC-cCCCCCc
Q 018487          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNS  273 (355)
Q Consensus       195 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~-~~~~~~~  273 (355)
                      ||+++++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.... .......
T Consensus        76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (327)
T cd05617          76 EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST  155 (327)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceec
Confidence            999999999999888889999999999999999999999999999999999999999999999999987532 2223345


Q ss_pred             ccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhh---------h-----------hhhhHHHHHhhh
Q 018487          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVI---------A-----------CNTMLLFYLIIF  333 (355)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~---------~-----------~~~~~~~~~~i~  333 (355)
                      .+||+.|+|||++.+..++.++|||||||++|+|++|+.||......         .           .........++.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~  235 (327)
T cd05617         156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLK  235 (327)
T ss_pred             ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            67999999999999999999999999999999999999999632110         0           011224577888


Q ss_pred             heeeecCCCcCC
Q 018487          334 HCLFVNSLELLS  345 (355)
Q Consensus       334 ~~l~~~~~e~~~  345 (355)
                      +||..+|.+++.
T Consensus       236 ~~L~~dP~~R~~  247 (327)
T cd05617         236 GFLNKDPKERLG  247 (327)
T ss_pred             HHhccCHHHcCC
Confidence            999999888764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.2e-42  Score=317.00  Aligned_cols=201  Identities=26%  Similarity=0.466  Sum_probs=171.8

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|++.++||+|+||.||+|+.+     .+++.||+|++.....  ......+.+|+.+++.++||||+++++++....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   76 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSK-----VNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKE   76 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEEC-----CCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCC
Confidence            468999999999999999999976     4577899999875432  222234667999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      ..|+||||+++ +|.+++... +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        77 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  155 (303)
T cd07869          77 TLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV  155 (303)
T ss_pred             eEEEEEECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence            99999999975 676766554 5689999999999999999999999999999999999999999999999999875432


Q ss_pred             C-CCCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          268 S-SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       268 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      . .......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  207 (303)
T cd07869         156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM  207 (303)
T ss_pred             CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            2 22334578999999999875 45788999999999999999999999865

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.8e-43  Score=310.10  Aligned_cols=203  Identities=28%  Similarity=0.456  Sum_probs=178.1

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc-ceecceeeecCC
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF-IVQLRYSFQTRS  188 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~  188 (355)
                      ..|+.+++||+|+||+||+|+.+     .+++.||+|.++..... +..-....+|+.+|+.++|+| ||.+++++....
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~-----~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~   84 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSK-----RTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSN   84 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEe-----cCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecc
Confidence            45778889999999999999987     56789999999876532 233344568999999999999 999999998877


Q ss_pred             ------eEEEEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEe
Q 018487          189 ------KLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTD  258 (355)
Q Consensus       189 ------~~~lv~e~~~~gsL~~~l~~~~----~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~D  258 (355)
                            .+++|+||++. +|..++....    .++...++.+++||++||+|||+++|+||||||.||||+++|.+||+|
T Consensus        85 ~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaD  163 (323)
T KOG0594|consen   85 NHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLAD  163 (323)
T ss_pred             cccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeec
Confidence                  89999999976 8888887765    477789999999999999999999999999999999999999999999


Q ss_pred             cCCccccCcCC-CCCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCchh
Q 018487          259 FGLAKEIDESS-RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSMQV  319 (355)
Q Consensus       259 fg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~~~  319 (355)
                      ||+|+.+.... .....++|..|+|||++.+. .|+...||||+||+++||++++..|.+...
T Consensus       164 FGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se  226 (323)
T KOG0594|consen  164 FGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE  226 (323)
T ss_pred             cchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence            99999776333 35667899999999999986 799999999999999999999999999765

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-42  Score=313.81  Aligned_cols=229  Identities=37%  Similarity=0.615  Sum_probs=195.2

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      .|++.+.||+|+||.||++.+.     .+++.||+|++.............+.+|+.+++.++|+||+++++.+..++.+
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEc-----CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeE
Confidence            4889999999999999999965     45788999999765443334445567899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      |+||||+++++|.+++...  ..+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||++......
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            9999999999998887654  35899999999999999999999999999999999999999999999999999876544


Q ss_pred             CCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh-----------------hhhhHHHHHh
Q 018487          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA-----------------CNTMLLFYLI  331 (355)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~-----------------~~~~~~~~~~  331 (355)
                      ......+|+..|+|||++.+..++.++|||||||++|+|++|+.||...+...                 ......+..+
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (285)
T cd05605         156 ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSI  235 (285)
T ss_pred             CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHH
Confidence            33345578999999999998889999999999999999999999998643211                 0122345778


Q ss_pred             hhheeeecCCCcC
Q 018487          332 IFHCLFVNSLELL  344 (355)
Q Consensus       332 i~~~l~~~~~e~~  344 (355)
                      |.+||..+|.+++
T Consensus       236 i~~~l~~~P~~R~  248 (285)
T cd05605         236 CRQLLTKDPGFRL  248 (285)
T ss_pred             HHHHccCCHHHhc
Confidence            8999999988877

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.4e-42  Score=318.75  Aligned_cols=225  Identities=37%  Similarity=0.703  Sum_probs=188.1

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHh-cCCCcceecceeeecCCeEEEEE
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTHPFIVQLRYSFQTRSKLYLIL  194 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~lv~  194 (355)
                      +.||+|+||+||+|+++     .+++.||+|+++..........+....|..++.. ++||||+++++++...+.+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELK-----GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEEC-----CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEE
Confidence            46999999999999976     4577899999987543333344455667777775 48999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc-CCCCCc
Q 018487          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE-SSRSNS  273 (355)
Q Consensus       195 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~-~~~~~~  273 (355)
                      ||+++|+|..++.....+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ......
T Consensus        76 ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05619          76 EYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT  155 (316)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceee
Confidence            9999999999998888899999999999999999999999999999999999999999999999999875422 222345


Q ss_pred             ccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHHhhhheeeecC
Q 018487          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYLIIFHCLFVNS  340 (355)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~~i~~~l~~~~  340 (355)
                      .+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.....             ......++|.+||.++|
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P  235 (316)
T cd05619         156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREP  235 (316)
T ss_pred             ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCH
Confidence            67899999999999989999999999999999999999999875432211             11234678889999988


Q ss_pred             CCcCC
Q 018487          341 LELLS  345 (355)
Q Consensus       341 ~e~~~  345 (355)
                      .+++.
T Consensus       236 ~~R~~  240 (316)
T cd05619         236 ERRLG  240 (316)
T ss_pred             hhcCC
Confidence            88753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.1e-42  Score=319.38  Aligned_cols=226  Identities=40%  Similarity=0.733  Sum_probs=193.0

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceeeecCCeEEEEE
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~  194 (355)
                      +.||+|+||+||+|.++     .+++.||+|++++.........+.+..|..+++.+ +||||+++++++...+.+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELK-----GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEEC-----CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEE
Confidence            46999999999999976     45778999999876544455556677888888887 6999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC-cCCCCCc
Q 018487          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNS  273 (355)
Q Consensus       195 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~-~~~~~~~  273 (355)
                      ||+++++|..++...+.+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++... .......
T Consensus        76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (318)
T cd05570          76 EYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST  155 (318)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccc
Confidence            999999999999888889999999999999999999999999999999999999999999999999987532 2222344


Q ss_pred             ccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHHhhhheeeecC
Q 018487          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYLIIFHCLFVNS  340 (355)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~~i~~~l~~~~  340 (355)
                      .+|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.....             ....+.++|.+||..+|
T Consensus       156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP  235 (318)
T cd05570         156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNP  235 (318)
T ss_pred             eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCH
Confidence            57999999999999999999999999999999999999999865432211             12345788889999998


Q ss_pred             CCcCCC
Q 018487          341 LELLSH  346 (355)
Q Consensus       341 ~e~~~~  346 (355)
                      .+++..
T Consensus       236 ~~R~s~  241 (318)
T cd05570         236 EKRLGC  241 (318)
T ss_pred             HHcCCC
Confidence            887654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.1e-42  Score=322.22  Aligned_cols=225  Identities=47%  Similarity=0.795  Sum_probs=188.1

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHH-HHHhcCCCcceecceeeecCCeEEEEE
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD-ILTKVTHPFIVQLRYSFQTRSKLYLIL  194 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~  194 (355)
                      +.||+|+||+||+|.++     .+++.||+|++.+...........+..|.. +++.++||||+++++++...+.+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRK-----LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEE
Confidence            46999999999999976     567889999997654433334444555554 577899999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC-cCCCCCc
Q 018487          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNS  273 (355)
Q Consensus       195 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~-~~~~~~~  273 (355)
                      ||+++++|..++...+.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... .......
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (325)
T cd05604          76 DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT  155 (325)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccc
Confidence            999999999999888889999999999999999999999999999999999999999999999999987542 2233345


Q ss_pred             ccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHHhhhheeeecC
Q 018487          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYLIIFHCLFVNS  340 (355)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~~i~~~l~~~~  340 (355)
                      .+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.....             ....+..++.+|+.++|
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p  235 (325)
T cd05604         156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDR  235 (325)
T ss_pred             ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCH
Confidence            67999999999999999999999999999999999999999876432211             11234567888888887


Q ss_pred             CCcCC
Q 018487          341 LELLS  345 (355)
Q Consensus       341 ~e~~~  345 (355)
                      .+++.
T Consensus       236 ~~R~~  240 (325)
T cd05604         236 QRRLG  240 (325)
T ss_pred             HhcCC
Confidence            77653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.5e-43  Score=311.79  Aligned_cols=196  Identities=31%  Similarity=0.544  Sum_probs=171.4

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC---
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR---  187 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~---  187 (355)
                      .|...+++|.|+||.||+|...     ++++.||||..-.+....       .+|+++|+.++|||||+++.+|...   
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~-----e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~   92 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLR-----ETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTES   92 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEc-----CCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCC
Confidence            5888999999999999999977     457889999886554322       2599999999999999998888632   


Q ss_pred             C--eEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCC-CcEEEEecC
Q 018487          188 S--KLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFG  260 (355)
Q Consensus       188 ~--~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~-~~~kl~Dfg  260 (355)
                      +  +..+|||||+. +|...++.    +..++.-.++.+.+||++||.|||+.||+||||||.|+|+|.+ |.+||||||
T Consensus        93 d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFG  171 (364)
T KOG0658|consen   93 DEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFG  171 (364)
T ss_pred             chhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCC
Confidence            2  45689999986 88888774    4668899999999999999999999999999999999999976 999999999


Q ss_pred             CccccCcCCCCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCchh
Q 018487          261 LAKEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQV  319 (355)
Q Consensus       261 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~~  319 (355)
                      .|+.+.......+...|..|+|||.+.| ..|+.+.||||.|||+.||+-|+.-|.+.+.
T Consensus       172 SAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~  231 (364)
T KOG0658|consen  172 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS  231 (364)
T ss_pred             cceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH
Confidence            9999988777777888999999999987 5799999999999999999999999999653

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1e-42  Score=323.11  Aligned_cols=229  Identities=39%  Similarity=0.709  Sum_probs=192.8

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++.+.||+|+||+||+|.++     ..++.||+|+++..........+.+.+|+.+++.++|+||+++++++...+.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~   75 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREK-----ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDN   75 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCe
Confidence            37999999999999999999976     4678899999987655445566778889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      +|+||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             EEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            99999999999999999876 67999999999999999999999999999999999999999999999999999876433


Q ss_pred             CC--CCcccccCccccchhhc------cCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-----------------h
Q 018487          269 SR--SNSMCGTTEYMAPEILL------SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-----------------N  323 (355)
Q Consensus       269 ~~--~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-----------------~  323 (355)
                      ..  .....||+.|+|||++.      +..++.++|||||||++|+|++|+.||...+....                 .
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (330)
T cd05601         156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPK  235 (330)
T ss_pred             CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCC
Confidence            22  23347899999999987      45678899999999999999999999976543221                 1


Q ss_pred             hhHHHHHhhhheeeecCCCcC
Q 018487          324 TMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       324 ~~~~~~~~i~~~l~~~~~e~~  344 (355)
                      ....+..+|..||. +|.+++
T Consensus       236 ~~~~~~~li~~ll~-~p~~R~  255 (330)
T cd05601         236 VSSDFLDLIQSLLC-GQKERL  255 (330)
T ss_pred             CCHHHHHHHHHHcc-ChhhCC
Confidence            12234566667775 666655

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-43  Score=309.04  Aligned_cols=208  Identities=28%  Similarity=0.475  Sum_probs=181.3

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec--
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--  186 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--  186 (355)
                      ...|..++.||+|+||.|+.|.++     .+++.||||.+.... ......++..+|+++|+.++|+||+.+++.+..  
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~-----~t~~~VAIKKi~~~F-~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~   94 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDK-----RTGEKVAIKKILNPF-ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPS   94 (359)
T ss_pred             cceecccccccCcceeeEEEEEEc-----CCCCEeehhhhhhhh-hchHHHHHHHHHHHHHHHhcCCCcceEEeeccccc
Confidence            356777899999999999999977     567889999986432 344555677789999999999999999999875  


Q ss_pred             ---CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          187 ---RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       187 ---~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                         -..+|+|+|+|+. +|...++.+..+++..+..+++|+++||.|+|+.+|+||||||.|+|++.+..+||||||+|+
T Consensus        95 ~~~f~DvYiV~elMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR  173 (359)
T KOG0660|consen   95 RDKFNDVYLVFELMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLAR  173 (359)
T ss_pred             ccccceeEEehhHHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEecccccee
Confidence               3479999999954 898888888889999999999999999999999999999999999999999999999999999


Q ss_pred             ccCc---CCCCCcccccCccccchhhc-cCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh
Q 018487          264 EIDE---SSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN  323 (355)
Q Consensus       264 ~~~~---~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~  323 (355)
                      ..+.   ....+..+.|.+|+|||++. ...|+.+.||||+||+|.||++|+..|.+.+.+..-
T Consensus       174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql  237 (359)
T KOG0660|consen  174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQL  237 (359)
T ss_pred             eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHH
Confidence            8864   33345678899999999976 468999999999999999999999999998765543

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2e-41  Score=317.28  Aligned_cols=224  Identities=28%  Similarity=0.451  Sum_probs=183.9

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|+++++||+|+||.||+|.++     .+++.||||++....  .....+.+.+|+.+++.++|+||+++++++..++.
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  146 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHR-----PTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGE  146 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEEC-----CCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCe
Confidence            46888899999999999999976     457789999986542  23445668899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      +|+||||+++++|...    ....+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus       147 ~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        147 IQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM  222 (353)
T ss_pred             EEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence            9999999999988542    345778888999999999999999999999999999999999999999999998764332


Q ss_pred             -CCCcccccCccccchhhcc-----CCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh-----------------hhhhH
Q 018487          270 -RSNSMCGTTEYMAPEILLS-----KGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA-----------------CNTML  326 (355)
Q Consensus       270 -~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~-----------------~~~~~  326 (355)
                       .....+||..|+|||++..     ...+.++|||||||++|||++|+.||.......                 .....
T Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (353)
T PLN00034        223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASR  302 (353)
T ss_pred             ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCH
Confidence             2234579999999998743     234568999999999999999999997422110                 11123


Q ss_pred             HHHHhhhheeeecCCCcC
Q 018487          327 LFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       327 ~~~~~i~~~l~~~~~e~~  344 (355)
                      .+.++|.+||..+|.+++
T Consensus       303 ~l~~li~~~l~~~P~~Rp  320 (353)
T PLN00034        303 EFRHFISCCLQREPAKRW  320 (353)
T ss_pred             HHHHHHHHHccCChhhCc
Confidence            567888999998888765

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.1e-41  Score=316.63  Aligned_cols=202  Identities=31%  Similarity=0.489  Sum_probs=179.2

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ..++|++.++||+|+||.||+|.++     .++..+|+|++....  .....+.+.+|+++++.++|+||++++++|..+
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~-----~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   75 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHK-----PSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD   75 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEEC-----CCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC
Confidence            3478999999999999999999976     456789999887542  233456688999999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~-~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                      +.+|+||||+++++|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..+.
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~  155 (333)
T cd06650          76 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (333)
T ss_pred             CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence            99999999999999999998888899999999999999999999975 79999999999999999999999999987653


Q ss_pred             cCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      ... .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       156 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         156 DSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             hhc-cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            322 23457899999999999888999999999999999999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=323.03  Aligned_cols=199  Identities=27%  Similarity=0.406  Sum_probs=174.4

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC-
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-  188 (355)
                      ++|.-...||+|+||.||+|...      .++.||||.+.......   ..+|.+|+.++.+++|||+|+|+|+|.+.+ 
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~------~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~  145 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLS------DGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGE  145 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEEC------CCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCc
Confidence            67888899999999999999875      23789999776543221   344999999999999999999999999988 


Q ss_pred             eEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          189 KLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCG---IVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~---iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      +.++|+|||++|+|.++|....  .++|.++..|+.++++||+|||...   |||||||++|||||++.++||+|||+|+
T Consensus       146 ~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~  225 (361)
T KOG1187|consen  146 HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAK  225 (361)
T ss_pred             eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcc
Confidence            5999999999999999998775  8999999999999999999999854   9999999999999999999999999997


Q ss_pred             ccCc-CCCCCcc-cccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          264 EIDE-SSRSNSM-CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       264 ~~~~-~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      .... ....... .||.+|+|||++..+..+.++|||||||+|+||+||+.+.+..
T Consensus       226 ~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~  281 (361)
T KOG1187|consen  226 LGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS  281 (361)
T ss_pred             cCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence            6544 3322233 7999999999999888999999999999999999999888753

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.5e-42  Score=320.38  Aligned_cols=227  Identities=47%  Similarity=0.803  Sum_probs=192.3

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEEEe
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  195 (355)
                      +.||+|+||.||+++....  ...++.||+|++...... ......+.+|+.++++++||||+++++++..++.+|+|||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~--~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITG--PDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD   78 (318)
T ss_pred             ceeeeCCCEEEEEEEEecc--CCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence            6799999999999986421  246788999999865432 2223456679999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC-CCCCcc
Q 018487          196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSM  274 (355)
Q Consensus       196 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~-~~~~~~  274 (355)
                      |+++++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......
T Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~  158 (318)
T cd05582          79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF  158 (318)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence            9999999999988888999999999999999999999999999999999999999999999999998865433 223456


Q ss_pred             cccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHHhhhheeeecCC
Q 018487          275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYLIIFHCLFVNSL  341 (355)
Q Consensus       275 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~~i~~~l~~~~~  341 (355)
                      +|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.....             ....+..+|.+||+.+|.
T Consensus       159 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~  238 (318)
T cd05582         159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPA  238 (318)
T ss_pred             cCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHh
Confidence            7999999999999888999999999999999999999999875432211             123457888999999998


Q ss_pred             CcCC
Q 018487          342 ELLS  345 (355)
Q Consensus       342 e~~~  345 (355)
                      +++.
T Consensus       239 ~R~~  242 (318)
T cd05582         239 NRLG  242 (318)
T ss_pred             HcCC
Confidence            8764

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.2e-41  Score=316.55  Aligned_cols=201  Identities=24%  Similarity=0.425  Sum_probs=171.4

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC---
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR---  187 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~---  187 (355)
                      +|++.++||+|+||.||+|.++     .+++.||||.+..... .......+.+|+.+++.++||||+++++++...   
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   74 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR   74 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEEC-----CCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence            5899999999999999999976     5678899999864322 222334577899999999999999999887543   


Q ss_pred             --CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          188 --SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       188 --~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                        ..+|+||||+. ++|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        75 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          75 EFKDIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             CCceEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence              35899999996 589899888888999999999999999999999999999999999999999999999999999764


Q ss_pred             CcCCC----CCcccccCccccchhhcc--CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          266 DESSR----SNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       266 ~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      .....    ....+||+.|+|||++.+  ..++.++|||||||++|+|+||+.||...+
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~  212 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN  212 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            32211    234578999999999875  678999999999999999999999997654

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-42  Score=317.33  Aligned_cols=204  Identities=41%  Similarity=0.777  Sum_probs=178.7

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++++.||+|+||+||+|+.+     .+++.||+|++.+.........+.+.+|+.+++.++|+||+++++++..++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   75 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMK-----NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENN   75 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEEC-----CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCe
Confidence            47999999999999999999976     4577899999976544444555668889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      +|+||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             EEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            9999999999999999876 456899999999999999999999999999999999999999999999999998765433


Q ss_pred             CC--CCcccccCccccchhhcc-----CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          269 SR--SNSMCGTTEYMAPEILLS-----KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       269 ~~--~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      ..  ....+||+.|+|||++.+     ..++.++|||||||++|+|++|+.||...+
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~  212 (331)
T cd05597         156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES  212 (331)
T ss_pred             CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence            22  223469999999999873     457889999999999999999999998754

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-44  Score=302.62  Aligned_cols=230  Identities=30%  Similarity=0.497  Sum_probs=197.5

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .+.|++.+.||+|.|+.||++.++     .+++.+|+|++........ ..+.+.+|++|.+.++|||||++.+.+...+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~-----~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~   83 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHK-----TTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEES   83 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhc-----cchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccc
Confidence            457889999999999999999876     5677889998876554433 4567889999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC---CCcEEEEecCCcccc
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEI  265 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~---~~~~kl~Dfg~a~~~  265 (355)
                      ..|+|+|+|+|++|..-+..+..++|..+-.+++||+++|.|+|.+||||||+||+|+|+..   ..-+||+|||+|..+
T Consensus        84 ~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   84 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             eeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            99999999999999888877788999999999999999999999999999999999999954   346999999999999


Q ss_pred             CcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhhhh-----------------HHH
Q 018487          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTM-----------------LLF  328 (355)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~~~-----------------~~~  328 (355)
                      ........++|||.|||||++...+|+..+|||+.||+||-||.|..||.+.+..+.-..                 ..-
T Consensus       164 ~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~A  243 (355)
T KOG0033|consen  164 NDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEA  243 (355)
T ss_pred             CCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence            866667788999999999999999999999999999999999999999998543332111                 122


Q ss_pred             HHhhhheeeecCCCcC
Q 018487          329 YLIIFHCLFVNSLELL  344 (355)
Q Consensus       329 ~~~i~~~l~~~~~e~~  344 (355)
                      ++.|.+.|..+|.++.
T Consensus       244 k~LvrrML~~dP~kRI  259 (355)
T KOG0033|consen  244 KSLIRRMLTVNPKKRI  259 (355)
T ss_pred             HHHHHHHhccChhhhc
Confidence            5666777777777654

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=8e-42  Score=309.86  Aligned_cols=222  Identities=34%  Similarity=0.585  Sum_probs=187.4

Q ss_pred             eccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEEEecc
Q 018487          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI  197 (355)
Q Consensus       118 lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  197 (355)
                      ||+|+||+||+|.++     .+++.||+|++...........+.+..|+.+++.++|+||+++.+++..+..+|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMR-----ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEc-----cCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCC
Confidence            699999999999976     467789999987655444444566778999999999999999999999999999999999


Q ss_pred             CCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCC-CC
Q 018487          198 NGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR-SN  272 (355)
Q Consensus       198 ~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~-~~  272 (355)
                      ++|+|..++..    ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..+..... ..
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~  155 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK  155 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccc
Confidence            99999877743    34589999999999999999999999999999999999999999999999999976543322 23


Q ss_pred             cccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh-----------------hhhhHHHHHhhhhe
Q 018487          273 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA-----------------CNTMLLFYLIIFHC  335 (355)
Q Consensus       273 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~-----------------~~~~~~~~~~i~~~  335 (355)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|+.||.......                 ......+..++.+|
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  235 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL  235 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHH
Confidence            4578999999999999999999999999999999999999997642110                 01123567788899


Q ss_pred             eeecCCCcC
Q 018487          336 LFVNSLELL  344 (355)
Q Consensus       336 l~~~~~e~~  344 (355)
                      |..+|.+++
T Consensus       236 l~~~P~~R~  244 (280)
T cd05608         236 LAKDPEKRL  244 (280)
T ss_pred             hcCCHHHhc
Confidence            999988876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5.4e-42  Score=323.34  Aligned_cols=239  Identities=23%  Similarity=0.352  Sum_probs=195.7

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceeccee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~  183 (355)
                      +.+..++|++.+.||+|+||.||+|.+....+..+...||+|+++....  ....+.+.+|+.+++.+ +|+||++++++
T Consensus        33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~  110 (374)
T cd05106          33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGA  110 (374)
T ss_pred             ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence            3455678999999999999999999987665556677899999976432  33456678899999999 89999999999


Q ss_pred             eecCCeEEEEEeccCCCChHHHHHhc------------------------------------------------------
Q 018487          184 FQTRSKLYLILDFINGGHLFFHLYRQ------------------------------------------------------  209 (355)
Q Consensus       184 ~~~~~~~~lv~e~~~~gsL~~~l~~~------------------------------------------------------  209 (355)
                      +...+.+|+||||+++|+|.+++...                                                      
T Consensus       111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (374)
T cd05106         111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS  190 (374)
T ss_pred             ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence            99999999999999999999888542                                                      


Q ss_pred             ----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCCC--
Q 018487          210 ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS--  271 (355)
Q Consensus       210 ----------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~--  271 (355)
                                      ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........  
T Consensus       191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~  270 (374)
T cd05106         191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV  270 (374)
T ss_pred             ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence                            13678889999999999999999999999999999999999999999999999865433211  


Q ss_pred             -CcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh---------------hhhHHHHHhhhh
Q 018487          272 -NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC---------------NTMLLFYLIIFH  334 (355)
Q Consensus       272 -~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~---------------~~~~~~~~~i~~  334 (355)
                       ....++..|||||++.+..++.++|||||||++|+|++ |+.||........               .....+..+|.+
T Consensus       271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  350 (374)
T cd05106         271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKM  350 (374)
T ss_pred             ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHH
Confidence             12234567999999998899999999999999999997 9999977532110               012346778888


Q ss_pred             eeeecCCCcCC
Q 018487          335 CLFVNSLELLS  345 (355)
Q Consensus       335 ~l~~~~~e~~~  345 (355)
                      ||+.+|.+++.
T Consensus       351 cl~~dp~~RPs  361 (374)
T cd05106         351 CWNLEPTERPT  361 (374)
T ss_pred             HcCCChhhCcC
Confidence            88888877653

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.6e-42  Score=318.84  Aligned_cols=204  Identities=40%  Similarity=0.762  Sum_probs=178.9

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++.++||+|+||.||+++++     .+++.||+|++.+...........+.+|+.++..++|+||+++++++...+.
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~   75 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMK-----HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENY   75 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEEC-----CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            47999999999999999999976     4677899999876443344445567889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      .|+||||++||+|..++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus        76 ~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             EEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            9999999999999999987 467899999999999999999999999999999999999999999999999999766433


Q ss_pred             CC--CCcccccCccccchhhcc-----CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          269 SR--SNSMCGTTEYMAPEILLS-----KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       269 ~~--~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      ..  ....+||+.|+|||++.+     ..++.++|||||||++|+|++|+.||...+
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~  212 (331)
T cd05624         156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES  212 (331)
T ss_pred             CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence            22  223579999999999875     457889999999999999999999998654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.5e-41  Score=310.07  Aligned_cols=237  Identities=22%  Similarity=0.326  Sum_probs=190.1

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCC-----------CCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCC
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVD-----------DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP  175 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----------~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  175 (355)
                      +..++|++.++||+|+||.||+|.+....           ....+..||+|++....  .......+.+|+.++++++||
T Consensus         2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~   79 (304)
T cd05096           2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDP   79 (304)
T ss_pred             CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCC
Confidence            34578999999999999999999865322           11234579999987543  234456688899999999999


Q ss_pred             cceecceeeecCCeEEEEEeccCCCChHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCC
Q 018487          176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-------------------IFREDQARFYTAEIVSAVSHLHKCGI  236 (355)
Q Consensus       176 nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------------~l~~~~~~~i~~ql~~~L~~LH~~~i  236 (355)
                      ||+++++++...+..++||||+++++|.+++....                   .+++..+..++.||+.||.|||+.||
T Consensus        80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i  159 (304)
T cd05096          80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF  159 (304)
T ss_pred             CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence            99999999999999999999999999999886532                   35778899999999999999999999


Q ss_pred             eeccCCCCcEEecCCCcEEEEecCCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc--CC
Q 018487          237 VHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQ  311 (355)
Q Consensus       237 iHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt--g~  311 (355)
                      +||||||+|||++.++.+||+|||+++.+.....   .....++..|+|||++.+..++.++||||||+++|||++  +.
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~  239 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE  239 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence            9999999999999999999999999986533221   223345788999999998889999999999999999986  67


Q ss_pred             CCCCCchhhhh--h-------------------hhHHHHHhhhheeeecCCCcCC
Q 018487          312 VNIKSMQVIAC--N-------------------TMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       312 ~pf~~~~~~~~--~-------------------~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      .||........  +                   ....+.+++.+|++.+|.+++.
T Consensus       240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs  294 (304)
T cd05096         240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPS  294 (304)
T ss_pred             CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcC
Confidence            78876432110  0                   0124567788888888777653

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.4e-41  Score=307.95  Aligned_cols=202  Identities=27%  Similarity=0.454  Sum_probs=173.3

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|++.++||.|+||.||+|..+     .+++.||+|+++....  ......+.+|+.+++.++||||+++++++...+
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   76 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSK-----LTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTER   76 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEEC-----CCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            357999999999999999999876     4577899999875432  222345678999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          189 KLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      ..++||||+++ +|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        77 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~  155 (288)
T cd07871          77 CLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV  155 (288)
T ss_pred             eEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence            99999999986 8888876654 478999999999999999999999999999999999999999999999999876533


Q ss_pred             CC-CCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          268 SS-RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       268 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      .. ......+++.|+|||++.+ ..++.++|||||||++|+|+||+.||...+
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~  208 (288)
T cd07871         156 PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST  208 (288)
T ss_pred             CCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            22 2234568999999999875 568999999999999999999999997654

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1e-41  Score=321.71  Aligned_cols=239  Identities=24%  Similarity=0.358  Sum_probs=194.9

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceeccee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~  183 (355)
                      +.+..++|++.+.||+|+||.||+|.+.+..+...+..||||+++....  ....+.+.+|+.+++.+ +||||++++++
T Consensus        30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~  107 (375)
T cd05104          30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGA  107 (375)
T ss_pred             cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence            3455668999999999999999999876555556677899999875432  23345678899999999 89999999999


Q ss_pred             eecCCeEEEEEeccCCCChHHHHHhcC-----------------------------------------------------
Q 018487          184 FQTRSKLYLILDFINGGHLFFHLYRQG-----------------------------------------------------  210 (355)
Q Consensus       184 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------------------------------------------  210 (355)
                      +...+..++||||+++|+|.+++....                                                     
T Consensus       108 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  187 (375)
T cd05104         108 CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR  187 (375)
T ss_pred             eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence            999999999999999999998886432                                                     


Q ss_pred             ----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          211 ----------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       211 ----------------------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                                            .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                                  3678889999999999999999999999999999999999999999999999866432


Q ss_pred             CC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh---------------hhhhHHHH
Q 018487          269 SR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA---------------CNTMLLFY  329 (355)
Q Consensus       269 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~---------------~~~~~~~~  329 (355)
                      ..   .....++..|+|||++.+..++.++|||||||++|||++ |..||.......               ......+.
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  347 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMY  347 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHH
Confidence            21   112234567999999999999999999999999999998 899997653211               01123467


Q ss_pred             HhhhheeeecCCCcCC
Q 018487          330 LIIFHCLFVNSLELLS  345 (355)
Q Consensus       330 ~~i~~~l~~~~~e~~~  345 (355)
                      ++|.+|++.+|.+++.
T Consensus       348 ~li~~cl~~dP~~RPs  363 (375)
T cd05104         348 DIMKSCWDADPLKRPT  363 (375)
T ss_pred             HHHHHHccCChhHCcC
Confidence            8888999888887653

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.1e-41  Score=306.76  Aligned_cols=230  Identities=36%  Similarity=0.611  Sum_probs=194.7

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      .|+..+.||+|+||+||+|.+.     .+++.||+|.+.............+.+|+.+++.++|+||+.+.+.+..++..
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~   75 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVR-----ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEC-----CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEE
Confidence            3788899999999999999976     45778999998765444444445577899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      |+||||+++++|..++...  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05632          76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG  155 (285)
T ss_pred             EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence            9999999999998887654  35899999999999999999999999999999999999999999999999999765443


Q ss_pred             CCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh-----------------hhhhHHHHHh
Q 018487          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA-----------------CNTMLLFYLI  331 (355)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~-----------------~~~~~~~~~~  331 (355)
                      .......|+..|+|||++.+..++.++|||||||++|+|++|..||.......                 ......+.++
T Consensus       156 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (285)
T cd05632         156 ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSI  235 (285)
T ss_pred             CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHH
Confidence            33345578999999999998899999999999999999999999998653211                 1122245778


Q ss_pred             hhheeeecCCCcCC
Q 018487          332 IFHCLFVNSLELLS  345 (355)
Q Consensus       332 i~~~l~~~~~e~~~  345 (355)
                      +..|++.+|.+++.
T Consensus       236 i~~~l~~~P~~R~~  249 (285)
T cd05632         236 CKMLLTKDPKQRLG  249 (285)
T ss_pred             HHHHccCCHhHcCC
Confidence            88999999887764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.9e-41  Score=328.00  Aligned_cols=229  Identities=27%  Similarity=0.391  Sum_probs=190.9

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ..|.+.+.||+|+||.||+|....    ..++.|++|.+...   .......+.+|+.+|+.++|||||++++++..++.
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~----~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~  139 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGS----DPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDK  139 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcC----CCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCE
Confidence            359999999999999999998652    12567888876543   23334567789999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          190 LYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      +|+||||+++|+|.+++..    ...+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..+
T Consensus       140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~  219 (478)
T PTZ00267        140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY  219 (478)
T ss_pred             EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence            9999999999999887753    346899999999999999999999999999999999999999999999999999876


Q ss_pred             CcCC---CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh--------------hhhHHH
Q 018487          266 DESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC--------------NTMLLF  328 (355)
Q Consensus       266 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~--------------~~~~~~  328 (355)
                      ....   .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....              .....+
T Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~  299 (478)
T PTZ00267        220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGM  299 (478)
T ss_pred             CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHH
Confidence            4332   23456799999999999999999999999999999999999999987543211              112346


Q ss_pred             HHhhhheeeecCCCcCC
Q 018487          329 YLIIFHCLFVNSLELLS  345 (355)
Q Consensus       329 ~~~i~~~l~~~~~e~~~  345 (355)
                      ..+|.+||.++|.+++.
T Consensus       300 ~~li~~~L~~dP~~Rps  316 (478)
T PTZ00267        300 KALLDPLLSKNPALRPT  316 (478)
T ss_pred             HHHHHHHhccChhhCcC
Confidence            77888888888777653

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.3e-41  Score=315.93  Aligned_cols=204  Identities=41%  Similarity=0.769  Sum_probs=178.2

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++.++||+|+||.||+++++     ..++.+|+|++.+...........+.+|+.++..++|+||+++++.+...+.
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   75 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLK-----NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENN   75 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEEC-----CCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCE
Confidence            47999999999999999999976     4567899999876444344445567889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      +|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             EEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            9999999999999999977 467899999999999999999999999999999999999999999999999998765332


Q ss_pred             CC--CCcccccCccccchhhc-----cCCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          269 SR--SNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       269 ~~--~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      ..  ....+||+.|+|||++.     ...++.++|||||||++|||++|+.||...+
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~  212 (332)
T cd05623         156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES  212 (332)
T ss_pred             CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence            22  23457999999999986     3467889999999999999999999998754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-42  Score=319.52  Aligned_cols=223  Identities=47%  Similarity=0.789  Sum_probs=185.9

Q ss_pred             eccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc---CCCcceecceeeecCCeEEEEE
Q 018487          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV---THPFIVQLRYSFQTRSKLYLIL  194 (355)
Q Consensus       118 lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~~lv~  194 (355)
                      ||+|+||+||+|+++     .+++.||+|++.+...........+..|..++...   +||||+++++.+.....+|+||
T Consensus         1 lG~G~~g~Vy~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKK-----DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEEC-----CCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEE
Confidence            799999999999976     56788999999765443333444455677777665   6999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC-cCCCCCc
Q 018487          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNS  273 (355)
Q Consensus       195 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~-~~~~~~~  273 (355)
                      ||+++++|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.... .......
T Consensus        76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~  155 (330)
T cd05586          76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT  155 (330)
T ss_pred             cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccC
Confidence            999999999999888889999999999999999999999999999999999999999999999999987542 2223345


Q ss_pred             ccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh--------------hhHHHHHhhhheeee
Q 018487          274 MCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN--------------TMLLFYLIIFHCLFV  338 (355)
Q Consensus       274 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~--------------~~~~~~~~i~~~l~~  338 (355)
                      .+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.....              .......+|.+||..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~  235 (330)
T cd05586         156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNR  235 (330)
T ss_pred             ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCC
Confidence            6799999999998754 5889999999999999999999999876432211              123446778899999


Q ss_pred             cCCCcCC
Q 018487          339 NSLELLS  345 (355)
Q Consensus       339 ~~~e~~~  345 (355)
                      +|.+++.
T Consensus       236 ~P~~R~~  242 (330)
T cd05586         236 NPQHRLG  242 (330)
T ss_pred             CHHHCCC
Confidence            9888763

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.3e-40  Score=322.84  Aligned_cols=200  Identities=25%  Similarity=0.460  Sum_probs=167.0

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCC------Ccceec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH------PFIVQL  180 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~nIv~l  180 (355)
                      ...++|+++++||+|+||+||+|.+.     ..++.||||+++...    .....+..|+.+++.++|      .+|+++
T Consensus       126 ~~~~~y~i~~~lG~G~fg~V~~a~~~-----~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i  196 (467)
T PTZ00284        126 VSTQRFKILSLLGEGTFGKVVEAWDR-----KRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKI  196 (467)
T ss_pred             cCCCcEEEEEEEEeccCEEEEEEEEc-----CCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeee
Confidence            34678999999999999999999976     457789999986432    122334557777776654      458888


Q ss_pred             ceeeecC-CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEecCCC------
Q 018487          181 RYSFQTR-SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDG------  252 (355)
Q Consensus       181 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDlkp~NILl~~~~------  252 (355)
                      +++|... .++|+|||++ |++|.+++...+.+++.++..++.||+.||.|||. .|||||||||+|||++.++      
T Consensus       197 ~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~  275 (467)
T PTZ00284        197 QRYFQNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPV  275 (467)
T ss_pred             EEEEEcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccc
Confidence            8888754 5799999998 66888999888889999999999999999999997 5999999999999998765      


Q ss_pred             ----------cEEEEecCCccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          253 ----------HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       253 ----------~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                                .+||+|||.+.....  .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+
T Consensus       276 ~~~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        276 TNRALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             cccccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                      499999998764322  2345689999999999999999999999999999999999999997643

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.5e-42  Score=324.00  Aligned_cols=218  Identities=26%  Similarity=0.438  Sum_probs=183.1

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-C-----Ccceecceee
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-H-----PFIVQLRYSF  184 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~nIv~l~~~~  184 (355)
                      +|++++.||+|+||.|.+|.+.     .+++.||||+++..    +....+...|+.+|..++ |     -|+|+++++|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~-----~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F  257 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDH-----KTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF  257 (586)
T ss_pred             EEEEEEEecccccceeEEEEec-----CCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence            6899999999999999999976     67889999999864    344555667999999997 4     3899999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC--cEEEEecC
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG--HVMLTDFG  260 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~--~~kl~Dfg  260 (355)
                      ...+++|||+|.+.. +|+++++.+..  ++...++.++.||+.||.+||+.||||+||||+||||.+-+  .|||+|||
T Consensus       258 ~fr~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFG  336 (586)
T KOG0667|consen  258 YFRNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFG  336 (586)
T ss_pred             ccccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecc
Confidence            999999999999965 89999998753  88999999999999999999999999999999999997543  79999999


Q ss_pred             CccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhhhhHHHHHhhhheeeecC
Q 018487          261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLIIFHCLFVNS  340 (355)
Q Consensus       261 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~~~~~~~~~i~~~l~~~~  340 (355)
                      .+........  +.+.+..|+|||++.|.+|+.+.||||||||++||++|...|.+.+..     +.+ ..|...+...|
T Consensus       337 SSc~~~q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~-----DQl-~~I~e~lG~Pp  408 (586)
T KOG0667|consen  337 SSCFESQRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY-----DQL-ARIIEVLGLPP  408 (586)
T ss_pred             cccccCCcce--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHH-----HHH-HHHHHHhCCCC
Confidence            9987655443  667899999999999999999999999999999999998888886432     222 23334444555


Q ss_pred             CCcCCC
Q 018487          341 LELLSH  346 (355)
Q Consensus       341 ~e~~~~  346 (355)
                      .+|++.
T Consensus       409 ~~mL~~  414 (586)
T KOG0667|consen  409 PKMLDT  414 (586)
T ss_pred             HHHHHh
Confidence            555444

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.5e-41  Score=306.48  Aligned_cols=230  Identities=37%  Similarity=0.633  Sum_probs=194.4

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      .|++.+.||+|+||.||+|.++     .+++.||+|.+...........+.+.+|+.+++.++|+||+++++.+...+.+
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~   75 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDAL   75 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEc-----CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEE
Confidence            4788899999999999999977     46788999998765544444455677899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          191 YLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      |+||||+++++|.+++...+  .+++.++..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus        76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05630          76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  155 (285)
T ss_pred             EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence            99999999999988886543  5899999999999999999999999999999999999999999999999998765443


Q ss_pred             CCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhh------h-----------hhhhHHHHHh
Q 018487          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVI------A-----------CNTMLLFYLI  331 (355)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~------~-----------~~~~~~~~~~  331 (355)
                      .......|+..|+|||++.+..++.++||||||+++|+|++|+.||......      .           ......+.++
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (285)
T cd05630         156 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSL  235 (285)
T ss_pred             ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHH
Confidence            3334457899999999999889999999999999999999999999864210      0           0112245778


Q ss_pred             hhheeeecCCCcCC
Q 018487          332 IFHCLFVNSLELLS  345 (355)
Q Consensus       332 i~~~l~~~~~e~~~  345 (355)
                      +.+||+.+|.+++.
T Consensus       236 i~~~l~~~p~~R~s  249 (285)
T cd05630         236 CKMLLCKDPKERLG  249 (285)
T ss_pred             HHHHhhcCHHHccC
Confidence            88999988888763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.6e-41  Score=318.39  Aligned_cols=196  Identities=28%  Similarity=0.370  Sum_probs=172.7

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      .+..++|+++++||+|+||.||+|.+.     .+++.||+|....         +.+.+|++++++++||||++++++|.
T Consensus        88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~-----~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~  153 (391)
T PHA03212         88 GIEKAGFSILETFTPGAEGFAFACIDN-----KTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFT  153 (391)
T ss_pred             ccccCCcEEEEEEcCCCCeEEEEEEEC-----CCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEE
Confidence            355678999999999999999999976     5678899996432         23567999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      .+...++|||++. ++|..++.....+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus       154 ~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~  232 (391)
T PHA03212        154 YNKFTCLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFP  232 (391)
T ss_pred             ECCeeEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence            9999999999996 588888888788999999999999999999999999999999999999999999999999999754


Q ss_pred             CcC--CCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCC
Q 018487          266 DES--SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKS  316 (355)
Q Consensus       266 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~  316 (355)
                      ...  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~  285 (391)
T PHA03212        233 VDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE  285 (391)
T ss_pred             ccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence            322  223346799999999999999999999999999999999999987753

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-43  Score=324.84  Aligned_cols=225  Identities=24%  Similarity=0.373  Sum_probs=197.7

Q ss_pred             eEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEE
Q 018487          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (355)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  191 (355)
                      |.-++.||.|+||.||.|++.     .+.+.||||.+....-...+.-..+..|+..|++++|||+|.+.++|..+...|
T Consensus        28 f~dLrEIGHGSFGAVYfArd~-----~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaW  102 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDV-----RNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAW  102 (948)
T ss_pred             HHHHHHhcCCccceeEEeecc-----CccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHH
Confidence            666788999999999999966     678899999998766555666677889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCC
Q 018487          192 LILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR  270 (355)
Q Consensus       192 lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~  270 (355)
                      +|||||-| +-.+++.. .+++.+.++..|+.+.+.||+|||+.+.||||||..|||+++.|.|||+|||.|....+   
T Consensus       103 LVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---  178 (948)
T KOG0577|consen  103 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---  178 (948)
T ss_pred             HHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence            99999976 66666654 46799999999999999999999999999999999999999999999999999977644   


Q ss_pred             CCcccccCccccchhhcc---CCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh---------------hhhhHHHHHhh
Q 018487          271 SNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA---------------CNTMLLFYLII  332 (355)
Q Consensus       271 ~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~---------------~~~~~~~~~~i  332 (355)
                      ..+++|||+|||||++..   +.|+-++||||||++..||.-.+.|+-+|+...               ..+.+.|..++
T Consensus       179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fv  258 (948)
T KOG0577|consen  179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV  258 (948)
T ss_pred             hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHH
Confidence            567899999999999874   579999999999999999999999998875443               23566889999


Q ss_pred             hheeeecCCCcCC
Q 018487          333 FHCLFVNSLELLS  345 (355)
Q Consensus       333 ~~~l~~~~~e~~~  345 (355)
                      ..||++.|.|++.
T Consensus       259 d~CLqKipqeRpt  271 (948)
T KOG0577|consen  259 DSCLQKIPQERPT  271 (948)
T ss_pred             HHHHhhCcccCCc
Confidence            9999999988763

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=9.7e-41  Score=304.18  Aligned_cols=228  Identities=44%  Similarity=0.755  Sum_probs=200.7

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++.+.||+|+||.||+|.+.     ..++.||+|++...........+.+.+|++++++++||||+++++.+..++.
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHK-----GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSN   75 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEc-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCe
Confidence            47999999999999999999976     4577899999976654445556778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      +|+||||+++++|.+++...+.+++..+..++.|++.||.|||++|++|+||+|+|||++.++.+||+|||++...... 
T Consensus        76 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-  154 (290)
T cd05580          76 LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-  154 (290)
T ss_pred             EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence            9999999999999999998888999999999999999999999999999999999999999999999999999876544 


Q ss_pred             CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-------------hhhHHHHHhhhhee
Q 018487          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-------------NTMLLFYLIIFHCL  336 (355)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-------------~~~~~~~~~i~~~l  336 (355)
                       .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+....             .....+.++|.+||
T Consensus       155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  233 (290)
T cd05580         155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLL  233 (290)
T ss_pred             -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHc
Confidence             3345789999999999888889999999999999999999999987653221             12246678999999


Q ss_pred             eecCCCcC
Q 018487          337 FVNSLELL  344 (355)
Q Consensus       337 ~~~~~e~~  344 (355)
                      ..+|.++.
T Consensus       234 ~~~p~~R~  241 (290)
T cd05580         234 QVDLTKRL  241 (290)
T ss_pred             cCCHHHcc
Confidence            99998876

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.7e-41  Score=305.02  Aligned_cols=224  Identities=35%  Similarity=0.595  Sum_probs=187.3

Q ss_pred             eccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEEEecc
Q 018487          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI  197 (355)
Q Consensus       118 lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  197 (355)
                      ||+|+||.||++..+     .+++.||+|.+.............+..|++++++++||||+++++.+..+..+|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~-----~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVK-----NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEc-----cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecC
Confidence            699999999999976     467889999987654433333344566999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCCCCccc
Q 018487          198 NGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMC  275 (355)
Q Consensus       198 ~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~  275 (355)
                      +|++|..++....  .+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.............
T Consensus        76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~  155 (277)
T cd05607          76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA  155 (277)
T ss_pred             CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccC
Confidence            9999988876543  48899999999999999999999999999999999999999999999999998765444334457


Q ss_pred             ccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhh-------h-----------hhhhHHHHHhhhheee
Q 018487          276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVI-------A-----------CNTMLLFYLIIFHCLF  337 (355)
Q Consensus       276 gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~-------~-----------~~~~~~~~~~i~~~l~  337 (355)
                      |+..|+|||++.+..++.++|||||||++|+|++|+.||......       .           ......+.+++.+||+
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  235 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLA  235 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhc
Confidence            899999999999888999999999999999999999999753210       0           0112235788889999


Q ss_pred             ecCCCcCCC
Q 018487          338 VNSLELLSH  346 (355)
Q Consensus       338 ~~~~e~~~~  346 (355)
                      .+|.+++..
T Consensus       236 ~~P~~R~~~  244 (277)
T cd05607         236 KKPEDRLGS  244 (277)
T ss_pred             cCHhhCCCC
Confidence            998887643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.9e-42  Score=333.43  Aligned_cols=236  Identities=25%  Similarity=0.430  Sum_probs=201.3

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +...+.+..+.||+|+||+||+|+..+.........||||.++...  +.+..++|++|++++..++|||||+|+|.|..
T Consensus       483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~  560 (774)
T KOG1026|consen  483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCRE  560 (774)
T ss_pred             echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence            5556788899999999999999998877766778899999998764  34466789999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQG--------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG  252 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~--------------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~  252 (355)
                      ++.+|||+|||..|+|.++|..+.              +++..+...|+.||+.||+||-++.++||||.++|+||.++.
T Consensus       561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL  640 (774)
T ss_pred             CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce
Confidence            999999999999999999997432              278889999999999999999999999999999999999999


Q ss_pred             cEEEEecCCccccCcCCCC---CcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCch---hhh----
Q 018487          253 HVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQ---VIA----  321 (355)
Q Consensus       253 ~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~---~~~----  321 (355)
                      .|||+|||+++.+-.....   ....-.+.|||||.+..+.|++++|||||||+|||+++ |+.||.+..   ++.    
T Consensus       641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~  720 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA  720 (774)
T ss_pred             EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc
Confidence            9999999999976322211   12234688999999999999999999999999999999 999998862   222    


Q ss_pred             -------hhhhHHHHHhhhheeeecCCCcC
Q 018487          322 -------CNTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       322 -------~~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                             .+....++++...||+++|.+++
T Consensus       721 g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RP  750 (774)
T KOG1026|consen  721 GQLLSCPENCPTEVYSLMLECWNENPKRRP  750 (774)
T ss_pred             CCcccCCCCCCHHHHHHHHHHhhcCcccCC
Confidence                   11223668888889988888865

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4e-41  Score=305.77  Aligned_cols=220  Identities=15%  Similarity=0.182  Sum_probs=187.7

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec----CCeEE
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT----RSKLY  191 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~  191 (355)
                      ..||+|++|.||+|.+.       ++.||||.++..........+.+.+|+.+|++++||||+++++++.+    ...++
T Consensus        26 ~~i~~g~~~~v~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~   98 (283)
T PHA02988         26 VLIKENDQNSIYKGIFN-------NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLS   98 (283)
T ss_pred             eEEeeCCceEEEEEEEC-------CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceE
Confidence            57999999999999864       56799999987654445556778899999999999999999999876    45789


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCC
Q 018487          192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR  270 (355)
Q Consensus       192 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~  270 (355)
                      +||||+++|+|.+++.....+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++.+.... 
T Consensus        99 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988         99 LILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             EEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            999999999999999988889999999999999999999998 499999999999999999999999999998654322 


Q ss_pred             CCcccccCccccchhhcc--CCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh---------------hhhHHHHHhhh
Q 018487          271 SNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC---------------NTMLLFYLIIF  333 (355)
Q Consensus       271 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~---------------~~~~~~~~~i~  333 (355)
                       ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||...+....               .....+..++.
T Consensus       178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~  256 (283)
T PHA02988        178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVE  256 (283)
T ss_pred             -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHH
Confidence             23468899999999976  6789999999999999999999999987642211               12235678888


Q ss_pred             heeeecCCCcC
Q 018487          334 HCLFVNSLELL  344 (355)
Q Consensus       334 ~~l~~~~~e~~  344 (355)
                      +||+.+|.+++
T Consensus       257 ~cl~~dp~~Rp  267 (283)
T PHA02988        257 ACTSHDSIKRP  267 (283)
T ss_pred             HHhcCCcccCc
Confidence            99988888865

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=8.1e-41  Score=313.93  Aligned_cols=201  Identities=26%  Similarity=0.443  Sum_probs=172.3

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|++.+.||+|+||.||+|.++     ..++.||+|++..... .......+.+|+.+++.++||||+++++++....
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   93 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDT-----VLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQK   93 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEc-----CCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence            368999999999999999999876     4678899999875432 3334456778999999999999999999986543


Q ss_pred             ------eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          189 ------KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       189 ------~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                            .+|+||||+++ +|...+.  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        94 ~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876          94 SLEEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             CccccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence                  57999999986 4555553  34789999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      +............||+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus       171 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~  226 (359)
T cd07876         171 RTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD  226 (359)
T ss_pred             cccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence            86654444455678999999999999999999999999999999999999998654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=7.8e-41  Score=336.04  Aligned_cols=230  Identities=25%  Similarity=0.355  Sum_probs=192.5

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++.++||+|+||.||+|.+.     .+++.||+|+++..........+.+.+|+.++++++||||+++++++.+++.
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~-----~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDP-----VCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEEC-----CCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCE
Confidence            68999999999999999999976     4578899999976544444455678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEe
Q 018487          190 LYLILDFINGGHLFFHLYRQ-----------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTD  258 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~-----------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~D  258 (355)
                      .|+||||++|++|.+++...           ..++...+..++.||++||+|||++||+||||||+|||++.++.+||+|
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiD  156 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD  156 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEe
Confidence            99999999999999888642           2345667888999999999999999999999999999999999999999


Q ss_pred             cCCccccCcCC-------------------CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchh
Q 018487          259 FGLAKEIDESS-------------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQV  319 (355)
Q Consensus       259 fg~a~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~  319 (355)
                      ||++.......                   .....+||+.|||||++.+..++.++|||||||++|||+||+.||...+.
T Consensus       157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~  236 (932)
T PRK13184        157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG  236 (932)
T ss_pred             cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence            99998652110                   01235799999999999999999999999999999999999999976432


Q ss_pred             hhh----------------hhhHHHHHhhhheeeecCCCcC
Q 018487          320 IAC----------------NTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       320 ~~~----------------~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                      ...                .....+..++.+|+..+|.+++
T Consensus       237 ~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~  277 (932)
T PRK13184        237 RKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERY  277 (932)
T ss_pred             hhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCc
Confidence            110                1112467788899999988875

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=8.4e-41  Score=304.36  Aligned_cols=203  Identities=29%  Similarity=0.424  Sum_probs=169.2

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc---CCCcceecceeee-
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV---THPFIVQLRYSFQ-  185 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~-  185 (355)
                      .+|++++.||+|+||.||+|++..    ..++.||+|+++...... .....+.+|+.+++.+   +||||+++++++. 
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~   75 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLK----NGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV   75 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcC----CCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEec
Confidence            379999999999999999998642    245779999987644322 2223344577666655   6999999999875 


Q ss_pred             ----cCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEec
Q 018487          186 ----TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (355)
Q Consensus       186 ----~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Df  259 (355)
                          ....+++||||+++ +|.+++...  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus        76 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          76 SRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             ccCCCCCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccc
Confidence                34569999999974 788888654  34899999999999999999999999999999999999999999999999


Q ss_pred             CCccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          260 GLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       260 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      |++.............|++.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       155 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  213 (290)
T cd07862         155 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS  213 (290)
T ss_pred             cceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence            99987655444455678999999999998899999999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-42  Score=342.77  Aligned_cols=218  Identities=40%  Similarity=0.756  Sum_probs=195.6

Q ss_pred             hhcCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecce
Q 018487          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (355)
Q Consensus       103 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~  182 (355)
                      .......++|++++.||+|+||.|.+++++     .++++||+|++.+-..........|..|.++|...+.+=|+++..
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k-----~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~Lhy  142 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHK-----STEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHY  142 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEee-----ccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHH
Confidence            344567789999999999999999999998     578899999998866555666678999999999999999999999


Q ss_pred             eeecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       183 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                      +|+++.++|+|||||+||+|...+.+.+.+++..+++++..|+-||..||+.|+|||||||+|||||..|.+||+|||.|
T Consensus       143 AFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsC  222 (1317)
T KOG0612|consen  143 AFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSC  222 (1317)
T ss_pred             HhcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhH
Confidence            99999999999999999999999998889999999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCC--CCcccccCccccchhhc----c-CCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhhhh
Q 018487          263 KEIDESSR--SNSMCGTTEYMAPEILL----S-KGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTM  325 (355)
Q Consensus       263 ~~~~~~~~--~~~~~gt~~y~aPE~~~----~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~~~  325 (355)
                      -.++....  ....+|||.|.+||++.    + +.|+..+|.||+||++|||+.|..||+....+..-..
T Consensus       223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~K  292 (1317)
T KOG0612|consen  223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGK  292 (1317)
T ss_pred             HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHH
Confidence            88764443  45678999999999986    2 5689999999999999999999999999877664433

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=7.9e-41  Score=321.53  Aligned_cols=198  Identities=27%  Similarity=0.429  Sum_probs=166.3

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      ...++|++.++||+|+||.||+|.+.     ..++.||||++....       ....+|+.+|+.++|+||++++++|..
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-----~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~  130 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEAICI-----DTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYT  130 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEEEEC-----CCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEee
Confidence            34568999999999999999999976     457789999885432       123469999999999999999887643


Q ss_pred             C--------CeEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC-c
Q 018487          187 R--------SKLYLILDFINGGHLFFHLY----RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-H  253 (355)
Q Consensus       187 ~--------~~~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~-~  253 (355)
                      .        ..+++||||+++ +|.+++.    ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .
T Consensus       131 ~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~  209 (440)
T PTZ00036        131 ECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHT  209 (440)
T ss_pred             cccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCc
Confidence            2        257799999986 5655554    345689999999999999999999999999999999999998665 7


Q ss_pred             EEEEecCCccccCcCCCCCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          254 VMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       254 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      +||+|||+++.+..........||+.|+|||++.+. .++.++|||||||++|||++|..||.+.
T Consensus       210 vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~  274 (440)
T PTZ00036        210 LKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ  274 (440)
T ss_pred             eeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999877554444556789999999998764 6899999999999999999999999875

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=9.1e-41  Score=300.59  Aligned_cols=234  Identities=21%  Similarity=0.267  Sum_probs=192.7

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ...+|++.+.||+|+||.||+|.++..  ...+..||+|.++...  .....+.+.+|+.+++.++||||+++++++..+
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~--~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   78 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLP--SKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG   78 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecC--CCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC
Confidence            346799999999999999999986532  2346789999987643  233345688899999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                      +..++||||+++|+|.+++... ..+++.+++.++.|++.||+|||++|++||||||+|||++.++.++++|||.+....
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          79 NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            9999999999999999998764 568999999999999999999999999999999999999999999999999876543


Q ss_pred             cCCCC--CcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh--------------hhhhHHHH
Q 018487          267 ESSRS--NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA--------------CNTMLLFY  329 (355)
Q Consensus       267 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~--------------~~~~~~~~  329 (355)
                      .....  ....++..|+|||++.+..++.++|||||||++|||++ |+.||.......              ......+.
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (266)
T cd05064         159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLH  238 (266)
T ss_pred             ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence            22111  12334678999999999999999999999999999875 999998654321              11124567


Q ss_pred             HhhhheeeecCCCcCC
Q 018487          330 LIIFHCLFVNSLELLS  345 (355)
Q Consensus       330 ~~i~~~l~~~~~e~~~  345 (355)
                      +++.+|++.+|.+++.
T Consensus       239 ~li~~c~~~~p~~RP~  254 (266)
T cd05064         239 QLMLDCWQKERGERPR  254 (266)
T ss_pred             HHHHHHcCCCchhCCC
Confidence            7888999888887654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=9.9e-41  Score=324.80  Aligned_cols=232  Identities=30%  Similarity=0.430  Sum_probs=192.1

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ..++|++.+.||+|+||+||+|++.     .+++.||||++..... .......+.+|+.++..++|+||++++..+...
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~-----~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~  103 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRV-----SDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK  103 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEc-----CCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence            3468999999999999999999876     4678899999976543 334455678899999999999999988777543


Q ss_pred             C--------eEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEE
Q 018487          188 S--------KLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM  255 (355)
Q Consensus       188 ~--------~~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~k  255 (355)
                      +        .+++||||+++|+|.+++...    ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus       104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vk  183 (496)
T PTZ00283        104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVK  183 (496)
T ss_pred             cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEE
Confidence            2        378999999999999888643    4589999999999999999999999999999999999999999999


Q ss_pred             EEecCCccccCcC---CCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh----------
Q 018487          256 LTDFGLAKEIDES---SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC----------  322 (355)
Q Consensus       256 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~----------  322 (355)
                      |+|||+++.+...   ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+....          
T Consensus       184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~  263 (496)
T PTZ00283        184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD  263 (496)
T ss_pred             EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence            9999999865432   123456799999999999999999999999999999999999999987543211          


Q ss_pred             ----hhhHHHHHhhhheeeecCCCcCC
Q 018487          323 ----NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       323 ----~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                          .....+..++.+||..+|.+++.
T Consensus       264 ~~~~~~~~~l~~li~~~L~~dP~~RPs  290 (496)
T PTZ00283        264 PLPPSISPEMQEIVTALLSSDPKRRPS  290 (496)
T ss_pred             CCCCCCCHHHHHHHHHHcccChhhCcC
Confidence                11234567788888887777653

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=9.3e-41  Score=316.76  Aligned_cols=240  Identities=25%  Similarity=0.355  Sum_probs=196.8

Q ss_pred             hcCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecce
Q 018487          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRY  182 (355)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~  182 (355)
                      .+.+..++|++.++||+|+||.||+|.+.+.........||||+++...  .....+.+.+|+.+++++. ||||+++++
T Consensus        31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~  108 (400)
T cd05105          31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLG  108 (400)
T ss_pred             ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence            3445677999999999999999999998765555556789999986543  2334466888999999996 999999999


Q ss_pred             eeecCCeEEEEEeccCCCChHHHHHhc-----------------------------------------------------
Q 018487          183 SFQTRSKLYLILDFINGGHLFFHLYRQ-----------------------------------------------------  209 (355)
Q Consensus       183 ~~~~~~~~~lv~e~~~~gsL~~~l~~~-----------------------------------------------------  209 (355)
                      ++...+.+|+|||||++|+|.+++..+                                                     
T Consensus       109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (400)
T cd05105         109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY  188 (400)
T ss_pred             EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence            999999999999999999999887642                                                     


Q ss_pred             -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q 018487          210 -------------------------------------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI  246 (355)
Q Consensus       210 -------------------------------------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NI  246 (355)
                                                                 ..+++.++..++.|++.||.|||+.+|+||||||+||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni  268 (400)
T cd05105         189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV  268 (400)
T ss_pred             chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence                                                       1367788899999999999999999999999999999


Q ss_pred             EecCCCcEEEEecCCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh-
Q 018487          247 LMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA-  321 (355)
Q Consensus       247 Ll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~-  321 (355)
                      |++.++.+||+|||+++.......   .....++..|+|||++.+..++.++|||||||++|||++ |..||....... 
T Consensus       269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~  348 (400)
T cd05105         269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST  348 (400)
T ss_pred             EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence            999999999999999986533221   223356788999999998899999999999999999997 999997652211 


Q ss_pred             --------------hhhhHHHHHhhhheeeecCCCcCC
Q 018487          322 --------------CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 --------------~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                                    ......+..++.+||+.+|.+++.
T Consensus       349 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt  386 (400)
T cd05105         349 FYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPS  386 (400)
T ss_pred             HHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcC
Confidence                          011234678889999998888754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=319.25  Aligned_cols=235  Identities=22%  Similarity=0.330  Sum_probs=197.5

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++..+.++||+|+||.||+|..+..... ....||+|..+.......+.+..+.+|.++|+.++|||||+++|+......
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~-~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGF-KVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP  235 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCc-eeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            4455668999999999999998743221 122289999887555667788889999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          190 LYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~-l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      +++|||+|.||+|.++|.+.+. ++..+...++.+.++||+|||++++|||||-.+|+|++.++.+||+|||+++.....
T Consensus       236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~  315 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY  315 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcce
Confidence            9999999999999999999874 999999999999999999999999999999999999999999999999998865421


Q ss_pred             CCCC-cccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhhhhhH---------------HHHHh
Q 018487          269 SRSN-SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACNTML---------------LFYLI  331 (355)
Q Consensus       269 ~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~~~~~---------------~~~~~  331 (355)
                      .... ...-...|+|||.+....|+.++|||||||++||+++ |..||.+++........               ....+
T Consensus       316 ~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~  395 (474)
T KOG0194|consen  316 VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKV  395 (474)
T ss_pred             eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHH
Confidence            1111 1124678999999999999999999999999999999 89999998765544333               34667


Q ss_pred             hhheeeecCCCcCC
Q 018487          332 IFHCLFVNSLELLS  345 (355)
Q Consensus       332 i~~~l~~~~~e~~~  345 (355)
                      +..|+..+|.++..
T Consensus       396 ~~~c~~~~p~~R~t  409 (474)
T KOG0194|consen  396 MKQCWKKDPEDRPT  409 (474)
T ss_pred             HHHhccCChhhccC
Confidence            77899888887653

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-42  Score=310.53  Aligned_cols=207  Identities=43%  Similarity=0.785  Sum_probs=192.0

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +..+.|+..++||+||||.||.++.+     .+++.||.|.+.+.....+.......+|-.+|.+++.+.||.+-.+|+.
T Consensus       182 vt~n~F~~~RvlGkGGFGEV~acqvr-----aTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT  256 (591)
T KOG0986|consen  182 VTKNTFRVYRVLGKGGFGEVCACQVR-----ATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET  256 (591)
T ss_pred             ccccceeeeEEEecccccceeEEEEe-----cchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC
Confidence            55678999999999999999999977     6789999999887776666666667889999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      .+.+|+||..|.||+|..++...+  .|++..++.++.+|+.||++||+.+||+|||||+|||+|+.|.++|+|+|+|..
T Consensus       257 kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAve  336 (591)
T KOG0986|consen  257 KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVE  336 (591)
T ss_pred             CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEe
Confidence            999999999999999999998876  699999999999999999999999999999999999999999999999999999


Q ss_pred             cCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          265 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      +.........+||.+|||||++.++.|+...|.|||||++|||+.|+-||+...
T Consensus       337 i~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K  390 (591)
T KOG0986|consen  337 IPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK  390 (591)
T ss_pred             cCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh
Confidence            988777777799999999999999999999999999999999999999998753

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-44  Score=306.89  Aligned_cols=224  Identities=25%  Similarity=0.457  Sum_probs=198.6

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      -|.++.+||+|+||.||+|.++     +++..+|+|.+..+.     .++.+..|+.++++++.|+||++|+.|.....+
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~-----EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDL  103 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHR-----ESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDL  103 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHh-----ccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCce
Confidence            3667889999999999999988     789999999987543     345677899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC-
Q 018487          191 YLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-  268 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~-  268 (355)
                      |+|||||..|+..+.+.. ++.+++.++..+++..++||+|||...-||||||..|||++.+|..||+|||.|..+.+. 
T Consensus       104 WIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM  183 (502)
T KOG0574|consen  104 WIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM  183 (502)
T ss_pred             EeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence            999999999999998875 467999999999999999999999999999999999999999999999999999877432 


Q ss_pred             CCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh----------------hhhHHHHHhh
Q 018487          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC----------------NTMLLFYLII  332 (355)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~----------------~~~~~~~~~i  332 (355)
                      ....+..||+.|||||++..-.|+.++||||||++..||..|+.||......+.                .....|.++|
T Consensus       184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi  263 (502)
T KOG0574|consen  184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFI  263 (502)
T ss_pred             HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHH
Confidence            335677899999999999999999999999999999999999999988655442                2445788999


Q ss_pred             hheeeecCCCcC
Q 018487          333 FHCLFVNSLELL  344 (355)
Q Consensus       333 ~~~l~~~~~e~~  344 (355)
                      ..||.++|.++-
T Consensus       264 ~~CLiK~PE~R~  275 (502)
T KOG0574|consen  264 RSCLIKKPEERK  275 (502)
T ss_pred             HHHhcCCHHHHH
Confidence            999999998753

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.1e-40  Score=302.34  Aligned_cols=234  Identities=21%  Similarity=0.363  Sum_probs=194.9

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|++.+.||+|+||.||+|...+.......+.|++|.+....  .......+.+|+.+++.++||||+++++++....
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~   81 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ   81 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence            35799999999999999999998765544556789999987543  3344566889999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC
Q 018487          189 KLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG  252 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~  252 (355)
                      ..|++|||+++++|.+++...                ..+++..+..++.|++.||.|||++|++||||||+||+++.++
T Consensus        82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence            999999999999999998765                4578889999999999999999999999999999999999999


Q ss_pred             cEEEEecCCccccCcCC---CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhhh-----
Q 018487          253 HVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACN-----  323 (355)
Q Consensus       253 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~~-----  323 (355)
                      .++|+|||++.......   ......+++.|+|||++.+..++.++|||||||++|||++ |..||.........     
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~  241 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS  241 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            99999999997653322   1223456788999999998889999999999999999998 99999764322211     


Q ss_pred             ---------hhHHHHHhhhheeeecCCCcC
Q 018487          324 ---------TMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       324 ---------~~~~~~~~i~~~l~~~~~e~~  344 (355)
                               ....+..++.+|+.++|.+++
T Consensus       242 ~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp  271 (283)
T cd05048         242 RQLLPCPEDCPARVYALMIECWNEIPARRP  271 (283)
T ss_pred             CCcCCCcccCCHHHHHHHHHHccCChhhCc
Confidence                     123567888899988888765

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-41  Score=327.20  Aligned_cols=232  Identities=25%  Similarity=0.360  Sum_probs=192.3

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecceee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSF  184 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~  184 (355)
                      .++..++++.+.|.+|||+.||+|+..     ..+..||+|.+-..   ++..++.+.+|+++|+.|. |+|||.+++..
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~-----~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss  104 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDV-----KGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSS  104 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEec-----CCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccc
Confidence            456668999999999999999999976     33378999988653   5777888999999999998 99999999943


Q ss_pred             e-c------CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCcEEecCCCc
Q 018487          185 Q-T------RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDGH  253 (355)
Q Consensus       185 ~-~------~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~--iiHrDlkp~NILl~~~~~  253 (355)
                      . .      .-++.|+||||+||.|-+++..+  ..|++.++..|+.|+++|+++||.+.  |||||||-+||||+.+|.
T Consensus       105 ~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~  184 (738)
T KOG1989|consen  105 AINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN  184 (738)
T ss_pred             cccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC
Confidence            2 1      23688999999999999998844  55999999999999999999999998  999999999999999999


Q ss_pred             EEEEecCCccccCcCCCC-C---------cccccCccccchhhc---cCCCCCcccHHHHHHHHHHHHcCCCCCCCc-hh
Q 018487          254 VMLTDFGLAKEIDESSRS-N---------SMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQVNIKSM-QV  319 (355)
Q Consensus       254 ~kl~Dfg~a~~~~~~~~~-~---------~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~~l~elltg~~pf~~~-~~  319 (355)
                      +||||||.+......... .         ...-|+.|+|||++.   +...++|+|||||||+||-|+....||+.. ..
T Consensus       185 ~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l  264 (738)
T KOG1989|consen  185 YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL  264 (738)
T ss_pred             EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce
Confidence            999999988754222211 1         123589999999974   678899999999999999999999999987 33


Q ss_pred             hhh----------hhhHHHHHhhhheeeecCCCcCC
Q 018487          320 IAC----------NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       320 ~~~----------~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ...          +-...+..+|..||+.+|.+++.
T Consensus       265 aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPn  300 (738)
T KOG1989|consen  265 AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPN  300 (738)
T ss_pred             eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCC
Confidence            222          23346788999999999998763

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.5e-40  Score=300.83  Aligned_cols=238  Identities=21%  Similarity=0.295  Sum_probs=194.3

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      .+..++|++.++||+|+||.||+|.+++......+..||+|++....  .......+.+|+.+++.++|+||+++++++.
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~   79 (277)
T cd05062           2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            34567899999999999999999998765544566789999986432  2223455778999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEE
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQG----------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM  255 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~~----------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~k  255 (355)
                      .+...++||||+++++|.+++....          .+++..+..++.|++.||.|||+.|++||||||+|||++.++.++
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence            9999999999999999999886532          256788899999999999999999999999999999999999999


Q ss_pred             EEecCCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh----------
Q 018487          256 LTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA----------  321 (355)
Q Consensus       256 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~----------  321 (355)
                      |+|||++........   .....++..|+|||++.+..++.++|||||||++|||++ |..||.......          
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~  239 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL  239 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence            999999876533221   112345778999999998889999999999999999999 788997653221          


Q ss_pred             ----hhhhHHHHHhhhheeeecCCCcCC
Q 018487          322 ----CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 ----~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                          ......+.+++.+|++.+|.+++.
T Consensus       240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps  267 (277)
T cd05062         240 LDKPDNCPDMLFELMRMCWQYNPKMRPS  267 (277)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcC
Confidence                112234678888999988888653

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.8e-40  Score=311.14  Aligned_cols=201  Identities=26%  Similarity=0.452  Sum_probs=172.7

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC-
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-  187 (355)
                      .++|++.+.||+|+||.||+|.+.     ..++.||+|++..... .......+.+|+.+++.++||||+++++++... 
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   89 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDA-----VLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK   89 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEec-----CCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccc
Confidence            368999999999999999999865     4577899999875432 333445677899999999999999999988643 


Q ss_pred             -----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       188 -----~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                           ..+|+||||+++ +|...+..  .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        90 ~~~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          90 SLEEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             cccccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence                 357999999976 56555543  4789999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      +............||+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus       167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  222 (355)
T cd07874         167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD  222 (355)
T ss_pred             ccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            87655544556679999999999999999999999999999999999999998654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3e-40  Score=310.64  Aligned_cols=201  Identities=26%  Similarity=0.457  Sum_probs=172.5

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC-
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-  187 (355)
                      .++|++.+.||+|+||.||+|.+.     ..++.||||++..... .......+.+|+.+++.++||||+++++++... 
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~   96 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDA-----ILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK   96 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEEC-----CCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccc
Confidence            368999999999999999999976     4577899999875432 233345577899999999999999999887543 


Q ss_pred             -----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       188 -----~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                           ..+|+||||+++ +|...+..  .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875          97 SLEEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             cccccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence                 358999999976 56666643  4788999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      +............||..|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus       174 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  229 (364)
T cd07875         174 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD  229 (364)
T ss_pred             cccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence            87655444455678999999999999999999999999999999999999998654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.1e-40  Score=310.18  Aligned_cols=238  Identities=24%  Similarity=0.387  Sum_probs=193.8

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceeccee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~  183 (355)
                      |.+..++|++.+.||+|+||.||+|...+..+..+++.||+|+++...  .....+.+..|+.+++++ +|+||++++++
T Consensus         2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~   79 (337)
T cd05054           2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGA   79 (337)
T ss_pred             cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence            445667899999999999999999987766666677899999987533  223345677899999999 79999999998


Q ss_pred             eec-CCeEEEEEeccCCCChHHHHHhc-----------------------------------------------------
Q 018487          184 FQT-RSKLYLILDFINGGHLFFHLYRQ-----------------------------------------------------  209 (355)
Q Consensus       184 ~~~-~~~~~lv~e~~~~gsL~~~l~~~-----------------------------------------------------  209 (355)
                      +.. +..++++|||+++++|.+++...                                                     
T Consensus        80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (337)
T cd05054          80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED  159 (337)
T ss_pred             EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence            764 45789999999999999888542                                                     


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCC---CCcccccC
Q 018487          210 --------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTT  278 (355)
Q Consensus       210 --------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~  278 (355)
                              ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+.....   .....++.
T Consensus       160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence                    2578899999999999999999999999999999999999999999999999987633221   22334567


Q ss_pred             ccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh---------------hhhhHHHHHhhhheeeecCCC
Q 018487          279 EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA---------------CNTMLLFYLIIFHCLFVNSLE  342 (355)
Q Consensus       279 ~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~---------------~~~~~~~~~~i~~~l~~~~~e  342 (355)
                      .|+|||++.+..++.++|||||||++|||++ |..||.......               ......+..++.+|++.+|.+
T Consensus       240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~  319 (337)
T cd05054         240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPED  319 (337)
T ss_pred             cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhh
Confidence            8999999999999999999999999999998 999997532110               011235677888999988887


Q ss_pred             cC
Q 018487          343 LL  344 (355)
Q Consensus       343 ~~  344 (355)
                      ++
T Consensus       320 RP  321 (337)
T cd05054         320 RP  321 (337)
T ss_pred             Cc
Confidence            65

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-42  Score=322.79  Aligned_cols=227  Identities=30%  Similarity=0.499  Sum_probs=196.1

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      +.|+++..||.|+||.||+|..+     .++-..|.|++.-   ...+.++.+.-|+.||..++||+||+|++.|..++.
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nk-----et~~lAAaKvIet---kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk  103 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNK-----ETKLLAAAKVIET---KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK  103 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcc-----cchhhhhhhhhcc---cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc
Confidence            45888999999999999999976     4556677787753   345667778889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC-c
Q 018487          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-E  267 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~-~  267 (355)
                      +||+.|||.||..+..+..- ..+.+.++..+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+.... .
T Consensus       104 LwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t  183 (1187)
T KOG0579|consen  104 LWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST  183 (1187)
T ss_pred             eEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH
Confidence            99999999999998776654 459999999999999999999999999999999999999999999999999886542 3


Q ss_pred             CCCCCcccccCccccchhhc-----cCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh----------------hhH
Q 018487          268 SSRSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN----------------TML  326 (355)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~----------------~~~  326 (355)
                      .....++.|||+|||||++.     ..+|+.++||||||++|.||..+..|....+..+.-                +..
T Consensus       184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~  263 (1187)
T KOG0579|consen  184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSR  263 (1187)
T ss_pred             HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhh
Confidence            33456789999999999975     468999999999999999999999999887665532                444


Q ss_pred             HHHHhhhheeeecCCCcC
Q 018487          327 LFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       327 ~~~~~i~~~l~~~~~e~~  344 (355)
                      .|.+++.+||.+||+.++
T Consensus       264 ~F~DfLk~cL~Knp~~Rp  281 (1187)
T KOG0579|consen  264 SFSDFLKRCLVKNPRNRP  281 (1187)
T ss_pred             HHHHHHHHHHhcCCccCC
Confidence            788999999999988765

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-40  Score=295.40  Aligned_cols=230  Identities=30%  Similarity=0.443  Sum_probs=194.8

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeeccccc--chhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII--KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ++|++.+.||+|++|.||+|...     .+++.|++|.+......  .....+.+.+|+.++++++||||+++++++...
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~-----~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   76 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDV-----DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD   76 (263)
T ss_pred             CcccccceecCCCceEEEEEEEc-----CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC
Confidence            57999999999999999999865     45778999998754322  223345688899999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      ..+++||||+++++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.....
T Consensus        77 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          77 ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             CeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            99999999999999999998888899999999999999999999999999999999999999999999999999876543


Q ss_pred             CCCC----CcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh---------------hhhHHH
Q 018487          268 SSRS----NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC---------------NTMLLF  328 (355)
Q Consensus       268 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~---------------~~~~~~  328 (355)
                      ....    ....++..|+|||++.+..++.++||||||+++|+|++|+.||...+....               .....+
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDA  236 (263)
T ss_pred             cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHH
Confidence            2211    234678899999999998899999999999999999999999976533221               122355


Q ss_pred             HHhhhheeeecCCCcC
Q 018487          329 YLIIFHCLFVNSLELL  344 (355)
Q Consensus       329 ~~~i~~~l~~~~~e~~  344 (355)
                      ..+|.+|+..+|.+++
T Consensus       237 ~~li~~~l~~~p~~Rp  252 (263)
T cd06625         237 RNFLRRTFVENAKKRP  252 (263)
T ss_pred             HHHHHHHhhcCcccCC
Confidence            6788888888887765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.4e-40  Score=312.19  Aligned_cols=201  Identities=26%  Similarity=0.406  Sum_probs=172.6

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC--
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS--  188 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--  188 (355)
                      +|++.++||+|+||.||+|.+.     .+++.||+|.+.... ......+.+.+|+.+++.++|+||+++++++...+  
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   74 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDP-----RDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHID   74 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEEC-----CCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence            4788999999999999999965     467889999986532 22333456788999999999999999999998776  


Q ss_pred             ---eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          189 ---KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       189 ---~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                         ..|+||||+.+ +|...+.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        75 ~~~~~~lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          75 PFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             ccceEEEEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence               89999999974 78888887788999999999999999999999999999999999999999999999999999865


Q ss_pred             CcCC--CCCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          266 DESS--RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       266 ~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      ....  ......+++.|+|||++.+. .++.++|||||||++|||++|+.||...+
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  209 (372)
T cd07853         154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS  209 (372)
T ss_pred             ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence            3222  22334678999999999874 57899999999999999999999997654

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.1e-40  Score=332.16  Aligned_cols=232  Identities=26%  Similarity=0.480  Sum_probs=190.0

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      ...++|+++++||+|+||+||+|.++     ..++.||+|++..... .......+..|+.+++.++|||||+++++|..
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk-----~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d   83 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHK-----RTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLN   83 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEEC-----CCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence            34568999999999999999999977     4677899999876543 33345668889999999999999999998854


Q ss_pred             --CCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-------CCeeccCCCCcEEecC---
Q 018487          187 --RSKLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKC-------GIVHRDLKPENILMDS---  250 (355)
Q Consensus       187 --~~~~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~ql~~~L~~LH~~-------~iiHrDlkp~NILl~~---  250 (355)
                        ...+||||||+++++|..++...    +.+++..++.|+.||+.||.|||+.       +||||||||+||||+.   
T Consensus        84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~  163 (1021)
T PTZ00266         84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR  163 (1021)
T ss_pred             cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence              45799999999999999888652    5699999999999999999999985       4999999999999964   


Q ss_pred             --------------CCcEEEEecCCccccCcCCCCCcccccCccccchhhcc--CCCCCcccHHHHHHHHHHHHcCCCCC
Q 018487          251 --------------DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQVNI  314 (355)
Q Consensus       251 --------------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~elltg~~pf  314 (355)
                                    .+.+||+|||++..+.........+||+.|+|||++.+  ..++.++|||||||+||+|+||+.||
T Consensus       164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF  243 (1021)
T PTZ00266        164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF  243 (1021)
T ss_pred             ccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence                          23489999999987755444456679999999999864  45889999999999999999999999


Q ss_pred             CCchhhhhh--------------hhHHHHHhhhheeeecCCCcC
Q 018487          315 KSMQVIACN--------------TMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       315 ~~~~~~~~~--------------~~~~~~~~i~~~l~~~~~e~~  344 (355)
                      ...+.....              ....+..+|..||..+|.+++
T Consensus       244 ~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRP  287 (1021)
T PTZ00266        244 HKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERP  287 (1021)
T ss_pred             CcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCc
Confidence            764321110              122467788888888877765

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.6e-40  Score=302.49  Aligned_cols=201  Identities=24%  Similarity=0.436  Sum_probs=171.8

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|.+.++||+|+||.||+|.++     .+++.||+|.++....  ......+.+|+.++++++|+||+++++++..++.
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   78 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSK-----LTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKS   78 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEec-----CCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCe
Confidence            57999999999999999999876     4567899999875432  2223346679999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      .|+||||+++ +|..++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  157 (309)
T cd07872          79 LTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP  157 (309)
T ss_pred             EEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence            9999999986 777777654 45899999999999999999999999999999999999999999999999998765332


Q ss_pred             C-CCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          269 S-RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       269 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      . ......+++.|+|||++.+ ..++.++|||||||++|+|+||+.||...+
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~  209 (309)
T cd07872         158 TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST  209 (309)
T ss_pred             ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            2 2234567899999999875 468899999999999999999999997654

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=7.7e-40  Score=300.91  Aligned_cols=200  Identities=30%  Similarity=0.479  Sum_probs=177.2

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++.+.||+|+||.||++.+.     .++..+++|.+....  .......+.+|++++++++||||+++++.+..++.
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~-----~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   73 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHR-----PSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGE   73 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEc-----CCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCE
Confidence            36999999999999999999876     456779999886542  23345567889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      +|+||||+++++|.+++...+.+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++......
T Consensus        74 ~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (308)
T cd06615          74 ISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  153 (308)
T ss_pred             EEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence            99999999999999999888889999999999999999999997 69999999999999999999999999998765433


Q ss_pred             CCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      . .....|+..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus       154 ~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~  201 (308)
T cd06615         154 M-ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP  201 (308)
T ss_pred             c-cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence            2 34457899999999998888999999999999999999999999643

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=5.7e-40  Score=298.45  Aligned_cols=200  Identities=30%  Similarity=0.418  Sum_probs=167.5

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc---CCCcceecceeeec-
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV---THPFIVQLRYSFQT-  186 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~-  186 (355)
                      +|++++.||+|+||+||+|.++     .+++.||+|.++...... .....+.+|+.+++.+   +||||+++++++.. 
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~   74 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDP-----HSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATS   74 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence            5899999999999999999976     567889999987643222 1122344566666554   79999999998764 


Q ss_pred             ----CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecC
Q 018487          187 ----RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG  260 (355)
Q Consensus       187 ----~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg  260 (355)
                          ...+++||||+.+ +|..++...  ..+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        75 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg  153 (288)
T cd07863          75 RTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFG  153 (288)
T ss_pred             cCCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccC
Confidence                3468999999985 787887654  348999999999999999999999999999999999999999999999999


Q ss_pred             CccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       261 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      ++.............|+..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~  210 (288)
T cd07863         154 LARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN  210 (288)
T ss_pred             ccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence            998765444444567899999999999889999999999999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=5.3e-40  Score=293.75  Aligned_cols=200  Identities=37%  Similarity=0.648  Sum_probs=178.2

Q ss_pred             eEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEE
Q 018487          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (355)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  191 (355)
                      |+++++||+|+||+||+|...     ..++.||+|++......... .....+|+.++++++|+||+++++++......+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~-----~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~   74 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNK-----KNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLY   74 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEET-----TTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEEC-----CCCeEEEEEEeccccccccc-cchhhhhhhcccccccccccccccccccccccc
Confidence            889999999999999999977     56678999999876543332 223455999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc-CcCCC
Q 018487          192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSR  270 (355)
Q Consensus       192 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~-~~~~~  270 (355)
                      +||||+++++|.+++.....+++.++..++.|+++||.+||++|++|+||||+||+++.++.++|+|||.+... .....
T Consensus        75 ~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~  154 (260)
T PF00069_consen   75 IVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN  154 (260)
T ss_dssp             EEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999999998888999999999999999999999999999999999999999999999999999763 22333


Q ss_pred             CCcccccCccccchhhc-cCCCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          271 SNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       271 ~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      .....++..|+|||++. +..++.++||||||+++|+|++|..||...
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~  202 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES  202 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            44567899999999998 788999999999999999999999999986

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9.5e-42  Score=290.21  Aligned_cols=230  Identities=27%  Similarity=0.490  Sum_probs=197.7

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeeccccc-----chhHHHHHHHHHHHHHhcC-CCcceeccee
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-----KKNHVDYMKAERDILTKVT-HPFIVQLRYS  183 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~  183 (355)
                      ..|.-.+.||+|..++|-++.++     .+++.+|+|++......     .....+.-.+|+.||+++. ||+|+++.+.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k-----~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~   91 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHK-----ETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV   91 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhc-----ccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence            46777889999999999998876     56778999988643221     2333455667999999985 9999999999


Q ss_pred             eecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       184 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      |+.+..+++|+|.|+.|.|+++|...-.+++...+.|++|+++|++|||.++|+||||||+|||++++.++||+|||++.
T Consensus        92 yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~  171 (411)
T KOG0599|consen   92 YESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFAC  171 (411)
T ss_pred             ccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceee
Confidence            99999999999999999999999999899999999999999999999999999999999999999999999999999999


Q ss_pred             ccCcCCCCCcccccCccccchhhcc------CCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh-hh-------------
Q 018487          264 EIDESSRSNSMCGTTEYMAPEILLS------KGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA-CN-------------  323 (355)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~-~~-------------  323 (355)
                      .+.........||||+|+|||.+..      ..|+..+|+||+||+||.||.|..||.+....- ..             
T Consensus       172 ~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~spe  251 (411)
T KOG0599|consen  172 QLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPE  251 (411)
T ss_pred             ccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcc
Confidence            9988888888999999999999863      367889999999999999999999998864322 11             


Q ss_pred             ---hhHHHHHhhhheeeecCCCcC
Q 018487          324 ---TMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       324 ---~~~~~~~~i~~~l~~~~~e~~  344 (355)
                         ...-.++.|.+||+.+|..+.
T Consensus       252 Wadis~~~KdLIsrlLqVdp~~Ri  275 (411)
T KOG0599|consen  252 WADISATVKDLISRLLQVDPTKRI  275 (411)
T ss_pred             hhhccccHHHHHHHHHeeCchhcc
Confidence               111337888899999887754

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.6e-40  Score=310.07  Aligned_cols=223  Identities=28%  Similarity=0.410  Sum_probs=186.2

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ...+|++++.||+|+||.||+|...+.   ..++.|++|.+....        ...+|+++|+.++||||+++++++...
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~---~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~  158 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGD---EQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWK  158 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCC---ccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeC
Confidence            346899999999999999999986532   356779999876432        245799999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      ..+|+|||++. ++|..++.....+++.+++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+..
T Consensus       159 ~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        159 STVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             CEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            99999999996 47888887778899999999999999999999999999999999999999999999999999976643


Q ss_pred             CCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhhhhHHHHHhhhheeeecCCCcC
Q 018487          268 SSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       268 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                      ...   .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+...   .......+.+|++..+.+++
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~l~~i~~~~~~~~~~~~  314 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS---SSSQLRSIIRCMQVHPLEFP  314 (392)
T ss_pred             ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC---cHHHHHHHHHHhccCccccC
Confidence            322   234579999999999999999999999999999999999999998765432   12222345566766666644


Q ss_pred             C
Q 018487          345 S  345 (355)
Q Consensus       345 ~  345 (355)
                      .
T Consensus       315 ~  315 (392)
T PHA03207        315 Q  315 (392)
T ss_pred             C
Confidence            3

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.5e-40  Score=298.57  Aligned_cols=234  Identities=22%  Similarity=0.360  Sum_probs=194.6

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|.+.+.||+|+||.||+|......+....+.||+|+++...  ..+..+.+.+|+++++.++|+||+++++++....
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   81 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEGD   81 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence            45799999999999999999987654434567889999987543  2334567889999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcE
Q 018487          189 KLYLILDFINGGHLFFHLYRQG--------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV  254 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~--------------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~  254 (355)
                      ..|+||||+++++|.+++...+              .+++.++..++.|++.||.|||++|++||||||+||+++.++.+
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence            9999999999999999987543              37888999999999999999999999999999999999999999


Q ss_pred             EEEecCCccccCcCC---CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------
Q 018487          255 MLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------  322 (355)
Q Consensus       255 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------  322 (355)
                      ||+|||++.......   ......+++.|+|||++.+..++.++|||||||++|||++ |..||...+....        
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~  241 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGR  241 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence            999999987653222   1223345788999999999999999999999999999998 9999976432221        


Q ss_pred             ------hhhHHHHHhhhheeeecCCCcC
Q 018487          323 ------NTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       323 ------~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                            .....+.+++.+||+.+|.+++
T Consensus       242 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp  269 (280)
T cd05049         242 LLQRPRTCPSEVYDIMLGCWKRDPQQRI  269 (280)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCcccCC
Confidence                  1123567888899988888865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=5.6e-40  Score=295.14  Aligned_cols=231  Identities=25%  Similarity=0.429  Sum_probs=194.4

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++.+.||+|+||.||+|.++     .+++.||+|.+.............+.+|+.+++.++||||+++++++...+.
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCL-----LDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEe-----CCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCe
Confidence            58999999999999999999976     4577899998876444455556678889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          190 LYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      .+++|||+++++|..++..    ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~  156 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence            9999999999999887753    345899999999999999999999999999999999999999999999999998866


Q ss_pred             CcCCC-CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhh--h---------------hhhhHH
Q 018487          266 DESSR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVI--A---------------CNTMLL  327 (355)
Q Consensus       266 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~--~---------------~~~~~~  327 (355)
                      ..... .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||......  .               ......
T Consensus       157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08228         157 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEK  236 (267)
T ss_pred             cchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHH
Confidence            43221 22346888999999999888999999999999999999999999654211  0               012235


Q ss_pred             HHHhhhheeeecCCCcCC
Q 018487          328 FYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       328 ~~~~i~~~l~~~~~e~~~  345 (355)
                      +.+++.+|+..+|.+++.
T Consensus       237 ~~~li~~cl~~~p~~Rp~  254 (267)
T cd08228         237 LRELVSMCIYPDPDQRPD  254 (267)
T ss_pred             HHHHHHHHCCCCcccCcC
Confidence            778888999888888663

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-41  Score=306.52  Aligned_cols=228  Identities=32%  Similarity=0.496  Sum_probs=196.5

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      +=|.+.+-||+|.|.+|-+|++.     .+++.||||++.+....+-. ...+.+|++.|+.++|||||++|++......
T Consensus        18 GLYDLekTlG~GHFAVVKLArHV-----FTGekVAVKviDKTKlD~~s-t~hlfqEVRCMKLVQHpNiVRLYEViDTQTK   91 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHV-----FTGEKVAVKVIDKTKLDTLS-TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTK   91 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhh-----cccceeEEEEecccccchhh-hhHHHHHHHHHHHhcCcCeeeeeehhcccce
Confidence            56888999999999999999876     78899999999887754433 3346679999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEec-CCCcEEEEecCCccccCc
Q 018487          190 LYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~-~~~~~kl~Dfg~a~~~~~  267 (355)
                      +|+|+|+-++|+|++++.++. -++|+.++.++.||+.|+.|+|+..++||||||+||.+- .-|-|||.|||++..+..
T Consensus        92 lyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   92 LYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             EEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            999999999999999998774 499999999999999999999999999999999999875 458999999999999998


Q ss_pred             CCCCCcccccCccccchhhccCCCC-CcccHHHHHHHHHHHHcCCCCCCCchhhhhhhhH-------------HHHHhhh
Q 018487          268 SSRSNSMCGTTEYMAPEILLSKGHN-KDADWWSVGILLYEMLTGQVNIKSMQVIACNTML-------------LFYLIIF  333 (355)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~elltg~~pf~~~~~~~~~~~~-------------~~~~~i~  333 (355)
                      .....+.||+..|-|||++.|..|+ +++||||||||||-|++|+.||...+....-.++             --++.|-
T Consensus       172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~  251 (864)
T KOG4717|consen  172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQ  251 (864)
T ss_pred             cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHH
Confidence            8888999999999999999999886 5789999999999999999999986543332222             1144555


Q ss_pred             heeeecCCCc
Q 018487          334 HCLFVNSLEL  343 (355)
Q Consensus       334 ~~l~~~~~e~  343 (355)
                      ..|+++|.++
T Consensus       252 sMLvRdPkkR  261 (864)
T KOG4717|consen  252 SMLVRDPKKR  261 (864)
T ss_pred             HHHhcCchhh
Confidence            6666666654

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=4.4e-40  Score=294.48  Aligned_cols=231  Identities=40%  Similarity=0.695  Sum_probs=201.3

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      +|++.+.||.|+||.||+|.++     .+++.|++|++.+.........+.+.+|++++++++||||+++++.+..+...
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKR-----DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEc-----cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeE
Confidence            4899999999999999999866     46778999999876555555677888999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCC
Q 018487          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR  270 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~  270 (355)
                      ++||||+.+++|..++.....+++..+..++.|+++||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~  155 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL  155 (258)
T ss_pred             EEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence            99999999999999998887899999999999999999999999999999999999999999999999999987655444


Q ss_pred             CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchh---hh-------------hhhhHHHHHhhhh
Q 018487          271 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQV---IA-------------CNTMLLFYLIIFH  334 (355)
Q Consensus       271 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~---~~-------------~~~~~~~~~~i~~  334 (355)
                      .....|+..|+|||++.+..++.++|+||||+++|+|++|+.||...+.   ..             ......+..+|.+
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  235 (258)
T cd05578         156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINK  235 (258)
T ss_pred             ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHH
Confidence            4456788999999999988899999999999999999999999987542   10             1122466788889


Q ss_pred             eeeecCCCcCCC
Q 018487          335 CLFVNSLELLSH  346 (355)
Q Consensus       335 ~l~~~~~e~~~~  346 (355)
                      ||.++|.++...
T Consensus       236 ~l~~~p~~R~~~  247 (258)
T cd05578         236 LLERDPQKRLGD  247 (258)
T ss_pred             HccCChhHcCCc
Confidence            999888887643

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-41  Score=286.58  Aligned_cols=230  Identities=29%  Similarity=0.428  Sum_probs=191.4

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecceeeecC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTR  187 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~  187 (355)
                      .++.+.+..||.|..|+||+++.+     .++..+|||.+++..  ..+..+++...++++...+ .|+||+.+|+|..+
T Consensus        91 indl~~l~dlGsGtcG~V~k~~~r-----s~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n  163 (391)
T KOG0983|consen   91 INDLENLGDLGSGTCGQVWKMRFR-----STGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN  163 (391)
T ss_pred             hHHhhhHHhhcCCCccceEEEEEc-----ccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC
Confidence            345677889999999999999988     568899999998764  4555667777887766655 89999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          188 SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      ..+++.||.|.. -+..++.+ .++++|..+-.+...++.||.||-+ +||||||+||+|||+|+.|++||||||++..+
T Consensus       164 ~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrl  242 (391)
T KOG0983|consen  164 TDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRL  242 (391)
T ss_pred             chHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccccccee
Confidence            999999999854 34444433 3679999999999999999999985 58999999999999999999999999999998


Q ss_pred             CcCCCCCcccccCccccchhhcc---CCCCCcccHHHHHHHHHHHHcCCCCCCCc--hhhh-----hh----------hh
Q 018487          266 DESSRSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQVNIKSM--QVIA-----CN----------TM  325 (355)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~~l~elltg~~pf~~~--~~~~-----~~----------~~  325 (355)
                      .++.......|.+.|||||.+.-   ..|+.++||||||++++||.||+.||+..  +...     ++          ..
T Consensus       243 vdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFS  322 (391)
T KOG0983|consen  243 VDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFS  322 (391)
T ss_pred             ecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcC
Confidence            88777778889999999999864   36889999999999999999999999983  2211     11          11


Q ss_pred             HHHHHhhhheeeecCCCcCCC
Q 018487          326 LLFYLIIFHCLFVNSLELLSH  346 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~~~  346 (355)
                      -.|..++..||+++..++++.
T Consensus       323 p~F~~fv~~CL~kd~r~RP~Y  343 (391)
T KOG0983|consen  323 PDFQSFVKDCLTKDHRKRPKY  343 (391)
T ss_pred             HHHHHHHHHHhhcCcccCcch
Confidence            267889999999999887653

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=9.1e-40  Score=292.20  Aligned_cols=227  Identities=22%  Similarity=0.425  Sum_probs=188.0

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|++.+.||+|+||.||+|.++      .+..+|+|.+.....    ..+.+.+|+.++++++||||+++++++...+
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~------~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   72 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWR------AQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK   72 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEec------cCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence            457999999999999999999875      234699998764432    1245778999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      ..++||||+++|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus        73 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05114          73 PLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD  152 (256)
T ss_pred             CEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence            999999999999999988753 5689999999999999999999999999999999999999999999999999886533


Q ss_pred             CCCC--CcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhhh--------------hhHHHHH
Q 018487          268 SSRS--NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACN--------------TMLLFYL  330 (355)
Q Consensus       268 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~~--------------~~~~~~~  330 (355)
                      ....  ....++..|+|||++.+..++.++||||||+++|+|++ |+.||...+.....              ....+..
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  232 (256)
T cd05114         153 DEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYE  232 (256)
T ss_pred             CceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence            2211  12234568999999998889999999999999999999 99999875432210              1223578


Q ss_pred             hhhheeeecCCCcCC
Q 018487          331 IIFHCLFVNSLELLS  345 (355)
Q Consensus       331 ~i~~~l~~~~~e~~~  345 (355)
                      ++.+|+..+|.+++.
T Consensus       233 li~~c~~~~p~~Rps  247 (256)
T cd05114         233 VMYSCWHEKPEGRPT  247 (256)
T ss_pred             HHHHHccCCcccCcC
Confidence            888999998888653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=6.8e-40  Score=300.61  Aligned_cols=234  Identities=25%  Similarity=0.363  Sum_probs=187.2

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceeee
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQ  185 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~  185 (355)
                      +..++|++.+.||+|+||.||+|.++..   .....+++|.+...  ........+.+|+.++.++ +|+||+++++++.
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~---~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~   78 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKD---GLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACE   78 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccC---CceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC
Confidence            3456899999999999999999997621   12234577766532  2334456788899999999 8999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEec
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD  249 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~  249 (355)
                      ..+.+|+||||+++++|.+++...+                .+++.+++.++.|++.||+|||++|++||||||+|||++
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~  158 (303)
T cd05088          79 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG  158 (303)
T ss_pred             CCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEec
Confidence            9999999999999999999987543                478899999999999999999999999999999999999


Q ss_pred             CCCcEEEEecCCccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh------
Q 018487          250 SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC------  322 (355)
Q Consensus       250 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~------  322 (355)
                      .++.+||+|||++.............++..|+|||++.+..++.++|||||||++|||+| |..||...+....      
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~  238 (303)
T cd05088         159 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  238 (303)
T ss_pred             CCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence            999999999999864322111222234567999999988889999999999999999998 9999976532210      


Q ss_pred             --------hhhHHHHHhhhheeeecCCCcCC
Q 018487          323 --------NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       323 --------~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                              .....+..++.+|+..+|.+++.
T Consensus       239 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~  269 (303)
T cd05088         239 GYRLEKPLNCDDEVYDLMRQCWREKPYERPS  269 (303)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCChhhCcC
Confidence                    01234567888898888887653

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.3e-39  Score=296.36  Aligned_cols=235  Identities=22%  Similarity=0.366  Sum_probs=194.8

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      .+.+|.+.+.||+|+||.||++......+...+..+|+|.+....   ....+.+.+|+.++++++|+||+++++++...
T Consensus         3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (288)
T cd05093           3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEG   79 (288)
T ss_pred             chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            456899999999999999999987654444556779999886532   33455688899999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcE
Q 018487          188 SKLYLILDFINGGHLFFHLYRQG-------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV  254 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~-------------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~  254 (355)
                      +.+++||||+++++|.+++...+             .+++.++..++.|++.||+|||++|++||||||+|||++.++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence            99999999999999999987543             38999999999999999999999999999999999999999999


Q ss_pred             EEEecCCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh---------
Q 018487          255 MLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA---------  321 (355)
Q Consensus       255 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~---------  321 (355)
                      ||+|||++........   .....++..|+|||++.+..++.++|||||||++|+|++ |..||.......         
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~  239 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR  239 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999999986532211   123345778999999998899999999999999999998 999997653211         


Q ss_pred             -----hhhhHHHHHhhhheeeecCCCcCC
Q 018487          322 -----CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 -----~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                           ......+.+++.+|++.+|.+++.
T Consensus       240 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt  268 (288)
T cd05093         240 VLQRPRTCPKEVYDLMLGCWQREPHMRLN  268 (288)
T ss_pred             cCCCCCCCCHHHHHHHHHHccCChhhCCC
Confidence                 011235678889999999888763

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-40  Score=311.37  Aligned_cols=208  Identities=32%  Similarity=0.561  Sum_probs=191.7

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      ...+.|.+.+.||.|.|+.|.+|++.     .++..||+|++.+...... ....+.+|+++|+.++|||||+++.+...
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~-----~t~~~VaiK~idkt~ln~~-~~~k~~rev~imk~l~HPnIvkl~~v~~t  126 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHI-----LTGTEVAIKIIDKTQLNPS-KRQKLGREVDIMKSLNHPNIVKLFSVIET  126 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEec-----CCCceEEEEEehhcccChH-HHHHHHHHHHHHHhcCCcceeeeeeeeee
Confidence            34568999999999999999999977     4677899999988775444 34448889999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                      ...+|+||||+.+|.+++++.+++.+.+..++.++.|++.|++|||+++|+|||||.+||||+.+.++||+|||++..+.
T Consensus       127 ~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  127 EATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD  206 (596)
T ss_pred             cceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCcccccCccccchhhccCCC-CCcccHHHHHHHHHHHHcCCCCCCCchhh
Q 018487          267 ESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQVNIKSMQVI  320 (355)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~elltg~~pf~~~~~~  320 (355)
                      ......++||++.|.|||++.+..| .+++|+||+|+++|.|+.|.+||++....
T Consensus       207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk  261 (596)
T KOG0586|consen  207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK  261 (596)
T ss_pred             ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc
Confidence            8888899999999999999998877 57899999999999999999999975443

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.4e-41  Score=311.62  Aligned_cols=213  Identities=44%  Similarity=0.806  Sum_probs=192.2

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      ....-|..++-||-|+||.|.+|...     ++...||+|.+++.....+..+...+.|.+||..-+.+-||+||..|++
T Consensus       626 MdKSmFvkik~iGvGAFGeV~Lv~Kv-----DT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD  700 (1034)
T KOG0608|consen  626 MDKSMFVKIKTIGVGAFGEVCLVRKV-----DTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD  700 (1034)
T ss_pred             ccccceEEEeeecccccceeEEEeec-----chhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc
Confidence            44566999999999999999999866     5678899999999888888888889999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                      ++.+|+||+|++||++..+|.+.+.|.|..+++++.++.+|+++.|..|+|||||||+|||||.+|.|||.|||+|.-+.
T Consensus       701 kdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR  780 (1034)
T KOG0608|consen  701 KDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  780 (1034)
T ss_pred             CCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccce
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999997552


Q ss_pred             cCCC-------------------------------------------CCcccccCccccchhhccCCCCCcccHHHHHHH
Q 018487          267 ESSR-------------------------------------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL  303 (355)
Q Consensus       267 ~~~~-------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~  303 (355)
                      ....                                           ....+||+.|+|||++....|+..+|.||.|||
T Consensus       781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi  860 (1034)
T KOG0608|consen  781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI  860 (1034)
T ss_pred             eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence            1110                                           012479999999999999999999999999999


Q ss_pred             HHHHHcCCCCCCCchhhhhhh
Q 018487          304 LYEMLTGQVNIKSMQVIACNT  324 (355)
Q Consensus       304 l~elltg~~pf~~~~~~~~~~  324 (355)
                      ||||+.|+.||........+.
T Consensus       861 l~em~~g~~pf~~~tp~~tq~  881 (1034)
T KOG0608|consen  861 LYEMLVGQPPFLADTPGETQY  881 (1034)
T ss_pred             HHHHhhCCCCccCCCCCccee
Confidence            999999999998876555443

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.7e-39  Score=288.60  Aligned_cols=229  Identities=29%  Similarity=0.501  Sum_probs=194.7

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      +|.+.+.||+|++|.||+|.++     .+++.|++|.+...... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~-----~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRK-----ADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKL   74 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEc-----CCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEE
Confidence            5889999999999999999976     45778999998765432 34456688899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      |+||||+++++|.+++...  ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..+...
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~  154 (256)
T cd08529          75 NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN  154 (256)
T ss_pred             EEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence            9999999999999998764  56899999999999999999999999999999999999999999999999998866443


Q ss_pred             CC-CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh--------------hhhHHHHHhhh
Q 018487          269 SR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC--------------NTMLLFYLIIF  333 (355)
Q Consensus       269 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~--------------~~~~~~~~~i~  333 (355)
                      .. .....|++.|+|||++.+..++.++||||||+++|+|++|+.||...+....              .....+..++.
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  234 (256)
T cd08529         155 TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLID  234 (256)
T ss_pred             cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHH
Confidence            22 2345688999999999988899999999999999999999999987643211              11234677888


Q ss_pred             heeeecCCCcCC
Q 018487          334 HCLFVNSLELLS  345 (355)
Q Consensus       334 ~~l~~~~~e~~~  345 (355)
                      +|++.+|.+++.
T Consensus       235 ~~l~~~p~~Rp~  246 (256)
T cd08529         235 QCLTKDYRQRPD  246 (256)
T ss_pred             HHccCCcccCcC
Confidence            999888888764

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.1e-39  Score=297.58  Aligned_cols=231  Identities=40%  Similarity=0.651  Sum_probs=195.9

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++.+.||+|+||.||++.++     ..++.|++|.+...........+.+.+|+++++.++||||+++++.+..++.
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   75 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHK-----ETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRH   75 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEEC-----CCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCE
Confidence            37999999999999999999976     4577899999876644344455678889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      +++||||++|++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++......
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          76 LCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            99999999999999999888889999999999999999999999999999999999999999999999999886321100


Q ss_pred             ----------------CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh---h--------
Q 018487          270 ----------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA---C--------  322 (355)
Q Consensus       270 ----------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~---~--------  322 (355)
                                      ......++..|+|||.+.+..++.++||||||+++|||++|..||.+.+...   .        
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~  235 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW  235 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC
Confidence                            0112457889999999988889999999999999999999999998653221   0        


Q ss_pred             -----hhhHHHHHhhhheeeecCCCcCC
Q 018487          323 -----NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       323 -----~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                           .....+..++.+|++.+|.+++.
T Consensus       236 ~~~~~~~~~~~~~li~~~l~~~P~~R~~  263 (305)
T cd05609         236 PEGDEALPADAQDLISRLLRQNPLERLG  263 (305)
T ss_pred             CCccccCCHHHHHHHHHHhccChhhccC
Confidence                 11234688999999999998764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-39  Score=289.44  Aligned_cols=229  Identities=27%  Similarity=0.491  Sum_probs=194.2

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|++.+.||.|+||.||+|.++     .+++.+++|++.....   ...+.+.+|+.+++.++||||+++++.+..+.
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   73 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDI-----ATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRD   73 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEec-----CCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence            368999999999999999999976     4567799999876432   24567888999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      .+|++|||+++++|.+++... ..+++.++..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++..+..
T Consensus        74 ~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          74 KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             EEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhh
Confidence            999999999999999988776 6799999999999999999999999999999999999999999999999999886643


Q ss_pred             CC-CCCcccccCccccchhhccC---CCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh------------------hhh
Q 018487          268 SS-RSNSMCGTTEYMAPEILLSK---GHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC------------------NTM  325 (355)
Q Consensus       268 ~~-~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~------------------~~~  325 (355)
                      .. ......++..|+|||++.+.   .++.++||||||+++|+|+||+.||...+....                  ...
T Consensus       154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (262)
T cd06613         154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWS  233 (262)
T ss_pred             hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhh
Confidence            32 23345688899999999876   788999999999999999999999976532111                  011


Q ss_pred             HHHHHhhhheeeecCCCcCC
Q 018487          326 LLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ..+.+++.+|+..+|.+++.
T Consensus       234 ~~~~~li~~~l~~~p~~Rpt  253 (262)
T cd06613         234 PVFHDFIKKCLTKDPKKRPT  253 (262)
T ss_pred             HHHHHHHHHHcCCChhhCCC
Confidence            24568888999888887653

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.4e-39  Score=294.88  Aligned_cols=224  Identities=26%  Similarity=0.415  Sum_probs=188.8

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++++.||+|+||.||+|.+.     .+++.||+|++....  .......+.+|+.++++++||||+++++.+...+.
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   73 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHL-----LTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENR   73 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEc-----CCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCE
Confidence            36889999999999999999866     467889999987543  23344568889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      .++||||+++++|..+    ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++..+....
T Consensus        74 ~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~  149 (279)
T cd06619          74 ISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI  149 (279)
T ss_pred             EEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence            9999999999988544    347889999999999999999999999999999999999999999999999998664332


Q ss_pred             CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh----------------------hhhhHH
Q 018487          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA----------------------CNTMLL  327 (355)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~----------------------~~~~~~  327 (355)
                       ....+|+..|+|||++.+..++.++||||||+++|+|++|+.||.......                      ......
T Consensus       150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (279)
T cd06619         150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEK  228 (279)
T ss_pred             -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHH
Confidence             334578999999999999899999999999999999999999996532110                      011224


Q ss_pred             HHHhhhheeeecCCCcCC
Q 018487          328 FYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       328 ~~~~i~~~l~~~~~e~~~  345 (355)
                      +.++|.+|++++|.+++.
T Consensus       229 ~~~li~~~l~~~P~~Rp~  246 (279)
T cd06619         229 FVHFITQCMRKQPKERPA  246 (279)
T ss_pred             HHHHHHHHhhCChhhCCC
Confidence            677888999998888753

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-39  Score=294.14  Aligned_cols=237  Identities=22%  Similarity=0.312  Sum_probs=195.4

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +..++|++.+.||+|+||.||+|..+........+.||+|.+....  .......+.+|+.+++.++|+||+++++++..
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (277)
T cd05032           3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVST   80 (277)
T ss_pred             cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence            4557899999999999999999998765545567889999986543  22334567789999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEE
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQG----------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML  256 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~----------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl  256 (355)
                      ....++||||+++++|.+++....          .+++..+..++.|++.||.|||+.+++||||||+|||++.++.+||
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence            999999999999999999886532          3678889999999999999999999999999999999999999999


Q ss_pred             EecCCccccCcCC---CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh-----------
Q 018487          257 TDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA-----------  321 (355)
Q Consensus       257 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~-----------  321 (355)
                      +|||+++.+....   ......++..|+|||++.+..++.++|||||||++|||+| |+.||...+...           
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~  240 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL  240 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCC
Confidence            9999987654322   1223456788999999988889999999999999999998 999997643221           


Q ss_pred             ---hhhhHHHHHhhhheeeecCCCcCC
Q 018487          322 ---CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 ---~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                         ......+..+|.+|++.+|.+++.
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rpt  267 (277)
T cd05032         241 DLPENCPDKLLELMRMCWQYNPKMRPT  267 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCCC
Confidence               112235578888999888888653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.5e-39  Score=292.44  Aligned_cols=228  Identities=27%  Similarity=0.432  Sum_probs=190.7

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|++.+.||+|+||.||+|.++     .+++.||+|++....   ......+.+|+.++++++|+||+++++++..+.
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~-----~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~   79 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNL-----HTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE   79 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEEC-----CCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Confidence            457999999999999999999976     456789999986542   223345778999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      .+|+||||+++++|.+++...+.+++.++..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++..+...
T Consensus        80 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06646          80 KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT  159 (267)
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999999876432


Q ss_pred             C-CCCcccccCccccchhhc---cCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh------------------hhhH
Q 018487          269 S-RSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC------------------NTML  326 (355)
Q Consensus       269 ~-~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~------------------~~~~  326 (355)
                      . ......|+..|+|||.+.   ...++.++|||||||++|||++|+.||........                  ....
T Consensus       160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd06646         160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSS  239 (267)
T ss_pred             ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCH
Confidence            2 223456889999999985   34578899999999999999999999965432110                  1123


Q ss_pred             HHHHhhhheeeecCCCcC
Q 018487          327 LFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       327 ~~~~~i~~~l~~~~~e~~  344 (355)
                      .+.+.|.+||..+|.+++
T Consensus       240 ~~~~li~~~l~~~P~~Rp  257 (267)
T cd06646         240 TFHNFVKISLTKNPKKRP  257 (267)
T ss_pred             HHHHHHHHHhhCChhhCc
Confidence            556788888888777764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.6e-39  Score=299.85  Aligned_cols=233  Identities=23%  Similarity=0.356  Sum_probs=189.0

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ...+|++.+.||+|+||.||+|.+..... .....||+|+++...  .....+.+.+|+.+++.++||||+++++++...
T Consensus         5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~   81 (316)
T cd05108           5 KETEFKKIKVLGSGAFGTVYKGLWIPEGE-KVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   81 (316)
T ss_pred             chhhceeeeeeecCCCceEEEEEEecCCC-ccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence            44689999999999999999998763221 223458999986432  233456688899999999999999999998764


Q ss_pred             CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                       ..++++||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence             578999999999999998875 458899999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCC---CcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhhh--------------hhHHH
Q 018487          267 ESSRS---NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACN--------------TMLLF  328 (355)
Q Consensus       267 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~~--------------~~~~~  328 (355)
                      .....   ....++..|+|||++.+..++.++|||||||++|||++ |+.||.........              ....+
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV  240 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence            33321   12234668999999999999999999999999999998 99999875432110              12346


Q ss_pred             HHhhhheeeecCCCcC
Q 018487          329 YLIIFHCLFVNSLELL  344 (355)
Q Consensus       329 ~~~i~~~l~~~~~e~~  344 (355)
                      ..++.+|+..+|.+++
T Consensus       241 ~~li~~cl~~~p~~Rp  256 (316)
T cd05108         241 YMIMVKCWMIDADSRP  256 (316)
T ss_pred             HHHHHHHccCChhhCc
Confidence            7788899988877764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.7e-39  Score=296.20  Aligned_cols=234  Identities=23%  Similarity=0.371  Sum_probs=194.4

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ..++|.+.+.||+|+||.||+|...+.........+++|.+....   ....+.+.+|+.++++++|+||+++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (291)
T cd05094           3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDG   79 (291)
T ss_pred             chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence            346799999999999999999987655444566779999876433   23335678899999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCC
Q 018487          188 SKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD  251 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~  251 (355)
                      +..++||||+++++|.+++....                .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~  159 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN  159 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence            99999999999999999987543                37889999999999999999999999999999999999999


Q ss_pred             CcEEEEecCCccccCcCC---CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh------
Q 018487          252 GHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA------  321 (355)
Q Consensus       252 ~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~------  321 (355)
                      +.++|+|||++.......   ......++..|+|||++.+..++.++||||||+++|||+| |+.||.......      
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~  239 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT  239 (291)
T ss_pred             CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence            999999999997653322   1223456788999999999999999999999999999999 999986643211      


Q ss_pred             --------hhhhHHHHHhhhheeeecCCCcC
Q 018487          322 --------CNTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       322 --------~~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                              ......+.+++.+|++++|.+++
T Consensus       240 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp  270 (291)
T cd05094         240 QGRVLERPRVCPKEVYDIMLGCWQREPQQRL  270 (291)
T ss_pred             CCCCCCCCccCCHHHHHHHHHHcccChhhCc
Confidence                    11123567889999999888876

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.1e-39  Score=294.17  Aligned_cols=234  Identities=20%  Similarity=0.334  Sum_probs=191.4

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      ..+|++.++||+|+||+||+|.+.... ...++.|++|.+....  .......+.+|+.+++.++|+||+++++++....
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~-~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   80 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPG-MDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ   80 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCC-CCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence            357999999999999999999864222 2356789999987532  2344466888999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCC
Q 018487          189 KLYLILDFINGGHLFFHLYRQ-----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD  251 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~-----------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~  251 (355)
                      ..|+||||+++++|.+++...                 ..+++.++..++.|++.||.|||++|++||||||+|||++.+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~  160 (283)
T cd05090          81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence            999999999999999988533                 237888899999999999999999999999999999999999


Q ss_pred             CcEEEEecCCccccCcCC---CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh------
Q 018487          252 GHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA------  321 (355)
Q Consensus       252 ~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~------  321 (355)
                      +.+||+|||++.......   ......++..|+|||++.+..++.++||||||+++|||++ |..||.......      
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~  240 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR  240 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            999999999998653322   1223345678999999988889999999999999999999 999997643211      


Q ss_pred             --------hhhhHHHHHhhhheeeecCCCcCC
Q 018487          322 --------CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 --------~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                              ......+.+++.+|+..+|.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~  272 (283)
T cd05090         241 KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPR  272 (283)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHcccCcccCcC
Confidence                    112345677888999888888663

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.1e-39  Score=295.05  Aligned_cols=238  Identities=20%  Similarity=0.293  Sum_probs=193.1

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      .+..++|++.++||+|+||.||+|..+.......+..||+|.+....  .......+.+|+.+++.++|+||+++++++.
T Consensus         2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   79 (288)
T cd05061           2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVS   79 (288)
T ss_pred             cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            45567899999999999999999987654444556789999876443  2223345678999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEE
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQG----------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM  255 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~~----------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~k  255 (355)
                      .....|+||||+++|+|.+++....          .+....+..++.|++.||.|||+++|+||||||+|||++.++.++
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence            9999999999999999999997532          245678889999999999999999999999999999999999999


Q ss_pred             EEecCCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh---------
Q 018487          256 LTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC---------  322 (355)
Q Consensus       256 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~---------  322 (355)
                      |+|||+++.......   .....++..|+|||.+.+..++.++|||||||++|||++ |..||...+....         
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~  239 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY  239 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            999999876532221   122345678999999998889999999999999999999 7889976543221         


Q ss_pred             -----hhhHHHHHhhhheeeecCCCcCC
Q 018487          323 -----NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       323 -----~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                           .....+..++.+|+..+|.+++.
T Consensus       240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps  267 (288)
T cd05061         240 LDQPDNCPERVTDLMRMCWQFNPKMRPT  267 (288)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhHCcC
Confidence                 11245678888999998888653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.6e-39  Score=288.97  Aligned_cols=228  Identities=30%  Similarity=0.516  Sum_probs=192.4

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      +|++.++||+|+||.||++.++     .+++.+++|.++...  .....+.+.+|+.+++.++|+||+++++.+..++.+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   73 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHV-----NSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHL   73 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEc-----CCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence            5899999999999999999976     456789999986543  233456677899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      |++|||+++++|.+++...  ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus        74 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  153 (255)
T cd08219          74 YIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP  153 (255)
T ss_pred             EEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence            9999999999998887653  45899999999999999999999999999999999999999999999999999866433


Q ss_pred             CC-CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh--------------hhhHHHHHhhh
Q 018487          269 SR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC--------------NTMLLFYLIIF  333 (355)
Q Consensus       269 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~--------------~~~~~~~~~i~  333 (355)
                      .. .....|+..|+|||++.+..++.++||||||+++|+|++|+.||...+....              .....+.++|.
T Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  233 (255)
T cd08219         154 GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIK  233 (255)
T ss_pred             ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHH
Confidence            22 2345688999999999988899999999999999999999999987643221              11224567888


Q ss_pred             heeeecCCCcCC
Q 018487          334 HCLFVNSLELLS  345 (355)
Q Consensus       334 ~~l~~~~~e~~~  345 (355)
                      +||.++|.+++.
T Consensus       234 ~~l~~~P~~Rp~  245 (255)
T cd08219         234 QMFKRNPRSRPS  245 (255)
T ss_pred             HHHhCCcccCCC
Confidence            888888888653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3.6e-39  Score=292.67  Aligned_cols=203  Identities=27%  Similarity=0.423  Sum_probs=175.7

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++.+.||+|+||.||+|.++     .+++.||+|++..... .....+.+.+|+.+++.++|+||+++++++.....
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   74 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNR-----ETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRK   74 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEEC-----CCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCE
Confidence            47999999999999999999976     4577899999865432 22233456789999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      .++||||+++++|..++.....+++.++..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus        75 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          75 LHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             EEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            99999999999888777766779999999999999999999999999999999999999999999999999998764433


Q ss_pred             -CCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          270 -RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       270 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                       ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~  205 (286)
T cd07847         155 DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS  205 (286)
T ss_pred             ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence             2234457889999999876 457889999999999999999999997653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-39  Score=304.52  Aligned_cols=200  Identities=27%  Similarity=0.472  Sum_probs=170.5

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC-
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-  187 (355)
                      .++|++++.||+|+||+||+|.+.     .+++.||+|++..... .....+.+.+|+.+++.++|+||+++++++... 
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDT-----RLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT   87 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEEC-----CCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence            468999999999999999999876     4677899999875432 223345567899999999999999999887543 


Q ss_pred             -----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       188 -----~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                           ...|++|+++ +++|..++. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        88 ~~~~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          88 SIENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             cccccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccc
Confidence                 4579999998 668876664 456899999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCCCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          263 KEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      ......  ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+
T Consensus       166 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  220 (343)
T cd07878         166 RQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND  220 (343)
T ss_pred             eecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence            876443  334578999999999976 568899999999999999999999998653

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-39  Score=297.35  Aligned_cols=231  Identities=42%  Similarity=0.704  Sum_probs=196.4

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++.+.||+|+||.||+|...     .+++.||+|.+...........+.+.+|+++++.++|+||+++++.+.....
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   75 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLK-----GTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETY   75 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEc-----CCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCE
Confidence            37999999999999999999876     3577899999987655444556678889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          190 LYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      .|+||||+.+++|.+++...  ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            99999999999999988764  4689999999999999999999999999999999999999999999999999875432


Q ss_pred             CC------------------------------CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          268 SS------------------------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       268 ~~------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      ..                              ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            11                              112346888999999999888999999999999999999999999765


Q ss_pred             hhhhhh---------------hhHHHHHhhhheeeecCCCcCC
Q 018487          318 QVIACN---------------TMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       318 ~~~~~~---------------~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      +....-               ....+..+|.+|+.++|.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s  278 (316)
T cd05574         236 NRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLG  278 (316)
T ss_pred             chHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCC
Confidence            432110               1335678888999988888765

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.5e-39  Score=290.12  Aligned_cols=230  Identities=23%  Similarity=0.385  Sum_probs=190.5

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      .+..++|+++++||+|+||.||+|...      .+..||+|.+....    ...+.+.+|+.+++.++|+||+++++.+.
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~------~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   71 (261)
T cd05072           2 EIPRESIKLVKKLGAGQFGEVWMGYYN------NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVT   71 (261)
T ss_pred             cCchHHeEEeeecCCcCCceEEEEEec------CCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            355678999999999999999999864      24569999876432    12456788999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      ..+..+++|||+++++|.+++...  ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||++.
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~  151 (261)
T cd05072          72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR  151 (261)
T ss_pred             CCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccce
Confidence            999999999999999999988754  458889999999999999999999999999999999999999999999999998


Q ss_pred             ccCcCCC--CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhhH
Q 018487          264 EIDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTML  326 (355)
Q Consensus       264 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~~  326 (355)
                      .......  .....++..|+|||++.+..++.++|||||||++|+|+| |+.||........              ....
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (261)
T cd05072         152 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPD  231 (261)
T ss_pred             ecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence            7643221  122335678999999988889999999999999999998 9999976432210              1123


Q ss_pred             HHHHhhhheeeecCCCcCC
Q 018487          327 LFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       327 ~~~~~i~~~l~~~~~e~~~  345 (355)
                      .+..++.+|+..+|.+++.
T Consensus       232 ~~~~li~~~l~~~p~~Rp~  250 (261)
T cd05072         232 ELYDIMKTCWKEKAEERPT  250 (261)
T ss_pred             HHHHHHHHHccCCcccCcC
Confidence            5677888998888887653

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.8e-39  Score=292.60  Aligned_cols=236  Identities=22%  Similarity=0.362  Sum_probs=191.0

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ..++|.+.+.||+|+||.||+|.++..........|++|.+....  .......+.+|+.+++.++|+||+++++++...
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER   81 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            346799999999999999999998753333467789999876443  233345577899999999999999999999988


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC---cEEEE
Q 018487          188 SKLYLILDFINGGHLFFHLYRQG-------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVMLT  257 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~-------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~---~~kl~  257 (355)
                      ...++||||+++++|.+++....       .+++.++..++.||+.||.|||+++++||||||+|||++.++   .+||+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence            89999999999999999987653       488999999999999999999999999999999999998655   59999


Q ss_pred             ecCCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhhh----------
Q 018487          258 DFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACN----------  323 (355)
Q Consensus       258 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~~----------  323 (355)
                      |||+++.+.....   ......+..|+|||++.+..++.++|||||||++|||++ |+.||.........          
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~  241 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD  241 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence            9999987632221   112233567999999998899999999999999999997 99999875322111          


Q ss_pred             ----hhHHHHHhhhheeeecCCCcCC
Q 018487          324 ----TMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       324 ----~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                          ....+..++.+|++.+|.+++.
T Consensus       242 ~~~~~~~~~~~~i~~cl~~~p~~Rps  267 (277)
T cd05036         242 PPKGCPGPVYRIMTDCWQHTPEDRPN  267 (277)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcC
Confidence                1124567888999988888653

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=9.4e-40  Score=293.80  Aligned_cols=228  Identities=28%  Similarity=0.453  Sum_probs=191.1

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|++.+.||+|+||.||+|.+.     .+++.||+|+++...   ......+.+|+.+++.++||||+++++.+...+
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~   79 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNV-----NTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD   79 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEc-----CCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence            357889999999999999999876     457789999987543   223345778999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      .+|+||||+++++|.+++...+.+++.++..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06645          80 KLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT  159 (267)
T ss_pred             EEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence            99999999999999999988889999999999999999999999999999999999999999999999999998765432


Q ss_pred             C-CCCcccccCccccchhhc---cCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh------------------hhhH
Q 018487          269 S-RSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC------------------NTML  326 (355)
Q Consensus       269 ~-~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~------------------~~~~  326 (355)
                      . ......|+..|+|||++.   ...++.++|||||||++|+|++|..||........                  ....
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd06645         160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSN  239 (267)
T ss_pred             ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCH
Confidence            2 223457899999999974   45688899999999999999999999865432110                  0112


Q ss_pred             HHHHhhhheeeecCCCcC
Q 018487          327 LFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       327 ~~~~~i~~~l~~~~~e~~  344 (355)
                      .+..+|.+||..+|.+++
T Consensus       240 ~~~~li~~~l~~~P~~R~  257 (267)
T cd06645         240 SFHHFVKMALTKNPKKRP  257 (267)
T ss_pred             HHHHHHHHHccCCchhCc
Confidence            456788889988888765

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5.6e-39  Score=288.38  Aligned_cols=231  Identities=26%  Similarity=0.424  Sum_probs=194.6

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++.+.||+|+||.||+|...     .+++.|++|.++..........+.+.+|+.++++++|+||+++++.+...+.
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICL-----LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEc-----CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence            58999999999999999999976     4577899999876544445556678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          190 LYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      .++||||+++++|..++..    ...+++.++..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++..+
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~  156 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence            9999999999999888864    245899999999999999999999999999999999999999999999999998765


Q ss_pred             CcCCC-CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh-----------------hhhhHH
Q 018487          266 DESSR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA-----------------CNTMLL  327 (355)
Q Consensus       266 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~-----------------~~~~~~  327 (355)
                      ..... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||.......                 ......
T Consensus       157 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08224         157 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEE  236 (267)
T ss_pred             cCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHH
Confidence            43322 234568899999999998889999999999999999999999996542110                 012225


Q ss_pred             HHHhhhheeeecCCCcCC
Q 018487          328 FYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       328 ~~~~i~~~l~~~~~e~~~  345 (355)
                      +..+|.+|+..+|.+++.
T Consensus       237 ~~~~i~~cl~~~p~~Rp~  254 (267)
T cd08224         237 LRDLVSRCINPDPEKRPD  254 (267)
T ss_pred             HHHHHHHHcCCCcccCCC
Confidence            677888888888877653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.6e-39  Score=291.51  Aligned_cols=230  Identities=32%  Similarity=0.495  Sum_probs=187.2

Q ss_pred             EEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEE
Q 018487          113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYL  192 (355)
Q Consensus       113 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  192 (355)
                      ++.+.||.|.||.||+|.++. .....+..|+||.++..  ......+.+.+|++.+++++||||+++++++...+..++
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~-~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~l   78 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQ-KDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFL   78 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEES-TTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEc-ccCCCCEEEEEEEeccc--cccccceeeeecccccccccccccccccccccccccccc
Confidence            567899999999999999985 33456788999999543  234446778899999999999999999999998888999


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCC
Q 018487          193 ILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR  270 (355)
Q Consensus       193 v~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~  270 (355)
                      ||||+++|+|.+++...  ..+++.++..|+.|++.||.|||+++++|+||+++|||++.++.+||+|||++........
T Consensus        79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999999987  6799999999999999999999999999999999999999999999999999987622211


Q ss_pred             ---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh--------------hhhhHHHHHhh
Q 018487          271 ---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA--------------CNTMLLFYLII  332 (355)
Q Consensus       271 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~--------------~~~~~~~~~~i  332 (355)
                         .....+...|+|||.+.+..++.++||||||+++|||++ |+.||...+...              ......++.+|
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  238 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI  238 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence               223346788999999998889999999999999999999 789998753322              11223568889


Q ss_pred             hheeeecCCCcCC
Q 018487          333 FHCLFVNSLELLS  345 (355)
Q Consensus       333 ~~~l~~~~~e~~~  345 (355)
                      ..||..+|.+|+.
T Consensus       239 ~~C~~~~p~~RPs  251 (259)
T PF07714_consen  239 QQCWSHDPEKRPS  251 (259)
T ss_dssp             HHHT-SSGGGS--
T ss_pred             HHHcCCChhhCcC
Confidence            9999998888764

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=8.6e-40  Score=296.66  Aligned_cols=234  Identities=20%  Similarity=0.326  Sum_probs=191.6

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      .+|++.++||+|+||.||+|.+.+......++.||+|++....  .....+.+.+|+.++..++||||+++++++...+.
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~   82 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP   82 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence            4688889999999999999998765444567789999987543  23344668889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCc
Q 018487          190 LYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH  253 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~  253 (355)
                      .++++||+.+++|..++...                ..+++..+..++.|++.||.|||++||+||||||+|||+++++.
T Consensus        83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc
Confidence            99999999999999888532                34788889999999999999999999999999999999999999


Q ss_pred             EEEEecCCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh-------
Q 018487          254 VMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC-------  322 (355)
Q Consensus       254 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~-------  322 (355)
                      +||+|||+++.......   .....+++.|+|||++.+..++.++|||||||++|||++ |..||........       
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~  242 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNR  242 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999886533221   123345778999999988889999999999999999998 8889876533211       


Q ss_pred             -------hhhHHHHHhhhheeeecCCCcCC
Q 018487          323 -------NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       323 -------~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                             .....+..++..|++.+|.+++.
T Consensus       243 ~~~~~~~~~~~~~~~li~~cl~~~p~~RP~  272 (283)
T cd05091         243 QVLPCPDDCPAWVYTLMLECWNEFPSRRPR  272 (283)
T ss_pred             CcCCCCCCCCHHHHHHHHHHhCCCcccCCC
Confidence                   11223567888888888887663

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.3e-39  Score=295.97  Aligned_cols=239  Identities=23%  Similarity=0.380  Sum_probs=196.1

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceeccee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~  183 (355)
                      +.+..++|.+.+.||+|+||.||+|.+.+.........||+|.++...  .....+.+.+|+.+++++ +|+||++++++
T Consensus        30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  107 (302)
T cd05055          30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGA  107 (302)
T ss_pred             ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence            345556899999999999999999987544444566789999887543  233456688899999999 79999999999


Q ss_pred             eecCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCC
Q 018487          184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (355)
Q Consensus       184 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~  261 (355)
                      +...+..|+||||+.+++|.+++....  .+++.++..++.|++.||.|||+++|+|+||||+|||++.++.++|+|||+
T Consensus       108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence            999999999999999999999987643  389999999999999999999999999999999999999999999999999


Q ss_pred             ccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh---------------
Q 018487          262 AKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC---------------  322 (355)
Q Consensus       262 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~---------------  322 (355)
                      +..+.....   .....++..|+|||++.+..++.++|||||||++|+|++ |..||........               
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  267 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPE  267 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCC
Confidence            986543221   122345678999999998889999999999999999998 9999976432110               


Q ss_pred             hhhHHHHHhhhheeeecCCCcCC
Q 018487          323 NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       323 ~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      .....+.+++.+|+.++|.+++.
T Consensus       268 ~~~~~~~~li~~cl~~~p~~Rpt  290 (302)
T cd05055         268 HAPAEIYDIMKTCWDADPLKRPT  290 (302)
T ss_pred             CCCHHHHHHHHHHcCCCchhCcC
Confidence            12245677888999888877653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.3e-39  Score=295.12  Aligned_cols=231  Identities=23%  Similarity=0.350  Sum_probs=186.4

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceeeecCC
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS  188 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  188 (355)
                      ++|++.+.||+|+||.||+|..+..   .....+++|.++...  .....+.+.+|+.++.++ +||||+++++++...+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~---~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKD---GLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRG   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCC---CCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCC
Confidence            5899999999999999999987632   122347888776322  233345678899999999 7999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC
Q 018487          189 KLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG  252 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~  252 (355)
                      .+|+||||+++++|.+++....                .+++..++.++.|++.||+|||++||+||||||+|||++.++
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~  156 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL  156 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC
Confidence            9999999999999999987542                478899999999999999999999999999999999999999


Q ss_pred             cEEEEecCCccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh----------
Q 018487          253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA----------  321 (355)
Q Consensus       253 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~----------  321 (355)
                      .+||+|||++..............+..|+|||++.+..++.++|||||||++|||++ |..||.......          
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~  236 (297)
T cd05089         157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  236 (297)
T ss_pred             eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence            999999999865432222222223557999999998889999999999999999997 999997754321          


Q ss_pred             ----hhhhHHHHHhhhheeeecCCCcCC
Q 018487          322 ----CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 ----~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                          ......+.+++.+|+..+|.+++.
T Consensus       237 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~  264 (297)
T cd05089         237 MEKPRNCDDEVYELMRQCWRDRPYERPP  264 (297)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcC
Confidence                012235678888999888888653

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=5.9e-39  Score=288.57  Aligned_cols=233  Identities=24%  Similarity=0.373  Sum_probs=192.5

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      +++|++.+.||+|+||.||+|.++...  .....||+|+++...  .......+.+|+.+++.++|+||+++++.+...+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~--~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPG--KKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR   78 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCC--CCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC
Confidence            467999999999999999999986431  235679999886543  3334456788999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      ..++||||+++++|.+++... +.+++.++..++.|++.||.|||+++|+||||||+|||++.++.++|+|||++..+..
T Consensus        79 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          79 PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             ceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            999999999999999998764 4689999999999999999999999999999999999999999999999999987642


Q ss_pred             CCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhhHHHH
Q 018487          268 SSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTMLLFY  329 (355)
Q Consensus       268 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~~~~~  329 (355)
                      ...   .....++..|+|||.+.+..++.++||||||+++|+|++ |..||........              .....+.
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  238 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALY  238 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence            111   112234578999999998899999999999999999998 9999976432210              1123567


Q ss_pred             HhhhheeeecCCCcCC
Q 018487          330 LIIFHCLFVNSLELLS  345 (355)
Q Consensus       330 ~~i~~~l~~~~~e~~~  345 (355)
                      +++.+|++.+|.+++.
T Consensus       239 ~li~~cl~~~p~~Rp~  254 (266)
T cd05033         239 QLMLDCWQKDRNERPT  254 (266)
T ss_pred             HHHHHHcCCCcccCcC
Confidence            8888999888888653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.1e-39  Score=291.36  Aligned_cols=231  Identities=25%  Similarity=0.411  Sum_probs=193.5

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++.+.||+|+||.||+|..+     .+++.++||.+...........+.+.+|+.+++.++|+||+++++++..++.
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~-----~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCL-----LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeec-----CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCe
Confidence            47889999999999999999976     4577899998876544444555678889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          190 LYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      .+++|||+++++|.+++..    ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence            9999999999999888763    345899999999999999999999999999999999999999999999999998766


Q ss_pred             CcCCC-CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh-----------------hhhhHH
Q 018487          266 DESSR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA-----------------CNTMLL  327 (355)
Q Consensus       266 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~-----------------~~~~~~  327 (355)
                      ..... .....|+..|+|||++.+..++.++||||||+++|+|++|..||.......                 ......
T Consensus       157 ~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08229         157 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE  236 (267)
T ss_pred             ccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHH
Confidence            43322 234568899999999998889999999999999999999999996542210                 012235


Q ss_pred             HHHhhhheeeecCCCcCC
Q 018487          328 FYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       328 ~~~~i~~~l~~~~~e~~~  345 (355)
                      +..++.+|+..+|.+++.
T Consensus       237 ~~~li~~~l~~~p~~Rpt  254 (267)
T cd08229         237 LRQLVNMCINPDPEKRPD  254 (267)
T ss_pred             HHHHHHHhcCCCcccCCC
Confidence            667788888888777654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.5e-39  Score=308.48  Aligned_cols=238  Identities=24%  Similarity=0.352  Sum_probs=194.3

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceeccee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYS  183 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~  183 (355)
                      +.+..++|.+.++||+|+||.||+|.+++.......+.||+|+++...  .....+.+.+|+.+|.++. ||||++++++
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~  109 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGA  109 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence            455567899999999999999999998765444567789999997543  2233456788999999997 9999999999


Q ss_pred             eecCCeEEEEEeccCCCChHHHHHhcC-----------------------------------------------------
Q 018487          184 FQTRSKLYLILDFINGGHLFFHLYRQG-----------------------------------------------------  210 (355)
Q Consensus       184 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------------------------------------------  210 (355)
                      +...+.+++||||+++|+|.+++....                                                     
T Consensus       110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence            999999999999999999999986532                                                     


Q ss_pred             ---------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q 018487          211 ---------------------------------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (355)
Q Consensus       211 ---------------------------------------------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~N  245 (355)
                                                                   .+++..+..++.|++.||.|||+.+++||||||+|
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N  269 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN  269 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence                                                         25667788899999999999999999999999999


Q ss_pred             EEecCCCcEEEEecCCccccCcCC---CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh
Q 018487          246 ILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA  321 (355)
Q Consensus       246 ILl~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~  321 (355)
                      ||++.++.+||+|||+++......   ......++..|+|||++.+..++.++|||||||++|||++ |+.||.......
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            999999999999999998653221   1223456788999999998889999999999999999998 899997642111


Q ss_pred             h---------------hhhHHHHHhhhheeeecCCCcC
Q 018487          322 C---------------NTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       322 ~---------------~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                      .               .....+.+++.+|+..+|.+++
T Consensus       350 ~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RP  387 (401)
T cd05107         350 QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRP  387 (401)
T ss_pred             HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCc
Confidence            0               1124567788899888877765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-41  Score=308.77  Aligned_cols=215  Identities=36%  Similarity=0.708  Sum_probs=199.2

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +.-.+++++.-||-||||.|-++..+.     ....+|+|++++....+....+.+..|.++|..++.|.||++|..|.+
T Consensus       417 v~l~dl~~iaTLGvGgFGRVELV~~~~-----~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd  491 (732)
T KOG0614|consen  417 VKLSDLKRIATLGVGGFGRVELVKVNS-----QKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD  491 (732)
T ss_pred             cchhhhhhhhhcccCccceEEEEEecc-----cchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc
Confidence            445678888999999999999998762     333699999999888888888889999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                      ..++|++||-|-||.|...+..++.|.+..++.++..+++|++|||++|||+|||||+|++++.+|-+||.|||+|+.+.
T Consensus       492 ~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~  571 (732)
T KOG0614|consen  492 SKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG  571 (732)
T ss_pred             chhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhhhhH
Q 018487          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTML  326 (355)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~~~~  326 (355)
                      .....-++|||+.|.|||++.++..+.++|.||||+++|||++|..||.+.+....-+.+
T Consensus       572 ~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I  631 (732)
T KOG0614|consen  572 SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI  631 (732)
T ss_pred             cCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH
Confidence            888888999999999999999999999999999999999999999999998766544433

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.2e-39  Score=302.04  Aligned_cols=191  Identities=28%  Similarity=0.427  Sum_probs=166.0

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      ..+|++++.||+|+||.||+|.+.     ..++.||+|+.....         ...|+.++++++|+||+++++++....
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~  130 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKP-----GQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGA  130 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEEC-----CCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCC
Confidence            457999999999999999999976     456789999854322         235899999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          189 KLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      ..++|||++.+ +|..++.. ...+++.++..|+.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       131 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  209 (357)
T PHA03209        131 ITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV  209 (357)
T ss_pred             eeEEEEEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence            99999999965 77777755 45689999999999999999999999999999999999999999999999999976443


Q ss_pred             CCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCC
Q 018487          268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNI  314 (355)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf  314 (355)
                      ........||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            33344567999999999999999999999999999999999865554

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4.8e-39  Score=291.57  Aligned_cols=235  Identities=23%  Similarity=0.360  Sum_probs=192.9

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ...+|++.++||+|+||.||+|......+...+..+++|.+...   .....+.+.+|+++++.++|+||+++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (280)
T cd05092           3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEG   79 (280)
T ss_pred             ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence            34579999999999999999998664444456778999987643   233455788899999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC
Q 018487          188 SKLYLILDFINGGHLFFHLYRQG---------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG  252 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~---------------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~  252 (355)
                      +..+++|||+++++|.+++....               .+++..+..++.|++.||+|||++|++||||||+|||+++++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence            99999999999999999987653               478899999999999999999999999999999999999999


Q ss_pred             cEEEEecCCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh-------
Q 018487          253 HVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA-------  321 (355)
Q Consensus       253 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~-------  321 (355)
                      .+||+|||++........   .....+++.|+|||++.+..++.++|||||||++|||++ |..||.......       
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  239 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ  239 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence            999999999875532211   122335678999999999999999999999999999998 999996643211       


Q ss_pred             -------hhhhHHHHHhhhheeeecCCCcCC
Q 018487          322 -------CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 -------~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                             ......+.+++..||.++|.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~  270 (280)
T cd05092         240 GRELERPRTCPPEVYAIMQGCWQREPQQRMV  270 (280)
T ss_pred             CccCCCCCCCCHHHHHHHHHHccCChhhCCC
Confidence                   011235678888999888887653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=6.2e-39  Score=288.02  Aligned_cols=230  Identities=24%  Similarity=0.361  Sum_probs=190.2

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +...+|.+.++||+|+||.||+|.++     ..++.|++|++....    ...+.+.+|+.+++.++|+||+++++++..
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   73 (263)
T cd05052           3 MERTDITMKHKLGGGQYGEVYEGVWK-----KYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR   73 (263)
T ss_pred             CchHHeEEeeecCCcccceEEEEEEe-----cCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcC
Confidence            44567999999999999999999976     456789999986432    224567789999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      .+.++++|||+++++|.+++...  ..+++..+..++.|++.||+|||++|++||||||+|||+++++.+||+|||++..
T Consensus        74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~  153 (263)
T cd05052          74 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL  153 (263)
T ss_pred             CCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccc
Confidence            99999999999999999988754  3588999999999999999999999999999999999999999999999999987


Q ss_pred             cCcCCCC--CcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhhh--------------hhHH
Q 018487          265 IDESSRS--NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACN--------------TMLL  327 (355)
Q Consensus       265 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~~--------------~~~~  327 (355)
                      .......  ....++..|+|||.+.+..++.++|||||||++|||++ |..||...+.....              ....
T Consensus       154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (263)
T cd05052         154 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPK  233 (263)
T ss_pred             cccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHH
Confidence            6443221  11223567999999998999999999999999999998 99999765332211              1124


Q ss_pred             HHHhhhheeeecCCCcCC
Q 018487          328 FYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       328 ~~~~i~~~l~~~~~e~~~  345 (355)
                      +.++|.+|+..+|.+++.
T Consensus       234 ~~~li~~cl~~~p~~Rp~  251 (263)
T cd05052         234 VYELMRACWQWNPSDRPS  251 (263)
T ss_pred             HHHHHHHHccCCcccCCC
Confidence            567888888887777653

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.4e-39  Score=301.03  Aligned_cols=238  Identities=22%  Similarity=0.386  Sum_probs=191.3

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceeccee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~  183 (355)
                      +.+..++|++.+.||+|+||+||+|.+.+..+...++.||||+++...  .......+.+|+.++.++ +|+||++++++
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~   79 (343)
T cd05103           2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA   79 (343)
T ss_pred             cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcce
Confidence            345567899999999999999999998776666678899999987543  233345677899999999 68999999998


Q ss_pred             eec-CCeEEEEEeccCCCChHHHHHhc-----------------------------------------------------
Q 018487          184 FQT-RSKLYLILDFINGGHLFFHLYRQ-----------------------------------------------------  209 (355)
Q Consensus       184 ~~~-~~~~~lv~e~~~~gsL~~~l~~~-----------------------------------------------------  209 (355)
                      +.. +..+++||||+++|+|.+++...                                                     
T Consensus        80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (343)
T cd05103          80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS  159 (343)
T ss_pred             eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence            764 45689999999999999888642                                                     


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCC---CC
Q 018487          210 --------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR---SN  272 (355)
Q Consensus       210 --------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~---~~  272 (355)
                                    ..+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..+.....   ..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence                          1357778889999999999999999999999999999999999999999999876532211   11


Q ss_pred             cccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh---h------------hhhHHHHHhhhhee
Q 018487          273 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA---C------------NTMLLFYLIIFHCL  336 (355)
Q Consensus       273 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~---~------------~~~~~~~~~i~~~l  336 (355)
                      ...++..|+|||++.+..++.++||||||+++|+|++ |..||.......   .            .....+..++.+|+
T Consensus       240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl  319 (343)
T cd05103         240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCW  319 (343)
T ss_pred             CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHc
Confidence            2235677999999998899999999999999999997 999997642110   0            01124567788888


Q ss_pred             eecCCCcC
Q 018487          337 FVNSLELL  344 (355)
Q Consensus       337 ~~~~~e~~  344 (355)
                      +.+|.+++
T Consensus       320 ~~~p~~Rp  327 (343)
T cd05103         320 HGEPSQRP  327 (343)
T ss_pred             cCChhhCc
Confidence            88887765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=8.6e-39  Score=292.33  Aligned_cols=229  Identities=26%  Similarity=0.429  Sum_probs=192.4

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ...+|++.+.||+|+||.||+|.++     ..++.|++|.+......   ..+.+.+|+.+++.++|+||+++++.+..+
T Consensus        18 ~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~   89 (296)
T cd06654          18 PKKKYTRFEKIGQGASGTVYTAMDV-----ATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVG   89 (296)
T ss_pred             cccceeeEEEecCCCCeEEEEEEEC-----CCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeC
Confidence            3468999999999999999999865     45678999988764422   235577899999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      ...|+||||+++++|.+++.. ..+++.++..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus        90 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~  168 (296)
T cd06654          90 DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (296)
T ss_pred             CEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence            999999999999999988854 4689999999999999999999999999999999999999999999999999876533


Q ss_pred             CCC-CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh----------------hhhHHHHH
Q 018487          268 SSR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC----------------NTMLLFYL  330 (355)
Q Consensus       268 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~----------------~~~~~~~~  330 (355)
                      ... .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||...+....                .....+.+
T Consensus       169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  248 (296)
T cd06654         169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD  248 (296)
T ss_pred             cccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHH
Confidence            221 2335688999999999988899999999999999999999999976543210                11234577


Q ss_pred             hhhheeeecCCCcCC
Q 018487          331 IIFHCLFVNSLELLS  345 (355)
Q Consensus       331 ~i~~~l~~~~~e~~~  345 (355)
                      +|.+||..+|.+++.
T Consensus       249 li~~~l~~~p~~Rpt  263 (296)
T cd06654         249 FLNRCLDMDVEKRGS  263 (296)
T ss_pred             HHHHHCcCCcccCcC
Confidence            888999888888653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=297.50  Aligned_cols=208  Identities=41%  Similarity=0.826  Sum_probs=188.9

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecceeee
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQ  185 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~  185 (355)
                      +...+|..+.+||+|+||.|.+|..++     +.+.+|||+++++...+.+.++.-..|-++|.... -|.++++...|+
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkg-----tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQ  420 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKG-----TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQ  420 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccC-----cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhh
Confidence            334579999999999999999999874     56789999999998888777777777888887765 678999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      ..+.+|+||||+.||+|..+++.-+.+.|..+..++.+|+-||-|||++|||+||||.+|||+|.+|.+||+|||+++.-
T Consensus       421 TmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  421 TMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             hhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999853


Q ss_pred             -CcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchh
Q 018487          266 -DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQV  319 (355)
Q Consensus       266 -~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~  319 (355)
                       -......++|||+.|+|||++..++|+..+|.||+||+||||+.|+.||++.+.
T Consensus       501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE  555 (683)
T KOG0696|consen  501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE  555 (683)
T ss_pred             ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence             334446789999999999999999999999999999999999999999998754

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.1e-38  Score=286.69  Aligned_cols=203  Identities=33%  Similarity=0.510  Sum_probs=176.2

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccc--cchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI--IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      .+|++.+.||+|+||.||++.++     .+++.|++|.+.....  ......+.+.+|+.++++++|+||+++++++.+.
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~-----~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   76 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDA-----DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP   76 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEc-----CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC
Confidence            57999999999999999999876     4577899998864321  1233456788899999999999999999988763


Q ss_pred             --CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          188 --SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       188 --~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                        ..++++|||+++++|.+++.....+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++...
T Consensus        77 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          77 MERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             CCceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence              568899999999999999988788999999999999999999999999999999999999999999999999998865


Q ss_pred             CcC----CCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          266 DES----SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       266 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      ...    .......|+..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  212 (265)
T cd06652         157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF  212 (265)
T ss_pred             ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence            321    1123356889999999999888999999999999999999999999764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.7e-39  Score=287.83  Aligned_cols=227  Identities=23%  Similarity=0.418  Sum_probs=188.0

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|++.+.||+|+||.||++.+++      ...+|+|.+.....    ..+.+.+|+.++++++||||+++++++...+
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~------~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   72 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRG------QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR   72 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecC------CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            4579999999999999999998652      33599998865432    1245788999999999999999999999988


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      ..++||||+.+++|.+++... ..+++.+++.++.|++.||.|||+.|++|+||||+|||++.++.+||+|||.++....
T Consensus        73 ~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05113          73 PIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD  152 (256)
T ss_pred             CcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCC
Confidence            999999999999999998764 4689999999999999999999999999999999999999999999999999876543


Q ss_pred             CCCC--CcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh--------------hhhhHHHHH
Q 018487          268 SSRS--NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA--------------CNTMLLFYL  330 (355)
Q Consensus       268 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~--------------~~~~~~~~~  330 (355)
                      ....  ....++..|+|||++.+..++.++||||||+++|+|++ |..||.......              ......+..
T Consensus       153 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (256)
T cd05113         153 DEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYA  232 (256)
T ss_pred             CceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence            2211  12234567999999988889999999999999999999 999997653211              011235678


Q ss_pred             hhhheeeecCCCcCC
Q 018487          331 IIFHCLFVNSLELLS  345 (355)
Q Consensus       331 ~i~~~l~~~~~e~~~  345 (355)
                      ++.+||..+|.+++.
T Consensus       233 li~~cl~~~p~~Rp~  247 (256)
T cd05113         233 IMYSCWHEKAEERPT  247 (256)
T ss_pred             HHHHHcCCCcccCCC
Confidence            888999888888653

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.7e-39  Score=293.58  Aligned_cols=236  Identities=22%  Similarity=0.360  Sum_probs=194.0

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCC-----------CCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVD-----------DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF  176 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----------~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  176 (355)
                      ..++|+++++||+|+||.||+|......           .......||+|.+.....  ....+.+.+|++++++++|+|
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~   80 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPN   80 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCC
Confidence            3468999999999999999999876432           122446799999876532  344567888999999999999


Q ss_pred             ceecceeeecCCeEEEEEeccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q 018487          177 IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-----------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (355)
Q Consensus       177 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~N  245 (355)
                      |+++++++..++..+++|||+++++|..++....           .+++..++.++.|++.||.|||++|++||||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N  160 (296)
T cd05051          81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN  160 (296)
T ss_pred             EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence            9999999999999999999999999999987765           68999999999999999999999999999999999


Q ss_pred             EEecCCCcEEEEecCCccccCcCC---CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc--CCCCCCCchhh
Q 018487          246 ILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQVNIKSMQVI  320 (355)
Q Consensus       246 ILl~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt--g~~pf~~~~~~  320 (355)
                      |+++.++.++|+|||+++......   ......++..|+|||++.+..++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            999999999999999987653322   1223456778999999988889999999999999999998  77888764321


Q ss_pred             hh---h------------------hhHHHHHhhhheeeecCCCcCC
Q 018487          321 AC---N------------------TMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       321 ~~---~------------------~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ..   .                  ....+.+++.+|++.+|.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt  286 (296)
T cd05051         241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPT  286 (296)
T ss_pred             HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCC
Confidence            10   0                  0135678888898888887653

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=5.6e-39  Score=292.53  Aligned_cols=232  Identities=22%  Similarity=0.363  Sum_probs=190.2

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      +|++.+.||+|+||.||+|.............+++|.+....  .....+.+.+|+.+++.++||||+++++.+...+..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence            478899999999999999987654444455679999886543  233346688899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q 018487          191 YLILDFINGGHLFFHLYRQ------------------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI  246 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NI  246 (355)
                      +++|||+.+++|.+++...                        ..+++..+..++.|++.||.|||+.|++||||||+||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni  158 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV  158 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence            9999999999999887642                        2477889999999999999999999999999999999


Q ss_pred             EecCCCcEEEEecCCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh
Q 018487          247 LMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC  322 (355)
Q Consensus       247 Ll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~  322 (355)
                      |+++++.+||+|||+++.......   .....++..|+|||++.+..++.++||||||+++|+|++ |..||........
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~  238 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL  238 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            999999999999999976532221   222345678999999988889999999999999999999 9999986543221


Q ss_pred             --------------hhhHHHHHhhhheeeecCCCcC
Q 018487          323 --------------NTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       323 --------------~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                                    .....+..++..|+..+|.+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp  274 (290)
T cd05045         239 FNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRP  274 (290)
T ss_pred             HHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCC
Confidence                          1123567888899988887765

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6e-39  Score=287.70  Aligned_cols=229  Identities=25%  Similarity=0.379  Sum_probs=190.1

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +..++|++.+.||+|++|.||+|.+.      ..+.||+|.++....    ..+.+.+|+.++++++|+||+++++++..
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   72 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWN------NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTL   72 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEec------CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEec
Confidence            45578999999999999999999864      245699999875432    23457789999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      .+..|+||||+++++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..
T Consensus        73 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~  152 (261)
T cd05068          73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARV  152 (261)
T ss_pred             CCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEE
Confidence            999999999999999999987654  689999999999999999999999999999999999999999999999999987


Q ss_pred             cCcCCCCC--cccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh--------------hhhhHH
Q 018487          265 IDESSRSN--SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA--------------CNTMLL  327 (355)
Q Consensus       265 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~--------------~~~~~~  327 (355)
                      ........  ....+..|+|||++.+..++.++||||||+++|+|+| |+.||.+.....              ......
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (261)
T cd05068         153 IKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKE  232 (261)
T ss_pred             ccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence            65322111  1122457999999998899999999999999999999 999997754321              012345


Q ss_pred             HHHhhhheeeecCCCcCC
Q 018487          328 FYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       328 ~~~~i~~~l~~~~~e~~~  345 (355)
                      +..++.+|+..+|.+++.
T Consensus       233 ~~~li~~~l~~~P~~Rp~  250 (261)
T cd05068         233 LYDIMLDCWKEDPDDRPT  250 (261)
T ss_pred             HHHHHHHHhhcCcccCCC
Confidence            677888888888887653

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=4.8e-39  Score=294.96  Aligned_cols=238  Identities=21%  Similarity=0.377  Sum_probs=193.6

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCC--CCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecc
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVD--DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLR  181 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~  181 (355)
                      +.+..++|.+.+.||+|+||.||+|++.+..  .......||+|.+....  .......+.+|+.+++.+ +||||++++
T Consensus        10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~   87 (304)
T cd05101          10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL   87 (304)
T ss_pred             ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchhee
Confidence            3455678999999999999999999865422  22345679999886542  233446688899999999 799999999


Q ss_pred             eeeecCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q 018487          182 YSFQTRSKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (355)
Q Consensus       182 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~N  245 (355)
                      +.+......|+||||+++++|.+++...                ..++..++..++.||+.||.|||++|++||||||+|
T Consensus        88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N  167 (304)
T cd05101          88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN  167 (304)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence            9999999999999999999999998764                236778899999999999999999999999999999


Q ss_pred             EEecCCCcEEEEecCCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh
Q 018487          246 ILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA  321 (355)
Q Consensus       246 ILl~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~  321 (355)
                      ||++.++.+||+|||+++.+.....   .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~  247 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  247 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence            9999999999999999987643221   222345678999999998889999999999999999998 888887653322


Q ss_pred             hh--------------hhHHHHHhhhheeeecCCCcC
Q 018487          322 CN--------------TMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       322 ~~--------------~~~~~~~~i~~~l~~~~~e~~  344 (355)
                      ..              ....++.+|.+|+..+|.+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp  284 (304)
T cd05101         248 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRP  284 (304)
T ss_pred             HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCC
Confidence            11              123567889999998888765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.3e-38  Score=284.40  Aligned_cols=228  Identities=28%  Similarity=0.470  Sum_probs=193.6

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      +|++++.||.|+||.||.++..     ..++.+++|.+..... .......+.+|++++++++|+||+++++++...+..
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~-----~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   74 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRT-----EDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTL   74 (256)
T ss_pred             CceEeeEecccCCceEEEEEEc-----CCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeE
Confidence            5899999999999999999866     4577899999865443 234455678899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      +++|||+++++|.+++...  ..+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus        75 ~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~  154 (256)
T cd08221          75 LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE  154 (256)
T ss_pred             EEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence            9999999999999998765  45899999999999999999999999999999999999999999999999999866433


Q ss_pred             C-CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh--------------hhHHHHHhhh
Q 018487          269 S-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN--------------TMLLFYLIIF  333 (355)
Q Consensus       269 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~--------------~~~~~~~~i~  333 (355)
                      . ......+++.|+|||++.+..++.++||||||+++|+|++|+.||...+.....              ....+..+|.
T Consensus       155 ~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  234 (256)
T cd08221         155 YSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVH  234 (256)
T ss_pred             cccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHH
Confidence            3 234456899999999998888899999999999999999999999875432211              1234677888


Q ss_pred             heeeecCCCcC
Q 018487          334 HCLFVNSLELL  344 (355)
Q Consensus       334 ~~l~~~~~e~~  344 (355)
                      +|+..+|.+++
T Consensus       235 ~~l~~~p~~R~  245 (256)
T cd08221         235 SLLQQDPEKRP  245 (256)
T ss_pred             HHcccCcccCC
Confidence            89888887764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.6e-39  Score=291.82  Aligned_cols=222  Identities=35%  Similarity=0.600  Sum_probs=188.4

Q ss_pred             eccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEEEecc
Q 018487          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI  197 (355)
Q Consensus       118 lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  197 (355)
                      ||+|+||+||+|.++     ..++.|++|++.............+.+|+.+++.++||||+++++.+...+.+|+||||+
T Consensus         1 lg~g~~g~vy~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVK-----ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEc-----CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecC
Confidence            699999999999866     457789999987654333344455678999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCCCCccc
Q 018487          198 NGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMC  275 (355)
Q Consensus       198 ~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~  275 (355)
                      ++++|.+++....  .+++.++..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.............
T Consensus        76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  155 (277)
T cd05577          76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA  155 (277)
T ss_pred             CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccccc
Confidence            9999999988766  68999999999999999999999999999999999999999999999999988765443344456


Q ss_pred             ccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-----------------hhhHHHHHhhhheeee
Q 018487          276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-----------------NTMLLFYLIIFHCLFV  338 (355)
Q Consensus       276 gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-----------------~~~~~~~~~i~~~l~~  338 (355)
                      ++..|+|||++.+..++.++||||||+++|+|++|+.||...+....                 .....+..+|.+||+.
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  235 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQK  235 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccC
Confidence            78899999999888899999999999999999999999976533100                 1123457888999998


Q ss_pred             cCCCcC
Q 018487          339 NSLELL  344 (355)
Q Consensus       339 ~~~e~~  344 (355)
                      +|.+++
T Consensus       236 ~p~~R~  241 (277)
T cd05577         236 DPEKRL  241 (277)
T ss_pred             ChhHcc
Confidence            888866

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=6.7e-39  Score=294.49  Aligned_cols=237  Identities=22%  Similarity=0.385  Sum_probs=190.8

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCC--CCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecce
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDG--DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY  182 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~  182 (355)
                      .+..++|.+.+.||+|+||.||+|.+.+....  .....+|+|.+....  .......+.+|+.+++.+ +|+||+++++
T Consensus        14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~   91 (307)
T cd05098          14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG   91 (307)
T ss_pred             eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            34457899999999999999999987643321  234579999987542  233345677899999999 7999999999


Q ss_pred             eeecCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q 018487          183 SFQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI  246 (355)
Q Consensus       183 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NI  246 (355)
                      ++...+..|+||||+++++|.+++....                .+++.++..++.|++.||+|||++|++||||||+||
T Consensus        92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni  171 (307)
T cd05098          92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV  171 (307)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence            9999999999999999999999997642                378889999999999999999999999999999999


Q ss_pred             EecCCCcEEEEecCCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh
Q 018487          247 LMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC  322 (355)
Q Consensus       247 Ll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~  322 (355)
                      |++.++.+||+|||++........   .....++..|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus       172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~  251 (307)
T cd05098         172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  251 (307)
T ss_pred             EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence            999999999999999876543211   111224568999999998889999999999999999998 8889876543221


Q ss_pred             --------------hhhHHHHHhhhheeeecCCCcC
Q 018487          323 --------------NTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       323 --------------~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                                    .....+..+|.+|+..+|.+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  287 (307)
T cd05098         252 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP  287 (307)
T ss_pred             HHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCc
Confidence                          1123556778888888877765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.5e-39  Score=290.20  Aligned_cols=231  Identities=26%  Similarity=0.359  Sum_probs=185.9

Q ss_pred             Ce-EEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec--C
Q 018487          111 DF-EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--R  187 (355)
Q Consensus       111 ~y-~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~  187 (355)
                      +| ++++.||+|+||+||++.+.... ...++.||+|+++...  .......+.+|+++++.++||||+++++++..  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPAN-DGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEcccc-CCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            45 99999999999999998765332 2456789999987542  22334567789999999999999999998765  3


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      ..+++||||+++++|.+++... .+++.+++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence            4689999999999999888764 589999999999999999999999999999999999999999999999999986643


Q ss_pred             CCC----CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh----------------------
Q 018487          268 SSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA----------------------  321 (355)
Q Consensus       268 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~----------------------  321 (355)
                      ...    .....++..|+|||.+.+..++.++||||||+++|+|+||..||.......                      
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER  239 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence            221    122245667999999988889999999999999999999999986432100                      


Q ss_pred             -------hhhhHHHHHhhhheeeecCCCcCC
Q 018487          322 -------CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 -------~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                             ......+..++.+|+..+|.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps  270 (283)
T cd05080         240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPT  270 (283)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHhccChhhCCC
Confidence                   001235677888888888877653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.8e-39  Score=293.85  Aligned_cols=239  Identities=22%  Similarity=0.412  Sum_probs=195.7

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceeccee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~  183 (355)
                      ..+..++|++.+.||+|+||.||++.+++.........+|+|.+....  .......+.+|+.+++++ +|+||++++++
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   84 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGV   84 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            445667899999999999999999998755444456789999987543  223345678899999999 79999999999


Q ss_pred             eecCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q 018487          184 FQTRSKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL  247 (355)
Q Consensus       184 ~~~~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NIL  247 (355)
                      +..++.++++|||+++++|..++...                ..+++..+..++.|++.||.|||+.||+||||||+|||
T Consensus        85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil  164 (293)
T cd05053          85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL  164 (293)
T ss_pred             EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence            99999999999999999999998642                35788999999999999999999999999999999999


Q ss_pred             ecCCCcEEEEecCCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh-
Q 018487          248 MDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC-  322 (355)
Q Consensus       248 l~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~-  322 (355)
                      ++.++.+||+|||+++.+.....   .....++..|+|||++.+..++.++|||||||++|||++ |..||........ 
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  244 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF  244 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence            99999999999999987643221   112234567999999988899999999999999999998 9999977543220 


Q ss_pred             -------------hhhHHHHHhhhheeeecCCCcCC
Q 018487          323 -------------NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       323 -------------~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                                   .....+.+++.+|+..+|.+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  280 (293)
T cd05053         245 KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPT  280 (293)
T ss_pred             HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcC
Confidence                         11235667888899888888653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=7e-39  Score=286.70  Aligned_cols=224  Identities=22%  Similarity=0.326  Sum_probs=184.8

Q ss_pred             eeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEEEec
Q 018487          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDF  196 (355)
Q Consensus       117 ~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  196 (355)
                      +||+|+||.||+|.++..   .+++.+|+|+++... ......+.+.+|+.+++.++|+||+++++++. ....++||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~---~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~   76 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMK---KSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMEL   76 (257)
T ss_pred             cCCCcCCcceEEeEEecC---CCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEec
Confidence            689999999999986532   346789999987543 23445567888999999999999999999875 4567899999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCC----CC
Q 018487          197 INGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR----SN  272 (355)
Q Consensus       197 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~----~~  272 (355)
                      +++++|.+++.....+++..+..++.|++.||.|||++||+||||||.||+++.++.+||+|||++........    ..
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          77 AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            99999999998888899999999999999999999999999999999999999999999999999986643321    11


Q ss_pred             cccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh--------------hhhhHHHHHhhhheee
Q 018487          273 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA--------------CNTMLLFYLIIFHCLF  337 (355)
Q Consensus       273 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~--------------~~~~~~~~~~i~~~l~  337 (355)
                      ...++..|+|||.+.+..++.++|||||||++|||++ |+.||.......              ......+.++|..|++
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~  236 (257)
T cd05116         157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWT  236 (257)
T ss_pred             CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhc
Confidence            2234578999999988889999999999999999998 999998653211              1123456788889998


Q ss_pred             ecCCCcCC
Q 018487          338 VNSLELLS  345 (355)
Q Consensus       338 ~~~~e~~~  345 (355)
                      .+|.+++.
T Consensus       237 ~~p~~Rp~  244 (257)
T cd05116         237 YGVDERPG  244 (257)
T ss_pred             cCchhCcC
Confidence            88888653

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-40  Score=312.71  Aligned_cols=203  Identities=35%  Similarity=0.529  Sum_probs=178.1

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC--
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--  187 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--  187 (355)
                      +.|..-+.||+|+||.||+++++     .+|+.||||.++...  .....+...+|+++|++++|+|||++.+.-...  
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnk-----etG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~   85 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNK-----ETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFL   85 (732)
T ss_pred             cceeehhhhcCCccceeeeeccc-----ccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCcccc
Confidence            35677789999999999999977     688999999998754  233456677899999999999999998876543  


Q ss_pred             ----CeEEEEEeccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEec--CCC--cEEE
Q 018487          188 ----SKLYLILDFINGGHLFFHLYRQ---GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD--SDG--HVML  256 (355)
Q Consensus       188 ----~~~~lv~e~~~~gsL~~~l~~~---~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~--~~~--~~kl  256 (355)
                          ....+|||||.||+|+..+...   .-+++.+...++.++..||.|||++||+||||||.||++-  ++|  ..||
T Consensus        86 ~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKL  165 (732)
T KOG4250|consen   86 GLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKL  165 (732)
T ss_pred             CcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEee
Confidence                3578999999999999999754   3499999999999999999999999999999999999994  334  4799


Q ss_pred             EecCCccccCcCCCCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCchh
Q 018487          257 TDFGLAKEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQV  319 (355)
Q Consensus       257 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~~  319 (355)
                      +|||.|+.+++.....+.+||..|.+||++.. +.|+..+|.|||||++|++.||..||....-
T Consensus       166 tDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~  229 (732)
T KOG4250|consen  166 TDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG  229 (732)
T ss_pred             ecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence            99999999998888889999999999999984 8899999999999999999999999987643

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=5.2e-39  Score=288.65  Aligned_cols=228  Identities=29%  Similarity=0.443  Sum_probs=191.1

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccc---cchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI---IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      +|++.+.||+|+||.||+|...      +++.+|+|.+.....   ........+.+|+.+++.++|+||+++++++...
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC
Confidence            4788999999999999999742      467799998865432   1233445688899999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      +..++||||+++++|.+++.....+++..+..++.|++.||+|||+.+|+|+||+|+||+++.++.++|+|||++.....
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            99999999999999999998888899999999999999999999999999999999999999999999999999876421


Q ss_pred             C-------CCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh----------------h
Q 018487          268 S-------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN----------------T  324 (355)
Q Consensus       268 ~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~----------------~  324 (355)
                      .       .......|+..|+|||++.+..++.++||||||+++|+|++|+.||...+.....                .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSF  234 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCC
Confidence            1       1122346889999999999888999999999999999999999999875432211                1


Q ss_pred             hHHHHHhhhheeeecCCCcC
Q 018487          325 MLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       325 ~~~~~~~i~~~l~~~~~e~~  344 (355)
                      ...+.++|.+||..+|.+++
T Consensus       235 ~~~~~~~i~~~l~~~p~~Rp  254 (265)
T cd06631         235 SAAAIDFVTSCLTRDQHERP  254 (265)
T ss_pred             CHHHHHHHHHHhcCCcccCC
Confidence            12456778888888887765

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=9.4e-39  Score=294.46  Aligned_cols=237  Identities=22%  Similarity=0.395  Sum_probs=191.9

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCC--CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecce
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY  182 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~  182 (355)
                      .+..++|.+.++||+|+||.||+|+..+...  ......+|+|.++...  .......+.+|+.+++.+ +||||+++++
T Consensus         8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (314)
T cd05099           8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLG   85 (314)
T ss_pred             cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence            4455789999999999999999998754322  2345679999887542  233455678899999999 5999999999


Q ss_pred             eeecCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q 018487          183 SFQTRSKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI  246 (355)
Q Consensus       183 ~~~~~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NI  246 (355)
                      ++...+.+|++|||+++++|.+++...                ..+++.++..++.|++.||.|||++|++||||||+||
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni  165 (314)
T cd05099          86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV  165 (314)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence            999999999999999999999998753                2478889999999999999999999999999999999


Q ss_pred             EecCCCcEEEEecCCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh-
Q 018487          247 LMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA-  321 (355)
Q Consensus       247 Ll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~-  321 (355)
                      |++.++.+||+|||+++.......   .....++..|+|||++.+..++.++||||||+++|+|++ |..||....... 
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~  245 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL  245 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999999986643221   111234467999999998889999999999999999999 899997753221 


Q ss_pred             -------------hhhhHHHHHhhhheeeecCCCcC
Q 018487          322 -------------CNTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       322 -------------~~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                                   .+....+..+|.+|+..+|.+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp  281 (314)
T cd05099         246 FKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRP  281 (314)
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCc
Confidence                         01123567888899988888765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.8e-39  Score=287.72  Aligned_cols=229  Identities=27%  Similarity=0.447  Sum_probs=192.0

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccc------hhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK------KNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      +|.+.+.||+|+||.||+|.+.     ..++.||+|.+.......      ....+.+.+|+.++++++||||+++++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   75 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNA-----SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS   75 (267)
T ss_pred             CccccceeecCCCeEEEEEEec-----CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            4778889999999999999865     456789999886543221      23345688899999999999999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      ...+..++||||+++++|..++...+.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.++.
T Consensus        76 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          76 LDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             EeCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence            99999999999999999999998888899999999999999999999999999999999999999999999999999886


Q ss_pred             cCcCC-------CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh--------------hh
Q 018487          265 IDESS-------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA--------------CN  323 (355)
Q Consensus       265 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~--------------~~  323 (355)
                      .....       ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+...              ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd06628         156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSN  235 (267)
T ss_pred             cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcc
Confidence            64211       1123457889999999998889999999999999999999999998653221              11


Q ss_pred             hhHHHHHhhhheeeecCCCcC
Q 018487          324 TMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       324 ~~~~~~~~i~~~l~~~~~e~~  344 (355)
                      ....+...|.+||+.+|.+++
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp  256 (267)
T cd06628         236 ISSEAIDFLEKTFEIDHNKRP  256 (267)
T ss_pred             cCHHHHHHHHHHccCCchhCc
Confidence            233556778888888877765

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.1e-38  Score=289.78  Aligned_cols=228  Identities=26%  Similarity=0.446  Sum_probs=193.1

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      ..+|++.+.||.|+||.||+|.+.     .+++.|++|.+....   ....+.+.+|+.+++.++|+||+++++.+....
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~-----~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDV-----ATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGD   89 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEc-----CCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence            457999999999999999999865     567789999986543   223456788999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      .+|+||||+++++|..++.. ..+++.++..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~  168 (296)
T cd06655          90 ELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE  168 (296)
T ss_pred             eEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence            99999999999999888764 46899999999999999999999999999999999999999999999999998765433


Q ss_pred             CC-CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh----------------hhhHHHHHh
Q 018487          269 SR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC----------------NTMLLFYLI  331 (355)
Q Consensus       269 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~----------------~~~~~~~~~  331 (355)
                      .. .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+....                .....+..+
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  248 (296)
T cd06655         169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDF  248 (296)
T ss_pred             cccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHH
Confidence            22 2345688999999999988899999999999999999999999987543221                112246778


Q ss_pred             hhheeeecCCCcCC
Q 018487          332 IFHCLFVNSLELLS  345 (355)
Q Consensus       332 i~~~l~~~~~e~~~  345 (355)
                      |.+||..+|.+++.
T Consensus       249 i~~~l~~dp~~Rpt  262 (296)
T cd06655         249 LNRCLEMDVEKRGS  262 (296)
T ss_pred             HHHHhhcChhhCCC
Confidence            88999888888654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=8.3e-39  Score=292.30  Aligned_cols=236  Identities=23%  Similarity=0.378  Sum_probs=189.9

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCC-----------CCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVD-----------DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF  176 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----------~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  176 (355)
                      ..++|++.++||+|+||.||+|.+....           .......||+|++....  .....+.+.+|+.+++.++|+|
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~   80 (296)
T cd05095           3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPN   80 (296)
T ss_pred             ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCC
Confidence            3467999999999999999998755321           12334579999987542  2344567888999999999999


Q ss_pred             ceecceeeecCCeEEEEEeccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q 018487          177 IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-----------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (355)
Q Consensus       177 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~N  245 (355)
                      |+++++++...+..++||||+++++|.+++....           .+++.++..++.|++.||+|||++|++||||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N  160 (296)
T cd05095          81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN  160 (296)
T ss_pred             cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence            9999999999999999999999999999887643           36677899999999999999999999999999999


Q ss_pred             EEecCCCcEEEEecCCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc--CCCCCCCchhh
Q 018487          246 ILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQVNIKSMQVI  320 (355)
Q Consensus       246 ILl~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt--g~~pf~~~~~~  320 (355)
                      ||++.++.++|+|||++..+.....   .....++..|++||+..+..++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            9999999999999999986533221   122334678999999888889999999999999999998  78898754321


Q ss_pred             h---------------------hhhhHHHHHhhhheeeecCCCcCC
Q 018487          321 A---------------------CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       321 ~---------------------~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      .                     ......+.+++.+||+.+|.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~  286 (296)
T cd05095         241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPS  286 (296)
T ss_pred             HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCC
Confidence            1                     011235567888899888888653

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.7e-38  Score=283.72  Aligned_cols=228  Identities=26%  Similarity=0.455  Sum_probs=189.2

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec-CCe
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-RSK  189 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~  189 (355)
                      +|++.+.||.|++|.||+|.++     .+++.|++|.+..... .....+.+.+|+.++++++|+||+++++.+.. ...
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHR-----TDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGL   74 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEc-----CCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCE
Confidence            4899999999999999999976     4567899999876443 23344567889999999999999999988764 446


Q ss_pred             EEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          190 LYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      +|++|||+++++|.+++...  ..+++.+++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus        75 ~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~  154 (257)
T cd08223          75 LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN  154 (257)
T ss_pred             EEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence            89999999999999988763  4589999999999999999999999999999999999999999999999999986633


Q ss_pred             CC-CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh--------------hhhHHHHHhh
Q 018487          268 SS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC--------------NTMLLFYLII  332 (355)
Q Consensus       268 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~--------------~~~~~~~~~i  332 (355)
                      .. ......+++.|+|||++.+..++.++||||||+++|+|++|+.||...+....              .....+.+++
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  234 (257)
T cd08223         155 QCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELI  234 (257)
T ss_pred             cCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHH
Confidence            22 23345688999999999999999999999999999999999999987543221              1113456777


Q ss_pred             hheeeecCCCcC
Q 018487          333 FHCLFVNSLELL  344 (355)
Q Consensus       333 ~~~l~~~~~e~~  344 (355)
                      .+|+..+|.+++
T Consensus       235 ~~~l~~~p~~Rp  246 (257)
T cd08223         235 ATMLSKRPEKRP  246 (257)
T ss_pred             HHHhccCcccCC
Confidence            888888877765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=9.1e-39  Score=288.62  Aligned_cols=234  Identities=24%  Similarity=0.409  Sum_probs=194.8

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|++++.||+|+||.||+|+.+...+....+.+++|.+....  .....+.+.+|++++++++|+||+++++++....
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   81 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE   81 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence            46899999999999999999998766555667789999876432  2334567888999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEec
Q 018487          189 KLYLILDFINGGHLFFHLYRQG---------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~---------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Df  259 (355)
                      ..|+||||+++++|.+++....         .+++..+..++.|++.||.|||+++|+||||||+|||++.++.++++||
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999999998765         6899999999999999999999999999999999999999999999999


Q ss_pred             CCccccCcCC--CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh---------------
Q 018487          260 GLAKEIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA---------------  321 (355)
Q Consensus       260 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~---------------  321 (355)
                      |++.......  ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......               
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  241 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP  241 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCC
Confidence            9987542211  1233456778999999988888999999999999999999 888996532211               


Q ss_pred             hhhhHHHHHhhhheeeecCCCcC
Q 018487          322 CNTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       322 ~~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                      ......+..++.+||..+|.+++
T Consensus       242 ~~~~~~l~~~i~~~l~~~p~~Rp  264 (275)
T cd05046         242 EGCPSRLYKLMTRCWAVNPKDRP  264 (275)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCC
Confidence            11123567888899988888764

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-38  Score=284.93  Aligned_cols=226  Identities=26%  Similarity=0.419  Sum_probs=191.6

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +..++|++.+.||.|+||.||+|...       ++.||+|.+.....    ..+.+.+|+.+++.++|+||+++++++..
T Consensus         3 ~~~~~~~~~~~ig~g~~g~v~~~~~~-------~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   71 (256)
T cd05039           3 INSKELKLGATIGKGEFGDVMLGDYR-------GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQ   71 (256)
T ss_pred             cChhhccceeeeecCCCceEEEEEec-------CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcC
Confidence            34568999999999999999999854       56799999875432    45668889999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      .+..++||||+++++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||.+..
T Consensus        72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~  151 (256)
T cd05039          72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKE  151 (256)
T ss_pred             CCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccc
Confidence            999999999999999999998765  689999999999999999999999999999999999999999999999999987


Q ss_pred             cCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhhh--------------hhHHHH
Q 018487          265 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACN--------------TMLLFY  329 (355)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~~--------------~~~~~~  329 (355)
                      ......  ....+..|+|||++.+..++.++||||||+++|+|++ |+.||.........              ....+.
T Consensus       152 ~~~~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (256)
T cd05039         152 ASQGQD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVY  229 (256)
T ss_pred             cccccc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHH
Confidence            643322  2334667999999988889999999999999999997 99999776432211              124567


Q ss_pred             HhhhheeeecCCCcCC
Q 018487          330 LIIFHCLFVNSLELLS  345 (355)
Q Consensus       330 ~~i~~~l~~~~~e~~~  345 (355)
                      .+|.+|+..+|.+++.
T Consensus       230 ~li~~~l~~~p~~Rp~  245 (256)
T cd05039         230 KVMKDCWELDPAKRPT  245 (256)
T ss_pred             HHHHHHhccChhhCcC
Confidence            7888898888877654

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=9.4e-39  Score=289.34  Aligned_cols=234  Identities=24%  Similarity=0.372  Sum_probs=188.1

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ...+|+++++||+|+||+||+|.+..... .....||+|+++...  .....+.+.+|+.+++.++|+||+++++++.. 
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~-~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-   80 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDGE-NVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-   80 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCCC-ccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-
Confidence            45689999999999999999999764322 123458999987543  33344567889999999999999999998875 


Q ss_pred             CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                      ...+++|||+++|+|.+++... +.+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 ~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence            4578999999999999998764 568999999999999999999999999999999999999999999999999998764


Q ss_pred             cCCCC---CcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh--------------hhhhHHH
Q 018487          267 ESSRS---NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA--------------CNTMLLF  328 (355)
Q Consensus       267 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~--------------~~~~~~~  328 (355)
                      .....   ....++..|+|||++.+..++.++|||||||++|||++ |..||.......              ......+
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDV  240 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHH
Confidence            33221   11234678999999998899999999999999999998 999997643211              0112345


Q ss_pred             HHhhhheeeecCCCcCC
Q 018487          329 YLIIFHCLFVNSLELLS  345 (355)
Q Consensus       329 ~~~i~~~l~~~~~e~~~  345 (355)
                      ..+|.+|+..+|.+++.
T Consensus       241 ~~li~~~l~~dp~~Rp~  257 (279)
T cd05109         241 YMIMVKCWMIDSECRPR  257 (279)
T ss_pred             HHHHHHHcCCChhhCcC
Confidence            67888888888777653

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-39  Score=287.25  Aligned_cols=226  Identities=22%  Similarity=0.407  Sum_probs=186.6

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      .+|++.+.||+|+||.||+|.++      ..+.+|+|++......    .+.+.+|+.+++.++|+||+++++++...+.
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~------~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR------GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRP   73 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec------CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            46889999999999999999865      2456999998654321    2346779999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      .|+||||+++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus        74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~  153 (256)
T cd05059          74 IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD  153 (256)
T ss_pred             eEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccc
Confidence            99999999999999998764 46899999999999999999999999999999999999999999999999998765432


Q ss_pred             CCC--CcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhhh--------------hhHHHHHh
Q 018487          269 SRS--NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACN--------------TMLLFYLI  331 (355)
Q Consensus       269 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~~--------------~~~~~~~~  331 (355)
                      ...  ....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+.....              ....+..+
T Consensus       154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  233 (256)
T cd05059         154 QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTI  233 (256)
T ss_pred             cccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHH
Confidence            211  11123457999999998899999999999999999999 89999765322211              12346788


Q ss_pred             hhheeeecCCCcCC
Q 018487          332 IFHCLFVNSLELLS  345 (355)
Q Consensus       332 i~~~l~~~~~e~~~  345 (355)
                      +.+|+..+|.+++.
T Consensus       234 i~~cl~~~p~~Rpt  247 (256)
T cd05059         234 MYSCWHEKPEDRPA  247 (256)
T ss_pred             HHHHhcCChhhCcC
Confidence            88999888888653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=9.5e-39  Score=286.48  Aligned_cols=223  Identities=39%  Similarity=0.681  Sum_probs=193.7

Q ss_pred             eccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEEEecc
Q 018487          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI  197 (355)
Q Consensus       118 lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  197 (355)
                      ||.|+||.||+|...     ..++.|++|++...........+.+.+|+.+++.++|+||+++++.+..+..+|++|||+
T Consensus         1 lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVK-----SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEEC-----CCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecC
Confidence            699999999999976     457889999998765544555677889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCCCCccccc
Q 018487          198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT  277 (355)
Q Consensus       198 ~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt  277 (355)
                      ++++|.+++.+...+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++.............++
T Consensus        76 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~  155 (262)
T cd05572          76 LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGT  155 (262)
T ss_pred             CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCC
Confidence            99999999988888999999999999999999999999999999999999999999999999999877554334445789


Q ss_pred             CccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCch--hhhh---------------hhhHHHHHhhhheeeecC
Q 018487          278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQ--VIAC---------------NTMLLFYLIIFHCLFVNS  340 (355)
Q Consensus       278 ~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~--~~~~---------------~~~~~~~~~i~~~l~~~~  340 (355)
                      ..|++||++.+..++.++|+||||+++|+|++|..||...+  ....               .....+..++.+||.++|
T Consensus       156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p  235 (262)
T cd05572         156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNP  235 (262)
T ss_pred             cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCCh
Confidence            99999999988889999999999999999999999998765  1110               012356788899999998


Q ss_pred             CCcCC
Q 018487          341 LELLS  345 (355)
Q Consensus       341 ~e~~~  345 (355)
                      .+++.
T Consensus       236 ~~R~~  240 (262)
T cd05572         236 EERLG  240 (262)
T ss_pred             hhCcC
Confidence            88764

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.3e-38  Score=289.09  Aligned_cols=201  Identities=30%  Similarity=0.482  Sum_probs=171.0

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      +|++.+.||+|++|.||+|..+     .+++.||+|+++.... .....+.+.+|+.+++.++||||+++++++..++.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNK-----KTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRL   74 (285)
T ss_pred             CceEeeEecccCceEEEEEEEC-----CCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeE
Confidence            5899999999999999999976     4577899999875432 233345677899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          191 YLILDFINGGHLFFHLYRQ---GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~---~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      |+||||+++ +|.+++...   ..+++.+++.++.|++.||.|||++|++||||||+|||++.++.++|+|||++.....
T Consensus        75 ~~v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  153 (285)
T cd07861          75 YLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI  153 (285)
T ss_pred             EEEEecCCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCC
Confidence            999999974 787777543   4589999999999999999999999999999999999999999999999999876543


Q ss_pred             CCC-CCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          268 SSR-SNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       268 ~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      ... .....+++.|+|||++.+. .++.++|||||||++|+|+||+.||...+
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~  206 (285)
T cd07861         154 PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS  206 (285)
T ss_pred             CcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            221 2334578899999998754 57889999999999999999999998653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-39  Score=323.26  Aligned_cols=236  Identities=24%  Similarity=0.384  Sum_probs=196.1

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +.....++.+.||+|+||.||.|.....+-......||+|.+++.  .+.+....|.+|..+|+.++|||||+++|.+..
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~  766 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD  766 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence            446778899999999999999999886543333556888887754  356667789999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEec
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQ-------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~-------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Df  259 (355)
                      ....+|++|||+||+|..+|+..       ..++..+...++.||++|+.||+++++|||||..+|+||++...+||+||
T Consensus       767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence            99999999999999999999876       34899999999999999999999999999999999999999999999999


Q ss_pred             CCccccCcCCCC---CcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh-------------
Q 018487          260 GLAKEIDESSRS---NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC-------------  322 (355)
Q Consensus       260 g~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~-------------  322 (355)
                      |+|+.+-.....   ....-...|||||.+....++.++|||||||+|||++| |..||.+.+-...             
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P  926 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPP  926 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCC
Confidence            999954322211   11133578999999999999999999999999999999 9999998642221             


Q ss_pred             -hhhHHHHHhhhheeeecCCCcC
Q 018487          323 -NTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       323 -~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                       .....++..+..||..+|.+++
T Consensus       927 ~~CP~~ly~lM~~CW~~~pe~RP  949 (1025)
T KOG1095|consen  927 SYCPEKLYQLMLQCWKHDPEDRP  949 (1025)
T ss_pred             CCCChHHHHHHHHHccCChhhCc
Confidence             1223557788888887777754

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.2e-38  Score=290.55  Aligned_cols=228  Identities=29%  Similarity=0.473  Sum_probs=189.4

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .+.|+++++||+|+||.||+|+..     .+++.|++|.+...   .....+.+.+|+.+++.++|+||+++++.+..++
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~-----~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   82 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNK-----ETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG   82 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEEC-----CCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC
Confidence            467999999999999999999876     45678999998653   3344566788999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          189 KLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      .+|+||||+++++|..++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus        83 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          83 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             eEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            99999999999999877654 45689999999999999999999999999999999999999999999999998875432


Q ss_pred             C-CCCCcccccCccccchhhc-----cCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh----------------hhh
Q 018487          268 S-SRSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC----------------NTM  325 (355)
Q Consensus       268 ~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~----------------~~~  325 (355)
                      . .......++..|+|||++.     ...++.++|||||||++|+|++|+.||...+....                ...
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (292)
T cd06644         163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWS  242 (292)
T ss_pred             cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccC
Confidence            2 2223456889999999985     34567899999999999999999999976532210                011


Q ss_pred             HHHHHhhhheeeecCCCcC
Q 018487          326 LLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~  344 (355)
                      ..+.++|.+||..+|.+++
T Consensus       243 ~~~~~li~~~l~~~p~~Rp  261 (292)
T cd06644         243 MEFRDFLKTALDKHPETRP  261 (292)
T ss_pred             HHHHHHHHHHhcCCcccCc
Confidence            3467788899988888765

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=8.2e-39  Score=290.00  Aligned_cols=222  Identities=36%  Similarity=0.651  Sum_probs=180.6

Q ss_pred             eeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHH---HHhcCCCcceecceeeecCCeEEEE
Q 018487          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI---LTKVTHPFIVQLRYSFQTRSKLYLI  193 (355)
Q Consensus       117 ~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~---l~~l~h~nIv~l~~~~~~~~~~~lv  193 (355)
                      .||+|+||.||+|.+.     .+++.+|+|.+.+.............+|..+   +...+|+||+.+++.+..++..++|
T Consensus         1 ~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKA-----DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEEC-----CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEE
Confidence            4899999999999976     4577899999876543322222333344433   3345799999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCCCCc
Q 018487          194 LDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS  273 (355)
Q Consensus       194 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~  273 (355)
                      |||+++++|.+++..++.+++..+..++.|++.||.|||+++|+||||||+|||++.++.++|+|||++....... ...
T Consensus        76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~  154 (279)
T cd05633          76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHA  154 (279)
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccC
Confidence            9999999999999888889999999999999999999999999999999999999999999999999987654332 233


Q ss_pred             ccccCccccchhhc-cCCCCCcccHHHHHHHHHHHHcCCCCCCCchhh---hh-------------hhhHHHHHhhhhee
Q 018487          274 MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVI---AC-------------NTMLLFYLIIFHCL  336 (355)
Q Consensus       274 ~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~---~~-------------~~~~~~~~~i~~~l  336 (355)
                      ..|+..|+|||++. +..++.++|||||||++|+|++|+.||......   ..             .....+..+|.+||
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  234 (279)
T cd05633         155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLL  234 (279)
T ss_pred             cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHh
Confidence            46899999999986 456899999999999999999999999753211   11             11234567888999


Q ss_pred             eecCCCcC
Q 018487          337 FVNSLELL  344 (355)
Q Consensus       337 ~~~~~e~~  344 (355)
                      .++|.+++
T Consensus       235 ~~~p~~R~  242 (279)
T cd05633         235 QRDVSKRL  242 (279)
T ss_pred             cCCHHHhc
Confidence            99988876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=9.3e-39  Score=284.88  Aligned_cols=223  Identities=22%  Similarity=0.377  Sum_probs=183.3

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEEEe
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  195 (355)
                      ++||+|+||.||+|.++     .+++.||+|.+....  ..+....+.+|+++++.++|+||+++++++.....+|+|||
T Consensus         1 ~~lg~g~~g~vy~~~~~-----~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   73 (252)
T cd05084           1 ERIGRGNFGEVFSGRLR-----ADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME   73 (252)
T ss_pred             CccCcccCccEEEEEEe-----cCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEe
Confidence            46999999999999976     457789999876432  33445668889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCCCC--
Q 018487          196 FINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN--  272 (355)
Q Consensus       196 ~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~--  272 (355)
                      |+++++|.+++...+ .+++.+++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++..........  
T Consensus        74 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  153 (252)
T cd05084          74 LVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG  153 (252)
T ss_pred             eccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence            999999999987654 58999999999999999999999999999999999999999999999999987654322111  


Q ss_pred             -cccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhhHHHHHhhhhee
Q 018487          273 -SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTMLLFYLIIFHCL  336 (355)
Q Consensus       273 -~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~~~~~~~i~~~l  336 (355)
                       ...++..|+|||.+.+..++.++||||||+++|+|++ |..||........              .....+.+++.+|+
T Consensus       154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  233 (252)
T cd05084         154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCW  233 (252)
T ss_pred             CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHc
Confidence             1122456999999998889999999999999999998 9999975432210              11235577888899


Q ss_pred             eecCCCcCC
Q 018487          337 FVNSLELLS  345 (355)
Q Consensus       337 ~~~~~e~~~  345 (355)
                      +.+|.+++.
T Consensus       234 ~~~p~~Rps  242 (252)
T cd05084         234 EYDPGQRPS  242 (252)
T ss_pred             CCChhhCcC
Confidence            888887653

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=7.3e-39  Score=295.42  Aligned_cols=194  Identities=28%  Similarity=0.475  Sum_probs=160.3

Q ss_pred             EeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec--CCeEEE
Q 018487          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--RSKLYL  192 (355)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~l  192 (355)
                      .++||+|+||+||+|.++.   ...++.||+|.+.....     ...+.+|+.++++++||||+++++.+..  ...+|+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~---~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l   77 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKD---GKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   77 (317)
T ss_pred             ccccccCCCeEEEEEEEcc---CCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEE
Confidence            3689999999999999762   24567899998865422     2345679999999999999999998854  457899


Q ss_pred             EEeccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEe----cCCCcEEEEec
Q 018487          193 ILDFINGGHLFFHLYRQ---------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM----DSDGHVMLTDF  259 (355)
Q Consensus       193 v~e~~~~gsL~~~l~~~---------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl----~~~~~~kl~Df  259 (355)
                      +|||+.+ +|..++...         ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+||
T Consensus        78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          78 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             EEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            9999965 777766532         248899999999999999999999999999999999999    45678999999


Q ss_pred             CCccccCcCC----CCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          260 GLAKEIDESS----RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       260 g~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      |+++.+....    ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            9998764322    2234578999999999986 45899999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.1e-38  Score=284.61  Aligned_cols=226  Identities=25%  Similarity=0.467  Sum_probs=193.5

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++.+.||+|+||.||+|.++     .+++.+++|.+.....     .+.+.+|+.+++.++|+||+++++.+.....
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~-----~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~   72 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHK-----ETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTD   72 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEc-----CCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCc
Confidence            57999999999999999999976     3467899999865421     5678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      +|+++||+++++|.+++... ..+++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++......
T Consensus        73 ~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          73 LWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             EEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence            99999999999999998753 56899999999999999999999999999999999999999999999999999876543


Q ss_pred             C-CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh----------------hhhHHHHHh
Q 018487          269 S-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC----------------NTMLLFYLI  331 (355)
Q Consensus       269 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~----------------~~~~~~~~~  331 (355)
                      . ......++..|+|||++.+..++.++||||||+++|+|++|+.||...+....                .....+.++
T Consensus       153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (256)
T cd06612         153 MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDF  232 (256)
T ss_pred             ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHH
Confidence            3 23345588999999999988999999999999999999999999976432211                111356788


Q ss_pred             hhheeeecCCCcCC
Q 018487          332 IFHCLFVNSLELLS  345 (355)
Q Consensus       332 i~~~l~~~~~e~~~  345 (355)
                      |.+|++.+|.+++.
T Consensus       233 i~~~l~~~P~~Rps  246 (256)
T cd06612         233 VKKCLVKDPEERPS  246 (256)
T ss_pred             HHHHHhcChhhCcC
Confidence            89999988887653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1e-38  Score=289.76  Aligned_cols=202  Identities=30%  Similarity=0.477  Sum_probs=174.6

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++.++||+|+||.||+|.++     ..++.||+|.+...... ....+.+.+|+.+++.++|+||+++++++..++.
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   74 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHK-----ETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKR   74 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEEC-----CCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCe
Confidence            47999999999999999999976     45778999998654432 2344567789999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      .|+||||+++++|..+......+++.++..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++..+....
T Consensus        75 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          75 LYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             EEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            99999999999888777766679999999999999999999999999999999999999999999999999988654322


Q ss_pred             -CCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          270 -RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       270 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                       ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||...
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~  204 (286)
T cd07846         155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD  204 (286)
T ss_pred             cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC
Confidence             2234567889999999875 34678999999999999999999999654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.8e-39  Score=291.55  Aligned_cols=230  Identities=25%  Similarity=0.383  Sum_probs=194.2

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ..++|++++.||+|+||+||+|.+.     ..++.||+|++....  .....+.+.+|+++++.++||||+++++.+...
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~-----~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   75 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHI-----PTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE   75 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEc-----CCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC
Confidence            3467999999999999999999976     457789999886542  233456788899999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                      +.+++||||+++++|..++...+.+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++....
T Consensus        76 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~  155 (284)
T cd06620          76 NNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI  155 (284)
T ss_pred             CEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence            9999999999999999998888889999999999999999999997 689999999999999999999999999987653


Q ss_pred             cCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhh-----------h---h----------
Q 018487          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVI-----------A---C----------  322 (355)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~-----------~---~----------  322 (355)
                      ... ....+|+..|+|||++.+..++.++|||||||++|+|++|+.||......           .   .          
T Consensus       156 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd06620         156 NSI-ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP  234 (284)
T ss_pred             hhc-cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC
Confidence            322 23457899999999998888999999999999999999999999864321           0   0          


Q ss_pred             --hhhHHHHHhhhheeeecCCCcCC
Q 018487          323 --NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       323 --~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                        .....+.++|.+|++.+|.+++.
T Consensus       235 ~~~~~~~~~~li~~~l~~dp~~Rpt  259 (284)
T cd06620         235 SSDFPEDLRDFVDACLLKDPTERPT  259 (284)
T ss_pred             chhcCHHHHHHHHHHhcCCcccCcC
Confidence              01124567788898888888753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.2e-38  Score=292.03  Aligned_cols=202  Identities=25%  Similarity=0.429  Sum_probs=172.0

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|+++++||.|+||.||+|.++     .+++.||+|.++....  ......+.+|+.+++.++|+||+++++++...+
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~   77 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSK-----LTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK   77 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEc-----CCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCC
Confidence            357999999999999999999876     4567899999875432  222334667999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      ..++||||+++ +|..++... ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++.....
T Consensus        78 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  156 (301)
T cd07873          78 SLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI  156 (301)
T ss_pred             eEEEEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence            99999999975 787877654 4689999999999999999999999999999999999999999999999999876533


Q ss_pred             CC-CCCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          268 SS-RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       268 ~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      .. ......+++.|+|||++.+. .++.++|||||||++|+|+||+.||...+
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~  209 (301)
T cd07873         157 PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST  209 (301)
T ss_pred             CCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            22 12334578999999998754 57889999999999999999999998654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-38  Score=288.28  Aligned_cols=227  Identities=28%  Similarity=0.521  Sum_probs=193.1

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++.+.||.|+||.||+|.+.     .+++.|++|++....  .......+.+|+++++.++|+||+++++++..+..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   73 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDK-----RTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSK   73 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEEC-----CCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCe
Confidence            36889999999999999999976     467789999987543  23344567889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC-
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-  268 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~-  268 (355)
                      +|+|+||+++++|.+++... .+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||+++..... 
T Consensus        74 ~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  152 (274)
T cd06609          74 LWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM  152 (274)
T ss_pred             EEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence            99999999999999888765 7899999999999999999999999999999999999999999999999999877544 


Q ss_pred             CCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh---------------hhHHHHHhhh
Q 018487          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN---------------TMLLFYLIIF  333 (355)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~---------------~~~~~~~~i~  333 (355)
                      .......++..|+|||++.+..++.++||||||+++|+|+||+.||...+.....               ....+..++.
T Consensus       153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  232 (274)
T cd06609         153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVS  232 (274)
T ss_pred             cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHH
Confidence            2334557888999999999888999999999999999999999999764322110               1234667788


Q ss_pred             heeeecCCCcC
Q 018487          334 HCLFVNSLELL  344 (355)
Q Consensus       334 ~~l~~~~~e~~  344 (355)
                      +||..+|.+++
T Consensus       233 ~~l~~~p~~Rp  243 (274)
T cd06609         233 LCLNKDPKERP  243 (274)
T ss_pred             HHhhCChhhCc
Confidence            88887777765

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.1e-38  Score=285.13  Aligned_cols=204  Identities=32%  Similarity=0.488  Sum_probs=176.3

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeeccccc--chhHHHHHHHHHHHHHhcCCCcceecceeeec-
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII--KKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-  186 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-  186 (355)
                      .+|++.+.||+|+||.||+|...     .+++.|++|.+......  .....+.+.+|+.+++.++|+||+++++.+.. 
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   76 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDV-----DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR   76 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEc-----CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC
Confidence            47899999999999999999866     45778999988654321  23345668889999999999999999998875 


Q ss_pred             -CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          187 -RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       187 -~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                       ...++++|||+++++|.+++...+.+++..+..++.|++.||+|||+++|+||||||+||+++.++.++|+|||++...
T Consensus        77 ~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          77 AEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             CCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence             4678999999999999999988888999999999999999999999999999999999999999999999999998765


Q ss_pred             CcCC----CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          266 DESS----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       266 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      ....    ......++..|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~  213 (266)
T cd06651         157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE  213 (266)
T ss_pred             ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc
Confidence            3321    1223457889999999998889999999999999999999999998653

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.9e-38  Score=283.32  Aligned_cols=229  Identities=31%  Similarity=0.479  Sum_probs=193.3

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccc--cchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI--IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      +|+..+.||+|+||.||+|..+     ..++.|++|.+.....  ..++..+.+.+|+.+++.++|+||+++++++....
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNL-----DDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEc-----CCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCC
Confidence            4778899999999999999865     4577899999865432  22445567889999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      .+|++|||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999998876544


Q ss_pred             CCCCcccccCccccchhhccCC-CCCcccHHHHHHHHHHHHcCCCCCCCchhhhh---------------hhhHHHHHhh
Q 018487          269 SRSNSMCGTTEYMAPEILLSKG-HNKDADWWSVGILLYEMLTGQVNIKSMQVIAC---------------NTMLLFYLII  332 (355)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~---------------~~~~~~~~~i  332 (355)
                      .......|+..|++||.+.... ++.++|+||||+++|+|++|+.||........               .....+.+++
T Consensus       156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  235 (258)
T cd06632         156 SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFI  235 (258)
T ss_pred             ccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHH
Confidence            4344567899999999998766 89999999999999999999999976532111               0112356677


Q ss_pred             hheeeecCCCcC
Q 018487          333 FHCLFVNSLELL  344 (355)
Q Consensus       333 ~~~l~~~~~e~~  344 (355)
                      .+||..+|.+++
T Consensus       236 ~~~l~~~p~~Rp  247 (258)
T cd06632         236 LKCLQRDPSLRP  247 (258)
T ss_pred             HHHhhcCcccCc
Confidence            888888777764

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.3e-38  Score=289.74  Aligned_cols=236  Identities=23%  Similarity=0.377  Sum_probs=194.1

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ..++|++.+.||+|+||.||+|.+.+..+....+.||+|++....  .......+.+|+.+++.++||||+++++++..+
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            346899999999999999999998754444567889999987543  233445688899999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q 018487          188 SKLYLILDFINGGHLFFHLYRQG----------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~----------------------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~N  245 (355)
                      ...|+||||+++++|.+++....                      .+++.++..++.|++.||.|||+++++||||||+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            99999999999999999987432                      36788899999999999999999999999999999


Q ss_pred             EEecCCCcEEEEecCCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh
Q 018487          246 ILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA  321 (355)
Q Consensus       246 ILl~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~  321 (355)
                      ||++.++.++|+|||++..+.....   ......+..|+|||++.+..++.++|||||||++|+|++ |..||.+.....
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999876532211   122234667999999998899999999999999999998 888997643222


Q ss_pred             h--------------hhhHHHHHhhhheeeecCCCcCC
Q 018487          322 C--------------NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 ~--------------~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      .              +....+.++|.+|++.+|.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt  278 (288)
T cd05050         241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPS  278 (288)
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCC
Confidence            1              12246788999999998888664

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.5e-38  Score=285.85  Aligned_cols=230  Identities=24%  Similarity=0.426  Sum_probs=190.6

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeeccccc---chhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII---KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      +|+..+.||+|+||.||+|..+     .+++.||+|++......   .....+.+.+|+.++++++|+||+++++++...
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDV-----KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEc-----CCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC
Confidence            4788899999999999999865     45778999998754321   123456788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC-cEEEEecCCccccC
Q 018487          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEID  266 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~-~~kl~Dfg~a~~~~  266 (355)
                      +.+++||||+++++|.+++...+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+....
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            99999999999999999998888899999999999999999999999999999999999998776 59999999987664


Q ss_pred             cCCC-----CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh------------------
Q 018487          267 ESSR-----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN------------------  323 (355)
Q Consensus       267 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~------------------  323 (355)
                      ....     .....++..|+|||++.+..++.++||||||+++|+|++|+.||...+.....                  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEH  235 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchh
Confidence            3211     22346788999999998888999999999999999999999999754321110                  


Q ss_pred             hhHHHHHhhhheeeecCCCcCC
Q 018487          324 TMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       324 ~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ....+..++..||..+|.+++.
T Consensus       236 ~~~~~~~~i~~~l~~~p~~R~~  257 (268)
T cd06630         236 LSPGLRDVTLRCLELQPEDRPP  257 (268)
T ss_pred             hCHHHHHHHHHHcCCCcccCcC
Confidence            1123456777888887777653

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.7e-38  Score=285.12  Aligned_cols=227  Identities=26%  Similarity=0.364  Sum_probs=185.8

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +..++|++.++||+|+||.||+|.+.+      ...||+|++.....    ..+.+.+|+++++.++|+||+++++.+..
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~------~~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~   72 (262)
T cd05071           3 IPRESLRLEVKLGQGCFGEVWMGTWNG------TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE   72 (262)
T ss_pred             CChHHeeEeeecCCCCCCcEEEEEecC------CceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEECC
Confidence            445789999999999999999998652      23599999875332    12457789999999999999999988754


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                       ...|+||||+++++|.+++...  ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||.+..
T Consensus        73 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~  151 (262)
T cd05071          73 -EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL  151 (262)
T ss_pred             -CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceee
Confidence             5689999999999999998763  3478999999999999999999999999999999999999999999999999976


Q ss_pred             cCcCCCC--CcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh--------------hhhhHH
Q 018487          265 IDESSRS--NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA--------------CNTMLL  327 (355)
Q Consensus       265 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~--------------~~~~~~  327 (355)
                      +......  ....++..|+|||++.+..++.++||||||+++|+|+| |+.||.......              ......
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (262)
T cd05071         152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES  231 (262)
T ss_pred             ccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHH
Confidence            6433221  12345678999999988889999999999999999999 888997653211              112245


Q ss_pred             HHHhhhheeeecCCCcC
Q 018487          328 FYLIIFHCLFVNSLELL  344 (355)
Q Consensus       328 ~~~~i~~~l~~~~~e~~  344 (355)
                      +..++.+|+.++|.+++
T Consensus       232 l~~li~~~l~~~p~~Rp  248 (262)
T cd05071         232 LHDLMCQCWRKEPEERP  248 (262)
T ss_pred             HHHHHHHHccCCcccCC
Confidence            67788899988888765

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.2e-38  Score=288.80  Aligned_cols=234  Identities=20%  Similarity=0.327  Sum_probs=186.6

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ..++|++.+.||+|+||+||+|.+..... .....+++|.+....  .......+..|+.++++++||||+++++++.. 
T Consensus         5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~-~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-   80 (279)
T cd05111           5 KETELRKLKLLGSGVFGTVHKGIWIPEGD-SIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-   80 (279)
T ss_pred             CHhhceeccccCccCCcceEEEEEcCCCC-ceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-
Confidence            34689999999999999999999763221 112247778765322  23344567778889999999999999998754 


Q ss_pred             CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                      ...++++||+++|+|.+++... +.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++.+.
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            5678999999999999999764 568999999999999999999999999999999999999999999999999998653


Q ss_pred             cCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhhHHH
Q 018487          267 ESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTMLLF  328 (355)
Q Consensus       267 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~~~~  328 (355)
                      ....   .....++..|+|||++.+..++.++||||||+++|||++ |+.||........              ......
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDV  240 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHH
Confidence            3221   223346778999999998889999999999999999998 9999987532210              012245


Q ss_pred             HHhhhheeeecCCCcCC
Q 018487          329 YLIIFHCLFVNSLELLS  345 (355)
Q Consensus       329 ~~~i~~~l~~~~~e~~~  345 (355)
                      ..++.+|+..+|.+++.
T Consensus       241 ~~li~~c~~~~p~~Rps  257 (279)
T cd05111         241 YMVMVKCWMIDENVRPT  257 (279)
T ss_pred             HHHHHHHcCCCcccCcC
Confidence            67888899888887653

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-38  Score=291.21  Aligned_cols=235  Identities=20%  Similarity=0.338  Sum_probs=188.6

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCC---------CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCccee
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDD---------GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQ  179 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~  179 (355)
                      .++|++.++||+|+||.||+|.+.+...         ......||+|.++...  .....+.+.+|++++++++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~   81 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR   81 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence            4689999999999999999998653211         1223468999987543  2344556888999999999999999


Q ss_pred             cceeeecCCeEEEEEeccCCCChHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q 018487          180 LRYSFQTRSKLYLILDFINGGHLFFHLYRQG------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL  247 (355)
Q Consensus       180 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NIL  247 (355)
                      +++++...+..++||||+++++|.+++....            .+++..+..++.|++.||.|||++|++||||||+|||
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil  161 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL  161 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence            9999999999999999999999999886532            3678889999999999999999999999999999999


Q ss_pred             ecCCCcEEEEecCCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc--CCCCCCCchhhh-
Q 018487          248 MDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQVNIKSMQVIA-  321 (355)
Q Consensus       248 l~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt--g~~pf~~~~~~~-  321 (355)
                      ++.++.+||+|||++..+.....   .....++..|+|||++.+..++.++|||||||++|+|++  |..||....... 
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            99999999999999976533221   122345678999999998889999999999999999988  677887642211 


Q ss_pred             --hh------------------hhHHHHHhhhheeeecCCCcCC
Q 018487          322 --CN------------------TMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 --~~------------------~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                        ..                  ....+.++|.+|+..+|.+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs  285 (295)
T cd05097         242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPT  285 (295)
T ss_pred             HHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcC
Confidence              00                  1134567888888888887653

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=8.1e-39  Score=290.31  Aligned_cols=199  Identities=25%  Similarity=0.447  Sum_probs=169.4

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      +|++.+.||+|+||.||+|.++     .+++.|++|.++.... .......+.+|+.++++++|+||+++++++.+...+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~-----~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   74 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNR-----ETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKL   74 (284)
T ss_pred             CceeEEEecccCCeEEEEEEEC-----CCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCce
Confidence            5899999999999999999976     4577899999876432 222334567799999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          191 YLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      |+|+||+++ +|..++.. .+.+++..++.++.||++||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus        75 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          75 TLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             EEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            999999975 67777654 5679999999999999999999999999999999999999999999999999998654332


Q ss_pred             C-CCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCC
Q 018487          270 R-SNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKS  316 (355)
Q Consensus       270 ~-~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~  316 (355)
                      . .....++..|+|||++.+. .++.++|||||||++|+|+||..||..
T Consensus       154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~  202 (284)
T cd07839         154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  202 (284)
T ss_pred             CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence            2 2234678899999998764 478999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2e-38  Score=283.92  Aligned_cols=223  Identities=23%  Similarity=0.338  Sum_probs=182.4

Q ss_pred             eeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEEEec
Q 018487          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDF  196 (355)
Q Consensus       117 ~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  196 (355)
                      .||+|+||.||+|.++..   ..+..||+|++....  .....+.+.+|+.++++++|+||+++++.+.. ...++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~---~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMR---KKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecC---CCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEe
Confidence            489999999999987632   234569999986542  34445668899999999999999999998764 578999999


Q ss_pred             cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCC----C
Q 018487          197 INGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR----S  271 (355)
Q Consensus       197 ~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~----~  271 (355)
                      +++++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++........    .
T Consensus        76 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          76 ASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             CCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            999999998875 45689999999999999999999999999999999999999999999999999976543221    1


Q ss_pred             CcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhhHHHHHhhhhee
Q 018487          272 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTMLLFYLIIFHCL  336 (355)
Q Consensus       272 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~~~~~~~i~~~l  336 (355)
                      ....++..|+|||++.+..++.++|||||||++|+|++ |..||........              .....+.++|.+|+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~  235 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCW  235 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHc
Confidence            11223578999999988889999999999999999996 9999986533211              11345678999999


Q ss_pred             eecCCCcCC
Q 018487          337 FVNSLELLS  345 (355)
Q Consensus       337 ~~~~~e~~~  345 (355)
                      +.++.+++.
T Consensus       236 ~~~~~~Rp~  244 (257)
T cd05115         236 IYKWEDRPN  244 (257)
T ss_pred             CCChhhCcC
Confidence            999988764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.4e-38  Score=289.04  Aligned_cols=227  Identities=26%  Similarity=0.415  Sum_probs=187.1

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++++.||+|+||.||+|.++     ..++.||+|.++...  .......+.+|+.++++++|+||+++++.+...+.
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~-----~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   73 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHR-----PTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGA   73 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEc-----CCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCe
Confidence            36899999999999999999976     457789999886542  23334667889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          190 LYLILDFINGGHLFFHLYRQ---GIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~---~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      +|+||||+++++|..++...   ..+++..+..++.|++.||.|||. .||+||||||+||+++.++.++|+|||++..+
T Consensus        74 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  153 (286)
T cd06622          74 VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL  153 (286)
T ss_pred             EEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            99999999999998887763   368999999999999999999996 59999999999999999999999999999766


Q ss_pred             CcCCCCCcccccCccccchhhccC------CCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-----------------
Q 018487          266 DESSRSNSMCGTTEYMAPEILLSK------GHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-----------------  322 (355)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-----------------  322 (355)
                      .... .....++..|+|||++.+.      .++.++|||||||++|+|++|+.||........                 
T Consensus       154 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd06622         154 VASL-AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPS  232 (286)
T ss_pred             cCCc-cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCc
Confidence            4332 2344688899999998654      347899999999999999999999975422110                 


Q ss_pred             hhhHHHHHhhhheeeecCCCcC
Q 018487          323 NTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       323 ~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                      .....+..+|.+||+.+|.+++
T Consensus       233 ~~~~~~~~li~~~l~~~p~~Rp  254 (286)
T cd06622         233 GYSDDAQDFVAKCLNKIPNRRP  254 (286)
T ss_pred             ccCHHHHHHHHHHcccCcccCC
Confidence            0112346778888888877764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-38  Score=288.34  Aligned_cols=202  Identities=29%  Similarity=0.529  Sum_probs=177.0

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++.+.||+|+||.||+|.++     .+++.|++|+++.... .....+.+.+|+++++.++|+||+++++.+..++.
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~-----~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   74 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNK-----ATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGR   74 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeC-----CCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCE
Confidence            47999999999999999999976     4567899999875432 33445678889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      .++||||++++.+..+......+++.++..++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||++.......
T Consensus        75 ~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          75 LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            99999999997777666666779999999999999999999999999999999999999999999999999998765443


Q ss_pred             --CCCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          270 --RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       270 --~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                        ......++..|+|||++.+. .++.++||||||+++|+|++|+.||...
T Consensus       155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~  205 (288)
T cd07833         155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD  205 (288)
T ss_pred             cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence              23345678999999999887 8899999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.7e-38  Score=283.81  Aligned_cols=229  Identities=27%  Similarity=0.454  Sum_probs=193.1

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++.+.||.|+||+||+|...     ..+..+++|++.......  ..+.+.+|+.+++.++|+||+++++.+.....
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICL-----PNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDE   73 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEc-----CCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCE
Confidence            47999999999999999999876     356789999987544322  55678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          190 LYLILDFINGGHLFFHLYRQ---GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~---~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                      .|+|||++++++|.+++...   ..+++..+..++.|++.||+|||++|++||||+|+||++++++.++|+|||++..+.
T Consensus        74 ~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~  153 (267)
T cd06610          74 LWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLA  153 (267)
T ss_pred             EEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhc
Confidence            99999999999999998764   458999999999999999999999999999999999999999999999999987664


Q ss_pred             cCCCC-----CcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh------------------
Q 018487          267 ESSRS-----NSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC------------------  322 (355)
Q Consensus       267 ~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~------------------  322 (355)
                      .....     ....|+..|+|||++... .++.++|+|||||++|+|++|+.||...+....                  
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (267)
T cd06610         154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADY  233 (267)
T ss_pred             cCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccc
Confidence            33222     344688999999998876 789999999999999999999999976532110                  


Q ss_pred             -hhhHHHHHhhhheeeecCCCcCC
Q 018487          323 -NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       323 -~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                       .....+.+++.+|+.++|.+++.
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rp~  257 (267)
T cd06610         234 KKYSKSFRKMISLCLQKDPSKRPT  257 (267)
T ss_pred             ccccHHHHHHHHHHcCCChhhCcC
Confidence             11234578888999988888753

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.9e-38  Score=281.17  Aligned_cols=229  Identities=27%  Similarity=0.466  Sum_probs=193.6

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      +|++.+.||+|+||.||+|...     .+++.+++|.+..... .......+.+|+.+++.++|+||+++++.+..++..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRK-----ADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKAL   74 (256)
T ss_pred             CceEEEEecccCceEEEEEEEc-----CCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEE
Confidence            5899999999999999999976     4678899999876543 233456788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC-cEEEEecCCccccCc
Q 018487          191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEIDE  267 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~-~~kl~Dfg~a~~~~~  267 (355)
                      ++||||+++++|.+++...  ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .+||+|||++.....
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (256)
T cd08220          75 MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS  154 (256)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence            9999999999999998764  3489999999999999999999999999999999999998654 689999999987765


Q ss_pred             CCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh--------------hhhHHHHHhhh
Q 018487          268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC--------------NTMLLFYLIIF  333 (355)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~--------------~~~~~~~~~i~  333 (355)
                      ........++..|+|||.+.+..++.++||||||+++|+|++|+.||...+....              .....+..++.
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  234 (256)
T cd08220         155 KSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLIL  234 (256)
T ss_pred             CccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHH
Confidence            5444556789999999999988889999999999999999999999987542111              11234677888


Q ss_pred             heeeecCCCcCC
Q 018487          334 HCLFVNSLELLS  345 (355)
Q Consensus       334 ~~l~~~~~e~~~  345 (355)
                      .|+..+|.+++.
T Consensus       235 ~~l~~~p~~Rpt  246 (256)
T cd08220         235 SMLNLDPSKRPQ  246 (256)
T ss_pred             HHccCChhhCCC
Confidence            888888877653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-39  Score=289.59  Aligned_cols=228  Identities=29%  Similarity=0.487  Sum_probs=190.7

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|++.++||.|+||.||+|.+.     .++..+++|++...   .....+.+.+|+.++++++|+||+++++.+..+.
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~-----~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHK-----ETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN   75 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEc-----CCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC
Confidence            357999999999999999999976     35678999998643   2334466778999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      ..|+||||+++++|..++... ..+++.+++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~  155 (280)
T cd06611          76 KLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS  155 (280)
T ss_pred             eEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence            999999999999999888764 4689999999999999999999999999999999999999999999999998876533


Q ss_pred             CC-CCCcccccCccccchhhc-----cCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh----------------hhh
Q 018487          268 SS-RSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC----------------NTM  325 (355)
Q Consensus       268 ~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~----------------~~~  325 (355)
                      .. ......++..|+|||++.     +..++.++||||||+++|+|++|+.||...+....                ...
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (280)
T cd06611         156 TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWS  235 (280)
T ss_pred             cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCC
Confidence            22 233456899999999985     34567899999999999999999999987643221                112


Q ss_pred             HHHHHhhhheeeecCCCcC
Q 018487          326 LLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~  344 (355)
                      ..+.++|.+||..+|.+++
T Consensus       236 ~~~~~li~~~l~~~p~~Rp  254 (280)
T cd06611         236 SSFNDFLKSCLVKDPDDRP  254 (280)
T ss_pred             HHHHHHHHHHhccChhhCc
Confidence            3456788888888887764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.3e-38  Score=295.14  Aligned_cols=198  Identities=22%  Similarity=0.396  Sum_probs=167.7

Q ss_pred             EEeeeccC--CcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEE
Q 018487          114 IFRVVGQG--AFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (355)
Q Consensus       114 ~~~~lG~G--~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  191 (355)
                      ++++||+|  +||+||++..+     .+++.||+|.+..... .....+.+.+|+.+++.++||||++++++|..++..|
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~   75 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYK-----PTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW   75 (327)
T ss_pred             hhhhccccccceEEEEEEeec-----ccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEE
Confidence            46789999  78999999977     5688899999876543 2344566888999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          192 LILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       192 lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      +||||+++++|.+++...  ..+++..++.++.|++.||.|||++||+||||||+|||++.++.++++||+.+.......
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~  155 (327)
T cd08227          76 VVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG  155 (327)
T ss_pred             EEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence            999999999999988653  458999999999999999999999999999999999999999999999998654332111


Q ss_pred             C--------CCcccccCccccchhhcc--CCCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          270 R--------SNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       270 ~--------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      .        .....++..|+|||++.+  ..++.++|||||||++|||++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  213 (327)
T cd08227         156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  213 (327)
T ss_pred             ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence            0        122346778999999976  45899999999999999999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.7e-38  Score=284.76  Aligned_cols=233  Identities=22%  Similarity=0.344  Sum_probs=189.8

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|++.+.||+|+||.||+|.++...  .....|++|.+....  .......+..|+.+++.++||||+++++++..+.
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~--~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   78 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPG--KREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR   78 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCC--CCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC
Confidence            357999999999999999999977432  234579999986542  3344567889999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      ..++||||+++++|.+++... +.+++.+++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.....
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence            999999999999999888754 5689999999999999999999999999999999999999999999999999876543


Q ss_pred             CCCCCc----cc--ccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhhH
Q 018487          268 SSRSNS----MC--GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTML  326 (355)
Q Consensus       268 ~~~~~~----~~--gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~~  326 (355)
                      ......    ..  .+..|+|||++.+..++.++|||||||++|||++ |..||...+....              ....
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~  238 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPT  238 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCH
Confidence            221111    11  1357999999998899999999999999999987 9999976543221              0122


Q ss_pred             HHHHhhhheeeecCCCcCC
Q 018487          327 LFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       327 ~~~~~i~~~l~~~~~e~~~  345 (355)
                      .+...+..|+.++|.+++.
T Consensus       239 ~~~~li~~~l~~~p~~Rp~  257 (269)
T cd05065         239 ALHQLMLDCWQKDRNARPK  257 (269)
T ss_pred             HHHHHHHHHcCCChhhCcC
Confidence            4567788888888887653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.4e-38  Score=284.83  Aligned_cols=233  Identities=22%  Similarity=0.352  Sum_probs=190.7

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|++.+.||+|+||.||+|.++...  .....+|+|.++...  .....+.+.+|+.++++++||||+++++++..++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPG--KREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK   78 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCC--CCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            458999999999999999999875321  234579999886543  2334567888999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      ..|+||||+++++|.+++... +.+++.++..++.|++.||.|||++|++||||||+|||++.++.++|+|||++..+..
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            999999999999999998765 4589999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCC----CcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhhHHH
Q 018487          268 SSRS----NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTMLLF  328 (355)
Q Consensus       268 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~~~~  328 (355)
                      ....    ....++..|+|||++.+..++.++||||||+++|++++ |..||........              .....+
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAAL  238 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHH
Confidence            2211    11223567999999998889999999999999999887 9999976532210              112356


Q ss_pred             HHhhhheeeecCCCcCC
Q 018487          329 YLIIFHCLFVNSLELLS  345 (355)
Q Consensus       329 ~~~i~~~l~~~~~e~~~  345 (355)
                      ..++.+|++++|.+++.
T Consensus       239 ~~li~~~l~~~p~~Rp~  255 (267)
T cd05066         239 HQLMLDCWQKDRNERPK  255 (267)
T ss_pred             HHHHHHHcccCchhCCC
Confidence            77888898888887653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=4.6e-38  Score=282.00  Aligned_cols=228  Identities=29%  Similarity=0.470  Sum_probs=193.9

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      +|.+.+.||+|+||.||+|...     .+++.|++|++...... ....+.+.+|+.+++.++|+||+++++.+...+.+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~   74 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNL-----DTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKV   74 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEEC-----CCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEE
Confidence            5889999999999999999865     45778999998765432 45667889999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCC
Q 018487          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR  270 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~  270 (355)
                      ++|+||+++++|.+++.....+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++........
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          75 YIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             EEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            99999999999999998887789999999999999999999999999999999999999999999999999887644322


Q ss_pred             C-----CcccccCccccchhhccCC---CCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-----------------hhh
Q 018487          271 S-----NSMCGTTEYMAPEILLSKG---HNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-----------------NTM  325 (355)
Q Consensus       271 ~-----~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-----------------~~~  325 (355)
                      .     ....++..|+|||++.+..   ++.++||||||+++|+|++|+.||...+....                 ...
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLS  234 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccC
Confidence            1     1346788999999998766   88999999999999999999999975421100                 012


Q ss_pred             HHHHHhhhheeeecCCCcC
Q 018487          326 LLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~  344 (355)
                      ..+.++|.+|++.+|.+++
T Consensus       235 ~~~~~li~~~l~~~p~~R~  253 (264)
T cd06626         235 PEGKDFLDRCLESDPKKRP  253 (264)
T ss_pred             HHHHHHHHHHccCCcccCC
Confidence            3456788899988888865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.5e-38  Score=294.18  Aligned_cols=238  Identities=21%  Similarity=0.385  Sum_probs=191.3

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCC--CCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecc
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDG--DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLR  181 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~  181 (355)
                      +.+...+|++.+.||+|+||.||+|.+.+....  .....||+|++....  .....+.+.+|+.+++++ +|+||++++
T Consensus         7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~   84 (334)
T cd05100           7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLL   84 (334)
T ss_pred             cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence            344456899999999999999999987654322  223468999876532  233456788899999999 799999999


Q ss_pred             eeeecCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q 018487          182 YSFQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (355)
Q Consensus       182 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~N  245 (355)
                      +++...+.++++|||+++++|.+++....                .++..++..++.|++.||.|||++|++||||||+|
T Consensus        85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N  164 (334)
T cd05100          85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN  164 (334)
T ss_pred             EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence            99999999999999999999999987532                36778889999999999999999999999999999


Q ss_pred             EEecCCCcEEEEecCCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh
Q 018487          246 ILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA  321 (355)
Q Consensus       246 ILl~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~  321 (355)
                      ||++.++.+||+|||+++.......   .....++..|+|||++.+..++.++||||||+++|||++ |..||...+...
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  244 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  244 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999986543221   112234567999999999999999999999999999998 889997754322


Q ss_pred             hh--------------hhHHHHHhhhheeeecCCCcC
Q 018487          322 CN--------------TMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       322 ~~--------------~~~~~~~~i~~~l~~~~~e~~  344 (355)
                      ..              ....+..++.+|+..+|.+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp  281 (334)
T cd05100         245 LFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRP  281 (334)
T ss_pred             HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCc
Confidence            11              112456788889888877764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.6e-38  Score=289.33  Aligned_cols=228  Identities=27%  Similarity=0.424  Sum_probs=191.9

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      ..+|++++.||+|+||.||+|...     .+++.||+|.+.....   ...+.+.+|+.+++.++|+||+++++++..++
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDI-----ATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGD   89 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEEC-----CCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            368999999999999999999865     4677899999875432   22355778999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      ..|+||||+++++|.+++.. ..+++.++..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++......
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~  168 (297)
T cd06656          90 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (297)
T ss_pred             EEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence            99999999999999988864 45799999999999999999999999999999999999999999999999998765433


Q ss_pred             CC-CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh----------------hhhhHHHHHh
Q 018487          269 SR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA----------------CNTMLLFYLI  331 (355)
Q Consensus       269 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~----------------~~~~~~~~~~  331 (355)
                      .. .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||...+...                ......+.++
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  248 (297)
T cd06656         169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDF  248 (297)
T ss_pred             ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHH
Confidence            22 233568899999999998889999999999999999999999997643211                0112345678


Q ss_pred             hhheeeecCCCcCC
Q 018487          332 IFHCLFVNSLELLS  345 (355)
Q Consensus       332 i~~~l~~~~~e~~~  345 (355)
                      +.+||..+|.+++.
T Consensus       249 i~~~l~~~p~~Rps  262 (297)
T cd06656         249 LNRCLEMDVDRRGS  262 (297)
T ss_pred             HHHHccCChhhCcC
Confidence            88999888887653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-38  Score=282.40  Aligned_cols=225  Identities=20%  Similarity=0.318  Sum_probs=185.3

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEEEe
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  195 (355)
                      ++||+|+||.||+|.+....  .....+|+|.+......  ...+.+.+|+.+++.+.|+||+++++++. ...+++|||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~--~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e   75 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKS--GKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVME   75 (257)
T ss_pred             CccCccCceeEEEeEeeccC--CCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEE
Confidence            47999999999999876432  13468999998765432  34456888999999999999999999876 456899999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCCC----
Q 018487          196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS----  271 (355)
Q Consensus       196 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~----  271 (355)
                      |+++++|.+++.....+++..+..++.|++.||.|||.++++||||||+|||++.++.+||+|||+++........    
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          76 LAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             eCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            9999999999988888999999999999999999999999999999999999999999999999999866433221    


Q ss_pred             CcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhhHHHHHhhhhee
Q 018487          272 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTMLLFYLIIFHCL  336 (355)
Q Consensus       272 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~~~~~~~i~~~l  336 (355)
                      ....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+....              .....++++|.+|+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  235 (257)
T cd05060         156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCW  235 (257)
T ss_pred             cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHh
Confidence            11123467999999998899999999999999999998 9999977543211              11235678899999


Q ss_pred             eecCCCcCC
Q 018487          337 FVNSLELLS  345 (355)
Q Consensus       337 ~~~~~e~~~  345 (355)
                      ..+|.+++.
T Consensus       236 ~~~p~~Rp~  244 (257)
T cd05060         236 KYRPEDRPT  244 (257)
T ss_pred             cCChhhCcC
Confidence            998888763

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.6e-38  Score=286.42  Aligned_cols=228  Identities=28%  Similarity=0.505  Sum_probs=187.3

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceeeecC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR  187 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~  187 (355)
                      .+.|++.+.||+|+||.||+|.++     ..++.||+|++....    .....+.+|+.+++++ +|+||+++++++...
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~-----~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   75 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHV-----KTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   75 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEc-----CCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeec
Confidence            467999999999999999999876     457789999986542    1234567899999998 699999999998742


Q ss_pred             ------CeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEec
Q 018487          188 ------SKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (355)
Q Consensus       188 ------~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Df  259 (355)
                            ..+|++|||+++++|.+++...  ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+||
T Consensus        76 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Df  155 (272)
T cd06637          76 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF  155 (272)
T ss_pred             CCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccC
Confidence                  4689999999999999988864  35899999999999999999999999999999999999999999999999


Q ss_pred             CCccccCcC-CCCCcccccCccccchhhc-----cCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh----------
Q 018487          260 GLAKEIDES-SRSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN----------  323 (355)
Q Consensus       260 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~----------  323 (355)
                      |++...... .......|+..|+|||++.     +..++.++|||||||++|+|++|+.||.........          
T Consensus       156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  235 (272)
T cd06637         156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR  235 (272)
T ss_pred             CCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCC
Confidence            999865432 2234467899999999986     345788999999999999999999999754322111          


Q ss_pred             -----hhHHHHHhhhheeeecCCCcCC
Q 018487          324 -----TMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       324 -----~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                           ....+.+++.+||..+|.+++.
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rpt  262 (272)
T cd06637         236 LKSKKWSKKFQSFIESCLVKNHSQRPT  262 (272)
T ss_pred             CCCCCcCHHHHHHHHHHcCCChhhCCC
Confidence                 1235677888999888887653

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-38  Score=285.79  Aligned_cols=230  Identities=21%  Similarity=0.333  Sum_probs=186.0

Q ss_pred             eEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe--
Q 018487          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK--  189 (355)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~--  189 (355)
                      |++.+.||+|+||.||+|.....  ......||+|.++.... .....+.+.+|+.+++.++|+||+++++.+.....  
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~--~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   77 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQD--DGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ   77 (273)
T ss_pred             CccccccCcCCCceEEEEEEecC--CCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence            56789999999999999987532  23457799999876432 23445668889999999999999999998765443  


Q ss_pred             ----EEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEec
Q 018487          190 ----LYLILDFINGGHLFFHLYRQ------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (355)
Q Consensus       190 ----~~lv~e~~~~gsL~~~l~~~------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Df  259 (355)
                          .+++|||+++++|..++...      ..+++..+..++.|++.||.|||+++++||||||+||++++++.+||+||
T Consensus        78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCc
Confidence                79999999999998887543      35899999999999999999999999999999999999999999999999


Q ss_pred             CCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh-------------
Q 018487          260 GLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC-------------  322 (355)
Q Consensus       260 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~-------------  322 (355)
                      |+++.......   .....++..|+|||++.+..++.++|||||||++|||++ |..||...+....             
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  237 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQP  237 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            99986543321   112234678999999988899999999999999999999 8999976532211             


Q ss_pred             -hhhHHHHHhhhheeeecCCCcC
Q 018487          323 -NTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       323 -~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                       .....+.+++.+|++.+|.+++
T Consensus       238 ~~~~~~~~~li~~~l~~~p~~Rp  260 (273)
T cd05035         238 EDCLDELYDLMYSCWRADPKDRP  260 (273)
T ss_pred             cCCCHHHHHHHHHHcCCChhhCc
Confidence             1123567888889998888865

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-38  Score=282.39  Aligned_cols=225  Identities=26%  Similarity=0.434  Sum_probs=188.8

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEEEe
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  195 (355)
                      +.||+|+||.||+|.+....  ..+..|++|++.......  ..+.+.+|+.+++.++|+||+++++++.....+++|||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~--~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   76 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKD--GKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE   76 (262)
T ss_pred             CccccCCceEEEEEEEecCC--CCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence            46999999999999976321  236789999987654322  45678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          196 FINGGHLFFHLYRQ---------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       196 ~~~~gsL~~~l~~~---------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                      |+++++|.+++...         ..+++.+++.++.|++.||.|||++|++||||||+||+++.++.++|+|||.+....
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence            99999999999875         679999999999999999999999999999999999999999999999999998765


Q ss_pred             cCC---CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhhHHH
Q 018487          267 ESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTMLLF  328 (355)
Q Consensus       267 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~~~~  328 (355)
                      ...   ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+....              .....+
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDEL  236 (262)
T ss_pred             cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHH
Confidence            432   2334457889999999988889999999999999999999 6999987633211              111345


Q ss_pred             HHhhhheeeecCCCcC
Q 018487          329 YLIIFHCLFVNSLELL  344 (355)
Q Consensus       329 ~~~i~~~l~~~~~e~~  344 (355)
                      ..++.+|+..+|.+++
T Consensus       237 ~~li~~~l~~~p~~Rp  252 (262)
T cd00192         237 YELMLSCWQLDPEDRP  252 (262)
T ss_pred             HHHHHHHccCCcccCc
Confidence            6778888888887765

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-39  Score=281.32  Aligned_cols=198  Identities=31%  Similarity=0.505  Sum_probs=171.9

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecceeeecCCeEEEEE
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLIL  194 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~  194 (355)
                      +.||+|+|+.|--+...     .++..||||++.+.   ......++.+|++++.+++ |+||++++++|+++..+|+||
T Consensus        84 e~LGeGAyasVqtcv~i-----~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf  155 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSI-----QTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF  155 (463)
T ss_pred             HHhcCccceeeeeeeee-----ccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence            56999999999988865     56788999999875   3344567788999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC---cEEEEecCCccccCcCCC-
Q 018487          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVMLTDFGLAKEIDESSR-  270 (355)
Q Consensus       195 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~---~~kl~Dfg~a~~~~~~~~-  270 (355)
                      |-|.||.|..++.++..|++.++..+.++|+.||.|||.+||.||||||+|||....+   -||||||.+...+..... 
T Consensus       156 EKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~  235 (463)
T KOG0607|consen  156 EKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC  235 (463)
T ss_pred             ecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence            9999999999999999999999999999999999999999999999999999997665   489999998875432221 


Q ss_pred             -------CCcccccCccccchhhc-----cCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh
Q 018487          271 -------SNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA  321 (355)
Q Consensus       271 -------~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~  321 (355)
                             ..+.+|+..|||||++.     ...|+.++|.||||||||-||+|..||-++=-..
T Consensus       236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d  298 (463)
T KOG0607|consen  236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD  298 (463)
T ss_pred             CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc
Confidence                   23568999999999864     2468999999999999999999999998863333

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-40  Score=301.58  Aligned_cols=202  Identities=36%  Similarity=0.583  Sum_probs=181.7

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEEEe
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  195 (355)
                      +.||.|.||+||-++++     .+++.||||++.+-....+. ...+++|+.||+.++||.||.+...|+..+.+++|||
T Consensus       570 evLGSGQFG~VYgg~hR-----ktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVME  643 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHR-----KTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVME  643 (888)
T ss_pred             hhccCCcceeeecceec-----ccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEeh
Confidence            67999999999999987     67899999999876654443 3678999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC---cEEEEecCCccccCcCCCC
Q 018487          196 FINGGHLFFHLY-RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVMLTDFGLAKEIDESSRS  271 (355)
Q Consensus       196 ~~~~gsL~~~l~-~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~---~~kl~Dfg~a~~~~~~~~~  271 (355)
                      .+.|.-|.-+|. ..+++++...+.++.||+.||.|||-++|+|+||||+|||+....   .+||||||+|+.+.+....
T Consensus       644 Kl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR  723 (888)
T KOG4236|consen  644 KLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR  723 (888)
T ss_pred             hhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence            998765655554 347899999999999999999999999999999999999996543   7999999999999998888


Q ss_pred             CcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh
Q 018487          272 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN  323 (355)
Q Consensus       272 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~  323 (355)
                      ...+||+.|+|||++.++.|+..-|+||+||++|.-|+|..||...+.+..+
T Consensus       724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ  775 (888)
T KOG4236|consen  724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ  775 (888)
T ss_pred             hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH
Confidence            8999999999999999999999999999999999999999999988666544

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.5e-38  Score=287.02  Aligned_cols=226  Identities=31%  Similarity=0.496  Sum_probs=188.1

Q ss_pred             eEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEE
Q 018487          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (355)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  191 (355)
                      |++.+.||+|+||.||+|.+.     ..+..+++|.+....   ....+.+.+|+.+++.++|+||+++++.+......|
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~-----~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~   78 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNK-----ETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW   78 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEEC-----CCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEE
Confidence            678899999999999999976     456778999885432   334556788999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC-C
Q 018487          192 LILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-S  269 (355)
Q Consensus       192 lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~-~  269 (355)
                      +||||+++++|..++.. ...+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++...... .
T Consensus        79 ~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~  158 (282)
T cd06643          79 ILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ  158 (282)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence            99999999999887765 456899999999999999999999999999999999999999999999999998765322 2


Q ss_pred             CCCcccccCccccchhhc-----cCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh----------------hhhHHH
Q 018487          270 RSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC----------------NTMLLF  328 (355)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~----------------~~~~~~  328 (355)
                      ......++..|+|||++.     +..++.++|||||||++|+|++|+.||...+....                .....+
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEF  238 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHH
Confidence            233456899999999984     34577899999999999999999999986532211                112357


Q ss_pred             HHhhhheeeecCCCcCC
Q 018487          329 YLIIFHCLFVNSLELLS  345 (355)
Q Consensus       329 ~~~i~~~l~~~~~e~~~  345 (355)
                      .++|.+||..+|.+++.
T Consensus       239 ~~li~~~l~~~p~~Rp~  255 (282)
T cd06643         239 KDFLKKCLEKNVDARWT  255 (282)
T ss_pred             HHHHHHHccCChhhCcC
Confidence            88889999988888754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-39  Score=297.27  Aligned_cols=231  Identities=22%  Similarity=0.337  Sum_probs=192.3

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      ++..+...+.++||+|.||.|.+|+-.      ....||||.++.+.  .......|.+|+++|.+|+|||||.++++|.
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeve------g~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~  605 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVE------GPLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCV  605 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEec------CceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeee
Confidence            455678899999999999999999865      35779999998765  3445677999999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      .++.+++|||||++|+|..++.++..  ........|+.||+.||+||.+.+++||||.++|+|++.++++||+|||+++
T Consensus       606 ~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR  685 (807)
T KOG1094|consen  606 QDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSR  685 (807)
T ss_pred             cCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccc
Confidence            99999999999999999999988733  4556677899999999999999999999999999999999999999999999


Q ss_pred             ccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc--CCCCCCCchhhh--hhhh-----------
Q 018487          264 EIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQVNIKSMQVIA--CNTM-----------  325 (355)
Q Consensus       264 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt--g~~pf~~~~~~~--~~~~-----------  325 (355)
                      .+-....   ....+-...|||+|.+..+.+++++|||+||+++||+++  ...||..+....  .|..           
T Consensus       686 ~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~  765 (807)
T KOG1094|consen  686 NLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVV  765 (807)
T ss_pred             ccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCccee
Confidence            6532221   234456789999999999999999999999999999865  788998764333  1111           


Q ss_pred             --------HHHHHhhhheeeecCCCcC
Q 018487          326 --------LLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       326 --------~~~~~~i~~~l~~~~~e~~  344 (355)
                              ..++..+.+|+.++.++++
T Consensus       766 l~~P~~cp~~lyelml~Cw~~es~~RP  792 (807)
T KOG1094|consen  766 LSRPPACPQGLYELMLRCWRRESEQRP  792 (807)
T ss_pred             ccCCCcCcHHHHHHHHHHhchhhhcCC
Confidence                    1346777888887776654

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.3e-38  Score=282.09  Aligned_cols=223  Identities=25%  Similarity=0.450  Sum_probs=185.0

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee-c
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ-T  186 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~  186 (355)
                      ...+|++.+.||+|+||.||++...       +..|++|.++...     ..+.+.+|+.++++++|+||+++++++. .
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~-------~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (256)
T cd05082           4 NMKELKLLQTIGKGEFGDVMLGDYR-------GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE   71 (256)
T ss_pred             cHHhCeeeeeecccCCCeEEEEEEc-------CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC
Confidence            3458999999999999999999754       4568999886432     2356788999999999999999998754 5


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      +...+++|||+++++|.+++....  .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++..
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~  151 (256)
T cd05082          72 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKE  151 (256)
T ss_pred             CCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCcccee
Confidence            567999999999999999987654  378999999999999999999999999999999999999999999999999876


Q ss_pred             cCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhhh--------------hhHHHH
Q 018487          265 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACN--------------TMLLFY  329 (355)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~~--------------~~~~~~  329 (355)
                      .....  ....++..|+|||++.+..++.++|||||||++|+|++ |+.||...+.....              ....+.
T Consensus       152 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (256)
T cd05082         152 ASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVY  229 (256)
T ss_pred             ccccC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence            54322  22345678999999998889999999999999999998 99999875432211              123467


Q ss_pred             HhhhheeeecCCCcC
Q 018487          330 LIIFHCLFVNSLELL  344 (355)
Q Consensus       330 ~~i~~~l~~~~~e~~  344 (355)
                      .++.+|+..+|.+++
T Consensus       230 ~li~~~l~~~p~~Rp  244 (256)
T cd05082         230 DVMKQCWHLDAATRP  244 (256)
T ss_pred             HHHHHHhcCChhhCc
Confidence            888899988888764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.6e-38  Score=295.26  Aligned_cols=201  Identities=27%  Similarity=0.466  Sum_probs=172.9

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC-
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-  187 (355)
                      .++|++.+.||+|+||.||+|.+.     .+++.||+|++..... .....+.+.+|+.+++.++|+||++++++|... 
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   88 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDT-----VTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQK   88 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEEC-----CCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCC
Confidence            368999999999999999999976     4677899999865432 233345567899999999999999999988643 


Q ss_pred             -----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       188 -----~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                           ...|+||||+.+ +|...+...  +++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        89 ~~~~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          89 SLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             CccccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence                 357999999975 777777654  899999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      .............++..|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~  221 (353)
T cd07850         166 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD  221 (353)
T ss_pred             eeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence            87655444445578899999999999999999999999999999999999997654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.3e-40  Score=306.37  Aligned_cols=224  Identities=24%  Similarity=0.362  Sum_probs=186.5

Q ss_pred             CCCCe-EEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccc-cchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          108 GPGDF-EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       108 ~~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      ..++| +...+||+|+|-+||+|.+.     ..+..||.-.++.+.. .....+++|..|+.+|+.|+|+|||+++++|.
T Consensus        37 p~gRy~k~~evLGrGafKtVYka~De-----~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~  111 (632)
T KOG0584|consen   37 PTGRYLKFDEVLGRGAFKTVYKAFDE-----EEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWV  111 (632)
T ss_pred             CCCceeehhhhcccccceeeeecccc-----ccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeehee
Confidence            34455 44578999999999999854     5566677655544332 34556788999999999999999999999998


Q ss_pred             cCC--eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCcEEecC-CCcEEEEecC
Q 018487          186 TRS--KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDS-DGHVMLTDFG  260 (355)
Q Consensus       186 ~~~--~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~--iiHrDlkp~NILl~~-~~~~kl~Dfg  260 (355)
                      +..  .+.+|+|++.+|+|..|+++.+.++...++.|++||++||.|||++.  |||||||-+||+|+. .|.|||+|+|
T Consensus       112 d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLG  191 (632)
T KOG0584|consen  112 DTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLG  191 (632)
T ss_pred             cCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchh
Confidence            755  48899999999999999999999999999999999999999999996  999999999999975 4899999999


Q ss_pred             CccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh--------h--------h
Q 018487          261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC--------N--------T  324 (355)
Q Consensus       261 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~--------~--------~  324 (355)
                      +|....... .....|||.|||||++. ..|+..+||||||++|+||+|+..||..-+--+.        .        .
T Consensus       192 LAtl~r~s~-aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~  269 (632)
T KOG0584|consen  192 LATLLRKSH-AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVK  269 (632)
T ss_pred             HHHHhhccc-cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccC
Confidence            999876655 34488999999999997 8899999999999999999999999986422110        0        1


Q ss_pred             hHHHHHhhhheeee
Q 018487          325 MLLFYLIIFHCLFV  338 (355)
Q Consensus       325 ~~~~~~~i~~~l~~  338 (355)
                      .--.+.+|++||..
T Consensus       270 dPevr~fIekCl~~  283 (632)
T KOG0584|consen  270 DPEVREFIEKCLAT  283 (632)
T ss_pred             CHHHHHHHHHHhcC
Confidence            11347899999966

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-39  Score=298.45  Aligned_cols=230  Identities=29%  Similarity=0.446  Sum_probs=189.5

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecceee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSF  184 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~  184 (355)
                      .+....|+++++||.||.+.||+|...      ..+.||+|.+.... .+...+..+.+|+.+|.+++ |.+||++++|-
T Consensus       357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s------~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE  429 (677)
T KOG0596|consen  357 KVKGREYEILKQIGSGGSSKVFKVLNS------DKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE  429 (677)
T ss_pred             EECcchhhHHHhhcCCCcceeeeeecC------CCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeee
Confidence            355667999999999999999999843      45678888776554 35667788999999999997 99999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      ..++.+||||||=+. +|..+|..... +....++.+.+||+.|+.++|..||||.||||.|+|+ -.|.+||+|||+|.
T Consensus       430 v~d~~lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~  507 (677)
T KOG0596|consen  430 VTDGYLYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIAN  507 (677)
T ss_pred             ccCceEEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhc
Confidence            999999999998644 89999987765 4435888999999999999999999999999999999 68899999999999


Q ss_pred             ccCcCCC---CCcccccCccccchhhccCC-----------CCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh------
Q 018487          264 EIDESSR---SNSMCGTTEYMAPEILLSKG-----------HNKDADWWSVGILLYEMLTGQVNIKSMQVIACN------  323 (355)
Q Consensus       264 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~-----------~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~------  323 (355)
                      .+.....   ....+||+.||+||.+....           .++++|||||||+||+|+.|+.||....-....      
T Consensus       508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~  587 (677)
T KOG0596|consen  508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITD  587 (677)
T ss_pred             ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcC
Confidence            8765543   35679999999999997543           357899999999999999999999876411111      


Q ss_pred             --hh--------HH-HHHhhhheeeecCCCcC
Q 018487          324 --TM--------LL-FYLIIFHCLFVNSLELL  344 (355)
Q Consensus       324 --~~--------~~-~~~~i~~~l~~~~~e~~  344 (355)
                        ..        .. +.+....||+++|+.+.
T Consensus       588 P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~  619 (677)
T KOG0596|consen  588 PNHEIEFPDIPENDELIDVMKCCLARDPKKRW  619 (677)
T ss_pred             CCccccccCCCCchHHHHHHHHHHhcCcccCC
Confidence              00        01 45677899999998864

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.4e-38  Score=304.12  Aligned_cols=191  Identities=25%  Similarity=0.348  Sum_probs=166.1

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      ...|.+.+.||+|+||.||+|.+.     ..++.||||....         ..+.+|+++|++++|+|||++++++..++
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~-----~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~  233 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHP-----DYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGG  233 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEEC-----CCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECC
Confidence            457999999999999999999976     4567899996422         12457999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      ..++|||++. ++|..++... ..+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus       234 ~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~  312 (461)
T PHA03211        234 LTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARG  312 (461)
T ss_pred             EEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence            9999999996 5787777654 4699999999999999999999999999999999999999999999999999986543


Q ss_pred             CCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCC
Q 018487          268 SSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNI  314 (355)
Q Consensus       268 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf  314 (355)
                      ...   ....+||..|+|||++.+..++.++|||||||+||||++|..++
T Consensus       313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence            221   22457999999999999999999999999999999999987654

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=6.1e-38  Score=288.11  Aligned_cols=229  Identities=24%  Similarity=0.364  Sum_probs=190.1

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ....|++.+.||+|+||.||+|...     ..++.|++|++...........+.+.+|+.+++.++||||+++.+++...
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~   87 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDV-----RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE   87 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEc-----CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC
Confidence            3457999999999999999999976     45778999998755444445556788899999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          188 SKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                      +..|+||||++| ++.+.+. ....+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++....
T Consensus        88 ~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~  166 (307)
T cd06607          88 HTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS  166 (307)
T ss_pred             CeEEEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecC
Confidence            999999999985 5656554 34568999999999999999999999999999999999999999999999999987653


Q ss_pred             cCCCCCcccccCccccchhhc---cCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh---------------hhhHHH
Q 018487          267 ESSRSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC---------------NTMLLF  328 (355)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~---------------~~~~~~  328 (355)
                      ..   ....++..|+|||++.   ...++.++||||||+++|+|+||+.||...+....               .....+
T Consensus       167 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (307)
T cd06607         167 PA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYF  243 (307)
T ss_pred             CC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHH
Confidence            32   2346788999999874   35688899999999999999999999987543221               112346


Q ss_pred             HHhhhheeeecCCCcCC
Q 018487          329 YLIIFHCLFVNSLELLS  345 (355)
Q Consensus       329 ~~~i~~~l~~~~~e~~~  345 (355)
                      ..+|.+||..+|.+++.
T Consensus       244 ~~li~~~l~~~p~~Rp~  260 (307)
T cd06607         244 RNFVDSCLQKIPQDRPS  260 (307)
T ss_pred             HHHHHHHhcCChhhCcC
Confidence            78889999999888753

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=5.7e-38  Score=282.37  Aligned_cols=234  Identities=22%  Similarity=0.358  Sum_probs=190.6

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ..++|+..+.||+|+||.||+|..+..  ......+++|.+....  .....+.+.+|+.++++++|+||+++.+++...
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~--~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   78 (268)
T cd05063           3 HPSHITKQKVIGAGEFGEVFRGILKMP--GRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF   78 (268)
T ss_pred             ChHHceEeeEecCCCCccEEEEEEecC--CCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC
Confidence            456799999999999999999997632  1234579999886542  233345678899999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                      +..|+||||+++++|.+++... +.+++.++..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++....
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          79 KPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence            9999999999999999998764 568999999999999999999999999999999999999999999999999987664


Q ss_pred             cCCCC----CcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhhHH
Q 018487          267 ESSRS----NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTMLL  327 (355)
Q Consensus       267 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~~~  327 (355)
                      .....    .....+..|+|||++.+..++.++|||||||++|||++ |+.||...+....              .....
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  238 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSA  238 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHH
Confidence            32211    11123457999999998889999999999999999998 9999976432110              11235


Q ss_pred             HHHhhhheeeecCCCcCC
Q 018487          328 FYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       328 ~~~~i~~~l~~~~~e~~~  345 (355)
                      +++++.+|++.+|.+++.
T Consensus       239 ~~~li~~c~~~~p~~Rp~  256 (268)
T cd05063         239 VYQLMLQCWQQDRARRPR  256 (268)
T ss_pred             HHHHHHHHcCCCcccCcC
Confidence            578888999888888763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-38  Score=281.32  Aligned_cols=228  Identities=25%  Similarity=0.361  Sum_probs=189.4

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +..++|++.++||+|+||.||+|..+      ..+.|++|.+.....    ..+.+.+|+.++++++|+||+++++++..
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~------~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   72 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWN------GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSE   72 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEc------CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeec
Confidence            55679999999999999999999865      235699999875432    23457789999999999999999999998


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      ....++||||+++++|.+++....  .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..
T Consensus        73 ~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~  152 (261)
T cd05034          73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARL  152 (261)
T ss_pred             CCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECcccccee
Confidence            899999999999999999987653  589999999999999999999999999999999999999999999999999887


Q ss_pred             cCcCCC--CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh--------------hhhhHH
Q 018487          265 IDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA--------------CNTMLL  327 (355)
Q Consensus       265 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~--------------~~~~~~  327 (355)
                      +.....  .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+...              ......
T Consensus       153 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (261)
T cd05034         153 IEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEE  232 (261)
T ss_pred             ccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence            643211  112234568999999998889999999999999999999 999997754321              001235


Q ss_pred             HHHhhhheeeecCCCcC
Q 018487          328 FYLIIFHCLFVNSLELL  344 (355)
Q Consensus       328 ~~~~i~~~l~~~~~e~~  344 (355)
                      +.+++.+|+..+|.+++
T Consensus       233 ~~~~i~~~l~~~p~~Rp  249 (261)
T cd05034         233 LYDLMLQCWDKDPEERP  249 (261)
T ss_pred             HHHHHHHHcccCcccCC
Confidence            67788888888887765

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.8e-38  Score=287.97  Aligned_cols=202  Identities=27%  Similarity=0.437  Sum_probs=173.2

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeeccccc--chhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII--KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      +|++.+.||+|+||.||+|.++     .+++.|++|.++.....  .......+..|+.+++.++|+||+++++++...+
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDK-----ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEEC-----CCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCC
Confidence            4889999999999999999976     45778999999765432  1223345677999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          189 KLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      ..++||||+ +++|..++.... .+++..+..++.||++||.|||++|++|+||||+|||++.++.++|+|||++.....
T Consensus        76 ~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          76 NINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             EEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            999999999 889999998776 799999999999999999999999999999999999999999999999999987644


Q ss_pred             CCC-CCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          268 SSR-SNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       268 ~~~-~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      ... .....++..|+|||.+.+ ..++.++|||||||++|+|++|..+|...+
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~  207 (298)
T cd07841         155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS  207 (298)
T ss_pred             CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc
Confidence            322 223456788999999864 467889999999999999999987776543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.1e-38  Score=282.11  Aligned_cols=228  Identities=22%  Similarity=0.377  Sum_probs=188.1

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +..++|+++++||+|+||.||+|..+      .++.||+|.+.....    ..+.+.+|+.++++++|+||+++++.+. 
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~------~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-   71 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYN------GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-   71 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecC------CCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-
Confidence            45678999999999999999999854      356799999875432    2345778999999999999999998864 


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      .+..+++|||+++++|.+++...  ..+++.++..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++..
T Consensus        72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  151 (260)
T cd05067          72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARL  151 (260)
T ss_pred             cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceee
Confidence            45789999999999999988654  3589999999999999999999999999999999999999999999999999976


Q ss_pred             cCcCCC--CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhhHH
Q 018487          265 IDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTMLL  327 (355)
Q Consensus       265 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~~~  327 (355)
                      ......  .....++..|+|||++.+..++.++||||||+++|+|++ |+.||...+....              .....
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (260)
T cd05067         152 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEE  231 (260)
T ss_pred             cCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHH
Confidence            652221  122345678999999998889999999999999999999 9999976542211              11235


Q ss_pred             HHHhhhheeeecCCCcCC
Q 018487          328 FYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       328 ~~~~i~~~l~~~~~e~~~  345 (355)
                      +..++.+|+..+|.+++.
T Consensus       232 ~~~li~~~l~~~p~~Rp~  249 (260)
T cd05067         232 LYELMRLCWKEKPEERPT  249 (260)
T ss_pred             HHHHHHHHccCChhhCCC
Confidence            788888999888888653

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.3e-38  Score=282.73  Aligned_cols=227  Identities=23%  Similarity=0.385  Sum_probs=186.0

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +..++|++.++||+|+||.||+|...      .+..+|+|.+......    .+.+.+|+.++++++|+||+++++++. 
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~------~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-   71 (260)
T cd05070           3 IPRESLQLIKKLGNGQFGEVWMGTWN------GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-   71 (260)
T ss_pred             CchHHhhhhheeccccCceEEEEEec------CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-
Confidence            44568999999999999999999865      2445999998754321    245788999999999999999998875 


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      ....|++|||+++++|.+++...  ..+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++..
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~  151 (260)
T cd05070          72 EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARL  151 (260)
T ss_pred             CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeee
Confidence            45689999999999999988754  3589999999999999999999999999999999999999999999999999986


Q ss_pred             cCcCCC--CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhhHH
Q 018487          265 IDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTMLL  327 (355)
Q Consensus       265 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~~~  327 (355)
                      +.....  .....++..|+|||++.+..++.++||||||+++|+|++ |..||...+....              .....
T Consensus       152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (260)
T cd05070         152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPIS  231 (260)
T ss_pred             ccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence            543221  112234567999999988889999999999999999999 8999977543221              11235


Q ss_pred             HHHhhhheeeecCCCcC
Q 018487          328 FYLIIFHCLFVNSLELL  344 (355)
Q Consensus       328 ~~~~i~~~l~~~~~e~~  344 (355)
                      +.+++.+|+.++|.+++
T Consensus       232 ~~~li~~~l~~~p~~Rp  248 (260)
T cd05070         232 LHELMLQCWKKDPEERP  248 (260)
T ss_pred             HHHHHHHHcccCcccCc
Confidence            67788889888888765

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.4e-38  Score=285.70  Aligned_cols=228  Identities=28%  Similarity=0.451  Sum_probs=193.6

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++.+.||.|+||.||+|.++     ..++.+++|.+.....  ....+.+.+|+.++++++||||+++++.+...+.
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   73 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHR-----PTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGD   73 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEc-----CCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCE
Confidence            36888999999999999999976     4678899999876532  2445667889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      +++++||+++++|.+++... ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||.+.....
T Consensus        74 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~  153 (265)
T cd06605          74 ISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN  153 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence            99999999999999999876 779999999999999999999999 9999999999999999999999999999876543


Q ss_pred             CCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCch--------hhhh------------hhhHH
Q 018487          268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQ--------VIAC------------NTMLL  327 (355)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~--------~~~~------------~~~~~  327 (355)
                      .... ...++..|+|||.+.+..++.++||||||+++|+|++|+.||...+        ....            .....
T Consensus       154 ~~~~-~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (265)
T cd06605         154 SLAK-TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPD  232 (265)
T ss_pred             HHhh-cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHH
Confidence            3222 2678899999999999999999999999999999999999997652        1000            01224


Q ss_pred             HHHhhhheeeecCCCcCC
Q 018487          328 FYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       328 ~~~~i~~~l~~~~~e~~~  345 (355)
                      +..+|.+|+..+|.+++.
T Consensus       233 ~~~li~~~l~~~p~~Rpt  250 (265)
T cd06605         233 FQDFVNLCLIKDPRERPS  250 (265)
T ss_pred             HHHHHHHHcCCCchhCcC
Confidence            567888899888888764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=5.1e-38  Score=284.64  Aligned_cols=222  Identities=36%  Similarity=0.642  Sum_probs=180.6

Q ss_pred             eeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHH---HHHHHhcCCCcceecceeeecCCeEEEE
Q 018487          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE---RDILTKVTHPFIVQLRYSFQTRSKLYLI  193 (355)
Q Consensus       117 ~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E---~~~l~~l~h~nIv~l~~~~~~~~~~~lv  193 (355)
                      .||+|+||.||+|.+.     .+++.||+|.+.+...........+..|   +.+++...||||+.+++++...+.+|+|
T Consensus         1 ~ig~g~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKA-----DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEe-----cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEE
Confidence            4899999999999866     4677899999876543322222222333   3345556899999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCCCCc
Q 018487          194 LDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS  273 (355)
Q Consensus       194 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~  273 (355)
                      |||+.|++|..++...+.+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++..+.... ...
T Consensus        76 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-~~~  154 (278)
T cd05606          76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHA  154 (278)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-CcC
Confidence            9999999999999888889999999999999999999999999999999999999999999999999987654332 334


Q ss_pred             ccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCch---hhhhh-------------hhHHHHHhhhhee
Q 018487          274 MCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSMQ---VIACN-------------TMLLFYLIIFHCL  336 (355)
Q Consensus       274 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~~---~~~~~-------------~~~~~~~~i~~~l  336 (355)
                      ..|+..|+|||++.+. .++.++||||+|+++|+|++|+.||....   .....             ....+...+.+||
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l  234 (278)
T cd05606         155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL  234 (278)
T ss_pred             cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHh
Confidence            5789999999999754 68999999999999999999999997652   11111             1235567888999


Q ss_pred             eecCCCcC
Q 018487          337 FVNSLELL  344 (355)
Q Consensus       337 ~~~~~e~~  344 (355)
                      .++|.+++
T Consensus       235 ~~~p~~R~  242 (278)
T cd05606         235 QRDVNRRL  242 (278)
T ss_pred             hcCHHhcc
Confidence            88888776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.9e-38  Score=283.65  Aligned_cols=233  Identities=24%  Similarity=0.385  Sum_probs=190.4

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ..++|++.+.||+|+||.||+|.++.... .....+|+|.+.....  ......+.+|+.++++++|+||+++++++.. 
T Consensus         5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~-~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   80 (279)
T cd05057           5 KETELEKIKVLGSGAFGTVYKGVWIPEGE-KVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-   80 (279)
T ss_pred             CHHHcEEcceecCCCCccEEEEEEecCCC-CcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence            34689999999999999999999764321 2244689998765532  3445667889999999999999999999887 


Q ss_pred             CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                      ...++||||+++|+|.+++... ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+++.+.
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            7899999999999999998774 468999999999999999999999999999999999999999999999999998764


Q ss_pred             cCCCCC---cccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhhh--------------hhHHH
Q 018487          267 ESSRSN---SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACN--------------TMLLF  328 (355)
Q Consensus       267 ~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~~--------------~~~~~  328 (355)
                      ......   ...++..|+|||.+....++.++||||||+++|||++ |+.||.........              ....+
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDV  240 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence            332211   1223567999999988889999999999999999999 99999875432211              12355


Q ss_pred             HHhhhheeeecCCCcC
Q 018487          329 YLIIFHCLFVNSLELL  344 (355)
Q Consensus       329 ~~~i~~~l~~~~~e~~  344 (355)
                      ..++.+|+..+|.+++
T Consensus       241 ~~~~~~~l~~~p~~Rp  256 (279)
T cd05057         241 YMVLVKCWMIDAESRP  256 (279)
T ss_pred             HHHHHHHcCCChhhCC
Confidence            6788899988887765

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=5.3e-38  Score=285.98  Aligned_cols=233  Identities=48%  Similarity=0.830  Sum_probs=191.7

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeeccccc-chhHHHHHHHHHHHHHhc-CCCcceecceeeecCC
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-KKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS  188 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  188 (355)
                      +|++.+.||.|+||.||+|......  .+++.||+|+++..... .....+.+.+|+++++++ +|+||+++++.+..+.
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~--~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGH--DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT   78 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCC--CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCC
Confidence            4889999999999999999865322  35678999998764322 223345677899999999 5999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      .+|+||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+|||++.++.+||+|||++......
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  158 (290)
T cd05613          79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED  158 (290)
T ss_pred             eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999999876432


Q ss_pred             C--CCCcccccCccccchhhccC--CCCCcccHHHHHHHHHHHHcCCCCCCCchhh------hh-----------hhhHH
Q 018487          269 S--RSNSMCGTTEYMAPEILLSK--GHNKDADWWSVGILLYEMLTGQVNIKSMQVI------AC-----------NTMLL  327 (355)
Q Consensus       269 ~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~~l~elltg~~pf~~~~~~------~~-----------~~~~~  327 (355)
                      .  ......|+..|+|||.+.+.  .++.++||||||+++|+|++|+.||......      ..           .....
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (290)
T cd05613         159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL  238 (290)
T ss_pred             cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHH
Confidence            2  22345688999999998753  4678999999999999999999999632110      00           11234


Q ss_pred             HHHhhhheeeecCCCcCC
Q 018487          328 FYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       328 ~~~~i~~~l~~~~~e~~~  345 (355)
                      +..++.+|++.+|.+++.
T Consensus       239 ~~~ll~~~l~~~p~~R~~  256 (290)
T cd05613         239 AKDIIQRLLMKDPKKRLG  256 (290)
T ss_pred             HHHHHHHHhcCCHHHhcC
Confidence            678889999999988763

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.4e-38  Score=285.03  Aligned_cols=229  Identities=26%  Similarity=0.383  Sum_probs=190.0

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ...+|++.++||.|+||.||+|.++     . ++.+++|++....   ......+.+|+.+++.++|+||+++++++...
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~-----~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   74 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWK-----N-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVG   74 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEec-----C-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecC
Confidence            3457999999999999999999976     2 6679999987543   22344577899999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          188 SKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      ...++||||+++++|.+++...  ..+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~  154 (261)
T cd05148          75 EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLI  154 (261)
T ss_pred             CCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhc
Confidence            9999999999999999998753  45899999999999999999999999999999999999999999999999999766


Q ss_pred             CcCCC-CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhhHHHH
Q 018487          266 DESSR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTMLLFY  329 (355)
Q Consensus       266 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~~~~~  329 (355)
                      ..... .....++..|+|||++.+..++.++||||||+++|+|++ |+.||...+....              .....+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (261)
T cd05148         155 KEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIY  234 (261)
T ss_pred             CCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHH
Confidence            43222 122335678999999998889999999999999999998 8999977542210              1113466


Q ss_pred             HhhhheeeecCCCcCC
Q 018487          330 LIIFHCLFVNSLELLS  345 (355)
Q Consensus       330 ~~i~~~l~~~~~e~~~  345 (355)
                      ++|.+|++++|.+++.
T Consensus       235 ~~i~~~l~~~p~~Rpt  250 (261)
T cd05148         235 KIMLECWAAEPEDRPS  250 (261)
T ss_pred             HHHHHHcCCCchhCcC
Confidence            7888888888877653

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=6.3e-38  Score=280.08  Aligned_cols=228  Identities=28%  Similarity=0.511  Sum_probs=190.8

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      +|++.+.||+|+||.||++...     ..++.|++|.+...... ....+.+.+|+.++++++|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~-----~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSK-----EDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNL   74 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEc-----CCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeE
Confidence            5899999999999999999976     45778999998754332 23345678899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          191 YLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      |+||||+++++|.+++....  .+++.++..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++......
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~  154 (256)
T cd08218          75 YIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST  154 (256)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence            99999999999999887643  5789999999999999999999999999999999999999999999999999766433


Q ss_pred             CC-CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh--------------hhhhHHHHHhhh
Q 018487          269 SR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA--------------CNTMLLFYLIIF  333 (355)
Q Consensus       269 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~--------------~~~~~~~~~~i~  333 (355)
                      .. .....|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+...              ......+..+|.
T Consensus       155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  234 (256)
T cd08218         155 VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVS  234 (256)
T ss_pred             hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHH
Confidence            22 223457889999999998889999999999999999999999997654321              111234577888


Q ss_pred             heeeecCCCcC
Q 018487          334 HCLFVNSLELL  344 (355)
Q Consensus       334 ~~l~~~~~e~~  344 (355)
                      +|+..+|.+++
T Consensus       235 ~~l~~~p~~Rp  245 (256)
T cd08218         235 QLFKRNPRDRP  245 (256)
T ss_pred             HHhhCChhhCc
Confidence            88887777654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.5e-38  Score=284.65  Aligned_cols=226  Identities=27%  Similarity=0.484  Sum_probs=190.8

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      .|+.+++||.|+||.||+|.++     ..++.||+|++....  .....+.+.+|+.+++.++|+||+++++.+..+...
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDN-----RTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKL   77 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEc-----cCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence            5888899999999999999876     456789999987543  233456788899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC-
Q 018487          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-  269 (355)
                      |+||||+++++|.+++.. +.+++.++..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++..+.... 
T Consensus        78 ~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          78 WIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            999999999999988864 568999999999999999999999999999999999999999999999999997654322 


Q ss_pred             CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh--------------hhhhHHHHHhhhhe
Q 018487          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA--------------CNTMLLFYLIIFHC  335 (355)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~--------------~~~~~~~~~~i~~~  335 (355)
                      ......++..|+|||++.+..++.++|+|||||++|+|+||..||.......              ......+..+|.+|
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  236 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDAC  236 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHH
Confidence            2233467889999999998889999999999999999999999997653221              01123456788899


Q ss_pred             eeecCCCcC
Q 018487          336 LFVNSLELL  344 (355)
Q Consensus       336 l~~~~~e~~  344 (355)
                      +..+|..++
T Consensus       237 l~~~p~~Rp  245 (277)
T cd06640         237 LNKDPSFRP  245 (277)
T ss_pred             cccCcccCc
Confidence            988887765

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=8.5e-38  Score=284.77  Aligned_cols=201  Identities=25%  Similarity=0.415  Sum_probs=169.0

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++++.||+|+||.||+|..+     ..++.|++|++.....  ......+.+|+.+++.++|+||+++++++..++.
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   77 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISR-----INGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKET   77 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEc-----CCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCe
Confidence            58999999999999999999876     4567899999875432  2222345679999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      .|+||||+. ++|..++.. ...+.+.++..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||+++.....
T Consensus        78 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          78 LTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             EEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            999999996 466666554 356788999999999999999999999999999999999999999999999998754322


Q ss_pred             C-CCCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          269 S-RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       269 ~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      . ......++..|+|||++.+. .++.++|||||||++|+|++|+.||...+
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~  208 (291)
T cd07870         157 SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS  208 (291)
T ss_pred             CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence            1 12334578899999998754 57889999999999999999999997643

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.1e-38  Score=283.80  Aligned_cols=230  Identities=22%  Similarity=0.336  Sum_probs=182.5

Q ss_pred             eEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec-----
Q 018487          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-----  186 (355)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-----  186 (355)
                      |.+.++||+|+||.||+|.+...   .....+|+|.++... ......+.+.+|+.+++.++|+||+++++.+..     
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~---~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQD---DSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESE   76 (272)
T ss_pred             CccccccCcccCceEEEeEEccC---CCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCccc
Confidence            34678999999999999987632   222468999887643 234445678889999999999999999987643     


Q ss_pred             -CCeEEEEEeccCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEec
Q 018487          187 -RSKLYLILDFINGGHLFFHLYR------QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (355)
Q Consensus       187 -~~~~~lv~e~~~~gsL~~~l~~------~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Df  259 (355)
                       ....+++|||+++|+|..++..      ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+||
T Consensus        77 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df  156 (272)
T cd05075          77 GYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADF  156 (272)
T ss_pred             CCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCC
Confidence             2357899999999999887742      134789999999999999999999999999999999999999999999999


Q ss_pred             CCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh--------------
Q 018487          260 GLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA--------------  321 (355)
Q Consensus       260 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~--------------  321 (355)
                      |+++.......   .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||.......              
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  236 (272)
T cd05075         157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQP  236 (272)
T ss_pred             CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            99987643221   122345678999999998899999999999999999999 899997643211              


Q ss_pred             hhhhHHHHHhhhheeeecCCCcCC
Q 018487          322 CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 ~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ......+..+|.+|+..+|.+++.
T Consensus       237 ~~~~~~~~~li~~~l~~~p~~Rps  260 (272)
T cd05075         237 PDCLDGLYSLMSSCWLLNPKDRPS  260 (272)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCcC
Confidence            111234677888999888888653

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=7.6e-38  Score=280.24  Aligned_cols=228  Identities=27%  Similarity=0.462  Sum_probs=190.7

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee--cCC
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ--TRS  188 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~  188 (355)
                      +|++.+.||.|+||.||+|.+.     .+++.|++|++..... .....+.+.+|+.+++.++|+||+++++.+.  .+.
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRK-----SDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ   74 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeec-----CCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCC
Confidence            5899999999999999999876     4567899999876543 3444566888999999999999999999775  345


Q ss_pred             eEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----HCCCeeccCCCCcEEecCCCcEEEEec
Q 018487          189 KLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLH-----KCGIVHRDLKPENILMDSDGHVMLTDF  259 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~L~~LH-----~~~iiHrDlkp~NILl~~~~~~kl~Df  259 (355)
                      ..|++|||+++++|.+++..    ...+++..++.++.||+.||.|||     +.+++|+||+|+||+++.++.+||+||
T Consensus        75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~  154 (265)
T cd08217          75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDF  154 (265)
T ss_pred             EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecc
Confidence            78999999999999988865    356899999999999999999999     889999999999999999999999999


Q ss_pred             CCccccCcCCC-CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh--------------hhh
Q 018487          260 GLAKEIDESSR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA--------------CNT  324 (355)
Q Consensus       260 g~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~--------------~~~  324 (355)
                      |++........ .....++..|+|||++.+..++.++||||||+++|+|++|+.||...+...              .+.
T Consensus       155 g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (265)
T cd08217         155 GLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRY  234 (265)
T ss_pred             cccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCcccc
Confidence            99987654432 334568999999999998889999999999999999999999998753211              112


Q ss_pred             hHHHHHhhhheeeecCCCcC
Q 018487          325 MLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       325 ~~~~~~~i~~~l~~~~~e~~  344 (355)
                      ...+.+++.+|++.+|.+++
T Consensus       235 ~~~~~~l~~~~l~~~p~~Rp  254 (265)
T cd08217         235 SSELNEVIKSMLNVDPDKRP  254 (265)
T ss_pred             CHHHHHHHHHHccCCcccCC
Confidence            23456778888888877765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=7e-38  Score=285.26  Aligned_cols=201  Identities=25%  Similarity=0.434  Sum_probs=170.6

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++.+.||+|++|.||+|..+     ..++.||+|.+......  .....+.+|+.+++.++|+||+++++++..++.
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   77 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSK-----LTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKT   77 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEc-----CCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCe
Confidence            58999999999999999999865     45678999998754321  122345679999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      .++||||+++ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        78 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  156 (291)
T cd07844          78 LTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP  156 (291)
T ss_pred             EEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence            9999999985 888888764 45899999999999999999999999999999999999999999999999998754322


Q ss_pred             C-CCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          269 S-RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       269 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      . ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||....
T Consensus       157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~  208 (291)
T cd07844         157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST  208 (291)
T ss_pred             CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence            1 1222356888999999875 457899999999999999999999997554

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4e-38  Score=286.05  Aligned_cols=232  Identities=26%  Similarity=0.368  Sum_probs=188.3

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC--C
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--S  188 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~  188 (355)
                      -|+++++||+|+||.||+|.+.... ...++.||+|.++...  .......+.+|+.+++.++|+||+++++++...  .
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEG-DNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCC-CCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            5789999999999999999865322 2457789999986542  234456788999999999999999999988765  5


Q ss_pred             eEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          189 KLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      ..++||||++|++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..+..
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            7899999999999999987653 589999999999999999999999999999999999999999999999999987643


Q ss_pred             CCC----CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchh------------------------
Q 018487          268 SSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQV------------------------  319 (355)
Q Consensus       268 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~------------------------  319 (355)
                      ...    .....++..|+|||++.+..++.++||||||+++|+|+|++.|+.....                        
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE  241 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence            221    1234567789999999988899999999999999999998765432100                        


Q ss_pred             -----hhhhhhHHHHHhhhheeeecCCCcCC
Q 018487          320 -----IACNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       320 -----~~~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                           ........+..++.+||+.+|.+++.
T Consensus       242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt  272 (284)
T cd05079         242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTT  272 (284)
T ss_pred             CccCCCCCCCCHHHHHHHHHHccCCcccCcC
Confidence                 00112245678899999999988764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-38  Score=278.79  Aligned_cols=225  Identities=38%  Similarity=0.803  Sum_probs=198.7

Q ss_pred             hcCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecce
Q 018487          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY  182 (355)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~  182 (355)
                      .+.++..+|.++++||+|+|..|.+++.+     .+.+.||+|+++++-..+.+.++..+.|-.+..+. +||.+|-+..
T Consensus       244 ~~~l~l~df~ll~vigrgsyakvl~~~~~-----~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhs  318 (593)
T KOG0695|consen  244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLK-----KTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHS  318 (593)
T ss_pred             ccccccccceeeeeecCcchhhhhheehc-----ccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhh
Confidence            44566789999999999999999999987     57789999999998877777888888888877665 6999999999


Q ss_pred             eeecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       183 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                      +|+.+..+++|.||++||+|..+++++..++++.++.+..+|+-||.|||++|||+||||.+|+|+|..|.+||.|+|++
T Consensus       319 cfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmc  398 (593)
T KOG0695|consen  319 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMC  398 (593)
T ss_pred             hhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccc-CcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCc--hhhhhhhhHHHHHhhh
Q 018487          263 KEI-DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSM--QVIACNTMLLFYLIIF  333 (355)
Q Consensus       263 ~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~--~~~~~~~~~~~~~~i~  333 (355)
                      +.- .......++|||+.|.|||.+.+..|...+|.|+|||+|+||+.|+-||+-.  +--..|....++.+|.
T Consensus       399 ke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil  472 (593)
T KOG0695|consen  399 KEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL  472 (593)
T ss_pred             hcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh
Confidence            864 4555567899999999999999999999999999999999999999999753  3333444444444443

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=279.40  Aligned_cols=203  Identities=33%  Similarity=0.502  Sum_probs=176.2

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeeccc--ccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDT--IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      .+|++.+.||+|+||.||+|.++     .+++.|++|.+....  .........+.+|+.++++++|+||+++++.+...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   76 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDA-----DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP   76 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEc-----CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC
Confidence            57999999999999999999876     457789999875432  12234556788999999999999999999998753


Q ss_pred             --CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          188 --SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       188 --~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                        ..++++|||+++++|.+++...+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++..
T Consensus        77 ~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          77 EEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             CCCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence              468999999999999999988788999999999999999999999999999999999999999999999999999865


Q ss_pred             CcCC----CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          266 DESS----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       266 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      ....    ......++..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  212 (264)
T cd06653         157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY  212 (264)
T ss_pred             ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence            3311    122356889999999999888999999999999999999999999765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.8e-38  Score=287.26  Aligned_cols=227  Identities=25%  Similarity=0.466  Sum_probs=190.4

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      .|+..+.||+|+||.||+|.+.     ..++.||+|.+....  .....+.+.+|+.+++.++|+||+++++.+..+...
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDN-----RTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKL   77 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEc-----CCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCce
Confidence            4677788999999999999865     456789999987543  233456788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC-
Q 018487          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-  269 (355)
                      |+||||+++++|.+++.. +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..+.... 
T Consensus        78 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          78 WIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            999999999999888754 568999999999999999999999999999999999999999999999999997664322 


Q ss_pred             CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh--------------hhhhHHHHHhhhhe
Q 018487          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA--------------CNTMLLFYLIIFHC  335 (355)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~--------------~~~~~~~~~~i~~~  335 (355)
                      ......++..|+|||++.+..++.++|||||||++|||++|+.||.......              ......+.++|.+|
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  236 (277)
T cd06642         157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEAC  236 (277)
T ss_pred             hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHH
Confidence            1233467889999999998889999999999999999999999997542211              01123467788899


Q ss_pred             eeecCCCcCC
Q 018487          336 LFVNSLELLS  345 (355)
Q Consensus       336 l~~~~~e~~~  345 (355)
                      +..+|.+++.
T Consensus       237 l~~~p~~Rp~  246 (277)
T cd06642         237 LNKDPRFRPT  246 (277)
T ss_pred             ccCCcccCcC
Confidence            9988888754

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=6e-38  Score=280.38  Aligned_cols=225  Identities=23%  Similarity=0.363  Sum_probs=186.3

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEEEe
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  195 (355)
                      ++||+|++|.||+|.+...  ......||+|.+......  ...+.+.+|+.++++++|+||+++++.+.. ...++|||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~--~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e   75 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTS--GGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTE   75 (257)
T ss_pred             CcCCccCcccEEeeeEecC--CCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEE
Confidence            4689999999999998632  123446999998776532  556678899999999999999999999988 88999999


Q ss_pred             ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCC---
Q 018487          196 FINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR---  270 (355)
Q Consensus       196 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~---  270 (355)
                      |+++++|.+++....  .+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++..+.....   
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999999998764  689999999999999999999999999999999999999999999999999987643221   


Q ss_pred             -CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh---------------hhhHHHHHhhh
Q 018487          271 -SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC---------------NTMLLFYLIIF  333 (355)
Q Consensus       271 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~---------------~~~~~~~~~i~  333 (355)
                       .....++..|+|||++.+..++.++|||||||++|+|++ |+.||...+....               .....+..++.
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  235 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVML  235 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHH
Confidence             123456788999999998899999999999999999999 9999965432210               11235567888


Q ss_pred             heeeecCCCcCC
Q 018487          334 HCLFVNSLELLS  345 (355)
Q Consensus       334 ~~l~~~~~e~~~  345 (355)
                      +|+..+|.+++.
T Consensus       236 ~~l~~~p~~Rps  247 (257)
T cd05040         236 QCWAHNPADRPT  247 (257)
T ss_pred             HHCCCCcccCCC
Confidence            888888888653

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=8.9e-38  Score=279.94  Aligned_cols=228  Identities=28%  Similarity=0.489  Sum_probs=195.6

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++.+.||+|++|.||+|..+     .+++.|++|++.....  ....+.+.+|+..+.+++|+||+++++.+.....
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~-----~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHK-----PTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGE   73 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEc-----CCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCe
Confidence            36899999999999999999976     4578899999876542  1445678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      .++||||+++++|.+++.....+++..+..++.|+++||.|||+ .|++||||+|+||+++.++.++|+|||.+......
T Consensus        74 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~  153 (264)
T cd06623          74 ISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT  153 (264)
T ss_pred             EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence            99999999999999999888889999999999999999999999 99999999999999999999999999999876543


Q ss_pred             CCC-CcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchh---hh--------------hh-hhHHHH
Q 018487          269 SRS-NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQV---IA--------------CN-TMLLFY  329 (355)
Q Consensus       269 ~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~---~~--------------~~-~~~~~~  329 (355)
                      ... ....++..|+|||.+.+..++.++||||||+++|+|+||+.||...+.   ..              .. ....+.
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  233 (264)
T cd06623         154 LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFR  233 (264)
T ss_pred             CCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHH
Confidence            332 245688999999999988899999999999999999999999987741   00              00 223567


Q ss_pred             HhhhheeeecCCCcC
Q 018487          330 LIIFHCLFVNSLELL  344 (355)
Q Consensus       330 ~~i~~~l~~~~~e~~  344 (355)
                      ++|.+|+..+|.+++
T Consensus       234 ~li~~~l~~~p~~R~  248 (264)
T cd06623         234 DFISACLQKDPKKRP  248 (264)
T ss_pred             HHHHHHccCChhhCC
Confidence            788888887777765

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=8e-38  Score=283.51  Aligned_cols=228  Identities=26%  Similarity=0.408  Sum_probs=182.3

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHH-HHHhcCCCcceecceeeecCC
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD-ILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      ++|++.+.||+|+||.||+|.++     .+++.||+|.++..... ... ..+..|+. .++.++|+||+++++++..++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~-~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~   73 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHV-----PTGTIMAVKRIRATVNS-QEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREG   73 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEc-----CCCcEEEEEEEecCCCc-HHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCC
Confidence            47999999999999999999976     56788999998765322 222 23444555 467778999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          189 KLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~L~~LH~~-~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      ..|++|||+++ +|..++..    ...+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||++.
T Consensus        74 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~  152 (283)
T cd06617          74 DVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG  152 (283)
T ss_pred             cEEEEhhhhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence            99999999974 77666653    24689999999999999999999997 99999999999999999999999999998


Q ss_pred             ccCcCCCCCcccccCccccchhhcc----CCCCCcccHHHHHHHHHHHHcCCCCCCCchh--h--hh------------h
Q 018487          264 EIDESSRSNSMCGTTEYMAPEILLS----KGHNKDADWWSVGILLYEMLTGQVNIKSMQV--I--AC------------N  323 (355)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~~l~elltg~~pf~~~~~--~--~~------------~  323 (355)
                      ............++..|+|||++.+    ..++.++|+|||||++|+|++|+.||.....  .  ..            .
T Consensus       153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd06617         153 YLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEK  232 (283)
T ss_pred             ccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccc
Confidence            7654433344568899999999865    4568899999999999999999999975321  0  00            0


Q ss_pred             hhHHHHHhhhheeeecCCCcCC
Q 018487          324 TMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       324 ~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ....+..+|.+||..+|.+++.
T Consensus       233 ~~~~l~~li~~~l~~~p~~Rp~  254 (283)
T cd06617         233 FSPEFQDFVNKCLKKNYKERPN  254 (283)
T ss_pred             cCHHHHHHHHHHccCChhhCcC
Confidence            1134567888888888877653

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-38  Score=283.37  Aligned_cols=224  Identities=25%  Similarity=0.374  Sum_probs=179.0

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceeeecCCeEEEEE
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~  194 (355)
                      +.||+|+||.||+|..+..   .....+++|.++...  .....+.+.+|+.+++++ +||||+++++++...+.+|+||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~---~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~   75 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKD---GLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI   75 (270)
T ss_pred             CcCCCCCCceEEEEEEcCC---CCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEE
Confidence            3689999999999997632   122346888776432  233445678899999999 7999999999999999999999


Q ss_pred             eccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEe
Q 018487          195 DFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTD  258 (355)
Q Consensus       195 e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~D  258 (355)
                      ||+++++|.+++....                .+++.++..++.|++.||+|||++|++||||||+|||++.++.+||+|
T Consensus        76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~d  155 (270)
T cd05047          76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIAD  155 (270)
T ss_pred             EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECC
Confidence            9999999999987543                378899999999999999999999999999999999999999999999


Q ss_pred             cCCccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh--------------hh
Q 018487          259 FGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA--------------CN  323 (355)
Q Consensus       259 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~--------------~~  323 (355)
                      ||++..............+..|+|||++.+..++.++|||||||++|||++ |..||...+...              ..
T Consensus       156 fgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  235 (270)
T cd05047         156 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN  235 (270)
T ss_pred             CCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCc
Confidence            999864322211222233567999999988889999999999999999997 999997653211              01


Q ss_pred             hhHHHHHhhhheeeecCCCcC
Q 018487          324 TMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       324 ~~~~~~~~i~~~l~~~~~e~~  344 (355)
                      ....+..++.+|+..+|.+++
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp  256 (270)
T cd05047         236 CDDEVYDLMRQCWREKPYERP  256 (270)
T ss_pred             CCHHHHHHHHHHcccChhhCC
Confidence            123467788889888887765

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=9e-38  Score=280.00  Aligned_cols=226  Identities=24%  Similarity=0.350  Sum_probs=184.9

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ..++|++.++||+|+||.||+|.+.+      ...+++|.+.....    ..+.+.+|+++++.++|+||+++++++.. 
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~------~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-   72 (260)
T cd05069           4 PRESLRLDVKLGQGCFGEVWMGTWNG------TTKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-   72 (260)
T ss_pred             ChHHeeeeeeecCcCCCeEEEEEEcC------CceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-
Confidence            34679999999999999999998752      23589998765432    23457789999999999999999988754 


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          188 SKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      +..+++|||+++++|.+++....  .+++..+..++.|++.||.|||+.|++|+||||+||++++++.++|+|||++...
T Consensus        73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~  152 (260)
T cd05069          73 EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLI  152 (260)
T ss_pred             CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEc
Confidence            56899999999999999987643  4789999999999999999999999999999999999999999999999999765


Q ss_pred             CcCCC--CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh--------------hhhhHHH
Q 018487          266 DESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA--------------CNTMLLF  328 (355)
Q Consensus       266 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~--------------~~~~~~~  328 (355)
                      .....  .....++..|+|||++.+..++.++||||||+++|+|+| |+.||.......              ......+
T Consensus       153 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (260)
T cd05069         153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESL  232 (260)
T ss_pred             cCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHH
Confidence            43221  112345678999999988889999999999999999999 999997753221              1122356


Q ss_pred             HHhhhheeeecCCCcC
Q 018487          329 YLIIFHCLFVNSLELL  344 (355)
Q Consensus       329 ~~~i~~~l~~~~~e~~  344 (355)
                      ..++.+|+.++|.+++
T Consensus       233 ~~li~~~l~~~p~~Rp  248 (260)
T cd05069         233 HELMKLCWKKDPDERP  248 (260)
T ss_pred             HHHHHHHccCCcccCc
Confidence            7888899998888865

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-38  Score=280.48  Aligned_cols=221  Identities=38%  Similarity=0.674  Sum_probs=183.3

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHH-HHhcCCCcceecceeeecCCeEEEEE
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQTRSKLYLIL  194 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~lv~  194 (355)
                      +.||+|+||.||+|.++     ..++.||+|++.+...........+..|..+ ....+|+||+++++.+..++.+|+||
T Consensus         2 ~~l~~g~~~~v~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKR-----STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEec-----CCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEE
Confidence            57999999999999876     4567899999876543333333334445544 44558999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCCCCcc
Q 018487          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM  274 (355)
Q Consensus       195 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~  274 (355)
                      ||+++++|..++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.....   ....
T Consensus        77 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~  153 (260)
T cd05611          77 EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKF  153 (260)
T ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccC
Confidence            9999999999998888899999999999999999999999999999999999999999999999999876533   2344


Q ss_pred             cccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-----------------hhhHHHHHhhhheee
Q 018487          275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-----------------NTMLLFYLIIFHCLF  337 (355)
Q Consensus       275 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-----------------~~~~~~~~~i~~~l~  337 (355)
                      .++..|+|||.+.+..++.++||||||+++|+|++|..||...+....                 .....+..+|.+||.
T Consensus       154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  233 (260)
T cd05611         154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLC  233 (260)
T ss_pred             CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHcc
Confidence            688999999999988889999999999999999999999976533221                 012345778888998


Q ss_pred             ecCCCcC
Q 018487          338 VNSLELL  344 (355)
Q Consensus       338 ~~~~e~~  344 (355)
                      .+|.+++
T Consensus       234 ~~p~~R~  240 (260)
T cd05611         234 MDPAKRL  240 (260)
T ss_pred             CCHHHcc
Confidence            8888876

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.9e-38  Score=305.16  Aligned_cols=205  Identities=24%  Similarity=0.398  Sum_probs=160.7

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCC----------CCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcce
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDG----------DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIV  178 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~----------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv  178 (355)
                      .++|+++++||+|+||+||+|..+.....          ..+...+.+++.+...........+.+|+.+|++++|+||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            36899999999999999999876522110          00011111111111112233445678999999999999999


Q ss_pred             ecceeeecCCeEEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCc
Q 018487          179 QLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH  253 (355)
Q Consensus       179 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~  253 (355)
                      ++++++...+..|+|++++.+ +|..++...     ......+++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~  305 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK  305 (501)
T ss_pred             cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence            999999999999999999965 666666432     22346678889999999999999999999999999999999999


Q ss_pred             EEEEecCCccccCcCC--CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCC
Q 018487          254 VMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNI  314 (355)
Q Consensus       254 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf  314 (355)
                      +||+|||++..+....  .....+||..|+|||++.+..++.++|||||||++|||++|..++
T Consensus       306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p  368 (501)
T PHA03210        306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP  368 (501)
T ss_pred             EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            9999999998764432  223467999999999999999999999999999999999988643

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.1e-37  Score=278.45  Aligned_cols=227  Identities=22%  Similarity=0.388  Sum_probs=188.1

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      +.+|++.+.||+|+||.||+|.+.      .++.+++|.+......    ...+.+|++++++++||||+++++++....
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~------~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWL------EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERS   72 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEe------CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCC
Confidence            468999999999999999999865      2456999988654322    235778999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      ..++||||+++++|.+++... +.+++..++.++.|++.||+|||+.+++||||||+||+++.++.++|+|||++.....
T Consensus        73 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  152 (256)
T cd05112          73 PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD  152 (256)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeeccc
Confidence            999999999999999988764 4689999999999999999999999999999999999999999999999999876533


Q ss_pred             CCC--CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhhh--------------hhHHHHH
Q 018487          268 SSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACN--------------TMLLFYL  330 (355)
Q Consensus       268 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~~--------------~~~~~~~  330 (355)
                      ...  .....++..|+|||++.+..++.++||||||+++|||++ |+.||.........              ....+..
T Consensus       153 ~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (256)
T cd05112         153 DQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYE  232 (256)
T ss_pred             CcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence            221  112234578999999998889999999999999999998 99999765322111              1234677


Q ss_pred             hhhheeeecCCCcCC
Q 018487          331 IIFHCLFVNSLELLS  345 (355)
Q Consensus       331 ~i~~~l~~~~~e~~~  345 (355)
                      ++.+|+..+|.+++.
T Consensus       233 l~~~~l~~~p~~Rp~  247 (256)
T cd05112         233 LMQHCWKERPEDRPS  247 (256)
T ss_pred             HHHHHcccChhhCCC
Confidence            888999888887653

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=7e-38  Score=288.73  Aligned_cols=194  Identities=27%  Similarity=0.473  Sum_probs=159.5

Q ss_pred             EeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee--cCCeEEE
Q 018487          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ--TRSKLYL  192 (355)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~l  192 (355)
                      ..+||+|+||.||+|..+.   ...++.||+|.+.....     ...+.+|+.+++.++||||+++++++.  .+..+|+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~---~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l   77 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKD---GKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWL   77 (317)
T ss_pred             ceEeccCCCeeEEEEEecC---CCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEE
Confidence            3689999999999999763   23567899998865321     234668999999999999999999885  3567899


Q ss_pred             EEeccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEe----cCCCcEEEEec
Q 018487          193 ILDFINGGHLFFHLYRQ---------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM----DSDGHVMLTDF  259 (355)
Q Consensus       193 v~e~~~~gsL~~~l~~~---------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl----~~~~~~kl~Df  259 (355)
                      ||||+++ +|.+++...         ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+||
T Consensus        78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          78 LFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             EEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            9999976 666665421         247889999999999999999999999999999999999    56679999999


Q ss_pred             CCccccCcCC----CCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          260 GLAKEIDESS----RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       260 g~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      |+++......    ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            9998764322    1234578999999999876 45789999999999999999999999753

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.3e-37  Score=282.73  Aligned_cols=229  Identities=27%  Similarity=0.450  Sum_probs=186.2

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceeee-
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQ-  185 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~-  185 (355)
                      ..++|++.+.||+|+||.||+|.++     ..++.+|+|++....    .....+.+|+.+++.+ +|+||+++++++. 
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~-----~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNK-----KNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEEC-----CCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            4578999999999999999999976     456789999875432    1224567899999999 6999999999873 


Q ss_pred             ----cCCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEE
Q 018487          186 ----TRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT  257 (355)
Q Consensus       186 ----~~~~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~  257 (355)
                          .++.+++||||+++++|.+++..    ...+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~  166 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV  166 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEc
Confidence                45679999999999999887653    3458899999999999999999999999999999999999999999999


Q ss_pred             ecCCccccCcCC-CCCcccccCccccchhhcc-----CCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh--------
Q 018487          258 DFGLAKEIDESS-RSNSMCGTTEYMAPEILLS-----KGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN--------  323 (355)
Q Consensus       258 Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~--------  323 (355)
                      |||++....... ......|+..|+|||++..     ..++.++|||||||++|+|++|+.||...+.....        
T Consensus       167 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~  246 (286)
T cd06638         167 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPP  246 (286)
T ss_pred             cCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCC
Confidence            999988654322 2234568999999999853     45788999999999999999999999765432210        


Q ss_pred             --------hhHHHHHhhhheeeecCCCcCC
Q 018487          324 --------TMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       324 --------~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                              ....+..+|.+||+.+|.+++.
T Consensus       247 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  276 (286)
T cd06638         247 PTLHQPELWSNEFNDFIRKCLTKDYEKRPT  276 (286)
T ss_pred             CcccCCCCcCHHHHHHHHHHccCCcccCCC
Confidence                    1124677888999988888653

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.7e-37  Score=278.19  Aligned_cols=228  Identities=24%  Similarity=0.392  Sum_probs=187.3

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +..++|++.++||+|+||.||+|...      ....+++|.+....    ...+.+.+|+.+++.++|+||+++++.+..
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~------~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   72 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYN------KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK   72 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEec------CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC
Confidence            45678999999999999999999854      23459999876432    234567889999999999999999999887


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                       ...+++|||+++++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++..
T Consensus        73 -~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~  151 (260)
T cd05073          73 -EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV  151 (260)
T ss_pred             -CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceee
Confidence             7789999999999999998764  3478889999999999999999999999999999999999999999999999876


Q ss_pred             cCcCCC--CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhhHH
Q 018487          265 IDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTMLL  327 (355)
Q Consensus       265 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~~~  327 (355)
                      +.....  .....++..|+|||++.+..++.++|||||||++|+|+| |+.||...+....              .....
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (260)
T cd05073         152 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEE  231 (260)
T ss_pred             ccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHH
Confidence            543221  112235577999999998889999999999999999999 9999987533211              11135


Q ss_pred             HHHhhhheeeecCCCcCC
Q 018487          328 FYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       328 ~~~~i~~~l~~~~~e~~~  345 (355)
                      +..++.+|+.++|.+++.
T Consensus       232 ~~~~i~~~l~~~p~~Rp~  249 (260)
T cd05073         232 LYNIMMRCWKNRPEERPT  249 (260)
T ss_pred             HHHHHHHHcccCcccCcC
Confidence            677888999988888653

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-39  Score=275.41  Aligned_cols=198  Identities=34%  Similarity=0.548  Sum_probs=171.8

Q ss_pred             CCCeEEE-eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHh-cCCCcceecceeeec
Q 018487          109 PGDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTHPFIVQLRYSFQT  186 (355)
Q Consensus       109 ~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~  186 (355)
                      .++|.+- ++||-|-.|.|..+.++     .+++.+|+|++....        ..++|+++.-. -.|||||.++++|..
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k-----~T~ekfALKvL~Ds~--------KARrEVeLHw~~s~h~~iV~IidVyeN  126 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHK-----RTQEKFALKVLLDSP--------KARREVELHWMASGHPHIVSIIDVYEN  126 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEec-----cchhhhHHHHHhcCH--------HHHhHhhhhhhhcCCCceEEeehhhhh
Confidence            4567664 57999999999999988     567789999985432        24567776444 459999999998863


Q ss_pred             ----CCeEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC---CCcEEEE
Q 018487          187 ----RSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLT  257 (355)
Q Consensus       187 ----~~~~~lv~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~---~~~~kl~  257 (355)
                          ..++.+|||.|+||.|+..+..++.  |+|.++..|++||..|+.|||+.+|.||||||+|+|...   |..+||+
T Consensus       127 s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt  206 (400)
T KOG0604|consen  127 SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT  206 (400)
T ss_pred             hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence                4578899999999999999998865  999999999999999999999999999999999999964   4579999


Q ss_pred             ecCCccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchh
Q 018487          258 DFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQV  319 (355)
Q Consensus       258 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~  319 (355)
                      |||+|+.-.......+.|-|++|.|||++....|+..+|+||+||++|-||+|..||.++.-
T Consensus       207 DfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg  268 (400)
T KOG0604|consen  207 DFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG  268 (400)
T ss_pred             ccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC
Confidence            99999987766777888999999999999999999999999999999999999999998643

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.6e-37  Score=281.85  Aligned_cols=232  Identities=24%  Similarity=0.364  Sum_probs=185.8

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec--C
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--R  187 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~  187 (355)
                      .+|++.+.||+|+||.||+|..+... ...++.|++|.+....   ....+.+.+|+++++.++||||+++++++..  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQ-DNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   79 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCc-CCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence            47999999999999999999865432 2457789999986532   3345668889999999999999999987643  3


Q ss_pred             CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                      ..+++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            4689999999999999998764 458999999999999999999999999999999999999999999999999998764


Q ss_pred             cCCCC----CcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh---------------------
Q 018487          267 ESSRS----NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA---------------------  321 (355)
Q Consensus       267 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~---------------------  321 (355)
                      .....    ....++..|+|||++.+..++.++|||||||++|||++|..++.......                     
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05081         160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL  239 (284)
T ss_pred             CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence            32211    11223456999999998889999999999999999999877654331110                     


Q ss_pred             ---------hhhhHHHHHhhhheeeecCCCcCC
Q 018487          322 ---------CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 ---------~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                               ......+.++|.+|+..+|.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt  272 (284)
T cd05081         240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPS  272 (284)
T ss_pred             hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCC
Confidence                     001235677888888888887653

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.6e-37  Score=281.36  Aligned_cols=235  Identities=20%  Similarity=0.337  Sum_probs=190.8

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +..++|++.+.||+|+||.||+|.+.... ......|++|.+....  .....+.+.+|+.+++.++|+||+++++++..
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~-~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~   79 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEK-PGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIE   79 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCC-CCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            45678999999999999999999987422 1236779999886432  34445678889999999999999999998765


Q ss_pred             -CCeEEEEEeccCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEE
Q 018487          187 -RSKLYLILDFINGGHLFFHLYRQ--------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT  257 (355)
Q Consensus       187 -~~~~~lv~e~~~~gsL~~~l~~~--------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~  257 (355)
                       +...++++||+++++|.+++...        ..+++.++..++.|++.||.|||+++++||||||+||+++.++.+||+
T Consensus        80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEEC
Confidence             56789999999999999998653        358899999999999999999999999999999999999999999999


Q ss_pred             ecCCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh-----------
Q 018487          258 DFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC-----------  322 (355)
Q Consensus       258 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~-----------  322 (355)
                      |||+++.+.....   .....++..|+|||++.+..++.++||||||+++||+++ |+.||...+....           
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  239 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLA  239 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCC
Confidence            9999986533221   122345678999999998889999999999999999999 9999976432211           


Q ss_pred             ---hhhHHHHHhhhheeeecCCCcC
Q 018487          323 ---NTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       323 ---~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                         .....+.+++.+|+..+|.+++
T Consensus       240 ~~~~~~~~~~~li~~~l~~~p~~Rp  264 (280)
T cd05043         240 QPINCPDELFAVMACCWALDPEERP  264 (280)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCC
Confidence               1123467788888888777654

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-38  Score=267.44  Aligned_cols=230  Identities=26%  Similarity=0.347  Sum_probs=188.9

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +...+|++.++||+|||+-||+++..     .+++.||+|.+....   .+..+..++|++..++++||||++++++...
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~-----s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~   89 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGL-----STGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLR   89 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeeccc-----Ccccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHH
Confidence            55679999999999999999999854     578889999987654   3455667889999999999999999888653


Q ss_pred             C-----CeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCcEEecCCCcEE
Q 018487          187 R-----SKLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDGHVM  255 (355)
Q Consensus       187 ~-----~~~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~ql~~~L~~LH~~~--iiHrDlkp~NILl~~~~~~k  255 (355)
                      +     ...|++++|...|+|.+.+...    ..+++.++..|+.++++||.+||+..  +.||||||.|||+.+.+.++
T Consensus        90 ~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~v  169 (302)
T KOG2345|consen   90 EEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPV  169 (302)
T ss_pred             hhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceE
Confidence            3     3599999999999999888653    35999999999999999999999999  99999999999999999999


Q ss_pred             EEecCCccccCcCCCC----------CcccccCccccchhhcc---CCCCCcccHHHHHHHHHHHHcCCCCCCCchhh--
Q 018487          256 LTDFGLAKEIDESSRS----------NSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQVNIKSMQVI--  320 (355)
Q Consensus       256 l~Dfg~a~~~~~~~~~----------~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~--  320 (355)
                      |.|||.+.........          .....|..|+|||.+.-   ...+.++|||||||+||+|+.|.-||+..-.-  
T Consensus       170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg  249 (302)
T KOG2345|consen  170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG  249 (302)
T ss_pred             EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC
Confidence            9999998765322111          12346889999999863   45688999999999999999999999763210  


Q ss_pred             --h---hh----------hhHHHHHhhhheeeecCCCcC
Q 018487          321 --A---CN----------TMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       321 --~---~~----------~~~~~~~~i~~~l~~~~~e~~  344 (355)
                        +   ++          -.+.+-.+|..||+++|-+++
T Consensus       250 SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP  288 (302)
T KOG2345|consen  250 SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRP  288 (302)
T ss_pred             eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCC
Confidence              0   11          123557789999999998865

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.5e-37  Score=282.04  Aligned_cols=200  Identities=29%  Similarity=0.488  Sum_probs=173.4

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      +|++.+.||+|+||.||+|.+.     .+++.|++|++...... ....+.+.+|+.++++++|+||+++++++.....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~-----~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDR-----ETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGF   74 (286)
T ss_pred             CceEEeecccCCCcEEEEEEEC-----CCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCee
Confidence            5899999999999999999976     45778999998765422 33345688899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          191 YLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      |+||||+ +++|.+++... ..+++.+++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus        75 ~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          75 VLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             EEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            9999999 99999888653 568999999999999999999999999999999999999999999999999998764433


Q ss_pred             C--CCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          270 R--SNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       270 ~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      .  .....++..|+|||++.+. .++.++||||||+++|+|++|+.+|...
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~  204 (286)
T cd07832         154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE  204 (286)
T ss_pred             CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence            1  3345689999999998754 4688999999999999999998888654

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.8e-37  Score=279.71  Aligned_cols=229  Identities=29%  Similarity=0.483  Sum_probs=188.6

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeeccccc-------chhHHHHHHHHHHHHHhcCCCcceeccee
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-------KKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~nIv~l~~~  183 (355)
                      +|.+.+.||+|+||.||+|...     .+++.+|+|.++.....       .....+.+.+|+.+++.++|+||++++++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~-----~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   76 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNV-----TTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGF   76 (272)
T ss_pred             ceeecceecccCceEEEEEeec-----CCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence            5888999999999999999865     45678999988642211       12234567889999999999999999999


Q ss_pred             eecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       184 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      +...+..++||||+++++|.+++...+.+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||++.
T Consensus        77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          77 ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             eccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence            99999999999999999999999888889999999999999999999999999999999999999999999999999987


Q ss_pred             ccCcCC---CCCcccccCccccchhhccCC--CCCcccHHHHHHHHHHHHcCCCCCCCchhhhh----------------
Q 018487          264 EIDESS---RSNSMCGTTEYMAPEILLSKG--HNKDADWWSVGILLYEMLTGQVNIKSMQVIAC----------------  322 (355)
Q Consensus       264 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~----------------  322 (355)
                      ......   ......|+..|+|||++....  ++.++|+||||+++|+|++|..||...+....                
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (272)
T cd06629         157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPD  236 (272)
T ss_pred             cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcc
Confidence            653221   122346788999999987654  78999999999999999999999976433210                


Q ss_pred             ---hhhHHHHHhhhheeeecCCCcC
Q 018487          323 ---NTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       323 ---~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                         .....+.+++.+|+..+|.+++
T Consensus       237 ~~~~~~~~~~~li~~~l~~~p~~Rp  261 (272)
T cd06629         237 VSMNLSPVALDFLNACFTINPDNRP  261 (272)
T ss_pred             ccccCCHHHHHHHHHHhcCChhhCC
Confidence               0123456677778777777654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.1e-37  Score=282.60  Aligned_cols=229  Identities=29%  Similarity=0.500  Sum_probs=187.4

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceeeec
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQT  186 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~  186 (355)
                      ..+.|++.+.||.|+||.||+|.++     ..++.+|+|++....    .....+..|+.+++++ +|+||+++++++..
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHV-----KTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEc-----CCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            3468999999999999999999976     456789999986532    2234577889999988 69999999999853


Q ss_pred             ------CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEe
Q 018487          187 ------RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTD  258 (355)
Q Consensus       187 ------~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~D  258 (355)
                            ...+|++|||+++++|.+++...  ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~d  164 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVD  164 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEee
Confidence                  46789999999999999888754  3488899999999999999999999999999999999999999999999


Q ss_pred             cCCccccCcCC-CCCcccccCccccchhhc-----cCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh----------
Q 018487          259 FGLAKEIDESS-RSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC----------  322 (355)
Q Consensus       259 fg~a~~~~~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~----------  322 (355)
                      ||++....... ......|+..|+|||++.     +..++.++|||||||++|+|++|..||........          
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  244 (282)
T cd06636         165 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPP  244 (282)
T ss_pred             CcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCC
Confidence            99987654322 234457899999999986     34678899999999999999999999976432111          


Q ss_pred             -----hhhHHHHHhhhheeeecCCCcCC
Q 018487          323 -----NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       323 -----~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                           .....+.++|.+||+.+|.+++.
T Consensus       245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~  272 (282)
T cd06636         245 KLKSKKWSKKFIDFIEGCLVKNYLSRPS  272 (282)
T ss_pred             CCcccccCHHHHHHHHHHhCCChhhCcC
Confidence                 11235678888999988888764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-40  Score=329.87  Aligned_cols=227  Identities=30%  Similarity=0.472  Sum_probs=195.0

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      ++.....||.|.||.||-|...     .+++..|+|.++..... ......+.+|..+|..++|||+|+++++-...+.+
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~-----~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNL-----DTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred             eeccccccCCcceeeeEEeecC-----CccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence            4666788999999999999965     67889999998876654 55566788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCC
Q 018487          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR  270 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~  270 (355)
                      +|.||||++|+|.+.+...+...+.....+..|++.|+.|||+.|||||||||.|||++.+|.+|++|||.|..+.....
T Consensus      1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred             HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence            99999999999999998888888888889999999999999999999999999999999999999999999998765431


Q ss_pred             -----CCcccccCccccchhhccC---CCCCcccHHHHHHHHHHHHcCCCCCCCchhhh---------------hhhhHH
Q 018487          271 -----SNSMCGTTEYMAPEILLSK---GHNKDADWWSVGILLYEMLTGQVNIKSMQVIA---------------CNTMLL  327 (355)
Q Consensus       271 -----~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~---------------~~~~~~  327 (355)
                           ....+||+.|||||++.+.   +...++||||||||+.||+||+.||...+-.=               .+...-
T Consensus      1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~ 1469 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSE 1469 (1509)
T ss_pred             cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHh
Confidence                 2356899999999999863   46678999999999999999999998764210               111223


Q ss_pred             HHHhhhheeeecCCCc
Q 018487          328 FYLIIFHCLFVNSLEL  343 (355)
Q Consensus       328 ~~~~i~~~l~~~~~e~  343 (355)
                      -+++|++||+.+|..+
T Consensus      1470 g~dFle~Cl~~dP~~R 1485 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPKMR 1485 (1509)
T ss_pred             HHHHHHHHHhcCchhh
Confidence            3789999999999865

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.8e-37  Score=281.35  Aligned_cols=229  Identities=28%  Similarity=0.484  Sum_probs=186.4

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceeeec
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQT  186 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~  186 (355)
                      ..++|++.+.||+|+||.||+|..+     .+++.+|+|++....    .....+.+|+.+++++ +||||+++++++..
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~-----~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNK-----KDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEEC-----CCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            3578999999999999999999976     467789999986432    1234567789999998 79999999999864


Q ss_pred             C-----CeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEE
Q 018487          187 R-----SKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT  257 (355)
Q Consensus       187 ~-----~~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~  257 (355)
                      .     +..|+||||+++++|.+++..    ...+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~  170 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLV  170 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEe
Confidence            3     468999999999999888753    3568999999999999999999999999999999999999999999999


Q ss_pred             ecCCccccCcCC-CCCcccccCccccchhhccC-----CCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh---------
Q 018487          258 DFGLAKEIDESS-RSNSMCGTTEYMAPEILLSK-----GHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC---------  322 (355)
Q Consensus       258 Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~---------  322 (355)
                      |||++....... ......|+..|+|||++...     .++.++|||||||++|+|++|+.||........         
T Consensus       171 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~  250 (291)
T cd06639         171 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPP  250 (291)
T ss_pred             ecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCC
Confidence            999988654322 22345688999999998643     367899999999999999999999987643211         


Q ss_pred             -------hhhHHHHHhhhheeeecCCCcCC
Q 018487          323 -------NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       323 -------~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                             .....+.++|.+|++.+|.+++.
T Consensus       251 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps  280 (291)
T cd06639         251 PTLLHPEKWCRSFNHFISQCLIKDFEARPS  280 (291)
T ss_pred             CCCCcccccCHHHHHHHHHHhhcChhhCcC
Confidence                   01123567888999888888653

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-39  Score=303.25  Aligned_cols=221  Identities=27%  Similarity=0.449  Sum_probs=186.8

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEEEe
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  195 (355)
                      -+||+|.||+||.|+++     .++...|||.+..+.   ....+-+.+|+.+.++++|.|||+++|.+.+++++-|.||
T Consensus       581 vVLGKGTYG~VYA~RD~-----~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFME  652 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDM-----DTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFME  652 (1226)
T ss_pred             EEeecCceeEEEeeccc-----cceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEee
Confidence            36999999999999976     567789999987543   3345668889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEec-CCCcEEEEecCCccccCc-CCC
Q 018487          196 FINGGHLFFHLYRQ-GIF--REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDE-SSR  270 (355)
Q Consensus       196 ~~~~gsL~~~l~~~-~~l--~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~-~~~~~kl~Dfg~a~~~~~-~~~  270 (355)
                      -++||+|...+... +++  +|..+..+.+||++||.|||++.|+|||||-+|||++ -.|.+||+|||.++.+.. ...
T Consensus       653 qVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~  732 (1226)
T KOG4279|consen  653 QVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC  732 (1226)
T ss_pred             cCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence            99999999998754 777  8889999999999999999999999999999999996 568999999999987743 334


Q ss_pred             CCcccccCccccchhhcc--CCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh----------------hhhhHHHHHhh
Q 018487          271 SNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA----------------CNTMLLFYLII  332 (355)
Q Consensus       271 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~----------------~~~~~~~~~~i  332 (355)
                      ..++.||..|||||++..  ..|+.++|||||||++.||.||+.||..+..-.                ......-+++|
T Consensus       733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Fi  812 (1226)
T KOG4279|consen  733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFI  812 (1226)
T ss_pred             ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHH
Confidence            567899999999999975  468999999999999999999999998753211                11222347788


Q ss_pred             hheeeecCCCcC
Q 018487          333 FHCLFVNSLELL  344 (355)
Q Consensus       333 ~~~l~~~~~e~~  344 (355)
                      .+|+..+|.+++
T Consensus       813 lrcFepd~~~R~  824 (1226)
T KOG4279|consen  813 LRCFEPDPCDRP  824 (1226)
T ss_pred             HHHcCCCcccCc
Confidence            899977776654

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.1e-37  Score=279.91  Aligned_cols=224  Identities=20%  Similarity=0.280  Sum_probs=179.3

Q ss_pred             eeeccCCcEEEEEEEEcCCCC-------CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          116 RVVGQGAFGKVFQVKKKGVDD-------GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~-------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      +.||+|+||.||++......+       ......|++|++....   ......+.+|+.+++.++||||+++++++....
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            468999999999998643221       1123458888875432   333456778899999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCc-------EEEEecC
Q 018487          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-------VMLTDFG  260 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~-------~kl~Dfg  260 (355)
                      ..++||||+++++|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.       ++++|||
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999998888754 56899999999999999999999999999999999999987664       8999999


Q ss_pred             CccccCcCCCCCcccccCccccchhhc-cCCCCCcccHHHHHHHHHHHH-cCCCCCCCchhhhhh------------hhH
Q 018487          261 LAKEIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEML-TGQVNIKSMQVIACN------------TML  326 (355)
Q Consensus       261 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~~l~ell-tg~~pf~~~~~~~~~------------~~~  326 (355)
                      ++.....   .....++..|+|||++. +..++.++|||||||++|||+ +|+.||.........            ...
T Consensus       158 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (262)
T cd05077         158 IPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTPSCK  234 (262)
T ss_pred             CCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCccCCCCChH
Confidence            9875532   22345788999999987 467899999999999999998 589998765432211            123


Q ss_pred             HHHHhhhheeeecCCCcCC
Q 018487          327 LFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       327 ~~~~~i~~~l~~~~~e~~~  345 (355)
                      .+..+|.+||+.+|.+++.
T Consensus       235 ~~~~li~~cl~~dp~~Rp~  253 (262)
T cd05077         235 ELADLMTHCMNYDPNQRPF  253 (262)
T ss_pred             HHHHHHHHHcCCChhhCcC
Confidence            4678899999998888763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2e-37  Score=275.86  Aligned_cols=222  Identities=23%  Similarity=0.385  Sum_probs=183.0

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEEEe
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  195 (355)
                      +.||+|+||.||+|...      .++.+|+|++....  .......+.+|+.+++.++||||+++++.+...+..++|||
T Consensus         1 ~~ig~g~~g~vy~~~~~------~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   72 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK------DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVME   72 (250)
T ss_pred             CccCCCCCceEEEEEec------CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEE
Confidence            36899999999999853      35679999886543  23334467889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCCC--C
Q 018487          196 FINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS--N  272 (355)
Q Consensus       196 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~--~  272 (355)
                      |+++++|.+++... ..+.+..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.........  .
T Consensus        73 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  152 (250)
T cd05085          73 LVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG  152 (250)
T ss_pred             CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence            99999999988754 45789999999999999999999999999999999999999999999999998764332211  1


Q ss_pred             cccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhhHHHHHhhhheee
Q 018487          273 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTMLLFYLIIFHCLF  337 (355)
Q Consensus       273 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~~~~~~~i~~~l~  337 (355)
                      ...++..|+|||++.+..++.++||||||+++|+|++ |..||........              .....+.+++.+|+.
T Consensus       153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  232 (250)
T cd05085         153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWD  232 (250)
T ss_pred             CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcc
Confidence            1234567999999988889999999999999999998 9999977543221              122456778889999


Q ss_pred             ecCCCcCC
Q 018487          338 VNSLELLS  345 (355)
Q Consensus       338 ~~~~e~~~  345 (355)
                      .+|.+++.
T Consensus       233 ~~p~~Rp~  240 (250)
T cd05085         233 YKPENRPK  240 (250)
T ss_pred             cCcccCCC
Confidence            88888653

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=9.4e-38  Score=284.79  Aligned_cols=202  Identities=27%  Similarity=0.470  Sum_probs=172.3

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC--
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--  187 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--  187 (355)
                      ++|++.+.||+|+||.||+|.++     .+++.+++|.++..... ......+.+|+.++++++||||+++++++...  
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   78 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDK-----KTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNL   78 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEEC-----CCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC
Confidence            47999999999999999999976     45678999998765432 22334566799999999999999999998877  


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          188 SKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                      ...|+||||+++ +|.+++.... .+++.+++.++.|++.||+|||++|++|+||||+|||++.++.++|+|||++....
T Consensus        79 ~~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          79 DKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             CcEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            899999999975 8888877644 58999999999999999999999999999999999999999999999999998765


Q ss_pred             cC-CCCCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          267 ES-SRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       267 ~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      .. .......++..|+|||++.+. .++.++||||||+++|+|++|+.||....
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~  211 (293)
T cd07843         158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS  211 (293)
T ss_pred             CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            43 223344678899999998764 46889999999999999999999997653

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5.7e-38  Score=286.34  Aligned_cols=225  Identities=24%  Similarity=0.426  Sum_probs=186.0

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      .|.....||+|+||.||++...     ..++.||||.+....   ....+.+.+|+.+++.++|+||+++++.+..++..
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~-----~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~   94 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEK-----HTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDEL   94 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEEC-----CCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeE
Confidence            3445577999999999999865     457789999886432   33445678899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC-
Q 018487          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-  269 (355)
                      |+||||+++++|.+++.. +.+++.++..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... 
T Consensus        95 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~  173 (292)
T cd06658          95 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP  173 (292)
T ss_pred             EEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence            999999999999887754 468999999999999999999999999999999999999999999999999987653222 


Q ss_pred             CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh----------------hhhHHHHHhhh
Q 018487          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC----------------NTMLLFYLIIF  333 (355)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~----------------~~~~~~~~~i~  333 (355)
                      ......|+..|+|||++.+..++.++||||||+++|||++|+.||...+....                .....+..++.
T Consensus       174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  253 (292)
T cd06658         174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLD  253 (292)
T ss_pred             cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHH
Confidence            22345688999999999888899999999999999999999999986543221                11223566777


Q ss_pred             heeeecCCCcC
Q 018487          334 HCLFVNSLELL  344 (355)
Q Consensus       334 ~~l~~~~~e~~  344 (355)
                      .|+..+|.+++
T Consensus       254 ~~l~~~P~~Rp  264 (292)
T cd06658         254 LMLVREPSQRA  264 (292)
T ss_pred             HHccCChhHCc
Confidence            88877777764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.5e-37  Score=280.89  Aligned_cols=231  Identities=38%  Similarity=0.665  Sum_probs=196.0

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecceeeecCC
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRS  188 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~  188 (355)
                      ++|.+.+.||+|+||.||+|..+     .+++.|++|++...........+.+.+|..++++++ |+||+++++.+...+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~   75 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEK-----ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE   75 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEc-----CCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc
Confidence            37999999999999999999976     467889999987755444444567888999999999 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      ..++||||+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          76 NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             eEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence            99999999999999999998888999999999999999999999999999999999999999999999999998865432


Q ss_pred             CC---------------------CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh----
Q 018487          269 SR---------------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN----  323 (355)
Q Consensus       269 ~~---------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~----  323 (355)
                      ..                     .....++..|+|||++.+..++.++||||||+++++|++|+.||.........    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  235 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL  235 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence            21                     22345788999999998888999999999999999999999999876432210    


Q ss_pred             ---------hhHHHHHhhhheeeecCCCcCC
Q 018487          324 ---------TMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       324 ---------~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                               ....+..+|.+||..+|.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~  266 (280)
T cd05581         236 KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLG  266 (280)
T ss_pred             hcCCCCCCccCHHHHHHHHHHhcCCHhhCCC
Confidence                     1124567788888877776553

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.2e-38  Score=279.54  Aligned_cols=221  Identities=18%  Similarity=0.249  Sum_probs=180.3

Q ss_pred             eeeccCCcEEEEEEEEcCCCC-----CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          116 RVVGQGAFGKVFQVKKKGVDD-----GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      +.||+|+||.||+|.+....+     ......+++|++.....    ....+.+|+.+++.++|+||+++++++.. ...
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence            469999999999999874331     11224577777654331    14667889999999999999999999888 778


Q ss_pred             EEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC-------cEEEEecCCc
Q 018487          191 YLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-------HVMLTDFGLA  262 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~-------~~kl~Dfg~a  262 (355)
                      ++||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++       .+||+|||++
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            99999999999999998766 689999999999999999999999999999999999999887       7999999999


Q ss_pred             cccCcCCCCCcccccCccccchhhccC--CCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh------------hhhhHH
Q 018487          263 KEIDESSRSNSMCGTTEYMAPEILLSK--GHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA------------CNTMLL  327 (355)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~------------~~~~~~  327 (355)
                      .....   .....++..|+|||++.+.  .++.++||||||+++|+|++ |..||...+...            ......
T Consensus       156 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (259)
T cd05037         156 ITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDCAE  232 (259)
T ss_pred             ccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCCCCCchH
Confidence            87543   2234567889999999876  78999999999999999999 688887663211            111246


Q ss_pred             HHHhhhheeeecCCCcC
Q 018487          328 FYLIIFHCLFVNSLELL  344 (355)
Q Consensus       328 ~~~~i~~~l~~~~~e~~  344 (355)
                      +.++|.+||..+|.+++
T Consensus       233 ~~~li~~~l~~~p~~Rp  249 (259)
T cd05037         233 LANLINQCWTYDPTKRP  249 (259)
T ss_pred             HHHHHHHHhccChhhCC
Confidence            67889999998888865

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.9e-37  Score=279.28  Aligned_cols=197  Identities=21%  Similarity=0.333  Sum_probs=162.6

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEEEe
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  195 (355)
                      +.||+|+||.||+|.+..   ......+++|.++....  ......+.+|+.++++++||||+++++++.....+++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~---~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNS---GYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcC---CCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEE
Confidence            368999999999998762   23456799998865432  2233467789999999999999999999999899999999


Q ss_pred             ccCCCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC-
Q 018487          196 FINGGHLFFHLYRQG-----IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (355)
Q Consensus       196 ~~~~gsL~~~l~~~~-----~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-  269 (355)
                      |+++|+|.+++....     ..++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||++....... 
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~  155 (269)
T cd05087          76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY  155 (269)
T ss_pred             CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence            999999999987532     35667788899999999999999999999999999999999999999999987543221 


Q ss_pred             --CCCcccccCccccchhhccC-------CCCCcccHHHHHHHHHHHHc-CCCCCCCc
Q 018487          270 --RSNSMCGTTEYMAPEILLSK-------GHNKDADWWSVGILLYEMLT-GQVNIKSM  317 (355)
Q Consensus       270 --~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwSlG~~l~ellt-g~~pf~~~  317 (355)
                        ......++..|+|||++.+.       .++.++||||||+++|||++ |+.||...
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~  213 (269)
T cd05087         156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL  213 (269)
T ss_pred             eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence              12234577889999998642       35789999999999999996 99999764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2e-37  Score=281.13  Aligned_cols=201  Identities=29%  Similarity=0.482  Sum_probs=170.7

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      +|++++.||.|++|.||+|.++     .+++.|+||.+..... .....+.+.+|++++++++||||+++++++...+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   74 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNK-----LTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL   74 (284)
T ss_pred             CceeeeeecCCCceEEEEEEEC-----CCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcE
Confidence            4899999999999999999976     4577899998875432 222335677899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      ++||||+. ++|..++...  ..+++..+..++.|++.||+|||+.|++||||+|+||+++.++.+||+|||++......
T Consensus        75 ~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~  153 (284)
T cd07860          75 YLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  153 (284)
T ss_pred             EEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            99999996 5788877653  46899999999999999999999999999999999999999999999999998765433


Q ss_pred             CC-CCcccccCccccchhhccCC-CCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          269 SR-SNSMCGTTEYMAPEILLSKG-HNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       269 ~~-~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      .. .....++..|+|||++.+.. ++.++||||||+++|+|+||+.||...+
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~  205 (284)
T cd07860         154 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS  205 (284)
T ss_pred             ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            22 23345688999999887644 5889999999999999999999997653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.9e-37  Score=274.29  Aligned_cols=228  Identities=31%  Similarity=0.470  Sum_probs=196.4

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC--C
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--S  188 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~  188 (355)
                      +|.+.+.||+|++|.||+|...     .+++.|++|++...... ....+.+.+|+.++++++|+||+++++.+...  .
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDK-----DTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKN   74 (260)
T ss_pred             CceeeeEeeecCceEEEEEEEC-----CCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCC
Confidence            4888999999999999999976     45778999998765432 44567788999999999999999999999988  8


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      .++++|||+++++|.+++.....+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          75 TLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             eEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999999877655


Q ss_pred             CC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCch-hh---------------hhhhhHHHH
Q 018487          269 SR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQ-VI---------------ACNTMLLFY  329 (355)
Q Consensus       269 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~-~~---------------~~~~~~~~~  329 (355)
                      ..   .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+ ..               .......+.
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  234 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAK  234 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHH
Confidence            43   345578899999999988889999999999999999999999998764 10               111223567


Q ss_pred             HhhhheeeecCCCcC
Q 018487          330 LIIFHCLFVNSLELL  344 (355)
Q Consensus       330 ~~i~~~l~~~~~e~~  344 (355)
                      ++|.+|+..+|.+++
T Consensus       235 ~~i~~~l~~~p~~Rp  249 (260)
T cd06606         235 DFLRKCLRRDPKKRP  249 (260)
T ss_pred             HHHHHhCcCChhhCC
Confidence            788888888877765

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.2e-37  Score=278.69  Aligned_cols=228  Identities=26%  Similarity=0.398  Sum_probs=187.2

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec--C
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--R  187 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~  187 (355)
                      ++|+..++||.|++|.||+|.++     ..++.+|+|.+....  .......+.+|+++++.++|+||++++++|..  .
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   73 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLK-----NTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESS   73 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEEC-----CCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCC
Confidence            47999999999999999999976     457889999987543  22445668889999999999999999998864  3


Q ss_pred             CeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          188 SKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      +.+|+||||+++++|.+++..    ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus        74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~  153 (287)
T cd06621          74 SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG  153 (287)
T ss_pred             CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccc
Confidence            478999999999999887653    3458999999999999999999999999999999999999999999999999987


Q ss_pred             ccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchh--------hh---h----------
Q 018487          264 EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQV--------IA---C----------  322 (355)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~--------~~---~----------  322 (355)
                      ...... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.....        ..   .          
T Consensus       154 ~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd06621         154 ELVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEP  232 (287)
T ss_pred             cccccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCC
Confidence            654332 2244678899999999988999999999999999999999999986521        00   0          


Q ss_pred             ----hhhHHHHHhhhheeeecCCCcCC
Q 018487          323 ----NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       323 ----~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                          .....+.+++.+|+..+|.+++.
T Consensus       233 ~~~~~~~~~~~~li~~~l~~~p~~Rpt  259 (287)
T cd06621         233 GNGIKWSEEFKDFIKQCLEKDPTRRPT  259 (287)
T ss_pred             CCCCchHHHHHHHHHHHcCCCcccCCC
Confidence                00123567777888777777653

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.2e-37  Score=282.56  Aligned_cols=227  Identities=27%  Similarity=0.447  Sum_probs=190.5

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|++.+.||+|+||.||++...     .+++.|++|.+....   ....+.+.+|+.+++.++||||+++++.+....
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~   89 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDV-----ATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGD   89 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEc-----CCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCC
Confidence            368999999999999999999865     456779999986432   223356778999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      ..|+|+||+++++|.+++... .+++.++..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~  168 (293)
T cd06647          90 ELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (293)
T ss_pred             cEEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence            999999999999999888654 5789999999999999999999999999999999999999999999999988765433


Q ss_pred             CC-CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh----------------hhhHHHHHh
Q 018487          269 SR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC----------------NTMLLFYLI  331 (355)
Q Consensus       269 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~----------------~~~~~~~~~  331 (355)
                      .. .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+....                .....+..+
T Consensus       169 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  248 (293)
T cd06647         169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF  248 (293)
T ss_pred             ccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHH
Confidence            22 2334688899999999888899999999999999999999999976533211                011246788


Q ss_pred             hhheeeecCCCcC
Q 018487          332 IFHCLFVNSLELL  344 (355)
Q Consensus       332 i~~~l~~~~~e~~  344 (355)
                      |.+|+..+|.+++
T Consensus       249 i~~~l~~~p~~Rp  261 (293)
T cd06647         249 LNRCLEMDVEKRG  261 (293)
T ss_pred             HHHHccCChhhCc
Confidence            9999998888865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-37  Score=280.07  Aligned_cols=227  Identities=29%  Similarity=0.526  Sum_probs=189.9

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC---CCcceecceeeecC
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT---HPFIVQLRYSFQTR  187 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~  187 (355)
                      .|++.+.||+|+||.||+|.+.     .+++.|++|++....  .....+.+.+|+.+++.++   |+||+++++++..+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~-----~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~   74 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHV-----PTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG   74 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEc-----CCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC
Confidence            4788899999999999999976     457889999987543  2334456778999999987   99999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      ...|+||||+++++|.+++.. +.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          75 PRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             CEEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            999999999999999888865 4789999999999999999999999999999999999999999999999999987643


Q ss_pred             CC-CCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh---------------hhHHHHH
Q 018487          268 SS-RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN---------------TMLLFYL  330 (355)
Q Consensus       268 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~---------------~~~~~~~  330 (355)
                      .. ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.....               ....+.+
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (277)
T cd06917         154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLRE  233 (277)
T ss_pred             CccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHH
Confidence            32 2334568899999999864 45788999999999999999999999775432211               2235677


Q ss_pred             hhhheeeecCCCcCC
Q 018487          331 IIFHCLFVNSLELLS  345 (355)
Q Consensus       331 ~i~~~l~~~~~e~~~  345 (355)
                      ++.+||..+|.+++.
T Consensus       234 ~i~~~l~~~p~~R~~  248 (277)
T cd06917         234 FVAACLDEEPKERLS  248 (277)
T ss_pred             HHHHHcCCCcccCcC
Confidence            888999888888753

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-37  Score=279.04  Aligned_cols=228  Identities=29%  Similarity=0.501  Sum_probs=186.2

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceeeecC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR  187 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~  187 (355)
                      .++|++.+.||+|+||.||+|.++     ..++.+++|++.....    ..+.+.+|+.+++++ +|+||+++++++...
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   75 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHK-----KTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKK   75 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEEC-----CCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEec
Confidence            478999999999999999999976     4567899999875432    235678899999999 699999999998654


Q ss_pred             C------eEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEE
Q 018487          188 S------KLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT  257 (355)
Q Consensus       188 ~------~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~  257 (355)
                      .      .+|+||||+++++|.+++..    ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~  155 (275)
T cd06608          76 NPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLV  155 (275)
T ss_pred             CCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEEC
Confidence            3      58999999999999888765    3468999999999999999999999999999999999999999999999


Q ss_pred             ecCCccccCcCC-CCCcccccCccccchhhcc-----CCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh---------
Q 018487          258 DFGLAKEIDESS-RSNSMCGTTEYMAPEILLS-----KGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC---------  322 (355)
Q Consensus       258 Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~---------  322 (355)
                      |||++....... ......|+..|+|||++..     ..++.++||||||+++|+|++|+.||........         
T Consensus       156 d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  235 (275)
T cd06608         156 DFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPP  235 (275)
T ss_pred             CCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCC
Confidence            999987654322 2234568899999999854     3467889999999999999999999976432111         


Q ss_pred             -------hhhHHHHHhhhheeeecCCCcCC
Q 018487          323 -------NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       323 -------~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                             .....+.++|.+||..+|.+++.
T Consensus       236 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt  265 (275)
T cd06608         236 PTLKSPENWSKKFNDFISECLIKNYEQRPF  265 (275)
T ss_pred             CCCCchhhcCHHHHHHHHHHhhcChhhCcC
Confidence                   01124567788888887777653

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.1e-37  Score=285.29  Aligned_cols=225  Identities=26%  Similarity=0.429  Sum_probs=187.1

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      .|.....||+|+||.||+|..+     ..++.||+|++.....   ...+.+.+|+.+++.++||||+++++.+..++..
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~   93 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREK-----HSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEEL   93 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEc-----CCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeE
Confidence            4555668999999999999865     4567899999865432   2335577899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC-
Q 018487          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-  269 (355)
                      |+||||+++++|..++.. ..+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..+.... 
T Consensus        94 ~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~  172 (297)
T cd06659          94 WVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP  172 (297)
T ss_pred             EEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence            999999999999876654 568999999999999999999999999999999999999999999999999987654322 


Q ss_pred             CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh----------------hhhHHHHHhhh
Q 018487          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC----------------NTMLLFYLIIF  333 (355)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~----------------~~~~~~~~~i~  333 (355)
                      ......|+..|+|||++.+..++.++|||||||++|||++|+.||...+....                .....+..++.
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~  252 (297)
T cd06659         173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLE  252 (297)
T ss_pred             cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHH
Confidence            22345789999999999988899999999999999999999999975532211                11234577888


Q ss_pred             heeeecCCCcC
Q 018487          334 HCLFVNSLELL  344 (355)
Q Consensus       334 ~~l~~~~~e~~  344 (355)
                      .|++.+|.+++
T Consensus       253 ~~l~~~P~~Rp  263 (297)
T cd06659         253 RMLTREPQERA  263 (297)
T ss_pred             HHhcCCcccCc
Confidence            88888877764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.2e-37  Score=277.24  Aligned_cols=223  Identities=43%  Similarity=0.740  Sum_probs=190.6

Q ss_pred             eccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEEEecc
Q 018487          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI  197 (355)
Q Consensus       118 lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  197 (355)
                      ||.|+||.||+|.+.     .+++.+++|++...........+.+.+|++++++++|+||+++++.+..+...|++|||+
T Consensus         1 lg~g~~~~vy~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKK-----STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEEC-----CCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecC
Confidence            689999999999976     457789999997765444556677889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC--------
Q 018487          198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--------  269 (355)
Q Consensus       198 ~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~--------  269 (355)
                      ++++|.+++...+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......        
T Consensus        76 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          76 PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            999999999887889999999999999999999999999999999999999999999999999987543321        


Q ss_pred             -CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh---------------hhhHHHHHhhh
Q 018487          270 -RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC---------------NTMLLFYLIIF  333 (355)
Q Consensus       270 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~---------------~~~~~~~~~i~  333 (355)
                       ......++..|+|||++.+..++.++||||||+++|+|++|+.||...+....               .....+..++.
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  235 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLIS  235 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHH
Confidence             12334678899999999888899999999999999999999999976532210               01345678888


Q ss_pred             heeeecCCCcCC
Q 018487          334 HCLFVNSLELLS  345 (355)
Q Consensus       334 ~~l~~~~~e~~~  345 (355)
                      +|++.+|.+++.
T Consensus       236 ~~l~~~p~~Rpt  247 (265)
T cd05579         236 KLLVPDPEKRLG  247 (265)
T ss_pred             HHhcCCHhhcCC
Confidence            999888887764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=5e-37  Score=273.87  Aligned_cols=228  Identities=26%  Similarity=0.432  Sum_probs=193.6

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      +|++.++||+|+||.||++.++     .+++.+++|.+...... ......+.+|+.+++.++|+||+++++.+......
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRL-----SDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKL   74 (256)
T ss_pred             CceEeeeecCCCceeEEEEEEC-----CCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEE
Confidence            5899999999999999999876     45678999998765432 33345677899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          191 YLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                      |+||||+++++|..++..    ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~  154 (256)
T cd08530          75 CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLK  154 (256)
T ss_pred             EEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhc
Confidence            999999999999988866    3568999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh--------------hhHHHHHhh
Q 018487          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN--------------TMLLFYLII  332 (355)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~--------------~~~~~~~~i  332 (355)
                      .. ......++..|++||.+.+..++.++|+||||+++|+|++|+.||...+.....              ....+..++
T Consensus       155 ~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  233 (256)
T cd08530         155 KN-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFI  233 (256)
T ss_pred             cC-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHH
Confidence            44 233456889999999999888999999999999999999999999876543211              123457788


Q ss_pred             hheeeecCCCcCC
Q 018487          333 FHCLFVNSLELLS  345 (355)
Q Consensus       333 ~~~l~~~~~e~~~  345 (355)
                      .+|+..+|.+++.
T Consensus       234 ~~~l~~~p~~Rp~  246 (256)
T cd08530         234 RSMLQVKPKLRPN  246 (256)
T ss_pred             HHHcCCCcccCCC
Confidence            8888888888653

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-37  Score=285.39  Aligned_cols=204  Identities=27%  Similarity=0.434  Sum_probs=170.8

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC--C
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--S  188 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~  188 (355)
                      +|++.++||+|+||.||+|.++..   ..++.||+|.+...........+.+.+|+.+++.++||||+++++++...  .
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~---~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNG---KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCC---CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCc
Confidence            488999999999999999997631   25788999999875422333445677899999999999999999999988  8


Q ss_pred             eEEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC----CCcEEEEec
Q 018487          189 KLYLILDFINGGHLFFHLYRQ-----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS----DGHVMLTDF  259 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~----~~~~kl~Df  259 (355)
                      .+|+||||+++ +|...+...     ..+++..++.++.|++.||.|||+++|+||||||+|||++.    ++.+||+||
T Consensus        78 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          78 SVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             eEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            89999999986 565555422     25899999999999999999999999999999999999999    899999999


Q ss_pred             CCccccCcCCC----CCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          260 GLAKEIDESSR----SNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       260 g~a~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      |++..+.....    .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  220 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE  220 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence            99987643322    234567889999998876 457899999999999999999999998654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.7e-37  Score=279.87  Aligned_cols=229  Identities=27%  Similarity=0.447  Sum_probs=194.7

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ..+.|++.+.||+|++|.||+|.+.     ..++.|++|++.....    ..+.+.+|+.+++.++|+||+++++.+...
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   87 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDR-----ATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVG   87 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEc-----cCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC
Confidence            4567999999999999999999976     3567899999875432    345677899999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          188 SKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                      ...|+++||+++++|.+++.... .+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  167 (286)
T cd06614          88 DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT  167 (286)
T ss_pred             CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence            99999999999999999998876 79999999999999999999999999999999999999999999999999887553


Q ss_pred             cCC-CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh----------------hhHHHH
Q 018487          267 ESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN----------------TMLLFY  329 (355)
Q Consensus       267 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~----------------~~~~~~  329 (355)
                      ... ......++..|+|||++.+..++.++||||||+++|+|++|+.||...+.....                ....+.
T Consensus       168 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  247 (286)
T cd06614         168 KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFK  247 (286)
T ss_pred             cchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHH
Confidence            322 123445788999999999888999999999999999999999999875432111                123467


Q ss_pred             HhhhheeeecCCCcCC
Q 018487          330 LIIFHCLFVNSLELLS  345 (355)
Q Consensus       330 ~~i~~~l~~~~~e~~~  345 (355)
                      .+|.+|++.+|.+++.
T Consensus       248 ~li~~~l~~~p~~Rpt  263 (286)
T cd06614         248 DFLNKCLVKDPEKRPS  263 (286)
T ss_pred             HHHHHHhccChhhCcC
Confidence            7888999988887653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=5.3e-37  Score=272.33  Aligned_cols=227  Identities=31%  Similarity=0.530  Sum_probs=195.4

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      +|.+.+.||+|++|.||+|.+.     .+++.+++|++.....   ...+.+.+|+.+++.++|+||+++++.+......
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~-----~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   72 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHK-----RTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDEL   72 (253)
T ss_pred             CceeeeeeccCCceEEEEEEEC-----CCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence            4888999999999999999976     3567899999876542   3456788899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          191 YLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      ++++||+++++|.+++... ..+++..+..++.|++.||.|||.+|++||||+|+||+++.++.++|+|||.+.......
T Consensus        73 ~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  152 (253)
T cd05122          73 WIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK  152 (253)
T ss_pred             EEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence            9999999999999988776 578999999999999999999999999999999999999999999999999998765543


Q ss_pred             CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh--------------hhh--hHHHHHhhh
Q 018487          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA--------------CNT--MLLFYLIIF  333 (355)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~--------------~~~--~~~~~~~i~  333 (355)
                      ......++..|+|||++.+..++.++||||||+++|+|++|+.||...+...              ...  ...+.++|.
T Consensus       153 ~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  232 (253)
T cd05122         153 ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLK  232 (253)
T ss_pred             cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHH
Confidence            2345678899999999988888999999999999999999999998762211              011  345678899


Q ss_pred             heeeecCCCcCC
Q 018487          334 HCLFVNSLELLS  345 (355)
Q Consensus       334 ~~l~~~~~e~~~  345 (355)
                      +|++.+|.+++.
T Consensus       233 ~~l~~~p~~R~t  244 (253)
T cd05122         233 KCLQKNPEKRPT  244 (253)
T ss_pred             HHccCChhhCCC
Confidence            999998888653

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.2e-37  Score=279.29  Aligned_cols=198  Identities=27%  Similarity=0.492  Sum_probs=166.6

Q ss_pred             eEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecceeeecC--C
Q 018487          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTR--S  188 (355)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~--~  188 (355)
                      |++.++||+|+||.||+|..+     ..++.||+|+++.... ..... ...+|+.+++++. |+||+++++++.+.  +
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~-----~~~~~~aik~~~~~~~-~~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   73 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSR-----KTGKYYAIKCMKKHFK-SLEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTG   73 (282)
T ss_pred             CceEeeccccccceEEEEEEc-----CCCcEEEEEEehhccC-Cchhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCC
Confidence            678999999999999999976     4577899999875432 22222 2346888888885 99999999999887  8


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      .+++||||+++ +|.+.+... ..+++.++..++.|++.||.|||+.|++||||+|+||+++. +.+||+|||++.....
T Consensus        74 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          74 RLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             cEEEEEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            89999999975 677777653 56899999999999999999999999999999999999999 9999999999987755


Q ss_pred             CCCCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          268 SSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      ........++..|+|||++.. ..++.++|||||||++|||++|..||...+
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~  203 (282)
T cd07831         152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN  203 (282)
T ss_pred             CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence            444445568899999998654 557889999999999999999999997653

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-37  Score=272.51  Aligned_cols=229  Identities=28%  Similarity=0.515  Sum_probs=196.7

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      +|++.+.||+|++|.||++.++     ..++.|++|.+...... ....+.+.+|++++++++|+|++++++++......
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNL-----ETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSL   74 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEc-----CCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Confidence            5889999999999999999876     45678999999776432 34556788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCC
Q 018487          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR  270 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~  270 (355)
                      +++|||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++........
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          75 YIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            99999999999999998888899999999999999999999999999999999999999999999999999987654332


Q ss_pred             -CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh--------------hhhHHHHHhhhhe
Q 018487          271 -SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC--------------NTMLLFYLIIFHC  335 (355)
Q Consensus       271 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~--------------~~~~~~~~~i~~~  335 (355)
                       .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+....              .....+..++.+|
T Consensus       155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  234 (254)
T cd06627         155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQC  234 (254)
T ss_pred             cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHH
Confidence             2345688999999999888889999999999999999999999976543221              1224567888899


Q ss_pred             eeecCCCcCC
Q 018487          336 LFVNSLELLS  345 (355)
Q Consensus       336 l~~~~~e~~~  345 (355)
                      |..+|.+++.
T Consensus       235 l~~~p~~R~~  244 (254)
T cd06627         235 FQKDPNLRPT  244 (254)
T ss_pred             HhCChhhCcC
Confidence            9888888653

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5e-37  Score=280.13  Aligned_cols=202  Identities=26%  Similarity=0.442  Sum_probs=169.2

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++.+.||+|++|.||+|.++     .+++.|++|.+..... .....+.+.+|+++++.++|+||+++++++.....
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDR-----VTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKR   75 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEec-----CCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCe
Confidence            57999999999999999999976     4577899999865432 22334567789999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC-CCcEEEEecCCccccC
Q 018487          190 LYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKEID  266 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~-~~~~kl~Dfg~a~~~~  266 (355)
                      .|+||||+++ +|..++.....  +++..+..++.||+.||+|||+++++||||+|+||+++. ++.+||+|||++....
T Consensus        76 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~  154 (294)
T PLN00009         76 LYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG  154 (294)
T ss_pred             EEEEEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence            9999999965 77777765433  578889999999999999999999999999999999985 5679999999997653


Q ss_pred             cCCC-CCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          267 ESSR-SNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       267 ~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      .... .....+++.|+|||++.+ ..++.++||||||+++|+|+||+.||...+
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~  208 (294)
T PLN00009        155 IPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS  208 (294)
T ss_pred             CCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            3221 233467889999999876 457889999999999999999999997653

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3.7e-37  Score=279.31  Aligned_cols=200  Identities=26%  Similarity=0.487  Sum_probs=171.0

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      +|++.++||.|++|.||+|.++     .+++.||+|+++....  ....+.+.+|+.+++.++|+||+++++++...+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   73 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNR-----TTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKL   73 (284)
T ss_pred             CceEeeeeccCCceEEEEEEEC-----CCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcE
Confidence            5899999999999999999976     4577899999876532  22334566799999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          191 YLILDFINGGHLFFHLYRQ---GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~---~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      ++||||+++ +|.+++...   ..+++.++..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus        74 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~  152 (284)
T cd07836          74 MLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI  152 (284)
T ss_pred             EEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence            999999986 787777654   3589999999999999999999999999999999999999999999999999976543


Q ss_pred             CCC-CCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          268 SSR-SNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       268 ~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      ... .....++..|++||++.+. .++.++||||||+++|+|++|+.||...+
T Consensus       153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~  205 (284)
T cd07836         153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN  205 (284)
T ss_pred             CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            221 2334578899999998654 57889999999999999999999997653

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.9e-37  Score=280.76  Aligned_cols=201  Identities=26%  Similarity=0.454  Sum_probs=167.3

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecceeeecCC
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRS  188 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~  188 (355)
                      ++|++.+.||+|+||.||+|.+.     .+++.||+|.+..... .......+.+|+.+++.+. |+||+++++.+....
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~-----~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   74 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDK-----NTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEE   74 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEEC-----CCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecC
Confidence            47999999999999999999976     4577899998865432 2223345777999999995 699999999987665


Q ss_pred             e-----EEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC-CCcEEEE
Q 018487          189 K-----LYLILDFINGGHLFFHLYRQ-----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLT  257 (355)
Q Consensus       189 ~-----~~lv~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~-~~~~kl~  257 (355)
                      .     .|+||||+++ +|..++...     ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+
T Consensus        75 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~  153 (295)
T cd07837          75 KNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIA  153 (295)
T ss_pred             CCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEe
Confidence            5     8999999986 787777543     34799999999999999999999999999999999999998 8899999


Q ss_pred             ecCCccccCcCC-CCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          258 DFGLAKEIDESS-RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       258 Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      |||++..+.... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...
T Consensus       154 dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~  215 (295)
T cd07837         154 DLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD  215 (295)
T ss_pred             ecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence            999988653322 1223356888999998865 45789999999999999999999999764

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.9e-37  Score=278.52  Aligned_cols=227  Identities=25%  Similarity=0.477  Sum_probs=189.6

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      -|++.++||.|+||.||+|.++     .+++.||+|++....  .....+.+.+|+.++++++|+||+++++.+..+...
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~-----~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   77 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDN-----RTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL   77 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEEC-----CCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeE
Confidence            4778899999999999999865     457789999876443  233446688899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC-
Q 018487          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-  269 (355)
                      |+||||+++++|..++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+.... 
T Consensus        78 ~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          78 WIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence            999999999999888764 468999999999999999999999999999999999999999999999999987654322 


Q ss_pred             CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh--------------hhhHHHHHhhhhe
Q 018487          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC--------------NTMLLFYLIIFHC  335 (355)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~--------------~~~~~~~~~i~~~  335 (355)
                      ......++..|+|||.+.+..++.++|+|||||++|+|++|..||........              .....+.++|.+|
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  236 (277)
T cd06641         157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEAC  236 (277)
T ss_pred             hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence            12334678899999999888889999999999999999999999976432210              0123467788899


Q ss_pred             eeecCCCcCC
Q 018487          336 LFVNSLELLS  345 (355)
Q Consensus       336 l~~~~~e~~~  345 (355)
                      ++.+|.+++.
T Consensus       237 l~~~p~~Rp~  246 (277)
T cd06641         237 LNKEPSFRPT  246 (277)
T ss_pred             ccCChhhCcC
Confidence            9888877653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7e-38  Score=280.48  Aligned_cols=224  Identities=17%  Similarity=0.264  Sum_probs=179.4

Q ss_pred             eeeccCCcEEEEEEEEcCCCC--CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEE
Q 018487          116 RVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLI  193 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  193 (355)
                      +.||+|+||.||+|.++...+  ......+++|.+...   .....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence            469999999999998764322  123445888877543   233445677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCc--------EEEEecCCccc
Q 018487          194 LDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--------VMLTDFGLAKE  264 (355)
Q Consensus       194 ~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~--------~kl~Dfg~a~~  264 (355)
                      |||+++|+|..++..++ .+++..+..++.||+.||+|||++||+||||||+|||++.++.        ++++|||++..
T Consensus        78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            99999999999987654 5899999999999999999999999999999999999987765        69999998875


Q ss_pred             cCcCCCCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcC-CCCCCCchhhhhh------------hhHHHHH
Q 018487          265 IDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTG-QVNIKSMQVIACN------------TMLLFYL  330 (355)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg-~~pf~~~~~~~~~------------~~~~~~~  330 (355)
                      ...   .....++..|+|||++.+ ..++.++||||||+++|+|++| ..||...+.....            ....+.+
T Consensus       158 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (258)
T cd05078         158 VLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTELAN  234 (258)
T ss_pred             cCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCCCCCcHHHHH
Confidence            532   233467889999999986 4578999999999999999998 4666654432211            1124677


Q ss_pred             hhhheeeecCCCcCC
Q 018487          331 IIFHCLFVNSLELLS  345 (355)
Q Consensus       331 ~i~~~l~~~~~e~~~  345 (355)
                      ++.+||+.+|.+++.
T Consensus       235 li~~~l~~~p~~Rps  249 (258)
T cd05078         235 LINQCMDYEPDFRPS  249 (258)
T ss_pred             HHHHHhccChhhCCC
Confidence            888999988888753

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=7.6e-39  Score=276.94  Aligned_cols=209  Identities=27%  Similarity=0.428  Sum_probs=175.0

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec-CC
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-RS  188 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~  188 (355)
                      ..|+.+..||+|.||.||+|..+.+.+.. .+.+|+|.++...... ..-....+|+.+++.++||||+.+..+|.. +.
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr-~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKR-TKEYAIKKFKGEKDGT-GISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCccc-chhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            36999999999999999999766554422 4579999987664322 233445679999999999999999999887 78


Q ss_pred             eEEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCC----CcEEEEec
Q 018487          189 KLYLILDFINGGHLFFHLYRQ-----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD----GHVMLTDF  259 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~----~~~kl~Df  259 (355)
                      .+|+++||.+. +|...++-+     ..++...++.|++||+.|+.|||++-|+||||||.|||+..+    |.|||+||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence            99999999987 677777533     358999999999999999999999999999999999999877    89999999


Q ss_pred             CCccccCcCC----CCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh
Q 018487          260 GLAKEIDESS----RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA  321 (355)
Q Consensus       260 g~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~  321 (355)
                      |+++.+....    .....+-|..|+|||.+.| ..|+.+.||||+||++.||+|-+..|...+...
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~  247 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKI  247 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhc
Confidence            9999875433    2345678999999999987 468999999999999999999999888765433

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.8e-37  Score=288.34  Aligned_cols=202  Identities=25%  Similarity=0.437  Sum_probs=172.5

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec---
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT---  186 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~---  186 (355)
                      ++|++.+.||+|+||.||+|..+     .+++.|++|++..... .......+.+|+.+++.++||||+++++++..   
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   78 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDT-----RSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA   78 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEc-----CCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCC
Confidence            68999999999999999999976     4577899999875432 23344567789999999999999999988763   


Q ss_pred             -CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          187 -RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       187 -~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                       ...+|+||||+. ++|..++.....+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus        79 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          79 DFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             CCceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence             357899999996 588888887788999999999999999999999999999999999999999999999999999765


Q ss_pred             CcCCC-----CCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          266 DESSR-----SNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       266 ~~~~~-----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      .....     .....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~  216 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN  216 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCC
Confidence            33221     123478899999999865 458899999999999999999999997654

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=5.9e-37  Score=275.83  Aligned_cols=227  Identities=26%  Similarity=0.393  Sum_probs=184.1

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      +.+.....||+|+||.||+|.+.     .++..|++|.+....   ....+.+.+|+.+++.++|+||+++++++..++.
T Consensus         8 ~~~~~~~~lg~g~~g~v~~~~~~-----~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (268)
T cd06624           8 DENGERVVLGKGTYGIVYAARDL-----STQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGF   79 (268)
T ss_pred             ccCCceEEEecCCceEEEEeEec-----CCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCE
Confidence            34444568999999999999865     457789999876542   2334568889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC-CCcEEEEecCCcccc
Q 018487          190 LYLILDFINGGHLFFHLYRQ-GIF--REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKEI  265 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~-~~l--~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~-~~~~kl~Dfg~a~~~  265 (355)
                      .++||||+++++|.+++... ..+  ++..+..++.|++.||.|||++||+||||||+||+++. ++.++|+|||++...
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          80 FKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            99999999999999988764 445  88889999999999999999999999999999999976 679999999998765


Q ss_pred             CcCC-CCCcccccCccccchhhccC--CCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh----------------hhhH
Q 018487          266 DESS-RSNSMCGTTEYMAPEILLSK--GHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC----------------NTML  326 (355)
Q Consensus       266 ~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~----------------~~~~  326 (355)
                      .... ......|+..|+|||++.+.  .++.++||||||+++|+|++|+.||...+....                ....
T Consensus       160 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (268)
T cd06624         160 AGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSA  239 (268)
T ss_pred             ccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCH
Confidence            3322 22334678999999998654  378899999999999999999999976432110                1122


Q ss_pred             HHHHhhhheeeecCCCcC
Q 018487          327 LFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       327 ~~~~~i~~~l~~~~~e~~  344 (355)
                      .++.++.+||..+|.+++
T Consensus       240 ~~~~li~~~l~~~p~~Rp  257 (268)
T cd06624         240 EAKNFILRCFEPDPDKRA  257 (268)
T ss_pred             HHHHHHHHHcCCCchhCC
Confidence            456788888888877764

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=4.3e-37  Score=280.82  Aligned_cols=236  Identities=16%  Similarity=0.151  Sum_probs=173.4

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhH--------HHHHHHHHHHHHhcCCCcce
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH--------VDYMKAERDILTKVTHPFIV  178 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~--------~~~~~~E~~~l~~l~h~nIv  178 (355)
                      +..++|++.++||+|+||+||+|.+....  ...+.+++|+...........        ......+...+..+.|+||+
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~--~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~   86 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDH--CINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP   86 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCc--ccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence            45578999999999999999999976321  224567777643322110000        00112233445667899999


Q ss_pred             ecceeeecCC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcE
Q 018487          179 QLRYSFQTRS----KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV  254 (355)
Q Consensus       179 ~l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~  254 (355)
                      ++++.+....    ..+++||++.. ++.+.+......++..+..++.|++.||.|||+++|+||||||+|||++.++.+
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         87 KYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             cEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence            9988765433    45778888754 566666665567889999999999999999999999999999999999999999


Q ss_pred             EEEecCCccccCcCC--------CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh-----
Q 018487          255 MLTDFGLAKEIDESS--------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA-----  321 (355)
Q Consensus       255 kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~-----  321 (355)
                      +|+|||+++.+....        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......     
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~  245 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA  245 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence            999999998663221        1123469999999999999999999999999999999999999998662110     


Q ss_pred             ----------------hhhhHHHHHhhhheeeecCCCcCC
Q 018487          322 ----------------CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 ----------------~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                                      .+....+.+++..|+..++.+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~  285 (294)
T PHA02882        246 AKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPD  285 (294)
T ss_pred             hHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCC
Confidence                            011223556777777777766553

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.5e-37  Score=279.57  Aligned_cols=222  Identities=19%  Similarity=0.256  Sum_probs=175.9

Q ss_pred             eeccCCcEEEEEEEEcCCC-------------------CCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcc
Q 018487          117 VVGQGAFGKVFQVKKKGVD-------------------DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI  177 (355)
Q Consensus       117 ~lG~G~~g~V~~~~~~~~~-------------------~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI  177 (355)
                      .||+|+||.||++......                   +......|++|++....   ......+.+|+.+++.++||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence            6999999999998754211                   11223458888875432   2333557788999999999999


Q ss_pred             eecceeeecCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC----
Q 018487          178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG----  252 (355)
Q Consensus       178 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~----  252 (355)
                      +++++++......++||||+++++|..++.. .+.+++..+..++.|+++||+|||++||+||||||+|||++..+    
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence            9999999999999999999999999888865 45689999999999999999999999999999999999997644    


Q ss_pred             ---cEEEEecCCccccCcCCCCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHH-cCCCCCCCchhhhh-----
Q 018487          253 ---HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEML-TGQVNIKSMQVIAC-----  322 (355)
Q Consensus       253 ---~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell-tg~~pf~~~~~~~~-----  322 (355)
                         .+|++|||++......   ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||........     
T Consensus       159 ~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~  235 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYE  235 (274)
T ss_pred             ccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHH
Confidence               3899999987654221   22357888999998875 56899999999999999984 79999976532210     


Q ss_pred             -------hhhHHHHHhhhheeeecCCCcC
Q 018487          323 -------NTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       323 -------~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                             .....+..+|.+||+.+|.+++
T Consensus       236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp  264 (274)
T cd05076         236 KKHRLPEPSCKELATLISQCLTYEPTQRP  264 (274)
T ss_pred             hccCCCCCCChHHHHHHHHHcccChhhCc
Confidence                   0112467888999998888875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.9e-37  Score=277.98  Aligned_cols=198  Identities=23%  Similarity=0.337  Sum_probs=161.8

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEEEe
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  195 (355)
                      ++||+|+||.||+|.....   .....+++|.+....  .......+.+|+.+++.++|+||+++++.+.....+|+|||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~---~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e   75 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRG---MSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLE   75 (269)
T ss_pred             CcCCccCCceEEEEEEecC---CCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEE
Confidence            3699999999999975422   345678888876432  23334567789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC-
Q 018487          196 FINGGHLFFHLYRQG-----IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (355)
Q Consensus       196 ~~~~gsL~~~l~~~~-----~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-  269 (355)
                      |+++|+|.+++....     ...+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~  155 (269)
T cd05042          76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY  155 (269)
T ss_pred             eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchh
Confidence            999999999987643     24677888999999999999999999999999999999999999999999986542221 


Q ss_pred             --CCCcccccCccccchhhcc-------CCCCCcccHHHHHHHHHHHHc-CCCCCCCch
Q 018487          270 --RSNSMCGTTEYMAPEILLS-------KGHNKDADWWSVGILLYEMLT-GQVNIKSMQ  318 (355)
Q Consensus       270 --~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~  318 (355)
                        ......++..|+|||++..       ..++.++|||||||++|||++ |..||....
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~  214 (269)
T cd05042         156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS  214 (269)
T ss_pred             eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence              1123345678999999753       356789999999999999999 788987653

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-37  Score=273.90  Aligned_cols=221  Identities=22%  Similarity=0.363  Sum_probs=183.0

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEEEe
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  195 (355)
                      ++||+|+||.||+|.+.     . ++.|++|++......  ...+.+.+|++++++++|+||+++++++......++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~-----~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   72 (251)
T cd05041           1 EKIGKGNFGDVYKGVLK-----G-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVME   72 (251)
T ss_pred             CccccCCCceEEEEEEe-----C-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEE
Confidence            46999999999999865     3 677999988765432  344668889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCCC---
Q 018487          196 FINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---  271 (355)
Q Consensus       196 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~---  271 (355)
                      |+++++|.+++... ..+++..+..++.|++.||.|||+++++||||||+|||++.++.++|+|||++.........   
T Consensus        73 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  152 (251)
T cd05041          73 LVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD  152 (251)
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence            99999999998654 46889999999999999999999999999999999999999999999999998765422111   


Q ss_pred             CcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhhHHHHHhhhhee
Q 018487          272 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTMLLFYLIIFHCL  336 (355)
Q Consensus       272 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~~~~~~~i~~~l  336 (355)
                      ....++..|+|||++.+..++.++||||||+++|+|+| |..||........              .....+.+++.+|+
T Consensus       153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  232 (251)
T cd05041         153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCW  232 (251)
T ss_pred             ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHh
Confidence            11233567999999988889999999999999999999 8899876532211              11235677888999


Q ss_pred             eecCCCcC
Q 018487          337 FVNSLELL  344 (355)
Q Consensus       337 ~~~~~e~~  344 (355)
                      ..+|.+++
T Consensus       233 ~~~p~~Rp  240 (251)
T cd05041         233 AYDPENRP  240 (251)
T ss_pred             ccChhhCc
Confidence            88888765

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=5.7e-37  Score=276.22  Aligned_cols=233  Identities=22%  Similarity=0.347  Sum_probs=188.0

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +...+|.+.++||+|+||.||+|.+....  .....|++|......  .....+.+.+|+.+++.++|+||+++++++..
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   78 (270)
T cd05056           3 IQREDITLGRCIGEGQFGDVYQGVYMSPE--NEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE   78 (270)
T ss_pred             echhhceeeeeeCCccceeEEEEEEecCC--CCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC
Confidence            34567999999999999999999876321  234568999886543  23445678889999999999999999998875


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                       ...|+||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++...
T Consensus        79 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          79 -NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             -CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeec
Confidence             45789999999999999997654 5899999999999999999999999999999999999999999999999998765


Q ss_pred             CcCCCC--CcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhhHHH
Q 018487          266 DESSRS--NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTMLLF  328 (355)
Q Consensus       266 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~~~~  328 (355)
                      ......  ....++..|+|||.+.+..++.++||||||+++|+|++ |..||........              .....+
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (270)
T cd05056         158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL  237 (270)
T ss_pred             ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHH
Confidence            433211  12234567999999988889999999999999999996 9999977542211              112356


Q ss_pred             HHhhhheeeecCCCcC
Q 018487          329 YLIIFHCLFVNSLELL  344 (355)
Q Consensus       329 ~~~i~~~l~~~~~e~~  344 (355)
                      ..+|.+|+..+|.+++
T Consensus       238 ~~li~~~l~~~P~~Rp  253 (270)
T cd05056         238 YSLMTKCWAYDPSKRP  253 (270)
T ss_pred             HHHHHHHcCCChhhCc
Confidence            7777888888877765

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.6e-37  Score=280.05  Aligned_cols=233  Identities=24%  Similarity=0.335  Sum_probs=191.1

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec--C
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--R  187 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~  187 (355)
                      ++|++.+.||+|+||.||+|.+.... ...++.+|+|++......  ...+.+.+|+.+++.+.|+||+++++++..  .
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLG-DNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCC-CCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence            57888999999999999999876332 245778999998765432  345678899999999999999999998877  5


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          188 SKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                      ...++||||+++++|.+++.... .+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++....
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            68999999999999999997755 58999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCC----CcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh---------------------
Q 018487          267 ESSRS----NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA---------------------  321 (355)
Q Consensus       267 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~---------------------  321 (355)
                      .....    ....++..|+|||.+.+..++.++||||||+++|||+||+.||.......                     
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK  240 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence            32211    12234567999999988889999999999999999999999987532111                     


Q ss_pred             --------hhhhHHHHHhhhheeeecCCCcCC
Q 018487          322 --------CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 --------~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                              ......+..++.+|+..+|.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt  272 (284)
T cd05038         241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPS  272 (284)
T ss_pred             cCCcCCCCccCCHHHHHHHHHHhccChhhCCC
Confidence                    001235667888999988888653

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-37  Score=286.68  Aligned_cols=200  Identities=26%  Similarity=0.460  Sum_probs=167.6

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC-
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-  187 (355)
                      .++|++.++||+|+||.||+|.++     .+++.||+|++....  .......+.+|+.++++++|+||+++++++... 
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   76 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHK-----PTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPS   76 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEc-----CCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeeccc
Confidence            468999999999999999999976     457789999986422  223445577899999999999999999876543 


Q ss_pred             ----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       188 ----~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                          ...|+||||+.+ +|...+. ...+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus        77 ~~~~~~~~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          77 FESFNDVYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             ccccceEEEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECccccee
Confidence                358999999975 7766664 4568999999999999999999999999999999999999999999999999987


Q ss_pred             ccCcCCC----CCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          264 EIDESSR----SNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       264 ~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      .......    .....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~  213 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK  213 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            6533221    123468899999998764 56889999999999999999999999754

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.1e-37  Score=282.94  Aligned_cols=233  Identities=21%  Similarity=0.344  Sum_probs=185.8

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ..++|+..+.||+|+||.||+|.+..... .....||+|.+....  .......+.+|+.+++.++|+||+++++.+...
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~   81 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGE-TVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP   81 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCC-cceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence            44689999999999999999998763321 122457888876543  233334577899999999999999999988754


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          188 SKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                       ..++++||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus        82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence             4679999999999999987654 58999999999999999999999999999999999999999999999999998664


Q ss_pred             cCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh--------------hhhhHHH
Q 018487          267 ESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA--------------CNTMLLF  328 (355)
Q Consensus       267 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~--------------~~~~~~~  328 (355)
                      ....   .....++..|+|||++.+..++.++||||||+++|||++ |+.||.......              ......+
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDV  240 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHH
Confidence            3222   122335678999999998899999999999999999997 999997642211              0112345


Q ss_pred             HHhhhheeeecCCCcC
Q 018487          329 YLIIFHCLFVNSLELL  344 (355)
Q Consensus       329 ~~~i~~~l~~~~~e~~  344 (355)
                      ..++.+|+..+|.+++
T Consensus       241 ~~li~~c~~~~p~~Rp  256 (303)
T cd05110         241 YMVMVKCWMIDADSRP  256 (303)
T ss_pred             HHHHHHHcCCChhhCc
Confidence            6778888888877765

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=5.1e-37  Score=273.95  Aligned_cols=230  Identities=24%  Similarity=0.425  Sum_probs=189.2

Q ss_pred             eEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEE
Q 018487          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (355)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  191 (355)
                      +++.+.||.|+||.||+|.+..... .....||+|++.....  ....+.+..|+.+++.++|+||+++++.+...+..+
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   77 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSG-EKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM   77 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCC-CCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeE
Confidence            3567899999999999999874321 2357899999865432  224567888999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          192 LILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       192 lv~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      ++|||+++++|.+++.....  +++.++..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus        78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            99999999999999876554  8999999999999999999999999999999999999999999999999998765432


Q ss_pred             CCC--cccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhhHHHHHhh
Q 018487          270 RSN--SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTMLLFYLII  332 (355)
Q Consensus       270 ~~~--~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~~~~~~~i  332 (355)
                      ...  ...++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+....              .....+.+++
T Consensus       158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  237 (258)
T smart00219      158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLM  237 (258)
T ss_pred             ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHH
Confidence            211  1236789999999988889999999999999999998 8889875432210              1123557788


Q ss_pred             hheeeecCCCcC
Q 018487          333 FHCLFVNSLELL  344 (355)
Q Consensus       333 ~~~l~~~~~e~~  344 (355)
                      .+|+..+|.+++
T Consensus       238 ~~~l~~~p~~Rp  249 (258)
T smart00219      238 LQCWAEDPEDRP  249 (258)
T ss_pred             HHHCcCChhhCc
Confidence            888888887765

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=9.1e-37  Score=271.97  Aligned_cols=229  Identities=29%  Similarity=0.517  Sum_probs=195.2

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      +|++.+.||.|+||.||+|.+.     .++..|++|++..... .....+.+.+|+++++.++|+|++++.+.+......
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~   74 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRK-----SDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKL   74 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEc-----CCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEE
Confidence            5899999999999999999976     3567899999876543 234456678899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          191 YLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                      ++|+||+++++|.+++...    ..+++.++..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~  154 (258)
T cd08215          75 CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS  154 (258)
T ss_pred             EEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecc
Confidence            9999999999999988764    669999999999999999999999999999999999999999999999999998764


Q ss_pred             cCC-CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh--------------hhhHHHHHh
Q 018487          267 ESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC--------------NTMLLFYLI  331 (355)
Q Consensus       267 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~--------------~~~~~~~~~  331 (355)
                      ... ......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||...+....              .....+..+
T Consensus       155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (258)
T cd08215         155 STVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNL  234 (258)
T ss_pred             cCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence            433 23345788999999999888899999999999999999999999977642221              122456778


Q ss_pred             hhheeeecCCCcCC
Q 018487          332 IFHCLFVNSLELLS  345 (355)
Q Consensus       332 i~~~l~~~~~e~~~  345 (355)
                      +.+||..+|.+++.
T Consensus       235 i~~~l~~~p~~Rp~  248 (258)
T cd08215         235 VSSLLQKDPEERPS  248 (258)
T ss_pred             HHHHcCCChhhCcC
Confidence            88898888887654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=5.3e-37  Score=279.15  Aligned_cols=233  Identities=47%  Similarity=0.792  Sum_probs=191.1

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeeccccc-chhHHHHHHHHHHHHHhc-CCCcceecceeeecCC
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-KKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS  188 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  188 (355)
                      +|++.+.||+|+||.||+|...+..  ..++.||+|++++.... .....+.+.+|+.++.++ +|+||+++++.+..+.
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~--~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~   78 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGH--DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT   78 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccc--cCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC
Confidence            4889999999999999999865432  35678999998754322 223345677899999999 5999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      .+|+||||+++++|.+++.....+++..+..++.|+++||.|||+.|++||||+|+||+++.++.++|+|||++..+...
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  158 (288)
T cd05583          79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE  158 (288)
T ss_pred             EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence            99999999999999999988788999999999999999999999999999999999999999999999999998765433


Q ss_pred             CC--CCcccccCccccchhhccCC--CCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-----------------hhhHH
Q 018487          269 SR--SNSMCGTTEYMAPEILLSKG--HNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-----------------NTMLL  327 (355)
Q Consensus       269 ~~--~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-----------------~~~~~  327 (355)
                      ..  .....|+..|+|||.+.+..  .+.++||||||+++|+|++|..||........                 .....
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd05583         159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAE  238 (288)
T ss_pred             cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHH
Confidence            21  22346889999999987654  78899999999999999999999964211100                 01234


Q ss_pred             HHHhhhheeeecCCCcCC
Q 018487          328 FYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       328 ~~~~i~~~l~~~~~e~~~  345 (355)
                      +.+++.+||+.+|.+++.
T Consensus       239 l~~li~~~l~~~p~~R~t  256 (288)
T cd05583         239 ARDFIQKLLEKDPKKRLG  256 (288)
T ss_pred             HHHHHHHHhcCCHhhccC
Confidence            577888999988887753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=8.3e-37  Score=277.66  Aligned_cols=225  Identities=26%  Similarity=0.441  Sum_probs=189.7

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      .|...+.||+|++|.||++..+     ..++.+++|++....   ....+.+.+|+.+++.++|+||+++++++...+..
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~-----~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~   91 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDK-----STGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDEL   91 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEEC-----CCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeE
Confidence            4666789999999999999866     456789999875432   23345577899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC-
Q 018487          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-  269 (355)
                      ++++||+++++|.+++.. ..+++.++..++.|++.||+|||++|++||||+|+||+++.++.++|+|||.+....... 
T Consensus        92 ~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~  170 (285)
T cd06648          92 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP  170 (285)
T ss_pred             EEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence            999999999999988877 678999999999999999999999999999999999999999999999999887553322 


Q ss_pred             CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh----------------hhHHHHHhhh
Q 018487          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN----------------TMLLFYLIIF  333 (355)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~----------------~~~~~~~~i~  333 (355)
                      ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...+.....                ....+.+++.
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLD  250 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHH
Confidence            223356889999999999888999999999999999999999999765432110                1235678899


Q ss_pred             heeeecCCCcC
Q 018487          334 HCLFVNSLELL  344 (355)
Q Consensus       334 ~~l~~~~~e~~  344 (355)
                      +||..+|.+++
T Consensus       251 ~~l~~~p~~Rp  261 (285)
T cd06648         251 RMLVRDPAQRA  261 (285)
T ss_pred             HHcccChhhCc
Confidence            99999988875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-37  Score=278.73  Aligned_cols=200  Identities=28%  Similarity=0.467  Sum_probs=171.1

Q ss_pred             eEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEE
Q 018487          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (355)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  191 (355)
                      |++.++||.|++|.||+|.++     .+++.|++|++..... .......+.+|+.+++.++|+||+++++++..++..|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~-----~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~   74 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDK-----LTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLY   74 (283)
T ss_pred             CchheEecCCCCeEEEEEEEc-----CCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEE
Confidence            678899999999999999976     4578899999876532 2233345778999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          192 LILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       192 lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      ++|||++ ++|..++....  .+++..+..++.|+++||.|||+++++||||+|+||+++.++.++|+|||++.......
T Consensus        75 iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~  153 (283)
T cd07835          75 LVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV  153 (283)
T ss_pred             EEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence            9999995 58988887765  68999999999999999999999999999999999999999999999999997654322


Q ss_pred             C-CCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          270 R-SNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       270 ~-~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      . .....++..|+|||++.+. .++.++||||||+++|+|++|+.||...+
T Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  204 (283)
T cd07835         154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDS  204 (283)
T ss_pred             cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            1 2233568899999988764 57889999999999999999999997654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4.9e-37  Score=282.31  Aligned_cols=204  Identities=27%  Similarity=0.435  Sum_probs=170.5

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ..++|++.+.||+|+||.||+|.++     .+++.||+|+++...... .....+.+|+.++++++|+||+++++++...
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   78 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDT-----TSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGK   78 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEEC-----CCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecC
Confidence            4568999999999999999999976     467789999987543222 2223355799999999999999999998754


Q ss_pred             --CeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          188 --SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       188 --~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                        +.+++||||+++ +|.+++.. ...+++.++..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++..
T Consensus        79 ~~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~  157 (309)
T cd07845          79 HLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLART  157 (309)
T ss_pred             CCCeEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeee
Confidence              568999999975 77777765 35689999999999999999999999999999999999999999999999999987


Q ss_pred             cCcCC-CCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          265 IDESS-RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       265 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      ..... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~  213 (309)
T cd07845         158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS  213 (309)
T ss_pred             cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            64332 2223345788999999875 557899999999999999999999997653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.2e-36  Score=280.83  Aligned_cols=227  Identities=24%  Similarity=0.377  Sum_probs=187.7

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ..|...+.||+|+||.||+|.+.     .++..||+|.+.............+.+|+++++.++|+|++++++++..+..
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   99 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDV-----RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHT   99 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEc-----CCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCe
Confidence            35888899999999999999976     4567899999876544444555678889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      .|+||||+.| +|.+.+.. ...+++.++..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++..... 
T Consensus       100 ~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-  177 (317)
T cd06635         100 AWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-  177 (317)
T ss_pred             EEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence            9999999976 66666644 45689999999999999999999999999999999999999999999999999875433 


Q ss_pred             CCCCcccccCccccchhhc---cCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh---------------hhhHHHHH
Q 018487          269 SRSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC---------------NTMLLFYL  330 (355)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~---------------~~~~~~~~  330 (355)
                        .....|+..|+|||++.   ...++.++|||||||++|+|++|+.||...+....               .....+..
T Consensus       178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  255 (317)
T cd06635         178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRN  255 (317)
T ss_pred             --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHH
Confidence              23446889999999974   35688899999999999999999999976532210               11224577


Q ss_pred             hhhheeeecCCCcCC
Q 018487          331 IIFHCLFVNSLELLS  345 (355)
Q Consensus       331 ~i~~~l~~~~~e~~~  345 (355)
                      ++.+|++.+|.+++.
T Consensus       256 li~~~l~~~p~~Rpt  270 (317)
T cd06635         256 FVDSCLQKIPQDRPT  270 (317)
T ss_pred             HHHHHccCCcccCcC
Confidence            888899888887653

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.8e-37  Score=274.93  Aligned_cols=220  Identities=25%  Similarity=0.415  Sum_probs=182.5

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++.+.||+|+||.||++..       .++.||+|.++...     ..+.+.+|+.+++.++|+||+++++++..+ .
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-------~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~   72 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-------TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-G   72 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-------CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-C
Confidence            5799999999999999998863       35669999986532     234577899999999999999999998764 4


Q ss_pred             EEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          190 LYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      .++||||+++++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus        73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~  152 (254)
T cd05083          73 LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM  152 (254)
T ss_pred             cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccc
Confidence            799999999999999987653  478999999999999999999999999999999999999999999999999876433


Q ss_pred             CCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhhHHHHHhh
Q 018487          268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTMLLFYLII  332 (355)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~~~~~~~i  332 (355)
                      ..  .....+..|+|||.+.+..++.++||||||+++|+|++ |+.||...+....              .....+..++
T Consensus       153 ~~--~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  230 (254)
T cd05083         153 GV--DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLM  230 (254)
T ss_pred             cC--CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHH
Confidence            21  22234568999999988889999999999999999998 9999977643210              1123567788


Q ss_pred             hheeeecCCCcC
Q 018487          333 FHCLFVNSLELL  344 (355)
Q Consensus       333 ~~~l~~~~~e~~  344 (355)
                      .+|+.++|.+++
T Consensus       231 ~~~l~~~p~~Rp  242 (254)
T cd05083         231 TSCWETEPKKRP  242 (254)
T ss_pred             HHHcCCChhhCc
Confidence            899988887765

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-37  Score=278.18  Aligned_cols=200  Identities=29%  Similarity=0.528  Sum_probs=172.0

Q ss_pred             eEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC--Ce
Q 018487          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--SK  189 (355)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~  189 (355)
                      |++.++||.|+||.||+|.+.     ..++.+++|.+.... ......+.+.+|+.+++.++|+|++++++++...  +.
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~-----~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNK-----KTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS   74 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEEC-----CCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCc
Confidence            678999999999999999976     456789999998754 2333445677899999999999999999999987  89


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      .++||||+++ +|..++... ..+++.+++.++.|++.||+|||+.|++|+||+|+||++++++.++|+|||++......
T Consensus        75 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          75 IYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             EEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            9999999975 787777665 57899999999999999999999999999999999999999999999999999876544


Q ss_pred             C--CCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          269 S--RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       269 ~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      .  ......++..|+|||.+.+ ..++.++||||||+++|+|+||+.||...+
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~  206 (287)
T cd07840         154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST  206 (287)
T ss_pred             CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            3  1233456888999998765 457899999999999999999999997654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=5e-37  Score=276.38  Aligned_cols=231  Identities=31%  Similarity=0.498  Sum_probs=190.1

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccc-------cchhHHHHHHHHHHHHHh-cCCCcceecce
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-------IKKNHVDYMKAERDILTK-VTHPFIVQLRY  182 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~  182 (355)
                      +|++.+.||+|+||.||+|.++.    ..++.+|+|.+.....       ........+.+|+.++.+ ++|+||+++++
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~----~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~   76 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKN----NGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYK   76 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcC----CCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEe
Confidence            47888999999999999999763    2467899998764321       123344556678887765 79999999999


Q ss_pred             eeecCCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEecCCCcEEEE
Q 018487          183 SFQTRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLT  257 (355)
Q Consensus       183 ~~~~~~~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDlkp~NILl~~~~~~kl~  257 (355)
                      .+..++..+++|||+++++|.+++..    ...+++..++.++.|++.||.|||. .+++|+||+|+|||++.++.++|+
T Consensus        77 ~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~  156 (269)
T cd08528          77 TFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTIT  156 (269)
T ss_pred             eEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEe
Confidence            99999999999999999999887743    3458999999999999999999996 789999999999999999999999


Q ss_pred             ecCCccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh---------------
Q 018487          258 DFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC---------------  322 (355)
Q Consensus       258 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~---------------  322 (355)
                      |||.+.............|+..|+|||++.+..++.++||||||+++|+|++|+.||...+....               
T Consensus       157 dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd08528         157 DFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG  236 (269)
T ss_pred             cccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcc
Confidence            99999876544344456789999999999988899999999999999999999999977543210               


Q ss_pred             hhhHHHHHhhhheeeecCCCcCC
Q 018487          323 NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       323 ~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      .....+..+|.+|++.+|.+++.
T Consensus       237 ~~~~~l~~li~~cl~~~p~~Rp~  259 (269)
T cd08528         237 MYSEDVTDVITSCLTPDAEARPD  259 (269)
T ss_pred             cCCHHHHHHHHHHCCCCCccCCC
Confidence            11235677888999888888653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.2e-37  Score=277.48  Aligned_cols=228  Identities=26%  Similarity=0.417  Sum_probs=184.0

Q ss_pred             eeeccCCcEEEEEEEEcCCCC-CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEEE
Q 018487          116 RVVGQGAFGKVFQVKKKGVDD-GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLIL  194 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  194 (355)
                      +.||+|+||.||+|+++.... ...++.+++|.+....  .......+.+|+.+++.++||||+++++++...+..++||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence            368999999999998764331 2334679999876542  1233456778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC-----cEEEEecCCc
Q 018487          195 DFINGGHLFFHLYRQ-------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----HVMLTDFGLA  262 (355)
Q Consensus       195 e~~~~gsL~~~l~~~-------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~-----~~kl~Dfg~a  262 (355)
                      ||+++++|.+++...       ..+++.++..++.|++.||.|||+.+++|+||||+||+++.++     .++|+|||++
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            999999999998643       2378899999999999999999999999999999999999877     8999999998


Q ss_pred             cccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hh
Q 018487          263 KEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NT  324 (355)
Q Consensus       263 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~  324 (355)
                      ........   .....++..|+|||++.+..++.++|||||||++|+|+| |+.||...+....              ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENC  238 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccc
Confidence            76532211   122345678999999998899999999999999999998 9999976432221              11


Q ss_pred             hHHHHHhhhheeeecCCCcCC
Q 018487          325 MLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       325 ~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ...+.++|.+||..+|.+++.
T Consensus       239 ~~~~~~li~~~l~~~p~~Rp~  259 (269)
T cd05044         239 PDKIYQLMTNCWAQDPSERPT  259 (269)
T ss_pred             hHHHHHHHHHHcCCCcccCCC
Confidence            134678899999998888764

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=8.2e-37  Score=272.77  Aligned_cols=228  Identities=29%  Similarity=0.502  Sum_probs=189.3

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      +|++.+.||+|+||.||+|..+     ..+..+|+|.+...... ....+.+.+|+.+++.++|+||+++++.+......
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~   74 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAK-----SDSEHCVIKEIDLTKMP-VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRL   74 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEc-----CCCceEEEEEeeHhhcc-chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeE
Confidence            5899999999999999999976     45677999998765322 23345677899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC-cEEEEecCCccccCc
Q 018487          191 YLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEIDE  267 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~-~~kl~Dfg~a~~~~~  267 (355)
                      |+|+||+++++|.+++....  .+++..+..++.|++.||.|||+++++|+||||+||+++.++ .+||+|||.+.....
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (257)
T cd08225          75 FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND  154 (257)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence            99999999999999887654  479999999999999999999999999999999999998886 469999999887644


Q ss_pred             CCC-CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh--------------hhHHHHHhh
Q 018487          268 SSR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN--------------TMLLFYLII  332 (355)
Q Consensus       268 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~--------------~~~~~~~~i  332 (355)
                      ... .....|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+.....              ....+..+|
T Consensus       155 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  234 (257)
T cd08225         155 SMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLI  234 (257)
T ss_pred             CcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHH
Confidence            332 22345889999999998888999999999999999999999999865432111              122466777


Q ss_pred             hheeeecCCCcC
Q 018487          333 FHCLFVNSLELL  344 (355)
Q Consensus       333 ~~~l~~~~~e~~  344 (355)
                      .+|+..+|.+++
T Consensus       235 ~~~l~~~p~~Rp  246 (257)
T cd08225         235 SQLFKVSPRDRP  246 (257)
T ss_pred             HHHhccChhhCc
Confidence            888887777755

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=6.8e-37  Score=274.30  Aligned_cols=226  Identities=22%  Similarity=0.316  Sum_probs=178.3

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee-cCCeEEEEE
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ-TRSKLYLIL  194 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~lv~  194 (355)
                      +.||+|+||.||+|.+....  .....+|+|.+....  .....+.+.+|+.+++.++||||+++++.+. .++..++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~--~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSD--GQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCC--CceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence            46899999999999875321  345679999875422  2334566788999999999999999999765 456789999


Q ss_pred             eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC----
Q 018487          195 DFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS----  269 (355)
Q Consensus       195 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~----  269 (355)
                      ||+.+++|.+++... ..+.+..+..++.|++.||.|||+.+++||||||+|||++.++.+||+|||+++......    
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            999999999998764 346778888999999999999999999999999999999999999999999997653221    


Q ss_pred             -CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcC-CCCCCCchhhh--------------hhhhHHHHHhhh
Q 018487          270 -RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG-QVNIKSMQVIA--------------CNTMLLFYLIIF  333 (355)
Q Consensus       270 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg-~~pf~~~~~~~--------------~~~~~~~~~~i~  333 (355)
                       ......++..|+|||.+.+..++.++|||||||++|||++| ..||...+...              ......+.+++.
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  236 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVML  236 (262)
T ss_pred             cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHH
Confidence             11223456789999999888899999999999999999995 55665533211              011235678888


Q ss_pred             heeeecCCCcCC
Q 018487          334 HCLFVNSLELLS  345 (355)
Q Consensus       334 ~~l~~~~~e~~~  345 (355)
                      .||..+|.+++.
T Consensus       237 ~cl~~~p~~Rp~  248 (262)
T cd05058         237 SCWHPKPEMRPT  248 (262)
T ss_pred             HHcCCChhhCCC
Confidence            999888887653

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6.4e-37  Score=281.08  Aligned_cols=203  Identities=28%  Similarity=0.418  Sum_probs=167.8

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC-
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-  187 (355)
                      .++|++.++||+|+||.||+|..+     .+++.||+|.+..... .......+.+|+.++++++||||+++++++... 
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   84 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHK-----KTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKA   84 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEEC-----CCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence            357999999999999999999976     4678899998865432 222223456799999999999999999987654 


Q ss_pred             -------CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEec
Q 018487          188 -------SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (355)
Q Consensus       188 -------~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Df  259 (355)
                             ...++||||+.+ +|...+... ..+++.+++.++.|++.||.|||++|++|+||||+||+++.++.+||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          85 TPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             ccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcC
Confidence                   346999999975 677776654 36899999999999999999999999999999999999999999999999


Q ss_pred             CCccccCcCCC-----CCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          260 GLAKEIDESSR-----SNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       260 g~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      |++........     .....++..|+|||++.+. .++.++||||||+++|+|++|+.||...+
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~  228 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT  228 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            99986543221     1234578889999998764 47889999999999999999999997653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=5.7e-37  Score=276.17  Aligned_cols=220  Identities=30%  Similarity=0.473  Sum_probs=179.4

Q ss_pred             CCeEEEeee--ccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceeeec
Q 018487          110 GDFEIFRVV--GQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQT  186 (355)
Q Consensus       110 ~~y~~~~~l--G~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~  186 (355)
                      ++|++.+.+  |+|+||.||++..+     .+++.+++|++........        |+.....+ +|+||+++++.|..
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~-----~~~~~~~~k~~~~~~~~~~--------e~~~~~~~~~h~~iv~~~~~~~~   80 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHK-----PTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNPNFIKLYYSVTT   80 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEc-----CCCcEEEEEEEehhhcchh--------hHHHHHHhhcCCCEEEEEEEEec
Confidence            356666666  99999999999976     4577899999865432111        22222222 69999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC-cEEEEecCCcccc
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEI  265 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~-~~kl~Dfg~a~~~  265 (355)
                      .+.+|+||||+++++|.+++.....+++.++..++.|+++||.|||+.|++||||||+||+++.++ .++|+|||++...
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~  160 (267)
T PHA03390         81 LKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII  160 (267)
T ss_pred             CCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence            999999999999999999998888899999999999999999999999999999999999999988 9999999998765


Q ss_pred             CcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-----------------hhhHHH
Q 018487          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-----------------NTMLLF  328 (355)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-----------------~~~~~~  328 (355)
                      ...   ....++..|+|||++.+..++.++||||||+++|+|++|+.||........                 .....+
T Consensus       161 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T PHA03390        161 GTP---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNA  237 (267)
T ss_pred             CCC---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHH
Confidence            432   234688999999999988999999999999999999999999975422110                 122345


Q ss_pred             HHhhhheeeecCCCcCC
Q 018487          329 YLIIFHCLFVNSLELLS  345 (355)
Q Consensus       329 ~~~i~~~l~~~~~e~~~  345 (355)
                      .++|.+||+.+|.+++.
T Consensus       238 ~~li~~~l~~~p~~R~~  254 (267)
T PHA03390        238 NDFVQSMLKYNINYRLT  254 (267)
T ss_pred             HHHHHHHhccChhhCCc
Confidence            67778888888777653

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-39  Score=289.92  Aligned_cols=230  Identities=28%  Similarity=0.452  Sum_probs=188.7

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccc----hhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK----KNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      .++|-++.+||+|||+.||+|.+.     ...+.||+|+-.....+.    ..+.+...+|.+|.+.|+||.||++|++|
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl-----~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf  536 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDL-----TEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF  536 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhccc-----chhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence            457999999999999999999855     678899999976544333    34455677899999999999999999999


Q ss_pred             e-cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCcEEecC---CCcEEEEe
Q 018487          185 Q-TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDS---DGHVMLTD  258 (355)
Q Consensus       185 ~-~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~--iiHrDlkp~NILl~~---~~~~kl~D  258 (355)
                      . +.+.+|-|+|||+|.+|+.+|+.+..+++.+++.|+.||+.||.||.+..  |||-||||.|||+..   .|.+||.|
T Consensus       537 slDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITD  616 (775)
T KOG1151|consen  537 SLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITD  616 (775)
T ss_pred             eeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeee
Confidence            7 45678999999999999999999999999999999999999999999875  999999999999953   47899999


Q ss_pred             cCCccccCcCCCC--------CcccccCccccchhhccC----CCCCcccHHHHHHHHHHHHcCCCCCCCchh----hhh
Q 018487          259 FGLAKEIDESSRS--------NSMCGTTEYMAPEILLSK----GHNKDADWWSVGILLYEMLTGQVNIKSMQV----IAC  322 (355)
Q Consensus       259 fg~a~~~~~~~~~--------~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~~l~elltg~~pf~~~~~----~~~  322 (355)
                      ||+++.++.....        ....||.+|++||.+.-.    ..+.++||||+||++|.++.|+.||...+.    +..
T Consensus       617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe  696 (775)
T KOG1151|consen  617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE  696 (775)
T ss_pred             cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence            9999988655432        345799999999987532    357899999999999999999999988632    112


Q ss_pred             hhhH---------------HHHHhhhheeeecCCCc
Q 018487          323 NTML---------------LFYLIIFHCLFVNSLEL  343 (355)
Q Consensus       323 ~~~~---------------~~~~~i~~~l~~~~~e~  343 (355)
                      |..+               --.++|++||+.-..++
T Consensus       697 NTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR  732 (775)
T KOG1151|consen  697 NTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDR  732 (775)
T ss_pred             hchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhh
Confidence            2211               12778999996544443

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.1e-37  Score=285.19  Aligned_cols=202  Identities=21%  Similarity=0.429  Sum_probs=172.2

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC-
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-  187 (355)
                      ..+|.+.+.||+|+||+||+|.+.     .+++.||||.+..... .......+.+|+.+++.++|+||+++++++... 
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~   77 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNS-----ETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPH   77 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEec-----CCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheeccc
Confidence            357999999999999999999966     5678899999875432 222344567899999999999999999987644 


Q ss_pred             ----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       188 ----~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                          ..+|+||||+. ++|.+++...+.+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++.
T Consensus        78 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          78 REAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             ccccCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence                35899999996 5788888888889999999999999999999999999999999999999999999999999998


Q ss_pred             ccCcC-CCCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          264 EIDES-SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       264 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      ..... .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  212 (337)
T cd07858         157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK  212 (337)
T ss_pred             ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence            76433 22334567889999999875 46889999999999999999999999764

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.5e-37  Score=280.26  Aligned_cols=228  Identities=26%  Similarity=0.425  Sum_probs=184.1

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecceeeecCC
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRS  188 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~  188 (355)
                      ++|+..+.||+|+||.||++.++     .+++.||+|.+......  .....+.+|+.++.++. |+||+++++++..++
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~-----~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~   76 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHK-----PSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG   76 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEEC-----CCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC
Confidence            35677789999999999999976     45788999998754322  34456788999999996 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHH---H--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          189 KLYLILDFINGGHLFFHL---Y--RQGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l---~--~~~~l~~~~~~~i~~ql~~~L~~LH~~-~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                      ..+++|||+.. ++..+.   .  ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus        77 ~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  155 (288)
T cd06616          77 DCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS  155 (288)
T ss_pred             cEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchh
Confidence            99999999865 443332   2  235689999999999999999999974 9999999999999999999999999999


Q ss_pred             cccCcCCCCCcccccCccccchhhccC---CCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-----------------
Q 018487          263 KEIDESSRSNSMCGTTEYMAPEILLSK---GHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-----------------  322 (355)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-----------------  322 (355)
                      ..+..........|+..|+|||++.+.   .++.++|||||||++|+|++|+.||........                 
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd06616         156 GQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSE  235 (288)
T ss_pred             HHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcC
Confidence            876544434445688999999999866   689999999999999999999999976431100                 


Q ss_pred             --hhhHHHHHhhhheeeecCCCcCC
Q 018487          323 --NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       323 --~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                        .....+.++|.+||+++|.+++.
T Consensus       236 ~~~~~~~l~~li~~~l~~~p~~Rpt  260 (288)
T cd06616         236 EREFSPSFVNFINLCLIKDESKRPK  260 (288)
T ss_pred             CCccCHHHHHHHHHHccCChhhCcC
Confidence              01224567888999888877653

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-39  Score=274.41  Aligned_cols=231  Identities=26%  Similarity=0.427  Sum_probs=185.9

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHH-HHHhcCCCcceecceeee
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD-ILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~  185 (355)
                      +..++.+-+..||.|+||+|++..++     .+++.+|||.++....  ....+++..|.+ +++.-+.||||+++|+..
T Consensus        61 F~~~~Lqdlg~iG~G~fG~V~KM~hk-----~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F  133 (361)
T KOG1006|consen   61 FTSDNLQDLGEIGNGAFGTVNKMLHK-----PSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALF  133 (361)
T ss_pred             cccchHHHHHHhcCCcchhhhhhhcC-----ccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh
Confidence            44456667788999999999999987     6789999999987654  233345556665 456667999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHH-----HhcCCCCHHHHHHHHHHHHHHHHHHH-HCCCeeccCCCCcEEecCCCcEEEEec
Q 018487          186 TRSKLYLILDFINGGHLFFHL-----YRQGIFREDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDF  259 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l-----~~~~~l~~~~~~~i~~ql~~~L~~LH-~~~iiHrDlkp~NILl~~~~~~kl~Df  259 (355)
                      .++..||.||+|+- +|..+-     ..+..++|..+-.|....+.||.||- ..+|||||+||+|||++..|.+|||||
T Consensus       134 ~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDF  212 (361)
T KOG1006|consen  134 SEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDF  212 (361)
T ss_pred             cCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecc
Confidence            99999999999975 553322     13456899999999999999999997 458999999999999999999999999


Q ss_pred             CCccccCcCCCCCcccccCccccchhhcc--CCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh--------------
Q 018487          260 GLAKEIDESSRSNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN--------------  323 (355)
Q Consensus       260 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~--------------  323 (355)
                      |++..+..+.....-.|...|||||.+..  ..|+.++||||||++|||+.||+.|+..-+.+-.+              
T Consensus       213 GIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~  292 (361)
T KOG1006|consen  213 GICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLF  292 (361)
T ss_pred             cchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecC
Confidence            99998877766667789999999999873  46899999999999999999999999875432211              


Q ss_pred             ------hhHHHHHhhhheeeecCCCcCC
Q 018487          324 ------TMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       324 ------~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                            -...+..+|--|+.++...++.
T Consensus       293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpk  320 (361)
T KOG1006|consen  293 DKECVHYSFSMVRFINTCLIKDRSDRPK  320 (361)
T ss_pred             cccccccCHHHHHHHHHHhhcccccCcc
Confidence                  1114467777888888776554

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-37  Score=271.16  Aligned_cols=223  Identities=52%  Similarity=0.877  Sum_probs=191.3

Q ss_pred             eccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEEEecc
Q 018487          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI  197 (355)
Q Consensus       118 lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  197 (355)
                      ||+|+||.||++.+.     ..++.+++|++...........+.+..|+.+++.++|+||+++++.+..+...|+||||+
T Consensus         1 lg~G~~~~v~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKK-----DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEEC-----CCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecC
Confidence            699999999999976     356789999998776555556677889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC-CCCCcccc
Q 018487          198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCG  276 (355)
Q Consensus       198 ~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~-~~~~~~~g  276 (355)
                      ++++|.+++.....+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++...... .......+
T Consensus        76 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  155 (250)
T cd05123          76 PGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCG  155 (250)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcC
Confidence            99999999988888999999999999999999999999999999999999999999999999999876443 22344568


Q ss_pred             cCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-------------hhhHHHHHhhhheeeecCCCc
Q 018487          277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-------------NTMLLFYLIIFHCLFVNSLEL  343 (355)
Q Consensus       277 t~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-------------~~~~~~~~~i~~~l~~~~~e~  343 (355)
                      +..|++||.+.+..++.++|+||||+++|+|++|+.||...+....             .....+.+++.+||..+|.++
T Consensus       156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R  235 (250)
T cd05123         156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKR  235 (250)
T ss_pred             CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhC
Confidence            8899999999888889999999999999999999999977653221             112245677788888877776


Q ss_pred             CC
Q 018487          344 LS  345 (355)
Q Consensus       344 ~~  345 (355)
                      +.
T Consensus       236 ~~  237 (250)
T cd05123         236 LG  237 (250)
T ss_pred             CC
Confidence            54

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.6e-36  Score=304.87  Aligned_cols=149  Identities=44%  Similarity=0.779  Sum_probs=137.8

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|+++++||+|+||+||+|.+.     ..++.||||+++............+.+|+.+++.++|+||+++++.+...+.
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~   78 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKK-----NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANN   78 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEEC-----CCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCE
Confidence            58999999999999999999976     4678899999987655555666778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      +|+||||+.+++|..++...+.+.+..++.++.||+.||.|||.+||+||||||+||||+.++.+||+|||+++
T Consensus        79 ~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          79 VYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999999999888889999999999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-38  Score=252.50  Aligned_cols=205  Identities=25%  Similarity=0.448  Sum_probs=176.2

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      +|...++||+|.||+||+|+.+     ++.+.||+|.++.+.. ++..-....+|+.+|+.++|.|||++++....+..+
T Consensus         3 ~ydkmekigegtygtvfkarn~-----~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkl   76 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNR-----ETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKL   76 (292)
T ss_pred             chHHHHhhcCCcceeeEecccC-----CccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCcee
Confidence            4666789999999999999976     6788999999988764 334444566899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          191 YLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      -+|+|||.. +|..+... ++.+..+.++.++.|+++||.|+|+++++||||||.|+||+.+|.+||+|||+++.++...
T Consensus        77 tlvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   77 TLVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             EEeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence            999999965 67666653 5779999999999999999999999999999999999999999999999999999886544


Q ss_pred             C-CCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh
Q 018487          270 R-SNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC  322 (355)
Q Consensus       270 ~-~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~  322 (355)
                      . ....+-|..|++|.++.|. -|++..|+||.||++.|+.. |+..|.+.++...
T Consensus       156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq  211 (292)
T KOG0662|consen  156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ  211 (292)
T ss_pred             EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH
Confidence            2 3345679999999999875 58999999999999999987 7777887765443

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-36  Score=274.13  Aligned_cols=200  Identities=29%  Similarity=0.435  Sum_probs=169.7

Q ss_pred             eEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc---CCCcceecceeeecCC
Q 018487          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV---THPFIVQLRYSFQTRS  188 (355)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~  188 (355)
                      |++.+.||+|+||.||+|+++     .+++.||+|+++.... .......+.+|+.+++++   +|+||+++++.+...+
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~-----~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   74 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDL-----NTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR   74 (287)
T ss_pred             CeEEEEecccCceEEEEEEEC-----CCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence            678999999999999999976     3577899999975443 222234455677777665   5999999999998777


Q ss_pred             e-----EEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCC
Q 018487          189 K-----LYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (355)
Q Consensus       189 ~-----~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~  261 (355)
                      .     ++++|||+.+ +|.+++....  .+++.+++.++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||+
T Consensus        75 ~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~  153 (287)
T cd07838          75 TDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGL  153 (287)
T ss_pred             CCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCc
Confidence            6     9999999975 7888877643  489999999999999999999999999999999999999999999999999


Q ss_pred             ccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          262 AKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      +.............++..|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~  210 (287)
T cd07838         154 ARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS  210 (287)
T ss_pred             ceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence            987755444444567889999999998889999999999999999999999997653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.5e-36  Score=278.26  Aligned_cols=226  Identities=24%  Similarity=0.364  Sum_probs=187.0

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      .|...++||+|+||+||+|.+.     .+++.|++|++...........+.+.+|+.+++.++|+|++++++++......
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~-----~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   96 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNS-----HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTA   96 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEEC-----CCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence            3777788999999999999865     46778999998765444445556688899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          191 YLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      |+||||+.+ +|.+.+.. ...+++.++..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++.....  
T Consensus        97 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--  173 (313)
T cd06633          97 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--  173 (313)
T ss_pred             EEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence            999999975 66666654 45689999999999999999999999999999999999999999999999998864322  


Q ss_pred             CCCcccccCccccchhhc---cCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh---------------hhhhHHHHHh
Q 018487          270 RSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA---------------CNTMLLFYLI  331 (355)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~---------------~~~~~~~~~~  331 (355)
                       .....|+..|+|||++.   +..++.++|||||||++|+|++|..||...+...               ......+..+
T Consensus       174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  252 (313)
T cd06633         174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGF  252 (313)
T ss_pred             -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHH
Confidence             23457889999999984   3567889999999999999999999997654211               0112246778


Q ss_pred             hhheeeecCCCcCC
Q 018487          332 IFHCLFVNSLELLS  345 (355)
Q Consensus       332 i~~~l~~~~~e~~~  345 (355)
                      +.+||+.+|.+++.
T Consensus       253 i~~~l~~~P~~Rp~  266 (313)
T cd06633         253 VDYCLQKIPQERPA  266 (313)
T ss_pred             HHHHccCChhhCcC
Confidence            88999998887653

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.2e-36  Score=279.49  Aligned_cols=203  Identities=27%  Similarity=0.458  Sum_probs=166.7

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC-
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-  187 (355)
                      .++|++.++||+|+||.||+|.++     .+++.+++|++....... .....+.+|+.+++.++|+||+++++.+... 
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQI-----KTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERP   80 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEEC-----CCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheeccc
Confidence            468999999999999999999976     456789999986543222 2223456799999999999999999887543 


Q ss_pred             -------CeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEec
Q 018487          188 -------SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (355)
Q Consensus       188 -------~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Df  259 (355)
                             ..+++||||+.+ +|...+.. ...+++.++..++.|+++||.|||++||+|+||||+|||++.++.++|+||
T Consensus        81 ~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          81 DKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             ccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcC
Confidence                   357999999976 56666654 356999999999999999999999999999999999999999999999999


Q ss_pred             CCccccCcCCC------------CCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          260 GLAKEIDESSR------------SNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       260 g~a~~~~~~~~------------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      |++........            .....+++.|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~  231 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS  231 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence            99976533221            1223568889999988654 57899999999999999999999997543

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.6e-36  Score=273.56  Aligned_cols=230  Identities=21%  Similarity=0.329  Sum_probs=183.7

Q ss_pred             eEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC---
Q 018487          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS---  188 (355)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---  188 (355)
                      |++.+.||+|+||.||+|.++..  ...++.||+|++..... .....+.+.+|+++++.++||||+++++++....   
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~--~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSE--DGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG   77 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeecc--CCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence            66788999999999999987632  23567899999876543 3334566788999999999999999999876432   


Q ss_pred             ---eEEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEec
Q 018487          189 ---KLYLILDFINGGHLFFHLYRQ------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (355)
Q Consensus       189 ---~~~lv~e~~~~gsL~~~l~~~------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Df  259 (355)
                         ..++++||+.+++|..++...      ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+||
T Consensus        78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcc
Confidence               347899999999998776432      24788999999999999999999999999999999999999999999999


Q ss_pred             CCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh-------------
Q 018487          260 GLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC-------------  322 (355)
Q Consensus       260 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~-------------  322 (355)
                      |+++.......   .....++..|++||.+.+..++.++||||||+++|+|++ |+.||...+....             
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  237 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQP  237 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence            99986543221   122345678999999998889999999999999999999 8999876543221             


Q ss_pred             -hhhHHHHHhhhheeeecCCCcC
Q 018487          323 -NTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       323 -~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                       .....+.+++.+|++.+|.+++
T Consensus       238 ~~~~~~~~~l~~~~l~~~p~~Rp  260 (273)
T cd05074         238 PDCLEDVYELMCQCWSPEPKCRP  260 (273)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCc
Confidence             1113557788888888887764

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.5e-36  Score=277.86  Aligned_cols=202  Identities=28%  Similarity=0.477  Sum_probs=168.5

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|++.+.||+|+||.||+|.++     ..++.||+|+++.... .......+.+|+.+++.++||||+++++++....
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~   79 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDK-----DTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQ   79 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEEC-----CCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcc
Confidence            468999999999999999999976     4567899999876432 2223345678999999999999999999887654


Q ss_pred             ----------eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEE
Q 018487          189 ----------KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT  257 (355)
Q Consensus       189 ----------~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~  257 (355)
                                .+|+||||+++ ++...+... ..+++.++..++.|++.||.|||+.||+||||||+||+++.++.+||+
T Consensus        80 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          80 DALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             hhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeC
Confidence                      79999999987 565666543 468999999999999999999999999999999999999999999999


Q ss_pred             ecCCccccCcCCC--CCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          258 DFGLAKEIDESSR--SNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       258 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      |||++........  .....++..|+|||++.+. .++.++|||||||++|+|++|+.||...
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~  221 (302)
T cd07864         159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN  221 (302)
T ss_pred             cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999987643321  2223567889999988653 5788999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-36  Score=282.20  Aligned_cols=201  Identities=27%  Similarity=0.447  Sum_probs=175.5

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC--
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS--  188 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--  188 (355)
                      +|++.+.||.|+||.||+|...     ..++.|++|.+.... ......+.+.+|+.+++.++|+||+++++++....  
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDK-----RTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPE   74 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeC-----CCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcc
Confidence            5899999999999999999976     457789999987543 22344566888999999999999999999988765  


Q ss_pred             ---eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          189 ---KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       189 ---~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                         .+|++|||+++ +|..++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...
T Consensus        75 ~~~~~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          75 DFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             cccceEEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence               79999999985 78888887778999999999999999999999999999999999999999999999999999876


Q ss_pred             CcCC----CCCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          266 DESS----RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       266 ~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      ....    ......++..|+|||++.+. .++.++||||||+++|+|++|+.||....
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~  211 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD  211 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence            5443    23345678899999999887 78999999999999999999999997654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-36  Score=273.83  Aligned_cols=198  Identities=31%  Similarity=0.545  Sum_probs=170.0

Q ss_pred             eEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecceeeecCCeE
Q 018487          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~  190 (355)
                      |++.+.||+|+||.||+|...     ..++.|++|.+......  .......+|+..+++++ |+||+++++.+..++..
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~-----~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   73 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNK-----ETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDEL   73 (283)
T ss_pred             CeeheeeccCCceEEEEEEEC-----CCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcE
Confidence            678899999999999999976     45678999988654321  11223446889999999 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          191 YLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      |+||||+ +++|.+++....  .+++.++..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        74 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~  152 (283)
T cd07830          74 YFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR  152 (283)
T ss_pred             EEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence            9999999 778988887765  6899999999999999999999999999999999999999999999999999876554


Q ss_pred             CCCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          269 SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      .......++..|+|||++.+ ..++.++|+||||+++|+|++|+.||...
T Consensus       153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~  202 (283)
T cd07830         153 PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS  202 (283)
T ss_pred             CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence            44445568899999998854 45789999999999999999999999654

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.4e-36  Score=280.87  Aligned_cols=201  Identities=28%  Similarity=0.479  Sum_probs=170.3

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ..++|++++.||+|+||.||+|...     .+++.||||++.... ......+.+.+|+.+++.++|+||+++++++...
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   86 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDR-----RTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPD   86 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEEC-----CCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCC
Confidence            3578999999999999999999866     457789999986532 2233345677899999999999999999988754


Q ss_pred             C------eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCC
Q 018487          188 S------KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (355)
Q Consensus       188 ~------~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~  261 (355)
                      .      .+++||||+ +++|..++. ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+
T Consensus        87 ~~~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          87 LSLDRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             ccccccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence            3      468999999 668877765 45789999999999999999999999999999999999999999999999999


Q ss_pred             ccccCcCCCCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          262 AKEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      +......  .....+++.|+|||++.+ ..++.++||||||+++|+|++|+.||...+
T Consensus       165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  220 (343)
T cd07880         165 ARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD  220 (343)
T ss_pred             ccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9865432  234467889999999876 457889999999999999999999998653

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.1e-36  Score=278.09  Aligned_cols=227  Identities=25%  Similarity=0.373  Sum_probs=187.0

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ..|...+.||+|+||.||+|.++     ..++.+++|.+...........+.+.+|+.+++.++|+|++++++++.....
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   89 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDV-----RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT   89 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEc-----CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCe
Confidence            35778889999999999999976     4567899998875433334445567789999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      .|+||||+.+ +|.+.+.. ...+++.++..++.|++.||.|||+++++||||+|+|||++.++.++|+|||++......
T Consensus        90 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          90 AWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             eEEEEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            9999999975 67666643 456899999999999999999999999999999999999999999999999998765432


Q ss_pred             CCCCcccccCccccchhhc---cCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh---------------hhhHHHHH
Q 018487          269 SRSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC---------------NTMLLFYL  330 (355)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~---------------~~~~~~~~  330 (355)
                         ....++..|+|||++.   ...++.++|||||||++|+|++|..||...+....               .....+..
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (308)
T cd06634         169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN  245 (308)
T ss_pred             ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHH
Confidence               3446889999999985   34578899999999999999999999976532110               12224577


Q ss_pred             hhhheeeecCCCcCC
Q 018487          331 IIFHCLFVNSLELLS  345 (355)
Q Consensus       331 ~i~~~l~~~~~e~~~  345 (355)
                      +|.+||..+|.+++.
T Consensus       246 li~~cl~~~P~~Rp~  260 (308)
T cd06634         246 FVDSCLQKIPQDRPT  260 (308)
T ss_pred             HHHHHhhCCcccCCC
Confidence            889999999988754

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3.7e-36  Score=274.79  Aligned_cols=232  Identities=30%  Similarity=0.443  Sum_probs=186.5

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecceee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSF  184 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~  184 (355)
                      .+..++|++.+.||+|+||.||+|.++     .+++.||||.++....  ......+..|+.++.+.. |+||+++++++
T Consensus        11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~   83 (296)
T cd06618          11 PADLNDLENLGEIGSGTCGQVYKMRFK-----KTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYF   83 (296)
T ss_pred             cCCcchheeeeEeeccCCeEEEEEEEC-----CCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheee
Confidence            345578999999999999999999976     4577899999875432  223344555776666665 99999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                      ......|+||||+.+ .|...+.. ...+++..+..++.|++.||.|||+ .||+||||+|+||+++.++.+||+|||++
T Consensus        84 ~~~~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~  162 (296)
T cd06618          84 ITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGIS  162 (296)
T ss_pred             ecCCeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccc
Confidence            999999999999865 66665554 4568999999999999999999997 69999999999999999999999999999


Q ss_pred             cccCcCCCCCcccccCccccchhhccCC----CCCcccHHHHHHHHHHHHcCCCCCCCchhhh-----------------
Q 018487          263 KEIDESSRSNSMCGTTEYMAPEILLSKG----HNKDADWWSVGILLYEMLTGQVNIKSMQVIA-----------------  321 (355)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~~l~elltg~~pf~~~~~~~-----------------  321 (355)
                      ..+..........++..|+|||++.+..    ++.++||||||+++|+|++|+.||...+...                 
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  242 (296)
T cd06618         163 GRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPN  242 (296)
T ss_pred             hhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCC
Confidence            8765444444456788999999987554    7889999999999999999999997632110                 


Q ss_pred             hhhhHHHHHhhhheeeecCCCcCC
Q 018487          322 CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 ~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ......+.+++.+||..+|.+++.
T Consensus       243 ~~~~~~l~~li~~~l~~~p~~Rp~  266 (296)
T cd06618         243 EGFSPDFCSFVDLCLTKDHRKRPK  266 (296)
T ss_pred             CCCCHHHHHHHHHHccCChhhCCC
Confidence            001234678888999988888764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-36  Score=273.72  Aligned_cols=200  Identities=29%  Similarity=0.522  Sum_probs=172.1

Q ss_pred             eEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEE
Q 018487          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (355)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  191 (355)
                      |++.+.||+|++|.||+|...     .+++.+++|.+..... .......+.+|+.++++++|+||+++++.+..++..+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDK-----LTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLY   74 (283)
T ss_pred             CccceeeecCCCceEEEEEcC-----CCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEE
Confidence            667889999999999999965     4678899999876543 2234456778999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC-
Q 018487          192 LILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (355)
Q Consensus       192 lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-  269 (355)
                      +||||+++ +|..++.. ...+++.++..++.|++.||.|||+.+|+|+||||+||+++.++.++|+|||.+....... 
T Consensus        75 ~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~  153 (283)
T cd05118          75 LVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR  153 (283)
T ss_pred             EEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence            99999986 77777765 3578999999999999999999999999999999999999999999999999988765433 


Q ss_pred             CCCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          270 RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      ......++..|+|||.+.+. .++.++||||||+++|+|+||+.||...+
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~  203 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS  203 (283)
T ss_pred             cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            22234578899999998876 78999999999999999999999997654

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.3e-36  Score=280.27  Aligned_cols=196  Identities=22%  Similarity=0.339  Sum_probs=163.8

Q ss_pred             eeeccC--CcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEE
Q 018487          116 RVVGQG--AFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLI  193 (355)
Q Consensus       116 ~~lG~G--~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  193 (355)
                      ..||+|  +||+||+|++.     ..++.||+|++..... .....+.+.+|+.+++.++||||++++++|..++..|+|
T Consensus         4 ~~ig~g~~~~~~v~~a~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v   77 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHT-----PTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVI   77 (328)
T ss_pred             HHhCCcccCceeEEEEEEc-----CCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEE
Confidence            356666  99999999976     5678999999876543 234457788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCCC
Q 018487          194 LDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS  271 (355)
Q Consensus       194 ~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~  271 (355)
                      |||+.+++|.+++....  .+++..+..++.|++.||+|||++||+||||||+|||++.++.++++||+.+.........
T Consensus        78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~  157 (328)
T cd08226          78 SPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK  157 (328)
T ss_pred             EecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence            99999999999887643  4899999999999999999999999999999999999999999999999865433211110


Q ss_pred             --------CcccccCccccchhhccC--CCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          272 --------NSMCGTTEYMAPEILLSK--GHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       272 --------~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                              ....++..|+|||++.+.  .++.++|||||||++|+|++|+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  213 (328)
T cd08226         158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM  213 (328)
T ss_pred             ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence                    112345679999999764  4788999999999999999999999764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.5e-36  Score=269.78  Aligned_cols=197  Identities=20%  Similarity=0.325  Sum_probs=159.4

Q ss_pred             eeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEEEec
Q 018487          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDF  196 (355)
Q Consensus       117 ~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  196 (355)
                      +||+|+||.||++.....   .....+++|.+....  .....+.+.+|+.+++.++||||+++++.+......|+||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~---~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~   76 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTD---TGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEY   76 (268)
T ss_pred             cCCCCcCceEEEEEEEcC---CCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEec
Confidence            699999999999975422   234456777765433  223356788899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC---C
Q 018487          197 INGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES---S  269 (355)
Q Consensus       197 ~~~gsL~~~l~~~----~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~---~  269 (355)
                      +++|+|.+++...    ..+.+..+..++.||+.||.|||+.+++||||||+|||++.++.++|+|||++......   .
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~  156 (268)
T cd05086          77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE  156 (268)
T ss_pred             CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence            9999999998764    23566778899999999999999999999999999999999999999999988643211   1


Q ss_pred             CCCcccccCccccchhhcc-------CCCCCcccHHHHHHHHHHHHc-CCCCCCCch
Q 018487          270 RSNSMCGTTEYMAPEILLS-------KGHNKDADWWSVGILLYEMLT-GQVNIKSMQ  318 (355)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~  318 (355)
                      ......++..|+|||++..       ..++.++|||||||++|||++ |..||...+
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~  213 (268)
T cd05086         157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS  213 (268)
T ss_pred             cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Confidence            1234567889999999853       245778999999999999997 577886543

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=293.38  Aligned_cols=233  Identities=24%  Similarity=0.362  Sum_probs=196.5

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +..++.++.++||+|.||.|+++.|+...  .....||||.++.+....  ....|.+|+.+|.+|+|+|+++|||...+
T Consensus       107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~ps--gk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~  182 (1039)
T KOG0199|consen  107 IPEEQIKLYELLGEGSFGVVKRGTWTQPS--GKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD  182 (1039)
T ss_pred             ccHHHHHHHHHhcCcceeeEeeccccCCC--CcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc
Confidence            33345677889999999999999998622  334569999998765432  66789999999999999999999999887


Q ss_pred             CCeEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          187 RSKLYLILDFINGGHLFFHLYR--QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                       ....||||++++|+|.+.|.+  +..|.......++.||+.||.||..+++|||||..+|+|+-....|||+|||+.+.
T Consensus       183 -qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRa  261 (1039)
T KOG0199|consen  183 -QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRA  261 (1039)
T ss_pred             -chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceec
Confidence             678999999999999999987  34588889999999999999999999999999999999999999999999999998


Q ss_pred             cCcCCCCCccc----ccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhh
Q 018487          265 IDESSRSNSMC----GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTM  325 (355)
Q Consensus       265 ~~~~~~~~~~~----gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~  325 (355)
                      +........+.    -...|+|||.+....++.++|||+|||++|||+| |+.||.+..-...              ...
T Consensus       262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~cs  341 (1039)
T KOG0199|consen  262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCS  341 (1039)
T ss_pred             cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCCh
Confidence            87766554332    2467999999999999999999999999999999 8999998633221              122


Q ss_pred             HHHHHhhhheeeecCCCcC
Q 018487          326 LLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~  344 (355)
                      +.+|.+...||.-+|.++.
T Consensus       342 edIY~imk~cWah~paDRp  360 (1039)
T KOG0199|consen  342 EDIYQIMKNCWAHNPADRP  360 (1039)
T ss_pred             HHHHHHHHHhccCCccccc
Confidence            3678899999988888765

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.4e-36  Score=280.85  Aligned_cols=203  Identities=27%  Similarity=0.355  Sum_probs=169.9

Q ss_pred             CCeEE-EeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchh-----------HHHHHHHHHHHHHhcCCCcc
Q 018487          110 GDFEI-FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN-----------HVDYMKAERDILTKVTHPFI  177 (355)
Q Consensus       110 ~~y~~-~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~nI  177 (355)
                      ++|.. .+.||.|+||+||+|.++     ..++.||||+++........           ....+.+|+.+++.++|+||
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   82 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDT-----LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENI   82 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEEC-----CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcce
Confidence            46654 577999999999999966     45778999998754322210           11246689999999999999


Q ss_pred             eecceeeecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEE
Q 018487          178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT  257 (355)
Q Consensus       178 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~  257 (355)
                      +++++++..++..|+||||+. ++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+
T Consensus        83 v~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         83 MGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             eeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEEC
Confidence            999999999999999999997 4898999888889999999999999999999999999999999999999999999999


Q ss_pred             ecCCccccCcC---------------CCCCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          258 DFGLAKEIDES---------------SRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       258 Dfg~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      |||++......               .......++..|+|||++.+. .++.++|||||||++|+|++|+.||...+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~  238 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN  238 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99998765411               111223467889999998764 46889999999999999999999997654

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.4e-36  Score=279.21  Aligned_cols=201  Identities=27%  Similarity=0.460  Sum_probs=168.9

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ..++|++.+.||+|+||.||+|.+.     .+++.||+|++..... .....+.+.+|+.++++++|+||+++++++...
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDT-----KTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEc-----CCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            4578999999999999999999865     4577899999875322 222345577899999999999999999887543


Q ss_pred             ------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCC
Q 018487          188 ------SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (355)
Q Consensus       188 ------~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~  261 (355)
                            ...|++++++ +++|..++.. ..+++..++.++.|+++||.|||++||+||||||+||+++.++.+||+|||+
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~  166 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL  166 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccc
Confidence                  3478899887 6788777654 4689999999999999999999999999999999999999999999999999


Q ss_pred             ccccCcCCCCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          262 AKEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      +......  .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+
T Consensus       167 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  222 (345)
T cd07877         167 ARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD  222 (345)
T ss_pred             ccccccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            8865432  234567899999999876 568889999999999999999999997643

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=5.5e-36  Score=278.17  Aligned_cols=203  Identities=27%  Similarity=0.414  Sum_probs=168.5

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceeeec---
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQT---  186 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~---  186 (355)
                      +|++.+.||+|+||.||+|.+....   .+..||+|.+..... .....+.+.+|+.+++++ +|+||+++++.+..   
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~---~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~   76 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETS---EEETVAIKKITNVFS-KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPG   76 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCC---cCceEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccc
Confidence            5899999999999999999977321   266799999865322 223345567899999999 49999999886542   


Q ss_pred             -CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          187 -RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       187 -~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                       ...+|++|||+. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+
T Consensus        77 ~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          77 NFNELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             cCCcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence             245889999986 589888888888999999999999999999999999999999999999999999999999999865


Q ss_pred             CcCCC-----CCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          266 DESSR-----SNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       266 ~~~~~-----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      .....     .....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...+
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~  214 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD  214 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence            43221     233578999999998765 568999999999999999999999997653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5e-36  Score=271.35  Aligned_cols=200  Identities=31%  Similarity=0.494  Sum_probs=173.2

Q ss_pred             eEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEE
Q 018487          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (355)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  191 (355)
                      |++.+.||+|++|.||+|...     .+++.|++|++.... ......+.+..|+.+++.++|+||+++++++...+..+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~-----~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   74 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDK-----KTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLY   74 (282)
T ss_pred             CeeehcccccCcceEEEeeec-----CCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceE
Confidence            677889999999999999976     457889999987654 22333455678999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC-
Q 018487          192 LILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (355)
Q Consensus       192 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-  269 (355)
                      +||||+++ +|.+++... ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++....... 
T Consensus        75 ~v~e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          75 LVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             EEecCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            99999985 899988876 579999999999999999999999999999999999999999999999999998764432 


Q ss_pred             CCCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          270 RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      ......++..|+|||++.+. .++.++||||||+++|||++|+.||....
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  203 (282)
T cd07829         154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS  203 (282)
T ss_pred             ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence            22334567889999998766 78999999999999999999999997754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.1e-36  Score=279.02  Aligned_cols=199  Identities=28%  Similarity=0.491  Sum_probs=167.1

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC-
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-  187 (355)
                      .++|.+.+.||+|+||.||+|.++     .+++.||+|++..... .......+.+|+.+++.++|+||+++++++... 
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~   87 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDK-----RTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAV   87 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeC-----CCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccc
Confidence            468999999999999999999976     4577899999875432 223344577899999999999999999988654 


Q ss_pred             -----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       188 -----~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                           ..+|+||||+.. +|..+.  ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++
T Consensus        88 ~~~~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          88 SGDEFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             cCCCCceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence                 357999999965 665554  346899999999999999999999999999999999999999999999999998


Q ss_pred             cccCcCCCCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          263 KEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      +.....  .....++..|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus       165 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~  219 (342)
T cd07879         165 RHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD  219 (342)
T ss_pred             cCCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            765332  234567889999999876 458899999999999999999999998754

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=6e-36  Score=279.07  Aligned_cols=199  Identities=27%  Similarity=0.442  Sum_probs=165.6

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC-
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-  187 (355)
                      .++|++.+.||.|+||.||+|..+     .+++.|++|++.....   ...+.+.+|+.+++.++||||+++++.+... 
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~-----~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~   75 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDS-----DCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSG   75 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEEC-----CCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccc
Confidence            368999999999999999999976     5678899999865432   3445677899999999999999998776543 


Q ss_pred             -------------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEec-CCCc
Q 018487          188 -------------SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGH  253 (355)
Q Consensus       188 -------------~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~-~~~~  253 (355)
                                   ...|+||||+++ +|..++. .+.+++..++.++.||+.||.|||+.||+||||||+||+++ .++.
T Consensus        76 ~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~  153 (342)
T cd07854          76 SDLTEDVGSLTELNSVYIVQEYMET-DLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLV  153 (342)
T ss_pred             cccccccccccccceEEEEeecccc-cHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCce
Confidence                         368999999975 7877765 35689999999999999999999999999999999999997 4567


Q ss_pred             EEEEecCCccccCcCCC----CCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          254 VMLTDFGLAKEIDESSR----SNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       254 ~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      +||+|||++..+.....    .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus       154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~  222 (342)
T cd07854         154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA  222 (342)
T ss_pred             EEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            89999999976532211    122357889999998764 56788999999999999999999999754

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=5.5e-36  Score=273.27  Aligned_cols=224  Identities=26%  Similarity=0.435  Sum_probs=186.2

Q ss_pred             EEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEE
Q 018487          113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYL  192 (355)
Q Consensus       113 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  192 (355)
                      ....+||+|+||.||++..+     .+++.||+|.+...   .....+.+.+|+.+++.++|+||+++++.+..++..|+
T Consensus        23 ~~~~~lg~g~~g~v~~~~~~-----~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   94 (292)
T cd06657          23 DNFIKIGEGSTGIVCIATVK-----SSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV   94 (292)
T ss_pred             hhHHHcCCCCCeEEEEEEEc-----CCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEE
Confidence            33467999999999999876     46778999987543   22344568889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC-CC
Q 018487          193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-RS  271 (355)
Q Consensus       193 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-~~  271 (355)
                      ||||+++++|.+++. ...+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++....... ..
T Consensus        95 v~e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~  173 (292)
T cd06657          95 VMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR  173 (292)
T ss_pred             EEecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccc
Confidence            999999999988764 4568999999999999999999999999999999999999999999999999887653322 22


Q ss_pred             CcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh----------------hhhHHHHHhhhhe
Q 018487          272 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC----------------NTMLLFYLIIFHC  335 (355)
Q Consensus       272 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~----------------~~~~~~~~~i~~~  335 (355)
                      ....|+..|+|||++.+..++.++|+||||+++|+|++|..||...+....                .....+..++.+|
T Consensus       174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  253 (292)
T cd06657         174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRL  253 (292)
T ss_pred             cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHH
Confidence            345688999999999888889999999999999999999999976533210                0123456778899


Q ss_pred             eeecCCCcCC
Q 018487          336 LFVNSLELLS  345 (355)
Q Consensus       336 l~~~~~e~~~  345 (355)
                      |..+|.+++.
T Consensus       254 l~~~P~~R~~  263 (292)
T cd06657         254 LVRDPAQRAT  263 (292)
T ss_pred             HhCCcccCcC
Confidence            9988888754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.8e-36  Score=280.75  Aligned_cols=201  Identities=30%  Similarity=0.518  Sum_probs=168.2

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceeeecC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR  187 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~  187 (355)
                      .++|++.+.||+|+||.||+|.++     .+++.+|+|.+..... .......+.+|+.+++++ +|+||+++++++...
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~   79 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDR-----RTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE   79 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEc-----CCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccC
Confidence            357999999999999999999865     4567899998864322 222334566799999999 999999999988643


Q ss_pred             --CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          188 --SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       188 --~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                        ...|+||||+++ +|..++... .+.+..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...
T Consensus        80 ~~~~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          80 NDKDIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             CCceEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence              468999999975 888887665 7899999999999999999999999999999999999999999999999999865


Q ss_pred             CcCC------CCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          266 DESS------RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       266 ~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      ....      ......|+..|+|||++.+ ..++.++||||||+++|+|+||+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~  216 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT  216 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence            3322      1223568899999998765 45788999999999999999999999753

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.1e-35  Score=275.83  Aligned_cols=201  Identities=26%  Similarity=0.430  Sum_probs=169.7

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec-
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-  186 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-  186 (355)
                      ..++|++.+.||.|+||.||+|.++     .+++.||+|.+.+... .....+.+.+|+.+++.++||||++++++|.. 
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   81 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQ-----LTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISP   81 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEEC-----CCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC
Confidence            4568999999999999999999966     5677899998765432 22334567789999999999999999999865 


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                      ....|++|||+. ++|..++. ...+++..+..++.|++.||.|||++||+||||+|+|||++.++.++|+|||++....
T Consensus        82 ~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~  159 (328)
T cd07856          82 LEDIYFVTELLG-TDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD  159 (328)
T ss_pred             CCcEEEEeehhc-cCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence            567899999994 57877665 3467888999999999999999999999999999999999999999999999987653


Q ss_pred             cCCCCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          267 ESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      ..  .....++..|+|||++.+ ..++.++||||||+++|+|++|+.||...+
T Consensus       160 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~  210 (328)
T cd07856         160 PQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD  210 (328)
T ss_pred             CC--cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            32  233467889999998765 568999999999999999999999997653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-37  Score=253.22  Aligned_cols=202  Identities=28%  Similarity=0.454  Sum_probs=170.0

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceeeec
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQT  186 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~  186 (355)
                      ..+....+..||+|++|.|-+.++.     .++...|+|.++....  .+..+++.+|+++..+. .+|.+|.+++.+..
T Consensus        44 ~ad~L~~i~elGrGayG~vekmrh~-----~sg~imAvKri~~tvn--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r  116 (282)
T KOG0984|consen   44 PADDLVGIEELGRGAYGVVEKMRHI-----QSGTIMAVKRIRATVN--SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR  116 (282)
T ss_pred             chhhhhhhhhhcCCccchhhheeec-----cCCeEEEEeeehhhcC--hHHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence            3445666788999999999888877     6789999999876543  33445567788876554 69999999999999


Q ss_pred             CCeEEEEEeccCCCChHHH----HHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCcEEecCCCcEEEEecCC
Q 018487          187 RSKLYLILDFINGGHLFFH----LYRQGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMLTDFGL  261 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~----l~~~~~l~~~~~~~i~~ql~~~L~~LH~~-~iiHrDlkp~NILl~~~~~~kl~Dfg~  261 (355)
                      .+.+|+.||.|.. +|..+    +...+.++|..+-.|+..++.||.|||++ .+||||+||+||||+.+|++|+||||.
T Consensus       117 egdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGI  195 (282)
T KOG0984|consen  117 EGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGI  195 (282)
T ss_pred             cccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccc
Confidence            9999999999975 66433    33456799999999999999999999965 899999999999999999999999999


Q ss_pred             ccccCcCCCCCcccccCccccchhhcc----CCCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          262 AKEIDESSRSNSMCGTTEYMAPEILLS----KGHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      +..+.++.....-.|...|||||.+..    ..|+-++||||||+++.||.+++.|+..-
T Consensus       196 sG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  196 SGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             ceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            988876655554678889999999863    47899999999999999999999999863

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.1e-36  Score=278.72  Aligned_cols=201  Identities=29%  Similarity=0.487  Sum_probs=170.8

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ..++|++.+.||+|++|.||+|++.     .+++.||+|++..... .....+.+.+|+.+++.++|+||+++++++...
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~-----~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   86 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDT-----KTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPA   86 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEEC-----CCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcc
Confidence            3568999999999999999999976     4577899998865422 233345577899999999999999999888765


Q ss_pred             Ce------EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCC
Q 018487          188 SK------LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (355)
Q Consensus       188 ~~------~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~  261 (355)
                      ..      .|+|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+
T Consensus        87 ~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          87 SSLEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             ccccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccc
Confidence            54      89999999 5688887765 5689999999999999999999999999999999999999999999999999


Q ss_pred             ccccCcCCCCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          262 AKEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      +......  .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+
T Consensus       165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~  220 (343)
T cd07851         165 ARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD  220 (343)
T ss_pred             ccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9876433  334467889999999865 367889999999999999999999997543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=283.42  Aligned_cols=231  Identities=23%  Similarity=0.354  Sum_probs=195.4

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      |.....+....++||-|.||.||.+.|+     .-.-.||||.++.+.    ..+++|..|..+|+.++|||+|+|+++|
T Consensus       262 WEmeRtdItMkhKLGGGQYGeVYeGvWK-----kyslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVC  332 (1157)
T KOG4278|consen  262 WEMERTDITMKHKLGGGQYGEVYEGVWK-----KYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVC  332 (1157)
T ss_pred             hhccchheeeeeccCCCcccceeeeeee-----ccceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhh
Confidence            3344456777899999999999999998     345569999987653    4567788999999999999999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                      ..+..+|||+|||..|.|.+||.+..+  ++.-.+.+++.||..||+||..+++|||||..+|+|+.++..||++|||++
T Consensus       333 T~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLs  412 (1157)
T KOG4278|consen  333 THEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLS  412 (1157)
T ss_pred             ccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchh
Confidence            999999999999999999999987543  777778899999999999999999999999999999999999999999999


Q ss_pred             cccCcCCCCC--cccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhhhhh--------------
Q 018487          263 KEIDESSRSN--SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACNTM--------------  325 (355)
Q Consensus       263 ~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~~~~--------------  325 (355)
                      +.+..+....  ...-.+.|.|||.+..+.++.++|||+|||+|||+.| |.-||.+.+....-..              
T Consensus       413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCP  492 (1157)
T KOG4278|consen  413 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCP  492 (1157)
T ss_pred             hhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCC
Confidence            9886554322  1223578999999999999999999999999999998 8899999876543222              


Q ss_pred             HHHHHhhhheeeecCCCcC
Q 018487          326 LLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~  344 (355)
                      ...++.+.+||+=+|.+++
T Consensus       493 pkVYeLMraCW~WsPsDRP  511 (1157)
T KOG4278|consen  493 PKVYELMRACWNWSPSDRP  511 (1157)
T ss_pred             HHHHHHHHHHhcCCcccCc
Confidence            2557888888887777754

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.2e-35  Score=273.43  Aligned_cols=196  Identities=24%  Similarity=0.372  Sum_probs=161.7

Q ss_pred             EeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEEE
Q 018487          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLIL  194 (355)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  194 (355)
                      .+.+|.|  |.||.++.+     .+++.||||++..... .....+.+.+|+.+++.++|+||+++++++......+++|
T Consensus         7 ~~~~~~~--~~v~~~~~~-----~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   78 (314)
T cd08216           7 GKCFEDL--MIVHLAKHK-----PTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVS   78 (314)
T ss_pred             hHhhcCC--ceEEEEEec-----CCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEE
Confidence            3344444  445555544     3578899999986532 3445677899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCC--
Q 018487          195 DFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR--  270 (355)
Q Consensus       195 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~--  270 (355)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||.+........  
T Consensus        79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~  158 (314)
T cd08216          79 PLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ  158 (314)
T ss_pred             eccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence            999999999988764  4589999999999999999999999999999999999999999999999998875432111  


Q ss_pred             ------CCcccccCccccchhhcc--CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          271 ------SNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       271 ------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                            .....++..|+|||++.+  ..++.++|||||||++|||++|+.||...+
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~  214 (314)
T cd08216         159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP  214 (314)
T ss_pred             cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence                  123356778999999876  358899999999999999999999998653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-37  Score=284.84  Aligned_cols=201  Identities=31%  Similarity=0.508  Sum_probs=177.7

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHH-----HHHHHHHHHHhcC---CCcceecc
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD-----YMKAERDILTKVT---HPFIVQLR  181 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~-----~~~~E~~~l~~l~---h~nIv~l~  181 (355)
                      .+|..++.+|.|+||.|++|.++     +....|+||.+.+........++     .+..|++||..++   |+||++++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K-----~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlL  635 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHK-----ENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLL  635 (772)
T ss_pred             ccceeeeeccccccceEEEeeec-----ccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhh
Confidence            46999999999999999999988     45778999998876543332222     2456999999998   99999999


Q ss_pred             eeeecCCeEEEEEeccC-CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecC
Q 018487          182 YSFQTRSKLYLILDFIN-GGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG  260 (355)
Q Consensus       182 ~~~~~~~~~~lv~e~~~-~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg  260 (355)
                      ++|++++++|++||... |.+|++++..+..++|.++..|++|++.|+++||++||||||||-+|+.++.+|-+||+|||
T Consensus       636 dfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  636 DFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             heeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeecc
Confidence            99999999999999854 55899999999999999999999999999999999999999999999999999999999999


Q ss_pred             CccccCcCCCCCcccccCccccchhhccCCC-CCcccHHHHHHHHHHHHcCCCCCCC
Q 018487          261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQVNIKS  316 (355)
Q Consensus       261 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~elltg~~pf~~  316 (355)
                      .+..... .....++||..|.|||++.|..| ...-|||++|++||.++....||..
T Consensus       716 saa~~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  716 SAAYTKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             chhhhcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            9987544 34677899999999999999877 6678999999999999999999874

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.4e-35  Score=265.63  Aligned_cols=229  Identities=26%  Similarity=0.429  Sum_probs=181.7

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccc--cchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI--IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      +|.+.++||+|+||.||+|.+...     +..+++|+++....  ........+..|+.+++.++||||+++++++....
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKA-----VAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCC-----CCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC
Confidence            589999999999999999987632     33345555443221  12223344667899999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          189 KLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      ..++||||+++++|..++..    ...+++.++..++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||++..
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~  154 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRL  154 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceee
Confidence            99999999999999887753    346899999999999999999999999999999999999964 6799999999876


Q ss_pred             cCcCCC-CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh--------------hhhHHHH
Q 018487          265 IDESSR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC--------------NTMLLFY  329 (355)
Q Consensus       265 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~--------------~~~~~~~  329 (355)
                      ...... .....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+....              .....+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (260)
T cd08222         155 LMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLN  234 (260)
T ss_pred             cCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHH
Confidence            643322 2345678899999999888889999999999999999999999976543221              1112456


Q ss_pred             HhhhheeeecCCCcCC
Q 018487          330 LIIFHCLFVNSLELLS  345 (355)
Q Consensus       330 ~~i~~~l~~~~~e~~~  345 (355)
                      +.|.+|+..+|.+++.
T Consensus       235 ~li~~~l~~~p~~Rp~  250 (260)
T cd08222         235 SIMQSMLNKDPSLRPS  250 (260)
T ss_pred             HHHHHHhcCChhhCcC
Confidence            6778888888777653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=7e-36  Score=264.32  Aligned_cols=210  Identities=29%  Similarity=0.445  Sum_probs=175.7

Q ss_pred             CCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEEEeccCCC
Q 018487          121 GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG  200 (355)
Q Consensus       121 G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  200 (355)
                      |.+|.||+|+++     .+++.||+|.++....        ..+|...+....||||+++++++......|+||||++++
T Consensus         4 g~~~~v~~~~~~-----~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   70 (237)
T cd05576           4 GVIDKVLLVMDT-----RTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGG   70 (237)
T ss_pred             cccceEEEEEEc-----cCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCC
Confidence            899999999976     5678899999876431        223455555667999999999999999999999999999


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCCCCcccccCcc
Q 018487          201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY  280 (355)
Q Consensus       201 sL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y  280 (355)
                      +|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||.+..+....  ....++..|
T Consensus        71 ~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~y  148 (237)
T cd05576          71 KLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC--DGEAVENMY  148 (237)
T ss_pred             CHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc--ccCCcCccc
Confidence            999999888789999999999999999999999999999999999999999999999999887654322  234567789


Q ss_pred             ccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhh---------hhhhhHHHHHhhhheeeecCCCcCC
Q 018487          281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVI---------ACNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       281 ~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~---------~~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      +|||++.+..++.++||||+|+++|+|++|+.||......         .......+..+|.+||+.+|.+++.
T Consensus       149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~  222 (237)
T cd05576         149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLG  222 (237)
T ss_pred             cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcccccccCCcccCCHHHHHHHHHHccCCHHHhcC
Confidence            9999998888999999999999999999999887643211         1112345678999999999998764

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-37  Score=292.06  Aligned_cols=236  Identities=23%  Similarity=0.389  Sum_probs=196.7

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      ..+......+.+.||.|-||.|++++.+...  +....||||.++...  .+.....|..|..||.+++||||++|.|+.
T Consensus       624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pg--kre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVV  699 (996)
T KOG0196|consen  624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPG--KREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVV  699 (996)
T ss_pred             hhcChhheEEEEEEecccccceecccccCCC--CcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEE
Confidence            3466677889999999999999999987433  456779999998754  344556788899999999999999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      .....+.||+|||++|+|+.+|+.+ +.|...++..+++.|+.||.||-+.|+|||||..+|||++.+...|++|||+++
T Consensus       700 Tks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSR  779 (996)
T KOG0196|consen  700 TKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSR  779 (996)
T ss_pred             ecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEecccccee
Confidence            9999999999999999999999876 679999999999999999999999999999999999999999999999999999


Q ss_pred             ccCcCCC-CCccc-c--cCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCch--hhhhh------------h
Q 018487          264 EIDESSR-SNSMC-G--TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQ--VIACN------------T  324 (355)
Q Consensus       264 ~~~~~~~-~~~~~-g--t~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~--~~~~~------------~  324 (355)
                      .+.++.. ..+.. |  ...|.|||.+....++.++||||||++|||.++ |..|+.++.  .+...            .
T Consensus       780 vledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDC  859 (996)
T KOG0196|consen  780 VLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDC  859 (996)
T ss_pred             ecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCC
Confidence            8744432 22222 2  478999999999999999999999999999888 999998872  11111            1


Q ss_pred             hHHHHHhhhheeeecCCCcC
Q 018487          325 MLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       325 ~~~~~~~i~~~l~~~~~e~~  344 (355)
                      ..-++.+..+|||++.-+++
T Consensus       860 P~aL~qLMldCWqkdR~~RP  879 (996)
T KOG0196|consen  860 PAALYQLMLDCWQKDRNRRP  879 (996)
T ss_pred             cHHHHHHHHHHHHHHhhcCC
Confidence            12456777788887766544

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.5e-36  Score=299.94  Aligned_cols=197  Identities=31%  Similarity=0.534  Sum_probs=162.6

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee-----
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF-----  184 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-----  184 (355)
                      .+|+.++.||+||||.||+|+.+     -+++.||||.+....  .......+.+|+..|.+|+|||||+++..|     
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNK-----lDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~  551 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNK-----LDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTA  551 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeec-----ccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCC
Confidence            36888899999999999999987     678899999998765  344456688899999999999999976321     


Q ss_pred             -------------------------------------------------------e------------------c-----
Q 018487          185 -------------------------------------------------------Q------------------T-----  186 (355)
Q Consensus       185 -------------------------------------------------------~------------------~-----  186 (355)
                                                                             .                  +     
T Consensus       552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S  631 (1351)
T KOG1035|consen  552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS  631 (1351)
T ss_pred             ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence                                                                   0                  0     


Q ss_pred             ----------------------------C--------CeEEEEEeccCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHH
Q 018487          187 ----------------------------R--------SKLYLILDFINGGHLFFHLYRQGIF-REDQARFYTAEIVSAVS  229 (355)
Q Consensus       187 ----------------------------~--------~~~~lv~e~~~~gsL~~~l~~~~~l-~~~~~~~i~~ql~~~L~  229 (355)
                                                  +        ..+||-||||+..+|.+++.++... ....++.++++|++||.
T Consensus       632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLa  711 (1351)
T KOG1035|consen  632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLA  711 (1351)
T ss_pred             cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHH
Confidence                                        0        2378999999997777777666554 47889999999999999


Q ss_pred             HHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC-------------------cCCCCCcccccCccccchhhccCC
Q 018487          230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-------------------ESSRSNSMCGTTEYMAPEILLSKG  290 (355)
Q Consensus       230 ~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~  290 (355)
                      |+|++|||||||||.||++++++.|||+|||+|....                   .....+..+||.-|+|||++.+..
T Consensus       712 YIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  712 YIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             HHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence            9999999999999999999999999999999998621                   011234578999999999998754


Q ss_pred             ---CCCcccHHHHHHHHHHHHcCCCCCCC
Q 018487          291 ---HNKDADWWSVGILLYEMLTGQVNIKS  316 (355)
Q Consensus       291 ---~~~~~DiwSlG~~l~elltg~~pf~~  316 (355)
                         |+.|+|+|||||||+||+   .||..
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~---yPF~T  817 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEML---YPFGT  817 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHh---ccCCc
Confidence               999999999999999999   44554

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-37  Score=270.80  Aligned_cols=221  Identities=27%  Similarity=0.466  Sum_probs=183.3

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC--CC----ccee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT--HP----FIVQ  179 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~----nIv~  179 (355)
                      ++...+|++++.+|+|.||.|-.+.++     ..+..||||+++.-.    ...+..+-|+++|+++.  .|    -+|.
T Consensus        85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~-----~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~  155 (415)
T KOG0671|consen   85 DILTNRYEIVDLLGEGTFGKVVECWDR-----ETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQ  155 (415)
T ss_pred             cccccceehhhhhcCCcccceEEEeec-----CCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence            445679999999999999999999976     457889999997532    23344556999999994  23    3788


Q ss_pred             cceeeecCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC-------
Q 018487          180 LRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-------  250 (355)
Q Consensus       180 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~-------  250 (355)
                      +.++|...++.|||+|.+ |-++++++..++  +++..+++.+++|++++++|||+.+++|.||||+|||+..       
T Consensus       156 m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~  234 (415)
T KOG0671|consen  156 MRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTY  234 (415)
T ss_pred             eehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEe
Confidence            899999999999999998 558999998875  4899999999999999999999999999999999999942       


Q ss_pred             -------------CCcEEEEecCCccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          251 -------------DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       251 -------------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                                   +..|+|+|||.|+.-...  ....+.|..|+|||++.+-+|+.++||||+||||+||+||...|...
T Consensus       235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH  312 (415)
T KOG0671|consen  235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH  312 (415)
T ss_pred             ccCCccceeccCCCcceEEEecCCcceeccC--cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence                         235899999999875443  35678899999999999999999999999999999999999999987


Q ss_pred             hhhhhhhhHHHHHhhhheeeecCCCcC
Q 018487          318 QVIACNTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       318 ~~~~~~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                      +     +.+.+ ....++|+..|..|.
T Consensus       313 e-----n~EHL-aMMerIlGp~P~~mi  333 (415)
T KOG0671|consen  313 E-----NLEHL-AMMERILGPIPSRMI  333 (415)
T ss_pred             C-----cHHHH-HHHHHhhCCCcHHHh
Confidence            6     22222 555666666665544

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-36  Score=281.72  Aligned_cols=223  Identities=33%  Similarity=0.503  Sum_probs=184.6

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceeeecC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR  187 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~  187 (355)
                      .+.|++...+|.|+|+.|-.+.+.     .+.+..++|++.+....       ..+|+.++... +||||+++.+.+.++
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~-----~t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~~~~  388 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESS-----PTDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVYEDG  388 (612)
T ss_pred             chhhccccccCCCCccceeeeecc-----ccccchhheeccccccc-------cccccchhhhhcCCCcceeecceecCC
Confidence            567899999999999999999877     45677999999776322       23466555444 699999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEe-cCCCcEEEEecCCccccC
Q 018487          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM-DSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl-~~~~~~kl~Dfg~a~~~~  266 (355)
                      .+.|+|||.+.|+.+.+.+.....+. .++..|+.+|+.|+.|||++|||||||||+|||+ +..+.++|+|||.++...
T Consensus       389 ~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  389 KEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE  467 (612)
T ss_pred             ceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence            99999999999998888888776666 8888999999999999999999999999999999 688999999999998875


Q ss_pred             cCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhh-hh-----------hhhHHHHHhhhh
Q 018487          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVI-AC-----------NTMLLFYLIIFH  334 (355)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~-~~-----------~~~~~~~~~i~~  334 (355)
                      ..  ....+-|..|.|||++...+|+.++||||||++||+||+|+.||.....- ..           ....--++.+..
T Consensus       468 ~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKdLl~~  545 (612)
T KOG0603|consen  468 RS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFSECVSDEAKDLLQQ  545 (612)
T ss_pred             hh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccccccCHHHHHHHHH
Confidence            55  33446789999999999999999999999999999999999999875221 11           111123667778


Q ss_pred             eeeecCCCcCCC
Q 018487          335 CLFVNSLELLSH  346 (355)
Q Consensus       335 ~l~~~~~e~~~~  346 (355)
                      +|+.+|.+++..
T Consensus       546 LL~~dP~~Rl~~  557 (612)
T KOG0603|consen  546 LLQVDPALRLGA  557 (612)
T ss_pred             hccCChhhCcCh
Confidence            888888887653

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-35  Score=284.73  Aligned_cols=228  Identities=27%  Similarity=0.497  Sum_probs=192.5

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecceeee-
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQ-  185 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~-  185 (355)
                      ..+.|++.+.||.|.+|.||+++.+     ..++.+|+|+...+...    .+.+..|.++|+.+. |||++.++++|. 
T Consensus        17 p~d~~ei~evig~Gtygkv~k~k~~-----~~~~~aa~kI~~~~~d~----deEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen   17 PADIFEIIEVIGNGTYGKVYKGRHV-----KTGQLAAIKIMDPTEDE----EEEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             CCCccEEEEEEeeccceeEEEEeee-----ecCceeeeEeecCCccc----cHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            3467999999999999999999977     56788999998765432    244667888888874 999999999986 


Q ss_pred             ----cCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEec
Q 018487          186 ----TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (355)
Q Consensus       186 ----~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Df  259 (355)
                          .++.+|+|||||.||+.-++++.-  ..+.|..+.+|++.++.||.+||++.+||||||-.|||++.++.|||+||
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDF  167 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDF  167 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeee
Confidence                356899999999999998887653  56899999999999999999999999999999999999999999999999


Q ss_pred             CCccccCcC-CCCCcccccCccccchhhccC-----CCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-----------
Q 018487          260 GLAKEIDES-SRSNSMCGTTEYMAPEILLSK-----GHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-----------  322 (355)
Q Consensus       260 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-----------  322 (355)
                      |++..++.. .+..+.+||+.|||||++...     .|+.++|+||||++..||--|..|+-++...+.           
T Consensus       168 GvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPk  247 (953)
T KOG0587|consen  168 GVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK  247 (953)
T ss_pred             eeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcc
Confidence            999887543 345677899999999999743     467789999999999999999999998866552           


Q ss_pred             -----hhhHHHHHhhhheeeecCCCcC
Q 018487          323 -----NTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       323 -----~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                           ++-..|.++|+.||-++-..++
T Consensus       248 Lkrp~kWs~~FndFIs~cL~Kd~e~RP  274 (953)
T KOG0587|consen  248 LKRPKKWSKKFNDFISTCLVKDYEQRP  274 (953)
T ss_pred             ccchhhHHHHHHHHHHHHHhhccccCc
Confidence                 3444778899999987765543

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-35  Score=275.86  Aligned_cols=202  Identities=23%  Similarity=0.411  Sum_probs=173.7

Q ss_pred             eEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEE
Q 018487          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (355)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  191 (355)
                      ....++||.|.||.||+|.+..... ...--||||+.+.+.  +.+..+.|..|.-+|+.++|||||+++|.+.+. ..|
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~k-ge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~W  466 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEK-GERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMW  466 (974)
T ss_pred             ccHHHhhcCCcccceeeeEeccccc-CcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-cee
Confidence            3445789999999999999874422 223348899887754  344467789999999999999999999999864 689


Q ss_pred             EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCC
Q 018487          192 LILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR  270 (355)
Q Consensus       192 lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~  270 (355)
                      ||||+++-|.|..+|..+. .++......++.||+.||+|||+.+++||||..+|||+.....|||+|||+++.+.+...
T Consensus       467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y  546 (974)
T KOG4257|consen  467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY  546 (974)
T ss_pred             EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence            9999999999999998774 588889999999999999999999999999999999999999999999999998876655


Q ss_pred             CCccc--ccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCc
Q 018487          271 SNSMC--GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSM  317 (355)
Q Consensus       271 ~~~~~--gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~  317 (355)
                      ...-.  -...|||||.+.-..++.++|||-|||++||++. |..||.+.
T Consensus       547 YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv  596 (974)
T KOG4257|consen  547 YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV  596 (974)
T ss_pred             hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccc
Confidence            43323  3577999999999999999999999999999988 99999875

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.3e-34  Score=301.20  Aligned_cols=187  Identities=24%  Similarity=0.350  Sum_probs=159.3

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      .|...+.||+|+||.||+|.++     ..++.||+|.+......       ...|++++++++|||||++++++...+..
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~  758 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSI-----KNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGA  758 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEEC-----CCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCC
Confidence            4566788999999999999976     45678999988643211       12468889999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH---KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH---~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      |+||||+++|+|.+++..   +++.++..++.|+++||+|||   ..+|+||||||+||+++.++..++. ||.......
T Consensus       759 ~lv~Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~  834 (968)
T PLN00113        759 YLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT  834 (968)
T ss_pred             EEEEeCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence            999999999999999863   789999999999999999999   6699999999999999998888776 665544322


Q ss_pred             CCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCC
Q 018487          268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKS  316 (355)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~  316 (355)
                         .....+++.|||||++.+..++.++|||||||++|||+||+.||..
T Consensus       835 ---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~  880 (968)
T PLN00113        835 ---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA  880 (968)
T ss_pred             ---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence               1233688999999999999999999999999999999999999853

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-36  Score=258.13  Aligned_cols=200  Identities=27%  Similarity=0.438  Sum_probs=168.3

Q ss_pred             EeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC-----e
Q 018487          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-----K  189 (355)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~  189 (355)
                      -+-||.|+||+||.+.     |.++++.|++|.+..-. ..--.-+.+.+|+++|..++|.|++..++..+...     +
T Consensus        58 DRPIGYGAFGVVWsVT-----DPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE  131 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVT-----DPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE  131 (449)
T ss_pred             CCcccccceeEEEecc-----CCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence            3579999999999988     44788999999886432 22223356778999999999999999888766432     5


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      +|+++|+|.. +|..++.....++.+.++-+++||++||.|||+.+|+||||||.|+|++.|..+||||||+++......
T Consensus       132 iYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~  210 (449)
T KOG0664|consen  132 LYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD  210 (449)
T ss_pred             HHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence            7889999975 788888888889999999999999999999999999999999999999999999999999999764332


Q ss_pred             --CCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh
Q 018487          270 --RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA  321 (355)
Q Consensus       270 --~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~  321 (355)
                        .....+-|.+|+|||.+.| ..|+.+.||||+||++.||+-.+..|..-..+.
T Consensus       211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Piq  265 (449)
T KOG0664|consen  211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIE  265 (449)
T ss_pred             hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHH
Confidence              2344567899999999987 468999999999999999999999998765444

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-36  Score=253.58  Aligned_cols=203  Identities=28%  Similarity=0.428  Sum_probs=169.0

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec--
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--  186 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--  186 (355)
                      .+.|+.+.+||+|.||.||+|+.+     .+++.||+|++--+.. ....-....+|+++|..++|+|++.+++.|..  
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~-----n~~kkvalkkvlmene-KeGfpitalreikiL~~lkHenv~nliEic~tk~   89 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSK-----NTGKKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKA   89 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhc-----CccchhHHHHHHHhcc-ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhcc
Confidence            457888899999999999999977     4566788887644332 22233345579999999999999999888752  


Q ss_pred             ------CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEec
Q 018487          187 ------RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (355)
Q Consensus       187 ------~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Df  259 (355)
                            ...+|+||.+|+. +|.-.+... ..++..++..++++++.||.|+|+..|+|||+|+.|+||+.+|.+||+||
T Consensus        90 Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADF  168 (376)
T KOG0669|consen   90 TPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADF  168 (376)
T ss_pred             CCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecc
Confidence                  3359999999987 777777665 56999999999999999999999999999999999999999999999999


Q ss_pred             CCccccCcCC-----CCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          260 GLAKEIDESS-----RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       260 g~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      |+++.+....     +....+-|..|++||.+.| ..|+++.|||..||+|.||+||..-|.+..
T Consensus       169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt  233 (376)
T KOG0669|consen  169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT  233 (376)
T ss_pred             ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh
Confidence            9998764322     1234567999999999886 579999999999999999999999888764

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-34  Score=256.55  Aligned_cols=222  Identities=26%  Similarity=0.424  Sum_probs=175.0

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHH--hcCCCcceecceeeecC
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT--KVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~--~l~h~nIv~l~~~~~~~  187 (355)
                      .+..+++.||+|.||.||+|.|+|       +.||||++.....      +...+|.++.+  .|+|+||+.++++-..+
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wrG-------e~VAVKiF~srdE------~SWfrEtEIYqTvmLRHENILgFIaaD~~~  277 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWRG-------EDVAVKIFSSRDE------RSWFRETEIYQTVMLRHENILGFIAADNKD  277 (513)
T ss_pred             heeEEEEEecCccccceeeccccC-------CceEEEEecccch------hhhhhHHHHHHHHHhccchhhhhhhccccC
Confidence            578999999999999999999984       4599999975432      22445666665  46899999998875533


Q ss_pred             ----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeeccCCCCcEEecCCCcEE
Q 018487          188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC--------GIVHRDLKPENILMDSDGHVM  255 (355)
Q Consensus       188 ----~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~--------~iiHrDlkp~NILl~~~~~~k  255 (355)
                          ..+|+|++|.+.|||+++|.+ ..++.+....++..++.||++||..        .|.|||||+.|||+..+|...
T Consensus       278 ~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~  356 (513)
T KOG2052|consen  278 NGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  356 (513)
T ss_pred             CCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence                369999999999999999998 5689999999999999999999943        399999999999999999999


Q ss_pred             EEecCCccccCcCC-----CCCcccccCccccchhhccCC----C-C-CcccHHHHHHHHHHHHcC----------CCCC
Q 018487          256 LTDFGLAKEIDESS-----RSNSMCGTTEYMAPEILLSKG----H-N-KDADWWSVGILLYEMLTG----------QVNI  314 (355)
Q Consensus       256 l~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~----~-~-~~~DiwSlG~~l~elltg----------~~pf  314 (355)
                      |+|+|+|.......     ..+..+||..|||||++...-    + + ..+||||||.++||+...          +.||
T Consensus       357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py  436 (513)
T KOG2052|consen  357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY  436 (513)
T ss_pred             EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence            99999998765442     235679999999999986421    1 1 358999999999999762          4577


Q ss_pred             CCchhhhh-------------------------hhhHHHHHhhhheeeecCCCcCC
Q 018487          315 KSMQVIAC-------------------------NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       315 ~~~~~~~~-------------------------~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      .+......                         ..+..+..+++.||..||..++.
T Consensus       437 yd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRlt  492 (513)
T KOG2052|consen  437 YDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLT  492 (513)
T ss_pred             ccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhH
Confidence            66432221                         12334567778888888876653

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-33  Score=254.47  Aligned_cols=133  Identities=23%  Similarity=0.439  Sum_probs=111.6

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-----C---Ccce
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-----H---PFIV  178 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~nIv  178 (355)
                      +..++|.++++||+|.|++||+|.+.     ...+.||+|+.+...    .+.+....|+.+|++++     |   ..||
T Consensus        75 F~~gRY~v~rKLGWGHFSTVWLawDt-----q~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV  145 (590)
T KOG1290|consen   75 FNGGRYHVQRKLGWGHFSTVWLAWDT-----QNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVV  145 (590)
T ss_pred             ccCceEEEEEeccccccceeEEEeec-----cCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceee
Confidence            33489999999999999999999976     678899999987543    34455667999999885     2   3699


Q ss_pred             ecceeeec----CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEec
Q 018487          179 QLRYSFQT----RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMD  249 (355)
Q Consensus       179 ~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDlkp~NILl~  249 (355)
                      +|++.|..    +.++|||+|++ |..|..++....  -++...++.|++||+.||.|||+ +||||.||||+|||+.
T Consensus       146 ~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  146 QLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             eeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence            99999974    56899999999 556777776553  48999999999999999999995 6999999999999993

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=280.04  Aligned_cols=239  Identities=23%  Similarity=0.402  Sum_probs=195.9

Q ss_pred             hcCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCC--CCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceec
Q 018487          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGD--SDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQL  180 (355)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l  180 (355)
                      .+.+...+..+.+.||+|.||.|++|..++.....  ....||||..+.....  ...+.+..|+.+|+.+. |+||+.+
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~l  367 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNL  367 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhh
Confidence            34555566677889999999999999877554432  3567999998876533  55677889999999985 9999999


Q ss_pred             ceeeecCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q 018487          181 RYSFQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPE  244 (355)
Q Consensus       181 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~  244 (355)
                      ++++...+.+++|+||+..|+|..++....                .++..+...+++||+.|++||++.++|||||..+
T Consensus       368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR  447 (609)
T KOG0200|consen  368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR  447 (609)
T ss_pred             eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence            999999999999999999999999998766                3888999999999999999999999999999999


Q ss_pred             cEEecCCCcEEEEecCCccccCcCCCC--Ccccc--cCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCch-
Q 018487          245 NILMDSDGHVMLTDFGLAKEIDESSRS--NSMCG--TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQ-  318 (355)
Q Consensus       245 NILl~~~~~~kl~Dfg~a~~~~~~~~~--~~~~g--t~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~-  318 (355)
                      |||+..+..+||+|||+|+........  ....|  ...|||||.+....|+.++|||||||+||||+| |..|+.+.. 
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~  527 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP  527 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence            999999999999999999965433322  11122  345999999999999999999999999999999 899999732 


Q ss_pred             --hh----h--------hhhhHHHHHhhhheeeecCCCcC
Q 018487          319 --VI----A--------CNTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       319 --~~----~--------~~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                        .+    .        ......++.+...|+..+|.+++
T Consensus       528 ~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP  567 (609)
T KOG0200|consen  528 TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRP  567 (609)
T ss_pred             HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCC
Confidence              11    0        11233557888999988888765

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-34  Score=260.30  Aligned_cols=187  Identities=25%  Similarity=0.461  Sum_probs=158.5

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHh--cCCCcceecceeeecC
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK--VTHPFIVQLRYSFQTR  187 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~  187 (355)
                      ...+++++||+|.||.||+|+..       ++.||||++...      ..+.+.+|-+|.+.  ++|+||++++++-...
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-------~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~  276 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-------NRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRG  276 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-------CceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccC
Confidence            45778899999999999999976       478999998643      33557778777664  5799999999987765


Q ss_pred             C----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CCeeccCCCCcEEecCCCcE
Q 018487          188 S----KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC---------GIVHRDLKPENILMDSDGHV  254 (355)
Q Consensus       188 ~----~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~---------~iiHrDlkp~NILl~~~~~~  254 (355)
                      .    .++||++|.+.|+|.++|..+ .+++.....++..|++||+|||+.         .|+|||||+.|||+..|++.
T Consensus       277 t~~~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc  355 (534)
T KOG3653|consen  277 TADRMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC  355 (534)
T ss_pred             CccccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence            5    899999999999999999865 579999999999999999999953         49999999999999999999


Q ss_pred             EEEecCCccccCcCC---CCCcccccCccccchhhccCC-CC-----CcccHHHHHHHHHHHHcC
Q 018487          255 MLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKG-HN-----KDADWWSVGILLYEMLTG  310 (355)
Q Consensus       255 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DiwSlG~~l~elltg  310 (355)
                      .|+|||+|..+....   .....+||..|||||++.+.- +.     .+.||||+|.|||||++.
T Consensus       356 cIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SR  420 (534)
T KOG3653|consen  356 CIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASR  420 (534)
T ss_pred             EeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhh
Confidence            999999999875433   234579999999999998642 22     258999999999999984

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=6.7e-33  Score=272.60  Aligned_cols=204  Identities=21%  Similarity=0.349  Sum_probs=146.7

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceeccee-
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS-  183 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~-  183 (355)
                      .....++|++.++||+|+||.||+|.+..... ..++.||+|.+.....     .+...++  .++...+.+++.++.. 
T Consensus       127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~-~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~  198 (566)
T PLN03225        127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQS-KKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGF  198 (566)
T ss_pred             CCCccCCeEEeEEEeeCCCeEEEEEEEcCCcc-ccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhh
Confidence            34556899999999999999999999873311 2367899998754321     1111111  1222223333333222 


Q ss_pred             -----eecCCeEEEEEeccCCCChHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCCee
Q 018487          184 -----FQTRSKLYLILDFINGGHLFFHLYRQGI--------------------FREDQARFYTAEIVSAVSHLHKCGIVH  238 (355)
Q Consensus       184 -----~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------l~~~~~~~i~~ql~~~L~~LH~~~iiH  238 (355)
                           ...+..+++||||+.+++|.+++.....                    ..+..+..++.||+.||.|||+++|+|
T Consensus       199 ~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiH  278 (566)
T PLN03225        199 LEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVH  278 (566)
T ss_pred             hcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence                 2356689999999999999988865421                    123446679999999999999999999


Q ss_pred             ccCCCCcEEecC-CCcEEEEecCCccccCcC--CCCCcccccCccccchhhccC----------------------CCCC
Q 018487          239 RDLKPENILMDS-DGHVMLTDFGLAKEIDES--SRSNSMCGTTEYMAPEILLSK----------------------GHNK  293 (355)
Q Consensus       239 rDlkp~NILl~~-~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~----------------------~~~~  293 (355)
                      |||||+|||++. ++.+||+|||+++.+...  ......++++.|||||.+...                      .++.
T Consensus       279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~  358 (566)
T PLN03225        279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD  358 (566)
T ss_pred             CcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence            999999999985 579999999999865332  223456789999999976432                      2344


Q ss_pred             cccHHHHHHHHHHHHcCCCCCCC
Q 018487          294 DADWWSVGILLYEMLTGQVNIKS  316 (355)
Q Consensus       294 ~~DiwSlG~~l~elltg~~pf~~  316 (355)
                      ++|||||||+||||+++..++..
T Consensus       359 k~DVwSlGviL~el~~~~~~~~~  381 (566)
T PLN03225        359 RFDIYSAGLIFLQMAFPNLRSDS  381 (566)
T ss_pred             CcccHHHHHHHHHHHhCcCCCch
Confidence            67999999999999998877654

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.1e-32  Score=241.01  Aligned_cols=216  Identities=44%  Similarity=0.719  Sum_probs=184.6

Q ss_pred             CcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEEEeccCCCC
Q 018487          122 AFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH  201 (355)
Q Consensus       122 ~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  201 (355)
                      +||.||+|.+.     .+++.+++|++........  .+.+.+|++.+++++|+||+++++.+......+++|||+++++
T Consensus         1 ~~g~v~~~~~~-----~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~   73 (244)
T smart00220        1 SFGKVYLARDK-----KTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGD   73 (244)
T ss_pred             CceEEEEEEEC-----CCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCC
Confidence            58999999976     3567899999876543221  5678899999999999999999999999999999999999999


Q ss_pred             hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCCCCcccccCccc
Q 018487          202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYM  281 (355)
Q Consensus       202 L~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~  281 (355)
                      |..++.....+++..+..++.+++.++.|||+.+++|+||+|+||+++.++.++|+|||.+.............++..|+
T Consensus        74 L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  153 (244)
T smart00220       74 LFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYM  153 (244)
T ss_pred             HHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCC
Confidence            99998877668999999999999999999999999999999999999999999999999998876554455667889999


Q ss_pred             cchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCC-chhhhhh----------------hhHHHHHhhhheeeecCCCcC
Q 018487          282 APEILLSKGHNKDADWWSVGILLYEMLTGQVNIKS-MQVIACN----------------TMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       282 aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~-~~~~~~~----------------~~~~~~~~i~~~l~~~~~e~~  344 (355)
                      +||.+.+..++.++||||||+++|+|++|..||.. .+.....                ....+..++.+|+..+|.+++
T Consensus       154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp  233 (244)
T smart00220      154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRL  233 (244)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhcc
Confidence            99999888889999999999999999999999977 2211100                224567788899988888765

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-33  Score=269.61  Aligned_cols=206  Identities=24%  Similarity=0.312  Sum_probs=176.2

Q ss_pred             eEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEE
Q 018487          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (355)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  191 (355)
                      .+..++||+|+||+||++.|... ...-+-+||+|++.....  ....+.+.+|.-+|.+++|||++++++++.... +.
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pe-ge~vKipVaiKvl~~~t~--~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q  773 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPE-GENVKIPVAIKVLIEFTS--PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ  773 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecC-CceecceeEEEEeeccCC--chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence            44567899999999999998865 234456799999876543  334466888999999999999999999998766 88


Q ss_pred             EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCC
Q 018487          192 LILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR  270 (355)
Q Consensus       192 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~  270 (355)
                      ||++||++|.|.++++.+ ..+..+....|+.||++||.|||.++++||||-.+|||+..-..+|+.|||+++.+.....
T Consensus       774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            999999999999999865 5688999999999999999999999999999999999999999999999999998765544


Q ss_pred             CCc---ccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh
Q 018487          271 SNS---MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA  321 (355)
Q Consensus       271 ~~~---~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~  321 (355)
                      ...   ..-.+.|||-|.+....|+.++|||||||++|||+| |..|+..+....
T Consensus       854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e  908 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE  908 (1177)
T ss_pred             cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH
Confidence            322   223577999999999999999999999999999999 999999875433

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=4.4e-32  Score=236.74  Aligned_cols=198  Identities=41%  Similarity=0.705  Sum_probs=174.7

Q ss_pred             eEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEE
Q 018487          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (355)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  191 (355)
                      |.+.+.||.|++|.||++...     ..++.+++|.+......  ...+.+.+|+..++.++|+|++++++.+......+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~   73 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDK-----GTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLY   73 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEc-----CCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceE
Confidence            567889999999999999976     34678999998765432  24567888999999999999999999999989999


Q ss_pred             EEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC-
Q 018487          192 LILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (355)
Q Consensus       192 lv~e~~~~gsL~~~l~~~~~-l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-  269 (355)
                      +++||+++++|.+++..... +++..+..++.+++.+|.+||+.+++|+||+|.||+++.++.++|+|||.+....... 
T Consensus        74 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~  153 (225)
T smart00221       74 LVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA  153 (225)
T ss_pred             EEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence            99999999999999988766 8999999999999999999999999999999999999999999999999998775543 


Q ss_pred             -CCCcccccCccccchhh-ccCCCCCcccHHHHHHHHHHHHcCCCCCCC
Q 018487          270 -RSNSMCGTTEYMAPEIL-LSKGHNKDADWWSVGILLYEMLTGQVNIKS  316 (355)
Q Consensus       270 -~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~~l~elltg~~pf~~  316 (355)
                       ......++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus       154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence             33445678899999998 667788899999999999999999999976

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2e-34  Score=271.04  Aligned_cols=232  Identities=28%  Similarity=0.441  Sum_probs=197.2

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      ...++|+++.++|.|.||.||+|+++     .+++..|+|+++...-   +...-+++|+-+++.++|+|||.+++.|..
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~-----~s~elaavkvVkLep~---dd~~~iqqei~~~~dc~h~nivay~gsylr   83 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDK-----RSGELAAVKVVKLEPG---DDFSGIQQEIGMLRDCRHPNIVAYFGSYLR   83 (829)
T ss_pred             CCccchhheeeecCCcccchhhhccc-----ccCchhhheeeeccCC---ccccccccceeeeecCCCcChHHHHhhhhh
Confidence            34578999999999999999999977     6788899999986543   334456789999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                      .+.+|++||||.||+|++.-+..+++++.++.+++++.++||+|||++|-+|||||-.|||+++.|.+|++|||.+..+.
T Consensus        84 ~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqit  163 (829)
T KOG0576|consen   84 RDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT  163 (829)
T ss_pred             hcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhh
Confidence            99999999999999999999889999999999999999999999999999999999999999999999999999988764


Q ss_pred             cC-CCCCcccccCccccchhhc---cCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh------------------hhh
Q 018487          267 ES-SRSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA------------------CNT  324 (355)
Q Consensus       267 ~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~------------------~~~  324 (355)
                      .. .....+.||++|||||+-.   ...|...+|||++|++..|+---+.|.-.....+                  ...
T Consensus       164 ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kw  243 (829)
T KOG0576|consen  164 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKW  243 (829)
T ss_pred             hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccc
Confidence            32 3356788999999999864   4679999999999999999865555443322211                  234


Q ss_pred             hHHHHHhhhheeeecCCCcCCC
Q 018487          325 MLLFYLIIFHCLFVNSLELLSH  346 (355)
Q Consensus       325 ~~~~~~~i~~~l~~~~~e~~~~  346 (355)
                      ..+|-+++.-||.++|+.++..
T Consensus       244 s~~fh~fvK~altknpKkRpta  265 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTA  265 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCCh
Confidence            5577889999999999887643

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=8e-32  Score=259.23  Aligned_cols=211  Identities=23%  Similarity=0.316  Sum_probs=155.8

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCC-----------CCCCCceEEEEEeecccccch-----------hHHHHHH
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVD-----------DGDSDGIYAMKVMRKDTIIKK-----------NHVDYMK  163 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----------~~~~~~~vavK~~~~~~~~~~-----------~~~~~~~  163 (355)
                      .+..++|++.++||+|+||+||+|......           +...++.||||.+........           ...+...
T Consensus       141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~  220 (507)
T PLN03224        141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM  220 (507)
T ss_pred             CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence            355779999999999999999999753221           223456799999864321100           0112233


Q ss_pred             HHHHHHHhcCCCcc-----eecceeeec--------CCeEEEEEeccCCCChHHHHHhcC--------------------
Q 018487          164 AERDILTKVTHPFI-----VQLRYSFQT--------RSKLYLILDFINGGHLFFHLYRQG--------------------  210 (355)
Q Consensus       164 ~E~~~l~~l~h~nI-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~--------------------  210 (355)
                      .|+.++.+++|.++     ++++++|..        .+..|+||||+++++|.+++....                    
T Consensus       221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~  300 (507)
T PLN03224        221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN  300 (507)
T ss_pred             HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence            46777777776554     566776643        356899999999999998886421                    


Q ss_pred             ----CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCCCCc--ccccCccccch
Q 018487          211 ----IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS--MCGTTEYMAPE  284 (355)
Q Consensus       211 ----~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~--~~gt~~y~aPE  284 (355)
                          .+.+..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++...........  ..+++.|+|||
T Consensus       301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence                235567888999999999999999999999999999999999999999999976543322222  23478999999


Q ss_pred             hhccCC--------------------C--CCcccHHHHHHHHHHHHcCCC-CCCC
Q 018487          285 ILLSKG--------------------H--NKDADWWSVGILLYEMLTGQV-NIKS  316 (355)
Q Consensus       285 ~~~~~~--------------------~--~~~~DiwSlG~~l~elltg~~-pf~~  316 (355)
                      ++....                    |  ..+.||||+||++|+|++|.. ||..
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~  435 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN  435 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence            986432                    1  124699999999999999986 7754

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.6e-33  Score=258.32  Aligned_cols=208  Identities=28%  Similarity=0.454  Sum_probs=175.1

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCC------Ccceec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH------PFIVQL  180 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~nIv~l  180 (355)
                      +.-++|.+..-.|+|-|++|..|.+.     ..+..||||+|+......+    .-..|+.+|++|+.      -++++|
T Consensus       429 ~LD~RY~V~~~~GkGvFs~Vvra~D~-----~r~~~vAiKIIRnNE~M~K----tGl~EleiLkKL~~AD~Edk~Hclrl  499 (752)
T KOG0670|consen  429 LLDSRYEVQGYTGKGVFSTVVRARDQ-----ARGQEVAIKIIRNNEVMHK----TGLKELEILKKLNDADPEDKFHCLRL  499 (752)
T ss_pred             hhcceeEEEeccccceeeeeeecccc-----CCCCeeEEEEeecchHHhh----hhhHHHHHHHHhhccCchhhhHHHHH
Confidence            44568999999999999999999866     4456899999987654332    33469999999963      389999


Q ss_pred             ceeeecCCeEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC-cEEE
Q 018487          181 RYSFQTRSKLYLILDFINGGHLFFHLYRQGI---FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVML  256 (355)
Q Consensus       181 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~-~~kl  256 (355)
                      +..|...+++|||+|.+. ..|.+.|.+-+.   |....+..+++|++-||..|-.+||+|.||||+|||+++.. .+||
T Consensus       500 ~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKL  578 (752)
T KOG0670|consen  500 FRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKL  578 (752)
T ss_pred             HHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeee
Confidence            999999999999999985 478899887654   77888999999999999999999999999999999998764 6899


Q ss_pred             EecCCccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhhhhHHH
Q 018487          257 TDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLF  328 (355)
Q Consensus       257 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~~~~~~  328 (355)
                      ||||.|........ ....-+..|.|||++.|-.|+...|+||+||+||||+||++.|.+..   +|.++.+
T Consensus       579 CDfGSA~~~~enei-tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T---NN~MLrl  646 (752)
T KOG0670|consen  579 CDFGSASFASENEI-TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT---NNQMLRL  646 (752)
T ss_pred             ccCccccccccccc-cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC---cHHHHHH
Confidence            99999987765543 33445778999999999999999999999999999999999999863   3444444

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.98  E-value=6.5e-33  Score=241.13  Aligned_cols=204  Identities=26%  Similarity=0.456  Sum_probs=173.6

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC-
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-  187 (355)
                      ..+|.-++.+|.|.- .|..|-+.     -.++.||+|.+.... ......++..+|..++..+.|+||++++.+|... 
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~-----v~~~~v~ikk~~~pf-~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~   88 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQ-----VLGRPVAIKKLSRPF-QNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQK   88 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchh-----hccCceehhhhcCcc-ccCccchhhhhhhhhhhhhcccceeeeeeccCccc
Confidence            357888899999999 66655533     567789999876653 3445556677899999999999999999998743 


Q ss_pred             -----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       188 -----~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                           ..+|+|||+|.. +|...+.  -.+.-..+..++.|+++|+.|||+.||+||||||+||++..+..+||.|||+|
T Consensus        89 ~l~~~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   89 TLEEFQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLA  165 (369)
T ss_pred             cHHHHHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhh
Confidence                 368999999976 6766665  33567788999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh
Q 018487          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC  322 (355)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~  322 (355)
                      +.-+..-.....+.|..|.|||++.+..|.+.+||||+||++.||++|.+.|.+.+.+..
T Consensus       166 r~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ  225 (369)
T KOG0665|consen  166 RTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQ  225 (369)
T ss_pred             cccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHH
Confidence            987766566777899999999999999999999999999999999999999998876653

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=1.4e-32  Score=228.88  Aligned_cols=197  Identities=25%  Similarity=0.436  Sum_probs=168.8

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecceeeec
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQT  186 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~  186 (355)
                      ..++|++++++|+|.|+.||.|...     .+.+.++||+++.-      ..+.+.+|+.+|+.+. ||||+++++...+
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~-----~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~D  104 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINI-----TNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKD  104 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhccccc-----CCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence            4578999999999999999998855     45667889988643      2356889999999998 9999999999876


Q ss_pred             C--CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCC-CcEEEEecCCcc
Q 018487          187 R--SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAK  263 (355)
Q Consensus       187 ~--~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~-~~~kl~Dfg~a~  263 (355)
                      .  ....+|+||+++.+....   -..++.-.++.++.+++.||.|+|++||+|||+||.|++||.. ..++|+|+|+|.
T Consensus       105 p~SktpaLiFE~v~n~Dfk~l---y~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAE  181 (338)
T KOG0668|consen  105 PESKTPSLIFEYVNNTDFKQL---YPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  181 (338)
T ss_pred             ccccCchhHhhhhccccHHHH---hhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHh
Confidence            4  467899999988655332   2347888999999999999999999999999999999999865 479999999999


Q ss_pred             ccCcCCCCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          264 EIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      ...........+.+..|--||.+.. +.|+..-|+|||||+|..|+..+.||-...
T Consensus       182 FYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~  237 (338)
T KOG0668|consen  182 FYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH  237 (338)
T ss_pred             hcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC
Confidence            9888777777888999999999875 568999999999999999999999997653

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=3.7e-31  Score=235.54  Aligned_cols=238  Identities=18%  Similarity=0.294  Sum_probs=194.5

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      ..+...+++....+-+|.||.||.|.|+..++....+.|.+|.++...  .+..+..+..|..++..+.|||+..+.+..
T Consensus       279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            345567899999999999999999999988887788889999887654  466677888999999999999999998887


Q ss_pred             ec-CCeEEEEEeccCCCChHHHHHh-----c---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEE
Q 018487          185 QT-RSKLYLILDFINGGHLFFHLYR-----Q---GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM  255 (355)
Q Consensus       185 ~~-~~~~~lv~e~~~~gsL~~~l~~-----~---~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~k  255 (355)
                      .+ ....++++.++..|.|..++..     .   ..++..+...++.|++.|++|||++||||.||..+|.+||+.-++|
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVk  436 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVK  436 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEE
Confidence            64 4567889999999999988872     1   2377788899999999999999999999999999999999999999


Q ss_pred             EEecCCccccCcCC---CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh----------
Q 018487          256 LTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA----------  321 (355)
Q Consensus       256 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~----------  321 (355)
                      |+|-.+++.+-...   ..........||+||.+.+..|+.++|||||||+||||+| |+.|+...|...          
T Consensus       437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyR  516 (563)
T KOG1024|consen  437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYR  516 (563)
T ss_pred             eccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccce
Confidence            99999999764322   2233344678999999999999999999999999999999 999998765533          


Q ss_pred             ----hhhhHHHHHhhhheeeecCCCcC
Q 018487          322 ----CNTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       322 ----~~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                          .|..+-++.+..=||...|.|++
T Consensus       517 laQP~NCPDeLf~vMacCWallpeeRP  543 (563)
T KOG1024|consen  517 LAQPFNCPDELFTVMACCWALLPEERP  543 (563)
T ss_pred             ecCCCCCcHHHHHHHHHHHhcCcccCC
Confidence                22333445555566666666644

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=1.6e-29  Score=217.24  Aligned_cols=203  Identities=36%  Similarity=0.612  Sum_probs=175.5

Q ss_pred             eccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEEEecc
Q 018487          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI  197 (355)
Q Consensus       118 lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  197 (355)
                      ||+|++|.||++...     ..++.+++|++.......  ..+.+.+|++.++.+.|++|+++++++......+++|||+
T Consensus         1 l~~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~   73 (215)
T cd00180           1 LGEGGFGTVYLARDK-----KTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYC   73 (215)
T ss_pred             CCcCCceEEEEEEec-----CCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecC
Confidence            689999999999965     357789999987654321  3466888999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC-CCcEEEEecCCccccCcCC-CCCcc
Q 018487          198 NGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKEIDESS-RSNSM  274 (355)
Q Consensus       198 ~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~-~~~~kl~Dfg~a~~~~~~~-~~~~~  274 (355)
                      ++++|.+++... ..+++..++.++.+++++|.+||+.|++|+||+|.||+++. ++.++|+|||.+....... .....
T Consensus        74 ~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~  153 (215)
T cd00180          74 EGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI  153 (215)
T ss_pred             CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence            999999998776 56899999999999999999999999999999999999999 8999999999998765432 12334


Q ss_pred             cccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhhhhHHHHHhhhheeeecCCCcCC
Q 018487          275 CGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       275 ~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      .+...|++||.+... .++.+.|+|++|+++++|                  ..+..++..|+..+|.+++.
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------~~~~~~l~~~l~~~p~~R~~  207 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------PELKDLIRKMLQKDPEKRPS  207 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------HHHHHHHHHHhhCCcccCcC
Confidence            578899999999876 788999999999999999                  56678899999988887664

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=4.4e-32  Score=261.15  Aligned_cols=192  Identities=29%  Similarity=0.445  Sum_probs=159.6

Q ss_pred             eEEEeeeccCCcEE-EEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecceeeecCCe
Q 018487          112 FEIFRVVGQGAFGK-VFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSK  189 (355)
Q Consensus       112 y~~~~~lG~G~~g~-V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~  189 (355)
                      |.-.+.+|.|+.|+ ||+|.+.       ++.||||.+-.      +..+...+|+..|+..+ |||||++++.-.+...
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-------~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF  577 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-------GREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQF  577 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-------CceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCce
Confidence            33446789999986 7888854       67899997643      34456778999999986 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC---C--CcEEEEecC
Q 018487          190 LYLILDFINGGHLFFHLYRQGI----FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---D--GHVMLTDFG  260 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~----l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~---~--~~~kl~Dfg  260 (355)
                      .||+.|.|.. +|.+++.....    ......+.++.|++.||++||+.+||||||||.||||+.   +  .+++|+|||
T Consensus       578 ~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfg  656 (903)
T KOG1027|consen  578 LYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFG  656 (903)
T ss_pred             EEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccc
Confidence            9999999977 89999987411    111446788999999999999999999999999999975   2  479999999


Q ss_pred             CccccCcCCC----CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcC-CCCCCCc
Q 018487          261 LAKEIDESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG-QVNIKSM  317 (355)
Q Consensus       261 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg-~~pf~~~  317 (355)
                      +++.+.....    .....||-+|+|||++....-..++|||||||++|+.++| ..||.+.
T Consensus       657 lsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~  718 (903)
T KOG1027|consen  657 LSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS  718 (903)
T ss_pred             cccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch
Confidence            9998754332    3456799999999999988888899999999999999996 9999875

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-31  Score=226.56  Aligned_cols=201  Identities=26%  Similarity=0.400  Sum_probs=160.8

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecce-eeecC
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRY-SFQTR  187 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~-~~~~~  187 (355)
                      +.|.+.+.||+|.||.+-+|+++     .++..+++|.+....    ..+..|.+|...--.|. |.||+.-|+ .|+..
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr-----~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~   94 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHR-----QSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS   94 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeecc-----CCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcC
Confidence            57999999999999999999998     467789999887543    33456777777655554 899998665 47888


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEec--CCCcEEEEecCCcccc
Q 018487          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD--SDGHVMLTDFGLAKEI  265 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~--~~~~~kl~Dfg~a~~~  265 (355)
                      +.++++|||++.|+|...+...+ +.|.-...++.|++.||.|+|+.+++|||||.+||||-  +..+|||||||+.+..
T Consensus        95 d~YvF~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen   95 DAYVFVQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             ceEEEeeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence            88999999999999988776644 68888999999999999999999999999999999994  3348999999998765


Q ss_pred             CcCCCCCcccccCccccchhhccC-----CCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh
Q 018487          266 DESSRSNSMCGTTEYMAPEILLSK-----GHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN  323 (355)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~  323 (355)
                      +..-  ....-+..|.+||++...     ...+.+|||.||+++|.++||..||.. ..+.+.
T Consensus       174 g~tV--~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk-a~~~d~  233 (378)
T KOG1345|consen  174 GTTV--KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK-ASIMDK  233 (378)
T ss_pred             Ccee--hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh-hhccCc
Confidence            4321  222345679999987532     236789999999999999999999994 344433

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=1.4e-29  Score=227.94  Aligned_cols=199  Identities=25%  Similarity=0.477  Sum_probs=165.0

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecceeeecC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTR  187 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~  187 (355)
                      ...|.++++||+|.|++||++.....  ....+.||+|.+....     ...++.+|+++|..+. +.||+++.+.+..+
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~--~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn  107 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQ--DTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNN  107 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhh--ccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence            35799999999999999999987642  2367889999886433     3345888999999996 99999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC-CCcEEEEecCCccccC
Q 018487          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKEID  266 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~-~~~~kl~Dfg~a~~~~  266 (355)
                      +.+.+||||++.....++...   ++..++..+++.++.||.++|.+|||||||||.|+|.+. .++-.|+|||+|...+
T Consensus       108 d~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d  184 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD  184 (418)
T ss_pred             CeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence            999999999999877666654   568899999999999999999999999999999999974 5789999999987210


Q ss_pred             c--------C------C-------------------------------CCCcccccCccccchhhccCC-CCCcccHHHH
Q 018487          267 E--------S------S-------------------------------RSNSMCGTTEYMAPEILLSKG-HNKDADWWSV  300 (355)
Q Consensus       267 ~--------~------~-------------------------------~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSl  300 (355)
                      .        .      .                               ......||++|+|||++...+ .++++||||.
T Consensus       185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~  264 (418)
T KOG1167|consen  185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA  264 (418)
T ss_pred             hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence            0        0      0                               001236999999999998654 5789999999


Q ss_pred             HHHHHHHHcCCCCCCCc
Q 018487          301 GILLYEMLTGQVNIKSM  317 (355)
Q Consensus       301 G~~l~elltg~~pf~~~  317 (355)
                      ||+++-+++++.||-..
T Consensus       265 GVI~Lslls~~~PFf~a  281 (418)
T KOG1167|consen  265 GVILLSLLSRRYPFFKA  281 (418)
T ss_pred             cceeehhhccccccccC
Confidence            99999999999999653

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=5.8e-28  Score=223.46  Aligned_cols=167  Identities=23%  Similarity=0.227  Sum_probs=129.2

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccc--cchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI--IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      ..++|.+.+.||+|+||+||+|.++.    ..++.||||++.....  ......+.+.+|+.+|++++|+||+..+..  
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~----~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--   89 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAG----DPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--   89 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcC----CCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE--
Confidence            35689999999999999999998762    1456689998753311  123345668899999999999999853322  


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccC-CCCcEEecCCCcEEEEecCCccc
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDL-KPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDl-kp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                       .+..|+||||++|++|.. +.   ...   ...++.|+++||.|||++||+|||| ||+|||++.++.+||+|||+|+.
T Consensus        90 -~~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~  161 (365)
T PRK09188         90 -TGKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV  161 (365)
T ss_pred             -cCCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence             245799999999999862 21   111   2467899999999999999999999 99999999999999999999987


Q ss_pred             cCcCCCC---------CcccccCccccchhhcc
Q 018487          265 IDESSRS---------NSMCGTTEYMAPEILLS  288 (355)
Q Consensus       265 ~~~~~~~---------~~~~gt~~y~aPE~~~~  288 (355)
                      +......         ...+++..|+|||.+..
T Consensus       162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             cccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            6443211         24567888999999864

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=3.2e-27  Score=198.39  Aligned_cols=203  Identities=22%  Similarity=0.329  Sum_probs=170.0

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCC-Ccceecceee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQLRYSF  184 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~  184 (355)
                      .+..+.|.++++||.|+||.+|.|...     .++..||||+-......     ..+.-|..+.+.+++ ..|..+..++
T Consensus        11 ~iv~gky~lvrkiGsGSFGdIy~~~~i-----~~ge~VAiK~Es~~a~h-----pqL~yEskvY~iL~~g~GiP~i~~y~   80 (341)
T KOG1163|consen   11 LIVGGKYKLVRKIGSGSFGDIYLGISI-----TSGEEVAIKLESSKAKH-----PQLLYESKVYRILQGGVGIPHIRHYG   80 (341)
T ss_pred             heeccceEEEEeecCCchhheeeeeec-----cCCceEEEEeecccCCC-----cchhHHHHHHHHhccCCCCchhhhhc
Confidence            355689999999999999999999976     57888999986654322     235568888888875 5677777788


Q ss_pred             ecCCeEEEEEeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC---CCcEEEEecC
Q 018487          185 QTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFG  260 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~---~~~~kl~Dfg  260 (355)
                      .+..+-.+||+++ |.+|.+... ....++...+..++.|++.-++|+|.+++|||||||+|+|+.-   ...+.|+|||
T Consensus        81 ~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFG  159 (341)
T KOG1163|consen   81 TEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFG  159 (341)
T ss_pred             cccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEecc
Confidence            8888899999998 678887765 3456899999999999999999999999999999999999963   4579999999


Q ss_pred             CccccCcCCC--------CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchh
Q 018487          261 LAKEIDESSR--------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQV  319 (355)
Q Consensus       261 ~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~  319 (355)
                      +|+.+.+...        .....||..|.+-....+...+.+.|+-|+|.+|..+.-|..||.+...
T Consensus       160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka  226 (341)
T KOG1163|consen  160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA  226 (341)
T ss_pred             chhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence            9987643322        2356799999999998888899999999999999999999999998754

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-26  Score=213.49  Aligned_cols=201  Identities=26%  Similarity=0.425  Sum_probs=164.4

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCC----Ccceecceee-e
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH----PFIVQLRYSF-Q  185 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----~nIv~l~~~~-~  185 (355)
                      +|.+.++||+|+||.||+|......    ...+|+|+..........   .+..|..++..+..    .++..+++.. .
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~----~~~~a~K~e~~~~~~~~~---~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~   91 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEK----NKEYAKKLEKKELGSKPS---VLKIEIQVLKKLEKKNGPSHFPKLLDHGRS   91 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCC----CeeEEEEEEEecccCCCc---cchhHHHHHHHHhhhcCCCCCCEEEEeccC
Confidence            8999999999999999999976322    457888887654321111   35668888888863    5888888888 5


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCC-----CcEEEEe
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-----GHVMLTD  258 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~-----~~~kl~D  258 (355)
                      .+...|+||+.+ |.+|.++....  +.++...+..++.|++.+|++||+.|++||||||.|+++...     ..+.|.|
T Consensus        92 ~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llD  170 (322)
T KOG1164|consen   92 TEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLD  170 (322)
T ss_pred             CCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEe
Confidence            778899999998 67998877544  469999999999999999999999999999999999999865     3699999


Q ss_pred             cCCccccC---cCC---C-----CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchh
Q 018487          259 FGLAKEID---ESS---R-----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQV  319 (355)
Q Consensus       259 fg~a~~~~---~~~---~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~  319 (355)
                      ||+++.+.   ...   .     ...+.||..|+++.+..+...+++.|+||++.++.+|+.|..||.....
T Consensus       171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~  242 (322)
T KOG1164|consen  171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM  242 (322)
T ss_pred             cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence            99999322   111   0     1234599999999999999999999999999999999999999977653

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=5.7e-28  Score=248.35  Aligned_cols=147  Identities=18%  Similarity=0.207  Sum_probs=115.7

Q ss_pred             HhcCC-Ccceecceeee-------cCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecc
Q 018487          170 TKVTH-PFIVQLRYSFQ-------TRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRD  240 (355)
Q Consensus       170 ~~l~h-~nIv~l~~~~~-------~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrD  240 (355)
                      +.++| .||++++++|.       ....++++|||+ +++|.+++... ..+++.+++.+++||++||+|||++||+|||
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD  105 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN  105 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence            34555 58888888872       334678889988 45999999754 4599999999999999999999999999999


Q ss_pred             CCCCcEEecCCC-------------------cEEEEecCCccccCcCC-----------------CCCcccccCccccch
Q 018487          241 LKPENILMDSDG-------------------HVMLTDFGLAKEIDESS-----------------RSNSMCGTTEYMAPE  284 (355)
Q Consensus       241 lkp~NILl~~~~-------------------~~kl~Dfg~a~~~~~~~-----------------~~~~~~gt~~y~aPE  284 (355)
                      |||+||||+..+                   .+|++|||+++......                 .....+||+.|||||
T Consensus       106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE  185 (793)
T PLN00181        106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE  185 (793)
T ss_pred             CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence            999999996544                   45566666655321100                 001235788999999


Q ss_pred             hhccCCCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          285 ILLSKGHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       285 ~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      ++.+..|+.++|||||||+||||++|..|+...
T Consensus       186 ~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~  218 (793)
T PLN00181        186 EDNGSSSNCASDVYRLGVLLFELFCPVSSREEK  218 (793)
T ss_pred             hhccCCCCchhhhhhHHHHHHHHhhCCCchhhH
Confidence            999999999999999999999999999988754

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.94  E-value=9.5e-26  Score=206.29  Aligned_cols=199  Identities=41%  Similarity=0.695  Sum_probs=174.2

Q ss_pred             eEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCC-cceecceeeecCCeE
Q 018487          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP-FIVQLRYSFQTRSKL  190 (355)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~  190 (355)
                      |.+.+.||.|+||.||++.+.        ..+++|.+.............+.+|+.+++.+.|+ +|+++++.+......
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEE
Confidence            788999999999999999865        56899998876654444567788999999999988 799999999887788


Q ss_pred             EEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC-cEEEEecCCccccC
Q 018487          191 YLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEID  266 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~-~~kl~Dfg~a~~~~  266 (355)
                      +++++++.++++.+++....   .+.+..+..++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||.+..+.
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~  153 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP  153 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence            99999999999987776664   799999999999999999999999999999999999999988 79999999998654


Q ss_pred             cCC-------CCCcccccCccccchhhcc---CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          267 ESS-------RSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       267 ~~~-------~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      ...       ......|+..|++||.+.+   ..+....|+||+|++++++++|..||....
T Consensus       154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~  215 (384)
T COG0515         154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK  215 (384)
T ss_pred             CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            432       2356789999999999987   578889999999999999999999987764

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=2e-26  Score=201.80  Aligned_cols=199  Identities=21%  Similarity=0.352  Sum_probs=168.1

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecceeeecCC
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRS  188 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~  188 (355)
                      -.|++.++||+|+||.+|.+...     -.++.||||.-....     ..-++..|.+..+.|. .++|...+.+...+-
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl-----~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~   97 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNL-----YNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGK   97 (449)
T ss_pred             ccceeccccccCcceeeeccccc-----ccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccc
Confidence            37999999999999999998855     568899999864432     1234667888888886 689998888778888


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCC-----CcEEEEecCCc
Q 018487          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-----GHVMLTDFGLA  262 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~-----~~~kl~Dfg~a  262 (355)
                      +-.||+|++ |.+|.++..-- ..|+...+..++.|++.-++|+|++.+|+|||||+|+||...     ..|.++|||+|
T Consensus        98 ~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA  176 (449)
T KOG1165|consen   98 YNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA  176 (449)
T ss_pred             hhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence            889999998 67888877654 459999999999999999999999999999999999999743     35899999999


Q ss_pred             cccCcCCC--------CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchh
Q 018487          263 KEIDESSR--------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQV  319 (355)
Q Consensus       263 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~  319 (355)
                      +...+...        .....||..||+-.-..|.+.+.+.|+-|||-+++..|-|.+||.+...
T Consensus       177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA  241 (449)
T KOG1165|consen  177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA  241 (449)
T ss_pred             hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence            97744332        2456799999999999999999999999999999999999999998753

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.94  E-value=1.8e-26  Score=199.30  Aligned_cols=177  Identities=15%  Similarity=0.169  Sum_probs=137.6

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHH------HHHHHHHHHhcCCCcce
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY------MKAERDILTKVTHPFIV  178 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~~l~h~nIv  178 (355)
                      .++..++|++++.||.|+||.||++..       ..+.+|||+++......+.....      +.+|++.+.++.|++|.
T Consensus        26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~-------~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~   98 (232)
T PRK10359         26 DDFLSYNIKTIKVFRNIDDTKVSLIDT-------DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLA   98 (232)
T ss_pred             HHHhhCceEEEEEecCCCceEEEEEec-------CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCC
Confidence            345678999999999999999998653       24459999998665444444333      57899999999999999


Q ss_pred             ecceeeecC--------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC
Q 018487          179 QLRYSFQTR--------SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS  250 (355)
Q Consensus       179 ~l~~~~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~  250 (355)
                      .+.+++...        +..+++|||++|.+|.++..    +++    ....+++.+|..||+.|++|||+||+||+++.
T Consensus        99 ~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~  170 (232)
T PRK10359         99 SLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSK  170 (232)
T ss_pred             cceEeeeecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeC
Confidence            998886532        35899999999999977632    233    34569999999999999999999999999999


Q ss_pred             CCcEEEEecCCccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHH
Q 018487          251 DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML  308 (355)
Q Consensus       251 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell  308 (355)
                      +| ++|+|||............           .++....|+.++|+|+||+++..+.
T Consensus       171 ~g-i~liDfg~~~~~~e~~a~d-----------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        171 NG-LRIIDLSGKRCTAQRKAKD-----------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CC-EEEEECCCcccccchhhHH-----------HHHHHhHhcccccccceeEeehHHH
Confidence            88 9999999887653322111           1344456778999999999887553

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.93  E-value=3.4e-25  Score=186.73  Aligned_cols=134  Identities=22%  Similarity=0.206  Sum_probs=111.3

Q ss_pred             CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCCCCcccccC
Q 018487          200 GHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT  278 (355)
Q Consensus       200 gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~  278 (355)
                      |+|.+++..+ ..+++.+++.++.|++.||.|||+++      ||+|||++.++.+|+  ||++.......    ..||+
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~   68 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDP   68 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCcc
Confidence            6888998874 45999999999999999999999999      999999999999999  99988654432    25899


Q ss_pred             ccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh---------------------hhH--HHHHhhhhe
Q 018487          279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN---------------------TML--LFYLIIFHC  335 (355)
Q Consensus       279 ~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~---------------------~~~--~~~~~i~~~  335 (355)
                      .|||||++.+..++.++|||||||++|||+||+.||.........                     ...  .+.++|.+|
T Consensus        69 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~c  148 (176)
T smart00750       69 YFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVC  148 (176)
T ss_pred             cccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHH
Confidence            999999999999999999999999999999999999764321100                     001  367888899


Q ss_pred             eeecCCCcCC
Q 018487          336 LFVNSLELLS  345 (355)
Q Consensus       336 l~~~~~e~~~  345 (355)
                      |..+|.+++.
T Consensus       149 l~~~p~~Rp~  158 (176)
T smart00750      149 ASRLPQRREA  158 (176)
T ss_pred             HhcccccccC
Confidence            9888887653

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.93  E-value=3.5e-25  Score=188.69  Aligned_cols=143  Identities=19%  Similarity=0.285  Sum_probs=110.9

Q ss_pred             EeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchh-----------------------HHHHHHHHHHHHHh
Q 018487          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN-----------------------HVDYMKAERDILTK  171 (355)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~-----------------------~~~~~~~E~~~l~~  171 (355)
                      ...||+|+||.||+|...      +++.||||+++........                       .......|+.++.+
T Consensus         2 ~~~ig~G~~~~Vy~a~~~------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   75 (190)
T cd05147           2 NGCISTGKEANVYHATTA------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKR   75 (190)
T ss_pred             CCccccccceEEEEEECC------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHH
Confidence            467999999999999853      4778999999765321111                       01233459999999


Q ss_pred             cCCCcceecceeeecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCCeeccCCCCcEEecC
Q 018487          172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL-HKCGIVHRDLKPENILMDS  250 (355)
Q Consensus       172 l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~L-H~~~iiHrDlkp~NILl~~  250 (355)
                      +.++++.........  ..++||||++|+++.........+++..+..++.|++.+|.+| |+.||+||||||+|||++ 
T Consensus        76 l~~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-  152 (190)
T cd05147          76 LVTAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-  152 (190)
T ss_pred             HHHCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-
Confidence            988876543332222  2389999999987765544556789999999999999999999 799999999999999998 


Q ss_pred             CCcEEEEecCCccccC
Q 018487          251 DGHVMLTDFGLAKEID  266 (355)
Q Consensus       251 ~~~~kl~Dfg~a~~~~  266 (355)
                      ++.++|+|||+|....
T Consensus       153 ~~~v~LiDFG~a~~~~  168 (190)
T cd05147         153 DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             CCcEEEEEccccccCC
Confidence            5889999999997643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=4e-24  Score=181.04  Aligned_cols=187  Identities=18%  Similarity=0.240  Sum_probs=138.6

Q ss_pred             EEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchh-HHHHHHHHHHHHHhcC-CCcceecceeeecCCeE
Q 018487          113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN-HVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       113 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~  190 (355)
                      .+...|++|+||+||.+..       .+..++.+.+......... ....+.+|+++|+++. |++|++++++    +..
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~   73 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGR   73 (218)
T ss_pred             ccceeecCCCcceEEEeec-------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCE
Confidence            3567899999999997662       3455665655443332221 1225788999999996 5788888875    346


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccC-CCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDL-KPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDl-kp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      |++|||+.|.+|......       ....++.|++.+|.++|++||+|||| ||+|||++.++.++|+|||++.......
T Consensus        74 ~lvmeyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         74 HLDRSYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             EEEEeeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            999999999988654321       12357889999999999999999999 7999999999999999999998655433


Q ss_pred             CC--------------CcccccCccccchhhccC-CCC-CcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          270 RS--------------NSMCGTTEYMAPEILLSK-GHN-KDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       270 ~~--------------~~~~gt~~y~aPE~~~~~-~~~-~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      ..              .....++.|++|+...-- ..+ ...+.++.|.-+|.++|+++++.+.
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            21              012357788888764321 233 4679999999999999999988764

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.92  E-value=3.5e-26  Score=215.76  Aligned_cols=191  Identities=50%  Similarity=0.856  Sum_probs=168.1

Q ss_pred             eccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecceeeecCCeEEEEEec
Q 018487          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDF  196 (355)
Q Consensus       118 lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~  196 (355)
                      +|+|+||.|++++..+..  ..+..+|+|+.++......... .-..|..++..++ ||.+|++...|+.+...++++++
T Consensus         2 lg~g~~gkvfLvrk~~g~--da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~   78 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGA--DAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDF   78 (612)
T ss_pred             CCcCCCcchHHHHHhccc--cccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhh
Confidence            799999999998755433  4577899999877654443333 4456888999998 99999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCCCCcccc
Q 018487          197 INGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG  276 (355)
Q Consensus       197 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~g  276 (355)
                      ..||.|...+.....+.+.....+...++-+++++|+.+|+|||+|++||+++.+|.+++.|||+++..-.....   ||
T Consensus        79 ~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cg  155 (612)
T KOG0603|consen   79 LRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CG  155 (612)
T ss_pred             cccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---cc
Confidence            999999999999888999999999999999999999999999999999999999999999999999876444333   99


Q ss_pred             cCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCC
Q 018487          277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKS  316 (355)
Q Consensus       277 t~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~  316 (355)
                      |..|||||++.  .....+|.||||++++||+||-.||..
T Consensus       156 t~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  156 TYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             chhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence            99999999997  677889999999999999999999998

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.91  E-value=6.6e-24  Score=181.23  Aligned_cols=144  Identities=20%  Similarity=0.263  Sum_probs=112.9

Q ss_pred             EeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccch-----------------------hHHHHHHHHHHHHHh
Q 018487          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-----------------------NHVDYMKAERDILTK  171 (355)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------------------~~~~~~~~E~~~l~~  171 (355)
                      .+.||+|+||.||+|.+.      +++.||||+++.......                       .....+..|...+.+
T Consensus         2 ~~~ig~G~~~~Vy~a~~~------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   75 (190)
T cd05145           2 NGCISTGKEANVYHARTG------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKR   75 (190)
T ss_pred             CceeecCCCcEEEEEEcC------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999999853      477899999986532100                       012234678999999


Q ss_pred             cCCCcceecceeeecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEecC
Q 018487          172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDS  250 (355)
Q Consensus       172 l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDlkp~NILl~~  250 (355)
                      +.|++|.....+....  .|+||||++|+++.........++..++..++.|++.+|.+||. +||+||||||+|||++ 
T Consensus        76 l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-  152 (190)
T cd05145          76 LYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-  152 (190)
T ss_pred             HHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-
Confidence            9999875544433322  48999999988654443345667889999999999999999999 9999999999999998 


Q ss_pred             CCcEEEEecCCccccCc
Q 018487          251 DGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       251 ~~~~kl~Dfg~a~~~~~  267 (355)
                      ++.++|+|||++.....
T Consensus       153 ~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCCEEEEEcccceecCC
Confidence            89999999999987643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=5.6e-25  Score=216.29  Aligned_cols=205  Identities=25%  Similarity=0.391  Sum_probs=163.6

Q ss_pred             EEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEE
Q 018487          113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYL  192 (355)
Q Consensus       113 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  192 (355)
                      .....+|.|++|.|+.+...........+.+.+| .. ...........+..|+.+-..+.|+|++..+..+.+....+-
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~-~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~  398 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VK-PTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQ  398 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcc-cC-CcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchh
Confidence            4567899999998888776533332223333333 11 111222222236667778888999999988888777776666


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCC--
Q 018487          193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR--  270 (355)
Q Consensus       193 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~--  270 (355)
                      +||||++ +|+..+...+.+...++..+++|++.|+.|+|..||.|||||++|+++..+|.+||+|||.+..+.....  
T Consensus       399 ~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~  477 (601)
T KOG0590|consen  399 SMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN  477 (601)
T ss_pred             hhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence            6999999 9999999888899999999999999999999999999999999999999999999999999987644332  


Q ss_pred             ---CCcccccCccccchhhccCCCCC-cccHHHHHHHHHHHHcCCCCCCCchhh
Q 018487          271 ---SNSMCGTTEYMAPEILLSKGHNK-DADWWSVGILLYEMLTGQVNIKSMQVI  320 (355)
Q Consensus       271 ---~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlG~~l~elltg~~pf~~~~~~  320 (355)
                         ....+|+-.|+|||++.+..|++ ..||||.|+++..|.+|+.||+.....
T Consensus       478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~  531 (601)
T KOG0590|consen  478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS  531 (601)
T ss_pred             hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence               35678999999999999999986 579999999999999999999876443

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=2.4e-23  Score=209.10  Aligned_cols=198  Identities=20%  Similarity=0.387  Sum_probs=162.7

Q ss_pred             hhcCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC---CCccee
Q 018487          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT---HPFIVQ  179 (355)
Q Consensus       103 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~  179 (355)
                      ....+....|.|.+.||+|+||.||+|...      .++.||||+-+....++-..-.      +++.+|+   -+.|..
T Consensus       691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~------~~~~~alK~e~P~~~WEfYI~~------q~~~RLk~~~~~~~~~  758 (974)
T KOG1166|consen  691 TEFEVGGEKFCISKEIGEGSYGSVYVATHS------NGKLVALKVEKPPNPWEFYICL------QVMERLKPQMLPSIMH  758 (974)
T ss_pred             ceeeecceeEEEEeeeccccceEEEEeecC------CCcEEEEEeecCCCceeeeehH------HHHHhhchhhhcchHH
Confidence            333456678999999999999999999865      2889999998776555432222      2333333   345666


Q ss_pred             cceeeecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC-------CC
Q 018487          180 LRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-------DG  252 (355)
Q Consensus       180 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~-------~~  252 (355)
                      +...+...+..++|+||.+.|+|.+++...+.+++..+..+..|+++.++.||..+|||+||||+|+||..       ..
T Consensus       759 ~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~  838 (974)
T KOG1166|consen  759 ISSAHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSK  838 (974)
T ss_pred             HHHHHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCccc
Confidence            66677777888999999999999999998888999999999999999999999999999999999999942       33


Q ss_pred             cEEEEecCCccccC---cCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCC
Q 018487          253 HVMLTDFGLAKEID---ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQV  312 (355)
Q Consensus       253 ~~kl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~  312 (355)
                      -++|+|||.+..+.   +.......++|-.+-.+|+..|+.|+..+|.|.|+.+++.||.|+.
T Consensus       839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            69999999987552   3334456678899999999999999999999999999999999976

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.89  E-value=3.5e-22  Score=177.73  Aligned_cols=224  Identities=24%  Similarity=0.299  Sum_probs=144.3

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCC---C-------cceec
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH---P-------FIVQL  180 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~-------nIv~l  180 (355)
                      .+...+.||.|+++.||.|.+.     ++++.+|||++...........+.+++|.-....+.+   |       .++..
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~-----~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P   87 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDV-----ETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP   87 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEET-----TTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred             EEEEccccccCCceEEEEEEEc-----cCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence            4677889999999999999976     6788999999876665555667777776655544332   1       12222


Q ss_pred             ceee---------ecC---C-----eEEEEEeccCCCChHHHHH---hcCCC----CHHHHHHHHHHHHHHHHHHHHCCC
Q 018487          181 RYSF---------QTR---S-----KLYLILDFINGGHLFFHLY---RQGIF----REDQARFYTAEIVSAVSHLHKCGI  236 (355)
Q Consensus       181 ~~~~---------~~~---~-----~~~lv~e~~~~gsL~~~l~---~~~~l----~~~~~~~i~~ql~~~L~~LH~~~i  236 (355)
                      ++..         ...   .     ..+++|+-+.+ +|.+.+.   .....    .......+..|+++.+++||..|+
T Consensus        88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~Gl  166 (288)
T PF14531_consen   88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGL  166 (288)
T ss_dssp             SEEEEETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             eEEEEEcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcce
Confidence            2221         111   1     24678888755 7766643   33222    112223455899999999999999


Q ss_pred             eeccCCCCcEEecCCCcEEEEecCCccccCcCCCCCcccccCccccchhhccC--------CCCCcccHHHHHHHHHHHH
Q 018487          237 VHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK--------GHNKDADWWSVGILLYEML  308 (355)
Q Consensus       237 iHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DiwSlG~~l~ell  308 (355)
                      +|+||+|+|+|++.+|.++|+||+.....+.....  ...+..|.+||.....        .++.+.|.|+||+++|.|+
T Consensus       167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             EEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             EecccceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            99999999999999999999999987765443322  3345789999987532        4678899999999999999


Q ss_pred             cCCCCCCCchhhhhhh---------hHHHHHhhhheeeecCCC
Q 018487          309 TGQVNIKSMQVIACNT---------MLLFYLIIFHCLFVNSLE  342 (355)
Q Consensus       309 tg~~pf~~~~~~~~~~---------~~~~~~~i~~~l~~~~~e  342 (355)
                      +|+.||..........         .+.....|...|++++.+
T Consensus       245 C~~lPf~~~~~~~~~~~~f~~C~~~Pe~v~~LI~~lL~~~~~~  287 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEWDFSRCRDMPEPVQFLIRGLLQRNPED  287 (288)
T ss_dssp             HSS-STCCCGGGSTSGGGGTTSS---HHHHHHHHHHT-SSGGG
T ss_pred             HccCCCCCCCccccccccchhcCCcCHHHHHHHHHHccCCccc
Confidence            9999998664433222         234555666666666544

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.87  E-value=1.7e-23  Score=207.24  Aligned_cols=203  Identities=25%  Similarity=0.373  Sum_probs=160.6

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccc-cc-hhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-IK-KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      +|...+.||.+.|=+|.+|++.       ++.|+||++.+... .. ....+++ +|++ ...+++||++++.-+.....
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-------eG~vVvKVFvk~~p~~sL~~~~qrL-~~ik-~~l~~~pn~lPfqk~~~t~k   94 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-------EGLVVVKVFVKQDPTISLRPFKQRL-EEIK-FALMKAPNCLPFQKVLVTDK   94 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-------CceEEEEEEeccCCCCCchHHHHHH-HHHH-HHhhcCCcccchHHHHHhhH
Confidence            7889999999999999999854       45599999876541 12 2233333 3455 66778999999988877778


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc---
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---  265 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~---  265 (355)
                      ..|||-+|+.. +|++++..+..+..-+.+.|+.|++.||.-+|+.||+|||||.+||||+.-+.+.|+||..-+..   
T Consensus        95 AAylvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP  173 (1431)
T KOG1240|consen   95 AAYLVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP  173 (1431)
T ss_pred             HHHHHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCC
Confidence            88999999976 89999999988999999999999999999999999999999999999999999999999976532   


Q ss_pred             -CcCCCCCccccc----CccccchhhccC----------C-CCCcccHHHHHHHHHHHHc-CCCCCCCchhhhhh
Q 018487          266 -DESSRSNSMCGT----TEYMAPEILLSK----------G-HNKDADWWSVGILLYEMLT-GQVNIKSMQVIACN  323 (355)
Q Consensus       266 -~~~~~~~~~~gt----~~y~aPE~~~~~----------~-~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~~  323 (355)
                       ++......+..|    ..|.|||.+...          . .+++.||||+||+++||++ |+.+|.-.+..+..
T Consensus       174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr  248 (1431)
T KOG1240|consen  174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYR  248 (1431)
T ss_pred             CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHh
Confidence             122222222222    469999987642          1 4678999999999999998 78888877666643

>PRK10345 hypothetical protein; Provisional

Probab=99.87  E-value=1.5e-21  Score=167.96  Aligned_cols=135  Identities=18%  Similarity=0.168  Sum_probs=104.1

Q ss_pred             EeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-----CCCcceecceeeecCC-
Q 018487          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-----THPFIVQLRYSFQTRS-  188 (355)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~nIv~l~~~~~~~~-  188 (355)
                      .+.||+|+||.||.  +.     .... .+||++.....   ...+.+.+|+.+++.+     .||||+++++++.++. 
T Consensus         7 ~~~LG~G~~~~Vy~--hp-----~~~~-k~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g   75 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HP-----EDAQ-RCIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG   75 (210)
T ss_pred             cceecCCCceEEEE--CC-----CCcC-eEEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC
Confidence            46899999999995  33     2222 46898865432   2345688999999999     5799999999998763 


Q ss_pred             --eEE-EEEec--cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHCCCeeccCCCCcEEecC----CCcEEEEe
Q 018487          189 --KLY-LILDF--INGGHLFFHLYRQGIFREDQARFYTAEIVSAV-SHLHKCGIVHRDLKPENILMDS----DGHVMLTD  258 (355)
Q Consensus       189 --~~~-lv~e~--~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L-~~LH~~~iiHrDlkp~NILl~~----~~~~kl~D  258 (355)
                        .++ +||||  +.+++|.+++... .+.+.  ..++.|++.++ +|||+++|+||||||+|||++.    ++.++|+|
T Consensus        76 ~g~v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         76 TGYVYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             CeEEEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence              434 78999  5579999999663 46655  35678888777 9999999999999999999974    33799999


Q ss_pred             cCCcc
Q 018487          259 FGLAK  263 (355)
Q Consensus       259 fg~a~  263 (355)
                      |+-+.
T Consensus       153 g~G~~  157 (210)
T PRK10345        153 NIGES  157 (210)
T ss_pred             CCCCc
Confidence            55443

>smart00090 RIO RIO-like kinase

Probab=99.87  E-value=1.1e-21  Score=172.83  Aligned_cols=149  Identities=23%  Similarity=0.244  Sum_probs=113.7

Q ss_pred             CeEEEeeeccCCcEEEEEEE-EcCCCCCCCCceEEEEEeecccccc---------------------hhHHHHHHHHHHH
Q 018487          111 DFEIFRVVGQGAFGKVFQVK-KKGVDDGDSDGIYAMKVMRKDTIIK---------------------KNHVDYMKAERDI  168 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~-~~~~~~~~~~~~vavK~~~~~~~~~---------------------~~~~~~~~~E~~~  168 (355)
                      -|.+.+.||+|+||.||+|. +.     .+++.||+|+++......                     ......+..|..+
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~-----~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~  103 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFD-----GSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN  103 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecC-----CCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence            58899999999999999998 33     357889999987543110                     0112345679999


Q ss_pred             HHhcCCCcceecceeeecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-CeeccCCCCcEE
Q 018487          169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG-IVHRDLKPENIL  247 (355)
Q Consensus       169 l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~-iiHrDlkp~NIL  247 (355)
                      ++++.+.. +.+...+.. ...++||||++|++|.........+...++..++.|++.+|.+||..| |+||||||+||+
T Consensus       104 L~~L~~~~-i~~p~~~~~-~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl  181 (237)
T smart00090      104 LQRLYEAG-VPVPKPIAW-RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL  181 (237)
T ss_pred             HHHHHhcC-CCCCeeeEe-cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence            99997533 222222222 235899999999888665544455677778899999999999999999 999999999999


Q ss_pred             ecCCCcEEEEecCCccccCc
Q 018487          248 MDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       248 l~~~~~~kl~Dfg~a~~~~~  267 (355)
                      ++ ++.++|+|||.+.....
T Consensus       182 i~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      182 VH-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             EE-CCCEEEEEChhhhccCC
Confidence            98 88999999999876543

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.86  E-value=3.4e-22  Score=171.02  Aligned_cols=222  Identities=19%  Similarity=0.310  Sum_probs=171.7

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .+...+.-+|.+...|..|+++|++-       .+++|++..+... ......|..|.-.|+-+.||||+.+++.|....
T Consensus       189 ~~~lnl~tkl~e~hsgelwrgrwqgn-------divakil~vr~~t-~risrdfneefp~lrifshpnilpvlgacnspp  260 (448)
T KOG0195|consen  189 VSSLNLITKLAESHSGELWRGRWQGN-------DIVAKILNVREVT-ARISRDFNEEFPALRIFSHPNILPVLGACNSPP  260 (448)
T ss_pred             hhhhhhhhhhccCCCcccccccccCc-------chhhhhhhhhhcc-hhhcchhhhhCcceeeecCCchhhhhhhccCCC
Confidence            34566677899999999999998843       3667887665533 223345777888899999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCcEEecCCCcEEEE--ecCCc
Q 018487          189 KLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDGHVMLT--DFGLA  262 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~ql~~~L~~LH~~~--iiHrDlkp~NILl~~~~~~kl~--Dfg~a  262 (355)
                      ++.++..||+.|+|+..+.....  +...++..++.++++|++|||+..  |.---|.+..+++|++.+.+|.  |--++
T Consensus       261 nlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs  340 (448)
T KOG0195|consen  261 NLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS  340 (448)
T ss_pred             CceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee
Confidence            99999999999999999987654  677899999999999999999886  4445789999999998876654  32222


Q ss_pred             cccCcCCCCCcccccCccccchhhccCCCC---CcccHHHHHHHHHHHHcCCCCCCCchhhhhhhhHH------------
Q 018487          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHN---KDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLL------------  327 (355)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwSlG~~l~elltg~~pf~~~~~~~~~~~~~------------  327 (355)
                        +....    ..-.+.||+||.+..++-+   .++|+|||++++|||.|..+||.......|...+.            
T Consensus       341 --fqe~g----r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgi  414 (448)
T KOG0195|consen  341 --FQEVG----RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGI  414 (448)
T ss_pred             --eeccc----cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCc
Confidence              22222    2346889999999876543   47899999999999999999999887766665542            


Q ss_pred             ---HHHhhhheeeecCCCcC
Q 018487          328 ---FYLIIFHCLFVNSLELL  344 (355)
Q Consensus       328 ---~~~~i~~~l~~~~~e~~  344 (355)
                         ....+.-|+..+|-+++
T Consensus       415 s~hm~klm~icmnedpgkrp  434 (448)
T KOG0195|consen  415 SRHMNKLMNICMNEDPGKRP  434 (448)
T ss_pred             cHHHHHHHHHHhcCCCCcCC
Confidence               23445567777766644

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=1.9e-20  Score=162.51  Aligned_cols=138  Identities=20%  Similarity=0.318  Sum_probs=113.6

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccc-----hhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-----KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      +.||+|++|.||+|.+.       +..+++|+........     ......+.+|+.++..+.|++|.....++......
T Consensus         2 ~~l~~G~~~~vy~~~~~-------~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFL-------GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENF   74 (211)
T ss_pred             cccccCceEEEEEEeeC-------CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCC
Confidence            57999999999999863       4458899865433211     11234577899999999999988777777777788


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      +++|||++|++|.+.+.....    ....++.+++.+|.+||+.|++|||++|.|||++ ++.++|+|||.+...
T Consensus        75 ~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~  144 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS  144 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence            999999999999988865432    7888999999999999999999999999999998 889999999998763

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.84  E-value=2.6e-21  Score=191.64  Aligned_cols=165  Identities=44%  Similarity=0.784  Sum_probs=124.3

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      ..+|..++.|..|+||.||.++++     .+.+.+|+|+ .++...       +++   ++.....|.+|          
T Consensus        82 e~df~~IklisngAygavylvrh~-----~trqrfa~ki-Nkq~li-------lRn---ilt~a~npfvv----------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHK-----ETRQRFAMKI-NKQNLI-------LRN---ILTFAGNPFVV----------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeecc-----ccccchhhcc-cccchh-------hhc---cccccCCccee----------
Confidence            357999999999999999999987     4566688744 322211       111   23333333333          


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                                 |+=...++..+.++..        ++.+++|||+.||+|||+||+|.||+.-|.+|+.|||+++.....
T Consensus       136 -----------gDc~tllk~~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms  196 (1205)
T KOG0606|consen  136 -----------GDCATLLKNIGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS  196 (1205)
T ss_pred             -----------chhhhhcccCCCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence                       3333444444454433        378999999999999999999999999999999999998753211


Q ss_pred             C----------------CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          269 S----------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       269 ~----------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      .                .....|||+.|.|||++..+.|...+|+|++|+++||.+-|.+||.+..
T Consensus       197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdt  262 (1205)
T KOG0606|consen  197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT  262 (1205)
T ss_pred             ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCC
Confidence            1                1234689999999999999999999999999999999999999999873

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.84  E-value=2.6e-20  Score=160.21  Aligned_cols=134  Identities=22%  Similarity=0.243  Sum_probs=107.2

Q ss_pred             eeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccc-----hhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEE
Q 018487          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-----KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (355)
Q Consensus       117 ~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  191 (355)
                      .||+|+||.||++.+.       ++.+++|+........     ......+.+|+++++.++|+++.....++......+
T Consensus         1 ~ig~G~~~~vy~~~~~-------~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL-------GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKT   73 (199)
T ss_pred             CCCCCceEEEEEeecC-------CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCE
Confidence            3899999999999853       4568999865432111     122356778999999999887665555556666779


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       192 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      +||||++|++|.+.+.....       .++.+++.+|.+||+.|++|||++|+||+++ ++.++++|||++...
T Consensus        74 lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             EEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            99999999999887754321       7889999999999999999999999999998 899999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.83  E-value=4.4e-20  Score=158.76  Aligned_cols=141  Identities=18%  Similarity=0.191  Sum_probs=108.2

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccch-------------------hHHHHHHHHHHHHHh
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-------------------NHVDYMKAERDILTK  171 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-------------------~~~~~~~~E~~~l~~  171 (355)
                      .|.+.+.||+|+||.||++...      +++.||||+++.......                   ........|..++..
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   89 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA   89 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence            3888899999999999999853      477899999765321000                   011235678888998


Q ss_pred             cCCCc--ceecceeeecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEec
Q 018487          172 VTHPF--IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD  249 (355)
Q Consensus       172 l~h~n--Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~  249 (355)
                      +.|.+  +...++    ....++||||++|++|.....      ......++.+++.++.++|+.||+||||||+||+++
T Consensus        90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~  159 (198)
T cd05144          90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD  159 (198)
T ss_pred             HHHcCCCCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc
Confidence            88774  333333    244589999999998865432      134667889999999999999999999999999999


Q ss_pred             CCCcEEEEecCCccccCc
Q 018487          250 SDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       250 ~~~~~kl~Dfg~a~~~~~  267 (355)
                      .++.++|+|||++..+..
T Consensus       160 ~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         160 DDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCCcEEEEECCccccCCC
Confidence            999999999999976544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.82  E-value=6.1e-20  Score=180.77  Aligned_cols=140  Identities=22%  Similarity=0.248  Sum_probs=111.5

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccc-----cchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-----IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      .|...++||+|+||+||++.+.+       +.+++|+......     ......+.+.+|+.+++.++|++|+....++.
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~-------~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~  406 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLG-------RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV  406 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecC-------ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE
Confidence            45667899999999999988652       2234443222111     11223456788999999999999988777777


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      .....++||||++|++|.+++.        ....++.|++++|.+||+.|++||||||+|||+ .++.++|+|||+++..
T Consensus       407 ~~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        407 DPEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             eCCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            7777899999999999988775        356789999999999999999999999999999 6789999999999865


Q ss_pred             C
Q 018487          266 D  266 (355)
Q Consensus       266 ~  266 (355)
                      .
T Consensus       478 ~  478 (535)
T PRK09605        478 D  478 (535)
T ss_pred             C
Confidence            3

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.82  E-value=9.9e-21  Score=169.83  Aligned_cols=209  Identities=28%  Similarity=0.414  Sum_probs=145.4

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCC------------------------------CCCCceEEEEEeeccccc-
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDD------------------------------GDSDGIYAMKVMRKDTII-  154 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~------------------------------~~~~~~vavK~~~~~~~~-  154 (355)
                      ++..++|++...||+|+...||.|.......                              ....-+.|||.+..-... 
T Consensus       153 kFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s  232 (598)
T KOG4158|consen  153 KFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDS  232 (598)
T ss_pred             ccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCC
Confidence            3445789999999999999999987653111                              001124566655332211 


Q ss_pred             -chhHHHHHHHHHH------HH--------Hh--------cCCCcceecceeeec-------------------------
Q 018487          155 -KKNHVDYMKAERD------IL--------TK--------VTHPFIVQLRYSFQT-------------------------  186 (355)
Q Consensus       155 -~~~~~~~~~~E~~------~l--------~~--------l~h~nIv~l~~~~~~-------------------------  186 (355)
                       ....++.+.+|..      ++        +.        -+|||||++.++|.+                         
T Consensus       233 ~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~  312 (598)
T KOG4158|consen  233 GDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGA  312 (598)
T ss_pred             chHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccccc
Confidence             1222333333321      11        11        259999998877632                         


Q ss_pred             --CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEec--CCC--cEEEEecC
Q 018487          187 --RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD--SDG--HVMLTDFG  260 (355)
Q Consensus       187 --~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~--~~~--~~kl~Dfg  260 (355)
                        +..+|+||.-.+. +|..++..+.. +....+.++.|+++|+.|||++||.|||+|++|||+.  +|+  .+.|+|||
T Consensus       313 g~~~tlylvMkrY~~-tLr~yl~~~~~-s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFG  390 (598)
T KOG4158|consen  313 GEPKTLYLVMKRYRQ-TLREYLWTRHR-SYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFG  390 (598)
T ss_pred             CCCceEEEehhcchh-hHHHHHhcCCC-chHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccc
Confidence              2358999988865 88888876654 6777888999999999999999999999999999994  333  58999999


Q ss_pred             CccccCc-------CCCCCcccccCccccchhhccCC------CCCcccHHHHHHHHHHHHcCCCCCCC
Q 018487          261 LAKEIDE-------SSRSNSMCGTTEYMAPEILLSKG------HNKDADWWSVGILLYEMLTGQVNIKS  316 (355)
Q Consensus       261 ~a~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwSlG~~l~elltg~~pf~~  316 (355)
                      .+---+.       ....-..-|.-.-||||+....+      .-.++|.|+.|.+.||+++...||.+
T Consensus       391 CcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~  459 (598)
T KOG4158|consen  391 CCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK  459 (598)
T ss_pred             eeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence            7743221       11112234777899999986432      12479999999999999999999998

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.78  E-value=1.6e-18  Score=147.58  Aligned_cols=140  Identities=24%  Similarity=0.301  Sum_probs=97.3

Q ss_pred             EeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHH---------------------HHHHHHHHHhcC
Q 018487          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY---------------------MKAERDILTKVT  173 (355)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~---------------------~~~E~~~l~~l~  173 (355)
                      .+.||+|+||+||+|...      .++.||||+++............                     ...|...+..+.
T Consensus         2 ~~~lg~G~~g~Vy~a~~~------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~   75 (187)
T cd05119           2 GGPIGTGKEADVYLALDG------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLY   75 (187)
T ss_pred             CcccccccceeEEEEECC------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHH
Confidence            467999999999999854      46789999987643221111111                     134555555554


Q ss_pred             CCc--ceecceeeecCCeEEEEEeccCCCChHHH-HHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEec
Q 018487          174 HPF--IVQLRYSFQTRSKLYLILDFINGGHLFFH-LYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMD  249 (355)
Q Consensus       174 h~n--Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDlkp~NILl~  249 (355)
                      +..  +.+.++.    ...++||||++++.+... +... .. ..++..++.+++.++.++|. .||+||||||+||+++
T Consensus        76 ~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~  149 (187)
T cd05119          76 EAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD  149 (187)
T ss_pred             HcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE
Confidence            332  3333322    235899999999543211 1111 11 16788899999999999999 9999999999999999


Q ss_pred             CCCcEEEEecCCccccCc
Q 018487          250 SDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       250 ~~~~~kl~Dfg~a~~~~~  267 (355)
                       ++.++|+|||.+.....
T Consensus       150 -~~~~~liDfg~a~~~~~  166 (187)
T cd05119         150 -DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             -CCcEEEEECcccccccC
Confidence             99999999999976544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.78  E-value=3.1e-20  Score=172.56  Aligned_cols=125  Identities=27%  Similarity=0.418  Sum_probs=109.2

Q ss_pred             CeEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          188 SKLYLILDFINGGHLFFHLYRQGI---FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~~---l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      .++||.|++|.-.+|.+|+.++..   .+......++.|++.|++|   +|.+|||+||.||++..+..+||.|||+...
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            368999999999999999986543   5677888999999999999   9999999999999999999999999999887


Q ss_pred             cCcCC-------CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCC
Q 018487          265 IDESS-------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIK  315 (355)
Q Consensus       265 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~  315 (355)
                      .....       .....+||..||+||.+.++.|+.++||||||++|+||++ -...|.
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e  464 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE  464 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH
Confidence            65544       3456789999999999999999999999999999999996 334443

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.77  E-value=6.5e-18  Score=149.07  Aligned_cols=138  Identities=23%  Similarity=0.324  Sum_probs=102.9

Q ss_pred             eeec-cCCcEEEEEEEEcCCCCCCCCceEEEEEeecccc----------cchhHHHHHHHHHHHHHhcCCCcc--eecce
Q 018487          116 RVVG-QGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI----------IKKNHVDYMKAERDILTKVTHPFI--VQLRY  182 (355)
Q Consensus       116 ~~lG-~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~nI--v~l~~  182 (355)
                      ..|| .||.|+||.+...       ++.++||.+.....          ........+.+|+.++..++|++|  +..++
T Consensus        37 ~~lg~~~g~gtv~~v~~~-------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~  109 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIA  109 (239)
T ss_pred             ceeecCCCCccEEEEEeC-------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEe
Confidence            3577 7888888888743       55688998754221          111233567889999999998875  55665


Q ss_pred             eeecC-C---eEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEE
Q 018487          183 SFQTR-S---KLYLILDFING-GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT  257 (355)
Q Consensus       183 ~~~~~-~---~~~lv~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~  257 (355)
                      +.... .   ..++|||+++| .+|.+++.. ..+++..    +.|++.+|.+||++||+||||||+|||++.++.++|+
T Consensus       110 ~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        110 ARVVRHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             eeeeecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEE
Confidence            54332 2   23599999997 688777754 3455543    5689999999999999999999999999999999999


Q ss_pred             ecCCcccc
Q 018487          258 DFGLAKEI  265 (355)
Q Consensus       258 Dfg~a~~~  265 (355)
                      |||.+...
T Consensus       185 Dfg~~~~~  192 (239)
T PRK01723        185 DFDRGELR  192 (239)
T ss_pred             ECCCcccC
Confidence            99988753

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.74  E-value=2e-17  Score=134.95  Aligned_cols=132  Identities=21%  Similarity=0.290  Sum_probs=110.3

Q ss_pred             EEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCC--CcceecceeeecCCeEE
Q 018487          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH--PFIVQLRYSFQTRSKLY  191 (355)
Q Consensus       114 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~  191 (355)
                      +++.||+|.++.||++...       ++.+++|.......     ...+.+|+.+++.+++  .++++++.++...+..+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~-------~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~   69 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK-------DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSY   69 (155)
T ss_pred             cceecccccccceEEEEec-------CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccE
Confidence            4578999999999999964       25699998865432     3457789999999976  58888888888878899


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC---GIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       192 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~---~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      ++|||++|+.+...       +......++.+++++|++||..   +++|+|++|+||+++.++.++++|||.+..
T Consensus        70 ~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          70 LLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            99999999877543       5566777889999999999985   699999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.70  E-value=8.3e-19  Score=172.81  Aligned_cols=204  Identities=28%  Similarity=0.467  Sum_probs=166.8

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecceeeecCCe
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSK  189 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~  189 (355)
                      .|.+.+.||+|+|+.|-.+...+    .....+|+|.+.... ......+.+..|..+-+.+. |.|++.+++.......
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~----~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~   95 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSR----DPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRS   95 (601)
T ss_pred             cccccccccccccchhhhhhhcC----CCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcc
Confidence            47777779999999998776542    234456666654432 23444455666787777787 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-HCCCeeccCCCCcEEecCCC-cEEEEecCCcccc
Q 018487          190 LYLILDFINGGHLFFHL-YRQG-IFREDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEI  265 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l-~~~~-~l~~~~~~~i~~ql~~~L~~LH-~~~iiHrDlkp~NILl~~~~-~~kl~Dfg~a~~~  265 (355)
                      .+++++|..|++++..+ .... ..+...+..++.|+..++.|+| ..++.|+||||+|.+++..+ .+++.|||+|..+
T Consensus        96 ~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen   96 YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence            99999999999998888 5444 5788889999999999999999 99999999999999999999 9999999999877


Q ss_pred             Cc-CCC---CCcccc-cCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCchh
Q 018487          266 DE-SSR---SNSMCG-TTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSMQV  319 (355)
Q Consensus       266 ~~-~~~---~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~~~  319 (355)
                      .. ...   ....+| ++.|+|||...+. ......|+||.|+++.-+++|..||.....
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~  235 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR  235 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc
Confidence            55 221   234578 9999999999885 456789999999999999999999987644

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.64  E-value=5.1e-16  Score=146.95  Aligned_cols=149  Identities=23%  Similarity=0.310  Sum_probs=125.1

Q ss_pred             HHhcCCCcceecceeeecCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCC-eeccCCCCcE
Q 018487          169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGI-VHRDLKPENI  246 (355)
Q Consensus       169 l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~i-iHrDlkp~NI  246 (355)
                      |+.+.|.|+.++++.+.++...++|.+||..|+|.+.+... ..+++--...++++++.||.|||.-.| .|+.+++.|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            46788999999999999999999999999999999999874 347777778899999999999998765 9999999999


Q ss_pred             EecCCCcEEEEecCCccccCcC---CCCCcccccCccccchhhccCC-------CCCcccHHHHHHHHHHHHcCCCCCCC
Q 018487          247 LMDSDGHVMLTDFGLAKEIDES---SRSNSMCGTTEYMAPEILLSKG-------HNKDADWWSVGILLYEMLTGQVNIKS  316 (355)
Q Consensus       247 Ll~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwSlG~~l~elltg~~pf~~  316 (355)
                      ++|....+||.|||+.......   .......-..-|.|||.+.+..       .+.+.||||||++++|+++.+-||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            9999999999999998765321   1111222346699999998631       35679999999999999999999987


Q ss_pred             c
Q 018487          317 M  317 (355)
Q Consensus       317 ~  317 (355)
                      .
T Consensus       161 ~  161 (484)
T KOG1023|consen  161 R  161 (484)
T ss_pred             c
Confidence            4

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.61  E-value=5.9e-15  Score=141.16  Aligned_cols=143  Identities=17%  Similarity=0.272  Sum_probs=96.3

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccch-------------------------------hHHH----
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-------------------------------NHVD----  160 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-------------------------------~~~~----  160 (355)
                      +.||.|++|+||+|+.+      +++.||||+.+......-                               +...    
T Consensus       123 ~plasaSigQVh~A~l~------~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~  196 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV------DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR  196 (437)
T ss_pred             cceeeeehhheEEEEec------CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence            56999999999999975      467899999865421100                               0000    


Q ss_pred             --HHHHHHHHHHhcC-----CCcceecceeeecCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHH
Q 018487          161 --YMKAERDILTKVT-----HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVS-AVSHL  231 (355)
Q Consensus       161 --~~~~E~~~l~~l~-----h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~-~L~~L  231 (355)
                        .+.+|...+.++.     +++|.-..-++...+..++||||++|++|.+..... ...   ....++.+++. .+..+
T Consensus       197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql  273 (437)
T TIGR01982       197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQV  273 (437)
T ss_pred             HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHH
Confidence              1223444444432     333332222223344578999999999997765432 112   23445666665 46789


Q ss_pred             HHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       232 H~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      |..|++|+|++|.||+++.+++++++|||++..+..
T Consensus       274 ~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       274 LRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HhCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            999999999999999999999999999999987754

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.60  E-value=1.2e-15  Score=147.78  Aligned_cols=142  Identities=22%  Similarity=0.397  Sum_probs=95.3

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccc-------------------------------hhHH
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-------------------------------KNHV  159 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------------------------~~~~  159 (355)
                      +|.. +.||.|++|+||+|+.+     .+++.||||+.++.....                               .+..
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~-----~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~  194 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLK-----DNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFE  194 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEEC-----CCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHH
Confidence            4665 78999999999999987     347889999997642100                               1122


Q ss_pred             HHHHHHHHHHHhcCCCcceecceeeec-------------CCeEEEEEeccCCCChHHH--HHhcC----CCCHHHHHHH
Q 018487          160 DYMKAERDILTKVTHPFIVQLRYSFQT-------------RSKLYLILDFINGGHLFFH--LYRQG----IFREDQARFY  220 (355)
Q Consensus       160 ~~~~~E~~~l~~l~h~nIv~l~~~~~~-------------~~~~~lv~e~~~~gsL~~~--l~~~~----~l~~~~~~~i  220 (355)
                      +.+.+|+++.+..  .|+.++...|..             ....++||||++|+.+.+.  +...+    .+.+..+..+
T Consensus       195 ~~l~~ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~  272 (537)
T PRK04750        195 KTLHDELDLMREA--ANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVF  272 (537)
T ss_pred             HHHHHhhCHHHHH--HHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHH
Confidence            3344455444433  233333333322             3345699999999998764  33333    2334444445


Q ss_pred             HHHHHHHHHHHHHCCCeeccCCCCcEEecCCC----cEEEEecCCccccCc
Q 018487          221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDG----HVMLTDFGLAKEIDE  267 (355)
Q Consensus       221 ~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~----~~kl~Dfg~a~~~~~  267 (355)
                      +.|+       ...|++|+|+||.||+++.+|    +++++|||++..++.
T Consensus       273 ~~Qi-------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        273 FTQV-------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHH-------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            5554       469999999999999999888    999999999987654

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.57  E-value=3.2e-14  Score=120.51  Aligned_cols=147  Identities=18%  Similarity=0.249  Sum_probs=102.4

Q ss_pred             eeeccCCcEEEEEEEEcCCC-CCCCCceEEEEEeeccccc-------------------chhHHHHH----HHHHHHHHh
Q 018487          116 RVVGQGAFGKVFQVKKKGVD-DGDSDGIYAMKVMRKDTII-------------------KKNHVDYM----KAERDILTK  171 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~-~~~~~~~vavK~~~~~~~~-------------------~~~~~~~~----~~E~~~l~~  171 (355)
                      ..||.|.-+.||.|...... ....+..+|||+.+.....                   .......+    .+|.+.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            46899999999999743100 0013568999997642110                   01112223    378999998


Q ss_pred             cCC--CcceecceeeecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCCeeccCCCCcEEe
Q 018487          172 VTH--PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL-HKCGIVHRDLKPENILM  248 (355)
Q Consensus       172 l~h--~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~L-H~~~iiHrDlkp~NILl  248 (355)
                      +..  -++.+++++    ..-++||||+.+..+.....+...+++.++..+..+++.+|..| |+.|++|+||++.|||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~  158 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLW  158 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence            864  345555543    34689999998754433222333456667788899999999998 89999999999999999


Q ss_pred             cCCCcEEEEecCCccccCc
Q 018487          249 DSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       249 ~~~~~~kl~Dfg~a~~~~~  267 (355)
                      . ++.+.|+|||.+...+.
T Consensus       159 ~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         159 H-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             E-CCcEEEEECCCceeCCC
Confidence            6 57899999998876644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.55  E-value=1.9e-14  Score=120.29  Aligned_cols=128  Identities=23%  Similarity=0.291  Sum_probs=94.3

Q ss_pred             EeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCccee-cceeeecCCeEEEE
Q 018487          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQ-LRYSFQTRSKLYLI  193 (355)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~-l~~~~~~~~~~~lv  193 (355)
                      ++.|+.|.++.||+++..       ++.|++|+......    ....+..|..+++.+.+.++++ ++...  ....++|
T Consensus         3 ~~~l~~G~~~~vy~~~~~-------~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv   69 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-------NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLI   69 (170)
T ss_pred             eeecCCcccCceEEEEEC-------CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEE
Confidence            467899999999998853       55699998765431    1123467888888887655443 44333  2335799


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCC-----eeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          194 LDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGI-----VHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       194 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~i-----iHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      |||++|.++...        ......++.+++++|+.||..++     +|+|++|.||+++ ++.++++|||.+..
T Consensus        70 ~e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          70 TEFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             EEecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            999999887532        11123456799999999999985     9999999999998 67899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.52  E-value=1.3e-13  Score=113.19  Aligned_cols=135  Identities=23%  Similarity=0.251  Sum_probs=102.9

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeeccc-----ccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDT-----IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      ..+++|+-+.+|.+.+.+       ..+++|.-.+..     ...+-..++..+|..++.+++--.|...+-++.+.+..
T Consensus         2 ~~i~~GAEa~i~~~~~~g-------~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~   74 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLG-------LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNG   74 (204)
T ss_pred             chhhCCcceeEEeeeccC-------cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC
Confidence            357899999999987652       236666533322     22333345567899999998866666666666777778


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      .|+|||++|..|.+.+...       ...+++.+-.-+.-||..||+|+||.++||++..+ ++.++|||++..-
T Consensus        75 ~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~s  141 (204)
T COG3642          75 LIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEFS  141 (204)
T ss_pred             EEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCccccc
Confidence            9999999998888888765       25577788888899999999999999999999654 4999999999753

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.51  E-value=2.3e-13  Score=130.51  Aligned_cols=163  Identities=20%  Similarity=0.334  Sum_probs=125.0

Q ss_pred             CCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEEEeccCCCChHHHHHhcCCCCHHHH
Q 018487          138 DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA  217 (355)
Q Consensus       138 ~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~  217 (355)
                      ..+..|.|.+.+....   ...+...+-+..|+.++||||+++++.+...+..|+|+|-+.  -|..++...+   ...+
T Consensus        35 ~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~---~~~v  106 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG---KEEV  106 (690)
T ss_pred             ccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---HHHH
Confidence            3455677766654432   444556778889999999999999999999999999999986  4666676654   6778


Q ss_pred             HHHHHHHHHHHHHHH-HCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCC-CCcccccCccccchhhccCCCCCcc
Q 018487          218 RFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR-SNSMCGTTEYMAPEILLSKGHNKDA  295 (355)
Q Consensus       218 ~~i~~ql~~~L~~LH-~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~  295 (355)
                      ...+.||+.||.||| +.+++|++|.-..|+++..|..||++|.++........ .....---.|..|+.+....  -..
T Consensus       107 ~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~  184 (690)
T KOG1243|consen  107 CLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSI  184 (690)
T ss_pred             HHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cch
Confidence            888999999999997 67899999999999999999999999998866543331 11112223466666553222  346


Q ss_pred             cHHHHHHHHHHHHcC
Q 018487          296 DWWSVGILLYEMLTG  310 (355)
Q Consensus       296 DiwSlG~~l~elltg  310 (355)
                      |.|-|||++++++.|
T Consensus       185 D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  185 DSWGLGCLIEELFNG  199 (690)
T ss_pred             hhhhHHHHHHHHhCc
Confidence            999999999999988

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.51  E-value=4.6e-14  Score=133.95  Aligned_cols=200  Identities=26%  Similarity=0.274  Sum_probs=156.3

Q ss_pred             CCeEEEeeecc--CCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecceeeec
Q 018487          110 GDFEIFRVVGQ--GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQT  186 (355)
Q Consensus       110 ~~y~~~~~lG~--G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~  186 (355)
                      ..+.+.+.+|.  |.+|.||.+....   ..+...+|+|.-+......... ..=.+|+...+.++ |+|.++.+..+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~---~~s~~~~a~k~s~~p~s~p~~~-~~k~~~~~s~~~i~~~~~~v~~~~~~e~  189 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTN---SESPHKFAVKKSKIPFSPPLDS-KRKLREFLSHHKIDSHENPVRDSPAWEG  189 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCc---ccCCcccccccccCCCCCcccc-ccccchhhcccccCccccccccCccccc
Confidence            35677889999  9999999987632   2566778888743222111111 11224566666665 9999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHHCCCeeccCCCCcEEecCC-CcEEEEecC
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVS----AVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFG  260 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~~-l~~~~~~~i~~ql~~----~L~~LH~~~iiHrDlkp~NILl~~~-~~~kl~Dfg  260 (355)
                      .+..++-+|++. .+|..+...... +++..++..+.+...    ||..+|..+++|-|+||.||++..+ ...+++|||
T Consensus       190 ~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~  268 (524)
T KOG0601|consen  190 SGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG  268 (524)
T ss_pred             CCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence            999999999995 688888877655 888999999999999    9999999999999999999999999 889999999


Q ss_pred             CccccCcCCCC------CcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCC
Q 018487          261 LAKEIDESSRS------NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIK  315 (355)
Q Consensus       261 ~a~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~  315 (355)
                      +...+......      ....|...|++||+.. .-++..+|||++|.++.+..+|...+.
T Consensus       269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~  328 (524)
T KOG0601|consen  269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPS  328 (524)
T ss_pred             eeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhccccc
Confidence            99887654422      2225778899999986 457889999999999999888765443

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.47  E-value=6.1e-13  Score=108.78  Aligned_cols=144  Identities=24%  Similarity=0.273  Sum_probs=108.2

Q ss_pred             EEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEe-----ecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM-----RKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       114 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~-----~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .+..|-+|+-+.|+++.+.       ++...||.-     +......+-...+..+|.++|.+++--.|.-..-+|.+..
T Consensus        11 ~l~likQGAEArv~~~~~~-------Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~   83 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-------GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY   83 (229)
T ss_pred             cceeeeccceeeEeeeccC-------CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC
Confidence            5678899999999999865       455666643     3333344455567888999999987666655555666666


Q ss_pred             eEEEEEeccCC-CChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC---cEEEEecCCc
Q 018487          189 KLYLILDFING-GHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVMLTDFGLA  262 (355)
Q Consensus       189 ~~~lv~e~~~~-gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~---~~kl~Dfg~a  262 (355)
                      .-.++|||++| .++.+++....  ...+.....+++++-+.+.-||..+|||+||.++||++..++   .+.++|||++
T Consensus        84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls  163 (229)
T KOG3087|consen   84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS  163 (229)
T ss_pred             CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence            67899999988 36666665542  233333478999999999999999999999999999997665   3589999998


Q ss_pred             cc
Q 018487          263 KE  264 (355)
Q Consensus       263 ~~  264 (355)
                      ..
T Consensus       164 ~~  165 (229)
T KOG3087|consen  164 SV  165 (229)
T ss_pred             hc
Confidence            64

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.42  E-value=3.8e-14  Score=141.38  Aligned_cols=207  Identities=34%  Similarity=0.534  Sum_probs=159.5

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ..+.+.+.+-+-+|.++.++.+.-.+.     +-..+.|+............+....+-.++-..++|-++...-.+...
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~s-----gh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~r  876 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGS-----GHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCR  876 (1205)
T ss_pred             CCccceecccccCCCCcccccCCcccc-----ccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCC
Confidence            456678888899999999998875533     333444544333222222233334444455555667777766666777


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      ...+++++|+.+++|...++.-+..+++-++.++..+..+++|||...+.|+|++|.|+|+..++..++.|||.......
T Consensus       877 sP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~  956 (1205)
T KOG0606|consen  877 SPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL  956 (1205)
T ss_pred             CCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccc
Confidence            88999999999999999999888888888888999999999999999999999999999999999999999984432210


Q ss_pred             C--------------------------------CCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCC
Q 018487          268 S--------------------------------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIK  315 (355)
Q Consensus       268 ~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~  315 (355)
                      .                                .......||+.|.+||.+.+......+|+|++|++++|.++|..||+
T Consensus       957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen  957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred             ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence            0                                01123468999999999999999999999999999999999999999


Q ss_pred             Cchh
Q 018487          316 SMQV  319 (355)
Q Consensus       316 ~~~~  319 (355)
                      ....
T Consensus      1037 a~tp 1040 (1205)
T KOG0606|consen 1037 AETP 1040 (1205)
T ss_pred             Ccch
Confidence            8643

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.41  E-value=1.3e-13  Score=130.78  Aligned_cols=201  Identities=27%  Similarity=0.328  Sum_probs=154.0

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecceeeecC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTR  187 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~  187 (355)
                      ..+|..+..||.|.|+.|+.+..+    ..++..|++|-..+......+.+..+ .|+-+...+. |.+++.+...|...
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r----~~~~~~Y~~ke~~~~l~~~~~di~sl-~ev~l~~~l~~~~~~~g~~~~W~~~  338 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKR----PEGDCIYAAKELLNGLATFASDIFSL-GEVILEAILGSHLPSVGKNSSWSQL  338 (524)
T ss_pred             cCCcceeEEccCCccccceeeeec----CCCCceEeChhhhccccchHhhhcch-hhhhHhhHhhcccccCCCCCCcccc
Confidence            457889999999999999988743    24567799998776554444433333 3666666664 88999998999988


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCC-CcEEEEecCCccccC
Q 018487          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEID  266 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~-~~~kl~Dfg~a~~~~  266 (355)
                      +..|+-.|||+++++.........+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||....+.
T Consensus       339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~  418 (524)
T KOG0601|consen  339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA  418 (524)
T ss_pred             ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence            8889999999999887777655668899999999999999999999999999999999999876 788999999886532


Q ss_pred             cCCCCCcccccCcc-ccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCC
Q 018487          267 ESSRSNSMCGTTEY-MAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIK  315 (355)
Q Consensus       267 ~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~  315 (355)
                      -.... ...++..| .+++......+..+.|++|||..+.+.++|..--.
T Consensus       419 ~~~~~-~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~  467 (524)
T KOG0601|consen  419 FSSGV-FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE  467 (524)
T ss_pred             eeccc-ccccccccccchhhccccccccccccccccccccccccCcccCc
Confidence            21111 11123334 35555556677889999999999999998865333

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.35  E-value=6e-12  Score=109.66  Aligned_cols=140  Identities=15%  Similarity=0.239  Sum_probs=101.6

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCC--cceecceeeecC---CeE
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP--FIVQLRYSFQTR---SKL  190 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~~~~~---~~~  190 (355)
                      +.||.|..+.||++...      .++.+++|+.......  .....+..|..+++.+.+.  ++.+++.+....   +..
T Consensus         4 ~~l~~G~~n~~~~v~~~------~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~   75 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG------GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTP   75 (223)
T ss_pred             eecCCCccceEEEEEec------CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCc
Confidence            56899999999999854      1457999997654321  1234567899999998763  355566665543   367


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 018487          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-------------------------------------  233 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~-------------------------------------  233 (355)
                      ++||||++|.++...+.. ..+++.+...++.+++++|..||+                                     
T Consensus        76 ~~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (223)
T cd05154          76 FYVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEP  154 (223)
T ss_pred             eEEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccccc
Confidence            899999999877654421 345666667777777777777763                                     


Q ss_pred             -------------------CCCeeccCCCCcEEecC--CCcEEEEecCCccc
Q 018487          234 -------------------CGIVHRDLKPENILMDS--DGHVMLTDFGLAKE  264 (355)
Q Consensus       234 -------------------~~iiHrDlkp~NILl~~--~~~~kl~Dfg~a~~  264 (355)
                                         ..++|+|+++.|||++.  ++.+.|+||+.+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         155 PAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                               23689999999999988  56789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.32  E-value=5.2e-12  Score=111.71  Aligned_cols=148  Identities=20%  Similarity=0.345  Sum_probs=115.1

Q ss_pred             HHHHHHhcCCCcceecceeeecC-----CeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 018487          165 ERDILTKVTHPFIVQLRYSFQTR-----SKLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCG  235 (355)
Q Consensus       165 E~~~l~~l~h~nIv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~ql~~~L~~LH~~~  235 (355)
                      -..-|-.+.|-|||+++.+|.+.     ....++.|||..|++..+|++.    ..+......+|+.||+.||.|||+..
T Consensus       117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~  196 (458)
T KOG1266|consen  117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence            34456667799999999988654     3588999999999999988764    34788888999999999999999986


Q ss_pred             --CeeccCCCCcEEecCCCcEEEEecCCccccCcC------CCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHH
Q 018487          236 --IVHRDLKPENILMDSDGHVMLTDFGLAKEIDES------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM  307 (355)
Q Consensus       236 --iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el  307 (355)
                        |+|+++..+.|++..+|-+|+.--.-. .....      .......+-++|.+||.=.....+.++|||+||...++|
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence              999999999999999998887632211 11110      011223456889999986666677889999999999999


Q ss_pred             HcCCCC
Q 018487          308 LTGQVN  313 (355)
Q Consensus       308 ltg~~p  313 (355)
                      ..|.+-
T Consensus       276 ailEiq  281 (458)
T KOG1266|consen  276 AILEIQ  281 (458)
T ss_pred             HHheec
Confidence            888764

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.23  E-value=1.1e-10  Score=98.51  Aligned_cols=129  Identities=24%  Similarity=0.328  Sum_probs=81.8

Q ss_pred             EEEEEEEcCCCCCCCCceEEEEEeecccc-----------------------cchhHHHHHHHHHHHHHhcCCC--ccee
Q 018487          125 KVFQVKKKGVDDGDSDGIYAMKVMRKDTI-----------------------IKKNHVDYMKAERDILTKVTHP--FIVQ  179 (355)
Q Consensus       125 ~V~~~~~~~~~~~~~~~~vavK~~~~~~~-----------------------~~~~~~~~~~~E~~~l~~l~h~--nIv~  179 (355)
                      .||.|...      .+..+|||+.+....                       ..........+|.+.|.++..-  ++.+
T Consensus         1 ~Vy~~~~~------~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~   74 (188)
T PF01163_consen    1 DVYHAIDP------DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPK   74 (188)
T ss_dssp             EEEEEEEC------TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--
T ss_pred             CEEEEECC------CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCc
Confidence            37877743      456799998764211                       1112234567899999999866  4555


Q ss_pred             cceeeecCCeEEEEEeccC--CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHCCCeeccCCCCcEEecCCCcEEE
Q 018487          180 LRYSFQTRSKLYLILDFIN--GGHLFFHLYRQGIFREDQARFYTAEIVSAVSH-LHKCGIVHRDLKPENILMDSDGHVML  256 (355)
Q Consensus       180 l~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~-LH~~~iiHrDlkp~NILl~~~~~~kl  256 (355)
                      ++++.    .-++||||++  |..+.. +.... ++......++.+++..+.. +|..||+|+||.+.|||++++ .+.|
T Consensus        75 p~~~~----~~~ivME~I~~~G~~~~~-l~~~~-~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   75 PYDYN----RNVIVMEYIGEDGVPLPR-LKDVD-LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             EEEEE----TTEEEEE--EETTEEGGC-HHHCG-GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE
T ss_pred             EEEEe----CCEEEEEecCCCccchhh-HHhcc-ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEE
Confidence            55432    2379999998  655533 32221 1245567788888886555 689999999999999999877 9999


Q ss_pred             EecCCccccC
Q 018487          257 TDFGLAKEID  266 (355)
Q Consensus       257 ~Dfg~a~~~~  266 (355)
                      +|||.+....
T Consensus       148 IDf~qav~~~  157 (188)
T PF01163_consen  148 IDFGQAVDSS  157 (188)
T ss_dssp             --GTTEEETT
T ss_pred             EecCcceecC
Confidence            9999887654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.22  E-value=4.1e-10  Score=100.66  Aligned_cols=103  Identities=15%  Similarity=0.075  Sum_probs=79.3

Q ss_pred             HHHHHHHHHhcCCCccee--cceeeec-----CCeEEEEEeccCCC-ChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHH
Q 018487          162 MKAERDILTKVTHPFIVQ--LRYSFQT-----RSKLYLILDFINGG-HLFFHLYR--QGIFREDQARFYTAEIVSAVSHL  231 (355)
Q Consensus       162 ~~~E~~~l~~l~h~nIv~--l~~~~~~-----~~~~~lv~e~~~~g-sL~~~l~~--~~~l~~~~~~~i~~ql~~~L~~L  231 (355)
                      +.+|...+.+|..-+|..  ++.++..     ....++|||++++. +|.+++..  ...........++.+++..+.-|
T Consensus        75 a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~L  154 (268)
T PRK15123         75 ADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDM  154 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH
Confidence            567888887775444332  3344432     23578999999986 78888753  24456777889999999999999


Q ss_pred             HHCCCeeccCCCCcEEecC-------CCcEEEEecCCccc
Q 018487          232 HKCGIVHRDLKPENILMDS-------DGHVMLTDFGLAKE  264 (355)
Q Consensus       232 H~~~iiHrDlkp~NILl~~-------~~~~kl~Dfg~a~~  264 (355)
                      |..||+|+|+++.|||++.       +..+.|+||+.+..
T Consensus       155 H~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        155 HAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            9999999999999999975       46899999998854

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.14  E-value=5.7e-10  Score=97.21  Aligned_cols=141  Identities=20%  Similarity=0.215  Sum_probs=103.6

Q ss_pred             eEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeeccccc-----------------c--hhHHHHHHHHHHHHHhc
Q 018487          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-----------------K--KNHVDYMKAERDILTKV  172 (355)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-----------------~--~~~~~~~~~E~~~l~~l  172 (355)
                      +.+..+||-|.-+.||.|...      .+..+|||.-+.....                 .  .-......+|.++|.++
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~------~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L  166 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP------KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRL  166 (304)
T ss_pred             HhhccccccCccceEEEEECC------CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHh
Confidence            446689999999999999854      5788999986542110                 0  11123356788889988


Q ss_pred             CCC--cceecceeeecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC
Q 018487          173 THP--FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS  250 (355)
Q Consensus       173 ~h~--nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~  250 (355)
                      ...  .|.+.+++    +...+||||++|..|...     ++.......++..|++-+.-+-..||||+|+++-|||+++
T Consensus       167 ~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~  237 (304)
T COG0478         167 YPEGVKVPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTE  237 (304)
T ss_pred             hhcCCCCCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEec
Confidence            754  56665543    456899999999766322     1245556677778888877777999999999999999999


Q ss_pred             CCcEEEEecCCccccCc
Q 018487          251 DGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       251 ~~~~kl~Dfg~a~~~~~  267 (355)
                      +|.+.++||-.+...+.
T Consensus       238 dg~~~vIDwPQ~v~~~h  254 (304)
T COG0478         238 DGDIVVIDWPQAVPISH  254 (304)
T ss_pred             CCCEEEEeCcccccCCC
Confidence            99999999987765443

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.06  E-value=3.4e-09  Score=91.52  Aligned_cols=104  Identities=27%  Similarity=0.312  Sum_probs=81.7

Q ss_pred             HHHHHHHHHHhcCCCcc--eecceeeecC----CeEEEEEeccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Q 018487          161 YMKAERDILTKVTHPFI--VQLRYSFQTR----SKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK  233 (355)
Q Consensus       161 ~~~~E~~~l~~l~h~nI--v~l~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~  233 (355)
                      ...+|...+..+..-.|  .+.+.+....    ...++|+|++++. +|.+++......+......++.+++..+.-||.
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~  136 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHD  136 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHH
Confidence            45667777777654332  3334443331    2468999999884 788888875557788889999999999999999


Q ss_pred             CCCeeccCCCCcEEecCCC---cEEEEecCCccc
Q 018487          234 CGIVHRDLKPENILMDSDG---HVMLTDFGLAKE  264 (355)
Q Consensus       234 ~~iiHrDlkp~NILl~~~~---~~kl~Dfg~a~~  264 (355)
                      .||+|+|+++.|||++.++   .+.|+||+-++.
T Consensus       137 ~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  137 AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9999999999999999887   899999998765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.05  E-value=3.1e-09  Score=97.50  Aligned_cols=191  Identities=17%  Similarity=0.255  Sum_probs=132.3

Q ss_pred             EeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCccee--------cceeee
Q 018487          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQ--------LRYSFQ  185 (355)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~--------l~~~~~  185 (355)
                      .+.||+|+.+.+|-.-..        +.-+.|++.........      ..+..|... .||-+-.        +++. .
T Consensus        16 gr~LgqGgea~ly~l~e~--------~d~VAKIYh~Pppa~~a------qk~a~la~~p~~p~~~~rvaWPqa~L~G~-~   80 (637)
T COG4248          16 GRPLGQGGEADLYTLGEV--------RDQVAKIYHAPPPAAQA------QKVAELAATPDAPLLNYRVAWPQATLHGG-R   80 (637)
T ss_pred             CccccCCccceeeecchh--------hchhheeecCCCchHHH------HHHHHhccCCCCcchhhhhcccHHHhhCC-C
Confidence            467999999999965422        11334777543321111      122233333 3553221        1111 1


Q ss_pred             cCCeEEEEEeccCCCChHHHHH----hc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEe
Q 018487          186 TRSKLYLILDFINGGHLFFHLY----RQ---GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTD  258 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~----~~---~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~D  258 (355)
                      ....+.++|..+.|..--..+.    ++   ..+.+.-+.++++.++.+.+.||..|.+-+|++++|+|+.+++.+.|.|
T Consensus        81 ~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVd  160 (637)
T COG4248          81 RGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVD  160 (637)
T ss_pred             ccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEc
Confidence            1223778899888763212221    11   2367888999999999999999999999999999999999999999999


Q ss_pred             cCCccccCcCCCCCcccccCccccchhhc-----cCCCCCcccHHHHHHHHHHHHcC-CCCCCCchhh
Q 018487          259 FGLAKEIDESSRSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTG-QVNIKSMQVI  320 (355)
Q Consensus       259 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~elltg-~~pf~~~~~~  320 (355)
                      -..-............+|...|.+||.-.     +-.-+...|.|.||+++++||.| +.||.+....
T Consensus       161 sDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~  228 (637)
T COG4248         161 SDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLI  228 (637)
T ss_pred             ccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccccc
Confidence            77655555555566778999999999865     33446778999999999999997 9999987543

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.02  E-value=6.8e-09  Score=97.48  Aligned_cols=166  Identities=19%  Similarity=0.321  Sum_probs=124.5

Q ss_pred             cEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec----CCeEEEEEeccC
Q 018487          123 FGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT----RSKLYLILDFIN  198 (355)
Q Consensus       123 ~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~e~~~  198 (355)
                      -.+.|+|...     .++..|++|.+..+.......   ...-+++++++.|.|||++.++|..    +..+++|++|.+
T Consensus       289 ~~Ttyk~~s~-----~DG~~YvLkRlhg~r~~~~nk---~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP  360 (655)
T KOG3741|consen  289 SITTYKATSN-----VDGNAYVLKRLHGDRDQSTNK---DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYP  360 (655)
T ss_pred             cceeEeeeec-----cCCceeeeeeeccccccCccc---chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCC
Confidence            3578888866     567789999884443322211   2235778999999999999988873    446899999988


Q ss_pred             CC-ChHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          199 GG-HLFFHLYRQ---------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       199 ~g-sL~~~l~~~---------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                      +. +|.++-...               ...+|..+|.++.|+..||.++|+.|+.-+-|.+.+||++.+.+++|...|..
T Consensus       361 ~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~  440 (655)
T KOG3741|consen  361 SSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIM  440 (655)
T ss_pred             CCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccce
Confidence            64 666554321               23678899999999999999999999999999999999998889999888877


Q ss_pred             cccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCC
Q 018487          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQV  312 (355)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~  312 (355)
                      ..+..+..           +|  +.   -..+-|.-.||.+++.|.||..
T Consensus       441 Dvl~~d~~-----------~~--le---~~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  441 DVLQEDPT-----------EP--LE---SQQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             eeecCCCC-----------cc--hh---HHhhhhHHHHHHHHHHHhhccc
Confidence            76654431           01  11   1234688899999999999954

>PRK09902 hypothetical protein; Provisional

Probab=98.99  E-value=1.1e-08  Score=87.20  Aligned_cols=139  Identities=9%  Similarity=0.091  Sum_probs=99.3

Q ss_pred             eccCCcEEEEEEEEcCCCCCCCCceEEEEEeeccc---ccchhHHHHHHHHHHHHHhcCCCc--ceecceeee---c--C
Q 018487          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDT---IIKKNHVDYMKAERDILTKVTHPF--IVQLRYSFQ---T--R  187 (355)
Q Consensus       118 lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~---~--~  187 (355)
                      -|+||-+.|+.....       ++.+-+|.-....   ..-+.-...|.+|...|..+..-+  +.+.. ++.   .  .
T Consensus        26 ~~rgG~SgV~r~~~~-------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~   97 (216)
T PRK09902         26 YRRNGMSGVQCVERN-------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGE   97 (216)
T ss_pred             cCCCCcceEEEEEeC-------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCc
Confidence            367999999987754       2357777643111   110233456888999988886433  33333 222   1  1


Q ss_pred             CeEEEEEeccCC-CChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCc--EEEEecCCc
Q 018487          188 SKLYLILDFING-GHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--VMLTDFGLA  262 (355)
Q Consensus       188 ~~~~lv~e~~~~-gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~--~kl~Dfg~a  262 (355)
                      -.-+||+|-++| .+|.+++...  ...+..+...++.+++..+.-||+.|+.|+|+.+.|||++.++.  ++++||.-+
T Consensus        98 ~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~  177 (216)
T PRK09902         98 WRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKS  177 (216)
T ss_pred             eEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence            246799997764 4788887653  34577778899999999999999999999999999999986677  999999876


Q ss_pred             cc
Q 018487          263 KE  264 (355)
Q Consensus       263 ~~  264 (355)
                      +.
T Consensus       178 r~  179 (216)
T PRK09902        178 RR  179 (216)
T ss_pred             ch
Confidence            54

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.92  E-value=1.8e-08  Score=86.14  Aligned_cols=146  Identities=19%  Similarity=0.208  Sum_probs=96.0

Q ss_pred             hhcCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHH------HHHHHHHHHhcCC--
Q 018487          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY------MKAERDILTKVTH--  174 (355)
Q Consensus       103 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~~l~h--  174 (355)
                      ...++..++|.+.+.+-......|.+..-       .++.+++|..+......+.....      ..+++..+.+++.  
T Consensus        24 l~~~i~~~~~~~~kv~k~~~r~~ValIei-------~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g   96 (229)
T PF06176_consen   24 LGEKILDNNYKIIKVFKNTKRNYVALIEI-------DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEG   96 (229)
T ss_pred             HHHHHHhCCceEEEeecCCCccEEEEEEE-------CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcC
Confidence            33456678999999999999898988774       35679999887654322222221      1223333333322  


Q ss_pred             -Ccceecceee-----ecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEe
Q 018487          175 -PFIVQLRYSF-----QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM  248 (355)
Q Consensus       175 -~nIv~l~~~~-----~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl  248 (355)
                       -....++.+.     ......+++|||++|..|.+...    +.+    .+...+.+++.-||+.|++|+|.+|.|+++
T Consensus        97 ~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv  168 (229)
T PF06176_consen   97 FTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLV  168 (229)
T ss_pred             ccccccceeeeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEE
Confidence             2222222222     22345678999999988755432    222    244667788999999999999999999999


Q ss_pred             cCCCcEEEEecCCccc
Q 018487          249 DSDGHVMLTDFGLAKE  264 (355)
Q Consensus       249 ~~~~~~kl~Dfg~a~~  264 (355)
                      +. +.++++||+..+.
T Consensus       169 ~~-~~i~iID~~~k~~  183 (229)
T PF06176_consen  169 SN-NGIRIIDTQGKRM  183 (229)
T ss_pred             EC-CcEEEEECccccc
Confidence            74 5599999987654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.87  E-value=3.9e-08  Score=85.01  Aligned_cols=140  Identities=23%  Similarity=0.254  Sum_probs=93.9

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchh---------------------HHHHHHHHHHHHHhcC-
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN---------------------HVDYMKAERDILTKVT-  173 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~---------------------~~~~~~~E~~~l~~l~-  173 (355)
                      -.|..|.-+.||+|..      ..++.+|+|+++......+.                     ...+...|..-|+++. 
T Consensus        54 g~istGKEA~Vy~a~~------~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~e  127 (268)
T COG1718          54 GCISTGKEANVYLAET------GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYE  127 (268)
T ss_pred             eeecCCcceEEEeecc------CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHH
Confidence            4677888889999874      24678999998754322111                     1123344555566553 


Q ss_pred             -CCcceecceeeecCCeEEEEEeccCCCCh-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEecC
Q 018487          174 -HPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDS  250 (355)
Q Consensus       174 -h~nIv~l~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDlkp~NILl~~  250 (355)
                       +-.+.+.+.+.    .-.+||||+....+ .-.|.. -.+...++..+..++++.+.-|-. .+++|+||..-|||+. 
T Consensus       128 AGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-  201 (268)
T COG1718         128 AGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-  201 (268)
T ss_pred             cCCCCCCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-
Confidence             22333333332    24799999865421 111211 123334788889999999998876 8999999999999998 


Q ss_pred             CCcEEEEecCCccccCc
Q 018487          251 DGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       251 ~~~~kl~Dfg~a~~~~~  267 (355)
                      ++.+.|+|||.|....+
T Consensus       202 ~~~p~iID~~QaV~~~h  218 (268)
T COG1718         202 DGEPYIIDVSQAVTIDH  218 (268)
T ss_pred             CCeEEEEECccccccCC
Confidence            89999999999876654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.75  E-value=1.1e-09  Score=105.08  Aligned_cols=184  Identities=20%  Similarity=0.258  Sum_probs=136.2

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc-ceecceeeecCCe
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF-IVQLRYSFQTRSK  189 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~  189 (355)
                      .|...+-+++|+++.+++.+..      ..+....+++...        ....-++++|.+++||| .+..++.++.++.
T Consensus       243 ws~~fh~fvK~altknpKkRpt------aeklL~h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~  308 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPT------AEKLLQHPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDY  308 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCC------hhhheeceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccc
Confidence            4667788999999999987633      2222335554322        22345889999999999 7888888888999


Q ss_pred             EEEEEeccCCC--ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          190 LYLILDFINGG--HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       190 ~~lv~e~~~~g--sL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      .+++|+++.++  +....-...-.+.+-+...+++.-++++++||+.--+|+|    ||+.. ++..+..||+....+..
T Consensus       309 ~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~  383 (829)
T KOG0576|consen  309 LWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQLTR  383 (829)
T ss_pred             cchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-ccccccccccCCcccCc
Confidence            99999999887  2211111111233344556677778899999998778998    77774 47899999999988766


Q ss_pred             CCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCC
Q 018487          268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVN  313 (355)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~p  313 (355)
                      ........+++.|+|||+.....+....|.|++|+-..+|--|-.|
T Consensus       384 ~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP  429 (829)
T KOG0576|consen  384 TMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP  429 (829)
T ss_pred             ccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence            6556677899999999999999999999999999866666555444

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.73  E-value=7.3e-08  Score=93.36  Aligned_cols=142  Identities=21%  Similarity=0.316  Sum_probs=90.8

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccc---------------------------h----hHHHHHHH
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK---------------------------K----NHVDYMKA  164 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~---------------------------~----~~~~~~~~  164 (355)
                      .-|+.++-|+||+|+.+      +++.||||+.+......                           .    +..+.+..
T Consensus       131 ~PiAsASIaQVH~A~L~------sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~  204 (517)
T COG0661         131 EPIASASIAQVHRAVLK------SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE  204 (517)
T ss_pred             CchhhhhHhhheeEEec------CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence            56899999999999987      48889999976532110                           0    01111222


Q ss_pred             ------HHHHHHhcC-----CCcceecceeeecCCeEEEEEeccCCCChHHHH--HhcCCCCHHHHHHHHHHHHHH-HHH
Q 018487          165 ------ERDILTKVT-----HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL--YRQGIFREDQARFYTAEIVSA-VSH  230 (355)
Q Consensus       165 ------E~~~l~~l~-----h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l--~~~~~l~~~~~~~i~~ql~~~-L~~  230 (355)
                            |..-+.+++     .++|.-..-+++..+.-.++|||++|..+.+..  .. ..++...   ++..++++ +.-
T Consensus       205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~---ia~~~~~~f~~q  280 (517)
T COG0661         205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKE---LAELLVRAFLRQ  280 (517)
T ss_pred             HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHH---HHHHHHHHHHHH
Confidence                  222222221     233333333344445668999999998887663  33 3344333   33333332 233


Q ss_pred             HHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       231 LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      +-..|++|.|.+|.||+++.+|++.+.|||+...++.
T Consensus       281 ~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         281 LLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            4458999999999999999999999999999887654

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.70  E-value=5.3e-09  Score=101.38  Aligned_cols=96  Identities=23%  Similarity=0.504  Sum_probs=75.9

Q ss_pred             HHHHHHHHHHHHC-CCeeccCCCCcEEecCCCcEEEEecCCccccCcCCCC----------CcccccCccccchhhccCC
Q 018487          222 AEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS----------NSMCGTTEYMAPEILLSKG  290 (355)
Q Consensus       222 ~ql~~~L~~LH~~-~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~  290 (355)
                      .+++.||.|+|+. ++||++|.|++|.++.++.+||+.|+.+.........          ....-...|.|||++.+..
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~  185 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT  185 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence            3455999999965 8999999999999999999999999988655432111          0112356799999999988


Q ss_pred             CCCcccHHHHHHHHHHHH-cCCCCCCCc
Q 018487          291 HNKDADWWSVGILLYEML-TGQVNIKSM  317 (355)
Q Consensus       291 ~~~~~DiwSlG~~l~ell-tg~~pf~~~  317 (355)
                      .+.++|+||+|+++|.+. .|+.-+...
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~  213 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAAN  213 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhcc
Confidence            899999999999999998 565555443

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.66  E-value=3.7e-07  Score=79.92  Aligned_cols=134  Identities=17%  Similarity=0.169  Sum_probs=81.2

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc--ceecceeeecCCeEEEE
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF--IVQLRYSFQTRSKLYLI  193 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~lv  193 (355)
                      ..||+|..+.||+..         +..+++|+.....     ....+.+|.++++.+..-.  +.+.+.+....+..++|
T Consensus         7 ~~i~~G~t~~~y~~~---------~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv   72 (226)
T TIGR02172         7 TQTGEGGNGESYTHK---------TGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLI   72 (226)
T ss_pred             eeecCCCCcceeEec---------CCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeee
Confidence            568999999999732         2247788876432     1234577999998886433  35566666677778899


Q ss_pred             EeccCCCC-hH--------------HHH-------Hhc--CCCCHHHH-HHHHH----------HHHH-HHHHHH----H
Q 018487          194 LDFINGGH-LF--------------FHL-------YRQ--GIFREDQA-RFYTA----------EIVS-AVSHLH----K  233 (355)
Q Consensus       194 ~e~~~~gs-L~--------------~~l-------~~~--~~l~~~~~-~~i~~----------ql~~-~L~~LH----~  233 (355)
                      ||+++|.. +.              ..+       +.-  ........ ..+..          .+.. ...+|.    .
T Consensus        73 ~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~  152 (226)
T TIGR02172        73 YELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDT  152 (226)
T ss_pred             eeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCC
Confidence            99999963 11              000       000  00111110 11110          1111 122222    1


Q ss_pred             CCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       234 ~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      ..++|+|+.|.||++++++ +.|+||+.+..
T Consensus       153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       153 STCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            2478999999999999888 99999998754

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.65  E-value=3.7e-07  Score=79.85  Aligned_cols=138  Identities=25%  Similarity=0.364  Sum_probs=79.6

Q ss_pred             EeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc--ceecceee---ecCCe
Q 018487          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF--IVQLRYSF---QTRSK  189 (355)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~---~~~~~  189 (355)
                      ++.|+.|..+.||++...       ++.+++|+....     .....+.+|..+++.+....  +.+++...   .....
T Consensus         2 i~~l~~G~~n~~~~v~~~-------~~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~   69 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTD-------DGRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGF   69 (239)
T ss_dssp             EEEEEESSSSEEEEEEET-------TSEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSE
T ss_pred             CccCCCCCeeeEEEEEEC-------CcEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccccccc
Confidence            467999999999999854       247999987543     23455667888887775332  44455432   23345


Q ss_pred             EEEEEeccCCCChHH----------------HHH---hc----CCCCHHH---------HHHH------------HHHHH
Q 018487          190 LYLILDFINGGHLFF----------------HLY---RQ----GIFREDQ---------ARFY------------TAEIV  225 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~----------------~l~---~~----~~l~~~~---------~~~i------------~~ql~  225 (355)
                      .+++|++++|..+..                .+.   ..    ..+....         ....            ...+.
T Consensus        70 ~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (239)
T PF01636_consen   70 PYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELE  149 (239)
T ss_dssp             EEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHH
T ss_pred             ceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHH
Confidence            799999999987766                110   00    0001000         0000            01122


Q ss_pred             H-HHHHHH-------HCCCeeccCCCCcEEec-CCCcEEEEecCCccc
Q 018487          226 S-AVSHLH-------KCGIVHRDLKPENILMD-SDGHVMLTDFGLAKE  264 (355)
Q Consensus       226 ~-~L~~LH-------~~~iiHrDlkp~NILl~-~~~~~kl~Dfg~a~~  264 (355)
                      . .+..++       ...++|+|+.+.|||++ .++.+.|+||+.+..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  150 ERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            2 233333       23599999999999999 667778999997653

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.53  E-value=1.1e-06  Score=77.94  Aligned_cols=135  Identities=13%  Similarity=0.085  Sum_probs=80.7

Q ss_pred             eeccCCc-EEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecceeeecCCeEEEEE
Q 018487          117 VVGQGAF-GKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLIL  194 (355)
Q Consensus       117 ~lG~G~~-g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~  194 (355)
                      .|..|.. ..||++...       +..+.||+.....      ...+.+|+++++.+. +--+.+++++....+..++||
T Consensus         5 ~~~~g~~~~~v~~~~~~-------~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   71 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-------NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLT   71 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-------CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEE
Confidence            4556666 788988632       2458888875432      123556888887774 333556677766666789999


Q ss_pred             eccCCCChHHHH-------------------HhcC----CCCHH--HHHHHHH--------------------HHHHHHH
Q 018487          195 DFINGGHLFFHL-------------------YRQG----IFRED--QARFYTA--------------------EIVSAVS  229 (355)
Q Consensus       195 e~~~~gsL~~~l-------------------~~~~----~l~~~--~~~~i~~--------------------ql~~~L~  229 (355)
                      |+++|.++....                   +...    .+...  .......                    .+...+.
T Consensus        72 e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (244)
T cd05150          72 SAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYA  151 (244)
T ss_pred             EeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHH
Confidence            999997765321                   0000    01100  0000000                    0111122


Q ss_pred             HHH-------HCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          230 HLH-------KCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       230 ~LH-------~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      .|-       ...++|+|+.|.|||+++++.+.|+||+.+..
T Consensus       152 ~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         152 ELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             HHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            221       23489999999999999877788999998754

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.50  E-value=2.2e-06  Score=72.54  Aligned_cols=128  Identities=25%  Similarity=0.360  Sum_probs=89.9

Q ss_pred             CCeEEEeeeccCCc-EEEEEEEEcCCCCCCCCceEEEEEeeccccc----------c-h-------hHHHHHHHHHHHHH
Q 018487          110 GDFEIFRVVGQGAF-GKVFQVKKKGVDDGDSDGIYAMKVMRKDTII----------K-K-------NHVDYMKAERDILT  170 (355)
Q Consensus       110 ~~y~~~~~lG~G~~-g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~----------~-~-------~~~~~~~~E~~~l~  170 (355)
                      .+++.++.||.|.- |.||+++..       ++.||||+++.-...          . .       ...+.|..|.+...
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-------g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfg  109 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-------GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFG  109 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-------CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhH
Confidence            58999999999999 999999965       668999994321000          0 0       22345667777655


Q ss_pred             hc---CCCcc--eecceeeecC------------------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHH
Q 018487          171 KV---THPFI--VQLRYSFQTR------------------SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA  227 (355)
Q Consensus       171 ~l---~h~nI--v~l~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~  227 (355)
                      ++   .+.++  |+++|+..-.                  ....||.||++...         .+...    -+.+|.+-
T Consensus       110 RLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~d  176 (207)
T PF13095_consen  110 RLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRD  176 (207)
T ss_pred             HHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHH
Confidence            55   45566  8888886311                  13567888887653         12222    34567788


Q ss_pred             HHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       228 L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                      |..+|..||+-+|+++.|..     .-||+|||.+
T Consensus       177 l~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  177 LKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence            89999999999999999986     3588999964

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.48  E-value=1.1e-06  Score=72.08  Aligned_cols=132  Identities=19%  Similarity=0.272  Sum_probs=90.7

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCccee-cceeeecCCe
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQ-LRYSFQTRSK  189 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~-l~~~~~~~~~  189 (355)
                      ..++.+.||+|.+|.||++.+.       +..+|+|+-+.+..     ...+..|.++|..+.-.++-+ ++.+-    .
T Consensus        23 ~~~v~~~L~KG~~s~Vyl~~~~-------~~~~a~Kvrr~ds~-----r~~l~kEakiLeil~g~~~~p~vy~yg----~   86 (201)
T COG2112          23 ELRVEKELAKGTTSVVYLGEWR-------GGEVALKVRRRDSP-----RRNLEKEAKILEILAGEGVTPEVYFYG----E   86 (201)
T ss_pred             hhhhhhhhhcccccEEEEeecc-------CceEEEEEecCCcc-----hhhHHHHHHHHHHhhhcCCCceEEEec----h
Confidence            3455678999999999999987       34699998765542     234677999998887665543 33322    2


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCC-CCcEEecCCCcEEEEecCCcccc
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK-PENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlk-p~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      -++.|||+.|-.|.......   ...+    +..+++...-|...||-|+.|. |..++|..++.+.|+||..|+.-
T Consensus        87 ~~i~me~i~G~~L~~~~~~~---~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          87 DFIRMEYIDGRPLGKLEIGG---DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             hhhhhhhhcCcchhhhhhcc---cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            34559999998886554322   2222    2345555556788999999886 44455556669999999998743

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.41  E-value=1.6e-06  Score=83.92  Aligned_cols=141  Identities=19%  Similarity=0.293  Sum_probs=87.0

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccc----------------------------hhHHHHHHHHHH
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK----------------------------KNHVDYMKAERD  167 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~----------------------------~~~~~~~~~E~~  167 (355)
                      +.||.-+.|.||+|+.+      .++.||||+-+......                            .+..+.+..|++
T Consensus       167 ~piaaASlaQVhrA~L~------~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELD  240 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLK------NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELD  240 (538)
T ss_pred             chhhhcchhheEEEEec------CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcc
Confidence            57999999999999987      37889999865432100                            011111222222


Q ss_pred             H----------HHhcCCCc------ceecceeeecCCeEEEEEeccCCCChHH--HHHhcCCCCHHHHHHHHHHHHHHHH
Q 018487          168 I----------LTKVTHPF------IVQLRYSFQTRSKLYLILDFINGGHLFF--HLYRQGIFREDQARFYTAEIVSAVS  229 (355)
Q Consensus       168 ~----------l~~l~h~n------Iv~l~~~~~~~~~~~lv~e~~~~gsL~~--~l~~~~~l~~~~~~~i~~ql~~~L~  229 (355)
                      .          .+.+.|-+      |.+++  +.....-.++||||+|..+.+  .+.+.+ ++...   ++..+.++..
T Consensus       241 F~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~---i~~~l~~~~~  314 (538)
T KOG1235|consen  241 FTKEAKNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKRG-ISPHD---ILNKLVEAYL  314 (538)
T ss_pred             hHHHHHhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHcC-CCHHH---HHHHHHHHHH
Confidence            2          22233433      33322  222345689999999986644  444444 34443   3333333322


Q ss_pred             -HHHHCCCeeccCCCCcEEecC----CCcEEEEecCCccccCcC
Q 018487          230 -HLHKCGIVHRDLKPENILMDS----DGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       230 -~LH~~~iiHrDlkp~NILl~~----~~~~kl~Dfg~a~~~~~~  268 (355)
                       -+-..|++|+|-.|.||++..    ++.+.+.|||+...+...
T Consensus       315 ~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  315 EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence             234678999999999999983    678999999999876544

>PLN02876 acyl-CoA dehydrogenase

Probab=98.36  E-value=6.4e-06  Score=85.60  Aligned_cols=147  Identities=14%  Similarity=0.277  Sum_probs=89.1

Q ss_pred             EEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcc--eecceeeecC---
Q 018487          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFI--VQLRYSFQTR---  187 (355)
Q Consensus       114 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI--v~l~~~~~~~---  187 (355)
                      .++.|+.|.++.+|+......   .....+++|+........  ....+.+|.++|+.+. |.+|  .+++.++.+.   
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~---~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~  116 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNG---GSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVI  116 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCC---CcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcC
Confidence            467889999999999875421   112357777754432111  1235778999999996 6664  5666666553   


Q ss_pred             CeEEEEEeccCCCChHH--------------------HH---HhcC-----------C--CCHHHHHHHHHH--------
Q 018487          188 SKLYLILDFINGGHLFF--------------------HL---YRQG-----------I--FREDQARFYTAE--------  223 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~--------------------~l---~~~~-----------~--l~~~~~~~i~~q--------  223 (355)
                      +..|+||||++|..+.+                    .+   +.-.           +  +...++..|..+        
T Consensus       117 G~~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~  196 (822)
T PLN02876        117 GTAFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEG  196 (822)
T ss_pred             CCceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhccc
Confidence            46789999999864311                    11   0000           0  111233332222        


Q ss_pred             -------HHHHHHHHHH-----------CCCeeccCCCCcEEecCC-Cc-EEEEecCCcccc
Q 018487          224 -------IVSAVSHLHK-----------CGIVHRDLKPENILMDSD-GH-VMLTDFGLAKEI  265 (355)
Q Consensus       224 -------l~~~L~~LH~-----------~~iiHrDlkp~NILl~~~-~~-~kl~Dfg~a~~~  265 (355)
                             +...+.+|..           ..+||+|+++.|||++.+ +. +-|.||.++..-
T Consensus       197 ~~~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G  258 (822)
T PLN02876        197 KPPRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG  258 (822)
T ss_pred             CCCCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence                   2233556632           249999999999999853 34 579999987643

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.26  E-value=5.7e-06  Score=72.92  Aligned_cols=30  Identities=30%  Similarity=0.423  Sum_probs=25.5

Q ss_pred             CCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       235 ~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      +++|+|+.+.|||++.++..-|+||+.+..
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            489999999999998665567999998754

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.25  E-value=2.9e-05  Score=66.20  Aligned_cols=130  Identities=24%  Similarity=0.259  Sum_probs=90.0

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccc-------------cchhHHHHHHHHHHHHHhcC------CCc
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-------------IKKNHVDYMKAERDILTKVT------HPF  176 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~~~E~~~l~~l~------h~n  176 (355)
                      ..||+|+.=.||.-  .      .....+||++.....             ......+...+|+.....+.      +.+
T Consensus         7 ~~i~~G~~R~cy~H--P------~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~   78 (199)
T PF10707_consen    7 DLIAQGGERDCYQH--P------DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSH   78 (199)
T ss_pred             cccccCCCceEEEC--C------CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccc
Confidence            46999999999952  2      223378899876550             00112344556766655555      778


Q ss_pred             ceecceeeecCCeEEEEEeccCC------CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC
Q 018487          177 IVQLRYSFQTRSKLYLILDFING------GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS  250 (355)
Q Consensus       177 Iv~l~~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~  250 (355)
                      |.+++|+.+.+-...+|+|.+.+      .+|.+++.. +.+++ ..   ...+-+-..||-+.+|+.+|++|.||++..
T Consensus        79 i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~  153 (199)
T PF10707_consen   79 IPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQR  153 (199)
T ss_pred             cccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEe
Confidence            99999999999889999998654      267777744 34555 33   334444566889999999999999999964


Q ss_pred             CC----cEEEEe
Q 018487          251 DG----HVMLTD  258 (355)
Q Consensus       251 ~~----~~kl~D  258 (355)
                      ..    .+.|+|
T Consensus       154 ~~~~~~~lvlID  165 (199)
T PF10707_consen  154 RDSGEFRLVLID  165 (199)
T ss_pred             cCCCceEEEEEe
Confidence            32    577777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.14  E-value=2.3e-05  Score=80.82  Aligned_cols=185  Identities=21%  Similarity=0.209  Sum_probs=129.8

Q ss_pred             HHHHHHHHHHHhcCCCcceecceeeecCCe----EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 018487          160 DYMKAERDILTKVTHPFIVQLRYSFQTRSK----LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG  235 (355)
Q Consensus       160 ~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~  235 (355)
                      ....-|+..+..+.|+|++.++.+-...-.    ..+..+++...++...+..-+.++...++.+..++++||.|+|+..
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~  306 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS  306 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence            334457778889999999998877654332    2245578888889888988899999999999999999999999996


Q ss_pred             CeeccCCCC---cEEecCCCcEEEE--ecCCccccCcCCCCCcccccCccccchhhccCCCCC--cccHHHHHHHHHHHH
Q 018487          236 IVHRDLKPE---NILMDSDGHVMLT--DFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNK--DADWWSVGILLYEML  308 (355)
Q Consensus       236 iiHrDlkp~---NILl~~~~~~kl~--Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~DiwSlG~~l~ell  308 (355)
                      ..|.-+..+   +...+..+.+.+.  ||+....+..........-+..|.++|......+..  ..|+|.+|..+..+.
T Consensus       307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~  386 (1351)
T KOG1035|consen  307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLS  386 (1351)
T ss_pred             cceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhh
Confidence            666555555   4444556667766  999888776666555555677788898887665554  479999999999998


Q ss_pred             cCCCCCCCchh----hhhhhhHHHHHhhhheeeecCCCcC
Q 018487          309 TGQVNIKSMQV----IACNTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       309 tg~~pf~~~~~----~~~~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                      .|..+-...-.    .......-......+|+.....+++
T Consensus       387 ~~~~i~~~~~~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl  426 (1351)
T KOG1035|consen  387 QGEDISEKSAVPVSLLDVLSTSELLDALPKCLDEDSEERL  426 (1351)
T ss_pred             hcCcccccccchhhhhccccchhhhhhhhhhcchhhhhcc
Confidence            87654332211    1111111234556677755554444

>PRK10593 hypothetical protein; Provisional

Probab=98.13  E-value=5.3e-05  Score=69.20  Aligned_cols=80  Identities=9%  Similarity=0.083  Sum_probs=54.1

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCC---Ccceecceeeec-
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH---PFIVQLRYSFQT-  186 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~nIv~l~~~~~~-  186 (355)
                      ...-.+.||.|..+.||.....       +..+.+|+.+...     ....+..|...|+.+..   -.+.++++.+.. 
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~~-------~~~~~~k~~~~~~-----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~   82 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYDS-------QGNPMPLMARSFS-----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE   82 (297)
T ss_pred             hhheeeecCCccceeEEEEEcC-------CCCEEEEEecccc-----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccC
Confidence            3445678999999999987632       2236777743211     11356778888888753   356667766643 


Q ss_pred             --CCeEEEEEeccCCCCh
Q 018487          187 --RSKLYLILDFINGGHL  202 (355)
Q Consensus       187 --~~~~~lv~e~~~~gsL  202 (355)
                        .+..++|||+++|.++
T Consensus        83 ~~~g~~~LVmE~i~G~~~  100 (297)
T PRK10593         83 QSPGPDVLLLERLRGVSV  100 (297)
T ss_pred             CcCCCeEEEEeccCCEec
Confidence              3668999999998754

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=98.10  E-value=3e-06  Score=76.07  Aligned_cols=139  Identities=12%  Similarity=0.175  Sum_probs=95.4

Q ss_pred             eEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeeccccc-----------------chhHH--HHHHHHHHHHHhc
Q 018487          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-----------------KKNHV--DYMKAERDILTKV  172 (355)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~--~~~~~E~~~l~~l  172 (355)
                      +.+.++||-|.-+.||.+.+.      .++..++|+-+.....                 ....+  -...+|...|+.+
T Consensus        94 ~svGnqIGVGKESDIY~v~d~------~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL  167 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE------EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKAL  167 (465)
T ss_pred             hhhccccccccccceEEEecC------CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHH
Confidence            567789999999999998854      4667888875432110                 00111  1234577777777


Q ss_pred             CC-C-cceecceeeecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC
Q 018487          173 TH-P-FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS  250 (355)
Q Consensus       173 ~h-~-nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~  250 (355)
                      .. . -|.+.++    .+..++|||++.|-.|...-.      ...+..+...+..-+.-|...|+||+|.+-=||++++
T Consensus       168 ~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~d  237 (465)
T KOG2268|consen  168 YERGFPVPKPID----HNRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKD  237 (465)
T ss_pred             HHcCCCCCCccc----ccceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEec
Confidence            52 2 2333333    345789999999876643221      1223445666777788899999999999999999999


Q ss_pred             CCcEEEEecCCccccC
Q 018487          251 DGHVMLTDFGLAKEID  266 (355)
Q Consensus       251 ~~~~kl~Dfg~a~~~~  266 (355)
                      ++.++++||-.+....
T Consensus       238 d~~i~vIDFPQmvS~s  253 (465)
T KOG2268|consen  238 DDKIVVIDFPQMVSTS  253 (465)
T ss_pred             CCCEEEeechHhhccC
Confidence            9999999998665443

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.09  E-value=1.4e-05  Score=67.77  Aligned_cols=98  Identities=16%  Similarity=0.164  Sum_probs=78.1

Q ss_pred             HHHHHHHhcCC-CcceecceeeecCCeEEEEEeccCCCChHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCC
Q 018487          164 AERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFH---LYRQGIFREDQARFYTAEIVSAVSHLHK---CGI  236 (355)
Q Consensus       164 ~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~---l~~~~~l~~~~~~~i~~ql~~~L~~LH~---~~i  236 (355)
                      .|.-+++.+++ +++++++|+|-.    ++|+||...+++...   +..-...++..+..++.++++.+.+|+.   ..+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            47788888886 699999999843    678999987655321   1122235899999999999999999987   347


Q ss_pred             eeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          237 VHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       237 iHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      .-.|++++|+-+++++++|++|...+...
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcchh
Confidence            77999999999999999999999976543

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.08  E-value=6.8e-05  Score=65.93  Aligned_cols=76  Identities=25%  Similarity=0.314  Sum_probs=46.2

Q ss_pred             EeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcc-eecceeeecCCeEEEE
Q 018487          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI-VQLRYSFQTRSKLYLI  193 (355)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv  193 (355)
                      ++.|..|-...+|++....    ..++.|++|+.......    .....+|..+++.+....+ .+++..+. +   .++
T Consensus         3 i~~l~gG~tN~~~~v~~~~----~~~~~~vlR~~~~~~~~----~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l   70 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKE----DNQDAVLVRVYGNKTEL----IIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLI   70 (235)
T ss_pred             EEEcCCcccceEEEEEcCC----CCCCeEEEEEccCCccc----eecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEE
Confidence            4567888889999986321    02456889977543211    1123458888888754333 33433332 2   479


Q ss_pred             EeccCCCCh
Q 018487          194 LDFINGGHL  202 (355)
Q Consensus       194 ~e~~~~gsL  202 (355)
                      |||++|.++
T Consensus        71 ~e~i~G~~l   79 (235)
T cd05157          71 YEFIPGRTL   79 (235)
T ss_pred             EEeeCCCcC
Confidence            999998765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.98  E-value=0.0001  Score=67.50  Aligned_cols=145  Identities=19%  Similarity=0.293  Sum_probs=99.3

Q ss_pred             EEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccc-----------------------hhHHHHHHHHHHHHH
Q 018487          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-----------------------KNHVDYMKAERDILT  170 (355)
Q Consensus       114 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~  170 (355)
                      +-.+|..|.-+.||.|...      .+..+|||+++-.....                       +-..-+...|++-|+
T Consensus       148 inGCiSTGKEANVYHat~~------dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLk  221 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEE------DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLK  221 (520)
T ss_pred             cccccccCccceeEeeecC------CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHH
Confidence            4467889999999998743      46669999876432211                       111223445777777


Q ss_pred             hcCCCcceecceeeecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCCeeccCCCCcEEec
Q 018487          171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMD  249 (355)
Q Consensus       171 ~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH-~~~iiHrDlkp~NILl~  249 (355)
                      +++...|...--...  ....|||+|+.......-.-+...++...+..+-.|++..|.-|- .+++||.||.--|+|+ 
T Consensus       222 Rl~~aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-  298 (520)
T KOG2270|consen  222 RLNNAGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-  298 (520)
T ss_pred             HHHhcCCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-
Confidence            776555432211111  234789999975433333334456788889999999999888874 6789999999999999 


Q ss_pred             CCCcEEEEecCCccccCc
Q 018487          250 SDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       250 ~~~~~kl~Dfg~a~~~~~  267 (355)
                      .+|.+.++|.+.+...+.
T Consensus       299 hdG~lyiIDVSQSVE~DH  316 (520)
T KOG2270|consen  299 HDGKLYIIDVSQSVEHDH  316 (520)
T ss_pred             ECCEEEEEEccccccCCC
Confidence            788999999998765543

>PRK05231 homoserine kinase; Provisional

Probab=97.95  E-value=0.00038  Score=64.19  Aligned_cols=31  Identities=32%  Similarity=0.514  Sum_probs=26.3

Q ss_pred             CCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       234 ~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      .++||+|+.+.|||++.+...-|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            3799999999999998665568999998753

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.91  E-value=0.00016  Score=65.89  Aligned_cols=141  Identities=18%  Similarity=0.222  Sum_probs=82.8

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc--ceeccee-----
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF--IVQLRYS-----  183 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~-----  183 (355)
                      +..-++.|..|....+|++...       ++.+++|+....   .   .+.+..|+.++..+.+-.  +.+++..     
T Consensus        15 ~~~~i~~i~~G~~n~~y~v~~~-------~~~~vLr~~~~~---~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~   81 (296)
T cd05153          15 ELLSFEGISAGIENTNYFVTTD-------SGRYVLTLFEKV---S---AEELPFFLALLDHLAERGLPVPRPIADRDGEY   81 (296)
T ss_pred             chhheecccCccccceEEEEeC-------CCcEEEEEcCCC---C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcE
Confidence            3444677888888999988632       335888987541   1   233556777777764322  3343321     


Q ss_pred             -eecCCeEEEEEeccCCCChHH----HH----------Hhc-CCC----------CHHHH----------HHHHHHHHHH
Q 018487          184 -FQTRSKLYLILDFINGGHLFF----HL----------YRQ-GIF----------REDQA----------RFYTAEIVSA  227 (355)
Q Consensus       184 -~~~~~~~~lv~e~~~~gsL~~----~l----------~~~-~~l----------~~~~~----------~~i~~ql~~~  227 (355)
                       ....+..++|++|++|..+..    ..          +.. ..+          .+...          ......+..+
T Consensus        82 ~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  161 (296)
T cd05153          82 LSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADE  161 (296)
T ss_pred             eeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHH
Confidence             123456789999999876421    00          000 000          00000          0011123334


Q ss_pred             HHHHHH-------CCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          228 VSHLHK-------CGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       228 L~~LH~-------~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      +.++.+       .+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus       162 ~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         162 LARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             HHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            445443       4699999999999999877778999998754

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.90  E-value=0.00041  Score=65.53  Aligned_cols=80  Identities=13%  Similarity=0.163  Sum_probs=51.9

Q ss_pred             EEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeeccccc--c--hhHHHHHHHHHHHHHhcC---CCcceecceeeec
Q 018487          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII--K--KNHVDYMKAERDILTKVT---HPFIVQLRYSFQT  186 (355)
Q Consensus       114 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~--~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~  186 (355)
                      -.+.||.|.+..||++...     ..++.++||........  .  ....++...|...|+.+.   -.++.+++.+  +
T Consensus        30 ~~~elggGn~N~VyrV~~~-----~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D  102 (401)
T PRK09550         30 TAREIGDGNLNLVFRVSDT-----EGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--D  102 (401)
T ss_pred             eeeEcCCCceEEEEEEEeC-----CCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--C
Confidence            3578999999999999854     22246999985422110  1  123456667888887763   2345666555  3


Q ss_pred             CCeEEEEEeccCCC
Q 018487          187 RSKLYLILDFINGG  200 (355)
Q Consensus       187 ~~~~~lv~e~~~~g  200 (355)
                      ....++||||+++.
T Consensus       103 ~~~~~lVME~L~~~  116 (401)
T PRK09550        103 EELAVTVMEDLSDH  116 (401)
T ss_pred             CCCCEEEEecCCCc
Confidence            35578999999864

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.84  E-value=0.00042  Score=63.63  Aligned_cols=143  Identities=20%  Similarity=0.273  Sum_probs=81.8

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc--ceeccee----
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF--IVQLRYS----  183 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~----  183 (355)
                      +....++.++.|....+|++...       ++.+++|+.....  .   .+.+..|..++..+....  +.+++..    
T Consensus        22 ~~~~~i~~~~~G~~n~~y~v~t~-------~~~~vLK~~~~~~--~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~   89 (307)
T TIGR00938        22 GELLSLKGIAEGVENSNYLLTTD-------VGRYILTLYEKRV--K---AEELPFFLALTTHLAARGLPVPKPVKSRDGR   89 (307)
T ss_pred             CCceeccccCCccccceEEEEeC-------CCcEEEEEecCCC--C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCC
Confidence            34555777888888899988632       3347789875421  1   122444666666664222  3333321    


Q ss_pred             --eecCCeEEEEEeccCCCChH----H-------H---HHhc-CCC--------CHH---HH-H-----------HHHHH
Q 018487          184 --FQTRSKLYLILDFINGGHLF----F-------H---LYRQ-GIF--------RED---QA-R-----------FYTAE  223 (355)
Q Consensus       184 --~~~~~~~~lv~e~~~~gsL~----~-------~---l~~~-~~l--------~~~---~~-~-----------~i~~q  223 (355)
                        ....+..+++++|++|..+.    .       .   ++.. ..+        ...   .. .           .....
T Consensus        90 ~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~  169 (307)
T TIGR00938        90 QLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAE  169 (307)
T ss_pred             eehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHH
Confidence              12345678999999985431    0       0   1100 000        000   00 0           00112


Q ss_pred             HHHHHHHHHH-------CCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          224 IVSAVSHLHK-------CGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       224 l~~~L~~LH~-------~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      +.+.++++..       .+++|+|+++.||+++.++.+.|+||+.+..
T Consensus       170 l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       170 LDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             HHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            3344555542       5799999999999999887778999998753

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.77  E-value=6e-06  Score=86.90  Aligned_cols=154  Identities=17%  Similarity=0.088  Sum_probs=114.3

Q ss_pred             HHHHHHHHHhcCCCcceecceeee--cCCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 018487          162 MKAERDILTKVTHPFIVQLRYSFQ--TRSKLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCG  235 (355)
Q Consensus       162 ~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~ql~~~L~~LH~~~  235 (355)
                      ...|.+.++...|+++.....-..  .....|..++|+.+|.++..+.+.    ..+...-+.....+.+.+..-+|++.
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            344666677788999887655544  344678999999999999888654    22344444444445466666666442


Q ss_pred             -----CeeccCCCCcEEecCCCcEEEEecCCcccc-CcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc
Q 018487          236 -----IVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT  309 (355)
Q Consensus       236 -----iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt  309 (355)
                           .+|+++|+-|.+|..+.++|+.++|+.+.. .........++++.|+.++....-.++.++|+|..|+-+|++.-
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence                 789999999999999999999999999832 22223345678889999999887788888999999999999887


Q ss_pred             CCCCCC
Q 018487          310 GQVNIK  315 (355)
Q Consensus       310 g~~pf~  315 (355)
                      |..+|-
T Consensus      1436 ~n~~fi 1441 (2724)
T KOG1826|consen 1436 GNAYFI 1441 (2724)
T ss_pred             ccHHHH
Confidence            766554

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.74  E-value=0.00033  Score=64.12  Aligned_cols=80  Identities=15%  Similarity=0.123  Sum_probs=46.9

Q ss_pred             EeeeccCCcEEEEEEEEcCC-CCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcce-ecceeeecCCeEEE
Q 018487          115 FRVVGQGAFGKVFQVKKKGV-DDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIV-QLRYSFQTRSKLYL  192 (355)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~~l  192 (355)
                      ++.|..|-...+|++..... .....++.+++|+......    ......+|..+++.+....+. +++..+. +   .+
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~   74 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYGIFP-N---GR   74 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cc
Confidence            35667777789998874310 0112346788999755321    112345688888777543333 3444443 2   36


Q ss_pred             EEeccCCCCh
Q 018487          193 ILDFINGGHL  202 (355)
Q Consensus       193 v~e~~~~gsL  202 (355)
                      |+||++|..+
T Consensus        75 v~e~i~G~~l   84 (302)
T cd05156          75 IEEFIPSRTL   84 (302)
T ss_pred             hhheeCCCcC
Confidence            8999998765

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.71  E-value=0.00026  Score=63.14  Aligned_cols=133  Identities=14%  Similarity=0.205  Sum_probs=74.1

Q ss_pred             eccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcce-ecceeeecCCeEEEEEec
Q 018487          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIV-QLRYSFQTRSKLYLILDF  196 (355)
Q Consensus       118 lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~~lv~e~  196 (355)
                      +..|-.+.+|++..       .++.+++|+.......-  .. ...+|..+++.+....++ +++...  .  -++||||
T Consensus         4 ~~~G~tn~~y~~~~-------~~~~~vlR~~~~~~~~~--~~-~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~   69 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-------PGISFVWRPQSPVCKAL--GV-DRQREYQILQALSALGLAPKPILVN--E--HWLLVEW   69 (256)
T ss_pred             CCCcCcCCeEEEEe-------CCccEEEeeCCcccccc--cC-cHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEe
Confidence            45677888998862       24458888754322110  01 135688888888643332 233322  2  2689999


Q ss_pred             cCCCChHHH--------------HH---hcC----CCCH-HHHHHHHHHH---------HHHHHHHHH--------CCCe
Q 018487          197 INGGHLFFH--------------LY---RQG----IFRE-DQARFYTAEI---------VSAVSHLHK--------CGIV  237 (355)
Q Consensus       197 ~~~gsL~~~--------------l~---~~~----~l~~-~~~~~i~~ql---------~~~L~~LH~--------~~ii  237 (355)
                      ++|..+...              +.   ...    .+.. ..+..+..++         ...+..+-.        ..++
T Consensus        70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  149 (256)
T TIGR02721        70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL  149 (256)
T ss_pred             ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence            998654211              11   111    1111 1112221111         111222222        2489


Q ss_pred             eccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          238 HRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       238 HrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      |+|+.|.||++++++ +.|+||..+..-
T Consensus       150 H~Dl~~~Nil~~~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       150 HMDVHAYNLVVTPQG-LKLIDWEYASDG  176 (256)
T ss_pred             cCCCCcCcEEEeCCC-CEEEeccccCcC
Confidence            999999999998877 789999988653

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PLN02236 choline kinase

Probab=97.48  E-value=0.0015  Score=61.05  Aligned_cols=144  Identities=17%  Similarity=0.189  Sum_probs=82.2

Q ss_pred             eEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcce-ecceeeecCCeE
Q 018487          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIV-QLRYSFQTRSKL  190 (355)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~  190 (355)
                      ..-+..|-.|-...+|++...+.. ....+.|++|+.....   ...++ ..+|..+++.+..-++. ++++.+.. +  
T Consensus        38 ~~~i~~l~gGlTN~~y~v~~~~~~-~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g--  109 (344)
T PLN02236         38 ALQVIPLKGAMTNEVFQIKWPTKE-GNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G--  109 (344)
T ss_pred             cEEEEEcCCcccceeEEEEeCCCC-CCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECC-c--
Confidence            334456666888999998754211 1234678899876542   22222 25688888877644443 34555533 2  


Q ss_pred             EEEEeccCCCChHHH-------H----------HhcC------CCCHHHHHHHHHHH-----------------HHHHHH
Q 018487          191 YLILDFINGGHLFFH-------L----------YRQG------IFREDQARFYTAEI-----------------VSAVSH  230 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~-------l----------~~~~------~l~~~~~~~i~~ql-----------------~~~L~~  230 (355)
                       .|++|+++.+|...       +          +...      .....++..++.++                 ...+..
T Consensus       110 -~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~  188 (344)
T PLN02236        110 -RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINL  188 (344)
T ss_pred             -eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHH
Confidence             58999988665311       0          0100      01122233333221                 111222


Q ss_pred             H----H----HCCCeeccCCCCcEEecC-CCcEEEEecCCccc
Q 018487          231 L----H----KCGIVHRDLKPENILMDS-DGHVMLTDFGLAKE  264 (355)
Q Consensus       231 L----H----~~~iiHrDlkp~NILl~~-~~~~kl~Dfg~a~~  264 (355)
                      |    .    ...++|+|+++.|||+++ ++.+.|+||..+..
T Consensus       189 L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        189 LEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             HHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            2    1    225899999999999986 46899999998864

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.47  E-value=0.0024  Score=58.41  Aligned_cols=149  Identities=15%  Similarity=0.171  Sum_probs=83.7

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCC--cceecceeeecCC
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP--FIVQLRYSFQTRS  188 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~~~~~~  188 (355)
                      ...+++.+..|.--.+|....       .++.++|+ ... ............+|..+++.+.--  -+...++.+..+.
T Consensus        26 ~~~~v~~~~~G~sn~t~~~~~-------~~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~   96 (321)
T COG3173          26 GLLIVEEISGGWSNDTFRLGD-------TGQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGY   96 (321)
T ss_pred             CCceeeeccCCcccceEEEec-------CCceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCC
Confidence            445555664444445555442       25567777 332 112233344566788888877532  2233345555444


Q ss_pred             --eEEEEEeccCCCCh---------H---------HHHHh--------------cCCCCHHHHHHHHHH-----------
Q 018487          189 --KLYLILDFINGGHL---------F---------FHLYR--------------QGIFREDQARFYTAE-----------  223 (355)
Q Consensus       189 --~~~lv~e~~~~gsL---------~---------~~l~~--------------~~~l~~~~~~~i~~q-----------  223 (355)
                        ..|.||+|++|..+         .         +.|..              .+.+...++..+..+           
T Consensus        97 ~g~pf~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~  176 (321)
T COG3173          97 LGTPFYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGR  176 (321)
T ss_pred             CCCceEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCC
Confidence              67999999998322         1         11110              000111222222222           


Q ss_pred             ---HHHHHHHHHHC--------CCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          224 ---IVSAVSHLHKC--------GIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       224 ---l~~~L~~LH~~--------~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                         ...-..+|+.+        .++|+|+.+.||+++.++.+-|+||+++..-+..
T Consensus       177 ~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~  232 (321)
T COG3173         177 IPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPL  232 (321)
T ss_pred             CchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcH
Confidence               22334455533        4899999999999999989999999998765443

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.41  E-value=0.0017  Score=58.58  Aligned_cols=32  Identities=44%  Similarity=0.569  Sum_probs=26.3

Q ss_pred             CCeeccCCCCcEEecCCCc-EEEEecCCccccC
Q 018487          235 GIVHRDLKPENILMDSDGH-VMLTDFGLAKEID  266 (355)
Q Consensus       235 ~iiHrDlkp~NILl~~~~~-~kl~Dfg~a~~~~  266 (355)
                      .++|+|+++.|||++.+++ .-|+||+.+..-+
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGD  218 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVGD  218 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccCC
Confidence            3899999999999987565 4699999886543

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.32  E-value=0.0025  Score=59.12  Aligned_cols=76  Identities=16%  Similarity=0.190  Sum_probs=46.0

Q ss_pred             eeccCCcEEEEEEEEcCCCCCCCCceEEEEEeeccccc----chhHHHHHHHHHHHHHhcC--CCc-ceecceeeecCCe
Q 018487          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII----KKNHVDYMKAERDILTKVT--HPF-IVQLRYSFQTRSK  189 (355)
Q Consensus       117 ~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~E~~~l~~l~--h~n-Iv~l~~~~~~~~~  189 (355)
                      .||.|....||++...     ..++-|+||.-......    -+-..++..-|...|+...  -|. +.+++  +.+...
T Consensus         2 EigdGnlN~VfrV~~~-----~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~   74 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQ-----EGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEM   74 (370)
T ss_pred             cCCCCceEEEEEEEcC-----CCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEcccc
Confidence            5899999999999843     22356999975432111    1233445556777777654  343 44433  234445


Q ss_pred             EEEEEeccCC
Q 018487          190 LYLILDFING  199 (355)
Q Consensus       190 ~~lv~e~~~~  199 (355)
                      ..+|||+++.
T Consensus        75 ~~~vMEdL~~   84 (370)
T TIGR01767        75 AVTVMEDLSH   84 (370)
T ss_pred             ceehHhhCcc
Confidence            6689999865

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.26  E-value=0.011  Score=54.17  Aligned_cols=29  Identities=31%  Similarity=0.549  Sum_probs=25.6

Q ss_pred             CCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          234 CGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       234 ~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47899999999999987 678999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.17  E-value=0.0051  Score=57.06  Aligned_cols=145  Identities=16%  Similarity=0.204  Sum_probs=80.0

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcce-ecceeeecCC
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIV-QLRYSFQTRS  188 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~l~~~~~~~~  188 (355)
                      +..++ +.|..|-...+|++...+..  .....|++|+......   ..++ ..+|..+++.+..-++- ++++++. ++
T Consensus        15 ~~i~i-~~l~gGlTN~~~~v~~~~~~--~~~~~~v~Ri~g~~t~---~~Id-R~~E~~il~~l~~~gl~P~~l~~~~-~G   86 (330)
T PLN02421         15 SDFSV-ERISGGITNLLLKVSVKEEN--GNEVSVTVRLFGPNTD---YVID-RERELQAIKYLSAAGFGAKLLGVFG-NG   86 (330)
T ss_pred             CceEE-EEeCCcccceEEEEEecCCC--CCCceEEEEEecCCcC---eEec-hHHHHHHHHHHHhcCCCCceeEEeC-Cc
Confidence            34444 44545778889998754321  1234688998754321   1122 34688888888654443 3455553 32


Q ss_pred             eEEEEEeccCCCChHH-------HH----------HhcC-C----C-CHHHHHHHHHHH---------------------
Q 018487          189 KLYLILDFINGGHLFF-------HL----------YRQG-I----F-REDQARFYTAEI---------------------  224 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~-------~l----------~~~~-~----l-~~~~~~~i~~ql---------------------  224 (355)
                         +|.+|++|..|..       .+          +... .    . ....+..+..++                     
T Consensus        87 ---~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~  163 (330)
T PLN02421         87 ---MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEE  163 (330)
T ss_pred             ---EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHH
Confidence               5899998765521       01          1101 0    1 112222222221                     


Q ss_pred             -HHHHHHH----HHCC----CeeccCCCCcEEecC-CCcEEEEecCCcccc
Q 018487          225 -VSAVSHL----HKCG----IVHRDLKPENILMDS-DGHVMLTDFGLAKEI  265 (355)
Q Consensus       225 -~~~L~~L----H~~~----iiHrDlkp~NILl~~-~~~~kl~Dfg~a~~~  265 (355)
                       ..-+..+    ...+    .+|.|+.+.|||+++ ++.++++||..|..-
T Consensus       164 l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n  214 (330)
T PLN02421        164 LRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS  214 (330)
T ss_pred             HHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence             1112222    1122    799999999999975 578999999988643

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.15  E-value=0.0061  Score=57.65  Aligned_cols=77  Identities=12%  Similarity=0.094  Sum_probs=49.2

Q ss_pred             EEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccch----hHHHHHHHHHHHHHhcC---CCcceecceeeec
Q 018487          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK----NHVDYMKAERDILTKVT---HPFIVQLRYSFQT  186 (355)
Q Consensus       114 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~  186 (355)
                      ..+.||.|.-..||++...       ++.++||.-........    ...++...|...|+.+.   ..++.+++.++. 
T Consensus        36 ~~~eiggGn~N~VyrV~~~-------~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de-  107 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS-------SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR-  107 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC-------CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC-
Confidence            4678999999999998742       23488997652221111    12333444666666554   246777777666 


Q ss_pred             CCeEEEEEeccCC
Q 018487          187 RSKLYLILDFING  199 (355)
Q Consensus       187 ~~~~~lv~e~~~~  199 (355)
                       +..+++|||+++
T Consensus       108 -d~~vlvME~L~~  119 (418)
T PLN02756        108 -TMALIGMRYLEP  119 (418)
T ss_pred             -CCCEEEEeecCC
Confidence             445788999977

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.13  E-value=0.0061  Score=55.26  Aligned_cols=76  Identities=17%  Similarity=0.291  Sum_probs=45.9

Q ss_pred             eEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC---CCcceecceeeecCC
Q 018487          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT---HPFIVQLRYSFQTRS  188 (355)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~  188 (355)
                      .+-.+.|+.|....+|++.       ..++.+.||+-....      ...+..|..-|+.|.   --.+.+++.+....+
T Consensus        19 i~~~~~v~GG~i~~a~~~~-------~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~   85 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD-------TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD   85 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE-------TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS
T ss_pred             eeeeEecCCCChhheEEEE-------CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC
Confidence            4556789999999999987       356779999876221      234566777777774   345667788777777


Q ss_pred             eEEEEEeccCCC
Q 018487          189 KLYLILDFINGG  200 (355)
Q Consensus       189 ~~~lv~e~~~~g  200 (355)
                      ..++||||++.+
T Consensus        86 ~~fLlle~l~~~   97 (288)
T PF03881_consen   86 DAFLLLEFLEMG   97 (288)
T ss_dssp             CCEEEEE-----
T ss_pred             CceEEEEeecCC
Confidence            779999999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.06  E-value=0.009  Score=54.87  Aligned_cols=30  Identities=23%  Similarity=0.243  Sum_probs=27.6

Q ss_pred             CCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       235 ~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      +++|+|+.++|||++.++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            699999999999999999999999998754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.87  E-value=0.0059  Score=56.24  Aligned_cols=72  Identities=29%  Similarity=0.380  Sum_probs=55.9

Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~-~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      ..+.|++|++. |+.+. .+   ..-..+++..|+++.+..++-+..+ ..=|||+...||||+ +|+|.|+||-+++.
T Consensus       298 ~~y~yl~~kdh-gt~is-~i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         298 TLYLYLHFKDH-GTPIS-II---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             ceEEEEEEecC-Cceee-ee---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence            34677888875 44442 22   2236778888999988888877754 688999999999998 99999999999984

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.81  E-value=0.014  Score=50.47  Aligned_cols=80  Identities=16%  Similarity=0.292  Sum_probs=54.6

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCC---CcceecceeeecC
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH---PFIVQLRYSFQTR  187 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~nIv~l~~~~~~~  187 (355)
                      +.+..+.+.-|.--..|.+.+       ....+.||+-      .......+..|+.-|..|.-   -+|.+++.+-...
T Consensus        17 ~i~er~~v~gG~inea~~v~d-------g~~~~FvK~n------~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~   83 (286)
T COG3001          17 EIKEREEVSGGDINEAWRLRD-------GTDPFFVKCN------QREQLSMFTAEADGLELLARSNTITVPKVIAVGASR   83 (286)
T ss_pred             hhhcccccCCccccceeEeec-------CCcceEEEec------chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCC
Confidence            344445666677777777663       3445888863      34445567778777666643   4566778888889


Q ss_pred             CeEEEEEeccCCCChH
Q 018487          188 SKLYLILDFINGGHLF  203 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~  203 (355)
                      ++.|+||||++-+.+.
T Consensus        84 ~~sylVle~L~~~~~d   99 (286)
T COG3001          84 DHSYLVLEYLPTGPLD   99 (286)
T ss_pred             CeeEEEEeeccCCCCC
Confidence            9999999999986653

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.80  E-value=0.035  Score=51.30  Aligned_cols=137  Identities=24%  Similarity=0.361  Sum_probs=78.3

Q ss_pred             EeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc------ceecce----ee
Q 018487          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF------IVQLRY----SF  184 (355)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~l~~----~~  184 (355)
                      ...|.+ .-..||++...       .+.+++|+.+.. . ..   ..+..|...|+.+.-..      |..+-|    ..
T Consensus        31 ~~~l~s-~eN~~f~~~~~-------~g~~iLki~~~~-~-~~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~   97 (331)
T COG2334          31 LRGLNS-EENSNFRVQTE-------DGRYILKIYRPG-W-TR---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEAL   97 (331)
T ss_pred             cccccc-ccCceEEEEec-------CCCeEEEEecCC-C-CH---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhc
Confidence            344555 66778888743       333599998775 2 22   33455777777764222      122211    12


Q ss_pred             ecCCeEEEEEeccCCCChHH-----HH----------Hh--cC----------CCCHH----HH---------HHHHHHH
Q 018487          185 QTRSKLYLILDFINGGHLFF-----HL----------YR--QG----------IFRED----QA---------RFYTAEI  224 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~-----~l----------~~--~~----------~l~~~----~~---------~~i~~ql  224 (355)
                      ......+-+++|++|..+..     .+          +.  ++          ...+.    ..         .....++
T Consensus        98 ~~~~r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~  177 (331)
T COG2334          98 SGGPRPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAAL  177 (331)
T ss_pred             cCCceeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHH
Confidence            22237788999999977651     11          00  00          01111    00         0122234


Q ss_pred             HHHHHHHHH--------CC--CeeccCCCCcEEecCCCc-EEEEecCCccc
Q 018487          225 VSAVSHLHK--------CG--IVHRDLKPENILMDSDGH-VMLTDFGLAKE  264 (355)
Q Consensus       225 ~~~L~~LH~--------~~--iiHrDlkp~NILl~~~~~-~kl~Dfg~a~~  264 (355)
                      ...+..+.+        .+  +||+|+.|.|||++.+.. +.++|||-+..
T Consensus       178 ~~~~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         178 LAALDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             HHHHHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence            444444442        24  999999999999998885 89999997753

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.72  E-value=0.004  Score=53.79  Aligned_cols=30  Identities=47%  Similarity=0.706  Sum_probs=21.5

Q ss_pred             CCeeccCCCCcEEe-cCCCcEEEEecCCccc
Q 018487          235 GIVHRDLKPENILM-DSDGHVMLTDFGLAKE  264 (355)
Q Consensus       235 ~iiHrDlkp~NILl-~~~~~~kl~Dfg~a~~  264 (355)
                      .++|.|+.+.|||+ +.++.++|+||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            48999999999999 8899999999998864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.64  E-value=0.018  Score=54.17  Aligned_cols=78  Identities=15%  Similarity=0.212  Sum_probs=48.9

Q ss_pred             EeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeeccccc--c-hhHHHHHHHHHHHHHhcC--CCc-ceecceeeecCC
Q 018487          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII--K-KNHVDYMKAERDILTKVT--HPF-IVQLRYSFQTRS  188 (355)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~-~~~~~~~~~E~~~l~~l~--h~n-Iv~l~~~~~~~~  188 (355)
                      .+.||.|.-..||++...     ..++-|+||.-......  + +-..++..-|...|+...  -|. +.+++.  .+..
T Consensus        34 ~~eigdGnlN~VfrV~~~-----~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e  106 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDE-----QKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSV  106 (409)
T ss_pred             eeEcCCCceEEEEEEeeC-----CCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcH
Confidence            678999999999999863     12345889875322111  1 334455666788887664  343 444432  3444


Q ss_pred             eEEEEEeccCC
Q 018487          189 KLYLILDFING  199 (355)
Q Consensus       189 ~~~lv~e~~~~  199 (355)
                      ...+|||+++.
T Consensus       107 ~~~~vMEdL~~  117 (409)
T PRK12396        107 MNCCVMEDLSD  117 (409)
T ss_pred             HhhHHHHhCcc
Confidence            56789999864

>PTZ00384 choline kinase; Provisional

Probab=96.63  E-value=0.027  Score=53.27  Aligned_cols=82  Identities=13%  Similarity=0.148  Sum_probs=46.5

Q ss_pred             EEEeeeccCCcEEEEEEEEcCCC-CCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcce-ecceeeecCCeE
Q 018487          113 EIFRVVGQGAFGKVFQVKKKGVD-DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIV-QLRYSFQTRSKL  190 (355)
Q Consensus       113 ~~~~~lG~G~~g~V~~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~  190 (355)
                      ..++.|..|-...+|++...+.. +....+.|++++....   ....++ -.+|+.+++.+...++- ++++.+..    
T Consensus        53 i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~---~~l~Id-R~~E~~i~~~Ls~~glgP~l~~~f~~----  124 (383)
T PTZ00384         53 IEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY---NSLVID-NDLQYNIAKLLGDNNFGPKIIGRFGD----  124 (383)
T ss_pred             EEEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC---CceEec-cHHHHHHHHHHHhCCCCCeEEEecCC----
Confidence            34456666888999999754221 0011123444443211   111122 34588899988755544 45555542    


Q ss_pred             EEEEeccCCCCh
Q 018487          191 YLILDFINGGHL  202 (355)
Q Consensus       191 ~lv~e~~~~gsL  202 (355)
                      ++++||++|..|
T Consensus       125 g~l~efIeGr~l  136 (383)
T PTZ00384        125 FTIQEWVEGNTM  136 (383)
T ss_pred             EEEEEEeccccC
Confidence            699999998765

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.45  E-value=0.17  Score=46.81  Aligned_cols=29  Identities=31%  Similarity=0.320  Sum_probs=24.5

Q ss_pred             CCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       234 ~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      .++||+|+.+.|||++ + .+.|+||+.+..
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            3689999999999995 4 688999998754

>PRK06148 hypothetical protein; Provisional

Probab=96.18  E-value=0.14  Score=54.78  Aligned_cols=31  Identities=39%  Similarity=0.624  Sum_probs=26.2

Q ss_pred             CCCeeccCCCCcEEecCCC--cEE-EEecCCccc
Q 018487          234 CGIVHRDLKPENILMDSDG--HVM-LTDFGLAKE  264 (355)
Q Consensus       234 ~~iiHrDlkp~NILl~~~~--~~k-l~Dfg~a~~  264 (355)
                      .++||+|+++.|||++.++  ++. |+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            4699999999999998775  565 999997754

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.09  E-value=0.012  Score=56.47  Aligned_cols=48  Identities=10%  Similarity=0.068  Sum_probs=37.4

Q ss_pred             HHHHHHHHHhcCCCcceecceeeecC-CeEEEEEeccCCCChHHHHHhcC
Q 018487          162 MKAERDILTKVTHPFIVQLRYSFQTR-SKLYLILDFINGGHLFFHLYRQG  210 (355)
Q Consensus       162 ~~~E~~~l~~l~h~nIv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~  210 (355)
                      +.-..++++.+.|+|...++++.... ....+|||++. .+|.+.+..+.
T Consensus        29 ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~   77 (725)
T KOG1093|consen   29 ILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN   77 (725)
T ss_pred             HhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc
Confidence            44567889999999999988877643 34788999985 48888887664

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=95.98  E-value=0.05  Score=49.44  Aligned_cols=80  Identities=11%  Similarity=0.137  Sum_probs=45.8

Q ss_pred             ccCCcEEEEEEEEcC--C-CCCCCCceEEEEEeecccccc--hhHHHHHHHHHHHHHhcC---------C----Ccceec
Q 018487          119 GQGAFGKVFQVKKKG--V-DDGDSDGIYAMKVMRKDTIIK--KNHVDYMKAERDILTKVT---------H----PFIVQL  180 (355)
Q Consensus       119 G~G~~g~V~~~~~~~--~-~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~---------h----~nIv~l  180 (355)
                      |.|-.|.+|++....  . ........++||.........  ......+.+|+.+.+.+-         .    ..+.++
T Consensus         2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~   81 (294)
T PF02958_consen    2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC   81 (294)
T ss_pred             CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence            677789999987654  2 122334568889876322111  122345777887766541         1    123445


Q ss_pred             ceeeecCCeEEEEEeccC
Q 018487          181 RYSFQTRSKLYLILDFIN  198 (355)
Q Consensus       181 ~~~~~~~~~~~lv~e~~~  198 (355)
                      +.........+||||-+.
T Consensus        82 ~~~~~~~~~~~lvlEDL~   99 (294)
T PF02958_consen   82 YYADEDPGDEVLVLEDLS   99 (294)
T ss_pred             EEeccCCCceeeehhhhh
Confidence            554444446788988764

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.46  E-value=0.083  Score=45.61  Aligned_cols=102  Identities=18%  Similarity=0.174  Sum_probs=64.5

Q ss_pred             ceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHH
Q 018487          141 GIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY  220 (355)
Q Consensus       141 ~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i  220 (355)
                      ....+|.++.-...  -....+.++.+++.+++  .|+++..-  .+-.+.++.|+|-....         .    ...+
T Consensus        86 G~L~lKKi~slp~~--~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i---------~----~~N~  146 (308)
T PF07387_consen   86 GPLFLKKIRSLPCC--INDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI---------N----FSNF  146 (308)
T ss_pred             chhhhhhccCCCcc--cchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc---------c----hhHH
Confidence            34566666543221  12234567888888875  56666532  33457789998854321         0    0111


Q ss_pred             HHHHHHHHHHHHH--CCCeeccCCCCcEEecCCCcEEEEecCC
Q 018487          221 TAEIVSAVSHLHK--CGIVHRDLKPENILMDSDGHVMLTDFGL  261 (355)
Q Consensus       221 ~~ql~~~L~~LH~--~~iiHrDlkp~NILl~~~~~~kl~Dfg~  261 (355)
                      +.-=+.+|.-+|+  .+.+|+|-.|+||+-|..|.+||.|=+.
T Consensus       147 i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  147 ITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             HHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence            1112456777783  4699999999999999999999999763

The function of this family is unknown.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	355
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-59
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		8e-59
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		8e-59
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-56
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-56
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-56
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-54
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-52
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-49
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-49
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-49
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-48
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-48
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-48
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-48
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-48
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-48
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-47
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-47
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-47
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-46
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-46
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-46
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-46
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-46
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-46
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-46
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-46
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-46
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-46
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-46
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-46
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-46
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-46
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-46
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-46
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-46
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-46
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-46
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-46
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-46
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-46
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-46
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-46
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-46
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-46
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-46
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-46
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-46
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-46
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-46
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-46
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-46
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		6e-46
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		7e-46
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		7e-46
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-46
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		9e-46
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-45
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-45
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-45
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-45
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-45
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-45
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-45
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-45
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-45
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-45
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-45
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-45
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-45
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-45
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		6e-45
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		6e-45
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		6e-45
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-45
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-45
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		9e-45
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-44
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-44
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-44
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-44
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		5e-44
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-44
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-43
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-43
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-43
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-43
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-43
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-43
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-43
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-43
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-43
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-43
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-43
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-43
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-43
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-43
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-43
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-42
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-41
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-40
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-40
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-40
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		8e-39
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		8e-39
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		9e-39
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-38
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-37
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-36
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		5e-36
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		6e-36
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		7e-36
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-34
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-34
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-34
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-34
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-34
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-34
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-32
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-32
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-32
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-32
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-30
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-30
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-30
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-30
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		6e-30
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-29
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-29
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-29
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-29
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-29
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-29
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-29
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-29
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-29
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-29
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-29
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		7e-29
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		7e-29
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		7e-29
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		9e-29
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		9e-29
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-28
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-28
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-28
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-28
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-28
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-28
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-28
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-28
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-28
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-28
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-28
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-28
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-28
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-28
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-28
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-28
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-28
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-28
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-28
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-28
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-28
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-28
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-27
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-27
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-27
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-27
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-27
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-27
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-27
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-27
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-27
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-27
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-27
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-27
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-27
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-27
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		6e-27
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		8e-27
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-26
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-26
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-26
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-26
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-26
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-25
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-25
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-25
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-25
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-25
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-25
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-25
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-25
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		6e-25
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		8e-25
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		9e-25
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-24
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-24
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-24
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-24
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-24
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-24
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-24
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-24
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-24
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-24
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-24
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-24
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-24
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-24
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-24
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-24
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-24
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		5e-24
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-24
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		5e-24
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-24
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		6e-24
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		6e-24
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		6e-24
3soa_A	444	Full-Length Human Camkii Length = 444		8e-24
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		8e-24
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		9e-24
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-23
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-23
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-23
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-23
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-23
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-23
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-23
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-23
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-23
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-23
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-23
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-23
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-23
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-23
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-23
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-23
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-23
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-23
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		5e-23
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		8e-23
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		9e-23
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-22
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-22
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-22
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-22
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-22
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		6e-22
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		6e-22
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		6e-22
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-22
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-22
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		6e-22
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		7e-22
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		7e-22
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		7e-22
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		7e-22
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		7e-22
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		8e-22
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		8e-22
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-21
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-21
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-21
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-21
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-21
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-21
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-21
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-20
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-20
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-20
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-20
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-20
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-20
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-20
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-20
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-20
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-20
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-20
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-20
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-20
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-20
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-20
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-20
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		8e-20
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		9e-20
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		9e-20
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-19
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-19
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-19
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-19
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-19
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-19
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-19
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-19
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-19
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-19
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-19
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-19
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-19
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-19
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-19
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-19
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-19
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-19
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		8e-19
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-19
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-18
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-18
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-18
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-18
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-18
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-18
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-18
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-18
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-18
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-18
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-18
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-18
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-18
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-18
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-18
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-18
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-18
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-18
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-18
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-18
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-18
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		8e-18
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		8e-18
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-17
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-17
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-17
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-17
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-17
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-17
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-17
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-17
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-17
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-17
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-17
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-17
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-17
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-17
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-17
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-17
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-17
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-17
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-17
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-17
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-17
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		6e-17
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-17
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		7e-17
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		8e-17
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-17
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-17
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-16
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-16
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-16
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-16
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-16
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-16
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-16
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-16
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-16
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-16
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-16
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		4e-16
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		5e-16
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-16
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-16
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-16
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		5e-16
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-16
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		5e-16
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		5e-16
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		6e-16
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-16
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		6e-16
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		7e-16
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-16
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		7e-16
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		7e-16
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-16
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		7e-16
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-16
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-16
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		7e-16
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		7e-16
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		7e-16
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		7e-16
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		7e-16
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		7e-16
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		7e-16
4exu_A	371	Mapk13, Inactive Form Length = 371		8e-16
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		8e-16
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-16
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		8e-16
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		8e-16
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		8e-16
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		8e-16
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		8e-16
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-16
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		9e-16
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		9e-16
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-15
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-15
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-15
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-15
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-15
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-15
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-15
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-15
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-15
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-15
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-15
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-15
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-15
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-15
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-15
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-15
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-15
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-15
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-15
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-15
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-15
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-15
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-15
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-15
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-15
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-15
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-15
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-15
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-15
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-15
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-15
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-15
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-15
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-15
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-15
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-15
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-15
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		5e-15
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-15
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-15
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-15
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-15
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-15
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		6e-15
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-15
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		7e-15
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-15
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		7e-15
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-15
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		7e-15
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		8e-15
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		8e-15
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		8e-15
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		8e-15
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		8e-15
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		8e-15
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		8e-15
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		8e-15
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		8e-15
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		8e-15
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		8e-15
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		8e-15
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		8e-15
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		8e-15
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		8e-15
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		9e-15
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		9e-15
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		9e-15
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		9e-15
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		9e-15
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		9e-15
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		9e-15
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-15
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		9e-15
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		9e-15
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		9e-15
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		9e-15
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		9e-15
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-14
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-14
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-14
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-14
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-14
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-14
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-14
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-14
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-14
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-14
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-14
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-14
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-14
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-14
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-14
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-14
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-14
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-14
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-14
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-14
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-14
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-14
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-14
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-14
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-14
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-14
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-14
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-14
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-14
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-14
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-14
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-14
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-14
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-14
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-14
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-14
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-14
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-14
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-14
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-14
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-14
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-14
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-14
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-14
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-14
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-14
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-14
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-14
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-14
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-14
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-14
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-14
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-14
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-14
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-14
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-14
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-14
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-14
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-14
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-14
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-14
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-14
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-14
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-14
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-14
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-14
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-14
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-14
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-14
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-14
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-14
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-14
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-14
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-14
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-14
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-14
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-14
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-14
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		6e-14
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-14
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		6e-14
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		6e-14
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-14
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		6e-14
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-14
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-14
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		7e-14
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-14
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-14
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-14
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-14
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-14
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-14
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-14
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-14
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-14
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		8e-14
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		8e-14
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		8e-14
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		8e-14
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-13
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-13
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-13
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-13
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-13
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-13
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-13
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-13
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-13
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-13
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-13
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-13
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-13
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-13
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-13
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-13
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-13
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-13
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-13
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-13
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-13
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-13
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-13
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-13
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-13
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-13
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		7e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-13
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		8e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		9e-13
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		9e-13
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		9e-13
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		9e-13
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-12
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-12
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-12
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-12
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-12
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-12
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-12
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-12
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-12
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-12
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-12
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-12
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-12
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-12
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-12
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		5e-12
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-12
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-12
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		7e-12
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		7e-12
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		8e-12
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		8e-12
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-12
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		9e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		9e-12
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		9e-12
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		9e-12
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		9e-12
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		9e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-11
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-11
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-11
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-11
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-11
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-11
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-11
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-11
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-11
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-11
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-11
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-11
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-11
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-11
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		2e-11
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-11
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-11
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-11
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-11
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-11
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-11
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-11
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-11
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-11
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-11
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-11
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-11
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-11
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-11
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-11
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-11
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-11
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-11
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-11
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-11
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-11
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-11
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-11
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-11
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-11
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-11
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-11
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-11
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		3e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-11
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-11
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-11
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-11
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-11
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-11
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-11
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-11
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		5e-11
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		5e-11
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		5e-11
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-11
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		6e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		7e-11
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		7e-11
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		7e-11
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		8e-11
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-11
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		8e-11
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		8e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-11
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-10
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-10
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-10
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-10
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-10
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-10
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-10
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-10
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-10
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-10
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		2e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-10
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-10
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-10
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-10
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-10
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-10
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		4e-10
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		4e-10
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-10
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-10
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		4e-10
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-10
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-10
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-10
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-10
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-10
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		5e-10
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		5e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-10
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-10
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		6e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-10
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		6e-10
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-10
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		7e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		7e-10
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		7e-10
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		7e-10
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		7e-10
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		8e-10
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		8e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		8e-10
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-10
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		8e-10
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-10
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-10
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		9e-10
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		9e-10
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		9e-10
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		9e-10
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		9e-10
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		9e-10
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		9e-10
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		9e-10
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-10
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		9e-10
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		9e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		9e-10
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		9e-10
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		9e-10
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		9e-10
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		9e-10
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		9e-10
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		9e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-09
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-09
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-09
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-09
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-09
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-09
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-09
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-09
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-09
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-09
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-09
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-09
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-09
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-09
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-09
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-09
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-09
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-09
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-09
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-09
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-09
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-09
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-09
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-09
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-09
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-09
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-09
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-09
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-09
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-09
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-09
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-09
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-09
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-09
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-09
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-09
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-09
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-09
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-09
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-09
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-09
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-09
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-09
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-09
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-09
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-09
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-09
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-09
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-09
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-09
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-09
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-09
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-09
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-09
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-09
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-09
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		5e-09
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-09
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		6e-09
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		6e-09
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		6e-09
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		6e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-09
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		7e-09
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		7e-09
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		7e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		8e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		8e-09
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		8e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		8e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		9e-09
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		9e-09
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-08
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-08
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-08
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-08
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-08
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-08
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-08
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-08
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		2e-08
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-08
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-08
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-08
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-08
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-08
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-08
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		2e-08
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		2e-08
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-08
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-08
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		2e-08
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-08
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		3e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-08
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		3e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-08
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		5e-08
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		5e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-08
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-08
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		6e-08
3gni_B	389	Structure Of Strad And Mo25 Length = 389		6e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		6e-08
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		7e-08
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		7e-08
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		7e-08
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		8e-08
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-07
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		2e-07
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-07
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-07
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-07
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-07
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-07
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-07
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-07
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-07
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-07
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-07

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  224 bits (571), Expect = 5e-59,   Method: Compositional matrix adjust.
 Identities = 109/227 (48%), Positives = 148/227 (65%), Gaps = 4/227 (1%)
Query: 102 ESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDY 161
           E   K  P  FE+ +V+GQG+F                  +YAMKV++K T+  ++ V  
Sbjct: 16  EGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQ--LYAMKVLKKATLKVRDRVR- 72
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
            K ERDIL +V HPFIV+L Y+FQT  KLYLILDF+ GG LF  L ++ +F E+  +FY 
Sbjct: 73  TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 132
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEY 280
           AE+  A+ HLH  GI++RDLKPENIL+D +GH+ LTDFGL+KE ID   ++ S CGT EY
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 192
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLL 327
           MAPE++  +GH + ADWWS G+L++EMLTG +  +        TM+L
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL 239

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  224 bits (570), Expect = 8e-59,   Method: Compositional matrix adjust.
 Identities = 109/227 (48%), Positives = 148/227 (65%), Gaps = 4/227 (1%)
Query: 102 ESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDY 161
           E   K  P  FE+ +V+GQG+F                  +YAMKV++K T+  ++ V  
Sbjct: 17  EGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQ--LYAMKVLKKATLKVRDRVR- 73
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
            K ERDIL +V HPFIV+L Y+FQT  KLYLILDF+ GG LF  L ++ +F E+  +FY 
Sbjct: 74  TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 133
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEY 280
           AE+  A+ HLH  GI++RDLKPENIL+D +GH+ LTDFGL+KE ID   ++ S CGT EY
Sbjct: 134 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 193
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLL 327
           MAPE++  +GH + ADWWS G+L++EMLTG +  +        TM+L
Sbjct: 194 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL 240

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  224 bits (570), Expect = 8e-59,   Method: Compositional matrix adjust.
 Identities = 109/227 (48%), Positives = 148/227 (65%), Gaps = 4/227 (1%)
Query: 102 ESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDY 161
           E   K  P  FE+ +V+GQG+F                  +YAMKV++K T+  ++ V  
Sbjct: 16  EGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQ--LYAMKVLKKATLKVRDRVR- 72
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
            K ERDIL +V HPFIV+L Y+FQT  KLYLILDF+ GG LF  L ++ +F E+  +FY 
Sbjct: 73  TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 132
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEY 280
           AE+  A+ HLH  GI++RDLKPENIL+D +GH+ LTDFGL+KE ID   ++ S CGT EY
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 192
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLL 327
           MAPE++  +GH + ADWWS G+L++EMLTG +  +        TM+L
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL 239

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  216 bits (551), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 107/207 (51%), Positives = 142/207 (68%), Gaps = 4/207 (1%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKK-NHVDYMKA 164
           KI P  FE+ RV+G+G +                  I+AMKV++K  I++      + KA
Sbjct: 13  KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGK--IFAMKVLKKAMIVRNAKDTAHTKA 70
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  L R+GIF ED A FY AEI
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 130
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAP 283
             A+ HLH+ GI++RDLKPENI+++  GHV LTDFGL KE I + + +++ CGT EYMAP
Sbjct: 131 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 190
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTG 310
           EIL+  GHN+  DWWS+G L+Y+MLTG
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  216 bits (551), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 108/230 (46%), Positives = 150/230 (65%), Gaps = 5/230 (2%)
Query: 99  LEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNH 158
           ++A SE K  P  FE+ +V+GQG+F                  +YAMKV++K T+  ++ 
Sbjct: 18  VKAGSE-KADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGH--LYAMKVLKKATLKVRDR 74
Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
           V   K ERDIL  V HPF+V+L Y+FQT  KLYLILDF+ GG LF  L ++ +F E+  +
Sbjct: 75  V-RTKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK 133
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGT 277
           FY AE+   + HLH  GI++RDLKPENIL+D +GH+ LTDFGL+KE ID   ++ S CGT
Sbjct: 134 FYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGT 193
Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLL 327
            EYMAPE++  +GH+  ADWWS G+L++EMLTG +  +        T++L
Sbjct: 194 VEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLIL 243

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  216 bits (549), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 107/207 (51%), Positives = 141/207 (68%), Gaps = 4/207 (1%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKK-NHVDYMKA 164
           KI P  FE+ RV+G+G +                  I+AMKV++K  I++      + KA
Sbjct: 13  KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGK--IFAMKVLKKAMIVRNAKDTAHTKA 70
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  L R+GIF ED A FY AEI
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 130
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAP 283
             A+ HLH+ GI++RDLKPENI+++  GHV LTDFGL KE I + + ++  CGT EYMAP
Sbjct: 131 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAP 190
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTG 310
           EIL+  GHN+  DWWS+G L+Y+MLTG
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  210 bits (534), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 100/204 (49%), Positives = 139/204 (68%), Gaps = 7/204 (3%)
Query: 109 PGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           P DF   +V+G+G+F                   YA+KV++K  I+KK    ++ +ER++
Sbjct: 37  PSDFHFLKVIGKGSFGKVLLARHKAEEV-----FYAVKVLQKKAILKKKEEKHIMSERNV 91
Query: 169 LTK-VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           L K V HPF+V L +SFQT  KLY +LD+INGG LF+HL R+  F E +ARFY AEI SA
Sbjct: 92  LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASA 151
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEIL 286
           + +LH   IV+RDLKPENIL+DS GH++LTDFGL KE I+ +S +++ CGT EY+APE+L
Sbjct: 152 LGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVL 211
Query: 287 LSKGHNKDADWWSVGILLYEMLTG 310
             + +++  DWW +G +LYEML G
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  203 bits (517), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 107/231 (46%), Positives = 153/231 (66%), Gaps = 10/231 (4%)
Query: 87  QIQELEHE-NDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAM 145
           Q+  ++HE   A L   +E K+G  +FE+ +V+G GA+                  +YAM
Sbjct: 31  QLLTVKHELRTANLTGHAE-KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGK--LYAM 87
Query: 146 KVMRKDTIIKK-NHVDYMKAERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           KV++K TI++K    ++ + ER +L  +   PF+V L Y+FQT +KL+LILD+INGG LF
Sbjct: 88  KVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELF 147
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK 263
            HL ++  F E + + Y  EIV A+ HLHK GI++RD+K ENIL+DS+GHV+LTDFGL+K
Sbjct: 148 THLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207
Query: 264 EI--DESSRSNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTG 310
           E   DE+ R+   CGT EYMAP+I+     GH+K  DWWS+G+L+YE+LTG
Sbjct: 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  191 bits (485), Expect = 5e-49,   Method: Compositional matrix adjust.
 Identities = 85/208 (40%), Positives = 133/208 (63%), Gaps = 6/208 (2%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G F                   YAMK++RK+ II K+ V +   E
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKVILVREKATGRY-----YAMKILRKEVIIAKDEVAHTVTE 58
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 59  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 118
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPE 284
           SA+ +LH   +V+RD+K EN+++D DGH+ +TDFGL KE I + +   + CGT EY+APE
Sbjct: 119 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 178
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQV 312
           +L    + +  DWW +G+++YEM+ G++
Sbjct: 179 VLEDNDYGRAVDWWGLGVVMYEMMCGRL 206

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  191 bits (485), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 85/208 (40%), Positives = 133/208 (63%), Gaps = 6/208 (2%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G F                   YAMK++RK+ II K+ V +   E
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRY-----YAMKILRKEVIIAKDEVAHTVTE 55
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPE 284
           SA+ +LH   +V+RD+K EN+++D DGH+ +TDFGL KE I + +   + CGT EY+APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQV 312
           +L    + +  DWW +G+++YEM+ G++
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRL 203

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  191 bits (484), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 85/208 (40%), Positives = 133/208 (63%), Gaps = 6/208 (2%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G F                   YAMK++RK+ II K+ V +   E
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRY-----YAMKILRKEVIIAKDEVAHTVTE 55
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPE 284
           SA+ +LH   +V+RD+K EN+++D DGH+ +TDFGL KE I + +   + CGT EY+APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQV 312
           +L    + +  DWW +G+++YEM+ G++
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRL 203

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  190 bits (482), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 85/208 (40%), Positives = 132/208 (63%), Gaps = 6/208 (2%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G F                   YAMK++RK+ II K+ V +   E
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRY-----YAMKILRKEVIIAKDEVAHTVTE 55
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPE 284
           SA+ +LH   +V+RD+K EN+++D DGH+ +TDFGL KE I + +     CGT EY+APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQV 312
           +L    + +  DWW +G+++YEM+ G++
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRL 203

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  190 bits (482), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 85/208 (40%), Positives = 132/208 (63%), Gaps = 6/208 (2%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G F                   YAMK++RK+ II K+ V +   E
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRY-----YAMKILRKEVIIAKDEVAHTVTE 55
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPE 284
           SA+ +LH   +V+RD+K EN+++D DGH+ +TDFGL KE I + +     CGT EY+APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQV 312
           +L    + +  DWW +G+++YEM+ G++
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRL 203

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  189 bits (481), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 85/208 (40%), Positives = 132/208 (63%), Gaps = 6/208 (2%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G F                   YAMK++RK+ II K+ V +   E
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKVILVREKATGRY-----YAMKILRKEVIIAKDEVAHTVTE 60
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 61  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 120
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPE 284
           SA+ +LH   +V+RD+K EN+++D DGH+ +TDFGL KE I + +     CGT EY+APE
Sbjct: 121 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE 180
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQV 312
           +L    + +  DWW +G+++YEM+ G++
Sbjct: 181 VLEDNDYGRAVDWWGLGVVMYEMMCGRL 208

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  189 bits (481), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 85/208 (40%), Positives = 132/208 (63%), Gaps = 6/208 (2%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G F                   YAMK++RK+ II K+ V +   E
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRY-----YAMKILRKEVIIAKDEVAHTVTE 55
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPE 284
           SA+ +LH   +V+RD+K EN+++D DGH+ +TDFGL KE I + +     CGT EY+APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQV 312
           +L    + +  DWW +G+++YEM+ G++
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRL 203

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  189 bits (479), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 86/214 (40%), Positives = 137/214 (64%), Gaps = 7/214 (3%)
Query: 101 AESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVD 160
           A+ + ++   +FE  +++G+G F                   YAMK+++K+ I+ K+ V 
Sbjct: 139 AKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGR-----YYAMKILKKEVIVAKDEVA 193
Query: 161 YMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
           +   E  +L    HPF+  L+YSFQT  +L  ++++ NGG LFFHL R+ +F ED+ARFY
Sbjct: 194 HTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY 253
Query: 221 TAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTT 278
            AEIVSA+ +LH +  +V+RDLK EN+++D DGH+ +TDFGL KE I + +   + CGT 
Sbjct: 254 GAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 313
Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
           EY+APE+L    + +  DWW +G+++YEM+ G++
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 347

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  188 bits (478), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 86/214 (40%), Positives = 137/214 (64%), Gaps = 7/214 (3%)
Query: 101 AESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVD 160
           A+ + ++   +FE  +++G+G F                   YAMK+++K+ I+ K+ V 
Sbjct: 142 AKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGR-----YYAMKILKKEVIVAKDEVA 196
Query: 161 YMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
           +   E  +L    HPF+  L+YSFQT  +L  ++++ NGG LFFHL R+ +F ED+ARFY
Sbjct: 197 HTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY 256
Query: 221 TAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTT 278
            AEIVSA+ +LH +  +V+RDLK EN+++D DGH+ +TDFGL KE I + +   + CGT 
Sbjct: 257 GAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 316
Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
           EY+APE+L    + +  DWW +G+++YEM+ G++
Sbjct: 317 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 350

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 85/209 (40%), Positives = 133/209 (63%), Gaps = 7/209 (3%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           ++   +FE  +++G+G F                   YAMK+++K+ I+ K+ V +   E
Sbjct: 5   RVTMNEFEYLKLLGKGTFGKVILVKEKATGR-----YYAMKILKKEVIVAKDEVAHTLTE 59
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+YSFQT  +L  ++++ NGG LFFHL R+ +F ED+ARFY AEIV
Sbjct: 60  NRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 119
Query: 226 SAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAP 283
           SA+ +LH +  +V+RDLK EN+++D DGH+ +TDFGL KE I + +     CGT EY+AP
Sbjct: 120 SALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAP 179
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQV 312
           E+L    + +  DWW +G+++YEM+ G++
Sbjct: 180 EVLEDNDYGRAVDWWGLGVVMYEMMCGRL 208

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 85/209 (40%), Positives = 133/209 (63%), Gaps = 7/209 (3%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           ++   +FE  +++G+G F                   YAMK+++K+ I+ K+ V +   E
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVILVKEKATGR-----YYAMKILKKEVIVAKDEVAHTLTE 58
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+YSFQT  +L  ++++ NGG LFFHL R+ +F ED+ARFY AEIV
Sbjct: 59  NRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 118
Query: 226 SAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAP 283
           SA+ +LH +  +V+RDLK EN+++D DGH+ +TDFGL KE I + +     CGT EY+AP
Sbjct: 119 SALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAP 178
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQV 312
           E+L    + +  DWW +G+++YEM+ G++
Sbjct: 179 EVLEDNDYGRAVDWWGLGVVMYEMMCGRL 207

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  186 bits (473), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 85/209 (40%), Positives = 133/209 (63%), Gaps = 7/209 (3%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           ++   +FE  +++G+G F                   YAMK+++K+ I+ K+ V +   E
Sbjct: 6   RVTMNEFEYLKLLGKGTFGKVILVKEKATGR-----YYAMKILKKEVIVAKDEVAHTLTE 60
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+YSFQT  +L  ++++ NGG LFFHL R+ +F ED+ARFY AEIV
Sbjct: 61  NRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 120
Query: 226 SAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAP 283
           SA+ +LH +  +V+RDLK EN+++D DGH+ +TDFGL KE I + +     CGT EY+AP
Sbjct: 121 SALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAP 180
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQV 312
           E+L    + +  DWW +G+++YEM+ G++
Sbjct: 181 EVLEDNDYGRAVDWWGLGVVMYEMMCGRL 209

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  183 bits (464), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 118/168 (70%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+ ++CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 190 KRV--KGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  183 bits (464), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 117/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  182 bits (463), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 117/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  182 bits (463), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 117/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  182 bits (463), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 117/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  182 bits (463), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 117/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 190 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  182 bits (463), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 117/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  182 bits (463), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 117/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  182 bits (463), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 117/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 90  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 149
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 150 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 209
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 210 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  182 bits (463), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 117/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFAEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  182 bits (463), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 117/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  182 bits (463), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 118/168 (70%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 55  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 114
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 115 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 174
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+ ++CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 175 KRV--KGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  182 bits (463), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 117/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  182 bits (463), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 117/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 64  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 123
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 124 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 183
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 184 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  182 bits (462), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 117/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  182 bits (462), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 117/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 190 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  182 bits (462), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 117/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           +AMK++ K  ++K   +++   E+ IL  V  PF+V+L YSF+  S LY++++++ GG +
Sbjct: 69  FAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  182 bits (462), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 117/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 190 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  182 bits (462), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 117/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 190 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  182 bits (462), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 117/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 56  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 115
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 116 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFA 175
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 176 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  182 bits (462), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 117/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           +AMK++ K  ++K   +++   E+ IL  V  PF+V+L YSF+  S LY++++++ GG +
Sbjct: 69  FAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  182 bits (462), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 117/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  182 bits (462), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 117/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           +AMK++ K  ++K   +++   E+ IL  V  PF+V+L YSF+  S LY++++++ GG +
Sbjct: 69  FAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  182 bits (462), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 117/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 190 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  182 bits (462), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 117/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  182 bits (461), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 117/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  182 bits (461), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 117/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  182 bits (461), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 117/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 62  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 121
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 122 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 181
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 182 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  182 bits (461), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 117/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 130 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 190 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  182 bits (461), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 117/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  182 bits (461), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 117/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 90  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 149
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 150 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 209
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 210 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  182 bits (461), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 117/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 62  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 121
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 122 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 181
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 182 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  181 bits (460), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 77/168 (45%), Positives = 117/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+Y+M  G
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  181 bits (459), Expect = 6e-46,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 117/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY+++++  GG +
Sbjct: 69  YAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G++ +TDFGLA
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  181 bits (458), Expect = 7e-46,   Method: Compositional matrix adjust.
 Identities = 77/168 (45%), Positives = 118/168 (70%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 90  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 149
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 150 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 209
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +  ++   ++CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 210 KRVKGATW--TLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  181 bits (458), Expect = 7e-46,   Method: Compositional matrix adjust.
 Identities = 76/168 (45%), Positives = 117/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI++SKG+NK  DWW++G+L+YEM  G
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  181 bits (458), Expect = 7e-46,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 117/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY+++++  GG +
Sbjct: 69  YAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G++ +TDFGLA
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  180 bits (457), Expect = 9e-46,   Method: Compositional matrix adjust.
 Identities = 77/168 (45%), Positives = 116/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+AP I+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  180 bits (456), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 82/199 (41%), Positives = 124/199 (62%), Gaps = 7/199 (3%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           FE  + +G G+F                   YAMK++ K  ++K   +++   E+ IL  
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNH-----YAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           V  PF+V+L +SF+  S LY++++++ GG +F HL R G F E  ARFY A+IV    +L
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGH 291
           H   +++RDLKPEN+L+D  G++ + DFG AK +    R+  +CGT EY+APEI+LSKG+
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGY 215
Query: 292 NKDADWWSVGILLYEMLTG 310
           NK  DWW++G+L+YEM  G
Sbjct: 216 NKAVDWWALGVLIYEMAAG 234

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  180 bits (456), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 77/168 (45%), Positives = 116/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY+++++  GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  179 bits (455), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 77/168 (45%), Positives = 116/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY+++++  GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G++ +TDFG A
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA 189
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 190 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  179 bits (455), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 77/168 (45%), Positives = 116/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY+++++  GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  179 bits (455), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 77/168 (45%), Positives = 116/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT E +APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 189 KRV--KGRTWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  179 bits (455), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 77/168 (45%), Positives = 116/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY+++++  GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  179 bits (455), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 77/168 (45%), Positives = 116/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  + GT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 189 KRV--KGRTWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  179 bits (454), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 84/226 (37%), Positives = 145/226 (64%), Gaps = 10/226 (4%)
Query: 91  LEHENDAELEAESER---KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKV 147
           +E E +A    ES +    +G  DF++ RV+G+G++                  IYAM+V
Sbjct: 30  IEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSY-----AKVLLVRLKKTDRIYAMRV 84
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           ++K+ +     +D+++ E+ +  + + HPF+V L   FQT S+L+ +++++NGG L FH+
Sbjct: 85  VKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM 144
Query: 207 YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-I 265
            RQ    E+ ARFY+AEI  A+++LH+ GI++RDLK +N+L+DS+GH+ LTD+G+ KE +
Sbjct: 145 QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204
Query: 266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
                +++ CGT  Y+APEIL  + +    DWW++G+L++EM+ G+
Sbjct: 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  179 bits (454), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 82/199 (41%), Positives = 124/199 (62%), Gaps = 7/199 (3%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           FE  + +G G+F                   YAMK++ K  ++K   +++   E+ IL  
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNH-----YAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           V  PF+V+L +SF+  S LY++++++ GG +F HL R G F E  ARFY A+IV    +L
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGH 291
           H   +++RDLKPEN+L+D  G++ + DFG AK +    R+  +CGT EY+APEI+LSKG+
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGY 215
Query: 292 NKDADWWSVGILLYEMLTG 310
           NK  DWW++G+L+YEM  G
Sbjct: 216 NKAVDWWALGVLIYEMAAG 234

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 82/199 (41%), Positives = 124/199 (62%), Gaps = 7/199 (3%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           FE  + +G G+F                   YAMK++ K  ++K   +++   E+ IL  
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNH-----YAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           V  PF+V+L +SF+  S LY++++++ GG +F HL R G F E  ARFY A+IV    +L
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGH 291
           H   +++RDLKPEN+L+D  G++ + DFG AK +    R+  +CGT EY+APEI+LSKG+
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGY 215
Query: 292 NKDADWWSVGILLYEMLTG 310
           NK  DWW++G+L+YEM  G
Sbjct: 216 NKAVDWWALGVLIYEMAAG 234

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 77/168 (45%), Positives = 116/168 (69%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  + GT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 189 KRV--KGRTWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  178 bits (452), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 80/207 (38%), Positives = 136/207 (65%), Gaps = 7/207 (3%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           +G  DF++ RV+G+G++                  IYAMKV++K+ +     +D+++ E+
Sbjct: 17  LGLQDFDLLRVIGRGSYAKVLLVRLKKTDR-----IYAMKVVKKELVNDDEDIDWVQTEK 71
Query: 167 DILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
            +  + + HPF+V L   FQT S+L+ +++++NGG L FH+ RQ    E+ ARFY+AEI 
Sbjct: 72  HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 131
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPE 284
            A+++LH+ GI++RDLK +N+L+DS+GH+ LTD+G+ KE +     ++  CGT  Y+APE
Sbjct: 132 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE 191
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQ 311
           IL  + +    DWW++G+L++EM+ G+
Sbjct: 192 ILRGEDYGFSVDWWALGVLMFEMMAGR 218

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  178 bits (451), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 80/207 (38%), Positives = 136/207 (65%), Gaps = 7/207 (3%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           +G  DF++ RV+G+G++                  IYAMKV++K+ +     +D+++ E+
Sbjct: 2   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDR-----IYAMKVVKKELVNDDEDIDWVQTEK 56
Query: 167 DILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
            +  + + HPF+V L   FQT S+L+ +++++NGG L FH+ RQ    E+ ARFY+AEI 
Sbjct: 57  HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 116
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPE 284
            A+++LH+ GI++RDLK +N+L+DS+GH+ LTD+G+ KE +     ++  CGT  Y+APE
Sbjct: 117 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE 176
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQ 311
           IL  + +    DWW++G+L++EM+ G+
Sbjct: 177 ILRGEDYGFSVDWWALGVLMFEMMAGR 203

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  178 bits (451), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 76/168 (45%), Positives = 115/168 (68%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+ +L +SF+  S LY+++++  GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G++ +TDFG A
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA 189
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 190 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  177 bits (450), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 83/199 (41%), Positives = 122/199 (61%), Gaps = 7/199 (3%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           FE  R +G G+F                   YAMK++ K  ++K   +++   E+ I   
Sbjct: 44  FERIRTLGTGSFGRVMLVKHKETGNH-----YAMKILDKQKVVKLKQIEHTLNEKRIQQA 98
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           V  PF+V+L +SF+  S LY++L++  GG +F HL R G F E  ARFY A+IV    +L
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGH 291
           H   +++RDLKPEN+L+D  G++ + DFG AK +    R+  +CGT EY+APEI+LSKG+
Sbjct: 159 HSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGY 216
Query: 292 NKDADWWSVGILLYEMLTG 310
           NK  DWW++G+L+YEM  G
Sbjct: 217 NKAVDWWALGVLIYEMAAG 235

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  177 bits (450), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 76/168 (45%), Positives = 115/168 (68%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+ +L +SF+  S LY+++++  GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G++ +TDFG A
Sbjct: 130 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA 189
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 190 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  177 bits (450), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 80/207 (38%), Positives = 136/207 (65%), Gaps = 7/207 (3%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           +G  DF++ RV+G+G++                  IYAMKV++K+ +     +D+++ E+
Sbjct: 6   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDR-----IYAMKVVKKELVNDDEDIDWVQTEK 60
Query: 167 DILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
            +  + + HPF+V L   FQT S+L+ +++++NGG L FH+ RQ    E+ ARFY+AEI 
Sbjct: 61  HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 120
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPE 284
            A+++LH+ GI++RDLK +N+L+DS+GH+ LTD+G+ KE +     ++  CGT  Y+APE
Sbjct: 121 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE 180
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQ 311
           IL  + +    DWW++G+L++EM+ G+
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAGR 207

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  177 bits (450), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 76/168 (45%), Positives = 115/168 (68%), Gaps = 2/168 (1%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+ +L +SF+  S LY+++++  GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G++ +TDFG A
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA 189
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G
Sbjct: 190 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  177 bits (449), Expect = 9e-45,   Method: Compositional matrix adjust.
 Identities = 91/231 (39%), Positives = 137/231 (59%), Gaps = 13/231 (5%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           RK  P DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  
Sbjct: 4   RKKRPEDFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTR 58
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ERD+++++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEI
Sbjct: 59  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 118
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYM 281
           VSA+ +LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y+
Sbjct: 119 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 178
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLII 332
           +PE+L  K   K +D W++G ++Y+++ G    +     A N  L+F  II
Sbjct: 179 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR-----AGNEYLIFQKII 224

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  177 bits (449), Expect = 9e-45,   Method: Compositional matrix adjust.
 Identities = 91/231 (39%), Positives = 137/231 (59%), Gaps = 13/231 (5%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           RK  P DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  
Sbjct: 5   RKKRPEDFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTR 59
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ERD+++++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEI
Sbjct: 60  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 119
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYM 281
           VSA+ +LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y+
Sbjct: 120 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 179
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLII 332
           +PE+L  K   K +D W++G ++Y+++ G    +     A N  L+F  II
Sbjct: 180 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR-----AGNEYLIFQKII 225

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 91/231 (39%), Positives = 137/231 (59%), Gaps = 13/231 (5%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           RK  P DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  
Sbjct: 3   RKKRPEDFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTR 57
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ERD+++++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEI
Sbjct: 58  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 117
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYM 281
           VSA+ +LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y+
Sbjct: 118 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 177
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLII 332
           +PE+L  K   K +D W++G ++Y+++ G    +     A N  L+F  II
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR-----AGNEYLIFQKII 223

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 91/231 (39%), Positives = 137/231 (59%), Gaps = 13/231 (5%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           RK  P DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  
Sbjct: 2   RKKRPEDFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTR 56
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ERD+++++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEI
Sbjct: 57  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 116
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYM 281
           VSA+ +LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y+
Sbjct: 117 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 176
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLII 332
           +PE+L  K   K +D W++G ++Y+++ G    +     A N  L+F  II
Sbjct: 177 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR-----AGNEYLIFQKII 222

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 87/210 (41%), Positives = 130/210 (61%), Gaps = 7/210 (3%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
           S  ++G  +FE  RV+G+G+F                  +YA+KV++KD I++ + V+  
Sbjct: 16  SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGD-----LYAVKVLKKDVILQDDDVECT 70
Query: 163 KAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
             E+ IL+    HPF+ QL   FQT  +L+ +++F+NGG L FH+ +   F E +ARFY 
Sbjct: 71  MTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYA 130
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEY 280
           AEI+SA+  LH  GI++RDLK +N+L+D +GH  L DFG+ KE I     + + CGT +Y
Sbjct: 131 AEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDY 190
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           +APEIL    +    DWW++G+LLYEML G
Sbjct: 191 IAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 83/200 (41%), Positives = 128/200 (64%), Gaps = 7/200 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+I R +G G+F                   YAMKV++K+ +++   V++   ER +L+
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRY-----YAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            VTHPFI+++  +FQ   ++++I+D+I GG LF  L +   F    A+FY AE+  A+ +
Sbjct: 62  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 121
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
           LH   I++RDLKPENIL+D +GH+ +TDFG AK + + +    +CGT +Y+APE++ +K 
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY--XLCGTPDYIAPEVVSTKP 179
Query: 291 HNKDADWWSVGILLYEMLTG 310
           +NK  DWWS GIL+YEML G
Sbjct: 180 YNKSIDWWSFGILIYEMLAG 199

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  174 bits (442), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 89/225 (39%), Positives = 136/225 (60%), Gaps = 13/225 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 87
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+NS  GT +Y++PE+L 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 207
Query: 288 SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLII 332
            K  +K +D W++G ++Y+++ G    +     A N  L+F  II
Sbjct: 208 EKSASKSSDLWALGCIIYQLVAGLPPFR-----AGNEYLIFQKII 247

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  174 bits (442), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 89/225 (39%), Positives = 135/225 (60%), Gaps = 13/225 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 88
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 89  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 148
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+NS  GT +Y++PE+L 
Sbjct: 149 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 208
Query: 288 SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLII 332
            K   K +D W++G ++Y+++ G    +     A N  L+F  II
Sbjct: 209 EKSACKSSDLWALGCIIYQLVAGLPPFR-----AGNEYLIFQKII 248

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 88/225 (39%), Positives = 135/225 (60%), Gaps = 13/225 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 85
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N+  GT +Y++PE+L 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLT 205
Query: 288 SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLII 332
            K   K +D W++G ++Y+++ G    +     A N  L+F  II
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFR-----AGNEYLIFQKII 245

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 88/225 (39%), Positives = 136/225 (60%), Gaps = 13/225 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 84
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 85  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 144
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +    + +R+NS  GT +Y++PE+L 
Sbjct: 145 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 204
Query: 288 SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLII 332
            K   K +D W++G ++Y+++ G    +     A N  L+F  II
Sbjct: 205 EKSACKSSDLWALGCIIYQLVAGLPPFR-----AGNEYLIFQKII 244

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 88/225 (39%), Positives = 134/225 (59%), Gaps = 13/225 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 31  DFKFGKILGEGSFSTTVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 85
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y++PE+L 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 288 SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLII 332
            K   K +D W++G ++Y+++ G    +     A N  L+F  II
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFR-----AGNEYLIFQKII 245

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 88/225 (39%), Positives = 134/225 (59%), Gaps = 13/225 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 36  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 90
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 91  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 150
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y++PE+L 
Sbjct: 151 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 210
Query: 288 SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLII 332
            K   K +D W++G ++Y+++ G    +     A N  L+F  II
Sbjct: 211 EKSACKSSDLWALGCIIYQLVAGLPPFR-----AGNEYLIFQKII 250

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 88/225 (39%), Positives = 134/225 (59%), Gaps = 13/225 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 87
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y++PE+L 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 288 SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLII 332
            K   K +D W++G ++Y+++ G    +     A N  L+F  II
Sbjct: 208 EKSAXKSSDLWALGCIIYQLVAGLPPFR-----AGNEGLIFAKII 247

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 88/225 (39%), Positives = 134/225 (59%), Gaps = 13/225 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 88
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 89  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 148
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y++PE+L 
Sbjct: 149 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 208
Query: 288 SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLII 332
            K   K +D W++G ++Y+++ G    +     A N  L+F  II
Sbjct: 209 EKSACKSSDLWALGCIIYQLVAGLPPFR-----AGNEYLIFQKII 248

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 88/225 (39%), Positives = 134/225 (59%), Gaps = 13/225 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 87
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y++PE+L 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 288 SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLII 332
            K   K +D W++G ++Y+++ G    +     A N  L+F  II
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFR-----AGNEYLIFQKII 247

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 88/225 (39%), Positives = 134/225 (59%), Gaps = 13/225 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 85
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y++PE+L 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 288 SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLII 332
            K   K +D W++G ++Y+++ G    +     A N  L+F  II
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFR-----AGNEYLIFQKII 245

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 88/225 (39%), Positives = 134/225 (59%), Gaps = 13/225 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 87
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y++PE+L 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 288 SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLII 332
            K   K +D W++G ++Y+++ G    +     A N  L+F  II
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFR-----AGNEYLIFQKII 247

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 88/225 (39%), Positives = 134/225 (59%), Gaps = 13/225 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 87
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y++PE+L 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 288 SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLII 332
            K   K +D W++G ++Y+++ G    +     A N  L+F  II
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFR-----AGNEYLIFQKII 247

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 88/225 (39%), Positives = 134/225 (59%), Gaps = 13/225 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 85
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y++PE+L 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 288 SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLII 332
            K   K +D W++G ++Y+++ G    +     A N  L+F  II
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFR-----AGNEYLIFQKII 245

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 88/225 (39%), Positives = 134/225 (59%), Gaps = 13/225 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 87
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y++PE+L 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 288 SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLII 332
            K   K +D W++G ++Y+++ G    +     A N  L+F  II
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFR-----AGNEGLIFAKII 247

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 87/225 (38%), Positives = 135/225 (60%), Gaps = 13/225 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 84
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 85  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 144
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +    + +R+N   GT +Y++PE+L 
Sbjct: 145 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 204
Query: 288 SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLII 332
            K   K +D W++G ++Y+++ G    +     A N  L+F  II
Sbjct: 205 EKSACKSSDLWALGCIIYQLVAGLPPFR-----AGNEYLIFQKII 244

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 88/225 (39%), Positives = 133/225 (59%), Gaps = 13/225 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 38  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 92
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L + FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 93  RLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 152
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y++PE+L 
Sbjct: 153 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 212
Query: 288 SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLII 332
            K   K +D W++G ++Y+++ G    +     A N  L+F  II
Sbjct: 213 EKSACKSSDLWALGCIIYQLVAGLPPFR-----AGNEYLIFQKII 252

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  171 bits (434), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 88/225 (39%), Positives = 134/225 (59%), Gaps = 13/225 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 15  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 69
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 70  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 129
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y++PE+L 
Sbjct: 130 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 189
Query: 288 SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLII 332
            K   K +D W++G ++Y+++ G    +     A N  L+F  II
Sbjct: 190 EKSACKSSDLWALGCIIYQLVAGLPPFR-----AGNEYLIFQKII 229

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 79/203 (38%), Positives = 126/203 (62%), Gaps = 7/203 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF    V+G+G+F                  +YA+K+++KD +I+ + V+    E+ +L 
Sbjct: 20  DFNFLMVLGKGSFGKVMLADRKGTEE-----LYAIKILKKDVVIQDDDVECTMVEKRVLA 74
Query: 171 KVTHP-FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
            +  P F+ QL   FQT  +LY +++++NGG L +H+ + G F+E QA FY AEI   + 
Sbjct: 75  LLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLF 134
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLS 288
            LHK GI++RDLK +N+++DS+GH+ + DFG+ KE + +   +   CGT +Y+APEI+  
Sbjct: 135 FLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAY 194
Query: 289 KGHNKDADWWSVGILLYEMLTGQ 311
           + + K  DWW+ G+LLYEML GQ
Sbjct: 195 QPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 79/208 (37%), Positives = 127/208 (61%), Gaps = 7/208 (3%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DFE+ +++G+G+F                   +A+K ++KD ++  + V+    E
Sbjct: 14  KLKIEDFELHKMLGKGSFGKVFLAEFKKTNQ-----FFAIKALKKDVVLMDDDVECTMVE 68
Query: 166 RDILT-KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           + +L+    HPF+  +  +FQT+  L+ +++++NGG L +H+     F   +A FY AEI
Sbjct: 69  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI 128
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAP 283
           +  +  LH  GIV+RDLK +NIL+D DGH+ + DFG+ KE +   +++N  CGT +Y+AP
Sbjct: 129 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAP 188
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQ 311
           EILL + +N   DWWS G+LLYEML GQ
Sbjct: 189 EILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 77/204 (37%), Positives = 122/204 (59%), Gaps = 7/204 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF    V+G+G+F                  +YA+K+++KD +I+ + V+    E+ +L 
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDE-----LYAVKILKKDVVIQDDDVECTMVEKRVLA 396
Query: 171 -KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
                PF+ QL   FQT  +LY +++++NGG L +H+ + G F+E  A FY AEI   + 
Sbjct: 397 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 456
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLS 288
            L   GI++RDLK +N+++DS+GH+ + DFG+ KE I +   +   CGT +Y+APEI+  
Sbjct: 457 FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAY 516
Query: 289 KGHNKDADWWSVGILLYEMLTGQV 312
           + + K  DWW+ G+LLYEML GQ 
Sbjct: 517 QPYGKSVDWWAFGVLLYEMLAGQA 540

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 77/204 (37%), Positives = 122/204 (59%), Gaps = 7/204 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF    V+G+G+F                  +YA+K+++KD +I+ + V+    E+ +L 
Sbjct: 21  DFNFLMVLGKGSFGKVMLSERKGTDE-----LYAVKILKKDVVIQDDDVECTMVEKRVLA 75
Query: 171 -KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
                PF+ QL   FQT  +LY +++++NGG L +H+ + G F+E  A FY AEI   + 
Sbjct: 76  LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 135
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLS 288
            L   GI++RDLK +N+++DS+GH+ + DFG+ KE I +   +   CGT +Y+APEI+  
Sbjct: 136 FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAY 195
Query: 289 KGHNKDADWWSVGILLYEMLTGQV 312
           + + K  DWW+ G+LLYEML GQ 
Sbjct: 196 QPYGKSVDWWAFGVLLYEMLAGQA 219

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  161 bits (408), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 78/208 (37%), Positives = 126/208 (60%), Gaps = 7/208 (3%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF + +++G+G+F                   +A+K ++KD ++  + V+    E
Sbjct: 13  KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQ-----FFAIKALKKDVVLMDDDVECTMVE 67
Query: 166 RDILT-KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           + +L+    HPF+  +  +FQT+  L+ +++++NGG L +H+     F   +A FY AEI
Sbjct: 68  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI 127
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAP 283
           +  +  LH  GIV+RDLK +NIL+D DGH+ + DFG+ KE +   +++N  CGT +Y+AP
Sbjct: 128 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAP 187
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQ 311
           EILL + +N   DWWS G+LLYEML GQ
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  157 bits (397), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 78/208 (37%), Positives = 125/208 (60%), Gaps = 12/208 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+E+ +V+G+GAF                  +YAMK++ K  +IK++   +   ERDI+ 
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRK-----VYAMKLLSKFEMIKRSDSAFFWEERDIMA 124
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
               P++VQL Y+FQ    LY++++++ GG L  +L       E  ARFYTAE+V A+  
Sbjct: 125 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDA 183
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILLS 288
           +H  G +HRD+KP+N+L+D  GH+ L DFG   ++++    R ++  GT +Y++PE+L S
Sbjct: 184 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 243
Query: 289 KG----HNKDADWWSVGILLYEMLTGQV 312
           +G    + ++ DWWSVG+ LYEML G  
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDT 271

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  157 bits (397), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 78/208 (37%), Positives = 125/208 (60%), Gaps = 12/208 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+E+ +V+G+GAF                  +YAMK++ K  +IK++   +   ERDI+ 
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRK-----VYAMKLLSKFEMIKRSDSAFFWEERDIMA 129
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
               P++VQL Y+FQ    LY++++++ GG L  +L       E  ARFYTAE+V A+  
Sbjct: 130 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDA 188
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILLS 288
           +H  G +HRD+KP+N+L+D  GH+ L DFG   ++++    R ++  GT +Y++PE+L S
Sbjct: 189 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 248
Query: 289 KG----HNKDADWWSVGILLYEMLTGQV 312
           +G    + ++ DWWSVG+ LYEML G  
Sbjct: 249 QGGDGYYGRECDWWSVGVFLYEMLVGDT 276

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 78/208 (37%), Positives = 125/208 (60%), Gaps = 12/208 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+E+ +V+G+GAF                  +YAMK++ K  +IK++   +   ERDI+ 
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRK-----VYAMKLLSKFEMIKRSDSAFFWEERDIMA 129
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
               P++VQL Y+FQ    LY++++++ GG L  +L       E  ARFYTAE+V A+  
Sbjct: 130 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDA 188
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILLS 288
           +H  G +HRD+KP+N+L+D  GH+ L DFG   ++++    R ++  GT +Y++PE+L S
Sbjct: 189 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 248
Query: 289 KG----HNKDADWWSVGILLYEMLTGQV 312
           +G    + ++ DWWSVG+ LYEML G  
Sbjct: 249 QGGDGYYGRECDWWSVGVFLYEMLVGDT 276

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  154 bits (390), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 74/203 (36%), Positives = 118/203 (58%), Gaps = 8/203 (3%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           FEI R +G+G+F                  +YAMK M K   +++N V  +  E  I+  
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKK-----MYAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HPF+V L YSFQ    +++++D + GG L +HL +   F+E+  + +  E+V A+ +L
Sbjct: 72  LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYL 131
Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK-- 289
               I+HRD+KP+NIL+D  GHV +TDF +A  +   ++  +M GT  YMAPE+  S+  
Sbjct: 132 QNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKG 191
Query: 290 -GHNKDADWWSVGILLYEMLTGQ 311
            G++   DWWS+G+  YE+L G+
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGR 214

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 75/208 (36%), Positives = 125/208 (60%), Gaps = 12/208 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ +V+G+GAF                  +YAMK++ K  +IK++   +   ERDI+ 
Sbjct: 76  DYDVVKVIGRGAFGEVQLVRHKASQK-----VYAMKLLSKFEMIKRSDSAFFWEERDIMA 130
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
               P++VQL  +FQ    LY++++++ GG L  +L       E  A+FYTAE+V A+  
Sbjct: 131 FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLV-NLMSNYDVPEKWAKFYTAEVVLALDA 189
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILLS 288
           +H  G++HRD+KP+N+L+D  GH+ L DFG   ++DE+     ++  GT +Y++PE+L S
Sbjct: 190 IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKS 249
Query: 289 KG----HNKDADWWSVGILLYEMLTGQV 312
           +G    + ++ DWWSVG+ L+EML G  
Sbjct: 250 QGGDGYYGRECDWWSVGVFLFEMLVGDT 277

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 82/219 (37%), Positives = 121/219 (55%), Gaps = 15/219 (6%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
            E ++   DFEI +V+G+GAF                  +YAMK+M K  ++K+  V   
Sbjct: 54  KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQ-----VYAMKIMNKWDMLKRGEVSCF 108
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYT 221
           + ERD+L      +I QL ++FQ  + LYL++++  GG L   L + G     + ARFY 
Sbjct: 109 REERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYL 168
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG--LAKEIDESSRSNSMCGTTE 279
           AEIV A+  +H+ G VHRD+KP+NIL+D  GH+ L DFG  L    D + RS    GT +
Sbjct: 169 AEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPD 228
Query: 280 YMAPEILLS-------KGHNKDADWWSVGILLYEMLTGQ 311
           Y++PEIL +         +  + DWW++G+  YEM  GQ
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score =  148 bits (373), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 80/210 (38%), Positives = 120/210 (57%), Gaps = 13/210 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI +V+G+GAF                  IYAMK++ K  ++K+      + ERD+L 
Sbjct: 75  DFEIIKVIGRGAFGEVAVVKMKNTER-----IYAMKILNKWEMLKRAETACFREERDVLV 129
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVS 229
                +I  L Y+FQ  + LYL++D+  GG L   L + +    ED ARFY  E+V A+ 
Sbjct: 130 NGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAID 189
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFG--LAKEIDESSRSNSMCGTTEYMAPEIL- 286
            +H+   VHRD+KP+N+L+D +GH+ L DFG  L    D + +S+   GT +Y++PEIL 
Sbjct: 190 SIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQ 249
Query: 287 -LSKGHNK---DADWWSVGILLYEMLTGQV 312
            +  G  K   + DWWS+G+ +YEML G+ 
Sbjct: 250 AMEDGMGKYGPECDWWSLGVCMYEMLYGET 279

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score =  148 bits (373), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 80/210 (38%), Positives = 120/210 (57%), Gaps = 13/210 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI +V+G+GAF                  IYAMK++ K  ++K+      + ERD+L 
Sbjct: 91  DFEIIKVIGRGAFGEVAVVKMKNTER-----IYAMKILNKWEMLKRAETACFREERDVLV 145
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVS 229
                +I  L Y+FQ  + LYL++D+  GG L   L + +    ED ARFY  E+V A+ 
Sbjct: 146 NGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAID 205
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFG--LAKEIDESSRSNSMCGTTEYMAPEIL- 286
            +H+   VHRD+KP+N+L+D +GH+ L DFG  L    D + +S+   GT +Y++PEIL 
Sbjct: 206 SIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQ 265
Query: 287 -LSKGHNK---DADWWSVGILLYEMLTGQV 312
            +  G  K   + DWWS+G+ +YEML G+ 
Sbjct: 266 AMEDGMGKYGPECDWWSLGVCMYEMLYGET 295

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  147 bits (372), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 79/210 (37%), Positives = 123/210 (58%), Gaps = 13/210 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI +V+G+GAF                  ++AMK++ K  ++K+      + ERD+L 
Sbjct: 75  DFEILKVIGRGAFGEVAVVKLKNADK-----VFAMKILNKWEMLKRAETACFREERDVLV 129
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVS 229
                +I  L Y+FQ  + LYL++D+  GG L   L + +    E+ ARFY AE+V A+ 
Sbjct: 130 NGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAID 189
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYMAPEILL 287
            +H+   VHRD+KP+NILMD +GH+ L DFG   ++  D + +S+   GT +Y++PEIL 
Sbjct: 190 SVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 288 S----KG-HNKDADWWSVGILLYEMLTGQV 312
           +    KG +  + DWWS+G+ +YEML G+ 
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGET 279

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 80/202 (39%), Positives = 112/202 (55%), Gaps = 7/202 (3%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F  +RV+G+G F                  +YA K + K  I K+        E+ IL K
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGK-----MYACKKLEKKRIKKRKGEAMALNEKQILEK 240
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVS 229
           V   F+V L Y+++T+  L L+L  +NGG L FH+Y  G   F E +A FY AEI   + 
Sbjct: 241 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
            LH+  IV+RDLKPENIL+D  GH+ ++D GLA  + E        GT  YMAPE++ ++
Sbjct: 301 DLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE 360
Query: 290 GHNKDADWWSVGILLYEMLTGQ 311
            +    DWW++G LLYEM+ GQ
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQ 382

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 80/202 (39%), Positives = 112/202 (55%), Gaps = 7/202 (3%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F  +RV+G+G F                  +YA K + K  I K+        E+ IL K
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGK-----MYACKKLEKKRIKKRKGEAMALNEKQILEK 240
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVS 229
           V   F+V L Y+++T+  L L+L  +NGG L FH+Y  G   F E +A FY AEI   + 
Sbjct: 241 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
            LH+  IV+RDLKPENIL+D  GH+ ++D GLA  + E        GT  YMAPE++ ++
Sbjct: 301 DLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE 360
Query: 290 GHNKDADWWSVGILLYEMLTGQ 311
            +    DWW++G LLYEM+ GQ
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 81/205 (39%), Positives = 118/205 (57%), Gaps = 12/205 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF + R++G+G F                  +YAMK + K  I  K        ER +L+
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGK-----MYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 171 KVTH---PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
            V+    PFIV + Y+F T  KL  ILD +NGG L +HL + G+F E   RFY AEI+  
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + H+H   +V+RDLKP NIL+D  GHV ++D GLA +  +  + ++  GT  YMAPE+ L
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEV-L 362
Query: 288 SKG--HNKDADWWSVGILLYEMLTG 310
            KG  ++  ADW+S+G +L+++L G
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 81/205 (39%), Positives = 118/205 (57%), Gaps = 12/205 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF + R++G+G F                  +YAMK + K  I  K        ER +L+
Sbjct: 189 DFSVHRIIGRGGFGEVYGCRKADTGK-----MYAMKCLDKKRIKMKQGETLALNERIMLS 243
Query: 171 KVTH---PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
            V+    PFIV + Y+F T  KL  ILD +NGG L +HL + G+F E   RFY AEI+  
Sbjct: 244 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 303
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + H+H   +V+RDLKP NIL+D  GHV ++D GLA +  +  + ++  GT  YMAPE+ L
Sbjct: 304 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEV-L 361
Query: 288 SKG--HNKDADWWSVGILLYEMLTG 310
            KG  ++  ADW+S+G +L+++L G
Sbjct: 362 QKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 81/205 (39%), Positives = 118/205 (57%), Gaps = 12/205 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF + R++G+G F                  +YAMK + K  I  K        ER +L+
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGK-----MYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 171 KVTH---PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
            V+    PFIV + Y+F T  KL  ILD +NGG L +HL + G+F E   RFY AEI+  
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + H+H   +V+RDLKP NIL+D  GHV ++D GLA +  +  + ++  GT  YMAPE+ L
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEV-L 362
Query: 288 SKG--HNKDADWWSVGILLYEMLTG 310
            KG  ++  ADW+S+G +L+++L G
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 81/205 (39%), Positives = 118/205 (57%), Gaps = 12/205 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF + R++G+G F                  +YAMK + K  I  K        ER +L+
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGK-----MYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 171 KVTH---PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
            V+    PFIV + Y+F T  KL  ILD +NGG L +HL + G+F E   RFY AEI+  
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + H+H   +V+RDLKP NIL+D  GHV ++D GLA +  +  + ++  GT  YMAPE+ L
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEV-L 362
Query: 288 SKG--HNKDADWWSVGILLYEMLTG 310
            KG  ++  ADW+S+G +L+++L G
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 77/210 (36%), Positives = 123/210 (58%), Gaps = 10/210 (4%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           +G   F  FRV+G+G F                  +YA K + K  + K+        E+
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGK-----LYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTA 222
            IL KV   FIV L Y+F+T++ L L++  +NGG + +H+Y        F+E +A FYTA
Sbjct: 237 KILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA 296
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEYM 281
           +IVS + HLH+  I++RDLKPEN+L+D DG+V ++D GLA E+    +++    GT  +M
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFM 356
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           APE+LL + ++   D++++G+ LYEM+  +
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 77/210 (36%), Positives = 123/210 (58%), Gaps = 10/210 (4%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           +G   F  FRV+G+G F                  +YA K + K  + K+        E+
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGK-----LYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTA 222
            IL KV   FIV L Y+F+T++ L L++  +NGG + +H+Y        F+E +A FYTA
Sbjct: 237 KILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA 296
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEYM 281
           +IVS + HLH+  I++RDLKPEN+L+D DG+V ++D GLA E+    +++    GT  +M
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFM 356
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           APE+LL + ++   D++++G+ LYEM+  +
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 77/210 (36%), Positives = 123/210 (58%), Gaps = 10/210 (4%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           +G   F  FRV+G+G F                  +YA K + K  + K+        E+
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGK-----LYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTA 222
            IL KV   FIV L Y+F+T++ L L++  +NGG + +H+Y        F+E +A FYTA
Sbjct: 237 KILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA 296
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEYM 281
           +IVS + HLH+  I++RDLKPEN+L+D DG+V ++D GLA E+    +++    GT  +M
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFM 356
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           APE+LL + ++   D++++G+ LYEM+  +
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 77/210 (36%), Positives = 123/210 (58%), Gaps = 10/210 (4%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           +G   F  FRV+G+G F                  +YA K + K  + K+        E+
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGK-----LYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTA 222
            IL KV   FIV L Y+F+T++ L L++  +NGG + +H+Y        F+E +A FYTA
Sbjct: 237 KILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA 296
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEYM 281
           +IVS + HLH+  I++RDLKPEN+L+D DG+V ++D GLA E+    +++    GT  +M
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFM 356
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           APE+LL + ++   D++++G+ LYEM+  +
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 76/214 (35%), Positives = 117/214 (54%), Gaps = 14/214 (6%)
Query: 100 EAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHV 159
           +AE  R I    ++   V+G GAF                  + A+K + K+ +  K   
Sbjct: 12  QAEDIRDI----YDFRDVLGTGAFSEVILAEDKRTQK-----LVAIKCIAKEALEGKEGS 62
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
             M+ E  +L K+ HP IV L   +++   LYLI+  ++GG LF  +  +G + E  A  
Sbjct: 63  --MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR 120
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENIL---MDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
              +++ AV +LH  GIVHRDLKPEN+L   +D D  +M++DFGL+K  D  S  ++ CG
Sbjct: 121 LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACG 180
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           T  Y+APE+L  K ++K  D WS+G++ Y +L G
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 76/214 (35%), Positives = 117/214 (54%), Gaps = 14/214 (6%)
Query: 100 EAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHV 159
           +AE  R I    ++   V+G GAF                  + A+K + K+ +  K   
Sbjct: 12  QAEDIRDI----YDFRDVLGTGAFSEVILAEDKRTQK-----LVAIKCIAKEALEGKEGS 62
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
             M+ E  +L K+ HP IV L   +++   LYLI+  ++GG LF  +  +G + E  A  
Sbjct: 63  --MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR 120
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENIL---MDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
              +++ AV +LH  GIVHRDLKPEN+L   +D D  +M++DFGL+K  D  S  ++ CG
Sbjct: 121 LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACG 180
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           T  Y+APE+L  K ++K  D WS+G++ Y +L G
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 76/214 (35%), Positives = 117/214 (54%), Gaps = 14/214 (6%)
Query: 100 EAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHV 159
           +AE  R I    ++   V+G GAF                  + A+K + K+ +  K   
Sbjct: 12  QAEDIRDI----YDFRDVLGTGAFSEVILAEDKRTQK-----LVAIKCIAKEALEGKEGS 62
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
             M+ E  +L K+ HP IV L   +++   LYLI+  ++GG LF  +  +G + E  A  
Sbjct: 63  --MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR 120
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENIL---MDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
              +++ AV +LH  GIVHRDLKPEN+L   +D D  +M++DFGL+K  D  S  ++ CG
Sbjct: 121 LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACG 180
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           T  Y+APE+L  K ++K  D WS+G++ Y +L G
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 76/214 (35%), Positives = 116/214 (54%), Gaps = 14/214 (6%)
Query: 100 EAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHV 159
           +AE  R I    ++   V+G GAF                  + A+K + K  +  K   
Sbjct: 12  QAEDIRDI----YDFRDVLGTGAFSEVILAEDKRTQK-----LVAIKCIAKKALEGKEGS 62
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
             M+ E  +L K+ HP IV L   +++   LYLI+  ++GG LF  +  +G + E  A  
Sbjct: 63  --MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR 120
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENIL---MDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
              +++ AV +LH  GIVHRDLKPEN+L   +D D  +M++DFGL+K  D  S  ++ CG
Sbjct: 121 LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACG 180
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           T  Y+APE+L  K ++K  D WS+G++ Y +L G
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  127 bits (320), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 66/171 (38%), Positives = 107/171 (62%), Gaps = 8/171 (4%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YA+KV++K T+ KK     ++ E  +L +++HP I++L+  F+T +++ L+L+ + GG L
Sbjct: 81  YALKVLKK-TVDKK----IVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL 135
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDF 259
           F  +  +G + E  A     +I+ AV++LH+ GIVHRDLKPEN+L  +   D  + + DF
Sbjct: 136 FDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADF 195
Query: 260 GLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           GL+K ++      ++CGT  Y APEIL    +  + D WSVGI+ Y +L G
Sbjct: 196 GLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 75/239 (31%), Positives = 124/239 (51%), Gaps = 10/239 (4%)
Query: 73  GPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXX 132
           GP P      S P    E E  +  + E   +R+    DFEI R +G+G F         
Sbjct: 1   GPQP----LPSAPENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREK 56
Query: 133 XXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYL 192
                    I A+KV+ K  + K      ++ E +I + + HP I++L   F   +++YL
Sbjct: 57  QSKF-----ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 111
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           IL++   G ++  L +   F E +   Y  E+ +A+S+ H   ++HRD+KPEN+L+ S G
Sbjct: 112 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG 171
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
            + + DFG +     SSR  ++CGT +Y+ PE++  + H++  D WS+G+L YE L G+
Sbjct: 172 ELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 75/239 (31%), Positives = 124/239 (51%), Gaps = 10/239 (4%)
Query: 73  GPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXX 132
           GP P      S P    E E  +  + E   +R+    DFEI R +G+G F         
Sbjct: 1   GPQP----LPSAPENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREK 56
Query: 133 XXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYL 192
                    I A+KV+ K  + K      ++ E +I + + HP I++L   F   +++YL
Sbjct: 57  QSKF-----ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 111
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           IL++   G ++  L +   F E +   Y  E+ +A+S+ H   ++HRD+KPEN+L+ S G
Sbjct: 112 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG 171
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
            + + DFG +     SSR + +CGT +Y+ PE++  + H++  D WS+G+L YE L G+
Sbjct: 172 ELKIADFGWSVHAP-SSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 61/153 (39%), Positives = 93/153 (60%), Gaps = 7/153 (4%)
Query: 165 ERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
           E DIL KV+ HP I+QL+ +++T +  +L+ D +  G LF +L  +    E + R     
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           ++  +  LHK  IVHRDLKPENIL+D D ++ LTDFG + ++D   +  S+CGT  Y+AP
Sbjct: 133 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAP 192
Query: 284 EILLSK------GHNKDADWWSVGILLYEMLTG 310
           EI+         G+ K+ D WS G+++Y +L G
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 115/202 (56%), Gaps = 12/202 (5%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F    V+G GAF                  ++A+K ++K    + +    ++ E  +L K
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGK-----LFALKCIKKSPAFRDSS---LENEIAVLKK 62
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + H  IV L   +++ +  YL++  ++GG LF  +  +G++ E  A     +++SAV +L
Sbjct: 63  IKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYL 122
Query: 232 HKCGIVHRDLKPENILM---DSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS 288
           H+ GIVHRDLKPEN+L    + +  +M+TDFGL+K ++++   ++ CGT  Y+APE+L  
Sbjct: 123 HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK-MEQNGIMSTACGTPGYVAPEVLAQ 181
Query: 289 KGHNKDADWWSVGILLYEMLTG 310
           K ++K  D WS+G++ Y +L G
Sbjct: 182 KPYSKAVDCWSIGVITYILLCG 203

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  125 bits (315), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 110/207 (53%), Gaps = 6/207 (2%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +RK    DF+I R +G+G F                  I A+KV+ K  + K+     ++
Sbjct: 8   KRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKF-----IMALKVLFKSQLEKEGVEHQLR 62
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I+++   F  R ++YL+L+F   G L+  L + G F E ++  +  E
Sbjct: 63  REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 122
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  A+ + H+  ++HRD+KPEN+LM   G + + DFG +     S R   MCGT +Y+ P
Sbjct: 123 LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHA-PSLRRRXMCGTLDYLPP 181
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTG 310
           E++  K H++  D W  G+L YE L G
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 115/212 (54%), Gaps = 6/212 (2%)
Query: 100 EAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHV 159
           E   +R+    DFEI R +G+G F                  I A+KV+ K  + K    
Sbjct: 15  EESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVE 69
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
             ++ E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   
Sbjct: 70  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT 129
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
           Y  E+ +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +
Sbjct: 130 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLD 188
Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           Y+ PE++  + H++  D WS+G+L YE L G+
Sbjct: 189 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 110/207 (53%), Gaps = 6/207 (2%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +RK    DF+I R +G+G F                  I A+KV+ K  + K+     ++
Sbjct: 9   KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKF-----IMALKVLFKSQLEKEGVEHQLR 63
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I+++   F  R ++YL+L+F   G L+  L + G F E ++  +  E
Sbjct: 64  REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 123
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  A+ + H+  ++HRD+KPEN+LM   G + + DFG +     S R   MCGT +Y+ P
Sbjct: 124 LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHA-PSLRRRXMCGTLDYLPP 182
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTG 310
           E++  K H++  D W  G+L YE L G
Sbjct: 183 EMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 114/209 (54%), Gaps = 6/209 (2%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
            +R+    DFEI R +G+G F                  I A+KV+ K  + K      +
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQL 60
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  
Sbjct: 61  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYIT 120
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           E+ +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ 
Sbjct: 121 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLP 179
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           PE++  + H++  D WS+G+L YE L G+
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 115/209 (55%), Gaps = 6/209 (2%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
           S+R+    DFEI R +G+G F                  I A+KV+ K  + K      +
Sbjct: 5   SKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQL 59
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  
Sbjct: 60  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 119
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           E+ +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ 
Sbjct: 120 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLP 178
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           PE++  + H++  D WS+G+L YE L G+
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 116/214 (54%), Gaps = 14/214 (6%)
Query: 100 EAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHV 159
           +AE  +KI    FE    +G GAF                  ++A+K + K  +  K   
Sbjct: 16  QAEDIKKI----FEFKETLGTGAFSEVVLAEEKATGK-----LFAVKCIPKKAL--KGKE 64
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
             ++ E  +L K+ H  IV L   +++ + LYL++  ++GG LF  +  +G + E  A  
Sbjct: 65  SSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDAST 124
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENIL---MDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
              +++ AV +LH+ GIVHRDLKPEN+L    D +  +M++DFGL+K   +    ++ CG
Sbjct: 125 LIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACG 184
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           T  Y+APE+L  K ++K  D WS+G++ Y +L G
Sbjct: 185 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  124 bits (311), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 60/153 (39%), Positives = 92/153 (60%), Gaps = 7/153 (4%)
Query: 165 ERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
           E DIL KV+ HP I+QL+ +++T +  +L+ D +  G LF +L  +    E + R     
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 119
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           ++  +  LHK  IVHRDLKPENIL+D D ++ LTDFG + ++D   +   +CGT  Y+AP
Sbjct: 120 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 179
Query: 284 EILLSK------GHNKDADWWSVGILLYEMLTG 310
           EI+         G+ K+ D WS G+++Y +L G
Sbjct: 180 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  124 bits (311), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 60/153 (39%), Positives = 92/153 (60%), Gaps = 7/153 (4%)
Query: 165 ERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
           E DIL KV+ HP I+QL+ +++T +  +L+ D +  G LF +L  +    E + R     
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           ++  +  LHK  IVHRDLKPENIL+D D ++ LTDFG + ++D   +   +CGT  Y+AP
Sbjct: 133 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 192
Query: 284 EILLSK------GHNKDADWWSVGILLYEMLTG 310
           EI+         G+ K+ D WS G+++Y +L G
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  124 bits (311), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 115/209 (55%), Gaps = 6/209 (2%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
            +R+    DFEI R +G+G F                  I A+KV+ K  + K      +
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQL 56
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  
Sbjct: 57  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 116
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           E+ +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR +++CGT +Y+ 
Sbjct: 117 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRDTLCGTLDYLP 175
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           PE++  + H++  D WS+G+L YE L G+
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  124 bits (310), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 114/209 (54%), Gaps = 6/209 (2%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
            +R+    DFEI R +G+G F                  I A+KV+ K  + K      +
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQL 58
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  
Sbjct: 59  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 118
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           E+ +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ 
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLP 177
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           PE++  + H++  D WS+G+L YE L G+
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  124 bits (310), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 113/207 (54%), Gaps = 6/207 (2%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R+    DFEI R +G+G F                  I A+KV+ K  + K      ++ 
Sbjct: 3   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLRR 57
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E+
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
            +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ PE
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPE 176
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQ 311
           ++  + H++  D WS+G+L YE L G+
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 114/208 (54%), Gaps = 6/208 (2%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 61
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 121
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ P
Sbjct: 122 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPP 180
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQ 311
           E++  + H++  D WS+G+L YE L G+
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 115/209 (55%), Gaps = 6/209 (2%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
           ++R+    DFEI R +G+G F                  I A+KV+ K  + K      +
Sbjct: 1   AKRQWALEDFEIGRPLGKGKFGNVYLAREKNSKF-----ILALKVLFKAQLEKAGVEHQL 55
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  
Sbjct: 56  RREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 115
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           E+ +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ 
Sbjct: 116 ELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRAALCGTLDYLP 174
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           PE++  + H++  D WS+G+L YE L G+
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 113/208 (54%), Gaps = 6/208 (2%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 61
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 121
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ P
Sbjct: 122 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPP 180
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQ 311
           E +  + H++  D WS+G+L YE L G+
Sbjct: 181 EXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 115/209 (55%), Gaps = 6/209 (2%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
           ++R+    DFEI R +G+G F                  I A+KV+ K  + K      +
Sbjct: 1   AKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQL 55
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  
Sbjct: 56  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 115
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           E+ +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ 
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRAALCGTLDYLP 174
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           PE++  + H++  D WS+G+L YE L G+
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 114/208 (54%), Gaps = 6/208 (2%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 1   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 55
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 56  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 115
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ P
Sbjct: 116 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPP 174
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQ 311
           E++  + H++  D WS+G+L YE L G+
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 116/208 (55%), Gaps = 6/208 (2%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
           S+R+    DF+I R +G+G F                  I A+KV+ K  + K      +
Sbjct: 5   SKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKF-----ILALKVLFKTQLEKAGVEHQL 59
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  
Sbjct: 60  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYIT 119
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           E+ +A+S+ H   ++HRD+KPEN+L+ S+G + + DFG +     SSR +++CGT +Y+ 
Sbjct: 120 ELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAP-SSRRDTLCGTLDYLP 178
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTG 310
           PE++  + H++  D WS+G+L YE L G
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 114/211 (54%), Gaps = 6/211 (2%)
Query: 101 AESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVD 160
           A   R+    DFEI R +G+G F                  I A+KV+ K  + K     
Sbjct: 2   AMGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEH 56
Query: 161 YMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
            ++ E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 116
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
             E+ +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y
Sbjct: 117 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRAALCGTLDY 175
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           + PE++  + H++  D WS+G+L YE L G+
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 112/207 (54%), Gaps = 6/207 (2%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R+    DFEI R +G+G F                  I A+KV+ K  + K      ++ 
Sbjct: 3   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLRR 57
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E+
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
            +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR   +CGT +Y+ PE
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTELCGTLDYLPPE 176
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQ 311
           ++  + H++  D WS+G+L YE L G+
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 113/208 (54%), Gaps = 6/208 (2%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 56
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR   +CGT +Y+ P
Sbjct: 117 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLCGTLDYLPP 175
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQ 311
           E++  + H++  D WS+G+L YE L G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 114/209 (54%), Gaps = 6/209 (2%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
            +R+    DFEI R +G+G F                  I A+KV+ K  + K      +
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQL 58
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  
Sbjct: 59  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 118
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           E+ +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ 
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLP 177
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           PE++  + H++  D WS+G+L YE L G+
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 113/209 (54%), Gaps = 6/209 (2%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
            +R+    DFEI R +G+G F                  I A+KV+ K  + K      +
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQL 56
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  
Sbjct: 57  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 116
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           E+ +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR   +CGT +Y+ 
Sbjct: 117 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLCGTLDYLP 175
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           PE++  + H++  D WS+G+L YE L G+
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 113/209 (54%), Gaps = 6/209 (2%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
            +R+    DFEI R +G+G F                  I A+KV+ K  + K      +
Sbjct: 1   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQL 55
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  
Sbjct: 56  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 115
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           E+ +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR   +CGT +Y+ 
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLCGTLDYLP 174
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           PE++  + H++  D WS+G+L YE L G+
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 113/209 (54%), Gaps = 6/209 (2%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
            +R+    DFEI R +G+G F                  I A+KV+ K  + K      +
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQL 60
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  
Sbjct: 61  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 120
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           E+ +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR   +CGT +Y+ 
Sbjct: 121 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLCGTLDYLP 179
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           PE++  + H++  D WS+G+L YE L G+
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 113/207 (54%), Gaps = 6/207 (2%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R+    DFEI R +G+G F                  I A+KV+ K  + K      ++ 
Sbjct: 6   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLRR 60
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E+
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
            +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR + +CGT +Y+ PE
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRDDLCGTLDYLPPE 179
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQ 311
           ++  + H++  D WS+G+L YE L G+
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 115/208 (55%), Gaps = 6/208 (2%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
           S+R+    DF+I R +G+G F                  I A+KV+ K  + K      +
Sbjct: 5   SKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKF-----ILALKVLFKTQLEKAGVEHQL 59
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  
Sbjct: 60  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYIT 119
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           E+ +A+S+ H   ++HRD+KPEN+L+ S+G + + DFG +     SSR  ++CGT +Y+ 
Sbjct: 120 ELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAP-SSRRTTLCGTLDYLP 178
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTG 310
           PE++  + H++  D WS+G+L YE L G
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 113/209 (54%), Gaps = 6/209 (2%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
            +R+    DFEI R +G+G F                  I A+KV+ K  + K      +
Sbjct: 3   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQL 57
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  
Sbjct: 58  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 117
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           E+ +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR   +CGT +Y+ 
Sbjct: 118 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRXXLCGTLDYLP 176
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           PE++  + H++  D WS+G+L YE L G+
Sbjct: 177 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 111/201 (55%), Gaps = 6/201 (2%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI R +G+G F                  I A+KV+ K  + K      ++ E +I +
Sbjct: 6   DFEIGRPLGKGKFGNVYLAREKQRKF-----ILALKVLFKAQLEKAGVEHQLRREVEIQS 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E+ +A+S+
Sbjct: 61  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 120
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
            H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ PE++  + 
Sbjct: 121 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRM 179
Query: 291 HNKDADWWSVGILLYEMLTGQ 311
           H++  D WS+G+L YE L G+
Sbjct: 180 HDEKVDLWSLGVLCYEFLVGK 200

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 113/209 (54%), Gaps = 6/209 (2%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
            +R+    DFEI R +G+G F                  I A+KV+ K  + K      +
Sbjct: 1   GKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQL 55
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  
Sbjct: 56  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 115
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           E+ +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR   +CGT +Y+ 
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTXLCGTLDYLP 174
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           PE++  + H++  D WS+G+L YE L G+
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 114/208 (54%), Gaps = 6/208 (2%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 4   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 58
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 59  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 118
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + +FG +     SSR  ++CGT +Y+ P
Sbjct: 119 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAP-SSRRTTLCGTLDYLPP 177
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQ 311
           E++  + H++  D WS+G+L YE L G+
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 113/209 (54%), Gaps = 6/209 (2%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
            +R+    DFEI R +G+G F                  I A+KV+ K  + K      +
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQL 58
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  
Sbjct: 59  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 118
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           E+ +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR   +CGT +Y+ 
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRXXLCGTLDYLP 177
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           PE++  + H++  D WS+G+L YE L G+
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 113/209 (54%), Gaps = 6/209 (2%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
            +R+    DFEI R +G+G F                  I A+KV+ K  + K      +
Sbjct: 1   GKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQL 55
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  
Sbjct: 56  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 115
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           E+ +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR   +CGT +Y+ 
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRXXLCGTLDYLP 174
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           PE++  + H++  D WS+G+L YE L G+
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 114/209 (54%), Gaps = 6/209 (2%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
            +R+    DFEI R +G+G F                  I A+KV+ K  + K      +
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQL 58
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  
Sbjct: 59  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 118
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           E+ +A+S+ H   ++HRD+KPEN+L+ S G + + +FG +     SSR  ++CGT +Y+ 
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAP-SSRRTTLCGTLDYLP 177
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           PE++  + H++  D WS+G+L YE L G+
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 124/229 (54%), Gaps = 14/229 (6%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A+K++ K T +    +  +  E  I+
Sbjct: 12  GNYRLLKTIGKGNFAKVKLARHILTGREV-----AIKIIDK-TQLNPTSLQKLFREVRIM 65
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYLI+++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 66  KILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ 125
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLK EN+L+D+D ++ + DFG + E     + ++ CG+  Y APE+   K
Sbjct: 126 YCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGK 185
Query: 290 GHNK-DADWWSVGILLYEMLTGQV-----NIKSM--QVIACNTMLLFYL 330
            ++  + D WS+G++LY +++G +     N+K +  +V+     + FY+
Sbjct: 186 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYM 234

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 126/229 (55%), Gaps = 14/229 (6%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A+K++ K T +  + +  +  E  I+
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEV-----AVKIIDK-TQLNSSSLQKLFREVRIM 67
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYL++++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLK EN+L+D+D ++ + DFG + E    ++ ++ CG+  Y APE+   K
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGK 187
Query: 290 GHNK-DADWWSVGILLYEMLTGQV-----NIKSM--QVIACNTMLLFYL 330
            ++  + D WS+G++LY +++G +     N+K +  +V+     + FY+
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYM 236

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 126/229 (55%), Gaps = 14/229 (6%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A+K++ K T +  + +  +  E  I+
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEV-----AVKIIDK-TQLNSSSLQKLFREVRIM 67
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYL++++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLK EN+L+D+D ++ + DFG + E    ++ ++ CG+  Y APE+   K
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGK 187
Query: 290 GHNK-DADWWSVGILLYEMLTGQV-----NIKSM--QVIACNTMLLFYL 330
            ++  + D WS+G++LY +++G +     N+K +  +V+     + FY+
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYM 236

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 123/229 (53%), Gaps = 14/229 (6%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A+K++ K T +    +  +  E  I+
Sbjct: 15  GNYRLLKTIGKGNFAKVKLARHILTGREV-----AIKIIDK-TQLNPTSLQKLFREVRIM 68
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYLI+++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 69  KILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ 128
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLK EN+L+D+D ++ + DFG + E     + ++ CG   Y APE+   K
Sbjct: 129 YCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGK 188
Query: 290 GHNK-DADWWSVGILLYEMLTGQV-----NIKSM--QVIACNTMLLFYL 330
            ++  + D WS+G++LY +++G +     N+K +  +V+     + FY+
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYM 237

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 113/208 (54%), Gaps = 6/208 (2%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 3   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 57
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 117
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++ GT +Y+ P
Sbjct: 118 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAP-SSRRTTLSGTLDYLPP 176
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQ 311
           E++  + H++  D WS+G+L YE L G+
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 126/229 (55%), Gaps = 14/229 (6%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A+K++ K T +  + +  +  E  I+
Sbjct: 7   GNYRLLKTIGKGNFAKVKLARHILTGKEV-----AVKIIDK-TQLNSSSLQKLFREVRIM 60
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYL++++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 61  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQ 120
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLK EN+L+D+D ++ + DFG + E    ++ ++ CG+  Y APE+   K
Sbjct: 121 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGK 180
Query: 290 GHNK-DADWWSVGILLYEMLTGQV-----NIKSM--QVIACNTMLLFYL 330
            ++  + D WS+G++LY +++G +     N+K +  +V+     + FY+
Sbjct: 181 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYM 229

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 112/209 (53%), Gaps = 6/209 (2%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
            +R+    DFEI R +G+G F                  I A+KV+ K  + K      +
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQL 60
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  
Sbjct: 61  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYIT 120
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           E+ +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR   + GT +Y+ 
Sbjct: 121 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRXXLXGTLDYLP 179
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           PE++  + H++  D WS+G+L YE L G+
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 125/229 (54%), Gaps = 14/229 (6%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A+K++ K T +  + +  +  E  I+
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEV-----AVKIIDK-TQLNSSSLQKLFREVRIM 67
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYL++++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLK EN+L+D+D ++ + DFG + E    ++ ++ CG   Y APE+   K
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGK 187
Query: 290 GHNK-DADWWSVGILLYEMLTGQV-----NIKSM--QVIACNTMLLFYL 330
            ++  + D WS+G++LY +++G +     N+K +  +V+     + FY+
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYM 236

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 126/229 (55%), Gaps = 14/229 (6%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A++++ K T +  + +  +  E  I+
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEV-----AVRIIDK-TQLNSSSLQKLFREVRIM 67
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYL++++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLK EN+L+D+D ++ + DFG + E    ++ ++ CG+  Y APE+   K
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGK 187
Query: 290 GHNK-DADWWSVGILLYEMLTGQV-----NIKSM--QVIACNTMLLFYL 330
            ++  + D WS+G++LY +++G +     N+K +  +V+     + FY+
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYM 236

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 58/155 (37%), Positives = 98/155 (63%), Gaps = 7/155 (4%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E +IL K+ HP I++++  F      Y++L+ + GG LF  +      +E   + Y 
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTT 278
            +++ AV +LH+ GI+HRDLKPEN+L+ S   D  + +TDFG +K + E+S   ++CGT 
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 279 EYMAPEILLS---KGHNKDADWWSVGILLYEMLTG 310
            Y+APE+L+S    G+N+  D WS+G++L+  L+G
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 125/229 (54%), Gaps = 14/229 (6%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A++++ K T +  + +  +  E  I+
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEV-----AVRIIDK-TQLNSSSLQKLFREVRIM 67
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYL++++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLK EN+L+D+D ++ + DFG + E    ++ +  CG+  Y APE+   K
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGK 187
Query: 290 GHNK-DADWWSVGILLYEMLTGQV-----NIKSM--QVIACNTMLLFYL 330
            ++  + D WS+G++LY +++G +     N+K +  +V+     + FY+
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYM 236

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 58/155 (37%), Positives = 98/155 (63%), Gaps = 7/155 (4%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E +IL K+ HP I++++  F      Y++L+ + GG LF  +      +E   + Y 
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTT 278
            +++ AV +LH+ GI+HRDLKPEN+L+ S   D  + +TDFG +K + E+S   ++CGT 
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 279 EYMAPEILLS---KGHNKDADWWSVGILLYEMLTG 310
            Y+APE+L+S    G+N+  D WS+G++L+  L+G
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 58/155 (37%), Positives = 98/155 (63%), Gaps = 7/155 (4%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E +IL K+ HP I++++  F      Y++L+ + GG LF  +      +E   + Y 
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTT 278
            +++ AV +LH+ GI+HRDLKPEN+L+ S   D  + +TDFG +K + E+S   ++CGT 
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 279 EYMAPEILLS---KGHNKDADWWSVGILLYEMLTG 310
            Y+APE+L+S    G+N+  D WS+G++L+  L+G
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 58/155 (37%), Positives = 98/155 (63%), Gaps = 7/155 (4%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E +IL K+ HP I++++  F      Y++L+ + GG LF  +      +E   + Y 
Sbjct: 61  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 119
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTT 278
            +++ AV +LH+ GI+HRDLKPEN+L+ S   D  + +TDFG +K + E+S   ++CGT 
Sbjct: 120 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 179
Query: 279 EYMAPEILLS---KGHNKDADWWSVGILLYEMLTG 310
            Y+APE+L+S    G+N+  D WS+G++L+  L+G
Sbjct: 180 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 58/155 (37%), Positives = 98/155 (63%), Gaps = 7/155 (4%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E +IL K+ HP I++++  F      Y++L+ + GG LF  +      +E   + Y 
Sbjct: 68  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 126
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTT 278
            +++ AV +LH+ GI+HRDLKPEN+L+ S   D  + +TDFG +K + E+S   ++CGT 
Sbjct: 127 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 186
Query: 279 EYMAPEILLS---KGHNKDADWWSVGILLYEMLTG 310
            Y+APE+L+S    G+N+  D WS+G++L+  L+G
Sbjct: 187 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 124/229 (54%), Gaps = 14/229 (6%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A+K++ K T +    +  +  E  I+
Sbjct: 15  GNYRLQKTIGKGNFAKVKLARHVLTGREV-----AVKIIDK-TQLNPTSLQKLFREVRIM 68
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYL++++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 69  KILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 128
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLK EN+L+D D ++ + DFG + E    ++ ++ CG+  Y APE+   K
Sbjct: 129 YCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGK 188
Query: 290 GHNK-DADWWSVGILLYEMLTGQV-----NIKSM--QVIACNTMLLFYL 330
            ++  + D WS+G++LY +++G +     N+K +  +V+     + FY+
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYM 237

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 58/155 (37%), Positives = 98/155 (63%), Gaps = 7/155 (4%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E +IL K+ HP I++++  F      Y++L+ + GG LF  +      +E   + Y 
Sbjct: 201 VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 259
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTT 278
            +++ AV +LH+ GI+HRDLKPEN+L+ S   D  + +TDFG +K + E+S   ++CGT 
Sbjct: 260 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 319
Query: 279 EYMAPEILLS---KGHNKDADWWSVGILLYEMLTG 310
            Y+APE+L+S    G+N+  D WS+G++L+  L+G
Sbjct: 320 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 58/155 (37%), Positives = 98/155 (63%), Gaps = 7/155 (4%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E +IL K+ HP I++++  F      Y++L+ + GG LF  +      +E   + Y 
Sbjct: 187 VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 245
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTT 278
            +++ AV +LH+ GI+HRDLKPEN+L+ S   D  + +TDFG +K + E+S   ++CGT 
Sbjct: 246 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 305
Query: 279 EYMAPEILLS---KGHNKDADWWSVGILLYEMLTG 310
            Y+APE+L+S    G+N+  D WS+G++L+  L+G
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 112/204 (54%), Gaps = 7/204 (3%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A+K++ K T +  + +  +  E  I 
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEV-----AVKIIDK-TQLNSSSLQKLFREVRIX 67
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYL+ ++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQ 127
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLK EN+L+D+D ++ + DFG + E    ++ ++ CG   Y APE+   K
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGK 187
Query: 290 GHNK-DADWWSVGILLYEMLTGQV 312
            ++  + D WS+G++LY +++G +
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSL 211

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 57/150 (38%), Positives = 90/150 (60%), Gaps = 3/150 (2%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFY 220
           + E  +L  + HP IVQ R SF+    LY+++D+  GG LF  +  Q   +F+EDQ   +
Sbjct: 71  RREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW 130
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMC-GTTE 279
             +I  A+ H+H   I+HRD+K +NI +  DG V L DFG+A+ ++ +      C GT  
Sbjct: 131 FVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPY 190
Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           Y++PEI  +K +N  +D W++G +LYE+ T
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCT 220

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 57/147 (38%), Positives = 91/147 (61%), Gaps = 4/147 (2%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
           HP IV+L   F  +   +L+++ +NGG LF  + ++  F E +A +   ++VSAVSH+H 
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 234 CGIVHRDLKPENILMDSDG---HVMLTDFGLAK-EIDESSRSNSMCGTTEYMAPEILLSK 289
            G+VHRDLKPEN+L   +     + + DFG A+ +  ++    + C T  Y APE+L   
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184
Query: 290 GHNKDADWWSVGILLYEMLTGQVNIKS 316
           G+++  D WS+G++LY ML+GQV  +S
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPFQS 211

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 60/156 (38%), Positives = 91/156 (58%), Gaps = 5/156 (3%)
Query: 160 DYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA 217
           D+ K ER+  I  K+ HP IV+L  S Q  S  YL+ D + GG LF  +  +  + E  A
Sbjct: 47  DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA 106
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESSRSNSM 274
                +I+ ++++ H  GIVHR+LKPEN+L+ S      V L DFGLA E+++S   +  
Sbjct: 107 SHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 166
Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            GT  Y++PE+L    ++K  D W+ G++LY +L G
Sbjct: 167 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 60/156 (38%), Positives = 91/156 (58%), Gaps = 5/156 (3%)
Query: 160 DYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA 217
           D+ K ER+  I  K+ HP IV+L  S Q  S  YL+ D + GG LF  +  +  + E  A
Sbjct: 48  DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA 107
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESSRSNSM 274
                +I+ ++++ H  GIVHR+LKPEN+L+ S      V L DFGLA E+++S   +  
Sbjct: 108 SHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 167
Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            GT  Y++PE+L    ++K  D W+ G++LY +L G
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 60/156 (38%), Positives = 91/156 (58%), Gaps = 5/156 (3%)
Query: 160 DYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA 217
           D+ K ER+  I  K+ HP IV+L  S Q  S  YL+ D + GG LF  +  +  + E  A
Sbjct: 71  DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA 130
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESSRSNSM 274
                +I+ ++++ H  GIVHR+LKPEN+L+ S      V L DFGLA E+++S   +  
Sbjct: 131 SHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 190
Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            GT  Y++PE+L    ++K  D W+ G++LY +L G
Sbjct: 191 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 60/156 (38%), Positives = 91/156 (58%), Gaps = 5/156 (3%)
Query: 160 DYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA 217
           D+ K ER+  I  K+ HP IV+L  S Q  S  YL+ D + GG LF  +  +  + E  A
Sbjct: 48  DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA 107
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESSRSNSM 274
                +I+ ++++ H  GIVHR+LKPEN+L+ S      V L DFGLA E+++S   +  
Sbjct: 108 SHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 167
Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            GT  Y++PE+L    ++K  D W+ G++LY +L G
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 105/200 (52%), Gaps = 6/200 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI R +G+G F                  I A+KV+ K  I K+     ++ E +I  
Sbjct: 24  DFEIGRPLGKGKFGNVYLAREKKSHF-----IVALKVLFKSQIEKEGVEHQLRREIEIQA 78
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP I++L   F  R ++YLIL++   G L+  L +   F E +      E+  A+ +
Sbjct: 79  HLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMY 138
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
            H   ++HRD+KPEN+L+   G + + DFG +     S R  +MCGT +Y+ PE++  + 
Sbjct: 139 CHGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAP-SLRRKTMCGTLDYLPPEMIEGRM 197
Query: 291 HNKDADWWSVGILLYEMLTG 310
           HN+  D W +G+L YE+L G
Sbjct: 198 HNEKVDLWCIGVLCYELLVG 217

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 57/155 (36%), Positives = 89/155 (57%), Gaps = 7/155 (4%)
Query: 163 KAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           + E  IL +V  HP I+ L  S+++ S ++L+ D +  G LF +L  +    E + R   
Sbjct: 147 RRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIM 206
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYM 281
             ++ AVS LH   IVHRDLKPENIL+D +  + L+DFG +  ++   +   +CGT  Y+
Sbjct: 207 RSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYL 266
Query: 282 APEILLSK------GHNKDADWWSVGILLYEMLTG 310
           APEIL         G+ K+ D W+ G++L+ +L G
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 117/215 (54%), Gaps = 13/215 (6%)
Query: 101 AESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVD 160
           A S+R IGP  + I   +G+G+F                    + ++++K  +       
Sbjct: 2   AISKRHIGP--YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDM------- 52
Query: 161 YMKAERDI--LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
           +M+ ER+I  L  + HP I++L     T + + +++++  GG LF ++  +    ED+ R
Sbjct: 53  HMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGR 111
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
            +  +I+ A+ + H+  IVHRDLKPEN+L+D + +V + DFGL+  + + +   + CG+ 
Sbjct: 112 RFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSP 171
Query: 279 EYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQV 312
            Y APE++  K +   + D WS GI+LY ML G++
Sbjct: 172 NYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRL 206

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  111 bits (277), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 101/203 (49%), Gaps = 10/203 (4%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +++F  +G+GAF                   YA K++    +  ++H   ++ E  I   
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQE-----YAAKIINTKKLSARDH-QKLEREARICRL 77
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP IV+L  S       YLI D + GG LF  +  +  + E  A     +I+ AV H 
Sbjct: 78  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 137
Query: 232 HKCGIVHRDLKPENILMDSD---GHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEILL 287
           H+ G+VHRDLKPEN+L+ S      V L DFGLA E++ E        GT  Y++PE+L 
Sbjct: 138 HQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 197
Query: 288 SKGHNKDADWWSVGILLYEMLTG 310
              + K  D W+ G++LY +L G
Sbjct: 198 KDPYGKPVDLWACGVILYILLVG 220

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  110 bits (276), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 55/171 (32%), Positives = 96/171 (56%), Gaps = 1/171 (0%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A KV+ K  ++K +  + M  E  I   + +P +V     F+    +Y++L+      
Sbjct: 69  VFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRS 128
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L     R+    E +AR++  + +  V +LH   ++HRDLK  N+ ++ D  V + DFGL
Sbjct: 129 LLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGL 188
Query: 262 AKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           A +I+ +  R  ++CGT  Y+APE+L  KGH+ + D WS+G +LY +L G+
Sbjct: 189 ATKIEFDGERKKTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  110 bits (276), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 96/171 (56%), Gaps = 1/171 (0%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A K++ K  ++K +  + M  E  I   + H  +V     F+    ++++L+      
Sbjct: 48  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 107
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L     R+    E +AR+Y  +IV    +LH+  ++HRDLK  N+ ++ D  V + DFGL
Sbjct: 108 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 167
Query: 262 AKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           A +++ +  R  ++CGT  Y+APE+L  KGH+ + D WS+G ++Y +L G+
Sbjct: 168 ATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 218

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 96/171 (56%), Gaps = 1/171 (0%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A K++ K  ++K +  + M  E  I   + H  +V     F+    ++++L+      
Sbjct: 44  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 103
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L     R+    E +AR+Y  +IV    +LH+  ++HRDLK  N+ ++ D  V + DFGL
Sbjct: 104 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 163
Query: 262 AKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           A +++ +  R  ++CGT  Y+APE+L  KGH+ + D WS+G ++Y +L G+
Sbjct: 164 ATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 214

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 96/171 (56%), Gaps = 1/171 (0%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A K++ K  ++K +  + M  E  I   + H  +V     F+    ++++L+      
Sbjct: 44  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 103
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L     R+    E +AR+Y  +IV    +LH+  ++HRDLK  N+ ++ D  V + DFGL
Sbjct: 104 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 163
Query: 262 AKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           A +++ +  R  ++CGT  Y+APE+L  KGH+ + D WS+G ++Y +L G+
Sbjct: 164 ATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 214

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 55/171 (32%), Positives = 95/171 (55%), Gaps = 1/171 (0%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A KV+ K  ++K +  + M  E  I   + +P +V     F+    +Y++L+      
Sbjct: 69  VFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRS 128
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L     R+    E +AR++  + +  V +LH   ++HRDLK  N+ ++ D  V + DFGL
Sbjct: 129 LLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGL 188
Query: 262 AKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           A +I+ +  R   +CGT  Y+APE+L  KGH+ + D WS+G +LY +L G+
Sbjct: 189 ATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 55/171 (32%), Positives = 95/171 (55%), Gaps = 1/171 (0%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A KV+ K  ++K +  + M  E  I   + +P +V     F+    +Y++L+      
Sbjct: 69  VFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRS 128
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L     R+    E +AR++  + +  V +LH   ++HRDLK  N+ ++ D  V + DFGL
Sbjct: 129 LLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGL 188
Query: 262 AKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           A +I+ +  R   +CGT  Y+APE+L  KGH+ + D WS+G +LY +L G+
Sbjct: 189 ATKIEFDGERKKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 55/171 (32%), Positives = 95/171 (55%), Gaps = 1/171 (0%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A KV+ K  ++K +  + M  E  I   + +P +V     F+    +Y++L+      
Sbjct: 53  VFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRS 112
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L     R+    E +AR++  + +  V +LH   ++HRDLK  N+ ++ D  V + DFGL
Sbjct: 113 LLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGL 172
Query: 262 AKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           A +I+ +  R   +CGT  Y+APE+L  KGH+ + D WS+G +LY +L G+
Sbjct: 173 ATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 223

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 99/170 (58%), Gaps = 1/170 (0%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K++ +  I   + V  +K E   L    HP I++L     T +  ++++++++GG LF
Sbjct: 40  AVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELF 99
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK 263
            ++ + G   E +AR    +I+SAV + H+  +VHRDLKPEN+L+D+  +  + DFGL+ 
Sbjct: 100 DYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN 159
Query: 264 EIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQV 312
            + +     + CG+  Y APE++  + +   + D WS G++LY +L G +
Sbjct: 160 MMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTL 209

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 95/171 (55%), Gaps = 1/171 (0%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A K++ K  ++K +  + M  E  I   + H  +V     F+    ++++L+      
Sbjct: 68  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 127
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L     R+    E +AR+Y  +IV    +LH+  ++HRDLK  N+ ++ D  V + DFGL
Sbjct: 128 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 187
Query: 262 AKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           A +++ +  R   +CGT  Y+APE+L  KGH+ + D WS+G ++Y +L G+
Sbjct: 188 ATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 95/171 (55%), Gaps = 1/171 (0%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A K++ K  ++K +  + M  E  I   + H  +V     F+    ++++L+      
Sbjct: 66  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 125
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L     R+    E +AR+Y  +IV    +LH+  ++HRDLK  N+ ++ D  V + DFGL
Sbjct: 126 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 185
Query: 262 AKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           A +++ +  R   +CGT  Y+APE+L  KGH+ + D WS+G ++Y +L G+
Sbjct: 186 ATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 236

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 95/171 (55%), Gaps = 1/171 (0%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A K++ K  ++K +  + M  E  I   + H  +V     F+    ++++L+      
Sbjct: 42  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 101
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L     R+    E +AR+Y  +IV    +LH+  ++HRDLK  N+ ++ D  V + DFGL
Sbjct: 102 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 161
Query: 262 AKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           A +++ +  R   +CGT  Y+APE+L  KGH+ + D WS+G ++Y +L G+
Sbjct: 162 ATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 98/170 (57%), Gaps = 1/170 (0%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K++ +  I   + V  +K E   L    HP I++L     T +  ++++++++GG LF
Sbjct: 40  AVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELF 99
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK 263
            ++ + G   E +AR    +I+SAV + H+  +VHRDLKPEN+L+D+  +  + DFGL+ 
Sbjct: 100 DYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN 159
Query: 264 EIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQV 312
            + +       CG+  Y APE++  + +   + D WS G++LY +L G +
Sbjct: 160 MMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTL 209

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 98/170 (57%), Gaps = 4/170 (2%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K+++K ++   ++   +  E  +L ++ HP I++L   F+ +   YL+++   GG LF
Sbjct: 50  AIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELF 109
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFG 260
             +  +  F E  A     +++S  ++LHK  IVHRDLKPEN+L++S   D  + + DFG
Sbjct: 110 DEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFG 169
Query: 261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           L+   +   +     GT  Y+APE+ L K +++  D WS G++LY +L G
Sbjct: 170 LSAHFEVGGKMKERLGTAYYIAPEV-LRKKYDEKCDVWSCGVILYILLCG 218

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 111/200 (55%), Gaps = 7/200 (3%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G+++I + +G+G+F                    A+K++ K  + K +    ++ E   L
Sbjct: 13  GNYQIVKTLGEGSFGKVKLAYHTTTGQKV-----ALKIINKKVLAKSDMQGRIEREISYL 67
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP I++L    +++ ++ +++++  G  LF ++ ++    E +AR +  +I+SAV 
Sbjct: 68  RLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVE 126
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLKPEN+L+D   +V + DFGL+  + + +   + CG+  Y APE++  K
Sbjct: 127 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGK 186
Query: 290 GH-NKDADWWSVGILLYEML 308
            +   + D WS G++LY ML
Sbjct: 187 LYAGPEVDVWSCGVILYVML 206

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 111/200 (55%), Gaps = 7/200 (3%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G+++I + +G+G+F                    A+K++ K  + K +    ++ E   L
Sbjct: 14  GNYQIVKTLGEGSFGKVKLAYHTTTGQKV-----ALKIINKKVLAKSDMQGRIEREISYL 68
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP I++L    +++ ++ +++++  G  LF ++ ++    E +AR +  +I+SAV 
Sbjct: 69  RLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVE 127
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLKPEN+L+D   +V + DFGL+  + + +   + CG+  Y APE++  K
Sbjct: 128 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGK 187
Query: 290 GH-NKDADWWSVGILLYEML 308
            +   + D WS G++LY ML
Sbjct: 188 LYAGPEVDVWSCGVILYVML 207

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 107/198 (54%), Gaps = 9/198 (4%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           RV+G+G+F                    A+KV+ K  + +K   + +  E  +L ++ HP
Sbjct: 32  RVLGKGSFGEVILCKDKITGQEC-----AVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
            I++L   F+ +   YL+ +   GG LF  +  +  F E  A     +++S ++++HK  
Sbjct: 87  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 236 IVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN 292
           IVHRDLKPEN+L++S   D ++ + DFGL+   + S +     GT  Y+APE+L    ++
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YD 205
Query: 293 KDADWWSVGILLYEMLTG 310
           +  D WS G++LY +L+G
Sbjct: 206 EKCDVWSTGVILYILLSG 223

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 111/200 (55%), Gaps = 7/200 (3%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G+++I + +G+G+F                    A+K++ K  + K +    ++ E   L
Sbjct: 4   GNYQIVKTLGEGSFGKVKLAYHTTTGQKV-----ALKIINKKVLAKSDMQGRIEREISYL 58
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP I++L    +++ ++ +++++  G  LF ++ ++    E +AR +  +I+SAV 
Sbjct: 59  RLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVE 117
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLKPEN+L+D   +V + DFGL+  + + +   + CG+  Y APE++  K
Sbjct: 118 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGK 177
Query: 290 GH-NKDADWWSVGILLYEML 308
            +   + D WS G++LY ML
Sbjct: 178 LYAGPEVDVWSCGVILYVML 197

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 111/200 (55%), Gaps = 7/200 (3%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G+++I + +G+G+F                    A+K++ K  + K +    ++ E   L
Sbjct: 8   GNYQIVKTLGEGSFGKVKLAYHTTTGQKV-----ALKIINKKVLAKSDMQGRIEREISYL 62
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP I++L    +++ ++ +++++  G  LF ++ ++    E +AR +  +I+SAV 
Sbjct: 63  RLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVE 121
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLKPEN+L+D   +V + DFGL+  + + +   + CG+  Y APE++  K
Sbjct: 122 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGK 181
Query: 290 GH-NKDADWWSVGILLYEML 308
            +   + D WS G++LY ML
Sbjct: 182 LYAGPEVDVWSCGVILYVML 201

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++F  +G+GAF                   YA K++    +  ++H   ++ E  I  
Sbjct: 32  DYQLFEELGKGAFSVVRRCVKKTPTQE-----YAAKIINTKKLSARDH-QKLEREARICR 85
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP IV+L  S       YL+ D + GG LF  +  +  + E  A     +I+ +V+H
Sbjct: 86  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNH 145
Query: 231 LHKCGIVHRDLKPENILMDSD---GHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEIL 286
           +H+  IVHRDLKPEN+L+ S      V L DFGLA E+  E        GT  Y++PE+L
Sbjct: 146 IHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVL 205
Query: 287 LSKGHNKDADWWSVGILLYEMLTG 310
               + K  D W+ G++LY +L G
Sbjct: 206 RKDPYGKPVDIWACGVILYILLVG 229

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 57/170 (33%), Positives = 99/170 (58%), Gaps = 4/170 (2%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+KV+ K  + +K   + +  E  +L ++ HP I++L   F+ +   YL+ +   GG LF
Sbjct: 78  AVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELF 137
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFG 260
             +  +  F E  A     +++S ++++HK  IVHRDLKPEN+L++S   D ++ + DFG
Sbjct: 138 DEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFG 197
Query: 261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           L+   + S +     GT  Y+APE+L    +++  D WS G++LY +L+G
Sbjct: 198 LSTHFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSG 246

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 57/170 (33%), Positives = 99/170 (58%), Gaps = 4/170 (2%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+KV+ K  + +K   + +  E  +L ++ HP I++L   F+ +   YL+ +   GG LF
Sbjct: 79  AVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELF 138
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFG 260
             +  +  F E  A     +++S ++++HK  IVHRDLKPEN+L++S   D ++ + DFG
Sbjct: 139 DEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFG 198
Query: 261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           L+   + S +     GT  Y+APE+L    +++  D WS G++LY +L+G
Sbjct: 199 LSTHFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSG 247

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 64/175 (36%), Positives = 105/175 (60%), Gaps = 7/175 (4%)
Query: 143 YAMKVMRK-DTIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  +   +  V   + ER+  IL +V HP I+ L   ++ R+ + LIL+ ++G
Sbjct: 40  YAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSG 99
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD---GHVM 255
           G LF  L ++    E++A  +  +I+  V++LH   I H DLKPENI L+D +    H+ 
Sbjct: 100 GELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           L DFGLA EI++     ++ GT E++APEI+  +    +AD WS+G++ Y +L+G
Sbjct: 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 107/198 (54%), Gaps = 9/198 (4%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           RV+G+G+F                    A+KV+ K  + +K   + +  E  +L ++ HP
Sbjct: 38  RVLGKGSFGEVILCKDKITGQEC-----AVKVISKRQVKQKTDKESLLREVQLLKQLDHP 92
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
            I++L   F+ +   YL+ +   GG LF  +  +  F E  A     +++S ++++HK  
Sbjct: 93  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 152
Query: 236 IVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN 292
           IVHRDLKPEN+L++S   D ++ + DFGL+   + S +     GT  Y+APE+L    ++
Sbjct: 153 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YD 211
Query: 293 KDADWWSVGILLYEMLTG 310
           +  D WS G++LY +L+G
Sbjct: 212 EKCDVWSTGVILYILLSG 229

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 98/170 (57%), Gaps = 4/170 (2%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K+++K ++   ++   +  E  +L ++ HP I++L   F+ +   YL+++   GG LF
Sbjct: 33  AIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELF 92
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFG 260
             +  +  F E  A     +++S  ++LHK  IVHRDLKPEN+L++S   D  + + DFG
Sbjct: 93  DEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFG 152
Query: 261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           L+   +   +     GT  Y+APE+L  K +++  D WS G++LY +L G
Sbjct: 153 LSAHFEVGGKMKERLGTAYYIAPEVLRKK-YDEKCDVWSCGVILYILLCG 201

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           ++++F  +G+GAF                   YA K++    +  ++H   ++ E  I  
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQE-----YAAKIINTKKLSARDH-QKLEREARICR 58
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP IV+L  S       YL+ D + GG LF  +  +  + E  A     +I+ +V+H
Sbjct: 59  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNH 118
Query: 231 LHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESSRSN-SMCGTTEYMAPEIL 286
            H  GIVHRDLKPEN+L+ S      V L DFGLA E+    ++     GT  Y++PE+L
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 287 LSKGHNKDADWWSVGILLYEMLTG 310
               + K  D W+ G++LY +L G
Sbjct: 179 RKDPYGKPVDMWACGVILYILLVG 202

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 98/170 (57%), Gaps = 1/170 (0%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K++ +  I   + V  ++ E   L    HP I++L     T S +++++++++GG LF
Sbjct: 45  AVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELF 104
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK 263
            ++ + G   E ++R    +I+S V + H+  +VHRDLKPEN+L+D+  +  + DFGL+ 
Sbjct: 105 DYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN 164
Query: 264 EIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQV 312
            + +       CG+  Y APE++  + +   + D WS G++LY +L G +
Sbjct: 165 MMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTL 214

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 10/204 (4%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           ++++F  +G+GAF                   YA  ++    +  ++H   ++ E  I  
Sbjct: 12  EYQLFEELGKGAFSVVRRCVKVLAGQE-----YAAMIINTKKLSARDH-QKLEREARICR 65
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP IV+L  S       YLI D + GG LF  +  +  + E  A     +I+ AV H
Sbjct: 66  LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLH 125
Query: 231 LHKCGIVHRDLKPENILMDSD---GHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEIL 286
            H+ G+VHR+LKPEN+L+ S      V L DFGLA E++ E        GT  Y++PE+L
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL 185
Query: 287 LSKGHNKDADWWSVGILLYEMLTG 310
               + K  D W+ G++LY +L G
Sbjct: 186 RKDPYGKPVDLWACGVILYILLVG 209

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           ++++F  +G+GAF                   YA K++    +  ++H   ++ E  I  
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQE-----YAAKIINTKKLSARDH-QKLEREARICR 58
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP IV+L  S       YL+ D + GG LF  +  +  + E  A     +I+ +V+H
Sbjct: 59  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNH 118
Query: 231 LHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESSRSN-SMCGTTEYMAPEIL 286
            H  GIVHRDLKPEN+L+ S      V L DFGLA E+    ++     GT  Y++PE+L
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 287 LSKGHNKDADWWSVGILLYEMLTG 310
               + K  D W+ G++LY +L G
Sbjct: 179 RKDPYGKPVDMWACGVILYILLVG 202

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT- 170
           +E+ + +G G F                  + A+K + +   I +N       +R+I+  
Sbjct: 21  YELVKDIGAGNFGVARLMRDKQANE-----LVAVKYIERGEKIDEN------VKREIINH 69
Query: 171 -KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+ +    T + L +++++ +GG LF  +   G F ED+ARF+  +++S VS
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 129
Query: 230 HLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + H   + HRDLK EN L+D      + + DFG +K     S+  S  GT  Y+APE+LL
Sbjct: 130 YAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLL 189
Query: 288 SKGHN-KDADWWSVGILLYEMLTG 310
            K ++ K AD WS G+ LY ML G
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT- 170
           +E+ + +G G F                  + A+K + +   I +N       +R+I+  
Sbjct: 20  YELVKDIGSGNFGVARLMRDKQSNE-----LVAVKYIERGEKIDEN------VKREIINH 68
Query: 171 -KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+ +    T + L +++++ +GG LF  +   G F ED+ARF+  +++S VS
Sbjct: 69  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 128
Query: 230 HLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + H   + HRDLK EN L+D      + + DFG +K     S+  S  GT  Y+APE+LL
Sbjct: 129 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 188
Query: 288 SKGHN-KDADWWSVGILLYEMLTG 310
            K ++ K AD WS G+ LY ML G
Sbjct: 189 KKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 57/170 (33%), Positives = 97/170 (57%), Gaps = 4/170 (2%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+KV+ K  + +K   + +  E  +L ++ HP I +L   F+ +   YL+ +   GG LF
Sbjct: 55  AVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELF 114
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFG 260
             +  +  F E  A     +++S +++ HK  IVHRDLKPEN+L++S   D ++ + DFG
Sbjct: 115 DEIISRKRFSEVDAARIIRQVLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFG 174
Query: 261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           L+   + S +     GT  Y+APE+L    +++  D WS G++LY +L+G
Sbjct: 175 LSTHFEASKKXKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSG 223

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 58/171 (33%), Positives = 100/171 (58%), Gaps = 5/171 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YA+KV+ K +   K+    ++ E ++L K+ HP I++L    +  S  Y++ +   GG L
Sbjct: 50  YAVKVINKASAKNKDTSTILR-EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL 108
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDF 259
           F  + ++  F E  A     ++ S ++++HK  IVHRDLKPENIL++S   D  + + DF
Sbjct: 109 FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF 168
Query: 260 GLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           GL+    ++++     GT  Y+APE+L    +++  D WS G++LY +L+G
Sbjct: 169 GLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSG 218

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 105/204 (51%), Gaps = 16/204 (7%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT- 170
           +E+ + +G G F                  + A+K + +   I  N       +R+I+  
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNE-----LVAVKYIERGEKIAAN------VKREIINH 69
Query: 171 -KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+ +    T + L +++++ +GG LF  +   G F ED+ARF+  +++S VS
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 129
Query: 230 HLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + H   + HRDLK EN L+D      + + DFG +K     S+  S  GT  Y+APE+LL
Sbjct: 130 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 189
Query: 288 SKGHN-KDADWWSVGILLYEMLTG 310
            K ++ K AD WS G+ LY ML G
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/173 (36%), Positives = 95/173 (54%), Gaps = 11/173 (6%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YA+KV      I K+  D  +    +L    HP I+ L+  +     +YL+ + + GG L
Sbjct: 55  YAVKV------IDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGEL 108
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL-MDSDGH---VMLTD 258
              + RQ  F E +A F    I   V +LH  G+VHRDLKP NIL +D  G+   + + D
Sbjct: 109 LDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICD 168
Query: 259 FGLAKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           FG AK++  E+    + C T  ++APE+L  +G+++  D WS+GILLY ML G
Sbjct: 169 FGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 64/173 (36%), Positives = 95/173 (54%), Gaps = 11/173 (6%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YA+KV      I K+  D  +    +L    HP I+ L+  +     +YL+ + + GG L
Sbjct: 55  YAVKV------IDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGEL 108
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL-MDSDGH---VMLTD 258
              + RQ  F E +A F    I   V +LH  G+VHRDLKP NIL +D  G+   + + D
Sbjct: 109 LDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICD 168
Query: 259 FGLAKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           FG AK++  E+    + C T  ++APE+L  +G+++  D WS+GILLY ML G
Sbjct: 169 FGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 57/170 (33%), Positives = 100/170 (58%), Gaps = 5/170 (2%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K++RK ++   ++   ++ E  +L  + HP I++L   F+ +   YL+++   GG LF
Sbjct: 66  AIKIIRKTSVSTSSNSKLLE-EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELF 124
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFG 260
             +  +  F E  A     +++S V++LHK  IVHRDLKPEN+L++S   D  + + DFG
Sbjct: 125 DEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFG 184
Query: 261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           L+   +   +     GT  Y+APE+ L K +++  D WS+G++L+ +L G
Sbjct: 185 LSAVFENQKKMKERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAG 233

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 55/155 (35%), Positives = 88/155 (56%), Gaps = 4/155 (2%)
Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
           VD  K E +I+  + HP I++L  +F+  + +YL+++   GG LF  +  + +FRE  A 
Sbjct: 67  VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA 126
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILM--DS-DGHVMLTDFGLAKEIDESSRSNSMC 275
               +++SAV++ HK  + HRDLKPEN L   DS D  + L DFGLA          +  
Sbjct: 127 RIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV 186
Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           GT  Y++P++ L   +  + D WS G+++Y +L G
Sbjct: 187 GTPYYVSPQV-LEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 58/171 (33%), Positives = 100/171 (58%), Gaps = 5/171 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YA+KV+ K +   K+    ++ E ++L K+ HP I++L    +  S  Y++ +   GG L
Sbjct: 50  YAVKVINKASAKNKDTSTILR-EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL 108
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDF 259
           F  + ++  F E  A     ++ S ++++HK  IVHRDLKPENIL++S   D  + + DF
Sbjct: 109 FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF 168
Query: 260 GLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           GL+    ++++     GT  Y+APE+L    +++  D WS G++LY +L+G
Sbjct: 169 GLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSG 218

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 58/171 (33%), Positives = 100/171 (58%), Gaps = 5/171 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YA+KV+ K +   K+    ++ E ++L K+ HP I++L    +  S  Y++ +   GG L
Sbjct: 50  YAVKVINKASAKNKDTSTILR-EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL 108
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDF 259
           F  + ++  F E  A     ++ S ++++HK  IVHRDLKPENIL++S   D  + + DF
Sbjct: 109 FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF 168
Query: 260 GLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           GL+    ++++     GT  Y+APE+L    +++  D WS G++LY +L+G
Sbjct: 169 GLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSG 218

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 55/155 (35%), Positives = 88/155 (56%), Gaps = 4/155 (2%)
Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
           VD  K E +I+  + HP I++L  +F+  + +YL+++   GG LF  +  + +FRE  A 
Sbjct: 50  VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA 109
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILM--DS-DGHVMLTDFGLAKEIDESSRSNSMC 275
               +++SAV++ HK  + HRDLKPEN L   DS D  + L DFGLA          +  
Sbjct: 110 RIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV 169
Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           GT  Y++P++ L   +  + D WS G+++Y +L G
Sbjct: 170 GTPYYVSPQV-LEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 62/174 (35%), Positives = 98/174 (56%), Gaps = 11/174 (6%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILT--KVTHPFIVQLRYSFQTRSKLYLILDFING 199
           + A+K + +   I +N       +R+I+    + HP IV+ +    T + L +I+++ +G
Sbjct: 47  LVAVKYIERGAAIDEN------VQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASG 100
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--GHVMLT 257
           G L+  +   G F ED+ARF+  +++S VS+ H   I HRDLK EN L+D      + + 
Sbjct: 101 GELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKIC 160
Query: 258 DFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN-KDADWWSVGILLYEMLTG 310
           DFG +K     S+  S  GT  Y+APE+LL + ++ K AD WS G+ LY ML G
Sbjct: 161 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +++++  +G+GAF                   YA K++    +  ++H   ++ E  I  
Sbjct: 5   EYQLYEDIGKGAFSVVRRCVKLCTGHE-----YAAKIINTKKLSARDH-QKLEREARICR 58
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + H  IV+L  S       YL+ D + GG LF  +  +  + E  A     +I+ AV H
Sbjct: 59  LLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLH 118
Query: 231 LHKCGIVHRDLKPENILMDSD---GHVMLTDFGLAKEIDESSRSN-SMCGTTEYMAPEIL 286
            H+ G+VHRDLKPEN+L+ S      V L DFGLA E+    ++     GT  Y++PE+L
Sbjct: 119 CHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 287 LSKGHNKDADWWSVGILLYEMLTG 310
             + + K  D W+ G++LY +L G
Sbjct: 179 RKEAYGKPVDIWACGVILYILLVG 202

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 110/203 (54%), Gaps = 7/203 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF++  ++G+G+F                    A+K++ K  + K   V  ++ E  I  
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEV-----AIKMIDKKAMYKAGMVQRVQNEVKIHC 66
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIVSAVS 229
           ++ HP I++L   F+  + +YL+L+  + G +  +L  R   F E++AR +  +I++ + 
Sbjct: 67  QLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEILLS 288
           +LH  GI+HRDL   N+L+  + ++ + DFGLA ++     +  ++CGT  Y++PEI   
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR 186
Query: 289 KGHNKDADWWSVGILLYEMLTGQ 311
             H  ++D WS+G + Y +L G+
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGR 209

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 62/175 (35%), Positives = 104/175 (59%), Gaps = 7/175 (4%)
Query: 143 YAMKVMRK-DTIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  +   +  V   + ER+  IL +V H  ++ L   ++ R+ + LIL+ ++G
Sbjct: 40  YAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSG 99
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD---GHVM 255
           G LF  L ++    E++A  +  +I+  V++LH   I H DLKPENI L+D +    H+ 
Sbjct: 100 GELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           L DFGLA EI++     ++ GT E++APEI+  +    +AD WS+G++ Y +L+G
Sbjct: 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 62/175 (35%), Positives = 104/175 (59%), Gaps = 7/175 (4%)
Query: 143 YAMKVMRK-DTIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  +   +  V   + ER+  IL +V H  ++ L   ++ R+ + LIL+ ++G
Sbjct: 40  YAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSG 99
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD---GHVM 255
           G LF  L ++    E++A  +  +I+  V++LH   I H DLKPENI L+D +    H+ 
Sbjct: 100 GELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           L DFGLA EI++     ++ GT E++APEI+  +    +AD WS+G++ Y +L+G
Sbjct: 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 62/175 (35%), Positives = 104/175 (59%), Gaps = 7/175 (4%)
Query: 143 YAMKVMRK-DTIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  +   +  V   + ER+  IL +V H  ++ L   ++ R+ + LIL+ ++G
Sbjct: 40  YAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSG 99
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD---GHVM 255
           G LF  L ++    E++A  +  +I+  V++LH   I H DLKPENI L+D +    H+ 
Sbjct: 100 GELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           L DFGLA EI++     ++ GT E++APEI+  +    +AD WS+G++ Y +L+G
Sbjct: 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 62/175 (35%), Positives = 104/175 (59%), Gaps = 7/175 (4%)
Query: 143 YAMKVMRK-DTIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  +   +  V   + ER+  IL +V H  ++ L   ++ R+ + LIL+ ++G
Sbjct: 40  YAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSG 99
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD---GHVM 255
           G LF  L ++    E++A  +  +I+  V++LH   I H DLKPENI L+D +    H+ 
Sbjct: 100 GELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           L DFGLA EI++     ++ GT E++APEI+  +    +AD WS+G++ Y +L+G
Sbjct: 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 62/175 (35%), Positives = 104/175 (59%), Gaps = 7/175 (4%)
Query: 143 YAMKVMRK-DTIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  +   +  V   + ER+  IL +V H  ++ L   ++ R+ + LIL+ ++G
Sbjct: 40  YAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSG 99
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD---GHVM 255
           G LF  L ++    E++A  +  +I+  V++LH   I H DLKPENI L+D +    H+ 
Sbjct: 100 GELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           L DFGLA EI++     ++ GT E++APEI+  +    +AD WS+G++ Y +L+G
Sbjct: 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 105/204 (51%), Gaps = 16/204 (7%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT- 170
           +E+ + +G G F                  + A+K + +   I +N       +R+I+  
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNE-----LVAVKYIERGEKIDEN------VKREIINH 69
Query: 171 -KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+ +    T + L +++++ +GG LF  +   G F ED+ARF+  +++S VS
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 129
Query: 230 HLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + H   + HRDLK EN L+D      + +  FG +K     S+  S  GT  Y+APE+LL
Sbjct: 130 YCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 189
Query: 288 SKGHN-KDADWWSVGILLYEMLTG 310
            K ++ K AD WS G+ LY ML G
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 59/163 (36%), Positives = 90/163 (55%), Gaps = 5/163 (3%)
Query: 153 IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
           II K+  D  +    +L    HP I+ L+  +     +Y++ + + GG L   + RQ  F
Sbjct: 54  IIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFF 113
Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL-MDSDGH---VMLTDFGLAKEID-E 267
            E +A      I   V +LH  G+VHRDLKP NIL +D  G+   + + DFG AK++  E
Sbjct: 114 SEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173
Query: 268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           +    + C T  ++APE+L  +G++   D WS+G+LLY MLTG
Sbjct: 174 NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 110/222 (49%), Gaps = 20/222 (9%)
Query: 102 ESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDY 161
           + E KIG   F++ R +G GA+                    A+KV++K    K  + D 
Sbjct: 29  KKEGKIGESYFKV-RKLGSGAYGEVLLCKEKNGHSEK-----AIKVIKKSQFDKGRYSDD 82
Query: 162 MKA----------ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI 211
            K           E  +L  + HP I++L   F+ +   YL+ +F  GG LF  +  +  
Sbjct: 83  NKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK 142
Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVMLTDFGLAKEIDES 268
           F E  A     +I+S + +LHK  IVHRD+KPENIL+++     ++ + DFGL+    + 
Sbjct: 143 FDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD 202
Query: 269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            +     GT  Y+APE+ L K +N+  D WS G+++Y +L G
Sbjct: 203 YKLRDRLGTAYYIAPEV-LKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/237 (30%), Positives = 120/237 (50%), Gaps = 23/237 (9%)
Query: 81  SSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXX 140
           SS + L  + L  ++  E   E   ++G G F I R   Q                    
Sbjct: 8   SSGVDLGTENLYFQSMVEDHYEMGEELGSGQFAIVRKCRQKGTGKE-------------- 53
Query: 141 XIYAMKVMRKDTIIK-KNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFI 197
             YA K ++K  +   +  V   + ER+  IL ++ HP I+ L   F+ ++ + LIL+ +
Sbjct: 54  --YAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELV 111
Query: 198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDS---DGH 253
           +GG LF  L  +    ED+A  +  +I+  V +LH   I H DLKPENI L+D    +  
Sbjct: 112 SGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPR 171
Query: 254 VMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           + L DFG+A +I+  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G
Sbjct: 172 IKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 61/175 (34%), Positives = 102/175 (58%), Gaps = 7/175 (4%)
Query: 143 YAMKVMRKDTIIK-KNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  +   +  V   + ER+  IL ++ HP I+ L   F+ ++ + LIL+ ++G
Sbjct: 40  YAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSG 99
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDS---DGHVM 255
           G LF  L  +    ED+A  +  +I+  V +LH   I H DLKPENI L+D    +  + 
Sbjct: 100 GELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIK 159
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           L DFG+A +I+  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G
Sbjct: 160 LIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT- 170
           +E+ + +G G F                  + A+K + +   I +N       +R+I+  
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNE-----LVAVKYIERGEKIDEN------VKREIINH 69
Query: 171 -KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+ +    T + L +++++ +GG LF  +   G F ED+ARF+  +++S VS
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 129
Query: 230 HLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + H   + HRDLK EN L+D      + +  FG +K     S+     GT  Y+APE+LL
Sbjct: 130 YCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLL 189
Query: 288 SKGHN-KDADWWSVGILLYEMLTG 310
            K ++ K AD WS G+ LY ML G
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 61/175 (34%), Positives = 102/175 (58%), Gaps = 7/175 (4%)
Query: 143 YAMKVMRKDTIIK-KNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  +   +  V   + ER+  IL ++ HP I+ L   F+ ++ + LIL+ ++G
Sbjct: 33  YAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSG 92
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDS---DGHVM 255
           G LF  L  +    ED+A  +  +I+  V +LH   I H DLKPENI L+D    +  + 
Sbjct: 93  GELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIK 152
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           L DFG+A +I+  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G
Sbjct: 153 LIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 60/175 (34%), Positives = 101/175 (57%), Gaps = 7/175 (4%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 38  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 97
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD---GHVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 98  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 157
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G
Sbjct: 158 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 60/175 (34%), Positives = 101/175 (57%), Gaps = 7/175 (4%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 38  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 97
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD---GHVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 98  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 157
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G
Sbjct: 158 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 60/175 (34%), Positives = 101/175 (57%), Gaps = 7/175 (4%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD---GHVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 60/175 (34%), Positives = 101/175 (57%), Gaps = 7/175 (4%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD---GHVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 60/175 (34%), Positives = 101/175 (57%), Gaps = 7/175 (4%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD---GHVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 60/175 (34%), Positives = 101/175 (57%), Gaps = 7/175 (4%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD---GHVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 58/163 (35%), Positives = 88/163 (53%), Gaps = 5/163 (3%)
Query: 153 IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
           II K+  D  +    +L    HP I+ L+  +     +Y++ +   GG L   + RQ  F
Sbjct: 54  IIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFF 113
Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL-MDSDGH---VMLTDFGLAKEID-E 267
            E +A      I   V +LH  G+VHRDLKP NIL +D  G+   + + DFG AK++  E
Sbjct: 114 SEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173
Query: 268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           +    + C T  ++APE+L  +G++   D WS+G+LLY  LTG
Sbjct: 174 NGLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 60/175 (34%), Positives = 101/175 (57%), Gaps = 7/175 (4%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD---GHVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 60/175 (34%), Positives = 101/175 (57%), Gaps = 7/175 (4%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD---GHVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 60/175 (34%), Positives = 101/175 (57%), Gaps = 7/175 (4%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD---GHVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 60/175 (34%), Positives = 101/175 (57%), Gaps = 7/175 (4%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD---GHVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 60/175 (34%), Positives = 101/175 (57%), Gaps = 7/175 (4%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD---GHVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 60/175 (34%), Positives = 101/175 (57%), Gaps = 7/175 (4%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD---GHVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/211 (34%), Positives = 106/211 (50%), Gaps = 16/211 (7%)
Query: 105 RKIGPGDF-EIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           R + P DF EI   +G GAF                  + A KV+  DT  ++   DYM 
Sbjct: 31  RDLNPEDFWEIIGELGDGAFGKVYKAQNKETSV-----LAAAKVI--DTKSEEELEDYM- 82
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTA 222
            E DIL    HP IV+L  +F   + L+++++F  GG +    L  +    E Q +    
Sbjct: 83  VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 142
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL-AKEIDESSRSNSMCGTTEYM 281
           + + A+++LH   I+HRDLK  NIL   DG + L DFG+ AK      R +S  GT  +M
Sbjct: 143 QTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWM 202
Query: 282 APEILL-----SKGHNKDADWWSVGILLYEM 307
           APE+++      + ++  AD WS+GI L EM
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/211 (34%), Positives = 106/211 (50%), Gaps = 16/211 (7%)
Query: 105 RKIGPGDF-EIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           R + P DF EI   +G GAF                  + A KV+  DT  ++   DYM 
Sbjct: 31  RDLNPEDFWEIIGELGDGAFGKVYKAQNKETSV-----LAAAKVI--DTKSEEELEDYM- 82
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTA 222
            E DIL    HP IV+L  +F   + L+++++F  GG +    L  +    E Q +    
Sbjct: 83  VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 142
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL-AKEIDESSRSNSMCGTTEYM 281
           + + A+++LH   I+HRDLK  NIL   DG + L DFG+ AK      R +S  GT  +M
Sbjct: 143 QTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWM 202
Query: 282 APEILL-----SKGHNKDADWWSVGILLYEM 307
           APE+++      + ++  AD WS+GI L EM
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 109/209 (52%), Gaps = 15/209 (7%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVM--RKDTIIKKNHVDYMKAERDIL 169
           +E+  V+G+GAF                   +A+K++   K T       + +K E  I 
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQ-----FAVKIVDVAKFTSSPGLSTEDLKREASIC 80
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEIV 225
             + HP IV+L  ++ +   LY++ +F++G  L F + ++     ++ E  A  Y  +I+
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESSR-SNSMCGTTEYM 281
            A+ + H   I+HRD+KPEN+L+ S  +   V L DFG+A ++ ES   +    GT  +M
Sbjct: 141 EALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFM 200
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTG 310
           APE++  + + K  D W  G++L+ +L+G
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 59/175 (33%), Positives = 100/175 (57%), Gaps = 7/175 (4%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD---GHVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           + DFGLA +ID  +   ++ GT  ++APEI+  +    +AD WS+G++ Y +L+G
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 59/175 (33%), Positives = 100/175 (57%), Gaps = 7/175 (4%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LI + + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD---GHVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 71/211 (33%), Positives = 105/211 (49%), Gaps = 16/211 (7%)
Query: 105 RKIGPGDF-EIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           R + P DF EI   +G GAF                  + A KV+  DT  ++   DYM 
Sbjct: 31  RDLNPEDFWEIIGELGDGAFGKVYKAQNKETSV-----LAAAKVI--DTKSEEELEDYM- 82
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTA 222
            E DIL    HP IV+L  +F   + L+++++F  GG +    L  +    E Q +    
Sbjct: 83  VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 142
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL-AKEIDESSRSNSMCGTTEYM 281
           + + A+++LH   I+HRDLK  NIL   DG + L DFG+ AK      R +   GT  +M
Sbjct: 143 QTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWM 202
Query: 282 APEILL-----SKGHNKDADWWSVGILLYEM 307
           APE+++      + ++  AD WS+GI L EM
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 87/144 (60%), Gaps = 2/144 (1%)
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           ++++H  IV +    +     YL++++I G  L  ++   G    D A  +T +I+  + 
Sbjct: 66  SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK 125
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILL 287
           H H   IVHRD+KP+NIL+DS+  + + DFG+AK + E+S  ++N + GT +Y +PE   
Sbjct: 126 HAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK 185
Query: 288 SKGHNKDADWWSVGILLYEMLTGQ 311
            +  ++  D +S+GI+LYEML G+
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGE 209

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 13/207 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEIXINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQV 312
             +  H +  D WS GI+L  ML G++
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 13/207 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 119
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQV 312
             +  H +  D WS GI+L  ML G++
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGEL 206

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 13/207 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQV 312
             +  H +  D WS GI+L  ML G++
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 13/207 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 119
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQV 312
             +  H +  D WS GI+L  ML G++
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGEL 206

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 13/207 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 119
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQV 312
             +  H +  D WS GI+L  ML G++
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGEL 206

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 13/207 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 119
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQV 312
             +  H +  D WS GI+L  ML G++
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGEL 206

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 13/207 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINA 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 119
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQV 312
             +  H +  D WS GI+L  ML G++
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGEL 206

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 13/207 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQV 312
             +  H +  D WS GI+L  ML G++
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 13/207 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 119
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQV 312
             +  H +  D WS GI+L  ML G++
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGEL 206

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 13/207 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 58
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 59  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 117
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 118 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQV 312
             +  H +  D WS GI+L  ML G++
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGEL 204

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 13/207 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 119
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQV 312
             +  H +  D WS GI+L  ML G++
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGEL 206

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 13/207 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQV 312
             +  H +  D WS GI+L  ML G++
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 13/207 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQV 312
             +  H +  D WS GI+L  ML G++
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 13/207 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQV 312
             +  H +  D WS GI+L  ML G++
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 13/207 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQV 312
             +  H +  D WS GI+L  ML G++
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 82/145 (56%), Gaps = 2/145 (1%)
Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           ++ +  +P IV    S+    +L+++++++ GG L   +  +    E Q      E + A
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQA 128
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEIL 286
           +  LH   ++HRD+K +NIL+  DG V LTDFG   +I  E S+ ++M GT  +MAPE++
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 287 LSKGHNKDADWWSVGILLYEMLTGQ 311
             K +    D WS+GI+  EM+ G+
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 81/145 (55%), Gaps = 2/145 (1%)
Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           ++ +  +P IV    S+    +L+++++++ GG L   +  +    E Q      E + A
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQA 128
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEIL 286
           +  LH   ++HRD+K +NIL+  DG V LTDFG   +I  E S+ + M GT  +MAPE++
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVV 188
Query: 287 LSKGHNKDADWWSVGILLYEMLTGQ 311
             K +    D WS+GI+  EM+ G+
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 51/127 (40%), Positives = 78/127 (61%), Gaps = 6/127 (4%)
Query: 191 YLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD 249
           YL L++ +GG LF  +    G+   D  RF+  ++++ V +LH  GI HRD+KPEN+L+D
Sbjct: 80  YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGIGITHRDIKPENLLLD 138
Query: 250 SDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEILLSKG-HNKDADWWSVGILLY 305
              ++ ++DFGLA     ++R    N MCGT  Y+APE+L  +  H +  D WS GI+L 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 198
Query: 306 EMLTGQV 312
            ML G++
Sbjct: 199 AMLAGEL 205

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 81/145 (55%), Gaps = 2/145 (1%)
Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           ++ +  +P IV    S+    +L+++++++ GG L   +  +    E Q      E + A
Sbjct: 71  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQA 129
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEIL 286
           +  LH   ++HRD+K +NIL+  DG V LTDFG   +I  E S+ + M GT  +MAPE++
Sbjct: 130 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVV 189
Query: 287 LSKGHNKDADWWSVGILLYEMLTGQ 311
             K +    D WS+GI+  EM+ G+
Sbjct: 190 TRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 81/145 (55%), Gaps = 2/145 (1%)
Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           ++ +  +P IV    S+    +L+++++++ GG L   +  +    E Q      E + A
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQA 128
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEIL 286
           +  LH   ++HRD+K +NIL+  DG V LTDFG   +I  E S+ + M GT  +MAPE++
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVV 188
Query: 287 LSKGHNKDADWWSVGILLYEMLTGQ 311
             K +    D WS+GI+  EM+ G+
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 81/148 (54%), Gaps = 2/148 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L++    ++ +   S+   SKL++I++++ GG     L R G F E Q      EI
Sbjct: 71  EITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSAL-DLLRAGPFDEFQIATMLKEI 129
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAP 283
           +  + +LH    +HRD+K  N+L+   G V L DFG+A ++ D   + N+  GT  +MAP
Sbjct: 130 LKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 189
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQ 311
           E++    ++  AD WS+GI   E+  G+
Sbjct: 190 EVIQQSAYDSKADIWSLGITAIELAKGE 217

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 104/207 (50%), Gaps = 10/207 (4%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            +F I + +G+G F                  +   KV   D +  K   D +K E D+L
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVP----VALKKVQIFDLMDAKARADCIK-EIDLL 86
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL---FFHLYRQG-IFREDQARFYTAEIV 225
            ++ HP +++   SF   ++L ++L+  + G L     H  +Q  +  E     Y  ++ 
Sbjct: 87  KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLC 146
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPE 284
           SA+ H+H   ++HRD+KP N+ + + G V L D GL +    +++ ++S+ GT  YM+PE
Sbjct: 147 SALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQ 311
            +   G+N  +D WS+G LLYEM   Q
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQ 233

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 82/145 (56%), Gaps = 2/145 (1%)
Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           ++ +  +P IV    S+    +L+++++++ GG L   +  +    E Q      E + A
Sbjct: 71  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQA 129
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEIL 286
           +  LH   ++HR++K +NIL+  DG V LTDFG   +I  E S+ ++M GT  +MAPE++
Sbjct: 130 LEFLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 189
Query: 287 LSKGHNKDADWWSVGILLYEMLTGQ 311
             K +    D WS+GI+  EM+ G+
Sbjct: 190 TRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 32/199 (16%)
Query: 143 YAMKVMRKDTIIK-----------------------KNHVDYMKAERDILTKVTHPFIVQ 179
           YAMKV+ K  +I+                       +  ++ +  E  IL K+ HP +V+
Sbjct: 41  YAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVK 100
Query: 180 LRYSFQTRSK--LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
           L       ++  LY++ + +N G +   +       EDQARFY  +++  + +LH   I+
Sbjct: 101 LVEVLDDPNEDHLYMVFELVNQGPVM-EVPTLKPLSEDQARFYFQDLIKGIEYLHYQKII 159
Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEIDESSR--SNSMCGTTEYMAPEILLSKGH---N 292
           HRD+KP N+L+  DGH+ + DFG++ E   S    SN++ GT  +MAPE L         
Sbjct: 160 HRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSG 218
Query: 293 KDADWWSVGILLYEMLTGQ 311
           K  D W++G+ LY  + GQ
Sbjct: 219 KALDVWAMGVTLYCFVFGQ 237

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 92/165 (55%), Gaps = 2/165 (1%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           ++K  + K+   + +  E  I+    H  +V +  S+    +L+++++F+ GG L   + 
Sbjct: 75  VKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALT-DIV 133
Query: 208 RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-D 266
                 E+Q       ++ A+S+LH  G++HRD+K ++IL+ SDG + L+DFG   ++  
Sbjct: 134 THTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK 193
Query: 267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           E  +   + GT  +MAPE++    +  + D WS+GI++ EM+ G+
Sbjct: 194 EVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 238

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 99/184 (53%), Gaps = 8/184 (4%)
Query: 147 VMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
            ++K  + K+   + +  E  I+    H  +V++  S+    +L+++++F+ GG L   +
Sbjct: 180 AVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DI 238
Query: 207 YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI- 265
                  E+Q       ++ A+S LH  G++HRD+K ++IL+  DG V L+DFG   ++ 
Sbjct: 239 VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 298
Query: 266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG------QVNIKSMQV 319
            E  R   + GT  +MAPE++    +  + D WS+GI++ EM+ G      +  +K+M++
Sbjct: 299 KEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM 358
Query: 320 IACN 323
           I  N
Sbjct: 359 IRDN 362

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 13/207 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEIXINK 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 119
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N M GT  Y+APE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 179
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQV 312
             +  H +  D WS GI+L  ML G++
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGEL 206

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 13/207 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEIXINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N M GT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQV 312
             +  H +  D WS GI+L  ML G++
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 99/183 (54%), Gaps = 8/183 (4%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           ++K  + K+   + +  E  I+    H  +V++  S+    +L+++++F+ GG L   + 
Sbjct: 104 VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIV 162
Query: 208 RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-D 266
                 E+Q       ++ A+S LH  G++HRD+K ++IL+  DG V L+DFG   ++  
Sbjct: 163 THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 222
Query: 267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG------QVNIKSMQVI 320
           E  R   + GT  +MAPE++    +  + D WS+GI++ EM+ G      +  +K+M++I
Sbjct: 223 EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 282
Query: 321 ACN 323
             N
Sbjct: 283 RDN 285

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 99/183 (54%), Gaps = 8/183 (4%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           ++K  + K+   + +  E  I+    H  +V++  S+    +L+++++F+ GG L   + 
Sbjct: 61  VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIV 119
Query: 208 RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-D 266
                 E+Q       ++ A+S LH  G++HRD+K ++IL+  DG V L+DFG   ++  
Sbjct: 120 THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 179
Query: 267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG------QVNIKSMQVI 320
           E  R   + GT  +MAPE++    +  + D WS+GI++ EM+ G      +  +K+M++I
Sbjct: 180 EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 239
Query: 321 ACN 323
             N
Sbjct: 240 RDN 242

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 99/183 (54%), Gaps = 8/183 (4%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           ++K  + K+   + +  E  I+    H  +V++  S+    +L+++++F+ GG L   + 
Sbjct: 59  VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIV 117
Query: 208 RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-D 266
                 E+Q       ++ A+S LH  G++HRD+K ++IL+  DG V L+DFG   ++  
Sbjct: 118 THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 177
Query: 267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG------QVNIKSMQVI 320
           E  R   + GT  +MAPE++    +  + D WS+GI++ EM+ G      +  +K+M++I
Sbjct: 178 EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 237
Query: 321 ACN 323
             N
Sbjct: 238 RDN 240

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 81/150 (54%), Gaps = 2/150 (1%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E  +L++   P++ +   S+   +KL++I++++ GG     L   G   E Q      
Sbjct: 73  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILR 131
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYM 281
           EI+  + +LH    +HRD+K  N+L+   G V L DFG+A ++ D   + N+  GT  +M
Sbjct: 132 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWM 191
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           APE++    ++  AD WS+GI   E+  G+
Sbjct: 192 APEVIKQSAYDSKADIWSLGITAIELARGE 221

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 99/183 (54%), Gaps = 8/183 (4%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           ++K  + K+   + +  E  I+    H  +V++  S+    +L+++++F+ GG L   + 
Sbjct: 50  VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIV 108
Query: 208 RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-D 266
                 E+Q       ++ A+S LH  G++HRD+K ++IL+  DG V L+DFG   ++  
Sbjct: 109 THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168
Query: 267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG------QVNIKSMQVI 320
           E  R   + GT  +MAPE++    +  + D WS+GI++ EM+ G      +  +K+M++I
Sbjct: 169 EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 228
Query: 321 ACN 323
             N
Sbjct: 229 RDN 231

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 99/183 (54%), Gaps = 8/183 (4%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           ++K  + K+   + +  E  I+    H  +V++  S+    +L+++++F+ GG L   + 
Sbjct: 54  VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIV 112
Query: 208 RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-D 266
                 E+Q       ++ A+S LH  G++HRD+K ++IL+  DG V L+DFG   ++  
Sbjct: 113 THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 172
Query: 267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG------QVNIKSMQVI 320
           E  R   + GT  +MAPE++    +  + D WS+GI++ EM+ G      +  +K+M++I
Sbjct: 173 EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 232
Query: 321 ACN 323
             N
Sbjct: 233 RDN 235

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 13/207 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N M GT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQV 312
             +  H +  D WS GI+L  ML G++
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 13/207 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N M GT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQV 312
             +  H +  D WS GI+L  ML G++
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 13/207 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N M GT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQV 312
             +  H +  D WS GI+L  ML G++
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 81/150 (54%), Gaps = 2/150 (1%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E  +L++   P++ +   S+   +KL++I++++ GG     L   G   E Q      
Sbjct: 53  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILR 111
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYM 281
           EI+  + +LH    +HRD+K  N+L+   G V L DFG+A ++ D   + N+  GT  +M
Sbjct: 112 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWM 171
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           APE++    ++  AD WS+GI   E+  G+
Sbjct: 172 APEVIKQSAYDSKADIWSLGITAIELARGE 201

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 80/150 (53%), Gaps = 2/150 (1%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E  +L++   P++ +   S+   +KL++I++++ GG     L   G   E Q      
Sbjct: 68  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILR 126
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYM 281
           EI+  + +LH    +HRD+K  N+L+   G V L DFG+A ++ D   + N   GT  +M
Sbjct: 127 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWM 186
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           APE++    ++  AD WS+GI   E+  G+
Sbjct: 187 APEVIKQSAYDSKADIWSLGITAIELARGE 216

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 89/158 (56%), Gaps = 2/158 (1%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           K+   + +  E  I+    H  +V++  S+    +L+++++F+ GG L   +  Q    E
Sbjct: 82  KQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT-DIVSQVRLNE 140
Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNS 273
           +Q       ++ A+++LH  G++HRD+K ++IL+  DG V L+DFG   +I +   +   
Sbjct: 141 EQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKX 200
Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           + GT  +MAPE++    +  + D WS+GI++ EM+ G+
Sbjct: 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 80/150 (53%), Gaps = 2/150 (1%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E  +L++   P++ +   S+   +KL++I++++ GG     L   G   E Q      
Sbjct: 53  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILR 111
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYM 281
           EI+  + +LH    +HRD+K  N+L+   G V L DFG+A ++ D   + N   GT  +M
Sbjct: 112 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWM 171
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           APE++    ++  AD WS+GI   E+  G+
Sbjct: 172 APEVIKQSAYDSKADIWSLGITAIELARGE 201

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 109/213 (51%), Gaps = 20/213 (9%)
Query: 105 RKIGPGD-FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           R + P + +EI   +G GAF                  + A KV+  +T  ++   DY+ 
Sbjct: 5   RDLDPNEVWEIVGELGDGAFGKVYKAKNKETGA-----LAAAKVI--ETKSEEELEDYI- 56
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH---LFFHLYRQGIFREDQARFY 220
            E +IL    HP+IV+L  ++    KL+++++F  GG    +   L R     E Q +  
Sbjct: 57  VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVV 114
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL-AKEIDESSRSNSMCGTTE 279
             +++ A++ LH   I+HRDLK  N+LM  +G + L DFG+ AK +    + +S  GT  
Sbjct: 115 CRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPY 174
Query: 280 YMAPEILLSKG-----HNKDADWWSVGILLYEM 307
           +MAPE+++ +      ++  AD WS+GI L EM
Sbjct: 175 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 87/157 (55%), Gaps = 8/157 (5%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQA 217
           +K E  I   + HP IV+L  ++ +   LY++ +F++G  L F + ++     ++ E  A
Sbjct: 75  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 134
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESSR-SNS 273
             Y  +I+ A+ + H   I+HRD+KP  +L+ S  +   V L  FG+A ++ ES   +  
Sbjct: 135 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 194
Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
             GT  +MAPE++  + + K  D W  G++L+ +L+G
Sbjct: 195 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 3/152 (1%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFY 220
           ++ E   ++ + HP +V L  +F+  +++ +I +F++GG LF  +  +     ED+A  Y
Sbjct: 201 VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY 260
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEIDESSRSNSMCGTT 278
             ++   + H+H+   VH DLKPENI+  +     + L DFGL   +D         GT 
Sbjct: 261 MRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA 320
Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           E+ APE+   K      D WSVG+L Y +L+G
Sbjct: 321 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 87/157 (55%), Gaps = 8/157 (5%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQA 217
           +K E  I   + HP IV+L  ++ +   LY++ +F++G  L F + ++     ++ E  A
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESSR-SNS 273
             Y  +I+ A+ + H   I+HRD+KP  +L+ S  +   V L  FG+A ++ ES   +  
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 192
Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
             GT  +MAPE++  + + K  D W  G++L+ +L+G
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 47/132 (35%), Positives = 75/132 (56%), Gaps = 5/132 (3%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 89  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 148
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +   + C T  Y+APE+L  + ++K  D W
Sbjct: 149 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 208
Query: 299 SVGILLYEMLTG 310
           S+G+++Y +L G
Sbjct: 209 SLGVIMYILLCG 220

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 47/132 (35%), Positives = 75/132 (56%), Gaps = 5/132 (3%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 88  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 147
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +   + C T  Y+APE+L  + ++K  D W
Sbjct: 148 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 207
Query: 299 SVGILLYEMLTG 310
           S+G+++Y +L G
Sbjct: 208 SLGVIMYILLCG 219

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 109/213 (51%), Gaps = 20/213 (9%)
Query: 105 RKIGPGD-FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           R + P + +EI   +G GAF                  + A KV+  +T  ++   DY+ 
Sbjct: 13  RDLDPNEVWEIVGELGDGAFGKVYKAKNKETGA-----LAAAKVI--ETKSEEELEDYI- 64
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH---LFFHLYRQGIFREDQARFY 220
            E +IL    HP+IV+L  ++    KL+++++F  GG    +   L R     E Q +  
Sbjct: 65  VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVV 122
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL-AKEIDESSRSNSMCGTTE 279
             +++ A++ LH   I+HRDLK  N+LM  +G + L DFG+ AK +    + +S  GT  
Sbjct: 123 CRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPY 182
Query: 280 YMAPEILLSKG-----HNKDADWWSVGILLYEM 307
           +MAPE+++ +      ++  AD WS+GI L EM
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 3/152 (1%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFY 220
           ++ E   ++ + HP +V L  +F+  +++ +I +F++GG LF  +  +     ED+A  Y
Sbjct: 95  VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY 154
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEIDESSRSNSMCGTT 278
             ++   + H+H+   VH DLKPENI+  +     + L DFGL   +D         GT 
Sbjct: 155 MRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA 214
Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           E+ APE+   K      D WSVG+L Y +L+G
Sbjct: 215 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 47/132 (35%), Positives = 75/132 (56%), Gaps = 5/132 (3%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 90  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 149
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +   + C T  Y+APE+L  + ++K  D W
Sbjct: 150 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 209
Query: 299 SVGILLYEMLTG 310
           S+G+++Y +L G
Sbjct: 210 SLGVIMYILLCG 221

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 47/132 (35%), Positives = 75/132 (56%), Gaps = 5/132 (3%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 187
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +   + C T  Y+APE+L  + ++K  D W
Sbjct: 188 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 247
Query: 299 SVGILLYEMLTG 310
           S+G+++Y +L G
Sbjct: 248 SLGVIMYILLCG 259

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 47/132 (35%), Positives = 75/132 (56%), Gaps = 5/132 (3%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 134 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 193
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +   + C T  Y+APE+L  + ++K  D W
Sbjct: 194 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 253
Query: 299 SVGILLYEMLTG 310
           S+G+++Y +L G
Sbjct: 254 SLGVIMYILLCG 265

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 47/132 (35%), Positives = 75/132 (56%), Gaps = 5/132 (3%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 84  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 143
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +   + C T  Y+APE+L  + ++K  D W
Sbjct: 144 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 203
Query: 299 SVGILLYEMLTG 310
           S+G+++Y +L G
Sbjct: 204 SLGVIMYILLCG 215

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 106/223 (47%), Gaps = 28/223 (12%)
Query: 109 PGDFEIF-----RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           PG FE        ++G+GA+                   YA+K++ K     ++ V   +
Sbjct: 7   PGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKE-----YAVKIIEKQAGHSRSRV--FR 59
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
               +     +  I++L   F+  ++ YL+ + + GG +  H+ +Q  F E +A     +
Sbjct: 60  EVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRD 119
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESSRSNSM------ 274
           + +A+  LH  GI HRDLKPENIL +S      V + DF L   +  ++    +      
Sbjct: 120 VAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELT 179
Query: 275 --CGTTEYMAPEIL-----LSKGHNKDADWWSVGILLYEMLTG 310
             CG+ EYMAPE++      +  ++K  D WS+G++LY ML+G
Sbjct: 180 TPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 47/132 (35%), Positives = 75/132 (56%), Gaps = 5/132 (3%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 83  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 142
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +   + C T  Y+APE+L  + ++K  D W
Sbjct: 143 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 202
Query: 299 SVGILLYEMLTG 310
           S+G+++Y +L G
Sbjct: 203 SLGVIMYILLCG 214

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 47/132 (35%), Positives = 75/132 (56%), Gaps = 5/132 (3%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 84  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 143
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +   + C T  Y+APE+L  + ++K  D W
Sbjct: 144 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 203
Query: 299 SVGILLYEMLTG 310
           S+G+++Y +L G
Sbjct: 204 SLGVIMYILLCG 215

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 47/132 (35%), Positives = 75/132 (56%), Gaps = 5/132 (3%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 82  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 141
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +   + C T  Y+APE+L  + ++K  D W
Sbjct: 142 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 201
Query: 299 SVGILLYEMLTG 310
           S+G+++Y +L G
Sbjct: 202 SLGVIMYILLCG 213

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 47/132 (35%), Positives = 75/132 (56%), Gaps = 5/132 (3%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 98  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 157
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +   + C T  Y+APE+L  + ++K  D W
Sbjct: 158 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 217
Query: 299 SVGILLYEMLTG 310
           S+G+++Y +L G
Sbjct: 218 SLGVIMYILLCG 229

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 47/132 (35%), Positives = 74/132 (56%), Gaps = 5/132 (3%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 82  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 141
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +     C T  Y+APE+L  + ++K  D W
Sbjct: 142 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMW 201
Query: 299 SVGILLYEMLTG 310
           S+G+++Y +L G
Sbjct: 202 SLGVIMYILLCG 213

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 80/150 (53%), Gaps = 2/150 (1%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E  +L++   P+I +   S+   +KL++I++++ GG     L + G   E        
Sbjct: 65  QQEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSAL-DLLKPGPLEETYIATILR 123
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYM 281
           EI+  + +LH    +HRD+K  N+L+   G V L DFG+A ++ D   + N   GT  +M
Sbjct: 124 EILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWM 183
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           APE++    ++  AD WS+GI   E+  G+
Sbjct: 184 APEVIKQSAYDFKADIWSLGITAIELAKGE 213

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 99/178 (55%), Gaps = 12/178 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL----YLILDFI 197
           A+KV+R D  + ++   Y++  R+      + HP IV +  + +  +      Y++++++
Sbjct: 41  AVKVLRAD--LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98
Query: 198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT 257
           +G  L   ++ +G     +A    A+   A++  H+ GI+HRD+KP NIL+ +   V + 
Sbjct: 99  DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVV 158
Query: 258 DFGLAKEIDESSRS----NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           DFG+A+ I +S  S     ++ GT +Y++PE       +  +D +S+G +LYE+LTG+
Sbjct: 159 DFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 47/132 (35%), Positives = 73/132 (55%), Gaps = 5/132 (3%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++ + ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 128 YAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHRDV 187
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +   + C T  Y+APE+L  + ++K  D W
Sbjct: 188 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDXW 247
Query: 299 SVGILLYEMLTG 310
           S+G++ Y +L G
Sbjct: 248 SLGVIXYILLCG 259

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 101/178 (56%), Gaps = 12/178 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL----YLILDFI 197
           A+KV+R D  + ++   Y++  R+      + HP IV +  + +  +      Y++++++
Sbjct: 41  AVKVLRAD--LARDPSFYLRFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYV 98
Query: 198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT 257
           +G  L   ++ +G     +A    A+   A++  H+ GI+HRD+KP NI++ +   V + 
Sbjct: 99  DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVM 158
Query: 258 DFGLAKEIDES----SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           DFG+A+ I +S    +++ ++ GT +Y++PE       +  +D +S+G +LYE+LTG+
Sbjct: 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 94/170 (55%), Gaps = 6/170 (3%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A K+++   +  K  V   K E  ++ ++ H  ++QL  +F++++ + L++++++GG LF
Sbjct: 118 AAKIIKTRGMKDKEEV---KNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174
Query: 204 FHLYRQGI-FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL-MDSDG-HVMLTDFG 260
             +  +     E     +  +I   + H+H+  I+H DLKPENIL ++ D   + + DFG
Sbjct: 175 DRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFG 234
Query: 261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           LA+      +     GT E++APE++     +   D WSVG++ Y +L+G
Sbjct: 235 LARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 88/170 (51%), Gaps = 15/170 (8%)
Query: 156 KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH---LFFHL-----Y 207
           +  +D +  E   +++  HP IV    SF  + +L+L++  ++GG    +  H+     +
Sbjct: 49  QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEH 108
Query: 208 RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK---- 263
           + G+  E        E++  + +LHK G +HRD+K  NIL+  DG V + DFG++     
Sbjct: 109 KSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLAT 168
Query: 264 --EIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTG 310
             +I  +    +  GT  +MAPE++   +G++  AD WS GI   E+ TG
Sbjct: 169 GGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 218

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 76/138 (55%), Gaps = 16/138 (11%)
Query: 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM 248
           + YL+ + + GG +  H++++  F E +A     ++ SA+  LH  GI HRDLKPENIL 
Sbjct: 85  RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILC 144
Query: 249 DSDGH---VMLTDFGLAKEIDESSRSNSM--------CGTTEYMAPEILLSKG-----HN 292
           +       V + DFGL   I  +   + +        CG+ EYMAPE++ +       ++
Sbjct: 145 EHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYD 204
Query: 293 KDADWWSVGILLYEMLTG 310
           K  D WS+G++LY +L+G
Sbjct: 205 KRCDLWSLGVILYILLSG 222

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 88/170 (51%), Gaps = 15/170 (8%)
Query: 156 KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHL-----Y 207
           +  +D +  E   +++  HP IV    SF  + +L+L++  ++GG    +  H+     +
Sbjct: 54  QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEH 113
Query: 208 RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK---- 263
           + G+  E        E++  + +LHK G +HRD+K  NIL+  DG V + DFG++     
Sbjct: 114 KSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLAT 173
Query: 264 --EIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTG 310
             +I  +    +  GT  +MAPE++   +G++  AD WS GI   E+ TG
Sbjct: 174 GGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 48/126 (38%), Positives = 74/126 (58%), Gaps = 6/126 (4%)
Query: 190 LYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL 247
           L +I++ + GG LF  +  +G   F E +A     +I +A+  LH   I HRD+KPEN+L
Sbjct: 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 160
Query: 248 MDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILL 304
             S   D  + LTDFG AKE  +++     C T  Y+APE+L  + ++K  D WS+G+++
Sbjct: 161 YTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
Query: 305 YEMLTG 310
           Y +L G
Sbjct: 220 YILLCG 225

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 81/158 (51%), Gaps = 12/158 (7%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKL------YLILDFINGGHLFFHLYR---QGIFRED 215
           E  I+ K+ HP +V  R       KL       L +++  GG L  +L +       +E 
Sbjct: 62  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 121
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML---TDFGLAKEIDESSRSN 272
             R   ++I SA+ +LH+  I+HRDLKPENI++      ++    D G AKE+D+     
Sbjct: 122 PIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT 181
Query: 273 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
              GT +Y+APE+L  K +    D+WS G L +E +TG
Sbjct: 182 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 81/158 (51%), Gaps = 12/158 (7%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKL------YLILDFINGGHLFFHLYR---QGIFRED 215
           E  I+ K+ HP +V  R       KL       L +++  GG L  +L +       +E 
Sbjct: 63  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 122
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML---TDFGLAKEIDESSRSN 272
             R   ++I SA+ +LH+  I+HRDLKPENI++      ++    D G AKE+D+     
Sbjct: 123 PIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT 182
Query: 273 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
              GT +Y+APE+L  K +    D+WS G L +E +TG
Sbjct: 183 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 48/126 (38%), Positives = 74/126 (58%), Gaps = 6/126 (4%)
Query: 190 LYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL 247
           L +I++ + GG LF  +  +G   F E +A     +I +A+  LH   I HRD+KPEN+L
Sbjct: 82  LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 141
Query: 248 MDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILL 304
             S   D  + LTDFG AKE  +++     C T  Y+APE+L  + ++K  D WS+G+++
Sbjct: 142 YTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 200
Query: 305 YEMLTG 310
           Y +L G
Sbjct: 201 YILLCG 206

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 101/178 (56%), Gaps = 12/178 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL----YLILDFI 197
           A+KV+R D  + ++   Y++  R+      + HP IV +  + +  +      Y++++++
Sbjct: 41  AVKVLRAD--LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98
Query: 198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT 257
           +G  L   ++ +G     +A    A+   A++  H+ GI+HRD+KP NI++ +   V + 
Sbjct: 99  DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVM 158
Query: 258 DFGLAKEIDES----SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           DFG+A+ I +S    +++ ++ GT +Y++PE       +  +D +S+G +LYE+LTG+
Sbjct: 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 101/178 (56%), Gaps = 12/178 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL----YLILDFI 197
           A+KV+R D  + ++   Y++  R+      + HP IV +  + +  +      Y++++++
Sbjct: 41  AVKVLRAD--LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98
Query: 198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT 257
           +G  L   ++ +G     +A    A+   A++  H+ GI+HRD+KP NI++ +   V + 
Sbjct: 99  DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVM 158
Query: 258 DFGLAKEIDES----SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           DFG+A+ I +S    +++ ++ GT +Y++PE       +  +D +S+G +LYE+LTG+
Sbjct: 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 101/178 (56%), Gaps = 12/178 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL----YLILDFI 197
           A+KV+R D  + ++   Y++  R+      + HP IV +  + +  +      Y++++++
Sbjct: 41  AVKVLRAD--LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98
Query: 198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT 257
           +G  L   ++ +G     +A    A+   A++  H+ GI+HRD+KP NI++ +   V + 
Sbjct: 99  DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVM 158
Query: 258 DFGLAKEIDES----SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           DFG+A+ I +S    +++ ++ GT +Y++PE       +  +D +S+G +LYE+LTG+
Sbjct: 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 87/159 (54%), Gaps = 8/159 (5%)
Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
           ++ ++AE ++L  + HP I+++   F+    +Y++++   GG L   +       +  + 
Sbjct: 64  MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSE 123
Query: 219 FYTAEIV----SAVSHLHKCGIVHRDLKPENILM-DSDGH--VMLTDFGLAKEIDESSRS 271
            Y AE++    +A+++ H   +VH+DLKPENIL  D+  H  + + DFGLA+       S
Sbjct: 124 GYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS 183
Query: 272 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            +  GT  YMAPE+   +      D WS G+++Y +LTG
Sbjct: 184 TNAAGTALYMAPEV-FKRDVTFKCDIWSAGVVMYFLLTG 221

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 84/152 (55%), Gaps = 3/152 (1%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFY 220
           +K E  I+ ++ HP ++ L  +F+ + ++ LIL+F++GG LF  +  +     E +   Y
Sbjct: 95  VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY 154
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEIDESSRSNSMCGTT 278
             +    + H+H+  IVH D+KPENI+ ++     V + DFGLA +++          T 
Sbjct: 155 MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATA 214
Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           E+ APEI+  +      D W++G+L Y +L+G
Sbjct: 215 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 101/178 (56%), Gaps = 12/178 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL----YLILDFI 197
           A+KV+R D  + ++   Y++  R+      + HP IV +  + +  +      Y++++++
Sbjct: 58  AVKVLRAD--LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 115
Query: 198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT 257
           +G  L   ++ +G     +A    A+   A++  H+ GI+HRD+KP NI++ +   V + 
Sbjct: 116 DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVM 175
Query: 258 DFGLAKEIDES----SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           DFG+A+ I +S    +++ ++ GT +Y++PE       +  +D +S+G +LYE+LTG+
Sbjct: 176 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 233

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 92/168 (54%), Gaps = 6/168 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 73  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 132
Query: 225 VSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  +++L  K  I+HRD+KP NIL++S G + L DFG++ ++ +S  +NS  GT  YM+P
Sbjct: 133 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSP 191
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLI 331
           E L    ++  +D WS+G+ L EM  G+  I S       +M +F L+
Sbjct: 192 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGS----GSGSMAIFELL 235

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 83/149 (55%), Gaps = 2/149 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L ++ HP IV L     +   L L+ +F+           +   ++ Q + Y  ++
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL 128
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMAP 283
           +  V+H H+  I+HRDLKP+N+L++SDG + L DFGLA+      RS +    T  Y AP
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAP 188
Query: 284 EILL-SKGHNKDADWWSVGILLYEMLTGQ 311
           ++L+ SK ++   D WS+G +  EM+TG+
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 83/149 (55%), Gaps = 2/149 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L ++ HP IV L     +   L L+ +F+           +   ++ Q + Y  ++
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL 128
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMAP 283
           +  V+H H+  I+HRDLKP+N+L++SDG + L DFGLA+      RS +    T  Y AP
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAP 188
Query: 284 EILL-SKGHNKDADWWSVGILLYEMLTGQ 311
           ++L+ SK ++   D WS+G +  EM+TG+
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 81/149 (54%), Gaps = 2/149 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAE 223
           E  I+ +   P +V+   S+   + L++++++   G +   +  R     ED+       
Sbjct: 74  EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQS 133
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMA 282
            +  + +LH    +HRD+K  NIL++++GH  L DFG+A ++ D  ++ N + GT  +MA
Sbjct: 134 TLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMA 193
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           PE++   G+N  AD WS+GI   EM  G+
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 85/151 (56%), Gaps = 2/151 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 116 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 175
Query: 225 VSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  +++L  K  I+HRD+KP NIL++S G + L DFG++ ++ + S +NS  GT  YM+P
Sbjct: 176 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSP 234
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQVNI 314
           E L    ++  +D WS+G+ L EM  G+  I
Sbjct: 235 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 37/90 (41%), Positives = 56/90 (62%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+    S        T  Y A
Sbjct: 134 QMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQV 312
           PE++L  G+ ++ D WSVG+++ EM+ G V
Sbjct: 194 PEVILGMGYKENVDIWSVGVIMGEMIKGGV 223

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 37/90 (41%), Positives = 56/90 (62%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+    S        T  Y A
Sbjct: 134 QMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQV 312
           PE++L  G+ ++ D WSVG+++ EM+ G V
Sbjct: 194 PEVILGMGYKENVDIWSVGVIMGEMIKGGV 223

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 25/205 (12%)
Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
           ++ ++ E  +   + HP I+ LR        L L+++F  GG L   L  + I   D   
Sbjct: 50  IENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRI-PPDILV 108
Query: 219 FYTAEIVSAVSHLHKCGIV---HRDLKPENILMD--------SDGHVMLTDFGLAKEIDE 267
            +  +I   +++LH   IV   HRDLK  NIL+         S+  + +TDFGLA+E   
Sbjct: 109 NWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR 168
Query: 268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLL 327
           +++  S  G   +MAPE++ +   +K +D WS G+LL+E+LTG+V  + +  +A      
Sbjct: 169 TTKM-SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA------ 221
Query: 328 FYLIIFHCLFVNSLELLSHFPENCP 352
               + + + +N L L    P  CP
Sbjct: 222 ----VAYGVAMNKLAL--PIPSTCP 240

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 85/151 (56%), Gaps = 2/151 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 225 VSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  +++L  K  I+HRD+KP NIL++S G + L DFG++ ++ + S +NS  GT  YM+P
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSP 172
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQVNI 314
           E L    ++  +D WS+G+ L EM  G+  I
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 85/151 (56%), Gaps = 2/151 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 225 VSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  +++L  K  I+HRD+KP NIL++S G + L DFG++ ++ + S +NS  GT  YM+P
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSP 172
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQVNI 314
           E L    ++  +D WS+G+ L EM  G+  I
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 85/151 (56%), Gaps = 2/151 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 225 VSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  +++L  K  I+HRD+KP NIL++S G + L DFG++ ++ + S +NS  GT  YM+P
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSP 172
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQVNI 314
           E L    ++  +D WS+G+ L EM  G+  I
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 75/138 (54%), Gaps = 16/138 (11%)
Query: 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM 248
           + YL+ + + GG +  H++++  F E +A     ++ SA+  LH  GI HRDLKPENIL 
Sbjct: 85  RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILC 144
Query: 249 DSDGH---VMLTDFGLAKEIDESSRSNSM--------CGTTEYMAPEILLSKG-----HN 292
           +       V + DF L   I  +   + +        CG+ EYMAPE++ +       ++
Sbjct: 145 EHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYD 204
Query: 293 KDADWWSVGILLYEMLTG 310
           K  D WS+G++LY +L+G
Sbjct: 205 KRCDLWSLGVILYILLSG 222

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 26/217 (11%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G FE+  +VG G +                  + A+KVM     +  +  + +K E ++L
Sbjct: 24  GIFELVELVGNGTYGQVYKGRHVKTGQ-----LAAIKVMD----VTGDEEEEIKQEINML 74
Query: 170 TKVTHPFIVQLRY-SFQTRS------KLYLILDFINGGHL--FFHLYRQGIFREDQARFY 220
            K +H   +   Y +F  ++      +L+L+++F   G +       +    +E+   + 
Sbjct: 75  KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI 134
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTE 279
             EI+  +SHLH+  ++HRD+K +N+L+  +  V L DFG++ ++D +  R N+  GT  
Sbjct: 135 CREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 194
Query: 280 YMAPEILLSKGHNKDA------DWWSVGILLYEMLTG 310
           +MAPE++     N DA      D WS+GI   EM  G
Sbjct: 195 WMAPEVIACD-ENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 85/151 (56%), Gaps = 2/151 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 225 VSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  +++L  K  I+HRD+KP NIL++S G + L DFG++ ++ + S +NS  GT  YM+P
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSP 172
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQVNI 314
           E L    ++  +D WS+G+ L EM  G+  I
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 85/151 (56%), Gaps = 2/151 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 225 VSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  +++L  K  I+HRD+KP NIL++S G + L DFG++ ++ + S +NS  GT  YM+P
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSP 172
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQVNI 314
           E L    ++  +D WS+G+ L EM  G+  I
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 85/151 (56%), Gaps = 2/151 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 140
Query: 225 VSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  +++L  K  I+HRD+KP NIL++S G + L DFG++ ++ + S +NS  GT  YM+P
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSP 199
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQVNI 314
           E L    ++  +D WS+G+ L EM  G+  I
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 77/140 (55%), Gaps = 5/140 (3%)
Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLH 232
           P ++ L   ++  S++ LIL++  GG +F     +   +  E+       +I+  V +LH
Sbjct: 89  PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH 148
Query: 233 KCGIVHRDLKPENILMDSD---GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           +  IVH DLKP+NIL+ S    G + + DFG++++I  +     + GT EY+APEIL   
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYD 208
Query: 290 GHNKDADWWSVGILLYEMLT 309
                 D W++GI+ Y +LT
Sbjct: 209 PITTATDMWNIGIIAYMLLT 228

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 37/90 (41%), Positives = 55/90 (61%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+    S        T  Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQV 312
           PE++L  G+ ++ D WSVG ++ EM+ G V
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGV 223

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 37/90 (41%), Positives = 55/90 (61%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+    S        T  Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQV 312
           PE++L  G+ ++ D WSVG ++ EM+ G V
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGV 223

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 112/229 (48%), Gaps = 41/229 (17%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE   V+GQGAF                   YA+K +R      +  +  + +E  +L 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRY-----YAIKKIRH----TEEKLSTILSEVMLLA 57
Query: 171 KVTHPFIVQL------RYSF-------QTRSKLYLILDFINGGHLFFHLYRQGIF--RED 215
            + H ++V+       R +F       + +S L++ +++   G L+  ++ + +   R++
Sbjct: 58  SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE 117
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES------- 268
             R +  +I+ A+S++H  GI+HRDLKP NI +D   +V + DFGLAK +  S       
Sbjct: 118 YWRLFR-QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 269 ------SRSN--SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEML 308
                 S  N  S  GT  Y+A E+L   GH N+  D +S+GI+ +EM+
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 37/90 (41%), Positives = 55/90 (61%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+    S        T  Y A
Sbjct: 134 QMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQV 312
           PE++L  G+ ++ D WSVG ++ EM+ G V
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGV 223

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/150 (34%), Positives = 85/150 (56%), Gaps = 6/150 (4%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+ +     LF  +  +G  +E+ AR +  ++
Sbjct: 64  LLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQV 123
Query: 225 VSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 124 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 182
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQV 312
           E I   + H + A  WS+GILLY+M+ G +
Sbjct: 183 EWIRYHRYHGRSAAVWSLGILLYDMVCGDI 212

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 7/222 (3%)
Query: 89  QELEHENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVM 148
           + +E E  A  E E  +K     +     +G GAF                      + +
Sbjct: 8   KAVELEGLAACEGEYSQK-----YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKV 62
Query: 149 RKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLY 207
            +D  I+   +  +  E  IL++V H  I+++   F+ +    L+++    G  LF  + 
Sbjct: 63  LEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFID 122
Query: 208 RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE 267
           R     E  A +   ++VSAV +L    I+HRD+K ENI++  D  + L DFG A  ++ 
Sbjct: 123 RHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER 182
Query: 268 SSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEML 308
                + CGT EY APE+L+   +   + + WS+G+ LY ++
Sbjct: 183 GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 8/165 (4%)
Query: 154 IKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
           +KK  ++  +AE  +    +T P IV L  + +    + + ++ + GG L   +  QG  
Sbjct: 123 VKKVRLEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCL 182
Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEIDESSRS 271
            ED+A +Y  + +  + +LH   I+H D+K +N+L+ SDG H  L DFG A  +      
Sbjct: 183 PEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLG 242
Query: 272 NSMC------GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            S+       GT  +MAPE++L +  +   D WS   ++  ML G
Sbjct: 243 KSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 37/90 (41%), Positives = 55/90 (61%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+    S        T  Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQV 312
           PE++L  G+ ++ D WSVG ++ EM+ G V
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGV 223

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 89/180 (49%), Gaps = 17/180 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERD-ILTK-VTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R+ +L K V H  I+ L   F  +  L      Y+
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+ G V
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 223

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 37/90 (41%), Positives = 55/90 (61%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+    S        T  Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQV 312
           PE++L  G+ ++ D WSVG ++ EM+ G V
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGV 223

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 108/208 (51%), Gaps = 21/208 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL---RYSFQTRSKLYLILDFIN 198
           ++A+KV    + ++   VD    E ++L K+ H  IV+L        TR K+ LI++F  
Sbjct: 36  LFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV-LIMEFCP 92
Query: 199 GGHLFFHLYR-QGIFREDQARFYTA--EIVSAVSHLHKCGIVHRDLKPENIL--MDSDGH 253
            G L+  L      +   ++ F     ++V  ++HL + GIVHR++KP NI+  +  DG 
Sbjct: 93  CGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQ 152
Query: 254 VM--LTDFGLAKEIDESSRSNSMCGTTEYMAPEI----LLSKGHNKD----ADWWSVGIL 303
            +  LTDFG A+E+++  +  S+ GT EY+ P++    +L K H K      D WS+G+ 
Sbjct: 153 SVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212
Query: 304 LYEMLTGQVNIKSMQVIACNTMLLFYLI 331
            Y   TG +  +  +    N  +++ +I
Sbjct: 213 FYHAATGSLPFRPFEGPRRNKEVMYKII 240

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 37/90 (41%), Positives = 55/90 (61%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+    S        T  Y A
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQV 312
           PE++L  G+ ++ D WSVG ++ EM+ G V
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMIKGGV 224

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/186 (30%), Positives = 94/186 (50%), Gaps = 11/186 (5%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH--PFIVQLRYSFQTRSKLYLILDFING 199
           + A+K MR+    ++N    M  + D++ K +H  P+IVQ   +F T + +++ ++ +  
Sbjct: 52  VIAVKQMRRSGNKEENKRILM--DLDVVLK-SHDCPYIVQCFGTFITNTDVFIAMELMGT 108
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHL-HKCGIVHRDLKPENILMDSDGHVMLTD 258
                    QG   E      T  IV A+ +L  K G++HRD+KP NIL+D  G + L D
Sbjct: 109 CAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCD 168
Query: 259 FGLAKEIDESSRSNSMCGTTEYMAPEIL-----LSKGHNKDADWWSVGILLYEMLTGQVN 313
           FG++  + +    +   G   YMAPE +         ++  AD WS+GI L E+ TGQ  
Sbjct: 169 FGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
Query: 314 IKSMQV 319
            K+ + 
Sbjct: 229 YKNCKT 234

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 99/222 (44%), Gaps = 51/222 (22%)
Query: 142 IYAMKVMRKDTI--IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           I A+K+M K+ I  I    V+ +K E  ++ K+ HP I +L   ++    + L+++  +G
Sbjct: 53  IRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHG 112
Query: 200 GHLF-------------------------------------FHLYRQG---IFREDQARF 219
           GHL                                       H +R+    + RE     
Sbjct: 113 GHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISN 172
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG--HVMLTDFGLAKEI-----DESSRSN 272
              +I SA+ +LH  GI HRD+KPEN L  ++    + L DFGL+KE       E     
Sbjct: 173 IMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMT 232
Query: 273 SMCGTTEYMAPEIL--LSKGHNKDADWWSVGILLYEMLTGQV 312
           +  GT  ++APE+L   ++ +    D WS G+LL+ +L G V
Sbjct: 233 TKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAV 274

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 37/90 (41%), Positives = 55/90 (61%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+    S        T  Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRA 193
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQV 312
           PE++L  G+ ++ D WSVG ++ EM+ G V
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGV 223

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 52/150 (34%), Positives = 84/150 (56%), Gaps = 6/150 (4%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 107 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 166
Query: 225 VSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 167 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 225
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQV 312
           E I   + H + A  WS+GILLY+M+ G +
Sbjct: 226 EWIRYHRYHGRSAAVWSLGILLYDMVCGDI 255

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 83/149 (55%), Gaps = 4/149 (2%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 57  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 116
Query: 225 VSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMA 282
           +  +++L  K  I+HRD+KP NIL++S G + L DFG++ + IDE   +N   GT  YM+
Sbjct: 117 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE--MANEFVGTRSYMS 174
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           PE L    ++  +D WS+G+ L EM  G+
Sbjct: 175 PERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 94/177 (53%), Gaps = 9/177 (5%)
Query: 144 AMKVMRKDTIIKKNHV---DYMKAERDILTKVTHPF--IVQLRYSFQTRSKLYLILDFIN 198
           A+K + KD I     +     +  E  +L KV+  F  +++L   F+      LIL+   
Sbjct: 80  AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 139
Query: 199 GGH-LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHVML 256
               LF  +  +G  +E+ AR +  +++ AV H H CG++HRD+K ENIL+D + G + L
Sbjct: 140 PVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKL 199
Query: 257 TDFGLAKEIDESSRSNSMCGTTEYMAPE-ILLSKGHNKDADWWSVGILLYEMLTGQV 312
            DFG    + ++  ++   GT  Y  PE I   + H + A  WS+GILLY+M+ G +
Sbjct: 200 IDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 255

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 94/177 (53%), Gaps = 9/177 (5%)
Query: 144 AMKVMRKDTIIKKNHV---DYMKAERDILTKVTHPF--IVQLRYSFQTRSKLYLILDFIN 198
           A+K + KD I     +     +  E  +L KV+  F  +++L   F+      LIL+   
Sbjct: 66  AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 125
Query: 199 GGH-LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHVML 256
               LF  +  +G  +E+ AR +  +++ AV H H CG++HRD+K ENIL+D + G + L
Sbjct: 126 PVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKL 185
Query: 257 TDFGLAKEIDESSRSNSMCGTTEYMAPE-ILLSKGHNKDADWWSVGILLYEMLTGQV 312
            DFG    + ++  ++   GT  Y  PE I   + H + A  WS+GILLY+M+ G +
Sbjct: 186 IDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 241

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 94/177 (53%), Gaps = 9/177 (5%)
Query: 144 AMKVMRKDTIIKKNHV---DYMKAERDILTKVTHPF--IVQLRYSFQTRSKLYLILDFIN 198
           A+K + KD I     +     +  E  +L KV+  F  +++L   F+      LIL+   
Sbjct: 65  AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 124
Query: 199 GGH-LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHVML 256
               LF  +  +G  +E+ AR +  +++ AV H H CG++HRD+K ENIL+D + G + L
Sbjct: 125 PVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKL 184
Query: 257 TDFGLAKEIDESSRSNSMCGTTEYMAPE-ILLSKGHNKDADWWSVGILLYEMLTGQV 312
            DFG    + ++  ++   GT  Y  PE I   + H + A  WS+GILLY+M+ G +
Sbjct: 185 IDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 240

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 94/177 (53%), Gaps = 9/177 (5%)
Query: 144 AMKVMRKDTIIKKNHV---DYMKAERDILTKVTHPF--IVQLRYSFQTRSKLYLILDFIN 198
           A+K + KD I     +     +  E  +L KV+  F  +++L   F+      LIL+   
Sbjct: 53  AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 112
Query: 199 GGH-LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHVML 256
               LF  +  +G  +E+ AR +  +++ AV H H CG++HRD+K ENIL+D + G + L
Sbjct: 113 PVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKL 172
Query: 257 TDFGLAKEIDESSRSNSMCGTTEYMAPE-ILLSKGHNKDADWWSVGILLYEMLTGQV 312
            DFG    + ++  ++   GT  Y  PE I   + H + A  WS+GILLY+M+ G +
Sbjct: 173 IDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 228

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 94/177 (53%), Gaps = 9/177 (5%)
Query: 144 AMKVMRKDTIIKKNHV---DYMKAERDILTKVTHPF--IVQLRYSFQTRSKLYLILDFIN 198
           A+K + KD I     +     +  E  +L KV+  F  +++L   F+      LIL+   
Sbjct: 66  AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 125
Query: 199 GGH-LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHVML 256
               LF  +  +G  +E+ AR +  +++ AV H H CG++HRD+K ENIL+D + G + L
Sbjct: 126 PVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKL 185
Query: 257 TDFGLAKEIDESSRSNSMCGTTEYMAPE-ILLSKGHNKDADWWSVGILLYEMLTGQV 312
            DFG    + ++  ++   GT  Y  PE I   + H + A  WS+GILLY+M+ G +
Sbjct: 186 IDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 241

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 94/177 (53%), Gaps = 9/177 (5%)
Query: 144 AMKVMRKDTIIKKNHV---DYMKAERDILTKVTHPF--IVQLRYSFQTRSKLYLILDFIN 198
           A+K + KD I     +     +  E  +L KV+  F  +++L   F+      LIL+   
Sbjct: 72  AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 131
Query: 199 GGH-LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHVML 256
               LF  +  +G  +E+ AR +  +++ AV H H CG++HRD+K ENIL+D + G + L
Sbjct: 132 PVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKL 191
Query: 257 TDFGLAKEIDESSRSNSMCGTTEYMAPE-ILLSKGHNKDADWWSVGILLYEMLTGQV 312
            DFG    + ++  ++   GT  Y  PE I   + H + A  WS+GILLY+M+ G +
Sbjct: 192 IDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 247

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 52/150 (34%), Positives = 84/150 (56%), Gaps = 6/150 (4%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 107 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 166
Query: 225 VSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 167 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 225
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQV 312
           E I   + H + A  WS+GILLY+M+ G +
Sbjct: 226 EWIRYHRYHGRSAAVWSLGILLYDMVCGDI 255

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 94/177 (53%), Gaps = 9/177 (5%)
Query: 144 AMKVMRKDTIIKKNHV---DYMKAERDILTKVTHPF--IVQLRYSFQTRSKLYLILDFIN 198
           A+K + KD I     +     +  E  +L KV+  F  +++L   F+      LIL+   
Sbjct: 66  AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 125
Query: 199 GGH-LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHVML 256
               LF  +  +G  +E+ AR +  +++ AV H H CG++HRD+K ENIL+D + G + L
Sbjct: 126 PVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKL 185
Query: 257 TDFGLAKEIDESSRSNSMCGTTEYMAPE-ILLSKGHNKDADWWSVGILLYEMLTGQV 312
            DFG    + ++  ++   GT  Y  PE I   + H + A  WS+GILLY+M+ G +
Sbjct: 186 IDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 241

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 94/177 (53%), Gaps = 9/177 (5%)
Query: 144 AMKVMRKDTIIKKNHV---DYMKAERDILTKVTHPF--IVQLRYSFQTRSKLYLILDFIN 198
           A+K + KD I     +     +  E  +L KV+  F  +++L   F+      LIL+   
Sbjct: 38  AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 97
Query: 199 GGH-LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHVML 256
               LF  +  +G  +E+ AR +  +++ AV H H CG++HRD+K ENIL+D + G + L
Sbjct: 98  PVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKL 157
Query: 257 TDFGLAKEIDESSRSNSMCGTTEYMAPE-ILLSKGHNKDADWWSVGILLYEMLTGQV 312
            DFG    + ++  ++   GT  Y  PE I   + H + A  WS+GILLY+M+ G +
Sbjct: 158 IDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 213

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 52/150 (34%), Positives = 84/150 (56%), Gaps = 6/150 (4%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 92  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 151
Query: 225 VSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 152 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 210
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQV 312
           E I   + H + A  WS+GILLY+M+ G +
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCGDI 240

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 52/150 (34%), Positives = 84/150 (56%), Gaps = 6/150 (4%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 92  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 151
Query: 225 VSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 152 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 210
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQV 312
           E I   + H + A  WS+GILLY+M+ G +
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCGDI 240

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 94/177 (53%), Gaps = 9/177 (5%)
Query: 144 AMKVMRKDTIIKKNHV---DYMKAERDILTKVTHPF--IVQLRYSFQTRSKLYLILDFIN 198
           A+K + KD I     +     +  E  +L KV+  F  +++L   F+      LIL+   
Sbjct: 85  AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 144
Query: 199 GGH-LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHVML 256
               LF  +  +G  +E+ AR +  +++ AV H H CG++HRD+K ENIL+D + G + L
Sbjct: 145 PVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKL 204
Query: 257 TDFGLAKEIDESSRSNSMCGTTEYMAPE-ILLSKGHNKDADWWSVGILLYEMLTGQV 312
            DFG    + ++  ++   GT  Y  PE I   + H + A  WS+GILLY+M+ G +
Sbjct: 205 IDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 260

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 52/150 (34%), Positives = 84/150 (56%), Gaps = 6/150 (4%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 79  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 138
Query: 225 VSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 139 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 197
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQV 312
           E I   + H + A  WS+GILLY+M+ G +
Sbjct: 198 EWIRYHRYHGRSAAVWSLGILLYDMVCGDI 227

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 52/150 (34%), Positives = 84/150 (56%), Gaps = 6/150 (4%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 79  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 138
Query: 225 VSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 139 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 197
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQV 312
           E I   + H + A  WS+GILLY+M+ G +
Sbjct: 198 EWIRYHRYHGRSAAVWSLGILLYDMVCGDI 227

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 37/90 (41%), Positives = 55/90 (61%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+    S        T  Y A
Sbjct: 136 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRA 195
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQV 312
           PE++L  G+ ++ D WSVG ++ EM+ G V
Sbjct: 196 PEVILGMGYKENVDIWSVGCIMGEMIKGGV 225

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 44/131 (33%), Positives = 71/131 (54%), Gaps = 3/131 (2%)
Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS 271
           F E++ ++   +++  + ++H  G+VHRDLKP N+ ++ D  + + DFGLA+  D  +  
Sbjct: 141 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD--AEM 198
Query: 272 NSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYL 330
                T  Y APE++LS  H N+  D WSVG ++ EMLTG+   K    +   T +L   
Sbjct: 199 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 258
Query: 331 IIFHCLFVNSL 341
            +    FV  L
Sbjct: 259 GVPGTEFVQKL 269

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 52/150 (34%), Positives = 84/150 (56%), Gaps = 6/150 (4%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 92  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 151
Query: 225 VSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 152 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 210
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQV 312
           E I   + H + A  WS+GILLY+M+ G +
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCGDI 240

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 52/150 (34%), Positives = 84/150 (56%), Gaps = 6/150 (4%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 93  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 152
Query: 225 VSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 153 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 211
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQV 312
           E I   + H + A  WS+GILLY+M+ G +
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCGDI 241

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 52/150 (34%), Positives = 84/150 (56%), Gaps = 6/150 (4%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 80  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 139
Query: 225 VSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 140 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 198
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQV 312
           E I   + H + A  WS+GILLY+M+ G +
Sbjct: 199 EWIRYHRYHGRSAAVWSLGILLYDMVCGDI 228

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 52/150 (34%), Positives = 84/150 (56%), Gaps = 6/150 (4%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 80  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 139
Query: 225 VSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 140 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 198
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQV 312
           E I   + H + A  WS+GILLY+M+ G +
Sbjct: 199 EWIRYHRYHGRSAAVWSLGILLYDMVCGDI 228

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 41/117 (35%), Positives = 67/117 (57%), Gaps = 3/117 (2%)
Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS 271
           F E++ ++   +++  + ++H  G+VHRDLKP N+ ++ D  + + DFGLA+  D  +  
Sbjct: 123 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD--AEM 180
Query: 272 NSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLL 327
                T  Y APE++LS  H N+  D WSVG ++ EMLTG+   K    +   T +L
Sbjct: 181 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 237

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 52/150 (34%), Positives = 84/150 (56%), Gaps = 6/150 (4%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 65  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 124
Query: 225 VSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 125 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 183
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQV 312
           E I   + H + A  WS+GILLY+M+ G +
Sbjct: 184 EWIRYHRYHGRSAAVWSLGILLYDMVCGDI 213

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 52/150 (34%), Positives = 84/150 (56%), Gaps = 6/150 (4%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 64  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 123
Query: 225 VSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 124 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 182
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQV 312
           E I   + H + A  WS+GILLY+M+ G +
Sbjct: 183 EWIRYHRYHGRSAAVWSLGILLYDMVCGDI 212

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           S +  S++YL+   +  G    ++ +     ++  +F   +++  + ++H  GI+HRDLK
Sbjct: 101 SIEDFSEVYLVTTLM--GADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLK 158
Query: 243 PENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVG 301
           P N+ ++ D  + + DFGLA++ DE         T  Y APEI+L+  H N+  D WSVG
Sbjct: 159 PSNVAVNEDSELRILDFGLARQADEE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 216
Query: 302 ILLYEMLTGQV 312
            ++ E+L G+ 
Sbjct: 217 CIMAELLQGKA 227

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 17/180 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDX 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+  ++
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 223

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 52/150 (34%), Positives = 84/150 (56%), Gaps = 6/150 (4%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 65  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 124
Query: 225 VSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 125 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 183
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQV 312
           E I   + H + A  WS+GILLY+M+ G +
Sbjct: 184 EWIRYHRYHGRSAAVWSLGILLYDMVCGDI 213

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 17/180 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LXQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDX 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+  ++
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 223

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 94/177 (53%), Gaps = 9/177 (5%)
Query: 144 AMKVMRKDTIIKKNHV---DYMKAERDILTKVTHPF--IVQLRYSFQTRSKLYLILDFIN 198
           A+K + KD I     +     +  E  +L KV+  F  +++L   F+      LIL+   
Sbjct: 60  AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 119
Query: 199 GGH-LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHVML 256
               LF  +  +G  +E+ AR +  +++ AV H H CG++HRD+K ENIL+D + G + L
Sbjct: 120 PVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKL 179
Query: 257 TDFGLAKEIDESSRSNSMCGTTEYMAPE-ILLSKGHNKDADWWSVGILLYEMLTGQV 312
            DFG    + ++  ++   GT  Y  PE I   + H + A  WS+GILLY+M+ G +
Sbjct: 180 IDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 235

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/150 (34%), Positives = 84/150 (56%), Gaps = 6/150 (4%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 63  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 122
Query: 225 VSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 123 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 181
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQV 312
           E I   + H + A  WS+GILLY+M+ G +
Sbjct: 182 EWIRYHRYHGRSAAVWSLGILLYDMVCGDI 211

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 94/177 (53%), Gaps = 9/177 (5%)
Query: 144 AMKVMRKDTIIKKNHV---DYMKAERDILTKVTHPF--IVQLRYSFQTRSKLYLILDFIN 198
           A+K + KD I     +     +  E  +L KV+  F  +++L   F+      LIL+   
Sbjct: 33  AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 92
Query: 199 GGH-LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHVML 256
               LF  +  +G  +E+ AR +  +++ AV H H CG++HRD+K ENIL+D + G + L
Sbjct: 93  PVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKL 152
Query: 257 TDFGLAKEIDESSRSNSMCGTTEYMAPE-ILLSKGHNKDADWWSVGILLYEMLTGQV 312
            DFG    + ++  ++   GT  Y  PE I   + H + A  WS+GILLY+M+ G +
Sbjct: 153 IDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 208

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/150 (34%), Positives = 84/150 (56%), Gaps = 6/150 (4%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 60  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 119
Query: 225 VSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 120 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 178
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQV 312
           E I   + H + A  WS+GILLY+M+ G +
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDI 208

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/187 (31%), Positives = 97/187 (51%), Gaps = 11/187 (5%)
Query: 144 AMKVMRKDTIIKKNHVD---YMKAERDILTKVT----HPFIVQLRYSFQTRSKLYLILDF 196
           A+KV+ ++ ++  + +        E  +L KV     HP +++L   F+T+    L+L+ 
Sbjct: 60  AIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLER 119
Query: 197 -INGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHV 254
            +    LF ++  +G   E  +R +  ++V+A+ H H  G+VHRD+K ENIL+D   G  
Sbjct: 120 PLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCA 179
Query: 255 MLTDFGLAKEIDESSRSNSMCGTTEYMAPE-ILLSKGHNKDADWWSVGILLYEMLTGQVN 313
            L DFG    + +   ++   GT  Y  PE I   + H   A  WS+GILLY+M+ G + 
Sbjct: 180 KLIDFGSGALLHDEPYTD-FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
Query: 314 IKSMQVI 320
            +  Q I
Sbjct: 239 FERDQEI 245

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 89/180 (49%), Gaps = 17/180 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERD-ILTK-VTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R+ +L K V H  I+ L   F  +  L      YL
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDX 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+  ++
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 223

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 89/180 (49%), Gaps = 17/180 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERD-ILTK-VTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R+ +L K V H  I+ L   F  +  L      YL
Sbjct: 40  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 99
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 100 VMELMDAN---LXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDX 156
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+  ++
Sbjct: 157 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 82/165 (49%), Gaps = 8/165 (4%)
Query: 154 IKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
           +KK  ++  +AE  +    +T P IV L  + +    + + ++ + GG L   +  QG  
Sbjct: 104 VKKVRLEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCL 163
Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEIDESSRS 271
            ED+A +Y  + +  + +LH   I+H D+K +N+L+ SDG H  L DFG A  +      
Sbjct: 164 PEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLG 223
Query: 272 NSMC------GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
             +       GT  +MAPE++L +  +   D WS   ++  ML G
Sbjct: 224 KDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/147 (33%), Positives = 85/147 (57%), Gaps = 7/147 (4%)
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQAR--FYTAEIVSAV 228
           + H  IVQ   SF     + + ++ + GG L   L  + G  ++++    FYT +I+  +
Sbjct: 76  LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGL 135
Query: 229 SHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKEIDE-SSRSNSMCGTTEYMAPEIL 286
            +LH   IVHRD+K +N+L+++  G + ++DFG +K +   +  + +  GT +YMAPEI+
Sbjct: 136 KYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEII 195
Query: 287 LS--KGHNKDADWWSVGILLYEMLTGQ 311
               +G+ K AD WS+G  + EM TG+
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 17/180 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDX 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+  ++
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 223

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 17/180 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 85  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 144
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 145 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 201
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+  ++
Sbjct: 202 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 81/166 (48%), Gaps = 15/166 (9%)
Query: 156 KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL------YLILDFINGGHLFFHLYRQ 209
           + H      E  +L  V H  I+ L   F  +  L      YL+++ ++          Q
Sbjct: 62  QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC------Q 115
Query: 210 GIFRE---DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID 266
            I  E   ++  +   +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+   
Sbjct: 116 VIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAS 175
Query: 267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            +        T  Y APE++L  G+ ++ D WSVG ++ E++ G V
Sbjct: 176 TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSV 221

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           S +  S++YL+   +  G    ++ +     ++  +F   +++  + ++H  GI+HRDLK
Sbjct: 101 SIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLK 158
Query: 243 PENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVG 301
           P N+ ++ D  + + DFGLA++ DE         T  Y APEI+L+  H N+  D WSVG
Sbjct: 159 PSNVAVNEDSELRILDFGLARQADEE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 216
Query: 302 ILLYEMLTGQV 312
            ++ E+L G+ 
Sbjct: 217 CIMAELLQGKA 227

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/147 (33%), Positives = 85/147 (57%), Gaps = 7/147 (4%)
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQAR--FYTAEIVSAV 228
           + H  IVQ   SF     + + ++ + GG L   L  + G  ++++    FYT +I+  +
Sbjct: 62  LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGL 121
Query: 229 SHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKEIDE-SSRSNSMCGTTEYMAPEIL 286
            +LH   IVHRD+K +N+L+++  G + ++DFG +K +   +  + +  GT +YMAPEI+
Sbjct: 122 KYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEII 181
Query: 287 LS--KGHNKDADWWSVGILLYEMLTGQ 311
               +G+ K AD WS+G  + EM TG+
Sbjct: 182 DKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 89/157 (56%), Gaps = 14/157 (8%)
Query: 164 AERDILTKVTHPFIVQL--RYSFQTRSKLYLILDFINGGHLFFHLY-----RQGIFREDQ 216
           +E ++L ++ HP IV+   R   +T + LY+++++  GG L   +      RQ +  E  
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 217 ARFYTAEIVSAVSHLHKCG-----IVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSR 270
            R  T ++  A+   H+       ++HRDLKP N+ +D   +V L DFGLA+ ++ ++S 
Sbjct: 114 LRVMT-QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF 172
Query: 271 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           + +  GT  YM+PE +    +N+ +D WS+G LLYE+
Sbjct: 173 AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 89/157 (56%), Gaps = 14/157 (8%)
Query: 164 AERDILTKVTHPFIVQL--RYSFQTRSKLYLILDFINGGHLFFHLY-----RQGIFREDQ 216
           +E ++L ++ HP IV+   R   +T + LY+++++  GG L   +      RQ +  E  
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 217 ARFYTAEIVSAVSHLHKCG-----IVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSR 270
            R  T ++  A+   H+       ++HRDLKP N+ +D   +V L DFGLA+ ++ ++S 
Sbjct: 114 LRVMT-QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF 172
Query: 271 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           + +  GT  YM+PE +    +N+ +D WS+G LLYE+
Sbjct: 173 AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 107/208 (51%), Gaps = 21/208 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL---RYSFQTRSKLYLILDFIN 198
           ++A+KV    + ++   VD    E ++L K+ H  IV+L        TR K+ LI++F  
Sbjct: 36  LFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV-LIMEFCP 92
Query: 199 GGHLFFHLYR-QGIFREDQARFYTA--EIVSAVSHLHKCGIVHRDLKPENIL--MDSDGH 253
            G L+  L      +   ++ F     ++V  ++HL + GIVHR++KP NI+  +  DG 
Sbjct: 93  CGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQ 152
Query: 254 VM--LTDFGLAKEIDESSRSNSMCGTTEYMAPEI----LLSKGHNKD----ADWWSVGIL 303
            +  LTDFG A+E+++  +   + GT EY+ P++    +L K H K      D WS+G+ 
Sbjct: 153 SVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212
Query: 304 LYEMLTGQVNIKSMQVIACNTMLLFYLI 331
            Y   TG +  +  +    N  +++ +I
Sbjct: 213 FYHAATGSLPFRPFEGPRRNKEVMYKII 240

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 17/180 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 85  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 144
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 145 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 201
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+  ++
Sbjct: 202 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 12/208 (5%)
Query: 108 GPGDFEIFRVV---GQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           GPG  E F+ V   G+G +                  + A+K +R DT  +      ++ 
Sbjct: 1   GPGSMENFQKVEKIGEGTYGVVYKARNKLTGE-----VVALKKIRLDTETEGVPSTAIR- 54
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAE 223
           E  +L ++ HP IV+L     T +KLYL+ +F++     F              + Y  +
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQ 114
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMA 282
           ++  ++  H   ++HRDLKP+N+L++++G + L DFGLA+      R+      T  Y A
Sbjct: 115 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 283 PEILLS-KGHNKDADWWSVGILLYEMLT 309
           PEILL  K ++   D WS+G +  EM+T
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 17/180 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 40  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 99
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 100 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 156
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+  ++
Sbjct: 157 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 17/180 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 41  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 100
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 101 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 157
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+  ++
Sbjct: 158 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 217

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 111/229 (48%), Gaps = 41/229 (17%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE   V+GQGAF                   YA+K +R      +  +  + +E  +L 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRY-----YAIKKIRH----TEEKLSTILSEVMLLA 57
Query: 171 KVTHPFIVQL------RYSF-------QTRSKLYLILDFINGGHLFFHLYRQGIF--RED 215
            + H ++V+       R +F       + +S L++ +++     L+  ++ + +   R++
Sbjct: 58  SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDE 117
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES------- 268
             R +  +I+ A+S++H  GI+HRDLKP NI +D   +V + DFGLAK +  S       
Sbjct: 118 YWRLFR-QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 269 ------SRSN--SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEML 308
                 S  N  S  GT  Y+A E+L   GH N+  D +S+GI+ +EM+
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 17/180 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 48  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 107
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 108 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 164
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+  ++
Sbjct: 165 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 224

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 84/151 (55%), Gaps = 2/151 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L       E+     +  +
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 123
Query: 225 VSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  +++L  K  I+HRD+KP NIL++S G + L DFG++ ++ +S  +NS  GT  YMAP
Sbjct: 124 LRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMAP 182
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQVNI 314
           E L    ++  +D WS+G+ L E+  G+  I
Sbjct: 183 ERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 17/180 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+  ++
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 223

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 17/180 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 41  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 100
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 101 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 157
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+  ++
Sbjct: 158 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 217

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 17/180 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 46  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 105
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 106 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 162
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+  ++
Sbjct: 163 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 222

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 17/180 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+  ++
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 223

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 17/180 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 48  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 107
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 108 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 164
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+  ++
Sbjct: 165 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 224

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           S +  S++YL+   +  G    ++ +     ++  +F   +++  + ++H  GI+HRDLK
Sbjct: 93  SIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLK 150
Query: 243 PENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVG 301
           P N+ ++ D  + + DFGLA++ DE         T  Y APEI+L+  H N+  D WSVG
Sbjct: 151 PSNVAVNEDCELRILDFGLARQADEE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 208
Query: 302 ILLYEMLTGQV 312
            ++ E+L G+ 
Sbjct: 209 CIMAELLQGKA 219

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 55/90 (61%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+    S        T  Y A
Sbjct: 128 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 187
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQV 312
           PE++L  G+ ++ D WSVG ++ EM+  ++
Sbjct: 188 PEVILGMGYKENVDLWSVGCIMGEMVCHKI 217

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 55/90 (61%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+    S        T  Y A
Sbjct: 139 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 198
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQV 312
           PE++L  G+ ++ D WSVG ++ EM+  ++
Sbjct: 199 PEVILGMGYKENVDLWSVGCIMGEMVCHKI 228

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 12/208 (5%)
Query: 108 GPGDFEIFRVV---GQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           GPG  E F+ V   G+G +                  + A+K +R DT  +      ++ 
Sbjct: 1   GPGSMENFQKVEKIGEGTYGVVYKARNKLTGE-----VVALKKIRLDTETEGVPSTAIR- 54
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAE 223
           E  +L ++ HP IV+L     T +KLYL+ +F++     F              + Y  +
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 114
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMA 282
           ++  ++  H   ++HRDLKP+N+L++++G + L DFGLA+      R+      T  Y A
Sbjct: 115 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 283 PEILLS-KGHNKDADWWSVGILLYEMLT 309
           PEILL  K ++   D WS+G +  EM+T
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 95/179 (53%), Gaps = 24/179 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A++ +R+  I+K     + K E  I       F +Q   SF+  +++Y+I + +    
Sbjct: 51  LFALRTLREIKILK-----HFKHENIITI-----FNIQRPDSFENFNEVYIIQELMQTD- 99
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
               +    +  +D  +++  + + AV  LH   ++HRDLKP N+L++S+  + + DFGL
Sbjct: 100 -LHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGL 158
Query: 262 AKEIDESSRSNS-----MCGTTEYM------APEILL-SKGHNKDADWWSVGILLYEML 308
           A+ IDES+  NS       G TEY+      APE++L S  +++  D WS G +L E+ 
Sbjct: 159 ARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 91/171 (53%), Gaps = 4/171 (2%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  +S  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 89  KKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 148
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
           LA+      R+ +    T  Y APEILL  K ++   D WS+G +  EM+T
Sbjct: 149 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 41/216 (18%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA----ERDILTK 171
           +V+G G+F                  +Y  K+     ++    V   KA    E  I+ K
Sbjct: 26  KVIGNGSFGV----------------VYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRK 69
Query: 172 VTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQG--IFREDQA------ 217
           + H  IV+LRY F +  +      L L+LD++        +YR      R  Q       
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPAT-----VYRVARHYSRAKQTLPVIYV 124
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     + S   
Sbjct: 125 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 184
Query: 277 TTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
           +  Y APE++  +  +    D WS G +L E+L GQ
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 85/174 (48%), Gaps = 17/174 (9%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           Y  + +R+  I+ +   + +   RDIL   T           +    +Y++ D +     
Sbjct: 84  YCQRTLREIQILLRFRHENVIGIRDILRAST----------LEAMRDVYIVQDLMETD-- 131
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            + L +      D   ++  +I+  + ++H   ++HRDLKP N+L+++   + + DFGLA
Sbjct: 132 LYKLLKSQQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLA 191
Query: 263 K----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
           +    E D +        T  Y APEI+L SKG+ K  D WSVG +L EML+ +
Sbjct: 192 RIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 90/167 (53%), Gaps = 9/167 (5%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE--DQARFYTA 222
           E  I+ ++ HP IV    +      L ++ ++++ G L+  L++ G   +  ++ R   A
Sbjct: 84  EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143
Query: 223 -EIVSAVSHLHKCG--IVHRDLKPENILMDSDGHVMLTDFGLAK-EIDESSRSNSMCGTT 278
            ++   +++LH     IVHRDLK  N+L+D    V + DFGL++ +      S    GT 
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTP 203
Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQV---NIKSMQVIAC 322
           E+MAPE+L  +  N+ +D +S G++L+E+ T Q    N+   QV+A 
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA 250

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 55/90 (61%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+    S        T  Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRA 193
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQV 312
           PE++L  G+ ++ D WSVG ++ EM+  ++
Sbjct: 194 PEVILGMGYKENVDLWSVGCIMGEMVCHKI 223

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 72/130 (55%), Gaps = 5/130 (3%)
Query: 188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL 247
           +  YL++ F+  G     L +     ED+ +F   +++  + ++H  GI+HRDLKP N+ 
Sbjct: 103 TDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLA 160
Query: 248 MDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYE 306
           ++ D  + + DFGLA++ D  S       T  Y APE++L+   + +  D WSVG ++ E
Sbjct: 161 VNEDCELKILDFGLARQAD--SEMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAE 218
Query: 307 MLTGQVNIKS 316
           M+TG+   K 
Sbjct: 219 MITGKTLFKG 228

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 90/171 (52%), Gaps = 4/171 (2%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 32  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 90
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKPEN+L++++G + L DFG
Sbjct: 91  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFG 150
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T
Sbjct: 151 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 93/168 (55%), Gaps = 11/168 (6%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE--DQARFYTA 222
           E  I+ ++ HP IV    +      L ++ ++++ G L+  L++ G   +  ++ R   A
Sbjct: 84  EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143
Query: 223 -EIVSAVSHLHKCG--IVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGT 277
            ++   +++LH     IVHR+LK  N+L+D    V + DFGL++ +  S+   S S  GT
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGT 202
Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQV---NIKSMQVIAC 322
            E+MAPE+L  +  N+ +D +S G++L+E+ T Q    N+   QV+A 
Sbjct: 203 PEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA 250

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 94/179 (52%), Gaps = 24/179 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A++ +R+  I+K     + K E  I       F +Q   SF+  +++Y+I + +    
Sbjct: 51  LFALRTLREIKILK-----HFKHENIITI-----FNIQRPDSFENFNEVYIIQELMQTD- 99
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
               +    +  +D  +++  + + AV  LH   ++HRDLKP N+L++S+  + + DFGL
Sbjct: 100 -LHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGL 158
Query: 262 AKEIDESSRSNS-----MCGTTE------YMAPEILL-SKGHNKDADWWSVGILLYEML 308
           A+ IDES+  NS       G TE      Y APE++L S  +++  D WS G +L E+ 
Sbjct: 159 ARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 90/171 (52%), Gaps = 4/171 (2%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 33  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDL 91
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKPEN+L++++G + L DFG
Sbjct: 92  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFG 151
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T
Sbjct: 152 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 55/90 (61%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+    S        T  Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRA 193
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQV 312
           PE++L  G+ ++ D WSVG ++ EM+  ++
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVCHKI 223

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 90/171 (52%), Gaps = 4/171 (2%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 31  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 89
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKPEN+L++++G + L DFG
Sbjct: 90  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFG 149
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T
Sbjct: 150 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 91/171 (53%), Gaps = 4/171 (2%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 37  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 95
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 96  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 155
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
           LA+      R+ +    T  Y APEILL  K ++   D WS+G +  EM+T
Sbjct: 156 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 206

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 90/171 (52%), Gaps = 4/171 (2%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 31  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDL 89
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKPEN+L++++G + L DFG
Sbjct: 90  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFG 149
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T
Sbjct: 150 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 91/171 (53%), Gaps = 4/171 (2%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 37  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 95
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 96  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 155
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
           LA+      R+ +    T  Y APEILL  K ++   D WS+G +  EM+T
Sbjct: 156 LARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 76/146 (52%), Gaps = 2/146 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +++HP I+ L  +F  +S + L+ DF+             +      + Y    
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-NSMCGTTEYMAP 283
           +  + +LH+  I+HRDLKP N+L+D +G + L DFGLAK     +R+      T  Y AP
Sbjct: 122 LQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAP 181
Query: 284 EILL-SKGHNKDADWWSVGILLYEML 308
           E+L  ++ +    D W+VG +L E+L
Sbjct: 182 ELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 87/165 (52%), Gaps = 17/165 (10%)
Query: 161 YMKAERDILTKVTHPFIVQLRYSF----QTRSKLYL--ILDFINGGHLFFHLYRQGIFRE 214
           +   E  I+ K+ H  IV+LRY F    + + ++YL  +LD++      + + R    R 
Sbjct: 93  FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARH-YSRA 149
Query: 215 DQA------RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDE 267
            Q       + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++  
Sbjct: 150 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209
Query: 268 SSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
              + S   +  Y APE++  +  +    D WS G +L E+L GQ
Sbjct: 210 GEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 86/161 (53%), Gaps = 17/161 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSF----QTRSKLYL--ILDFINGGHLFFHLYRQGIFREDQA- 217
           E  I+ K+ H  IV+LRY F    + + ++YL  +LD++      + + R    R  Q  
Sbjct: 82  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 138
Query: 218 -----RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 139 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 198
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
            S   +  Y APE++  +  +    D WS G +L E+L GQ
Sbjct: 199 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 87/165 (52%), Gaps = 17/165 (10%)
Query: 161 YMKAERDILTKVTHPFIVQLRYSF----QTRSKLYL--ILDFINGGHLFFHLYRQGIFRE 214
           +   E  I+ K+ H  IV+LRY F    + + ++YL  +LD++      + + R    R 
Sbjct: 87  FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARH-YSRA 143
Query: 215 DQA------RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDE 267
            Q       + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++  
Sbjct: 144 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 203
Query: 268 SSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
              + S   +  Y APE++  +  +    D WS G +L E+L GQ
Sbjct: 204 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 87/165 (52%), Gaps = 17/165 (10%)
Query: 161 YMKAERDILTKVTHPFIVQLRYSF----QTRSKLYL--ILDFINGGHLFFHLYRQGIFRE 214
           +   E  I+ K+ H  IV+LRY F    + + ++YL  +LD++      + + R    R 
Sbjct: 67  FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRA 123
Query: 215 DQA------RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDE 267
            Q       + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++  
Sbjct: 124 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 183
Query: 268 SSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
              + S   +  Y APE++  +  +    D WS G +L E+L GQ
Sbjct: 184 GEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 92/179 (51%), Gaps = 24/179 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A++ +R+  I+K     + K E  I       F +Q   SF+  +++Y+I + +    
Sbjct: 51  LFALRTLREIKILK-----HFKHENIITI-----FNIQRPDSFENFNEVYIIQELMQTD- 99
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
               +    +  +D  +++  + + AV  LH   ++HRDLKP N+L++S+  + + DFGL
Sbjct: 100 -LHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGL 158
Query: 262 AKEIDESSRSNS-----------MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEML 308
           A+ IDES+  NS              T  Y APE++L S  +++  D WS G +L E+ 
Sbjct: 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 17/161 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQA- 217
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 142 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARH-YSRAKQTL 198
Query: 218 -----RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 199 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 258
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
            S   +  Y APE++  +  +    D WS G +L E+L GQ
Sbjct: 259 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 91/171 (53%), Gaps = 4/171 (2%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 31  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 89
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 90  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 149
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
           LA+      R+ +    T  Y APEILL  K ++   D WS+G +  EM+T
Sbjct: 150 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 86/161 (53%), Gaps = 17/161 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSF----QTRSKLYL--ILDFINGGHLFFHLYRQGIFREDQA- 217
           E  I+ K+ H  IV+LRY F    + + ++YL  +LD++      + + R    R  Q  
Sbjct: 99  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARH-YSRAKQTL 155
Query: 218 -----RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 156 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 215
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
            S   +  Y APE++  +  +    D WS G +L E+L GQ
Sbjct: 216 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 93/188 (49%), Gaps = 21/188 (11%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKA----ERDILTKVTHPFIVQLRYSFQTRSK------LY 191
           +Y  K+     ++    V   KA    E  I+ K+ H  IV+LRY F +  +      L 
Sbjct: 36  VYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95
Query: 192 LILDFINGGHLFFHLYRQGIFREDQA------RFYTAEIVSAVSHLHKCGIVHRDLKPEN 245
           L+LD++      + + R    R  Q       + Y  ++  +++++H  GI HRD+KP+N
Sbjct: 96  LVLDYVP--ETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN 152
Query: 246 ILMDSDGHVM-LTDFGLAKEIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGIL 303
           +L+D D  V+ L DFG AK++     + S   +  Y APE++  +  +    D WS G +
Sbjct: 153 LLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCV 212
Query: 304 LYEMLTGQ 311
           L E+L GQ
Sbjct: 213 LAELLLGQ 220

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 85/165 (51%), Gaps = 17/165 (10%)
Query: 161 YMKAERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFRE 214
           +   E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R 
Sbjct: 97  FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARH-YSRA 153
Query: 215 DQA------RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDE 267
            Q       + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++  
Sbjct: 154 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 213
Query: 268 SSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
              + S   +  Y APE++  +  +    D WS G +L E+L GQ
Sbjct: 214 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 145 MKVMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           M V R  + + +     +  + D++ + +  P+IVQ   +       ++ ++ ++     
Sbjct: 50  MAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDK 109
Query: 204 FHLYRQGIFR----EDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTD 258
           F+ Y   +      E+     T   V A++HL +   I+HRD+KP NIL+D  G++ L D
Sbjct: 110 FYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCD 169
Query: 259 FGLAKEIDESSRSNSMCGTTEYMAPEIL----LSKGHNKDADWWSVGILLYEMLTGQ 311
           FG++ ++ +S       G   YMAPE +      +G++  +D WS+GI LYE+ TG+
Sbjct: 170 FGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 37/100 (37%), Positives = 59/100 (59%), Gaps = 3/100 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 130 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE--MTG 187
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQV 312
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+ 
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 87/165 (52%), Gaps = 17/165 (10%)
Query: 161 YMKAERDILTKVTHPFIVQLRYSF----QTRSKLYL--ILDFINGGHLFFHLYRQGIFRE 214
           +   E  I+ K+ H  IV+LRY F    + + ++YL  +LD++      + + R    R 
Sbjct: 93  FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARH-YSRA 149
Query: 215 DQA------RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDE 267
            Q       + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++  
Sbjct: 150 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209
Query: 268 SSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
              + S   +  Y APE++  +  +    D WS G +L E+L GQ
Sbjct: 210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 87/165 (52%), Gaps = 17/165 (10%)
Query: 161 YMKAERDILTKVTHPFIVQLRYSF----QTRSKLYL--ILDFINGGHLFFHLYRQGIFRE 214
           +   E  I+ K+ H  IV+LRY F    + + ++YL  +LD++      + + R    R 
Sbjct: 71  FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARH-YSRA 127
Query: 215 DQA------RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDE 267
            Q       + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++  
Sbjct: 128 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 187
Query: 268 SSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
              + S   +  Y APE++  +  +    D WS G +L E+L GQ
Sbjct: 188 GEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 91/171 (53%), Gaps = 4/171 (2%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 29  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 87
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 88  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 147
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
           LA+      R+ +    T  Y APEILL  K ++   D WS+G +  EM+T
Sbjct: 148 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 86/161 (53%), Gaps = 17/161 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSF----QTRSKLYL--ILDFINGGHLFFHLYRQGIFREDQA- 217
           E  I+ K+ H  IV+LRY F    + + ++YL  +LD++      + + R    R  Q  
Sbjct: 75  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARH-YSRAKQTL 131
Query: 218 -----RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 132 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 191
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
            S   +  Y APE++  +  +    D WS G +L E+L GQ
Sbjct: 192 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 91/171 (53%), Gaps = 4/171 (2%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 89  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 148
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
           LA+      R+ +    T  Y APEILL  K ++   D WS+G +  EM+T
Sbjct: 149 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 91/171 (53%), Gaps = 4/171 (2%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 29  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 87
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 88  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 147
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
           LA+      R+ +    T  Y APEILL  K ++   D WS+G +  EM+T
Sbjct: 148 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 37/214 (17%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA----ERDILTK 171
           +V+G G+F                  +Y  K+     ++    V   KA    E  I+ K
Sbjct: 26  KVIGNGSFGV----------------VYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRK 69
Query: 172 VTHPFIVQLRYSF----QTRSKLYL--ILDFINGGHLFFHLYRQGIFREDQA------RF 219
           + H  IV+LRY F    + + ++YL  +LD++      + + R    R  Q       + 
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARH-YSRAKQTLPVIYVKL 126
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCGTT 278
           Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     + S   + 
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 186
Query: 279 EYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
            Y APE++  +  +    D WS G +L E+L GQ
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 91/171 (53%), Gaps = 4/171 (2%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 89  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 148
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
           LA+      R+ +    T  Y APEILL  K ++   D WS+G +  EM+T
Sbjct: 149 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 91/171 (53%), Gaps = 4/171 (2%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 34  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 92
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 93  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 152
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
           LA+      R+ +    T  Y APEILL  K ++   D WS+G +  EM+T
Sbjct: 153 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 37/100 (37%), Positives = 59/100 (59%), Gaps = 3/100 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 126 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE--MTG 183
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQV 312
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+ 
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 223

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 17/161 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQA- 217
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYV--PETVYRVARH-YSRAKQTL 119
Query: 218 -----RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
            S   +  Y APE++  +  +    D WS G +L E+L GQ
Sbjct: 180 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 86/161 (53%), Gaps = 17/161 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSF----QTRSKLYL--ILDFINGGHLFFHLYRQGIFREDQA- 217
           E  I+ K+ H  IV+LRY F    + + ++YL  +LD++      + + R    R  Q  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 119
Query: 218 -----RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
            S   +  Y APE++  +  +    D WS G +L E+L GQ
Sbjct: 180 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 17/161 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQA- 217
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 68  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARH-YSRAKQTL 124
Query: 218 -----RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 125 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 184
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
            S   +  Y APE++  +  +    D WS G +L E+L GQ
Sbjct: 185 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 90/171 (52%), Gaps = 4/171 (2%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKPEN+L++++G + L DFG
Sbjct: 89  KDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFG 148
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T
Sbjct: 149 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 17/161 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQA- 217
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 67  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARH-YSRAKQTL 123
Query: 218 -----RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 124 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 183
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
            S   +  Y APE++  +  +    D WS G +L E+L GQ
Sbjct: 184 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 87/165 (52%), Gaps = 17/165 (10%)
Query: 161 YMKAERDILTKVTHPFIVQLRYSF----QTRSKLYL--ILDFINGGHLFFHLYRQGIFRE 214
           +   E  I+ K+ H  IV+LRY F    + + ++YL  +LD++      + + R    R 
Sbjct: 59  FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRA 115
Query: 215 DQA------RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDE 267
            Q       + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++  
Sbjct: 116 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175
Query: 268 SSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
              + S   +  Y APE++  +  +    D WS G +L E+L GQ
Sbjct: 176 GEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 86/161 (53%), Gaps = 17/161 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSF----QTRSKLYL--ILDFINGGHLFFHLYRQGIFREDQA- 217
           E  I+ K+ H  IV+LRY F    + + ++YL  +LD++      + + R    R  Q  
Sbjct: 64  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 120
Query: 218 -----RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 121 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 180
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
            S   +  Y APE++  +  +    D WS G +L E+L GQ
Sbjct: 181 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 86/161 (53%), Gaps = 17/161 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSF----QTRSKLYL--ILDFINGGHLFFHLYRQGIFREDQA- 217
           E  I+ K+ H  IV+LRY F    + + ++YL  +LD++      + + R    R  Q  
Sbjct: 76  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 132
Query: 218 -----RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 133 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 192
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
            S   +  Y APE++  +  +    D WS G +L E+L GQ
Sbjct: 193 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 182 YVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 91/171 (53%), Gaps = 4/171 (2%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 89  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 148
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
           LA+      R+ +    T  Y APEILL  K ++   D WS+G +  EM+T
Sbjct: 149 LARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 86/161 (53%), Gaps = 17/161 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSF----QTRSKLYL--ILDFINGGHLFFHLYRQGIFREDQA- 217
           E  I+ K+ H  IV+LRY F    + + ++YL  +LD++      + + R    R  Q  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 119
Query: 218 -----RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
            S   +  Y APE++  +  +    D WS G +L E+L GQ
Sbjct: 180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 182 XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 129 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE--MTG 186
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 37/100 (37%), Positives = 59/100 (59%), Gaps = 3/100 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 135 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE--MTG 192
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQV 312
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+ 
Sbjct: 193 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 232

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 129 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE--MTG 186
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 90/171 (52%), Gaps = 4/171 (2%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 32  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 90
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 91  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 150
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T
Sbjct: 151 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 177
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 90/171 (52%), Gaps = 4/171 (2%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 33  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 91
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 92  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 151
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T
Sbjct: 152 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 90/171 (52%), Gaps = 4/171 (2%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 32  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 90
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 91  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 150
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T
Sbjct: 151 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 90/171 (52%), Gaps = 4/171 (2%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 34  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 92
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 93  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 152
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T
Sbjct: 153 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 177
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 90/171 (52%), Gaps = 4/171 (2%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 89  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 148
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T
Sbjct: 149 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 121 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 178
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 179 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 90/171 (52%), Gaps = 4/171 (2%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 31  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 89
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 90  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 149
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T
Sbjct: 150 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 12/208 (5%)
Query: 108 GPGDFEIFRVV---GQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           GPG  E F+ V   G+G +                  + A+K +R DT  +      ++ 
Sbjct: 1   GPGSMENFQKVEKIGEGTYGVVYKARNKLTGE-----VVALKKIRLDTETEGVPSTAIR- 54
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAE 223
           E  +L ++ HP IV+L     T +KLYL+ + ++     F              + Y  +
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQ 114
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMA 282
           ++  ++  H   ++HRDLKP+N+L++++G + L DFGLA+      R+      T  Y A
Sbjct: 115 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 283 PEILLS-KGHNKDADWWSVGILLYEMLT 309
           PEILL  K ++   D WS+G +  EM+T
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 90/171 (52%), Gaps = 4/171 (2%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 29  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 87
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 88  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 147
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T
Sbjct: 148 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 121 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 178
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 179 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 90/171 (52%), Gaps = 4/171 (2%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 89  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 148
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T
Sbjct: 149 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 122 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 179
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 180 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 129 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 186
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 90/171 (52%), Gaps = 4/171 (2%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 31  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 89
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 90  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 149
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T
Sbjct: 150 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 177
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 90/171 (52%), Gaps = 4/171 (2%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 29  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 87
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 88  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 147
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T
Sbjct: 148 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 37/100 (37%), Positives = 59/100 (59%), Gaps = 3/100 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 126 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 183
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQV 312
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+ 
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 223

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 37/100 (37%), Positives = 59/100 (59%), Gaps = 3/100 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 130 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 187
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQV 312
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+ 
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 129 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 186
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 37/100 (37%), Positives = 59/100 (59%), Gaps = 3/100 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 136 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 193
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQV 312
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+ 
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 233

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 123 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 180
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 181 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 37/100 (37%), Positives = 59/100 (59%), Gaps = 3/100 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 136 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 193
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQV 312
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+ 
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 233

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 90/171 (52%), Gaps = 4/171 (2%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 89  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 148
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T
Sbjct: 149 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 134 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 191
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 192 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 37/100 (37%), Positives = 59/100 (59%), Gaps = 3/100 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 130 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 187
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQV 312
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+ 
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 80/166 (48%), Gaps = 15/166 (9%)
Query: 156 KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL------YLILDFINGGHLFFHLYRQ 209
           + H      E  +L  V H  I+ L   F  +  L      YL+++ ++          Q
Sbjct: 64  QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC------Q 117
Query: 210 GIFRE---DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID 266
            I  E   ++  +   +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+   
Sbjct: 118 VIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 177
Query: 267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            +        T  Y APE++L  G+  + D WSVG ++ E++ G V
Sbjct: 178 TNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKGCV 223

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 126 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 183
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 37/100 (37%), Positives = 59/100 (59%), Gaps = 3/100 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 135 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 192
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQV 312
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+ 
Sbjct: 193 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 232

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 37/100 (37%), Positives = 59/100 (59%), Gaps = 3/100 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 136 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 193
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQV 312
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+ 
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 233

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 37/100 (37%), Positives = 59/100 (59%), Gaps = 3/100 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 126 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 183
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQV 312
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+ 
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 223

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 37/100 (37%), Positives = 59/100 (59%), Gaps = 3/100 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 130 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 187
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQV 312
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+ 
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MAG 177
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 178 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 86/157 (54%), Gaps = 14/157 (8%)
Query: 164 AERDILTKVTHPFIVQL--RYSFQTRSKLYLILDFINGGHLFFHLY-----RQGIFREDQ 216
           +E ++L ++ HP IV+   R   +T + LY+++++  GG L   +      RQ +  E  
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 217 ARFYTAEIVSAVSHLHKCG-----IVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSR 270
            R  T ++  A+   H+       ++HRDLKP N+ +D   +V L DFGLA+ ++ +   
Sbjct: 114 LRVMT-QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDF 172
Query: 271 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +    GT  YM+PE +    +N+ +D WS+G LLYE+
Sbjct: 173 AKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 188
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MAG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 182 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MAG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 182 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 37/100 (37%), Positives = 59/100 (59%), Gaps = 3/100 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 144 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 201
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQV 312
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+ 
Sbjct: 202 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 241

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 147 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 204
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 205 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 37/100 (37%), Positives = 59/100 (59%), Gaps = 3/100 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 143 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 200
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQV 312
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+ 
Sbjct: 201 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 240

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 144 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 201
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 202 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 143 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 200
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 201 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 90/171 (52%), Gaps = 4/171 (2%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 89  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 148
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T
Sbjct: 149 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 80/148 (54%), Gaps = 3/148 (2%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAE 223
           E  +L ++ HP IV+L     T +KLYL+ +F++     F              + Y  +
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMA 282
           ++  ++  H   ++HRDLKP+N+L++++G + L DFGLA+      R+ +    T  Y A
Sbjct: 112 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 171
Query: 283 PEILLS-KGHNKDADWWSVGILLYEMLT 309
           PEILL  K ++   D WS+G +  EM+T
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 80/148 (54%), Gaps = 3/148 (2%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAE 223
           E  +L ++ HP IV+L     T +KLYL+ +F++     F              + Y  +
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMA 282
           ++  ++  H   ++HRDLKP+N+L++++G + L DFGLA+      R+ +    T  Y A
Sbjct: 111 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 170
Query: 283 PEILLS-KGHNKDADWWSVGILLYEMLT 309
           PEILL  K ++   D WS+G +  EM+T
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 37/100 (37%), Positives = 59/100 (59%), Gaps = 3/100 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 147 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MXG 204
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQV 312
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+ 
Sbjct: 205 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 244

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 90/171 (52%), Gaps = 4/171 (2%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 33  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDL 91
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 92  KDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 151
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T
Sbjct: 152 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 144 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MXG 201
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 202 XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 90/171 (52%), Gaps = 4/171 (2%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 32  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDL 90
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 91  KDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 150
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T
Sbjct: 151 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 109/229 (47%), Gaps = 41/229 (17%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE   V+GQGAF                   YA+K +R      +  +  + +E  +L 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRY-----YAIKKIRH----TEEKLSTILSEVXLLA 57
Query: 171 KVTHPFIVQL------RYSF-------QTRSKLYLILDFINGGHLFFHLYRQGIF--RED 215
            + H ++V+       R +F       + +S L++  ++     L+  ++ + +   R++
Sbjct: 58  SLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDE 117
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES------- 268
             R +  +I+ A+S++H  GI+HR+LKP NI +D   +V + DFGLAK +  S       
Sbjct: 118 YWRLFR-QILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 269 ------SRSN--SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEML 308
                 S  N  S  GT  Y+A E+L   GH N+  D +S+GI+ +E +
Sbjct: 177 SQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 83/150 (55%), Gaps = 6/150 (4%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 60  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 119
Query: 225 VSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H  G++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 120 LEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 178
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQV 312
           E I   + H + A  WS+GILLY+M+ G +
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDI 208

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 37/100 (37%), Positives = 58/100 (58%), Gaps = 3/100 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 153 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTG 210
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQV 312
              T  Y APEI+L+  H N   D WSVG ++ E+LTG+ 
Sbjct: 211 YVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRT 250

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 58/100 (58%), Gaps = 3/100 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGL +  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQV 312
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+ 
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + D+GLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 90/171 (52%), Gaps = 4/171 (2%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ + ++   
Sbjct: 29  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEHVHQDL 87
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 88  KTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 147
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
           LA+      R+ +    T  Y APEILL  K ++   D WS+G +  EM+T
Sbjct: 148 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 71/134 (52%), Gaps = 7/134 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 96  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 153
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 154 PSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 213
Query: 298 WSVGILLYEMLTGQ 311
           WSVG +L EML+ +
Sbjct: 214 WSVGCILAEMLSNR 227

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 71/134 (52%), Gaps = 7/134 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 94  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 151
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 152 PSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 211
Query: 298 WSVGILLYEMLTGQ 311
           WSVG +L EML+ +
Sbjct: 212 WSVGCILAEMLSNR 225

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 71/134 (52%), Gaps = 7/134 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 94  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 151
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 152 PSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 211
Query: 298 WSVGILLYEMLTGQ 311
           WSVG +L EML+ +
Sbjct: 212 WSVGCILAEMLSNR 225

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 71/134 (52%), Gaps = 7/134 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 94  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 151
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 152 PSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 211
Query: 298 WSVGILLYEMLTGQ 311
           WSVG +L EML+ +
Sbjct: 212 WSVGCILAEMLSNR 225

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 71/134 (52%), Gaps = 7/134 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 94  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 151
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 152 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 211
Query: 298 WSVGILLYEMLTGQ 311
           WSVG +L EML+ +
Sbjct: 212 WSVGCILAEMLSNR 225

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 71/134 (52%), Gaps = 7/134 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 96  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 153
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 154 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 213
Query: 298 WSVGILLYEMLTGQ 311
           WSVG +L EML+ +
Sbjct: 214 WSVGCILAEMLSNR 227

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 71/134 (52%), Gaps = 7/134 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 98  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 155
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 156 PSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 215
Query: 298 WSVGILLYEMLTGQ 311
           WSVG +L EML+ +
Sbjct: 216 WSVGCILAEMLSNR 229

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 71/134 (52%), Gaps = 7/134 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 114 TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 171
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 172 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 231
Query: 298 WSVGILLYEMLTGQ 311
           WSVG +L EML+ +
Sbjct: 232 WSVGCILAEMLSNR 245

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 81/157 (51%), Gaps = 8/157 (5%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYT 221
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+  +  F   +     
Sbjct: 68  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIA 126
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SMCGTT 278
            +    + +LH   I+HRDLK  NI +  D  V + DFGLA E    S S+    + G+ 
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 279 EYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQV 312
            +MAPE++  +  N     +D ++ GI+LYE++TGQ+
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL 223

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 71/134 (52%), Gaps = 7/134 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 98  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 155
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 156 PSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 215
Query: 298 WSVGILLYEMLTGQ 311
           WSVG +L EML+ +
Sbjct: 216 WSVGCILAEMLSNR 229

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 71/134 (52%), Gaps = 7/134 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 96  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 153
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 154 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 213
Query: 298 WSVGILLYEMLTGQ 311
           WSVG +L EML+ +
Sbjct: 214 WSVGCILAEMLSNR 227

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 71/134 (52%), Gaps = 7/134 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 92  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 149
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 150 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 209
Query: 298 WSVGILLYEMLTGQ 311
           WSVG +L EML+ +
Sbjct: 210 WSVGCILAEMLSNR 223

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 71/134 (52%), Gaps = 7/134 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 98  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 155
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 156 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 215
Query: 298 WSVGILLYEMLTGQ 311
           WSVG +L EML+ +
Sbjct: 216 WSVGCILAEMLSNR 229

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 71/134 (52%), Gaps = 7/134 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 99  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 156
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 157 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 216
Query: 298 WSVGILLYEMLTGQ 311
           WSVG +L EML+ +
Sbjct: 217 WSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 71/134 (52%), Gaps = 7/134 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 100 TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 157
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 158 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 217
Query: 298 WSVGILLYEMLTGQ 311
           WSVG +L EML+ +
Sbjct: 218 WSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 71/134 (52%), Gaps = 7/134 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 91  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 148
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 149 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 208
Query: 298 WSVGILLYEMLTGQ 311
           WSVG +L EML+ +
Sbjct: 209 WSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 71/134 (52%), Gaps = 7/134 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 98  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 155
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 156 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 215
Query: 298 WSVGILLYEMLTGQ 311
           WSVG +L EML+ +
Sbjct: 216 WSVGCILAEMLSNR 229

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 71/134 (52%), Gaps = 7/134 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 92  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 149
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 150 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 209
Query: 298 WSVGILLYEMLTGQ 311
           WSVG +L EML+ +
Sbjct: 210 WSVGCILAEMLSNR 223

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 71/134 (52%), Gaps = 7/134 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 98  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 155
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 156 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDI 215
Query: 298 WSVGILLYEMLTGQ 311
           WSVG +L EML+ +
Sbjct: 216 WSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 71/134 (52%), Gaps = 7/134 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 99  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 156
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 157 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDI 216
Query: 298 WSVGILLYEMLTGQ 311
           WSVG +L EML+ +
Sbjct: 217 WSVGCILAEMLSNR 230

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 71/134 (52%), Gaps = 7/134 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 102 TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 159
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 160 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 219
Query: 298 WSVGILLYEMLTGQ 311
           WSVG +L EML+ +
Sbjct: 220 WSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 71/134 (52%), Gaps = 7/134 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 94  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 151
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 152 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 211
Query: 298 WSVGILLYEMLTGQ 311
           WSVG +L EML+ +
Sbjct: 212 WSVGCILAEMLSNR 225

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 58/99 (58%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+    +     
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--ADEMTG 188
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 58/99 (58%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+    +     
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--ADEMTG 188
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 71/134 (52%), Gaps = 7/134 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +YL+   +  G   + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 114 TIEQMKDVYLVTHLM--GADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 171
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 172 PSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 231
Query: 298 WSVGILLYEMLTGQ 311
           WSVG +L EML+ +
Sbjct: 232 WSVGCILAEMLSNR 245

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 58/99 (58%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+    +     
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--ADEMTG 188
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 78/149 (52%), Gaps = 5/149 (3%)
Query: 164 AERDILTKVTHPFIVQL-RYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFY 220
           AE  ++T++ H  +VQL     + +  LY++ +++  G L  +L  +G  +   D    +
Sbjct: 235 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 294
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
           + ++  A+ +L     VHRDL   N+L+  D    ++DFGL KE   +  +  +    ++
Sbjct: 295 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKW 352
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT 309
            APE L  K  +  +D WS GILL+E+ +
Sbjct: 353 TAPEALREKKFSTKSDVWSFGILLWEIYS 381

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 77/147 (52%), Gaps = 5/147 (3%)
Query: 164 AERDILTKVTHPFIVQL-RYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFY 220
           AE  ++T++ H  +VQL     + +  LY++ +++  G L  +L  +G  +   D    +
Sbjct: 48  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 107
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
           + ++  A+ +L     VHRDL   N+L+  D    ++DFGL KE   +  +  +    ++
Sbjct: 108 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKW 165
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEM 307
            APE L  K  +  +D WS GILL+E+
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILLWEI 192

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 78/149 (52%), Gaps = 5/149 (3%)
Query: 164 AERDILTKVTHPFIVQL-RYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFY 220
           AE  ++T++ H  +VQL     + +  LY++ +++  G L  +L  +G  +   D    +
Sbjct: 63  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 122
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
           + ++  A+ +L     VHRDL   N+L+  D    ++DFGL KE   +  +  +    ++
Sbjct: 123 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKW 180
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT 309
            APE L  K  +  +D WS GILL+E+ +
Sbjct: 181 TAPEALREKKFSTKSDVWSFGILLWEIYS 209

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 71/134 (52%), Gaps = 7/134 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 98  TIEQMKDVYIVQDLMETD--LYKLLKCQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 155
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 156 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 215
Query: 298 WSVGILLYEMLTGQ 311
           WSVG +L EML+ +
Sbjct: 216 WSVGCILAEMLSNR 229

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 58/99 (58%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + +  FGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 18/216 (8%)
Query: 108 GPGDFEIF--------RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHV 159
           GPGD  +F        R +G+G F                  + A+K ++ D      H 
Sbjct: 21  GPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMV-AVKALKADA--GPQHR 77
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTR--SKLYLILDFINGGHLFFHLYRQGIFREDQA 217
              K E DIL  + H  I++ +   +    + L L+++++  G L  +L R  I    Q 
Sbjct: 78  SGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLA-QL 136
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
             +  +I   +++LH    +HRDL   N+L+D+D  V + DFGLAK + E      +   
Sbjct: 137 LLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVRED 196
Query: 278 TE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            +    + APE L        +D WS G+ LYE+LT
Sbjct: 197 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 84/164 (51%), Gaps = 8/164 (4%)
Query: 151 DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQ 209
           D ++KK  +  +K    +L ++ H  +V L    + + + YL+ +F++   L    L+  
Sbjct: 64  DKMVKKIAMREIK----LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPN 119
Query: 210 GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS 269
           G+  +   + Y  +I++ +   H   I+HRD+KPENIL+   G V L DFG A+ +    
Sbjct: 120 GLDYQVVQK-YLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178
Query: 270 RS-NSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQ 311
              +    T  Y APE+L+    + K  D W++G L+ EM  G+
Sbjct: 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 58/99 (58%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + D GLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 80/148 (54%), Gaps = 2/148 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  IL ++ H  IV+L     T+ +L L+ + ++          +G      A+ +  ++
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL 109
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMAP 283
           ++ +++ H   ++HRDLKP+N+L++ +G + + DFGLA+      R  +    T  Y AP
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAP 169
Query: 284 EILL-SKGHNKDADWWSVGILLYEMLTG 310
           ++L+ SK ++   D WSVG +  EM+ G
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 80/148 (54%), Gaps = 2/148 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  IL ++ H  IV+L     T+ +L L+ + ++          +G      A+ +  ++
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL 109
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMAP 283
           ++ +++ H   ++HRDLKP+N+L++ +G + + DFGLA+      R  +    T  Y AP
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAP 169
Query: 284 EILL-SKGHNKDADWWSVGILLYEMLTG 310
           ++L+ SK ++   D WSVG +  EM+ G
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 80/157 (50%), Gaps = 8/157 (5%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYT 221
           K E  +L K  H  I+ L   + T  +L ++  +  G  L+ HL+  +  F   +     
Sbjct: 68  KNEVGVLRKTRHVNIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIA 126
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SMCGTT 278
            +    + +LH   I+HRDLK  NI +  D  V + DFGLA E    S S+    + G+ 
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 279 EYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQV 312
            +MAPE++  +  N     +D ++ GI+LYE++TGQ+
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL 223

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 81/165 (49%), Gaps = 8/165 (4%)
Query: 154 IKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
           +KK  ++  + E  +    ++ P IV L  + +    + + ++ + GG L   + + G  
Sbjct: 104 VKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCL 163
Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEIDESSRS 271
            ED+A +Y  + +  + +LH   I+H D+K +N+L+ SDG    L DFG A  +      
Sbjct: 164 PEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 223
Query: 272 NSMC------GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            S+       GT  +MAPE+++ K  +   D WS   ++  ML G
Sbjct: 224 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 58/99 (58%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + D GLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 58/99 (58%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DF LA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 31/210 (14%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK----AER 166
           + E+  VVG+GAF                  +   K   KD  IK+   +  +     E 
Sbjct: 10  EIEVEEVVGRGAFGV----------------VCKAKWRAKDVAIKQIESESERKAFIVEL 53
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ---GIFREDQARFYTAE 223
             L++V HP IV+L  +    + + L++++  GG L+  L+       +    A  +  +
Sbjct: 54  RQLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ 111
Query: 224 IVSAVSHLHKC---GIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCGTTE 279
               V++LH      ++HRDLKP N+L+ + G V+ + DFG A +I     +N   G+  
Sbjct: 112 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAA 169
Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           +MAPE+     +++  D +S GI+L+E++T
Sbjct: 170 WMAPEVFEGSNYSEKCDVFSWGIILWEVIT 199

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 80/148 (54%), Gaps = 2/148 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  IL ++ H  IV+L     T+ +L L+ + ++          +G      A+ +  ++
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL 109
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMAP 283
           ++ +++ H   ++HRDLKP+N+L++ +G + + DFGLA+      R  +    T  Y AP
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAP 169
Query: 284 EILL-SKGHNKDADWWSVGILLYEMLTG 310
           ++L+ SK ++   D WSVG +  EM+ G
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 81/165 (49%), Gaps = 8/165 (4%)
Query: 154 IKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
           +KK  ++  + E  +    ++ P IV L  + +    + + ++ + GG L   + + G  
Sbjct: 88  VKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCL 147
Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEIDESSRS 271
            ED+A +Y  + +  + +LH   I+H D+K +N+L+ SDG    L DFG A  +      
Sbjct: 148 PEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207
Query: 272 NSMC------GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            S+       GT  +MAPE+++ K  +   D WS   ++  ML G
Sbjct: 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 91/184 (49%), Gaps = 30/184 (16%)
Query: 156 KNHVDYMKAERDI--LTKVT-HPFIVQLRYSFQTRSK--LYLILDFINGGHLFFHLYRQG 210
           +N  D  +  R+I  LT+++ H  IV L    +  +   +YL+ D++        + R  
Sbjct: 47  QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETD--LHAVIRAN 104
Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK------- 263
           I      ++   +++  + +LH  G++HRD+KP NIL++++ HV + DFGL++       
Sbjct: 105 ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164
Query: 264 -------EIDESSRS--------NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEM 307
                   I+E++ +             T  Y APEILL S  + K  D WS+G +L E+
Sbjct: 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224
Query: 308 LTGQ 311
           L G+
Sbjct: 225 LCGK 228

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 58/99 (58%), Gaps = 3/99 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + D GLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 81/165 (49%), Gaps = 8/165 (4%)
Query: 154 IKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
           +KK  ++  + E  +    ++ P IV L  + +    + + ++ + GG L   + + G  
Sbjct: 102 VKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCL 161
Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEIDESSRS 271
            ED+A +Y  + +  + +LH   I+H D+K +N+L+ SDG    L DFG A  +      
Sbjct: 162 PEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 221
Query: 272 NSMC------GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            S+       GT  +MAPE+++ K  +   D WS   ++  ML G
Sbjct: 222 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 76/147 (51%), Gaps = 5/147 (3%)
Query: 164 AERDILTKVTHPFIVQL-RYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFY 220
           AE  ++T++ H  +VQL     + +  LY++ +++  G L  +L  +G  +   D    +
Sbjct: 54  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 113
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
           + ++  A+ +L     VHRDL   N+L+  D    ++DFGL KE   +  +  +    ++
Sbjct: 114 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKW 171
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEM 307
            APE L     +  +D WS GILL+E+
Sbjct: 172 TAPEALREAAFSTKSDVWSFGILLWEI 198

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 31/210 (14%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK----AER 166
           + E+  VVG+GAF                  +   K   KD  IK+   +  +     E 
Sbjct: 9   EIEVEEVVGRGAFGV----------------VCKAKWRAKDVAIKQIESESERKAFIVEL 52
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ---GIFREDQARFYTAE 223
             L++V HP IV+L  +    + + L++++  GG L+  L+       +    A  +  +
Sbjct: 53  RQLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ 110
Query: 224 IVSAVSHLHKC---GIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCGTTE 279
               V++LH      ++HRDLKP N+L+ + G V+ + DFG A +I     +N   G+  
Sbjct: 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAA 168
Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           +MAPE+     +++  D +S GI+L+E++T
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVIT 198

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 87/165 (52%), Gaps = 12/165 (7%)
Query: 151 DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFH---LY 207
           D +IKK  +  ++    +L ++ HP +V L   F+ + +L+L+ ++ +  H   H    Y
Sbjct: 42  DPVIKKIALREIR----MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD--HTVLHELDRY 95
Query: 208 RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-D 266
           ++G+  E   +  T + + AV+  HK   +HRD+KPENIL+     + L DFG A+ +  
Sbjct: 96  QRGV-PEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG 154
Query: 267 ESSRSNSMCGTTEYMAPEILLSKG-HNKDADWWSVGILLYEMLTG 310
            S   +    T  Y +PE+L+    +    D W++G +  E+L+G
Sbjct: 155 PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 76/150 (50%), Gaps = 4/150 (2%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L  + H  IV L     T   L L+ ++++     +      I      + +  ++
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQL 109
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL--AKEIDESSRSNSMCGTTEYMA 282
           +  +++ H+  ++HRDLKP+N+L++  G + L DFGL  AK I   +  N +  T  Y  
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRP 168
Query: 283 PEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
           P+ILL S  ++   D W VG + YEM TG+
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 83/161 (51%), Gaps = 16/161 (9%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-----QGIFREDQA 217
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+      + I   D A
Sbjct: 52  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 110
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SM 274
           R    +    + +LH   I+HRDLK  NI +  D  V + DFGLA E    S S+    +
Sbjct: 111 R----QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQL 166
Query: 275 CGTTEYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQV 312
            G+  +MAPE++  +  N     +D ++ GI+LYE++TGQ+
Sbjct: 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL 207

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 81/157 (51%), Gaps = 8/157 (5%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYT 221
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+  +  F   +     
Sbjct: 72  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 130
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SMCGTT 278
            +    + +LH   I+HRDLK  NI +  D  V + DFGLA E    S S+    + G+ 
Sbjct: 131 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSI 190
Query: 279 EYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQV 312
            +MAPE++  +  N     +D ++ GI+LYE++TGQ+
Sbjct: 191 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL 227

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 80/157 (50%), Gaps = 8/157 (5%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYT 221
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+  +  F   +     
Sbjct: 56  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIA 114
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SMCGTT 278
            +    + +LH   I+HRDLK  NI +  D  V + DFGLA      S S+    + G+ 
Sbjct: 115 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSI 174
Query: 279 EYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQV 312
            +MAPE++  +  N     +D ++ GI+LYE++TGQ+
Sbjct: 175 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL 211

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 86/155 (55%), Gaps = 9/155 (5%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR------QGIFREDQAR 218
           E  ++ ++ H  IV+L     T +KL L+ +F++     +   R      +G+   +  +
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGL-ELNLVK 111
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-NSMCGT 277
           ++  +++  ++  H+  I+HRDLKP+N+L++  G + L DFGLA+       + +S   T
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVT 171
Query: 278 TEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
             Y AP++L+ S+ ++   D WS G +L EM+TG+
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 81/157 (51%), Gaps = 8/157 (5%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYT 221
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+  +  F   +     
Sbjct: 80  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 138
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SMCGTT 278
            +    + +LH   I+HRDLK  NI +  D  V + DFGLA E    S S+    + G+ 
Sbjct: 139 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSI 198
Query: 279 EYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQV 312
            +MAPE++  +  N     +D ++ GI+LYE++TGQ+
Sbjct: 199 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL 235

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 38/169 (22%), Positives = 92/169 (54%), Gaps = 7/169 (4%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +R+  + +++ ++    E +++ K++HP +VQL      ++ + L+ +F+  G L 
Sbjct: 35  AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 90
Query: 204 FHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            +L  Q G+F  +       ++   +++L +  ++HRDL   N L+  +  + ++DFG+ 
Sbjct: 91  DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDLAARNCLVGENQVIKVSDFGMT 150
Query: 263 KEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           + +  D+ + S       ++ +PE+     ++  +D WS G+L++E+ +
Sbjct: 151 RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 199

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 35/86 (40%), Positives = 48/86 (55%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +++  +  LH   +VHRDLKP+NIL+ S G + L DFGLA+         S+  T  Y A
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 283 PEILLSKGHNKDADWWSVGILLYEML 308
           PE+LL   +    D WSVG +  EM 
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 37/86 (43%), Positives = 47/86 (54%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           + +  +  LH   IVHRDLKPENIL+ S G V L DFGLA+        + +  T  Y A
Sbjct: 120 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRA 179
Query: 283 PEILLSKGHNKDADWWSVGILLYEML 308
           PE+LL   +    D WSVG +  EM 
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 35/86 (40%), Positives = 48/86 (55%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +++  +  LH   +VHRDLKP+NIL+ S G + L DFGLA+         S+  T  Y A
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 283 PEILLSKGHNKDADWWSVGILLYEML 308
           PE+LL   +    D WSVG +  EM 
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +V+G GAF                  + A+KV+R++T  K N    +  E  ++  V  P
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPV-AIKVLRENTSPKANK--EILDEAYVMAGVGSP 79
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-------YTAEIVSAV 228
           ++ +L       S + L+   +  G L  H+      RE++ R        +  +I   +
Sbjct: 80  YVSRL-LGICLTSTVQLVTQLMPYGCLLDHV------RENRGRLGSQDLLNWCMQIAKGM 132
Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESS-RSNSMCGTTEYMAPEI 285
           S+L    +VHRDL   N+L+ S  HV +TDFGLA+  +IDE+   ++      ++MA E 
Sbjct: 133 SYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 192
Query: 286 LLSKGHNKDADWWSVGILLYEMLT 309
           +L +     +D WS G+ ++E++T
Sbjct: 193 ILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 29/217 (13%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F++ R+ GQG F                    A+K + +D   +   +  M+     L  
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSV-----AIKKVIQDPRFRNRELQIMQD----LAV 75
Query: 172 VTHPFIVQLRYSFQT-----RSKLYL--ILDFINGGHLFFHLYRQGIFREDQA------R 218
           + HP IVQL+  F T     R  +YL  +++++       H   +  +R   A      +
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDT---LHRCCRNYYRRQVAPPPILIK 132
Query: 219 FYTAEIVSAVS--HLHKCGIVHRDLKPENILM-DSDGHVMLTDFGLAKEIDESSRSNSMC 275
            +  +++ ++   HL    + HRD+KP N+L+ ++DG + L DFG AK++  S  + +  
Sbjct: 133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI 192
Query: 276 GTTEYMAPEILLSKGHNKDA-DWWSVGILLYEMLTGQ 311
            +  Y APE++    H   A D WSVG +  EM+ G+
Sbjct: 193 CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 35/86 (40%), Positives = 48/86 (55%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +++  +  LH   +VHRDLKP+NIL+ S G + L DFGLA+         S+  T  Y A
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 283 PEILLSKGHNKDADWWSVGILLYEML 308
           PE+LL   +    D WSVG +  EM 
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 37/86 (43%), Positives = 46/86 (53%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           + +  +  LH   IVHRDLKPENIL+ S G V L DFGLA+          +  T  Y A
Sbjct: 128 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRA 187
Query: 283 PEILLSKGHNKDADWWSVGILLYEML 308
           PE+LL   +    D WSVG +  EM 
Sbjct: 188 PEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 38/169 (22%), Positives = 92/169 (54%), Gaps = 7/169 (4%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +R+  + +++ ++    E +++ K++HP +VQL      ++ + L+ +F+  G L 
Sbjct: 33  AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 88
Query: 204 FHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            +L  Q G+F  +       ++   +++L +  ++HRDL   N L+  +  + ++DFG+ 
Sbjct: 89  DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 148
Query: 263 KEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           + +  D+ + S       ++ +PE+     ++  +D WS G+L++E+ +
Sbjct: 149 RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 197

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 38/169 (22%), Positives = 92/169 (54%), Gaps = 7/169 (4%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +R+  + +++ ++    E +++ K++HP +VQL      ++ + L+ +F+  G L 
Sbjct: 35  AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 90
Query: 204 FHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            +L  Q G+F  +       ++   +++L +  ++HRDL   N L+  +  + ++DFG+ 
Sbjct: 91  DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 150
Query: 263 KEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           + +  D+ + S       ++ +PE+     ++  +D WS G+L++E+ +
Sbjct: 151 RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 199

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 38/169 (22%), Positives = 92/169 (54%), Gaps = 7/169 (4%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +R+  + +++ ++    E +++ K++HP +VQL      ++ + L+ +F+  G L 
Sbjct: 38  AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 93
Query: 204 FHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            +L  Q G+F  +       ++   +++L +  ++HRDL   N L+  +  + ++DFG+ 
Sbjct: 94  DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 153
Query: 263 KEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           + +  D+ + S       ++ +PE+     ++  +D WS G+L++E+ +
Sbjct: 154 RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 202

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 82/155 (52%), Gaps = 9/155 (5%)
Query: 163 KAERDILTKVTHPFIVQLR-YSFQT-RSKLYLILDFINGGHLFFHLYRQGIFREDQARF- 219
           + E  IL  +   FIV+ R  S+   R +L L+++++  G L   L R    R D +R  
Sbjct: 56  QREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRA-RLDASRLL 114
Query: 220 -YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRSNSMCG 276
            Y+++I   + +L     VHRDL   NIL++S+ HV + DFGLAK   +D+        G
Sbjct: 115 LYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPG 174
Query: 277 TTE--YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            +   + APE L     ++ +D WS G++LYE+ T
Sbjct: 175 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 37/86 (43%), Positives = 46/86 (53%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           + +  +  LH   IVHRDLKPENIL+ S G V L DFGLA+          +  T  Y A
Sbjct: 120 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRA 179
Query: 283 PEILLSKGHNKDADWWSVGILLYEML 308
           PE+LL   +    D WSVG +  EM 
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 82/172 (47%), Gaps = 9/172 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF--QTRSKLYLILDFINGGH 201
           A+K ++ D      H    K E DIL  + H  I++ +     Q    L L+++++  G 
Sbjct: 47  AVKALKADC--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGS 104
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L  +L R  I    Q   +  +I   +++LH    +HR+L   N+L+D+D  V + DFGL
Sbjct: 105 LRDYLPRHSIGLA-QLLLFAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGL 163
Query: 262 AKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           AK + E      +    +    + APE L        +D WS G+ LYE+LT
Sbjct: 164 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 82/172 (47%), Gaps = 9/172 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF--QTRSKLYLILDFINGGH 201
           A+K ++ D      H    K E DIL  + H  I++ +     Q    L L+++++  G 
Sbjct: 47  AVKALKADC--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGS 104
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L  +L R  I    Q   +  +I   +++LH    +HR+L   N+L+D+D  V + DFGL
Sbjct: 105 LRDYLPRHSIGLA-QLLLFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGL 163
Query: 262 AKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           AK + E      +    +    + APE L        +D WS G+ LYE+LT
Sbjct: 164 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/169 (22%), Positives = 92/169 (54%), Gaps = 7/169 (4%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +R+  + +++ ++    E +++ K++HP +VQL      ++ + L+ +F+  G L 
Sbjct: 36  AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLS 91
Query: 204 FHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            +L  Q G+F  +       ++   +++L +  ++HRDL   N L+  +  + ++DFG+ 
Sbjct: 92  DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 151
Query: 263 KEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           + +  D+ + S       ++ +PE+     ++  +D WS G+L++E+ +
Sbjct: 152 RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 70/154 (45%), Gaps = 16/154 (10%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSHLH 232
           HP  V+L  +++    LYL  +   G  L  H    G    E Q   Y  + + A++HLH
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN 292
             G+VH D+KP NI +   G   L DFGL  E+  +       G   YMAPE LL   + 
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPE-LLQGSYG 233
Query: 293 KDADWWSVGILLYEMLTGQVNIKSMQVIACNTML 326
             AD +S+G+ + E             +ACN  L
Sbjct: 234 TAADVFSLGLTILE-------------VACNMEL 254

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 37/86 (43%), Positives = 46/86 (53%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           + +  +  LH   IVHRDLKPENIL+ S G V L DFGLA+          +  T  Y A
Sbjct: 120 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRA 179
Query: 283 PEILLSKGHNKDADWWSVGILLYEML 308
           PE+LL   +    D WSVG +  EM 
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 82/174 (47%), Gaps = 13/174 (7%)
Query: 145 MKVMRKDTIIKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           M V R    +       +  + DI +  V  PF V    +      +++ ++ ++     
Sbjct: 79  MAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTS--L 136
Query: 204 FHLYRQGIFR-----EDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLT 257
              Y+Q I +     ED        IV A+ HLH K  ++HRD+KP N+L+++ G V + 
Sbjct: 137 DKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMC 196
Query: 258 DFGLAKEIDESSRSNSMCGTTEYMAPEI----LLSKGHNKDADWWSVGILLYEM 307
           DFG++  + +S       G   YMAPE     L  KG++  +D WS+GI + E+
Sbjct: 197 DFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 250

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 82/161 (50%), Gaps = 16/161 (9%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-----QGIFREDQA 217
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+      + I   D A
Sbjct: 52  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 110
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SM 274
           R    +    + +LH   I+HRDLK  NI +  D  V + DFGLA      S S+    +
Sbjct: 111 R----QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 166
Query: 275 CGTTEYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQV 312
            G+  +MAPE++  +  N     +D ++ GI+LYE++TGQ+
Sbjct: 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL 207

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 82/161 (50%), Gaps = 16/161 (9%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-----QGIFREDQA 217
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+      + I   D A
Sbjct: 57  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 115
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SM 274
           R    +    + +LH   I+HRDLK  NI +  D  V + DFGLA      S S+    +
Sbjct: 116 R----QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 171
Query: 275 CGTTEYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQV 312
            G+  +MAPE++  +  N     +D ++ GI+LYE++TGQ+
Sbjct: 172 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL 212

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 82/161 (50%), Gaps = 16/161 (9%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-----QGIFREDQA 217
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+      + I   D A
Sbjct: 54  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 112
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SM 274
           R    +    + +LH   I+HRDLK  NI +  D  V + DFGLA      S S+    +
Sbjct: 113 R----QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 168
Query: 275 CGTTEYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQV 312
            G+  +MAPE++  +  N     +D ++ GI+LYE++TGQ+
Sbjct: 169 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL 209

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 82/161 (50%), Gaps = 16/161 (9%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-----QGIFREDQA 217
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+      + I   D A
Sbjct: 57  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 115
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SM 274
           R    +    + +LH   I+HRDLK  NI +  D  V + DFGLA      S S+    +
Sbjct: 116 R----QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 171
Query: 275 CGTTEYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQV 312
            G+  +MAPE++  +  N     +D ++ GI+LYE++TGQ+
Sbjct: 172 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL 212

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 80/158 (50%), Gaps = 6/158 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ +++N G L  F         R  Q    +A
Sbjct: 60  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSA 118
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 119 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKW 178
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSM 317
            APE  L       +D WS GILL E+ T G+V    M
Sbjct: 179 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 216

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 80/158 (50%), Gaps = 6/158 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ +++N G L  F         R  Q    +A
Sbjct: 60  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSA 118
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 119 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 178
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSM 317
            APE  L       +D WS GILL E+ T G+V    M
Sbjct: 179 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 216

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 81/155 (52%), Gaps = 9/155 (5%)
Query: 163 KAERDILTKVTHPFIVQLR-YSFQT-RSKLYLILDFINGGHLFFHLYRQGIFREDQARF- 219
           + E  IL  +   FIV+ R  S+   R  L L+++++  G L   L R    R D +R  
Sbjct: 60  QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLL 118
Query: 220 -YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRSNSMCG 276
            Y+++I   + +L     VHRDL   NIL++S+ HV + DFGLAK   +D+        G
Sbjct: 119 LYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG 178
Query: 277 TTE--YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            +   + APE L     ++ +D WS G++LYE+ T
Sbjct: 179 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 81/155 (52%), Gaps = 9/155 (5%)
Query: 163 KAERDILTKVTHPFIVQLR-YSFQT-RSKLYLILDFINGGHLFFHLYRQGIFREDQARF- 219
           + E  IL  +   FIV+ R  S+   R  L L+++++  G L   L R    R D +R  
Sbjct: 59  QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLL 117
Query: 220 -YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRSNSMCG 276
            Y+++I   + +L     VHRDL   NIL++S+ HV + DFGLAK   +D+        G
Sbjct: 118 LYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG 177
Query: 277 TTE--YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            +   + APE L     ++ +D WS G++LYE+ T
Sbjct: 178 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 37/169 (21%), Positives = 92/169 (54%), Gaps = 7/169 (4%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++ ++ + + ++    E +++ K++HP +VQL      ++ + L+ +F+  G L 
Sbjct: 55  AIKTIKEGSMSEDDFIE----EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 110
Query: 204 FHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            +L  Q G+F  +       ++   +++L +  ++HRDL   N L+  +  + ++DFG+ 
Sbjct: 111 DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 170
Query: 263 KEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           + +  D+ + S       ++ +PE+     ++  +D WS G+L++E+ +
Sbjct: 171 RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 219

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 81/155 (52%), Gaps = 9/155 (5%)
Query: 163 KAERDILTKVTHPFIVQLR-YSFQT-RSKLYLILDFINGGHLFFHLYRQGIFREDQARF- 219
           + E  IL  +   FIV+ R  S+   R  L L+++++  G L   L R    R D +R  
Sbjct: 72  QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLL 130
Query: 220 -YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRSNSMCG 276
            Y+++I   + +L     VHRDL   NIL++S+ HV + DFGLAK   +D+        G
Sbjct: 131 LYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG 190
Query: 277 TTE--YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            +   + APE L     ++ +D WS G++LYE+ T
Sbjct: 191 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 80/157 (50%), Gaps = 8/157 (5%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYT 221
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+  +  F   +     
Sbjct: 79  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 137
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SMCGTT 278
            +    + +LH   I+HRDLK  NI +  D  V + DFGLA      S S+    + G+ 
Sbjct: 138 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 197
Query: 279 EYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQV 312
            +MAPE++  +  N     +D ++ GI+LYE++TGQ+
Sbjct: 198 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL 234

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 80/157 (50%), Gaps = 8/157 (5%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYT 221
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+  +  F   +     
Sbjct: 80  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 138
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SMCGTT 278
            +    + +LH   I+HRDLK  NI +  D  V + DFGLA      S S+    + G+ 
Sbjct: 139 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 198
Query: 279 EYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQV 312
            +MAPE++  +  N     +D ++ GI+LYE++TGQ+
Sbjct: 199 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL 235

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 95/202 (47%), Gaps = 39/202 (19%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKV-----THPFIVQLRYSFQTRSKLYLILDFI 197
           YA+KV+R    IKK +    K E DIL K+      +  IV+    F     + LI + +
Sbjct: 63  YAVKVVRN---IKK-YTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL 118
Query: 198 NGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD------ 249
            G  L+  + R     F  +  + Y  EI+ A+++L K  + H DLKPENIL+D      
Sbjct: 119 -GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEK 177
Query: 250 --------SDGH-----------VMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
                   +DG            + L DFG A    +S    S+  T +Y APE++L+ G
Sbjct: 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF--KSDYHGSIINTRQYRAPEVILNLG 235
Query: 291 HNKDADWWSVGILLYEMLTGQV 312
            +  +D WS G +L E+ TG +
Sbjct: 236 WDVSSDMWSFGCVLAELYTGSL 257

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 100/220 (45%), Gaps = 50/220 (22%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTI-IKKNHVD--YMKAERDILTKV 172
           +V+G G+F                  ++  K++  D + IKK   D  +   E  I+  V
Sbjct: 46  KVIGNGSFGV----------------VFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIV 89
Query: 173 THPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ---------- 216
            HP +V L+  F +         L L+L+++           + ++R  +          
Sbjct: 90  KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP----------ETVYRASRHYAKLKQTMP 139
Query: 217 ---ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSN 272
               + Y  +++ +++++H  GI HRD+KP+N+L+D    V+ L DFG AK +     + 
Sbjct: 140 MLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV 199
Query: 273 SMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
           S   +  Y APE++  +  +  + D WS G ++ E++ GQ
Sbjct: 200 SXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 72/128 (56%), Gaps = 12/128 (9%)
Query: 205 HLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAK 263
           ++  QG   E+ AR +  +++  + ++H   ++HRDLKP N+ ++++  V+ + DFGLA+
Sbjct: 110 NVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLAR 169
Query: 264 EIDE--SSRSNSMCG--TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQV------ 312
            +D   S + +   G  T  Y +P +LLS   + K  D W+ G +  EMLTG+       
Sbjct: 170 IMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229
Query: 313 NIKSMQVI 320
            ++ MQ+I
Sbjct: 230 ELEQMQLI 237

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 6/158 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y+++++++ G L  F         R  Q     A
Sbjct: 63  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW 181
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSM 317
            APE  L       +D WS GILL E+ T G+V    M
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 219

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 87/171 (50%), Gaps = 10/171 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I++F+  G+L 
Sbjct: 43  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLL 98
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 99  DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 157
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T
Sbjct: 158 LSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 81/161 (50%), Gaps = 16/161 (9%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-----QGIFREDQA 217
           K E  +L K  H  I+ L   + T  +L ++  +  G  L+ HL+      + I   D A
Sbjct: 52  KNEVGVLRKTRHVNIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 110
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SM 274
           R    +    + +LH   I+HRDLK  NI +  D  V + DFGLA      S S+    +
Sbjct: 111 R----QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 166
Query: 275 CGTTEYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQV 312
            G+  +MAPE++  +  N     +D ++ GI+LYE++TGQ+
Sbjct: 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL 207

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 82/174 (47%), Gaps = 13/174 (7%)
Query: 145 MKVMRKDTIIKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           M V R    +       +  + DI +  V  PF V    +      +++ ++ ++     
Sbjct: 35  MAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTS--L 92
Query: 204 FHLYRQGIFR-----EDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLT 257
              Y+Q I +     ED        IV A+ HLH K  ++HRD+KP N+L+++ G V + 
Sbjct: 93  DKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMC 152
Query: 258 DFGLAKEIDESSRSNSMCGTTEYMAPEI----LLSKGHNKDADWWSVGILLYEM 307
           DFG++  + +    +   G   YMAPE     L  KG++  +D WS+GI + E+
Sbjct: 153 DFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 87/171 (50%), Gaps = 10/171 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I++F+  G+L 
Sbjct: 40  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLL 95
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 96  DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 154
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T
Sbjct: 155 LSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 87/171 (50%), Gaps = 10/171 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I++F+  G+L 
Sbjct: 47  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLL 102
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 103 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 161
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T
Sbjct: 162 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 110/228 (48%), Gaps = 27/228 (11%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++F+ 
Sbjct: 44  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEFLP 99
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 100 YGSLREYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 158
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T   
Sbjct: 159 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 218
Query: 313 NIKS-----MQVIACNT---MLLFYLIIFHCLFVNSLELLSHFPENCP 352
             KS     M++I  +    M++F+LI    L  N+  L    P+ CP
Sbjct: 219 KSKSPPAEFMRMIGNDKQGQMIVFHLIE---LLKNNGRLPR--PDGCP 261

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 79/157 (50%), Gaps = 8/157 (5%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYT 221
           + E  +L K  H  I+ L   + T+  L ++  +  G  L+ HL+ Q   F+  Q     
Sbjct: 80  RNEVAVLRKTRHVNIL-LFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIA 138
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM---CGTT 278
            +    + +LH   I+HRD+K  NI +     V + DFGLA      S S  +    G+ 
Sbjct: 139 RQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSV 198
Query: 279 EYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQV 312
            +MAPE++  + +N     +D +S GI+LYE++TG++
Sbjct: 199 LWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGEL 235

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 82/159 (51%), Gaps = 12/159 (7%)
Query: 162 MKAERDILTKVTHPFIVQLRYSF--QTRSKLYLILDF-INGGHLFFHLYRQGIFREDQAR 218
           +K E  +L ++ H  ++QL      + + K+Y+++++ + G         +  F   QA 
Sbjct: 53  VKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAH 112
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-----DESSRSNS 273
            Y  +++  + +LH  GIVH+D+KP N+L+ + G + ++  G+A+ +     D++ R++ 
Sbjct: 113 GYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 274 MCGTTEYMAPEIL--LSKGHNKDADWWSVGILLYEMLTG 310
             G+  +  PEI   L        D WS G+ LY + TG
Sbjct: 173 --GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/142 (34%), Positives = 70/142 (49%), Gaps = 2/142 (1%)
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++  P +V +    +   +LY+    ING  L   L RQG     +A     +I SA+  
Sbjct: 90  RLQEPHVVPIHDFGEIDGQLYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDA 149
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDES-SRSNSMCGTTEYMAPEILLS 288
            H  G  HRD+KPENIL+ +D    L DFG+A    DE  ++  +  GT  Y APE    
Sbjct: 150 AHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSE 209
Query: 289 KGHNKDADWWSVGILLYEMLTG 310
                 AD +++  +LYE LTG
Sbjct: 210 SHATYRADIYALTCVLYECLTG 231

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 6/158 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y+++++++ G L  F         R  Q     A
Sbjct: 63  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSM 317
            APE  L       +D WS GILL E+ T G+V    M
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 219

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 88/179 (49%), Gaps = 20/179 (11%)
Query: 150 KDTIIKKNHVDYMKAERDI--LTKVTHPFIVQ-------LRYSFQTRSK---------LY 191
           K  +IK+   +  KAER++  L K+ H  IV          Y  +T SK         L+
Sbjct: 37  KTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLF 96
Query: 192 LILDFINGGHLFFHLYRQGIFREDQ--ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD 249
           + ++F + G L   + ++   + D+  A     +I   V ++H   +++RDLKP NI + 
Sbjct: 97  IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV 156
Query: 250 SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
               V + DFGL   +    +     GT  YM+PE + S+ + K+ D +++G++L E+L
Sbjct: 157 DTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 87/171 (50%), Gaps = 10/171 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I++F+  G+L 
Sbjct: 42  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLL 97
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 98  DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 156
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T
Sbjct: 157 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 74/152 (48%), Gaps = 3/152 (1%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFY 220
           +K E  IL    H  I+ L  SF++  +L +I +FI+G  +F  +        E +   Y
Sbjct: 48  VKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY 107
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDS--DGHVMLTDFGLAKEIDESSRSNSMCGTT 278
             ++  A+  LH   I H D++PENI+  +     + + +FG A+++        +    
Sbjct: 108 VHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP 167
Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           EY APE+      +   D WS+G L+Y +L+G
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 86/171 (50%), Gaps = 29/171 (16%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF----- 219
           E  ++  + HP +++         +L  I ++I GG L      +GI +   +++     
Sbjct: 57  EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL------RGIIKSMDSQYPWSQR 110
Query: 220 --YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK-EIDESSRSNSM-- 274
             +  +I S +++LH   I+HRDL   N L+  + +V++ DFGLA+  +DE ++   +  
Sbjct: 111 VSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRS 170
Query: 275 ------------CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVN 313
                        G   +MAPE++  + +++  D +S GI+L E++ G+VN
Sbjct: 171 LKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVN 220

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 87/171 (50%), Gaps = 10/171 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I++F+  G+L 
Sbjct: 42  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLL 97
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 98  DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 156
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T
Sbjct: 157 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L  F         R  Q     A
Sbjct: 63  EAQVMKKIRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSM 317
            APE  L       +D WS GILL E+ T G+V    M
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 219

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 6/158 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y+++++++ G L  F         R  Q     A
Sbjct: 63  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSM 317
            APE  L       +D WS GILL E+ T G+V    M
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 219

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 10/171 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 47  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 102
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 103 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 161
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T
Sbjct: 162 LSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 10/171 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 43  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 98
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 99  DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 157
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T
Sbjct: 158 LSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 10/171 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 44  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 99
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 100 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 158
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T
Sbjct: 159 LSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 88/179 (49%), Gaps = 10/179 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL- 202
           A+K ++  T+  +  +     E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L 
Sbjct: 295 AIKTLKPGTMSPEAFLQ----EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLL 349
Query: 203 -FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
            F         R  Q     A+I S ++++ +   VHRDL+  NIL+  +    + DFGL
Sbjct: 350 DFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL 409
Query: 262 AKEIDESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSM 317
           A+ I+++  +         ++ APE  L       +D WS GILL E+ T G+V    M
Sbjct: 410 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 468

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L  F         R  Q     A
Sbjct: 56  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 114
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 115 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 174
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSM 317
            APE  L       +D WS GILL E+ T G+V    M
Sbjct: 175 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 212

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 78/153 (50%), Gaps = 7/153 (4%)
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI---- 224
           L+   HP +V L      R+++ LI  ++  G+L  HLY   +     +     EI    
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK---EIDESSRSNSMCGTTEYM 281
              + +LH   I+HRD+K  NIL+D +    +TDFG++K   E+D++     + GT  Y+
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYI 208
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQVNI 314
            PE  +     + +D +S G++L+E+L  +  I
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L  F         R  Q     A
Sbjct: 63  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSM 317
            APE  L       +D WS GILL E+ T G+V    M
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 219

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 10/171 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 40  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 95
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 96  DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 154
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T
Sbjct: 155 LSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 66/132 (50%), Gaps = 26/132 (19%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 84  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 143
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE            TT          + ++K  D W
Sbjct: 144 KPENLLYTSKRPNAILKLTDFGFAKE------------TT---------GEKYDKSCDMW 182
Query: 299 SVGILLYEMLTG 310
           S+G+++Y +L G
Sbjct: 183 SLGVIMYILLCG 194

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 7/160 (4%)
Query: 157 NHVDYMKAERDILTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYR-QGIFR 213
           NH+  +K E +IL  + H  IV+ +   +    + + LI++F+  G L  +L + +    
Sbjct: 65  NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKIN 124
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
             Q   Y  +I   + +L     VHRDL   N+L++S+  V + DFGL K I+      +
Sbjct: 125 LKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXT 184
Query: 274 MCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           +    +    + APE L+       +D WS G+ L+E+LT
Sbjct: 185 VKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 10/171 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 42  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 97
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 98  DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 156
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T
Sbjct: 157 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 97/229 (42%), Gaps = 35/229 (15%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRK--------------DTIIK 155
            D+ I R + QG F                   YA+K   K              D I  
Sbjct: 31  NDYRIIRTLNQGKFNKIILCEKDNK-------FYALKKYEKSLLEKKRDFTKSNNDKISI 83
Query: 156 KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI-NGGHLFFHLYRQGIFRE 214
           K+  D  K E  I+T + + + +          ++Y+I +++ N   L F  Y   +  +
Sbjct: 84  KSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYF-FVLDK 142
Query: 215 DQARFYTAEIVSAV--------SHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI 265
           +   F   +++  +        S++H +  I HRD+KP NILMD +G V L+DFG ++ +
Sbjct: 143 NYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM 202
Query: 266 DESSRSNSMCGTTEYMAPEILLSKGHNKDA--DWWSVGILLYEMLTGQV 312
            +     S  GT E+M PE   ++     A  D WS+GI LY M    V
Sbjct: 203 VDKKIKGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 10/171 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 47  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 102
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 103 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 161
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T
Sbjct: 162 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L  F         R  Q     A
Sbjct: 52  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 110
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 111 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 170
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSM 317
            APE  L       +D WS GILL E+ T G+V    M
Sbjct: 171 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 208

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 10/171 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 46  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 101
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 102 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 160
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T
Sbjct: 161 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L  F         R  Q     A
Sbjct: 63  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSM 317
            APE  L       +D WS GILL E+ T G+V    M
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 219

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 10/171 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 47  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 102
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 103 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 161
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T
Sbjct: 162 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 7/160 (4%)
Query: 157 NHVDYMKAERDILTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYR-QGIFR 213
           NH+  +K E +IL  + H  IV+ +   +    + + LI++F+  G L  +L + +    
Sbjct: 53  NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKIN 112
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
             Q   Y  +I   + +L     VHRDL   N+L++S+  V + DFGL K I+      +
Sbjct: 113 LKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXT 172
Query: 274 MCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           +    +    + APE L+       +D WS G+ L+E+LT
Sbjct: 173 VKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 10/171 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 42  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 97
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 98  DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 156
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T
Sbjct: 157 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L  F         R  Q     A
Sbjct: 54  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 112
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 113 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 172
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSM 317
            APE  L       +D WS GILL E+ T G+V    M
Sbjct: 173 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 210

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 10/171 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 47  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 102
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 103 DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 161
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T
Sbjct: 162 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 110/228 (48%), Gaps = 27/228 (11%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 48  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 103
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 104 YGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 162
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T   
Sbjct: 163 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 222
Query: 313 NIKS-----MQVIACNT---MLLFYLIIFHCLFVNSLELLSHFPENCP 352
             KS     M++I  +    M++F+LI    L  N+  L    P+ CP
Sbjct: 223 KSKSPPAEFMRMIGNDKQGQMIVFHLIE---LLKNNGRLPR--PDGCP 265

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 110/228 (48%), Gaps = 27/228 (11%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 72  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 127
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 128 YGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 186
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T   
Sbjct: 187 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 246
Query: 313 NIKS-----MQVIACNT---MLLFYLIIFHCLFVNSLELLSHFPENCP 352
             KS     M++I  +    M++F+LI    L  N+  L    P+ CP
Sbjct: 247 KSKSPPAEFMRMIGNDKQGQMIVFHLIE---LLKNNGRLPR--PDGCP 289

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 49/86 (56%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +I   V ++H   ++HRDLKP NI +     V + DFGL   +    +     GT  YM+
Sbjct: 144 QITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMS 203
Query: 283 PEILLSKGHNKDADWWSVGILLYEML 308
           PE + S+ + K+ D +++G++L E+L
Sbjct: 204 PEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 10/171 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 55  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 110
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 111 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 169
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T
Sbjct: 170 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 220

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 10/171 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 44  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 99
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 100 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 158
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T
Sbjct: 159 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 10/171 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 42  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 97
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 98  DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 156
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T
Sbjct: 157 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L  F         R  Q     A
Sbjct: 229 EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSM 317
            APE  L       +D WS GILL E+ T G+V    M
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 10/171 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 44  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 99
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 100 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 158
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T
Sbjct: 159 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 110/228 (48%), Gaps = 27/228 (11%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 44  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 99
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 100 YGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 158
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T   
Sbjct: 159 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 218
Query: 313 NIKS-----MQVIACNT---MLLFYLIIFHCLFVNSLELLSHFPENCP 352
             KS     M++I  +    M++F+LI    L  N+  L    P+ CP
Sbjct: 219 KSKSPPAEFMRMIGNDKQGQMIVFHLIE---LLKNNGRLPR--PDGCP 261

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 110/228 (48%), Gaps = 27/228 (11%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 39  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 94
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 95  YGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 153
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T   
Sbjct: 154 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 213
Query: 313 NIKS-----MQVIACNT---MLLFYLIIFHCLFVNSLELLSHFPENCP 352
             KS     M++I  +    M++F+LI    L  N+  L    P+ CP
Sbjct: 214 KSKSPPAEFMRMIGNDKQGQMIVFHLIE---LLKNNGRLPR--PDGCP 256

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 110/228 (48%), Gaps = 27/228 (11%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 40  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 95
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 96  YGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 154
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T   
Sbjct: 155 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 214
Query: 313 NIKS-----MQVIACNT---MLLFYLIIFHCLFVNSLELLSHFPENCP 352
             KS     M++I  +    M++F+LI    L  N+  L    P+ CP
Sbjct: 215 KSKSPPAEFMRMIGNDKQGQMIVFHLIE---LLKNNGRLPR--PDGCP 257

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 110/228 (48%), Gaps = 27/228 (11%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 46  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 101
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 102 YGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 160
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T   
Sbjct: 161 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 220
Query: 313 NIKS-----MQVIACNT---MLLFYLIIFHCLFVNSLELLSHFPENCP 352
             KS     M++I  +    M++F+LI    L  N+  L    P+ CP
Sbjct: 221 KSKSPPAEFMRMIGNDKQGQMIVFHLIE---LLKNNGRLPR--PDGCP 263

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 110/228 (48%), Gaps = 27/228 (11%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 47  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 102
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 103 YGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 161
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T   
Sbjct: 162 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 221
Query: 313 NIKS-----MQVIACNT---MLLFYLIIFHCLFVNSLELLSHFPENCP 352
             KS     M++I  +    M++F+LI    L  N+  L    P+ CP
Sbjct: 222 KSKSPPAEFMRMIGNDKQGQMIVFHLIE---LLKNNGRLPR--PDGCP 264

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 10/171 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 42  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 97
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 98  DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 156
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T
Sbjct: 157 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L  F         R  Q     A
Sbjct: 229 EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSM 317
            APE  L       +D WS GILL E+ T G+V    M
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 110/228 (48%), Gaps = 27/228 (11%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 45  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 100
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 101 YGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 159
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T   
Sbjct: 160 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 219
Query: 313 NIKS-----MQVIACNT---MLLFYLIIFHCLFVNSLELLSHFPENCP 352
             KS     M++I  +    M++F+LI    L  N+  L    P+ CP
Sbjct: 220 KSKSPPAEFMRMIGNDKQGQMIVFHLIE---LLKNNGRLPR--PDGCP 262

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 110/228 (48%), Gaps = 27/228 (11%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 41  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 96
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 97  YGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 155
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T   
Sbjct: 156 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 215
Query: 313 NIKS-----MQVIACNT---MLLFYLIIFHCLFVNSLELLSHFPENCP 352
             KS     M++I  +    M++F+LI    L  N+  L    P+ CP
Sbjct: 216 KSKSPPAEFMRMIGNDKQGQMIVFHLIE---LLKNNGRLPR--PDGCP 258

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 110/228 (48%), Gaps = 27/228 (11%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 59  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 114
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 115 YGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 173
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T   
Sbjct: 174 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 233
Query: 313 NIKS-----MQVIACNT---MLLFYLIIFHCLFVNSLELLSHFPENCP 352
             KS     M++I  +    M++F+LI    L  N+  L    P+ CP
Sbjct: 234 KSKSPPAEFMRMIGNDKQGQMIVFHLIE---LLKNNGRLPR--PDGCP 276

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 87/173 (50%), Gaps = 18/173 (10%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HL 202
           A + +R+  I+K    D + A +DIL + T P+       F++   +Y++LD +    H 
Sbjct: 98  AKRTLRELKILKHFKHDNIIAIKDIL-RPTVPY-----GEFKS---VYVVLDLMESDLHQ 148
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
             H  +      +  R++  +++  + ++H   ++HRDLKP N+L++ +  + + DFG+A
Sbjct: 149 IIHSSQPLTL--EHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMA 206
Query: 263 KEIDESSRS-----NSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
           + +  S             T  Y APE++LS   + +  D WSVG +  EML 
Sbjct: 207 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 259

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 110/228 (48%), Gaps = 27/228 (11%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 41  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 96
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 97  YGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 155
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T   
Sbjct: 156 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 215
Query: 313 NIKS-----MQVIACNT---MLLFYLIIFHCLFVNSLELLSHFPENCP 352
             KS     M++I  +    M++F+LI    L  N+  L    P+ CP
Sbjct: 216 KSKSPPAEFMRMIGNDKQGQMIVFHLIE---LLKNNGRLPR--PDGCP 258

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 56/94 (59%), Gaps = 2/94 (2%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKEIDESSRSNSMCGTT 278
           Y  ++  AV  +H  GI HRD+KP+N+L++S D  + L DFG AK++  S  S +   + 
Sbjct: 146 YIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXICSR 205
Query: 279 EYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
            Y APE++L +  +    D WS+G +  E++ G+
Sbjct: 206 FYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L  F         R  Q     A
Sbjct: 63  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSM 317
            APE  L       +D WS GILL E+ T G+V    M
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 219

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 110/228 (48%), Gaps = 27/228 (11%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 59  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 114
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 115 YGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 173
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T   
Sbjct: 174 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 233
Query: 313 NIKS-----MQVIACNT---MLLFYLIIFHCLFVNSLELLSHFPENCP 352
             KS     M++I  +    M++F+LI    L  N+  L    P+ CP
Sbjct: 234 KSKSPPAEFMRMIGNDKQGQMIVFHLIE---LLKNNGRLPR--PDGCP 276

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 10/171 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 40  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 95
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 96  DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 154
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T
Sbjct: 155 LSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 94/190 (49%), Gaps = 24/190 (12%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HL 202
           A + +R+  I+K    D + A +DIL + T P+       F++   +Y++LD +    H 
Sbjct: 97  AKRTLRELKILKHFKHDNIIAIKDIL-RPTVPY-----GEFKS---VYVVLDLMESDLHQ 147
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
             H  +      +  R++  +++  + ++H   ++HRDLKP N+L++ +  + + DFG+A
Sbjct: 148 IIHSSQPLTL--EHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMA 205
Query: 263 KEIDESSRS-----NSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT------G 310
           + +  S             T  Y APE++LS   + +  D WSVG +  EML       G
Sbjct: 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG 265
Query: 311 QVNIKSMQVI 320
           +  +  +Q+I
Sbjct: 266 KNYVHQLQLI 275

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K ++  T+  ++ ++    E  I+ K+ H  +VQL Y+  +   +Y++ +++N G L 
Sbjct: 37  AIKTLKPGTMSPESFLE----EAQIMKKLKHDKLVQL-YAVVSEEPIYIVTEYMNKGSLL 91
Query: 204 FHLYRQGIFREDQARFY--------TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
             L      ++ + R           A++ + ++++ +   +HRDL+  NIL+ +     
Sbjct: 92  DFL------KDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGNGLICK 145
Query: 256 LTDFGLAKEIDESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQV 312
           + DFGLA+ I+++  +         ++ APE  L       +D WS GILL E++T G+V
Sbjct: 146 IADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRV 205
Query: 313 NIKSM 317
               M
Sbjct: 206 PYPGM 210

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 86/171 (50%), Gaps = 10/171 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 288 AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 343
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HR+L   N L+  +  V + DFG
Sbjct: 344 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFG 402
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T
Sbjct: 403 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L  F         R  Q     A
Sbjct: 229 EAQVMKKLRHEKLVQL-YAVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSM 317
            APE  L       +D WS GILL E+ T G+V    M
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 109/228 (47%), Gaps = 27/228 (11%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 44  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 99
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L      R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 100 YGSLRDYLQAHAE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 158
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T   
Sbjct: 159 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 218
Query: 313 NIKS-----MQVIACNT---MLLFYLIIFHCLFVNSLELLSHFPENCP 352
             KS     M++I  +    M++F+LI    L  N+  L    P+ CP
Sbjct: 219 KSKSPPAEFMRMIGNDKQGQMIVFHLIE---LLKNNGRLPR--PDGCP 261

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 72/151 (47%), Gaps = 8/151 (5%)
Query: 165 ERDILTKVTHPFIVQLRYSF-----QTRSKLYLILDFINGGHLFFHLYRQGIFREDQ-AR 218
           E  +L    HP I+ LR  F         KLYL+ + +    L   ++ Q I    Q  +
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQVIHDQRIVISPQHIQ 137
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
           ++   I+  +  LH+ G+VHRDL P NIL+  +  + + DF LA+E    +         
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR 197
Query: 279 EYMAPEILLS-KGHNKDADWWSVGILLYEML 308
            Y APE+++  KG  K  D WS G ++ EM 
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 72/151 (47%), Gaps = 8/151 (5%)
Query: 165 ERDILTKVTHPFIVQLRYSF-----QTRSKLYLILDFINGGHLFFHLYRQGIFREDQ-AR 218
           E  +L    HP I+ LR  F         KLYL+ + +    L   ++ Q I    Q  +
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQVIHDQRIVISPQHIQ 137
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
           ++   I+  +  LH+ G+VHRDL P NIL+  +  + + DF LA+E    +         
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR 197
Query: 279 EYMAPEILLS-KGHNKDADWWSVGILLYEML 308
            Y APE+++  KG  K  D WS G ++ EM 
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 6/158 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L  F         R  Q     A
Sbjct: 63  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL   NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 122 QIASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSM 317
            APE  L       +D WS GILL E+ T G+V    M
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 219

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 86/171 (50%), Gaps = 10/171 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 249 AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 304
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HR+L   N L+  +  V + DFG
Sbjct: 305 DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFG 363
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T
Sbjct: 364 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 97/184 (52%), Gaps = 15/184 (8%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+KV+++ T  +K   + M  E  I+ ++ +P+IV+L    Q  + L L+++   GG L 
Sbjct: 41  AIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLH 97
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVS----HLHKCGIVHRDLKPENILMDSDGHVMLTDF 259
             L  +   RE+      AE++  VS    +L +   VHRDL   N+L+ +  +  ++DF
Sbjct: 98  KFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDF 154
Query: 260 GLAKEI--DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNI 314
           GL+K +  D+S  +    G    ++ APE +  +  +  +D WS G+ ++E L+ GQ   
Sbjct: 155 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 214
Query: 315 KSMQ 318
           K M+
Sbjct: 215 KKMK 218

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 97/184 (52%), Gaps = 15/184 (8%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+KV+++ T  +K   + M  E  I+ ++ +P+IV+L    Q  + L L+++   GG L 
Sbjct: 367 AIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLH 423
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVS----HLHKCGIVHRDLKPENILMDSDGHVMLTDF 259
             L  +   RE+      AE++  VS    +L +   VHR+L   N+L+ +  +  ++DF
Sbjct: 424 KFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDF 480
Query: 260 GLAKEI--DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNI 314
           GL+K +  D+S  +    G    ++ APE +  +  +  +D WS G+ ++E L+ GQ   
Sbjct: 481 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 540
Query: 315 KSMQ 318
           K M+
Sbjct: 541 KKMK 544

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 102/214 (47%), Gaps = 27/214 (12%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           +I P D    + +G G F                    A+K++++ ++ +   ++    E
Sbjct: 5   EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV------AIKMIKEGSMSEDEFIE----E 54
Query: 166 RDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
             ++  ++H  +VQL Y   T+ + +++I +++  G L  +L      RE + RF T ++
Sbjct: 55  AKVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLLNYL------REMRHRFQTQQL 107
Query: 225 VS-------AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMC 275
           +        A+ +L     +HRDL   N L++  G V ++DFGL++ +  DE + S    
Sbjct: 108 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSK 167
Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
               +  PE+L+    +  +D W+ G+L++E+ +
Sbjct: 168 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 102/214 (47%), Gaps = 27/214 (12%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           +I P D    + +G G F                    A+K++++ ++ +   ++    E
Sbjct: 20  EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV------AIKMIKEGSMSEDEFIE----E 69
Query: 166 RDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
             ++  ++H  +VQL Y   T+ + +++I +++  G L  +L      RE + RF T ++
Sbjct: 70  AKVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLLNYL------REMRHRFQTQQL 122
Query: 225 VS-------AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMC 275
           +        A+ +L     +HRDL   N L++  G V ++DFGL++ +  DE + S    
Sbjct: 123 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSK 182
Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
               +  PE+L+    +  +D W+ G+L++E+ +
Sbjct: 183 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 89/193 (46%), Gaps = 30/193 (15%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAER--DILTKVTHPFIVQL-RYSFQTRS---KLYLILDF 196
           YA+K      I+     D  +A+R  D+     HP I++L  Y  + R    + +L+L F
Sbjct: 57  YALK-----RILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPF 111
Query: 197 INGGHLFFHLYR---QGIF-REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
              G L+  + R   +G F  EDQ  +    I   +  +H  G  HRDLKP NIL+  +G
Sbjct: 112 FKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG 171
Query: 253 HVMLTDFGLAKEI---DESSR--------SNSMCGTTEYMAPEILLSKGH---NKDADWW 298
             +L D G   +     E SR        +   C T  Y APE+   + H   ++  D W
Sbjct: 172 QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC-TISYRAPELFSVQSHCVIDERTDVW 230
Query: 299 SVGILLYEMLTGQ 311
           S+G +LY M+ G+
Sbjct: 231 SLGCVLYAMMFGE 243

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 7/151 (4%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D +K  R  L K+ HP  +Q R  +      +L++++  G         +   +E +   
Sbjct: 100 DIIKEVR-FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA 158
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
            T   +  +++LH   ++HRD+K  NIL+   G V L DFG A  +   + +N   GT  
Sbjct: 159 VTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANXFVGTPY 215
Query: 280 YMAPEILLSKG---HNKDADWWSVGILLYEM 307
           +MAPE++L+     ++   D WS+GI   E+
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 6/158 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L  F         R  Q     A
Sbjct: 230 EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 288
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGL + I+++  +         ++
Sbjct: 289 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKW 348
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSM 317
            APE  L       +D WS GILL E+ T G+V    M
Sbjct: 349 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 386

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 80/177 (45%), Gaps = 37/177 (20%)
Query: 168 ILTKVTHPFIVQ-----LRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF-REDQARFYT 221
           IL ++ H  +V+     +    +   +LY++L+  +    F  L+R  ++  E   +   
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD--FKKLFRTPVYLTELHIKTLL 162
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-------- 273
             ++  V ++H  GI+HRDLKP N L++ D  V + DFGLA+ +D     NS        
Sbjct: 163 YNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222
Query: 274 -----------------MCG---TTEYMAPE-ILLSKGHNKDADWWSVGILLYEMLT 309
                            + G   T  Y APE ILL + + +  D WS+G +  E+L 
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 110/228 (48%), Gaps = 27/228 (11%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 41  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 96
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 97  YGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 155
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T   
Sbjct: 156 GDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 215
Query: 313 NIKS-----MQVIACNT---MLLFYLIIFHCLFVNSLELLSHFPENCP 352
             KS     M++I  +    M++F+LI    L  N+  L    P+ CP
Sbjct: 216 KSKSPPAEFMRMIGNDKQGQMIVFHLIE---LLKNNGRLPR--PDGCP 258

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 69/149 (46%), Gaps = 17/149 (11%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-------------S 269
           +I  AV  LH  G++HRDLKP NI    D  V + DFGL   +D+              +
Sbjct: 126 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML----TGQVNIKSMQVIACNTM 325
           R     GT  YM+PE +    ++   D +S+G++L+E+L    T    ++++  +     
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKF 245
Query: 326 LLFYLIIFHCLFVNSLELLSHFPENCPAS 354
              +   + C +V   ++LS  P   P +
Sbjct: 246 PPLFTQKYPCEYVMVQDMLSPSPMERPEA 274

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 102/214 (47%), Gaps = 27/214 (12%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           +I P D    + +G G F                    A+K++++ ++ +   ++    E
Sbjct: 20  EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV------AIKMIKEGSMSEDEFIE----E 69
Query: 166 RDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
             ++  ++H  +VQL Y   T+ + +++I +++  G L  +L      RE + RF T ++
Sbjct: 70  AKVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLLNYL------REMRHRFQTQQL 122
Query: 225 VS-------AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMC 275
           +        A+ +L     +HRDL   N L++  G V ++DFGL++ +  DE + S    
Sbjct: 123 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 182
Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
               +  PE+L+    +  +D W+ G+L++E+ +
Sbjct: 183 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 7/151 (4%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D +K  R  L K+ HP  +Q R  +      +L++++  G         +   +E +   
Sbjct: 61  DIIKEVR-FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA 119
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
            T   +  +++LH   ++HRD+K  NIL+   G V L DFG A  +   + +N   GT  
Sbjct: 120 VTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANXFVGTPY 176
Query: 280 YMAPEILLSKG---HNKDADWWSVGILLYEM 307
           +MAPE++L+     ++   D WS+GI   E+
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 77/153 (50%), Gaps = 7/153 (4%)
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI---- 224
           L+   HP +V L      R+++ LI  ++  G+L  HLY   +     +     EI    
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK---EIDESSRSNSMCGTTEYM 281
              + +LH   I+HRD+K  NIL+D +    +TDFG++K   E+ ++     + GT  Y+
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYI 208
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQVNI 314
            PE  +     + +D +S G++L+E+L  +  I
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 6/158 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   + ++ ++++ G L  F         R  Q     A
Sbjct: 53  EAQVMKKLRHEKLVQL-YAVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 111
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 112 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW 171
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSM 317
            APE  L       +D WS GILL E+ T G+V    M
Sbjct: 172 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 209

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 102/214 (47%), Gaps = 27/214 (12%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           +I P D    + +G G F                    A+K++++ ++ +   ++    E
Sbjct: 4   EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV------AIKMIKEGSMSEDEFIE----E 53
Query: 166 RDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
             ++  ++H  +VQL Y   T+ + +++I +++  G L  +L      RE + RF T ++
Sbjct: 54  AKVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLLNYL------REMRHRFQTQQL 106
Query: 225 VS-------AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMC 275
           +        A+ +L     +HRDL   N L++  G V ++DFGL++ +  DE + S    
Sbjct: 107 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 166
Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
               +  PE+L+    +  +D W+ G+L++E+ +
Sbjct: 167 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 200

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 102/214 (47%), Gaps = 27/214 (12%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           +I P D    + +G G F                    A+K++++ ++ +   ++    E
Sbjct: 5   EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV------AIKMIKEGSMSEDEFIE----E 54
Query: 166 RDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
             ++  ++H  +VQL Y   T+ + +++I +++  G L  +L      RE + RF T ++
Sbjct: 55  AKVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLLNYL------REMRHRFQTQQL 107
Query: 225 VS-------AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMC 275
           +        A+ +L     +HRDL   N L++  G V ++DFGL++ +  DE + S    
Sbjct: 108 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 167
Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
               +  PE+L+    +  +D W+ G+L++E+ +
Sbjct: 168 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 90/182 (49%), Gaps = 21/182 (11%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 74  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 207 ---------YRQGIFR--EDQARFY-----TAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 308 LT 309
            T
Sbjct: 253 FT 254

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 68/147 (46%), Gaps = 27/147 (18%)
Query: 188 SKLYLILDFINGGHLFFHLYRQGIF-REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI 246
            +LY++L+  +       L++  IF  E+  +     ++   + +H+ GI+HRDLKP N 
Sbjct: 103 DELYIVLEIADSD--LKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANC 160
Query: 247 LMDSDGHVMLTDFGLAKEIDESSRSN-----------------------SMCGTTEYMAP 283
           L++ D  V + DFGLA+ I+    +N                       S   T  Y AP
Sbjct: 161 LLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAP 220
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLT 309
           E ILL + + K  D WS G +  E+L 
Sbjct: 221 ELILLQENYTKSIDIWSTGCIFAELLN 247

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 79/154 (51%), Gaps = 9/154 (5%)
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYT 221
           +E  I+ +  HP I++L         + ++ +F+  G L  F  L   G F   Q     
Sbjct: 66  SEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGML 124
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS----RSNSMCGT 277
             I S + +L +   VHRDL   NIL++S+    ++DFGL++ ++E+S     ++S+ G 
Sbjct: 125 RGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGK 184
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
               + APE +  +     +D WS GI+++E+++
Sbjct: 185 IPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 218

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 101/213 (47%), Gaps = 27/213 (12%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           I P D    + +G G F                    A+K++++ ++ +   ++    E 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDV------AIKMIKEGSMSEDEFIE----EA 50
Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
            ++  ++H  +VQL Y   T+ + +++I +++  G L  +L      RE + RF T +++
Sbjct: 51  KVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLLNYL------REMRHRFQTQQLL 103
Query: 226 S-------AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCG 276
                   A+ +L     +HRDL   N L++  G V ++DFGL++ +  DE + S     
Sbjct: 104 EMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF 163
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
              +  PE+L+    +  +D W+ G+L++E+ +
Sbjct: 164 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 196

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 102/214 (47%), Gaps = 27/214 (12%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           +I P D    + +G G F                    A+K++++ ++ +   ++    E
Sbjct: 11  EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV------AIKMIKEGSMSEDEFIE----E 60
Query: 166 RDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
             ++  ++H  +VQL Y   T+ + +++I +++  G L  +L      RE + RF T ++
Sbjct: 61  AKVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLLNYL------REMRHRFQTQQL 113
Query: 225 VS-------AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMC 275
           +        A+ +L     +HRDL   N L++  G V ++DFGL++ +  DE + S    
Sbjct: 114 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 173
Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
               +  PE+L+    +  +D W+ G+L++E+ +
Sbjct: 174 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 207

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 110/228 (48%), Gaps = 27/228 (11%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 42  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 97
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HR+L   NIL++++  V +
Sbjct: 98  YGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRNLATRNILVENENRVKI 156
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T   
Sbjct: 157 GDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 216
Query: 313 NIKS-----MQVIACNT---MLLFYLIIFHCLFVNSLELLSHFPENCP 352
             KS     M++I  +    M++F+LI    L  N+  L    P+ CP
Sbjct: 217 KSKSPPAEFMRMIGNDKQGQMIVFHLIE---LLKNNGRLPR--PDGCP 259

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/142 (26%), Positives = 70/142 (49%), Gaps = 2/142 (1%)
Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           +L ++ H  IV+L     +  KL L+ +F +     +     G    +  + +  +++  
Sbjct: 54  LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM-CGTTEYMAPEIL 286
           +   H   ++HRDLKP+N+L++ +G + L DFGLA+      R  S    T  Y  P++L
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 287 L-SKGHNKDADWWSVGILLYEM 307
             +K ++   D WS G +  E+
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAEL 195

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 71/139 (51%), Gaps = 12/139 (8%)
Query: 192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-S 250
           L+ ++IN    F  LY+  I  +   RFY  E++ A+ + H  GI+HRD+KP N+++D  
Sbjct: 112 LVFEYINNTD-FKQLYQ--ILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQ 168
Query: 251 DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEML- 308
              + L D+GLA+    +   N    +  +  PE+L+  + ++   D WS+G +L  M+ 
Sbjct: 169 QKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 228
Query: 309 ------TGQVNIKSMQVIA 321
                  GQ N   +  IA
Sbjct: 229 RREPFFHGQDNYDQLVRIA 247

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 79/154 (51%), Gaps = 9/154 (5%)
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYT 221
           +E  I+ +  HP I++L         + ++ +F+  G L  F  L   G F   Q     
Sbjct: 64  SEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGML 122
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR----SNSMCGT 277
             I S + +L +   VHRDL   NIL++S+    ++DFGL++ ++E+S     ++S+ G 
Sbjct: 123 RGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGK 182
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
               + APE +  +     +D WS GI+++E+++
Sbjct: 183 IPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 216

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 72/151 (47%), Gaps = 8/151 (5%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAE 223
           E  IL + +HP IV+L      +  +Y++++ + GG     L  +G   R         +
Sbjct: 162 EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGD 221
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT-----T 278
             + + +L     +HRDL   N L+     + ++DFG+++E  E+    +  G       
Sbjct: 222 AAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSRE--EADGVXAASGGLRQVPV 279
Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           ++ APE L    ++ ++D WS GILL+E  +
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 71/139 (51%), Gaps = 12/139 (8%)
Query: 192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-S 250
           L+ ++IN    F  LY+  I  +   RFY  E++ A+ + H  GI+HRD+KP N+++D  
Sbjct: 117 LVFEYINNTD-FKQLYQ--ILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQ 173
Query: 251 DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEML- 308
              + L D+GLA+    +   N    +  +  PE+L+  + ++   D WS+G +L  M+ 
Sbjct: 174 QKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 233
Query: 309 ------TGQVNIKSMQVIA 321
                  GQ N   +  IA
Sbjct: 234 RREPFFHGQDNYDQLVRIA 252

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 73/141 (51%), Gaps = 20/141 (14%)
Query: 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIV 237
           T ++L+L+ D+   G LF +L R  +  E   +   +   S ++HLH        K  I 
Sbjct: 111 TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHMEIVGTQGKPAIA 169
Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-----NSMCGTTEYMAPEIL---LSK 289
           HRDLK +NIL+  +G   + D GLA   D ++ +     N   GT  YMAPE+L   ++ 
Sbjct: 170 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 229
Query: 290 GH---NKDADWWSVGILLYEM 307
            H    K AD +++G++ +E+
Sbjct: 230 KHFESFKRADIYAMGLVFWEI 250

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 85/171 (49%), Gaps = 10/171 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y++ +++  G+L 
Sbjct: 61  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLL 116
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+    E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 117 DYL-RECNREEVTAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFG 175
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T
Sbjct: 176 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 88/182 (48%), Gaps = 21/182 (11%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 74  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 207 -----------YRQGIFREDQARFY-----TAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                      Y      E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 133 RARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 308 LT 309
            T
Sbjct: 253 FT 254

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 73/141 (51%), Gaps = 20/141 (14%)
Query: 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIV 237
           T ++L+L+ D+   G LF +L R  +  E   +   +   S ++HLH        K  I 
Sbjct: 72  TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHMEIVGTQGKPAIA 130
Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-----NSMCGTTEYMAPEIL---LSK 289
           HRDLK +NIL+  +G   + D GLA   D ++ +     N   GT  YMAPE+L   ++ 
Sbjct: 131 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 190
Query: 290 GH---NKDADWWSVGILLYEM 307
            H    K AD +++G++ +E+
Sbjct: 191 KHFESFKRADIYAMGLVFWEI 211

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 73/141 (51%), Gaps = 20/141 (14%)
Query: 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIV 237
           T ++L+L+ D+   G LF +L R  +  E   +   +   S ++HLH        K  I 
Sbjct: 98  TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHMEIVGTQGKPAIA 156
Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-----NSMCGTTEYMAPEIL---LSK 289
           HRDLK +NIL+  +G   + D GLA   D ++ +     N   GT  YMAPE+L   ++ 
Sbjct: 157 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 216
Query: 290 GH---NKDADWWSVGILLYEM 307
            H    K AD +++G++ +E+
Sbjct: 217 KHFESFKRADIYAMGLVFWEI 237

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 72/151 (47%), Gaps = 8/151 (5%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAE 223
           E  IL + +HP IV+L      +  +Y++++ + GG     L  +G   R         +
Sbjct: 162 EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGD 221
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT-----T 278
             + + +L     +HRDL   N L+     + ++DFG+++E  E+    +  G       
Sbjct: 222 AAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSRE--EADGVYAASGGLRQVPV 279
Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           ++ APE L    ++ ++D WS GILL+E  +
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 90/182 (49%), Gaps = 21/182 (11%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 63  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 121
Query: 207 ---------YRQGIFR--EDQARFY-----TAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 122 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 181
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 182 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 241
Query: 308 LT 309
            T
Sbjct: 242 FT 243

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           +K   D++  E  I+ +  HP I++L         + ++ +++  G L          R+
Sbjct: 87  EKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRK 139
Query: 215 DQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EI 265
             A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGLA+  E 
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLED 199
Query: 266 DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           D  +   +  G     + +PE +  +     +D WS GI+L+E+++
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 73/141 (51%), Gaps = 20/141 (14%)
Query: 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIV 237
           T ++L+L+ D+   G LF +L R  +  E   +   +   S ++HLH        K  I 
Sbjct: 73  TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHMEIVGTQGKPAIA 131
Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-----NSMCGTTEYMAPEIL---LSK 289
           HRDLK +NIL+  +G   + D GLA   D ++ +     N   GT  YMAPE+L   ++ 
Sbjct: 132 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 191
Query: 290 GH---NKDADWWSVGILLYEM 307
            H    K AD +++G++ +E+
Sbjct: 192 KHFESFKRADIYAMGLVFWEI 212

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 90/182 (49%), Gaps = 21/182 (11%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 120 MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 178
Query: 207 ---------YRQGIFR--EDQARFY-----TAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 179 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 238
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298
Query: 308 LT 309
            T
Sbjct: 299 FT 300

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 87/170 (51%), Gaps = 9/170 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K M+  ++     V+   AE +++  + H  +V+L ++  T+  +Y+I +F+  G L 
Sbjct: 43  AVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLL 97
Query: 204 FHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
             L      ++   +   ++A+I   ++ + +   +HRDL+  NIL+ +     + DFGL
Sbjct: 98  DFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL 157
Query: 262 AKEIDESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           A+ I+++  +         ++ APE +        +D WS GILL E++T
Sbjct: 158 ARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 207

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 106/250 (42%), Gaps = 37/250 (14%)
Query: 92  EHENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKD 151
           E+E D + E   E      + E  +V+G GAF                    A+K++++ 
Sbjct: 33  EYEYDLKWEFPRE------NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK 86
Query: 152 TIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQ 209
                +  + + +E  ++T++ +H  IV L  +      +YLI ++   G L  +L  ++
Sbjct: 87  A--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKR 144
Query: 210 GIFREDQARF----------------------YTAEIVSAVSHLHKCGIVHRDLKPENIL 247
             F ED+  +                      +  ++   +  L     VHRDL   N+L
Sbjct: 145 EKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 204
Query: 248 MDSDGHVMLTDFGLAKEIDESS----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
           +     V + DFGLA++I   S    R N+     ++MAPE L    +   +D WS GIL
Sbjct: 205 VTHGKVVKICDFGLARDIMSDSNYVVRGNARL-PVKWMAPESLFEGIYTIKSDVWSYGIL 263
Query: 304 LYEMLTGQVN 313
           L+E+ +  VN
Sbjct: 264 LWEIFSLGVN 273

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 90/182 (49%), Gaps = 21/182 (11%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 74  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 207 ---------YRQGIFR--EDQARFY-----TAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 308 LT 309
            T
Sbjct: 253 FT 254

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 73/141 (51%), Gaps = 20/141 (14%)
Query: 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIV 237
           T ++L+L+ D+   G LF +L R  +  E   +   +   S ++HLH        K  I 
Sbjct: 78  TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHMEIVGTQGKPAIA 136
Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-----NSMCGTTEYMAPEIL---LSK 289
           HRDLK +NIL+  +G   + D GLA   D ++ +     N   GT  YMAPE+L   ++ 
Sbjct: 137 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 196
Query: 290 GH---NKDADWWSVGILLYEM 307
            H    K AD +++G++ +E+
Sbjct: 197 KHFESFKRADIYAMGLVFWEI 217

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 90/182 (49%), Gaps = 21/182 (11%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 61  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 119
Query: 207 ---------YRQGIFR--EDQARFY-----TAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 120 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTE 179
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 180 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 239
Query: 308 LT 309
            T
Sbjct: 240 FT 241

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 90/182 (49%), Gaps = 21/182 (11%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 66  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 124
Query: 207 ---------YRQGIFR--EDQARFY-----TAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 125 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 184
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 185 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 244
Query: 308 LT 309
            T
Sbjct: 245 FT 246

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 73/141 (51%), Gaps = 20/141 (14%)
Query: 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIV 237
           T ++L+L+ D+   G LF +L R  +  E   +   +   S ++HLH        K  I 
Sbjct: 75  TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHMEIVGTQGKPAIA 133
Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-----NSMCGTTEYMAPEIL---LSK 289
           HRDLK +NIL+  +G   + D GLA   D ++ +     N   GT  YMAPE+L   ++ 
Sbjct: 134 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 193
Query: 290 GH---NKDADWWSVGILLYEM 307
            H    K AD +++G++ +E+
Sbjct: 194 KHFESFKRADIYAMGLVFWEI 214

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 90/182 (49%), Gaps = 21/182 (11%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 74  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 207 ---------YRQGIFR--EDQARFY-----TAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 251 DGHVMLTDFGLAKEIDE-SSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++I+      N+  G    ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 308 LT 309
            T
Sbjct: 253 FT 254

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 73/139 (52%), Gaps = 20/139 (14%)
Query: 188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIVHR 239
           ++LYLI D+   G L+ +L    +  +   +   +  VS + HLH        K  I HR
Sbjct: 108 TQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSS-VSGLCHLHTEIFSTQGKPAIAHR 166
Query: 240 DLKPENILMDSDGHVMLTDFGLA-KEIDESSR----SNSMCGTTEYMAPEIL---LSKGH 291
           DLK +NIL+  +G   + D GLA K I +++      N+  GT  YM PE+L   L++ H
Sbjct: 167 DLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNH 226
Query: 292 NKD---ADWWSVGILLYEM 307
            +    AD +S G++L+E+
Sbjct: 227 FQSYIMADMYSFGLILWEV 245

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 13/99 (13%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM-------- 274
           +I  AV  LH  G++HRDLKP NI    D  V + DFGL   +D+     ++        
Sbjct: 172 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231
Query: 275 -----CGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
                 GT  YM+PE +    ++   D +S+G++L+E+L
Sbjct: 232 THXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 224 IVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           IV A+ HLH K  ++HRD+KP N+L+++ G V   DFG++  + +    +   G   Y A
Sbjct: 145 IVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXA 204
Query: 283 PEI----LLSKGHNKDADWWSVGILLYEM 307
           PE     L  KG++  +D WS+GI   E+
Sbjct: 205 PERINPELNQKGYSVKSDIWSLGITXIEL 233

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 58/110 (52%), Gaps = 15/110 (13%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---N 272
           + + Y   ++ AV  +H+ GIVH DLKP N L+  DG + L DFG+A ++   + S   +
Sbjct: 112 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD 170
Query: 273 SMCGTTEYMAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQ 311
           S  GT  YM PE +     +++           +D WS+G +LY M  G+
Sbjct: 171 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 220

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 58/111 (52%), Gaps = 15/111 (13%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---N 272
           + + Y   ++ AV  +H+ GIVH DLKP N L+  DG + L DFG+A ++   + S   +
Sbjct: 109 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD 167
Query: 273 SMCGTTEYMAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQV 312
           S  GT  YM PE +     +++           +D WS+G +LY M  G+ 
Sbjct: 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 218

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 90/182 (49%), Gaps = 21/182 (11%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 74  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 207 ---------YRQGIFR--EDQARFY-----TAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 308 LT 309
            T
Sbjct: 253 FT 254

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 58/110 (52%), Gaps = 15/110 (13%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---N 272
           + + Y   ++ AV  +H+ GIVH DLKP N L+  DG + L DFG+A ++   + S   +
Sbjct: 128 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD 186
Query: 273 SMCGTTEYMAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQ 311
           S  GT  YM PE +     +++           +D WS+G +LY M  G+
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 90/182 (49%), Gaps = 21/182 (11%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 74  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 207 ---------YRQGIFR--EDQARFY-----TAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 308 LT 309
            T
Sbjct: 253 FT 254

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 58/110 (52%), Gaps = 15/110 (13%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---N 272
           + + Y   ++ AV  +H+ GIVH DLKP N L+  DG + L DFG+A ++   + S   +
Sbjct: 108 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD 166
Query: 273 SMCGTTEYMAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQ 311
           S  GT  YM PE +     +++           +D WS+G +LY M  G+
Sbjct: 167 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 216

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 92/216 (42%), Gaps = 22/216 (10%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D +   V+G+G F                  I  MK    +   K +H D+   E ++L 
Sbjct: 26  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK----EYASKDDHRDFA-GELEVLC 80
Query: 171 KVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED-------------- 215
           K+ H P I+ L  + + R  LYL +++   G+L   L +  +   D              
Sbjct: 81  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140
Query: 216 --QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
             Q   + A++   + +L +   +HRDL   NIL+  +    + DFGL++  +   +   
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 200
Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
                 +MA E L    +  ++D WS G+LL+E+++
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 58/111 (52%), Gaps = 15/111 (13%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---N 272
           + + Y   ++ AV  +H+ GIVH DLKP N L+  DG + L DFG+A ++   + S   +
Sbjct: 156 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD 214
Query: 273 SMCGTTEYMAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQV 312
           S  GT  YM PE +     +++           +D WS+G +LY M  G+ 
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 53/93 (56%), Gaps = 2/93 (2%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+L+D +   + L D+GLA+        N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEML 308
           +  +  PE+L+  + ++   D WS+G +L  M+
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 58/111 (52%), Gaps = 15/111 (13%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---N 272
           + + Y   ++ AV  +H+ GIVH DLKP N L+  DG + L DFG+A ++   + S   +
Sbjct: 156 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD 214
Query: 273 SMCGTTEYMAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQV 312
           S  GT  YM PE +     +++           +D WS+G +LY M  G+ 
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 92/216 (42%), Gaps = 22/216 (10%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D +   V+G+G F                  I  MK    +   K +H D+   E ++L 
Sbjct: 16  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK----EYASKDDHRDFA-GELEVLC 70
Query: 171 KVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED-------------- 215
           K+ H P I+ L  + + R  LYL +++   G+L   L +  +   D              
Sbjct: 71  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 130
Query: 216 --QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
             Q   + A++   + +L +   +HRDL   NIL+  +    + DFGL++  +   +   
Sbjct: 131 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 190
Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
                 +MA E L    +  ++D WS G+LL+E+++
Sbjct: 191 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 74/153 (48%), Gaps = 7/153 (4%)
Query: 163 KAERDILTKVTHPFIVQLRYSF--QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
           + E +IL  + H  IV+ +     Q    + L+++++  G L  +L R  +    Q   +
Sbjct: 59  QREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLA-QLLLF 117
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE- 279
             +I   +++LH    +HR L   N+L+D+D  V + DFGLAK + E      +    + 
Sbjct: 118 AQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 177
Query: 280 ---YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
              + APE L        +D WS G+ LYE+LT
Sbjct: 178 PVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 79/160 (49%), Gaps = 6/160 (3%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFR 213
           +K   D++  E  I+ +  HP +V L         + ++++F+  G L   L +  G F 
Sbjct: 85  EKQRRDFL-CEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFT 143
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-- 271
             Q       I + + +L   G VHRDL   NIL++S+    ++DFGL++ I++   +  
Sbjct: 144 VIQLVGMLRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVY 203
Query: 272 NSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            +  G     + APE +  +     +D WS GI+++E+++
Sbjct: 204 TTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           +K   D++  E  I+ +  HP I++L         + ++ +++  G L          R+
Sbjct: 87  EKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRK 139
Query: 215 DQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EI 265
             A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGL++  E 
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 266 DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           D  +   +  G     + +PE +  +     +D WS GI+L+E+++
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 87/170 (51%), Gaps = 9/170 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K M+  ++     V+   AE +++  + H  +V+L ++  T+  +Y+I +F+  G L 
Sbjct: 216 AVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLL 270
Query: 204 FHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
             L      ++   +   ++A+I   ++ + +   +HRDL+  NIL+ +     + DFGL
Sbjct: 271 DFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL 330
Query: 262 AKEIDESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           A+ I+++  +         ++ APE +        +D WS GILL E++T
Sbjct: 331 ARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 74/153 (48%), Gaps = 7/153 (4%)
Query: 163 KAERDILTKVTHPFIVQLRYSF--QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
           + E +IL  + H  IV+ +     Q    + L+++++  G L  +L R  +    Q   +
Sbjct: 58  QREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLA-QLLLF 116
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE- 279
             +I   +++LH    +HR L   N+L+D+D  V + DFGLAK + E      +    + 
Sbjct: 117 AQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 176
Query: 280 ---YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
              + APE L        +D WS G+ LYE+LT
Sbjct: 177 PVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 97/204 (47%), Gaps = 10/204 (4%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           + +  +V+G GAF                  + A+K++ + T  K N V++M  E  I+ 
Sbjct: 39  ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPV-AIKILNETTGPKAN-VEFMD-EALIMA 95
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAV 228
            + HP +V+L         + L+   +  G L  + H ++  I  +     +  +I   +
Sbjct: 96  SMDHPHLVRL-LGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN-WCVQIAKGM 153
Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG---TTEYMAPEI 285
            +L +  +VHRDL   N+L+ S  HV +TDFGLA+ ++   +  +  G     ++MA E 
Sbjct: 154 MYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 213
Query: 286 LLSKGHNKDADWWSVGILLYEMLT 309
           +  +     +D WS G+ ++E++T
Sbjct: 214 IHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 101/228 (44%), Gaps = 21/228 (9%)
Query: 93  HENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDT 152
           +E+  +   E  +++   +  I +VVG G F                    A+K + K  
Sbjct: 28  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISV--AIKTL-KVG 84
Query: 153 IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
             +K   D++  E  I+ +  HP I++L         + ++ +++  G L          
Sbjct: 85  YTEKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFL 137
Query: 213 REDQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK-- 263
           R+  A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGL++  
Sbjct: 138 RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 264 EIDESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           E D  +   +  G     + +PE +  +     +D WS GI+L+E+++
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 101/228 (44%), Gaps = 21/228 (9%)
Query: 93  HENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDT 152
           +E+  +   E  +++   +  I +VVG G F                    A+K + K  
Sbjct: 26  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISV--AIKTL-KVG 82
Query: 153 IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
             +K   D++  E  I+ +  HP I++L         + ++ +++  G L          
Sbjct: 83  YTEKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFL 135
Query: 213 REDQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK-- 263
           R+  A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGL++  
Sbjct: 136 RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL 195
Query: 264 EIDESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           E D  +   +  G     + +PE +  +     +D WS GI+L+E+++
Sbjct: 196 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 89/182 (48%), Gaps = 21/182 (11%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+ + + G+L  +L
Sbjct: 74  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYL 132
Query: 207 ---------YRQGIFR--EDQARFY-----TAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 308 LT 309
            T
Sbjct: 253 FT 254

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 70/142 (49%), Gaps = 2/142 (1%)
Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           +L ++ H  IV+L     +  KL L+ +F +     +     G    +  + +  +++  
Sbjct: 54  LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM-CGTTEYMAPEIL 286
           +   H   ++HRDLKP+N+L++ +G + L +FGLA+      R  S    T  Y  P++L
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 287 L-SKGHNKDADWWSVGILLYEM 307
             +K ++   D WS G +  E+
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAEL 195

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 50/96 (52%), Gaps = 4/96 (4%)
Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--VMLTDFGLAKEIDESSRSNSM 274
            R +   I+  +  LHK  I+H DLKPENIL+   G   + + DFG      E  R  + 
Sbjct: 202 VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTX 259
Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
             +  Y APE++L   +    D WS+G +L E+LTG
Sbjct: 260 IQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 50/96 (52%), Gaps = 4/96 (4%)
Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--VMLTDFGLAKEIDESSRSNSM 274
            R +   I+  +  LHK  I+H DLKPENIL+   G   + + DFG      E  R  + 
Sbjct: 202 VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTX 259
Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
             +  Y APE++L   +    D WS+G +L E+LTG
Sbjct: 260 IQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 101/228 (44%), Gaps = 21/228 (9%)
Query: 93  HENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDT 152
           +E+  +   E  +++   +  I +VVG G F                    A+K + K  
Sbjct: 28  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISV--AIKTL-KVG 84
Query: 153 IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
             +K   D++  E  I+ +  HP I++L         + ++ +++  G L          
Sbjct: 85  YTEKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFL 137
Query: 213 REDQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK-- 263
           R+  A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGL++  
Sbjct: 138 RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 264 EIDESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           E D  +   +  G     + +PE +  +     +D WS GI+L+E+++
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 53/93 (56%), Gaps = 2/93 (2%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEML 308
           +  +  PE+L+  + ++   D WS+G +L  M+
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 95/199 (47%), Gaps = 10/199 (5%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +V+G GAF                  + A+K++ + T  K N V++M  E  I+  + HP
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPV-AIKILNETTGPKAN-VEFMD-EALIMASMDHP 77
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
            +V+L         + L+   +  G L  + H ++  I  +     +  +I   + +L +
Sbjct: 78  HLVRL-LGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN-WCVQIAKGMMYLEE 135
Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG---TTEYMAPEILLSKG 290
             +VHRDL   N+L+ S  HV +TDFGLA+ ++   +  +  G     ++MA E +  + 
Sbjct: 136 RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 195
Query: 291 HNKDADWWSVGILLYEMLT 309
               +D WS G+ ++E++T
Sbjct: 196 FTHQSDVWSYGVTIWELMT 214

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 77/146 (52%), Gaps = 10/146 (6%)
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARF--YTAEI 224
           + +  HP IV+L     T + +++I++    G L  F  + +   F  D A    Y  ++
Sbjct: 65  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQL 120
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMA 282
            +A+++L     VHRD+   N+L+ S+  V L DFGL++ +++S+   +  G    ++MA
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMA 180
Query: 283 PEILLSKGHNKDADWWSVGILLYEML 308
           PE +  +     +D W  G+ ++E+L
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 87/172 (50%), Gaps = 9/172 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLIL-DFINGGHL 202
           A+K + K    ++   D++ +E  I+ +  HP I++L     TR +L +I+ +++  G L
Sbjct: 81  AIKAL-KAGYTERQRRDFL-SEASIMGQFDHPNIIRLE-GVVTRGRLAMIVTEYMENGSL 137
Query: 203 -FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
             F     G F   Q       + + + +L   G VHRDL   N+L+DS+    ++DFGL
Sbjct: 138 DTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGL 197
Query: 262 AK--EIDESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           ++  E D  +   +  G     + APE +  +  +  +D WS G++++E+L 
Sbjct: 198 SRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 93/203 (45%), Gaps = 8/203 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F+  +V+G GAF                  + A+K +R+ T  K N    +  E  ++ 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILDEAYVMA 73
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAEIVSAVS 229
            V +P + +L       S + LI+  +  G L  ++         Q    +  +I   ++
Sbjct: 74  SVDNPHVCRL-LGICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMN 132
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT---EYMAPEIL 286
           +L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++MA E +
Sbjct: 133 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 192
Query: 287 LSKGHNKDADWWSVGILLYEMLT 309
           L + +   +D WS G+ ++E++T
Sbjct: 193 LHRIYTHQSDVWSYGVTVWELMT 215

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 53/93 (56%), Gaps = 2/93 (2%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEML 308
           +  +  PE+L+  + ++   D WS+G +L  M+
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           +K   D++  E  I+ +  HP I++L         + ++ +++  G L          R+
Sbjct: 87  EKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRK 139
Query: 215 DQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EI 265
             A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGL++  E 
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 266 DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           D  +   +  G     + +PE +  +     +D WS GI+L+E+++
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 89/182 (48%), Gaps = 21/182 (11%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+ + + G+L  +L
Sbjct: 74  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYL 132
Query: 207 ---------YRQGIFR--EDQARFY-----TAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 308 LT 309
            T
Sbjct: 253 FT 254

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 53/93 (56%), Gaps = 2/93 (2%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 133 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 192
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEML 308
           +  +  PE+L+  + ++   D WS+G +L  M+
Sbjct: 193 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 225

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           +K   D++  E  I+ +  HP I++L         + ++ +++  G L          R+
Sbjct: 75  EKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRK 127
Query: 215 DQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EI 265
             A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGL++  E 
Sbjct: 128 HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 187
Query: 266 DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           D  +   +  G     + +PE +  +     +D WS GI+L+E+++
Sbjct: 188 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 53/93 (56%), Gaps = 2/93 (2%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEML 308
           +  +  PE+L+  + ++   D WS+G +L  M+
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 79/166 (47%), Gaps = 18/166 (10%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           +K   D++  E  I+ +  HP I++L         + ++ +++  G L          R+
Sbjct: 87  EKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRK 139
Query: 215 DQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EI 265
             A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGL +  E 
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199
Query: 266 DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           D  +   +  G     + +PE +  +     +D WS GI+L+E+++
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 53/93 (56%), Gaps = 2/93 (2%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEML 308
           +  +  PE+L+  + ++   D WS+G +L  M+
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 53/93 (56%), Gaps = 2/93 (2%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 139 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 198
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEML 308
           +  +  PE+L+  + ++   D WS+G +L  M+
Sbjct: 199 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 231

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 53/93 (56%), Gaps = 2/93 (2%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEML 308
           +  +  PE+L+  + ++   D WS+G +L  M+
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 53/93 (56%), Gaps = 2/93 (2%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEML 308
           +  +  PE+L+  + ++   D WS+G +L  M+
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 19/155 (12%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL---------YRQGIFR--EDQARFY-- 220
           H  I+ L  +      LY+I+++ + G+L  +L         Y   I R  E+Q  F   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 221 ---TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE---IDESSRSNSM 274
              T ++   + +L     +HRDL   N+L+  +  + + DFGLA++   ID   ++ + 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
               ++MAPE L  + +   +D WS G+L++E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 53/93 (56%), Gaps = 2/93 (2%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEML 308
           +  +  PE+L+  + ++   D WS+G +L  M+
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 53/93 (56%), Gaps = 2/93 (2%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 133 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 192
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEML 308
           +  +  PE+L+  + ++   D WS+G +L  M+
Sbjct: 193 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 225

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 93/203 (45%), Gaps = 8/203 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F+  +V+G GAF                  + A+K +R+ T  K N    +  E  ++ 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILDEAYVMA 76
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAEIVSAVS 229
            V +P + +L       S + LI+  +  G L  ++         Q    +  +I   ++
Sbjct: 77  SVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 135
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT---EYMAPEIL 286
           +L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++MA E +
Sbjct: 136 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 195
Query: 287 LSKGHNKDADWWSVGILLYEMLT 309
           L + +   +D WS G+ ++E++T
Sbjct: 196 LHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           +K   D++  E  I+ +  HP I++L         + ++ +++  G L          R+
Sbjct: 58  EKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRK 110
Query: 215 DQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EI 265
             A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGL++  E 
Sbjct: 111 HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 170
Query: 266 DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           D  +   +  G     + +PE +  +     +D WS GI+L+E+++
Sbjct: 171 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 53/93 (56%), Gaps = 2/93 (2%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEML 308
           +  +  PE+L+  + ++   D WS+G +L  M+
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 53/93 (56%), Gaps = 2/93 (2%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEML 308
           +  +  PE+L+  + ++   D WS+G +L  M+
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 53/93 (56%), Gaps = 2/93 (2%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEML 308
           +  +  PE+L+  + ++   D WS+G +L  M+
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 53/93 (56%), Gaps = 2/93 (2%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 132 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 191
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEML 308
           +  +  PE+L+  + ++   D WS+G +L  M+
Sbjct: 192 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 224

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           +K   D++  E  I+ +  HP I++L         + ++ +++  G L          R+
Sbjct: 87  EKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRK 139
Query: 215 DQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EI 265
             A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGL++  E 
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 266 DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           D  +   +  G     + +PE +  +     +D WS GI+L+E+++
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 93/203 (45%), Gaps = 8/203 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F+  +V+G GAF                  + A+K +R+ T  K N    +  E  ++ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILDEAYVMA 75
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAEIVSAVS 229
            V +P + +L       S + LI+  +  G L  ++         Q    +  +I   ++
Sbjct: 76  SVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 134
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT---EYMAPEIL 286
           +L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++MA E +
Sbjct: 135 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 287 LSKGHNKDADWWSVGILLYEMLT 309
           L + +   +D WS G+ ++E++T
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 93/203 (45%), Gaps = 8/203 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F+  +V+G GAF                  + A+K +R+ T  K N    +  E  ++ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILDEAYVMA 74
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAEIVSAVS 229
            V +P + +L       S + LI+  +  G L  ++         Q    +  +I   ++
Sbjct: 75  SVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT---EYMAPEIL 286
           +L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++MA E +
Sbjct: 134 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 287 LSKGHNKDADWWSVGILLYEMLT 309
           L + +   +D WS G+ ++E++T
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 93/203 (45%), Gaps = 8/203 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F+  +V+G GAF                  + A+K +R+ T  K N    +  E  ++ 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILDEAYVMA 73
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAEIVSAVS 229
            V +P + +L       S + LI+  +  G L  ++         Q    +  +I   ++
Sbjct: 74  SVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 132
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT---EYMAPEIL 286
           +L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++MA E +
Sbjct: 133 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 192
Query: 287 LSKGHNKDADWWSVGILLYEMLT 309
           L + +   +D WS G+ ++E++T
Sbjct: 193 LHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 93/203 (45%), Gaps = 8/203 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F+  +V+G GAF                  + A+K +R+ T  K N    +  E  ++ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILDEAYVMA 72
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAEIVSAVS 229
            V +P + +L       S + LI+  +  G L  ++         Q    +  +I   ++
Sbjct: 73  SVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT---EYMAPEIL 286
           +L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++MA E +
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 287 LSKGHNKDADWWSVGILLYEMLT 309
           L + +   +D WS G+ ++E++T
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 49/96 (51%), Gaps = 4/96 (4%)
Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--VMLTDFGLAKEIDESSRSNSM 274
            R +   I+  +  LHK  I+H DLKPENIL+   G   + + DFG      E  R    
Sbjct: 202 VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYXX 259
Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
             +  Y APE++L   +    D WS+G +L E+LTG
Sbjct: 260 IQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 87/172 (50%), Gaps = 9/172 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLIL-DFINGGHL 202
           A+K + K    ++   D++ +E  I+ +  HP I++L     TR +L +I+ +++  G L
Sbjct: 81  AIKAL-KAGYTERQRRDFL-SEASIMGQFDHPNIIRLE-GVVTRGRLAMIVTEYMENGSL 137
Query: 203 -FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
             F     G F   Q       + + + +L   G VHRDL   N+L+DS+    ++DFGL
Sbjct: 138 DTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGL 197
Query: 262 AK--EIDESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           ++  E D  +   +  G     + APE +  +  +  +D WS G++++E+L 
Sbjct: 198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 92/216 (42%), Gaps = 22/216 (10%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D +   V+G+G F                  I  MK    +   K +H D+   E ++L 
Sbjct: 23  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK----EYASKDDHRDFA-GELEVLC 77
Query: 171 KVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED-------------- 215
           K+ H P I+ L  + + R  LYL +++   G+L   L +  +   D              
Sbjct: 78  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 137
Query: 216 --QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
             Q   + A++   + +L +   +HR+L   NIL+  +    + DFGL++  +   +   
Sbjct: 138 SQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 197
Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
                 +MA E L    +  ++D WS G+LL+E+++
Sbjct: 198 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 91/199 (45%), Gaps = 8/199 (4%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +V+G G F                  + A+K + K    +K  VD++  E  I+ + +H 
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPV-AIKTL-KAGYTEKQRVDFL-GEAGIMGQFSHH 106
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
            I++L         + +I +++  G L  F   + G F   Q       I + + +L   
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTT---EYMAPEILLSKG 290
             VHRDL   NIL++S+    ++DFGL++ + D+   + +  G      + APE +  + 
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 226
Query: 291 HNKDADWWSVGILLYEMLT 309
               +D WS GI+++E++T
Sbjct: 227 FTSASDVWSFGIVMWEVMT 245

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 77/146 (52%), Gaps = 10/146 (6%)
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARF--YTAEI 224
           + +  HP IV+L     T + +++I++    G L  F  + +   F  D A    Y  ++
Sbjct: 445 MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQL 500
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMA 282
            +A+++L     VHRD+   N+L+ S+  V L DFGL++ +++S+   +  G    ++MA
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 560
Query: 283 PEILLSKGHNKDADWWSVGILLYEML 308
           PE +  +     +D W  G+ ++E+L
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/111 (32%), Positives = 57/111 (51%), Gaps = 15/111 (13%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---N 272
           + + Y   ++ AV  +H+ GIVH DLKP N L+  DG + L DFG+A ++   + S   +
Sbjct: 156 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD 214
Query: 273 SMCGTTEYMAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQV 312
           S  G   YM PE +     +++           +D WS+G +LY M  G+ 
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/179 (22%), Positives = 89/179 (49%), Gaps = 21/179 (11%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K + K    +K   D++ +E  I+ +  HP ++ L       + + +I +F+  G L 
Sbjct: 65  AIKTL-KSGYTEKQRRDFL-SEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL- 121
Query: 204 FHLYRQGIFREDQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
                    R++  +F   ++V       + + +L     VHRDL   NIL++S+    +
Sbjct: 122 -----DSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKV 176
Query: 257 TDFGLAKEIDESSR----SNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           +DFGL++ +++ +     ++++ G     + APE +  +     +D WS GI+++E+++
Sbjct: 177 SDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 235

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 8/203 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F+  +V+G GAF                  + A+K +R+ T  K N    +  E  ++ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILDEAYVMA 72
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAEIVSAVS 229
            V +P + +L       S + LI   +  G L  ++         Q    +  +I   ++
Sbjct: 73  SVDNPHVCRL-LGICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT---EYMAPEIL 286
           +L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++MA E +
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 287 LSKGHNKDADWWSVGILLYEMLT 309
           L + +   +D WS G+ ++E++T
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 75/149 (50%), Gaps = 5/149 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE-DQARFYTAE 223
           E   + K++HP +V+          +Y++ ++I+ G L  +L   G   E  Q      +
Sbjct: 53  EAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYD 112
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           +   ++ L     +HRDL   N L+D D  V ++DFG+ + + +    +S+ GT    ++
Sbjct: 113 VCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV-GTKFPVKW 171
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT 309
            APE+     ++  +D W+ GIL++E+ +
Sbjct: 172 SAPEVFHYFKYSSKSDVWAFGILMWEVFS 200

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 56/110 (50%), Gaps = 15/110 (13%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR---SN 272
           + + Y   ++ AV  +H+ GIVH DLKP N L+  DG + L DFG+A ++         +
Sbjct: 128 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKD 186
Query: 273 SMCGTTEYMAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQ 311
           S  GT  YM PE +     +++           +D WS+G +LY M  G+
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/243 (22%), Positives = 106/243 (43%), Gaps = 28/243 (11%)
Query: 88  IQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKV 147
           + E E   D   E   +R +      + + +G+GAF                  +  + V
Sbjct: 53  VSEYELPEDPRWELPRDRLV------LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAV 106
Query: 148 -MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFH 205
            M K    +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +
Sbjct: 107 KMLKSDATEKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 165
Query: 206 L---------YRQGIFREDQARFYTAEIVS-------AVSHLHKCGIVHRDLKPENILMD 249
           L         Y        + +  + ++VS        + +L     +HRDL   N+L+ 
Sbjct: 166 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 225
Query: 250 SDGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYE 306
            D  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+LL+E
Sbjct: 226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 285
Query: 307 MLT 309
           + T
Sbjct: 286 IFT 288

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 29/175 (16%)
Query: 162 MKAERDI--LTKVTHPFIVQLRYSFQTRS--KLYLILDFINGGHLFFHLYRQGIFREDQA 217
           M A R+I  L ++ HP ++ L+  F + +  K++L+ D+    H  +H+ +    R  +A
Sbjct: 63  MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE--HDLWHIIK--FHRASKA 118
Query: 218 ------------RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD----GHVMLTDFGL 261
                       +    +I+  + +LH   ++HRDLKP NIL+  +    G V + D G 
Sbjct: 119 NKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 178
Query: 262 AKEIDESSRS----NSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ 311
           A+  +   +     + +  T  Y APE+LL   H  K  D W++G +  E+LT +
Sbjct: 179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 79/166 (47%), Gaps = 18/166 (10%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           +K   D++  E  I+ +  HP I++L         + ++ + +  G L          R+
Sbjct: 87  EKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL------DSFLRK 139
Query: 215 DQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EI 265
             A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGL++  E 
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 266 DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           D  +   +  G     + +PE +  +     +D WS GI+L+E+++
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 8/203 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F+  +V+G GAF                  + A+K +R+ T  K N    +  E  ++ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILDEAYVMA 74
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAEIVSAVS 229
            V +P + +L       S + LI   +  G L  ++         Q    +  +I   ++
Sbjct: 75  SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT---EYMAPEIL 286
           +L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++MA E +
Sbjct: 134 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 287 LSKGHNKDADWWSVGILLYEMLT 309
           L + +   +D WS G+ ++E++T
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 8/203 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F+  +V+G GAF                  + A+K +R+ T  K N    +  E  ++ 
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILDEAYVMA 78
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAEIVSAVS 229
            V +P + +L       S + LI   +  G L  ++         Q    +  +I   ++
Sbjct: 79  SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 137
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT---EYMAPEIL 286
           +L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++MA E +
Sbjct: 138 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 197
Query: 287 LSKGHNKDADWWSVGILLYEMLT 309
           L + +   +D WS G+ ++E++T
Sbjct: 198 LHRIYTHQSDVWSYGVTVWELMT 220

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 78/165 (47%), Gaps = 18/165 (10%)
Query: 156 KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED 215
           K   D++ +E  I+ +  HP I+ L         + +I +++  G L          R++
Sbjct: 72  KQRRDFL-SEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKN 124
Query: 216 QARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EID 266
             RF   ++V       S + +L     VHRDL   NIL++S+    ++DFG+++  E D
Sbjct: 125 DGRFTVIQLVGMLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 184
Query: 267 ESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             +   +  G     + APE +  +     +D WS GI+++E+++
Sbjct: 185 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 8/203 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F+  +V+G GAF                  + A+K +R+ T  K N    +  E  ++ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILDEAYVMA 75
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAEIVSAVS 229
            V +P + +L       S + LI   +  G L  ++         Q    +  +I   ++
Sbjct: 76  SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 134
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT---EYMAPEIL 286
           +L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++MA E +
Sbjct: 135 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 287 LSKGHNKDADWWSVGILLYEMLT 309
           L + +   +D WS G+ ++E++T
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 77/146 (52%), Gaps = 10/146 (6%)
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARF--YTAEI 224
           + +  HP IV+L     T + +++I++    G L  F  + +  +   D A    Y  ++
Sbjct: 93  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 148
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMA 282
            +A+++L     VHRD+   N+L+ S+  V L DFGL++ +++S+   +  G    ++MA
Sbjct: 149 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 208
Query: 283 PEILLSKGHNKDADWWSVGILLYEML 308
           PE +  +     +D W  G+ ++E+L
Sbjct: 209 PESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 8/203 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F+  +V+G GAF                  + A+K +R+ T  K N    +  E  ++ 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILDEAYVMA 79
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAEIVSAVS 229
            V +P + +L       S + LI   +  G L  ++         Q    +  +I   ++
Sbjct: 80  SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 138
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT---EYMAPEIL 286
           +L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++MA E +
Sbjct: 139 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 287 LSKGHNKDADWWSVGILLYEMLT 309
           L + +   +D WS G+ ++E++T
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 100/228 (43%), Gaps = 21/228 (9%)
Query: 93  HENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDT 152
           +E+  +   E  +++   +  I +VVG G F                    A+K + K  
Sbjct: 28  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISV--AIKTL-KVG 84
Query: 153 IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
             +K   D++  E  I+ +  HP I++L         + ++ + +  G L          
Sbjct: 85  YTEKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL------DSFL 137
Query: 213 REDQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK-- 263
           R+  A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGL++  
Sbjct: 138 RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 264 EIDESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           E D  +   +  G     + +PE +  +     +D WS GI+L+E+++
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 77/146 (52%), Gaps = 10/146 (6%)
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARF--YTAEI 224
           + +  HP IV+L     T + +++I++    G L  F  + +  +   D A    Y  ++
Sbjct: 65  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 120
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMA 282
            +A+++L     VHRD+   N+L+ S+  V L DFGL++ +++S+   +  G    ++MA
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 180
Query: 283 PEILLSKGHNKDADWWSVGILLYEML 308
           PE +  +     +D W  G+ ++E+L
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 77/146 (52%), Gaps = 10/146 (6%)
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARF--YTAEI 224
           + +  HP IV+L     T + +++I++    G L  F  + +  +   D A    Y  ++
Sbjct: 67  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 122
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMA 282
            +A+++L     VHRD+   N+L+ S+  V L DFGL++ +++S+   +  G    ++MA
Sbjct: 123 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 182
Query: 283 PEILLSKGHNKDADWWSVGILLYEML 308
           PE +  +     +D W  G+ ++E+L
Sbjct: 183 PESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 8/203 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F+  +V+G GAF                  + A+K +R+ T  K N    +  E  ++ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILDEAYVMA 75
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAEIVSAVS 229
            V +P + +L       S + LI   +  G L  ++         Q    +  +I   ++
Sbjct: 76  SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 134
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT---EYMAPEIL 286
           +L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++MA E +
Sbjct: 135 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 287 LSKGHNKDADWWSVGILLYEMLT 309
           L + +   +D WS G+ ++E++T
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/243 (22%), Positives = 106/243 (43%), Gaps = 28/243 (11%)
Query: 88  IQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKV 147
           + E E   D   E   +R +      + + +G+GAF                  +  + V
Sbjct: 4   VSEYELPEDPRWELPRDRLV------LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAV 57
Query: 148 -MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFH 205
            M K    +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +
Sbjct: 58  KMLKSDATEKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 116
Query: 206 L---------YRQGIFREDQARFYTAEIVS-------AVSHLHKCGIVHRDLKPENILMD 249
           L         Y        + +  + ++VS        + +L     +HRDL   N+L+ 
Sbjct: 117 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 176
Query: 250 SDGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYE 306
            D  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+LL+E
Sbjct: 177 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 236
Query: 307 MLT 309
           + T
Sbjct: 237 IFT 239

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 8/203 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F+  +V+G GAF                  + A+K +R+ T  K N    +  E  ++ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILDEAYVMA 72
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAEIVSAVS 229
            V +P + +L       S + LI   +  G L  ++         Q    +  +I   ++
Sbjct: 73  SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT---EYMAPEIL 286
           +L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++MA E +
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 287 LSKGHNKDADWWSVGILLYEMLT 309
           L + +   +D WS G+ ++E++T
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 8/203 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F+  +V+G GAF                  + A+K +R+ T  K N    +  E  ++ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILDEAYVMA 75
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAEIVSAVS 229
            V +P + +L       S + LI   +  G L  ++         Q    +  +I   ++
Sbjct: 76  SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 134
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT---EYMAPEIL 286
           +L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++MA E +
Sbjct: 135 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 287 LSKGHNKDADWWSVGILLYEMLT 309
           L + +   +D WS G+ ++E++T
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 77/146 (52%), Gaps = 10/146 (6%)
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARF--YTAEI 224
           + +  HP IV+L     T + +++I++    G L  F  + +  +   D A    Y  ++
Sbjct: 65  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 120
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMA 282
            +A+++L     VHRD+   N+L+ S+  V L DFGL++ +++S+   +  G    ++MA
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 180
Query: 283 PEILLSKGHNKDADWWSVGILLYEML 308
           PE +  +     +D W  G+ ++E+L
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/243 (22%), Positives = 106/243 (43%), Gaps = 28/243 (11%)
Query: 88  IQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKV 147
           + E E   D   E   +R +      + + +G+GAF                  +  + V
Sbjct: 12  VSEYELPEDPRWELPRDRLV------LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAV 65
Query: 148 -MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFH 205
            M K    +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +
Sbjct: 66  KMLKSDATEKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 124
Query: 206 L---------YRQGIFREDQARFYTAEIVS-------AVSHLHKCGIVHRDLKPENILMD 249
           L         Y        + +  + ++VS        + +L     +HRDL   N+L+ 
Sbjct: 125 LQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 184
Query: 250 SDGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYE 306
            D  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+LL+E
Sbjct: 185 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 244
Query: 307 MLT 309
           + T
Sbjct: 245 IFT 247

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 77/160 (48%), Gaps = 6/160 (3%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFR 213
           +K   D++  E  I+ +  HP I+ L         + ++ +++  G L   L +  G F 
Sbjct: 64  EKQRRDFL-GEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFT 122
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRS 271
             Q       I + + +L   G VHRDL   NIL++S+    ++DFGL++  E D  +  
Sbjct: 123 VIQLVGMLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 182
Query: 272 NSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            +  G     + APE +  +     +D WS GI+++E+++
Sbjct: 183 TTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVS 222

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 8/203 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F+  +V+G GAF                  + A+K +R+ T  K N    +  E  ++ 
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILDEAYVMA 97
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAEIVSAVS 229
            V +P + +L       S + LI   +  G L  ++         Q    +  +I   ++
Sbjct: 98  SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 156
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT---EYMAPEIL 286
           +L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++MA E +
Sbjct: 157 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 216
Query: 287 LSKGHNKDADWWSVGILLYEMLT 309
           L + +   +D WS G+ ++E++T
Sbjct: 217 LHRIYTHQSDVWSYGVTVWELMT 239

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 77/146 (52%), Gaps = 10/146 (6%)
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARF--YTAEI 224
           + +  HP IV+L     T + +++I++    G L  F  + +  +   D A    Y  ++
Sbjct: 62  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 117
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMA 282
            +A+++L     VHRD+   N+L+ S+  V L DFGL++ +++S+   +  G    ++MA
Sbjct: 118 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 177
Query: 283 PEILLSKGHNKDADWWSVGILLYEML 308
           PE +  +     +D W  G+ ++E+L
Sbjct: 178 PESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/243 (22%), Positives = 106/243 (43%), Gaps = 28/243 (11%)
Query: 88  IQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKV 147
           + E E   D   E   +R +      + + +G+GAF                  +  + V
Sbjct: 5   VSEYELPEDPRWELPRDRLV------LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAV 58
Query: 148 -MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFH 205
            M K    +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +
Sbjct: 59  KMLKSDATEKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 117
Query: 206 L---------YRQGIFREDQARFYTAEIVS-------AVSHLHKCGIVHRDLKPENILMD 249
           L         Y        + +  + ++VS        + +L     +HRDL   N+L+ 
Sbjct: 118 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 177
Query: 250 SDGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYE 306
            D  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+LL+E
Sbjct: 178 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 237
Query: 307 MLT 309
           + T
Sbjct: 238 IFT 240

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 77/146 (52%), Gaps = 10/146 (6%)
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARF--YTAEI 224
           + +  HP IV+L     T + +++I++    G L  F  + +  +   D A    Y  ++
Sbjct: 68  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 123
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMA 282
            +A+++L     VHRD+   N+L+ S+  V L DFGL++ +++S+   +  G    ++MA
Sbjct: 124 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 183
Query: 283 PEILLSKGHNKDADWWSVGILLYEML 308
           PE +  +     +D W  G+ ++E+L
Sbjct: 184 PESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/243 (22%), Positives = 106/243 (43%), Gaps = 28/243 (11%)
Query: 88  IQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKV 147
           + E E   D   E   +R +      + + +G+GAF                  +  + V
Sbjct: 12  VSEYELPEDPRWELPRDRLV------LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAV 65
Query: 148 -MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFH 205
            M K    +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +
Sbjct: 66  KMLKSDATEKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 124
Query: 206 L---------YRQGIFREDQARFYTAEIVS-------AVSHLHKCGIVHRDLKPENILMD 249
           L         Y        + +  + ++VS        + +L     +HRDL   N+L+ 
Sbjct: 125 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 184
Query: 250 SDGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYE 306
            D  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+LL+E
Sbjct: 185 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 244
Query: 307 MLT 309
           + T
Sbjct: 245 IFT 247

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/112 (31%), Positives = 58/112 (51%), Gaps = 25/112 (22%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDG-------------HVMLTDFGLAKEIDESS 269
           +I S V+HLH   I+HRDLKP+NIL+ +                ++++DFGL K++D   
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 270 RS-----NSMCGTTEYMAPEILLSKGH-------NKDADWWSVGILLYEMLT 309
            S     N+  GT+ + APE+L    +        +  D +S+G + Y +L+
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 77/146 (52%), Gaps = 10/146 (6%)
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARF--YTAEI 224
           + +  HP IV+L     T + +++I++    G L  F  + +  +   D A    Y  ++
Sbjct: 70  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 125
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMA 282
            +A+++L     VHRD+   N+L+ S+  V L DFGL++ +++S+   +  G    ++MA
Sbjct: 126 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 185
Query: 283 PEILLSKGHNKDADWWSVGILLYEML 308
           PE +  +     +D W  G+ ++E+L
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 8/203 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F+  +V+G GAF                  + A+K +R+ T  K N    +  E  ++ 
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILDEAYVMA 82
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAEIVSAVS 229
            V +P + +L       S + LI   +  G L  ++         Q    +  +I   ++
Sbjct: 83  SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 141
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT---EYMAPEIL 286
           +L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++MA E +
Sbjct: 142 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 201
Query: 287 LSKGHNKDADWWSVGILLYEMLT 309
           L + +   +D WS G+ ++E++T
Sbjct: 202 LHRIYTHQSDVWSYGVTVWELMT 224

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 8/203 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F+  +V+G GAF                  + A+K +R+ T  K N    +  E  ++ 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILDEAYVMA 69
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAEIVSAVS 229
            V +P + +L       S + LI   +  G L  ++         Q    +  +I   ++
Sbjct: 70  SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMN 128
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT---EYMAPEIL 286
           +L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++MA E +
Sbjct: 129 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 188
Query: 287 LSKGHNKDADWWSVGILLYEMLT 309
           L + +   +D WS G+ ++E++T
Sbjct: 189 LHRIYTHQSDVWSYGVTVWELMT 211

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 78/154 (50%), Gaps = 5/154 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 53  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 111
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 112 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAK 171
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
              ++ APE +        +D WS GILL E++T
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 78/150 (52%), Gaps = 6/150 (4%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHL--FFHLYRQGIFREDQARFYT 221
           E +++  + H  +V+L Y+  TR + +Y+I +++  G L  F      G     +   ++
Sbjct: 58  EANLMKTLQHDKLVRL-YAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFS 116
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TE 279
           A+I   ++++ +   +HRDL+  N+L+       + DFGLA+ I+++  +         +
Sbjct: 117 AQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK 176
Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           + APE +        +D WS GILLYE++T
Sbjct: 177 WTAPEAINFGCFTIKSDVWSFGILLYEIVT 206

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 105/238 (44%), Gaps = 28/238 (11%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D  + R +G+GAF                  + A+K ++  T+  +   D+ + E ++LT
Sbjct: 16  DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK--DFQR-EAELLT 72
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAE--- 223
            + H  IV+          L ++ +++  G L   L   G    I  + Q R    E   
Sbjct: 73  NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132
Query: 224 ---------IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM 274
                    I S + +L     VHRDL   N L+ ++  V + DFG+++++  S+    +
Sbjct: 133 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV-YSTDYYRV 191
Query: 275 CGTT----EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQ---VNIKSMQVIACNT 324
            G T     +M PE ++ +    ++D WS G++L+E+ T G+     + + +VI C T
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 249

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 79/166 (47%), Gaps = 18/166 (10%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           +K   D++  E  I+ +  HP I++L         + ++ + +  G L          R+
Sbjct: 58  EKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL------DSFLRK 110
Query: 215 DQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EI 265
             A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGL++  E 
Sbjct: 111 HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 170
Query: 266 DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           D  +   +  G     + +PE +  +     +D WS GI+L+E+++
Sbjct: 171 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 57/108 (52%), Gaps = 21/108 (19%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDG-------------HVMLTDFGLAKEIDESS 269
           +I S V+HLH   I+HRDLKP+NIL+ +                ++++DFGL K++D   
Sbjct: 141 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 200
Query: 270 RS-----NSMCGTTEYMAPEIL---LSKGHNKDADWWSVGILLYEMLT 309
                  N+  GT+ + APE+L     +   +  D +S+G + Y +L+
Sbjct: 201 XXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/238 (22%), Positives = 94/238 (39%), Gaps = 49/238 (20%)
Query: 109 PGDFEIFRVVGQGAF---------XXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHV 159
           P ++EI  ++G+G++                           I   +++R+ TI+ +   
Sbjct: 27  PDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 86
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQ-AR 218
           DY+    D++          +        +LY++L+  +       L++  IF  +Q  +
Sbjct: 87  DYIIRLHDLI----------IPEDLLKFDELYIVLEIADSD--LKKLFKTPIFLTEQHVK 134
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE----------- 267
                ++     +H+ GI+HRDLKP N L++ D  V + DFGLA+ I+            
Sbjct: 135 TILYNLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLE 194
Query: 268 ---------------SSRSNSMCGTTEYMAPE-ILLSKGHNKDADWWSVGILLYEMLT 309
                            +  S   T  Y APE ILL + +    D WS G +  E+L 
Sbjct: 195 EKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLN 252

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 57/108 (52%), Gaps = 21/108 (19%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDG-------------HVMLTDFGLAKEIDESS 269
           +I S V+HLH   I+HRDLKP+NIL+ +                ++++DFGL K++D   
Sbjct: 141 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 200
Query: 270 RS-----NSMCGTTEYMAPEIL---LSKGHNKDADWWSVGILLYEMLT 309
                  N+  GT+ + APE+L     +   +  D +S+G + Y +L+
Sbjct: 201 XXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 78/165 (47%), Gaps = 18/165 (10%)
Query: 156 KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED 215
           K   D++ +E  I+ +  HP I+ L         + +I +++  G L          R++
Sbjct: 57  KQRRDFL-SEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKN 109
Query: 216 QARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EID 266
             RF   ++V       S + +L     VHRDL   NIL++S+    ++DFG+++  E D
Sbjct: 110 DGRFTVIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 169
Query: 267 ESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             +   +  G     + APE +  +     +D WS GI+++E+++
Sbjct: 170 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 214

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 94/209 (44%), Gaps = 8/209 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 4   RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 60
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 61  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 119
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT---EY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 120 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT 309
           MA E +L + +   +D WS G+ ++E++T
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 8/203 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F+  +V+G GAF                  + A+K +R+ T  K N    +  E  ++ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILDEAYVMA 72
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAEIVSAVS 229
            V +P + +L       S + LI   +  G L  ++         Q    +  +I   ++
Sbjct: 73  SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT---EYMAPEIL 286
           +L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++MA E +
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 287 LSKGHNKDADWWSVGILLYEMLT 309
           L + +   +D WS G+ ++E++T
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 70/151 (46%), Gaps = 20/151 (13%)
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--- 232
           FI     S  + ++L+LI  +   G L+ +L    +      R   + I S ++HLH   
Sbjct: 96  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLS-IASGLAHLHIEI 154
Query: 233 -----KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR-----SNSMCGTTEYMA 282
                K  I HRDLK +NIL+  +G   + D GLA    +S+      +N   GT  YMA
Sbjct: 155 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 214
Query: 283 PEILLSK------GHNKDADWWSVGILLYEM 307
           PE+L            K  D W+ G++L+E+
Sbjct: 215 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 92/186 (49%), Gaps = 22/186 (11%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           A+K+++ D   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L
Sbjct: 53  AVKMLKSDAT-EKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 110
Query: 203 FFHL---------YRQGIFREDQARFYTAEIVS-------AVSHLHKCGIVHRDLKPENI 246
             +L         Y        + +  + ++VS        + +L     +HRDL   N+
Sbjct: 111 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 170
Query: 247 LMDSDGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
           L+  D  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L
Sbjct: 171 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 230
Query: 304 LYEMLT 309
           L+E+ T
Sbjct: 231 LWEIFT 236

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 70/151 (46%), Gaps = 20/151 (13%)
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--- 232
           FI     S  + ++L+LI  +   G L+ +L    +      R   + I S ++HLH   
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLS-IASGLAHLHIEI 125
Query: 233 -----KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR-----SNSMCGTTEYMA 282
                K  I HRDLK +NIL+  +G   + D GLA    +S+      +N   GT  YMA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 283 PEILLSK------GHNKDADWWSVGILLYEM 307
           PE+L            K  D W+ G++L+E+
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 78/154 (50%), Gaps = 5/154 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 61  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 119
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 120 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 179
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
              ++ APE +        +D WS GILL E++T
Sbjct: 180 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 213

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 78/165 (47%), Gaps = 18/165 (10%)
Query: 156 KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED 215
           K   D++ +E  I+ +  HP I+ L         + +I +++  G L          R++
Sbjct: 51  KQRRDFL-SEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKN 103
Query: 216 QARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EID 266
             RF   ++V       S + +L     VHRDL   NIL++S+    ++DFG+++  E D
Sbjct: 104 DGRFTVIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 163
Query: 267 ESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             +   +  G     + APE +  +     +D WS GI+++E+++
Sbjct: 164 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 208

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 78/154 (50%), Gaps = 5/154 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 62  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 120
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 121 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 180
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
              ++ APE +        +D WS GILL E++T
Sbjct: 181 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 214

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 78/154 (50%), Gaps = 5/154 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 53  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 111
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 112 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 171
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
              ++ APE +        +D WS GILL E++T
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 78/154 (50%), Gaps = 5/154 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 59  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 117
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 118 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 177
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
              ++ APE +        +D WS GILL E++T
Sbjct: 178 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 70/151 (46%), Gaps = 20/151 (13%)
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--- 232
           FI     S  + ++L+LI  +   G L+ +L    +      R   + I S ++HLH   
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLS-IASGLAHLHIEI 125
Query: 233 -----KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR-----SNSMCGTTEYMA 282
                K  I HRDLK +NIL+  +G   + D GLA    +S+      +N   GT  YMA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 283 PEILLSK------GHNKDADWWSVGILLYEM 307
           PE+L            K  D W+ G++L+E+
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/243 (22%), Positives = 108/243 (44%), Gaps = 28/243 (11%)
Query: 88  IQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKV 147
           + E E   D   E   +R +      + + +G+GAF                  +  + V
Sbjct: 12  VSEYELPEDPRWELPRDRLV------LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAV 65
Query: 148 -MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFH 205
            M K    +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +
Sbjct: 66  KMLKSDATEKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 124
Query: 206 LYRQ---GI------FREDQARFYTAEIVS-------AVSHLHKCGIVHRDLKPENILMD 249
           L  +   G+          + +  + ++VS        + +L     +HRDL   N+L+ 
Sbjct: 125 LQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 184
Query: 250 SDGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYE 306
            D  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+LL+E
Sbjct: 185 EDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 244
Query: 307 MLT 309
           + T
Sbjct: 245 IFT 247

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 78/154 (50%), Gaps = 5/154 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 55  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 113
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 114 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 173
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
              ++ APE +        +D WS GILL E++T
Sbjct: 174 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 207

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 78/154 (50%), Gaps = 5/154 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 53  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 111
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 112 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 171
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
              ++ APE +        +D WS GILL E++T
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/243 (22%), Positives = 106/243 (43%), Gaps = 28/243 (11%)
Query: 88  IQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKV 147
           + E E   D   E   +R +      + + +G+GAF                  +  + V
Sbjct: 12  VSEYELPEDPRWELPRDRLV------LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAV 65
Query: 148 -MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFH 205
            M K    +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +
Sbjct: 66  KMLKSDATEKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 124
Query: 206 L---------YRQGIFREDQARFYTAEIVS-------AVSHLHKCGIVHRDLKPENILMD 249
           L         Y        + +  + ++VS        + +L     +HRDL   N+L+ 
Sbjct: 125 LQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 184
Query: 250 SDGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYE 306
            D  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+LL+E
Sbjct: 185 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 244
Query: 307 MLT 309
           + T
Sbjct: 245 IFT 247

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 78/154 (50%), Gaps = 5/154 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 54  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 112
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 113 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 172
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
              ++ APE +        +D WS GILL E++T
Sbjct: 173 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 206

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 78/154 (50%), Gaps = 5/154 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 48  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 106
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 107 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 166
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
              ++ APE +        +D WS GILL E++T
Sbjct: 167 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 200

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/172 (23%), Positives = 85/172 (49%), Gaps = 6/172 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 415 DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 473
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT 277
              ++   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +  DE+       G 
Sbjct: 474 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 533
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACNTML 326
              ++ APE +     +  +D WS G+L++E  + GQ   + M+      ML
Sbjct: 534 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 585

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 92/203 (45%), Gaps = 8/203 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F+  +V+G GAF                  + A+K +R+ T  K N    +  E  ++ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILDEAYVMA 74
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAEIVSAVS 229
            V +P + +L       S + LI+  +  G L  ++         Q    +  +I   ++
Sbjct: 75  SVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT---EYMAPEIL 286
           +L    +VHRDL   N+L+ +  HV +TDFG AK +    +     G     ++MA E +
Sbjct: 134 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 287 LSKGHNKDADWWSVGILLYEMLT 309
           L + +   +D WS G+ ++E++T
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 74/141 (52%), Gaps = 10/141 (7%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARF--YTAEIVSAVS 229
           HP IV+L     T + +++I++    G L  F  + +   F  D A    Y  ++ +A++
Sbjct: 70  HPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALA 125
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEILL 287
           +L     VHRD+   N+L+ +   V L DFGL++ +++S+   +  G    ++MAPE + 
Sbjct: 126 YLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 185
Query: 288 SKGHNKDADWWSVGILLYEML 308
            +     +D W  G+ ++E+L
Sbjct: 186 FRRFTSASDVWMFGVCMWEIL 206

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 78/154 (50%), Gaps = 5/154 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 63  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 121
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 122 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 181
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
              ++ APE +        +D WS GILL E++T
Sbjct: 182 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 215

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 78/154 (50%), Gaps = 5/154 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 58  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 116
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 117 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 176
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
              ++ APE +        +D WS GILL E++T
Sbjct: 177 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 210

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 78/154 (50%), Gaps = 5/154 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 59  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 117
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 118 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 177
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
              ++ APE +        +D WS GILL E++T
Sbjct: 178 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 92/203 (45%), Gaps = 8/203 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F+  +V+G GAF                  + A+K +R+ T  K N    +  E  ++ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILDEAYVMA 74
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAEIVSAVS 229
            V +P + +L       S + LI+  +  G L  ++         Q    +  +I   ++
Sbjct: 75  SVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT---EYMAPEIL 286
           +L    +VHRDL   N+L+ +  HV +TDFG AK +    +     G     ++MA E +
Sbjct: 134 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 287 LSKGHNKDADWWSVGILLYEMLT 309
           L + +   +D WS G+ ++E++T
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 92/186 (49%), Gaps = 22/186 (11%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           A+K+++ D   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L
Sbjct: 49  AVKMLKSDAT-EKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 106
Query: 203 FFHL---------YRQGIFREDQARFYTAEIVS-------AVSHLHKCGIVHRDLKPENI 246
             +L         Y        + +  + ++VS        + +L     +HRDL   N+
Sbjct: 107 REYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 166
Query: 247 LMDSDGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
           L+  D  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L
Sbjct: 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 226
Query: 304 LYEMLT 309
           L+E+ T
Sbjct: 227 LWEIFT 232

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/172 (23%), Positives = 85/172 (49%), Gaps = 6/172 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 416 DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 474
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT 277
              ++   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +  DE+       G 
Sbjct: 475 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 534
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACNTML 326
              ++ APE +     +  +D WS G+L++E  + GQ   + M+      ML
Sbjct: 535 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 586

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 92/203 (45%), Gaps = 8/203 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F+  +V+G GAF                  + A+K +R+ T  K N    +  E  ++ 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILDEAYVMA 76
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAEIVSAVS 229
            V +P + +L       S + LI+  +  G L  ++         Q    +  +I   ++
Sbjct: 77  SVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 135
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG---TTEYMAPEIL 286
           +L    +VHRDL   N+L+ +  HV +TDFG AK +    +     G     ++MA E +
Sbjct: 136 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 195
Query: 287 LSKGHNKDADWWSVGILLYEMLT 309
           L + +   +D WS G+ ++E++T
Sbjct: 196 LHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 73/149 (48%), Gaps = 4/149 (2%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
           E +++  + H  +V+L         +Y+I +F+  G L  F      G     +   ++A
Sbjct: 57  EANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSA 116
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I   ++++ +   +HRDL+  N+L+       + DFGLA+ I+++  +         ++
Sbjct: 117 QIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW 176
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT 309
            APE +        ++ WS GILLYE++T
Sbjct: 177 TAPEAINFGCFTIKSNVWSFGILLYEIVT 205

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 59/97 (60%), Gaps = 9/97 (9%)
Query: 221 TAEIVSAVSHLHK-CGIVHRDLKPENILM---DSDGHVM---LTDFGLAKEIDESSRSNS 273
           + +++  + ++H+ CGI+H D+KPEN+LM   DS  +++   + D G A   DE   +NS
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-TNS 195
Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           +  T EY +PE+LL       AD WS   L++E++TG
Sbjct: 196 IQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 78/154 (50%), Gaps = 5/154 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 53  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 111
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 112 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 171
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
              ++ APE +        +D WS GILL E++T
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 59/97 (60%), Gaps = 9/97 (9%)
Query: 221 TAEIVSAVSHLHK-CGIVHRDLKPENILM---DSDGHVM---LTDFGLAKEIDESSRSNS 273
           + +++  + ++H+ CGI+H D+KPEN+LM   DS  +++   + D G A   DE   +NS
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-TNS 195
Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           +  T EY +PE+LL       AD WS   L++E++TG
Sbjct: 196 IQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 76/146 (52%), Gaps = 10/146 (6%)
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARF--YTAEI 224
           + +  HP IV+L     T + +++I++    G L  F  + +   F  D A    Y  ++
Sbjct: 445 MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQL 500
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMA 282
            +A+++L     VHRD+   N+L+ +   V L DFGL++ +++S+   +  G    ++MA
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 560
Query: 283 PEILLSKGHNKDADWWSVGILLYEML 308
           PE +  +     +D W  G+ ++E+L
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/89 (35%), Positives = 56/89 (62%), Gaps = 4/89 (4%)
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYM 281
            + ++ LH+   +HRD+K  NIL+D      ++DFGLA+  ++ +++   + + GTT YM
Sbjct: 143 ANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYM 202
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTG 310
           APE L  +   K +D +S G++L E++TG
Sbjct: 203 APEALRGEITPK-SDIYSFGVVLLEIITG 230

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 92/203 (45%), Gaps = 8/203 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F+  +V+  GAF                  + A+K +R+ T  K N    +  E  ++ 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILDEAYVMA 79
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAEIVSAVS 229
            V +P + +L       S + LI+  +  G L  ++         Q    +  +I   ++
Sbjct: 80  SVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 138
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT---EYMAPEIL 286
           +L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++MA E +
Sbjct: 139 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 287 LSKGHNKDADWWSVGILLYEMLT 309
           L + +   +D WS G+ ++E++T
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMT 221

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/118 (31%), Positives = 54/118 (45%), Gaps = 21/118 (17%)
Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH------------------ 253
           FR D  R    +I  +V+ LH   + H DLKPENIL     +                  
Sbjct: 115 FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174
Query: 254 -VMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            + + DFG A   DE    +++  T  Y APE++L+ G ++  D WS+G +L E   G
Sbjct: 175 DIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 57/107 (53%), Gaps = 4/107 (3%)
Query: 206 LYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI 265
            Y++ I  ED    Y+ ++   +  L     +HRDL   NIL+  +  V + DFGLA++I
Sbjct: 191 FYKEPITMEDLIS-YSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDI 249
Query: 266 DESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            ++    R        ++MAPE +  K ++  +D WS G+LL+E+ +
Sbjct: 250 YKNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 52/93 (55%), Gaps = 3/93 (3%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG--- 276
           +  +I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G   
Sbjct: 156 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 215
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             ++MA E +L + +   +D WS G+ ++E++T
Sbjct: 216 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 78/151 (51%), Gaps = 20/151 (13%)
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKL------YLILDFINGGHLFFHLYRQGIFREDQARF 219
           R  L +V HP IVQ+ ++F   +        Y++++++ G  L     ++    E  A  
Sbjct: 130 RQFLAEVVHPSIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA-- 186
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS---MCG 276
           Y  EI+ A+S+LH  G+V+ DLKPENI++ ++  + L D G        SR NS   + G
Sbjct: 187 YLLEILPALSYLHSIGLVYNDLKPENIML-TEEQLKLIDLGAV------SRINSFGYLYG 239
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           T  + APEI+ + G     D ++VG  L  +
Sbjct: 240 TPGFQAPEIVRT-GPTVATDIYTVGRTLAAL 269

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 81/169 (47%), Gaps = 9/169 (5%)
Query: 150 KDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK----LYLILDFINGGHLFFH 205
           +D  + K+     K E + L  + HP IV+   S+++  K    + L+ +    G L  +
Sbjct: 60  QDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTY 119
Query: 206 LYRQGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDS-DGHVMLTDFGLA 262
           L R  + +    R +  +I+  +  LH     I+HRDLK +NI +    G V + D GLA
Sbjct: 120 LKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
             +  +S + ++ GT E+ APE    K +++  D ++ G    E  T +
Sbjct: 180 T-LKRASFAKAVIGTPEFXAPEXYEEK-YDESVDVYAFGXCXLEXATSE 226

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/227 (21%), Positives = 98/227 (43%), Gaps = 41/227 (18%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G+G F                    A+K+++++     + +  + +E ++L +V HP
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHP 86
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE--------------------- 214
            +++L  +      L LI+++   G L      +G  RE                     
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSL------RGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 215 --DQARFYTAEIVS-------AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI 265
             D+      +++S        + +L +  +VHRDL   NIL+     + ++DFGL++++
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 266 -DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            +E S      G    ++MA E L    +   +D WS G+LL+E++T
Sbjct: 201 YEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 84/169 (49%), Gaps = 6/169 (3%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K  +KD  +  N   +M +E  I+  + HP IV+L          ++I++    G L 
Sbjct: 56  AVKTCKKDCTLD-NKEKFM-SEAVIMKNLDHPHIVKL-IGIIEEEPTWIIMELYPYGELG 112
Query: 204 FHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            +L R +   +      Y+ +I  A+++L     VHRD+   NIL+ S   V L DFGL+
Sbjct: 113 HYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 172
Query: 263 KEIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           + I++    +++      ++M+PE +  +     +D W   + ++E+L+
Sbjct: 173 RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 221

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 57/112 (50%), Gaps = 25/112 (22%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDG-------------HVMLTDFGLAKEIDESS 269
           +I S V+HLH   I+HRDLKP+NIL+ +                ++++DFGL K++D   
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 270 RS-----NSMCGTTEYMAPEILLSKGH-------NKDADWWSVGILLYEMLT 309
                  N+  GT+ + APE+L    +        +  D +S+G + Y +L+
Sbjct: 183 XXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 52/93 (55%), Gaps = 3/93 (3%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG--- 276
           +  +I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G   
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             ++MA E +L + +   +D WS G+ ++E++T
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/89 (35%), Positives = 55/89 (61%), Gaps = 4/89 (4%)
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYM 281
            + ++ LH+   +HRD+K  NIL+D      ++DFGLA+  ++ +++     + GTT YM
Sbjct: 143 ANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYM 202
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTG 310
           APE L  +   K +D +S G++L E++TG
Sbjct: 203 APEALRGEITPK-SDIYSFGVVLLEIITG 230

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 52/93 (55%), Gaps = 3/93 (3%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT- 278
           +  +I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G   
Sbjct: 129 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 188
Query: 279 --EYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             ++MA E +L + +   +D WS G+ ++E++T
Sbjct: 189 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 84/169 (49%), Gaps = 6/169 (3%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K  +KD  +  N   +M +E  I+  + HP IV+L          ++I++    G L 
Sbjct: 40  AVKTCKKDCTLD-NKEKFM-SEAVIMKNLDHPHIVKL-IGIIEEEPTWIIMELYPYGELG 96
Query: 204 FHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            +L R +   +      Y+ +I  A+++L     VHRD+   NIL+ S   V L DFGL+
Sbjct: 97  HYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 156
Query: 263 KEIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           + I++    +++      ++M+PE +  +     +D W   + ++E+L+
Sbjct: 157 RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 205

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 84/169 (49%), Gaps = 6/169 (3%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K  +KD  +  N   +M +E  I+  + HP IV+L          ++I++    G L 
Sbjct: 44  AVKTCKKDCTLD-NKEKFM-SEAVIMKNLDHPHIVKL-IGIIEEEPTWIIMELYPYGELG 100
Query: 204 FHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            +L R +   +      Y+ +I  A+++L     VHRD+   NIL+ S   V L DFGL+
Sbjct: 101 HYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 160
Query: 263 KEIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           + I++    +++      ++M+PE +  +     +D W   + ++E+L+
Sbjct: 161 RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 209

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/172 (23%), Positives = 85/172 (49%), Gaps = 6/172 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 71  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 129
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT 277
              ++   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +  DE+       G 
Sbjct: 130 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 189
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACNTML 326
              ++ APE +     +  +D WS G+L++E  + GQ   + M+      ML
Sbjct: 190 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 241

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/172 (23%), Positives = 85/172 (49%), Gaps = 6/172 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 57  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 115
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT 277
              ++   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +  DE+       G 
Sbjct: 116 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGK 175
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACNTML 326
              ++ APE +     +  +D WS G+L++E  + GQ   + M+      ML
Sbjct: 176 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 227

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/172 (23%), Positives = 85/172 (49%), Gaps = 6/172 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 73  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 131
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT 277
              ++   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +  DE+       G 
Sbjct: 132 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 191
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACNTML 326
              ++ APE +     +  +D WS G+L++E  + GQ   + M+      ML
Sbjct: 192 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 243

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/172 (23%), Positives = 85/172 (49%), Gaps = 6/172 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 73  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 131
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT 277
              ++   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +  DE+       G 
Sbjct: 132 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 191
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACNTML 326
              ++ APE +     +  +D WS G+L++E  + GQ   + M+      ML
Sbjct: 192 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 243

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/227 (21%), Positives = 98/227 (43%), Gaps = 41/227 (18%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G+G F                    A+K+++++     + +  + +E ++L +V HP
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHP 86
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE--------------------- 214
            +++L  +      L LI+++   G L      +G  RE                     
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSL------RGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 215 --DQARFYTAEIVS-------AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI 265
             D+      +++S        + +L +  +VHRDL   NIL+     + ++DFGL++++
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 266 -DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            +E S      G    ++MA E L    +   +D WS G+LL+E++T
Sbjct: 201 YEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 91/203 (44%), Gaps = 8/203 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F+  +V+G GAF                  + A+K +R+ T  K N    +  E  ++ 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILDEAYVMA 79
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAEIVSAVS 229
            V +P + +L       S + LI   +  G L  ++         Q    +  +I   ++
Sbjct: 80  SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 138
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT---EYMAPEIL 286
           +L    +VHRDL   N+L+ +  HV +TDFG AK +    +     G     ++MA E +
Sbjct: 139 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 287 LSKGHNKDADWWSVGILLYEMLT 309
           L + +   +D WS G+ ++E++T
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 91/203 (44%), Gaps = 8/203 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F+  +V+G GAF                  + A+K +R+ T  K N    +  E  ++ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILDEAYVMA 74
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAEIVSAVS 229
            V +P + +L       S + LI   +  G L  ++         Q    +  +I   ++
Sbjct: 75  SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT---EYMAPEIL 286
           +L    +VHRDL   N+L+ +  HV +TDFG AK +    +     G     ++MA E +
Sbjct: 134 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 287 LSKGHNKDADWWSVGILLYEMLT 309
           L + +   +D WS G+ ++E++T
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 91/203 (44%), Gaps = 8/203 (3%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F+  +V+G GAF                  + A+K +R+ T  K N    +  E  ++ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILDEAYVMA 72
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAEIVSAVS 229
            V +P + +L       S + LI   +  G L  ++         Q    +  +I   ++
Sbjct: 73  SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT---EYMAPEIL 286
           +L    +VHRDL   N+L+ +  HV +TDFG AK +    +     G     ++MA E +
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 287 LSKGHNKDADWWSVGILLYEMLT 309
           L + +   +D WS G+ ++E++T
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 66/134 (49%), Gaps = 12/134 (8%)
Query: 185 QTRSKLYLILDFIN---GGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           + ++ +YL+ DF      G L   L +   F   + +     +++ + ++H+  I+HRD+
Sbjct: 95  RCKASIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLYYIHRNKILHRDM 151
Query: 242 KPENILMDSDGHVMLTDFGLAKEI-----DESSRSNSMCGTTEYMAPEILLS-KGHNKDA 295
           K  N+L+  DG + L DFGLA+        + +R  +   T  Y  PE+LL  + +    
Sbjct: 152 KAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPI 211
Query: 296 DWWSVGILLYEMLT 309
           D W  G ++ EM T
Sbjct: 212 DLWGAGCIMAEMWT 225

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 65/134 (48%), Gaps = 12/134 (8%)
Query: 185 QTRSKLYLILDFIN---GGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           + +  +YL+ DF      G L   L +   F   + +     +++ + ++H+  I+HRD+
Sbjct: 95  RCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLYYIHRNKILHRDM 151
Query: 242 KPENILMDSDGHVMLTDFGLAKEI-----DESSRSNSMCGTTEYMAPEILLS-KGHNKDA 295
           K  N+L+  DG + L DFGLA+        + +R  +   T  Y  PE+LL  + +    
Sbjct: 152 KAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPI 211
Query: 296 DWWSVGILLYEMLT 309
           D W  G ++ EM T
Sbjct: 212 DLWGAGCIMAEMWT 225

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 78/154 (50%), Gaps = 5/154 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 49  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 107
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HR+L+  NIL+       + DFGLA+ I+++  +      
Sbjct: 108 LDMAAQIAEGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 167
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
              ++ APE +        +D WS GILL E++T
Sbjct: 168 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 201

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/172 (23%), Positives = 85/172 (49%), Gaps = 6/172 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 57  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 115
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT 277
              ++   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +  DE+       G 
Sbjct: 116 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 175
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACNTML 326
              ++ APE +     +  +D WS G+L++E  + GQ   + M+      ML
Sbjct: 176 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 227

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 2/93 (2%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCG 276
           R+Y  E++ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 128 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 187
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEML 308
           +  +  PE+L+  + ++   D WS+G +   M+
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 220

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 2/93 (2%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCG 276
           R+Y  E++ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 130 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 189
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEML 308
           +  +  PE+L+  + ++   D WS+G +   M+
Sbjct: 190 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 222

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/89 (35%), Positives = 54/89 (60%), Gaps = 4/89 (4%)
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYM 281
            + ++ LH+   +HRD+K  NIL+D      ++DFGLA+  ++ ++      + GTT YM
Sbjct: 137 ANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYM 196
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTG 310
           APE L  +   K +D +S G++L E++TG
Sbjct: 197 APEALRGEITPK-SDIYSFGVVLLEIITG 224

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 2/93 (2%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCG 276
           R+Y  E++ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 129 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 188
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEML 308
           +  +  PE+L+  + ++   D WS+G +   M+
Sbjct: 189 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 221

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 2/93 (2%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCG 276
           R+Y  E++ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 128 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 187
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEML 308
           +  +  PE+L+  + ++   D WS+G +   M+
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 220

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 2/93 (2%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCG 276
           R+Y  E++ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 128 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 187
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEML 308
           +  +  PE+L+  + ++   D WS+G +   M+
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 220

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 2/93 (2%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCG 276
           R+Y  E++ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 128 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 187
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEML 308
           +  +  PE+L+  + ++   D WS+G +   M+
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 220

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/227 (21%), Positives = 98/227 (43%), Gaps = 41/227 (18%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G+G F                    A+K+++++     + +  + +E ++L +V HP
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHP 86
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE--------------------- 214
            +++L  +      L LI+++   G L      +G  RE                     
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSL------RGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 215 --DQARFYTAEIVS-------AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI 265
             D+      +++S        + +L +  +VHRDL   NIL+     + ++DFGL++++
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 266 -DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            +E S      G    ++MA E L    +   +D WS G+LL+E++T
Sbjct: 201 YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/172 (23%), Positives = 85/172 (49%), Gaps = 6/172 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 63  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 121
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT 277
              ++   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +  DE+       G 
Sbjct: 122 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 181
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACNTML 326
              ++ APE +     +  +D WS G+L++E  + GQ   + M+      ML
Sbjct: 182 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 2/93 (2%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCG 276
           R+Y  E++ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 128 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 187
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEML 308
           +  +  PE+L+  + ++   D WS+G +   M+
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 220

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 2/93 (2%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCG 276
           R+Y  E++ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 128 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 187
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEML 308
           +  +  PE+L+  + ++   D WS+G +   M+
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 220

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 2/93 (2%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCG 276
           R+Y  E++ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 129 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 188
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEML 308
           +  +  PE+L+  + ++   D WS+G +   M+
Sbjct: 189 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 221

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 2/93 (2%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCG 276
           R+Y  E++ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 149 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 208
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEML 308
           +  +  PE+L+  + ++   D WS+G +   M+
Sbjct: 209 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 241

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/179 (22%), Positives = 88/179 (49%), Gaps = 21/179 (11%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K + K    +K   D++ +E  I+ +  HP ++ L       + + +I +F+  G L 
Sbjct: 39  AIKTL-KSGYTEKQRRDFL-SEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL- 95
Query: 204 FHLYRQGIFREDQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
                    R++  +F   ++V       + + +L     VHR L   NIL++S+    +
Sbjct: 96  -----DSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRALAARNILVNSNLVCKV 150
Query: 257 TDFGLAKEIDESSR----SNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           +DFGL++ +++ +     ++++ G     + APE +  +     +D WS GI+++E+++
Sbjct: 151 SDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 209

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 65/134 (48%), Gaps = 12/134 (8%)
Query: 185 QTRSKLYLILDFIN---GGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           + +  +YL+ DF      G L   L +   F   + +     +++ + ++H+  I+HRD+
Sbjct: 94  RCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLYYIHRNKILHRDM 150
Query: 242 KPENILMDSDGHVMLTDFGLAKEI-----DESSRSNSMCGTTEYMAPEILLS-KGHNKDA 295
           K  N+L+  DG + L DFGLA+        + +R  +   T  Y  PE+LL  + +    
Sbjct: 151 KAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPI 210
Query: 296 DWWSVGILLYEMLT 309
           D W  G ++ EM T
Sbjct: 211 DLWGAGCIMAEMWT 224

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/172 (23%), Positives = 85/172 (49%), Gaps = 6/172 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 51  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 109
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT 277
              ++   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +  DE+       G 
Sbjct: 110 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 169
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACNTML 326
              ++ APE +     +  +D WS G+L++E  + GQ   + M+      ML
Sbjct: 170 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 221

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 65/134 (48%), Gaps = 12/134 (8%)
Query: 185 QTRSKLYLILDFIN---GGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           + +  +YL+ DF      G L   L +   F   + +     +++ + ++H+  I+HRD+
Sbjct: 95  RCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLYYIHRNKILHRDM 151
Query: 242 KPENILMDSDGHVMLTDFGLAKEI-----DESSRSNSMCGTTEYMAPEILLS-KGHNKDA 295
           K  N+L+  DG + L DFGLA+        + +R  +   T  Y  PE+LL  + +    
Sbjct: 152 KAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPI 211
Query: 296 DWWSVGILLYEMLT 309
           D W  G ++ EM T
Sbjct: 212 DLWGAGCIMAEMWT 225

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/172 (23%), Positives = 85/172 (49%), Gaps = 6/172 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 53  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 111
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT 277
              ++   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +  DE+       G 
Sbjct: 112 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACNTML 326
              ++ APE +     +  +D WS G+L++E  + GQ   + M+      ML
Sbjct: 172 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 223

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F + R++G+G F                    A+K+++ D I   +  ++++ E   + +
Sbjct: 25  FTLGRMLGKGEFGSVREAQLKQEDGSFVKV--AVKMLKADIIASSDIEEFLR-EAACMKE 81
Query: 172 VTHPFIVQL-RYSFQTRSKLYL-----ILDFINGG--HLFFHLYRQG-----IFREDQAR 218
             HP + +L   S ++R+K  L     IL F+  G  H F    R G     +  +   R
Sbjct: 82  FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT- 277
           F   +I   + +L     +HRDL   N ++  D  V + DFGL+++I         C + 
Sbjct: 142 F-MVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASK 200
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
              +++A E L    +   +D W+ G+ ++E++T
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 3/93 (3%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I +     R      
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 203
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             ++MAPE +  + +   +D WS G+LL+E+ +
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 3/93 (3%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I +     R      
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 203
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             ++MAPE +  + +   +D WS G+LL+E+ +
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 48/78 (61%), Gaps = 2/78 (2%)
Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR--SNSMCGTTEYMAPEILLSKGHNK 293
           I+HRD+K  NIL+D +   ++ DFGLAK +D        ++ GT  ++APE L +   ++
Sbjct: 163 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSE 222
Query: 294 DADWWSVGILLYEMLTGQ 311
             D +  G++L E++TGQ
Sbjct: 223 KTDVFGYGVMLLELITGQ 240

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 74/143 (51%), Gaps = 11/143 (7%)
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE---DQARFYTAEIVSAVSHLH 232
           +IV L+  F  R+ L L+ + ++  +  + L R   FR    +  R +  ++ +A+  L 
Sbjct: 98  YIVHLKRHFMFRNHLCLVFEMLS--YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 155
Query: 233 --KCGIVHRDLKPENILM--DSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS 288
             +  I+H DLKPENIL+       + + DFG + ++ +  R      +  Y +PE+LL 
Sbjct: 156 TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--RIYQXIQSRFYRSPEVLLG 213
Query: 289 KGHNKDADWWSVGILLYEMLTGQ 311
             ++   D WS+G +L EM TG+
Sbjct: 214 MPYDLAIDMWSLGCILVEMHTGE 236

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 83/171 (48%), Gaps = 21/171 (12%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K M+  ++     V+   AE +++  + H  +V+L ++  T+  +Y+I +F+  G L 
Sbjct: 210 AVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLL 264
Query: 204 FHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
             L      ++   +   ++A+I   ++ + +   +HRDL+  NIL+ +     + DFGL
Sbjct: 265 DFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL 324
Query: 262 AKEIDESSRSNSMCGTT---EYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           A+            G     ++ APE +        +D WS GILL E++T
Sbjct: 325 AR-----------VGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 364

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 3/93 (3%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I +     R      
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             ++MAPE +  + +   +D WS G+LL+E+ +
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 3/93 (3%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I +     R      
Sbjct: 153 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             ++MAPE +  + +   +D WS G+LL+E+ +
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 3/93 (3%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I +     R      
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             ++MAPE +  + +   +D WS G+LL+E+ +
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 74/143 (51%), Gaps = 11/143 (7%)
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE---DQARFYTAEIVSAVSHLH 232
           +IV L+  F  R+ L L+ + ++  +  + L R   FR    +  R +  ++ +A+  L 
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLS--YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 233 --KCGIVHRDLKPENILM--DSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS 288
             +  I+H DLKPENIL+       + + DFG + ++ +  R      +  Y +PE+LL 
Sbjct: 175 TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--RIYQXIQSRFYRSPEVLLG 232
Query: 289 KGHNKDADWWSVGILLYEMLTGQ 311
             ++   D WS+G +L EM TG+
Sbjct: 233 MPYDLAIDMWSLGCILVEMHTGE 255

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 3/93 (3%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARL 212
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             ++MAPE +  + +   +D WS G+LL+E+ +
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 75/143 (52%), Gaps = 11/143 (7%)
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE---DQARFYTAEIVSAVSHLH 232
           +IV L+  F  R+ L L+ + ++  +  + L R   FR    +  R +  ++ +A+  L 
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLS--YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 233 --KCGIVHRDLKPENILMDSDGH--VMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS 288
             +  I+H DLKPENIL+ +     + + DFG + ++ +  R      +  Y +PE+LL 
Sbjct: 175 TPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQ--RIYQXIQSRFYRSPEVLLG 232
Query: 289 KGHNKDADWWSVGILLYEMLTGQ 311
             ++   D WS+G +L EM TG+
Sbjct: 233 MPYDLAIDMWSLGCILVEMHTGE 255

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 3/93 (3%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I +     R      
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 203
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             ++MAPE +  + +   +D WS G+LL+E+ +
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 3/93 (3%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I +     R      
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 203
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             ++MAPE +  + +   +D WS G+LL+E+ +
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 3/93 (3%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I +     R      
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             ++MAPE +  + +   +D WS G+LL+E+ +
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 3/93 (3%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I +     R      
Sbjct: 190 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 249
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             ++MAPE +  + +   +D WS G+LL+E+ +
Sbjct: 250 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 3/93 (3%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 149 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARL 208
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             ++MAPE +  + +   +D WS G+LL+E+ +
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 3/93 (3%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I +     R      
Sbjct: 196 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 255
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             ++MAPE +  + +   +D WS G+LL+E+ +
Sbjct: 256 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/208 (21%), Positives = 86/208 (41%), Gaps = 8/208 (3%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           IG  D  +   +G G+F                    A+K ++ D + +   +D    E 
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVS--VAVKCLKPDVLSQPEAMDDFIREV 72
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIV 225
           + +  + H  +++L Y       + ++ +    G L   L + QG F       Y  ++ 
Sbjct: 73  NAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 131
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE----YM 281
             + +L     +HRDL   N+L+ +   V + DFGL + + ++     M    +    + 
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 191
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT 309
           APE L ++  +  +D W  G+ L+EM T
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 3/93 (3%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 212
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             ++MAPE +  + +   +D WS G+LL+E+ +
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 3/93 (3%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I +     R      
Sbjct: 203 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 262
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             ++MAPE +  + +   +D WS G+LL+E+ +
Sbjct: 263 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 3/93 (3%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I +     R      
Sbjct: 155 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 214
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             ++MAPE +  + +   +D WS G+LL+E+ +
Sbjct: 215 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/208 (21%), Positives = 86/208 (41%), Gaps = 8/208 (3%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           IG  D  +   +G G+F                    A+K ++ D + +   +D    E 
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVS--VAVKCLKPDVLSQPEAMDDFIREV 62
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIV 225
           + +  + H  +++L Y       + ++ +    G L   L + QG F       Y  ++ 
Sbjct: 63  NAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE----YM 281
             + +L     +HRDL   N+L+ +   V + DFGL + + ++     M    +    + 
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 181
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT 309
           APE L ++  +  +D W  G+ L+EM T
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 3/93 (3%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 149 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 208
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             ++MAPE +  + +   +D WS G+LL+E+ +
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 3/93 (3%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I +     R      
Sbjct: 205 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 264
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             ++MAPE +  + +   +D WS G+LL+E+ +
Sbjct: 265 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 53/118 (44%), Gaps = 21/118 (17%)
Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH------------------ 253
           FR D  R    +I  +V+ LH   + H DLKPENIL     +                  
Sbjct: 115 FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174
Query: 254 -VMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            + + DFG A   DE    +++     Y APE++L+ G ++  D WS+G +L E   G
Sbjct: 175 DIKVVDFGSATYDDE--HHSTLVXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 54/89 (60%), Gaps = 4/89 (4%)
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYM 281
            + ++ LH+   +HRD+K  NIL+D      ++DFGLA+  ++ ++    + + GTT Y 
Sbjct: 134 ANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYX 193
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTG 310
           APE L  +   K +D +S G++L E++TG
Sbjct: 194 APEALRGEITPK-SDIYSFGVVLLEIITG 221

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 67/151 (44%), Gaps = 20/151 (13%)
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--- 232
           FI     S  + ++L+LI  +   G L+  L RQ +      R   +     ++HLH   
Sbjct: 67  FIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSA-ACGLAHLHVEI 125
Query: 233 -----KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR-----SNSMCGTTEYMA 282
                K  I HRD K  N+L+ S+    + D GLA    + S      +N   GT  YMA
Sbjct: 126 FGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMA 185
Query: 283 PEILLSKGHN------KDADWWSVGILLYEM 307
           PE+L  +         K  D W+ G++L+E+
Sbjct: 186 PEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 78/174 (44%), Gaps = 18/174 (10%)
Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH---LFFHLYRQGIFRED 215
           V +++ E  +     HP IV  R +F   ++L+++  F+  G    L    +  G+  E 
Sbjct: 54  VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGM-NEL 112
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM- 274
              +    ++ A+ ++H  G VHR +K  +IL+  DG V L+  GL   +   S      
Sbjct: 113 AIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMISHGQRQR 170
Query: 275 ---------CGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQVNIKSM 317
                         +++PE+L    +G++  +D +SVGI   E+  G V  K M
Sbjct: 171 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 224

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/208 (21%), Positives = 86/208 (41%), Gaps = 8/208 (3%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           IG  D  +   +G G+F                    A+K ++ D + +   +D    E 
Sbjct: 9   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVS--VAVKCLKPDVLSQPEAMDDFIREV 66
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIV 225
           + +  + H  +++L Y       + ++ +    G L   L + QG F       Y  ++ 
Sbjct: 67  NAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 125
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE----YM 281
             + +L     +HRDL   N+L+ +   V + DFGL + + ++     M    +    + 
Sbjct: 126 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 185
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT 309
           APE L ++  +  +D W  G+ L+EM T
Sbjct: 186 APESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 78/174 (44%), Gaps = 18/174 (10%)
Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH---LFFHLYRQGIFRED 215
           V +++ E  +     HP IV  R +F   ++L+++  F+  G    L    +  G+  E 
Sbjct: 70  VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGM-NEL 128
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM- 274
              +    ++ A+ ++H  G VHR +K  +IL+  DG V L+  GL   +   S      
Sbjct: 129 AIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMISHGQRQR 186
Query: 275 ---------CGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQVNIKSM 317
                         +++PE+L    +G++  +D +SVGI   E+  G V  K M
Sbjct: 187 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 56/99 (56%), Gaps = 12/99 (12%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILM---DSDGHV--MLTDFGLAKEIDES----SRSNS 273
           +  S ++HLH   IVHRDLKP NIL+   ++ G +  M++DFGL K++       SR + 
Sbjct: 126 QTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185
Query: 274 MCGTTEYMAPEIL---LSKGHNKDADWWSVGILLYEMLT 309
           + GT  ++APE+L     +      D +S G + Y +++
Sbjct: 186 VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/208 (21%), Positives = 86/208 (41%), Gaps = 8/208 (3%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           IG  D  +   +G G+F                    A+K ++ D + +   +D    E 
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVS--VAVKCLKPDVLSQPEAMDDFIREV 72
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIV 225
           + +  + H  +++L Y       + ++ +    G L   L + QG F       Y  ++ 
Sbjct: 73  NAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 131
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE----YM 281
             + +L     +HRDL   N+L+ +   V + DFGL + + ++     M    +    + 
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT 309
           APE L ++  +  +D W  G+ L+EM T
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/208 (21%), Positives = 86/208 (41%), Gaps = 8/208 (3%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           IG  D  +   +G G+F                    A+K ++ D + +   +D    E 
Sbjct: 9   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVS--VAVKCLKPDVLSQPEAMDDFIREV 66
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIV 225
           + +  + H  +++L Y       + ++ +    G L   L + QG F       Y  ++ 
Sbjct: 67  NAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 125
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE----YM 281
             + +L     +HRDL   N+L+ +   V + DFGL + + ++     M    +    + 
Sbjct: 126 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 185
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT 309
           APE L ++  +  +D W  G+ L+EM T
Sbjct: 186 APESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/208 (21%), Positives = 86/208 (41%), Gaps = 8/208 (3%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           IG  D  +   +G G+F                    A+K ++ D + +   +D    E 
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVS--VAVKCLKPDVLSQPEAMDDFIREV 62
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIV 225
           + +  + H  +++L Y       + ++ +    G L   L + QG F       Y  ++ 
Sbjct: 63  NAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE----YM 281
             + +L     +HRDL   N+L+ +   V + DFGL + + ++     M    +    + 
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT 309
           APE L ++  +  +D W  G+ L+EM T
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/208 (21%), Positives = 86/208 (41%), Gaps = 8/208 (3%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           IG  D  +   +G G+F                    A+K ++ D + +   +D    E 
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVS--VAVKCLKPDVLSQPEAMDDFIREV 62
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIV 225
           + +  + H  +++L Y       + ++ +    G L   L + QG F       Y  ++ 
Sbjct: 63  NAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE----YM 281
             + +L     +HRDL   N+L+ +   V + DFGL + + ++     M    +    + 
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT 309
           APE L ++  +  +D W  G+ L+EM T
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 28/78 (35%), Positives = 47/78 (60%), Gaps = 2/78 (2%)
Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR--SNSMCGTTEYMAPEILLSKGHNK 293
           I+HRD+K  NIL+D +   ++ DFGLAK +D        ++ G   ++APE L +   ++
Sbjct: 155 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYLSTGKSSE 214
Query: 294 DADWWSVGILLYEMLTGQ 311
             D +  G++L E++TGQ
Sbjct: 215 KTDVFGYGVMLLELITGQ 232

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/86 (36%), Positives = 49/86 (56%), Gaps = 8/86 (9%)
Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES---SRSNSMCGTTEYMAPEILLS 288
           HK  I HRD K +N+L+ SD   +L DFGLA   +       ++   GT  YMAPE+L  
Sbjct: 140 HKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEG 199
Query: 289 K-GHNKDA----DWWSVGILLYEMLT 309
                +DA    D +++G++L+E+++
Sbjct: 200 AINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 54/115 (46%), Gaps = 23/115 (20%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENIL-MDSDGHVMLTDFGLAKEIDESS----- 269
           Q R    ++  AV  LH   + H DLKPENIL ++SD  +    + L K+ DE S     
Sbjct: 138 QVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELT---YNLEKKRDERSVKSTA 194
Query: 270 --------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
                           +++  T  Y APE++L  G ++  D WS+G +++E   G
Sbjct: 195 VRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVG 249

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGT 277
            AEI   +++L+    VHRDL   N ++  D  V + DFG+ ++I E++   +       
Sbjct: 136 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLP 195
Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             +MAPE L        +D WS G++L+E+ +
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/219 (22%), Positives = 94/219 (42%), Gaps = 29/219 (13%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +  + R +G GAF                    A+K +  +   +++ +D++  E  I++
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFL-MEALIIS 103
Query: 171 KVTHPFIVQ-LRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           K+ H  IV+ +  S Q+  + +++L+ + GG L      +   RE + R      ++ + 
Sbjct: 104 KLNHQNIVRCIGVSLQSLPR-FILLELMAGGDL------KSFLRETRPRPSQPSSLAMLD 156
Query: 230 HLH-----KCG--------IVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESS---R 270
            LH      CG         +HRD+   N L+   G      + DFG+A++I  +S   +
Sbjct: 157 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 216
Query: 271 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
                   ++M PE  +        D WS G+LL+E+ +
Sbjct: 217 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 47/92 (51%), Gaps = 3/92 (3%)
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGT 277
            AEI   +++L+    VHRDL   N ++  D  V + DFG+ ++I E+    +       
Sbjct: 136 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 195
Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             +MAPE L        +D WS G++L+E+ +
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 47/92 (51%), Gaps = 3/92 (3%)
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGT 277
            AEI   +++L+    VHRDL   N ++  D  V + DFG+ ++I E+    +       
Sbjct: 136 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 195
Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             +MAPE L        +D WS G++L+E+ +
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 47/92 (51%), Gaps = 3/92 (3%)
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGT 277
            AEI   +++L+    VHRDL   N ++  D  V + DFG+ ++I E+    +       
Sbjct: 133 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 192
Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             +MAPE L        +D WS G++L+E+ +
Sbjct: 193 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/219 (22%), Positives = 94/219 (42%), Gaps = 29/219 (13%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +  + R +G GAF                    A+K +  +   +++ +D++  E  I++
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFL-MEALIIS 89
Query: 171 KVTHPFIVQ-LRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           K+ H  IV+ +  S Q+  + +++L+ + GG L      +   RE + R      ++ + 
Sbjct: 90  KLNHQNIVRCIGVSLQSLPR-FILLELMAGGDL------KSFLRETRPRPSQPSSLAMLD 142
Query: 230 HLH-----KCG--------IVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESS---R 270
            LH      CG         +HRD+   N L+   G      + DFG+A++I  +S   +
Sbjct: 143 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 202
Query: 271 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
                   ++M PE  +        D WS G+LL+E+ +
Sbjct: 203 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/219 (22%), Positives = 93/219 (42%), Gaps = 29/219 (13%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +  + R +G GAF                    A+K +  +   +++ +D++  E  I++
Sbjct: 23  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFL-MEALIIS 80
Query: 171 KVTHPFIVQ-LRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           K  H  IV+ +  S Q+  + +++L+ + GG L      +   RE + R      ++ + 
Sbjct: 81  KFNHQNIVRCIGVSLQSLPR-FILLELMAGGDL------KSFLRETRPRPSQPSSLAMLD 133
Query: 230 HLH-----KCG--------IVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESS---R 270
            LH      CG         +HRD+   N L+   G      + DFG+A++I  +S   +
Sbjct: 134 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 193
Query: 271 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
                   ++M PE  +        D WS G+LL+E+ +
Sbjct: 194 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 57/99 (57%), Gaps = 7/99 (7%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESS----RSNSM 274
           +++++   ++ L     +HRD+   N+L+ ++GHV  + DFGLA++I   S    + N+ 
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLL-TNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVN 313
               ++MAPE +    +   +D WS GILL+E+ +  +N
Sbjct: 228 L-PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN 265

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/219 (22%), Positives = 93/219 (42%), Gaps = 29/219 (13%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +  + R +G GAF                    A+K +  +   +++ +D++  E  I++
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFL-MEALIIS 88
Query: 171 KVTHPFIVQ-LRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           K  H  IV+ +  S Q+  + +++L+ + GG L      +   RE + R      ++ + 
Sbjct: 89  KFNHQNIVRCIGVSLQSLPR-FILLELMAGGDL------KSFLRETRPRPSQPSSLAMLD 141
Query: 230 HLH-----KCG--------IVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESS---R 270
            LH      CG         +HRD+   N L+   G      + DFG+A++I  +S   +
Sbjct: 142 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 201
Query: 271 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
                   ++M PE  +        D WS G+LL+E+ +
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 57/99 (57%), Gaps = 7/99 (7%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESS----RSNSM 274
           +++++   ++ L     +HRD+   N+L+ ++GHV  + DFGLA++I   S    + N+ 
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLL-TNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVN 313
               ++MAPE +    +   +D WS GILL+E+ +  +N
Sbjct: 228 L-PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN 265

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 57/99 (57%), Gaps = 7/99 (7%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESS----RSNSM 274
           +++++   ++ L     +HRD+   N+L+ ++GHV  + DFGLA++I   S    + N+ 
Sbjct: 171 FSSQVAQGMAFLASKNCIHRDVAARNVLL-TNGHVAKIGDFGLARDIMNDSNYIVKGNAR 229
Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVN 313
               ++MAPE +    +   +D WS GILL+E+ +  +N
Sbjct: 230 L-PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN 267
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	355
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-130
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-129
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-128
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-127
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-126
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-126
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-125
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-124
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-123
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-123
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-123
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-123
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-122
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-118
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-118
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-117
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-116
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-116
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-116
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-115
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-113
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-113
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-91
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	6e-89
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-80
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	7e-74
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-69
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-68
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-68
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-68
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-67
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-67
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-67
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-64
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-63
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-63
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-63
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-62
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-62
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-61
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-61
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-61
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-61
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-61
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-60
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-60
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-60
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-60
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	7e-60
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	8e-60
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-59
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-59
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-59
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-59
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-59
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-59
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-59
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-58
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-58
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-58
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-58
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-58
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-58
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-58
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-58
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-57
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-57
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-57
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	6e-57
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-56
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-56
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-54
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-54
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-54
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-54
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-53
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-53
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	7e-53
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-52
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-52
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-52
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-52
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-52
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-51
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-51
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-51
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-51
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-50
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-50
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-50
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-50
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	6e-50
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-49
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-49
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	9e-49
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-46
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-46
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-46
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-44
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-44
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-43
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-43
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	6e-43
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-42
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-42
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	8e-42
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	8e-42
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-41
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-41
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-41
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-41
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	8e-41
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-40
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-40
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	9e-40
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-39
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-39
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-39
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-38
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-38
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-38
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-38
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-38
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-38
3fme_A	290	Dual specificity mitogen-activated protein kinase;	7e-38
3an0_A	340	Dual specificity mitogen-activated protein kinase;	9e-38
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-37
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-37
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-36
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-36
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-36
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	6e-36
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	6e-36
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-32
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-31
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-31
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-31
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-31
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-31
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-30
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-30
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-30
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-30
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-30
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-29
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-29
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-29
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-29
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-28
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-27
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-26
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	8e-26
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-25
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-25
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-25
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	6e-25
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	7e-25
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	9e-25
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-24
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-24
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-24
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-24
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-24
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	5e-24
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-24
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	9e-24
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-23
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-23
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-23
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-23
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-23
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-23
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-23
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-23
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-23
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-23
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	6e-23
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-23
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	9e-23
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-22
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-22
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-22
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-22
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-22
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-22
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-22
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-22
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-22
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	7e-22
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	9e-22
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	9e-22
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-21
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-21
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-21
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-21
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-21
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-21
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	6e-21
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	6e-21
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	7e-21
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	9e-21
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	9e-21
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-20
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-20
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	4e-20
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-20
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	5e-20
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	5e-20
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-20
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	8e-20
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-20
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-19
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-19
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-19
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-19
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-19
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-19
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	7e-19
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	7e-19
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	8e-19
3pls_A	298	Macrophage-stimulating protein receptor; protein k	8e-19
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-18
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-18
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-17
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-17
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-16
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-15
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-15
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	7e-15
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	9e-15
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-14
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-14
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	6e-14
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	8e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-05
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	3e-04

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  374 bits (963), Expect = e-130
 Identities = 114/223 (51%), Positives = 153/223 (68%), Gaps = 4/223 (1%)

Query: 90  ELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR 149
            ++         E   K  P  FE+ +V+GQG+FGKVF VKK      D+  +YAMKV++
Sbjct: 4   SIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKIS--GSDARQLYAMKVLK 61

Query: 150 KDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ 209
           K T+  ++ V   K ERDIL +V HPFIV+L Y+FQT  KLYLILDF+ GG LF  L ++
Sbjct: 62  KATLKVRDRVR-TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE 120

Query: 210 GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDES 268
            +F E+  +FY AE+  A+ HLH  GI++RDLKPENIL+D +GH+ LTDFGL+KE ID  
Sbjct: 121 VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180

Query: 269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
            ++ S CGT EYMAPE++  +GH + ADWWS G+L++EMLTG 
Sbjct: 181 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  373 bits (960), Expect = e-129
 Identities = 114/212 (53%), Positives = 152/212 (71%), Gaps = 4/212 (1%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-NHVD 160
               KI P  FE+ RV+G+G +GKVFQV+K      ++  I+AMKV++K  I++      
Sbjct: 9   RGPEKIRPECFELLRVLGKGGYGKVFQVRKVT--GANTGKIFAMKVLKKAMIVRNAKDTA 66

Query: 161 YMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
           + KAER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  L R+GIF ED A FY
Sbjct: 67  HTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY 126

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTE 279
            AEI  A+ HLH+ GI++RDLKPENI+++  GHV LTDFGL KE I + + +++ CGT E
Sbjct: 127 LAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIE 186

Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           YMAPEIL+  GHN+  DWWS+G L+Y+MLTG 
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  368 bits (947), Expect = e-128
 Identities = 86/206 (41%), Positives = 137/206 (66%), Gaps = 7/206 (3%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           K    DF+I R +G G+FG+V  ++ +      +   YAMKV++K+ +++   V++   E
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSR-----HNGRYYAMKVLKKEIVVRLKQVEHTNDE 56

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
           R +L+ VTHPFI+++  +FQ   ++++I+D+I GG LF  L +   F    A+FY AE+ 
Sbjct: 57  RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC 116

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEI 285
            A+ +LH   I++RDLKPENIL+D +GH+ +TDFG AK + +   + ++CGT +Y+APE+
Sbjct: 117 LALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEV 174

Query: 286 LLSKGHNKDADWWSVGILLYEMLTGQ 311
           + +K +NK  DWWS GIL+YEML G 
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEMLAGY 200

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  367 bits (945), Expect = e-127
 Identities = 108/241 (44%), Positives = 149/241 (61%), Gaps = 7/241 (2%)

Query: 73  GPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKK 132
           G S                       L   S     P DF   +V+G+G+FGKV   + K
Sbjct: 1   GISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHK 60

Query: 133 GVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTHPFIVQLRYSFQTRSKLY 191
                  +  YA+KV++K  I+KK    ++ +ER++L K V HPF+V L +SFQT  KLY
Sbjct: 61  -----AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115

Query: 192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
            +LD+INGG LF+HL R+  F E +ARFY AEI SA+ +LH   IV+RDLKPENIL+DS 
Sbjct: 116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ 175

Query: 252 GHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           GH++LTDFGL KE I+ +S +++ CGT EY+APE+L  + +++  DWW +G +LYEML G
Sbjct: 176 GHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

Query: 311 Q 311
            
Sbjct: 236 L 236

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  365 bits (938), Expect = e-126
 Identities = 111/231 (48%), Positives = 157/231 (67%), Gaps = 8/231 (3%)

Query: 87  QIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMK 146
           Q+  ++HE           K+G  +FE+ +V+G GA+GKVF V+K      D+  +YAMK
Sbjct: 31  QLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKIS--GHDTGKLYAMK 88

Query: 147 VMRKDTII-KKNHVDYMKAERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFF 204
           V++K TI+ K    ++ + ER +L  +   PF+V L Y+FQT +KL+LILD+INGG LF 
Sbjct: 89  VLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFT 148

Query: 205 HLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE 264
           HL ++  F E + + Y  EIV A+ HLHK GI++RD+K ENIL+DS+GHV+LTDFGL+KE
Sbjct: 149 HLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208

Query: 265 --IDESSRSNSMCGTTEYMAPEILL--SKGHNKDADWWSVGILLYEMLTGQ 311
              DE+ R+   CGT EYMAP+I+     GH+K  DWWS+G+L+YE+LTG 
Sbjct: 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  363 bits (933), Expect = e-126
 Identities = 86/212 (40%), Positives = 135/212 (63%), Gaps = 8/212 (3%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
             RK  P DF+  +++G+G+F  V   ++       +   YA+K++ K  IIK+N V Y+
Sbjct: 23  QPRKKRPEDFKFGKILGEGSFSTVVLAREL-----ATSREYAIKILEKRHIIKENKVPYV 77

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
             ERD+++++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTA
Sbjct: 78  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 137

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCGTTE 279
           EIVSA+ +LH  GI+HRDLKPENIL++ D H+ +TDFG AK +    + +R+NS  GT +
Sbjct: 138 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197

Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           Y++PE+L  K   K +D W++G ++Y+++ G 
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  362 bits (932), Expect = e-125
 Identities = 80/213 (37%), Positives = 128/213 (60%), Gaps = 8/213 (3%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
           +    +    FEI R +G+G+FGKV  V+K      D+  +YAMK M K   +++N V  
Sbjct: 7   DENEDVNFDHFEILRAIGKGSFGKVCIVQKN-----DTKKMYAMKYMNKQKCVERNEVRN 61

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           +  E  I+  + HPF+V L YSFQ    +++++D + GG L +HL +   F+E+  + + 
Sbjct: 62  VFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFI 121

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYM 281
            E+V A+ +L    I+HRD+KP+NIL+D  GHV +TDF +A  +   ++  +M GT  YM
Sbjct: 122 CELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYM 181

Query: 282 APEILLSK---GHNKDADWWSVGILLYEMLTGQ 311
           APE+  S+   G++   DWWS+G+  YE+L G+
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  360 bits (926), Expect = e-124
 Identities = 90/207 (43%), Positives = 140/207 (67%), Gaps = 6/207 (2%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G FGKV  V++K      +   YAMK++RK+ II K+ V +   E
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREK-----ATGRYYAMKILRKEVIIAKDEVAHTVTE 55

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPE 284
           SA+ +LH   +V+RD+K EN+++D DGH+ +TDFGL KE I + +   + CGT EY+APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQ 311
           +L    + +  DWW +G+++YEM+ G+
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  360 bits (926), Expect = e-123
 Identities = 89/250 (35%), Positives = 159/250 (63%), Gaps = 8/250 (3%)

Query: 65  HNRSHSFVGPSP-RYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAF 123
           H+  H +  P+        ++   I+E +   +     ++   +G  DF++ RV+G+G++
Sbjct: 6   HHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSY 65

Query: 124 GKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRY 182
            KV  V+ K      +D IYAM+V++K+ +     +D+++ E+ +  + + HPF+V L  
Sbjct: 66  AKVLLVRLK-----KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHS 120

Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
            FQT S+L+ +++++NGG L FH+ RQ    E+ ARFY+AEI  A+++LH+ GI++RDLK
Sbjct: 121 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLK 180

Query: 243 PENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVG 301
            +N+L+DS+GH+ LTD+G+ KE +     +++ CGT  Y+APEIL  + +    DWW++G
Sbjct: 181 LDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALG 240

Query: 302 ILLYEMLTGQ 311
           +L++EM+ G+
Sbjct: 241 VLMFEMMAGR 250

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  358 bits (921), Expect = e-123
 Identities = 91/222 (40%), Positives = 139/222 (62%), Gaps = 7/222 (3%)

Query: 92  EHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD 151
             +    +   S  ++G  +FE  RV+G+G+FGKV   + K     ++  +YA+KV++KD
Sbjct: 5   SSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVK-----ETGDLYAVKVLKKD 59

Query: 152 TIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG 210
            I++ + V+    E+ IL+    HPF+ QL   FQT  +L+ +++F+NGG L FH+ +  
Sbjct: 60  VILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR 119

Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESS 269
            F E +ARFY AEI+SA+  LH  GI++RDLK +N+L+D +GH  L DFG+ KE I    
Sbjct: 120 RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV 179

Query: 270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
            + + CGT +Y+APEIL    +    DWW++G+LLYEML G 
Sbjct: 180 TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  356 bits (917), Expect = e-123
 Identities = 82/211 (38%), Positives = 134/211 (63%), Gaps = 7/211 (3%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           +  ++   DF    V+G+G+FGKV   ++K      +D +YA+K+++KD +I+ + V+  
Sbjct: 13  NRDRMKLTDFNFLMVLGKGSFGKVMLSERK-----GTDELYAVKILKKDVVIQDDDVECT 67

Query: 163 KAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
             E+ +L      PF+ QL   FQT  +LY +++++NGG L +H+ + G F+E  A FY 
Sbjct: 68  MVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYA 127

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEY 280
           AEI   +  L   GI++RDLK +N+++DS+GH+ + DFG+ KE I +   + + CGT +Y
Sbjct: 128 AEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDY 187

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           +APEI+  + + K  DWW+ G+LLYEML GQ
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  356 bits (916), Expect = e-123
 Identities = 85/211 (40%), Positives = 145/211 (68%), Gaps = 7/211 (3%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           +   +G  DF++ RV+G+G++ KV  V+ K      +D IYAMKV++K+ +     +D++
Sbjct: 2   AMDPLGLQDFDLLRVIGRGSYAKVLLVRLK-----KTDRIYAMKVVKKELVNDDEDIDWV 56

Query: 163 KAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           + E+ +  + + HPF+V L   FQT S+L+ +++++NGG L FH+ RQ    E+ ARFY+
Sbjct: 57  QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS 116

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEY 280
           AEI  A+++LH+ GI++RDLK +N+L+DS+GH+ LTD+G+ KE +     +++ CGT  Y
Sbjct: 117 AEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNY 176

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           +APEIL  + +    DWW++G+L++EM+ G+
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  354 bits (910), Expect = e-122
 Identities = 90/240 (37%), Positives = 146/240 (60%), Gaps = 7/240 (2%)

Query: 72  VGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKK 131
              + + +   S+   + + + +   + E  S+       F+  + +G G+FG+V  VK 
Sbjct: 3   AAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKH 62

Query: 132 KGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY 191
           K     +S   YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY
Sbjct: 63  K-----ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117

Query: 192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
           ++++++ GG +F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  
Sbjct: 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177

Query: 252 GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           G++ +TDFG AK +    R+ ++CGT E +APEI+LSKG+NK  DWW++G+L+YEM  G 
Sbjct: 178 GYIQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  346 bits (890), Expect = e-118
 Identities = 86/219 (39%), Positives = 129/219 (58%), Gaps = 15/219 (6%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
            E ++   DFEI +V+G+GAF +V  VK K      +  +YAMK+M K  ++K+  V   
Sbjct: 54  KEVRLQRDDFEILKVIGRGAFSEVAVVKMK-----QTGQVYAMKIMNKWDMLKRGEVSCF 108

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYT 221
           + ERD+L      +I QL ++FQ  + LYL++++  GG L   L + G     + ARFY 
Sbjct: 109 REERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYL 168

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTE 279
           AEIV A+  +H+ G VHRD+KP+NIL+D  GH+ L DFG   ++  D + RS    GT +
Sbjct: 169 AEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPD 228

Query: 280 YMAPEILLSKG-------HNKDADWWSVGILLYEMLTGQ 311
           Y++PEIL + G       +  + DWW++G+  YEM  GQ
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  347 bits (893), Expect = e-118
 Identities = 93/225 (41%), Positives = 145/225 (64%), Gaps = 7/225 (3%)

Query: 89  QELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM 148
                E      A+ + ++   +FE  +++G+G FGKV  VK+K      +   YAMK++
Sbjct: 127 DNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEK-----ATGRYYAMKIL 181

Query: 149 RKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR 208
           +K+ I+ K+ V +   E  +L    HPF+  L+YSFQT  +L  ++++ NGG LFFHL R
Sbjct: 182 KKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR 241

Query: 209 QGIFREDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-ID 266
           + +F ED+ARFY AEIVSA+ +LH +  +V+RDLK EN+++D DGH+ +TDFGL KE I 
Sbjct: 242 ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301

Query: 267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           + +   + CGT EY+APE+L    + +  DWW +G+++YEM+ G+
Sbjct: 302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  344 bits (885), Expect = e-117
 Identities = 83/217 (38%), Positives = 133/217 (61%), Gaps = 13/217 (5%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
            + ++   DFEI +V+G+GAFG+V  VK K     ++D ++AMK++ K  ++K+      
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVAVVKLK-----NADKVFAMKILNKWEMLKRAETACF 121

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYT 221
           + ERD+L      +I  L Y+FQ  + LYL++D+  GG L   L + +    E+ ARFY 
Sbjct: 122 REERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYL 181

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTE 279
           AE+V A+  +H+   VHRD+KP+NILMD +GH+ L DFG   ++  D + +S+   GT +
Sbjct: 182 AEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD 241

Query: 280 YMAPEILLSK-----GHNKDADWWSVGILLYEMLTGQ 311
           Y++PEIL +       +  + DWWS+G+ +YEML G+
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  348 bits (895), Expect = e-116
 Identities = 96/299 (32%), Positives = 142/299 (47%), Gaps = 18/299 (6%)

Query: 15  TKLKKLTITPPSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGP 74
              + LT    S + PD         +T C    +            ++ H   +  V P
Sbjct: 100 ACGRNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHE--YLSVAP 157

Query: 75  SPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGV 134
              Y  S      +Q    E          + +    F  +RV+G+G FG+V   + +  
Sbjct: 158 FADYLDSIYFNRFLQWKWLER---------QPVTKNTFRQYRVLGKGGFGEVCACQVR-- 206

Query: 135 DDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLIL 194
               +  +YA K + K  I K+        E+ IL KV   F+V L Y+++T+  L L+L
Sbjct: 207 ---ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263

Query: 195 DFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
             +NGG L FH+Y  G   F E +A FY AEI   +  LH+  IV+RDLKPENIL+D  G
Sbjct: 264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG 323

Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           H+ ++D GLA  + E        GT  YMAPE++ ++ +    DWW++G LLYEM+ GQ
Sbjct: 324 HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  339 bits (871), Expect = e-116
 Identities = 83/211 (39%), Positives = 136/211 (64%), Gaps = 7/211 (3%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
            + K+   DF + +++G+G+FGKVF  + K      ++  +A+K ++KD ++  + V+  
Sbjct: 10  LQIKLKIEDFILHKMLGKGSFGKVFLAEFK-----KTNQFFAIKALKKDVVLMDDDVECT 64

Query: 163 KAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
             E+ +L+    HPF+  +  +FQT+  L+ +++++NGG L +H+     F   +A FY 
Sbjct: 65  MVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYA 124

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEY 280
           AEI+  +  LH  GIV+RDLK +NIL+D DGH+ + DFG+ KE +   +++N+ CGT +Y
Sbjct: 125 AEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDY 184

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           +APEILL + +N   DWWS G+LLYEML GQ
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  341 bits (876), Expect = e-116
 Identities = 81/215 (37%), Positives = 134/215 (62%), Gaps = 12/215 (5%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
            + ++   D+E+ +V+G+GAFG+V  V+ K      +  +YAMK++ K  +IK++   + 
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHK-----STRKVYAMKLLSKFEMIKRSDSAFF 116

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
             ERDI+     P++VQL Y+FQ    LY++++++ GG L   +       E  ARFYTA
Sbjct: 117 WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTA 175

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEY 280
           E+V A+  +H  G +HRD+KP+N+L+D  GH+ L DFG   ++++    R ++  GT +Y
Sbjct: 176 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 235

Query: 281 MAPEILLSKG----HNKDADWWSVGILLYEMLTGQ 311
           ++PE+L S+G    + ++ DWWSVG+ LYEML G 
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  344 bits (885), Expect = e-115
 Identities = 81/212 (38%), Positives = 130/212 (61%), Gaps = 10/212 (4%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
           + +G   F  FRV+G+G FG+VF  + K      +  +YA K + K  + K+        
Sbjct: 180 QPMGEDWFLDFRVLGRGGFGEVFACQMK-----ATGKLYACKKLNKKRLKKRKGYQGAMV 234

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY----RQGIFREDQARFY 220
           E+ IL KV   FIV L Y+F+T++ L L++  +NGG + +H+Y        F+E +A FY
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTE 279
           TA+IVS + HLH+  I++RDLKPEN+L+D DG+V ++D GLA E     +++    GT  
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354

Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           +MAPE+LL + ++   D++++G+ LYEM+  +
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  344 bits (883), Expect = e-113
 Identities = 84/214 (39%), Positives = 125/214 (58%), Gaps = 10/214 (4%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
           E    +   DF + R++G+G FG+V+  +K      D+  +YAMK + K  I  K     
Sbjct: 181 ELNIHLTMNDFSVHRIIGRGGFGEVYGCRKA-----DTGKMYAMKCLDKKRIKMKQGETL 235

Query: 162 MKAERDILTKV---THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
              ER +L+ V     PFIV + Y+F T  KL  ILD +NGG L +HL + G+F E   R
Sbjct: 236 ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR 295

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
           FY AEI+  + H+H   +V+RDLKP NIL+D  GHV ++D GLA +  +  + ++  GT 
Sbjct: 296 FYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTH 354

Query: 279 EYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQ 311
            YMAPE+L     ++  ADW+S+G +L+++L G 
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  342 bits (879), Expect = e-113
 Identities = 88/286 (30%), Positives = 149/286 (52%), Gaps = 8/286 (2%)

Query: 29  SPDFDFTEVFGPLTPCRHNNQSPASTSA-SLGDPQVIHNRSHSFVGPSPRYALSSSLPLQ 87
           S  F  +E+            S       ++  P      +        R  +       
Sbjct: 259 SLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAP 318

Query: 88  IQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKV 147
            ++  +         +  ++   DF    V+G+G+FGKV   ++K      +D +YA+K+
Sbjct: 319 EEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERK-----GTDELYAVKI 373

Query: 148 MRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           ++KD +I+ + V+    E+ +L      PF+ QL   FQT  +LY +++++NGG L +H+
Sbjct: 374 LKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI 433

Query: 207 YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-I 265
            + G F+E  A FY AEI   +  L   GI++RDLK +N+++DS+GH+ + DFG+ KE I
Sbjct: 434 QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493

Query: 266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
            +   + + CGT +Y+APEI+  + + K  DWW+ G+LLYEML GQ
Sbjct: 494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  274 bits (702), Expect = 2e-91
 Identities = 71/212 (33%), Positives = 119/212 (56%), Gaps = 6/212 (2%)

Query: 99  LEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH 158
           L    +RK    DF+I R +G+G FG V+  ++K      +  I A+KV+ K  + K+  
Sbjct: 3   LAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREK-----QNKFIMALKVLFKSQLEKEGV 57

Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
              ++ E +I + + HP I+++   F  R ++YL+L+F   G L+  L + G F E ++ 
Sbjct: 58  EHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA 117

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
            +  E+  A+ + H+  ++HRD+KPEN+LM   G + + DFG +     S R  +MCGT 
Sbjct: 118 TFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTMCGTL 176

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           +Y+ PE++  K H++  D W  G+L YE L G
Sbjct: 177 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  267 bits (686), Expect = 6e-89
 Identities = 71/207 (34%), Positives = 119/207 (57%), Gaps = 6/207 (2%)

Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G FG V+  ++K      S  I A+KV+ K  + K      ++
Sbjct: 3   KRQWALEDFEIGRPLGKGKFGNVYLAREK-----QSKFILALKVLFKAQLEKAGVEHQLR 57

Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 117

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR   +CGT +Y+ P
Sbjct: 118 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLCGTLDYLPP 176

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTG 310
           E++  + H++  D WS+G+L YE L G
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVG 203

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  247 bits (633), Expect = 1e-80
 Identities = 67/268 (25%), Positives = 108/268 (40%), Gaps = 20/268 (7%)

Query: 46  HNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESER 105
           H++   +       +         S     PR      +  + +  E       +     
Sbjct: 3   HHHHHSSGVDLGTENLYF-----QSMHQLQPR-----RVSFRGEASETLQSPGYDPSRPE 52

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
                 F+    +G G++G+VF+V+ K  +DG    +YA+K         K+    +  E
Sbjct: 53  SFFQQSFQRLSRLGHGSYGEVFKVRSK--EDGR---LYAVKRSMSPFRGPKDRARKLA-E 106

Query: 166 RDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAE 223
                KV  HP  V+L  +++    LYL  +   G  L  H    G    E Q   Y  +
Sbjct: 107 VGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRD 165

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
            + A++HLH  G+VH D+KP NI +   G   L DFGL  E+  +       G   YMAP
Sbjct: 166 TLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAP 225

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQ 311
           E+ L   +   AD +S+G+ + E+    
Sbjct: 226 EL-LQGSYGTAADVFSLGLTILEVACNM 252

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  231 bits (591), Expect = 7e-74
 Identities = 55/234 (23%), Positives = 96/234 (41%), Gaps = 33/234 (14%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK----- 156
             E+     D+ I R + QG F K+   +K           YA+K   K  + KK     
Sbjct: 23  VKEKDKYINDYRIIRTLNQGKFNKIILCEKDN-------KFYALKKYEKSLLEKKRDFTK 75

Query: 157 ---------NHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
                    +  D  K E  I+T + + + +          ++Y+I +++    +     
Sbjct: 76  SNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDE 135

Query: 208 RQGI--------FREDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTD 258
              +              +     ++++ S++H +  I HRD+KP NILMD +G V L+D
Sbjct: 136 YFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSD 195

Query: 259 FGLAKEIDESSRSNSMCGTTEYMAPEILLSKG--HNKDADWWSVGILLYEMLTG 310
           FG ++ + +        GT E+M PE   ++   +    D WS+GI LY M   
Sbjct: 196 FGESEYMVDKKI-KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  221 bits (563), Expect = 2e-69
 Identities = 38/233 (16%), Positives = 96/233 (41%), Gaps = 22/233 (9%)

Query: 98  ELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN 157
            ++ ++E ++G     +  ++G+GAF +V++  +  ++D  +   + +KV +     +  
Sbjct: 53  AIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFY 112

Query: 158 HVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-----YRQGIF 212
                    + L        ++   +   ++   L+ +  + G L   +       + + 
Sbjct: 113 I---GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVM 169

Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM-----------DSDGHVMLTDFGL 261
            +     +   ++  +  +H C I+H D+KP+N ++           D    + L D G 
Sbjct: 170 PQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ 229

Query: 262 AKEI---DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           + ++    + +   + C T+ +   E+L +K  N   D++ V   +Y ML G 
Sbjct: 230 SIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  217 bits (555), Expect = 1e-68
 Identities = 67/242 (27%), Positives = 119/242 (49%), Gaps = 9/242 (3%)

Query: 73  GPSPRYALSSSLPLQIQELEHENDAELEAESERKIGP---GDFEIFRVVGQGAFGKVFQV 129
           GP+P     + +P              +   E  + P     +   R +G+G F K F++
Sbjct: 1   GPAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEI 60

Query: 130 KKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189
                 D D+  ++A K++ K  ++K +  + M  E  I   + H  +V     F+    
Sbjct: 61  S-----DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF 115

Query: 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD 249
           ++++L+      L     R+    E +AR+Y  +IV    +LH+  ++HRDLK  N+ ++
Sbjct: 116 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 175

Query: 250 SDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            D  V + DFGLA +++ +  R   +CGT  Y+APE+L  KGH+ + D WS+G ++Y +L
Sbjct: 176 EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLL 235

Query: 309 TG 310
            G
Sbjct: 236 VG 237

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  214 bits (547), Expect = 4e-68
 Identities = 59/203 (29%), Positives = 114/203 (56%), Gaps = 7/203 (3%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            DF++  ++G+G+F  V++ +        +    A+K++ K  + K   V  ++ E  I 
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESI-----HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEIVSAV 228
            ++ HP I++L   F+  + +YL+L+  + G +  +L  R   F E++AR +  +I++ +
Sbjct: 66  CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGM 125

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEILL 287
            +LH  GI+HRDL   N+L+  + ++ + DFGLA ++     +  ++CGT  Y++PEI  
Sbjct: 126 LYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT 185

Query: 288 SKGHNKDADWWSVGILLYEMLTG 310
              H  ++D WS+G + Y +L G
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIG 208

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  217 bits (555), Expect = 6e-68
 Identities = 61/226 (26%), Positives = 103/226 (45%), Gaps = 24/226 (10%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
             +      + +  ++GQGA   VF+ + K      +  ++A+KV    + ++   VD  
Sbjct: 2   GSQSTSNHLWLLSDILGQGATANVFRGRHK-----KTGDLFAIKVFNNISFLRP--VDVQ 54

Query: 163 KAERDILTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYRQG---IFREDQA 217
             E ++L K+ H  IV+L       T     LI++F   G L+  L          E + 
Sbjct: 55  MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114

Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILM----DSDGHVMLTDFGLAKEIDESSRSNS 273
                ++V  ++HL + GIVHR++KP NI+     D      LTDFG A+E+++  +  S
Sbjct: 115 LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS 174

Query: 274 MCGTTEYMAPEIL--------LSKGHNKDADWWSVGILLYEMLTGQ 311
           + GT EY+ P++           K +    D WS+G+  Y   TG 
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  213 bits (545), Expect = 2e-67
 Identities = 64/231 (27%), Positives = 112/231 (48%), Gaps = 41/231 (17%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           DFE   V+GQGAFG+V + +         D   YA+K +R      +  +  + +E  +L
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNA------LDSRYYAIKKIRH----TEEKLSTILSEVMLL 56

Query: 170 TKVTHPFIVQLRYSFQ-------------TRSKLYLILDFINGGHLFFHLYRQGIF-RED 215
             + H ++V+   ++               +S L++ +++   G L+  ++ + +  + D
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116

Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---- 271
           +      +I+ A+S++H  GI+HRDLKP NI +D   +V + DFGLAK +  S       
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 272 -----------NSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTG 310
                       S  GT  Y+A E+L   GH N+  D +S+GI+ +EM+  
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  213 bits (544), Expect = 2e-67
 Identities = 61/202 (30%), Positives = 108/202 (53%), Gaps = 6/202 (2%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             +   R +G+G F K F++      D D+  ++A K++ K  ++K +  + M  E  I 
Sbjct: 15  RRYVRGRFLGKGGFAKCFEIS-----DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIH 69

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + H  +V     F+    ++++L+      L     R+    E +AR+Y  +IV    
Sbjct: 70  RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 129

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEILLS 288
           +LH+  ++HRDLK  N+ ++ D  V + DFGLA +++ +  R   +CGT  Y+APE+L  
Sbjct: 130 YLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK 189

Query: 289 KGHNKDADWWSVGILLYEMLTG 310
           KGH+ + D WS+G ++Y +L G
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVG 211

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  213 bits (544), Expect = 3e-67
 Identities = 61/226 (26%), Positives = 103/226 (45%), Gaps = 24/226 (10%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
             +      + +  ++GQGA   VF+ + K      +  ++A+KV    + ++   VD  
Sbjct: 2   GSQSTSNHLWLLSDILGQGATANVFRGRHK-----KTGDLFAIKVFNNISFLRP--VDVQ 54

Query: 163 KAERDILTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYRQG---IFREDQA 217
             E ++L K+ H  IV+L       T     LI++F   G L+  L          E + 
Sbjct: 55  MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114

Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILM----DSDGHVMLTDFGLAKEIDESSRSNS 273
                ++V  ++HL + GIVHR++KP NI+     D      LTDFG A+E+++  +  S
Sbjct: 115 LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS 174

Query: 274 MCGTTEYMAPEIL--------LSKGHNKDADWWSVGILLYEMLTGQ 311
           + GT EY+ P++           K +    D WS+G+  Y   TG 
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  207 bits (529), Expect = 1e-64
 Identities = 71/227 (31%), Positives = 119/227 (52%), Gaps = 11/227 (4%)

Query: 89  QELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKV 147
               H +  +L  E+        +   + +G+G+FGK   VK         DG  Y +K 
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKST------EDGRQYVIKE 56

Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           +    +  K   +  + E  +L  + HP IVQ R SF+    LY+++D+  GG LF  + 
Sbjct: 57  INISRMSSKEREESRR-EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRIN 115

Query: 208 RQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI 265
            Q   +F+EDQ   +  +I  A+ H+H   I+HRD+K +NI +  DG V L DFG+A+ +
Sbjct: 116 AQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175

Query: 266 DES-SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           + +   + +  GT  Y++PEI  +K +N  +D W++G +LYE+ T +
Sbjct: 176 NSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  202 bits (516), Expect = 2e-63
 Identities = 65/202 (32%), Positives = 109/202 (53%), Gaps = 9/202 (4%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +++   +G+GAF  V +   K      +   +A K++    +  ++    ++ E  I  K
Sbjct: 8   YDVKEELGKGAFSVVRRCVHK-----TTGLEFAAKIINTKKLSARDFQK-LEREARICRK 61

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP IV+L  S Q  S  YL+ D + GG LF  +  +  + E  A     +I+ ++++ 
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121

Query: 232 HKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS 288
           H  GIVHR+LKPEN+L+ S      V L DFGLA E+++S   +   GT  Y++PE+L  
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK 181

Query: 289 KGHNKDADWWSVGILLYEMLTG 310
             ++K  D W+ G++LY +L G
Sbjct: 182 DPYSKPVDIWACGVILYILLVG 203

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  203 bits (519), Expect = 5e-63
 Identities = 76/268 (28%), Positives = 130/268 (48%), Gaps = 27/268 (10%)

Query: 46  HNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESER 105
           H++   +       +       S +        +L     +     +  +D         
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSD--------- 53

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
                 FE+   +G+GA   V++ K+KG     +   YA+KV     + K      ++ E
Sbjct: 54  -----FFEVESELGRGATSIVYRCKQKG-----TQKPYALKV-----LKKTVDKKIVRTE 98

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L +++HP I++L+  F+T +++ L+L+ + GG LF  +  +G + E  A     +I+
Sbjct: 99  IGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQIL 158

Query: 226 SAVSHLHKCGIVHRDLKPENILM---DSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
            AV++LH+ GIVHRDLKPEN+L      D  + + DFGL+K ++      ++CGT  Y A
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCA 218

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTG 310
           PEIL    +  + D WSVGI+ Y +L G
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCG 246

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  203 bits (519), Expect = 6e-63
 Identities = 68/241 (28%), Positives = 114/241 (47%), Gaps = 18/241 (7%)

Query: 73  GPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKK 132
           GP            +  E       +             +++   +G+GAF  V +   K
Sbjct: 1   GPHMASMTGGQQMGRGSEFMMNASTKFSDN---------YDVKEELGKGAFSVVRRCVHK 51

Query: 133 GVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYL 192
                 +   +A K++    +  ++    ++ E  I  K+ HP IV+L  S Q  S  YL
Sbjct: 52  -----TTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQHPNIVRLHDSIQEESFHYL 105

Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-- 250
           + D + GG LF  +  +  + E  A     +I+ ++++ H  GIVHR+LKPEN+L+ S  
Sbjct: 106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA 165

Query: 251 -DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
               V L DFGLA E+++S   +   GT  Y++PE+L    ++K  D W+ G++LY +L 
Sbjct: 166 KGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV 225

Query: 310 G 310
           G
Sbjct: 226 G 226

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  200 bits (511), Expect = 2e-62
 Identities = 70/203 (34%), Positives = 123/203 (60%), Gaps = 12/203 (5%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            F    V+G GAF +VF VK++      +  ++A+K ++K    + + +   + E  +L 
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQR-----LTGKLFALKCIKKSPAFRDSSL---ENEIAVLK 61

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           K+ H  IV L   +++ +  YL++  ++GG LF  +  +G++ E  A     +++SAV +
Sbjct: 62  KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKY 121

Query: 231 LHKCGIVHRDLKPENIL---MDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           LH+ GIVHRDLKPEN+L    + +  +M+TDFGL+K ++++   ++ CGT  Y+APE+L 
Sbjct: 122 LHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK-MEQNGIMSTACGTPGYVAPEVLA 180

Query: 288 SKGHNKDADWWSVGILLYEMLTG 310
            K ++K  D WS+G++ Y +L G
Sbjct: 181 QKPYSKAVDCWSIGVITYILLCG 203

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  199 bits (509), Expect = 2e-62
 Identities = 63/206 (30%), Positives = 113/206 (54%), Gaps = 12/206 (5%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH---VDYMKAERDI 168
           +E+   +G G F  V + ++K      +   YA K ++K  +         + ++ E +I
Sbjct: 7   YEMGEELGSGQFAIVRKCRQK-----GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           L ++ HP I+ L   F+ ++ + LIL+ ++GG LF  L  +    ED+A  +  +I+  V
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 121

Query: 229 SHLHKCGIVHRDLKPENILMDS----DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
            +LH   I H DLKPENI++      +  + L DFG+A +I+  +   ++ GT E++APE
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTG 310
           I+  +    +AD WS+G++ Y +L+G
Sbjct: 182 IVNYEPLGLEADMWSIGVITYILLSG 207

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  199 bits (508), Expect = 1e-61
 Identities = 64/206 (31%), Positives = 112/206 (54%), Gaps = 12/206 (5%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH---VDYMKAERDI 168
           ++I   +G G F  V + ++K      +   YA K ++K            + ++ E  I
Sbjct: 14  YDIGEELGSGQFAIVKKCREK-----STGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           L +V H  ++ L   ++ R+ + LIL+ ++GG LF  L ++    E++A  +  +I+  V
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128

Query: 229 SHLHKCGIVHRDLKPENILMDS----DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
           ++LH   I H DLKPENI++        H+ L DFGLA EI++     ++ GT E++APE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTG 310
           I+  +    +AD WS+G++ Y +L+G
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSG 214

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  199 bits (509), Expect = 2e-61
 Identities = 66/206 (32%), Positives = 113/206 (54%), Gaps = 12/206 (5%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH---VDYMKAERDI 168
           ++I   +G G F  V + ++K      +   YA K ++K            + ++ E  I
Sbjct: 14  YDIGEELGSGQFAIVKKCREK-----STGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           L +V HP I+ L   ++ R+ + LIL+ ++GG LF  L ++    E++A  +  +I+  V
Sbjct: 69  LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128

Query: 229 SHLHKCGIVHRDLKPENILMDS----DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
           ++LH   I H DLKPENI++        H+ L DFGLA EI++     ++ GT E++APE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTG 310
           I+  +    +AD WS+G++ Y +L+G
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSG 214

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  198 bits (506), Expect = 2e-61
 Identities = 60/206 (29%), Positives = 109/206 (52%), Gaps = 12/206 (5%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH---VDYMKAERDI 168
           ++    +G G F  V + ++K      +   YA K ++K            + ++ E  I
Sbjct: 13  YDTGEELGSGQFAVVKKCREK-----STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           L ++ HP ++ L   ++ ++ + LIL+ + GG LF  L  +    E++A  +  +I++ V
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127

Query: 229 SHLHKCGIVHRDLKPENILMDS----DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
            +LH   I H DLKPENI++         + + DFGLA +ID  +   ++ GT E++APE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTG 310
           I+  +    +AD WS+G++ Y +L+G
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSG 213

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  197 bits (503), Expect = 4e-61
 Identities = 58/208 (27%), Positives = 106/208 (50%), Gaps = 12/208 (5%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDI 168
            +F I + +G+G F +V++           DG   A+K ++   ++          E D+
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACL------LDGVPVALKKVQIFDLMDAKARADCIKEIDL 85

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEI 224
           L ++ HP +++   SF   ++L ++L+  + G L   +        +  E     Y  ++
Sbjct: 86  LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAP 283
            SA+ H+H   ++HRD+KP N+ + + G V L D GL +    +++ ++S+ GT  YM+P
Sbjct: 146 CSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQ 311
           E +   G+N  +D WS+G LLYEM   Q
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQ 233

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  197 bits (503), Expect = 5e-61
 Identities = 59/222 (26%), Positives = 97/222 (43%), Gaps = 25/222 (11%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
            +    + I + +G G   KVFQV  +         IYA+K +  +    +    Y   E
Sbjct: 24  SVKGRIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEADNQTLDSYRN-E 76

Query: 166 RDILTKVTHP--FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
              L K+      I++L     T   +Y++++      L   L ++      + + Y   
Sbjct: 77  IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKN 135

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEY 280
           ++ AV  +H+ GIVH DLKP N L+  DG + L DFG+A ++   + S   +S  GT  Y
Sbjct: 136 MLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNY 194

Query: 281 MAPEILLSKG-----------HNKDADWWSVGILLYEMLTGQ 311
           M PE +                +  +D WS+G +LY M  G+
Sbjct: 195 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  195 bits (498), Expect = 1e-60
 Identities = 65/202 (32%), Positives = 115/202 (56%), Gaps = 10/202 (4%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           + I  ++G+G+FG+V + K +      +   YA+KV+ K +   K+    +  E ++L K
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRI-----TQQEYAVKVINKASAKNKD-TSTILREVELLKK 77

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP I++L    +  S  Y++ +   GG LF  + ++  F E  A     ++ S ++++
Sbjct: 78  LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137

Query: 232 HKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS 288
           HK  IVHRDLKPENIL++S   D  + + DFGL+    ++++     GT  Y+APE+ L 
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV-LR 196

Query: 289 KGHNKDADWWSVGILLYEMLTG 310
             +++  D WS G++LY +L+G
Sbjct: 197 GTYDEKCDVWSAGVILYILLSG 218

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  196 bits (500), Expect = 2e-60
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 25/222 (11%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
            +    + I + +G G   KVFQV  +         IYA+K +  +    +    Y   E
Sbjct: 5   SVKGRIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEADNQTLDSYRN-E 57

Query: 166 RDILTKVTHP--FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
              L K+      I++L     T   +Y++++      L   L ++      + + Y   
Sbjct: 58  IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKN 116

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEY 280
           ++ AV  +H+ GIVH DLKP N L+  DG + L DFG+A ++   + S   +S  GT  Y
Sbjct: 117 MLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNY 175

Query: 281 MAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQ 311
           M PE +     +++           +D WS+G +LY M  G+
Sbjct: 176 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  195 bits (497), Expect = 4e-60
 Identities = 66/200 (33%), Positives = 108/200 (54%), Gaps = 16/200 (8%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-H 174
           + +G+G+F    +   K      S+  +A+K      II K      + E   L     H
Sbjct: 17  KPLGEGSFSICRKCVHK-----KSNQAFAVK------IISKRMEANTQKEITALKLCEGH 65

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           P IV+L   F  +   +L+++ +NGG LF  + ++  F E +A +   ++VSAVSH+H  
Sbjct: 66  PNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV 125

Query: 235 GIVHRDLKPENILM---DSDGHVMLTDFGLAKEIDESSRS-NSMCGTTEYMAPEILLSKG 290
           G+VHRDLKPEN+L    + +  + + DFG A+     ++   + C T  Y APE+L   G
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNG 185

Query: 291 HNKDADWWSVGILLYEMLTG 310
           +++  D WS+G++LY ML+G
Sbjct: 186 YDESCDLWSLGVILYTMLSG 205

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  199 bits (508), Expect = 6e-60
 Identities = 66/203 (32%), Positives = 115/203 (56%), Gaps = 9/203 (4%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            ++  RV+G+G+FG+V   K K      +    A+KV+ K  + +K   + +  E  +L 
Sbjct: 27  RYKGQRVLGKGSFGEVILCKDKI-----TGQECAVKVISKRQVKQKTDKESLLREVQLLK 81

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HP I++L   F+ +   YL+ +   GG LF  +  +  F E  A     +++S +++
Sbjct: 82  QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITY 141

Query: 231 LHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           +HK  IVHRDLKPEN+L++S   D ++ + DFGL+   + S +     GT  Y+APE+ L
Sbjct: 142 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV-L 200

Query: 288 SKGHNKDADWWSVGILLYEMLTG 310
              +++  D WS G++LY +L+G
Sbjct: 201 HGTYDEKCDVWSTGVILYILLSG 223

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  196 bits (500), Expect = 7e-60
 Identities = 67/273 (24%), Positives = 112/273 (41%), Gaps = 35/273 (12%)

Query: 65  HNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERK----------IGPGDFEI 114
           H+  H   G  PR +          E +H +  +L  + + K          +    + I
Sbjct: 1   HHHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSI 60

Query: 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
            + +G G   KVFQV  +         IYA+K +  +    +    Y   E   L K+  
Sbjct: 61  LKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEADNQTLDSYRN-EIAYLNKLQQ 113

Query: 175 P--FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
               I++L     T   +Y++++      L   L ++      + + Y   ++ AV  +H
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172

Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEILLSK 289
           + GIVH DLKP N L+  DG + L DFG+A ++   + S   +S  G   YM PE +   
Sbjct: 173 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231

Query: 290 G-----------HNKDADWWSVGILLYEMLTGQ 311
                        +  +D WS+G +LY M  G+
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  194 bits (495), Expect = 8e-60
 Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 12/202 (5%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           + I   +G+G FG V +  +       S   Y  K ++     K      +K E  IL  
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETS-----SKKTYMAKFVKV----KGTDQVLVKKEISILNI 57

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGIFREDQARFYTAEIVSAVSH 230
             H  I+ L  SF++  +L +I +FI+G  +F           E +   Y  ++  A+  
Sbjct: 58  ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117

Query: 231 LHKCGIVHRDLKPENILMDS--DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS 288
           LH   I H D++PENI+  +     + + +FG A+++        +    EY APE+   
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH 177

Query: 289 KGHNKDADWWSVGILLYEMLTG 310
              +   D WS+G L+Y +L+G
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSG 199

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  195 bits (497), Expect = 1e-59
 Identities = 55/209 (26%), Positives = 106/209 (50%), Gaps = 15/209 (7%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER--DIL 169
           +E+  V+G+G F  V +   +     ++   +A+K++          +     +R   I 
Sbjct: 26  YELCEVIGKGPFSVVRRCINR-----ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 80

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEIV 225
             + HP IV+L  ++ +   LY++ +F++G  L F + ++     ++ E  A  Y  +I+
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140

Query: 226 SAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESS-RSNSMCGTTEYM 281
            A+ + H   I+HRD+KP  +L+ S      V L  FG+A ++ ES   +    GT  +M
Sbjct: 141 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFM 200

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTG 310
           APE++  + + K  D W  G++L+ +L+G
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSG 229

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  192 bits (490), Expect = 1e-59
 Identities = 53/220 (24%), Positives = 95/220 (43%), Gaps = 32/220 (14%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           DF+   ++G G FG+VF+ K +       DG  Y +K ++ +        +  + E   L
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHR------IDGKTYVIKRVKYNN-------EKAEREVKAL 58

Query: 170 TKVTHPFIVQLRYSFQ----------------TRSKLYLILDFINGGHLFFHL--YRQGI 211
            K+ H  IV     +                     L++ ++F + G L   +   R   
Sbjct: 59  AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118

Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS 271
             +  A     +I   V ++H   +++RDLKP NI +     V + DFGL   +    + 
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178

Query: 272 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
               GT  YM+PE + S+ + K+ D +++G++L E+L   
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVC 218

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  196 bits (501), Expect = 3e-59
 Identities = 67/204 (32%), Positives = 105/204 (51%), Gaps = 10/204 (4%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           ++++F  +G+GAF  V +  K       +   YA  ++    +  ++H   ++ E  I  
Sbjct: 12  EYQLFEELGKGAFSVVRRCVKVL-----AGQEYAAMIINTKKLSARDHQK-LEREARICR 65

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP IV+L  S       YLI D + GG LF  +  +  + E  A     +I+ AV H
Sbjct: 66  LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLH 125

Query: 231 LHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEIL 286
            H+ G+VHR+LKPEN+L+ S      V L DFGLA E++ E        GT  Y++PE+L
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL 185

Query: 287 LSKGHNKDADWWSVGILLYEMLTG 310
               + K  D W+ G++LY +L G
Sbjct: 186 RKDPYGKPVDLWACGVILYILLVG 209

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  197 bits (503), Expect = 3e-59
 Identities = 65/203 (32%), Positives = 115/203 (56%), Gaps = 10/203 (4%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            + I  ++G+G+FG+V + K +      +   YA+KV+ K +   K+    +  E ++L 
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRI-----TQQEYAVKVINKASAKNKD-TSTILREVELLK 76

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           K+ HP I++L    +  S  Y++ +   GG LF  + ++  F E  A     ++ S +++
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITY 136

Query: 231 LHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           +HK  IVHRDLKPENIL++S   D  + + DFGL+    ++++     GT  Y+APE+ L
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV-L 195

Query: 288 SKGHNKDADWWSVGILLYEMLTG 310
              +++  D WS G++LY +L+G
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSG 218

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  191 bits (488), Expect = 3e-59
 Identities = 62/202 (30%), Positives = 106/202 (52%), Gaps = 12/202 (5%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           + +   +G+G++G+V    +KG     +    A K + K        VD  K E +I+  
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKG-----TRIRRAAKKIPKY---FVEDVDRFKQEIEIMKS 62

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP I++L  +F+  + +YL+++   GG LF  +  + +FRE  A     +++SAV++ 
Sbjct: 63  LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYC 122

Query: 232 HKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS 288
           HK  + HRDLKPEN L  +   D  + L DFGLA          +  GT  Y++P++ L 
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQV-LE 181

Query: 289 KGHNKDADWWSVGILLYEMLTG 310
             +  + D WS G+++Y +L G
Sbjct: 182 GLYGPECDEWSAGVMMYVLLCG 203

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  191 bits (488), Expect = 6e-59
 Identities = 66/212 (31%), Positives = 110/212 (51%), Gaps = 18/212 (8%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD---- 167
           +E   ++G+G    V +   K      +   YA+K++        +  +  +        
Sbjct: 19  YEPKEILGRGVSSVVRRCIHK-----PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 73

Query: 168 --ILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
             IL KV+ HP I+QL+ +++T +  +L+ D +  G LF +L  +    E + R     +
Sbjct: 74  VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
           +  +  LHK  IVHRDLKPENIL+D D ++ LTDFG + ++D   +   +CGT  Y+APE
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 193

Query: 285 IL------LSKGHNKDADWWSVGILLYEMLTG 310
           I+         G+ K+ D WS G+++Y +L G
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  194 bits (494), Expect = 7e-59
 Identities = 58/202 (28%), Positives = 104/202 (51%), Gaps = 11/202 (5%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           ++I   +G GAFG V +  +K      +  ++  K +     + K  V   K E  I+ +
Sbjct: 53  YDILEELGSGAFGVVHRCVEKA-----TGRVFVAKFINTPYPLDKYTV---KNEISIMNQ 104

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSH 230
           + HP ++ L  +F+ + ++ LIL+F++GG LF  +  +     E +   Y  +    + H
Sbjct: 105 LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKH 164

Query: 231 LHKCGIVHRDLKPENILMDS--DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS 288
           +H+  IVH D+KPENI+ ++     V + DFGLA +++          T E+ APEI+  
Sbjct: 165 MHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR 224

Query: 289 KGHNKDADWWSVGILLYEMLTG 310
           +      D W++G+L Y +L+G
Sbjct: 225 EPVGFYTDMWAIGVLGYVLLSG 246

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  196 bits (499), Expect = 1e-58
 Identities = 63/203 (31%), Positives = 113/203 (55%), Gaps = 10/203 (4%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            ++  + +G GA+G+V   + K      +    A+K++RK ++   ++   +  E  +L 
Sbjct: 38  MYQRVKKLGSGAYGEVLLCRDKV-----THVERAIKIIRKTSVSTSSNSK-LLEEVAVLK 91

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP I++L   F+ +   YL+++   GG LF  +  +  F E  A     +++S V++
Sbjct: 92  LLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTY 151

Query: 231 LHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           LHK  IVHRDLKPEN+L++S   D  + + DFGL+   +   +     GT  Y+APE+ L
Sbjct: 152 LHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEV-L 210

Query: 288 SKGHNKDADWWSVGILLYEMLTG 310
            K +++  D WS+G++L+ +L G
Sbjct: 211 RKKYDEKCDVWSIGVILFILLAG 233

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  191 bits (487), Expect = 2e-58
 Identities = 66/211 (31%), Positives = 118/211 (55%), Gaps = 17/211 (8%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER---- 166
           ++ + + +G GA G+V    ++      +    A+K++ K      +  +   A      
Sbjct: 11  EYIMSKTLGSGACGEVKLAFER-----KTCKKVAIKIISKRKFAIGSAREADPALNVETE 65

Query: 167 -DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
            +IL K+ HP I++++  F      Y++L+ + GG LF  +      +E   + Y  +++
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124

Query: 226 SAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
            AV +LH+ GI+HRDLKPEN+L+ S   D  + +TDFG +K + E+S   ++CGT  Y+A
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184

Query: 283 PEILLS---KGHNKDADWWSVGILLYEMLTG 310
           PE+L+S    G+N+  D WS+G++L+  L+G
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  192 bits (489), Expect = 2e-58
 Identities = 74/302 (24%), Positives = 125/302 (41%), Gaps = 24/302 (7%)

Query: 26  SASSPDFDFT-EVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSL 84
            +S  D  F  E        RH          +            + +    +    +  
Sbjct: 7   HSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKK--LNDA 64

Query: 85  PLQIQELEHENDAELEAESERKIGPGDF----EIFRVVGQGAFGKVFQVKKKGVDDGDSD 140
             +  E  +      E E        +F    +   V+G+G    V +   +      + 
Sbjct: 65  QPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHR-----ATG 119

Query: 141 GIYAMKVMRKDTIIKKNHV-----DYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLIL 194
             +A+K+M                +  + E  IL +V  HP I+ L  S+++ S ++L+ 
Sbjct: 120 HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF 179

Query: 195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
           D +  G LF +L  +    E + R     ++ AVS LH   IVHRDLKPENIL+D +  +
Sbjct: 180 DLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQI 239

Query: 255 MLTDFGLAKEIDESSRSNSMCGTTEYMAPEIL------LSKGHNKDADWWSVGILLYEML 308
            L+DFG +  ++   +   +CGT  Y+APEIL         G+ K+ D W+ G++L+ +L
Sbjct: 240 RLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL 299

Query: 309 TG 310
            G
Sbjct: 300 AG 301

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  193 bits (492), Expect = 3e-58
 Identities = 66/226 (29%), Positives = 120/226 (53%), Gaps = 21/226 (9%)

Query: 100 EAESERKIGPGDF----EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK 155
               ++ + P        + + +G GA G+V    ++      +    A++++ K     
Sbjct: 121 LTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFER-----KTCKKVAIRIISKRKFAI 175

Query: 156 KNHVDYMKAER-----DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG 210
            +  +   A       +IL K+ HP I++++  F      Y++L+ + GG LF  +    
Sbjct: 176 GSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNK 234

Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDE 267
             +E   + Y  +++ AV +LH+ GI+HRDLKPEN+L+ S   D  + +TDFG +K + E
Sbjct: 235 RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 294

Query: 268 SSRSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTG 310
           +S   ++CGT  Y+APE+L+S    G+N+  D WS+G++L+  L+G
Sbjct: 295 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  189 bits (482), Expect = 3e-58
 Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 15/206 (7%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F   R +G GAFG V  V+++      S     +K + KD    +  ++ ++AE ++L  
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERS-----SGLERVIKTINKDRS--QVPMEQIEAEIEVLKS 76

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLF----FHLYRQGIFREDQARFYTAEIVSA 227
           + HP I+++   F+    +Y++++   GG L         R     E        ++++A
Sbjct: 77  LDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA 136

Query: 228 VSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
           +++ H   +VH+DLKPENIL         + + DFGLA+       S +  GT  YMAPE
Sbjct: 137 LAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE 196

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTG 310
           +   +      D WS G+++Y +LTG
Sbjct: 197 V-FKRDVTFKCDIWSAGVVMYFLLTG 221

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  190 bits (485), Expect = 3e-58
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 17/230 (7%)

Query: 92  EHENDAELEAESERKIGPGDFEIF-----RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMK 146
            H +  +L  E+       +F  F     + +G+G F  V Q   K      +   YA K
Sbjct: 6   HHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISK-----STGQEYAAK 60

Query: 147 VMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFH 205
            ++K    +    + +  E  +L      P ++ L   ++  S++ LIL++  GG +F  
Sbjct: 61  FLKKRRRGQDCRAE-ILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSL 119

Query: 206 LY--RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHVMLTDFG 260
                  +  E+       +I+  V +LH+  IVH DLKP+NIL+      G + + DFG
Sbjct: 120 CLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179

Query: 261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           ++++I  +     + GT EY+APEIL         D W++GI+ Y +LT 
Sbjct: 180 MSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  198 bits (505), Expect = 4e-58
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 19/214 (8%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G +E+   +G G FG V +   +     D+    A+K  R++   K  + +    E  I+
Sbjct: 14  GPWEMKERLGTGGFGYVLRWIHQ-----DTGEQVAIKQCRQELSPK--NRERWCLEIQIM 66

Query: 170 TKVTHPFIVQLRYSFQTRSKL------YLILDFINGGHLFFHLY---RQGIFREDQARFY 220
            K+ HP +V  R       KL       L +++  GG L  +L         +E   R  
Sbjct: 67  KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 126

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESSRSNSMCGT 277
            ++I SA+ +LH+  I+HRDLKPENI++          + D G AKE+D+        GT
Sbjct: 127 LSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGT 186

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
            +Y+APE+L  K +    D+WS G L +E +TG 
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  188 bits (480), Expect = 4e-58
 Identities = 57/214 (26%), Positives = 110/214 (51%), Gaps = 20/214 (9%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           D+E+   +G G++G+  ++++K      SDG I   K +   ++ +      + +E ++L
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRK------SDGKILVWKELDYGSMTEAE-KQMLVSEVNLL 59

Query: 170 TKVTHPFIVQLRYSFQTRS--KLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAE 223
            ++ HP IV+       R+   LY+++++  GG L   + +         E+       +
Sbjct: 60  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119

Query: 224 IVSAVSHLHKCG-----IVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGT 277
           +  A+   H+       ++HRDLKP N+ +D   +V L DFGLA+ ++ ++S + +  GT
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGT 179

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
             YM+PE +    +N+ +D WS+G LLYE+    
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 213

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  189 bits (483), Expect = 1e-57
 Identities = 65/206 (31%), Positives = 105/206 (50%), Gaps = 18/206 (8%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            +E+   +G G++    +   K      ++  +A+K      II K+  D    E +IL 
Sbjct: 23  GYEVKEDIGVGSYSVCKRCIHK-----ATNMEFAVK------IIDKSKRD-PTEEIEILL 70

Query: 171 KVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           +   HP I+ L+  +     +Y++ + + GG L   + RQ  F E +A      I   V 
Sbjct: 71  RYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVE 130

Query: 230 HLHKCGIVHRDLKPENILMDSDGH----VMLTDFGLAKEI-DESSRSNSMCGTTEYMAPE 284
           +LH  G+VHRDLKP NIL   +      + + DFG AK++  E+    + C T  ++APE
Sbjct: 131 YLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE 190

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTG 310
           +L  +G++   D WS+G+LLY MLTG
Sbjct: 191 VLERQGYDAACDIWSLGVLLYTMLTG 216

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  195 bits (497), Expect = 1e-57
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 11/202 (5%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           ++I   +G GAFG V +V ++      +   +A K +       ++  + ++ E   ++ 
Sbjct: 159 YDIHEELGTGAFGVVHRVTERA-----TGNNFAAKFVMTP---HESDKETVRKEIQTMSV 210

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGIFREDQARFYTAEIVSAVSH 230
           + HP +V L  +F+  +++ +I +F++GG LF           ED+A  Y  ++   + H
Sbjct: 211 LRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCH 270

Query: 231 LHKCGIVHRDLKPENILMDS--DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS 288
           +H+   VH DLKPENI+  +     + L DFGL   +D         GT E+ APE+   
Sbjct: 271 MHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 330

Query: 289 KGHNKDADWWSVGILLYEMLTG 310
           K      D WSVG+L Y +L+G
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSG 352

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  189 bits (481), Expect = 4e-57
 Identities = 51/203 (25%), Positives = 103/203 (50%), Gaps = 11/203 (5%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
                 ++G G FG+V + ++       +    A K+++          + +K E  ++ 
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETA-----TGLKLAAKIIKTR---GMKDKEEVKNEISVMN 141

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVS 229
           ++ H  ++QL  +F++++ + L++++++GG LF  +  +     E     +  +I   + 
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIR 201

Query: 230 HLHKCGIVHRDLKPENILMDS--DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           H+H+  I+H DLKPENIL  +     + + DFGLA+      +     GT E++APE++ 
Sbjct: 202 HMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVN 261

Query: 288 SKGHNKDADWWSVGILLYEMLTG 310
               +   D WSVG++ Y +L+G
Sbjct: 262 YDFVSFPTDMWSVGVIAYMLLSG 284

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  191 bits (488), Expect = 6e-57
 Identities = 66/213 (30%), Positives = 109/213 (51%), Gaps = 19/213 (8%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK----------KNHVD 160
            +   R +G GA+G+V   K+K           A+KV++K    K          +   +
Sbjct: 37  SYFKVRKLGSGAYGEVLLCKEKN-----GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHE 91

Query: 161 YMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
            +  E  +L  + HP I++L   F+ +   YL+ +F  GG LF  +  +  F E  A   
Sbjct: 92  EIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI 151

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGT 277
             +I+S + +LHK  IVHRD+KPENIL+++     ++ + DFGL+    +  +     GT
Sbjct: 152 MKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGT 211

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
             Y+APE+ L K +N+  D WS G+++Y +L G
Sbjct: 212 AYYIAPEV-LKKKYNEKCDVWSCGVIMYILLCG 243

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  188 bits (478), Expect = 1e-56
 Identities = 46/314 (14%), Positives = 90/314 (28%), Gaps = 57/314 (18%)

Query: 46  HNNQSPASTSASLGDP-----QVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELE 100
           H++ S    +     P     + + NR       +    + S+    +            
Sbjct: 4   HHHHSSGRENLYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFR 63

Query: 101 AESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD 160
            ESE    P       V+GQ       +   +  + G+    + + V         N + 
Sbjct: 64  VESELGERPRTLVRGTVLGQEDPYAYLEATDQ--ETGE---SFEVHVPYFTERPPSNAIK 118

Query: 161 YMKAER-------------------------DILTKVTHPFIVQLRYSFQTRSKLYLIL- 194
            MK E                          D++       ++++R   +    L     
Sbjct: 119 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 178

Query: 195 -------DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL 247
                      G  L  H               T +++  ++ LH  G+VH  L+P +I+
Sbjct: 179 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIV 238

Query: 248 MDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG-----------HNKDAD 296
           +D  G V LT F                 +  +  PE+   +                 D
Sbjct: 239 LDQRGGVFLTGFEHLVRDGARV---VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFD 295

Query: 297 WWSVGILLYEMLTG 310
            W++G+++Y +   
Sbjct: 296 AWALGLVIYWIWCA 309

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  185 bits (472), Expect = 3e-56
 Identities = 63/251 (25%), Positives = 106/251 (42%), Gaps = 56/251 (22%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER--DI 168
            + +   +GQG++G V    +       +  I A+K+M K+ I + N  D  + +    +
Sbjct: 27  KYHLKGAIGQGSYGVVRVAIEN-----QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRL 81

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG------------------ 210
           + K+ HP I +L   ++    + L+++  +GGHL   L                      
Sbjct: 82  MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141

Query: 211 ----------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM 248
                                 + RE        +I SA+ +LH  GI HRD+KPEN L 
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF 201

Query: 249 DSDG--HVMLTDFGLAKEID-----ESSRSNSMCGTTEYMAPEIL--LSKGHNKDADWWS 299
            ++    + L DFGL+KE       E     +  GT  ++APE+L   ++ +    D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 300 VGILLYEMLTG 310
            G+LL+ +L G
Sbjct: 262 AGVLLHLLLMG 272

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  180 bits (460), Expect = 1e-54
 Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 25/211 (11%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HP 175
           V+G+GA  +V            +   YA+K++ K      +    +  E ++L +   H 
Sbjct: 20  VLGEGAHARVQTCINLI-----TSQEYAVKIIEKQ---PGHIRSRVFREVEMLYQCQGHR 71

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
            +++L   F+   + YL+ + + GG +  H++++  F E +A     ++ SA+  LH  G
Sbjct: 72  NVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG 131

Query: 236 IVHRDLKPENILM---DSDGHVMLTDFGLAKEIDESSRSNSM--------CGTTEYMAPE 284
           I HRDLKPENIL    +    V + DF L   I  +   + +        CG+ EYMAPE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191

Query: 285 IL-----LSKGHNKDADWWSVGILLYEMLTG 310
           ++      +  ++K  D WS+G++LY +L+G
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  178 bits (455), Expect = 2e-54
 Identities = 62/212 (29%), Positives = 112/212 (52%), Gaps = 13/212 (6%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           +   +    +++ + +G+GA+G+V    +  V+   ++   A+K++     +     + +
Sbjct: 2   AVPFVED--WDLVQTLGEGAYGEV----QLAVNR-VTEEAVAVKIVDMKRAVD--CPENI 52

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           K E  I   + H  +V+     +  +  YL L++ +GG LF  +       E  A+ +  
Sbjct: 53  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH 112

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTE 279
           ++++ V +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172

Query: 280 YMAPEILLSKG-HNKDADWWSVGILLYEMLTG 310
           Y+APE+L  +  H +  D WS GI+L  ML G
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  182 bits (463), Expect = 4e-54
 Identities = 67/274 (24%), Positives = 127/274 (46%), Gaps = 28/274 (10%)

Query: 48  NQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKI 107
           + S   +            +  +   P P        P Q  +   ++  +++  +    
Sbjct: 3   SNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIID- 61

Query: 108 GPGDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
              D+++  +V+G G  GKV Q+  K      +   +A+K+++     ++        E 
Sbjct: 62  ---DYKVTSQVLGLGINGKVLQIFNKR-----TQEKFALKMLQDCPKARR--------EV 105

Query: 167 DILTKVT-HPFIVQLRYSFQT----RSKLYLILDFINGGHLFFHLYRQGI--FREDQARF 219
           ++  + +  P IV++   ++     R  L ++++ ++GG LF  +  +G   F E +A  
Sbjct: 106 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 165

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCG 276
               I  A+ +LH   I HRD+KPEN+L  S   +  + LTDFG AKE    +   + C 
Sbjct: 166 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 225

Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           T  Y+APE+L  + ++K  D WS+G+++Y +L G
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  177 bits (452), Expect = 5e-54
 Identities = 65/212 (30%), Positives = 114/212 (53%), Gaps = 8/212 (3%)

Query: 100 EAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV 159
           + +   KIG   + +   +G G FGKV    K G        + A+K++ +  I   + V
Sbjct: 3   KHDGRVKIGH--YVLGDTLGVGTFGKV----KIGEHQLTGHKV-AVKILNRQKIRSLDVV 55

Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
             +K E   L    HP I++L     T +  ++++++++GG LF ++ + G   E +AR 
Sbjct: 56  GKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARR 115

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
              +I+SAV + H+  +VHRDLKPEN+L+D+  +  + DFGL+  + +     + CG+  
Sbjct: 116 LFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN 175

Query: 280 YMAPEILLSKG-HNKDADWWSVGILLYEMLTG 310
           Y APE++  +     + D WS G++LY +L G
Sbjct: 176 YAAPEVISGRLYAGPEVDIWSCGVILYALLCG 207

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  178 bits (454), Expect = 2e-53
 Identities = 59/279 (21%), Positives = 110/279 (39%), Gaps = 24/279 (8%)

Query: 52  ASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGD 111
            S S S G    + + + ++   S +            E     +     + E +     
Sbjct: 1   GSGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETED-NEGVLLTEKLKPVDYEYREEVHW 59

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
                 VG+G+FG+V     +  D   +    A+K +R +    +        E      
Sbjct: 60  MTHQPRVGRGSFGEVH----RMKD-KQTGFQCAVKKVRLEVFRVE--------ELVACAG 106

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           ++ P IV L  + +    + + ++ + GG L   + + G   ED+A +Y  + +  + +L
Sbjct: 107 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYL 166

Query: 232 HKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEIDESSRS------NSMCGTTEYMAPE 284
           H   I+H D+K +N+L+ SDG    L DFG A  +            + + GT  +MAPE
Sbjct: 167 HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQ---VNIKSMQVI 320
           +++ K  +   D WS   ++  ML G           + 
Sbjct: 227 VVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC 265

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  177 bits (451), Expect = 4e-53
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 12/208 (5%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER--- 166
             +     +G GAFG V       VD   +  +  +K ++K+ +++   ++  K  +   
Sbjct: 24  QKYSTMSPLGSGAFGFV----WTAVDKEKNKEV-VVKFIKKEKVLEDCWIEDPKLGKVTL 78

Query: 167 --DILTKVTHPFIVQLRYSFQTRSKLYLILDF-INGGHLFFHLYRQGIFREDQARFYTAE 223
              IL++V H  I+++   F+ +    L+++   +G  LF  + R     E  A +   +
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +VSAV +L    I+HRD+K ENI++  D  + L DFG A  ++      + CGT EY AP
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAP 198

Query: 284 EILLSKGHN-KDADWWSVGILLYEMLTG 310
           E+L+   +   + + WS+G+ LY ++  
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFE 226

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  176 bits (448), Expect = 7e-53
 Identities = 62/212 (29%), Positives = 112/212 (52%), Gaps = 13/212 (6%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           +   +    +++ + +G+GA+G+V    +  V+   ++   A+K++     +     + +
Sbjct: 2   AVPFVED--WDLVQTLGEGAYGEV----QLAVNR-VTEEAVAVKIVDMKRAVD--CPENI 52

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           K E  I   + H  +V+     +  +  YL L++ +GG LF  +       E  A+ +  
Sbjct: 53  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH 112

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTE 279
           ++++ V +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172

Query: 280 YMAPEILLSKG-HNKDADWWSVGILLYEMLTG 310
           Y+APE+L  +  H +  D WS GI+L  ML G
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  175 bits (447), Expect = 2e-52
 Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 24/204 (11%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HP 175
           V+G G  GKV +   +      +    A+K++      ++        E D   + +  P
Sbjct: 36  VLGLGVNGKVLECFHRR-----TGQKCALKLLYDSPKARQ--------EVDHHWQASGGP 82

Query: 176 FIVQLRYSFQT----RSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVS 229
            IV +   ++     +  L +I++ + GG LF  +  +G   F E +A     +I +A+ 
Sbjct: 83  HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 142

Query: 230 HLHKCGIVHRDLKPENILM---DSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEIL 286
            LH   I HRD+KPEN+L    + D  + LTDFG AKE  +++   + C T  Y+APE+L
Sbjct: 143 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ-TPCYTPYYVAPEVL 201

Query: 287 LSKGHNKDADWWSVGILLYEMLTG 310
             + ++K  D WS+G+++Y +L G
Sbjct: 202 GPEKYDKSCDMWSLGVIMYILLCG 225

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  175 bits (447), Expect = 2e-52
 Identities = 71/215 (33%), Positives = 118/215 (54%), Gaps = 17/215 (7%)

Query: 101 AESERKIGPGDFEIFRVVGQGAFGKVFQVKKKG--VDDGDSDGIYAMKVMRKDTIIKKNH 158
           A+ +  IG   + + + +G+G F KV    K    +  G      A+K++ K    + N 
Sbjct: 8   ADEQPHIGN--YRLLKTIGKGNFAKV----KLARHILTGRE---VAIKIIDKT---QLNP 55

Query: 159 VDYMKAER--DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQ 216
               K  R   I+  + HP IV+L    +T   LYLI+++ +GG +F +L   G  +E +
Sbjct: 56  TSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKE 115

Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
           AR    +IVSAV + H+  IVHRDLK EN+L+D+D ++ + DFG + E     + ++ CG
Sbjct: 116 ARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCG 175

Query: 277 TTEYMAPEILLSKGHN-KDADWWSVGILLYEMLTG 310
              Y APE+   K ++  + D WS+G++LY +++G
Sbjct: 176 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  176 bits (447), Expect = 3e-52
 Identities = 66/204 (32%), Positives = 108/204 (52%), Gaps = 12/204 (5%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             ++  + +G G FG       + + D  +  + A+K + +   I +N    ++ E    
Sbjct: 20  DRYDFVKDIGSGNFGVA-----RLMRDKLTKELVAVKYIERGAAIDEN----VQREIINH 70

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+ +    T + L +I+++ +GG L+  +   G F ED+ARF+  +++S VS
Sbjct: 71  RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVS 130

Query: 230 HLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + H   I HRDLK EN L+D      + + DFG +K     S+  S  GT  Y+APE+LL
Sbjct: 131 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 190

Query: 288 SKGHN-KDADWWSVGILLYEMLTG 310
            + ++ K AD WS G+ LY ML G
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVG 214

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  174 bits (442), Expect = 3e-52
 Identities = 61/230 (26%), Positives = 96/230 (41%), Gaps = 41/230 (17%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAER--D 167
           DFE  + +G+G FG VF+ K K       D   YA+K +R    +    +   K  R   
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNK------VDDCNYAIKRIR----LPNRELAREKVMREVK 55

Query: 168 ILTKVTHPFIVQLRYSF------------QTRSKLYLILDFINGGHLFFHLYRQG---IF 212
            L K+ HP IV+   ++              +  LY+ +      +L   +  +      
Sbjct: 56  ALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER 115

Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES---- 268
                     +I  AV  LH  G++HRDLKP NI    D  V + DFGL   +D+     
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175

Query: 269 ---------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
                    +R     GT  YM+PE +    ++   D +S+G++L+E+L 
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  177 bits (449), Expect = 5e-52
 Identities = 46/288 (15%), Positives = 84/288 (29%), Gaps = 45/288 (15%)

Query: 64  IHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAF 123
           + NR       +    + S+    +             ESE    P       V+GQ   
Sbjct: 32  LFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDP 91

Query: 124 GKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER----------------- 166
               +       D ++   + + V         N +  MK E                  
Sbjct: 92  YAYLEAT-----DQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 146

Query: 167 --------DILTKVTHPFIVQLRYSFQTRSKLYLILDFIN--------GGHLFFHLYRQG 210
                   D++       ++++R   +    L     +          G  L  H     
Sbjct: 147 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 206

Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS- 269
                     T +++  ++ LH  G+VH  L+P +I++D  G V LT F        S+ 
Sbjct: 207 SLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAV 266

Query: 270 -RSNSMCGTTEYMAPEILLSKGHNKD-----ADWWSVGILLYEMLTGQ 311
                     E  A  +L    H+        D W++G+ +Y +    
Sbjct: 267 SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  172 bits (439), Expect = 1e-51
 Identities = 54/227 (23%), Positives = 89/227 (39%), Gaps = 29/227 (12%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
            I    +   + +G+G F  V  V+            YA+K +      ++   +  + E
Sbjct: 25  IIDNKHYLFIQKLGEGGFSYVDLVEGL-----HDGHFYALKRILCH---EQQDREEAQRE 76

Query: 166 RDILTKVTHPFIVQLRYSFQTRS----KLYLILDFINGGHLFFHLYRQ----GIFREDQA 217
            D+     HP I++L            + +L+L F   G L+  + R         EDQ 
Sbjct: 77  ADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI 136

Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM--- 274
            +    I   +  +H  G  HRDLKP NIL+  +G  +L D G   +       +     
Sbjct: 137 LWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALT 196

Query: 275 -------CGTTEYMAPEILLSKGH---NKDADWWSVGILLYEMLTGQ 311
                    T  Y APE+   + H   ++  D WS+G +LY M+ G+
Sbjct: 197 LQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  174 bits (442), Expect = 2e-51
 Identities = 36/250 (14%), Positives = 77/250 (30%), Gaps = 41/250 (16%)

Query: 96  DAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK 155
           +AE   +S    G    ++   +  G    VF V+       +    +A+KV        
Sbjct: 48  NAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDV-----ERLEDFALKVFTMGAENS 102

Query: 156 KNHVDYMKAERDILTKVTHPFIVQLR--------------------------YSFQTRSK 189
           ++ ++ +        ++      + R                                + 
Sbjct: 103 RSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVAN 162

Query: 190 LYLILDFING------GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKP 243
             L++   +         L F    +G          TA+++   ++L   G+VH    P
Sbjct: 163 YLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTP 222

Query: 244 ENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG--HNKDADWWSVG 301
           +N+ +  DG +ML D     ++    R  +      Y   E L +         + W +G
Sbjct: 223 DNLFIMPDGRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLG 280

Query: 302 ILLYEMLTGQ 311
           + +Y +    
Sbjct: 281 LSIYRVWCLF 290

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  172 bits (437), Expect = 4e-51
 Identities = 70/254 (27%), Positives = 118/254 (46%), Gaps = 21/254 (8%)

Query: 65  HNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFG 124
           H+  H   G  PR +  +            +  +L    E++     +++  ++G G FG
Sbjct: 5   HHHHHHSSGLVPRGSHMAPCN-------DLHATKLAPGKEKEPLESQYQVGPLLGSGGFG 57

Query: 125 KVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM---KAERDILTKVTH--PFIVQ 179
            V+   +  V D       A+K + KD I     +        E  +L KV+     +++
Sbjct: 58  SVYSGIR--VSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 112

Query: 180 LRYSFQTRSKLYLILDFING-GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVH 238
           L   F+      LIL+       LF  +  +G  +E+ AR +  +++ AV H H CG++H
Sbjct: 113 LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLH 172

Query: 239 RDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG-HNKDAD 296
           RD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  PE +     H + A 
Sbjct: 173 RDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF-DGTRVYSPPEWIRYHRYHGRSAA 231

Query: 297 WWSVGILLYEMLTG 310
            WS+GILLY+M+ G
Sbjct: 232 VWSLGILLYDMVCG 245

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  169 bits (429), Expect = 2e-50
 Identities = 43/237 (18%), Positives = 86/237 (36%), Gaps = 35/237 (14%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F     +G G FG VF+  K+   DG    IYA+K  +K      +  + ++       
Sbjct: 12  EFHELEKIGSGEFGSVFKCVKR--LDGC---IYAIKRSKKPLAGSVDEQNALREVYAHAV 66

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGG----HLFFHLYRQGIFREDQARFYTAEIVS 226
              H  +V+   ++     + +  ++ NGG     +  +      F+E + +    ++  
Sbjct: 67  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVM-------------------LTDFGLAKEIDE 267
            + ++H   +VH D+KP NI +                          + D G    I  
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 184

Query: 268 SSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQV---NIKSMQVI 320
            S      G + ++A E+L  +  H   AD +++ + +      +    N      I
Sbjct: 185 -SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI 240

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  170 bits (432), Expect = 3e-50
 Identities = 68/211 (32%), Positives = 117/211 (55%), Gaps = 9/211 (4%)

Query: 101 AESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD 160
           A S+R IGP  + I   +G+G+FGKV    K          + A+K + +  + K +   
Sbjct: 2   AISKRHIGP--YIIRETLGEGSFGKV----KLATHYKTQQKV-ALKFISRQLLKKSDMHM 54

Query: 161 YMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
            ++ E   L  + HP I++L     T + + +++++  GG LF ++  +    ED+ R +
Sbjct: 55  RVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRF 113

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
             +I+ A+ + H+  IVHRDLKPEN+L+D + +V + DFGL+  + + +   + CG+  Y
Sbjct: 114 FQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNY 173

Query: 281 MAPEILLSKGHN-KDADWWSVGILLYEMLTG 310
            APE++  K +   + D WS GI+LY ML G
Sbjct: 174 AAPEVINGKLYAGPEVDVWSCGIVLYVMLVG 204

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  169 bits (430), Expect = 3e-50
 Identities = 66/240 (27%), Positives = 114/240 (47%), Gaps = 16/240 (6%)

Query: 81  SSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSD 140
             + PLQ                +R+    ++ +  ++G+G FG VF   +  + D    
Sbjct: 2   MLTKPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHR--LTDRLQ- 58

Query: 141 GIYAMKVMRKDTIIKKNHVDYM---KAERDILTKV----THPFIVQLRYSFQTRSKLYLI 193
              A+KV+ ++ ++  + +        E  +L KV     HP +++L   F+T+    L+
Sbjct: 59  --VAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLV 116

Query: 194 LDF-INGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD- 251
           L+  +    LF ++  +G   E  +R +  ++V+A+ H H  G+VHRD+K ENIL+D   
Sbjct: 117 LERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRR 176

Query: 252 GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG-HNKDADWWSVGILLYEMLTG 310
           G   L DFG    + +   ++   GT  Y  PE +     H   A  WS+GILLY+M+ G
Sbjct: 177 GCAKLIDFGSGALLHDEPYTDF-DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  168 bits (428), Expect = 4e-50
 Identities = 51/211 (24%), Positives = 108/211 (51%), Gaps = 16/211 (7%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY-MKAERDI 168
           G + +  ++G+G++GKV     K V D ++    A+K+++K  + +  + +  +K E  +
Sbjct: 5   GKYLMGDLLGEGSYGKV-----KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQL 59

Query: 169 LTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGH--LFFHLYRQGIFREDQARFYTAEI 224
           L ++ H  ++QL      + + K+Y+++++   G   +   +  +  F   QA  Y  ++
Sbjct: 60  LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGYFCQL 118

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM---CGTTEYM 281
           +  + +LH  GIVH+D+KP N+L+ + G + ++  G+A+ +   +  ++     G+  + 
Sbjct: 119 IDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178

Query: 282 APEILL-SKG-HNKDADWWSVGILLYEMLTG 310
            PEI            D WS G+ LY + TG
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  173 bits (439), Expect = 6e-50
 Identities = 63/212 (29%), Positives = 116/212 (54%), Gaps = 8/212 (3%)

Query: 100 EAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV 159
           + +   KIG   + +   +G G FGKV    K G  +     + A+K++ +  I   + V
Sbjct: 8   KHDGRVKIGH--YILGDTLGVGTFGKV----KVGKHELTGHKV-AVKILNRQKIRSLDVV 60

Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
             ++ E   L    HP I++L     T S +++++++++GG LF ++ + G   E ++R 
Sbjct: 61  GKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRR 120

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
              +I+S V + H+  +VHRDLKPEN+L+D+  +  + DFGL+  + +     + CG+  
Sbjct: 121 LFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN 180

Query: 280 YMAPEILLSKGHN-KDADWWSVGILLYEMLTG 310
           Y APE++  + +   + D WS G++LY +L G
Sbjct: 181 YAAPEVISGRLYAGPEVDIWSSGVILYALLCG 212

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  167 bits (425), Expect = 1e-49
 Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 37/240 (15%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
               ++    + +   +G+G++G V    K   ++ D+   YAMKV+ K  +I++     
Sbjct: 7   GDCVQLNQ--YTLKDEIGKGSYGVV----KLAYNENDNT-YYAMKVLSKKKLIRQAGFPR 59

Query: 162 MKAERD-----------------------ILTKVTHPFIVQLR--YSFQTRSKLYLILDF 196
               R                        IL K+ HP +V+L           LY++ + 
Sbjct: 60  RPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFEL 119

Query: 197 INGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
           +N G +   +       EDQARFY  +++  + +LH   I+HRD+KP N+L+  DGH+ +
Sbjct: 120 VNQGPVM-EVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKI 178

Query: 257 TDFGLAKEI-DESSRSNSMCGTTEYMAPEILLSKGHN---KDADWWSVGILLYEMLTGQV 312
            DFG++ E     +  ++  GT  +MAPE L         K  D W++G+ LY  + GQ 
Sbjct: 179 ADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  171 bits (434), Expect = 1e-49
 Identities = 55/231 (23%), Positives = 96/231 (41%), Gaps = 27/231 (11%)

Query: 94  ENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI 153
           E D   E  S   +G   F    V+G GA G +     +G+ D       A+K       
Sbjct: 8   EQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIV---YRGMFDNRD---VAVK------R 55

Query: 154 IKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI- 211
           I      +   E  +L +   HP +++   + + R   Y+ ++      L  ++ ++   
Sbjct: 56  ILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFA 114

Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----VMLTDFGLAKEID 266
               +      +  S ++HLH   IVHRDLKP NIL+           M++DFGL K++ 
Sbjct: 115 HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174

Query: 267 ESSRS----NSMCGTTEYMAPEIL---LSKGHNKDADWWSVGILLYEMLTG 310
               S    + + GT  ++APE+L     +      D +S G + Y +++ 
Sbjct: 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  165 bits (419), Expect = 9e-49
 Identities = 62/224 (27%), Positives = 108/224 (48%), Gaps = 20/224 (8%)

Query: 100 EAESERKIGPGDFEIFR-----VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII 154
           E + E  +   D+E        V+G+G +G V+     G D   +    A+K + +    
Sbjct: 7   EGDCESDLLEYDYEYDENGDRVVLGKGTYGIVY----AGRD-LSNQVRIAIKEIPER--- 58

Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQGI 211
              +   +  E  +   + H  IVQ   SF     + + ++ + GG    L    +    
Sbjct: 59  DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLK 118

Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKEI-DESS 269
             E    FYT +I+  + +LH   IVHRD+K +N+L+++  G + ++DFG +K +   + 
Sbjct: 119 DNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178

Query: 270 RSNSMCGTTEYMAPEILL--SKGHNKDADWWSVGILLYEMLTGQ 311
            + +  GT +YMAPEI+    +G+ K AD WS+G  + EM TG+
Sbjct: 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  159 bits (404), Expect = 2e-46
 Identities = 60/222 (27%), Positives = 116/222 (52%), Gaps = 10/222 (4%)

Query: 92  EHENDAELEAESERKIGPGD-FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRK 150
                + L      K  P + F     +G+G+FG+VF    KG+D+  +  + A+K++  
Sbjct: 3   HSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVF----KGIDN-RTQKVVAIKIIDL 57

Query: 151 DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG 210
           +    ++ ++ ++ E  +L++   P++ +   S+   +KL++I++++ GG     L   G
Sbjct: 58  EEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPG 114

Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-S 269
              E Q      EI+  + +LH    +HRD+K  N+L+   G V L DFG+A ++ ++  
Sbjct: 115 PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174

Query: 270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           + N+  GT  +MAPE++    ++  AD WS+GI   E+  G+
Sbjct: 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  158 bits (402), Expect = 4e-46
 Identities = 67/266 (25%), Positives = 127/266 (47%), Gaps = 28/266 (10%)

Query: 65  HNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFG 124
           H+  H    P   Y + ++  L  Q     +  +++      I   D  I   +G G+FG
Sbjct: 3   HHHHHH---PMSDYDIPTTENLYFQGAM--DGDDMD------IPWCDLNIKEKIGAGSFG 51

Query: 125 KVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184
            V + +  G D        A+K++ +     +   ++++ E  I+ ++ HP IV    + 
Sbjct: 52  TVHRAEWHGSD-------VAVKILMEQDFHAERVNEFLR-EVAIMKRLRHPNIVLFMGAV 103

Query: 185 QTRSKLYLILDFINGGHLFFHLYRQGIFRE---DQARFYTAEIVSAVSHLHKCG--IVHR 239
                L ++ ++++ G L+  L++ G   +    +      ++   +++LH     IVHR
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHR 163

Query: 240 DLKPENILMDSDGHVMLTDFGLAKEIDESSRS-NSMCGTTEYMAPEILLSKGHNKDADWW 298
           +LK  N+L+D    V + DFGL++    +  S  S  GT E+MAPE+L  +  N+ +D +
Sbjct: 164 NLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVY 223

Query: 299 SVGILLYEMLTGQV---NIKSMQVIA 321
           S G++L+E+ T Q    N+   QV+A
Sbjct: 224 SFGVILWELATLQQPWGNLNPAQVVA 249

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  161 bits (408), Expect = 6e-46
 Identities = 56/232 (24%), Positives = 98/232 (42%), Gaps = 46/232 (19%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
               +++G G+ G V     +G   G      A+K       +  +  D    E  +LT+
Sbjct: 17  VVSEKILGYGSSGTV---VFQGSFQGRP---VAVK------RMLIDFCDIALMEIKLLTE 64

Query: 172 VT-HPFIVQLRYSFQTRSKLYLILDFINGGHLF-------FHLYRQGIFREDQARFYTAE 223
              HP +++   S  T   LY+ L+  N   L               + +E        +
Sbjct: 65  SDDHPNVIRYYCSETTDRFLYIALELCNLN-LQDLVESKNVSDENLKLQKEYNPISLLRQ 123

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDS-------------DGHVMLTDFGLAKEIDE--- 267
           I S V+HLH   I+HRDLKP+NIL+ +             +  ++++DFGL K++D    
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183

Query: 268 --SSRSNSMCGTTEYMAPEILLS-------KGHNKDADWWSVGILLYEMLTG 310
              +  N+  GT+ + APE+L         +   +  D +S+G + Y +L+ 
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  154 bits (392), Expect = 1e-44
 Identities = 67/271 (24%), Positives = 130/271 (47%), Gaps = 35/271 (12%)

Query: 64  IHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGD----FEIFRVVG 119
           +H+  H   G       + +L  Q   + HE   + +A     +  GD     + +  +G
Sbjct: 1   MHHHHHHSSGVDLG---TENLYFQSGVVTHE---QFKAALRMVVDQGDPRLLLDSYVKIG 54

Query: 120 QGAFGKVFQVKKKGVDDGDSDGIYAMKVM------RKDTIIKKNHVDYMKAERDILTKVT 173
           +G+ G V   ++K      S    A+K+M      R++ +           E  I+    
Sbjct: 55  EGSTGIVCLAREK-----HSGRQVAVKMMDLRKQQRRELLFN---------EVVIMRDYQ 100

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
           H  +V++  S+    +L+++++F+ GG L   +  Q    E+Q       ++ A+++LH 
Sbjct: 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALT-DIVSQVRLNEEQIATVCEAVLQALAYLHA 159

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPEILLSKGHN 292
            G++HRD+K ++IL+  DG V L+DFG   +I  +  +  S+ GT  +MAPE++    + 
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYA 219

Query: 293 KDADWWSVGILLYEMLTGQ---VNIKSMQVI 320
            + D WS+GI++ EM+ G+    +   +Q +
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 250

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  153 bits (389), Expect = 2e-44
 Identities = 66/240 (27%), Positives = 116/240 (48%), Gaps = 29/240 (12%)

Query: 95  NDAELEAESERKIGPGD----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM-- 148
           +D E+  +    +  GD    +  F  +GQGA G V+           +    A++ M  
Sbjct: 1   SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDV-----ATGQEVAIRQMNL 55

Query: 149 ----RKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFF 204
               +K+ II          E  ++ +  +P IV    S+    +L+++++++ GG L  
Sbjct: 56  QQQPKKELIIN---------EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT- 105

Query: 205 HLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE 264
            +  +    E Q      E + A+  LH   ++HRD+K +NIL+  DG V LTDFG   +
Sbjct: 106 DVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165

Query: 265 I-DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ---VNIKSMQVI 320
           I  E S+ ++M GT  +MAPE++  K +    D WS+GI+  EM+ G+   +N   ++ +
Sbjct: 166 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  151 bits (383), Expect = 1e-43
 Identities = 61/243 (25%), Positives = 114/243 (46%), Gaps = 19/243 (7%)

Query: 89  QELEHENDAELEAESERKIGPGDFEIFR-VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKV 147
           +  + ++  ELE ++      G F  F   +G+G+F  V+    KG+D   +    A   
Sbjct: 4   RNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVY----KGLDTETTV-EVAWCE 58

Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF----QTRSKLYLILDFINGGHLF 203
           + +D  + K+     K E ++L  + HP IV+   S+    + +  + L+ + +  G L 
Sbjct: 59  L-QDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLK 117

Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDS-DGHVMLTDFG 260
            +L R  + +    R +  +I+  +  LH     I+HRDLK +NI +    G V + D G
Sbjct: 118 TYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177

Query: 261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ---VNIKSM 317
           LA     S    ++ GT E+MAPE +  + +++  D ++ G+ + EM T +      ++ 
Sbjct: 178 LATLKRASFAK-AVIGTPEFMAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNA 235

Query: 318 QVI 320
             I
Sbjct: 236 AQI 238

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  150 bits (380), Expect = 4e-43
 Identities = 72/273 (26%), Positives = 117/273 (42%), Gaps = 31/273 (11%)

Query: 92  EHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD 151
            H +    +A  + +I  G   + + +G G+FG V+    KG   GD     A+K++   
Sbjct: 6   HHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVY----KGKWHGD----VAVKMLNVT 57

Query: 152 TIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI 211
               +    + K E  +L K  H  I+     + T  +L ++  +  G  L+ HL+    
Sbjct: 58  APTPQQLQAF-KNEVGVLRKTRHVNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHASET 115

Query: 212 -FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR 270
            F   +      +    + +LH   I+HRDLK  NI +  D  V + DFGLA E    S 
Sbjct: 116 KFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175

Query: 271 SNSM---CGTTEYMAPEILLSKGHNKD---ADWWSVGILLYEMLTGQV---NIKSMQVIA 321
           S+      G+  +MAPE++  +  N     +D ++ GI+LYE++TGQ+   NI +     
Sbjct: 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-- 233

Query: 322 CNTMLLFYLIIFHCLFVNSLELLSHFPENCPAS 354
                    II      +    LS    NCP  
Sbjct: 234 ---------IIEMVGRGSLSPDLSKVRSNCPKR 257

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  150 bits (380), Expect = 6e-43
 Identities = 61/244 (25%), Positives = 125/244 (51%), Gaps = 15/244 (6%)

Query: 82  SSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG 141
           S   +Q++        +L+ +S  K     F++   +G+G++G V++   K     ++  
Sbjct: 1   SLETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHK-----ETGQ 55

Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           I A+K +  ++ +++     +  E  I+ +   P +V+   S+   + L++++++   G 
Sbjct: 56  IVAIKQVPVESDLQE-----IIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGS 110

Query: 202 LF-FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
           +      R     ED+        +  + +LH    +HRD+K  NIL++++GH  L DFG
Sbjct: 111 VSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFG 170

Query: 261 LAKEIDES-SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ---VNIKS 316
           +A ++ ++ ++ N++ GT  +MAPE++   G+N  AD WS+GI   EM  G+    +I  
Sbjct: 171 VAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP 230

Query: 317 MQVI 320
           M+ I
Sbjct: 231 MRAI 234

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  148 bits (376), Expect = 2e-42
 Identities = 60/217 (27%), Positives = 108/217 (49%), Gaps = 23/217 (10%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           S   I   + E+  VVG+GAFG V + K +  D        A+K +  ++  K     ++
Sbjct: 1   SLHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKD-------VAIKQIESESERK----AFI 49

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
             E   L++V HP IV+L  +    + + L++++  GG L+  L+         A    +
Sbjct: 50  V-ELRQLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS 106

Query: 223 ---EIVSAVSHLHKC---GIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMC 275
              +    V++LH      ++HRDLKP N+L+ + G V+ + DFG A +I       +  
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM--TNNK 164

Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
           G+  +MAPE+     +++  D +S GI+L+E++T + 
Sbjct: 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 201

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  149 bits (377), Expect = 4e-42
 Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 14/215 (6%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F   R +G G+FG V+       D   +  + A+K M             +  E   L K
Sbjct: 56  FSDLREIGHGSFGAVY----FARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 110

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP  +Q R  +      +L++++  G         +   +E +    T   +  +++L
Sbjct: 111 LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 170

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS--- 288
           H   ++HRD+K  NIL+   G V L DFG A  +   + +NS  GT  +MAPE++L+   
Sbjct: 171 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANSFVGTPYWMAPEVILAMDE 227

Query: 289 KGHNKDADWWSVGILLYEMLTGQ---VNIKSMQVI 320
             ++   D WS+GI   E+   +    N+ +M  +
Sbjct: 228 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 262

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  147 bits (372), Expect = 8e-42
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 45/211 (21%)

Query: 111 DFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           D+++  +V+G G  GKV Q+  K      +   +A+K+++     ++        E ++ 
Sbjct: 18  DYKVTSQVLGLGINGKVLQIFNKR-----TQEKFALKMLQDCPKARR--------EVELH 64

Query: 170 TKVT-HPFIVQLRYSFQT----RSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTA 222
            + +  P IV++   ++     R  L ++++ ++GG LF  +  +G   F E +A     
Sbjct: 65  WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 124

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
            I  A+ +LH   I HRD+KPEN+L  S   +  + LTDFG AKE               
Sbjct: 125 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-------------- 170

Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
                    + ++K  D WS+G+++Y +L G
Sbjct: 171 -------TGEKYDKSCDMWSLGVIMYILLCG 194

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  147 bits (373), Expect = 1e-41
 Identities = 57/235 (24%), Positives = 96/235 (40%), Gaps = 37/235 (15%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           ++G     + RV+ +G F  V++ +     D  S   YA+K +  +   ++     +  E
Sbjct: 24  ELGELRLRVRRVLAEGGFAFVYEAQ-----DVGSGREYALKRLLSN---EEEKNRAIIQE 75

Query: 166 RDILTKVT-HPFIVQLRYSF-------QTRSKLYLILDFINGGHLFFHLYR---QGIFRE 214
              + K++ HP IVQ   +         T    +L+L  +  G L   L +   +G    
Sbjct: 76  VCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSC 135

Query: 215 DQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN 272
           D       +   AV H+H+    I+HRDLK EN+L+ + G + L DFG A  I      +
Sbjct: 136 DTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS 195

Query: 273 S-------------MCGTTEYMAPEILLSKGH---NKDADWWSVGILLYEMLTGQ 311
                            T  Y  PEI+    +    +  D W++G +LY +   Q
Sbjct: 196 WSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  148 bits (374), Expect = 1e-41
 Identities = 66/233 (28%), Positives = 115/233 (49%), Gaps = 16/233 (6%)

Query: 87  QIQELEHENDAELEAESERKIG-------PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDS 139
           +++ELE +       E+              DFE    +G G  G VF+V  K      S
Sbjct: 3   KLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKP-----S 57

Query: 140 DGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
             + A K++  +  IK    + +  E  +L +   P+IV    +F +  ++ + ++ ++G
Sbjct: 58  GLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 115

Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTD 258
           G L   L + G   E      +  ++  +++L  K  I+HRD+KP NIL++S G + L D
Sbjct: 116 GSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCD 175

Query: 259 FGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           FG++ ++   S +NS  GT  YM+PE L    ++  +D WS+G+ L EM  G+
Sbjct: 176 FGVSGQL-IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  144 bits (366), Expect = 6e-41
 Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 22/230 (9%)

Query: 97  AELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK 156
           +E  +     I   D+E+  V+G GA   V                 A+K +  +    +
Sbjct: 2   SEDSSALPWSINRDDYELQEVIGSGATAVVQ----AAYCA-PKKEKVAIKRINLEKC--Q 54

Query: 157 NHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQ---- 209
             +D +  E   +++  HP IV    SF  + +L+L++  ++GG    +  H+  +    
Sbjct: 55  TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHK 114

Query: 210 -GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES 268
            G+  E        E++  + +LHK G +HRD+K  NIL+  DG V + DFG++  +   
Sbjct: 115 SGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG 174

Query: 269 ------SRSNSMCGTTEYMAPE-ILLSKGHNKDADWWSVGILLYEMLTGQ 311
                     +  GT  +MAPE +   +G++  AD WS GI   E+ TG 
Sbjct: 175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  144 bits (366), Expect = 6e-41
 Identities = 65/219 (29%), Positives = 115/219 (52%), Gaps = 18/219 (8%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +EI   +G GAFGKV++ K K     ++  + A KV+       +  ++    E +IL  
Sbjct: 21  WEIVGELGDGAFGKVYKAKNK-----ETGALAAAKVI---ETKSEEELEDYIVEIEILAT 72

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGIFREDQARFYTAEIVSAVSH 230
             HP+IV+L  ++    KL+++++F  GG +    L       E Q +    +++ A++ 
Sbjct: 73  CDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNF 132

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEYMAPEILLS- 288
           LH   I+HRDLK  N+LM  +G + L DFG++ +  ++  + +S  GT  +MAPE+++  
Sbjct: 133 LHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCE 192

Query: 289 ----KGHNKDADWWSVGILLYEMLTGQ---VNIKSMQVI 320
                 ++  AD WS+GI L EM   +     +  M+V+
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL 231

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  145 bits (367), Expect = 8e-41
 Identities = 52/266 (19%), Positives = 87/266 (32%), Gaps = 66/266 (24%)

Query: 111 DFEIFRVVGQGAFGKVFQVK----------KK---------------------------- 132
           DFE  + +G+G FG VF+ K          K+                            
Sbjct: 7   DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66

Query: 133 ------------GVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL 180
                            + D I+         +   + +D    +   +   +    V  
Sbjct: 67  VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126

Query: 181 RYSFQTRSKLYLILDFINGGHLFFHLYRQGIF---REDQARFYTAEIVSAVSHLHKCGIV 237
                 +  LY+ +      +L   + R+                +I  AV  LH  G++
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLM 186

Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEIDESS-------------RSNSMCGTTEYMAPE 284
           HRDLKP NI    D  V + DFGL   +D+                     GT  YM+PE
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTG 310
            +    ++   D +S+G++L+E+L  
Sbjct: 247 QIHGNNYSHKVDIFSLGLILFELLYS 272

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  144 bits (365), Expect = 1e-40
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 14/217 (6%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
               +    D E    +G G  G+V++++ +      +  + A+K MR+     K     
Sbjct: 17  GQRYQAEINDLENLGEMGSGTCGQVWKMRFRK-----TGHVIAVKQMRRS--GNKEENKR 69

Query: 162 MKAERDILTK-VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
           +  + D++ K    P+IVQ   +F T + +++ ++ +           QG   E      
Sbjct: 70  ILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKM 129

Query: 221 TAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
           T  IV A+ +L  K G++HRD+KP NIL+D  G + L DFG++  + +    +   G   
Sbjct: 130 TVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAA 189

Query: 280 YMAPEILLS-----KGHNKDADWWSVGILLYEMLTGQ 311
           YMAPE +         ++  AD WS+GI L E+ TGQ
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  142 bits (361), Expect = 2e-40
 Identities = 66/230 (28%), Positives = 109/230 (47%), Gaps = 24/230 (10%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-IKKNHVDYMKAE 165
           I   +  +  ++G G FGKV++    G +        A+K  R D        ++ ++ E
Sbjct: 4   IDFAELTLEEIIGIGGFGKVYRAFWIGDE-------VAVKAARHDPDEDISQTIENVRQE 56

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +   + HP I+ LR        L L+++F  GG L   L  + I   D    +  +I 
Sbjct: 57  AKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRI-PPDILVNWAVQIA 115

Query: 226 SAVSHLHKCG---IVHRDLKPENILMDSDGH--------VMLTDFGLAKEIDESSRSNSM 274
             +++LH      I+HRDLK  NIL+             + +TDFGLA+E   +++  S 
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM-SA 174

Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQV---NIKSMQVIA 321
            G   +MAPE++ +   +K +D WS G+LL+E+LTG+V    I  + V  
Sbjct: 175 AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY 224

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  142 bits (359), Expect = 9e-40
 Identities = 53/234 (22%), Positives = 99/234 (42%), Gaps = 29/234 (12%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I     EI  ++G+G FG+V+     G   G+     A++++  +   +     + K E 
Sbjct: 30  IPFEQLEIGELIGKGRFGQVY----HGRWHGE----VAIRLIDIERDNEDQLKAF-KREV 80

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIV 225
               +  H  +V    +  +   L +I     G  L+  +    I    ++ R    EIV
Sbjct: 81  MAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIV 140

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID---ESSRSNSM---CGTTE 279
             + +LH  GI+H+DLK +N+  D +G V++TDFGL           R + +    G   
Sbjct: 141 KGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLC 199

Query: 280 YMAPEIL---------LSKGHNKDADWWSVGILLYEMLTGQV---NIKSMQVIA 321
           ++APEI+              +K +D +++G + YE+   +       +  +I 
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW 253

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  140 bits (354), Expect = 2e-39
 Identities = 49/248 (19%), Positives = 101/248 (40%), Gaps = 40/248 (16%)

Query: 96  DAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY-------AMKVM 148
            +E        +   + E  + +G+G FG V +            G         A+K +
Sbjct: 5   GSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHK------------GRLVKDKSVVAIKSL 52

Query: 149 RKDTIIKKNHVDYM----KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFF 204
                  +  +       + E  I++ + HP IV+L       +   ++++F+  G L+ 
Sbjct: 53  ILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYH 110

Query: 205 HLYRQGIFREDQARFYTA-EIVSAVSHLHKCG--IVHRDLKPENILMDSDG-----HVML 256
            L  +    +   +     +I   + ++      IVHRDL+  NI + S          +
Sbjct: 111 RLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170

Query: 257 TDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG--HNKDADWWSVGILLYEMLTGQV-- 312
            DFGL+++   S   + + G  ++MAPE + ++   + + AD +S  ++LY +LTG+   
Sbjct: 171 ADFGLSQQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

Query: 313 -NIKSMQV 319
                 ++
Sbjct: 229 DEYSYGKI 236

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  140 bits (355), Expect = 4e-39
 Identities = 61/229 (26%), Positives = 113/229 (49%), Gaps = 27/229 (11%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G FE+  +VG G +G+V+    KG     +  + A+KVM     +  +  + +K E ++L
Sbjct: 24  GIFELVELVGNGTYGQVY----KGRHV-KTGQLAAIKVMD----VTGDEEEEIKQEINML 74

Query: 170 TKV-THPFIVQLRYSF------QTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFY 220
            K   H  I     +F          +L+L+++F   G +       +    +E+   + 
Sbjct: 75  KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI 134

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTE 279
             EI+  +SHLH+  ++HRD+K +N+L+  +  V L DFG++ ++D +  R N+  GT  
Sbjct: 135 CREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 194

Query: 280 YMAPEILLSK-----GHNKDADWWSVGILLYEMLTGQ---VNIKSMQVI 320
           +MAPE++         ++  +D WS+GI   EM  G     ++  M+ +
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 243

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  139 bits (353), Expect = 6e-39
 Identities = 63/206 (30%), Positives = 98/206 (47%), Gaps = 9/206 (4%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G + + R+VG+G  G V++ +     D   + I A+K+M +           M+ E    
Sbjct: 34  GPYRLRRLVGRGGMGDVYEAE-----DTVRERIVALKLMSETLSSDPVFRTRMQREARTA 88

Query: 170 TKVTHPFIVQLRYSF-QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
            ++  P +V + + F +   +LY+ +  ING  L   L RQG     +A     +I SA+
Sbjct: 89  GRLQEPHVVPI-HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSAL 147

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEIL 286
              H  G  HRD+KPENIL+ +D    L DFG+A    +    +  +  GT  YMAPE  
Sbjct: 148 DAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERF 207

Query: 287 LSKGHNKDADWWSVGILLYEMLTGQV 312
                   AD +++  +LYE LTG  
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSP 233

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  139 bits (352), Expect = 1e-38
 Identities = 59/231 (25%), Positives = 108/231 (46%), Gaps = 17/231 (7%)

Query: 91  LEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRK 150
           +E     ++  E        D +    +G+GA+G V ++  K      S  I A+K +R 
Sbjct: 3   IESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHK-----PSGQIMAVKRIRS 57

Query: 151 DTIIKKNHVDYMKAERDILTK-VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFF----H 205
              + +     +  + D++ +    P+IVQ   +       ++ ++ ++     F    +
Sbjct: 58  T--VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVY 115

Query: 206 LYRQGIFREDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKE 264
                +  E+     T   V A++HL     I+HRD+KP NIL+D  G++ L DFG++ +
Sbjct: 116 SVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175

Query: 265 IDESSRSNSMCGTTEYMAPEIL----LSKGHNKDADWWSVGILLYEMLTGQ 311
           + +S       G   YMAPE +      +G++  +D WS+GI LYE+ TG+
Sbjct: 176 LVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  144 bits (365), Expect = 1e-38
 Identities = 54/222 (24%), Positives = 95/222 (42%), Gaps = 33/222 (14%)

Query: 106 KIGPGD-----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD 160
           ++ PGD     +E+   +  G  G ++      +D   +     +K +           +
Sbjct: 71  QLNPGDIVAGQYEVKGCIAHGGLGWIY----LALDRNVNGRPVVLKGLVHS-----GDAE 121

Query: 161 YMK---AERDILTKVTHPFIVQLRYSF------QTRSKLYLILDFINGGHLFFHLYRQGI 211
                 AER  L +V HP IVQ+ ++F            Y++++++ G  L     +   
Sbjct: 122 AQAMAMAERQFLAEVVHPSIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSL--KRSKGQK 178

Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS 271
               +A  Y  EI+ A+S+LH  G+V+ DLKPENI++  +  + L D G    I+     
Sbjct: 179 LPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRIN---SF 234

Query: 272 NSMCGTTEYMAPEILLSKGHNKDA-DWWSVGILLYEMLTGQV 312
             + GT  + APEI+  +     A D ++VG  L  +     
Sbjct: 235 GYLYGTPGFQAPEIV--RTGPTVATDIYTVGRTLAALTLDLP 274

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  136 bits (346), Expect = 2e-38
 Identities = 42/227 (18%), Positives = 90/227 (39%), Gaps = 24/227 (10%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I          + +   G++++ + +G D         +KV++      +   D+ + E 
Sbjct: 7   IDFKQLNFLTKLNENHSGELWKGRWQGND-------IVVKVLKVRDWSTRKSRDFNE-EC 58

Query: 167 DILTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED--QARFYTA 222
             L   +HP ++ +             LI  ++  G L+  L+    F  D  QA  +  
Sbjct: 59  PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118

Query: 223 EIVSAVSHLHKCG--IVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
           ++   ++ LH     I    L   ++++D D    ++   +        R         +
Sbjct: 119 DMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR----MYAPAW 174

Query: 281 MAPEILLSKGHNKD---ADWWSVGILLYEMLTGQV---NIKSMQVIA 321
           +APE L  K  + +   AD WS  +LL+E++T +V   ++ +M++  
Sbjct: 175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM 221

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  137 bits (348), Expect = 3e-38
 Identities = 49/226 (21%), Positives = 98/226 (43%), Gaps = 24/226 (10%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
             R   P D     V+G+G FG+  +V  +      +  +  MK + +     +      
Sbjct: 3   PHRIFRPSDLIHGEVLGKGCFGQAIKVTHRE-----TGEVMVMKELIRFD---EETQRTF 54

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYT 221
             E  ++  + HP +++         +L  I ++I GG L   +      +   Q   + 
Sbjct: 55  LKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFA 114

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS------------ 269
            +I S +++LH   I+HRDL   N L+  + +V++ DFGLA+ + +              
Sbjct: 115 KDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174

Query: 270 ---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
              +  ++ G   +MAPE++  + +++  D +S GI+L E++    
Sbjct: 175 DRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN 220

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  139 bits (351), Expect = 4e-38
 Identities = 48/245 (19%), Positives = 99/245 (40%), Gaps = 23/245 (9%)

Query: 93  HENDAELEAESERKIGPGDFEIFRVVGQGA--FGKVFQVKKKGVDDGDSDGIYAMKVMRK 150
           H  +   +  S      G +E+  V+G+G      V   + K      +     ++ +  
Sbjct: 8   HMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKP-----TGEYVTVRRINL 62

Query: 151 DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF--FHLYR 208
           +       V +++ E  +     HP IV  R +F   ++L+++  F+  G        + 
Sbjct: 63  EAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF 121

Query: 209 QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES 268
                E    +    ++ A+ ++H  G VHR +K  +IL+  DG V L+       +   
Sbjct: 122 MDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181

Query: 269 -SRSNSMC-------GTTEYMAPEIL--LSKGHNKDADWWSVGILLYEMLTGQV---NIK 315
             R   +            +++PE+L    +G++  +D +SVGI   E+  G V   ++ 
Sbjct: 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241

Query: 316 SMQVI 320
           + Q++
Sbjct: 242 ATQML 246

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  136 bits (345), Expect = 6e-38
 Identities = 62/207 (29%), Positives = 108/207 (52%), Gaps = 11/207 (5%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             ++I   +G G    V+  +     D   +   A+K +      K+  +   + E    
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAE-----DTILNIKVAIKAIFIPPREKEETLKRFEREVHNS 65

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           ++++H  IV +    +     YL++++I G  L  ++   G    D A  +T +I+  + 
Sbjct: 66  SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK 125

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILL 287
           H H   IVHRD+KP+NIL+DS+  + + DFG+AK + E+S  ++N + GT +Y +PE   
Sbjct: 126 HAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE--Q 183

Query: 288 SKGHNKDA--DWWSVGILLYEMLTGQV 312
           +KG   D   D +S+GI+LYEML G+ 
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEP 210

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  136 bits (344), Expect = 7e-38
 Identities = 52/215 (24%), Positives = 98/215 (45%), Gaps = 16/215 (7%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           ++   D E    +G+GA+G V +++        S  I A+K +R    +       +  +
Sbjct: 3   EVKADDLEPIMELGRGAYGVVEKMRHV-----PSGQIMAVKRIRAT--VNSQEQKRLLMD 55

Query: 166 RDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFF---HLYRQGIFREDQARFYT 221
            DI  +    PF V    +      +++ ++ ++     F    + +     ED      
Sbjct: 56  LDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIA 115

Query: 222 AEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
             IV A+ HLH K  ++HRD+KP N+L+++ G V + DFG++  + +    +   G   Y
Sbjct: 116 VSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPY 175

Query: 281 MAPEILLSKGHNKD----ADWWSVGILLYEMLTGQ 311
           MAPE +  + + K     +D WS+GI + E+   +
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  135 bits (341), Expect = 2e-37
 Identities = 57/225 (25%), Positives = 93/225 (41%), Gaps = 39/225 (17%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-- 168
           D  +   VG+G +G+V++   +G +        A+K      I           E ++  
Sbjct: 9   DITLLECVGKGRYGEVWRGSWQGEN-------VAVK------IFSSRDEKSWFRETELYN 55

Query: 169 LTKVTHPFIVQL----RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
              + H  I+        S  + ++L+LI  +   G L+ +L    +      R     I
Sbjct: 56  TVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRI-VLSI 114

Query: 225 VSAVSHLH--------KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-----RS 271
            S ++HLH        K  I HRDLK +NIL+  +G   + D GLA    +S+      +
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174

Query: 272 NSMCGTTEYMAPEIL------LSKGHNKDADWWSVGILLYEMLTG 310
           N   GT  YMAPE+L            K  D W+ G++L+E+   
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  133 bits (337), Expect = 1e-36
 Identities = 48/255 (18%), Positives = 95/255 (37%), Gaps = 39/255 (15%)

Query: 88  IQELEHENDAELEAESER-KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMK 146
           +    H + + ++  +E         ++  V  +G FG V++ +             A+K
Sbjct: 1   MGHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY-------VAVK 53

Query: 147 VMRKDTIIKKNHVDYMKAERDI--LTKVTHPFIVQL----RYSFQTRSKLYLILDFINGG 200
           +               + E ++  L  + H  I+Q     +        L+LI  F   G
Sbjct: 54  IF------PIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKG 107

Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLH----------KCGIVHRDLKPENILMDS 250
            L   L    +   +        +   +++LH          K  I HRD+K +N+L+ +
Sbjct: 108 SLSDFLKANVVSWNELCHIAE-TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN 166

Query: 251 DGHVMLTDFGLAKEIDESSRSNSM---CGTTEYMAPEIL-----LSKGHNKDADWWSVGI 302
           +    + DFGLA + +    +       GT  YMAPE+L       +      D +++G+
Sbjct: 167 NLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGL 226

Query: 303 LLYEMLTGQVNIKSM 317
           +L+E+ +        
Sbjct: 227 VLWELASRCTAADGP 241

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  132 bits (335), Expect = 3e-36
 Identities = 56/213 (26%), Positives = 107/213 (50%), Gaps = 17/213 (7%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             +E+  ++G G   +V   +     D       A+KV+R D     +     + E    
Sbjct: 12  DRYELGEILGFGGMSEVHLAR-----DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNA 66

Query: 170 TKVTHPFIVQL----RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             + HP IV +              Y+++++++G  L   ++ +G     +A    A+  
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 126

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS----RSNSMCGTTEYM 281
            A++  H+ GI+HRD+KP NI++ +   V + DFG+A+ I +S     ++ ++ GT +Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186

Query: 282 APEILLSKGHNKDA--DWWSVGILLYEMLTGQV 312
           +PE   ++G + DA  D +S+G +LYE+LTG+ 
Sbjct: 187 SPE--QARGDSVDARSDVYSLGCVLYEVLTGEP 217

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  133 bits (336), Expect = 3e-36
 Identities = 54/229 (23%), Positives = 92/229 (40%), Gaps = 39/229 (17%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
                 ++ + +G+G +G+V+  K +G          A+K      +           E 
Sbjct: 34  TIAKQIQMVKQIGKGRYGEVWMGKWRGEK-------VAVK------VFFTTEEASWFRET 80

Query: 167 DI--LTKVTHPFIVQL----RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
           +I     + H  I+           + ++LYLI D+   G L+ +L    +  +   +  
Sbjct: 81  EIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKL- 139

Query: 221 TAEIVSAVSHLH--------KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR-- 270
               VS + HLH        K  I HRDLK +NIL+  +G   + D GLA +    +   
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199

Query: 271 ---SNSMCGTTEYMAPEILLSKGHNKD------ADWWSVGILLYEMLTG 310
               N+  GT  YM PE+L    +         AD +S G++L+E+   
Sbjct: 200 DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  132 bits (334), Expect = 6e-36
 Identities = 58/229 (25%), Positives = 94/229 (41%), Gaps = 39/229 (17%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
                  +   +G+G FG+V++ K +G +        A+K      I           E 
Sbjct: 39  TIARTIVLQESIGKGRFGEVWRGKWRGEE-------VAVK------IFSSREERSWFREA 85

Query: 167 DI--LTKVTHPFIVQL----RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
           +I     + H  I+           T ++L+L+ D+   G LF +L R  +  E   +  
Sbjct: 86  EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL- 144

Query: 221 TAEIVSAVSHLH--------KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR-- 270
                S ++HLH        K  I HRDLK +NIL+  +G   + D GLA   D ++   
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 204

Query: 271 ---SNSMCGTTEYMAPEILLSKG------HNKDADWWSVGILLYEMLTG 310
               N   GT  YMAPE+L            K AD +++G++ +E+   
Sbjct: 205 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  132 bits (333), Expect = 6e-36
 Identities = 52/244 (21%), Positives = 99/244 (40%), Gaps = 48/244 (19%)

Query: 100 EAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY-AMKVMRKDTIIKKNH 158
            A SE  +   + ++  ++G+G +G V++        G  D    A+KV          +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYK--------GSLDERPVAVKVF------SFAN 48

Query: 159 VDYMKAERDI--LTKVTHPFIVQL-----RYSFQTRSKLYLILDFINGGHLFFHLYRQGI 211
                 E++I  +  + H  I +      R +   R +  L++++   G L  +L     
Sbjct: 49  RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS 108

Query: 212 FREDQARFYTAEIVSAVSHLH---------KCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
                 R     +   +++LH         K  I HRDL   N+L+ +DG  +++DFGL+
Sbjct: 109 DWVSSCRL-AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167

Query: 263 KEIDESSR---------SNSMCGTTEYMAPEIL-------LSKGHNKDADWWSVGILLYE 306
             +  +           + S  GT  YMAPE+L         +   K  D +++G++ +E
Sbjct: 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE 227

Query: 307 MLTG 310
           +   
Sbjct: 228 IFMR 231

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  121 bits (307), Expect = 2e-32
 Identities = 56/209 (26%), Positives = 100/209 (47%), Gaps = 20/209 (9%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-- 168
            +E    +G+G++G VF+ + +     D+  I A+K   +    + + V    A R+I  
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNR-----DTGQIVAIKKFLES---EDDPVIKKIALREIRM 55

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           L ++ HP +V L   F+ + +L+L+ ++ +   L      Q    E   +  T + + AV
Sbjct: 56  LKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAV 115

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE-----YMAP 283
           +  HK   +HRD+KPENIL+     + L DFG A+ +   S         E     Y +P
Sbjct: 116 NFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY----DDEVATRWYRSP 171

Query: 284 EILL-SKGHNKDADWWSVGILLYEMLTGQ 311
           E+L+    +    D W++G +  E+L+G 
Sbjct: 172 ELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  122 bits (307), Expect = 1e-31
 Identities = 62/211 (29%), Positives = 104/211 (49%), Gaps = 23/211 (10%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +   +V+G G+FG V+Q K       DS  + A+K + +D         +   E  I+ K
Sbjct: 56  YTDTKVIGNGSFGVVYQAK-----LCDSGELVAIKKVLQDK-------RFKNRELQIMRK 103

Query: 172 VTHPFIVQLRYSFQTRS------KLYLILDFINGG-HLFFHLYRQG--IFREDQARFYTA 222
           + H  IV+LRY F +         L L+LD++    +     Y +          + Y  
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCGTTEYM 281
           ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     + S   +  Y 
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 223

Query: 282 APEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
           APE++  +  +    D WS G +L E+L GQ
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  120 bits (303), Expect = 2e-31
 Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 20/209 (9%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-- 168
            +E   +VG+G++G V + + K     D+  I A+K   +      + +    A R+I  
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNK-----DTGRIVAIKKFLES---DDDKMVKKIAMREIKL 77

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           L ++ H  +V L    + + + YL+ +F++   L               + Y  +I++ +
Sbjct: 78  LKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGI 137

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE-----YMAP 283
              H   I+HRD+KPENIL+   G V L DFG A+ +  ++         E     Y AP
Sbjct: 138 GFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL--AAPGEVY--DDEVATRWYRAP 193

Query: 284 EILL-SKGHNKDADWWSVGILLYEMLTGQ 311
           E+L+    + K  D W++G L+ EM  G+
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  119 bits (300), Expect = 3e-31
 Identities = 51/219 (23%), Positives = 103/219 (47%), Gaps = 36/219 (16%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-------TIIKKNHVDYMK 163
            F+    +G G +  V++       +  +    A+K ++ D       T I+        
Sbjct: 6   QFKQLEKLGNGTYATVYKGL-----NKTTGVYVALKEVKLDSEEGTPSTAIR-------- 52

Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFIN---GGHL--FFHLYRQGIFREDQAR 218
            E  ++ ++ H  IV+L     T +KL L+ +F++     ++              +  +
Sbjct: 53  -EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK 111

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
           ++  +++  ++  H+  I+HRDLKP+N+L++  G + L DFGLA+       +     ++
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF----SS 167

Query: 279 E-----YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
           E     Y AP++L+ S+ ++   D WS G +L EM+TG+
Sbjct: 168 EVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  117 bits (296), Expect = 6e-31
 Identities = 52/221 (23%), Positives = 101/221 (45%), Gaps = 45/221 (20%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--- 167
            +     +G+G +G V++ +            +A+K +R            ++ E +   
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN------YGETFALKKIR------------LEKEDEGIP 44

Query: 168 --------ILTKVTHPFIVQLRYSFQTRSKLYLILDFIN---GGHLFFHLYRQGIFREDQ 216
                   IL ++ H  IV+L     T+ +L L+ + ++      L      +G      
Sbjct: 45  STTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC---EGGLESVT 101

Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
           A+ +  ++++ +++ H   ++HRDLKP+N+L++ +G + + DFGLA+      R      
Sbjct: 102 AKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY---- 157

Query: 277 TTE-----YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
           T E     Y AP++L+ SK ++   D WSVG +  EM+ G 
Sbjct: 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  119 bits (300), Expect = 1e-30
 Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 24/211 (11%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +   +V+G G+FG VFQ K             A+K + +D         +   E  I+  
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLV------ESDEVAIKKVLQDK-------RFKNRELQIMRI 88

Query: 172 VTHPFIVQLRYSFQTRS------KLYLILDFING---GHLFFHLYRQGIFREDQARFYTA 222
           V HP +V L+  F +         L L+L+++          +   +        + Y  
Sbjct: 89  VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMY 148

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCGTTEYM 281
           +++ +++++H  GI HRD+KP+N+L+D    V+ L DFG AK +     + S   +  Y 
Sbjct: 149 QLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR 208

Query: 282 APEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
           APE++  +  +  + D WS G ++ E++ GQ
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  117 bits (295), Expect = 1e-30
 Identities = 63/221 (28%), Positives = 106/221 (47%), Gaps = 45/221 (20%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--- 167
            ++    VG+G +G V++ K           I A+K +R            + AE +   
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDS------QGRIVALKRIR------------LDAEDEGIP 63

Query: 168 --------ILTKVTHPFIVQLRYSFQTRSKLYLILDFIN---GGHLFFHLYRQGIFREDQ 216
                   +L ++ HP IV L     +   L L+ +F+       L  +   +   ++ Q
Sbjct: 64  STAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN---KTGLQDSQ 120

Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
            + Y  +++  V+H H+  I+HRDLKP+N+L++SDG + L DFGLA+      RS     
Sbjct: 121 IKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY---- 176

Query: 277 TTE-----YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
           T E     Y AP++L+ SK ++   D WS+G +  EM+TG+
Sbjct: 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  117 bits (295), Expect = 2e-30
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 22/214 (10%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-- 168
            +E    +G+GA+GKVF    K  D  +     A+K +R  T   +  +  +   R++  
Sbjct: 12  QYECVAEIGEGAYGKVF----KARDLKNGGRFVALKRVRVQT--GEEGMP-LSTIREVAV 64

Query: 169 ---LTKVTHPFIVQLR-----YSFQTRSKLYLILDFINGGH---LFFHLYRQGIFREDQA 217
              L    HP +V+L            +KL L+ + ++       +     +     +  
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD--QDLTTYLDKVPEPGVPTETI 122

Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
           +    +++  +  LH   +VHRDLKP+NIL+ S G + L DFGLA+         S+  T
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT 182

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
             Y APE+LL   +    D WSVG +  EM   +
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  115 bits (291), Expect = 5e-30
 Identities = 56/214 (26%), Positives = 87/214 (40%), Gaps = 20/214 (9%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-- 168
            +E    +G GA+G V++ +     D  S    A+K +R            +   R++  
Sbjct: 10  RYEPVAEIGVGAYGTVYKAR-----DPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64

Query: 169 ---LTKVTHPFIVQLR-----YSFQTRSKLYLILDFINGGH---LFFHLYRQGIFREDQA 217
              L    HP +V+L             K+ L+ + ++       +           +  
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD--QDLRTYLDKAPPPGLPAETI 122

Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
           +    + +  +  LH   IVHRDLKPENIL+ S G V L DFGLA+          +  T
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVT 182

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
             Y APE+LL   +    D WSVG +  EM   +
Sbjct: 183 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  116 bits (293), Expect = 6e-30
 Identities = 63/217 (29%), Positives = 105/217 (48%), Gaps = 33/217 (15%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK------A 164
            +E    +G+G F  V++ + K     +++ I A+K   K   IK  H    K      A
Sbjct: 11  RYEKLDFLGEGQFATVYKARDK-----NTNQIVAIK---K---IKLGHRSEAKDGINRTA 59

Query: 165 ERDI--LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGI-FREDQARFY 220
            R+I  L +++HP I+ L  +F  +S + L+ DF+     L   +    +       + Y
Sbjct: 60  LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME--TDLEVIIKDNSLVLTPSHIKAY 117

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE- 279
               +  + +LH+  I+HRDLKP N+L+D +G + L DFGLAK     +R+     T + 
Sbjct: 118 MLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY----THQV 173

Query: 280 ----YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
               Y APE+L  ++ +    D W+VG +L E+L   
Sbjct: 174 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  114 bits (288), Expect = 1e-29
 Identities = 47/219 (21%), Positives = 94/219 (42%), Gaps = 44/219 (20%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--- 167
            +E    +G+G +G VF+ K     + ++  I A+K +R            +  + +   
Sbjct: 3   KYEKLEKIGEGTYGTVFKAK-----NRETHEIVALKRVR------------LDDDDEGVP 45

Query: 168 --------ILTKVTHPFIVQLRYSFQTRSKLYLILDFIN---GGHLFFHLYRQGIFREDQ 216
                   +L ++ H  IV+L     +  KL L+ +F +     +        G    + 
Sbjct: 46  SSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC---NGDLDPEI 102

Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
            + +  +++  +   H   ++HRDLKP+N+L++ +G + L +FGLA+      R      
Sbjct: 103 VKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY---- 158

Query: 277 TTE-----YMAPEILL-SKGHNKDADWWSVGILLYEMLT 309
           + E     Y  P++L  +K ++   D WS G +  E+  
Sbjct: 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN 197

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  114 bits (288), Expect = 2e-29
 Identities = 54/217 (24%), Positives = 99/217 (45%), Gaps = 37/217 (17%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-------TIIKKNHVDYMK 163
            +     +G+G +  V++ K K      +D + A+K +R +       T I+        
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSK-----LTDNLVALKEIRLEHEEGAPCTAIR-------- 49

Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFIN---GGHLFFHLYRQGIFREDQARFY 220
            E  +L  + H  IV L     T   L L+ ++++     +L        I      + +
Sbjct: 50  -EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYL---DDCGNIINMHNVKLF 105

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE- 279
             +++  +++ H+  ++HRDLKP+N+L++  G + L DFGLA+     +++       E 
Sbjct: 106 LFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY----DNEV 161

Query: 280 ----YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
               Y  P+ILL S  ++   D W VG + YEM TG+
Sbjct: 162 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  115 bits (289), Expect = 2e-29
 Identities = 54/228 (23%), Positives = 93/228 (40%), Gaps = 46/228 (20%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--- 167
            +E    +GQG FG+VF+ +        +    A+K +             M+ E++   
Sbjct: 18  KYEKLAKIGQGTFGEVFKAR-----HRKTGQKVALKKVL------------MENEKEGFP 60

Query: 168 --------ILTKVTHPFIVQLR--------YSFQTRSKLYLILDFINGGH-LFFHLYRQG 210
                   IL  + H  +V L            + +  +YL+ DF    H L   L    
Sbjct: 61  ITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE--HDLAGLLSNVL 118

Query: 211 I-FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS 269
           + F   + +     +++ + ++H+  I+HRD+K  N+L+  DG + L DFGLA+    + 
Sbjct: 119 VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178

Query: 270 RSNSMCGTTE-----YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
            S     T       Y  PE+LL  + +    D W  G ++ EM T  
Sbjct: 179 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  113 bits (284), Expect = 6e-29
 Identities = 47/224 (20%), Positives = 94/224 (41%), Gaps = 46/224 (20%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--- 167
            +     +G+G +G+V++          ++   A+K +R            ++ E +   
Sbjct: 35  RYRRITKLGEGTYGEVYKAIDT-----VTNETVAIKRIR------------LEHEEEGVP 77

Query: 168 --------ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQAR 218
                   +L ++ H  I++L+       +L+LI ++    + L  ++ +         +
Sbjct: 78  GTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE--NDLKKYMDKNPDVSMRVIK 135

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-----DGHVMLTDFGLAKEIDESSRSNS 273
            +  ++++ V+  H    +HRDLKP+N+L+          + + DFGLA+      R   
Sbjct: 136 SFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF- 194

Query: 274 MCGTTE-----YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
              T E     Y  PEILL S+ ++   D WS+  +  EML   
Sbjct: 195 ---THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  111 bits (280), Expect = 4e-28
 Identities = 55/214 (25%), Positives = 103/214 (48%), Gaps = 23/214 (10%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F++ R+ GQG FG V   K     +  +    A+K + +D   +   +  M+     L  
Sbjct: 25  FQVERMAGQGTFGTVQLGK-----EKSTGMSVAIKKVIQDPRFRNRELQIMQ----DLAV 75

Query: 172 VTHPFIVQLRYSFQTRSK-------LYLILDFING---GHLFFHLYRQGIFREDQARFYT 221
           + HP IVQL+  F T  +       L ++++++          +  RQ        + + 
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFL 135

Query: 222 AEIVSAVSHLHKC--GIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
            +++ ++  LH     + HRD+KP N+L++ +DG + L DFG AK++  S  + +   + 
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR 195

Query: 279 EYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
            Y APE++  ++ +    D WSVG +  EM+ G+
Sbjct: 196 YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  109 bits (273), Expect = 6e-27
 Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 33/216 (15%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHP 175
           VG+G +G V++ K+K   DG  D  YA+K +    I        M A R+I  L ++ HP
Sbjct: 29  VGRGTYGHVYKAKRK---DGKDDKDYALKQIEGTGIS-------MSACREIALLRELKHP 78

Query: 176 FIVQLR--YSFQTRSKLYLILDF--------INGGHLFFHLYRQGIFREDQARFYTAEIV 225
            ++ L+  +      K++L+ D+        I          +         +    +I+
Sbjct: 79  NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSD----GHVMLTDFGLAKEIDESSRSNSMCGTTE-- 279
             + +LH   ++HRDLKP NIL+  +    G V + D G A+  +   +  +        
Sbjct: 139 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD-LDPVVV 197

Query: 280 ---YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
              Y APE+LL ++ + K  D W++G +  E+LT +
Sbjct: 198 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  107 bits (268), Expect = 4e-26
 Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 44/222 (19%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA---ERDI 168
           +E+ +V+G+G+FG+V +       D       A+K++R       N   + +    E  I
Sbjct: 99  YEVLKVIGKGSFGQVVKAY-----DHKVHQHVALKMVR-------NEKRFHRQAAEEIRI 146

Query: 169 LTKV-------THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFR---EDQAR 218
           L  +       T   ++ +  +F  R+ + +   F       + L ++  F+       R
Sbjct: 147 LEHLRKQDKDNTM-NVIHMLENFTFRNHICMT--FELLSMNLYELIKKNKFQGFSLPLVR 203

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--VMLTDFGLAKEIDE------SSR 270
            +   I+  +  LHK  I+H DLKPENIL+   G   + + DFG +    +       SR
Sbjct: 204 KFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSR 263

Query: 271 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
                    Y APE++L   +    D WS+G +L E+LTG  
Sbjct: 264 F--------YRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  105 bits (264), Expect = 8e-26
 Identities = 56/243 (23%), Positives = 101/243 (41%), Gaps = 55/243 (22%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           + + + +G G+FG V +V      D +S   +A+K   K     +    Y   E DI+  
Sbjct: 9   YSLGKTLGTGSFGIVCEVF-----DIESGKRFALK---KVLQDPR----YKNRELDIMKV 56

Query: 172 VTHPFIVQLRYSFQTRSK--------------------------------------LYLI 193
           + H  I++L   F T                                         L +I
Sbjct: 57  LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116

Query: 194 LDFINGG-HLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
           ++++    H     + +       +    Y  ++  AV  +H  GI HRD+KP+N+L++S
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176

Query: 251 DGHVM-LTDFGLAKEIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEML 308
             + + L DFG AK++  S  S +   +  Y APE++L +  +    D WS+G +  E++
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236

Query: 309 TGQ 311
            G+
Sbjct: 237 LGK 239

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  105 bits (263), Expect = 1e-25
 Identities = 52/224 (23%), Positives = 91/224 (40%), Gaps = 32/224 (14%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-------IYAMKVMRKDTIIKKNHVDY 161
              + + R +  G++G V           DS+G       ++      +   I  +    
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGV-------DSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73

Query: 162 MKAERDI--LTKVTHPFIVQLR-----YSFQTRSKLYLILDFINGGHLFFHLYR-----Q 209
            +  R+I  L    HP I+ LR     +      KLYL+ + +        L +     +
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-----TDLAQVIHDQR 128

Query: 210 GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS 269
            +      +++   I+  +  LH+ G+VHRDL P NIL+  +  + + DF LA+E    +
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA 188

Query: 270 RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQV 312
                     Y APE+++  KG  K  D WS G ++ EM   + 
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  106 bits (265), Expect = 1e-25
 Identities = 54/212 (25%), Positives = 99/212 (46%), Gaps = 19/212 (8%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
              ++  + +G GA G V         D   D   A+K   K +   +N     +A R++
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAY-----DAVLDRNVAIK---KLSRPFQNQTHAKRAYREL 112

Query: 169 --LTKVTHPFIVQLR------YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
             +  V H  I+ L        + +    +YL+++ +        + +  +   ++  + 
Sbjct: 113 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQMEL-DHERMSYL 169

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
             +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+    S        T  Y
Sbjct: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 229

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            APE++L  G+ ++ D WSVG ++ EM+  ++
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  102 bits (256), Expect = 5e-25
 Identities = 49/209 (23%), Positives = 95/209 (45%), Gaps = 23/209 (11%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
             D+++ R +G+G + +VF+       +  ++    +K+++         V   K +R+I
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAI-----NITNNEKVVVKILKP--------VKKKKIKREI 81

Query: 169 --LTKVT-HPFIVQLRYSFQTRS--KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
             L  +   P I+ L    +        L+ + +N          Q    +   RFY  E
Sbjct: 82  KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF--KQLYQ-TLTDYDIRFYMYE 138

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCGTTEYMA 282
           I+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    +  +  
Sbjct: 139 ILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 198

Query: 283 PEILL-SKGHNKDADWWSVGILLYEMLTG 310
           PE+L+  + ++   D WS+G +L  M+  
Sbjct: 199 PELLVDYQMYDYSLDMWSLGCMLASMIFR 227

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  102 bits (257), Expect = 6e-25
 Identities = 53/235 (22%), Positives = 91/235 (38%), Gaps = 56/235 (23%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA---ERDI 168
           + + R +G G F  V+  K     D  ++   AMK++R           Y +A   E  +
Sbjct: 21  YILVRKLGWGHFSTVWLAK-----DMVNNTHVAMKIVR-------GDKVYTEAAEDEIKL 68

Query: 169 LTKVT-----------HPFIVQLRYSFQTRSKLYLILDFINGGHL-------------FF 204
           L +V               I++L   F  +          NG H+               
Sbjct: 69  LQRVNDADNTKEDSMGANHILKLLDHFNHKGP--------NGVHVVMVFEVLGENLLALI 120

Query: 205 HLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMD------SDGHVMLT 257
             Y          +  + +++  + ++H+ CGI+H D+KPEN+LM+      +   + + 
Sbjct: 121 KKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIA 180

Query: 258 DFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
           D G A          +   T EY +PE+LL       AD WS   L++E++TG  
Sbjct: 181 DLGNA--CWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  101 bits (255), Expect = 7e-25
 Identities = 58/227 (25%), Positives = 109/227 (48%), Gaps = 18/227 (7%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGV--DDGDSDGIY-AMKVMRKDTIIKKNHVDY 161
           R +   +F+  +V+G GAFG V+    KG+   +G+   I  A+K +R+ T   K + + 
Sbjct: 10  RILKETEFKKIKVLGSGAFGTVY----KGLWIPEGEKVKIPVAIKELREATS-PKANKEI 64

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFY 220
           +  E  ++  V +P + +L       S + LI   +  G L  ++   +          +
Sbjct: 65  LD-EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 122

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--- 277
             +I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G    
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQV---NIKSMQVI 320
            ++MA E +L + +   +D WS G+ ++E++T G      I + ++ 
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  104 bits (261), Expect = 9e-25
 Identities = 54/247 (21%), Positives = 111/247 (44%), Gaps = 12/247 (4%)

Query: 68  SHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVF 127
           ++   G        S      + ++ E+   + +  + +I     E+ R +G+G FG V 
Sbjct: 348 NNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVH 407

Query: 128 QVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185
               +G+     +     A+K  +  T        +++ E   + +  HP IV+L     
Sbjct: 408 ----QGIYMSPENPAMAVAIKTCKNCTS-DSVREKFLQ-EALTMRQFDHPHIVKL-IGVI 460

Query: 186 TRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPE 244
           T + +++I++    G L   L  R+          Y  ++ +A+++L     VHRD+   
Sbjct: 461 TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAAR 520

Query: 245 NILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGI 302
           N+L+ S+  V L DFGL++ +++S+   +  G    ++MAPE +  +     +D W  G+
Sbjct: 521 NVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGV 580

Query: 303 LLYEMLT 309
            ++E+L 
Sbjct: 581 CMWEILM 587

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  101 bits (254), Expect = 1e-24
 Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 34/226 (15%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
              +   + +G G  G VF        D D D   A+K   K  I+  +      A R+I
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAV-----DNDCDKRVAIK---K--IVLTDPQSVKHALREI 59

Query: 169 --LTKVTHPFIVQL----RYSFQTRSKLYLILDFINGGHLFFHLY--------RQGIFRE 214
             + ++ H  IV++      S    +     L  +N  ++              QG   E
Sbjct: 60  KIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLE 119

Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKEIDESSRSNS 273
           + AR +  +++  + ++H   ++HRDLKP N+ +++ D  + + DFGLA+ +D       
Sbjct: 120 EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179

Query: 274 MCGTTEYM------APEILLS-KGHNKDADWWSVGILLYEMLTGQV 312
               +E +      +P +LLS   + K  D W+ G +  EMLTG+ 
Sbjct: 180 H--LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  100 bits (252), Expect = 1e-24
 Identities = 56/220 (25%), Positives = 104/220 (47%), Gaps = 19/220 (8%)

Query: 101 AESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD 160
                +      +  + +G+G FG V   +   + D   + + A+K ++  T  +++  D
Sbjct: 1   GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVV-AVKKLQHST--EEHLRD 57

Query: 161 YMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQ 216
           + + E +IL  + H  IV+ +   YS   R+ L LI++++  G L  +L + +      +
Sbjct: 58  FER-EIEILKSLQHDNIVKYKGVCYSAGRRN-LKLIMEYLPYGSLRDYLQKHKERIDHIK 115

Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
              YT++I   + +L     +HRDL   NIL++++  V + DFGL K + +      +  
Sbjct: 116 LLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE 175

Query: 277 TTEY----MAPEILLSKGHNK---DADWWSVGILLYEMLT 309
             E      APE L     +K    +D WS G++LYE+ T
Sbjct: 176 PGESPIFWYAPESLT---ESKFSVASDVWSFGVVLYELFT 212

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  101 bits (253), Expect = 1e-24
 Identities = 57/244 (23%), Positives = 109/244 (44%), Gaps = 19/244 (7%)

Query: 77  RYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDD 136
            +        +    +    +  E     +      +  + +G+G FG V   +   + D
Sbjct: 8   HHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQD 67

Query: 137 GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLI 193
              + + A+K ++  T  +++  D+ + E +IL  + H  IV+ +   YS   R+ L LI
Sbjct: 68  NTGEVV-AVKKLQHST--EEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRN-LKLI 122

Query: 194 LDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           ++++  G L  +L + +      +   YT++I   + +L     +HRDL   NIL++++ 
Sbjct: 123 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN 182

Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEY----MAPEILLSKGHNK---DADWWSVGILLY 305
            V + DFGL K + +      +    E      APE L     +K    +D WS G++LY
Sbjct: 183 RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT---ESKFSVASDVWSFGVVLY 239

Query: 306 EMLT 309
           E+ T
Sbjct: 240 ELFT 243

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  101 bits (254), Expect = 2e-24
 Identities = 57/229 (24%), Positives = 104/229 (45%), Gaps = 42/229 (18%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-----NHVDYMK 163
             DF++  ++G+GA+G V            +  I A         IKK       +  ++
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSAT-----HKPTGEIVA---------IKKIEPFDKPLFALR 55

Query: 164 AERDI--LTKVTHPFIVQLRYSFQTRSK-----LYLILDFINGG-HLFFHLYRQGIFRED 215
             R+I  L    H  I+ +    +  S      +Y+I + +    H    +    +  +D
Sbjct: 56  TLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLH---RVISTQMLSDD 112

Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMC 275
             +++  + + AV  LH   ++HRDLKP N+L++S+  + + DFGLA+ IDES+  NS  
Sbjct: 113 HIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172

Query: 276 GT-----TEYM------APEILLS-KGHNKDADWWSVGILLYEMLTGQV 312
                   E++      APE++L+   +++  D WS G +L E+   + 
Sbjct: 173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  100 bits (251), Expect = 5e-24
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 19/212 (8%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
              ++  + +G GA G V         D   +   A+K   K +   +N     +A R++
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAY-----DAILERNVAIK---KLSRPFQNQTHAKRAYREL 75

Query: 169 --LTKVTHPFIVQLR------YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
             +  V H  I+ L        S +    +Y++++ +        + +  +   ++  + 
Sbjct: 76  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM--DANLCQVIQMEL-DHERMSYL 132

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
             +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+    S        T  Y
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 192

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQV 312
            APE++L  G+ ++ D WSVG ++ EM+ G V
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  100 bits (250), Expect = 5e-24
 Identities = 53/236 (22%), Positives = 88/236 (37%), Gaps = 54/236 (22%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA---ERDI 168
           +EI   +G+GAFGKV +      D        A+K+++       N   Y +A   E  +
Sbjct: 16  YEIVDTLGEGAFGKVVECI----DHKAGGRHVAVKIVK-------NVDRYCEAARSEIQV 64

Query: 169 LTKV--------THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-------RQGIFR 213
           L  +             VQ+   F+    + ++ +      L    Y           FR
Sbjct: 65  LEHLNTTDPNSTFR--CVQMLEWFEHHGHICIVFEL-----LGLSTYDFIKENGFLP-FR 116

Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN- 272
            D  R    +I  +V+ LH   + H DLKPENIL     +    +  + ++       + 
Sbjct: 117 LDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176

Query: 273 ------SMCGTTEYM----------APEILLSKGHNKDADWWSVGILLYEMLTGQV 312
                 S     E+           APE++L+ G ++  D WS+G +L E   G  
Sbjct: 177 KVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFT 232

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  100 bits (250), Expect = 5e-24
 Identities = 52/242 (21%), Positives = 85/242 (35%), Gaps = 66/242 (27%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA---ERDI 168
           +EI   +G+G FGKV +      D        A+K++R       N   Y +A   E ++
Sbjct: 21  YEIVGNLGEGTFGKVVECL----DHARGKSQVALKIIR-------NVGKYREAARLEINV 69

Query: 169 LTKV--------THPFIVQLRYSFQTRSKLYLILDFINGGHLF----------FHLYRQG 210
           L K+             V +   F               GH+           F   ++ 
Sbjct: 70  LKKIKEKDKENKFL--CVLMSDWFNFH------------GHMCIAFELLGKNTFEFLKEN 115

Query: 211 IFR---EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE 267
            F+       R    ++  A+  LH+  + H DLKPENIL  +     L +   + E   
Sbjct: 116 NFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175

Query: 268 SSRSN-------SMCGTTEYM----------APEILLSKGHNKDADWWSVGILLYEMLTG 310
              ++       S     E+            PE++L  G  +  D WS+G +L+E   G
Sbjct: 176 VKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235

Query: 311 QV 312
             
Sbjct: 236 FT 237

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 98.1 bits (245), Expect = 9e-24
 Identities = 53/231 (22%), Positives = 93/231 (40%), Gaps = 22/231 (9%)

Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDY 161
              IG  D  +   +G G+FG V     +G  D  S      A+K ++ D + +   +D 
Sbjct: 12  TCLIGEKDLRLLEKLGDGSFGVVR----RGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD 67

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFY 220
              E + +  + H  +++L Y       + ++ +    G L   L   QG F       Y
Sbjct: 68  FIREVNAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY 126

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
             ++   + +L     +HRDL   N+L+ +   V + DFGL + + ++     M    + 
Sbjct: 127 AVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186

Query: 281 ----MAPEILLSKGHNK---DADWWSVGILLYEMLT-GQV---NIKSMQVI 320
                APE L           +D W  G+ L+EM T GQ     +   Q++
Sbjct: 187 PFAWCAPESLK---TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL 234

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 99.3 bits (248), Expect = 1e-23
 Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 35/220 (15%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
              +   + VG GA+G V         DG +    A+K   K     ++ +   +A R++
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAV-----DGRTGAKVAIK---KLYRPFQSELFAKRAYREL 75

Query: 169 --LTKVTHPFIVQLR------YSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARF 219
             L  + H  ++ L        +    +  YL++ F+         L +     ED+ +F
Sbjct: 76  RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLG---KLMKHEKLGEDRIQF 132

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
              +++  + ++H  GI+HRDLKP N+ ++ D  + + DFGLA++ D     + M   T 
Sbjct: 133 LVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD-----SEM---TG 184

Query: 280 YM------APEILLS-KGHNKDADWWSVGILLYEMLTGQV 312
           Y+      APE++L+   + +  D WSVG ++ EM+TG+ 
Sbjct: 185 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 98.6 bits (246), Expect = 1e-23
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY---AMKVMRKDTIIKKNHVDYMKAERD 167
             +  R +G+G FGKV         D  +DG     A+K ++ D    ++   + + E D
Sbjct: 32  YLKKIRDLGEGHFGKVS----LYCYDPTNDGTGEMVAVKALKADAG-PQHRSGWKQ-EID 85

Query: 168 ILTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
           IL  + H  I++ +        + L L+++++  G L  +L R  I       F   +I 
Sbjct: 86  ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF-AQQIC 144

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY----M 281
             +++LH    +HRDL   N+L+D+D  V + DFGLAK + E      +    +      
Sbjct: 145 EGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 204

Query: 282 APEILLSKGHNK---DADWWSVGILLYEMLT 309
           APE L      K    +D WS G+ LYE+LT
Sbjct: 205 APECLK---EYKFYYASDVWSFGVTLYELLT 232

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 97.7 bits (244), Expect = 1e-23
 Identities = 46/241 (19%), Positives = 95/241 (39%), Gaps = 38/241 (15%)

Query: 101 AESERKIGPGDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIY-AMKVMRKDTIIKKNH 158
              E  +      +  + +G G FG V     KG           A+K+++ +       
Sbjct: 7   RPKEVYLDRKLLTLEDKELGSGNFGTVK----KGYYQMKKVVKTVAVKILKNEANDPALK 62

Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
            + +  E +++ ++ +P+IV++           L+++    G L  +L +    ++    
Sbjct: 63  DELLA-EANVMQQLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNII 120

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
               ++   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +             
Sbjct: 121 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--------N 172

Query: 279 EY------------MAPEILLSKGHNK---DADWWSVGILLYEMLT-GQV---NIKSMQV 319
            Y             APE +    + K    +D WS G+L++E  + GQ     +K  +V
Sbjct: 173 YYKAQTHGKWPVKWYAPECIN---YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 229

Query: 320 I 320
            
Sbjct: 230 T 230

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 98.9 bits (247), Expect = 1e-23
 Identities = 55/224 (24%), Positives = 97/224 (43%), Gaps = 39/224 (17%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-----NHVDYMK 163
              +     +G+GA+G V         D  +    A         IKK     +     +
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAY-----DNLNKVRVA---------IKKISPFEHQTYCQR 71

Query: 164 AERDI--LTKVTHPFIVQLRYSFQTRSK-----LYLILDFINGG-HLFFHLYRQGIFRED 215
             R+I  L +  H  I+ +    +  +      +Y++ D +    +    L +      D
Sbjct: 72  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY---KLLKTQHLSND 128

Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMC 275
              ++  +I+  + ++H   ++HRDLKP N+L+++   + + DFGLA+  D         
Sbjct: 129 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF- 187

Query: 276 GTTEYM------APEILLS-KGHNKDADWWSVGILLYEMLTGQV 312
             TEY+      APEI+L+ KG+ K  D WSVG +L EML+ + 
Sbjct: 188 -LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 98.5 bits (246), Expect = 2e-23
 Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 34/219 (15%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           P  +     VG GA+G V         D  S    A+K   K +   ++ +   +A R++
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAI-----DKRSGEKVAIK---KLSRPFQSEIFAKRAYREL 74

Query: 169 --LTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQARFY 220
             L  + H  ++ L   F   S        YL++ F+    L         F E++ ++ 
Sbjct: 75  LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDL--QKIMGLKFSEEKIQYL 131

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
             +++  + ++H  G+VHRDLKP N+ ++ D  + + DFGLA+  D           T Y
Sbjct: 132 VYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM--------TGY 183

Query: 281 M------APEILLS-KGHNKDADWWSVGILLYEMLTGQV 312
           +      APE++LS   +N+  D WSVG ++ EMLTG+ 
Sbjct: 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 98.2 bits (245), Expect = 3e-23
 Identities = 59/249 (23%), Positives = 109/249 (43%), Gaps = 57/249 (22%)

Query: 95  NDAELEAESERKIGPGD-----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR 149
           ND   +   +  +  G+     +EI  ++G+G+FG+V +       D       A+K+++
Sbjct: 34  NDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAY-----DRVEQEWVAIKIIK 88

Query: 150 KDTIIKKNHVDYMKA---ERDILTKVTHP------FIVQLRYSFQTRSKLYLILDFINGG 200
                  N   ++     E  +L  +         +IV L+  F  R+ L L+ +     
Sbjct: 89  -------NKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE----- 136

Query: 201 HLFFHLY-------RQGIFREDQARFYTAEIVSAVSHLH--KCGIVHRDLKPENILMDSD 251
            L ++LY        +G    +  R +  ++ +A+  L   +  I+H DLKPENIL+ + 
Sbjct: 137 MLSYNLYDLLRNTNFRG-VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNP 195

Query: 252 GH--VMLTDFGLAKEIDE------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
               + + DFG + ++ +       SR         Y +PE+LL   ++   D WS+G +
Sbjct: 196 KRSAIKIVDFGSSCQLGQRIYQYIQSRF--------YRSPEVLLGMPYDLAIDMWSLGCI 247

Query: 304 LYEMLTGQV 312
           L EM TG+ 
Sbjct: 248 LVEMHTGEP 256

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 97.4 bits (243), Expect = 3e-23
 Identities = 56/212 (26%), Positives = 104/212 (49%), Gaps = 14/212 (6%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGV--DDGDSDGIY-AMKVMRKDTIIKKNHVDY 161
           R +   +F+  +V+G GAFG V+    KG+   +G+   I  A+K +R+ T   K + + 
Sbjct: 10  RILKETEFKKIKVLGSGAFGTVY----KGLWIPEGEKVKIPVAIKELREATS-PKANKEI 64

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFY 220
           +  E  ++  V +P + +L       S + LI   +  G L  ++   +          +
Sbjct: 65  LD-EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 122

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--- 277
             +I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G    
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            ++MA E +L + +   +D WS G+ ++E++T
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 96.5 bits (241), Expect = 3e-23
 Identities = 51/221 (23%), Positives = 96/221 (43%), Gaps = 32/221 (14%)

Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDY 161
           + +I     E+ R +G+G FG V     +G+     +     A+K  +  T        +
Sbjct: 9   DYEIQRERIELGRCIGEGQFGDVH----QGIYMSPENPALAVAIKTCKNCTS-DSVREKF 63

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFY 220
           ++ E   + +  HP IV+L     T + +++I++    G L   L  R+          Y
Sbjct: 64  LQ-EALTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILY 121

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
             ++ +A+++L     VHRD+   N+L+ S+  V L DFGL++ +++S           Y
Sbjct: 122 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS----------TY 171

Query: 281 ------------MAPEILLSKGHNKDADWWSVGILLYEMLT 309
                       MAPE +  +     +D W  G+ ++E+L 
Sbjct: 172 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 212

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 96.4 bits (240), Expect = 4e-23
 Identities = 28/203 (13%), Positives = 63/203 (31%), Gaps = 33/203 (16%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G + +    G     + +Q       D   D   A+  +    ++  + +    +    L
Sbjct: 31  GRYRLLIFHGGVPPLQFWQAL-----DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRL 85

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           +++  P + ++     TR+   ++ ++I GG L   +          A      + +A  
Sbjct: 86  SRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQ-EVADTSP-SPVGAIRAMQSLAAAAD 143

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
             H+ G+      P  + +  DG V+L       + +                       
Sbjct: 144 AAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMPDANPQD-------------------- 183

Query: 290 GHNKDADWWSVGILLYEMLTGQV 312
                 D   +G  LY +L  + 
Sbjct: 184 ------DIRGIGASLYALLVNRW 200

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 96.6 bits (241), Expect = 4e-23
 Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 22/212 (10%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY---AMKVMRKDTIIKKNHVDYMKAERD 167
             +  R +G+G FGKV         D + D      A+K ++ ++    +  D  K E +
Sbjct: 22  FLKRIRDLGEGHFGKVE----LCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKK-EIE 75

Query: 168 ILTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEI 224
           IL  + H  IV+ +   +    + + LI++F+  G L  +L + +      Q   Y  +I
Sbjct: 76  ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY---- 280
              + +L     VHRDL   N+L++S+  V + DFGL K I+      ++    +     
Sbjct: 136 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFW 195

Query: 281 MAPEILLSKGHNK---DADWWSVGILLYEMLT 309
            APE L+    +K    +D WS G+ L+E+LT
Sbjct: 196 YAPECLM---QSKFYIASDVWSFGVTLHELLT 224

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 96.6 bits (241), Expect = 6e-23
 Identities = 63/240 (26%), Positives = 100/240 (41%), Gaps = 42/240 (17%)

Query: 93  HENDAELEAESERK-IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY---AMKVM 148
           H + A+L A  +         +    +G+G FG V         D   D      A+K +
Sbjct: 5   HHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVE----LCRYDPLGDNTGALVAVKQL 60

Query: 149 RKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFINGGHLFFH 205
           +     ++   D+ + E  IL  +   FIV+ R   Y    +S L L+++++  G L   
Sbjct: 61  QHSGPDQQR--DFQR-EIQILKALHSDFIVKYRGVSYGPGRQS-LRLVMEYLPSGCLRDF 116

Query: 206 LYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE 264
           L R +      +   Y+++I   + +L     VHRDL   NIL++S+ HV + DFGLAK 
Sbjct: 117 LQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 176

Query: 265 IDESSRSNSMCGTTEY------------MAPEILLSKGHNK---DADWWSVGILLYEMLT 309
           +              Y             APE L     N     +D WS G++LYE+ T
Sbjct: 177 LPLDK--------DYYVVREPGQSPIFWYAPESLS---DNIFSRQSDVWSFGVVLYELFT 225

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 98.0 bits (244), Expect = 7e-23
 Identities = 64/298 (21%), Positives = 115/298 (38%), Gaps = 55/298 (18%)

Query: 50  SPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGP 109
           S  + +A   +    H  S S      R    SS P           +     S+ +I  
Sbjct: 3   SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTA---------SMPRPHSDWQIPD 53

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI- 168
             +EI  ++G G++G V +       D     + A+K   K   + ++ +D  +  R+I 
Sbjct: 54  -RYEIRHLIGTGSYGHVCEAY-----DKLEKRVVAIK---KILRVFEDLIDCKRILREIA 104

Query: 169 -LTKVTHPFIVQLR-----YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
            L ++ H  +V++         +   +LY++L+                  E   +    
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLY 163

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT----- 277
            ++  V ++H  GI+HRDLKP N L++ D  V + DFGLA+ +D     NS         
Sbjct: 164 NLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223

Query: 278 -----------------TEYM------APEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
                            T ++      APE++L  + + +  D WS+G +  E+L   
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 96.2 bits (240), Expect = 9e-23
 Identities = 56/259 (21%), Positives = 104/259 (40%), Gaps = 23/259 (8%)

Query: 64  IHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEA--ESERKIGPGDFEIFRVVGQG 121
           +H+  H   G    Y        Q     H  +    A     R+I      I +++G G
Sbjct: 1   MHHHHHHSSGRENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSG 60

Query: 122 AFGKVFQVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQ 179
             G+V      G            A+K ++     ++   D++  E  I+ +  HP I++
Sbjct: 61  DSGEVC----YGRLRVPGQRDVPVAIKALKAGYT-ERQRRDFLS-EASIMGQFDHPNIIR 114

Query: 180 LRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
           L     TR +   ++ +++  G L   L    G F   Q       + + + +L   G V
Sbjct: 115 L-EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYV 173

Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY----MAPEILLSKGHNK 293
           HRDL   N+L+DS+    ++DFGL++ +++   +       +      APE +       
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA---FRT 230

Query: 294 ---DADWWSVGILLYEMLT 309
               +D WS G++++E+L 
Sbjct: 231 FSSASDVWSFGVVMWEVLA 249

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 95.9 bits (239), Expect = 1e-22
 Identities = 50/212 (23%), Positives = 92/212 (43%), Gaps = 14/212 (6%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGV--DDGDSDGIY-AMKVMRKDTIIKKNHVDY 161
           R     +    +V+G G FG V     KGV   +G+S  I   +KV+   +  +++    
Sbjct: 8   RIFKETELRKLKVLGSGVFGTVH----KGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAV 62

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFY 220
                  +  + H  IV+L       S L L+  ++  G L  H+   +G         +
Sbjct: 63  TD-HMLAIGSLDHAHIVRL-LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW 120

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--- 277
             +I   + +L + G+VHR+L   N+L+ S   V + DFG+A  +    +          
Sbjct: 121 GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            ++MA E +    +   +D WS G+ ++E++T
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 97.5 bits (243), Expect = 1e-22
 Identities = 59/259 (22%), Positives = 113/259 (43%), Gaps = 35/259 (13%)

Query: 61  PQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQ 120
            Q++   S    G   R  L++  P    + +       E      I      +   +GQ
Sbjct: 143 QQLVAYYSKHADGLCHR--LTTVCPTSKPQTQGLAKDAWE------IPRESLRLEVKLGQ 194

Query: 121 GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL 180
           G FG+V+     G          A+K ++  T+  +    +++ E  ++ K+ H  +VQL
Sbjct: 195 GCFGEVWMGTWNGTTR------VAIKTLKPGTMSPE---AFLQ-EAQVMKKLRHEKLVQL 244

Query: 181 RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT--------AEIVSAVSHLH 232
            Y+  +   +Y++ ++++ G L   L      + +  ++          A+I S ++++ 
Sbjct: 245 -YAVVSEEPIYIVTEYMSKGSLLDFL------KGETGKYLRLPQLVDMAAQIASGMAYVE 297

Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEILLSKG 290
           +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++ APE  L   
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357

Query: 291 HNKDADWWSVGILLYEMLT 309
               +D WS GILL E+ T
Sbjct: 358 FTIKSDVWSFGILLTELTT 376

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 96.2 bits (240), Expect = 1e-22
 Identities = 55/219 (25%), Positives = 102/219 (46%), Gaps = 33/219 (15%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           P  ++    VG GA+G V         D  +    A+K   K +   ++ +   +  R++
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAF-----DTKTGLRVAVK---KLSRPFQSIIHAKRTYREL 79

Query: 169 --LTKVTHPFIVQLR------YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
             L  + H  ++ L        S +  + +YL+   +  G    ++ +     +D  +F 
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 137

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
             +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+        + M   T Y
Sbjct: 138 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA-----DEM---TGY 189

Query: 281 M------APEILLS-KGHNKDADWWSVGILLYEMLTGQV 312
           +      APEI+L+   +N+  D WSVG ++ E+LTG+ 
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 97.3 bits (242), Expect = 2e-22
 Identities = 59/259 (22%), Positives = 113/259 (43%), Gaps = 35/259 (13%)

Query: 61  PQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQ 120
            Q++   S    G   R  L++  P    + +       E      I      +   +GQ
Sbjct: 226 QQLVAYYSKHADGLCHR--LTTVCPTSKPQTQGLAKDAWE------IPRESLRLEVKLGQ 277

Query: 121 GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL 180
           G FG+V+     G          A+K ++  T+  +    +++ E  ++ K+ H  +VQL
Sbjct: 278 GCFGEVWMGTWNGTTR------VAIKTLKPGTMSPE---AFLQ-EAQVMKKLRHEKLVQL 327

Query: 181 RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT--------AEIVSAVSHLH 232
            Y+  +   +Y++ ++++ G L   L      + +  ++          A+I S ++++ 
Sbjct: 328 -YAVVSEEPIYIVTEYMSKGSLLDFL------KGETGKYLRLPQLVDMAAQIASGMAYVE 380

Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEILLSKG 290
           +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++ APE  L   
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 440

Query: 291 HNKDADWWSVGILLYEMLT 309
               +D WS GILL E+ T
Sbjct: 441 FTIKSDVWSFGILLTELTT 459

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 95.5 bits (238), Expect = 2e-22
 Identities = 65/249 (26%), Positives = 98/249 (39%), Gaps = 76/249 (30%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA---ERDI 168
           F + R +G G FG+V   +       D+   YA+KV+R       N   Y ++   E DI
Sbjct: 37  FLVIRKMGDGTFGRVLLCQ-----HIDNKKYYAVKVVR-------NIKKYTRSAKIEADI 84

Query: 169 LTKV-------THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-------RQGIFRE 214
           L K+        +  IV+    F     + LI +      L   LY         G F  
Sbjct: 85  LKKIQNDDINNNN--IVKYHGKFMYYDHMCLIFEP-----LGPSLYEIITRNNYNG-FHI 136

Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT----------------- 257
           +  + Y  EI+ A+++L K  + H DLKPENIL+D                         
Sbjct: 137 EDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196

Query: 258 --------DFGLAKEIDE------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
                   DFG A    +      ++R         Y APE++L+ G +  +D WS G +
Sbjct: 197 KSTGIKLIDFGCATFKSDYHGSIINTRQ--------YRAPEVILNLGWDVSSDMWSFGCV 248

Query: 304 LYEMLTGQV 312
           L E+ TG +
Sbjct: 249 LAELYTGSL 257

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 93.8 bits (234), Expect = 3e-22
 Identities = 61/267 (22%), Positives = 109/267 (40%), Gaps = 52/267 (19%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDYMKA 164
           I   D  + R++G+G FG+V+    +GV           A+K  +KD     N   +M  
Sbjct: 9   IAREDVVLNRILGEGFFGEVY----EGVYTNHKGEKINVAVKTCKKDCT-LDNKEKFMS- 62

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAE 223
           E  I+  + HP IV+L          ++I++    G L  +L   +   +      Y+ +
Sbjct: 63  EAVIMKNLDHPHIVKL-IGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ 121

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY--- 280
           I  A+++L     VHRD+   NIL+ S   V L DFGL++ I++           +Y   
Sbjct: 122 ICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE----------DYYKA 171

Query: 281 ---------MAPEILLSKGHNKDADWWSVGILLYEMLT-GQV---NIKSMQVIACNTMLL 327
                    M+PE +  +     +D W   + ++E+L+ G+     +++  VI       
Sbjct: 172 SVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG------ 225

Query: 328 FYLIIFHCLFVNSLELLSHFPENCPAS 354
                     +   + L   P+ CP  
Sbjct: 226 ---------VLEKGDRLPK-PDLCPPV 242

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 93.4 bits (233), Expect = 3e-22
 Identities = 46/210 (21%), Positives = 104/210 (49%), Gaps = 21/210 (10%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I P +    + +G G FG V        D        A+K +R+  + ++   D+++ E 
Sbjct: 5   IDPSELTFVQEIGSGQFGLVHLGYWLNKDK------VAIKTIREGAMSEE---DFIE-EA 54

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEI 224
           +++ K++HP +VQL Y        + L+ +F+  G L  +L  ++G+F  +       ++
Sbjct: 55  EVMMKLSHPKLVQL-YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 113

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMA 282
              +++L +  ++HRDL   N L+  +  + ++DFG+ + + +   ++S       ++ +
Sbjct: 114 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS 173

Query: 283 PEILLSKGHNK---DADWWSVGILLYEMLT 309
           PE+      ++    +D WS G+L++E+ +
Sbjct: 174 PEVFS---FSRYSSKSDVWSFGVLMWEVFS 200

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 94.3 bits (235), Expect = 4e-22
 Identities = 55/224 (24%), Positives = 103/224 (45%), Gaps = 30/224 (13%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGV---DDGDSDGIYAMKVMRKDTIIKKNH 158
           +   +I P      +V+G G FG+V+    KG+     G  +   A+K ++     +K  
Sbjct: 36  KFTTEIHPSCVTRQKVIGAGEFGEVY----KGMLKTSSGKKEVPVAIKTLKAGYT-EKQR 90

Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQ 216
           VD++  E  I+ + +H  I++L     ++ K + +I +++  G L   L  + G F   Q
Sbjct: 91  VDFLG-EAGIMGQFSHHNIIRL-EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQ 148

Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
                  I + + +L     VHRDL   NIL++S+    ++DFGL++ +++         
Sbjct: 149 LVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE------ 202

Query: 277 TTEY-----------MAPEILLSKGHNKDADWWSVGILLYEMLT 309
              Y            APE +  +     +D WS GI+++E++T
Sbjct: 203 -ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 94.7 bits (236), Expect = 5e-22
 Identities = 55/222 (24%), Positives = 104/222 (46%), Gaps = 11/222 (4%)

Query: 94  ENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI 153
           E+  +   E  +++   +  I +VVG G FG+V   + K     +     A+K ++    
Sbjct: 29  EDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEIS--VAIKTLKVGYT 86

Query: 154 IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGI 211
            +K   D++  E  I+ +  HP I++L     T+SK + ++ +++  G L   L      
Sbjct: 87  -EKQRRDFLG-EASIMGQFDHPNIIRL-EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ 143

Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS 271
           F   Q       I S + +L   G VHRDL   NIL++S+    ++DFGL + +++   +
Sbjct: 144 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA 203

Query: 272 NSMCGTTEY----MAPEILLSKGHNKDADWWSVGILLYEMLT 309
                  +      +PE +  +     +D WS GI+L+E+++
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 94.6 bits (236), Expect = 7e-22
 Identities = 50/209 (23%), Positives = 94/209 (44%), Gaps = 15/209 (7%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +   D  +   +G+G FG+VF     G    D+  + A+K  R+          +++ E 
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVF----SGRLRADNTLV-AVKSCRETLP-PDLKAKFLQ-EA 163

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEI 224
            IL + +HP IV+L     T+ + +Y++++ + GG     L       R         + 
Sbjct: 164 RILKQYSHPNIVRL-IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDA 222

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY---- 280
            + + +L     +HRDL   N L+     + ++DFG+++E  +     +  G  +     
Sbjct: 223 AAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV-YAASGGLRQVPVKW 281

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT 309
            APE L    ++ ++D WS GILL+E  +
Sbjct: 282 TAPEALNYGRYSSESDVWSFGILLWETFS 310

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 94.8 bits (236), Expect = 9e-22
 Identities = 47/213 (22%), Positives = 98/213 (46%), Gaps = 15/213 (7%)

Query: 101 AESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD 160
            +   +I     ++ + +G G FG+V+                A+K M+  ++  +    
Sbjct: 179 EKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTK------VAVKTMKPGSMSVE---A 229

Query: 161 YMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQAR 218
           ++  E +++  + H  +V+L ++  T+  +Y+I +F+  G L  F            +  
Sbjct: 230 FLA-EANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI 287

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCG 276
            ++A+I   ++ + +   +HRDL+  NIL+ +     + DFGLA+ I+++          
Sbjct: 288 DFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF 347

Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             ++ APE +        +D WS GILL E++T
Sbjct: 348 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 93.0 bits (232), Expect = 9e-22
 Identities = 54/216 (25%), Positives = 97/216 (44%), Gaps = 29/216 (13%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN--HVDYMKAERDILTKVTH 174
            +G+G FG V+    KG  +       A+K +     I        +   E  ++ K  H
Sbjct: 38  KMGEGGFGVVY----KGYVNN---TTVAVKKLAAMVDITTEELKQQF-DQEIKVMAKCQH 89

Query: 175 PFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA------RFYTAE-IVS 226
             +V+L  +S        L+  ++  G L   L       +         R   A+   +
Sbjct: 90  ENLVELLGFSSDGDDLC-LVYVYMPNGSLLDRLSC----LDGTPPLSWHMRCKIAQGAAN 144

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAP 283
            ++ LH+   +HRD+K  NIL+D      ++DFGLA+  ++ ++   ++ + GTT YMAP
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAP 204

Query: 284 EILLSKGH-NKDADWWSVGILLYEMLTGQVNIKSMQ 318
           E L  +G     +D +S G++L E++TG   +   +
Sbjct: 205 EAL--RGEITPKSDIYSFGVVLLEIITGLPAVDEHR 238

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 94.4 bits (235), Expect = 1e-21
 Identities = 53/235 (22%), Positives = 103/235 (43%), Gaps = 40/235 (17%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           P ++ I  ++G+G++G V+        D +++   A+K   K   + ++ +D  +  R+I
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAY-----DKNTEKNVAIK---KVNRMFEDLIDCKRILREI 76

Query: 169 --LTKVTHPFIVQLR-----YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
             L ++   +I++L             +LY++L+      L           E+  +   
Sbjct: 77  TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTIL 135

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---- 277
             ++   + +H+ GI+HRDLKP N L++ D  V + DFGLA+ I+    +N +       
Sbjct: 136 YNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195

Query: 278 -------------TEYM------APEILL-SKGHNKDADWWSVGILLYEMLTGQV 312
                        T ++      APE++L  + + K  D WS G +  E+L    
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 91.5 bits (228), Expect = 2e-21
 Identities = 50/217 (23%), Positives = 104/217 (47%), Gaps = 35/217 (16%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I P D    + +G G FG V   K +G  D       A+K++++ ++ +    ++++ E 
Sbjct: 21  IDPKDLTFLKELGTGQFGVVKYGKWRGQYD------VAIKMIKEGSMSED---EFIE-EA 70

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEI 224
            ++  ++H  +VQL Y   T+ + +++I +++  G L  +L   +  F+  Q      ++
Sbjct: 71  KVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 129

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY---- 280
             A+ +L     +HRDL   N L++  G V ++DFGL++ + +           EY    
Sbjct: 130 CEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD----------DEYTSSV 179

Query: 281 --------MAPEILLSKGHNKDADWWSVGILLYEMLT 309
                     PE+L+    +  +D W+ G+L++E+ +
Sbjct: 180 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 91.6 bits (228), Expect = 4e-21
 Identities = 48/229 (20%), Positives = 92/229 (40%), Gaps = 40/229 (17%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I    F + R++G+G FG V + + K  D        A+K+++ D I   +  ++++ E 
Sbjct: 20  IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVK--VAVKMLKADIIASSDIEEFLR-EA 76

Query: 167 DILTKVTHPFIVQL------RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF- 219
             + +  HP + +L        +        +IL F+  G L   L       E+     
Sbjct: 77  ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL-LASRIGENPFNLP 135

Query: 220 ------YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
                 +  +I   + +L     +HRDL   N ++  D  V + DFGL+++I        
Sbjct: 136 LQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG----- 190

Query: 274 MCGTTEY-------------MAPEILLSKGHNKDADWWSVGILLYEMLT 309
                +Y             +A E L    +   +D W+ G+ ++E++T
Sbjct: 191 -----DYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 91.6 bits (228), Expect = 4e-21
 Identities = 52/254 (20%), Positives = 103/254 (40%), Gaps = 43/254 (16%)

Query: 80  LSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDS 139
           ++S  P      +     E E      +      + R +GQG+FG V++   KGV   + 
Sbjct: 1   MASVNPEYFSAADVYVPDEWE------VAREKITMSRELGQGSFGMVYEGVAKGVVKDEP 54

Query: 140 DGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFIN 198
           +   A+K + +     +  ++++  E  ++ +     +V+L     ++ +   +I++ + 
Sbjct: 55  ETRVAIKTVNEAAS-MRERIEFLN-EASVMKEFNCHHVVRL-LGVVSQGQPTLVIMELMT 111

Query: 199 GGHL--FFHLYRQGIFREDQARFYT--------AEIVSAVSHLHKCGIVHRDLKPENILM 248
            G L  +    R  +         +         EI   +++L+    VHRDL   N ++
Sbjct: 112 RGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV 171

Query: 249 DSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY-------------MAPEILLSKGHNKDA 295
             D  V + DFG+ ++I E          T+Y             M+PE L        +
Sbjct: 172 AEDFTVKIGDFGMTRDIYE----------TDYYRKGGKGLLPVRWMSPESLKDGVFTTYS 221

Query: 296 DWWSVGILLYEMLT 309
           D WS G++L+E+ T
Sbjct: 222 DVWSFGVVLWEIAT 235

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 90.3 bits (225), Expect = 5e-21
 Identities = 46/207 (22%), Positives = 96/207 (46%), Gaps = 15/207 (7%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +     ++   +G G FG+V+     G          A+K +++ ++       ++  E 
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYNGHTK------VAVKSLKQGSMSPD---AFLA-EA 59

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEI 224
           +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F           ++     A+I
Sbjct: 60  NLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMA 282
              ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +         ++ A
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 178

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLT 309
           PE +        +D WS GILL E++T
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVT 205

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 92.9 bits (231), Expect = 5e-21
 Identities = 52/208 (25%), Positives = 100/208 (48%), Gaps = 15/208 (7%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +   D  +   +G G +G+V+    +GV    S  + A+K +++DT+  +   +++K E 
Sbjct: 217 MERTDITMKHKLGGGQYGEVY----EGVWKKYSLTV-AVKTLKEDTMEVE---EFLK-EA 267

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHL--FFHLYRQGIFREDQARFYTAE 223
            ++ ++ HP +VQL     TR    Y+I +F+  G+L  +     +         +   +
Sbjct: 268 AVMKEIKHPNLVQL-LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 326

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY--M 281
           I SA+ +L K   +HR+L   N L+  +  V + DFGL++ +   + +            
Sbjct: 327 ISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 386

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT 309
           APE L     +  +D W+ G+LL+E+ T
Sbjct: 387 APESLAYNKFSIKSDVWAFGVLLWEIAT 414

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 92.1 bits (229), Expect = 6e-21
 Identities = 61/232 (26%), Positives = 108/232 (46%), Gaps = 38/232 (16%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
              +E+ + +G+GA+G V++       D  +  + A+K   K     +N  D  +  R+I
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSI-----DRRTGEVVAVK---KIFDAFQNSTDAQRTFREI 59

Query: 169 --LTK-VTHPFIVQLRYSFQTRSK--LYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
             LT+   H  IV L    +  +   +YL+ D++        + R  I      ++   +
Sbjct: 60  MILTELSGHENIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIRANILEPVHKQYVVYQ 117

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT------ 277
           ++  + +LH  G++HRD+KP NIL++++ HV + DFGL++      R  +          
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 278 ----------TEYM------APEILL-SKGHNKDADWWSVGILLYEMLTGQV 312
                     T+Y+      APEILL S  + K  D WS+G +L E+L G+ 
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 89.9 bits (224), Expect = 6e-21
 Identities = 46/207 (22%), Positives = 101/207 (48%), Gaps = 15/207 (7%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +   +  + + +G G FG V   K KG  D       A+K++++ ++ +    ++ + E 
Sbjct: 5   LKREEITLLKELGSGQFGVVKLGKWKGQYD------VAVKMIKEGSMSED---EFFQ-EA 54

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEI 224
             + K++HP +V+  Y   ++   +Y++ ++I+ G L  +L          Q      ++
Sbjct: 55  QTMMKLSHPKLVKF-YGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDV 113

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMA 282
              ++ L     +HRDL   N L+D D  V ++DFG+ + + +    +S+      ++ A
Sbjct: 114 CEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSA 173

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLT 309
           PE+     ++  +D W+ GIL++E+ +
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFS 200

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 93.1 bits (231), Expect = 7e-21
 Identities = 64/325 (19%), Positives = 127/325 (39%), Gaps = 40/325 (12%)

Query: 15  TKLKKLTITPPSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGP 74
             LK+      ++++       +    +   H  +   + ++    P+     S     P
Sbjct: 248 YCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRP 307

Query: 75  SPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGV 134
            P   + +S+         E   +        +   D E+    G G FG V     +GV
Sbjct: 308 MP---MDTSVFESPFSDPEELKDKKLFLKRDNLLIADIEL----GCGNFGSVR----QGV 356

Query: 135 DDGDSDGIY-AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLI 193
                  I  A+KV+++ T  K +  + M+ E  I+ ++ +P+IV+L         L L+
Sbjct: 357 YRMRKKQIDVAIKVLKQGTE-KADTEEMMR-EAQIMHQLDNPYIVRL-IGVCQAEALMLV 413

Query: 194 LDFINGGHLFFHL-YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           ++   GG L   L  ++             ++   + +L +   VHR+L   N+L+ +  
Sbjct: 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH 473

Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEY------------MAPEILLSKGHNKDADWWSV 300
           +  ++DFGL+K +            + Y             APE +  +  +  +D WS 
Sbjct: 474 YAKISDFGLSKALGADD--------SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSY 525

Query: 301 GILLYEMLT-GQV---NIKSMQVIA 321
           G+ ++E L+ GQ     +K  +V+A
Sbjct: 526 GVTMWEALSYGQKPYKKMKGPEVMA 550

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 90.0 bits (224), Expect = 9e-21
 Identities = 51/221 (23%), Positives = 93/221 (42%), Gaps = 36/221 (16%)

Query: 107 IGPGDFEIFRVV-GQGAFGKVFQVKKKGVDDGDSDGIY-AMKVMRKDTIIKKNHVDYMKA 164
           +   +  I  +  G G FG V     +GV       I  A+KV+++ T  K +  + M+ 
Sbjct: 6   LKRDNLLIADIELGCGNFGSVR----QGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMR- 59

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAE 223
           E  I+ ++ +P+IV+L         L L+++   GG L   L  ++             +
Sbjct: 60  EAQIMHQLDNPYIVRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY--- 280
           +   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +            + Y   
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD--------SYYTAR 170

Query: 281 ---------MAPEILLSKGHNK---DADWWSVGILLYEMLT 309
                     APE +      K    +D WS G+ ++E L+
Sbjct: 171 SAGKWPLKWYAPECIN---FRKFSSRSDVWSYGVTMWEALS 208

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 89.6 bits (223), Expect = 9e-21
 Identities = 50/210 (23%), Positives = 95/210 (45%), Gaps = 25/210 (11%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +   + ++ + +G+G FG V     +G          A+K ++ D   +     ++  E 
Sbjct: 18  LNMKELKLLQTIGKGEFGDVMLGDYRGNK-------VAVKCIKNDATAQ----AFLA-EA 65

Query: 167 DILTKVTHPFIVQLRYSFQTRSK--LYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
            ++T++ H  +VQL        K  LY++ +++  G L  +     + +   D    ++ 
Sbjct: 66  SVMTQLRHSNLVQL-LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 124

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TE 279
           ++  A+ +L     VHRDL   N+L+  D    ++DFGL KE   +             +
Sbjct: 125 DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVK 179

Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           + APE L  K  +  +D WS GILL+E+ +
Sbjct: 180 WTAPEALREKKFSTKSDVWSFGILLWEIYS 209

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 89.6 bits (223), Expect = 1e-20
 Identities = 52/231 (22%), Positives = 93/231 (40%), Gaps = 24/231 (10%)

Query: 90  ELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGV--DDGDSDGIYAMKV 147
           EL       +   S   +         V+G+G FG V+     G   D+       A+K 
Sbjct: 10  ELVQAVQHVVIGPSSLIV-----HFNEVIGRGHFGCVY----HGTLLDNDGKKIHCAVKS 60

Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHL--FF 204
           +            ++  E  I+   +HP ++ L     ++     ++L ++  G L  F 
Sbjct: 61  L-NRITDIGEVSQFLT-EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 118

Query: 205 HLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE 264
                    +D   F   ++   + +L     VHRDL   N ++D    V + DFGLA++
Sbjct: 119 RNETHNPTVKDLIGF-GLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 177

Query: 265 IDESSRSNSMCGTTE------YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           + +     S+   T       +MA E L ++     +D WS G+LL+E++T
Sbjct: 178 MYDKE-YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 90.6 bits (225), Expect = 2e-20
 Identities = 56/273 (20%), Positives = 103/273 (37%), Gaps = 19/273 (6%)

Query: 49  QSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIG 108
             P  +    G   +    +  +                  +L   N   ++A     IG
Sbjct: 26  LVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIG 85

Query: 109 PGDFEI--FRVVGQGAFGKVFQVKKKGV--DDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
           P    +    V+G+G FG V+     G   D+       A+K +            ++  
Sbjct: 86  PSSLIVHFNEVIGRGHFGCVY----HGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLT- 139

Query: 165 ERDILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYT 221
           E  I+   +HP ++ L     ++     ++L ++  G L  F          +D   F  
Sbjct: 140 EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-G 198

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT--- 278
            ++   +  L     VHRDL   N ++D    V + DFGLA+++ +    +    T    
Sbjct: 199 LQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 258

Query: 279 --EYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             ++MA E L ++     +D WS G+LL+E++T
Sbjct: 259 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 88.8 bits (221), Expect = 4e-20
 Identities = 59/217 (27%), Positives = 111/217 (51%), Gaps = 23/217 (10%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGV-DDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
            +F    ++G+G FGKV+    KG   DG    + A+K + K+   +   + + + E ++
Sbjct: 30  DNFSNKNILGRGGFGKVY----KGRLADGT---LVAVKRL-KEERTQGGELQF-QTEVEM 80

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED---QARFYTAEIV 225
           ++   H  +++LR    T ++  L+  ++  G +   L  +   +       R   A + 
Sbjct: 81  ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA-LG 139

Query: 226 SA--VSHLH-KCG--IVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR--SNSMCGTT 278
           SA  +++LH  C   I+HRD+K  NIL+D +   ++ DFGLAK +D      + ++ GT 
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 199

Query: 279 EYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQVNI 314
            ++APE L + G  ++  D +  G++L E++TGQ   
Sbjct: 200 GHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAF 235

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 88.5 bits (220), Expect = 5e-20
 Identities = 57/257 (22%), Positives = 90/257 (35%), Gaps = 50/257 (19%)

Query: 85  PLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYA 144
            + I   +   D + E               + +G GAFGKV +    G+   D+    A
Sbjct: 4   YVYIDPTQLPYDHKWE------FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVA 57

Query: 145 MKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSK-LYLILDFINGGHL 202
           +K M K +         M  E  +L+ +  H  IV L     T      +I ++   G L
Sbjct: 58  VK-MLKPSAHLTEREALMS-ELKVLSYLGNHMNIVNL-LGACTIGGPTLVITEYCCYGDL 114

Query: 203 ----------FFHLYRQGIFREDQARFYT--------AEIVSAVSHLHKCGIVHRDLKPE 244
                     F          ED               ++   ++ L     +HRDL   
Sbjct: 115 LNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174

Query: 245 NILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY------------MAPEILLSKGHN 292
           NIL+       + DFGLA++I   S          Y            MAPE + +  + 
Sbjct: 175 NILLTHGRITKICDFGLARDIKNDS---------NYVVKGNARLPVKWMAPESIFNCVYT 225

Query: 293 KDADWWSVGILLYEMLT 309
            ++D WS GI L+E+ +
Sbjct: 226 FESDVWSYGIFLWELFS 242

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 87.7 bits (218), Expect = 5e-20
 Identities = 44/224 (19%), Positives = 87/224 (38%), Gaps = 34/224 (15%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDYMK 163
           KI   D      +GQG F K+F+  ++ V D          +KV+ K      N+ +   
Sbjct: 4   KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFF 60

Query: 164 AERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYR-QGIFREDQARFYT 221
               +++K++H  +V   Y          L+ +F+  G L  +L + +            
Sbjct: 61  EAASMMSKLSHKHLVLN-YGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVA 119

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--------VMLTDFGLAKEIDESSRSNS 273
            ++ +A+  L +  ++H ++  +NIL+  +          + L+D G++  +        
Sbjct: 120 KQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK----- 174

Query: 274 MCGTTEY-------MAPE-ILLSKGHNKDADWWSVGILLYEMLT 309
                +        + PE I   K  N   D WS G  L+E+ +
Sbjct: 175 -----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 89.7 bits (223), Expect = 5e-20
 Identities = 54/254 (21%), Positives = 111/254 (43%), Gaps = 27/254 (10%)

Query: 61  PQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQ 120
            Q++ + +    G   R      +   +   +    +         +   + ++ + +G+
Sbjct: 150 MQLVEHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWA------LNMKELKLLQTIGK 203

Query: 121 GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL 180
           G FG V     +G          A+K ++ D   +     ++  E  ++T++ H  +VQL
Sbjct: 204 GEFGDVMLGDYRGNK-------VAVKCIKNDATAQ----AFLA-EASVMTQLRHSNLVQL 251

Query: 181 RY--SFQTRSKLYLILDFINGGHLFFHL---YRQGIFREDQARFYTAEIVSAVSHLHKCG 235
                 + +  LY++ +++  G L  +L    R  +  +   +F + ++  A+ +L    
Sbjct: 252 -LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF-SLDVCEAMEYLEGNN 309

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDA 295
            VHRDL   N+L+  D    ++DFGL KE   +  +  +    ++ APE L  K  +  +
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALREKKFSTKS 367

Query: 296 DWWSVGILLYEMLT 309
           D WS GILL+E+ +
Sbjct: 368 DVWSFGILLWEIYS 381

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 87.7 bits (218), Expect = 6e-20
 Identities = 53/208 (25%), Positives = 102/208 (49%), Gaps = 15/208 (7%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +   D  +   +G G +G+V+    +GV    S  + A+K +++DT+  +   +++K E 
Sbjct: 10  MERTDITMKHKLGGGQYGEVY----EGVWKKYSLTV-AVKTLKEDTMEVE---EFLK-EA 60

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHL--FFHLYRQGIFREDQARFYTAE 223
            ++ ++ HP +VQL     TR    Y+I +F+  G+L  +     +         +   +
Sbjct: 61  AVMKEIKHPNLVQL-LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 119

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYM 281
           I SA+ +L K   +HRDL   N L+  +  V + DFGL++ +   + +         ++ 
Sbjct: 120 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT 309
           APE L     +  +D W+ G+LL+E+ T
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIAT 207

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 87.6 bits (218), Expect = 8e-20
 Identities = 64/221 (28%), Positives = 110/221 (49%), Gaps = 36/221 (16%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGV-DDGDSDGIYAMKVMRKDTIIKKNHVDYM------K 163
           +F+   ++G G FGKV+    KGV  DG        KV      +K+   +        +
Sbjct: 40  NFDHKFLIGHGVFGKVY----KGVLRDG-------AKVA-----LKRRTPESSQGIEEFE 83

Query: 164 AERDILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED---QARF 219
            E + L+   HP +V L  +  + R+++ LI  ++  G+L  HLY   +       + R 
Sbjct: 84  TEIETLSFCRHPHLVSLIGFCDE-RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142

Query: 220 YTAEIVSA--VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK---EIDESSRSNSM 274
               I +A  + +LH   I+HRD+K  NIL+D +    +TDFG++K   E+D++  S  +
Sbjct: 143 EIC-IGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVV 201

Query: 275 CGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQVNI 314
            GT  Y+ PE  +  G   + +D +S G++L+E+L  +  I
Sbjct: 202 KGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAI 241

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 87.7 bits (218), Expect = 8e-20
 Identities = 59/264 (22%), Positives = 106/264 (40%), Gaps = 47/264 (17%)

Query: 75  SPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGV 134
           SP     S L   I E    N           I   D  +   +G+GAFGKVF  +   +
Sbjct: 10  SPTEGKGSGLQGHIIE----NPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNL 65

Query: 135 DDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLI 193
                  + A+K +++ +  +    D+ + E ++LT + H  IV+  +   T  + L ++
Sbjct: 66  LPEQDKMLVAVKALKEAS--ESARQDFQR-EAELLTMLQHQHIVRF-FGVCTEGRPLLMV 121

Query: 194 LDFINGGHLFFHLYRQGIFREDQARFYT---------------AEIVSAVSHLHKCGIVH 238
            +++  G L   L   G   +  A                   +++ + + +L     VH
Sbjct: 122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVH 181

Query: 239 RDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY-------------MAPEI 285
           RDL   N L+     V + DFG++++I            T+Y             M PE 
Sbjct: 182 RDLATRNCLVGQGLVVKIGDFGMSRDIYS----------TDYYRVGGRTMLPIRWMPPES 231

Query: 286 LLSKGHNKDADWWSVGILLYEMLT 309
           +L +    ++D WS G++L+E+ T
Sbjct: 232 ILYRKFTTESDVWSFGVVLWEIFT 255

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 87.3 bits (217), Expect = 1e-19
 Identities = 48/221 (21%), Positives = 88/221 (39%), Gaps = 37/221 (16%)

Query: 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV 172
            + +++G+G FG V +   K  D        A+K M+ D   ++   +++  E   +   
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLK--VAVKTMKLDNSSQREIEEFLS-EAACMKDF 93

Query: 173 THPFIVQL-----RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-------Y 220
           +HP +++L       S Q   K  +IL F+  G L  +L                    +
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL-LYSRLETGPKHIPLQTLLKF 152

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
             +I   + +L     +HRDL   N ++  D  V + DFGL+K+I              Y
Sbjct: 153 MVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD---------YY 203

Query: 281 ------------MAPEILLSKGHNKDADWWSVGILLYEMLT 309
                       +A E L  + +   +D W+ G+ ++E+ T
Sbjct: 204 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 87.8 bits (218), Expect = 1e-19
 Identities = 61/282 (21%), Positives = 112/282 (39%), Gaps = 52/282 (18%)

Query: 61  PQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQ 120
               H+  H +  P+        +   + E E   D   E      +      + + +G+
Sbjct: 26  GYYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWE------LPRDRLVLGKPLGE 79

Query: 121 GAFGKVFQVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFI 177
           GAFG+V   +  G+D    + +   A+K M K    +K+  D +  E +++  +  H  I
Sbjct: 80  GAFGQVVLAEAIGLDKDKPNRVTKVAVK-MLKSDATEKDLSDLIS-EMEMMKMIGKHKNI 137

Query: 178 VQLRYSFQTRSK-LYLILDFINGGHL-----------------FFHLYRQGIFREDQARF 219
           + L     T+   LY+I+++ + G+L                   H   + +  +D    
Sbjct: 138 INL-LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
              ++   + +L     +HRDL   N+L+  D  + + DFGLA++I              
Sbjct: 197 -AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID---------Y 246

Query: 280 Y------------MAPEILLSKGHNKDADWWSVGILLYEMLT 309
           Y            MAPE L  + +   +D WS G+LL+E+ T
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 85.8 bits (213), Expect = 3e-19
 Identities = 60/262 (22%), Positives = 104/262 (39%), Gaps = 54/262 (20%)

Query: 82  SSLPL--QIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDS 139
             LPL    + L ++   + E            ++ + +G+GAFG+V +    G+D   +
Sbjct: 4   DELPLDEHCERLPYDAS-KWE------FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTAT 56

Query: 140 DGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY--SFQTRSKLYLILDF 196
               A+K M K+      H   M  E  IL  +  H  +V L      +    L +I++F
Sbjct: 57  CRTVAVK-MLKEGATHSEHRALMS-ELKILIHIGHHLNVVNL-LGACTKPGGPLMVIVEF 113

Query: 197 INGGHL-----------------FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHR 239
              G+L                    LY+  +  E    + + ++   +  L     +HR
Sbjct: 114 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY-SFQVAKGMEFLASRKCIHR 172

Query: 240 DLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY------------MAPEILL 287
           DL   NIL+     V + DFGLA++I +           +Y            MAPE + 
Sbjct: 173 DLAARNILLSEKNVVKICDFGLARDIYKDP---------DYVRKGDARLPLKWMAPETIF 223

Query: 288 SKGHNKDADWWSVGILLYEMLT 309
            + +   +D WS G+LL+E+ +
Sbjct: 224 DRVYTIQSDVWSFGVLLWEIFS 245

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 86.2 bits (214), Expect = 3e-19
 Identities = 50/231 (21%), Positives = 97/231 (41%), Gaps = 39/231 (16%)

Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK 163
            +++   +  + R +G GAFG+V++ +  G+ +  S    A+K +  +   +++ +D++ 
Sbjct: 24  LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLM 82

Query: 164 AERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYT- 221
            E  I++K  H  IV+       +S   +++++ + GG L   L R+   R  Q      
Sbjct: 83  -EALIISKFNHQNIVRC-IGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLAM 139

Query: 222 -------AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESSRS 271
                   +I     +L +   +HRD+   N L+   G      + DFG+A++I      
Sbjct: 140 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR---- 195

Query: 272 NSMCGTTEY-------------MAPEILLSKGHNKDADWWSVGILLYEMLT 309
                   Y             M PE  +        D WS G+LL+E+ +
Sbjct: 196 ------ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 85.8 bits (213), Expect = 5e-19
 Identities = 58/265 (21%), Positives = 101/265 (38%), Gaps = 42/265 (15%)

Query: 75  SPRYALSSSLPLQIQ--ELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKK 132
            P+Y +   +    +       +  +L    + +    + +  + +G GAFGKV +    
Sbjct: 9   KPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAF 68

Query: 133 GVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSK-L 190
           G+   D+    A+K M K T         M  E  I++ +  H  IV L     T    +
Sbjct: 69  GLGKEDAVLKVAVK-MLKSTAHADEKEALMS-ELKIMSHLGQHENIVNL-LGACTHGGPV 125

Query: 191 YLILDFINGGHLFFHLYRQGIFREDQARFYT--------------AEIVSAVSHLHKCGI 236
            +I ++   G L   L R+    E    F                +++   ++ L     
Sbjct: 126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNC 185

Query: 237 VHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY------------MAPE 284
           +HRD+   N+L+ +     + DFGLA++I   S          Y            MAPE
Sbjct: 186 IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS---------NYIVKGNARLPVKWMAPE 236

Query: 285 ILLSKGHNKDADWWSVGILLYEMLT 309
            +    +   +D WS GILL+E+ +
Sbjct: 237 SIFDCVYTVQSDVWSYGILLWEIFS 261

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 85.4 bits (212), Expect = 5e-19
 Identities = 61/272 (22%), Positives = 114/272 (41%), Gaps = 52/272 (19%)

Query: 72  VGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKK 131
           +G S  +   S  P+     E+E   + + E  R        + + +G+GAFG+V   + 
Sbjct: 1   MGSSHHHHHHSQDPMLAGVSEYELPEDPKWEFPRD----KLTLGKPLGEGAFGQVVMAEA 56

Query: 132 KGVDDGDSDGIYAMKV---MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR 187
            G+D        A+ V   M KD   +K+  D +  E +++  +  H  I+ L     T+
Sbjct: 57  VGIDKDKPK--EAVTVAVKMLKDDATEKDLSDLVS-EMEMMKMIGKHKNIINL-LGACTQ 112

Query: 188 SK-LYLILDFINGGHL-----------------FFHLYRQGIFREDQARFYTAEIVSAVS 229
              LY+I+++ + G+L                    +  + +  +D     T ++   + 
Sbjct: 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC-TYQLARGME 171

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY--------- 280
           +L     +HRDL   N+L+  +  + + DFGLA++I+             Y         
Sbjct: 172 YLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID---------YYKKTTNGRLP 222

Query: 281 ---MAPEILLSKGHNKDADWWSVGILLYEMLT 309
              MAPE L  + +   +D WS G+L++E+ T
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 84.6 bits (210), Expect = 7e-19
 Identities = 53/236 (22%), Positives = 100/236 (42%), Gaps = 44/236 (18%)

Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK 163
            + I   D  + R +G+GAFGKVF  +   +       + A+K ++  T       D+ +
Sbjct: 9   VQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQR 66

Query: 164 AERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHL---------FFHLYRQGIFR 213
            E ++LT + H  IV+  Y        L ++ +++  G L            +   G  R
Sbjct: 67  -EAELLTNLQHEHIVKF-YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 124

Query: 214 EDQARFYT-------AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID 266
           + +            ++I S + +L     VHRDL   N L+ ++  V + DFG+++++ 
Sbjct: 125 QAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY 184

Query: 267 ESSRSNSMCGTTEY-------------MAPEILLSKGHNKDADWWSVGILLYEMLT 309
                      T+Y             M PE ++ +    ++D WS G++L+E+ T
Sbjct: 185 S----------TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 85.5 bits (212), Expect = 7e-19
 Identities = 51/241 (21%), Positives = 97/241 (40%), Gaps = 39/241 (16%)

Query: 94  ENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI 153
                      +++   +  + R +G GAFG+V++ +  G+ +  S    A+K +  +  
Sbjct: 55  FAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVC 113

Query: 154 IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIF 212
            +++ +D++  E  I++K  H  IV+       +S   +++L+ + GG L   L R+   
Sbjct: 114 SEQDELDFLM-EALIISKFNHQNIVRC-IGVSLQSLPRFILLELMAGGDLKSFL-RETRP 170

Query: 213 REDQARFYT--------AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGL 261
           R  Q              +I     +L +   +HRD+   N L+   G      + DFG+
Sbjct: 171 RPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 230

Query: 262 AKEIDESSRSNSMCGTTEY-------------MAPEILLSKGHNKDADWWSVGILLYEML 308
           A++I              Y             M PE  +        D WS G+LL+E+ 
Sbjct: 231 ARDIYR----------AGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280

Query: 309 T 309
           +
Sbjct: 281 S 281

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 85.5 bits (212), Expect = 8e-19
 Identities = 64/299 (21%), Positives = 118/299 (39%), Gaps = 61/299 (20%)

Query: 45  RHNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESE 104
           +    + +S+S +   P V      S    +P  A  S       E E   D + E    
Sbjct: 29  QVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVS-------EYELPEDPKWE---- 77

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKV---MRKDTIIKKNHVDY 161
                    + + +G+G FG+V   +  G+D        A+ V   M KD   +K+  D 
Sbjct: 78  --FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPK--EAVTVAVKMLKDDATEKDLSDL 133

Query: 162 MKAERDILTKV-THPFIVQLRYSFQTRSK-LYLILDFINGGHL----------------- 202
           +  E +++  +  H  I+ L     T+   LY+I+++ + G+L                 
Sbjct: 134 VS-EMEMMKMIGKHKNIINL-LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 191

Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
              +  + +  +D     T ++   + +L     +HRDL   N+L+  +  + + DFGLA
Sbjct: 192 INRVPEEQMTFKDLVSC-TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 250

Query: 263 KEIDESSRSNSMCGTTEY------------MAPEILLSKGHNKDADWWSVGILLYEMLT 309
           ++I+             Y            MAPE L  + +   +D WS G+L++E+ T
Sbjct: 251 RDINNID---------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 84.6 bits (210), Expect = 8e-19
 Identities = 47/206 (22%), Positives = 89/206 (43%), Gaps = 15/206 (7%)

Query: 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV 172
              RV+G+G FG V+  +             A+K + + T   +    +++ E  ++  +
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQ--CAIKSLSRITE-MQQVEAFLR-EGLLMRGL 79

Query: 173 THPFIVQLRY--SFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAV 228
            HP ++ L            +++L ++  G L  F    ++    +D   F   ++   +
Sbjct: 80  NHPNVLAL-IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF-GLQVARGM 137

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE-----YMAP 283
            +L +   VHRDL   N ++D    V + DFGLA++I +    +            + A 
Sbjct: 138 EYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197

Query: 284 EILLSKGHNKDADWWSVGILLYEMLT 309
           E L +      +D WS G+LL+E+LT
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT 223

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 83.8 bits (208), Expect = 1e-18
 Identities = 47/232 (20%), Positives = 92/232 (39%), Gaps = 41/232 (17%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I          +G+  FGKV++    G   G+     A+K ++          ++   E 
Sbjct: 6   ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-GPLREEFRH-EA 63

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYT---- 221
            +  ++ HP +V L     T+ + L +I  + + G L   L  +    +  +        
Sbjct: 64  MLRARLQHPNVVCL-LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122

Query: 222 ------------AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS 269
                       A+I + + +L    +VH+DL   N+L+    +V ++D GL +E+  + 
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182

Query: 270 RSNSMCGTTEY------------MAPEILLSKGHNKDADWWSVGILLYEMLT 309
                     Y            MAPE ++    + D+D WS G++L+E+ +
Sbjct: 183 ---------YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 82.3 bits (204), Expect = 6e-18
 Identities = 54/254 (21%), Positives = 102/254 (40%), Gaps = 51/254 (20%)

Query: 94  ENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI 153
            +  ++  + + +    +  + + +G+G FGKV +     +         A+K M K+  
Sbjct: 7   VDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK-MLKENA 65

Query: 154 IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHL---------- 202
                 D +  E ++L +V HP +++L Y   ++   L LI+++   G L          
Sbjct: 66  SPSELRDLLS-EFNVLKQVNHPHVIKL-YGACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123

Query: 203 ---------------FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL 247
                            H   + +   D   F   +I   + +L +  +VHRDL   NIL
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISF-AWQISQGMQYLAEMKLVHRDLAARNIL 182

Query: 248 MDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY------------MAPEILLSKGHNKDA 295
           +     + ++DFGL++++ E            Y            MA E L    +   +
Sbjct: 183 VAEGRKMKISDFGLSRDVYEED---------SYVKRSQGRIPVKWMAIESLFDHIYTTQS 233

Query: 296 DWWSVGILLYEMLT 309
           D WS G+LL+E++T
Sbjct: 234 DVWSFGVLLWEIVT 247

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 82.3 bits (203), Expect = 1e-17
 Identities = 60/309 (19%), Positives = 101/309 (32%), Gaps = 101/309 (32%)

Query: 85  PLQIQELEHENDAELEAESERKIG------PGD-----FEIFRVVGQGAFGKVFQVKKKG 133
           P Q +E+   +D E E  ++   G       GD     + + R +G G F  V+      
Sbjct: 1   PEQEEEILGSDDDEQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSW--- 57

Query: 134 VDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-----THP---FIVQLRYSFQ 185
             D       AMKV++      +++ +    E  +L  V       P    +VQL   F+
Sbjct: 58  --DIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111

Query: 186 TRSKLYLILDFINGGHL-------------FFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
                       NG H+             +              +    +++  + +LH
Sbjct: 112 ISGV--------NGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH 163

Query: 233 -KCGIVHRDLKPENILM------------------------------------------- 248
            KC I+H D+KPENIL+                                           
Sbjct: 164 TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVN 223

Query: 249 ------DSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGI 302
                      V + D G A  + +    +    T +Y + E+L+  G+N  AD WS   
Sbjct: 224 PLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ--TRQYRSLEVLIGSGYNTPADIWSTAC 281

Query: 303 LLYEMLTGQ 311
           + +E+ TG 
Sbjct: 282 MAFELATGD 290

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 81.6 bits (202), Expect = 1e-17
 Identities = 63/257 (24%), Positives = 100/257 (38%), Gaps = 49/257 (19%)

Query: 90  ELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR 149
           E  + +  E E + + +    + E  +V+G GAFGKV      G+         A+K M 
Sbjct: 25  EYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK-ML 83

Query: 150 KDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSK-LYLILDFINGGHL----- 202
           K+          M  E  ++T++ +H  IV L     T S  +YLI ++   G L     
Sbjct: 84  KEKADSSEREALMS-ELKMMTQLGSHENIVNL-LGACTLSGPIYLIFEYCCYGDLLNYLR 141

Query: 203 ----------FFHLYRQGIFREDQARFYT--------AEIVSAVSHLHKCGIVHRDLKPE 244
                       +  ++ +  E+     T         ++   +  L     VHRDL   
Sbjct: 142 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201

Query: 245 NILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY------------MAPEILLSKGHN 292
           N+L+     V + DFGLA++I   S          Y            MAPE L    + 
Sbjct: 202 NVLVTHGKVVKICDFGLARDIMSDS---------NYVVRGNARLPVKWMAPESLFEGIYT 252

Query: 293 KDADWWSVGILLYEMLT 309
             +D WS GILL+E+ +
Sbjct: 253 IKSDVWSYGILLWEIFS 269

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 78.9 bits (195), Expect = 1e-16
 Identities = 56/274 (20%), Positives = 105/274 (38%), Gaps = 64/274 (23%)

Query: 74  PSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKG 133
           P+P Y     L L  + L  E                + E  R +G+GAFG+VFQ +  G
Sbjct: 24  PNPMYQ-RMPLLLNPKLLSLE------------YPRNNIEYVRDIGEGAFGRVFQARAPG 70

Query: 134 VDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYL 192
           +   +   + A+K M K+        D+ + E  ++ +  +P IV+L        K + L
Sbjct: 71  LLPYEPFTMVAVK-MLKEEASADMQADFQR-EAALMAEFDNPNIVKL-LGVCAVGKPMCL 127

Query: 193 ILDFINGGHL----------------FFHLYRQGIFREDQARFYT--------AEIVSAV 228
           + +++  G L                   L  +           +         ++ + +
Sbjct: 128 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGM 187

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY-------- 280
           ++L +   VHRDL   N L+  +  V + DFGL++ I             +Y        
Sbjct: 188 AYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS----------ADYYKADGNDA 237

Query: 281 -----MAPEILLSKGHNKDADWWSVGILLYEMLT 309
                M PE +    +  ++D W+ G++L+E+ +
Sbjct: 238 IPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 56/255 (21%), Positives = 102/255 (40%), Gaps = 52/255 (20%)

Query: 88  IQELEHENDAELEAESERK--IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY-A 144
           +++  H +  +   +      +   D +   V+G+G FG+V     K     D   +  A
Sbjct: 1   MKKHHHHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVL----KARIKKDGLRMDAA 56

Query: 145 MKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSK-LYLILDFINGGHL 202
           +K   K+   K +H D+   E ++L K+  HP I+ L          LYL +++   G+L
Sbjct: 57  IK-RMKEYASKDDHRDFAG-ELEVLCKLGHHPNIINL-LGACEHRGYLYLAIEYAPHGNL 113

Query: 203 FFHLYRQGIFREDQARFYT----------------AEIVSAVSHLHKCGIVHRDLKPENI 246
              L +  +   D A                    A++   + +L +   +HRDL   NI
Sbjct: 114 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI 173

Query: 247 LMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY------------MAPEILLSKGHNKD 294
           L+  +    + DFGL++  +             Y            MA E L    +  +
Sbjct: 174 LVGENYVAKIADFGLSRGQE------------VYVKKTMGRLPVRWMAIESLNYSVYTTN 221

Query: 295 ADWWSVGILLYEMLT 309
           +D WS G+LL+E+++
Sbjct: 222 SDVWSYGVLLWEIVS 236

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 74.3 bits (183), Expect = 4e-15
 Identities = 49/232 (21%), Positives = 94/232 (40%), Gaps = 43/232 (18%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
               +G  +F + + +G G FG++   K     +  ++   A+K+        K+    +
Sbjct: 3   GVLMVG-PNFRVGKKIGCGNFGELRLGK-----NLYTNEYVAIKLEPM-----KSRAPQL 51

Query: 163 KAERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFI--NGGHLFFHLYRQGIFREDQARF 219
             E     ++     I Q+ Y         ++L+ +  +   LF    R          F
Sbjct: 52  HLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDR---------TF 102

Query: 220 --YTA-----EIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----VMLTDFGLAKE-ID 266
              T      +++S + ++H   +++RD+KPEN L+   G+     + + DF LAKE ID
Sbjct: 103 SLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162

Query: 267 ESSRS-------NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
             ++         S+ GT  YM+    L K  ++  D  ++G +    L G 
Sbjct: 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 73.2 bits (180), Expect = 7e-15
 Identities = 41/225 (18%), Positives = 89/225 (39%), Gaps = 29/225 (12%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
               +G   +++ R +G+G+FG +F+       +  ++   A+K   + +      +   
Sbjct: 4   QNNVVG-VHYKVGRRIGEGSFGVIFEGT-----NLLNNQQVAIKFEPRRS--DAPQLRD- 54

Query: 163 KAERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFI--NGGHLFFHLYRQGIFREDQARF 219
             E      +     I  + Y  Q      L++D +  +   L     R+  F       
Sbjct: 55  --EYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK--FSVKTVAM 110

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----VMLTDFGLAKE-IDESSRS-- 271
              ++++ V  +H+  +V+RD+KP+N L+          + + DFG+ K   D  ++   
Sbjct: 111 AAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 170

Query: 272 -----NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
                 ++ GT  YM+    L +  ++  D  ++G +    L G 
Sbjct: 171 PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 72.8 bits (179), Expect = 9e-15
 Identities = 47/222 (21%), Positives = 88/222 (39%), Gaps = 27/222 (12%)

Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK 163
           E ++G   + + R +G G+FG ++        D  +    A+K+    T  K   +    
Sbjct: 4   ELRVG-NRYRLGRKIGSGSFGDIYLGT-----DIAAGEEVAIKLECVKT--KHPQLHI-- 53

Query: 164 AERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFI--NGGHLFFHLYRQGIFREDQARFY 220
            E  I   +     I  +R+         ++++ +  +   LF    R+  F        
Sbjct: 54  -ESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLL 110

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKE-IDESSRS----- 271
             +++S + ++H    +HRD+KP+N LM        V + DFGLAK+  D  +       
Sbjct: 111 ADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYR 170

Query: 272 --NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
              ++ GT  Y +    L    ++  D  S+G +L     G 
Sbjct: 171 ENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 72.1 bits (177), Expect = 3e-14
 Identities = 43/232 (18%), Positives = 85/232 (36%), Gaps = 38/232 (16%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDT--------IIKKNHVDY 161
             +++   +GQG FG ++       +   SD    +KV   D           ++     
Sbjct: 35  AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94

Query: 162 MKAERDILTKVTHPFIVQLRYS----FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA 217
              +     K+ +  + +   S       +S  ++I+D   G  L      Q I+  +  
Sbjct: 95  QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDL------QKIYEANAK 147

Query: 218 RF-------YTAEIVSAVSHLHKCGIVHRDLKPENILMD--SDGHVMLTDFGLAK----- 263
           RF        +  I+  + ++H+   VH D+K  N+L++  +   V L D+GLA      
Sbjct: 148 RFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE 207

Query: 264 ----EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
                     +     GT E+ + +       ++  D   +G  + + LTG 
Sbjct: 208 GVHKAYAADPKR-CHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 72.0 bits (176), Expect = 5e-14
 Identities = 51/222 (22%), Positives = 91/222 (40%), Gaps = 27/222 (12%)

Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK 163
           E ++G   F + R +G G+FG+++        +  ++   A+K+    T  K   + Y  
Sbjct: 2   EPRVG-NKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVKT--KHPQLLY-- 51

Query: 164 AERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFI--NGGHLFFHLYRQGIFREDQARFY 220
            E  I   +     I  +R+         L++D +  +   LF    R+           
Sbjct: 52  -ESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLML 108

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKE-IDESSRS----- 271
             ++++ V  +H    +HRD+KP+N LM        V + DFGLAK+  D S+       
Sbjct: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168

Query: 272 --NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
              ++ GT  Y +    L    ++  D  S+G +L   L G 
Sbjct: 169 ENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 70.9 bits (174), Expect = 6e-14
 Identities = 36/223 (16%), Positives = 78/223 (34%), Gaps = 24/223 (10%)

Query: 112 FEIFRVVGQGAFGKVF---QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD- 167
           +++     +   G ++          D G     +++K+  KD  +      + +A +  
Sbjct: 44  WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103

Query: 168 ------ILTKVTHPFIVQLRYSFQTRSKL-YLILDFINGGHL--FFHLYRQGIFREDQAR 218
                  L       I         + K  +L+L  + G  L     +  + +  E    
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVL 162

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKE-IDESS------ 269
                ++ A+  LH+   VH ++  ENI +D +    V L  +G A              
Sbjct: 163 QVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222

Query: 270 -RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
              +   G  E+++ ++    G ++ +D  S+G  + + L G 
Sbjct: 223 GSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 70.5 bits (173), Expect = 8e-14
 Identities = 42/270 (15%), Positives = 98/270 (36%), Gaps = 41/270 (15%)

Query: 65  HNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFG 124
           H+ S   +G    Y  S   P              E +    +    + + + +G G FG
Sbjct: 6   HHSSGVDLGTENLYFQSMPFP--------------EGKVLDDMEGNQWVLGKKIGSGGFG 51

Query: 125 KVFQVKKKGVDDGDSDGIYAMKVMRKDT--------IIKKNHVDYMKAERDILTKVTHPF 176
            ++       +  + D  + +KV  ++           ++        +     ++ +  
Sbjct: 52  LIYLAFP--TNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLG 109

Query: 177 IVQLRYS--FQTRSKLY--LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
           I     S   + + + Y  ++++ + G  L     + G F++         ++  + ++H
Sbjct: 110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIH 168

Query: 233 KCGIVHRDLKPENILMD--SDGHVMLTDFGLAK---------EIDESSRSNSMCGTTEYM 281
           +   VH D+K  N+L+   +   V L D+GL+          +  E+ R     GT E+ 
Sbjct: 169 ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPR-KGHNGTIEFT 227

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           + +       ++ +D   +G  +   L G+
Sbjct: 228 SLDAHKGVALSRRSDVEILGYCMLRWLCGK 257

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 66.8 bits (162), Expect = 2e-12
 Identities = 32/202 (15%), Positives = 59/202 (29%), Gaps = 55/202 (27%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
             +    +G+G FG+VFQ               A+K++  +     N   + K   +IL 
Sbjct: 21  KLQRCEKIGEGVFGEVFQTIADH-------TPVAIKIIAIEGPDLVN-GSHQKTFEEILP 72

Query: 171 KVT---------------HP--------FIVQLRY----------------------SFQ 185
           ++                            VQ  Y                       F 
Sbjct: 73  EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132

Query: 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPE 244
              +L+++L+F  GG       R  +     A+    ++ ++++         HRDL   
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQ-MRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWG 191

Query: 245 NILMDSDGHVMLTDFGLAKEID 266
           N+L+       L      K   
Sbjct: 192 NVLLKKTSLKKLHYTLNGKSST 213

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 30/118 (25%), Positives = 52/118 (44%), Gaps = 22/118 (18%)

Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK 263
             LY+  +  E    + + ++   +  L     +HRDL   NIL+     V + DFGLA+
Sbjct: 183 EDLYKDFLTLEHLICY-SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241

Query: 264 EIDESSRSNSMCGTTEY------------MAPEILLSKGHNKDADWWSVGILLYEMLT 309
           +I +           +Y            MAPE +  + +   +D WS G+LL+E+ +
Sbjct: 242 DIYKDP---------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 52.6 bits (126), Expect = 8e-08
 Identities = 38/190 (20%), Positives = 69/190 (36%), Gaps = 16/190 (8%)

Query: 109 PGDFEIFR-------VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
              +E  R        +G+GAFG+V +    G+D   +    A+K M K+      H   
Sbjct: 14  ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK-MLKEGATHSEHRAL 72

Query: 162 MKAERDILTKV-THPFIVQ-LRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           M  E  IL  +  H  +V  L    +    L +I++F   G+L  +L      + ++   
Sbjct: 73  MS-ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS----KRNEFVP 127

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT-T 278
           Y  +           G +  DLK     + S      + F   K + +     +      
Sbjct: 128 YKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYK 187

Query: 279 EYMAPEILLS 288
           +++  E L+ 
Sbjct: 188 DFLTLEHLIC 197

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.4 bits (109), Expect = 1e-05
 Identities = 31/249 (12%), Positives = 78/249 (31%), Gaps = 44/249 (17%)

Query: 30  PDFDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQ 89
            ++ F      ++P +   + P+  +    +     +R ++      +Y +S        
Sbjct: 89  INYKFL-----MSPIKTEQRQPSMMTRMYIEQ---RDRLYNDNQVFAKYNVSR--LQPYL 138

Query: 90  ELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGK---VFQV-KKKGVDDGDSDGIYAM 145
           +L     A LE    + +         + G    GK      V     V       I+ +
Sbjct: 139 KLR---QALLELRPAKNVL--------IDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWL 187

Query: 146 KVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFH 205
            +   ++         ++  + +L ++   +  +  +S   + +++ I   +    L   
Sbjct: 188 NLKNCNS-----PETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELR--RLLKS 240

Query: 206 -LYRQG--IFREDQARFYTAEIVSAVSHLHKCGIV--HRDLKPENILM-DSDGHVMLTDF 259
             Y     +          A+  +A +    C I+   R  +  + L   +  H+ L   
Sbjct: 241 KPYENCLLVLLN----VQNAKAWNAFN--LSCKILLTTRFKQVTDFLSAATTTHISLDHH 294

Query: 260 GLAKEIDES 268
            +    DE 
Sbjct: 295 SMTLTPDEV 303

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 41.9 bits (99), Expect = 3e-04
 Identities = 16/45 (35%), Positives = 23/45 (51%), Gaps = 2/45 (4%)

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE 267
           +I   V  LHK  ++H DL   N + D D  + + DFGL K  + 
Sbjct: 439 KIGEIVGKLHKNDVIHNDLTTSNFIFDKD--LYIIDFGLGKISNL 481

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	355
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.97
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.94
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.89
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.82
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.54
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.38
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.35
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.29
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	99.0
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.8
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.79
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.71
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.59
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.55
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.46
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.43
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.38
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.24
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	98.04
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	98.03
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.78
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.74
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.73
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.68
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.63
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.53
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.51
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.32
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.31
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.79
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.7
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.24
3ls8_A	614	Phosphatidylinositol 3-kinase catalytic subunit ty	86.94
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	85.62
2x6h_A	696	GH13170P, VPS34, phosphotidylinositol 3 kinase 59F	85.4
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	84.24
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	84.06
1cja_A	342	Protein (actin-fragmin kinase); transferase; HET:	80.01

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=9.1e-60  Score=428.13  Aligned_cols=232  Identities=38%  Similarity=0.671  Sum_probs=206.2

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|++++.||+|+||+||+|+++     .+++.||||++.+.........+.+.+|+++|++++|||||+++++|.+++
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~-----~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  105 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLAREL-----ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE  105 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccccEEEEEEecccCeEEEEEEEC-----CCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence            357999999999999999999987     568899999998776555666778999999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      .+|+|||||+||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.+...
T Consensus       106 ~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          106 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999987433


Q ss_pred             C---CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhhh-------------hHHHHHhh
Q 018487          269 S---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNT-------------MLLFYLII  332 (355)
Q Consensus       269 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~~-------------~~~~~~~i  332 (355)
                      .   ...+.+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+......             .....++|
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli  265 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLV  265 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHH
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHH
Confidence            2   3456799999999999999999999999999999999999999998764432111             12346788


Q ss_pred             hheeeecCCCcCC
Q 018487          333 FHCLFVNSLELLS  345 (355)
Q Consensus       333 ~~~l~~~~~e~~~  345 (355)
                      .+||.++|.+++.
T Consensus       266 ~~lL~~dp~~R~t  278 (311)
T 4aw0_A          266 EKLLVLDATKRLG  278 (311)
T ss_dssp             HHHSCSSGGGSTT
T ss_pred             HHHccCCHhHCcC
Confidence            8899988888763

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=7.4e-58  Score=421.50  Aligned_cols=227  Identities=25%  Similarity=0.415  Sum_probs=198.7

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ..|+++++||+|+||+||+|+++     .+++.||||++.......   .+.+.+|+.+|+.++|||||+++++|.+++.
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~-----~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  145 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVR-----SSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDE  145 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             HhcEEeEEeecCcCeEEEEEEEC-----CCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            56999999999999999999987     568899999997654322   3457789999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC-
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-  268 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~-  268 (355)
                      +|||||||+||+|.+++.. +.+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+... 
T Consensus       146 ~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  224 (346)
T 4fih_A          146 LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  224 (346)
T ss_dssp             EEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred             EEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence            9999999999999998865 57999999999999999999999999999999999999999999999999999987543 


Q ss_pred             CCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh----------------hhHHHHHhh
Q 018487          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN----------------TMLLFYLII  332 (355)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~----------------~~~~~~~~i  332 (355)
                      ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+....-                ....+.++|
T Consensus       225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli  304 (346)
T 4fih_A          225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL  304 (346)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHH
T ss_pred             CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHH
Confidence            3456789999999999999999999999999999999999999999876433211                112457788


Q ss_pred             hheeeecCCCcCC
Q 018487          333 FHCLFVNSLELLS  345 (355)
Q Consensus       333 ~~~l~~~~~e~~~  345 (355)
                      .+||.++|.+++.
T Consensus       305 ~~~L~~dP~~R~t  317 (346)
T 4fih_A          305 DRLLVRDPAQRAT  317 (346)
T ss_dssp             HHHSCSSTTTSCC
T ss_pred             HHHcCCChhHCcC
Confidence            8999988888753

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.5e-58  Score=410.71  Aligned_cols=229  Identities=29%  Similarity=0.517  Sum_probs=183.9

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++++.||+|+||+||+|+++     .+++.||||++.+.........+.+.+|+.+|+.++|||||+++++|.+.+.
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   87 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHT-----TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDE   87 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECT-----TTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             eCeEEEEEEecCcCeEEEEEEEC-----CCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            68999999999999999999976     5688999999987766556666788999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      +|+||||+ +|+|.+++..++.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus        88 ~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  166 (275)
T 3hyh_A           88 IIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN  166 (275)
T ss_dssp             EEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             EEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence            99999999 57999999999999999999999999999999999999999999999999999999999999998876666


Q ss_pred             CCCcccccCccccchhhccCCC-CCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHHhhhhe
Q 018487          270 RSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYLIIFHC  335 (355)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~~i~~~  335 (355)
                      .....+||+.|||||++.+..| +.++|||||||++|+|+||+.||.+.+.....             ....+.++|.+|
T Consensus       167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  246 (275)
T 3hyh_A          167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRM  246 (275)
T ss_dssp             --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHH
T ss_pred             ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            6667899999999999998876 57999999999999999999999876432211             112456778888


Q ss_pred             eeecCCCcC
Q 018487          336 LFVNSLELL  344 (355)
Q Consensus       336 l~~~~~e~~  344 (355)
                      |.++|.+++
T Consensus       247 L~~dP~~R~  255 (275)
T 3hyh_A          247 LIVNPLNRI  255 (275)
T ss_dssp             SCSSGGGSC
T ss_pred             ccCChhHCc
Confidence            888887765

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=9e-58  Score=430.93  Aligned_cols=228  Identities=25%  Similarity=0.412  Sum_probs=199.2

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .+.|+++++||+|+||+||+|+++     .+++.||||++.......   .+.+.+|+.+|+.++|||||+++++|..++
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~-----~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  221 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVR-----SSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGD  221 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hHhcEeeeEeccCcCcEEEEEEEC-----CCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECC
Confidence            356999999999999999999987     568899999997654322   345778999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      .+|||||||+||+|.+++.. +.+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus       222 ~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~  300 (423)
T 4fie_A          222 ELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  300 (423)
T ss_dssp             EEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred             EEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence            99999999999999998864 56999999999999999999999999999999999999999999999999999987543


Q ss_pred             -CCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh----------------hhHHHHHh
Q 018487          269 -SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN----------------TMLLFYLI  331 (355)
Q Consensus       269 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~----------------~~~~~~~~  331 (355)
                       ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+....-                ....+.++
T Consensus       301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dl  380 (423)
T 4fie_A          301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGF  380 (423)
T ss_dssp             CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHH
T ss_pred             CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHH
Confidence             3456789999999999999999999999999999999999999999876433211                11245778


Q ss_pred             hhheeeecCCCcCC
Q 018487          332 IFHCLFVNSLELLS  345 (355)
Q Consensus       332 i~~~l~~~~~e~~~  345 (355)
                      |.+||.++|.+++.
T Consensus       381 i~~~L~~dP~~R~t  394 (423)
T 4fie_A          381 LDRLLVRDPAQRAT  394 (423)
T ss_dssp             HHHHSCSSTTTSCC
T ss_pred             HHHHcCCChhHCcC
Confidence            88999999888753

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.4e-58  Score=424.42  Aligned_cols=230  Identities=29%  Similarity=0.495  Sum_probs=194.9

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|+++++||+|+||+||+|+++     .+++.||||++.+... .....+.+.+|+.+|++++|||||+++++|.+++
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~   96 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKST-----EDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENG   96 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEET-----TTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             ccceEEeEEEecCCCeEEEEEEEC-----CCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC
Confidence            368999999999999999999987     5688999999987654 3345677899999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          189 KLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                      .+|||||||+||+|.+++..+  ..+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+.
T Consensus        97 ~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  176 (350)
T 4b9d_A           97 SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN  176 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence            999999999999999999755  357999999999999999999999999999999999999999999999999998775


Q ss_pred             cCC-CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh--------------hhHHHHHh
Q 018487          267 ESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN--------------TMLLFYLI  331 (355)
Q Consensus       267 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~--------------~~~~~~~~  331 (355)
                      ... .....+||+.|||||++.+..|+.++|||||||+||||+||+.||...+....-              ....+.++
T Consensus       177 ~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~l  256 (350)
T 4b9d_A          177 STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSL  256 (350)
T ss_dssp             HHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHH
T ss_pred             CCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence            432 234568999999999999999999999999999999999999999886443211              11245778


Q ss_pred             hhheeeecCCCcC
Q 018487          332 IFHCLFVNSLELL  344 (355)
Q Consensus       332 i~~~l~~~~~e~~  344 (355)
                      |.+||.++|.+++
T Consensus       257 i~~~L~~dP~~R~  269 (350)
T 4b9d_A          257 VSQLFKRNPRDRP  269 (350)
T ss_dssp             HHHHTCSSGGGSC
T ss_pred             HHHHccCChhHCc
Confidence            8889988888875

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4e-58  Score=417.07  Aligned_cols=236  Identities=47%  Similarity=0.816  Sum_probs=198.1

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +.+++|++++.||+|+||+||+|++...  ..+++.||||++++....... ...+.+|+.+|++++|||||+++++|.+
T Consensus        21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~--~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~   97 (304)
T 3ubd_A           21 ADPSQFELLKVLGQGSFGKVFLVKKISG--SDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQT   97 (304)
T ss_dssp             CCGGGEEEEEEEECGGGCEEEEEEECSS--TTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEE
T ss_pred             CCccccEEEEEEecCCCeEEEEEEEccC--CCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence            4457899999999999999999987532  246789999999875543322 2357789999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                      ++.+|+|||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus        98 ~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A           98 EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             TTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999998653


Q ss_pred             c-CCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHHhh
Q 018487          267 E-SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYLII  332 (355)
Q Consensus       267 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~~i  332 (355)
                      . .......+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+....-             ....+.++|
T Consensus       178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  257 (304)
T 3ubd_A          178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLL  257 (304)
T ss_dssp             ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence            3 33455679999999999999999999999999999999999999999886543321             122457888


Q ss_pred             hheeeecCCCcCC
Q 018487          333 FHCLFVNSLELLS  345 (355)
Q Consensus       333 ~~~l~~~~~e~~~  345 (355)
                      .+||.++|.+++.
T Consensus       258 ~~~L~~dP~~R~t  270 (304)
T 3ubd_A          258 RMLFKRNPANRLG  270 (304)
T ss_dssp             HHHTCSSGGGSTT
T ss_pred             HHHcccCHHHCCC
Confidence            8999999988875

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.9e-56  Score=402.01  Aligned_cols=228  Identities=26%  Similarity=0.386  Sum_probs=194.1

Q ss_pred             CCCe-EEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec-
Q 018487          109 PGDF-EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-  186 (355)
Q Consensus       109 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-  186 (355)
                      .++| ++.++||+|+||+||+|.++     .+++.||+|++..... .....+.+.+|+.+|++++|||||+++++|.. 
T Consensus        24 ~gr~~~~~~~iG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~   97 (290)
T 3fpq_A           24 DGRFLKFDIEIGRGSFKTVYKGLDT-----ETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST   97 (290)
T ss_dssp             TSSEEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred             CCceEEeeeEEecCcCcEEEEEEEC-----CCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeec
Confidence            3555 78889999999999999987     5678899999986653 34456778999999999999999999999864 


Q ss_pred             ---CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCcEEec-CCCcEEEEecC
Q 018487          187 ---RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMD-SDGHVMLTDFG  260 (355)
Q Consensus       187 ---~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~--iiHrDlkp~NILl~-~~~~~kl~Dfg  260 (355)
                         +..+|||||||+||+|.+++.+.+.+++.+++.|+.||+.||+|||++|  ||||||||+||||+ .+|.+||+|||
T Consensus        98 ~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFG  177 (290)
T 3fpq_A           98 VKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             ETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTT
T ss_pred             cCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCc
Confidence               4568999999999999999999999999999999999999999999999  99999999999997 47999999999


Q ss_pred             CccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh----------------hhh
Q 018487          261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA----------------CNT  324 (355)
Q Consensus       261 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~----------------~~~  324 (355)
                      +|+.... ......+||+.|||||++.+ .|+.++|||||||+||||+||+.||...+...                ...
T Consensus       178 la~~~~~-~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~  255 (290)
T 3fpq_A          178 LATLKRA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA  255 (290)
T ss_dssp             GGGGCCT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCC
T ss_pred             CCEeCCC-CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccC
Confidence            9986433 34556789999999999865 69999999999999999999999997642211                001


Q ss_pred             hHHHHHhhhheeeecCCCcC
Q 018487          325 MLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       325 ~~~~~~~i~~~l~~~~~e~~  344 (355)
                      ...+.++|.+||.++|.+++
T Consensus       256 ~~~~~~li~~~L~~dP~~R~  275 (290)
T 3fpq_A          256 IPEVKEIIEGCIRQNKDERY  275 (290)
T ss_dssp             CHHHHHHHHHHSCSSGGGSC
T ss_pred             CHHHHHHHHHHccCChhHCc
Confidence            12457788899999988876

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6.6e-57  Score=413.93  Aligned_cols=223  Identities=25%  Similarity=0.337  Sum_probs=193.8

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .+.|++.++||+|+||+||+|+++     .+++.||||+++.+..        ..+|+.+|+.++|||||+++++|.+++
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~-----~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~  123 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDK-----QTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGP  123 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETT
T ss_pred             hhheEeCcEeccCCCeEEEEEEEC-----CCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            357999999999999999999987     5678999999986542        235999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC-cEEEEecCCccccCc
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEIDE  267 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~-~~kl~Dfg~a~~~~~  267 (355)
                      .+|||||||+||+|.+++...+.+++.+++.|+.||+.||+|||++|||||||||+||||+.+| .+||+|||+|+.+..
T Consensus       124 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~  203 (336)
T 4g3f_A          124 WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQP  203 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred             EEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence            9999999999999999999999999999999999999999999999999999999999999987 699999999987754


Q ss_pred             CCC------CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh----------------hhhh
Q 018487          268 SSR------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA----------------CNTM  325 (355)
Q Consensus       268 ~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~----------------~~~~  325 (355)
                      ...      ....+||+.|||||++.+..|+.++|||||||++|||+||+.||...+...                ....
T Consensus       204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s  283 (336)
T 4g3f_A          204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCA  283 (336)
T ss_dssp             ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSC
T ss_pred             CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCC
Confidence            322      234689999999999999999999999999999999999999998753211                1122


Q ss_pred             HHHHHhhhheeeecCCCcC
Q 018487          326 LLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~  344 (355)
                      ..+.++|.+||.++|.+++
T Consensus       284 ~~~~~li~~~L~~dP~~R~  302 (336)
T 4g3f_A          284 PLTAQAIQEGLRKEPVHRA  302 (336)
T ss_dssp             HHHHHHHHHHTCSSGGGSC
T ss_pred             HHHHHHHHHHccCCHhHCc
Confidence            3567889999999998876

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.6e-56  Score=409.27  Aligned_cols=236  Identities=22%  Similarity=0.351  Sum_probs=194.5

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      .+...+|.+.++||+|+||+||+|++++..+..+++.||||+++..   .....+.|.+|+++|++++|||||+++++|.
T Consensus        37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~  113 (329)
T 4aoj_A           37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCT  113 (329)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            3455689999999999999999999987666677889999999753   3445577999999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQ---------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS  250 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~---------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~  250 (355)
                      +.+.+|||||||++|+|.+++...               +.+++.++..|+.|++.||+|||+++||||||||+||||+.
T Consensus       114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~  193 (329)
T 4aoj_A          114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ  193 (329)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence            999999999999999999998754               35899999999999999999999999999999999999999


Q ss_pred             CCcEEEEecCCccccCcCC---CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh----
Q 018487          251 DGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC----  322 (355)
Q Consensus       251 ~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~----  322 (355)
                      ++.+||+|||+++.+....   .....+||+.|||||++.+..|+.++|||||||+||||+| |+.||...+....    
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  273 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI  273 (329)
T ss_dssp             TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred             CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            9999999999998764332   2235679999999999999999999999999999999999 9999987643221    


Q ss_pred             ----------hhhHHHHHhhhheeeecCCCcC
Q 018487          323 ----------NTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       323 ----------~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                                .....+++++.+||.++|.+++
T Consensus       274 ~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RP  305 (329)
T 4aoj_A          274 TQGRELERPRACPPEVYAIMRGCWQREPQQRH  305 (329)
T ss_dssp             HHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSC
T ss_pred             HcCCCCCCcccccHHHHHHHHHHcCcChhHCc
Confidence                      1122567888899998888875

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.7e-56  Score=406.82  Aligned_cols=235  Identities=21%  Similarity=0.355  Sum_probs=198.3

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +..++|.+.++||+|+||+||+|++++..+..++..||||+++..   .....+.|.+|+++|++++|||||++++++.+
T Consensus        10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~   86 (299)
T 4asz_A           10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVE   86 (299)
T ss_dssp             CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence            455689999999999999999999887655567889999999753   34455678999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCc
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQ-------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH  253 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~-------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~  253 (355)
                      ++.+|+|||||++|+|.+++...             ..+++.++..|+.||+.||+|||+++||||||||+||||+.++.
T Consensus        87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~  166 (299)
T 4asz_A           87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL  166 (299)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc
Confidence            99999999999999999999764             35899999999999999999999999999999999999999999


Q ss_pred             EEEEecCCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh-------
Q 018487          254 VMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC-------  322 (355)
Q Consensus       254 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~-------  322 (355)
                      +||+|||+|+.......   ....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+....       
T Consensus       167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~  246 (299)
T 4asz_A          167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG  246 (299)
T ss_dssp             EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT
T ss_pred             EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999986643322   234578999999999999999999999999999999999 9999988643221       


Q ss_pred             -------hhhHHHHHhhhheeeecCCCcC
Q 018487          323 -------NTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       323 -------~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                             .....+++++.+||.++|.+++
T Consensus       247 ~~~~~p~~~~~~~~~li~~cl~~dP~~RP  275 (299)
T 4asz_A          247 RVLQRPRTCPQEVYELMLGCWQREPHMRK  275 (299)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             CCCCCCccchHHHHHHHHHHcCCChhHCc
Confidence                   1223567888899988888865

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.9e-56  Score=404.93  Aligned_cols=237  Identities=20%  Similarity=0.330  Sum_probs=197.5

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      .+..+++++.++||+|+||+||+|.+.+..+...++.||||+++...  .....+.|.+|+.+|++++|||||++++++.
T Consensus        22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~   99 (308)
T 4gt4_A           22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVT   99 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence            34556899999999999999999998876666678899999997543  3344567899999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEec
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD  249 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~  249 (355)
                      ..+.+|+|||||++|+|.+++..+                ..+++.++..|+.||++||+|||+++||||||||+||||+
T Consensus       100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY  179 (308)
T ss_dssp             SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence            999999999999999999999653                3589999999999999999999999999999999999999


Q ss_pred             CCCcEEEEecCCccccCcCC---CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh---
Q 018487          250 SDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC---  322 (355)
Q Consensus       250 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~---  322 (355)
                      +++.+||+|||+++.+....   .....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+....   
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~  259 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM  259 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            99999999999998764322   2345689999999999999999999999999999999999 8999988643221   


Q ss_pred             -----------hhhHHHHHhhhheeeecCCCcC
Q 018487          323 -----------NTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       323 -----------~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                                 .....+++++.+||..+|.+++
T Consensus       260 i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RP  292 (308)
T 4gt4_A          260 IRNRQVLPCPDDCPAWVYALMIECWNEFPSRRP  292 (308)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             HHcCCCCCCcccchHHHHHHHHHHcCCChhHCc
Confidence                       1223467788888888888765

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.1e-55  Score=398.92  Aligned_cols=231  Identities=24%  Similarity=0.342  Sum_probs=191.8

Q ss_pred             hcCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceeccee
Q 018487          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (355)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~  183 (355)
                      .|.+..++|++.++||+|+||+||+|+++        ..||||+++... ......+.|.+|+.+|++++|||||+++++
T Consensus        30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~--------~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~  100 (307)
T 3omv_A           30 YWEIEASEVMLSTRIGSGSFGTVYKGKWH--------GDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGY  100 (307)
T ss_dssp             CCBCCTTSCCEEEECCCCSSSEEEEEESS--------SEEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             CcEEcHHHeEEeeEEeeCCCcEEEEEEEC--------CcEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            45677889999999999999999999864        249999987543 344556789999999999999999999998


Q ss_pred             eecCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          184 FQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       184 ~~~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                      +.. +.+|||||||+||+|.+++... ..+++.++..|+.||+.||+|||+++||||||||+||||++++.+||+|||+|
T Consensus       101 ~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  179 (307)
T 3omv_A          101 MTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLA  179 (307)
T ss_dssp             ECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSC
T ss_pred             EEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCc
Confidence            765 5689999999999999999765 57999999999999999999999999999999999999999999999999999


Q ss_pred             cccCcC---CCCCcccccCccccchhhcc---CCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh---------------
Q 018487          263 KEIDES---SRSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA---------------  321 (355)
Q Consensus       263 ~~~~~~---~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~---------------  321 (355)
                      +.....   ......+||+.|||||++.+   ..|+.++|||||||+||||+||+.||...+...               
T Consensus       180 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~  259 (307)
T 3omv_A          180 TVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDL  259 (307)
T ss_dssp             BC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCS
T ss_pred             eecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCc
Confidence            876432   22345689999999999974   358999999999999999999999998743211               


Q ss_pred             ----hhhhHHHHHhhhheeeecCCCcC
Q 018487          322 ----CNTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       322 ----~~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                          .+....+.+++.+||.++|.+++
T Consensus       260 ~~~~~~~~~~l~~li~~cl~~dP~~RP  286 (307)
T 3omv_A          260 SKLYKNCPKAMKRLVADCVKKVKEERP  286 (307)
T ss_dssp             TTSCTTSCHHHHHHHHHHTCSSSTTSC
T ss_pred             ccccccchHHHHHHHHHHcCCCHhHCc
Confidence                01123467888899999988875

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.7e-54  Score=399.81  Aligned_cols=239  Identities=22%  Similarity=0.383  Sum_probs=203.3

Q ss_pred             hcCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCC-Ccceecce
Q 018487          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQLRY  182 (355)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~  182 (355)
                      .|.+..++|++.++||+|+||+||+|.+++.......+.||||.+....  .....+.+.+|+.+|++++| ||||++++
T Consensus        58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g  135 (353)
T 4ase_A           58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG  135 (353)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence            4667788999999999999999999999987777778899999997653  23445678899999999975 89999999


Q ss_pred             eeec-CCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q 018487          183 SFQT-RSKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (355)
Q Consensus       183 ~~~~-~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~N  245 (355)
                      +|.. ++.+|+|||||++|+|.+++...                ..+++.++..++.||++||+|||+++||||||||+|
T Consensus       136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N  215 (353)
T 4ase_A          136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  215 (353)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence            9865 46799999999999999999753                348999999999999999999999999999999999


Q ss_pred             EEecCCCcEEEEecCCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh
Q 018487          246 ILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA  321 (355)
Q Consensus       246 ILl~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~  321 (355)
                      ||+++++.+||+|||+|+.+.....   ....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+...
T Consensus       216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~  295 (353)
T 4ase_A          216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  295 (353)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999987644332   235678999999999999999999999999999999998 999998753211


Q ss_pred             ---h------------hhhHHHHHhhhheeeecCCCcC
Q 018487          322 ---C------------NTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       322 ---~------------~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                         .            .....++.++.+||..+|.+++
T Consensus       296 ~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RP  333 (353)
T 4ase_A          296 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP  333 (353)
T ss_dssp             HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCc
Confidence               0            1122467888899998888865

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.7e-53  Score=399.43  Aligned_cols=204  Identities=24%  Similarity=0.423  Sum_probs=178.6

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec--
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--  186 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--  186 (355)
                      .++|+++++||+|+||+||+|+++     .+++.||||+++.... .....+.+.+|+++|+.++|||||++++++..  
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~-----~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  126 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRR-----LTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTV  126 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSS
T ss_pred             CCCeEEEEEEecccCeEEEEEEEC-----CCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeeccc
Confidence            368999999999999999999987     5688999999976543 33445667889999999999999999998753  


Q ss_pred             ----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          187 ----RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       187 ----~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                          .+.+|||||||+ |+|.+++...+.+++.+++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|
T Consensus       127 ~~~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          127 PYGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             CTTTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             ccccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeeccee
Confidence                467999999996 579999998899999999999999999999999999999999999999999999999999999


Q ss_pred             cccCcC-----CCCCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCchh
Q 018487          263 KEIDES-----SRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSMQV  319 (355)
Q Consensus       263 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~~~  319 (355)
                      +.+...     ......+||+.|||||++.+. .|+.++||||+||++|||++|+.||.+.+.
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~  268 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY  268 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH
Confidence            876432     234567999999999998875 569999999999999999999999987643

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.7e-53  Score=385.26  Aligned_cols=225  Identities=28%  Similarity=0.429  Sum_probs=178.4

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC--
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS--  188 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--  188 (355)
                      +|++++.||+|+||+||+|+++     .+++.||||+++...  .....+.+.+|+.+|++++|||||+++++|...+  
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~   78 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNK-----VDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT   78 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEET-----TTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--
T ss_pred             hCEEeeEEecCCCeEEEEEEEC-----CCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcc
Confidence            6999999999999999999987     567889999997643  3444567889999999999999999999987544  


Q ss_pred             ----------eEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEE
Q 018487          189 ----------KLYLILDFINGGHLFFHLYRQGI---FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM  255 (355)
Q Consensus       189 ----------~~~lv~e~~~~gsL~~~l~~~~~---l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~k  255 (355)
                                .+|+|||||+||+|.+++.....   ..+..++.++.||+.||+|||++||+||||||+||||+.++.+|
T Consensus        79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vK  158 (299)
T 4g31_A           79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVK  158 (299)
T ss_dssp             --------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred             ccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEE
Confidence                      47999999999999999987755   34567889999999999999999999999999999999999999


Q ss_pred             EEecCCccccCcCCC-------------CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh
Q 018487          256 LTDFGLAKEIDESSR-------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC  322 (355)
Q Consensus       256 l~Dfg~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~  322 (355)
                      |+|||+|+.+.....             ....+||+.|||||++.+..|+.++|||||||++|||++   ||........
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~  235 (299)
T 4g31_A          159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR  235 (299)
T ss_dssp             ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence            999999987654321             234589999999999999999999999999999999996   8876421110


Q ss_pred             h---------------hhHHHHHhhhheeeecCCCcCC
Q 018487          323 N---------------TMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       323 ~---------------~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      .               .......+|.+||+++|.+++.
T Consensus       236 ~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps  273 (299)
T 4g31_A          236 TLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPE  273 (299)
T ss_dssp             HHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCC
T ss_pred             HHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcC
Confidence            0               0012245778888888887753

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=7.5e-53  Score=414.82  Aligned_cols=234  Identities=35%  Similarity=0.626  Sum_probs=199.9

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHH---HHHHHHhcCCCcceecce
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA---ERDILTKVTHPFIVQLRY  182 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~---E~~~l~~l~h~nIv~l~~  182 (355)
                      .+..++|++++.||+|+||+||+|+++     .+++.||||++.+...........+.+   ++.+++.++|||||++++
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~~-----~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~  259 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRKA-----DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY  259 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEEC-----CCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEE
Confidence            455679999999999999999999987     578899999998765443333333334   456677789999999999


Q ss_pred             eeecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       183 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                      +|.+.+.+|+|||||+||+|..++...+.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|
T Consensus       260 ~f~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA  339 (689)
T 3v5w_A          260 AFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA  339 (689)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEeccccee
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCCCCcccccCccccchhhc-cCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh----------------hhh
Q 018487          263 KEIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC----------------NTM  325 (355)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~----------------~~~  325 (355)
                      +.+.... ..+.+||+.|||||++. +..|+.++|||||||+||||++|+.||.+.+....                ...
T Consensus       340 ~~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S  418 (689)
T 3v5w_A          340 CDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS  418 (689)
T ss_dssp             EECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred             eecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCC
Confidence            8875543 45679999999999997 45799999999999999999999999976422110                011


Q ss_pred             HHHHHhhhheeeecCCCcCC
Q 018487          326 LLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ....++|.+||.++|.+++.
T Consensus       419 ~~a~dLI~~lL~~dP~~Rl~  438 (689)
T 3v5w_A          419 PELRSLLEGLLQRDVNRRLG  438 (689)
T ss_dssp             HHHHHHHHHHTCSCGGGCTT
T ss_pred             HHHHHHHHHHccCCHhHCCC
Confidence            23578888999999998874

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.1e-50  Score=376.52  Aligned_cols=199  Identities=24%  Similarity=0.442  Sum_probs=171.0

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceeeecC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR  187 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~  187 (355)
                      .++|++.++||+|+||+||+|+++..  ..+++.||+|.+....     ....+.+|+++|+.+ +|||||+++++|...
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~--~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~   92 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQ--VGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN   92 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBT--TSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred             cCcEEEEEEEecccCcEEEEEEEccc--CCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence            36899999999999999999987521  2357889999886542     234567899999998 599999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCC-CcEEEEecCCccccC
Q 018487          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEID  266 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~-~~~kl~Dfg~a~~~~  266 (355)
                      +++|+|||||+||+|.+++.   .+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus        93 ~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~  169 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH  169 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred             CEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence            99999999999999998883   58999999999999999999999999999999999999877 799999999997653


Q ss_pred             cCC-----------------------------CCCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCC
Q 018487          267 ESS-----------------------------RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKS  316 (355)
Q Consensus       267 ~~~-----------------------------~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~  316 (355)
                      ...                             .....+||+.|||||++.+. .|+.++||||+||++|||+||+.||..
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~  249 (361)
T 4f9c_A          170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK  249 (361)
T ss_dssp             TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence            221                             12345799999999999875 589999999999999999999999964


Q ss_pred             c
Q 018487          317 M  317 (355)
Q Consensus       317 ~  317 (355)
                      .
T Consensus       250 ~  250 (361)
T 4f9c_A          250 A  250 (361)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.4e-51  Score=372.90  Aligned_cols=193  Identities=27%  Similarity=0.394  Sum_probs=160.9

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC-
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-  188 (355)
                      .+|.+.++||+|+||+||+|+++       ++.||||++.....    .......|+..+.+++|||||++++++...+ 
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~-------g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~   71 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR-------GEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNG   71 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET-------TEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-------CEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCC
Confidence            36899999999999999999865       56799999865421    1122345777778899999999999998653 


Q ss_pred             ---eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeeccCCCCcEEecCCCcEEEE
Q 018487          189 ---KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC--------GIVHRDLKPENILMDSDGHVMLT  257 (355)
Q Consensus       189 ---~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~--------~iiHrDlkp~NILl~~~~~~kl~  257 (355)
                         .+|||||||++|+|.+++... .+++.++..++.|++.||+|||++        +||||||||+||||+.++.+||+
T Consensus        72 ~~~~~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~  150 (303)
T 3hmm_A           72 TWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  150 (303)
T ss_dssp             SSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             CceEEEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEE
Confidence               689999999999999999764 589999999999999999999987        99999999999999999999999


Q ss_pred             ecCCccccCcCCC-----CCcccccCccccchhhccC------CCCCcccHHHHHHHHHHHHcCCCCC
Q 018487          258 DFGLAKEIDESSR-----SNSMCGTTEYMAPEILLSK------GHNKDADWWSVGILLYEMLTGQVNI  314 (355)
Q Consensus       258 Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~~l~elltg~~pf  314 (355)
                      |||+|+.......     ....+||+.|||||++.+.      .++.++|||||||+||||+||+.||
T Consensus       151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~  218 (303)
T 3hmm_A          151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG  218 (303)
T ss_dssp             CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred             eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCC
Confidence            9999987644322     2345899999999999764      3567999999999999999997655

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.3e-50  Score=399.39  Aligned_cols=227  Identities=27%  Similarity=0.458  Sum_probs=199.1

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++++.||+|+||+||+|.++     .+++.||+|++....   ....+.+.+|+.+|+.++|||||+++++|.+.+.
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~-----~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  228 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTER-----ATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE  228 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSE
T ss_pred             cccEEEEEEeeccCeEEEEEEEC-----CCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            58999999999999999999987     568899999997643   2334567889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCC--CcEEEEecCCccccC
Q 018487          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEID  266 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~--~~~kl~Dfg~a~~~~  266 (355)
                      +|+|||||+||+|.+++.. .+.+++.+++.++.||+.||.|||++||+||||||+|||++.+  +.+||+|||+|+.+.
T Consensus       229 ~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~  308 (573)
T 3uto_A          229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  308 (573)
T ss_dssp             EEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred             EEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence            9999999999999999864 4679999999999999999999999999999999999999854  899999999999887


Q ss_pred             cCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-----------------hhHHHH
Q 018487          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-----------------TMLLFY  329 (355)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-----------------~~~~~~  329 (355)
                      ........+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+.....                 ......
T Consensus       309 ~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  388 (573)
T 3uto_A          309 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK  388 (573)
T ss_dssp             TTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHH
T ss_pred             CCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            766666789999999999999999999999999999999999999999876432211                 112446


Q ss_pred             HhhhheeeecCCCcC
Q 018487          330 LIIFHCLFVNSLELL  344 (355)
Q Consensus       330 ~~i~~~l~~~~~e~~  344 (355)
                      ++|.+||.++|.+++
T Consensus       389 dli~~~L~~dp~~R~  403 (573)
T 3uto_A          389 DFIRKLLLADPNTRM  403 (573)
T ss_dssp             HHHHTTSCSSGGGSC
T ss_pred             HHHHHHccCChhHCc
Confidence            788888888888765

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.8e-48  Score=359.87  Aligned_cols=232  Identities=39%  Similarity=0.730  Sum_probs=204.5

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ..++|++++.||+|+||+||+|+++     .+++.||+|++++.........+.+.+|+.+++.++||||+++++++...
T Consensus         3 ~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~   77 (337)
T 1o6l_A            3 TMNDFDYLKLLGKGTFGKVILVREK-----ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH   77 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS
T ss_pred             ChHHeEEEEEEecCCCeEEEEEEEC-----CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC
Confidence            3468999999999999999999976     56788999999876544455567788899999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC-
Q 018487          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-  266 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~-  266 (355)
                      +.+|+||||++||+|..++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++... 
T Consensus        78 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           78 DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            9999999999999999999988899999999999999999999999999999999999999999999999999998643 


Q ss_pred             cCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHHhhh
Q 018487          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYLIIF  333 (355)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~~i~  333 (355)
                      ........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.....             ....+..+|.
T Consensus       158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  237 (337)
T 1o6l_A          158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLA  237 (337)
T ss_dssp             TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred             CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            333455678999999999999999999999999999999999999999876443221             1234577889


Q ss_pred             heeeecCCCcC
Q 018487          334 HCLFVNSLELL  344 (355)
Q Consensus       334 ~~l~~~~~e~~  344 (355)
                      +||.++|.+++
T Consensus       238 ~lL~~dP~~R~  248 (337)
T 1o6l_A          238 GLLKKDPKQRL  248 (337)
T ss_dssp             HHTCSSTTTST
T ss_pred             HHhhcCHHHhc
Confidence            99999998876

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.2e-48  Score=367.51  Aligned_cols=235  Identities=37%  Similarity=0.747  Sum_probs=201.1

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~  184 (355)
                      .+..++|+++++||+|+||+||+|+++     .+++.||+|++++.........+.+.+|..+++++ +||||++++++|
T Consensus        48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~-----~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~  122 (396)
T 4dc2_A           48 SLGLQDFDLLRVIGRGSYAKVLLVRLK-----KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF  122 (396)
T ss_dssp             -CCGGGEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             CCChhHcEEEEEEeeCCCeEEEEEEEC-----CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE
Confidence            355678999999999999999999987     56789999999887655555556678899999887 899999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      ...+.+|+||||++||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus       123 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~  202 (396)
T 4dc2_A          123 QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  202 (396)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence            99999999999999999999999989999999999999999999999999999999999999999999999999999986


Q ss_pred             c-CcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh----------------------
Q 018487          265 I-DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA----------------------  321 (355)
Q Consensus       265 ~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~----------------------  321 (355)
                      . .........+||+.|+|||++.+..++.++|||||||++|||++|+.||.......                      
T Consensus       203 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p  282 (396)
T 4dc2_A          203 GLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP  282 (396)
T ss_dssp             CCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC
T ss_pred             cccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC
Confidence            3 33444567789999999999999999999999999999999999999996421100                      


Q ss_pred             hhhhHHHHHhhhheeeecCCCcCC
Q 018487          322 CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 ~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      .........+|.+||.++|.+++.
T Consensus       283 ~~~s~~~~~li~~lL~~dP~~R~~  306 (396)
T 4dc2_A          283 RSLSVKAASVLKSFLNKDPKERLG  306 (396)
T ss_dssp             TTSCHHHHHHHHHHTCSCTTTSTT
T ss_pred             CcCCHHHHHHHHHHhcCCHhHcCC
Confidence            011224567888999999988875

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.6e-48  Score=362.35  Aligned_cols=235  Identities=39%  Similarity=0.710  Sum_probs=199.9

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceeee
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQ  185 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~  185 (355)
                      +..++|++++.||+|+||+||+|+++     .+++.||||++++.........+.+.+|..+++.+ +||||++++++|.
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~   94 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVK-----ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ   94 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEc-----CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE
Confidence            44578999999999999999999987     56788999999876555556667788899999988 6999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      ..+.+|+||||++||+|..++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        95 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A           95 TPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence            99999999999999999999999899999999999999999999999999999999999999999999999999999864


Q ss_pred             C-cCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHHh
Q 018487          266 D-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYLI  331 (355)
Q Consensus       266 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~~  331 (355)
                      . ........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.....             .......+
T Consensus       175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l  254 (353)
T 3txo_A          175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGI  254 (353)
T ss_dssp             CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            3 233345678999999999999999999999999999999999999999876543211             12345778


Q ss_pred             hhheeeecCCCcCCC
Q 018487          332 IFHCLFVNSLELLSH  346 (355)
Q Consensus       332 i~~~l~~~~~e~~~~  346 (355)
                      |.+||.++|.+++..
T Consensus       255 i~~lL~~dP~~R~~~  269 (353)
T 3txo_A          255 LKSFMTKNPTMRLGS  269 (353)
T ss_dssp             HHHHTCSSGGGSTTS
T ss_pred             HHHHhhhCHHHccCC
Confidence            889999999887754

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.2e-47  Score=354.39  Aligned_cols=230  Identities=29%  Similarity=0.529  Sum_probs=203.1

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|++++.||+|+||.||+|.+.     .+++.||||++..... .....+.+.+|+.+++.++||||+++++++...+
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   87 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHI-----LTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK   87 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEEC-----CCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            468999999999999999999976     5678899999987543 3445567889999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      .+|+||||+++++|.+++...+.+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           88 TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             EEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            99999999999999999999899999999999999999999999999999999999999999999999999999887666


Q ss_pred             CCCCcccccCccccchhhccCCCC-CcccHHHHHHHHHHHHcCCCCCCCchhhhhhh-------------hHHHHHhhhh
Q 018487          269 SRSNSMCGTTEYMAPEILLSKGHN-KDADWWSVGILLYEMLTGQVNIKSMQVIACNT-------------MLLFYLIIFH  334 (355)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~elltg~~pf~~~~~~~~~~-------------~~~~~~~i~~  334 (355)
                      ......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...+......             ...+.+++.+
T Consensus       168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  247 (328)
T 3fe3_A          168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKR  247 (328)
T ss_dssp             CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            556677899999999999988775 78999999999999999999998865433221             2345678889


Q ss_pred             eeeecCCCcC
Q 018487          335 CLFVNSLELL  344 (355)
Q Consensus       335 ~l~~~~~e~~  344 (355)
                      ||..+|.+++
T Consensus       248 ~L~~dP~~R~  257 (328)
T 3fe3_A          248 FLVLNPIKRG  257 (328)
T ss_dssp             HCCSSTTTSC
T ss_pred             HCCCChhHCc
Confidence            9988888765

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.9e-47  Score=355.28  Aligned_cols=236  Identities=36%  Similarity=0.688  Sum_probs=203.5

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~  184 (355)
                      .+..++|++.+.||+|+||.||+|+++     .+++.||+|++++.........+.+..|..+++.+ +||||+++++++
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~   87 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFK-----KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF   87 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEET-----TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEEC-----CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE
Confidence            345679999999999999999999987     56789999999876544445556677899999877 899999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      ...+.+|+||||++||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus        88 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           88 QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            99999999999999999999999888999999999999999999999999999999999999999999999999999986


Q ss_pred             cC-cCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHH
Q 018487          265 ID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYL  330 (355)
Q Consensus       265 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~  330 (355)
                      .. ........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.....             ......+
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  247 (345)
T 1xjd_A          168 NMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD  247 (345)
T ss_dssp             CCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             cccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHH
Confidence            43 223345678999999999999999999999999999999999999999876433211             1234578


Q ss_pred             hhhheeeecCCCcCCC
Q 018487          331 IIFHCLFVNSLELLSH  346 (355)
Q Consensus       331 ~i~~~l~~~~~e~~~~  346 (355)
                      +|.+||.++|.+++..
T Consensus       248 li~~lL~~dp~~R~~~  263 (345)
T 1xjd_A          248 LLVKLFVREPEKRLGV  263 (345)
T ss_dssp             HHHHHSCSSGGGSBTT
T ss_pred             HHHHHhcCCHhHcCCC
Confidence            8899999998887643

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=361.37  Aligned_cols=235  Identities=35%  Similarity=0.650  Sum_probs=206.7

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      .+..++|++++.||+|+||.||+|.++     .+++.||+|++.+.........+.+.+|+.+|+.++|||||+++++|.
T Consensus        11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~-----~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~   85 (384)
T 4fr4_A           11 DVNFDHFEILRAIGKGSFGKVCIVQKN-----DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ   85 (384)
T ss_dssp             CCCGGGEEEEEEEECCTTCCEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEEC-----CCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            345578999999999999999999977     567889999998766555566677889999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      ..+.+|+||||+.||+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+
T Consensus        86 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~  165 (384)
T 4fr4_A           86 DEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML  165 (384)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeec
Confidence            99999999999999999999998889999999999999999999999999999999999999999999999999999987


Q ss_pred             CcCCCCCcccccCccccchhhcc---CCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh----------------hhhH
Q 018487          266 DESSRSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC----------------NTML  326 (355)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~----------------~~~~  326 (355)
                      .........+||+.|+|||++.+   ..++.++|||||||++|+|++|+.||........                ....
T Consensus       166 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~  245 (384)
T 4fr4_A          166 PRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQ  245 (384)
T ss_dssp             CTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCH
T ss_pred             cCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCH
Confidence            76666677899999999999974   4589999999999999999999999975322111                1123


Q ss_pred             HHHHhhhheeeecCCCcCC
Q 018487          327 LFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       327 ~~~~~i~~~l~~~~~e~~~  345 (355)
                      .+..+|.+||..+|.+++.
T Consensus       246 ~~~~li~~lL~~dP~~R~s  264 (384)
T 4fr4_A          246 EMVSLLKKLLEPNPDQRFS  264 (384)
T ss_dssp             HHHHHHHHHSCSSGGGSCC
T ss_pred             HHHHHHHHHhcCCHhHhcc
Confidence            4678889999999998875

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-47  Score=350.93  Aligned_cols=230  Identities=37%  Similarity=0.700  Sum_probs=203.1

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ..++|++++.||+|+||+||+|+++     .+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~   78 (318)
T 1fot_A            4 SLQDFQILRTLGTGSFGRVHLIRSR-----HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA   78 (318)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS
T ss_pred             ChHHcEEEEEEeeCCCEEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC
Confidence            3468999999999999999999976     56789999999876544445566788899999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      ..+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus        79 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           79 QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             CEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            99999999999999999999988999999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHHhhhh
Q 018487          268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYLIIFH  334 (355)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~~i~~  334 (355)
                      .  ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.....             ....+..+|.+
T Consensus       159 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  236 (318)
T 1fot_A          159 V--TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR  236 (318)
T ss_dssp             C--BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             c--cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            2  34568999999999999999999999999999999999999999876433211             12346788889


Q ss_pred             eeeecCCCcC
Q 018487          335 CLFVNSLELL  344 (355)
Q Consensus       335 ~l~~~~~e~~  344 (355)
                      ||.++|.+++
T Consensus       237 lL~~dp~~R~  246 (318)
T 1fot_A          237 LITRDLSQRL  246 (318)
T ss_dssp             HTCSCTTTCT
T ss_pred             HhccCHHHcC
Confidence            9999998877

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.5e-47  Score=355.63  Aligned_cols=234  Identities=35%  Similarity=0.679  Sum_probs=203.7

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceeee
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQ  185 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~  185 (355)
                      +..++|++++.||+|+||+||+|+++     .+++.||+|++++.........+.+.+|..++..+ +||||+++++++.
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~   91 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERK-----GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ   91 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEET-----TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEEC-----CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE
Confidence            45679999999999999999999977     46788999999876554455566788899999988 7999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      ..+.+|+||||++||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus        92 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           92 TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            99999999999999999999998889999999999999999999999999999999999999999999999999999864


Q ss_pred             C-cCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHHh
Q 018487          266 D-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYLI  331 (355)
Q Consensus       266 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~~  331 (355)
                      . ........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.....             ....+..+
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  251 (353)
T 2i0e_A          172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAI  251 (353)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            3 233355678999999999999999999999999999999999999999876433211             12345788


Q ss_pred             hhheeeecCCCcCC
Q 018487          332 IFHCLFVNSLELLS  345 (355)
Q Consensus       332 i~~~l~~~~~e~~~  345 (355)
                      |.+||.++|.+++.
T Consensus       252 i~~lL~~dP~~R~~  265 (353)
T 2i0e_A          252 CKGLMTKHPGKRLG  265 (353)
T ss_dssp             HHHHTCSCTTSCTT
T ss_pred             HHHHhhcCHHHcCC
Confidence            88999999988773

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.6e-47  Score=353.65  Aligned_cols=234  Identities=38%  Similarity=0.749  Sum_probs=203.2

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceeee
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQ  185 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~  185 (355)
                      +..++|++++.||+|+||.||+|+++     .+++.||+|++.+.........+.+.+|..+++++ +||||++++++|.
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~   80 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLK-----KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ   80 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             CchhheEEEEEEEecCCeEEEEEEEC-----CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE
Confidence            34568999999999999999999987     56789999999887666666677788999999988 8999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      ..+.+|+||||++||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~  160 (345)
T 3a8x_A           81 TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  160 (345)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence            99999999999999999999998889999999999999999999999999999999999999999999999999999864


Q ss_pred             C-cCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchh-----------hh-----------h
Q 018487          266 D-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQV-----------IA-----------C  322 (355)
Q Consensus       266 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~-----------~~-----------~  322 (355)
                      . ........+||+.|+|||++.+..++.++|||||||++|||++|+.||.....           ..           .
T Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~  240 (345)
T 3a8x_A          161 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR  240 (345)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT
T ss_pred             cCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC
Confidence            3 33344567899999999999999999999999999999999999999975210           00           0


Q ss_pred             hhhHHHHHhhhheeeecCCCcCC
Q 018487          323 NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       323 ~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      .....+..+|.+||.++|.+++.
T Consensus       241 ~~s~~~~~li~~lL~~dP~~R~~  263 (345)
T 3a8x_A          241 SLSVKAASVLKSFLNKDPKERLG  263 (345)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSTT
T ss_pred             CCCHHHHHHHHHHhcCCHhHCCC
Confidence            11224567888899888888765

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=5.1e-47  Score=344.96  Aligned_cols=234  Identities=26%  Similarity=0.403  Sum_probs=201.0

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +..++|++++.||+|+||.||+|.+.     ..++.||+|++...........+.+.+|+.+++.++||||+++++++..
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~   82 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDT-----ILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE   82 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEET-----TTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEEC-----CCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee
Confidence            34578999999999999999999976     5678899999977665566677889999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                      .+.+|+||||++|++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        83 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           83 DDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             CCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            99999999999999999999998899999999999999999999999999999999999999999999999999998764


Q ss_pred             cCCC--CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh------------------hhhH
Q 018487          267 ESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC------------------NTML  326 (355)
Q Consensus       267 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~------------------~~~~  326 (355)
                      ....  ....+||+.|+|||++.+..++.++||||||+++|+|+||+.||........                  ....
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (294)
T 4eqm_A          163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ  242 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCH
T ss_pred             cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCH
Confidence            4322  3345799999999999999999999999999999999999999987643221                  1224


Q ss_pred             HHHHhhhheeeecCCCcCC
Q 018487          327 LFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       327 ~~~~~i~~~l~~~~~e~~~  345 (355)
                      .+..+|.+||.++|.+++.
T Consensus       243 ~l~~li~~~l~~dp~~R~~  261 (294)
T 4eqm_A          243 SLSNVILRATEKDKANRYK  261 (294)
T ss_dssp             HHHHHHHHHSCSSGGGSCS
T ss_pred             HHHHHHHHHhcCCHhHccc
Confidence            5778899999999988763

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3e-47  Score=354.86  Aligned_cols=232  Identities=39%  Similarity=0.710  Sum_probs=205.6

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      ...++|++++.||+|+||.||+|+++     .+++.||+|++.+.........+.+.+|+.+++.++||||+++++++..
T Consensus        38 ~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  112 (350)
T 1rdq_E           38 AQLDQFDRIKTLGTGSFGRVMLVKHK-----ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD  112 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             CCHHHCEEEEEeecCcCcEEEEEEEC-----CCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            44578999999999999999999977     5678899999987655455556778899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                      .+.+|+||||++||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus       113 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~  192 (350)
T 1rdq_E          113 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceecc
Confidence            99999999999999999999988899999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHHhhh
Q 018487          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYLIIF  333 (355)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~~i~  333 (355)
                      ..  ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.....             ....+..+|.
T Consensus       193 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  270 (350)
T 1rdq_E          193 GR--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR  270 (350)
T ss_dssp             SC--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHH
T ss_pred             CC--cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            43  34568999999999999999999999999999999999999999876433211             1235678899


Q ss_pred             heeeecCCCcCC
Q 018487          334 HCLFVNSLELLS  345 (355)
Q Consensus       334 ~~l~~~~~e~~~  345 (355)
                      +||..+|.+++.
T Consensus       271 ~lL~~dp~~R~~  282 (350)
T 1rdq_E          271 NLLQVDLTKRFG  282 (350)
T ss_dssp             HHSCSCTTTCTT
T ss_pred             HHhhcCHHhccC
Confidence            999999998875

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3e-47  Score=357.54  Aligned_cols=233  Identities=45%  Similarity=0.792  Sum_probs=194.0

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHH-HHhcCCCcceecceeeec
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~  186 (355)
                      ..++|++++.||+|+||.||+|+++     .+++.||+|++.+...........+.+|..+ ++.++||||++++++|..
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~  110 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHK-----AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT  110 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEET-----TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEc-----CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe
Confidence            3468999999999999999999987     5678899999988765555555566677776 577899999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc-
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-  265 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~-  265 (355)
                      .+.+|+||||++||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.. 
T Consensus       111 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          111 ADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            9999999999999999999999889999999999999999999999999999999999999999999999999999864 


Q ss_pred             CcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHHhh
Q 018487          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYLII  332 (355)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~~i  332 (355)
                      .........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.....             ....+..+|
T Consensus       191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li  270 (373)
T 2r5t_A          191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLL  270 (373)
T ss_dssp             CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHH
T ss_pred             cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Confidence            3333456678999999999999999999999999999999999999999876433211             123457788


Q ss_pred             hheeeecCCCcCC
Q 018487          333 FHCLFVNSLELLS  345 (355)
Q Consensus       333 ~~~l~~~~~e~~~  345 (355)
                      .+||.++|.+++.
T Consensus       271 ~~lL~~dp~~R~~  283 (373)
T 2r5t_A          271 EGLLQKDRTKRLG  283 (373)
T ss_dssp             HHHTCSSGGGSTT
T ss_pred             HHHcccCHHhCCC
Confidence            8999998888764

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.2e-46  Score=351.93  Aligned_cols=232  Identities=31%  Similarity=0.474  Sum_probs=202.0

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccc---hhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK---KNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      .++|++.+.||+|+||+||+|.++     .+++.||+|++.+.....   ....+.+.+|+.+|+.++||||++++++|.
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~   85 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREK-----STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE   85 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEEC-----CCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE
Confidence            357999999999999999999977     567889999998754322   123466889999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC----cEEEEecCC
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG----HVMLTDFGL  261 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~----~~kl~Dfg~  261 (355)
                      ..+.+|+||||++||+|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++.++    .+||+|||+
T Consensus        86 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~  165 (361)
T 2yab_A           86 NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (361)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence            9999999999999999999999888999999999999999999999999999999999999998777    799999999


Q ss_pred             ccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-----------------hh
Q 018487          262 AKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-----------------NT  324 (355)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-----------------~~  324 (355)
                      +..+.........+||+.|+|||++.+..++.++|||||||++|+|++|..||...+....                 ..
T Consensus       166 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (361)
T 2yab_A          166 AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT  245 (361)
T ss_dssp             CEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred             ceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCC
Confidence            9987666556677899999999999999999999999999999999999999987543221                 11


Q ss_pred             hHHHHHhhhheeeecCCCcCC
Q 018487          325 MLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       325 ~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ...+.++|.+||..+|.+++.
T Consensus       246 s~~~~~li~~~L~~dP~~R~t  266 (361)
T 2yab_A          246 SELAKDFIRKLLVKETRKRLT  266 (361)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCC
T ss_pred             CHHHHHHHHHHCCCChhHCcC
Confidence            224577888999888887664

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=6.3e-47  Score=350.57  Aligned_cols=231  Identities=27%  Similarity=0.477  Sum_probs=201.5

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|++.+.||+|+||+||+|.+.     .+++.||+|++.............+.+|+.+++.++||||+++++++...+
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   82 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHY-----KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT   82 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cCCEEEEEEEecCCCeEEEEEEEC-----CCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence            368999999999999999999976     567889999998655444444567889999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      .+|+||||+ +|+|.+++...+.+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        83 ~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           83 DIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             EEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             EEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            999999999 6789999988889999999999999999999999999999999999999999999999999999887666


Q ss_pred             CCCCcccccCccccchhhccCCC-CCcccHHHHHHHHHHHHcCCCCCCCchhhh-------------hhhhHHHHHhhhh
Q 018487          269 SRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQVNIKSMQVIA-------------CNTMLLFYLIIFH  334 (355)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~elltg~~pf~~~~~~~-------------~~~~~~~~~~i~~  334 (355)
                      ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......             ......+.++|.+
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  241 (336)
T 3h4j_B          162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRR  241 (336)
T ss_dssp             BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHT
T ss_pred             cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence            66667789999999999988776 689999999999999999999998753221             1123356788999


Q ss_pred             eeeecCCCcCC
Q 018487          335 CLFVNSLELLS  345 (355)
Q Consensus       335 ~l~~~~~e~~~  345 (355)
                      ||..+|.+++.
T Consensus       242 ~L~~dP~~Rpt  252 (336)
T 3h4j_B          242 MIVADPMQRIT  252 (336)
T ss_dssp             TSCSSGGGSCC
T ss_pred             HcCCChhHCcC
Confidence            99998888753

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.7e-46  Score=349.13  Aligned_cols=230  Identities=30%  Similarity=0.498  Sum_probs=200.5

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++.+.||+|+||.||+|.++     .+++.||+|++..... .....+.+.+|+.+++.++||||+++++++...+.
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  102 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHK-----TTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESF  102 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cCeEEeeEEecCCCeEEEEEEEC-----CCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            47999999999999999999976     5678899999986553 33445678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC---cEEEEecCCccccC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVMLTDFGLAKEID  266 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~---~~kl~Dfg~a~~~~  266 (355)
                      .|+||||++|++|.+++.....+++.++..++.||+.||.|||++||+||||||+|||++.++   .+||+|||++....
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          103 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             EEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            999999999999999999888899999999999999999999999999999999999998654   59999999998876


Q ss_pred             cCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-----------------hhhHHHH
Q 018487          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-----------------NTMLLFY  329 (355)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-----------------~~~~~~~  329 (355)
                      ........+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....                 .....+.
T Consensus       183 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  262 (362)
T 2bdw_A          183 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK  262 (362)
T ss_dssp             TCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHH
T ss_pred             CCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            65555667899999999999998999999999999999999999999987543211                 1123457


Q ss_pred             HhhhheeeecCCCcCC
Q 018487          330 LIIFHCLFVNSLELLS  345 (355)
Q Consensus       330 ~~i~~~l~~~~~e~~~  345 (355)
                      ++|.+||..+|.+++.
T Consensus       263 ~li~~~L~~dP~~R~t  278 (362)
T 2bdw_A          263 SLIDSMLTVNPKKRIT  278 (362)
T ss_dssp             HHHHHHSCSSGGGSCC
T ss_pred             HHHHHHcCCChhhCcC
Confidence            7888888888887653

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.4e-46  Score=339.35  Aligned_cols=228  Identities=26%  Similarity=0.440  Sum_probs=197.4

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|+++++||+|+||+||+|.+.     .+++.||+|++......   ..+.+.+|+.+++.++||||+++++++...+
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   90 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDV-----ATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGD   90 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBT-----TTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hhceeeeeeeccCCCeEEEEEEEC-----CCCcEEEEEEeeccccc---HHHHHHHHHHHHhcCCCCCCCeEeEEEEECC
Confidence            468999999999999999999965     56788999998765432   2356788999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      .+|+||||+++++|.+++... .+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (297)
T 3fxz_A           91 ELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (297)
T ss_dssp             EEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence            999999999999999988764 6899999999999999999999999999999999999999999999999999876543


Q ss_pred             C-CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh----------------hhhHHHHHh
Q 018487          269 S-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC----------------NTMLLFYLI  331 (355)
Q Consensus       269 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~----------------~~~~~~~~~  331 (355)
                      . .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....                .....+.++
T Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  249 (297)
T 3fxz_A          170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF  249 (297)
T ss_dssp             TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHH
T ss_pred             ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHH
Confidence            3 23456899999999999999999999999999999999999999987643321                122346788


Q ss_pred             hhheeeecCCCcCC
Q 018487          332 IFHCLFVNSLELLS  345 (355)
Q Consensus       332 i~~~l~~~~~e~~~  345 (355)
                      |.+||..+|.+++.
T Consensus       250 i~~~l~~dp~~Rps  263 (297)
T 3fxz_A          250 LNRCLEMDVEKRGS  263 (297)
T ss_dssp             HHHHSCSSTTTSCC
T ss_pred             HHHHccCChhHCcC
Confidence            88999998888754

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-46  Score=356.11  Aligned_cols=235  Identities=37%  Similarity=0.638  Sum_probs=199.5

Q ss_pred             hcCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceeccee
Q 018487          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (355)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~  183 (355)
                      ...+..++|++++.||+|+||+||+|+++     .+++.||+|++.+.........+.+.+|..++..++||||++++++
T Consensus        55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~-----~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~  129 (412)
T 2vd5_A           55 EVRLQRDDFEILKVIGRGAFSEVAVVKMK-----QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA  129 (412)
T ss_dssp             HHSCCGGGEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred             hccCChhhEEEEEEEeeCCCeEEEEEEEC-----CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence            44567789999999999999999999987     5678999999986544444445567889999999999999999999


Q ss_pred             eecCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          184 FQTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       184 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                      |.+.+.+|+||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus       130 ~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla  209 (412)
T 2vd5_A          130 FQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSC  209 (412)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhh
Confidence            999999999999999999999998764 7999999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCC--CCcccccCccccchhhc-------cCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh----------
Q 018487          263 KEIDESSR--SNSMCGTTEYMAPEILL-------SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN----------  323 (355)
Q Consensus       263 ~~~~~~~~--~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~----------  323 (355)
                      +.......  ....+||+.|+|||++.       +..++.++|||||||++|||++|+.||...+.....          
T Consensus       210 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~  289 (412)
T 2vd5_A          210 LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL  289 (412)
T ss_dssp             EECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred             eeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCc
Confidence            87654332  33568999999999997       356899999999999999999999999876432211          


Q ss_pred             --------hhHHHHHhhhheeeecCCCcC
Q 018487          324 --------TMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       324 --------~~~~~~~~i~~~l~~~~~e~~  344 (355)
                              ......++|.+||. +|.+++
T Consensus       290 ~~p~~~~~~s~~~~dli~~lL~-~p~~Rl  317 (412)
T 2vd5_A          290 SLPLVDEGVPEEARDFIQRLLC-PPETRL  317 (412)
T ss_dssp             CCC----CCCHHHHHHHHTTSS-CGGGCT
T ss_pred             CCCccccCCCHHHHHHHHHHcC-ChhhcC
Confidence                    11234677788887 666653

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.4e-46  Score=356.79  Aligned_cols=233  Identities=36%  Similarity=0.694  Sum_probs=197.6

Q ss_pred             hcCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceeccee
Q 018487          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (355)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~  183 (355)
                      ...+..++|+++++||+|+||+||+|+++     .+++.||+|++.+.........+.+.+|+.+++.++||||++++++
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~-----~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~  137 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHK-----STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA  137 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEEC-----CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            44567789999999999999999999987     5678899999976544333334457789999999999999999999


Q ss_pred             eecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       184 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      |.+.+.+|+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus       138 ~~~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~  216 (410)
T 3v8s_A          138 FQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM  216 (410)
T ss_dssp             EECSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence            9999999999999999999998865 468999999999999999999999999999999999999999999999999998


Q ss_pred             ccCcCC--CCCcccccCccccchhhccCC----CCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh--------------
Q 018487          264 EIDESS--RSNSMCGTTEYMAPEILLSKG----HNKDADWWSVGILLYEMLTGQVNIKSMQVIACN--------------  323 (355)
Q Consensus       264 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~--------------  323 (355)
                      ......  .....+||+.|+|||++.+..    ++.++|||||||++|||++|+.||...+.....              
T Consensus       217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~  296 (410)
T 3v8s_A          217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD  296 (410)
T ss_dssp             ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCT
T ss_pred             eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCC
Confidence            765443  234678999999999998765    789999999999999999999999876433211              


Q ss_pred             ---hhHHHHHhhhheeeecCCC
Q 018487          324 ---TMLLFYLIIFHCLFVNSLE  342 (355)
Q Consensus       324 ---~~~~~~~~i~~~l~~~~~e  342 (355)
                         ......++|.+||..++.+
T Consensus       297 ~~~~s~~~~~li~~lL~~~~~r  318 (410)
T 3v8s_A          297 DNDISKEAKNLICAFLTDREVR  318 (410)
T ss_dssp             TCCCCHHHHHHHHHHSSCGGGC
T ss_pred             cccccHHHHHHHHHHccChhhh
Confidence               1124567788888766554

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.7e-46  Score=359.01  Aligned_cols=234  Identities=36%  Similarity=0.655  Sum_probs=197.3

Q ss_pred             hcCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceeccee
Q 018487          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (355)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~  183 (355)
                      ...+..++|+++++||+|+||+||+|+++     .+++.||+|++.+.........+.+.+|+.++..++||||++++++
T Consensus        68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~  142 (437)
T 4aw2_A           68 QMRLHREDFEILKVIGRGAFGEVAVVKLK-----NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYA  142 (437)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred             cccCChhheEEEEEEEeCCCEEEEEEEEc-----CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            34566789999999999999999999987     4678899999986544333444457889999999999999999999


Q ss_pred             eecCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          184 FQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       184 ~~~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                      |.+.+.+|+|||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus       143 ~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla  222 (437)
T 4aw2_A          143 FQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSC  222 (437)
T ss_dssp             EECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence            9999999999999999999999987 467999999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCC--CCcccccCccccchhhc-----cCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh------------
Q 018487          263 KEIDESSR--SNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN------------  323 (355)
Q Consensus       263 ~~~~~~~~--~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~------------  323 (355)
                      +.......  ....+||+.|+|||++.     ...++.++|||||||++|||++|+.||...+.....            
T Consensus       223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~  302 (437)
T 4aw2_A          223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF  302 (437)
T ss_dssp             EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred             hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccC
Confidence            87644332  23468999999999997     456899999999999999999999999876433211            


Q ss_pred             ------hhHHHHHhhhheeeecCCC
Q 018487          324 ------TMLLFYLIIFHCLFVNSLE  342 (355)
Q Consensus       324 ------~~~~~~~~i~~~l~~~~~e  342 (355)
                            ......++|.+||..++.+
T Consensus       303 p~~~~~~s~~~~dLi~~lL~~~~~r  327 (437)
T 4aw2_A          303 PTQVTDVSENAKDLIRRLICSREHR  327 (437)
T ss_dssp             CSSCCCSCHHHHHHHHTTSSCGGGC
T ss_pred             CcccccCCHHHHHHHHHHhcccccc
Confidence                  1224466777777655443

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.1e-46  Score=345.29  Aligned_cols=232  Identities=23%  Similarity=0.392  Sum_probs=194.6

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|++.+.||+|+||.||+|.++     .+++.||||++.............+.+|+.++++++||||+++++++....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   85 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDL-----RDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET   85 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEEC-----CCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence            468999999999999999999976     567889999998766556666778899999999999999999999987544


Q ss_pred             ----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          189 ----KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       189 ----~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                          ..|+||||++|++|.+++...+.+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        86 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           86 PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             TTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             CCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence                4599999999999999999888999999999999999999999999999999999999999999999999999987


Q ss_pred             cCcCC----CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-----------------
Q 018487          265 IDESS----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-----------------  323 (355)
Q Consensus       265 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-----------------  323 (355)
                      +....    .....+||+.|+|||++.+..++.++||||||+++|+|++|+.||...+.....                 
T Consensus       166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (311)
T 3ork_A          166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG  245 (311)
T ss_dssp             ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTT
T ss_pred             ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCC
Confidence            64332    223456899999999999999999999999999999999999999876543211                 


Q ss_pred             hhHHHHHhhhheeeecCCCcCC
Q 018487          324 TMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       324 ~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ....+..+|.+||..+|.+++.
T Consensus       246 ~~~~l~~li~~~l~~dP~~R~~  267 (311)
T 3ork_A          246 LSADLDAVVLKALAKNPENRYQ  267 (311)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCS
T ss_pred             CCHHHHHHHHHHHhcCHhhChh
Confidence            1234678899999999988764

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=7e-46  Score=342.43  Aligned_cols=231  Identities=28%  Similarity=0.457  Sum_probs=200.7

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccc---hhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK---KNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      ++|++.+.||+|+||.||+|.++     .+++.||+|++.......   ....+.+.+|+.+++.++||||+++++++..
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   85 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREK-----STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN   85 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEET-----TTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             cceEeceEEeeCCCeEEEEEEEC-----CCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            46999999999999999999976     567889999997654322   1235678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC----cEEEEecCCc
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG----HVMLTDFGLA  262 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~----~~kl~Dfg~a  262 (355)
                      ...+|+||||+++++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||++
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            999999999999999999998888899999999999999999999999999999999999998887    8999999999


Q ss_pred             cccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-----------------hhh
Q 018487          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-----------------NTM  325 (355)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-----------------~~~  325 (355)
                      ............+||+.|+|||++.+..++.++|||||||++|+|++|+.||........                 ...
T Consensus       166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (326)
T 2y0a_A          166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS  245 (326)
T ss_dssp             EECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred             eECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCC
Confidence            887655555667899999999999989999999999999999999999999976533211                 112


Q ss_pred             HHHHHhhhheeeecCCCcCC
Q 018487          326 LLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ..+.++|.+||..+|.+++.
T Consensus       246 ~~~~~li~~~L~~dP~~Rpt  265 (326)
T 2y0a_A          246 ALAKDFIRRLLVKDPKKRMT  265 (326)
T ss_dssp             HHHHHHHHHHSCSSGGGSCC
T ss_pred             HHHHHHHHHHccCChhhCCC
Confidence            34567888999888888764

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.6e-46  Score=361.16  Aligned_cols=234  Identities=39%  Similarity=0.729  Sum_probs=193.7

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      .+..++|+++++||+|+||.||+|.++     .+++.||||++.............+.+|+.+++.++||||+++++++.
T Consensus       144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~  218 (446)
T 4ejn_A          144 RVTMNEFEYLKLLGKGTFGKVILVKEK-----ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ  218 (446)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE
T ss_pred             CCChHHcEEeEEEeeCcCEEEEEEEEc-----CCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe
Confidence            345578999999999999999999976     567889999998765445555566788999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      ..+.+|+||||+++++|..++.....+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++.
T Consensus       219 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~  298 (446)
T 4ejn_A          219 THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE  298 (446)
T ss_dssp             ETTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred             eCCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence            999999999999999999999998999999999999999999999998 9999999999999999999999999999986


Q ss_pred             cC-cCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHH
Q 018487          265 ID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYL  330 (355)
Q Consensus       265 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~  330 (355)
                      .. ........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.....             ....+.+
T Consensus       299 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  378 (446)
T 4ejn_A          299 GIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKS  378 (446)
T ss_dssp             TCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             ccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHH
Confidence            43 233345678999999999999999999999999999999999999999876443221             1234578


Q ss_pred             hhhheeeecCCCcC
Q 018487          331 IIFHCLFVNSLELL  344 (355)
Q Consensus       331 ~i~~~l~~~~~e~~  344 (355)
                      +|.+||..+|.+++
T Consensus       379 li~~~L~~dP~~R~  392 (446)
T 4ejn_A          379 LLSGLLKKDPKQRL  392 (446)
T ss_dssp             HHHHHTCSSTTTST
T ss_pred             HHHHHcccCHHHhC
Confidence            89999999998886

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=8.5e-46  Score=341.98  Aligned_cols=238  Identities=49%  Similarity=0.817  Sum_probs=193.2

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeeccccc-chhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-KKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      .+..++|++.+.||+|+||.||+|++...  ..+++.||+|++++.... .......+.+|+.+++.++||||+++++++
T Consensus        13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   90 (327)
T 3a62_A           13 KIRPECFELLRVLGKGGYGKVFQVRKVTG--ANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF   90 (327)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEECSS--TTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred             CCCHHHeEEEEEEEeCCCEEEEEEEEecc--CCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence            34557899999999999999999987521  246789999999765432 223345577899999999999999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      ...+.+|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           91 QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             ECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            99999999999999999999999888999999999999999999999999999999999999999999999999999976


Q ss_pred             cCc-CCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHH
Q 018487          265 IDE-SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYL  330 (355)
Q Consensus       265 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~  330 (355)
                      ... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.....             ....+.+
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  250 (327)
T 3a62_A          171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD  250 (327)
T ss_dssp             --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHHH
T ss_pred             cccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            432 22344568999999999999999999999999999999999999999876432211             1235678


Q ss_pred             hhhheeeecCCCcCC
Q 018487          331 IIFHCLFVNSLELLS  345 (355)
Q Consensus       331 ~i~~~l~~~~~e~~~  345 (355)
                      +|.+||..+|.+++.
T Consensus       251 li~~~L~~dp~~R~~  265 (327)
T 3a62_A          251 LLKKLLKRNAASRLG  265 (327)
T ss_dssp             HHHHHSCSCGGGSTT
T ss_pred             HHHHHHhcCHhhccC
Confidence            899999999988873

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=7e-46  Score=348.26  Aligned_cols=238  Identities=21%  Similarity=0.388  Sum_probs=199.8

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCC--CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecc
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLR  181 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~  181 (355)
                      +.+..++|++.+.||+|+||.||+|++.+...  ...+..||||+++...  .....+.+.+|+.+++.+ +||||++++
T Consensus        76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~  153 (370)
T 2psq_A           76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL  153 (370)
T ss_dssp             TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred             ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence            34556789999999999999999999865332  2456779999997653  344566788999999999 899999999


Q ss_pred             eeeecCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q 018487          182 YSFQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (355)
Q Consensus       182 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~N  245 (355)
                      +++...+.+|+||||+++|+|.+++....                .+++.++..++.||+.||.|||++||+||||||+|
T Consensus       154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N  233 (370)
T 2psq_A          154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN  233 (370)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred             EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence            99999999999999999999999998653                47899999999999999999999999999999999


Q ss_pred             EEecCCCcEEEEecCCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh
Q 018487          246 ILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA  321 (355)
Q Consensus       246 ILl~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~  321 (355)
                      ||++.++.+||+|||+++.+.....   .....+|+.|+|||++.+..++.++|||||||++|||+| |+.||.......
T Consensus       234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~  313 (370)
T 2psq_A          234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  313 (370)
T ss_dssp             EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            9999999999999999986643321   233457889999999999999999999999999999999 999998754322


Q ss_pred             h--------------hhhHHHHHhhhheeeecCCCcC
Q 018487          322 C--------------NTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       322 ~--------------~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                      .              .....+..+|.+||..+|.+++
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp  350 (370)
T 2psq_A          314 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRP  350 (370)
T ss_dssp             HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCc
Confidence            1              1122567788889988887764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1e-45  Score=338.77  Aligned_cols=233  Identities=26%  Similarity=0.388  Sum_probs=191.1

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      ..+..++|++.++||+|+||+||+|++.       ++.||||++..... .....+.+.+|+.++++++||||+++++++
T Consensus        32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~~-------~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  103 (309)
T 3p86_A           32 MDIPWCDLNIKEKIGAGSFGTVHRAEWH-------GSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAV  103 (309)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEET-------TEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCChhHceeeeEeecCCCeEEEEEEEC-------CCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            3456679999999999999999999864       56799999876543 344556788999999999999999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCcEEecCCCcEEEEec
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQGI---FREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDGHVMLTDF  259 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~~~---l~~~~~~~i~~ql~~~L~~LH~~~--iiHrDlkp~NILl~~~~~~kl~Df  259 (355)
                      ...+.+++||||+++++|.+++...+.   +++..++.++.|++.||+|||++|  |+||||||+|||++.++.+||+||
T Consensus       104 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Df  183 (309)
T 3p86_A          104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDF  183 (309)
T ss_dssp             CSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred             EECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCC
Confidence            999999999999999999999987653   899999999999999999999999  999999999999999999999999


Q ss_pred             CCccccCcCC-CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh---------------
Q 018487          260 GLAKEIDESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN---------------  323 (355)
Q Consensus       260 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~---------------  323 (355)
                      |+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.....               
T Consensus       184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  263 (309)
T 3p86_A          184 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN  263 (309)
T ss_dssp             C-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTT
T ss_pred             CCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCcc
Confidence            9997654332 234567999999999999999999999999999999999999999876433221               


Q ss_pred             hhHHHHHhhhheeeecCCCcCC
Q 018487          324 TMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       324 ~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ....+..+|.+||..+|.+++.
T Consensus       264 ~~~~l~~li~~~l~~dP~~Rps  285 (309)
T 3p86_A          264 LNPQVAAIIEGCWTNEPWKRPS  285 (309)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCHHHHHHHHHHccCChhhCcC
Confidence            1234678888999988888653

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=353.32  Aligned_cols=230  Identities=29%  Similarity=0.489  Sum_probs=197.7

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++.++||+|+||+||+|.++     .+++.||+|++..... .....+.+.+|+.+++.++||||+++++++...+.
T Consensus        11 ~~Y~i~~~LG~G~fg~V~~~~~~-----~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   84 (444)
T 3soa_A           11 EEYQLFEELGKGAFSVVRRCVKV-----LAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGH   84 (444)
T ss_dssp             HHEEEEEEEEEC--CEEEEEEET-----TTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSE
T ss_pred             CCeEEEEEeccCCCeEEEEEEEC-----CCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCE
Confidence            47999999999999999999976     5678899999987553 33345668899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEec---CCCcEEEEecCCccccC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD---SDGHVMLTDFGLAKEID  266 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~---~~~~~kl~Dfg~a~~~~  266 (355)
                      .|+||||++||+|.+.+...+.+++.++..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++....
T Consensus        85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            999999999999999999999999999999999999999999999999999999999998   46789999999998765


Q ss_pred             cCCC-CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-----------------hhhHHH
Q 018487          267 ESSR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-----------------NTMLLF  328 (355)
Q Consensus       267 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-----------------~~~~~~  328 (355)
                      .... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....                 .....+
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  244 (444)
T 3soa_A          165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA  244 (444)
T ss_dssp             TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence            4332 3456899999999999998999999999999999999999999977543221                 122346


Q ss_pred             HHhhhheeeecCCCcCC
Q 018487          329 YLIIFHCLFVNSLELLS  345 (355)
Q Consensus       329 ~~~i~~~l~~~~~e~~~  345 (355)
                      .++|.+||..+|.+++.
T Consensus       245 ~~li~~~L~~dP~~Rpt  261 (444)
T 3soa_A          245 KDLINKMLTINPSKRIT  261 (444)
T ss_dssp             HHHHHHHSCSSTTTSCC
T ss_pred             HHHHHHHcCCChhHCCC
Confidence            77888888888887653

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=6e-46  Score=364.13  Aligned_cols=234  Identities=36%  Similarity=0.632  Sum_probs=204.6

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      .+..++|++.+.||+|+||.||+|+++     .+++.||+|++.+...........+.+|+.+|+.++||||+++++++.
T Consensus       180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~  254 (576)
T 2acx_A          180 PVTKNTFRQYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE  254 (576)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CccccceEEEEEEeeCCCEEEEEEEEC-----CCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe
Confidence            466788999999999999999999977     467899999998765444555567888999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      ..+.+|+||||++||+|.+++...+.  +++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.
T Consensus       255 ~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~  334 (576)
T 2acx_A          255 TKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAV  334 (576)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccce
Confidence            99999999999999999999987654  9999999999999999999999999999999999999999999999999998


Q ss_pred             ccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh-----------------hhhhH
Q 018487          264 EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA-----------------CNTML  326 (355)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~-----------------~~~~~  326 (355)
                      .+.........+||+.|+|||++.+..++.++|||||||++|||++|+.||.......                 .....
T Consensus       335 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~  414 (576)
T 2acx_A          335 HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSP  414 (576)
T ss_dssp             ECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred             ecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCH
Confidence            8765555556789999999999999899999999999999999999999998753210                 01123


Q ss_pred             HHHHhhhheeeecCCCcC
Q 018487          327 LFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       327 ~~~~~i~~~l~~~~~e~~  344 (355)
                      .+.++|.+||.++|.+++
T Consensus       415 ~~~dLI~~lL~~dP~~R~  432 (576)
T 2acx_A          415 QARSLCSQLLCKDPAERL  432 (576)
T ss_dssp             HHHHHHHHHTCSSGGGST
T ss_pred             HHHHHHHHhccCCHHHcC
Confidence            457788899999988876

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-45  Score=339.90  Aligned_cols=228  Identities=23%  Similarity=0.381  Sum_probs=197.2

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|++.+.||+|+||+||+|.++     .+++.||+|++....    ...+.+.+|+.+++.++||||+++++++...+
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~   74 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVET-----SSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESME   74 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred             hhceEeeeEEecCCCeEEEEEEEC-----CCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC
Confidence            468999999999999999999976     567889999987432    23456788999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC--CCcEEEEecCCcccc
Q 018487          189 KLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS--DGHVMLTDFGLAKEI  265 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~--~~~~kl~Dfg~a~~~  265 (355)
                      .+|+||||++|++|.+++.... .+++.+++.++.|++.||.|||++||+||||||+|||++.  ++.+||+|||++..+
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~  154 (321)
T 1tki_A           75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence            9999999999999999997654 6999999999999999999999999999999999999987  789999999999887


Q ss_pred             CcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-----------------hhhHHH
Q 018487          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-----------------NTMLLF  328 (355)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-----------------~~~~~~  328 (355)
                      ..........||+.|+|||++.+..++.++|||||||++|+|++|+.||........                 .....+
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  234 (321)
T 1tki_A          155 KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA  234 (321)
T ss_dssp             CTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred             CCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHH
Confidence            665555567899999999999988889999999999999999999999987543221                 112345


Q ss_pred             HHhhhheeeecCCCcCC
Q 018487          329 YLIIFHCLFVNSLELLS  345 (355)
Q Consensus       329 ~~~i~~~l~~~~~e~~~  345 (355)
                      .++|.+||..+|.+++.
T Consensus       235 ~~li~~~L~~dp~~Rpt  251 (321)
T 1tki_A          235 MDFVDRLLVKERKSRMT  251 (321)
T ss_dssp             HHHHHTTSCSSGGGSCC
T ss_pred             HHHHHHHcCCChhHCcC
Confidence            67788888888877653

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.5e-45  Score=360.26  Aligned_cols=236  Identities=35%  Similarity=0.591  Sum_probs=204.6

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      ..+..++|++++.||+|+||+||+|+++     .+++.||+|++.+.........+.+.+|+.+++.++||||++++++|
T Consensus       180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~  254 (543)
T 3c4z_A          180 QPMGEDWFLDFRVLGRGGFGEVFACQMK-----ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF  254 (543)
T ss_dssp             SCCCGGGEEEEEEEEECSSSEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCChhheEEEEEEeeCCCeEEEEEEEC-----CCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            3456689999999999999999999976     56789999999876554555567788999999999999999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecC
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG  260 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg  260 (355)
                      ...+.+|+||||++||+|..++...    ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||
T Consensus       255 ~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFG  334 (543)
T 3c4z_A          255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLG  334 (543)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             eeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecc
Confidence            9999999999999999999998764    369999999999999999999999999999999999999999999999999


Q ss_pred             CccccCcCCC-CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhh------h-----------h
Q 018487          261 LAKEIDESSR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVI------A-----------C  322 (355)
Q Consensus       261 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~------~-----------~  322 (355)
                      +++.+..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......      .           .
T Consensus       335 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~  414 (543)
T 3c4z_A          335 LAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD  414 (543)
T ss_dssp             TCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCT
T ss_pred             eeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCc
Confidence            9987654433 34468999999999999999999999999999999999999999875210      0           1


Q ss_pred             hhhHHHHHhhhheeeecCCCcCC
Q 018487          323 NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       323 ~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      .....+..+|.+||.++|.+++.
T Consensus       415 ~~s~~~~~li~~lL~~dP~~R~~  437 (543)
T 3c4z_A          415 KFSPASKDFCEALLQKDPEKRLG  437 (543)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCC
T ss_pred             ccCHHHHHHHHHhccCCHhHCCC
Confidence            11235578889999999988874

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.6e-45  Score=343.53  Aligned_cols=231  Identities=25%  Similarity=0.481  Sum_probs=194.3

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccc--hhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK--KNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ++|++.+.||+|+||+||+|.++     .+++.||||++.......  ....+.+.+|+.+++.++||||+++++++...
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~   98 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINR-----ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD   98 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             cceEEeeEEeeCCCEEEEEEEEC-----CCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            47999999999999999999976     567889999987543221  12346688999999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCc---EEEEecC
Q 018487          188 SKLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFG  260 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~---~kl~Dfg  260 (355)
                      +.+|+||||++|++|.+.+...    ..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||
T Consensus        99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A           99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence            9999999999999998877643    24899999999999999999999999999999999999987654   9999999


Q ss_pred             CccccCcCCC-CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh----------------h
Q 018487          261 LAKEIDESSR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC----------------N  323 (355)
Q Consensus       261 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~----------------~  323 (355)
                      ++........ ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||........                .
T Consensus       179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~~~~~~~~~  258 (351)
T 3c0i_A          179 VAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSH  258 (351)
T ss_dssp             TCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred             ceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCCCCcccccc
Confidence            9987754432 3456899999999999999999999999999999999999999987532111                1


Q ss_pred             hhHHHHHhhhheeeecCCCcCC
Q 018487          324 TMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       324 ~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ....+.++|.+||..+|.+++.
T Consensus       259 ~s~~~~~li~~~L~~dP~~R~s  280 (351)
T 3c0i_A          259 ISESAKDLVRRMLMLDPAERIT  280 (351)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCC
T ss_pred             CCHHHHHHHHHHCCCChhHCcC
Confidence            1234567888888888887653

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=9e-46  Score=357.44  Aligned_cols=234  Identities=27%  Similarity=0.495  Sum_probs=204.2

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +..++|.+.+.||+|+||.||+|.++     .+++.||||++...........+.+.+|+.+++.++||||+++++++..
T Consensus        13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~   87 (476)
T 2y94_A           13 VKIGHYILGDTLGVGTFGKVKVGKHE-----LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST   87 (476)
T ss_dssp             CEETTEEEEEEEECCSSSCEEEEEET-----TTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ceecCEEEEEEEeeCCCeEEEEEEEC-----CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            44578999999999999999999976     5678899999987654444556778899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                      .+.+|+||||+++++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        88 ~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~  167 (476)
T 2y94_A           88 PSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  167 (476)
T ss_dssp             SSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence            99999999999999999999988889999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCCcccccCccccchhhccCCC-CCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHHhh
Q 018487          267 ESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYLII  332 (355)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~~i  332 (355)
                      ........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.....             ....+.++|
T Consensus       168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li  247 (476)
T 2y94_A          168 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLL  247 (476)
T ss_dssp             TTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHH
T ss_pred             ccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHH
Confidence            6555566789999999999998765 67999999999999999999999875432211             122456788


Q ss_pred             hheeeecCCCcCC
Q 018487          333 FHCLFVNSLELLS  345 (355)
Q Consensus       333 ~~~l~~~~~e~~~  345 (355)
                      .+||..+|.+++.
T Consensus       248 ~~~L~~dP~~Rpt  260 (476)
T 2y94_A          248 KHMLQVDPMKRAT  260 (476)
T ss_dssp             HHHTCSSTTTSCC
T ss_pred             HHHcCCCchhCcC
Confidence            8888888877653

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.5e-45  Score=370.53  Aligned_cols=236  Identities=35%  Similarity=0.675  Sum_probs=204.3

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~  184 (355)
                      .+..++|++++.||+|+||.||+|+++     .+++.||||++++.........+.+..|..++..+ +|++|++++++|
T Consensus       337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~-----~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~  411 (674)
T 3pfq_A          337 RMKLTDFNFLMVLGKGSFGKVMLSERK-----GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF  411 (674)
T ss_dssp             ---CTTEEEEEESSBTTTBCEEEEEES-----SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC
T ss_pred             cccccceEEEEEEccCCCEEEEEEEEC-----CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE
Confidence            345678999999999999999999987     46788999999876544455566778899999987 699999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      ...+.+|+||||++||+|..++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.
T Consensus       412 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~  491 (674)
T 3pfq_A          412 QTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  491 (674)
T ss_dssp             BCSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred             EeCCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeec
Confidence            99999999999999999999999989999999999999999999999999999999999999999999999999999986


Q ss_pred             cC-cCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHH
Q 018487          265 ID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYL  330 (355)
Q Consensus       265 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~  330 (355)
                      .. ........+||+.|+|||++.+..|+.++|||||||+||||++|+.||...+.....             ......+
T Consensus       492 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  571 (674)
T 3pfq_A          492 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVA  571 (674)
T ss_dssp             CCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHH
T ss_pred             cccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHH
Confidence            43 333455678999999999999999999999999999999999999999886443211             1224577


Q ss_pred             hhhheeeecCCCcCCC
Q 018487          331 IIFHCLFVNSLELLSH  346 (355)
Q Consensus       331 ~i~~~l~~~~~e~~~~  346 (355)
                      +|.+||.++|.+++..
T Consensus       572 li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          572 ICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             HHHHHSCSSSTTCTTC
T ss_pred             HHHHHccCCHHHCCCC
Confidence            8889999999887743

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.4e-45  Score=336.06  Aligned_cols=231  Identities=23%  Similarity=0.388  Sum_probs=196.6

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +..++|++.++||+|+||+||+|.++     .+++.||+|++...   .....+.+.+|+.+++.++||||+++++++..
T Consensus         7 ~~~~~~~~~~~lG~G~~g~V~~~~~~-----~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   78 (310)
T 3s95_A            7 FRPSDLIHGEVLGKGCFGQAIKVTHR-----ETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK   78 (310)
T ss_dssp             ECGGGEEEEEEEECCSSEEEEEEEET-----TTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             eChhHeeccceecCCCCEEEEEEEEC-----CCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEec
Confidence            44578999999999999999999976     46788999988542   34556778899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          187 RSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      ++..++||||+++++|.+++.. ...+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  158 (310)
T 3s95_A           79 DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLM  158 (310)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEEC
T ss_pred             CCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceec
Confidence            9999999999999999999987 467999999999999999999999999999999999999999999999999999876


Q ss_pred             CcCCCC---------------CcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh---------
Q 018487          266 DESSRS---------------NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA---------  321 (355)
Q Consensus       266 ~~~~~~---------------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~---------  321 (355)
                      ......               ...+||+.|+|||++.+..++.++||||||+++|+|++|..||.......         
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~  238 (310)
T 3s95_A          159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG  238 (310)
T ss_dssp             C--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHH
T ss_pred             ccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhc
Confidence            433221               14579999999999999999999999999999999999999987632211         


Q ss_pred             -------hhhhHHHHHhhhheeeecCCCcCC
Q 018487          322 -------CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 -------~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                             .+....+..++.+||..+|.+++.
T Consensus       239 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps  269 (310)
T 3s95_A          239 FLDRYCPPNCPPSFFPITVRCCDLDPEKRPS  269 (310)
T ss_dssp             HHHHTCCTTCCTTHHHHHHHHTCSSGGGSCC
T ss_pred             cccccCCCCCCHHHHHHHHHHccCChhhCcC
Confidence                   111224677888999888888653

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.3e-45  Score=332.37  Aligned_cols=201  Identities=23%  Similarity=0.427  Sum_probs=175.5

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|+++++||+|+||+||+|.++     .+++.||+|++..... .....+.+.+|+.++++++||||+++++++..++.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   75 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNR-----ETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK   75 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEET-----TTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             CCceeeeEecCCCCeEEEEEEEC-----CCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCE
Confidence            58999999999999999999976     5678899999986653 34455667889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      +|+||||++++.+..+....+.+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        76 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           76 LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             EEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            99999999875554444456789999999999999999999999999999999999999999999999999998765332


Q ss_pred             -CCCcccccCccccchhhccCC-CCCcccHHHHHHHHHHHHcCCCCCCC
Q 018487          270 -RSNSMCGTTEYMAPEILLSKG-HNKDADWWSVGILLYEMLTGQVNIKS  316 (355)
Q Consensus       270 -~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~elltg~~pf~~  316 (355)
                       ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||..
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~  204 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred             ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC
Confidence             234567899999999998765 89999999999999999999888643

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.8e-45  Score=343.03  Aligned_cols=229  Identities=29%  Similarity=0.475  Sum_probs=185.2

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ..++|++++.||+|+||+||+|+++     .+++.||||++.......    +.+.+|+.+++.++||||+++++++...
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~   88 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDK-----LTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTP   88 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEET-----TTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEEC-----CCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeC
Confidence            3468999999999999999999976     567899999997644322    4467899999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCc--EEEEecCCcccc
Q 018487          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--VMLTDFGLAKEI  265 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~--~kl~Dfg~a~~~  265 (355)
                      +.+|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..
T Consensus        89 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A           89 THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred             CEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence            999999999999999999998889999999999999999999999999999999999999987765  999999999865


Q ss_pred             CcCCCCCcccccCccccchhhccCCCCCc-ccHHHHHHHHHHHHcCCCCCCCchhhhh-------------------hhh
Q 018487          266 DESSRSNSMCGTTEYMAPEILLSKGHNKD-ADWWSVGILLYEMLTGQVNIKSMQVIAC-------------------NTM  325 (355)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~~l~elltg~~pf~~~~~~~~-------------------~~~  325 (355)
                      .........+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........                   ...
T Consensus       169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  248 (361)
T 3uc3_A          169 VLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRIS  248 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCC
T ss_pred             cccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCC
Confidence            54444556789999999999988887665 8999999999999999999987432110                   112


Q ss_pred             HHHHHhhhheeeecCCCcCC
Q 018487          326 LLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ..+..+|.+||..+|.+++.
T Consensus       249 ~~~~~li~~~L~~dP~~Rps  268 (361)
T 3uc3_A          249 PECCHLISRIFVADPATRIS  268 (361)
T ss_dssp             HHHHHHHHHHSCSCTTTSCC
T ss_pred             HHHHHHHHHHccCChhHCcC
Confidence            34577888999988888763

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=8e-46  Score=341.62  Aligned_cols=230  Identities=27%  Similarity=0.438  Sum_probs=194.3

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|++++.||+|+||+||+|.++     .+++.||||++.....  ....+.+.+|+.+++.++||||+++++++..++
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~   78 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNR-----VTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGN   78 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhceeeeEEecCCCEEEEEEEEC-----CCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            368999999999999999999976     5678899999875432  222355778999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      ..|+||||+++++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           79 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             eEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999999865322


Q ss_pred             C---CCCcccccCccccchhhccCCC-CCcccHHHHHHHHHHHHcCCCCCCCchhhh----------------hhhhHHH
Q 018487          269 S---RSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQVNIKSMQVIA----------------CNTMLLF  328 (355)
Q Consensus       269 ~---~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~elltg~~pf~~~~~~~----------------~~~~~~~  328 (355)
                      .   .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+...                ......+
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (323)
T 3tki_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP  238 (323)
T ss_dssp             TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred             CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHH
Confidence            2   2345689999999999987765 778999999999999999999998653321                1122345


Q ss_pred             HHhhhheeeecCCCcCC
Q 018487          329 YLIIFHCLFVNSLELLS  345 (355)
Q Consensus       329 ~~~i~~~l~~~~~e~~~  345 (355)
                      ..+|.+||..+|.+++.
T Consensus       239 ~~li~~~L~~dP~~R~t  255 (323)
T 3tki_A          239 LALLHKILVENPSARIT  255 (323)
T ss_dssp             HHHHHHHSCSSTTTSCC
T ss_pred             HHHHHHHccCChhhCcC
Confidence            67888999999888764

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.2e-45  Score=342.30  Aligned_cols=227  Identities=32%  Similarity=0.547  Sum_probs=180.5

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|++.+.||+|+||.||+|.++     .+++.||||++....     ..+.+.+|+.++++++||||+++++++...+
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  121 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQK-----GTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT  121 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSS
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEEC-----CCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCC
Confidence            457999999999999999999976     457789999987543     2245778999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC---CCcEEEEecCCcccc
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEI  265 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~---~~~~kl~Dfg~a~~~  265 (355)
                      .+++||||+++++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++..
T Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          122 EISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             EEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             eEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            99999999999999999998888999999999999999999999999999999999999975   889999999999877


Q ss_pred             CcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh------------------hhhhHH
Q 018487          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA------------------CNTMLL  327 (355)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~------------------~~~~~~  327 (355)
                      .........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......                  ......
T Consensus       202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  281 (349)
T 2w4o_A          202 EHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN  281 (349)
T ss_dssp             -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred             CcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHH
Confidence            65554556789999999999999999999999999999999999999997643211                  011234


Q ss_pred             HHHhhhheeeecCCCcCC
Q 018487          328 FYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       328 ~~~~i~~~l~~~~~e~~~  345 (355)
                      +.++|.+||..+|.+++.
T Consensus       282 ~~~li~~~L~~dP~~Rpt  299 (349)
T 2w4o_A          282 AKDLVRKLIVLDPKKRLT  299 (349)
T ss_dssp             HHHHHHTTSCSSGGGSCC
T ss_pred             HHHHHHHHccCChhhCcC
Confidence            567888888888887664

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.2e-45  Score=345.17  Aligned_cols=204  Identities=23%  Similarity=0.393  Sum_probs=181.1

Q ss_pred             CCCCeEEEeeeccC--CcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          108 GPGDFEIFRVVGQG--AFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       108 ~~~~y~~~~~lG~G--~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      ..++|+++++||+|  +||+||+|+++     .+++.||||++..... .....+.+.+|+.+++.++|||||++++++.
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   96 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYK-----PTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFI   96 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEET-----TTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEc-----CCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE
Confidence            34689999999999  99999999977     4678999999987653 3455677889999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      ..+.+|+||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+.
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~  176 (389)
T 3gni_B           97 ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL  176 (389)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             ECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccce
Confidence            999999999999999999999876  679999999999999999999999999999999999999999999999999886


Q ss_pred             ccCcC--------CCCCcccccCccccchhhcc--CCCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          264 EIDES--------SRSNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       264 ~~~~~--------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      .....        ......+||+.|+|||++.+  ..++.++|||||||++|+|++|+.||...
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  240 (389)
T 3gni_B          177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  240 (389)
T ss_dssp             ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence            54221        11233478999999999987  67899999999999999999999999874

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.8e-44  Score=325.86  Aligned_cols=231  Identities=30%  Similarity=0.498  Sum_probs=201.7

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|++.+.||+|+||.||+|.++     .+++.||+|++..... .....+.+.+|+.++++++||||+++++++...+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHK-----TTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEES   78 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEc-----CCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC
Confidence            578999999999999999999976     5678899999976653 3444567889999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCc---EEEEecCCcccc
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEI  265 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~---~kl~Dfg~a~~~  265 (355)
                      ..++||||+++++|.+.+.....+++..+..++.|++.||.|||++||+||||||+|||++.++.   +||+|||++...
T Consensus        79 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           79 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            99999999999999999998889999999999999999999999999999999999999986655   999999999887


Q ss_pred             CcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-----------------hhhHHH
Q 018487          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-----------------NTMLLF  328 (355)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-----------------~~~~~~  328 (355)
                      ..........||+.|+|||++.+..++.++||||||+++|+|++|+.||...+....                 .....+
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T 3kk8_A          159 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA  238 (284)
T ss_dssp             CSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             ccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHH
Confidence            666555667899999999999999999999999999999999999999977543321                 112346


Q ss_pred             HHhhhheeeecCCCcCC
Q 018487          329 YLIIFHCLFVNSLELLS  345 (355)
Q Consensus       329 ~~~i~~~l~~~~~e~~~  345 (355)
                      ..+|.+||..+|.+++.
T Consensus       239 ~~li~~~l~~dp~~Rps  255 (284)
T 3kk8_A          239 KSLIDSMLTVNPKKRIT  255 (284)
T ss_dssp             HHHHHHHSCSSTTTSCC
T ss_pred             HHHHHHHcccChhhCCC
Confidence            77888888888887653

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5e-45  Score=335.40  Aligned_cols=204  Identities=29%  Similarity=0.502  Sum_probs=179.7

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      ...++|++.++||+|+||+||+|.++     .+++.||||++.....  ....+.+.+|+.++++++||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   78 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHK-----KTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEE   78 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEEC-----CCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeec
Confidence            34568999999999999999999977     4678899999976442  2334567789999999999999999999876


Q ss_pred             CC--eEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEe----cCCCcEEEE
Q 018487          187 RS--KLYLILDFINGGHLFFHLYRQGI---FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM----DSDGHVMLT  257 (355)
Q Consensus       187 ~~--~~~lv~e~~~~gsL~~~l~~~~~---l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl----~~~~~~kl~  257 (355)
                      ..  ..|+||||+++++|.+++.....   +++.+++.++.||+.||.|||++||+||||||+|||+    +.++.+||+
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~  158 (319)
T 4euu_A           79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT  158 (319)
T ss_dssp             TTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEEC
T ss_pred             CCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEc
Confidence            55  78999999999999999986543   8999999999999999999999999999999999999    778889999


Q ss_pred             ecCCccccCcCCCCCcccccCccccchhhc--------cCCCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          258 DFGLAKEIDESSRSNSMCGTTEYMAPEILL--------SKGHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       258 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      |||+++............||+.|+|||++.        +..++.++|||||||++|||+||+.||...
T Consensus       159 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  226 (319)
T 4euu_A          159 DFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF  226 (319)
T ss_dssp             CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECT
T ss_pred             cCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999876666566678999999999986        567899999999999999999999999743

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=5.8e-45  Score=328.49  Aligned_cols=234  Identities=30%  Similarity=0.514  Sum_probs=200.5

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      .+..++|++.+.||+|+||+||+|.++     .+++.||+|++...........+.+.+|+.+++.++||||+++++++.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   79 (279)
T 3fdn_A            5 QWALEDFEIGRPLGKGKFGNVYLAREK-----QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH   79 (279)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             eeecccEEEeeEEecCCCeEEEEEEEc-----cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe
Confidence            345578999999999999999999976     567789999997765444555667889999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      ..+..++||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        80 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~  159 (279)
T 3fdn_A           80 DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA  159 (279)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred             cCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence            99999999999999999999998889999999999999999999999999999999999999999999999999998655


Q ss_pred             CcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHHhh
Q 018487          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYLII  332 (355)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~~i  332 (355)
                      .... .....|++.|+|||++.+..++.++||||||+++|+|++|+.||...+.....             ....+..+|
T Consensus       160 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  238 (279)
T 3fdn_A          160 PSSR-RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI  238 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHH
T ss_pred             Cccc-ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHH
Confidence            4332 34557899999999999999999999999999999999999999876543221             123467888


Q ss_pred             hheeeecCCCcCC
Q 018487          333 FHCLFVNSLELLS  345 (355)
Q Consensus       333 ~~~l~~~~~e~~~  345 (355)
                      .+||..+|.+++.
T Consensus       239 ~~~l~~~p~~Rps  251 (279)
T 3fdn_A          239 SRLLKHNPSQRPM  251 (279)
T ss_dssp             HHHCCSSGGGSCC
T ss_pred             HHHhccChhhCCC
Confidence            9999998888764

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.5e-45  Score=334.21  Aligned_cols=202  Identities=30%  Similarity=0.500  Sum_probs=172.7

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|+++++||+|+||+||+|.+.      .++.||+|++..... .....+.+.+|+.++++++||||+++++++...+
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   92 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS------QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSER   92 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET------TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC------CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC
Confidence            468999999999999999999864      367899999976542 3344566788999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      .+|+||||+++ +|.+.+... ..+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        93 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           93 CLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             CEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             EEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            99999999986 677777654 4599999999999999999999999999999999999999999999999999987653


Q ss_pred             CC-CCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          268 SS-RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       268 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      .. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  224 (311)
T 3niz_A          172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT  224 (311)
T ss_dssp             CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCC
Confidence            32 2344578999999999976 568999999999999999999999997653

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=8.7e-45  Score=350.39  Aligned_cols=201  Identities=26%  Similarity=0.448  Sum_probs=171.1

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC-
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-  187 (355)
                      .++|+++++||+|+||+||+|.++     .+++.||||++.... ......+.+.+|+.+|+.++||||+++++++... 
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~-----~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  134 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDA-----VLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK  134 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEET-----TTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEEC-----CCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCC
Confidence            368999999999999999999976     567889999997653 2444556788999999999999999999998654 


Q ss_pred             -----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       188 -----~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                           ..+|+||||++++ |...+.  ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus       135 ~~~~~~~~~lv~E~~~~~-l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          135 TLEEFQDVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             STTTCCEEEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             ccccCCeEEEEEeCCCCC-HHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence                 4689999999875 555554  34899999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      +...........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+
T Consensus       212 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~  267 (464)
T 3ttj_A          212 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD  267 (464)
T ss_dssp             -----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            98766655667789999999999999999999999999999999999999998764

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.5e-45  Score=346.17  Aligned_cols=223  Identities=30%  Similarity=0.503  Sum_probs=180.9

Q ss_pred             CCeEEE-eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHH-HhcCCCcceecceeeec-
Q 018487          110 GDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL-TKVTHPFIVQLRYSFQT-  186 (355)
Q Consensus       110 ~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~-  186 (355)
                      ++|.+. +.||+|+||+||+|.++     .+++.||||++...        ..+.+|+.++ +..+||||++++++|.. 
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~  127 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNK-----RTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL  127 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEEC-----CCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeec
Confidence            468887 78999999999999976     56788999998642        2355688776 45589999999998875 


Q ss_pred             ---CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC---CCcEEEEe
Q 018487          187 ---RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTD  258 (355)
Q Consensus       187 ---~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~---~~~~kl~D  258 (355)
                         ...+|+||||++||+|.+++...+  .+++.+++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|
T Consensus       128 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~D  207 (400)
T 1nxk_A          128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  207 (400)
T ss_dssp             ETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred             ccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEe
Confidence               668999999999999999998754  5999999999999999999999999999999999999987   78999999


Q ss_pred             cCCccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh-----------------
Q 018487          259 FGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA-----------------  321 (355)
Q Consensus       259 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~-----------------  321 (355)
                      ||+++...........+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...                 
T Consensus       208 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~  287 (400)
T 1nxk_A          208 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  287 (400)
T ss_dssp             CTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC
T ss_pred             cccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC
Confidence            999987765555566789999999999999999999999999999999999999997653211                 


Q ss_pred             ----hhhhHHHHHhhhheeeecCCCcCC
Q 018487          322 ----CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 ----~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                          ......+.++|.+||..+|.+++.
T Consensus       288 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt  315 (400)
T 1nxk_A          288 NPEWSEVSEEVKMLIRNLLKTEPTQRMT  315 (400)
T ss_dssp             TTTTTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred             CcccccCCHHHHHHHHHHCCCChhHCcC
Confidence                112234677888999888887653

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=6e-45  Score=343.53  Aligned_cols=228  Identities=26%  Similarity=0.447  Sum_probs=197.1

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++++.||+|+||.||+|.++     .+++.||+|++....   ......+.+|+.+|+.++||||+++++++.....
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~-----~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  122 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEK-----ATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE  122 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred             cceEEEEEEecCCCEEEEEEEEC-----CCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE
Confidence            57999999999999999999976     567889999987543   2233467889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC--CCcEEEEecCCccccC
Q 018487          190 LYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS--DGHVMLTDFGLAKEID  266 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~--~~~~kl~Dfg~a~~~~  266 (355)
                      +|+||||+++++|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||++....
T Consensus       123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~  202 (387)
T 1kob_A          123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  202 (387)
T ss_dssp             EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence            999999999999999887654 6999999999999999999999999999999999999974  4679999999999876


Q ss_pred             cCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-----------------hhhHHHH
Q 018487          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-----------------NTMLLFY  329 (355)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-----------------~~~~~~~  329 (355)
                      ........+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....                 .....+.
T Consensus       203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  282 (387)
T 1kob_A          203 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK  282 (387)
T ss_dssp             TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred             CCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence            55555566899999999999999999999999999999999999999987643221                 1123567


Q ss_pred             HhhhheeeecCCCcCC
Q 018487          330 LIIFHCLFVNSLELLS  345 (355)
Q Consensus       330 ~~i~~~l~~~~~e~~~  345 (355)
                      ++|.+||..+|.+++.
T Consensus       283 ~li~~~L~~dP~~Rpt  298 (387)
T 1kob_A          283 DFIKNLLQKEPRKRLT  298 (387)
T ss_dssp             HHHHTTSCSSGGGSCC
T ss_pred             HHHHHHcCCChhHCcC
Confidence            8888999888887653

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.4e-44  Score=332.85  Aligned_cols=231  Identities=30%  Similarity=0.467  Sum_probs=200.4

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccch---hHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK---NHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      ++|++.+.||+|+||.||+|.++     .+++.||+|++........   ...+.+.+|+.+++.++||||+++++++..
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   86 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREK-----STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN   86 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             ccEEEeeEeeecCCEEEEEEEEC-----CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            46999999999999999999976     4678899999976543221   235678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC----cEEEEecCCc
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG----HVMLTDFGLA  262 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~----~~kl~Dfg~a  262 (355)
                      .+.+|+||||+++++|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++    .+||+|||++
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            999999999999999999999888899999999999999999999999999999999999999888    7999999999


Q ss_pred             cccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-----------------hhh
Q 018487          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-----------------NTM  325 (355)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-----------------~~~  325 (355)
                      .............||+.|+|||++.+..++.++||||||+++|+|++|+.||........                 ...
T Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  246 (321)
T 2a2a_A          167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS  246 (321)
T ss_dssp             EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred             eecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccC
Confidence            887665555667899999999999999999999999999999999999999977533221                 112


Q ss_pred             HHHHHhhhheeeecCCCcCC
Q 018487          326 LLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ..+.++|.+||..+|.+++.
T Consensus       247 ~~~~~li~~~l~~dp~~Rps  266 (321)
T 2a2a_A          247 ELAKDFIRKLLVKETRKRLT  266 (321)
T ss_dssp             HHHHHHHHTTSCSSTTTSCC
T ss_pred             HHHHHHHHHHcCCChhhCcC
Confidence            34577888888888877653

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=330.30  Aligned_cols=204  Identities=26%  Similarity=0.401  Sum_probs=176.1

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|+++++||+|+||+||+|.++     .+++.||+|++.... ......+.+.+|+.++++++||||+++++++...+.
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   76 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNR-----DTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRR   76 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             ccceEeeEEeecCCeEEEEEEeC-----CCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCe
Confidence            68999999999999999999976     467889999986654 234445667889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      .++||||+++++|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           77 LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             EEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            99999999999999988888889999999999999999999999999999999999999999999999999998765332


Q ss_pred             -CCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCchh
Q 018487          270 -RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQV  319 (355)
Q Consensus       270 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~~  319 (355)
                       ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+.
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  208 (311)
T 4agu_A          157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD  208 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence             2345678999999999976 6789999999999999999999999987643

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.1e-44  Score=333.74  Aligned_cols=232  Identities=27%  Similarity=0.496  Sum_probs=203.2

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|++.+.||+|+||.||+|.+.     .+++.||+|++...........+.+.+|+.+++.++|+||+++++++...+
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  114 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDA-----DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND  114 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEC-----CCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            468999999999999999999976     567889999998776556666778889999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      .+|+||||+++++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       115 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          115 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             eEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999999876432


Q ss_pred             -CCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-------------hhhHHHHHhhhh
Q 018487          269 -SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-------------NTMLLFYLIIFH  334 (355)
Q Consensus       269 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-------------~~~~~~~~~i~~  334 (355)
                       .......||+.|+|||++.+..++.++||||||+++|+|++|+.||........             .....+..+|.+
T Consensus       195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  274 (335)
T 2owb_A          195 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK  274 (335)
T ss_dssp             TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHH
T ss_pred             cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence             223456799999999999999999999999999999999999999987543221             112345778889


Q ss_pred             eeeecCCCcCC
Q 018487          335 CLFVNSLELLS  345 (355)
Q Consensus       335 ~l~~~~~e~~~  345 (355)
                      ||..+|.+++.
T Consensus       275 ~l~~dp~~Rps  285 (335)
T 2owb_A          275 MLQTDPTARPT  285 (335)
T ss_dssp             HTCSSGGGSCC
T ss_pred             HccCChhHCcC
Confidence            99888887653

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=4.4e-45  Score=342.10  Aligned_cols=233  Identities=16%  Similarity=0.321  Sum_probs=191.0

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC---CCcceecce
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT---HPFIVQLRY  182 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~  182 (355)
                      .+..++|++.++||+|+||+||+|.+....+...++.||||++....      ...+..|+.+++.++   |+||+++++
T Consensus        61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~  134 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYS  134 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred             EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence            35567899999999999999999976544445678899999986542      234566788888777   999999999


Q ss_pred             eeecCCeEEEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC-------
Q 018487          183 SFQTRSKLYLILDFINGGHLFFHLYR-----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-------  250 (355)
Q Consensus       183 ~~~~~~~~~lv~e~~~~gsL~~~l~~-----~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~-------  250 (355)
                      ++...+..|+||||+++|+|.+++..     ...+++.+++.++.||+.||+|||++||+||||||+|||++.       
T Consensus       135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~  214 (365)
T 3e7e_A          135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD  214 (365)
T ss_dssp             EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred             eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence            99999999999999999999999974     456999999999999999999999999999999999999998       


Q ss_pred             ----CCcEEEEecCCccccC---cCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh--
Q 018487          251 ----DGHVMLTDFGLAKEID---ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA--  321 (355)
Q Consensus       251 ----~~~~kl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~--  321 (355)
                          ++.+||+|||+++.+.   ........+||+.|+|||++.+..++.++|||||||++|||+||+.||.......  
T Consensus       215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~  294 (365)
T 3e7e_A          215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK  294 (365)
T ss_dssp             ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE
T ss_pred             cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee
Confidence                8999999999997553   2223455689999999999999999999999999999999999999997543211  


Q ss_pred             -------hhhhHHHHHhhhheeeecCCCcC
Q 018487          322 -------CNTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       322 -------~~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                             ......+..++..||..++.+++
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~  324 (365)
T 3e7e_A          295 PEGLFRRLPHLDMWNEFFHVMLNIPDCHHL  324 (365)
T ss_dssp             ECSCCTTCSSHHHHHHHHHHHHCCCCTTCC
T ss_pred             echhccccCcHHHHHHHHHHHcCCCCCCcc
Confidence                   12234566778888888776653

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.2e-44  Score=326.08  Aligned_cols=233  Identities=27%  Similarity=0.495  Sum_probs=203.7

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ..++|++.+.||+|+||.||+|.++     .+++.||+|++...........+.+.+|+.+++.++||||+++++++...
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   87 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDA-----DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN   87 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEEEEeecCCEEEEEEEEC-----CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence            3468999999999999999999976     56788999999877655566677888999999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      +..++||||+++++|.+++.....+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        88 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           88 DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            99999999999999999998888899999999999999999999999999999999999999999999999999987643


Q ss_pred             C-CCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-------------hhhHHHHHhhh
Q 018487          268 S-SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-------------NTMLLFYLIIF  333 (355)
Q Consensus       268 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-------------~~~~~~~~~i~  333 (355)
                      . .......||+.|+|||++.+..++.++||||||+++|+|++|+.||........             .....+..+|.
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  247 (294)
T 2rku_A          168 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ  247 (294)
T ss_dssp             TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHH
T ss_pred             CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHH
Confidence            2 223456789999999999998899999999999999999999999987643221             12235678888


Q ss_pred             heeeecCCCcCC
Q 018487          334 HCLFVNSLELLS  345 (355)
Q Consensus       334 ~~l~~~~~e~~~  345 (355)
                      +||..+|.+++.
T Consensus       248 ~~l~~~p~~Rps  259 (294)
T 2rku_A          248 KMLQTDPTARPT  259 (294)
T ss_dssp             HHTCSSGGGSCC
T ss_pred             HHcccChhhCcC
Confidence            999888887654

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-45  Score=343.14  Aligned_cols=238  Identities=21%  Similarity=0.320  Sum_probs=196.9

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      .+..++|++++.||+|+||+||+|.+.+..+...++.||||+++...  .......+.+|+.++++++||||+++++++.
T Consensus        67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  144 (367)
T 3l9p_A           67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL  144 (367)
T ss_dssp             BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            35567899999999999999999998766555678899999986532  3344456788999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC---cEE
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQG-------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVM  255 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~~-------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~---~~k  255 (355)
                      .....|+||||+++|+|.+++....       .+++.+++.++.||+.||.|||++||+||||||+|||++.++   .+|
T Consensus       145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence            9999999999999999999998753       489999999999999999999999999999999999998555   599


Q ss_pred             EEecCCccccCcC---CCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhhh--------
Q 018487          256 LTDFGLAKEIDES---SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACN--------  323 (355)
Q Consensus       256 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~~--------  323 (355)
                      |+|||+++.+...   .......||+.|+|||++.+..++.++|||||||++|||+| |+.||...+.....        
T Consensus       225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~  304 (367)
T 3l9p_A          225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR  304 (367)
T ss_dssp             ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred             ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            9999999865322   22334568999999999999999999999999999999998 99999876433211        


Q ss_pred             ------hhHHHHHhhhheeeecCCCcCC
Q 018487          324 ------TMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       324 ------~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                            ....+..++.+||..+|.+++.
T Consensus       305 ~~~~~~~~~~l~~li~~~l~~dP~~Rps  332 (367)
T 3l9p_A          305 MDPPKNCPGPVYRIMTQCWQHQPEDRPN  332 (367)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCCccCCHHHHHHHHHHcCCCHhHCcC
Confidence                  1224678888999988888653

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=341.63  Aligned_cols=231  Identities=25%  Similarity=0.413  Sum_probs=200.4

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccch-----hHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-----NHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      ++|++.+.||+|+||+||+|.++     .+++.||||++........     ...+.+.+|+.+++.++||||+++++++
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~   98 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDK-----EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF   98 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEET-----TTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cceEEEeEEEecCCEEEEEEEEC-----CCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            47999999999999999999976     5678899999987543221     1233466799999999999999999999


Q ss_pred             ecCCeEEEEEeccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          185 QTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~g-sL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      ...+.+++||||+.+| +|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        99 ~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  178 (335)
T 3dls_A           99 ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA  178 (335)
T ss_dssp             ECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             eeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence            9999999999999777 999999988889999999999999999999999999999999999999999999999999998


Q ss_pred             ccCcCCCCCcccccCccccchhhccCCC-CCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------hhHHHHHhhhhe
Q 018487          264 EIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------TMLLFYLIIFHC  335 (355)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------~~~~~~~~i~~~  335 (355)
                      ...........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.........       ....+..+|.+|
T Consensus       179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~l~~li~~~  258 (335)
T 3dls_A          179 YLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSLVSGL  258 (335)
T ss_dssp             ECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTTCCCCSSCCCHHHHHHHHHH
T ss_pred             ECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhhccCCCcccCHHHHHHHHHH
Confidence            8766665666789999999999988776 78899999999999999999999875433221       233568899999


Q ss_pred             eeecCCCcCC
Q 018487          336 LFVNSLELLS  345 (355)
Q Consensus       336 l~~~~~e~~~  345 (355)
                      |..+|.+++.
T Consensus       259 L~~dP~~Rps  268 (335)
T 3dls_A          259 LQPVPERRTT  268 (335)
T ss_dssp             TCSSGGGSCC
T ss_pred             ccCChhhCcC
Confidence            9999988764

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=8.9e-45  Score=333.67  Aligned_cols=202  Identities=25%  Similarity=0.451  Sum_probs=162.8

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|+++++||+|+||+||+|.++     .+++.||+|+++...  .....+.+.+|+.+++.++||||+++++++..++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   76 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNK-----TTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTEN   76 (317)
T ss_dssp             ---------------CEEEEEECS-----SSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTT
T ss_pred             ccceeEeeEECCCCCEEEEEEEEC-----CCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECC
Confidence            358999999999999999999865     567889999997654  2223355778999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          189 KLYLILDFINGGHLFFHLYRQ------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                      .+|+||||+++ +|.+++...      ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        77 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~  155 (317)
T 2pmi_A           77 KLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA  155 (317)
T ss_dssp             EEEEEEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSC
T ss_pred             eEEEEEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccc
Confidence            99999999985 888888754      35899999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCC-CCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          263 KEIDESS-RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       263 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      ....... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+
T Consensus       156 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  213 (317)
T 2pmi_A          156 RAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN  213 (317)
T ss_dssp             EETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             eecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            8765332 2345678999999999986 468999999999999999999999998754

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3e-44  Score=323.35  Aligned_cols=227  Identities=28%  Similarity=0.471  Sum_probs=198.0

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++.+.||+|+||.||+|.++     .++..||+|++.....   ...+.+.+|+.+++.++||||+++++++...+.
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQK-----GTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTD   80 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             hhEEeeeEEeecCCEEEEEEEeC-----CCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe
Confidence            47999999999999999999976     4567899999876543   234568889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEe---cCCCcEEEEecCCccccC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl---~~~~~~kl~Dfg~a~~~~  266 (355)
                      .|+||||+++++|.+++.....+++.+++.++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            99999999999999999988889999999999999999999999999999999999999   788999999999998876


Q ss_pred             cCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-----------------hhhHHHH
Q 018487          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-----------------NTMLLFY  329 (355)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-----------------~~~~~~~  329 (355)
                      .........||+.|+|||++.+. ++.++||||||+++|+|++|+.||...+....                 +....+.
T Consensus       161 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (277)
T 3f3z_A          161 PGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAE  239 (277)
T ss_dssp             TTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHH
T ss_pred             CccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHH
Confidence            66666677899999999998754 89999999999999999999999987543221                 1233567


Q ss_pred             HhhhheeeecCCCcCC
Q 018487          330 LIIFHCLFVNSLELLS  345 (355)
Q Consensus       330 ~~i~~~l~~~~~e~~~  345 (355)
                      .+|.+||..+|.+++.
T Consensus       240 ~li~~~l~~dp~~R~s  255 (277)
T 3f3z_A          240 SLIRRLLTKSPKQRIT  255 (277)
T ss_dssp             HHHHHHTCSSTTTSCC
T ss_pred             HHHHHHccCChhhCcC
Confidence            7888888888887653

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3.5e-45  Score=341.57  Aligned_cols=239  Identities=22%  Similarity=0.376  Sum_probs=200.6

Q ss_pred             hcCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecce
Q 018487          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY  182 (355)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~  182 (355)
                      .+.+..++|++.+.||+|+||.||+|.+.+..+..+++.||||+++...  .....+.+.+|+.+++++ +||||+++++
T Consensus        16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~   93 (359)
T 3vhe_A           16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG   93 (359)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence            3456778999999999999999999998876666788999999997643  334456788999999999 7999999999


Q ss_pred             eeecCC-eEEEEEeccCCCChHHHHHhcCC--------------------------------------------------
Q 018487          183 SFQTRS-KLYLILDFINGGHLFFHLYRQGI--------------------------------------------------  211 (355)
Q Consensus       183 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------  211 (355)
                      ++...+ .+++||||+++|+|.+++.....                                                  
T Consensus        94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (359)
T 3vhe_A           94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL  173 (359)
T ss_dssp             EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred             eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence            988754 59999999999999999976543                                                  


Q ss_pred             ----------------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCC---CC
Q 018487          212 ----------------FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR---SN  272 (355)
Q Consensus       212 ----------------l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~---~~  272 (355)
                                      +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.....   ..
T Consensus       174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (359)
T 3vhe_A          174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG  253 (359)
T ss_dssp             ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC-
T ss_pred             chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcc
Confidence                            89999999999999999999999999999999999999999999999999986643322   23


Q ss_pred             cccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh---------------hhhhHHHHHhhhhee
Q 018487          273 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA---------------CNTMLLFYLIIFHCL  336 (355)
Q Consensus       273 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~---------------~~~~~~~~~~i~~~l  336 (355)
                      ...||+.|+|||++.+..++.++|||||||++|+|+| |+.||.......               ......+..++.+||
T Consensus       254 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  333 (359)
T 3vhe_A          254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCW  333 (359)
T ss_dssp             -CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHT
T ss_pred             ccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHc
Confidence            4568899999999999999999999999999999999 999998753211               011225678888999


Q ss_pred             eecCCCcC
Q 018487          337 FVNSLELL  344 (355)
Q Consensus       337 ~~~~~e~~  344 (355)
                      ..+|.+++
T Consensus       334 ~~dP~~Rp  341 (359)
T 3vhe_A          334 HGEPSQRP  341 (359)
T ss_dssp             CSSGGGSC
T ss_pred             cCChhhCC
Confidence            88888765

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.8e-44  Score=326.14  Aligned_cols=234  Identities=31%  Similarity=0.548  Sum_probs=202.4

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      .+..++|++.+.||+|+||.||+|.+.     .+++.||+|++...........+.+.+|+.+++.++||||+++++++.
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   84 (284)
T 2vgo_A           10 KFTIDDFDIGRPLGKGKFGNVYLAREK-----QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH   84 (284)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             chhhhhceeeheecCCCCeEEEEEEEc-----CCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence            344578999999999999999999976     467789999997655444444567889999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      ..+..|+||||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  164 (284)
T 2vgo_A           85 DRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHA  164 (284)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccC
Confidence            99999999999999999999998888999999999999999999999999999999999999999999999999998765


Q ss_pred             CcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHHhh
Q 018487          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYLII  332 (355)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~~i  332 (355)
                      ... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...+.....             ....+..+|
T Consensus       165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  243 (284)
T 2vgo_A          165 PSL-RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLI  243 (284)
T ss_dssp             SSS-CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHH
T ss_pred             ccc-ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHH
Confidence            433 234567999999999999999999999999999999999999999875433211             123457788


Q ss_pred             hheeeecCCCcCC
Q 018487          333 FHCLFVNSLELLS  345 (355)
Q Consensus       333 ~~~l~~~~~e~~~  345 (355)
                      .+||..+|.+++.
T Consensus       244 ~~~l~~~p~~Rps  256 (284)
T 2vgo_A          244 SKLLRYHPPQRLP  256 (284)
T ss_dssp             HHHSCSSGGGSCC
T ss_pred             HHHhhcCHhhCCC
Confidence            8898888887654

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=9.7e-45  Score=336.36  Aligned_cols=239  Identities=21%  Similarity=0.353  Sum_probs=202.3

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      ..+..++|++.+.||+|+||.||+|++++.....+++.||||+++...  .....+.+.+|+.+++.++||||+++++++
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  119 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVC  119 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            456678999999999999999999998865555667899999997653  344556788999999999999999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQ------------------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRD  240 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrD  240 (355)
                      ...+.+|+||||+++++|.+++...                        ..+++.+++.++.||+.||.|||++||+|||
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D  199 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD  199 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            9999999999999999999999764                        5689999999999999999999999999999


Q ss_pred             CCCCcEEecCCCcEEEEecCCccccCcCC---CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCC
Q 018487          241 LKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKS  316 (355)
Q Consensus       241 lkp~NILl~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~  316 (355)
                      |||+|||++.++.+||+|||++.......   ......+|+.|+|||++.+..++.++||||||+++|+|+| |+.||..
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            99999999999999999999998654322   2234567899999999999999999999999999999999 9999987


Q ss_pred             chhhhh--------------hhhHHHHHhhhheeeecCCCcCC
Q 018487          317 MQVIAC--------------NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       317 ~~~~~~--------------~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ......              .....+..+|.+||..+|.+++.
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps  322 (343)
T 1luf_A          280 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPS  322 (343)
T ss_dssp             SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCC
Confidence            643221              11235677888999888887653

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=330.62  Aligned_cols=207  Identities=28%  Similarity=0.387  Sum_probs=174.6

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccc--hhHHHHHHHHHHHHHhc---CCCcceecc
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK--KNHVDYMKAERDILTKV---THPFIVQLR  181 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l---~h~nIv~l~  181 (355)
                      +..++|+++++||+|+||+||+|+++     .+++.||||++.......  ......+.+|+.+++.+   +||||++++
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~   80 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDP-----HSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLM   80 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECT-----TTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEEC-----CCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEee
Confidence            34579999999999999999999965     567899999987543211  11123345667666655   599999999


Q ss_pred             eeeecCC-----eEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcE
Q 018487          182 YSFQTRS-----KLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV  254 (355)
Q Consensus       182 ~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~  254 (355)
                      +++....     .+++||||+.+ +|.+++.....  +++.+++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus        81 ~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~  159 (308)
T 3g33_A           81 DVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTV  159 (308)
T ss_dssp             EEEEECCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCE
T ss_pred             eeeeccCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCE
Confidence            9987654     58999999975 99999887654  9999999999999999999999999999999999999999999


Q ss_pred             EEEecCCccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchh
Q 018487          255 MLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQV  319 (355)
Q Consensus       255 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~  319 (355)
                      ||+|||++............+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus       160 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~  224 (308)
T 3g33_A          160 KLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE  224 (308)
T ss_dssp             EECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH
T ss_pred             EEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999999887666656677899999999999999999999999999999999999999987643

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=334.54  Aligned_cols=235  Identities=20%  Similarity=0.323  Sum_probs=196.0

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      .+..++|++.+.||+|+||+||+|.++...  ..+..||||+++...  .....+.+.+|+.+++.++||||+++++++.
T Consensus        45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  120 (325)
T 3kul_A           45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPG--QRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVT  120 (325)
T ss_dssp             BCCGGGEEEEEEEEETTTEEEEEEEECCTT--SCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccChhHeEEeeEEEeCCCcEEEEEEEecCC--CCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            355678999999999999999999986432  345679999997543  3444567889999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      ..+..|+||||+++++|.+++... +.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          121 RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             GGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             eCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            999999999999999999999755 5799999999999999999999999999999999999999999999999999987


Q ss_pred             cCcCCC----CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhhh--------------hh
Q 018487          265 IDESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACN--------------TM  325 (355)
Q Consensus       265 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~~--------------~~  325 (355)
                      ......    .....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.........              ..
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCP  280 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcC
Confidence            644322    122345778999999998899999999999999999999 99999776432211              12


Q ss_pred             HHHHHhhhheeeecCCCcC
Q 018487          326 LLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~  344 (355)
                      ..+..+|.+||..+|.+++
T Consensus       281 ~~l~~li~~~l~~dp~~Rp  299 (325)
T 3kul_A          281 HALHQLMLDCWHKDRAQRP  299 (325)
T ss_dssp             HHHHHHHHHHTCSSGGGSC
T ss_pred             HHHHHHHHHHccCChhhCc
Confidence            3567788899988888865

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.5e-44  Score=329.45  Aligned_cols=231  Identities=28%  Similarity=0.407  Sum_probs=191.4

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|++.+.||+|+||.||+|.+.     .+++.||+|++...........+.+.+|+.+++.++||||+++++++...+
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDT-----VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG  107 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEET-----TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEc-----CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence            368999999999999999999976     467889999998765555566678899999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      .+|+||||+++++|.+++...+.+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            99999999999999999998888999999999999999999999999999999999999999999999999999866443


Q ss_pred             C--CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh----------------hhhHHHHH
Q 018487          269 S--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC----------------NTMLLFYL  330 (355)
Q Consensus       269 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~----------------~~~~~~~~  330 (355)
                      .  ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...+....                +....+..
T Consensus       188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  267 (309)
T 2h34_A          188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDA  267 (309)
T ss_dssp             ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHH
T ss_pred             ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHH
Confidence            2  22345789999999999999999999999999999999999999987654321                11224677


Q ss_pred             hhhheeeecCCCcC
Q 018487          331 IIFHCLFVNSLELL  344 (355)
Q Consensus       331 ~i~~~l~~~~~e~~  344 (355)
                      +|.+||..+|.+++
T Consensus       268 li~~~l~~dP~~Rp  281 (309)
T 2h34_A          268 VIARGMAKNPEDRY  281 (309)
T ss_dssp             HHHHHTCSSGGGSC
T ss_pred             HHHHhccCCHHHHH
Confidence            88899998888876

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-44  Score=338.73  Aligned_cols=238  Identities=22%  Similarity=0.388  Sum_probs=201.2

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCC--CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecce
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY  182 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~  182 (355)
                      .+..++|++.++||+|+||+||+|.+.+...  ...+..||||++....  .....+.+.+|+.+++.+ +||||+++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  142 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG  142 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence            4556789999999999999999999875432  2345679999997653  344556788999999999 8999999999


Q ss_pred             eeecCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q 018487          183 SFQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI  246 (355)
Q Consensus       183 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NI  246 (355)
                      ++...+..|+||||+++++|.+++....                .+++.+++.++.||+.||.|||++||+||||||+||
T Consensus       143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  222 (382)
T 3tt0_A          143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV  222 (382)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence            9999999999999999999999998754                489999999999999999999999999999999999


Q ss_pred             EecCCCcEEEEecCCccccCcCC---CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh
Q 018487          247 LMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC  322 (355)
Q Consensus       247 Ll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~  322 (355)
                      |++.++.+||+|||+++......   ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...+....
T Consensus       223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~  302 (382)
T 3tt0_A          223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  302 (382)
T ss_dssp             EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999998764432   2334467889999999999999999999999999999999 9999987643321


Q ss_pred             h--------------hhHHHHHhhhheeeecCCCcCC
Q 018487          323 N--------------TMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       323 ~--------------~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      .              ....+..+|.+||..+|.+++.
T Consensus       303 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps  339 (382)
T 3tt0_A          303 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPT  339 (382)
T ss_dssp             HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcC
Confidence            1              1235677888999888887653

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2e-44  Score=324.22  Aligned_cols=235  Identities=28%  Similarity=0.503  Sum_probs=193.6

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      .+..++|++.+.||+|+||.||+|.++     .+++.||||++...........+.+.+|+.+++.++||||+++++++.
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   81 (276)
T 2h6d_A            7 RVKIGHYVLGDTLGVGTFGKVKIGEHQ-----LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS   81 (276)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             cceeccEEEEeeecCCCCeEEEEEEEC-----CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence            344578999999999999999999976     467889999997765444455677889999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      ..+..|+||||+++++|.+++...+.+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        82 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  161 (276)
T 2h6d_A           82 TPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM  161 (276)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence            99999999999999999999998888999999999999999999999999999999999999999999999999999877


Q ss_pred             CcCCCCCcccccCccccchhhccCCC-CCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHHh
Q 018487          266 DESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYLI  331 (355)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~~  331 (355)
                      ..........|++.|+|||++.+..+ +.++||||||+++|+|++|+.||...+.....             ....+..+
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  241 (276)
T 2h6d_A          162 SDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATL  241 (276)
T ss_dssp             CC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             CCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHH
Confidence            65544455678999999999987765 57999999999999999999999875432211             12356778


Q ss_pred             hhheeeecCCCcCC
Q 018487          332 IFHCLFVNSLELLS  345 (355)
Q Consensus       332 i~~~l~~~~~e~~~  345 (355)
                      |.+||..+|.+++.
T Consensus       242 i~~~l~~~p~~Rps  255 (276)
T 2h6d_A          242 LMHMLQVDPLKRAT  255 (276)
T ss_dssp             HHHHTCSSGGGSCC
T ss_pred             HHHHccCChhhCCC
Confidence            88888888877653

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.2e-44  Score=329.09  Aligned_cols=228  Identities=26%  Similarity=0.357  Sum_probs=184.8

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHH-hcCCCcceecceeeecCC
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT-KVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~~~  188 (355)
                      ++|+++++||+|+||+||+|.++     .+++.||||++...........+ ...|+..+. ..+|+||+++++++..++
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~-~~~e~~~~~~~~~h~~iv~l~~~~~~~~  130 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSK-----EDGRLYAVKRSMSPFRGPKDRAR-KLAEVGSHEKVGQHPCCVRLEQAWEEGG  130 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEET-----TTSCEEEEEEESSSCCSHHHHHH-HHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hheeeeheeccCCCeEEEEEEEC-----CCCeEEEEEEecccccChHHHHH-HHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence            47999999999999999999976     56788999998765433333333 334555444 448999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      .+|+||||+ +++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          131 ILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             EEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            999999999 55888877665 4599999999999999999999999999999999999999999999999999988766


Q ss_pred             CCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh------------hhhhHHHHHhhhhe
Q 018487          268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA------------CNTMLLFYLIIFHC  335 (355)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~------------~~~~~~~~~~i~~~  335 (355)
                      ........||+.|+|||++.+ .++.++|||||||++|||++|..+|...+...            ......+..+|.+|
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  288 (311)
T 3p1a_A          210 AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMM  288 (311)
T ss_dssp             -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCCCHHHHTTSCHHHHHHHHHH
T ss_pred             CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCCCcccccCCCHHHHHHHHHH
Confidence            555566779999999999876 78999999999999999999977766543221            11234567888899


Q ss_pred             eeecCCCcCC
Q 018487          336 LFVNSLELLS  345 (355)
Q Consensus       336 l~~~~~e~~~  345 (355)
                      |..+|.+++.
T Consensus       289 L~~dP~~Rpt  298 (311)
T 3p1a_A          289 LEPDPKLRAT  298 (311)
T ss_dssp             SCSSTTTSCC
T ss_pred             cCCChhhCcC
Confidence            9888888653

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=8.6e-45  Score=352.62  Aligned_cols=230  Identities=30%  Similarity=0.480  Sum_probs=202.0

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++.+.||+|+||.||+|.++     .+++.||||++...........+.+.+|+.++++++||||+++++++...+.
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  100 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDK-----ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY  100 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CceEEeeEEecCCCEEEEEEEEC-----CCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            47999999999999999999976     5678899999987665555566778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEe---cCCCcEEEEecCCccccC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl---~~~~~~kl~Dfg~a~~~~  266 (355)
                      +|+||||+.+++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..+.
T Consensus       101 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          101 FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             EEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            99999999999999999998999999999999999999999999999999999999999   567899999999998876


Q ss_pred             cCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-----------------hhhHHHH
Q 018487          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-----------------NTMLLFY  329 (355)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-----------------~~~~~~~  329 (355)
                      ........+||+.|+|||++.+ .++.++|||||||++|+|++|+.||...+....                 .....+.
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  259 (484)
T 3nyv_A          181 ASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK  259 (484)
T ss_dssp             CCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHH
T ss_pred             cccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHH
Confidence            6555566789999999999976 699999999999999999999999987643221                 1123467


Q ss_pred             HhhhheeeecCCCcCC
Q 018487          330 LIIFHCLFVNSLELLS  345 (355)
Q Consensus       330 ~~i~~~l~~~~~e~~~  345 (355)
                      .+|.+||..+|.+++.
T Consensus       260 ~li~~~L~~dp~~R~s  275 (484)
T 3nyv_A          260 DLIRKMLTYVPSMRIS  275 (484)
T ss_dssp             HHHHHHTCSSGGGSCC
T ss_pred             HHHHHHCCCChhHCcC
Confidence            7888999888888764

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=328.24  Aligned_cols=231  Identities=29%  Similarity=0.514  Sum_probs=187.8

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccc-----------------------hhHHHHHHHH
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-----------------------KNHVDYMKAE  165 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~E  165 (355)
                      .++|++.+.||+|+||.||+|.++     .+++.||||++.......                       ....+.+.+|
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E   86 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNE-----NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQE   86 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEET-----TTTEEEEEEEEECC-------------------------------CHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEEC-----CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHH
Confidence            468999999999999999999976     567889999997654221                       1223567889


Q ss_pred             HHHHHhcCCCcceecceeeec--CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q 018487          166 RDILTKVTHPFIVQLRYSFQT--RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKP  243 (355)
Q Consensus       166 ~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp  243 (355)
                      +.+++.++||||+++++++..  .+.+|+||||+++++|.+++ ....+++.+++.++.||+.||.|||++||+||||||
T Consensus        87 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp  165 (298)
T 2zv2_A           87 IAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKP  165 (298)
T ss_dssp             HHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             HHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence            999999999999999999986  67899999999999997654 345799999999999999999999999999999999


Q ss_pred             CcEEecCCCcEEEEecCCccccCcCC-CCCcccccCccccchhhccCC---CCCcccHHHHHHHHHHHHcCCCCCCCchh
Q 018487          244 ENILMDSDGHVMLTDFGLAKEIDESS-RSNSMCGTTEYMAPEILLSKG---HNKDADWWSVGILLYEMLTGQVNIKSMQV  319 (355)
Q Consensus       244 ~NILl~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~~l~elltg~~pf~~~~~  319 (355)
                      +|||++.++.+||+|||++....... ......||+.|+|||++.+..   ++.++|||||||++|+|++|+.||...+.
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  245 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI  245 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             HHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence            99999999999999999998765432 234567999999999998665   37789999999999999999999987543


Q ss_pred             hhh---------------hhhHHHHHhhhheeeecCCCcCC
Q 018487          320 IAC---------------NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       320 ~~~---------------~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ...               .....+..+|.+||..+|.+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s  286 (298)
T 2zv2_A          246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIV  286 (298)
T ss_dssp             HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCC
T ss_pred             HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCC
Confidence            221               12235677888888888887653

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.1e-44  Score=326.52  Aligned_cols=201  Identities=24%  Similarity=0.444  Sum_probs=171.9

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++++.||+|+||+||+|++.      .++.||+|++..... .....+.+.+|+.+++.++||||+++++++...+.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNN------YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR   74 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET------TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred             ccchhhhhcccCCCEEEEEEEcC------CCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCe
Confidence            58999999999999999999863      467899999876542 22333567789999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      +|+||||+++ +|.+++... +.+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        75 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (288)
T 1ob3_A           75 LVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (288)
T ss_dssp             EEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             EEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence            9999999986 888888764 67999999999999999999999999999999999999999999999999999876432


Q ss_pred             C-CCCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          269 S-RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       269 ~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      . ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  205 (288)
T 1ob3_A          154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS  205 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            2 23445789999999999764 58999999999999999999999998754

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.8e-44  Score=332.04  Aligned_cols=227  Identities=19%  Similarity=0.256  Sum_probs=192.2

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceeeec
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQT  186 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~  186 (355)
                      ..++|++.+.||+|+||+||+|.+.     .+++.||||++......     +.+.+|+.+++.+ +||||+++++++..
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~   76 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNL-----YTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPC   76 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEET-----TTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEEC-----CCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEec
Confidence            3578999999999999999999976     56789999998754322     2367899999999 89999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCc-----EEEEecC
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----VMLTDFG  260 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~-----~kl~Dfg  260 (355)
                      .+..++||||+ +++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.     +||+|||
T Consensus        77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg  155 (330)
T 2izr_A           77 GKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFA  155 (330)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred             CCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence            99999999999 88999998864 67999999999999999999999999999999999999998887     9999999


Q ss_pred             CccccCcCCC--------CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh----------
Q 018487          261 LAKEIDESSR--------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC----------  322 (355)
Q Consensus       261 ~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~----------  322 (355)
                      +++.+.....        ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+....          
T Consensus       156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~  235 (330)
T 2izr_A          156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT  235 (330)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH
T ss_pred             cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh
Confidence            9987643322        2456899999999999999999999999999999999999999987421110          


Q ss_pred             ----------hhhHHHHHhhhheeeecCCCcCC
Q 018487          323 ----------NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       323 ----------~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                                ...-.+..++..|+..+|.+++.
T Consensus       236 ~~~~~~~~~~~~~p~~~~li~~~l~~~p~~RP~  268 (330)
T 2izr_A          236 KRATPIEVLCENFPEMATYLRYVRRLDFFEKPD  268 (330)
T ss_dssp             HHHSCHHHHTTTCHHHHHHHHHHHHCCTTCCCC
T ss_pred             hccCCHHHHhccChHHHHHHHHHHhCCCCCCCC
Confidence                      00115677888899888887653

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.8e-44  Score=332.53  Aligned_cols=229  Identities=28%  Similarity=0.400  Sum_probs=189.0

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC-
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-  188 (355)
                      ++|++++.||+|+||.||+|+++     .+++.||||+++...  .....+.+.+|+.++++++||||++++++|.... 
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~-----~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   78 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNK-----VDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPP   78 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEET-----TTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCS
T ss_pred             hcCceeeEecCCCCeEEEEEEEc-----CCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEecc
Confidence            47999999999999999999976     467889999997643  3345567889999999999999999999885433 


Q ss_pred             --------------------------------------------------------eEEEEEeccCCCChHHHHHhcCC-
Q 018487          189 --------------------------------------------------------KLYLILDFINGGHLFFHLYRQGI-  211 (355)
Q Consensus       189 --------------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~-  211 (355)
                                                                              .+++||||+++++|.+++..... 
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~  158 (332)
T 3qd2_B           79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL  158 (332)
T ss_dssp             CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred             chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence                                                                    38999999999999999987644 


Q ss_pred             --CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC-------------CCCcccc
Q 018487          212 --FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-------------RSNSMCG  276 (355)
Q Consensus       212 --l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-------------~~~~~~g  276 (355)
                        ..+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......             .....+|
T Consensus       159 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g  238 (332)
T 3qd2_B          159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG  238 (332)
T ss_dssp             GGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred             cchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence              5666789999999999999999999999999999999999999999999998765432             2234579


Q ss_pred             cCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh------------hhhHHHHHhhhheeeecCCCcC
Q 018487          277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC------------NTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       277 t~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~------------~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                      |+.|+|||++.+..++.++|||||||++|+|++|..|+........            .....+..+|.+||..+|.+++
T Consensus       239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  318 (332)
T 3qd2_B          239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERP  318 (332)
T ss_dssp             CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSC
T ss_pred             CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCC
Confidence            9999999999999999999999999999999999888754322211            1122346788899998888875


Q ss_pred             C
Q 018487          345 S  345 (355)
Q Consensus       345 ~  345 (355)
                      .
T Consensus       319 s  319 (332)
T 3qd2_B          319 E  319 (332)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5.8e-44  Score=322.36  Aligned_cols=231  Identities=29%  Similarity=0.488  Sum_probs=195.1

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccc---hhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK---KNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      ++|++.+.||+|+||.||+|.++     .+++.||+|++.......   ....+.+.+|+.+++.++||||+++++++..
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   79 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQK-----GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN   79 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhHHhhcccCceEEEEEEEc-----CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC
Confidence            46999999999999999999976     457889999987654322   1235678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC----cEEEEecCCc
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG----HVMLTDFGLA  262 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~----~~kl~Dfg~a  262 (355)
                      .+..++||||+++++|.+++.....+++.++..++.|++.||.|||++||+||||||+||+++.++    .+||+|||++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           80 KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             CCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            999999999999999999998888899999999999999999999999999999999999998877    8999999999


Q ss_pred             cccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-----------------hhh
Q 018487          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-----------------NTM  325 (355)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-----------------~~~  325 (355)
                      .............|++.|+|||++.+..++.++||||||+++|+|++|+.||........                 ...
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T 3bhy_A          160 HKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS  239 (283)
T ss_dssp             EECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred             eeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCC
Confidence            877655555566799999999999989999999999999999999999999987543221                 112


Q ss_pred             HHHHHhhhheeeecCCCcCC
Q 018487          326 LLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ..+..++.+||..+|.+++.
T Consensus       240 ~~~~~li~~~l~~dp~~Rps  259 (283)
T 3bhy_A          240 ELAKDFIRRLLVKDPKRRMT  259 (283)
T ss_dssp             HHHHHHHHTTSCSSGGGSCC
T ss_pred             HHHHHHHHHHccCCHhHCcC
Confidence            34677888888888877653

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.9e-44  Score=339.36  Aligned_cols=201  Identities=27%  Similarity=0.492  Sum_probs=164.8

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecceeeecCC
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRS  188 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~  188 (355)
                      ++|++++.||+|+||.||+|.++     .+++.||||++.... ......+.+.+|+.+++.+. ||||+++++++...+
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~   82 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDR-----RTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN   82 (388)
T ss_dssp             TTEEEEEC-------CEEEEEET-----TTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred             CceEEEEEeeeCCCeEEEEEEEC-----CCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence            58999999999999999999976     567889999986543 23444566778999999998 999999999997543


Q ss_pred             --eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          189 --KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       189 --~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                        .+|+|||||++ +|..++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus        83 ~~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A           83 DRDVYLVFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV  160 (388)
T ss_dssp             SSCEEEEEECCSE-EHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred             CCEEEEEecccCc-CHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence              79999999985 88887765 578999999999999999999999999999999999999999999999999998653


Q ss_pred             cC----------------------CCCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          267 ES----------------------SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       267 ~~----------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      ..                      ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  235 (388)
T 3oz6_A          161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS  235 (388)
T ss_dssp             SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            21                      11234579999999999986 678999999999999999999999998764

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=5e-44  Score=332.94  Aligned_cols=227  Identities=25%  Similarity=0.379  Sum_probs=194.4

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      +.|++++.||+|+||+||+|.+.     .+++.||||++...........+.+.+|+.++++++||||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  128 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDV-----RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT  128 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             hheeeeeEEccCCCEEEEEEEEc-----cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCe
Confidence            35999999999999999999976     5678899999987654455566778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          190 LYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      .|+||||+.| +|.+.+. ....+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... 
T Consensus       129 ~~lv~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-  206 (348)
T 1u5q_A          129 AWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  206 (348)
T ss_dssp             EEEEEECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             EEEEEecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence            9999999985 6767665 456799999999999999999999999999999999999999999999999999987643 


Q ss_pred             CCCCcccccCccccchhhc---cCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh---------------hhhHHHHH
Q 018487          269 SRSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC---------------NTMLLFYL  330 (355)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~---------------~~~~~~~~  330 (355)
                        ....+||+.|+|||++.   +..++.++|||||||++|||++|+.||...+....               .....+..
T Consensus       207 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  284 (348)
T 1u5q_A          207 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN  284 (348)
T ss_dssp             --BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHH
T ss_pred             --CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence              23457999999999985   46789999999999999999999999987543221               12235678


Q ss_pred             hhhheeeecCCCcCC
Q 018487          331 IIFHCLFVNSLELLS  345 (355)
Q Consensus       331 ~i~~~l~~~~~e~~~  345 (355)
                      +|.+||..+|.+++.
T Consensus       285 li~~~l~~dP~~Rps  299 (348)
T 1u5q_A          285 FVDSCLQKIPQDRPT  299 (348)
T ss_dssp             HHHHHTCSSGGGSCC
T ss_pred             HHHHHcccChhhCcC
Confidence            889999988888653

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=324.64  Aligned_cols=231  Identities=28%  Similarity=0.509  Sum_probs=178.7

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++.+.||+|+||.||+|.+.     .+++.||+|++...........+.+.+|+.+++.++||||+++++++...+.
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   85 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESI-----HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNY   85 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSE
T ss_pred             ccceeeeeecCCCceEEEEEEEc-----cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCe
Confidence            57999999999999999999976     4678899999976554444556778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      .|+||||+++++|.+++... ..+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           86 VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            99999999999999998876 56999999999999999999999999999999999999999999999999999876432


Q ss_pred             C-CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh-------------hhhhHHHHHhhhh
Q 018487          269 S-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA-------------CNTMLLFYLIIFH  334 (355)
Q Consensus       269 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~-------------~~~~~~~~~~i~~  334 (355)
                      . ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+...             ......+..+|.+
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  245 (278)
T 3cok_A          166 HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQ  245 (278)
T ss_dssp             --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHH
T ss_pred             CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHH
Confidence            2 2334678999999999998889999999999999999999999998653221             1123356788999


Q ss_pred             eeeecCCCcCC
Q 018487          335 CLFVNSLELLS  345 (355)
Q Consensus       335 ~l~~~~~e~~~  345 (355)
                      ||..+|.+++.
T Consensus       246 ~l~~dp~~Rps  256 (278)
T 3cok_A          246 LLRRNPADRLS  256 (278)
T ss_dssp             HSCSSGGGSCC
T ss_pred             HcccCHhhCCC
Confidence            99988887663

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2e-44  Score=330.00  Aligned_cols=239  Identities=21%  Similarity=0.349  Sum_probs=201.9

Q ss_pred             hcCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceeccee
Q 018487          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (355)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~  183 (355)
                      .+.+..++|++.+.||+|+||.||+|.+........++.||+|++....  .....+.+.+|+.+++.++||||++++++
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   94 (314)
T 2ivs_A           17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGA   94 (314)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence            3456677999999999999999999998655444567889999997543  34455678899999999999999999999


Q ss_pred             eecCCeEEEEEeccCCCChHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 018487          184 FQTRSKLYLILDFINGGHLFFHLYRQGI------------------------FREDQARFYTAEIVSAVSHLHKCGIVHR  239 (355)
Q Consensus       184 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------l~~~~~~~i~~ql~~~L~~LH~~~iiHr  239 (355)
                      +...+..++||||+++++|.+++.....                        +++.+++.++.||+.||.|||++||+||
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~  174 (314)
T 2ivs_A           95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR  174 (314)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence            9999999999999999999999987543                        8999999999999999999999999999


Q ss_pred             cCCCCcEEecCCCcEEEEecCCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCC
Q 018487          240 DLKPENILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIK  315 (355)
Q Consensus       240 Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~  315 (355)
                      ||||+|||++.++.+||+|||++........   .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||.
T Consensus       175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  254 (314)
T 2ivs_A          175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP  254 (314)
T ss_dssp             CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999987643321   233457888999999998889999999999999999999 999998


Q ss_pred             Cchhhhh--------------hhhHHHHHhhhheeeecCCCcC
Q 018487          316 SMQVIAC--------------NTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       316 ~~~~~~~--------------~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                      .......              .....+..+|.+||..+|.+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  297 (314)
T 2ivs_A          255 GIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRP  297 (314)
T ss_dssp             TCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             CCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCc
Confidence            7543221              1223567888889888888765

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=6.5e-44  Score=334.32  Aligned_cols=231  Identities=30%  Similarity=0.505  Sum_probs=197.9

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeeccccc-----chhHHHHHHHHHHHHHhc-CCCcceeccee
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-----KKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~  183 (355)
                      ++|++.+.||+|+||.||+|.++     .+++.||||+++.....     .....+.+.+|+.+++++ +||||++++++
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHR-----ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhcccceEEecCCCEEEEEEEEC-----CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            47999999999999999999976     45788999998765321     123345678899999999 79999999999


Q ss_pred             eecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       184 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      +...+..|+||||++|++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus       169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~  248 (365)
T 2y7j_A          169 YESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC  248 (365)
T ss_dssp             EEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence            99999999999999999999999988889999999999999999999999999999999999999999999999999998


Q ss_pred             ccCcCCCCCcccccCccccchhhcc------CCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh---------------
Q 018487          264 EIDESSRSNSMCGTTEYMAPEILLS------KGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC---------------  322 (355)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~---------------  322 (355)
                      .+.........+||+.|+|||++.+      ..++.++|||||||++|+|++|+.||...+....               
T Consensus       249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  328 (365)
T 2y7j_A          249 HLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE  328 (365)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred             ccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence            8776655667789999999999864      3578899999999999999999999977533221               


Q ss_pred             --hhhHHHHHhhhheeeecCCCcCC
Q 018487          323 --NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       323 --~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                        .....+..+|.+||..+|.+++.
T Consensus       329 ~~~~~~~~~~li~~~L~~dP~~Rps  353 (365)
T 2y7j_A          329 WDDRSSTVKDLISRLLQVDPEARLT  353 (365)
T ss_dssp             HSSSCHHHHHHHHHHSCSSTTTSCC
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcC
Confidence              11123677888888888877653

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=5.5e-44  Score=323.40  Aligned_cols=228  Identities=26%  Similarity=0.445  Sum_probs=188.5

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|.+.++||+|+||.||+|.++     .+++.||+|++.....  ....+.+.+|+.+++.++||||+++++++.....
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   94 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEER-----SSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN   94 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             hheeecceeccCCCeEEEEEEEc-----cCCceEEEEEeecccc--chhHHHHHHHHHHHHhCCCchHHhHHHheecCCe
Confidence            47999999999999999999976     4678899999876542  3335678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEe---cCCCcEEEEecCCc
Q 018487          190 LYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHVMLTDFGLA  262 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl---~~~~~~kl~Dfg~a  262 (355)
                      .|+||||+++++|.+++...    ..+++..++.++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a  174 (285)
T 3is5_A           95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA  174 (285)
T ss_dssp             EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred             EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence            99999999999998888543    679999999999999999999999999999999999999   45678999999999


Q ss_pred             cccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhhh----------------hH
Q 018487          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNT----------------ML  326 (355)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~~----------------~~  326 (355)
                      .............||+.|+|||++. ..++.++||||||+++|+|++|+.||..........                ..
T Consensus       175 ~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (285)
T 3is5_A          175 ELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTP  253 (285)
T ss_dssp             CC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCH
T ss_pred             eecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCH
Confidence            8776655556678999999999986 568899999999999999999999998764333211                23


Q ss_pred             HHHHhhhheeeecCCCcCC
Q 018487          327 LFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       327 ~~~~~i~~~l~~~~~e~~~  345 (355)
                      .+..+|.+||..+|.+++.
T Consensus       254 ~~~~li~~~L~~dP~~Rps  272 (285)
T 3is5_A          254 QAVDLLKQMLTKDPERRPS  272 (285)
T ss_dssp             HHHHHHHHHTCSCTTTSCC
T ss_pred             HHHHHHHHHccCChhhCcC
Confidence            4567888888888877653

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.2e-44  Score=328.53  Aligned_cols=238  Identities=23%  Similarity=0.360  Sum_probs=202.4

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceeccee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~  183 (355)
                      +.+..++|++.+.||+|+||.||+|.+.+..+...++.||+|++....  .....+.+.+|+.+++++ +||||++++++
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   95 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence            456667999999999999999999998765556778899999997653  233456788999999999 89999999999


Q ss_pred             eecCCeEEEEEeccCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q 018487          184 FQTRSKLYLILDFINGGHLFFHLYRQG------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (355)
Q Consensus       184 ~~~~~~~~lv~e~~~~gsL~~~l~~~~------------------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~N  245 (355)
                      +...+..++||||+++++|.+++....                  .+++.+++.++.||+.||.|||++||+||||||+|
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N  175 (313)
T 1t46_A           96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN  175 (313)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence            999999999999999999999998654                  48999999999999999999999999999999999


Q ss_pred             EEecCCCcEEEEecCCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh
Q 018487          246 ILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA  321 (355)
Q Consensus       246 ILl~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~  321 (355)
                      ||++.++.+||+|||++........   .....+|+.|+|||++.+..++.++||||||+++|+|+| |+.||.......
T Consensus       176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  255 (313)
T 1t46_A          176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (313)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence            9999999999999999987654332   223457789999999999999999999999999999999 999998753211


Q ss_pred             ---------------hhhhHHHHHhhhheeeecCCCcC
Q 018487          322 ---------------CNTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       322 ---------------~~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                                     ......+..+|.+||..+|.+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp  293 (313)
T 1t46_A          256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRP  293 (313)
T ss_dssp             HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred             HHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCc
Confidence                           11223567788889888888765

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.6e-44  Score=335.14  Aligned_cols=206  Identities=30%  Similarity=0.485  Sum_probs=183.5

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      ..+..++|+++++||+|+||.||+|.++     .+++.||+|++....  .....+.+.+|+.+++.++||||+++++++
T Consensus        28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  100 (360)
T 3eqc_A           28 GELKDDDFEKISELGAGNGGVVFKVSHK-----PSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAF  100 (360)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEE
T ss_pred             cccccccceeeeeecCCCCeEEEEEEEC-----CCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEE
Confidence            3466789999999999999999999976     567889999997653  344556788999999999999999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~-~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      ...+.+|+||||+++++|.+++...+.+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++.
T Consensus       101 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  180 (360)
T 3eqc_A          101 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG  180 (360)
T ss_dssp             EETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred             EECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCc
Confidence            99999999999999999999999888999999999999999999999996 99999999999999999999999999997


Q ss_pred             ccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          264 EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      ...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus       181 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  234 (360)
T 3eqc_A          181 QLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  234 (360)
T ss_dssp             HHHHHC-----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred             cccccc-ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            653322 344579999999999999999999999999999999999999998754

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.3e-44  Score=346.18  Aligned_cols=202  Identities=25%  Similarity=0.407  Sum_probs=162.6

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec--
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--  186 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--  186 (355)
                      .++|++++.||+|+||+||+|.++     .+++.||||++.... ......+.+.+|+.+|+.++||||+++++++..  
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  125 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDK-----LEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD  125 (458)
T ss_dssp             CTTEEECCC-------CEEEEEEC-----C--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEEC-----CCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence            478999999999999999999976     567889999986543 334455678899999999999999999999843  


Q ss_pred             ---CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          187 ---RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       187 ---~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                         ...+|+||||+. ++|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus       126 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          126 VEKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             TTTCCCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             cccCceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccch
Confidence               357999999985 5899999888889999999999999999999999999999999999999999999999999998


Q ss_pred             ccCcCC----------------------------CCCcccccCccccchhhc-cCCCCCcccHHHHHHHHHHHHc-----
Q 018487          264 EIDESS----------------------------RSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLT-----  309 (355)
Q Consensus       264 ~~~~~~----------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~~l~ellt-----  309 (355)
                      ......                            .....+||+.|+|||++. +..|+.++|||||||+||||++     
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~  284 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN  284 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence            764321                            123457899999999864 5679999999999999999999     


Q ss_pred             ------CCCCCCCc
Q 018487          310 ------GQVNIKSM  317 (355)
Q Consensus       310 ------g~~pf~~~  317 (355)
                            |+.+|.+.
T Consensus       285 ~~~~~~~~p~f~g~  298 (458)
T 3rp9_A          285 VAYHADRGPLFPGS  298 (458)
T ss_dssp             CSSGGGCCCSCC--
T ss_pred             ccccccccccCCCC
Confidence                  66777554

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=9.9e-44  Score=327.34  Aligned_cols=226  Identities=25%  Similarity=0.428  Sum_probs=194.1

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      .|...++||+|+||.||+|.++     .+++.||||++....   ....+.+.+|+.+++.++||||+++++++...+..
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~-----~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  117 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREK-----HSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL  117 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             hhhccEEeccCCCeEEEEEEEC-----CCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence            3888999999999999999976     467889999987643   23345678899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC-
Q 018487          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-  269 (355)
                      |+||||+++++|.+++.. ..+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus       118 ~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  196 (321)
T 2c30_A          118 WVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP  196 (321)
T ss_dssp             EEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred             EEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc
Confidence            999999999999888764 568999999999999999999999999999999999999999999999999998765432 


Q ss_pred             CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh----------------hhhHHHHHhhh
Q 018487          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC----------------NTMLLFYLIIF  333 (355)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~----------------~~~~~~~~~i~  333 (355)
                      ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+....                .....+..+|.
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  276 (321)
T 2c30_A          197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLE  276 (321)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHH
T ss_pred             ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHH
Confidence            23456899999999999999999999999999999999999999987543221                11224677888


Q ss_pred             heeeecCCCcCC
Q 018487          334 HCLFVNSLELLS  345 (355)
Q Consensus       334 ~~l~~~~~e~~~  345 (355)
                      +||..+|.+++.
T Consensus       277 ~~l~~dp~~Rps  288 (321)
T 2c30_A          277 RMLVRDPQERAT  288 (321)
T ss_dssp             HHSCSSTTTSCC
T ss_pred             HHccCChhhCcC
Confidence            899888887653

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=4e-44  Score=348.09  Aligned_cols=229  Identities=28%  Similarity=0.494  Sum_probs=195.2

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|+++++||+|+||+||+|.++     .+++.||||++...... ......+.+|+.++++++||||+++++++.....
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   95 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDR-----ITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSS   95 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEET-----TTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cceEEeEEEeecCCEEEEEEEEC-----CCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE
Confidence            47999999999999999999976     56788999999765432 2234667889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEec---CCCcEEEEecCCccccC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD---SDGHVMLTDFGLAKEID  266 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~---~~~~~kl~Dfg~a~~~~  266 (355)
                      +|+||||+.+++|.+.+...+.+++.+++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..+.
T Consensus        96 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A           96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            999999999999999999888999999999999999999999999999999999999995   45679999999998876


Q ss_pred             cCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-----------------hhhHHHH
Q 018487          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-----------------NTMLLFY  329 (355)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-----------------~~~~~~~  329 (355)
                      ........+||+.|+|||++.+ .++.++|||||||++|+|++|+.||...+....                 .....+.
T Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  254 (486)
T 3mwu_A          176 QNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK  254 (486)
T ss_dssp             CC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHH
T ss_pred             CCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHH
Confidence            6655666789999999999875 589999999999999999999999987643221                 1122457


Q ss_pred             HhhhheeeecCCCcCC
Q 018487          330 LIIFHCLFVNSLELLS  345 (355)
Q Consensus       330 ~~i~~~l~~~~~e~~~  345 (355)
                      .+|.+||..+|.+++.
T Consensus       255 ~li~~~L~~dp~~R~t  270 (486)
T 3mwu_A          255 DLIRKMLTFHPSLRIT  270 (486)
T ss_dssp             HHHHHHTCSSTTTSCC
T ss_pred             HHHHHHcCCChhhCcC
Confidence            7888888888887653

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=9.4e-44  Score=346.97  Aligned_cols=231  Identities=30%  Similarity=0.472  Sum_probs=196.2

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccc----------hhHHHHHHHHHHHHHhcCCCcce
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK----------KNHVDYMKAERDILTKVTHPFIV  178 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~~~E~~~l~~l~h~nIv  178 (355)
                      .++|+++++||+|+||+||+|.++     .+++.||+|++.......          ....+.+.+|+.+++.++||||+
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  109 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEK-----NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNII  109 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEET-----TTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBC
T ss_pred             ccceEEEeEecccCCeEEEEEEEC-----CCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCC
Confidence            358999999999999999999977     567889999997654322          13456788999999999999999


Q ss_pred             ecceeeecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC---cEE
Q 018487          179 QLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVM  255 (355)
Q Consensus       179 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~---~~k  255 (355)
                      ++++++.....+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+|
T Consensus       110 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          110 KLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             CEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred             eEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEE
Confidence            99999999999999999999999999999888999999999999999999999999999999999999998776   699


Q ss_pred             EEecCCccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-------------
Q 018487          256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-------------  322 (355)
Q Consensus       256 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-------------  322 (355)
                      |+|||++............+||+.|+|||++. ..++.++|||||||++|+|++|+.||...+....             
T Consensus       190 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~  268 (504)
T 3q5i_A          190 IVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF  268 (504)
T ss_dssp             ECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH
T ss_pred             EEECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence            99999999877666566778999999999987 4689999999999999999999999987643221             


Q ss_pred             ----hhhHHHHHhhhheeeecCCCcCC
Q 018487          323 ----NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       323 ----~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                          .....+..+|.+||..+|.+++.
T Consensus       269 ~~~~~~s~~~~~li~~~L~~dp~~R~t  295 (504)
T 3q5i_A          269 NDWKNISDEAKELIKLMLTYDYNKRCT  295 (504)
T ss_dssp             HHHTTSCHHHHHHHHHHTCSSTTTSCC
T ss_pred             cccCCCCHHHHHHHHHHcCCChhHCCC
Confidence                11234577888888888887663

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.8e-44  Score=326.66  Aligned_cols=235  Identities=24%  Similarity=0.365  Sum_probs=192.3

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      .+..++|+++++||+|+||+||+|++..... .+++.||||++...   .....+.+.+|+.++++++||||+++++++.
T Consensus         6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   81 (295)
T 3ugc_A            6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY   81 (295)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEECTTCS-SCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cCCHHHhhhhheeeccCCEEEEEEEEecccC-CCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            4556789999999999999999999754332 46789999998754   3445567889999999999999999999985


Q ss_pred             c--CCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          186 T--RSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       186 ~--~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                      .  ...+++||||+++++|.+++.... .+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence            4  456899999999999999998754 4999999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCC----CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh-----------------
Q 018487          263 KEIDESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA-----------------  321 (355)
Q Consensus       263 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~-----------------  321 (355)
                      ........    .....++..|+|||++.+..++.++||||||+++|+|+||..||.......                 
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  241 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence            87643321    223457788999999999999999999999999999999999987643210                 


Q ss_pred             -------------hhhhHHHHHhhhheeeecCCCcC
Q 018487          322 -------------CNTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       322 -------------~~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                                   ......+..+|.+||..+|.+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp  277 (295)
T 3ugc_A          242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP  277 (295)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred             HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCC
Confidence                         01123467788889888888765

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.4e-43  Score=331.12  Aligned_cols=201  Identities=33%  Similarity=0.540  Sum_probs=177.4

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-----CCcceec
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-----HPFIVQL  180 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~nIv~l  180 (355)
                      .+..++|+++++||+|+||+||+|++.     .+++.||||+++..    ....+.+..|+.+++.+.     ||||+++
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~  101 (360)
T 3llt_A           31 MLLNNAFLVIRKMGDGTFGRVLLCQHI-----DNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKY  101 (360)
T ss_dssp             CEETTTEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred             eEecCEEEEEEEEcccCCeEEEEEEEC-----CCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence            344679999999999999999999976     46788999998642    233455677999999987     9999999


Q ss_pred             ceeeecCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC--------
Q 018487          181 RYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS--------  250 (355)
Q Consensus       181 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~--------  250 (355)
                      ++++...+..|+||||+ +++|.+++....  .+++.+++.++.||+.||.|||++||+||||||+|||++.        
T Consensus       102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~  180 (360)
T 3llt_A          102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLI  180 (360)
T ss_dssp             EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEE
T ss_pred             cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccccc
Confidence            99999999999999999 889999998764  4899999999999999999999999999999999999975        


Q ss_pred             -----------------CCcEEEEecCCccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCC
Q 018487          251 -----------------DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVN  313 (355)
Q Consensus       251 -----------------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~p  313 (355)
                                       ++.+||+|||++......  .....||+.|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p  258 (360)
T 3llt_A          181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL  258 (360)
T ss_dssp             EEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             chhcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCC
Confidence                             789999999999865432  3456799999999999999999999999999999999999999


Q ss_pred             CCCch
Q 018487          314 IKSMQ  318 (355)
Q Consensus       314 f~~~~  318 (355)
                      |...+
T Consensus       259 f~~~~  263 (360)
T 3llt_A          259 FRTHE  263 (360)
T ss_dssp             CCCSS
T ss_pred             CCCCc
Confidence            98754

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.4e-44  Score=337.05  Aligned_cols=238  Identities=18%  Similarity=0.162  Sum_probs=188.7

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHH--------HHHHHHHHHHHhcCCCcce
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV--------DYMKAERDILTKVTHPFIV  178 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~--------~~~~~E~~~l~~l~h~nIv  178 (355)
                      ...++|++.++||+|+||+||+|.++.......++.||||++...........        ..+..|+..++.++|+||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            44578999999999999999999987554444578899999876532111111        1233455667788899999


Q ss_pred             ecceeeecC----CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEec--CC
Q 018487          179 QLRYSFQTR----SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD--SD  251 (355)
Q Consensus       179 ~l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~--~~  251 (355)
                      ++++++...    ...|+||||+ |++|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||++  .+
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence            999998764    5689999999 99999999876 6799999999999999999999999999999999999999  88


Q ss_pred             CcEEEEecCCccccCcCCC--------CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh--
Q 018487          252 GHVMLTDFGLAKEIDESSR--------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA--  321 (355)
Q Consensus       252 ~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~--  321 (355)
                      +.+||+|||+++.+.....        ....+||+.|+|||++.+..++.++|||||||++|||+||+.||.......  
T Consensus       191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~  270 (364)
T 3op5_A          191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY  270 (364)
T ss_dssp             TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred             CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence            9999999999987643221        134469999999999999999999999999999999999999998631110  


Q ss_pred             ----------------------hhhhHHHHHhhhheeeecCCCcCC
Q 018487          322 ----------------------CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 ----------------------~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                                            .+....+..++..|+..+|.+++.
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~  316 (364)
T 3op5_A          271 VRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPL  316 (364)
T ss_dssp             HHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCC
T ss_pred             HHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCC
Confidence                                  011234566777888877777653

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.9e-44  Score=334.93  Aligned_cols=224  Identities=29%  Similarity=0.472  Sum_probs=189.7

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceeeecCC
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS  188 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  188 (355)
                      ++|++.+.||+|+||.||+|.++     .+++.||||++.+....       ..+|+.++.++ +||||+++++++.+.+
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~   89 (342)
T 2qr7_A           22 DGYEVKEDIGVGSYSVCKRCIHK-----ATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGK   89 (342)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             ccEEEEEEEeeCCCEEEEEEEEC-----CCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence            47999999999999999999977     56788999999765422       23578888887 7999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCC----CcEEEEecCCccc
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD----GHVMLTDFGLAKE  264 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~----~~~kl~Dfg~a~~  264 (355)
                      .+|+||||++||+|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||+..+    +.+||+|||++..
T Consensus        90 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           90 YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            999999999999999999988899999999999999999999999999999999999998543    3599999999987


Q ss_pred             cCcC-CCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh--------------------hh
Q 018487          265 IDES-SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA--------------------CN  323 (355)
Q Consensus       265 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~--------------------~~  323 (355)
                      .... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......                    ..
T Consensus       170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  249 (342)
T 2qr7_A          170 LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS  249 (342)
T ss_dssp             CBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred             CcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence            6443 23446689999999999998889999999999999999999999998531100                    01


Q ss_pred             hhHHHHHhhhheeeecCCCcCC
Q 018487          324 TMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       324 ~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ....+.++|.+||..+|.+++.
T Consensus       250 ~s~~~~~li~~~L~~dP~~R~t  271 (342)
T 2qr7_A          250 VSDTAKDLVSKMLHVDPHQRLT  271 (342)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCC
T ss_pred             CCHHHHHHHHHHCCCChhHCcC
Confidence            2234567888888888888764

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4.2e-44  Score=330.37  Aligned_cols=224  Identities=32%  Similarity=0.550  Sum_probs=173.1

Q ss_pred             CeEEE---eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecceeeec
Q 018487          111 DFEIF---RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQT  186 (355)
Q Consensus       111 ~y~~~---~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~  186 (355)
                      +|++.   +.||+|+||+||+|.++     .+++.||||++...      ....+.+|+.+++.+. ||||+++++++.+
T Consensus         9 ~y~~~~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~   77 (325)
T 3kn6_A            9 HYDLDLKDKPLGEGSFSICRKCVHK-----KSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHD   77 (325)
T ss_dssp             HEEECTTSCCSEEETTEEEEEEEET-----TTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             ccccccCCCccccCCCeEEEEEEEC-----CCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc
Confidence            46665   78999999999999976     56788999998653      2345678999999997 9999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC---cEEEEecCCcc
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVMLTDFGLAK  263 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~---~~kl~Dfg~a~  263 (355)
                      ....|+||||+++++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           78 QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred             CCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence            999999999999999999999999999999999999999999999999999999999999997766   89999999998


Q ss_pred             ccCcCC-CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh---------------------
Q 018487          264 EIDESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA---------------------  321 (355)
Q Consensus       264 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~---------------------  321 (355)
                      ...... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...                     
T Consensus       158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~  237 (325)
T 3kn6_A          158 LKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG  237 (325)
T ss_dssp             ECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCS
T ss_pred             ecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCc
Confidence            654332 2345678999999999999999999999999999999999999998643210                     


Q ss_pred             ---hhhhHHHHHhhhheeeecCCCcCC
Q 018487          322 ---CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 ---~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                         ......+.++|.+||..+|.+++.
T Consensus       238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt  264 (325)
T 3kn6_A          238 EAWKNVSQEAKDLIQGLLTVDPNKRLK  264 (325)
T ss_dssp             HHHHTSCHHHHHHHHHHHCCCTTTCCC
T ss_pred             ccccCCCHHHHHHHHHHCCCChhHCCC
Confidence               012335677889999999888764

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=5.5e-44  Score=335.67  Aligned_cols=224  Identities=24%  Similarity=0.425  Sum_probs=187.1

Q ss_pred             EEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEE
Q 018487          113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYL  192 (355)
Q Consensus       113 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  192 (355)
                      ...+.||+|+||.||+|.+.     .+++.||+|+++....   ...+.+.+|+.++++++||||+++++++...+.+|+
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~-----~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  163 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEET-----ATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL  163 (373)
T ss_dssp             EEEEECC-----CEEEEEET-----TTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecceEEecCcCEEEEEEEEc-----CCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            34678999999999999976     4678899999976432   334568899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEe--cCCCcEEEEecCCccccCcCC
Q 018487          193 ILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM--DSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       193 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl--~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      ||||+++++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||+  +.++.+||+|||+++......
T Consensus       164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~  243 (373)
T 2x4f_A          164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE  243 (373)
T ss_dssp             EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred             EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence            99999999998888655 469999999999999999999999999999999999999  567899999999999876665


Q ss_pred             CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-----------------hhhHHHHHhh
Q 018487          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-----------------NTMLLFYLII  332 (355)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-----------------~~~~~~~~~i  332 (355)
                      .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....                 .....+.++|
T Consensus       244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  323 (373)
T 2x4f_A          244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFI  323 (373)
T ss_dssp             BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHH
T ss_pred             ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHH
Confidence            55666899999999999988899999999999999999999999987643221                 1123456778


Q ss_pred             hheeeecCCCcC
Q 018487          333 FHCLFVNSLELL  344 (355)
Q Consensus       333 ~~~l~~~~~e~~  344 (355)
                      .+||..+|.+++
T Consensus       324 ~~~L~~dp~~Rp  335 (373)
T 2x4f_A          324 SKLLIKEKSWRI  335 (373)
T ss_dssp             HTTSCSSGGGSC
T ss_pred             HHHcCCChhhCC
Confidence            888888877765

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5e-44  Score=320.69  Aligned_cols=230  Identities=21%  Similarity=0.385  Sum_probs=194.8

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      +.+..++|++.+.||+|+||.||+|.+.      .++.||+|++......    .+.+.+|+.++++++||||+++++++
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~   74 (269)
T 4hcu_A            5 WVIDPSELTFVQEIGSGQFGLVHLGYWL------NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVC   74 (269)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEET------TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             EEeChhhceeeheecCCCccEEEEEEec------CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            4566789999999999999999999975      3556999999765432    24578899999999999999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      ...+..|+||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        75 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  154 (269)
T 4hcu_A           75 LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR  154 (269)
T ss_dssp             CSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred             ecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccc
Confidence            9999999999999999999999754 458999999999999999999999999999999999999999999999999998


Q ss_pred             ccCcCC--CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhhh--------------hhH
Q 018487          264 EIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACN--------------TML  326 (355)
Q Consensus       264 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~~--------------~~~  326 (355)
                      ......  ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+.....              ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T 4hcu_A          155 FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST  234 (269)
T ss_dssp             GBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCH
T ss_pred             cccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCH
Confidence            654322  2233456788999999999999999999999999999999 99999876433211              123


Q ss_pred             HHHHhhhheeeecCCCcC
Q 018487          327 LFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       327 ~~~~~i~~~l~~~~~e~~  344 (355)
                      .+..++.+||..+|.+++
T Consensus       235 ~~~~li~~~l~~~p~~Rp  252 (269)
T 4hcu_A          235 HVYQIMNHCWRERPEDRP  252 (269)
T ss_dssp             HHHHHHHHHTCSSGGGSC
T ss_pred             HHHHHHHHHccCCcccCc
Confidence            456788888888887765

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.1e-43  Score=340.04  Aligned_cols=199  Identities=26%  Similarity=0.448  Sum_probs=171.0

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC-
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-  187 (355)
                      .++|++++.||+|+||+||+|.++     .+++.||||++.... ......+.+.+|+.+|+.++|+||+++++++... 
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~-----~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~   98 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDK-----NTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDD   98 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEET-----TTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEEC-----CCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence            578999999999999999999977     567889999997543 2344556788999999999999999999999766 


Q ss_pred             ----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       188 ----~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                          ..+|+||||+++ +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        99 ~~~~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A           99 LLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             TTTCCCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CCcCCeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence                579999999975 999999888889999999999999999999999999999999999999999999999999998


Q ss_pred             ccCcCC-----------------------CCCcccccCccccchhh-ccCCCCCcccHHHHHHHHHHHHcCCCCC
Q 018487          264 EIDESS-----------------------RSNSMCGTTEYMAPEIL-LSKGHNKDADWWSVGILLYEMLTGQVNI  314 (355)
Q Consensus       264 ~~~~~~-----------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~~l~elltg~~pf  314 (355)
                      ......                       .....+||+.|+|||++ .+..++.++|||||||++|||++|..||
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            764332                       12456899999999986 4567999999999999999999854443

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3e-44  Score=331.88  Aligned_cols=203  Identities=22%  Similarity=0.345  Sum_probs=169.3

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|+++++||+|+||+||+|.++     .+++.||||+++.... .....+.+.+|+.+++.++||||+++++++...+.
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (329)
T 3gbz_A           34 DRYRRITKLGEGTYGEVYKAIDT-----VTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR  107 (329)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET-----TTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred             hhEEEEEEEEecCCeEEEEEEEC-----CCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence            58999999999999999999976     5678999999976542 33344567789999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEec-----CCCcEEEEecCCccc
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-----SDGHVMLTDFGLAKE  264 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~-----~~~~~kl~Dfg~a~~  264 (355)
                      +|+||||+++ +|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++     .++.+||+|||++..
T Consensus       108 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~  186 (329)
T 3gbz_A          108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA  186 (329)
T ss_dssp             EEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred             EEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence            9999999985 8999999888899999999999999999999999999999999999994     455699999999987


Q ss_pred             cCcCC-CCCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCchh
Q 018487          265 IDESS-RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSMQV  319 (355)
Q Consensus       265 ~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~~~  319 (355)
                      +.... .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.
T Consensus       187 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  243 (329)
T 3gbz_A          187 FGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE  243 (329)
T ss_dssp             HC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH
Confidence            64332 23445789999999999874 489999999999999999999999987643

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-44  Score=333.58  Aligned_cols=240  Identities=25%  Similarity=0.398  Sum_probs=199.1

Q ss_pred             hcCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecce
Q 018487          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY  182 (355)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~  182 (355)
                      .+.+..++|++.+.||+|+||.||+|.+.+......++.||+|++....  .....+.+.+|+.+++++ +||||+++++
T Consensus        39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  116 (344)
T 1rjb_A           39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLG  116 (344)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            3456678999999999999999999998655445567889999997543  233346688999999999 8999999999


Q ss_pred             eeecCCeEEEEEeccCCCChHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 018487          183 SFQTRSKLYLILDFINGGHLFFHLYRQG-----------------------IFREDQARFYTAEIVSAVSHLHKCGIVHR  239 (355)
Q Consensus       183 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------------~l~~~~~~~i~~ql~~~L~~LH~~~iiHr  239 (355)
                      ++...+..|+||||+++|+|.+++....                       .+++..++.++.||+.||.|||++||+||
T Consensus       117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~  196 (344)
T 1rjb_A          117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR  196 (344)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            9999999999999999999999997653                       27899999999999999999999999999


Q ss_pred             cCCCCcEEecCCCcEEEEecCCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCC
Q 018487          240 DLKPENILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIK  315 (355)
Q Consensus       240 Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~  315 (355)
                      ||||+|||++.++.+||+|||++........   .....||+.|+|||++.+..++.++||||||+++|+|+| |+.||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            9999999999999999999999987644332   233457889999999999999999999999999999998 999998


Q ss_pred             Cchhhh---------------hhhhHHHHHhhhheeeecCCCcCC
Q 018487          316 SMQVIA---------------CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       316 ~~~~~~---------------~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ......               ......+..+|.+||..+|.+++.
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps  321 (344)
T 1rjb_A          277 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS  321 (344)
T ss_dssp             TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             cCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcC
Confidence            753211               111235677888999888887653

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.9e-44  Score=342.65  Aligned_cols=231  Identities=29%  Similarity=0.549  Sum_probs=184.3

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeeccccc-----chhHHHHHHHHHHHHHhcCCCcceeccee
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-----KKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~  183 (355)
                      .++|.+.+.||+|+||+||+|.++     .+++.||||++......     .......+.+|+.+|++++||||++++++
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  208 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFER-----KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF  208 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEET-----TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEE
T ss_pred             hccEEEEeEEeeCCCeEEEEEEEC-----CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            368999999999999999999976     56788999999765422     12222347789999999999999999999


Q ss_pred             eecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC---cEEEEecC
Q 018487          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVMLTDFG  260 (355)
Q Consensus       184 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~---~~kl~Dfg  260 (355)
                      +.. +.+|+||||+++++|.+++...+.+++.+++.++.|++.||.|||++||+||||||+|||++.++   .+||+|||
T Consensus       209 ~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG  287 (419)
T 3i6u_A          209 FDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG  287 (419)
T ss_dssp             EES-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred             Eec-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecc
Confidence            864 56899999999999999998888899999999999999999999999999999999999997544   59999999


Q ss_pred             CccccCcCCCCCcccccCccccchhhcc---CCCCCcccHHHHHHHHHHHHcCCCCCCCchhh-------h---------
Q 018487          261 LAKEIDESSRSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQVNIKSMQVI-------A---------  321 (355)
Q Consensus       261 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~-------~---------  321 (355)
                      +++...........+||+.|+|||++.+   ..++.++|||||||++|+|++|+.||......       .         
T Consensus       288 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~  367 (419)
T 3i6u_A          288 HSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE  367 (419)
T ss_dssp             TTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHH
T ss_pred             cceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCch
Confidence            9998776655667789999999999864   56788999999999999999999999764211       0         


Q ss_pred             --hhhhHHHHHhhhheeeecCCCcCC
Q 018487          322 --CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 --~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                        ......+.++|.+||..+|.+++.
T Consensus       368 ~~~~~~~~~~~li~~~L~~dP~~Rps  393 (419)
T 3i6u_A          368 VWAEVSEKALDLVKKLLVVDPKARFT  393 (419)
T ss_dssp             HHTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred             hhcccCHHHHHHHHHHccCChhHCcC
Confidence              112335677888999888888653

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=7.9e-44  Score=329.17  Aligned_cols=205  Identities=27%  Similarity=0.430  Sum_probs=176.9

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|++++.||+|+||.||+|.++     .+++.||||++.... ......+.+.+|+.+++.++||||+++++++...+
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   97 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNK-----DTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK   97 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEET-----TTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hhhheeeeEEeecCCEEEEEEEEC-----CCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC
Confidence            358999999999999999999976     567889999987654 23444566788999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      ..|+||||+++++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus        98 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A           98 RWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             EEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             EEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            99999999999999888887788999999999999999999999999999999999999999999999999999876432


Q ss_pred             C-CCCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCchh
Q 018487          269 S-RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSMQV  319 (355)
Q Consensus       269 ~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~~~  319 (355)
                      . ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.
T Consensus       178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  230 (331)
T 4aaa_A          178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD  230 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence            2 23455789999999999875 789999999999999999999999987643

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.8e-44  Score=330.25  Aligned_cols=230  Identities=27%  Similarity=0.418  Sum_probs=189.5

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCC--Ccceecceee
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH--PFIVQLRYSF  184 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~  184 (355)
                      +..++|++++.||+|+||.||+|.+.      .++.||||++..... .....+.+.+|+.+|+.++|  +||+++++++
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~   78 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE   78 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECT------TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeC------CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeE
Confidence            45678999999999999999999853      467899999976543 44556778899999999986  9999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      ...+.+|+|||+ .+++|.+++.....+++.++..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.
T Consensus        79 ~~~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~  156 (343)
T 3dbq_A           79 ITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ  156 (343)
T ss_dssp             ECSSEEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred             eeCCEEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccc
Confidence            999999999995 5779999999988999999999999999999999999999999999999996 68899999999987


Q ss_pred             cCcCCC---CCcccccCccccchhhcc-----------CCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh---------
Q 018487          265 IDESSR---SNSMCGTTEYMAPEILLS-----------KGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA---------  321 (355)
Q Consensus       265 ~~~~~~---~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~---------  321 (355)
                      +.....   ....+||+.|+|||++.+           ..++.++|||||||++|+|++|+.||.......         
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  236 (343)
T 3dbq_A          157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP  236 (343)
T ss_dssp             C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred             cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcC
Confidence            644332   235679999999999865           678889999999999999999999998632110         


Q ss_pred             -------hhhhHHHHHhhhheeeecCCCcCC
Q 018487          322 -------CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 -------~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                             ......+..+|.+||..+|.+++.
T Consensus       237 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt  267 (343)
T 3dbq_A          237 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRIS  267 (343)
T ss_dssp             TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCC
T ss_pred             CcccCCcccCCHHHHHHHHHHcCCChhHCCC
Confidence                   001125678899999999888763

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=4.6e-45  Score=343.54  Aligned_cols=228  Identities=17%  Similarity=0.191  Sum_probs=184.9

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHH---HHHHhcCCCcceecc----
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER---DILTKVTHPFIVQLR----  181 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~nIv~l~----  181 (355)
                      .++|++.+.||+|+||+||+|.++     .+++.||||++...........+.+.+|+   +++++++|||||+++    
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~  146 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQ-----ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI  146 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC------CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred             CceEEEcceeecCCCEEEEEEEEC-----CCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhh
Confidence            568999999999999999999965     46789999999876555566677888999   555666899999998    


Q ss_pred             ---eeeecCC-----------------eEEEEEeccCCCChHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHHC
Q 018487          182 ---YSFQTRS-----------------KLYLILDFINGGHLFFHLYRQGIFRE-------DQARFYTAEIVSAVSHLHKC  234 (355)
Q Consensus       182 ---~~~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~l~~-------~~~~~i~~ql~~~L~~LH~~  234 (355)
                         +++...+                 ..|+||||+ +|+|.+++...+.+++       ..++.++.||+.||+|||++
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  225 (377)
T 3byv_A          147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY  225 (377)
T ss_dssp             CCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence               5555443                 288999999 5799999987665555       77888999999999999999


Q ss_pred             CCeeccCCCCcEEecCCCcEEEEecCCccccCcCCCCCcccccCccccchhhccC-----------CCCCcccHHHHHHH
Q 018487          235 GIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK-----------GHNKDADWWSVGIL  303 (355)
Q Consensus       235 ~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwSlG~~  303 (355)
                      ||+||||||+|||++.++.+||+|||+++....  .....+| +.|+|||++.+.           .++.++|||||||+
T Consensus       226 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          226 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             CeecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            999999999999999999999999999986433  2345567 999999999987           89999999999999


Q ss_pred             HHHHHcCCCCCCCchhhh---------hhhhHHHHHhhhheeeecCCCcCC
Q 018487          304 LYEMLTGQVNIKSMQVIA---------CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       304 l~elltg~~pf~~~~~~~---------~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      +|||++|+.||...+...         ......+..+|.+||..+|.+++.
T Consensus       303 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt  353 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLL  353 (377)
T ss_dssp             HHHHHHSSCCC------CCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCC
T ss_pred             HHHHHHCCCCCcccccccchhhhhhhccCCCHHHHHHHHHHcCCCchhCCC
Confidence            999999999998754322         122345678899999998888763

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1e-43  Score=318.35  Aligned_cols=229  Identities=21%  Similarity=0.354  Sum_probs=194.0

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      .+..++|++.+.||+|+||.||+|.++      .++.||+|++......    .+.+.+|+.++++++||||+++++++.
T Consensus         4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~   73 (268)
T 3sxs_A            4 ELKREEITLLKELGSGQFGVVKLGKWK------GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCS   73 (268)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET------TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             EechhheeeeeeeccCCCceEEEEEec------CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            345678999999999999999999865      3556999999765432    245788999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      ..+..++||||+++++|.+++...+ .+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  153 (268)
T 3sxs_A           74 KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY  153 (268)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEE
T ss_pred             cCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCcccee
Confidence            9999999999999999999998764 499999999999999999999999999999999999999999999999999986


Q ss_pred             cCcCCC--CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhhh--------------hhHH
Q 018487          265 IDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACN--------------TMLL  327 (355)
Q Consensus       265 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~~--------------~~~~  327 (355)
                      ......  .....+|+.|+|||++.+..++.++||||||+++|+|+| |+.||...+.....              ....
T Consensus       154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (268)
T 3sxs_A          154 VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDT  233 (268)
T ss_dssp             CCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHH
T ss_pred             cchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHH
Confidence            644322  223346778999999998889999999999999999999 99999875433211              1234


Q ss_pred             HHHhhhheeeecCCCcC
Q 018487          328 FYLIIFHCLFVNSLELL  344 (355)
Q Consensus       328 ~~~~i~~~l~~~~~e~~  344 (355)
                      +..++..||..+|.+++
T Consensus       234 l~~li~~~l~~~p~~Rp  250 (268)
T 3sxs_A          234 IYQIMYSCWHELPEKRP  250 (268)
T ss_dssp             HHHHHHHTTCSSGGGSC
T ss_pred             HHHHHHHHcCCChhhCc
Confidence            67788899988888765

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.5e-43  Score=344.81  Aligned_cols=228  Identities=29%  Similarity=0.483  Sum_probs=191.8

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|+++++||+|+||+||+|+++     .+++.||+|++...... ......+.+|+.+++.++||||++++++|.....
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  110 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDK-----VTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRN  110 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEET-----TTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cCeEEeeEEecCCCEEEEEEEEC-----CCCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            36999999999999999999976     56788999999865432 2234567889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCC---CcEEEEecCCccccC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---GHVMLTDFGLAKEID  266 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~---~~~kl~Dfg~a~~~~  266 (355)
                      +|+||||+++|+|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++..+.
T Consensus       111 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~  190 (494)
T 3lij_A          111 YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE  190 (494)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred             EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence            99999999999999999988899999999999999999999999999999999999999764   459999999998876


Q ss_pred             cCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-----------------hhhHHHH
Q 018487          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-----------------NTMLLFY  329 (355)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-----------------~~~~~~~  329 (355)
                      ........+||+.|+|||++. ..++.++|||||||++|+|++|+.||........                 .....+.
T Consensus       191 ~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  269 (494)
T 3lij_A          191 NQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAK  269 (494)
T ss_dssp             TTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHH
T ss_pred             CCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHH
Confidence            665566778999999999986 5699999999999999999999999987643221                 1123456


Q ss_pred             HhhhheeeecCCCcC
Q 018487          330 LIIFHCLFVNSLELL  344 (355)
Q Consensus       330 ~~i~~~l~~~~~e~~  344 (355)
                      .+|.+||..+|.+++
T Consensus       270 ~li~~~L~~dp~~R~  284 (494)
T 3lij_A          270 DLIKQMLQFDSQRRI  284 (494)
T ss_dssp             HHHHHHTCSSTTTSC
T ss_pred             HHHHHHCCCChhhCc
Confidence            788888888887765

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=7.4e-44  Score=321.81  Aligned_cols=230  Identities=22%  Similarity=0.399  Sum_probs=191.9

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      +.+..++|++++.||+|+||+||+|.++      .++.||+|++......    .+.+.+|+.+++.++||||+++++++
T Consensus        19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~   88 (283)
T 3gen_A           19 WEIDPKDLTFLKELGTGQFGVVKYGKWR------GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVC   88 (283)
T ss_dssp             TBCCGGGEEEEEECC---CEEEEEEEET------TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccCCHHHHHhHhhcCCCCCceEEEEEEc------CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEE
Confidence            3455678999999999999999999875      3567999999765432    24577899999999999999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      ...+.+|+||||+++++|.+++.. ...+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~  168 (283)
T 3gen_A           89 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR  168 (283)
T ss_dssp             CSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGG
T ss_pred             ecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccc
Confidence            999999999999999999999976 4679999999999999999999999999999999999999999999999999998


Q ss_pred             ccCcCC--CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhhh--------------hhH
Q 018487          264 EIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACN--------------TML  326 (355)
Q Consensus       264 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~~--------------~~~  326 (355)
                      ......  ......+|+.|+|||++.+..++.++||||||+++|+|+| |+.||...+.....              ...
T Consensus       169 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (283)
T 3gen_A          169 YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE  248 (283)
T ss_dssp             GBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             cccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCH
Confidence            654322  1223456788999999998899999999999999999998 99999875433211              123


Q ss_pred             HHHHhhhheeeecCCCcC
Q 018487          327 LFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       327 ~~~~~i~~~l~~~~~e~~  344 (355)
                      .+..+|.+||..+|.+++
T Consensus       249 ~l~~li~~~l~~~p~~Rp  266 (283)
T 3gen_A          249 KVYTIMYSCWHEKADERP  266 (283)
T ss_dssp             HHHHHHHHTTCSSGGGSC
T ss_pred             HHHHHHHHHccCChhHCc
Confidence            467788888888887765

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.2e-43  Score=331.41  Aligned_cols=202  Identities=26%  Similarity=0.449  Sum_probs=167.0

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|++++.||+|+||.||+|.++     .+++.||||++.... ......+.+.+|+.+++.++||||+++++++...+
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   97 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDA-----ILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK   97 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEEC-----CCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeecccc
Confidence            368999999999999999999976     567889999997643 23445567888999999999999999999987654


Q ss_pred             ------eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          189 ------KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       189 ------~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                            .+|+||||+++ +|.+.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        98 ~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A           98 SLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             STTTCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ccccccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence                  78999999986 6777775  45899999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchh
Q 018487          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQV  319 (355)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~  319 (355)
                      +...........+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus       175 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  231 (371)
T 2xrw_A          175 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH  231 (371)
T ss_dssp             ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            877655445567899999999999999999999999999999999999999987543

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.7e-44  Score=339.72  Aligned_cols=233  Identities=21%  Similarity=0.361  Sum_probs=196.0

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      +.+..++|++.+.||+|+||.||+|.++     .+++.||||+++...  .....+.+.+|+.+++.++||||+++++++
T Consensus       109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  181 (377)
T 3cbl_A          109 WVLNHEDLVLGEQIGRGNFGEVFSGRLR-----ADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVC  181 (377)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cEEchHHeEEeeEeccCCCCeEEEEEEe-----cCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            3455678999999999999999999987     457789999987542  334445678899999999999999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      ...+.+|+||||+++|+|.+++...+ .+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus       182 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~  261 (377)
T 3cbl_A          182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSR  261 (377)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             ecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCce
Confidence            99999999999999999999998764 59999999999999999999999999999999999999999999999999998


Q ss_pred             ccCcCCCC---CcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhhh--------------hh
Q 018487          264 EIDESSRS---NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACN--------------TM  325 (355)
Q Consensus       264 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~~--------------~~  325 (355)
                      ........   ....+++.|+|||++.+..++.++|||||||++|||+| |+.||...+.....              ..
T Consensus       262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (377)
T 3cbl_A          262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCP  341 (377)
T ss_dssp             ECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             ecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            65432211   12235778999999998889999999999999999998 99999876432211              12


Q ss_pred             HHHHHhhhheeeecCCCcC
Q 018487          326 LLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~  344 (355)
                      ..+..++.+||..+|.+++
T Consensus       342 ~~l~~li~~cl~~dP~~Rp  360 (377)
T 3cbl_A          342 DAVFRLMEQCWAYEPGQRP  360 (377)
T ss_dssp             HHHHHHHHHHTCSSGGGSC
T ss_pred             HHHHHHHHHHcCCCchhCc
Confidence            3567788899988888765

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-44  Score=335.17  Aligned_cols=236  Identities=46%  Similarity=0.803  Sum_probs=194.6

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeeccccc-chhHHHHHHHHHHHHHhc-CCCcceecceee
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-KKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~  184 (355)
                      +..++|++++.||+|+||+||+|++...  ..+++.||||+++..... .....+.+.+|+.+++.+ +||||+++++++
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  128 (355)
T 1vzo_A           51 VGIENFELLKVLGTGAYGKVFLVRKISG--HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF  128 (355)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSS--TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred             ccccceEEEEEeccCCCEEEEEEEEccc--CCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence            3446899999999999999999997531  246789999998764321 122234456799999999 699999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      ...+.+|+||||+++++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          129 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            99999999999999999999999888999999999999999999999999999999999999999999999999999986


Q ss_pred             cCcCC--CCCcccccCccccchhhcc--CCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh-----------------hh
Q 018487          265 IDESS--RSNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA-----------------CN  323 (355)
Q Consensus       265 ~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~-----------------~~  323 (355)
                      +....  .....+||+.|+|||++.+  ..++.++|||||||++|+|++|+.||.......                 ..
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE  288 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred             cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcc
Confidence            53322  2345679999999999986  347899999999999999999999997432111                 11


Q ss_pred             hhHHHHHhhhheeeecCCCcC
Q 018487          324 TMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       324 ~~~~~~~~i~~~l~~~~~e~~  344 (355)
                      ....+..+|.+||..+|.+++
T Consensus       289 ~~~~~~~li~~~L~~dP~~R~  309 (355)
T 1vzo_A          289 MSALAKDLIQRLLMKDPKKRL  309 (355)
T ss_dssp             SCHHHHHHHHHHTCSSGGGST
T ss_pred             cCHHHHHHHHHHhhhCHHHhc
Confidence            123457889999999998887

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.6e-44  Score=332.23  Aligned_cols=231  Identities=29%  Similarity=0.458  Sum_probs=189.9

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeeccccc--chhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII--KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ++|++.+.||+|+||+||+|.++     .+++.||+|++......  .....+.+.+|+.+++.++||||+++++++...
T Consensus        26 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           26 KKYHLKGAIGQGSYGVVRVAIEN-----QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hheeecceeeecCCeEEEEEEEC-----CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            37999999999999999999976     56788999999765322  344567788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHH
Q 018487          188 SKLYLILDFINGGHLFFHLYR----------------------------------------QGIFREDQARFYTAEIVSA  227 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~----------------------------------------~~~l~~~~~~~i~~ql~~~  227 (355)
                      +..|+||||+++|+|.+++..                                        ...+++..++.++.||+.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            999999999999999988842                                        1123677889999999999


Q ss_pred             HHHHHHCCCeeccCCCCcEEecCCC--cEEEEecCCccccCcCC-----CCCcccccCccccchhhcc--CCCCCcccHH
Q 018487          228 VSHLHKCGIVHRDLKPENILMDSDG--HVMLTDFGLAKEIDESS-----RSNSMCGTTEYMAPEILLS--KGHNKDADWW  298 (355)
Q Consensus       228 L~~LH~~~iiHrDlkp~NILl~~~~--~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~Diw  298 (355)
                      |.|||++||+||||||+|||++.++  .+||+|||++..+....     ......||+.|+|||++.+  ..++.++|||
T Consensus       181 l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw  260 (345)
T 3hko_A          181 LHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW  260 (345)
T ss_dssp             HHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHH
T ss_pred             HHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHH
Confidence            9999999999999999999998776  89999999998653322     1245679999999999975  6789999999


Q ss_pred             HHHHHHHHHHcCCCCCCCchhhhhh-----------------hhHHHHHhhhheeeecCCCcCC
Q 018487          299 SVGILLYEMLTGQVNIKSMQVIACN-----------------TMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       299 SlG~~l~elltg~~pf~~~~~~~~~-----------------~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ||||++|+|++|+.||...+.....                 ....+..+|.+||..+|.+++.
T Consensus       261 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  324 (345)
T 3hko_A          261 SAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFD  324 (345)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred             HHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCC
Confidence            9999999999999999875432211                 1235678888999988888764

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.8e-43  Score=333.32  Aligned_cols=200  Identities=28%  Similarity=0.439  Sum_probs=170.6

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      ...++|++.+.||+|+||+||+|.+.     .+++.||||++..+...       ..+|+.+++.++||||++++++|..
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~   71 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDI-----ESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYT   71 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEET-----TTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             cccceEEEEEEEEeccCEEEEEEEEC-----CCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeee
Confidence            34578999999999999999999976     56789999998754321       2369999999999999999999843


Q ss_pred             --------------------------------------CCeEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHH
Q 018487          187 --------------------------------------RSKLYLILDFINGGHLFFHLY----RQGIFREDQARFYTAEI  224 (355)
Q Consensus       187 --------------------------------------~~~~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~ql  224 (355)
                                                            ...+++||||+++ +|.+.+.    ....+++..++.++.||
T Consensus        72 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi  150 (383)
T 3eb0_A           72 TGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQL  150 (383)
T ss_dssp             C-------------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHH
T ss_pred             cCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHH
Confidence                                                  3458999999985 6665554    35679999999999999


Q ss_pred             HHHHHHHHHCCCeeccCCCCcEEec-CCCcEEEEecCCccccCcCCCCCcccccCccccchhhccC-CCCCcccHHHHHH
Q 018487          225 VSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGI  302 (355)
Q Consensus       225 ~~~L~~LH~~~iiHrDlkp~NILl~-~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~  302 (355)
                      +.||.|||++||+||||||+|||++ .++.+||+|||+++.+..........||+.|+|||++.+. .++.++|||||||
T Consensus       151 ~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~  230 (383)
T 3eb0_A          151 FRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC  230 (383)
T ss_dssp             HHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred             HHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence            9999999999999999999999997 6889999999999987666656667899999999998875 4899999999999


Q ss_pred             HHHHHHcCCCCCCCchh
Q 018487          303 LLYEMLTGQVNIKSMQV  319 (355)
Q Consensus       303 ~l~elltg~~pf~~~~~  319 (355)
                      ++|+|++|+.||...+.
T Consensus       231 il~ell~g~~pf~~~~~  247 (383)
T 3eb0_A          231 VFGELILGKPLFSGETS  247 (383)
T ss_dssp             HHHHHHHSSCSSCCSSH
T ss_pred             HHHHHHhCCCCCCCCCh
Confidence            99999999999987643

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.3e-43  Score=318.00  Aligned_cols=230  Identities=29%  Similarity=0.459  Sum_probs=182.9

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccc-hhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-KNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      +..++|++.+.||+|+||.||+|.+.       ++.||||+++...... ....+.+.+|+.+++.++||||+++++++.
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   76 (271)
T 3dtc_A            4 IDFAELTLEEIIGIGGFGKVYRAFWI-------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL   76 (271)
T ss_dssp             CCTTSEEEEEEEEEETTEEEEEEEET-------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhheeeeeeeccCCCeEEEEEEEc-------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            45679999999999999999999964       5679999987654322 334567889999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeeccCCCCcEEecC--------CCcE
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG---IVHRDLKPENILMDS--------DGHV  254 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~---iiHrDlkp~NILl~~--------~~~~  254 (355)
                      ..+..|+||||+++++|.+++. ...+++..++.++.|++.||.|||++|   |+||||||+|||++.        ++.+
T Consensus        77 ~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~  155 (271)
T 3dtc_A           77 KEPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL  155 (271)
T ss_dssp             CC--CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred             cCCceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcce
Confidence            9999999999999999988875 457899999999999999999999999   999999999999986        6789


Q ss_pred             EEEecCCccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh------------
Q 018487          255 MLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC------------  322 (355)
Q Consensus       255 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~------------  322 (355)
                      ||+|||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+....            
T Consensus       156 kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  234 (271)
T 3dtc_A          156 KITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP  234 (271)
T ss_dssp             EECCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCC
T ss_pred             EEccCCccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCC
Confidence            999999998765433 2345789999999999999999999999999999999999999987643321            


Q ss_pred             ---hhhHHHHHhhhheeeecCCCcCC
Q 018487          323 ---NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       323 ---~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                         .....+..+|.+||..+|.+++.
T Consensus       235 ~~~~~~~~~~~li~~~l~~~p~~Rps  260 (271)
T 3dtc_A          235 IPSTCPEPFAKLMEDCWNPDPHSRPS  260 (271)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCcccCHHHHHHHHHHhcCCcccCcC
Confidence               11235678899999888888653

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=5.1e-43  Score=318.50  Aligned_cols=232  Identities=30%  Similarity=0.501  Sum_probs=199.5

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccc------cchhHHHHHHHHHHHHHhcC-CCcceecc
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI------IKKNHVDYMKAERDILTKVT-HPFIVQLR  181 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~~E~~~l~~l~-h~nIv~l~  181 (355)
                      .++|++.+.||+|+||.||+|.++     .+++.||||++.....      ......+.+.+|+.+++++. ||||++++
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~   90 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHK-----PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK   90 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhccceeeeecCCCceEEEEEEEc-----CcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeee
Confidence            468999999999999999999976     4678899999975431      11233456788999999996 99999999


Q ss_pred             eeeecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCC
Q 018487          182 YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (355)
Q Consensus       182 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~  261 (355)
                      +++...+..++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        91 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           91 DTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             eeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccc
Confidence            99999999999999999999999999888899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCcCCCCCcccccCccccchhhc------cCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-------------
Q 018487          262 AKEIDESSRSNSMCGTTEYMAPEILL------SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-------------  322 (355)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-------------  322 (355)
                      +.............|++.|+|||++.      ...++.++||||||+++|+|++|+.||...+....             
T Consensus       171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  250 (298)
T 1phk_A          171 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS  250 (298)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred             hhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence            98876655556678999999999985      45678899999999999999999999977543221             


Q ss_pred             ----hhhHHHHHhhhheeeecCCCcCC
Q 018487          323 ----NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       323 ----~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                          .....+..+|.+||..+|.+++.
T Consensus       251 ~~~~~~~~~l~~li~~~l~~dp~~Rps  277 (298)
T 1phk_A          251 PEWDDYSDTVKDLVSRFLVVQPQKRYT  277 (298)
T ss_dssp             TTGGGSCHHHHHHHHHHCCSSGGGSCC
T ss_pred             ccccccCHHHHHHHHHHccCCcccCCC
Confidence                12234678888999888887653

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-43  Score=331.10  Aligned_cols=201  Identities=27%  Similarity=0.458  Sum_probs=170.9

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC-
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-  187 (355)
                      .++|++++.||+|+||.||+|.++     .+++.||||++.... ......+.+.+|+.+++.++||||+++++++... 
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   97 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDG-----RTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE   97 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEET-----TTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred             cceEEEeEEeeecCCeEEEEEEEC-----CCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCC
Confidence            468999999999999999999976     567889999986543 2344556788999999999999999999999765 


Q ss_pred             -----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       188 -----~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                           ..+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A           98 TLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             STTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             ccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecc
Confidence                 3569999999 7799888876 57899999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCCCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCchh
Q 018487          263 KEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQV  319 (355)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~~  319 (355)
                      +.....  ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.
T Consensus       176 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  231 (367)
T 1cm8_A          176 RQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH  231 (367)
T ss_dssp             EECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            876533  345678999999999987 6799999999999999999999999987643

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=9.3e-44  Score=321.06  Aligned_cols=234  Identities=22%  Similarity=0.346  Sum_probs=184.0

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      .+..++|++.+.||+|+||.||+|.+....  ..+..||+|++....  .....+.+.+|+.+++.++||||+++++++.
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   86 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPE--NPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT   86 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC----CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCC--CCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence            455678999999999999999999976432  345679999986542  3445567889999999999999999999985


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                       .+..|+||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence             457899999999999999998664 699999999999999999999999999999999999999999999999999987


Q ss_pred             cCcCCC--CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhhHH
Q 018487          265 IDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTMLL  327 (355)
Q Consensus       265 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~~~  327 (355)
                      ......  .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||...+....              +....
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (281)
T 1mp8_A          166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT  245 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred             cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence            644332  223456788999999998999999999999999999997 9999987533211              11234


Q ss_pred             HHHhhhheeeecCCCcC
Q 018487          328 FYLIIFHCLFVNSLELL  344 (355)
Q Consensus       328 ~~~~i~~~l~~~~~e~~  344 (355)
                      +..++.+||..+|.+++
T Consensus       246 l~~li~~~l~~~p~~Rp  262 (281)
T 1mp8_A          246 LYSLMTKCWAYDPSRRP  262 (281)
T ss_dssp             HHHHHHHHTCSSGGGSC
T ss_pred             HHHHHHHHccCChhhCc
Confidence            67788888888887765

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.1e-43  Score=326.80  Aligned_cols=238  Identities=22%  Similarity=0.347  Sum_probs=181.2

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      ..+..++|++.+.||+|+||+||+|.++...  .....||||+++.... .....+.+.+|+.++++++||||+++++++
T Consensus        18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   94 (323)
T 3qup_A           18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQED--GSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGVS   94 (323)
T ss_dssp             TBCC---CEEEEEEEEETTEEEEEEEC---------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred             cccChhHeEEeceecccCCeEEEEEEEcccC--CcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence            3466789999999999999999999876322  1224799999976543 234456788999999999999999999999


Q ss_pred             ecCCeE------EEEEeccCCCChHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC
Q 018487          185 QTRSKL------YLILDFINGGHLFFHLYRQG------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG  252 (355)
Q Consensus       185 ~~~~~~------~lv~e~~~~gsL~~~l~~~~------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~  252 (355)
                      ......      ++||||+++++|.+++....      .+++.+++.++.|++.||.|||++||+||||||+|||++.++
T Consensus        95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~  174 (323)
T 3qup_A           95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM  174 (323)
T ss_dssp             ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS
T ss_pred             eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC
Confidence            876655      99999999999999986543      589999999999999999999999999999999999999999


Q ss_pred             cEEEEecCCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh------
Q 018487          253 HVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC------  322 (355)
Q Consensus       253 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~------  322 (355)
                      .+||+|||+++.......   .....+++.|+|||++.+..++.++|||||||++|+|++ |+.||...+....      
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~  254 (323)
T 3qup_A          175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG  254 (323)
T ss_dssp             CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred             CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc
Confidence            999999999987643322   223456788999999999999999999999999999999 9999987543221      


Q ss_pred             --------hhhHHHHHhhhheeeecCCCcCC
Q 018487          323 --------NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       323 --------~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                              .....+..+|.+||..+|.+++.
T Consensus       255 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps  285 (323)
T 3qup_A          255 GNRLKQPPECMEEVYDLMYQCWSADPKQRPS  285 (323)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCC
T ss_pred             CCCCCCCCccCHHHHHHHHHHccCChhhCcC
Confidence                    12235678899999998888764

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=8.8e-44  Score=326.36  Aligned_cols=229  Identities=28%  Similarity=0.455  Sum_probs=187.6

Q ss_pred             CCCeEEE-eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceeeec
Q 018487          109 PGDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQT  186 (355)
Q Consensus       109 ~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~  186 (355)
                      .+.|++. +.||+|+||+||+|.++     .+++.||||++....   ....+.+.+|+.+++++ +||||+++++++..
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~   82 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINL-----ITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEE   82 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECS-----SSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEc-----CCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            4679995 78999999999999965     567889999997653   23345678899999885 79999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCc---EEEEecCCcc
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAK  263 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~---~kl~Dfg~a~  263 (355)
                      .+.+|+||||+++++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++.
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~  162 (316)
T 2ac3_A           83 EDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS  162 (316)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred             CCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence            9999999999999999999998889999999999999999999999999999999999999988776   9999999987


Q ss_pred             ccCcCC--------CCCcccccCccccchhhcc-----CCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh---------
Q 018487          264 EIDESS--------RSNSMCGTTEYMAPEILLS-----KGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA---------  321 (355)
Q Consensus       264 ~~~~~~--------~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~---------  321 (355)
                      ......        .....+||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.......         
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  242 (316)
T 2ac3_A          163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC  242 (316)
T ss_dssp             -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred             ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence            653221        1224569999999999975     457899999999999999999999998642110         


Q ss_pred             -----------------------hhhhHHHHHhhhheeeecCCCcCC
Q 018487          322 -----------------------CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 -----------------------~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                                             ......+.++|.+||..+|.+++.
T Consensus       243 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps  289 (316)
T 2ac3_A          243 PACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLS  289 (316)
T ss_dssp             HHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred             hhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCC
Confidence                                   011234577888888888887764

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.4e-44  Score=331.50  Aligned_cols=199  Identities=23%  Similarity=0.351  Sum_probs=170.5

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +..++|++.++||+|+||+||+|++.       ++.||||++....    .......+|+.++++++||||+++++++..
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   89 (322)
T 3soc_A           21 FQSMPLQLLEVKARGRFGCVWKAQLL-------NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKR   89 (322)
T ss_dssp             ETTEEEEEEEEEECSTTCEEEEEEET-------TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred             cchhhchhhheecccCceEEEEEEEC-------CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceecc
Confidence            45578999999999999999999865       5789999986542    222345568999999999999999999987


Q ss_pred             CC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC----------CCeeccCCCCcEEecCCC
Q 018487          187 RS----KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC----------GIVHRDLKPENILMDSDG  252 (355)
Q Consensus       187 ~~----~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~----------~iiHrDlkp~NILl~~~~  252 (355)
                      ..    .+|+||||+++|+|.+++... .+++..++.++.|++.||.|||+.          ||+||||||+|||++.++
T Consensus        90 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~  168 (322)
T 3soc_A           90 GTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL  168 (322)
T ss_dssp             ECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred             CCCCCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC
Confidence            43    579999999999999999764 589999999999999999999999          999999999999999999


Q ss_pred             cEEEEecCCccccCcCCC---CCcccccCccccchhhccC-----CCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          253 HVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSK-----GHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       253 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      .+||+|||+++.+.....   ....+||+.|+|||++.+.     .++.++|||||||++|||+||+.||...
T Consensus       169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~  241 (322)
T 3soc_A          169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP  241 (322)
T ss_dssp             CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred             eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence            999999999987643322   2345799999999999863     4556889999999999999999999753

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=5.2e-43  Score=317.45  Aligned_cols=231  Identities=25%  Similarity=0.357  Sum_probs=194.7

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      .....|++.+.||+|+||+||+|.+.     .++..||+|++..... .....+.+.+|+.+++.++||||+++++++..
T Consensus        23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   96 (290)
T 1t4h_A           23 NDGRFLKFDIEIGRGSFKTVYKGLDT-----ETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWES   96 (290)
T ss_dssp             TTSCEEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             cCceeEEeeeeccCCCCeEEEEeEec-----CCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecc
Confidence            33456999999999999999999976     5678899999886553 34456778899999999999999999998865


Q ss_pred             ----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCcEEec-CCCcEEEEec
Q 018487          187 ----RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMD-SDGHVMLTDF  259 (355)
Q Consensus       187 ----~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~--iiHrDlkp~NILl~-~~~~~kl~Df  259 (355)
                          ...+|+||||+++++|.+++.....+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+||
T Consensus        97 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Df  176 (290)
T 1t4h_A           97 TVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL  176 (290)
T ss_dssp             ESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred             ccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeC
Confidence                4579999999999999999998888999999999999999999999999  99999999999997 7899999999


Q ss_pred             CCccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh----------------h
Q 018487          260 GLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC----------------N  323 (355)
Q Consensus       260 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~----------------~  323 (355)
                      |++...... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||........                .
T Consensus       177 g~~~~~~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  254 (290)
T 1t4h_A          177 GLATLKRAS-FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV  254 (290)
T ss_dssp             TGGGGCCTT-SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGC
T ss_pred             CCccccccc-ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCC
Confidence            999754433 234567999999999887 4589999999999999999999999987322111                1


Q ss_pred             hhHHHHHhhhheeeecCCCcCC
Q 018487          324 TMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       324 ~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ....+..+|.+||..+|.+++.
T Consensus       255 ~~~~l~~li~~~l~~dp~~Rps  276 (290)
T 1t4h_A          255 AIPEVKEIIEGCIRQNKDERYS  276 (290)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCC
T ss_pred             CCHHHHHHHHHHccCChhhCCC
Confidence            1134678889999988888663

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.5e-43  Score=319.40  Aligned_cols=228  Identities=19%  Similarity=0.282  Sum_probs=193.4

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceeee
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQ  185 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~  185 (355)
                      +..++|++.+.||+|+||.||+|.+.     .+++.||||++......     +.+.+|+.+++.+ +|+||+++++++.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~   76 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNL-----LNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQ   76 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEET-----TTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEE
T ss_pred             ccccceEEEEEEeecCCEEEEEEEEC-----CCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecC
Confidence            45678999999999999999999976     56788999998654321     2366799999999 7999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCc-----EEEEec
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----VMLTDF  259 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~-----~kl~Df  259 (355)
                      .....++||||+ +++|.+++...+ .+++.++..++.|++.||.|||++||+||||||+|||++.++.     +||+||
T Consensus        77 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df  155 (298)
T 1csn_A           77 EGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF  155 (298)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred             CCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence            999999999999 889999998754 5999999999999999999999999999999999999987776     999999


Q ss_pred             CCccccCcCCC--------CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh----------
Q 018487          260 GLAKEIDESSR--------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA----------  321 (355)
Q Consensus       260 g~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~----------  321 (355)
                      |++........        .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+...          
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (298)
T 1csn_A          156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE  235 (298)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred             ccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh
Confidence            99987654322        345679999999999999999999999999999999999999998742110          


Q ss_pred             -----------hhhhHHHHHhhhheeeecCCCcCC
Q 018487          322 -----------CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 -----------~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                                 ......+..++..||..+|.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~  270 (298)
T 1csn_A          236 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPD  270 (298)
T ss_dssp             HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCC
T ss_pred             hccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCC
Confidence                       011235678888999988888763

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.1e-43  Score=328.70  Aligned_cols=238  Identities=22%  Similarity=0.391  Sum_probs=198.3

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCC--CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecc
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLR  181 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~  181 (355)
                      +.+..++|++.+.||+|+||.||+|.+.+...  ...++.||+|++....  .....+.+.+|+.+++.+ +||||++++
T Consensus        30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~  107 (334)
T 2pvf_A           30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL  107 (334)
T ss_dssp             TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence            45666899999999999999999999865332  2456789999997643  344556788999999999 899999999


Q ss_pred             eeeecCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q 018487          182 YSFQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (355)
Q Consensus       182 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~N  245 (355)
                      +++...+.+|+||||+++++|.+++....                .+++.+++.++.||+.||.|||++||+||||||+|
T Consensus       108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  187 (334)
T 2pvf_A          108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN  187 (334)
T ss_dssp             EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence            99999999999999999999999998654                38999999999999999999999999999999999


Q ss_pred             EEecCCCcEEEEecCCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh
Q 018487          246 ILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA  321 (355)
Q Consensus       246 ILl~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~  321 (355)
                      ||++.++.+||+|||++........   .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||.......
T Consensus       188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  267 (334)
T 2pvf_A          188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  267 (334)
T ss_dssp             EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence            9999999999999999987654321   233456788999999998889999999999999999999 999998754322


Q ss_pred             h--------------hhhHHHHHhhhheeeecCCCcC
Q 018487          322 C--------------NTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       322 ~--------------~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                      .              .....+..+|.+||..+|.+++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp  304 (334)
T 2pvf_A          268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRP  304 (334)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             HHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCc
Confidence            1              1123567788889988887765

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.2e-43  Score=330.53  Aligned_cols=202  Identities=26%  Similarity=0.411  Sum_probs=172.4

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec---
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT---  186 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~---  186 (355)
                      ++|+++++||+|+||+||+|+++     .+++.||+|++...... ......+.+|+.+++.++||||+++++++..   
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   90 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHR-----KTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKAS   90 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEET-----TTCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred             cceeEEEEEecCCCcEEEEEEEC-----CCCCEEEEEEEeccccc-ccchHHHHHHHHHHHhccCCCcccHhheeecccc
Confidence            58999999999999999999976     56788999998765432 2333456789999999999999999999876   


Q ss_pred             -----CCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecC
Q 018487          187 -----RSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG  260 (355)
Q Consensus       187 -----~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg  260 (355)
                           .+.+|+||||+++ +|...+.. ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        91 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           91 PYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             ------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccch
Confidence                 4578999999987 56566554 3679999999999999999999999999999999999999999999999999


Q ss_pred             CccccCcC-----CCCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          261 LAKEIDES-----SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       261 ~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      ++..+...     ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  233 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT  233 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99876422     22344578999999999976 458999999999999999999999998764

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.4e-44  Score=339.83  Aligned_cols=203  Identities=30%  Similarity=0.502  Sum_probs=177.9

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      ...++|++.++||+|+||+||+|.++     .+++.||||++.....  ....+.+.+|+.++++++||||+++++++..
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~   78 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHK-----KTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEE   78 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEEC-----CCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence            34568999999999999999999976     4678899999976432  2334567789999999999999999999886


Q ss_pred             CC--eEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEe----cCCCcEEEE
Q 018487          187 RS--KLYLILDFINGGHLFFHLYRQGI---FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM----DSDGHVMLT  257 (355)
Q Consensus       187 ~~--~~~lv~e~~~~gsL~~~l~~~~~---l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl----~~~~~~kl~  257 (355)
                      .+  ..|+||||+++++|.+++.....   +++..++.++.||+.||+|||++||+||||||+|||+    +.++.+||+
T Consensus        79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~  158 (396)
T 4eut_A           79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT  158 (396)
T ss_dssp             TTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred             CCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEe
Confidence            55  78999999999999999876543   8999999999999999999999999999999999999    777889999


Q ss_pred             ecCCccccCcCCCCCcccccCccccchhhcc--------CCCCCcccHHHHHHHHHHHHcCCCCCCC
Q 018487          258 DFGLAKEIDESSRSNSMCGTTEYMAPEILLS--------KGHNKDADWWSVGILLYEMLTGQVNIKS  316 (355)
Q Consensus       258 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~~l~elltg~~pf~~  316 (355)
                      |||+++............||+.|+|||++.+        ..++.++|||||||++|||++|+.||..
T Consensus       159 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~  225 (396)
T 4eut_A          159 DFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP  225 (396)
T ss_dssp             CGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred             cCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            9999988766555566789999999999875        4677899999999999999999999975

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.3e-43  Score=327.36  Aligned_cols=235  Identities=23%  Similarity=0.358  Sum_probs=188.0

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +..++|++.++||+|+||+||+|.+..... .....||+|.++...  .....+.+.+|+.++++++||||+++++++..
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   88 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGE-KVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLT   88 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC-----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCc-eEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence            345689999999999999999999763321 122346888776432  23345678899999999999999999999987


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      .. .++||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        89 ~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             SS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             CC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            65 78999999999999998874 56999999999999999999999999999999999999999999999999999876


Q ss_pred             CcCCCC---CcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhhh--------------hhHH
Q 018487          266 DESSRS---NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACN--------------TMLL  327 (355)
Q Consensus       266 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~~--------------~~~~  327 (355)
                      ......   ....+|+.|+|||++.+..++.++|||||||++|||+| |+.||.........              ....
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID  247 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence            443322   23456789999999999999999999999999999999 99999875332211              2224


Q ss_pred             HHHhhhheeeecCCCcCC
Q 018487          328 FYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       328 ~~~~i~~~l~~~~~e~~~  345 (355)
                      +..++.+||..+|.+++.
T Consensus       248 ~~~li~~~l~~~p~~Rps  265 (327)
T 3poz_A          248 VYMIMVKCWMIDADSRPK  265 (327)
T ss_dssp             HHHHHHHHTCSCGGGSCC
T ss_pred             HHHHHHHHcCCChhhCCC
Confidence            678888999998888754

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.5e-43  Score=333.19  Aligned_cols=229  Identities=26%  Similarity=0.411  Sum_probs=189.4

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC--CCcceecceeee
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT--HPFIVQLRYSFQ  185 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~  185 (355)
                      ...+|++++.||+|+||+||+|.+.      .++.||||++..... .....+.+.+|+.+|+.++  |+||+++++++.
T Consensus        54 ~~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~  126 (390)
T 2zmd_A           54 KGRIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI  126 (390)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECT------TCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             cCCceEEEEEEccCCCeEEEEEEcC------CCCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe
Confidence            3456999999999999999999854      367899999976543 4455677889999999997  599999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      ..+.+|+||| +.+++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+
T Consensus       127 ~~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~  204 (390)
T 2zmd_A          127 TDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM  204 (390)
T ss_dssp             CSSEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred             cCCEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence            9999999999 56789999999988999999999999999999999999999999999999995 689999999999876


Q ss_pred             CcCC---CCCcccccCccccchhhcc-----------CCCCCcccHHHHHHHHHHHHcCCCCCCCchhh-hh--------
Q 018487          266 DESS---RSNSMCGTTEYMAPEILLS-----------KGHNKDADWWSVGILLYEMLTGQVNIKSMQVI-AC--------  322 (355)
Q Consensus       266 ~~~~---~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~-~~--------  322 (355)
                      ....   .....+||+.|+|||++.+           ..++.++|||||||++|||++|+.||...... ..        
T Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~  284 (390)
T 2zmd_A          205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN  284 (390)
T ss_dssp             ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTT
T ss_pred             cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcc
Confidence            4432   2345679999999999875           36888999999999999999999999864211 00        


Q ss_pred             -------hhhHHHHHhhhheeeecCCCcCC
Q 018487          323 -------NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       323 -------~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                             .....+..+|.+||..+|.+++.
T Consensus       285 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps  314 (390)
T 2zmd_A          285 HEIEFPDIPEKDLQDVLKCCLKRDPKQRIS  314 (390)
T ss_dssp             SCCCCCCCSCHHHHHHHHHHTCSSTTTSCC
T ss_pred             ccCCCCccchHHHHHHHHHHcccChhhCCC
Confidence                   01124678888999988888764

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.1e-43  Score=325.56  Aligned_cols=238  Identities=22%  Similarity=0.376  Sum_probs=200.0

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceeccee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~  183 (355)
                      +.+..++|++.+.||+|+||+||+|.+.+..+..+++.||||++....  .....+.+.+|+.+++++ +||||++++++
T Consensus        22 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~   99 (316)
T 2xir_A           22 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA   99 (316)
T ss_dssp             HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             eecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence            446678999999999999999999998776666778999999997653  334456788999999999 69999999999


Q ss_pred             eecCC-eEEEEEeccCCCChHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q 018487          184 FQTRS-KLYLILDFINGGHLFFHLYRQGI----------------FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI  246 (355)
Q Consensus       184 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~----------------l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NI  246 (355)
                      +...+ .+++||||+++++|.+++.....                +++..++.++.|++.||.|||++||+||||||+||
T Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni  179 (316)
T 2xir_A          100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI  179 (316)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence            87654 59999999999999999987654                88999999999999999999999999999999999


Q ss_pred             EecCCCcEEEEecCCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh-
Q 018487          247 LMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA-  321 (355)
Q Consensus       247 Ll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~-  321 (355)
                      |++.++.+||+|||++........   .....||+.|+|||++.+..++.++||||||+++|+|+| |+.||....... 
T Consensus       180 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~  259 (316)
T 2xir_A          180 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  259 (316)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             EECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence            999999999999999987643322   234567889999999999999999999999999999998 999997753211 


Q ss_pred             --------------hhhhHHHHHhhhheeeecCCCcC
Q 018487          322 --------------CNTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       322 --------------~~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                                    ......+..+|.+||..+|.+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp  296 (316)
T 2xir_A          260 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP  296 (316)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             HHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCc
Confidence                          11223567888899988887765

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.1e-44  Score=329.63  Aligned_cols=202  Identities=26%  Similarity=0.446  Sum_probs=167.3

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|+++++||+|+||+||+|.++     .+++.||+|++......  .....+.+|+.+++.++||||+++++++...+.
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSK-----LTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS   74 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSC
T ss_pred             CceEEEEEEcCCCCEEEEEEEEC-----CCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCE
Confidence            58999999999999999999976     46788999998654321  111124469999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      +|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        75 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  153 (324)
T 3mtl_A           75 LTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP  153 (324)
T ss_dssp             EEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred             EEEEeccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence            9999999985 788887765 45899999999999999999999999999999999999999999999999999865432


Q ss_pred             C-CCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCchh
Q 018487          269 S-RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQV  319 (355)
Q Consensus       269 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~~  319 (355)
                      . ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~  206 (324)
T 3mtl_A          154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV  206 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            2 2344578999999999986 5689999999999999999999999987643

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.5e-43  Score=327.20  Aligned_cols=238  Identities=22%  Similarity=0.356  Sum_probs=200.8

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceeccee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~  183 (355)
                      +.+..++|++.+.||+|+||.||+|.+.+.......+.||+|++....  .....+.+.+|+.+++.+ +||||++++++
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  118 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGA  118 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            446678999999999999999999998866555566789999987643  334456788999999999 89999999999


Q ss_pred             eecCCeEEEEEeccCCCChHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEec
Q 018487          184 FQTRSKLYLILDFINGGHLFFHLYRQ--------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD  249 (355)
Q Consensus       184 ~~~~~~~~lv~e~~~~gsL~~~l~~~--------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~  249 (355)
                      +...+.+|+||||+++|+|.+++...              ..+++..++.++.|++.||.|||++||+||||||+|||++
T Consensus       119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT  198 (333)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred             EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence            99999999999999999999998753              3579999999999999999999999999999999999999


Q ss_pred             CCCcEEEEecCCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh---
Q 018487          250 SDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC---  322 (355)
Q Consensus       250 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~---  322 (355)
                      .++.+||+|||++........   .....+|+.|+|||++.+..++.++||||||+++|+|+| |..||........   
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  278 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK  278 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence            999999999999986643322   233456789999999999999999999999999999999 9999987532110   


Q ss_pred             ------------hhhHHHHHhhhheeeecCCCcC
Q 018487          323 ------------NTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       323 ------------~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                                  .....+..+|.+||..+|.+++
T Consensus       279 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  312 (333)
T 2i1m_A          279 LVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRP  312 (333)
T ss_dssp             HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCc
Confidence                        1123567888899988888865

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.7e-43  Score=338.93  Aligned_cols=229  Identities=24%  Similarity=0.429  Sum_probs=193.0

Q ss_pred             hhhcCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecc
Q 018487          102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR  181 (355)
Q Consensus       102 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~  181 (355)
                      ...+.+..++|++.+.||+|+||.||+|.++       ++.||||+++...     ..+.+.+|+.+|++++||||++++
T Consensus       185 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-------~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~  252 (450)
T 1k9a_A          185 RSGWALNMKELKLLQTIGKGEFGDVMLGDYR-------GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLL  252 (450)
T ss_dssp             HTTCBCCGGGEEEEEEEEECSSEEEEEEEET-------TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             ccccccChHHeEEEeeecCcCCeeEEEEEec-------CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEE
Confidence            3445677789999999999999999999865       4579999997543     235678899999999999999999


Q ss_pred             eeeecCC-eEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEe
Q 018487          182 YSFQTRS-KLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTD  258 (355)
Q Consensus       182 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~D  258 (355)
                      +++.... .+|+||||+++|+|.+++...+.  +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus       253 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~D  332 (450)
T 1k9a_A          253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSD  332 (450)
T ss_dssp             EEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECC
T ss_pred             EEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEee
Confidence            9977654 79999999999999999987654  79999999999999999999999999999999999999999999999


Q ss_pred             cCCccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------h
Q 018487          259 FGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------N  323 (355)
Q Consensus       259 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~  323 (355)
                      ||+++......  ....+++.|+|||++.+..++.++|||||||++|||+| |+.||...+....              .
T Consensus       333 fG~a~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~  410 (450)
T 1k9a_A          333 FGLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG  410 (450)
T ss_dssp             CTTCEECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTT
T ss_pred             CCCcccccccc--cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCc
Confidence            99998654322  23367889999999999999999999999999999999 9999987532211              1


Q ss_pred             hhHHHHHhhhheeeecCCCcC
Q 018487          324 TMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       324 ~~~~~~~~i~~~l~~~~~e~~  344 (355)
                      ....+..+|.+||..+|.+++
T Consensus       411 ~~~~l~~li~~cl~~dp~~Rp  431 (450)
T 1k9a_A          411 CPPAVYDVMKNCWHLDAATRP  431 (450)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSC
T ss_pred             CCHHHHHHHHHHcCCChhHCc
Confidence            123567888899988888865

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.2e-43  Score=321.12  Aligned_cols=227  Identities=33%  Similarity=0.571  Sum_probs=194.0

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++.+.||+|+||.||+|.++     .+++.||+|++.....   ...+.+.+|+.+++.++||||+++++++...+.
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQR-----LTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTH   80 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ccceeeeeccCCCCceEEEEEEC-----CCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCE
Confidence            47999999999999999999976     4678899999976432   223457789999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEe---cCCCcEEEEecCCccccC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl---~~~~~~kl~Dfg~a~~~~  266 (355)
                      +|+||||+++++|.+++...+.+++.++..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           81 YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             EEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            99999999999999999888899999999999999999999999999999999999999   788999999999997654


Q ss_pred             cCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-----------------hhhHHHH
Q 018487          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-----------------NTMLLFY  329 (355)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-----------------~~~~~~~  329 (355)
                      .. ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........                 .....+.
T Consensus       161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  239 (304)
T 2jam_A          161 NG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAK  239 (304)
T ss_dssp             CB-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHH
T ss_pred             CC-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHH
Confidence            32 23445789999999999998999999999999999999999999987543211                 1224567


Q ss_pred             HhhhheeeecCCCcCC
Q 018487          330 LIIFHCLFVNSLELLS  345 (355)
Q Consensus       330 ~~i~~~l~~~~~e~~~  345 (355)
                      .+|.+||..+|.+++.
T Consensus       240 ~li~~~l~~dp~~Rps  255 (304)
T 2jam_A          240 DFICHLLEKDPNERYT  255 (304)
T ss_dssp             HHHHHHHCSSTTTSCC
T ss_pred             HHHHHHcCCChhHCcC
Confidence            7888898888887653

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.6e-43  Score=325.55  Aligned_cols=237  Identities=21%  Similarity=0.299  Sum_probs=198.3

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      .+..++|++.+.||+|+||.||+|.+++......++.||+|++....  .......+.+|+.+++.++||||+++++++.
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            45567899999999999999999998754444567889999987543  2334456888999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEE
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQ----------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM  255 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~k  255 (355)
                      ..+..++||||+++++|.+++...          ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~k  178 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK  178 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEE
Confidence            999999999999999999998753          3568999999999999999999999999999999999999999999


Q ss_pred             EEecCCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh---------
Q 018487          256 LTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC---------  322 (355)
Q Consensus       256 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~---------  322 (355)
                      |+|||++........   .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+....         
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~  258 (322)
T 1p4o_A          179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL  258 (322)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred             ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc
Confidence            999999986543321   223456889999999999999999999999999999999 8999987543221         


Q ss_pred             -----hhhHHHHHhhhheeeecCCCcC
Q 018487          323 -----NTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       323 -----~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                           .....+..+|.+||..+|.+++
T Consensus       259 ~~~~~~~~~~l~~li~~~l~~dp~~Rp  285 (322)
T 1p4o_A          259 LDKPDNCPDMLFELMRMCWQYNPKMRP  285 (322)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCc
Confidence                 1123467788889888887765

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.7e-43  Score=326.57  Aligned_cols=230  Identities=27%  Similarity=0.418  Sum_probs=191.9

Q ss_pred             CCeEEE-eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecceeeecC
Q 018487          110 GDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTR  187 (355)
Q Consensus       110 ~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~  187 (355)
                      ++|.+. ++||+|+||+||+|.++     .+++.||+|++..... .......+.+|+.+++.+. ||||+++++++...
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~  101 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISK-----STGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYENT  101 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             hEEeeccceeCCCCCeEEEEEEEC-----CCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence            368887 89999999999999976     5678899999987543 2334456788999999995 69999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC---CCcEEEEecCCc
Q 018487          188 SKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLA  262 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~---~~~~kl~Dfg~a  262 (355)
                      +.+|+||||+++++|.+++...  ..+++.+++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a  181 (327)
T 3lm5_A          102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS  181 (327)
T ss_dssp             SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred             CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence            9999999999999999888553  66999999999999999999999999999999999999987   789999999999


Q ss_pred             cccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-----------------hhh
Q 018487          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-----------------NTM  325 (355)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-----------------~~~  325 (355)
                      .............||+.|+|||++.+..++.++||||||+++|+|++|+.||...+....                 ...
T Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  261 (327)
T 3lm5_A          182 RKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVS  261 (327)
T ss_dssp             EEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred             cccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccC
Confidence            987665555667899999999999999999999999999999999999999987643321                 122


Q ss_pred             HHHHHhhhheeeecCCCcCC
Q 018487          326 LLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ..+..+|.+||..+|.+++.
T Consensus       262 ~~~~~li~~~L~~dP~~Rpt  281 (327)
T 3lm5_A          262 QLATDFIQSLLVKNPEKRPT  281 (327)
T ss_dssp             HHHHHHHHHHSCSSGGGSCC
T ss_pred             HHHHHHHHHHcCCChhhCcC
Confidence            34677888999988887654

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=6.9e-44  Score=328.12  Aligned_cols=228  Identities=25%  Similarity=0.387  Sum_probs=192.5

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ..++|++.+.||+|+||.||+|.++      +++.||||++....   ....+.+.+|+.+++.++||||+++++++...
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  107 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVLR------DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDER  107 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEECT------TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred             HHhccCccceeecCCCeeEEEEEEC------CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            4578999999999999999999854      46789999886543   33456788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          188 SKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~----~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      +..++||||+++++|.+++....    .+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  187 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK  187 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred             CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence            99999999999999998886543    48999999999999999999999999999999999999999999999999998


Q ss_pred             ccCcCC---CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhh--------------------
Q 018487          264 EIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVI--------------------  320 (355)
Q Consensus       264 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~--------------------  320 (355)
                      ......   ......||+.|+|||++.+..++.++||||||+++|+|+||+.||......                    
T Consensus       188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (321)
T 2qkw_B          188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ  267 (321)
T ss_dssp             ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence            653322   223456899999999999889999999999999999999999999753211                    


Q ss_pred             ----------hhhhhHHHHHhhhheeeecCCCcC
Q 018487          321 ----------ACNTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       321 ----------~~~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                                .......+..++.+||..+|.+++
T Consensus       268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp  301 (321)
T 2qkw_B          268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRP  301 (321)
T ss_dssp             SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSC
T ss_pred             hcChhhccccCHHHHHHHHHHHHHHcCCCcccCc
Confidence                      011223456778888888887765

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.1e-43  Score=333.54  Aligned_cols=235  Identities=22%  Similarity=0.359  Sum_probs=185.8

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      .+..++|++.+.||+|+||.||+|+++..  ...+..||||+++...  .....+.+.+|+.++++++||||+++++++.
T Consensus        41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~--~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  116 (373)
T 2qol_A           41 ELDATNISIDKVVGAGEFGEVCSGRLKLP--SKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVT  116 (373)
T ss_dssp             BCCGGGCCCCEEEEECSSSEEEEC-CBCT--TSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             hcCHhhceeeeEEeeCCCeEEEEEEEecC--CCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            34556899999999999999999986522  2356779999987643  3445567889999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      ..+.+|+||||+++++|.+++...+ .+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       117 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          117 KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             eCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence            9999999999999999999998764 699999999999999999999999999999999999999999999999999987


Q ss_pred             cCcCCC----CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhh
Q 018487          265 IDESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTM  325 (355)
Q Consensus       265 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~  325 (355)
                      ......    .....+++.|+|||++.+..++.++|||||||++|||++ |+.||...+....              ...
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~  276 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP  276 (373)
T ss_dssp             -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCB
T ss_pred             cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccc
Confidence            643321    112235678999999999999999999999999999998 9999977543221              112


Q ss_pred             HHHHHhhhheeeecCCCcC
Q 018487          326 LLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~  344 (355)
                      ..+..+|.+||..+|.+++
T Consensus       277 ~~l~~li~~cl~~dp~~RP  295 (373)
T 2qol_A          277 AALYQLMLDCWQKDRNNRP  295 (373)
T ss_dssp             HHHHHHHHHHTCSSGGGSC
T ss_pred             HHHHHHHHHHhCcChhhCc
Confidence            3567888899988888765

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.9e-43  Score=320.67  Aligned_cols=231  Identities=25%  Similarity=0.409  Sum_probs=184.8

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++.+.||+|+||.||+|.+.     .+++.||||++...........+.+.+|+.+++.++||||+++++++...+.
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~  106 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACL-----LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE  106 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEET-----TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             cceEEEEeecCCCCceEEEEEEc-----CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence            57999999999999999999976     4578899999986554556666778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          190 LYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      .++||||+++++|.+++..    ...+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++...
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            9999999999999988864    456899999999999999999999999999999999999999999999999999866


Q ss_pred             CcCC-CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh-----------------hhhhHH
Q 018487          266 DESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA-----------------CNTMLL  327 (355)
Q Consensus       266 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~-----------------~~~~~~  327 (355)
                      .... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||.......                 ......
T Consensus       187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (310)
T 2wqm_A          187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE  266 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHH
T ss_pred             cCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHH
Confidence            4332 2334578999999999999999999999999999999999999997642110                 112235


Q ss_pred             HHHhhhheeeecCCCcCC
Q 018487          328 FYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       328 ~~~~i~~~l~~~~~e~~~  345 (355)
                      +..++.+||..+|.+++.
T Consensus       267 l~~li~~~l~~dp~~Rps  284 (310)
T 2wqm_A          267 LRQLVNMCINPDPEKRPD  284 (310)
T ss_dssp             HHHHHHHHTCSSGGGSCC
T ss_pred             HHHHHHHHcCCChhhCCC
Confidence            678888888888887653

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.3e-43  Score=326.32  Aligned_cols=230  Identities=29%  Similarity=0.555  Sum_probs=189.0

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeeccccc-----chhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-----KKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      ++|++.+.||+|+||.||+|.++     .+++.||||++......     .......+.+|+.+++.++||||+++++++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   84 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFER-----KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF   84 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hceeEeeEEecCCCEEEEEEEEc-----CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEE
Confidence            47999999999999999999976     56788999998764321     122334577899999999999999999998


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCc---EEEEecCC
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGL  261 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~---~kl~Dfg~  261 (355)
                      .... +|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+
T Consensus        85 ~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  163 (322)
T 2ycf_A           85 DAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH  163 (322)
T ss_dssp             ESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred             cCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence            7665 8999999999999999988888999999999999999999999999999999999999987664   99999999


Q ss_pred             ccccCcCCCCCcccccCccccchhhc---cCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh-----------------
Q 018487          262 AKEIDESSRSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA-----------------  321 (355)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~-----------------  321 (355)
                      +.............||+.|+|||++.   ...++.++|||||||++|+|++|+.||.......                 
T Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (322)
T 2ycf_A          164 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV  243 (322)
T ss_dssp             CEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHH
T ss_pred             ceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchh
Confidence            98765543334567899999999974   4678899999999999999999999997642210                 


Q ss_pred             -hhhhHHHHHhhhheeeecCCCcCC
Q 018487          322 -CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 -~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                       ......+..+|.+||..+|.+++.
T Consensus       244 ~~~~~~~~~~li~~~l~~dP~~Rps  268 (322)
T 2ycf_A          244 WAEVSEKALDLVKKLLVVDPKARFT  268 (322)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred             hhhcCHHHHHHHHHHcccCHhhCCC
Confidence             112234678888999888887653

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=6.4e-43  Score=322.57  Aligned_cols=194  Identities=24%  Similarity=0.437  Sum_probs=173.3

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecceeeec-
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQT-  186 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~-  186 (355)
                      .++|+++++||+|+||+||+|.+.     .+++.||||++....      .+.+.+|+.+++.++ ||||+++++++.. 
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~  103 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINI-----TNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDP  103 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred             CCceEEEEEecccCCeEEEEEEEC-----CCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccC
Confidence            468999999999999999999976     467889999986432      345788999999997 9999999999987 


Q ss_pred             -CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC-cEEEEecCCccc
Q 018487          187 -RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKE  264 (355)
Q Consensus       187 -~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~-~~kl~Dfg~a~~  264 (355)
                       ....++||||+++++|..++.   .+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus       104 ~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~  180 (330)
T 3nsz_A          104 VSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  180 (330)
T ss_dssp             TTCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             CCCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence             678999999999999988774   389999999999999999999999999999999999999776 899999999987


Q ss_pred             cCcCCCCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCC
Q 018487          265 IDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKS  316 (355)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~  316 (355)
                      ...........|+..|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus       181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~  233 (330)
T 3nsz_A          181 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH  233 (330)
T ss_dssp             CCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             cCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            766555666789999999999987 6789999999999999999999999954

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.3e-43  Score=317.10  Aligned_cols=229  Identities=27%  Similarity=0.442  Sum_probs=195.7

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++.+.||+|+||.||+|.++     .+++.||+|++.....  ....+.+.+|+.+++.++||||+++++++...+.
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNR-----VTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNI   79 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEET-----TTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeecCCCcEEEEEEEC-----CCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCE
Confidence            47999999999999999999976     4677899999876542  3345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      .|+||||+++++|.+++.....+++.+++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           80 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            99999999999999998877789999999999999999999999999999999999999999999999999998653322


Q ss_pred             ---CCCcccccCccccchhhccCCC-CCcccHHHHHHHHHHHHcCCCCCCCchhhh----------------hhhhHHHH
Q 018487          270 ---RSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQVNIKSMQVIA----------------CNTMLLFY  329 (355)
Q Consensus       270 ---~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~elltg~~pf~~~~~~~----------------~~~~~~~~  329 (355)
                         ......|++.|+|||++.+..+ +.++||||||+++|+|++|+.||.......                ......+.
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL  239 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHH
Confidence               2345678999999999987665 678999999999999999999998753211                11223567


Q ss_pred             HhhhheeeecCCCcCC
Q 018487          330 LIIFHCLFVNSLELLS  345 (355)
Q Consensus       330 ~~i~~~l~~~~~e~~~  345 (355)
                      .+|.+||..+|.+++.
T Consensus       240 ~li~~~l~~~p~~Rps  255 (276)
T 2yex_A          240 ALLHKILVENPSARIT  255 (276)
T ss_dssp             HHHHHHSCSSTTTSCC
T ss_pred             HHHHHHCCCCchhCCC
Confidence            7888999888888654

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.7e-43  Score=322.62  Aligned_cols=237  Identities=22%  Similarity=0.353  Sum_probs=191.6

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      ..+..++|++.+.||+|+||+||+|.++... ...+..||||+++...  .......+.+|+.+++.++||||+++++++
T Consensus        39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  115 (333)
T 1mqb_A           39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSS-GKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVI  115 (333)
T ss_dssp             CBCCTTTEEEEEEEEECSSSEEEEEEEEC----CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccCChHHhhcccEEecCCCeEEEEEEEecCC-CCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            3566789999999999999999999977432 1235679999987543  334455688999999999999999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      ...+..++||||+++++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          116 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             ecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence            9999999999999999999999765 569999999999999999999999999999999999999999999999999998


Q ss_pred             ccCcCCC----CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hh
Q 018487          264 EIDESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NT  324 (355)
Q Consensus       264 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~  324 (355)
                      .......    .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+....              ..
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  275 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC  275 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred             hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccC
Confidence            7643321    122345788999999998999999999999999999999 9999976533211              11


Q ss_pred             hHHHHHhhhheeeecCCCcC
Q 018487          325 MLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       325 ~~~~~~~i~~~l~~~~~e~~  344 (355)
                      ...+..+|.+||..+|.+++
T Consensus       276 ~~~l~~li~~~l~~~p~~Rp  295 (333)
T 1mqb_A          276 PSAIYQLMMQCWQQERARRP  295 (333)
T ss_dssp             BHHHHHHHHHHTCSSTTTSC
T ss_pred             CHHHHHHHHHHcCCChhhCc
Confidence            23567888899988888765

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.3e-42  Score=316.87  Aligned_cols=228  Identities=25%  Similarity=0.473  Sum_probs=196.5

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      +.|++++.||+|+||.||+|.+.     .+++.||||++.....  ....+.+.+|+.+++.++||||+++++++.....
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   94 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDN-----RTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK   94 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEET-----TTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             HHHHHhhhhcccCCeEEEEEEEC-----CCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence            46999999999999999999876     4678899999976542  3345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      +|+||||+++++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        95 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A           95 LWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             EEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             EEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            9999999999999888864 578999999999999999999999999999999999999999999999999998764432


Q ss_pred             -CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh--------------hhhHHHHHhhhh
Q 018487          270 -RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC--------------NTMLLFYLIIFH  334 (355)
Q Consensus       270 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~--------------~~~~~~~~~i~~  334 (355)
                       ......|++.|+|||++.+..++.++||||||+++|+|++|+.||........              .....+..+|.+
T Consensus       174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  253 (303)
T 3a7i_A          174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA  253 (303)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHH
T ss_pred             cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHH
Confidence             23456789999999999999999999999999999999999999987543321              112346788889


Q ss_pred             eeeecCCCcCC
Q 018487          335 CLFVNSLELLS  345 (355)
Q Consensus       335 ~l~~~~~e~~~  345 (355)
                      ||..+|.+++.
T Consensus       254 ~l~~dp~~Rps  264 (303)
T 3a7i_A          254 CLNKEPSFRPT  264 (303)
T ss_dssp             HCCSSGGGSCC
T ss_pred             HcCCChhhCcC
Confidence            99888887653

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=4.4e-43  Score=318.00  Aligned_cols=232  Identities=26%  Similarity=0.399  Sum_probs=182.7

Q ss_pred             hhcCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecce
Q 018487          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (355)
Q Consensus       103 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~  182 (355)
                      ....+..++|++.++||+|+||+||+|.+.        ..||+|+++.... .....+.+.+|+.+++.++||||+++++
T Consensus        17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--------~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (289)
T 3og7_A           17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWH--------GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMG   87 (289)
T ss_dssp             -CCBCCTTSCEEEEEEEECSSEEEEEEESS--------SEEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             CCCccCccceeeeeEecCCCCeEEEEEEEc--------CceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEe
Confidence            345677889999999999999999999854        2499999876542 4455677889999999999999999998


Q ss_pred             eeecCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCC
Q 018487          183 SFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (355)
Q Consensus       183 ~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~  261 (355)
                      ++ .....++||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        88 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~  166 (289)
T 3og7_A           88 YS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGL  166 (289)
T ss_dssp             EE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred             ec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEcccee
Confidence            55 556789999999999999998644 5699999999999999999999999999999999999999999999999999


Q ss_pred             ccccCcC---CCCCcccccCccccchhhc---cCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-------------
Q 018487          262 AKEIDES---SRSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-------------  322 (355)
Q Consensus       262 a~~~~~~---~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-------------  322 (355)
                      +......   .......||+.|+|||++.   +..++.++||||||+++|+|++|+.||........             
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  246 (289)
T 3og7_A          167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD  246 (289)
T ss_dssp             -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC
T ss_pred             ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc
Confidence            9765432   2233457899999999987   56788899999999999999999999987432110             


Q ss_pred             ------hhhHHHHHhhhheeeecCCCcC
Q 018487          323 ------NTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       323 ------~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                            .....+..+|.+||..+|.+++
T Consensus       247 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp  274 (289)
T 3og7_A          247 LSKVRSNCPKRMKRLMAECLKKKRDERP  274 (289)
T ss_dssp             TTSSCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred             hhhccccCCHHHHHHHHHHccCChhhCC
Confidence                  1123567788888888888765

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.8e-43  Score=317.94  Aligned_cols=235  Identities=19%  Similarity=0.288  Sum_probs=194.3

Q ss_pred             CcCCCCeEEEe-eeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          106 KIGPGDFEIFR-VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       106 ~~~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      .+..++|++.+ .||+|+||+||+|.+..   ...++.||||++.... ......+.+.+|+.+++.++||||+++++++
T Consensus        12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   87 (291)
T 1xbb_A           12 YLDRKLLTLEDKELGSGNFGTVKKGYYQM---KKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC   87 (291)
T ss_dssp             BCCGGGEEEEEEEEEECSSEEEEEEEEEC---SSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             eecchhhhhccCccccccCeeeEeeeecC---CCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            34557899998 99999999999997652   2457889999997653 2344456788999999999999999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                       ..+..++||||+++++|.+++.....+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        88 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           88 -EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             -ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             -CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence             5667899999999999999999888899999999999999999999999999999999999999999999999999987


Q ss_pred             cCcCCC----CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhh
Q 018487          265 IDESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTM  325 (355)
Q Consensus       265 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~  325 (355)
                      ......    .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||...+....              ...
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCP  246 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            644322    122346788999999998889999999999999999999 9999987543221              112


Q ss_pred             HHHHHhhhheeeecCCCcCC
Q 018487          326 LLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ..+..+|.+||..+|.+++.
T Consensus       247 ~~l~~li~~~l~~dp~~Rps  266 (291)
T 1xbb_A          247 REMYDLMNLCWTYDVENRPG  266 (291)
T ss_dssp             HHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHHHHcCCChhhCcC
Confidence            35678888999888887653

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.8e-43  Score=328.74  Aligned_cols=236  Identities=16%  Similarity=0.162  Sum_probs=186.4

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchh--------HHHHHHHHHHHHHhcCCCcce
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN--------HVDYMKAERDILTKVTHPFIV  178 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~--------~~~~~~~E~~~l~~l~h~nIv  178 (355)
                      +..++|++.+.||+|+||.||+|.+...  ...+..||+|++.........        ....+.+|+.+++.++||||+
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~--~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~  111 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNK--PEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP  111 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSS--CGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCC--CCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence            4457899999999999999999998742  135778999998765321111        112355788899999999999


Q ss_pred             ecceeeec----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC--
Q 018487          179 QLRYSFQT----RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG--  252 (355)
Q Consensus       179 ~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~--  252 (355)
                      ++++++..    ....|+||||+ +++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++  
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred             eeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence            99999887    77899999999 899999998888899999999999999999999999999999999999999887  


Q ss_pred             cEEEEecCCccccCcCCC--------CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCch--hhh-
Q 018487          253 HVMLTDFGLAKEIDESSR--------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQ--VIA-  321 (355)
Q Consensus       253 ~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~--~~~-  321 (355)
                      .+||+|||+++.+.....        .....||+.|+|||++.+..++.++|||||||++|||++|+.||....  ... 
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  270 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV  270 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence            999999999987643221        134579999999999999999999999999999999999999996521  110 


Q ss_pred             -h--------------------hhhHHHHHhhhheeeecCCCcCC
Q 018487          322 -C--------------------NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 -~--------------------~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                       .                    .....+..+|..||..+|.+++.
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps  315 (345)
T 2v62_A          271 QTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPN  315 (345)
T ss_dssp             HHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCC
T ss_pred             HHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCC
Confidence             0                    11225677888888888887653

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.9e-43  Score=329.18  Aligned_cols=201  Identities=27%  Similarity=0.454  Sum_probs=158.5

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC-
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-  187 (355)
                      .++|++++.||+|+||.||+|.+.     .+++.||||++.... ......+.+.+|+.+++.++||||+++++++... 
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  101 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDT-----KTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR  101 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEET-----TTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             CCceEEeeEEeecCCeEEEEEEEC-----CCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence            368999999999999999999976     567889999987543 2344456778899999999999999999998654 


Q ss_pred             -----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       188 -----~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                           ..+|+|||++ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus       102 ~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          102 SLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             SGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----
T ss_pred             ccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccc
Confidence                 5689999999 6789888765 57999999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCCCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCchh
Q 018487          263 KEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQV  319 (355)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~~  319 (355)
                      +.....  ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.
T Consensus       180 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  235 (367)
T 2fst_X          180 RHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH  235 (367)
T ss_dssp             -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            875432  344679999999999987 6789999999999999999999999987653

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.3e-43  Score=327.00  Aligned_cols=234  Identities=20%  Similarity=0.339  Sum_probs=186.8

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +..++|++++.||+|+||+||+|.+..... .....||+|++.....  ....+.+.+|+.+++.++||||+++++++. 
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-   85 (325)
T 3kex_A           10 FKETELRKLKVLGSGVFGTVHKGVWIPEGE-SIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-   85 (325)
T ss_dssp             CCTTTEEEEEEEECCSSCEEEEEEECCTTC-SCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred             cCHhHceeeeeeeecCCceEEEEEEcCCCc-eEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence            456789999999999999999999874321 1223477787754321  222234567999999999999999999886 


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      ++..++||||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus        86 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           86 GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence            45689999999999999998765 57899999999999999999999999999999999999999999999999999876


Q ss_pred             CcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhhhh--------------hHH
Q 018487          266 DESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACNT--------------MLL  327 (355)
Q Consensus       266 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~~~--------------~~~  327 (355)
                      .....   .....|+..|+|||++.+..++.++|||||||++|+|+| |+.||..........              ...
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTID  245 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTT
T ss_pred             CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHH
Confidence            44332   234567889999999999999999999999999999999 999998754322111              113


Q ss_pred             HHHhhhheeeecCCCcC
Q 018487          328 FYLIIFHCLFVNSLELL  344 (355)
Q Consensus       328 ~~~~i~~~l~~~~~e~~  344 (355)
                      +..++.+||..+|.+++
T Consensus       246 ~~~li~~~l~~dp~~Rp  262 (325)
T 3kex_A          246 VYMVMVKCWMIDENIRP  262 (325)
T ss_dssp             TTHHHHHHTCSCTTTSC
T ss_pred             HHHHHHHHcCCChhhCc
Confidence            45678888888887764

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4.3e-43  Score=317.64  Aligned_cols=232  Identities=25%  Similarity=0.368  Sum_probs=178.5

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +..++|++++.||+|+||+||+|.+.     .+++.||+|++..... .....+.+.++...++.++||||+++++++..
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~   77 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHV-----PSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFR   77 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEec-----CCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec
Confidence            45678999999999999999999976     5678899999976532 23333445556666888999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCcEEecCCCcEEEEecCC
Q 018487          187 RSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMLTDFGL  261 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~L~~LH~~-~iiHrDlkp~NILl~~~~~~kl~Dfg~  261 (355)
                      .+..|+||||+++ +|.+++..    ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus        78 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T 3fme_A           78 EGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGI  156 (290)
T ss_dssp             SSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--
T ss_pred             cCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCC
Confidence            9999999999986 77666543    46799999999999999999999998 999999999999999999999999999


Q ss_pred             ccccCcCCCCCcccccCccccchhh----ccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh----------------
Q 018487          262 AKEIDESSRSNSMCGTTEYMAPEIL----LSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA----------------  321 (355)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~----------------  321 (355)
                      +.............||+.|+|||++    .+..++.++||||||+++|+|++|+.||.......                
T Consensus       157 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  236 (290)
T 3fme_A          157 SGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA  236 (290)
T ss_dssp             -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCT
T ss_pred             cccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccc
Confidence            9877665555556799999999996    45678899999999999999999999998531111                


Q ss_pred             hhhhHHHHHhhhheeeecCCCcCC
Q 018487          322 CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 ~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ......+.++|.+||..+|.+++.
T Consensus       237 ~~~~~~~~~li~~~l~~~p~~Rpt  260 (290)
T 3fme_A          237 DKFSAEFVDFTSQCLKKNSKERPT  260 (290)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred             ccCCHHHHHHHHHHhhcChhhCcC
Confidence            112235677888999888887653

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.3e-43  Score=318.36  Aligned_cols=233  Identities=19%  Similarity=0.257  Sum_probs=190.8

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCC--CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      +..++|++.+.||+|+||+||+|.++...+  ...+..||+|++....   ....+.+.+|+.+++.++||||+++++++
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   81 (289)
T 4fvq_A            5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVC   81 (289)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred             echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            455789999999999999999999774321  0112569999986542   34456788999999999999999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCc--------EE
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--------VM  255 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~--------~k  255 (355)
                      ...+..++||||+++++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++.        +|
T Consensus        82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence            999999999999999999999987654 999999999999999999999999999999999999998887        99


Q ss_pred             EEecCCccccCcCCCCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCC-CCCCCchhhhhhh---------
Q 018487          256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQ-VNIKSMQVIACNT---------  324 (355)
Q Consensus       256 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~-~pf~~~~~~~~~~---------  324 (355)
                      |+|||++.....   .....||+.|+|||++.+ ..++.++||||||+++|+|++|. .||...+......         
T Consensus       162 l~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  238 (289)
T 4fvq_A          162 LSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLP  238 (289)
T ss_dssp             ECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred             eccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCC
Confidence            999999876533   233468899999999987 67899999999999999999954 4554433222111         


Q ss_pred             ---hHHHHHhhhheeeecCCCcCC
Q 018487          325 ---MLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       325 ---~~~~~~~i~~~l~~~~~e~~~  345 (355)
                         ...+..++.+||..+|.+++.
T Consensus       239 ~~~~~~l~~li~~~l~~dp~~Rps  262 (289)
T 4fvq_A          239 APKAAELANLINNCMDYEPDHRPS  262 (289)
T ss_dssp             CCSSCTTHHHHHHHSCSSGGGSCC
T ss_pred             CCCCHHHHHHHHHHcCCChhHCcC
Confidence               123567888999888887653

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=8e-43  Score=315.65  Aligned_cols=230  Identities=21%  Similarity=0.335  Sum_probs=190.1

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhH----HHHHHHHHHHHHhcCCCcceecc
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH----VDYMKAERDILTKVTHPFIVQLR  181 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~~E~~~l~~l~h~nIv~l~  181 (355)
                      .+..++|++.+.||+|+||+||+|.+.     .+++.||+|++..........    .+.+.+|+.++++++||||++++
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   89 (287)
T 4f0f_A           15 TLADNEIEYEKQIGKGGFGLVHKGRLV-----KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLY   89 (287)
T ss_dssp             BCCSTTEEEEEECCCCSSSCEEEEEET-----TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             hhhhccceehhccccCCceeEEEEEEc-----CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhh
Confidence            355679999999999999999999976     467889999987654322221    25688999999999999999999


Q ss_pred             eeeecCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCcEEecCCCc-----
Q 018487          182 YSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDGH-----  253 (355)
Q Consensus       182 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~--iiHrDlkp~NILl~~~~~-----  253 (355)
                      +++....  ++||||+++++|.+.+... ..+++..++.++.|++.||.|||++|  |+||||||+|||++.++.     
T Consensus        90 ~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~  167 (287)
T 4f0f_A           90 GLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVC  167 (287)
T ss_dssp             EEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred             eeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCcee
Confidence            9997766  6999999999998887655 46999999999999999999999999  999999999999988776     


Q ss_pred             EEEEecCCccccCcCCCCCcccccCccccchhhc--cCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh---------
Q 018487          254 VMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL--SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC---------  322 (355)
Q Consensus       254 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~---------  322 (355)
                      +||+|||+++....  ......||+.|+|||++.  ...++.++|||||||++|+|++|+.||........         
T Consensus       168 ~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  245 (287)
T 4f0f_A          168 AKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE  245 (287)
T ss_dssp             EEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS
T ss_pred             EEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc
Confidence            99999999975443  234467999999999984  45578899999999999999999999976532111         


Q ss_pred             --------hhhHHHHHhhhheeeecCCCcC
Q 018487          323 --------NTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       323 --------~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                              .....+..+|.+||..+|.+++
T Consensus       246 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp  275 (287)
T 4f0f_A          246 GLRPTIPEDCPPRLRNVIELCWSGDPKKRP  275 (287)
T ss_dssp             CCCCCCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred             CCCCCCCcccCHHHHHHHHHHhcCChhhCc
Confidence                    1122467888889888888765

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=6.5e-43  Score=318.39  Aligned_cols=233  Identities=25%  Similarity=0.341  Sum_probs=190.9

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC-
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-  187 (355)
                      ..+|+++++||+|+||.||+|.+.... ...++.||+|++....  .....+.+.+|+.+++.++||||+++++++... 
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEG-DNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG   96 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTS-SSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred             hhhhhhhhccCCCCceEEEEEEEcccc-CccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence            457999999999999999999965432 2568899999997653  233456788999999999999999999999876 


Q ss_pred             -CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          188 -SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       188 -~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                       ..+++||||+++++|.+++... ..+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence             6799999999999999999554 56999999999999999999999999999999999999999999999999999876


Q ss_pred             CcCCC----CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh--------------------
Q 018487          266 DESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA--------------------  321 (355)
Q Consensus       266 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~--------------------  321 (355)
                      .....    .....||..|+|||++.+..++.++||||||+++|+|+||..|+.......                    
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL  256 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred             cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence            54332    234567888999999999889999999999999999999999875432110                    


Q ss_pred             ---------hhhhHHHHHhhhheeeecCCCcC
Q 018487          322 ---------CNTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       322 ---------~~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                               ......+..+|.+||..+|.+++
T Consensus       257 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp  288 (302)
T 4e5w_A          257 KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRT  288 (302)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSC
T ss_pred             hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCC
Confidence                     01113467788888888887764

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=6.1e-43  Score=322.58  Aligned_cols=236  Identities=24%  Similarity=0.336  Sum_probs=197.5

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      .+..++|++++.||+|+||.||+|++.... ...++.||||++...   .....+.+.+|+.++++++|+||+++++++.
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   94 (327)
T 3lxl_A           19 IFEERHLKYISQLGKGNFGSVELCRYDPLG-DNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSY   94 (327)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEECTTS-SSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hhchhhhhhhhhccCCCCeEEEEEEeccCC-CCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEe
Confidence            355678999999999999999999975432 256789999998754   2344566889999999999999999999886


Q ss_pred             --cCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          186 --TRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       186 --~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                        ....+|+||||+++++|.+++... ..+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  174 (327)
T 3lxl_A           95 GPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA  174 (327)
T ss_dssp             CSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred             cCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccc
Confidence              556799999999999999999874 56999999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCC----CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh----------------
Q 018487          263 KEIDESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC----------------  322 (355)
Q Consensus       263 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~----------------  322 (355)
                      ........    .....||+.|+|||++.+..++.++||||||+++|+|++|+.||........                
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3lxl_A          175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL  254 (327)
T ss_dssp             EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred             eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence            87643332    2344678889999999988899999999999999999999999976543210                


Q ss_pred             -------------hhhHHHHHhhhheeeecCCCcCC
Q 018487          323 -------------NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       323 -------------~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                                   .....+..+|.+||..+|.+++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps  290 (327)
T 3lxl_A          255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPS  290 (327)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcC
Confidence                         11234678888999888888653

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.4e-43  Score=337.90  Aligned_cols=230  Identities=24%  Similarity=0.393  Sum_probs=193.8

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      +.+..++|++.++||+|+||.||+|.++      .+..||||+++...    ...+.+.+|+.+|+.++||||+++++++
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~  252 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYN------KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVV  252 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEET------TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEEC------CccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEE
Confidence            4566778999999999999999999975      35679999997643    2346688999999999999999999998


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                      . ...+|+||||+++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus       253 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a  331 (454)
T 1qcf_A          253 T-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA  331 (454)
T ss_dssp             C-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred             e-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence            6 56789999999999999999754  36899999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCC--CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhh
Q 018487          263 KEIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTM  325 (355)
Q Consensus       263 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~  325 (355)
                      +......  ......++..|+|||++.+..++.++|||||||++|||+| |+.||...+....              +..
T Consensus       332 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~  411 (454)
T 1qcf_A          332 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCP  411 (454)
T ss_dssp             GGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSC
T ss_pred             eEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            8764321  1223346788999999998999999999999999999999 9999987643221              112


Q ss_pred             HHHHHhhhheeeecCCCcCC
Q 018487          326 LLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ..+..+|.+||..+|.+++.
T Consensus       412 ~~l~~li~~cl~~dp~~RPt  431 (454)
T 1qcf_A          412 EELYNIMMRCWKNRPEERPT  431 (454)
T ss_dssp             HHHHHHHHHHTCSSGGGSCC
T ss_pred             HHHHHHHHHHccCChhHCcC
Confidence            35678889999988888653

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=4.6e-43  Score=317.26  Aligned_cols=231  Identities=23%  Similarity=0.351  Sum_probs=197.3

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      +.+..++|++.+.||+|+||+||+|.++     ..++.||+|++....    ...+.+.+|+.+++.++||||+++++++
T Consensus         8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~   78 (288)
T 3kfa_A            8 WEMERTDITMKHKLGGGQYGEVYEGVWK-----KYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVC   78 (288)
T ss_dssp             TBCCGGGEEEEEESGGGTTCSEEEEEEG-----GGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccccccceeEEeecCCCCceeEEEeEec-----CCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            4456678999999999999999999987     457889999987532    3446688899999999999999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                      ...+.+|+||||+++++|.+++...  ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        79 ~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~  158 (288)
T 3kfa_A           79 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS  158 (288)
T ss_dssp             CSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred             ccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccc
Confidence            9999999999999999999999874  34899999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCC--CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhhh--------------hh
Q 018487          263 KEIDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACN--------------TM  325 (355)
Q Consensus       263 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~~--------------~~  325 (355)
                      ........  .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+.....              ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T 3kfa_A          159 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP  238 (288)
T ss_dssp             GTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCC
T ss_pred             eeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCC
Confidence            87654332  233456788999999999999999999999999999999 99999875432211              12


Q ss_pred             HHHHHhhhheeeecCCCcC
Q 018487          326 LLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~  344 (355)
                      ..+..++.+||..+|.+++
T Consensus       239 ~~l~~li~~~l~~dp~~Rp  257 (288)
T 3kfa_A          239 EKVYELMRACWQWNPSDRP  257 (288)
T ss_dssp             HHHHHHHHHHTCSSGGGSC
T ss_pred             HHHHHHHHHHhCCChhhCc
Confidence            3467888889988888765

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2e-42  Score=317.09  Aligned_cols=229  Identities=24%  Similarity=0.436  Sum_probs=190.7

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      ...++|++.+.||+|+||.||+|.++     .+++.||+|++....     ..+.+.+|+.+++.++||||+++++++..
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   95 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHK-----ETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFK   95 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEET-----TTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEEC-----CCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence            34578999999999999999999976     467889999987543     23457789999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          187 RSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      .+.+|+||||+++++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++...
T Consensus        96 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  175 (314)
T 3com_A           96 NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL  175 (314)
T ss_dssp             TTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence            9999999999999999999874 467999999999999999999999999999999999999999999999999999876


Q ss_pred             CcCC-CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh----------------hhhHHH
Q 018487          266 DESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC----------------NTMLLF  328 (355)
Q Consensus       266 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~----------------~~~~~~  328 (355)
                      .... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...+....                .....+
T Consensus       176 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  255 (314)
T 3com_A          176 TDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNF  255 (314)
T ss_dssp             BTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred             hhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHH
Confidence            4432 23455789999999999998999999999999999999999999987543221                112356


Q ss_pred             HHhhhheeeecCCCcCC
Q 018487          329 YLIIFHCLFVNSLELLS  345 (355)
Q Consensus       329 ~~~i~~~l~~~~~e~~~  345 (355)
                      ..+|.+||..+|.+++.
T Consensus       256 ~~li~~~l~~dp~~Rpt  272 (314)
T 3com_A          256 TDFVKQCLVKSPEQRAT  272 (314)
T ss_dssp             HHHHHHHTCSCTTTSCC
T ss_pred             HHHHHHHccCChhhCcC
Confidence            78888999888887653

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=9.1e-43  Score=332.43  Aligned_cols=196  Identities=31%  Similarity=0.497  Sum_probs=167.0

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec---
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT---  186 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~---  186 (355)
                      .+|++.+.||+|+||+||+|+++     .+++.||||++......       ..+|+++|+.++|||||+++++|..   
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vaiK~~~~~~~~-------~~~E~~il~~l~hpniv~l~~~~~~~~~  121 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLC-----DSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGE  121 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEEET
T ss_pred             ceEEeeeEEeeCCCEEEEEEEEC-----CCCcEEEEEEecccchh-------HHHHHHHHHHcCCCCccceeeEEeccCC
Confidence            36999999999999999999986     46788999998654321       2369999999999999999998853   


Q ss_pred             ---CCeEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCC-CcEEEEe
Q 018487          187 ---RSKLYLILDFINGGHLFFHLY----RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTD  258 (355)
Q Consensus       187 ---~~~~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~-~~~kl~D  258 (355)
                         ...+++||||+++ +|...+.    ....+++..++.++.||++||.|||++||+||||||+|||++.+ +.+||+|
T Consensus       122 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~D  200 (420)
T 1j1b_A          122 KKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCD  200 (420)
T ss_dssp             TTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred             CCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEecc
Confidence               2247799999987 5555443    34679999999999999999999999999999999999999965 5789999


Q ss_pred             cCCccccCcCCCCCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          259 FGLAKEIDESSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       259 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      ||+++.+.........+||+.|+|||++.+. .++.++|||||||++|||++|+.||...+
T Consensus       201 FG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~  261 (420)
T 1j1b_A          201 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS  261 (420)
T ss_dssp             CTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             chhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            9999987655555567899999999999764 78999999999999999999999998764

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.3e-42  Score=323.61  Aligned_cols=201  Identities=26%  Similarity=0.439  Sum_probs=174.1

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC-
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-  187 (355)
                      .++|++++.||+|+||.||+|.+.     .+++.||||++....  .....+.+.+|+.++++++||||+++++++... 
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   98 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDN-----LNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPT   98 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred             cccEEEEEEeecCCCeEEEEEEEC-----CCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCC
Confidence            368999999999999999999976     567889999987532  344456788999999999999999999998654 


Q ss_pred             ----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       188 ----~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                          ...|+||||+++ +|.+++.. ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        99 ~~~~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A           99 IEQMKDVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             TTTCCCEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             ccccceEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceE
Confidence                479999999975 88888765 468999999999999999999999999999999999999999999999999998


Q ss_pred             ccCcCCC----CCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          264 EIDESSR----SNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       264 ~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      .......    ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  236 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH  236 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC
Confidence            7643322    244589999999998764 458999999999999999999999998754

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.1e-42  Score=313.93  Aligned_cols=234  Identities=23%  Similarity=0.354  Sum_probs=191.7

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      .+..++|++.+.||+|+||+||+|.+....  ..+..||+|++....  .....+.+.+|+.+++.++||||+++++++.
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   83 (281)
T 3cc6_A            8 GIAREDVVLNRILGEGFFGEVYEGVYTNHK--GEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE   83 (281)
T ss_dssp             SCCGGGEEEEEEEEECSSSEEEEEEEECTT--CCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred             eecccceEEEEEEEecCCeeEEEeEEcCCC--CCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence            455678999999999999999999876432  345679999987653  3344567889999999999999999999987


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      .+ ..|+||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        84 ~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           84 EE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             SS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             CC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            54 5689999999999999997654 599999999999999999999999999999999999999999999999999987


Q ss_pred             cCcCCC--CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhhHH
Q 018487          265 IDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTMLL  327 (355)
Q Consensus       265 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~~~  327 (355)
                      ......  .....+++.|+|||++.+..++.++||||||+++|+|+| |+.||...+....              .....
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPV  242 (281)
T ss_dssp             C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHH
T ss_pred             cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHH
Confidence            644321  233456889999999998999999999999999999998 9999975432211              11234


Q ss_pred             HHHhhhheeeecCCCcC
Q 018487          328 FYLIIFHCLFVNSLELL  344 (355)
Q Consensus       328 ~~~~i~~~l~~~~~e~~  344 (355)
                      +..+|.+||..+|.+++
T Consensus       243 l~~li~~~l~~~p~~Rp  259 (281)
T 3cc6_A          243 LYTLMTRCWDYDPSDRP  259 (281)
T ss_dssp             HHHHHHHHTCSSGGGSC
T ss_pred             HHHHHHHHccCCchhCc
Confidence            67888888888888765

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=5.8e-43  Score=321.65  Aligned_cols=230  Identities=27%  Similarity=0.358  Sum_probs=191.7

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec--CC
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--RS  188 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~  188 (355)
                      .|+++++||+|+||+||++.++.... .+++.||||++....  .....+.+.+|+.+++.++||||+++++++..  ..
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTND-GTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA  108 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC---CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCC-CCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence            35999999999999999998765433 568899999997653  34456678899999999999999999999987  46


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      .+++||||+++++|.+++... .+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          109 SLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             EEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             eEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            899999999999999988765 4899999999999999999999999999999999999999999999999999876543


Q ss_pred             CC----CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh-----------------------
Q 018487          269 SR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA-----------------------  321 (355)
Q Consensus       269 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~-----------------------  321 (355)
                      ..    .....+|..|+|||++.+..++.++||||||+++|+|+||+.||.......                       
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG  267 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred             ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence            22    234467888999999998889999999999999999999999998653210                       


Q ss_pred             ------hhhhHHHHHhhhheeeecCCCcC
Q 018487          322 ------CNTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       322 ------~~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                            ......+..+|.+||..+|.+++
T Consensus       268 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rp  296 (318)
T 3lxp_A          268 ERLPRPDKCPAEVYHLMKNCWETEASFRP  296 (318)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             cCCCCCccccHHHHHHHHHHcCCCcccCc
Confidence                  01123467788888888887765

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.6e-43  Score=342.88  Aligned_cols=231  Identities=23%  Similarity=0.357  Sum_probs=196.4

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      +.+...+|++.++||+|+||.||+|.++     ..+..||||+++....    ..+.+.+|+.+|++++||||+++++++
T Consensus       215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~  285 (495)
T 1opk_A          215 WEMERTDITMKHKLGGGQYGEVYEGVWK-----KYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVC  285 (495)
T ss_dssp             CBCCGGGEEEEEESGGGTTSSEEEEEEG-----GGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCHHHceeeeEecCCCCeEEEEEEEc-----CCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            3455678999999999999999999987     3567899999876432    245688899999999999999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                      ...+.+|+||||+++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus       286 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a  365 (495)
T 1opk_A          286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLS  365 (495)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred             ecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccc
Confidence            9999999999999999999999864  45899999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCC--CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhh
Q 018487          263 KEIDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTM  325 (355)
Q Consensus       263 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~  325 (355)
                      +.......  .....+++.|+|||++.+..++.++|||||||++|||+| |+.||...+....              ...
T Consensus       366 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  445 (495)
T 1opk_A          366 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP  445 (495)
T ss_dssp             ECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCC
T ss_pred             eeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            87643321  223346788999999998899999999999999999999 9999987643221              112


Q ss_pred             HHHHHhhhheeeecCCCcC
Q 018487          326 LLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~  344 (355)
                      ..+..+|.+||..+|.+++
T Consensus       446 ~~l~~li~~cl~~dP~~RP  464 (495)
T 1opk_A          446 EKVYELMRACWQWNPSDRP  464 (495)
T ss_dssp             HHHHHHHHHHTCSSGGGSC
T ss_pred             HHHHHHHHHHcCcChhHCc
Confidence            3567888899988888765

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=6.5e-43  Score=315.31  Aligned_cols=223  Identities=23%  Similarity=0.348  Sum_probs=190.8

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec---
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT---  186 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~---  186 (355)
                      ++|++++.||+|+||.||+|.++     .+++.||+|++....       +.+.+|+.+++.++||||+++++++..   
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   78 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHR-----IDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDY   78 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEET-----TTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEE
T ss_pred             cccceeeeeccCCceEEEEEEEc-----CCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEecccc
Confidence            47999999999999999999976     467889999987543       235679999999999999999998854   


Q ss_pred             -------------CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCC
Q 018487          187 -------------RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD  251 (355)
Q Consensus       187 -------------~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~  251 (355)
                                   ...+++||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus        79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~  158 (284)
T 2a19_B           79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT  158 (284)
T ss_dssp             C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred             CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC
Confidence                         45689999999999999999754  579999999999999999999999999999999999999999


Q ss_pred             CcEEEEecCCccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh---------
Q 018487          252 GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC---------  322 (355)
Q Consensus       252 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~---------  322 (355)
                      +.+||+|||++.............||+.|+|||++.+..++.++||||||+++|+|++|..||........         
T Consensus       159 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T 2a19_B          159 KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISD  238 (284)
T ss_dssp             TEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHHTTCCCT
T ss_pred             CCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHHHhhcccccc
Confidence            99999999999887665555566799999999999999999999999999999999999999865322111         


Q ss_pred             hhhHHHHHhhhheeeecCCCcC
Q 018487          323 NTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       323 ~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                      .....+..+|.+||..+|.+++
T Consensus       239 ~~~~~~~~li~~~l~~dp~~Rp  260 (284)
T 2a19_B          239 IFDKKEKTLLQKLLSKKPEDRP  260 (284)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSC
T ss_pred             cCCHHHHHHHHHHccCChhhCc
Confidence            1223456788888888887765

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.1e-43  Score=327.22  Aligned_cols=231  Identities=22%  Similarity=0.360  Sum_probs=192.3

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      ...++|++.+.||+|+||.||+|...      +++.||||++.......  ....+.+|+.+++.++||||+++++++..
T Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   98 (326)
T 3uim_A           27 VASDNFSNKNILGRGGFGKVYKGRLA------DGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMT   98 (326)
T ss_dssp             TTTTSSCSTTEEECCSSSEEEEECCS------SSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECC
T ss_pred             HHhhccccceeEecCCCcEEEEEEec------CCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEEec
Confidence            45678999999999999999999743      46789999987654222  12247789999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeeccCCCCcEEecCCCcEEEEec
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEIVSAVSHLHKC---GIVHRDLKPENILMDSDGHVMLTDF  259 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~----~l~~~~~~~i~~ql~~~L~~LH~~---~iiHrDlkp~NILl~~~~~~kl~Df  259 (355)
                      .+..++||||+++++|.+++....    .+++..+..++.|++.||.|||++   ||+||||||+|||++.++.+||+||
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Df  178 (326)
T 3uim_A           99 PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF  178 (326)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCC
T ss_pred             CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccC
Confidence            999999999999999999998653    389999999999999999999999   9999999999999999999999999


Q ss_pred             CCccccCcCCC--CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh----------------
Q 018487          260 GLAKEIDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA----------------  321 (355)
Q Consensus       260 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~----------------  321 (355)
                      |++........  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......                
T Consensus       179 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  258 (326)
T 3uim_A          179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE  258 (326)
T ss_dssp             SSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS
T ss_pred             ccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc
Confidence            99987643322  334569999999999998889999999999999999999999996321110                


Q ss_pred             ----------------hhhhHHHHHhhhheeeecCCCcCC
Q 018487          322 ----------------CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 ----------------~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                                      ......+..++.+||..+|.+++.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps  298 (326)
T 3uim_A          259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPK  298 (326)
T ss_dssp             CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCC
T ss_pred             hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCC
Confidence                            111245678888999999888763

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.5e-43  Score=312.27  Aligned_cols=230  Identities=21%  Similarity=0.380  Sum_probs=194.5

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      +.+..++|++.+.||+|+||.||+|.+.      .++.||+|++......    .+.+.+|+.+++.++||||+++++++
T Consensus         3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~   72 (267)
T 3t9t_A            3 WVIDPSELTFVQEIGSGQFGLVHLGYWL------NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVC   72 (267)
T ss_dssp             CBCCGGGEEEEEEEEEETTEEEEEEEET------TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             eEEchhheeeeeEecCCCceeEEEEEec------CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            3456678999999999999999999975      3567999999765432    24578899999999999999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      ...+..++||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.
T Consensus        73 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~  152 (267)
T 3t9t_A           73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR  152 (267)
T ss_dssp             CSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGG
T ss_pred             ccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccc
Confidence            9999999999999999999999765 568999999999999999999999999999999999999999999999999998


Q ss_pred             ccCcCC--CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhhh--------------hhH
Q 018487          264 EIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACN--------------TML  326 (355)
Q Consensus       264 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~~--------------~~~  326 (355)
                      ......  ......++..|+|||++.+..++.++||||||+++|+|++ |+.||...+.....              ...
T Consensus       153 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~  232 (267)
T 3t9t_A          153 FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST  232 (267)
T ss_dssp             GBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCH
T ss_pred             ccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcH
Confidence            653321  1233457788999999998899999999999999999999 89999875432211              123


Q ss_pred             HHHHhhhheeeecCCCcC
Q 018487          327 LFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       327 ~~~~~i~~~l~~~~~e~~  344 (355)
                      .+..++.+||..+|.+++
T Consensus       233 ~l~~li~~~l~~~p~~Rp  250 (267)
T 3t9t_A          233 HVYQIMNHCWRERPEDRP  250 (267)
T ss_dssp             HHHHHHHHHTCSSGGGSC
T ss_pred             HHHHHHHHHccCChhhCc
Confidence            467788888888887765

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.7e-42  Score=330.04  Aligned_cols=199  Identities=26%  Similarity=0.444  Sum_probs=173.8

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc------CCCcceecc
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV------THPFIVQLR  181 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~nIv~l~  181 (355)
                      ..++|+++++||+|+||+||+|.+.     .+++.||||+++..    ....+.+.+|+.+++.+      .|+||++++
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~-----~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~  165 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDH-----KVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHML  165 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEET-----TTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEEC-----CCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence            3468999999999999999999976     56788999999753    23334566788888777      577999999


Q ss_pred             eeeecCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCc--EEEE
Q 018487          182 YSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--VMLT  257 (355)
Q Consensus       182 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~--~kl~  257 (355)
                      +++...+.+|+||||+. ++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+
T Consensus       166 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~  244 (429)
T 3kvw_A          166 ENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVI  244 (429)
T ss_dssp             EEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEEC
T ss_pred             eecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEe
Confidence            99999999999999996 58888887664  4899999999999999999999999999999999999999887  9999


Q ss_pred             ecCCccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          258 DFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       258 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      |||++......  ....+||+.|+|||++.+..++.++|||||||++|||+||+.||...+
T Consensus       245 DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          245 DFGSSCYEHQR--VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             CCTTCEETTCC--CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ecccceecCCc--ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            99999765432  345689999999999999999999999999999999999999998764

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-42  Score=319.88  Aligned_cols=235  Identities=23%  Similarity=0.349  Sum_probs=186.1

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +..++|+++++||+|+||+||+|.+..... .....|++|.+....  .....+.+.+|+.+++.++||||+++++++..
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   88 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGE-KVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLT   88 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTC-SCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCc-eEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence            456799999999999999999999874321 112235777665432  23445678889999999999999999999987


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      .. .++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        89 ~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             SS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             CC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            65 78999999999999998864 56999999999999999999999999999999999999999999999999999876


Q ss_pred             CcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhhHH
Q 018487          266 DESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTMLL  327 (355)
Q Consensus       266 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~~~  327 (355)
                      .....   .....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||........              .....
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID  247 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence            43322   223356788999999999999999999999999999999 9999987543221              12224


Q ss_pred             HHHhhhheeeecCCCcCC
Q 018487          328 FYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       328 ~~~~i~~~l~~~~~e~~~  345 (355)
                      +..+|.+||..+|.+++.
T Consensus       248 l~~li~~~l~~dp~~Rps  265 (327)
T 3lzb_A          248 VYMIMRKCWMIDADSRPK  265 (327)
T ss_dssp             HHHHHHHHTCSSGGGSCC
T ss_pred             HHHHHHHHcCCChhHCcC
Confidence            677888999888887653

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.6e-42  Score=313.88  Aligned_cols=229  Identities=28%  Similarity=0.491  Sum_probs=196.0

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++.+.||+|+||.||+|.++     .+++.||+|++...... ....+.+.+|+.++++++||||+++++++...+.
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   95 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDR-----ITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSS   95 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             hcceeeEEEcCCCCEEEEEEEEc-----CCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence            57999999999999999999976     46788999999765432 3345668889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCC---CcEEEEecCCccccC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---GHVMLTDFGLAKEID  266 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~---~~~kl~Dfg~a~~~~  266 (355)
                      +|+||||+++++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++....
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            99999999999999999888889999999999999999999999999999999999999754   469999999998776


Q ss_pred             cCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-----------------hhhHHHH
Q 018487          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-----------------NTMLLFY  329 (355)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-----------------~~~~~~~  329 (355)
                      .........|++.|+|||++.+ .++.++||||||+++|+|++|+.||...+....                 .....+.
T Consensus       176 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (287)
T 2wei_A          176 QNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK  254 (287)
T ss_dssp             CCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHH
T ss_pred             CCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHH
Confidence            5555556678999999999875 489999999999999999999999987543221                 1123457


Q ss_pred             HhhhheeeecCCCcCC
Q 018487          330 LIIFHCLFVNSLELLS  345 (355)
Q Consensus       330 ~~i~~~l~~~~~e~~~  345 (355)
                      .+|.+||..+|.+++.
T Consensus       255 ~li~~~l~~dp~~Rps  270 (287)
T 2wei_A          255 DLIRKMLTFHPSLRIT  270 (287)
T ss_dssp             HHHHHHTCSSGGGSCC
T ss_pred             HHHHHHcccChhhCcC
Confidence            7888888888877653

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.7e-42  Score=324.02  Aligned_cols=205  Identities=25%  Similarity=0.410  Sum_probs=166.6

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeeccccc--------chhHHHHHHHHHHHHHhcCCCcce
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII--------KKNHVDYMKAERDILTKVTHPFIV  178 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~~~E~~~l~~l~h~nIv  178 (355)
                      ...++|++.+.||+|+||.||+|.+.      .++.||||++......        .....+.+.+|+.++++++||||+
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           19 AMQSPYTVQRFISSGSYGAVCAGVDS------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HTTCSCEEEEEEEEETTEEEEEEECT------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HhccceEEeEEeccCCCEEEEEEECC------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            45679999999999999999999854      3778999998654321        233346788999999999999999


Q ss_pred             ecceeee-----cCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC
Q 018487          179 QLRYSFQ-----TRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG  252 (355)
Q Consensus       179 ~l~~~~~-----~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~  252 (355)
                      ++++++.     ....+|+||||+++ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~  171 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN  171 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC
T ss_pred             ceeeeEEeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCC
Confidence            9999984     34478999999985 677776654 4699999999999999999999999999999999999999999


Q ss_pred             cEEEEecCCccccCcCCCCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       253 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      .+||+|||++.............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus       172 ~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  238 (362)
T 3pg1_A          172 DITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST  238 (362)
T ss_dssp             CEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence            999999999987655555556789999999999987 678999999999999999999999998754

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.9e-42  Score=312.49  Aligned_cols=227  Identities=19%  Similarity=0.258  Sum_probs=190.2

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceeeecCC
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS  188 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  188 (355)
                      ++|++.+.||+|+||+||+|.++     .+++.||+|++....... .....+.+|+..+..+ +||||+++++++...+
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~   84 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKR-----LDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD   84 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred             chhhhhhhhcCCCceEEEEEEEc-----CCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence            47999999999999999999976     467889999998654322 3345677899999999 8999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCC-------------
Q 018487          189 KLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-------------  251 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~-------------  251 (355)
                      ..++||||+++++|.+++...    ..+++.+++.++.||+.||.|||++||+||||||+|||++.+             
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred             eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence            999999999999999999765    669999999999999999999999999999999999999844             


Q ss_pred             ------CcEEEEecCCccccCcCCCCCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh--
Q 018487          252 ------GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC--  322 (355)
Q Consensus       252 ------~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~--  322 (355)
                            ..+||+|||++.......   ...||+.|+|||++.+. .++.++|||||||++|+|++|..++...+....  
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~  241 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIR  241 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHHH
T ss_pred             cccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHHH
Confidence                  479999999998765432   34689999999999865 566799999999999999999987766543221  


Q ss_pred             ---------hhhHHHHHhhhheeeecCCCcCC
Q 018487          323 ---------NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       323 ---------~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                               .....+..+|.+||..+|.+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps  273 (289)
T 1x8b_A          242 QGRLPRIPQVLSQEFTELLKVMIHPDPERRPS  273 (289)
T ss_dssp             TTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             cCCCCCCCcccCHHHHHHHHHHhCCCcccCCC
Confidence                     12345678889999888887653

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=5.6e-43  Score=330.57  Aligned_cols=198  Identities=24%  Similarity=0.401  Sum_probs=171.0

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC--------CCccee
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT--------HPFIVQ  179 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~nIv~  179 (355)
                      ..++|++.++||+|+||+||+|.+.     .+++.||||++...    ....+.+.+|+.+++.++        |+||++
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~  105 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDI-----QGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQ  105 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEec-----CCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence            3578999999999999999999876     56788999998743    334456788999999886        788999


Q ss_pred             cceeee----cCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCcEEecCCC
Q 018487          180 LRYSFQ----TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDG  252 (355)
Q Consensus       180 l~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~-~iiHrDlkp~NILl~~~~  252 (355)
                      ++++|.    ....+|+||||+.+ +|.+.+...  ..+++.+++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus       106 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~  184 (397)
T 1wak_A          106 LLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNE  184 (397)
T ss_dssp             EEEEEEEEETTEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCH
T ss_pred             eecceeecCCCCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccc
Confidence            999987    56689999999955 555665544  4699999999999999999999998 999999999999998775


Q ss_pred             -------------------------------------------------cEEEEecCCccccCcCCCCCcccccCccccc
Q 018487          253 -------------------------------------------------HVMLTDFGLAKEIDESSRSNSMCGTTEYMAP  283 (355)
Q Consensus       253 -------------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aP  283 (355)
                                                                       .+||+|||++......  ....+||+.|+||
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aP  262 (397)
T 1wak_A          185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSL  262 (397)
T ss_dssp             HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCH
T ss_pred             hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCC
Confidence                                                             7999999999876543  3445799999999


Q ss_pred             hhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          284 EILLSKGHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       284 E~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      |++.+..++.++|||||||++|+|+||+.||...
T Consensus       263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  296 (397)
T 1wak_A          263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPH  296 (397)
T ss_dssp             HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred             hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCC
Confidence            9999999999999999999999999999999754

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.4e-43  Score=315.95  Aligned_cols=230  Identities=25%  Similarity=0.455  Sum_probs=192.4

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee--cC
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ--TR  187 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~  187 (355)
                      ++|++++.||+|+||.||+|.++     .+++.||+|++..... .....+.+.+|+.++++++||||+++++++.  ..
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRK-----SDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN   79 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET-----TTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGG
T ss_pred             hheeeehhccCCCCcEEEEEEEC-----CCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCC
Confidence            58999999999999999999976     4678899999976543 3445567889999999999999999999874  46


Q ss_pred             CeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----CeeccCCCCcEEecCCCcEEEEe
Q 018487          188 SKLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCG-----IVHRDLKPENILMDSDGHVMLTD  258 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~ql~~~L~~LH~~~-----iiHrDlkp~NILl~~~~~~kl~D  258 (355)
                      ..+|+||||+++++|.+++...    ..+++..++.++.|++.||.|||++|     |+||||||+|||++.++.+||+|
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~d  159 (279)
T 2w5a_A           80 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD  159 (279)
T ss_dssp             TEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECC
T ss_pred             ceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEec
Confidence            7899999999999999998754    34899999999999999999999999     99999999999999999999999


Q ss_pred             cCCccccCcCCC-CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh--------------h
Q 018487          259 FGLAKEIDESSR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC--------------N  323 (355)
Q Consensus       259 fg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~--------------~  323 (355)
                      ||++........ .....|++.|+|||++.+..++.++||||||+++|+|++|+.||...+....              .
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~  239 (279)
T 2w5a_A          160 FGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR  239 (279)
T ss_dssp             CCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred             CchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcc
Confidence            999987643321 2345689999999999988999999999999999999999999987643221              1


Q ss_pred             hhHHHHHhhhheeeecCCCcCC
Q 018487          324 TMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       324 ~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ....+..+|.+||..+|.+++.
T Consensus       240 ~~~~l~~li~~~l~~~p~~Rps  261 (279)
T 2w5a_A          240 YSDELNEIITRMLNLKDYHRPS  261 (279)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCC
T ss_pred             cCHHHHHHHHHHcCCCcccCCC
Confidence            1235678888999888887653

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1e-42  Score=318.94  Aligned_cols=236  Identities=22%  Similarity=0.344  Sum_probs=186.0

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      .+..++|.+.+.||+|+||.||+|.+....  ..++.||+|++..... .....+.+.+|+.++++++||||+++++++.
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  106 (313)
T 3brb_A           30 VIDRNLLILGKILGEGEFGSVMEGNLKQED--GTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCI  106 (313)
T ss_dssp             BCCGGGEEEEEEEEC-CCCCEEEEEEECTT--SCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred             ccCHHHeeeccceeecCCeEEEEEEEeccC--CceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence            355678999999999999999999876322  3567899999876543 3444567889999999999999999999988


Q ss_pred             cCC-----eEEEEEeccCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcE
Q 018487          186 TRS-----KLYLILDFINGGHLFFHLYR------QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV  254 (355)
Q Consensus       186 ~~~-----~~~lv~e~~~~gsL~~~l~~------~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~  254 (355)
                      ..+     ..++||||+++++|.+++..      ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus       107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~  186 (313)
T 3brb_A          107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTV  186 (313)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCE
T ss_pred             eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcE
Confidence            655     35999999999999999843      3569999999999999999999999999999999999999999999


Q ss_pred             EEEecCCccccCcCC---CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------
Q 018487          255 MLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------  322 (355)
Q Consensus       255 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------  322 (355)
                      ||+|||++.......   ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||........        
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  266 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH  266 (313)
T ss_dssp             EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred             EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC
Confidence            999999998764332   1223457889999999999999999999999999999999 9999987543221        


Q ss_pred             ------hhhHHHHHhhhheeeecCCCcC
Q 018487          323 ------NTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       323 ------~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                            .....+..+|.+||..+|.+++
T Consensus       267 ~~~~~~~~~~~l~~li~~~l~~dp~~Rp  294 (313)
T 3brb_A          267 RLKQPEDCLDELYEIMYSCWRTDPLDRP  294 (313)
T ss_dssp             CCCCBTTCCHHHHHHHHHTTCSSGGGSC
T ss_pred             CCCCCccccHHHHHHHHHHcCCChhhCc
Confidence                  1123567888899988888765

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=7.2e-43  Score=312.74  Aligned_cols=227  Identities=17%  Similarity=0.258  Sum_probs=192.0

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      .+..++|++.+.||+|+||.||+|.++       ++.||+|++..... .....+.+.+|+.++++++||||+++++++.
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   77 (271)
T 3kmu_A            6 GIDFKQLNFLTKLNENHSGELWKGRWQ-------GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQ   77 (271)
T ss_dssp             CCCGGGCEEEEEEEEETTEEEEEEEET-------TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEEC
T ss_pred             CCCHHHhHHHHHhcCCCcceEEEEEEC-------CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEc
Confidence            355678999999999999999999964       56799999986543 3444567889999999999999999999998


Q ss_pred             cC--CeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCcEEecCCCcEEEEec
Q 018487          186 TR--SKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDGHVMLTDF  259 (355)
Q Consensus       186 ~~--~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~--iiHrDlkp~NILl~~~~~~kl~Df  259 (355)
                      ..  +..++||||+++++|.+++....  .+++.+++.++.|++.||.|||++|  |+||||||+|||++.++.++|+||
T Consensus        78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~  157 (271)
T 3kmu_A           78 SPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMA  157 (271)
T ss_dssp             TTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGG
T ss_pred             cCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEec
Confidence            76  78999999999999999998765  4899999999999999999999999  999999999999999999999999


Q ss_pred             CCccccCcCCCCCcccccCccccchhhccCCCCC---cccHHHHHHHHHHHHcCCCCCCCchhhhh--------------
Q 018487          260 GLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQVNIKSMQVIAC--------------  322 (355)
Q Consensus       260 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwSlG~~l~elltg~~pf~~~~~~~~--------------  322 (355)
                      |++....    .....||+.|+|||++.+..++.   ++||||||+++|+|++|+.||...+....              
T Consensus       158 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  233 (271)
T 3kmu_A          158 DVKFSFQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP  233 (271)
T ss_dssp             GSCCTTS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCC
T ss_pred             cceeeec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCC
Confidence            9876532    23456899999999998765554   79999999999999999999987543321              


Q ss_pred             -hhhHHHHHhhhheeeecCCCcC
Q 018487          323 -NTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       323 -~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                       .....+..++.+||..+|.+++
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rp  256 (271)
T 3kmu_A          234 PGISPHVSKLMKICMNEDPAKRP  256 (271)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             CCCCHHHHHHHHHHcCCChhhCc
Confidence             1223567788889888888765

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=5.5e-43  Score=322.90  Aligned_cols=230  Identities=25%  Similarity=0.373  Sum_probs=189.9

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCc--eEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceee
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG--IYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~  184 (355)
                      ..++|++.+.||+|+||.||+|.++.     ++.  .+++|.+....  .....+.+.+|+.+++++ +||||+++++++
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~   95 (327)
T 1fvr_A           23 DWNDIKFQDVIGEGNFGQVLKARIKK-----DGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGAC   95 (327)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEE-----TTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred             cHHHccceeeeecCCCceEEEEEEcc-----CCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceee
Confidence            34689999999999999999999762     344  35889886432  233445688899999999 899999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEe
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM  248 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl  248 (355)
                      ...+.+|+||||+++++|.+++....                .+++.+++.++.||+.||.|||++||+||||||+|||+
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~  175 (327)
T 1fvr_A           96 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV  175 (327)
T ss_dssp             EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             eeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE
Confidence            99999999999999999999997654                68999999999999999999999999999999999999


Q ss_pred             cCCCcEEEEecCCccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh-----
Q 018487          249 DSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC-----  322 (355)
Q Consensus       249 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~-----  322 (355)
                      +.++.+||+|||+++............+++.|+|||++.+..++.++||||||+++|+|+| |+.||...+....     
T Consensus       176 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~  255 (327)
T 1fvr_A          176 GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP  255 (327)
T ss_dssp             CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred             cCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence            9999999999999986544333444567889999999998889999999999999999998 9999987643221     


Q ss_pred             ---------hhhHHHHHhhhheeeecCCCcC
Q 018487          323 ---------NTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       323 ---------~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                               .....+..+|.+||..+|.+++
T Consensus       256 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp  286 (327)
T 1fvr_A          256 QGYRLEKPLNCDDEVYDLMRQCWREKPYERP  286 (327)
T ss_dssp             GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSC
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence                     1123567888899988887765

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.4e-43  Score=330.03  Aligned_cols=228  Identities=14%  Similarity=0.208  Sum_probs=175.3

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc--CCCcceecc------
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV--THPFIVQLR------  181 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~nIv~l~------  181 (355)
                      .+|++.+.||+|+||+||+|.++     .+++.||||++...........+.+.+|+.+++.+  +||||++++      
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p  136 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDV-----ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLP  136 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCC
T ss_pred             eeeeeeeeccCCCCEEEEEEEEC-----CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEee
Confidence            35999999999999999999976     56789999999887654556666788885544444  699988755      


Q ss_pred             -eeeecC-----------------CeEEEEEeccCCCChHHHHHhcC-CCCHHHH------HHHHHHHHHHHHHHHHCCC
Q 018487          182 -YSFQTR-----------------SKLYLILDFINGGHLFFHLYRQG-IFREDQA------RFYTAEIVSAVSHLHKCGI  236 (355)
Q Consensus       182 -~~~~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~------~~i~~ql~~~L~~LH~~~i  236 (355)
                       +.+...                 ..+|+||||++ ++|.+++...+ .+.+..+      ..++.||+.||+|||++||
T Consensus       137 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~i  215 (371)
T 3q60_A          137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGL  215 (371)
T ss_dssp             CEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             ehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCC
Confidence             333322                 34899999999 79999998643 3444445      5777999999999999999


Q ss_pred             eeccCCCCcEEecCCCcEEEEecCCccccCcCCCCCcccccCccccchhhcc--CCCCCcccHHHHHHHHHHHHcCCCCC
Q 018487          237 VHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQVNI  314 (355)
Q Consensus       237 iHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~elltg~~pf  314 (355)
                      +||||||+|||++.++.+||+|||+++......  ....+|+.|+|||++.+  ..++.++|||||||++|+|+||+.||
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf  293 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF  293 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCCCc--cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999998764322  14457799999999987  67999999999999999999999999


Q ss_pred             CCchhhh----------------------hhhhHHHHHhhhheeeecCCCcCC
Q 018487          315 KSMQVIA----------------------CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       315 ~~~~~~~----------------------~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      .......                      ......+.++|.+||..+|.+++.
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  346 (371)
T 3q60_A          294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLL  346 (371)
T ss_dssp             TBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCC
T ss_pred             CCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCC
Confidence            8762210                      122346778899999998888763

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-42  Score=314.39  Aligned_cols=232  Identities=23%  Similarity=0.331  Sum_probs=192.5

Q ss_pred             cCCCCeEEEe-eeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          107 IGPGDFEIFR-VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       107 ~~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      +..++|.+.+ .||+|+||.||+|.++..   ..++.||+|+++...  .....+.+.+|+.+++.++||||+++++++ 
T Consensus         6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-   79 (287)
T 1u59_A            6 LKRDNLLIADIELGCGNFGSVRQGVYRMR---KKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-   79 (287)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC------CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred             ccHHHhhhhhccccccCceeEEEeEeccC---CCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-
Confidence            4456888887 999999999999987532   356789999997653  345567788999999999999999999999 


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      ..+..++||||+++++|.+++... ..+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~  159 (287)
T 1u59_A           80 QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA  159 (287)
T ss_dssp             ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceee
Confidence            456699999999999999998754 4599999999999999999999999999999999999999999999999999987


Q ss_pred             cCcCCC----CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh--------------hhhh
Q 018487          265 IDESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA--------------CNTM  325 (355)
Q Consensus       265 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~--------------~~~~  325 (355)
                      ......    .....+|+.|+|||++.+..++.++||||||+++|+|+| |+.||...+...              ....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~  239 (287)
T 1u59_A          160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP  239 (287)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCC
T ss_pred             eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcC
Confidence            643322    223456889999999998889999999999999999999 999998754321              1122


Q ss_pred             HHHHHhhhheeeecCCCcC
Q 018487          326 LLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~  344 (355)
                      ..+..+|.+||..+|.+++
T Consensus       240 ~~l~~li~~~l~~~p~~Rp  258 (287)
T 1u59_A          240 PELYALMSDCWIYKWEDRP  258 (287)
T ss_dssp             HHHHHHHHHTTCSSGGGSC
T ss_pred             HHHHHHHHHHcCCChhhCc
Confidence            3567788888888887765

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=5.6e-43  Score=322.82  Aligned_cols=237  Identities=21%  Similarity=0.322  Sum_probs=190.2

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +..++|++.+.||+|+||.||+|.+.+..+..+++.||||++....  .......+.+|+.++++++||||+++++++..
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  104 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence            4456899999999999999999997655455678899999986432  33445568889999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC---CCcEEE
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQG-------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVML  256 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~-------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~---~~~~kl  256 (355)
                      ....|+||||+++++|.+++....       .+++.+++.++.|++.||.|||++||+||||||+|||++.   +..+||
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence            999999999999999999998763       4899999999999999999999999999999999999984   446999


Q ss_pred             EecCCccccCcCC---CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh----------
Q 018487          257 TDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC----------  322 (355)
Q Consensus       257 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~----------  322 (355)
                      +|||++.......   ......|++.|+|||++.+..++.++||||||+++|+|+| |+.||........          
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~  264 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM  264 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCC
Confidence            9999987553222   2234567899999999998999999999999999999998 9999987543221          


Q ss_pred             ----hhhHHHHHhhhheeeecCCCcCC
Q 018487          323 ----NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       323 ----~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                          .....+..+|.+||..+|.+++.
T Consensus       265 ~~~~~~~~~l~~li~~~l~~dp~~Rps  291 (327)
T 2yfx_A          265 DPPKNCPGPVYRIMTQCWQHQPEDRPN  291 (327)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcC
Confidence                11234677888999888887653

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.6e-43  Score=325.52  Aligned_cols=204  Identities=27%  Similarity=0.451  Sum_probs=169.7

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccc--hhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK--KNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      .++|++.+.||+|+||.||+|.++     .+++.||||++.......  ....+.+.+|+.+++.++||||+++++++..
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   83 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDK-----NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH   83 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECS-----SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             hcccEEEeEEeecCCEEEEEEEEC-----CCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee
Confidence            468999999999999999999966     467889999987543221  1122457789999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      .+..++||||+++ +|..++... ..+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus        84 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           84 KSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             TTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             CCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            9999999999987 787777665 45899999999999999999999999999999999999999999999999999876


Q ss_pred             CcCC-CCCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          266 DESS-RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       266 ~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      .... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+
T Consensus       163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~  217 (346)
T 1ua2_A          163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS  217 (346)
T ss_dssp             TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence            4332 33456799999999999764 58899999999999999999999998764

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.7e-43  Score=318.50  Aligned_cols=225  Identities=26%  Similarity=0.397  Sum_probs=181.6

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHh--cCCCcceecceee
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK--VTHPFIVQLRYSF  184 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~  184 (355)
                      ...++|++.+.||+|+||+||+|.+.       ++.||||++....      ...+.+|.+++..  ++||||+++++++
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~   71 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSWQ-------GENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASD   71 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEET-------TEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEEC-------CEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEee
Confidence            44578999999999999999999863       6679999986532      2334456666666  7899999999986


Q ss_pred             ec----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCCeeccCCCCcEEecCCC
Q 018487          185 QT----RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIVHRDLKPENILMDSDG  252 (355)
Q Consensus       185 ~~----~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH--------~~~iiHrDlkp~NILl~~~~  252 (355)
                      ..    ...+|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||        ++||+||||||+|||++.++
T Consensus        72 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~  150 (301)
T 3q4u_A           72 MTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG  150 (301)
T ss_dssp             EEEETTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS
T ss_pred             ccccCCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC
Confidence            53    3568999999999999999854 56899999999999999999999        99999999999999999999


Q ss_pred             cEEEEecCCccccCcCCC-----CCcccccCccccchhhccC------CCCCcccHHHHHHHHHHHHcC----------C
Q 018487          253 HVMLTDFGLAKEIDESSR-----SNSMCGTTEYMAPEILLSK------GHNKDADWWSVGILLYEMLTG----------Q  311 (355)
Q Consensus       253 ~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~~l~elltg----------~  311 (355)
                      .+||+|||+++.......     .....||+.|+|||++.+.      .++.++|||||||++|||+||          +
T Consensus       151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~  230 (301)
T 3q4u_A          151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK  230 (301)
T ss_dssp             CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence            999999999976543322     2334799999999999876      345689999999999999999          8


Q ss_pred             CCCCCchhhh-------------------------hhhhHHHHHhhhheeeecCCCcCC
Q 018487          312 VNIKSMQVIA-------------------------CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       312 ~pf~~~~~~~-------------------------~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      .||.......                         ......+..++.+||..+|.+++.
T Consensus       231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps  289 (301)
T 3q4u_A          231 PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT  289 (301)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCC
T ss_pred             ccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCC
Confidence            8886531100                         011234678899999998888753

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=4.7e-42  Score=311.69  Aligned_cols=226  Identities=18%  Similarity=0.262  Sum_probs=188.6

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee-ecC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF-QTR  187 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~  187 (355)
                      .++|++.+.||+|+||.||+|++.     .+++.||||++......     +.+.+|+.+++.++|++++..+..+ ...
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDI-----AAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEG   77 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEET-----TTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEc-----CCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCC
Confidence            468999999999999999999976     56789999998764322     2467899999999998877666555 567


Q ss_pred             CeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEe---cCCCcEEEEecCCcc
Q 018487          188 SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHVMLTDFGLAK  263 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl---~~~~~~kl~Dfg~a~  263 (355)
                      +..++||||+ +++|.+++.. ...+++.+++.++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus        78 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  156 (296)
T 3uzp_A           78 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             CceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence            7889999999 8899999874 4569999999999999999999999999999999999999   488999999999998


Q ss_pred             ccCcCCC--------CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh--------------
Q 018487          264 EIDESSR--------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA--------------  321 (355)
Q Consensus       264 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~--------------  321 (355)
                      .......        .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......              
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (296)
T 3uzp_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  236 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC
Confidence            7654332        245679999999999999999999999999999999999999998742110              


Q ss_pred             -------hhhhHHHHHhhhheeeecCCCcCC
Q 018487          322 -------CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 -------~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                             ......+..+|.+||..+|.+++.
T Consensus       237 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps  267 (296)
T 3uzp_A          237 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPD  267 (296)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCC
T ss_pred             CchHHHHhhCCHHHHHHHHHHHhcCcCcCCC
Confidence                   111235678888999888888653

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.9e-42  Score=327.63  Aligned_cols=196  Identities=29%  Similarity=0.460  Sum_probs=165.8

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC-
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-  188 (355)
                      .+|++.+.||+|+||+||+|++.     .++ .||+|++......       ..+|+.+++.++||||++++++|...+ 
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~-----~~~-~~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~  106 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLV-----ESD-EVAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGD  106 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEET-----TTE-EEEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESS
T ss_pred             ceEEEeEEEeeCCCeEEEEEEEC-----CCC-eEEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCC
Confidence            47999999999999999999976     233 3888877654321       225999999999999999999985433 


Q ss_pred             -----eEEEEEeccCCCChHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEec-CCCcEEEEec
Q 018487          189 -----KLYLILDFINGGHLFFHL---YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDF  259 (355)
Q Consensus       189 -----~~~lv~e~~~~gsL~~~l---~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~-~~~~~kl~Df  259 (355)
                           .+++||||++++.+....   .....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus       107 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DF  186 (394)
T 4e7w_A          107 KKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDF  186 (394)
T ss_dssp             SSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             CCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeC
Confidence                 488999999886443322   2356799999999999999999999999999999999999999 7999999999


Q ss_pred             CCccccCcCCCCCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          260 GLAKEIDESSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       260 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      |+++.+..........||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+
T Consensus       187 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  246 (394)
T 4e7w_A          187 GSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES  246 (394)
T ss_dssp             TTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999887665556667899999999999765 58999999999999999999999998764

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.2e-42  Score=317.17  Aligned_cols=205  Identities=28%  Similarity=0.414  Sum_probs=173.9

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc---CCCcceecceeee
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV---THPFIVQLRYSFQ  185 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~  185 (355)
                      .++|++.+.||+|+||.||+|.+..    ..++.||+|++....... .....+.+|+.+++.+   +||||+++++++.
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~   84 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLK----NGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCT   84 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETT----TTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred             hhceeeeeeecccccEEEEEEEecC----CCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeee
Confidence            3689999999999999999999741    356789999987654221 1112344566666655   8999999999987


Q ss_pred             -----cCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEe
Q 018487          186 -----TRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTD  258 (355)
Q Consensus       186 -----~~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~D  258 (355)
                           ....+++||||++ ++|.+++....  .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           85 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             EEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             ecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEec
Confidence                 5678999999998 58999887754  489999999999999999999999999999999999999999999999


Q ss_pred             cCCccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchh
Q 018487          259 FGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQV  319 (355)
Q Consensus       259 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~  319 (355)
                      ||++.............||+.|+|||++.+..++.++||||||+++|+|++|+.||...+.
T Consensus       164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  224 (326)
T 1blx_A          164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD  224 (326)
T ss_dssp             CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             CcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence            9999877654445566799999999999999999999999999999999999999987643

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1e-42  Score=324.41  Aligned_cols=228  Identities=16%  Similarity=0.201  Sum_probs=186.3

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCC---CCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCccee------
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDG---DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQ------  179 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~------  179 (355)
                      .++|++.+.||+|+||.||+|.++.+.+.   ..++.||+|++...        +.+.+|+.++++++||||++      
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~  112 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY  112 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence            47899999999999999999998743211   13678999998754        23678999999999999998      


Q ss_pred             ---------cceeeec-CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q 018487          180 ---------LRYSFQT-RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL  247 (355)
Q Consensus       180 ---------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NIL  247 (355)
                               +++++.. +...|+||||+ +++|.+++...  ..+++.+++.++.||+.||.|||++||+||||||+|||
T Consensus       113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF  191 (352)
T ss_dssp             TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred             cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence                     4555554 67899999999 99999999876  77999999999999999999999999999999999999


Q ss_pred             ecCCC--cEEEEecCCccccCcCCC--------CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          248 MDSDG--HVMLTDFGLAKEIDESSR--------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       248 l~~~~--~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      ++.++  .+||+|||+++.+.....        .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  999999999987643221        23457999999999999989999999999999999999999999875


Q ss_pred             hhh----hh--------------------hhhHHHHHhhhheeeecCCCcCC
Q 018487          318 QVI----AC--------------------NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       318 ~~~----~~--------------------~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ...    ..                    .....+..+|.+||..+|.+++.
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps  323 (352)
T 2jii_A          272 LPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPP  323 (352)
T ss_dssp             TTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCC
T ss_pred             CcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCC
Confidence            311    00                    01345677888888888877653

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.6e-42  Score=312.46  Aligned_cols=230  Identities=22%  Similarity=0.368  Sum_probs=192.8

Q ss_pred             hcCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceeccee
Q 018487          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (355)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~  183 (355)
                      .+.+..++|++++.||+|+||.||+|.+.      .++.||+|++.....    ..+.+.+|+.+++.++||||++++++
T Consensus         7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~   76 (279)
T 1qpc_A            7 EWEVPRETLKLVERLGAGQFGEVWMGYYN------GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAV   76 (279)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEET------TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hcccCHHhhhheeeecCCCCeEEEEEEEc------CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEE
Confidence            35566789999999999999999999865      356799999875432    23567889999999999999999998


Q ss_pred             eecCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCC
Q 018487          184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (355)
Q Consensus       184 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~  261 (355)
                      +.. +..++||||+++++|.+++....  .+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        77 ~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~  155 (279)
T 1qpc_A           77 VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL  155 (279)
T ss_dssp             ECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             EcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcc
Confidence            874 46899999999999999987543  689999999999999999999999999999999999999999999999999


Q ss_pred             ccccCcCCC--CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hh
Q 018487          262 AKEIDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NT  324 (355)
Q Consensus       262 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~  324 (355)
                      +........  .....++..|+|||++.+..++.++||||||+++|+|++ |+.||...+....              ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  235 (279)
T 1qpc_A          156 ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC  235 (279)
T ss_dssp             CEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred             cccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccc
Confidence            987654322  223456788999999998889999999999999999999 9999987543221              11


Q ss_pred             hHHHHHhhhheeeecCCCcC
Q 018487          325 MLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       325 ~~~~~~~i~~~l~~~~~e~~  344 (355)
                      ...+..++.+|+..+|.+++
T Consensus       236 ~~~l~~li~~~l~~~p~~Rp  255 (279)
T 1qpc_A          236 PEELYQLMRLCWKERPEDRP  255 (279)
T ss_dssp             CHHHHHHHHHHTCSSGGGSC
T ss_pred             cHHHHHHHHHHhccChhhCC
Confidence            23567888899988888765

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.4e-43  Score=319.37  Aligned_cols=234  Identities=26%  Similarity=0.432  Sum_probs=175.9

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      +.+..++|++.+.||+|+||.||+|.+.     .+++.||||++.....  ....+.+.+|+.+++.++||||+++++++
T Consensus        10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   82 (303)
T 2vwi_A           10 WSINRDDYELQEVIGSGATAVVQAAYCA-----PKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSF   82 (303)
T ss_dssp             ---CCCCCEEEEECC---CCCEEEEEC---------CEEEEECCC------------------CCCCCCCTTBCCEEEEE
T ss_pred             cccchhhhhhhheeccccceEEEEEEEC-----CCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence            4466789999999999999999999865     4577899999865432  23345677899999999999999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEE
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYR--------QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML  256 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~--------~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl  256 (355)
                      ...+..++||||+++++|.+++..        ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus        83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl  162 (303)
T 2vwi_A           83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQI  162 (303)
T ss_dssp             ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEE
T ss_pred             eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEE
Confidence            999999999999999999998874        355899999999999999999999999999999999999999999999


Q ss_pred             EecCCccccCcCC------CCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh------
Q 018487          257 TDFGLAKEIDESS------RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN------  323 (355)
Q Consensus       257 ~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~------  323 (355)
                      +|||++.......      ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.........      
T Consensus       163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  242 (303)
T 2vwi_A          163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN  242 (303)
T ss_dssp             CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS
T ss_pred             EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc
Confidence            9999987654321      1234578999999999876 56899999999999999999999999875322110      


Q ss_pred             -----------------hhHHHHHhhhheeeecCCCcCC
Q 018487          324 -----------------TMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       324 -----------------~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                                       ....+..+|.+||..+|.+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps  281 (303)
T 2vwi_A          243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT  281 (303)
T ss_dssp             SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcC
Confidence                             1124567888899888887653

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.2e-42  Score=314.98  Aligned_cols=230  Identities=28%  Similarity=0.478  Sum_probs=186.9

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceeee
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQ  185 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~  185 (355)
                      ...++|++.+.||+|+||.||+|.+.     .+++.||||++.....    ..+.+.+|+.+++++ +||||+++++++.
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   91 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHV-----KTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFI   91 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEEC-----CCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence            34678999999999999999999976     4678899999875432    234577899999999 7999999999997


Q ss_pred             c------CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEE
Q 018487          186 T------RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT  257 (355)
Q Consensus       186 ~------~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~  257 (355)
                      .      .+.+|+||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~  171 (326)
T 2x7f_A           92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLV  171 (326)
T ss_dssp             ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred             eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEe
Confidence            6      56899999999999999999864  568999999999999999999999999999999999999999999999


Q ss_pred             ecCCccccCcCC-CCCcccccCccccchhhc-----cCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh--------
Q 018487          258 DFGLAKEIDESS-RSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN--------  323 (355)
Q Consensus       258 Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~--------  323 (355)
                      |||++....... ......||+.|+|||++.     +..++.++|||||||++|+|++|+.||...+.....        
T Consensus       172 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  251 (326)
T 2x7f_A          172 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA  251 (326)
T ss_dssp             CCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred             eCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc
Confidence            999998764332 234557899999999997     567889999999999999999999999876433211        


Q ss_pred             -------hhHHHHHhhhheeeecCCCcCC
Q 018487          324 -------TMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       324 -------~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                             ....+..+|.+||..+|.+++.
T Consensus       252 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps  280 (326)
T 2x7f_A          252 PRLKSKKWSKKFQSFIESCLVKNHSQRPA  280 (326)
T ss_dssp             CCCSCSCSCHHHHHHHHHHCCSSGGGSCC
T ss_pred             ccCCccccCHHHHHHHHHHhccChhhCCC
Confidence                   1235678888999888887653

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5e-42  Score=322.20  Aligned_cols=199  Identities=30%  Similarity=0.470  Sum_probs=170.3

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|.+.+.||+|+||.||+|.++     .+++.||||++.... ......+.+.+|+.+++.++||||+++++++...+
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  114 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDK-----RSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS  114 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             cccEEEEeEEecCCCeEEEEEEEC-----CCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccC
Confidence            368999999999999999999976     567899999997654 23445567889999999999999999999998766


Q ss_pred             eE------EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          189 KL------YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       189 ~~------~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                      ..      |+||||+.+ +|...+.  ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus       115 ~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          115 SLRNFYDFYLVMPFMQT-DLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             SSTTCCCCEEEEECCCE-EHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             CcccceeEEEEEccccc-cHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence            54      999999984 7776663  34899999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCCCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          263 KEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      +.....  ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+
T Consensus       192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  246 (371)
T 4exu_A          192 RHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD  246 (371)
T ss_dssp             ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            865433  344578999999999987 688999999999999999999999998764

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.5e-42  Score=322.38  Aligned_cols=200  Identities=28%  Similarity=0.441  Sum_probs=159.9

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC-
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-  188 (355)
                      ++|++.+.||+|+||+||+|.++     .+++.||||++.......    ....+++..++.++||||++++++|...+ 
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           23 DRFQVERMAGQGTFGTVQLGKEK-----STGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             TTEEEC----------CEEEEET-----TTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             cceEEEEEEecCCCeEEEEEEEC-----CCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            58999999999999999999976     467889999986543222    23456788889999999999999986533 


Q ss_pred             ------eEEEEEeccCCCChHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH--HCCCeeccCCCCcEEecC-CCcEE
Q 018487          189 ------KLYLILDFINGGHLFFHL----YRQGIFREDQARFYTAEIVSAVSHLH--KCGIVHRDLKPENILMDS-DGHVM  255 (355)
Q Consensus       189 ------~~~lv~e~~~~gsL~~~l----~~~~~l~~~~~~~i~~ql~~~L~~LH--~~~iiHrDlkp~NILl~~-~~~~k  255 (355)
                            .+++||||++++ |...+    .....+++..++.++.|++.||.|||  ++||+||||||+|||++. ++.+|
T Consensus        94 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             SCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             ccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEE
Confidence                  388999999875 43333    34567899999999999999999999  999999999999999997 89999


Q ss_pred             EEecCCccccCcCCCCCcccccCccccchhhccCC-CCCcccHHHHHHHHHHHHcCCCCCCCchh
Q 018487          256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG-HNKDADWWSVGILLYEMLTGQVNIKSMQV  319 (355)
Q Consensus       256 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~elltg~~pf~~~~~  319 (355)
                      |+|||++.............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+.
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~  237 (360)
T 3e3p_A          173 LCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS  237 (360)
T ss_dssp             ECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             EeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh
Confidence            99999999877666566678999999999997654 89999999999999999999999987643

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.7e-42  Score=333.58  Aligned_cols=229  Identities=25%  Similarity=0.362  Sum_probs=188.6

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      +.+..++|++.++||+|+||.||+|.+++      ...||||+++....    ..+.+.+|+.+|++++||||+++++++
T Consensus       179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~  248 (452)
T 1fmk_A          179 WEIPRESLRLEVKLGQGCFGEVWMGTWNG------TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVV  248 (452)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETT------TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccChhHceeeeeecCCCCeEEEEEEECC------CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            44666789999999999999999999762      35699999976432    235678899999999999999999998


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                      .. +.+|+||||+++|+|.+++...  ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus       249 ~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a  327 (452)
T 1fmk_A          249 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA  327 (452)
T ss_dssp             CS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             cC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccc
Confidence            76 6789999999999999999753  56899999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCC--CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhh
Q 018487          263 KEIDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTM  325 (355)
Q Consensus       263 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~  325 (355)
                      +.......  .....++..|+|||++.+..++.++|||||||++|||+| |+.||........              ...
T Consensus       328 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~  407 (452)
T 1fmk_A          328 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP  407 (452)
T ss_dssp             C--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSC
T ss_pred             eecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            87643321  223456788999999998999999999999999999999 9999987643211              122


Q ss_pred             HHHHHhhhheeeecCCCcC
Q 018487          326 LLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~  344 (355)
                      ..+..+|.+||..+|.+++
T Consensus       408 ~~l~~li~~cl~~dP~~Rp  426 (452)
T 1fmk_A          408 ESLHDLMCQCWRKEPEERP  426 (452)
T ss_dssp             HHHHHHHHHHTCSSGGGSC
T ss_pred             HHHHHHHHHHccCChhhCc
Confidence            3567889999999888875

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.9e-42  Score=317.64  Aligned_cols=230  Identities=23%  Similarity=0.380  Sum_probs=188.9

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee-
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ-  185 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-  185 (355)
                      +..++|++.+.||+|+||.||+|.++     .+++.||||++...   .....+.+.+|+.+++.++||||+++++++. 
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   97 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGL-----HDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLR   97 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEET-----TTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEec-----CCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEe
Confidence            44568999999999999999999976     46788999998653   3345567889999999999999999999987 


Q ss_pred             ---cCCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEe
Q 018487          186 ---TRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTD  258 (355)
Q Consensus       186 ---~~~~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~D  258 (355)
                         .....|+||||+++++|.+++..    ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus        98 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~d  177 (317)
T 2buj_A           98 ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMD  177 (317)
T ss_dssp             EETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECC
T ss_pred             ccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEe
Confidence               34578999999999999998876    46699999999999999999999999999999999999999999999999


Q ss_pred             cCCccccCcCCCC----------CcccccCccccchhhccCC---CCCcccHHHHHHHHHHHHcCCCCCCCchhhh----
Q 018487          259 FGLAKEIDESSRS----------NSMCGTTEYMAPEILLSKG---HNKDADWWSVGILLYEMLTGQVNIKSMQVIA----  321 (355)
Q Consensus       259 fg~a~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~~l~elltg~~pf~~~~~~~----  321 (355)
                      ||++.........          ....||+.|+|||++.+..   ++.++||||||+++|+|++|+.||.......    
T Consensus       178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~  257 (317)
T 2buj_A          178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA  257 (317)
T ss_dssp             CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH
T ss_pred             cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh
Confidence            9998765321111          1235799999999987554   6889999999999999999999996421110    


Q ss_pred             ------------hhhhHHHHHhhhheeeecCCCcC
Q 018487          322 ------------CNTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       322 ------------~~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                                  ......+..+|.+||..+|.+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp  292 (317)
T 2buj_A          258 LAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRP  292 (317)
T ss_dssp             HHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred             HHhhccCCCCccccCCHHHHHHHHHHhhcChhhCC
Confidence                        11233567889999998888875

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5.2e-42  Score=311.24  Aligned_cols=226  Identities=18%  Similarity=0.262  Sum_probs=185.6

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee-ecC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF-QTR  187 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~  187 (355)
                      .++|++.+.||+|+||+||+|.+.     .+++.||||++......     +.+.+|+.+++.++|++++..+..+ ...
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDI-----AAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEG   77 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEET-----TTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred             CCceEEeeeecCCCCeEEEEEEEc-----CCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCC
Confidence            468999999999999999999976     56788999987654322     2366799999999988877766655 667


Q ss_pred             CeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEe---cCCCcEEEEecCCcc
Q 018487          188 SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHVMLTDFGLAK  263 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl---~~~~~~kl~Dfg~a~  263 (355)
                      +..++||||+ +++|.+++.. ...+++.++..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus        78 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~  156 (296)
T 4hgt_A           78 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             CceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence            7899999999 8899999875 4569999999999999999999999999999999999999   788999999999998


Q ss_pred             ccCcCCC--------CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh--------------
Q 018487          264 EIDESSR--------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA--------------  321 (355)
Q Consensus       264 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~--------------  321 (355)
                      .......        .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......              
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (296)
T 4hgt_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  236 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred             eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence            7654322        235679999999999999999999999999999999999999998642211              


Q ss_pred             -------hhhhHHHHHhhhheeeecCCCcCC
Q 018487          322 -------CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 -------~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                             ......+..+|..||..+|.+++.
T Consensus       237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt  267 (296)
T 4hgt_A          237 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPD  267 (296)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCC
T ss_pred             chhhhhhccCCHHHHHHHHHHHhcCCCCCCC
Confidence                   111335678888999888888653

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1e-42  Score=315.24  Aligned_cols=236  Identities=21%  Similarity=0.348  Sum_probs=185.6

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +..++|++.+.||+|+||+||+|.+....  .....||+|+++..........+.+.+|+.+++.++||||+++++++..
T Consensus        15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   92 (291)
T 1u46_A           15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPS--GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT   92 (291)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTT--SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cchhHeeeeeeecCCCceeEEEEEeccCC--CceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence            44568999999999999999999875321  2334699999987655455667788999999999999999999999987


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      .. .++||||+++++|.+++... ..+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            65 88999999999999998765 56999999999999999999999999999999999999999999999999999876


Q ss_pred             CcCCC----CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh---------------hhh
Q 018487          266 DESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC---------------NTM  325 (355)
Q Consensus       266 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~---------------~~~  325 (355)
                      .....    .....+|..|+|||++.+..++.++||||||+++|+|++ |+.||...+....               ...
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP  251 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcC
Confidence            44322    223457788999999998889999999999999999999 9999987543221               122


Q ss_pred             HHHHHhhhheeeecCCCcCC
Q 018487          326 LLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ..+..+|.+||..+|.+++.
T Consensus       252 ~~l~~li~~~l~~~p~~Rps  271 (291)
T 1u46_A          252 QDIYNVMVQCWAHKPEDRPT  271 (291)
T ss_dssp             HHHHHHHHHHTCSSGGGSCC
T ss_pred             HHHHHHHHHHccCCcccCcC
Confidence            35678888999888887653

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.1e-42  Score=315.03  Aligned_cols=229  Identities=29%  Similarity=0.464  Sum_probs=188.1

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|++++.||+|+||.||+|.++     .+++.||+|++....   ....+.+.+|+.+++.++||||+++++++...+
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNK-----ETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDG   89 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEET-----TTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-
T ss_pred             ccceeecceeccCCCeEEEEEEEc-----CCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC
Confidence            358999999999999999999976     457889999986543   234566788999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          189 KLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      ..++||||+++++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++.....
T Consensus        90 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (302)
T 2j7t_A           90 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK  169 (302)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred             eEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence            99999999999999988876 45699999999999999999999999999999999999999999999999998764321


Q ss_pred             -CCCCCcccccCccccchhhc-----cCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh----------------hhh
Q 018487          268 -SSRSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC----------------NTM  325 (355)
Q Consensus       268 -~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~----------------~~~  325 (355)
                       ........||+.|+|||++.     +..++.++||||||+++|+|++|+.||...+....                ...
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (302)
T 2j7t_A          170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWS  249 (302)
T ss_dssp             HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSC
T ss_pred             cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccC
Confidence             11223457899999999984     56789999999999999999999999987643221                112


Q ss_pred             HHHHHhhhheeeecCCCcCC
Q 018487          326 LLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ..+..+|.+||..+|.+++.
T Consensus       250 ~~l~~li~~~l~~dp~~Rps  269 (302)
T 2j7t_A          250 VEFRDFLKIALDKNPETRPS  269 (302)
T ss_dssp             HHHHHHHHHHSCSCTTTSCC
T ss_pred             HHHHHHHHHHcccChhhCCC
Confidence            34678888999888887653

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.8e-42  Score=344.48  Aligned_cols=230  Identities=19%  Similarity=0.303  Sum_probs=189.2

Q ss_pred             CCeEEE-eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          110 GDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       110 ~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      ..+.+. ++||+|+||+||+|.+..   ...++.||||+++... ......+.+.+|+.+|++++|||||++++++.. +
T Consensus       368 ~~~~l~~~~LG~G~fG~Vy~~~~~~---~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~  442 (635)
T 4fl3_A          368 KLLTLEDKELGSGNFGTVKKGYYQM---KKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-E  442 (635)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEEC---SSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred             hhccccCCEeccCCCEEEEEEEEcC---CCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            345544 489999999999997652   2456789999997654 334456778899999999999999999999875 4


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      .+++||||+++|+|.+++.....+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus       443 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~  522 (635)
T 4fl3_A          443 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  522 (635)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred             CEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence            58899999999999999998888999999999999999999999999999999999999999999999999999876433


Q ss_pred             CC----CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhhh--------------hhHHHH
Q 018487          269 SR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACN--------------TMLLFY  329 (355)
Q Consensus       269 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~~--------------~~~~~~  329 (355)
                      ..    .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||...+.....              ....+.
T Consensus       523 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~  602 (635)
T 4fl3_A          523 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY  602 (635)
T ss_dssp             ------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             ccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence            21    223356788999999999999999999999999999998 99999886433211              122567


Q ss_pred             HhhhheeeecCCCcC
Q 018487          330 LIIFHCLFVNSLELL  344 (355)
Q Consensus       330 ~~i~~~l~~~~~e~~  344 (355)
                      .+|..||..+|.+++
T Consensus       603 ~li~~cl~~dP~~RP  617 (635)
T 4fl3_A          603 DLMNLCWTYDVENRP  617 (635)
T ss_dssp             HHHHHHTCSSTTTSC
T ss_pred             HHHHHHcCCCHhHCc
Confidence            788888888888765

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=9.3e-43  Score=320.62  Aligned_cols=235  Identities=27%  Similarity=0.437  Sum_probs=197.1

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccch---hHHHHHHHHHHHHHhcC--CCccee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK---NHVDYMKAERDILTKVT--HPFIVQ  179 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--h~nIv~  179 (355)
                      .....++|++.+.||+|+||.||+|.++     .+++.||||++........   ...+.+.+|+.++++++  |+||++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~  112 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRV-----SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR  112 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEET-----TTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCC
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEEC-----CCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceE
Confidence            3445678999999999999999999976     4678899999976543221   11234567999999996  599999


Q ss_pred             cceeeecCCeEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEec-CCCcEEEE
Q 018487          180 LRYSFQTRSKLYLILDFING-GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLT  257 (355)
Q Consensus       180 l~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~-~~~~~kl~  257 (355)
                      +++++...+..++|||++.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus       113 ~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          113 LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             EEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             EEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEe
Confidence            99999999999999999986 89999999888999999999999999999999999999999999999999 78999999


Q ss_pred             ecCCccccCcCCCCCcccccCccccchhhccCCC-CCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------hhHHHH
Q 018487          258 DFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------TMLLFY  329 (355)
Q Consensus       258 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------~~~~~~  329 (355)
                      |||++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||...+.....       ....+.
T Consensus       193 Dfg~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  271 (320)
T 3a99_A          193 DFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ  271 (320)
T ss_dssp             CCTTCEECCSSC-BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHHHH
T ss_pred             eCcccccccccc-ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhcccccccccCCHHHH
Confidence            999998765433 345679999999999987765 67899999999999999999999876543321       234577


Q ss_pred             HhhhheeeecCCCcCC
Q 018487          330 LIIFHCLFVNSLELLS  345 (355)
Q Consensus       330 ~~i~~~l~~~~~e~~~  345 (355)
                      .+|.+||..+|.+++.
T Consensus       272 ~li~~~l~~dp~~Rps  287 (320)
T 3a99_A          272 HLIRWCLALRPSDRPT  287 (320)
T ss_dssp             HHHHHHTCSSGGGSCC
T ss_pred             HHHHHHccCChhhCcC
Confidence            8999999999888764

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4.8e-42  Score=312.21  Aligned_cols=231  Identities=21%  Similarity=0.303  Sum_probs=187.3

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee-ecCC
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF-QTRS  188 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~  188 (355)
                      .+|++.++||+|+||+||+|.+....  .....+|+|.+....  .....+.+.+|+.++++++||||+++++++ ..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  100 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDND--GKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  100 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-------CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred             eehhhcceeeecCCceEEEEEEecCC--CceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence            46999999999999999999876322  234568999886532  345566788999999999999999999985 5566


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      ..++||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            889999999999999999764 4589999999999999999999999999999999999999999999999999986543


Q ss_pred             CC-----CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhhHH
Q 018487          268 SS-----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTMLL  327 (355)
Q Consensus       268 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~~~  327 (355)
                      ..     ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+....              .....
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP  260 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHH
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHH
Confidence            22     1233457789999999999999999999999999999999 5666665432211              12335


Q ss_pred             HHHhhhheeeecCCCcC
Q 018487          328 FYLIIFHCLFVNSLELL  344 (355)
Q Consensus       328 ~~~~i~~~l~~~~~e~~  344 (355)
                      +..++.+||..+|.+++
T Consensus       261 l~~li~~~l~~~p~~Rp  277 (298)
T 3f66_A          261 LYEVMLKCWHPKAEMRP  277 (298)
T ss_dssp             HHHHHHHHTCSSGGGSC
T ss_pred             HHHHHHHHcCCChhhCc
Confidence            67888999998888865

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=9.7e-42  Score=315.02  Aligned_cols=202  Identities=27%  Similarity=0.472  Sum_probs=175.3

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCC------cceec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP------FIVQL  180 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~------nIv~l  180 (355)
                      +..++|++.+.||+|+||.||+|.+..    ..++.||||+++..    ....+.+.+|+.+++.++|+      +|+++
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~   82 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHK----AGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQM   82 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETT----TTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecC----CCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence            345789999999999999999998631    35788999998643    23445677899999888765      49999


Q ss_pred             ceeeecCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC--------
Q 018487          181 RYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS--------  250 (355)
Q Consensus       181 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~--------  250 (355)
                      ++++...+.+|+||||+ +++|.+++...+  .+++.+++.++.||+.||+|||++||+||||||+|||++.        
T Consensus        83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~  161 (339)
T 1z57_A           83 LEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN  161 (339)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred             ecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccC
Confidence            99999999999999999 779999988765  5899999999999999999999999999999999999987        


Q ss_pred             -----------CCcEEEEecCCccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchh
Q 018487          251 -----------DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQV  319 (355)
Q Consensus       251 -----------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~  319 (355)
                                 ++.+||+|||++......  .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus       162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  239 (339)
T 1z57_A          162 PKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS  239 (339)
T ss_dssp             ----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred             CccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                       668999999999865432  3456799999999999999999999999999999999999999987543

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.8e-42  Score=318.53  Aligned_cols=230  Identities=27%  Similarity=0.393  Sum_probs=173.2

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecceeee
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQ  185 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~  185 (355)
                      +...+|++.++||+|+||.||+|+++     .+++.||||++...   .....+.+.+|+.+++++. ||||+++++++.
T Consensus        25 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~   96 (337)
T 3ll6_A           25 LGELRLRVRRVLAEGGFAFVYEAQDV-----GSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAAS   96 (337)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEEET-----TTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             ccCceEEEEEEEccCCceEEEEEEEC-----CCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccc
Confidence            34458999999999999999999976     46788999998654   2344566788999999996 999999999983


Q ss_pred             --------cCCeEEEEEeccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCcEEecCCC
Q 018487          186 --------TRSKLYLILDFINGGHLFFHLYR---QGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDG  252 (355)
Q Consensus       186 --------~~~~~~lv~e~~~~gsL~~~l~~---~~~l~~~~~~~i~~ql~~~L~~LH~~~--iiHrDlkp~NILl~~~~  252 (355)
                              ....+++||||+. |+|.+++..   .+.+++.+++.++.||+.||.|||++|  |+||||||+|||++.++
T Consensus        97 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~  175 (337)
T 3ll6_A           97 IGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG  175 (337)
T ss_dssp             ECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS
T ss_pred             ccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC
Confidence                    4456899999996 588887764   456999999999999999999999999  99999999999999999


Q ss_pred             cEEEEecCCccccCcCCCC-------------CcccccCccccchhh---ccCCCCCcccHHHHHHHHHHHHcCCCCCCC
Q 018487          253 HVMLTDFGLAKEIDESSRS-------------NSMCGTTEYMAPEIL---LSKGHNKDADWWSVGILLYEMLTGQVNIKS  316 (355)
Q Consensus       253 ~~kl~Dfg~a~~~~~~~~~-------------~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~~l~elltg~~pf~~  316 (355)
                      .+||+|||++.........             ....||+.|+|||++   .+..++.++|||||||++|+|++|+.||..
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  255 (337)
T 3ll6_A          176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED  255 (337)
T ss_dssp             CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence            9999999999876443221             145689999999998   566788999999999999999999999986


Q ss_pred             chhhhhh-----------hhHHHHHhhhheeeecCCCcCC
Q 018487          317 MQVIACN-----------TMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       317 ~~~~~~~-----------~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      .......           ....+..+|.+||..+|.+++.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  295 (337)
T 3ll6_A          256 GAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLS  295 (337)
T ss_dssp             ----------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCC
T ss_pred             hhHHHhhcCcccCCcccccchHHHHHHHHHccCChhhCcC
Confidence            5432211           1124567888999888888763

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.3e-42  Score=311.29  Aligned_cols=226  Identities=24%  Similarity=0.434  Sum_probs=183.6

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      +.+..++|++.+.||+|+||+||+|.+.       ++.||||++....     ..+.+.+|+.++++++||||+++++++
T Consensus        16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~   83 (278)
T 1byg_A           16 WALNMKELKLLQTIGKGEFGDVMLGDYR-------GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVI   83 (278)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEET-------TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEE
T ss_pred             ccCChhhceEEeEEecCCCceEEEEEEc-------CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            4455678999999999999999999864       5679999987542     345678899999999999999999986


Q ss_pred             ec-CCeEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCC
Q 018487          185 QT-RSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (355)
Q Consensus       185 ~~-~~~~~lv~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~  261 (355)
                      .. .+.+|+||||+++++|.+++.....  +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~  163 (278)
T 1byg_A           84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL  163 (278)
T ss_dssp             CCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred             EcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccc
Confidence            54 4578999999999999999986643  89999999999999999999999999999999999999999999999999


Q ss_pred             ccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhhH
Q 018487          262 AKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTML  326 (355)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~~  326 (355)
                      +.......  ....+++.|+|||++.+..++.++||||||+++|+|+| |+.||........              ....
T Consensus       164 ~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (278)
T 1byg_A          164 TKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP  241 (278)
T ss_dssp             --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCH
T ss_pred             cccccccc--cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCH
Confidence            98654332  23457889999999999999999999999999999998 9999987533221              1123


Q ss_pred             HHHHhhhheeeecCCCcC
Q 018487          327 LFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       327 ~~~~~i~~~l~~~~~e~~  344 (355)
                      .+..+|.+||..+|.+++
T Consensus       242 ~l~~li~~~l~~~p~~Rp  259 (278)
T 1byg_A          242 AVYEVMKNCWHLDAAMRP  259 (278)
T ss_dssp             HHHHHHHHHTCSSGGGSC
T ss_pred             HHHHHHHHHhcCChhhCC
Confidence            567888899988888865

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4.1e-42  Score=313.54  Aligned_cols=231  Identities=23%  Similarity=0.395  Sum_probs=188.6

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccc-hhHHHHHHHHHHHHHhcCCCcceecceee--e
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-KNHVDYMKAERDILTKVTHPFIVQLRYSF--Q  185 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~--~  185 (355)
                      .++|++.+.||+|+||.||+|.++     .+++.||+|++....... ....+.+.+|+.+++.++||||+++++++  .
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   78 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDS-----ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE   78 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBT-----TTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC
T ss_pred             ccceeEeeEEecCCCeEEEEEEEC-----CCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence            368999999999999999999965     567889999997654322 34456788999999999999999999998  4


Q ss_pred             cCCeEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          186 TRSKLYLILDFINGGHLFFHLYR--QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      .....|+||||++++ |.+++..  ...+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        79 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           79 EKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             ---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccccc
Confidence            456899999999987 6666665  3569999999999999999999999999999999999999999999999999998


Q ss_pred             ccCcCC---CCCcccccCccccchhhccCCC--CCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hh
Q 018487          264 EIDESS---RSNSMCGTTEYMAPEILLSKGH--NKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TM  325 (355)
Q Consensus       264 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~--~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~  325 (355)
                      ......   ......||+.|+|||++.+...  +.++||||||+++|+|++|+.||...+.....             ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~  237 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCG  237 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSC
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccC
Confidence            764322   2234568999999999986443  77999999999999999999999876433211             12


Q ss_pred             HHHHHhhhheeeecCCCcCC
Q 018487          326 LLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ..+..+|.+||..+|.+++.
T Consensus       238 ~~l~~li~~~l~~dp~~Rps  257 (305)
T 2wtk_C          238 PPLSDLLKGMLEYEPAKRFS  257 (305)
T ss_dssp             HHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHHHHccCChhhCCC
Confidence            34678888999888887663

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.6e-42  Score=314.17  Aligned_cols=222  Identities=27%  Similarity=0.412  Sum_probs=181.0

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +..++|++.+.||+|+||+||+|.+.       ++.||+|++...     ...+.+.+|+.++++++||||+++++++.+
T Consensus         5 i~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   72 (307)
T 2eva_A            5 IDYKEIEVEEVVGRGAFGVVCKAKWR-------AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN   72 (307)
T ss_dssp             CCGGGEEEEEEEECCSSSEEEEEEET-------TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT
T ss_pred             CCHhHeeeeeEeecCCCceEEEEEEC-------CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence            34568999999999999999999865       466999998642     334568889999999999999999998874


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCeeccCCCCcEEecCCCc-EEEEec
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHK---CGIVHRDLKPENILMDSDGH-VMLTDF  259 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~ql~~~L~~LH~---~~iiHrDlkp~NILl~~~~~-~kl~Df  259 (355)
                        ..|+||||+++++|.+++....   .+++..+..++.|+++||.|||+   +||+||||||+|||++.++. +||+||
T Consensus        73 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Df  150 (307)
T 2eva_A           73 --PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDF  150 (307)
T ss_dssp             --TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCC
T ss_pred             --CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccc
Confidence              4799999999999999998665   37899999999999999999999   89999999999999998886 799999


Q ss_pred             CCccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh----------------hh
Q 018487          260 GLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA----------------CN  323 (355)
Q Consensus       260 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~----------------~~  323 (355)
                      |++......  .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.......                .+
T Consensus       151 g~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (307)
T 2eva_A          151 GTACDIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKN  228 (307)
T ss_dssp             CC--------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTT
T ss_pred             ccccccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccc
Confidence            999765432  233468999999999999999999999999999999999999998542111                11


Q ss_pred             hhHHHHHhhhheeeecCCCcC
Q 018487          324 TMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       324 ~~~~~~~~i~~~l~~~~~e~~  344 (355)
                      ....+..+|.+||..+|.+++
T Consensus       229 ~~~~l~~li~~~l~~dp~~Rp  249 (307)
T 2eva_A          229 LPKPIESLMTRCWSKDPSQRP  249 (307)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSC
T ss_pred             cCHHHHHHHHHHhcCChhhCc
Confidence            223567888999998888775

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.1e-41  Score=311.16  Aligned_cols=227  Identities=22%  Similarity=0.312  Sum_probs=188.1

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccc-cchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      .|...+.||+|+||.||+|.+       .++.||+|++..... ......+.+.+|+.+++.++||||+++++++...+.
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~  104 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYV-------NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDD  104 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEES-------SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ccccCCccccCCCeEEEEEEE-------CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCc
Confidence            355568999999999999984       356799999875432 234456778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          190 LYLILDFINGGHLFFHLYRQ---GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~---~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                      .++||||+++++|.+++...   ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  184 (307)
T 2nru_A          105 LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASE  184 (307)
T ss_dssp             CEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             eEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccc
Confidence            99999999999999998743   458999999999999999999999999999999999999999999999999998664


Q ss_pred             cCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh----------------------
Q 018487          267 ESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA----------------------  321 (355)
Q Consensus       267 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~----------------------  321 (355)
                      ....   .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.......                      
T Consensus       185 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (307)
T 2nru_A          185 KFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDK  263 (307)
T ss_dssp             SCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCS
T ss_pred             cccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccc
Confidence            3222   234578999999999875 48899999999999999999999998643211                      


Q ss_pred             ------hhhhHHHHHhhhheeeecCCCcCC
Q 018487          322 ------CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 ------~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                            ......+..++..||..+|.+++.
T Consensus       264 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps  293 (307)
T 2nru_A          264 KMNDADSTSVEAMYSVASQCLHEKKNKRPD  293 (307)
T ss_dssp             SCSCCCHHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             cccccchHHHHHHHHHHHHHcCCCcccCcC
Confidence                  011134567888888888877653

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.3e-42  Score=341.49  Aligned_cols=232  Identities=23%  Similarity=0.338  Sum_probs=190.1

Q ss_pred             cCCCCeEEEe-eeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          107 IGPGDFEIFR-VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       107 ~~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      +..+++.+.+ +||+|+||.||+|.++..   ..+..||||+++...  .....+.+.+|+++|++++|||||++++++.
T Consensus       332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~---~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~  406 (613)
T 2ozo_A          332 LKRDNLLIADIELGCGNFGSVRQGVYRMR---KKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ  406 (613)
T ss_dssp             CCTTSEEEEEEEEEECSSSEEEEEEEECS---SCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             ccccceeEcCcEEecCCCcEEEEEEEecC---CCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEec
Confidence            4556777777 899999999999987632   245679999997653  3344567889999999999999999999997


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      . +.+|+||||+++|+|.+++... ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       407 ~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~  485 (613)
T 2ozo_A          407 A-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKA  485 (613)
T ss_dssp             S-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred             c-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence            6 5699999999999999998754 4599999999999999999999999999999999999999999999999999987


Q ss_pred             cCcCCC----CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhh
Q 018487          265 IDESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTM  325 (355)
Q Consensus       265 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~  325 (355)
                      +.....    .....+++.|+|||++.+..++.++|||||||++|||+| |+.||...+....              ...
T Consensus       486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~  565 (613)
T 2ozo_A          486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP  565 (613)
T ss_dssp             CC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCC
T ss_pred             ccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCC
Confidence            643221    122345688999999999999999999999999999998 9999987543221              122


Q ss_pred             HHHHHhhhheeeecCCCcC
Q 018487          326 LLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~  344 (355)
                      ..+..+|.+||..+|.+++
T Consensus       566 ~~l~~li~~cl~~dP~~RP  584 (613)
T 2ozo_A          566 PELYALMSDCWIYKWEDRP  584 (613)
T ss_dssp             HHHHHHHHHTTCSSTTTSC
T ss_pred             HHHHHHHHHHcCCChhHCc
Confidence            4567888899988888765

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=7.3e-42  Score=315.29  Aligned_cols=233  Identities=25%  Similarity=0.417  Sum_probs=172.1

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHH-HHHhcCCCcceeccee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD-ILTKVTHPFIVQLRYS  183 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~nIv~l~~~  183 (355)
                      +.+..++|++++.||+|+||.||+|.++     .+++.||||++.....  ......+..|+. +++.++||||++++++
T Consensus        17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~   89 (327)
T 3aln_A           17 WDFTAEDLKDLGEIGRGAYGSVNKMVHK-----PSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGA   89 (327)
T ss_dssp             ECCCSCSEEC-CEEEECSSEEEEEEEET-----TTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEE
T ss_pred             cccCHHHhhehheeccCCCEEEEEEEEc-----CCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeE
Confidence            4566789999999999999999999976     4678899999976532  223334445555 7788899999999999


Q ss_pred             eecCCeEEEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCcEEecCCCcEEEE
Q 018487          184 FQTRSKLYLILDFINGGHLFFHLYR-----QGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMLT  257 (355)
Q Consensus       184 ~~~~~~~~lv~e~~~~gsL~~~l~~-----~~~l~~~~~~~i~~ql~~~L~~LH~~-~iiHrDlkp~NILl~~~~~~kl~  257 (355)
                      +...+..++||||+++ +|.+++..     ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+
T Consensus        90 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~  168 (327)
T 3aln_A           90 LFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLC  168 (327)
T ss_dssp             EECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEEC
T ss_pred             EEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEc
Confidence            9999999999999986 77666653     56789999999999999999999999 99999999999999999999999


Q ss_pred             ecCCccccCcCCCCCcccccCccccchhh----ccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh------------
Q 018487          258 DFGLAKEIDESSRSNSMCGTTEYMAPEIL----LSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA------------  321 (355)
Q Consensus       258 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~------------  321 (355)
                      |||++.............||+.|+|||++    .+..++.++||||||+++|+|++|+.||.......            
T Consensus       169 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  248 (327)
T 3aln_A          169 DFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP  248 (327)
T ss_dssp             CCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCC
T ss_pred             cCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCC
Confidence            99999877655444555799999999998    45678999999999999999999999998643210            


Q ss_pred             -------hhhhHHHHHhhhheeeecCCCcCC
Q 018487          322 -------CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 -------~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                             ......+..+|.+||..+|.+++.
T Consensus       249 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps  279 (327)
T 3aln_A          249 QLSNSEEREFSPSFINFVNLCLTKDESKRPK  279 (327)
T ss_dssp             CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCCcccccCCHHHHHHHHHHhhCChhhCcC
Confidence                   012335678899999988888653

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3e-42  Score=338.42  Aligned_cols=227  Identities=26%  Similarity=0.368  Sum_probs=191.3

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +..++|++.++||+|+||.||+|.+++      ...||||+++....    ..+.+.+|+.+|++++|+||+++++++..
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~  333 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNG------TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE  333 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT------TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cchhhhhhheecccCCCeEEEEEEECC------CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            445679999999999999999999762      35699999976442    23567889999999999999999999876


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                       ..+|+||||+++|+|.+++...  ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       334 -~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  412 (535)
T 2h8h_A          334 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL  412 (535)
T ss_dssp             -SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred             -ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence             6789999999999999999753  5689999999999999999999999999999999999999999999999999987


Q ss_pred             cCcCC--CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhhHH
Q 018487          265 IDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTMLL  327 (355)
Q Consensus       265 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~~~  327 (355)
                      +....  ......++..|+|||++.+..++.++|||||||+||||+| |+.||........              .....
T Consensus       413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~  492 (535)
T 2h8h_A          413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES  492 (535)
T ss_dssp             CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence            64321  1223456788999999998999999999999999999999 9999987643221              11234


Q ss_pred             HHHhhhheeeecCCCcC
Q 018487          328 FYLIIFHCLFVNSLELL  344 (355)
Q Consensus       328 ~~~~i~~~l~~~~~e~~  344 (355)
                      +..+|.+||..+|.+++
T Consensus       493 l~~li~~cl~~dP~~RP  509 (535)
T 2h8h_A          493 LHDLMCQCWRKEPEERP  509 (535)
T ss_dssp             HHHHHHHHTCSSGGGSC
T ss_pred             HHHHHHHHcCCChhHCc
Confidence            67889999999888865

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.4e-41  Score=316.53  Aligned_cols=202  Identities=27%  Similarity=0.452  Sum_probs=172.9

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ..++|++.+.||+|+||.||+|.++     .+++.||||++....  .......+.+|+.+++.++||||+++++++...
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   81 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHK-----PTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPD   81 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred             cccceEEeeEEcCCCCeEEEEEEEC-----CCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeeccc
Confidence            3578999999999999999999976     567889999986432  344456678899999999999999999887654


Q ss_pred             -----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       188 -----~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                           ...|+||||+.+ +|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        82 ~~~~~~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (353)
T 2b9h_A           82 SFENFNEVYIIQELMQT-DLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLA  159 (353)
T ss_dssp             CSTTCCCEEEEECCCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             ccCccceEEEEEeccCc-cHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccc
Confidence                 679999999975 88888765 56899999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCC-----------CCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          263 KEIDESSR-----------SNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       263 ~~~~~~~~-----------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      ........           ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  227 (353)
T 2b9h_A          160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD  227 (353)
T ss_dssp             EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            87643221           123578999999998765 678999999999999999999999998764

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-42  Score=324.55  Aligned_cols=231  Identities=20%  Similarity=0.290  Sum_probs=181.4

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee-cCC
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ-TRS  188 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~  188 (355)
                      ..|++.+.||+|+||+||+|.+....  .....||+|.++..  ......+.+.+|+.++++++||||+++++++. ..+
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~--~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  164 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDND--GKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  164 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETT--TEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSS
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCC--CcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCC
Confidence            35889999999999999999876321  23456899988653  23445677889999999999999999999864 456


Q ss_pred             eEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          189 KLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      ..|+||||+++++|.+++.... .+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus       165 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          165 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             CeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccc
Confidence            8899999999999999997654 589999999999999999999999999999999999999999999999999986533


Q ss_pred             CCC-----CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh--------------hhhhHH
Q 018487          268 SSR-----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA--------------CNTMLL  327 (355)
Q Consensus       268 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~--------------~~~~~~  327 (355)
                      ...     .....+|+.|+|||++.+..++.++|||||||++|||+| |..||...+...              ......
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~  324 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP  324 (373)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHH
T ss_pred             cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence            221     223456788999999999999999999999999999999 677887643211              112235


Q ss_pred             HHHhhhheeeecCCCcC
Q 018487          328 FYLIIFHCLFVNSLELL  344 (355)
Q Consensus       328 ~~~~i~~~l~~~~~e~~  344 (355)
                      +..++.+||..+|.+++
T Consensus       325 l~~li~~cl~~dp~~RP  341 (373)
T 3c1x_A          325 LYEVMLKCWHPKAEMRP  341 (373)
T ss_dssp             HHHHHHHHTCSSGGGSC
T ss_pred             HHHHHHHHcCCChhhCc
Confidence            67888999998888765

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=311.06  Aligned_cols=201  Identities=26%  Similarity=0.433  Sum_probs=166.7

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee---
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ---  185 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~---  185 (355)
                      .++|++++.||+|+||.||+|.++     .+++.||+|++...   .....+.+.+|+.+++.++||||+++++++.   
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   81 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDN-----DCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSG   81 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEET-----TTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTS
T ss_pred             CCceeEEEEeccCCCeEEEEEEEC-----CCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccc
Confidence            478999999999999999999976     46788999998754   3445567889999999999999999998873   


Q ss_pred             -----------cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEec-CCCc
Q 018487          186 -----------TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGH  253 (355)
Q Consensus       186 -----------~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~-~~~~  253 (355)
                                 .....|+||||++ ++|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++ .++.
T Consensus        82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~  159 (320)
T 2i6l_A           82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLV  159 (320)
T ss_dssp             CBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTE
T ss_pred             cccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCe
Confidence                       4468999999998 589888754 5789999999999999999999999999999999999997 5679


Q ss_pred             EEEEecCCccccCcC----CCCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCchh
Q 018487          254 VMLTDFGLAKEIDES----SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQV  319 (355)
Q Consensus       254 ~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~~  319 (355)
                      +||+|||++......    .......+|..|+|||++.+ ..++.++||||||+++|+|++|+.||...+.
T Consensus       160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  230 (320)
T 2i6l_A          160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE  230 (320)
T ss_dssp             EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH
Confidence            999999999876432    12234567999999999875 6789999999999999999999999987643

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.8e-42  Score=316.57  Aligned_cols=235  Identities=23%  Similarity=0.353  Sum_probs=193.7

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      .+..++|++++.||+|+||.||+|++.... ...++.||||++...   .....+.+.+|+.+++.++||||+++++++.
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  112 (326)
T 2w1i_A           37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQ-DNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY  112 (326)
T ss_dssp             CCCGGGEEEEEEEECCSSEEEEEEEECTTS-SSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             ccCHHHceeeeeeccCCCeEEEEEEecccc-CCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence            445578999999999999999999865332 246889999998753   3345567889999999999999999999887


Q ss_pred             cCC--eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          186 TRS--KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       186 ~~~--~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                      ..+  .+++||||+++++|.+++... ..+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus       113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT  192 (326)
T ss_dssp             C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence            544  789999999999999999876 45999999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCC----CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh-----------------
Q 018487          263 KEIDESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA-----------------  321 (355)
Q Consensus       263 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~-----------------  321 (355)
                      ........    .....++..|+|||++.+..++.++||||||+++|+|+||..||.......                 
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  272 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence            87654332    223456788999999998889999999999999999999999987541100                 


Q ss_pred             -------------hhhhHHHHHhhhheeeecCCCcC
Q 018487          322 -------------CNTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       322 -------------~~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                                   ......+..+|.+||..+|.+++
T Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp  308 (326)
T 2w1i_A          273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP  308 (326)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred             HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCc
Confidence                         01123567788888888887765

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-41  Score=307.20  Aligned_cols=231  Identities=21%  Similarity=0.292  Sum_probs=188.9

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      .|.+.++||+|+||+||+|.+....  ..+..||+|++....  .....+.+.+|+.+++.++||||+++++++...+..
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   97 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQA--QNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL   97 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSS--SCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             EEccCceeccCCCceEEEEEEecCC--Cceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCC
Confidence            5777899999999999999976322  344579999986532  344567788999999999999999999999866654


Q ss_pred             -EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          191 -YLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       191 -~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                       ++||||+.+++|.+++... ..+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A           98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence             9999999999999999763 56899999999999999999999999999999999999999999999999999865332


Q ss_pred             -----CCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCC-CCchhhhh--------------hhhHHH
Q 018487          269 -----SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNI-KSMQVIAC--------------NTMLLF  328 (355)
Q Consensus       269 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf-~~~~~~~~--------------~~~~~~  328 (355)
                           .......+++.|+|||.+.+..++.++||||||+++|+|++|..|| ...+....              .....+
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  257 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSL  257 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred             cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHH
Confidence                 1223456789999999999999999999999999999999965554 43322211              112356


Q ss_pred             HHhhhheeeecCCCcCC
Q 018487          329 YLIIFHCLFVNSLELLS  345 (355)
Q Consensus       329 ~~~i~~~l~~~~~e~~~  345 (355)
                      ..++.+||..+|.+++.
T Consensus       258 ~~li~~~l~~~p~~Rps  274 (298)
T 3pls_A          258 YQVMQQCWEADPAVRPT  274 (298)
T ss_dssp             HHHHHHHTCSSGGGSCC
T ss_pred             HHHHHHHccCChhhCcC
Confidence            78888999888888653

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.9e-42  Score=327.47  Aligned_cols=199  Identities=28%  Similarity=0.471  Sum_probs=156.1

Q ss_pred             CCeEE-EeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee--c
Q 018487          110 GDFEI-FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ--T  186 (355)
Q Consensus       110 ~~y~~-~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~  186 (355)
                      +.|++ .++||+|+||+||+|+++.   ...++.||||++......     ..+.+|+.+|+.++||||+++++++.  .
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~---~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~   91 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKD---GKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHA   91 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESS---SSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETT
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEcc---CCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCC
Confidence            45777 4589999999999999773   235678999998754321     34678999999999999999999994  4


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEe----cCCCc
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQ---------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM----DSDGH  253 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~---------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl----~~~~~  253 (355)
                      ...+|+||||+++ +|.+++...         ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.
T Consensus        92 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~  170 (405)
T 3rgf_A           92 DRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR  170 (405)
T ss_dssp             TTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred             CCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc
Confidence            7789999999976 676766532         248999999999999999999999999999999999999    67889


Q ss_pred             EEEEecCCccccCcC----CCCCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          254 VMLTDFGLAKEIDES----SRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       254 ~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      +||+|||+++.+...    ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...
T Consensus       171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  239 (405)
T 3rgf_A          171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  239 (405)
T ss_dssp             EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence            999999999876432    223456899999999999874 5899999999999999999999999754

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-42  Score=316.88  Aligned_cols=232  Identities=28%  Similarity=0.441  Sum_probs=187.6

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccch---hHHHHHHHHHHHHHhc----CCCcceec
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK---NHVDYMKAERDILTKV----THPFIVQL  180 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l----~h~nIv~l  180 (355)
                      ..++|++.+.||+|+||.||+|.++     .+++.||||++........   .....+.+|+.+++++    +|+||+++
T Consensus        29 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~  103 (312)
T 2iwi_A           29 FEAEYRLGPLLGKGGFGTVFAGHRL-----TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL  103 (312)
T ss_dssp             ----CEEEEEEEEETTEEEEEEECT-----TTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred             hhhceEEeeEEEcCCCEEEEEEEEc-----cCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence            3468999999999999999999865     4678899999976543221   1222355689999988    89999999


Q ss_pred             ceeeecCCeEEEEEec-cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEec-CCCcEEEEe
Q 018487          181 RYSFQTRSKLYLILDF-INGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTD  258 (355)
Q Consensus       181 ~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~-~~~~~kl~D  258 (355)
                      ++++...+..++|||+ +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus       104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~d  183 (312)
T 2iwi_A          104 LDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLID  183 (312)
T ss_dssp             EEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECC
T ss_pred             EEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEE
Confidence            9999999999999999 78999999999888899999999999999999999999999999999999999 889999999


Q ss_pred             cCCccccCcCCCCCcccccCccccchhhccCCCC-CcccHHHHHHHHHHHHcCCCCCCCchhhhh-------hhhHHHHH
Q 018487          259 FGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN-KDADWWSVGILLYEMLTGQVNIKSMQVIAC-------NTMLLFYL  330 (355)
Q Consensus       259 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~elltg~~pf~~~~~~~~-------~~~~~~~~  330 (355)
                      ||++....... .....|+..|+|||++.+..+. .++||||||+++|+|++|+.||...+....       .....+..
T Consensus       184 fg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  262 (312)
T 2iwi_A          184 FGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPDCCA  262 (312)
T ss_dssp             CSSCEECCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHTCCCCCTTSCHHHHH
T ss_pred             cchhhhcccCc-ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhhhccCCcccCCHHHHH
Confidence            99998765433 3456799999999999877664 489999999999999999999987644322       12335678


Q ss_pred             hhhheeeecCCCcCC
Q 018487          331 IIFHCLFVNSLELLS  345 (355)
Q Consensus       331 ~i~~~l~~~~~e~~~  345 (355)
                      +|.+||..+|.+++.
T Consensus       263 li~~~l~~~p~~Rps  277 (312)
T 2iwi_A          263 LIRRCLAPKPSSRPS  277 (312)
T ss_dssp             HHHHHTCSSTTTSCC
T ss_pred             HHHHHccCChhhCcC
Confidence            899999998888754

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.2e-42  Score=319.70  Aligned_cols=197  Identities=21%  Similarity=0.379  Sum_probs=161.5

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHH--HHHHHHHhcCCCcceeccee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK--AERDILTKVTHPFIVQLRYS  183 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~--~E~~~l~~l~h~nIv~l~~~  183 (355)
                      .+..++|++.+.||+|+||.||+|++.       ++.||||++.....      ..+.  .|+..+..++|+||+++++.
T Consensus         9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~   75 (336)
T 3g2f_A            9 SLDLDNLKLLELIGRGRYGAVYKGSLD-------ERPVAVKVFSFANR------QNFINEKNIYRVPLMEHDNIARFIVG   75 (336)
T ss_dssp             CCCTTSEEEEEEEEECSSEEEEEEEET-------TEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred             CcChHHhheeeecccCCCeEEEEEEEC-------CeEEEEEEeeccch------hhHHHHHHHHHHHhccCcchhhheec
Confidence            455689999999999999999999753       57899999875431      2222  34444556899999999875


Q ss_pred             ee-----cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CCeeccCCCCcEEec
Q 018487          184 FQ-----TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC---------GIVHRDLKPENILMD  249 (355)
Q Consensus       184 ~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~---------~iiHrDlkp~NILl~  249 (355)
                      +.     ....+|+||||+++|+|.+++.... .++..+..++.||+.||.|||++         ||+||||||+|||++
T Consensus        76 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~  154 (336)
T 3g2f_A           76 DERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK  154 (336)
T ss_dssp             EEEECTTSCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEEC
T ss_pred             ccccccCCCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEc
Confidence            43     3346899999999999999997654 48999999999999999999999         999999999999999


Q ss_pred             CCCcEEEEecCCccccCcCC---------CCCcccccCccccchhhcc-------CCCCCcccHHHHHHHHHHHHcCCCC
Q 018487          250 SDGHVMLTDFGLAKEIDESS---------RSNSMCGTTEYMAPEILLS-------KGHNKDADWWSVGILLYEMLTGQVN  313 (355)
Q Consensus       250 ~~~~~kl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~~l~elltg~~p  313 (355)
                      .++.+||+|||++..+....         .....+||+.|+|||++.+       ..++.++|||||||++|||++|..|
T Consensus       155 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p  234 (336)
T 3g2f_A          155 NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD  234 (336)
T ss_dssp             TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGG
T ss_pred             CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCc
Confidence            99999999999998764321         1234579999999999986       3556789999999999999999887


Q ss_pred             CCC
Q 018487          314 IKS  316 (355)
Q Consensus       314 f~~  316 (355)
                      |..
T Consensus       235 ~~~  237 (336)
T 3g2f_A          235 LFP  237 (336)
T ss_dssp             GST
T ss_pred             CCC
Confidence            744

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.4e-41  Score=328.65  Aligned_cols=225  Identities=21%  Similarity=0.295  Sum_probs=187.6

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCC-cceecceeeecC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP-FIVQLRYSFQTR  187 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-nIv~l~~~~~~~  187 (355)
                      .++|+++++||+|+||.||+|.+.     .+++.||||++.......     .+.+|+.+++.++|. +|..+..++...
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAvK~~~~~~~~~-----~~~~E~~il~~L~~~~~i~~i~~~~~~~   75 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKHP-----QLLYESKIYRILQGGTGIPNVRWFGVEG   75 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEET-----TTCCEEEEEEEETTCSSC-----CHHHHHHHHHHTTTSTTCCCEEEEEEET
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEEC-----CCCcEEEEEEeccccccH-----HHHHHHHHHHHhcCCCCCCeEEEEEeeC
Confidence            478999999999999999999976     467889999887554322     366799999999875 555555666778


Q ss_pred             CeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEe---cCCCcEEEEecCCcc
Q 018487          188 SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHVMLTDFGLAK  263 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl---~~~~~~kl~Dfg~a~  263 (355)
                      +..++||||+ +++|.+++.. ...+++.+++.|+.||+.||.|||++||+||||||+||||   +.++.+||+|||+++
T Consensus        76 ~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~  154 (483)
T 3sv0_A           76 DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (483)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             CEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence            8899999999 8899999875 4579999999999999999999999999999999999999   688999999999998


Q ss_pred             ccCcCCC--------CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh--------------
Q 018487          264 EIDESSR--------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA--------------  321 (355)
Q Consensus       264 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~--------------  321 (355)
                      .+.....        ....+||+.|+|||++.+..++.++|||||||+||||++|+.||.......              
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (483)
T 3sv0_A          155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA  234 (483)
T ss_dssp             ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH
T ss_pred             eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc
Confidence            7654332        225679999999999999999999999999999999999999998743210              


Q ss_pred             -------hhhhHHHHHhhhheeeecCCCcC
Q 018487          322 -------CNTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       322 -------~~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                             ......+..+|..||..+|.+++
T Consensus       235 ~~~~~l~~~~p~~l~~li~~cl~~dP~~RP  264 (483)
T 3sv0_A          235 TSIEALCRGYPTEFASYFHYCRSLRFDDKP  264 (483)
T ss_dssp             SCHHHHHTTSCHHHHHHHHHHHTCCTTCCC
T ss_pred             ccHHHHhcCCcHHHHHHHHHHhcCChhhCc
Confidence                   11123567888899998888875

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=316.47  Aligned_cols=199  Identities=30%  Similarity=0.466  Sum_probs=170.0

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|.+.+.||+|+||.||+|.++     .+++.||||++.... ......+.+.+|+.+++.++||||+++++++....
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   96 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDK-----RSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS   96 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             CceEEEeeeEecCCCeEEEEEEEC-----CCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEeccc
Confidence            368999999999999999999976     567899999987643 23445567889999999999999999999998765


Q ss_pred             e------EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          189 K------LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       189 ~------~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                      .      +|+||||+++ +|.+++.  ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A           97 SLRNFYDFYLVMPFMQT-DLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             SGGGCCCCEEEEECCSE-EGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             ccccceeEEEEeccccC-CHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccc
Confidence            3      5999999984 7876664  35899999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCCCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          263 KEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      ......  .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+
T Consensus       174 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  228 (353)
T 3coi_A          174 RHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD  228 (353)
T ss_dssp             TC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred             cCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            875433  334578999999999987 678999999999999999999999998764

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.9e-42  Score=320.43  Aligned_cols=229  Identities=26%  Similarity=0.410  Sum_probs=193.4

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchh--------------HHHHHHHHHHHHHhcC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN--------------HVDYMKAERDILTKVT  173 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~--------------~~~~~~~E~~~l~~l~  173 (355)
                      ..++|++.+.||+|+||.||+|.+       +++.||||++.........              ..+.+.+|+.++++++
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  101 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEK-------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK  101 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEE-------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEc-------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC
Confidence            347899999999999999999996       4678999999765432221              1267889999999999


Q ss_pred             CCcceecceeeecCCeEEEEEeccCCCChHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCC
Q 018487          174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFH------LYR--QGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPE  244 (355)
Q Consensus       174 h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~------l~~--~~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDlkp~  244 (355)
                      ||||+++++++...+.+|+||||+++++|.++      +..  ...+++..++.++.|++.||.|||+ +||+||||||+
T Consensus       102 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~  181 (348)
T 2pml_X          102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS  181 (348)
T ss_dssp             CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGG
T ss_pred             CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChH
Confidence            99999999999999999999999999999888      655  5679999999999999999999999 99999999999


Q ss_pred             cEEecCCCcEEEEecCCccccCcCCCCCcccccCccccchhhccC-CCCC-cccHHHHHHHHHHHHcCCCCCCCchhh-h
Q 018487          245 NILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK-GHNK-DADWWSVGILLYEMLTGQVNIKSMQVI-A  321 (355)
Q Consensus       245 NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwSlG~~l~elltg~~pf~~~~~~-~  321 (355)
                      |||++.++.+||+|||++...... ......|++.|+|||++.+. .++. ++||||||+++|+|++|+.||...... .
T Consensus       182 Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  260 (348)
T 2pml_X          182 NILMDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE  260 (348)
T ss_dssp             GEEECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred             hEEEcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence            999999999999999999876443 33456789999999999877 5666 999999999999999999999875330 0


Q ss_pred             --------------------------------hhhhHHHHHhhhheeeecCCCcC
Q 018487          322 --------------------------------CNTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       322 --------------------------------~~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                                                      ......+..+|.+||..+|.+++
T Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  315 (348)
T 2pml_X          261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI  315 (348)
T ss_dssp             HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSC
T ss_pred             HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCC
Confidence                                            11234567788888888887765

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.1e-41  Score=312.93  Aligned_cols=200  Identities=25%  Similarity=0.431  Sum_probs=171.5

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc------ceecc
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF------IVQLR  181 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~l~  181 (355)
                      ..++|++.+.||+|+||+||+|.++.    ..++.||+|+++..    ....+.+.+|+.+++.++|++      ++.++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~   88 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHA----RGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMS   88 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETT----TTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecC----CCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence            35789999999999999999999762    22368999998743    233456778999999987665      88899


Q ss_pred             eeeecCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEe-----------
Q 018487          182 YSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM-----------  248 (355)
Q Consensus       182 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl-----------  248 (355)
                      +++...+.+|+||||+. ++|.+++....  .+++.+++.++.||+.||.|||++||+||||||+|||+           
T Consensus        89 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~  167 (355)
T 2eu9_A           89 DWFNFHGHMCIAFELLG-KNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNE  167 (355)
T ss_dssp             EEEEETTEEEEEEECCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECC
T ss_pred             eeeeeCCeEEEEEeccC-CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccc
Confidence            99999999999999995 56666666553  69999999999999999999999999999999999999           


Q ss_pred             --------cCCCcEEEEecCCccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          249 --------DSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       249 --------~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                              +.++.+||+|||++......  .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (355)
T 2eu9_A          168 HKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE  243 (355)
T ss_dssp             C-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence                    56789999999999865432  345679999999999999999999999999999999999999998754

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-41  Score=312.21  Aligned_cols=222  Identities=26%  Similarity=0.388  Sum_probs=179.2

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHh--cCCCcceecceeeecC
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK--VTHPFIVQLRYSFQTR  187 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~  187 (355)
                      ++|++.++||+|+||.||+|+++       ++.||||++.....      ....+|..++..  ++||||+++++++...
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~  103 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKWR-------GEKVAVKVFFTTEE------ASWFRETEIYQTVLMRHENILGFIAADIKG  103 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEET-------TEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred             cceEEEeEeecCCCeEEEEEEEC-------CceEEEEEEecccc------chhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence            57999999999999999999864       57799999864321      223345555544  4899999999998876


Q ss_pred             ----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeeccCCCCcEEecCCCcEE
Q 018487          188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC--------GIVHRDLKPENILMDSDGHVM  255 (355)
Q Consensus       188 ----~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~--------~iiHrDlkp~NILl~~~~~~k  255 (355)
                          ..+|+||||+++++|.+++... .+++..++.++.|++.||.|||++        ||+||||||+|||++.++.+|
T Consensus       104 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          104 TGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             CGGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             CCCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence                7899999999999999999654 689999999999999999999999        999999999999999999999


Q ss_pred             EEecCCccccCcCCCC-----CcccccCccccchhhccCCCCCc------ccHHHHHHHHHHHHcC----------CCCC
Q 018487          256 LTDFGLAKEIDESSRS-----NSMCGTTEYMAPEILLSKGHNKD------ADWWSVGILLYEMLTG----------QVNI  314 (355)
Q Consensus       256 l~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~------~DiwSlG~~l~elltg----------~~pf  314 (355)
                      |+|||++..+......     ...+||+.|+|||++.+..+...      +|||||||++|||+||          +.||
T Consensus       183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~  262 (337)
T 3mdy_A          183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY  262 (337)
T ss_dssp             ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence            9999999766433221     24579999999999988776665      9999999999999999          7777


Q ss_pred             CCchhhh-------------------------hhhhHHHHHhhhheeeecCCCcCC
Q 018487          315 KSMQVIA-------------------------CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       315 ~~~~~~~-------------------------~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      .......                         ......+..+|.+||..+|.+++.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps  318 (337)
T 3mdy_A          263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT  318 (337)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCC
T ss_pred             hhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCC
Confidence            6531100                         012234678899999999888753

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.6e-41  Score=308.74  Aligned_cols=230  Identities=27%  Similarity=0.416  Sum_probs=187.1

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC--CCcceecceee
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT--HPFIVQLRYSF  184 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~  184 (355)
                      +..++|++++.||+|+||.||+|.+.      .++.||||++..... .....+.+.+|+.++++++  |+||+++++++
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~   97 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE   97 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECT------TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcC------CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence            44568999999999999999999864      367899999976543 3445677889999999997  59999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      ...+.+|+||| +.+++|.+++.....+++.+++.++.|++.||.|||++||+||||||+|||++ ++.+||+|||++..
T Consensus        98 ~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~  175 (313)
T 3cek_A           98 ITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ  175 (313)
T ss_dssp             ECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred             ecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccc
Confidence            99999999999 55789999999888999999999999999999999999999999999999996 58999999999987


Q ss_pred             cCcCCC---CCcccccCccccchhhcc-----------CCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh---------
Q 018487          265 IDESSR---SNSMCGTTEYMAPEILLS-----------KGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA---------  321 (355)
Q Consensus       265 ~~~~~~---~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~---------  321 (355)
                      ......   .....||+.|+|||++.+           ..++.++||||||+++|+|++|+.||.......         
T Consensus       176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  255 (313)
T 3cek_A          176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP  255 (313)
T ss_dssp             --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred             ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhc
Confidence            644322   234578999999999875           467889999999999999999999998642111         


Q ss_pred             -------hhhhHHHHHhhhheeeecCCCcCC
Q 018487          322 -------CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 -------~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                             ......+..+|.+||..+|.+++.
T Consensus       256 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps  286 (313)
T 3cek_A          256 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRIS  286 (313)
T ss_dssp             TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCC
T ss_pred             ccccCCcccchHHHHHHHHHHccCCcccCcC
Confidence                   011234677888898888887653

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=5.9e-41  Score=316.07  Aligned_cols=198  Identities=26%  Similarity=0.460  Sum_probs=172.0

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CC-----cceecce
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HP-----FIVQLRY  182 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----nIv~l~~  182 (355)
                      .++|++.+.||+|+||+||+|.++     .+++.||||+++..    ......+.+|+.+++.++ |+     +|+++++
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~  123 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDR-----VEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR  123 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEET-----TTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEc-----CCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence            478999999999999999999976     56788999999743    233455677888888875 55     4899999


Q ss_pred             eeecCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCCeeccCCCCcEEec--CCCcEEE
Q 018487          183 SFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLH--KCGIVHRDLKPENILMD--SDGHVML  256 (355)
Q Consensus       183 ~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH--~~~iiHrDlkp~NILl~--~~~~~kl  256 (355)
                      ++...+.+|+||||+++ +|.+++...  ..+++..++.++.|++.||.|||  +.||+||||||+|||++  .++.+||
T Consensus       124 ~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL  202 (382)
T 2vx3_A          124 HFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKI  202 (382)
T ss_dssp             EEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred             eeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEE
Confidence            99999999999999975 898988765  45899999999999999999999  57999999999999995  4778999


Q ss_pred             EecCCccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          257 TDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       257 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      +|||+++.....  ....+||+.|+|||++.+..++.++|||||||++|||+||+.||...+
T Consensus       203 ~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          203 VDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             CCCTTCEETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EeccCceecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999876433  345679999999999999999999999999999999999999998754

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2e-41  Score=307.43  Aligned_cols=228  Identities=25%  Similarity=0.369  Sum_probs=186.2

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|.....||+|+||.||+|.+.     .+++.||+|++....   ....+.+.+|+.+++.++||||+++++++...+.
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   93 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDL-----SNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF   93 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEET-----TTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             cCCCCcEEEeecCcEEEEEEEEC-----CCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence            34555568999999999999976     467789999987643   2344668889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC-CCcEEEEecCCcccc
Q 018487          190 LYLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKEI  265 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~-~~~~kl~Dfg~a~~~  265 (355)
                      .++||||+++++|.+++....   .+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~  173 (295)
T 2clq_A           94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL  173 (295)
T ss_dssp             EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred             EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence            999999999999999987652   4678999999999999999999999999999999999987 899999999999876


Q ss_pred             CcCC-CCCcccccCccccchhhccCC--CCCcccHHHHHHHHHHHHcCCCCCCCchhhh----------------hhhhH
Q 018487          266 DESS-RSNSMCGTTEYMAPEILLSKG--HNKDADWWSVGILLYEMLTGQVNIKSMQVIA----------------CNTML  326 (355)
Q Consensus       266 ~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~~l~elltg~~pf~~~~~~~----------------~~~~~  326 (355)
                      .... ......|++.|+|||++.+..  ++.++||||||+++|+|++|+.||.......                .....
T Consensus       174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (295)
T 2clq_A          174 AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSA  253 (295)
T ss_dssp             CC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCH
T ss_pred             CCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCH
Confidence            4322 234557899999999997643  7899999999999999999999997542111                11123


Q ss_pred             HHHHhhhheeeecCCCcCC
Q 018487          327 LFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       327 ~~~~~i~~~l~~~~~e~~~  345 (355)
                      .+..+|.+||..+|.+++.
T Consensus       254 ~~~~li~~~l~~dp~~Rps  272 (295)
T 2clq_A          254 EAKAFILKCFEPDPDKRAC  272 (295)
T ss_dssp             HHHHHHHHTTCSSTTTSCC
T ss_pred             HHHHHHHHHccCChhhCCC
Confidence            4567888888888877653

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.9e-41  Score=316.47  Aligned_cols=198  Identities=25%  Similarity=0.424  Sum_probs=169.7

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-----------CCc
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-----------HPF  176 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~n  176 (355)
                      ..++|++.+.||+|+||+||+|.++     .+++.||||++....    ...+.+.+|+.++++++           |+|
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~   87 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDM-----VNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANH   87 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEec-----CCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccch
Confidence            4568999999999999999999976     567889999987532    23455778999888876           899


Q ss_pred             ceecceeeecCC----eEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCcEEec
Q 018487          177 IVQLRYSFQTRS----KLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMD  249 (355)
Q Consensus       177 Iv~l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~-~iiHrDlkp~NILl~  249 (355)
                      |+++++++...+    .+++||||+ +++|.+++...  ..+++..++.++.||+.||.|||++ ||+||||||+|||++
T Consensus        88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~  166 (373)
T 1q8y_A           88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME  166 (373)
T ss_dssp             BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEE
T ss_pred             HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEe
Confidence            999999998654    799999999 88999998764  4599999999999999999999998 999999999999994


Q ss_pred             ------CCCcEEEEecCCccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          250 ------SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       250 ------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                            ..+.+||+|||++......  .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus       167 ~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  238 (373)
T 1q8y_A          167 IVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD  238 (373)
T ss_dssp             EEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             ccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence                  3448999999999876543  33457899999999999999999999999999999999999999864

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.7e-41  Score=308.19  Aligned_cols=230  Identities=28%  Similarity=0.414  Sum_probs=171.5

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|++++.||+|+||.||+|.++     .+++.||||++..... .....+.+.++..+++.++||||+++++++...+
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~   97 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFR-----KTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT   97 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEET-----TTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             hccccccceeeecCCeeEEEEEEe-----cCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence            458999999999999999999976     4678899999976542 2233344555666788899999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          189 KLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~~-~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                      .+|+||||+ ++.+..+... ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++....
T Consensus        98 ~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  176 (318)
T 2dyl_A           98 DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV  176 (318)
T ss_dssp             EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence            999999999 4455544443 46799999999999999999999995 99999999999999999999999999998765


Q ss_pred             cCCCCCcccccCccccchhhc-----cCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-----------------hh
Q 018487          267 ESSRSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-----------------NT  324 (355)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-----------------~~  324 (355)
                      .........||+.|+|||++.     +..++.++||||||+++|+|++|+.||........                 ..
T Consensus       177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (318)
T 2dyl_A          177 DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGF  256 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCC
T ss_pred             CCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCC
Confidence            554455667999999999994     45688999999999999999999999986321100                 11


Q ss_pred             hHHHHHhhhheeeecCCCcCC
Q 018487          325 MLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       325 ~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ...+..+|.+||..+|.+++.
T Consensus       257 ~~~l~~li~~~l~~dp~~Rps  277 (318)
T 2dyl_A          257 SGDFQSFVKDCLTKDHRKRPK  277 (318)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCC
T ss_pred             CHHHHHHHHHHccCChhHCcC
Confidence            235678888899888887653

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=5.9e-41  Score=304.96  Aligned_cols=224  Identities=29%  Similarity=0.460  Sum_probs=179.8

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec---
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT---  186 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~---  186 (355)
                      ++|++++.||+|+||.||+|.+.     .+++.||||++...    ....+.+.+|+.+++.++||||+++++++..   
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   76 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNA-----LDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRN   76 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCC
T ss_pred             ccchhhheeccCCcEEEEEEEEc-----CCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcc
Confidence            47999999999999999999976     46788999998643    3445678889999999999999999998754   


Q ss_pred             ----------CCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEE
Q 018487          187 ----------RSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM  255 (355)
Q Consensus       187 ----------~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~k  255 (355)
                                .+..|+||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus        77 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~k  156 (303)
T 1zy4_A           77 FVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVK  156 (303)
T ss_dssp             CCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEE
T ss_pred             hhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEE
Confidence                      457899999999999999998654 578899999999999999999999999999999999999999999


Q ss_pred             EEecCCccccCcC---------------CCCCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCchh
Q 018487          256 LTDFGLAKEIDES---------------SRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSMQV  319 (355)
Q Consensus       256 l~Dfg~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~~~  319 (355)
                      |+|||++......               .......||+.|+|||++.+. .++.++|||||||++|+|++   ||.....
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~  233 (303)
T 1zy4_A          157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME  233 (303)
T ss_dssp             ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred             EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence            9999999865422               112345689999999999864 68999999999999999998   5553211


Q ss_pred             hh------------------hhhhHHHHHhhhheeeecCCCcCC
Q 018487          320 IA------------------CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       320 ~~------------------~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ..                  ......+..+|.+||..+|.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps  277 (303)
T 1zy4_A          234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPG  277 (303)
T ss_dssp             HHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCC
T ss_pred             HHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcC
Confidence            10                  011123577888888888887653

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.5e-41  Score=314.64  Aligned_cols=224  Identities=29%  Similarity=0.456  Sum_probs=163.5

Q ss_pred             CCCeEEEe-eeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec-
Q 018487          109 PGDFEIFR-VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-  186 (355)
Q Consensus       109 ~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-  186 (355)
                      .++|++.+ .||+|+||+||+|.++     .+++.||||++....       ....+....++.+.||||+++++++.. 
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~   94 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHR-----RTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENM   94 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEEC-----CCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhc
Confidence            35899965 5999999999999977     567889999986532       112223345677899999999999876 


Q ss_pred             ---CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC---CCcEEEEe
Q 018487          187 ---RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTD  258 (355)
Q Consensus       187 ---~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~---~~~~kl~D  258 (355)
                         ...+++||||+++|+|.+++....  .+++.+++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|
T Consensus        95 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~D  174 (336)
T 3fhr_A           95 HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTD  174 (336)
T ss_dssp             ETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             cCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEec
Confidence               556899999999999999998764  5999999999999999999999999999999999999976   44599999


Q ss_pred             cCCccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh----------------
Q 018487          259 FGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC----------------  322 (355)
Q Consensus       259 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~----------------  322 (355)
                      ||++....... ....+||+.|+|||++.+..++.++||||||+++|+|++|+.||........                
T Consensus       175 fg~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  253 (336)
T 3fhr_A          175 FGFAKETTQNA-LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFP  253 (336)
T ss_dssp             CTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCC
T ss_pred             cccceeccccc-cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccC
Confidence            99998765332 3456789999999999888899999999999999999999999976532211                


Q ss_pred             -----hhhHHHHHhhhheeeecCCCcCC
Q 018487          323 -----NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       323 -----~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                           .....+..+|.+||..+|.+++.
T Consensus       254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt  281 (336)
T 3fhr_A          254 NPEWSEVSEDAKQLIRLLLKTDPTERLT  281 (336)
T ss_dssp             TTTSTTCCHHHHHHHHHHSCSSGGGSCC
T ss_pred             chhhccCCHHHHHHHHHHCCCChhHCcC
Confidence                 12335677888999888887653

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=7.6e-42  Score=313.74  Aligned_cols=230  Identities=23%  Similarity=0.350  Sum_probs=187.3

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      +.+..++|++.+.||+|+||.||+|.+++        .+|+|++..... .....+.+.+|+.++++++|+||+++++++
T Consensus        28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--------~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   98 (319)
T 2y4i_B           28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG--------EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGAC   98 (319)
T ss_dssp             SSSCCSCEECCCBCCCSSSSEEEEEEESS--------SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEE
T ss_pred             ccCCHHHeEEeeEeccCCceEEEEEEEcC--------eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence            45667899999999999999999998752        399999875432 222234466799999999999999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      ...+.+++||||+++++|.+++...+ .+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.
T Consensus        99 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~  177 (319)
T 2y4i_B           99 MSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFS  177 (319)
T ss_dssp             ECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred             ecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcc
Confidence            99999999999999999999997755 689999999999999999999999999999999999997 7899999999987


Q ss_pred             ccCc------CCCCCcccccCccccchhhcc---------CCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh------
Q 018487          264 EIDE------SSRSNSMCGTTEYMAPEILLS---------KGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC------  322 (355)
Q Consensus       264 ~~~~------~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~------  322 (355)
                      ....      ........|++.|+|||++.+         ..++.++||||||+++|+|++|+.||........      
T Consensus       178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~  257 (319)
T 2y4i_B          178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT  257 (319)
T ss_dssp             ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHT
T ss_pred             ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc
Confidence            5432      112234468999999999874         3578899999999999999999999987643321      


Q ss_pred             ---------hhhHHHHHhhhheeeecCCCcC
Q 018487          323 ---------NTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       323 ---------~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                               .....+..+|.+||..+|.+++
T Consensus       258 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  288 (319)
T 2y4i_B          258 GMKPNLSQIGMGKEISDILLFCWAFEQEERP  288 (319)
T ss_dssp             TCCCCCCCSSCCTTHHHHHHHHHCSSTTTSC
T ss_pred             CCCCCCCcCCCCHHHHHHHHHHhcCChhhCc
Confidence                     1123567888899988888765

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=8.2e-41  Score=335.08  Aligned_cols=235  Identities=22%  Similarity=0.343  Sum_probs=192.6

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      ..+..++|++.+.||+|+||.||+|.++...  ..+..||+|++....  .....+.+.+|+.++++++||||+++++++
T Consensus       385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  460 (656)
T 2j0j_A          385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPE--NPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVI  460 (656)
T ss_dssp             TBCCGGGEEEEEEEECCSSCCEEEEEECCSS--SCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccccEEEeeEEeeCCCEEEEEEEEecCC--CccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            3455678999999999999999999987432  345679999886542  344556788999999999999999999998


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      .+ +..|+||||+++|+|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       461 ~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          461 TE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             CS-SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             ec-CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCe
Confidence            54 56899999999999999998654 68999999999999999999999999999999999999999999999999998


Q ss_pred             ccCcCCC--CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhhH
Q 018487          264 EIDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTML  326 (355)
Q Consensus       264 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~~  326 (355)
                      .......  .....+|+.|+|||++.+..++.++|||||||++|||++ |..||...+....              +...
T Consensus       540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  619 (656)
T 2j0j_A          540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP  619 (656)
T ss_dssp             SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCH
T ss_pred             ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccH
Confidence            7644332  223456789999999998999999999999999999997 9999987543221              1123


Q ss_pred             HHHHhhhheeeecCCCcC
Q 018487          327 LFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       327 ~~~~~i~~~l~~~~~e~~  344 (355)
                      .+..+|.+||..+|.+++
T Consensus       620 ~l~~li~~~l~~dP~~RP  637 (656)
T 2j0j_A          620 TLYSLMTKCWAYDPSRRP  637 (656)
T ss_dssp             HHHHHHHHHTCSSGGGSC
T ss_pred             HHHHHHHHHcCCChhHCc
Confidence            567788888888888765

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.1e-40  Score=309.03  Aligned_cols=222  Identities=27%  Similarity=0.424  Sum_probs=184.1

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHh--cCCCcceecceeeecC
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK--VTHPFIVQLRYSFQTR  187 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~  187 (355)
                      ++|++.+.||+|+||.||+|.+.       ++.||||++....      ...+.+|.++++.  ++||||+++++++...
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKWR-------GEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEET-------TEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             ccEEEEeeecCCCCcEEEEEEEc-------CccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            47999999999999999999863       6789999986432      2446678888887  7899999999999876


Q ss_pred             C----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCCeeccCCCCcEEecCCCcEE
Q 018487          188 S----KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIVHRDLKPENILMDSDGHVM  255 (355)
Q Consensus       188 ~----~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH--------~~~iiHrDlkp~NILl~~~~~~k  255 (355)
                      .    .+|+||||+++++|.+++.. ..+++.+++.++.|++.||.|||        ++||+||||||+|||++.++.+|
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~k  187 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  187 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEE
T ss_pred             CCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEE
Confidence            5    89999999999999999975 46899999999999999999999        89999999999999999999999


Q ss_pred             EEecCCccccCcCC-----CCCcccccCccccchhhccCC------CCCcccHHHHHHHHHHHHcC----------CCCC
Q 018487          256 LTDFGLAKEIDESS-----RSNSMCGTTEYMAPEILLSKG------HNKDADWWSVGILLYEMLTG----------QVNI  314 (355)
Q Consensus       256 l~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwSlG~~l~elltg----------~~pf  314 (355)
                      |+|||++.......     ......||+.|+|||++.+..      ++.++|||||||++|||+||          +.||
T Consensus       188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~  267 (342)
T 1b6c_B          188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  267 (342)
T ss_dssp             ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence            99999998765433     234557999999999998653      23689999999999999999          8899


Q ss_pred             CCchhh-------h------------------hhhhHHHHHhhhheeeecCCCcCC
Q 018487          315 KSMQVI-------A------------------CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       315 ~~~~~~-------~------------------~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ......       .                  ......+..++.+||..+|.+++.
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps  323 (342)
T 1b6c_B          268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT  323 (342)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCC
T ss_pred             cccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCC
Confidence            764210       0                  011235678889999988888653

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.3e-40  Score=298.97  Aligned_cols=204  Identities=15%  Similarity=0.167  Sum_probs=175.2

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +..++|++.+.||+|+||.||+|.+.     ..++.||||++...........+.+.+|+.++++++||||+++++++..
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~  102 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDT-----ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT  102 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEET-----TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEec-----CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE
Confidence            34478999999999999999999976     5678899999987765556666788899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                      .+..|+||||++|++|.+++.. + ....++..++.|++.||.|||++||+||||||+|||++.+|.+||+++|      
T Consensus       103 ~~~~~lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------  174 (286)
T 3uqc_A          103 RAGGLVVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------  174 (286)
T ss_dssp             TTEEEEEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred             CCcEEEEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc------
Confidence            9999999999999999999854 3 4666789999999999999999999999999999999999999998544      


Q ss_pred             cCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh--------------------hhhhH
Q 018487          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA--------------------CNTML  326 (355)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~--------------------~~~~~  326 (355)
                                   |++       .++.++|||||||++|+|+||+.||...+...                    .....
T Consensus       175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T 3uqc_A          175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPF  234 (286)
T ss_dssp             -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCH
T ss_pred             -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCH
Confidence                         333       36889999999999999999999998753211                    12334


Q ss_pred             HHHHhhhheeeecCCCc
Q 018487          327 LFYLIIFHCLFVNSLEL  343 (355)
Q Consensus       327 ~~~~~i~~~l~~~~~e~  343 (355)
                      .+..+|.+||..+|.++
T Consensus       235 ~l~~li~~~l~~dP~~R  251 (286)
T 3uqc_A          235 QISAVAARSVQGDGGIR  251 (286)
T ss_dssp             HHHHHHHHHHCTTSSCC
T ss_pred             HHHHHHHHHcccCCccC
Confidence            57889999999999886

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.5e-40  Score=335.32  Aligned_cols=226  Identities=23%  Similarity=0.342  Sum_probs=187.1

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +..++|++.++||+|+||+||+|.++.    .+++.||||++....  .....+.+.+|+.++++++||||+++++++..
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~----~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  150 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRN----VNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEH  150 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGG----GTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcC----CCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEee
Confidence            345789999999999999999999762    146789999986532  34455678889999999999999999999987


Q ss_pred             CCe-----EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCC
Q 018487          187 RSK-----LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (355)
Q Consensus       187 ~~~-----~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~  261 (355)
                      .+.     .|+||||++|++|.+++..  .+++.+++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+
T Consensus       151 ~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~  227 (681)
T 2pzi_A          151 TDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGA  227 (681)
T ss_dssp             ECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred             cCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEeccc
Confidence            655     7999999999999887754  78999999999999999999999999999999999999875 999999999


Q ss_pred             ccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh-------hhhhHHHHHhhhh
Q 018487          262 AKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA-------CNTMLLFYLIIFH  334 (355)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~-------~~~~~~~~~~i~~  334 (355)
                      ++.....   ...+||+.|+|||++.+. ++.++|||||||++|+|++|..||.......       ......+..+|.+
T Consensus       228 a~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  303 (681)
T 2pzi_A          228 VSRINSF---GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRR  303 (681)
T ss_dssp             CEETTCC---SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCCTTCHHHHHCHHHHHHHHH
T ss_pred             chhcccC---CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccccccccccccCHHHHHHHhh
Confidence            9876543   455799999999998765 4889999999999999999999887642111       1122456789999


Q ss_pred             eeeecCCCcCC
Q 018487          335 CLFVNSLELLS  345 (355)
Q Consensus       335 ~l~~~~~e~~~  345 (355)
                      ||..+|.+++.
T Consensus       304 ~l~~dP~~R~~  314 (681)
T 2pzi_A          304 AIDPDPRQRFT  314 (681)
T ss_dssp             HTCSSGGGSCS
T ss_pred             hccCChhhCCC
Confidence            99999988764

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=5.7e-41  Score=332.40  Aligned_cols=230  Identities=27%  Similarity=0.385  Sum_probs=192.1

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec---
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT---  186 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~---  186 (355)
                      ++|++.++||+|+||.||+|.++     .+++.||||+++...  .....+.+.+|+.++++++||||+++++++..   
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~-----~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~   86 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQ-----DTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK   86 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCT-----TTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEEC-----CCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc
Confidence            68999999999999999999865     467889999987642  34455678899999999999999999988765   


Q ss_pred             ---CCeEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCc---EEEE
Q 018487          187 ---RSKLYLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLT  257 (355)
Q Consensus       187 ---~~~~~lv~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~---~kl~  257 (355)
                         ++..|+||||++|++|.+++....   .+++..++.++.|++.||.|||++||+||||||+|||++.++.   +||+
T Consensus        87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~  166 (676)
T 3qa8_A           87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKII  166 (676)
T ss_dssp             CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred             ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEc
Confidence               677899999999999999998754   5899999999999999999999999999999999999997765   9999


Q ss_pred             ecCCccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhh-----------------
Q 018487          258 DFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVI-----------------  320 (355)
Q Consensus       258 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~-----------------  320 (355)
                      |||++.............||+.|+|||++.+..++.++|||||||++|+|++|+.||......                 
T Consensus       167 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~  246 (676)
T 3qa8_A          167 DLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV  246 (676)
T ss_dssp             SCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred             ccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence            999999876666566678999999999999999999999999999999999999999653110                 


Q ss_pred             --------------------hhhhhHHHHHhhhheeeecCCCcCCC
Q 018487          321 --------------------ACNTMLLFYLIIFHCLFVNSLELLSH  346 (355)
Q Consensus       321 --------------------~~~~~~~~~~~i~~~l~~~~~e~~~~  346 (355)
                                          .......+..+|..||..+|.+++..
T Consensus       247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa  292 (676)
T 3qa8_A          247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTD  292 (676)
T ss_dssp             CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CC
T ss_pred             hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCH
Confidence                                01123457788889999888887643

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=7.3e-40  Score=313.65  Aligned_cols=224  Identities=26%  Similarity=0.344  Sum_probs=173.9

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceeeecC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR  187 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~  187 (355)
                      .+.|.+.+.||+|+||+||.+..      .+++.||||++..+.      .+.+.+|+.+++++ +||||+++++++...
T Consensus        14 ~~~~~~~~~LG~G~~g~V~~~~~------~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~   81 (434)
T 2rio_A           14 KNLVVSEKILGYGSSGTVVFQGS------FQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTD   81 (434)
T ss_dssp             SSCEEEEEEEEECSTTCEEEEEE------SSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred             hheeeccCeEeeCCCeEEEEEEE------ECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence            35677889999999999986543      257889999986532      24467899999876 899999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCC-------HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCC---------
Q 018487          188 SKLYLILDFINGGHLFFHLYRQGIFR-------EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---------  251 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~~l~-------~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~---------  251 (355)
                      +.+|+||||++ |+|.+++.......       +..++.++.||+.||+|||++||+||||||+|||++.+         
T Consensus        82 ~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~  160 (434)
T 2rio_A           82 RFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQT  160 (434)
T ss_dssp             SEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTT
T ss_pred             CeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccccc
Confidence            99999999996 59999998765432       23457799999999999999999999999999999754         


Q ss_pred             ----CcEEEEecCCccccCcCCC-----CCcccccCccccchhhcc-------CCCCCcccHHHHHHHHHHHHc-CCCCC
Q 018487          252 ----GHVMLTDFGLAKEIDESSR-----SNSMCGTTEYMAPEILLS-------KGHNKDADWWSVGILLYEMLT-GQVNI  314 (355)
Q Consensus       252 ----~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~~l~ellt-g~~pf  314 (355)
                          +.+||+|||++........     ....+||+.|+|||++.+       ..++.++|||||||++|||+| |+.||
T Consensus       161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf  240 (434)
T 2rio_A          161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF  240 (434)
T ss_dssp             CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence                4899999999987654321     234579999999999976       568999999999999999999 99999


Q ss_pred             CCchhhhh------------------hhhHHHHHhhhheeeecCCCcCC
Q 018487          315 KSMQVIAC------------------NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       315 ~~~~~~~~------------------~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ........                  .....+.++|.+||..+|.+++.
T Consensus       241 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps  289 (434)
T 2rio_A          241 GDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPT  289 (434)
T ss_dssp             CSTTTHHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCchhhHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCC
Confidence            76422111                  01134678888999988887653

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-40  Score=316.11  Aligned_cols=228  Identities=23%  Similarity=0.323  Sum_probs=177.9

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceeccee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~  183 (355)
                      ..++..+|.+.+.||+|+||+||....      .+++.||||++......      .+.+|+.+|+.+ +|||||+++++
T Consensus        19 ~~i~~~~y~~~~~LG~G~~G~V~~~~~------~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~   86 (432)
T 3p23_A           19 VIVGKISFCPKDVLGHGAEGTIVYRGM------FDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCT   86 (432)
T ss_dssp             EEETTEEEEEEEEEEECGGGCEEEEEE------SSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEE
T ss_pred             EEEccEEEecCCeeecCcCEEEEEEEE------eCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEE
Confidence            345566799999999999999664332      35678999998654322      145699999999 79999999999


Q ss_pred             eecCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC-----CCcEEEE
Q 018487          184 FQTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-----DGHVMLT  257 (355)
Q Consensus       184 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~-----~~~~kl~  257 (355)
                      +......|+||||+.+ +|.+++.... .+.+..++.++.||+.||.|||++||+||||||+|||++.     ...+||+
T Consensus        87 ~~~~~~~~lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~  165 (432)
T 3p23_A           87 EKDRQFQYIAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMIS  165 (432)
T ss_dssp             EEETTEEEEEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEEC
T ss_pred             EecCCEEEEEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEe
Confidence            9999999999999975 8989887664 3566678899999999999999999999999999999953     2368899


Q ss_pred             ecCCccccCcCC----CCCcccccCccccchhhc---cCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhhh------
Q 018487          258 DFGLAKEIDESS----RSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACN------  323 (355)
Q Consensus       258 Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~~------  323 (355)
                      |||+++......    .....+||+.|+|||++.   +..++.++|||||||++|||+| |..||........+      
T Consensus       166 DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~  245 (432)
T 3p23_A          166 DFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGAC  245 (432)
T ss_dssp             CTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCC
T ss_pred             cccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccC
Confidence            999998765332    234467999999999997   4567889999999999999999 99999764322211      


Q ss_pred             ----------hhHHHHHhhhheeeecCCCcCC
Q 018487          324 ----------TMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       324 ----------~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                                ....+.++|.+||..+|.+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps  277 (432)
T 3p23_A          246 SLDCLHPEKHEDVIARELIEKMIAMDPQKRPS  277 (432)
T ss_dssp             CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCC
T ss_pred             CccccCccccccHHHHHHHHHHHhCCHhhCCC
Confidence                      1123567899999999888763

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=9.9e-42  Score=315.75  Aligned_cols=218  Identities=14%  Similarity=0.194  Sum_probs=175.3

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeeccccc-----chhHHHHHHHHHHHHHhcC----------
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-----KKNHVDYMKAERDILTKVT----------  173 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~----------  173 (355)
                      .++|+++++||+|+||+||+|++.       ++.||||++......     .....+.+.+|+.+++.++          
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h   91 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIAD-------HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRT   91 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEET-------TEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBC
T ss_pred             cccchheeeecccCceEEEEEEeC-------CceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccC
Confidence            357999999999999999999863       578999999875421     2334466788999998886          


Q ss_pred             ----------------CCcceecceeeec-------------CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH
Q 018487          174 ----------------HPFIVQLRYSFQT-------------RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI  224 (355)
Q Consensus       174 ----------------h~nIv~l~~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql  224 (355)
                                      ||||++++++|..             .+.+|+||||+++|++.+.+.+ ..+++.+++.++.||
T Consensus        92 ~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi  170 (336)
T 2vuw_A           92 EGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQL  170 (336)
T ss_dssp             CCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHH
T ss_pred             CchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHH
Confidence                            5666666666654             7889999999999976666643 568999999999999


Q ss_pred             HHHHHHHH-HCCCeeccCCCCcEEecCCC--------------------cEEEEecCCccccCcCCCCCcccccCccccc
Q 018487          225 VSAVSHLH-KCGIVHRDLKPENILMDSDG--------------------HVMLTDFGLAKEIDESSRSNSMCGTTEYMAP  283 (355)
Q Consensus       225 ~~~L~~LH-~~~iiHrDlkp~NILl~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aP  283 (355)
                      +.||.||| ++||+||||||+|||++.++                    .+||+|||+|+.....    ..+||+.|+||
T Consensus       171 ~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aP  246 (336)
T 2vuw_A          171 TASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDE  246 (336)
T ss_dssp             HHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCS
T ss_pred             HHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccCh
Confidence            99999999 99999999999999999887                    8999999999876532    45799999999


Q ss_pred             hhhccCCCCCcccHHHHHHH-HHHHHcCCCCCCCchhh---------------------hhhhhHHHHHhhhheeeec
Q 018487          284 EILLSKGHNKDADWWSVGIL-LYEMLTGQVNIKSMQVI---------------------ACNTMLLFYLIIFHCLFVN  339 (355)
Q Consensus       284 E~~~~~~~~~~~DiwSlG~~-l~elltg~~pf~~~~~~---------------------~~~~~~~~~~~i~~~l~~~  339 (355)
                      |++.+.. +.++||||||++ .+++++|..||......                     .......+.++|.+||.++
T Consensus       247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d  323 (336)
T 2vuw_A          247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS  323 (336)
T ss_dssp             GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS
T ss_pred             hhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC
Confidence            9998766 889999998777 78899999999753110                     0112234677888888765

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=6.3e-40  Score=312.14  Aligned_cols=228  Identities=17%  Similarity=0.154  Sum_probs=175.6

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCC-Ccceecc------
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQLR------  181 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~------  181 (355)
                      ...|...+.||+|+||+||+|.+.     .+++.||||++...........+.+.+|+.+++.++| .|+....      
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~  151 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQ-----ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI  151 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBC
T ss_pred             ceeEEEecccccCCCEEEEEEEec-----CCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccc
Confidence            446889999999999999999976     5677999999885544444456778899999999987 3221111      


Q ss_pred             ---------------eeeec-----CCeEEEEEeccCCCChHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC
Q 018487          182 ---------------YSFQT-----RSKLYLILDFINGGHLFFHLYR-------QGIFREDQARFYTAEIVSAVSHLHKC  234 (355)
Q Consensus       182 ---------------~~~~~-----~~~~~lv~e~~~~gsL~~~l~~-------~~~l~~~~~~~i~~ql~~~L~~LH~~  234 (355)
                                     .++..     ...++++|+++ +++|.+++..       ...+++..+..++.||+.||+|||++
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  230 (413)
T 3dzo_A          152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY  230 (413)
T ss_dssp             CCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             cchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence                           11111     22467788876 5688888742       23477888999999999999999999


Q ss_pred             CCeeccCCCCcEEecCCCcEEEEecCCccccCcCCCCCcccccCccccchhh----------ccCCCCCcccHHHHHHHH
Q 018487          235 GIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEIL----------LSKGHNKDADWWSVGILL  304 (355)
Q Consensus       235 ~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DiwSlG~~l  304 (355)
                      ||+||||||+|||++.++.+||+|||+++.....  ....+| +.|+|||++          .+..++.++|||||||++
T Consensus       231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             CcccCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            9999999999999999999999999999876543  345578 999999999          555688899999999999


Q ss_pred             HHHHcCCCCCCCchhhhh---------hhhHHHHHhhhheeeecCCCcCC
Q 018487          305 YEMLTGQVNIKSMQVIAC---------NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       305 ~elltg~~pf~~~~~~~~---------~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      |||+||+.||...+....         .....+..+|.+||..+|.+++.
T Consensus       308 ~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt  357 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLL  357 (413)
T ss_dssp             HHHHHSSCCCCTTGGGSCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             HHHHHCCCCCCCcchhhhHHHHHhhcccCCHHHHHHHHHHccCChhhCcC
Confidence            999999999987643221         12236778899999999888764

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.3e-38  Score=288.39  Aligned_cols=202  Identities=29%  Similarity=0.504  Sum_probs=168.6

Q ss_pred             CCeEEE-eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHH-HhcCCCcceecceeeec-
Q 018487          110 GDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL-TKVTHPFIVQLRYSFQT-  186 (355)
Q Consensus       110 ~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~-  186 (355)
                      ++|.+. +.||+|+||.||+|.++     .+++.||+|++...        ..+.+|+.++ +.++||||+++++++.. 
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~   83 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNK-----RTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL   83 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEc-----CCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence            468887 78999999999999976     56788999998642        2355688877 66689999999999876 


Q ss_pred             ---CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC---CCcEEEEe
Q 018487          187 ---RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTD  258 (355)
Q Consensus       187 ---~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~---~~~~kl~D  258 (355)
                         ...+|+||||+++++|.+++....  .+++.+++.++.|++.||.|||++||+||||||+|||++.   ++.+||+|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D  163 (299)
T 3m2w_A           84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  163 (299)
T ss_dssp             ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence               678999999999999999998764  6999999999999999999999999999999999999998   78999999


Q ss_pred             cCCccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh-----------------
Q 018487          259 FGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA-----------------  321 (355)
Q Consensus       259 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~-----------------  321 (355)
                      ||++....                     +..++.++|||||||++|+|++|+.||.......                 
T Consensus       164 fg~a~~~~---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  222 (299)
T 3m2w_A          164 FGFAKETT---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  222 (299)
T ss_dssp             CTTCEECT---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSC
T ss_pred             cccccccc---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCC
Confidence            99986532                     2346788999999999999999999997643221                 


Q ss_pred             ----hhhhHHHHHhhhheeeecCCCcCC
Q 018487          322 ----CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 ----~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                          ......+..+|.+||..+|.+++.
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~dP~~Rps  250 (299)
T 3m2w_A          223 NPEWSEVSEEVKMLIRNLLKTEPTQRMT  250 (299)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCC
T ss_pred             chhcccCCHHHHHHHHHHcccChhhCCC
Confidence                122345678899999999988764

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=7e-37  Score=301.50  Aligned_cols=190  Identities=16%  Similarity=0.133  Sum_probs=136.5

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeeccccc-------chhHHHHHHHHHHHHHhc-CCCcceecceeeecC
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-------KKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR  187 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~  187 (355)
                      ...+.|++|.+..++..     ..++.|++|++.++...       .+...+.+.+|+++|+++ .|+||++++++++++
T Consensus       240 ~~~~~~~~~~h~~~rr~-----~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~  314 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRY-----FFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA  314 (569)
T ss_dssp             CC-C--------CCEEE-----EECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS
T ss_pred             hccccCCcccccccccc-----cccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC
Confidence            34567777766665543     34667999999765321       233446789999999999 699999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      +.+||||||++|++|.+++...+.+++.   .|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+....
T Consensus       315 ~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          315 QSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             SEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             CEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            9999999999999999999999888865   4789999999999999999999999999999999999999999987654


Q ss_pred             C-CCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCC
Q 018487          268 S-SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNI  314 (355)
Q Consensus       268 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf  314 (355)
                      . ......+||+.|||||++.+. +..++|+||+|+++++|.++..+|
T Consensus       392 ~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          392 DCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             --CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             CCccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence            3 334567899999999999764 667899999999988876654443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.97  E-value=1.7e-31  Score=261.66  Aligned_cols=185  Identities=19%  Similarity=0.151  Sum_probs=146.2

Q ss_pred             EEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccc-----hhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-----KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       114 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      ..+.||+|+||+||+|.+       .++.+++|.........     ....+.+.+|++++++++||||+++..++...+
T Consensus       340 ~~~~LG~G~fg~Vy~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~  412 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSY-------LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD  412 (540)
T ss_dssp             --------CCEEEEEEEC-------SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT
T ss_pred             CCCEEeeCCCEEEEEEEE-------CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC
Confidence            356899999999999963       35668888865433222     222456789999999999999997666666777


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      ..|+||||++|++|.+++..        +..++.|+++||.|||++||+||||||+|||++.  .+||+|||+++.....
T Consensus       413 ~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          413 NKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             TTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             ccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            78999999999999998875        6689999999999999999999999999999988  9999999999987543


Q ss_pred             CC--------CCcccccCccccchhhcc--CCCCCcccHHHHHHHHHHHHcCCCCCC
Q 018487          269 SR--------SNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQVNIK  315 (355)
Q Consensus       269 ~~--------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~elltg~~pf~  315 (355)
                      ..        ....+||+.|||||++..  ..|+..+|+|+..+-..+-+.++-+|.
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            22        135689999999999986  668888999999988888877766653

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.94  E-value=2.3e-27  Score=213.95  Aligned_cols=148  Identities=20%  Similarity=0.218  Sum_probs=117.5

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccch---------------hHHHHHHHHHHHHHhcCC
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK---------------NHVDYMKAERDILTKVTH  174 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~h  174 (355)
                      ..|.+.+.||+|+||.||+|.+.      +++.||||+++.......               .....+.+|+.++++++ 
T Consensus        90 ~~~~~~~~iG~G~~g~Vy~~~~~------~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-  162 (282)
T 1zar_A           90 KVDAIGKLMGEGKESAVFNCYSE------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-  162 (282)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEET------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred             eEEEecCEeccCCCceEEEEEeC------CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence            34666699999999999999962      467899999865332111               23456889999999999 


Q ss_pred             CcceecceeeecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcE
Q 018487          175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV  254 (355)
Q Consensus       175 ~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~  254 (355)
                       | +++.+.+.. +..|+||||++|++|.+ +.      ..+...++.|++.||.|||++||+||||||+|||++ ++.+
T Consensus       163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~v  231 (282)
T 1zar_A          163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGI  231 (282)
T ss_dssp             -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEE
T ss_pred             -C-CCcCeEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcE
Confidence             5 667676544 45699999999999976 31      234567999999999999999999999999999999 9999


Q ss_pred             EEEecCCccccCcCCCCCcccccCccccchhhc
Q 018487          255 MLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL  287 (355)
Q Consensus       255 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~  287 (355)
                      ||+|||+++.            +..++|||++.
T Consensus       232 kl~DFG~a~~------------~~~~~a~e~l~  252 (282)
T 1zar_A          232 WIIDFPQSVE------------VGEEGWREILE  252 (282)
T ss_dssp             EECCCTTCEE------------TTSTTHHHHHH
T ss_pred             EEEECCCCeE------------CCCCCHHHHHH
Confidence            9999999864            34578999875

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.89  E-value=3.8e-23  Score=183.92  Aligned_cols=141  Identities=21%  Similarity=0.182  Sum_probs=107.1

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCce--EEEEEeecccccc---------------------hhHHHHHHHHHH
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGI--YAMKVMRKDTIIK---------------------KNHVDYMKAERD  167 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~--vavK~~~~~~~~~---------------------~~~~~~~~~E~~  167 (355)
                      -|++.+.||+|+||.||+|.+.     .+++.  ||||+++......                     ......+.+|+.
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~-----~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  122 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGV-----FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFR  122 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEE-----ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEc-----CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHH
Confidence            3789999999999999999974     24667  9999976432110                     111235788999


Q ss_pred             HHHhcCCCcce--ecceeeecCCeEEEEEeccCC-C----ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCCeec
Q 018487          168 ILTKVTHPFIV--QLRYSFQTRSKLYLILDFING-G----HLFFHLYRQGIFREDQARFYTAEIVSAVSHLH-KCGIVHR  239 (355)
Q Consensus       168 ~l~~l~h~nIv--~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH-~~~iiHr  239 (355)
                      +|+.+.|++|.  .+++.    +..++||||+.+ |    +|.+....   .++..+..++.|++.||.||| ++||+||
T Consensus       123 ~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHr  195 (258)
T 1zth_A          123 NLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHA  195 (258)
T ss_dssp             HHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECS
T ss_pred             HHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence            99999888642  23321    346899999942 3    56554332   235568899999999999999 9999999


Q ss_pred             cCCCCcEEecCCCcEEEEecCCcccc
Q 018487          240 DLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       240 Dlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      ||||+|||++.  .++|+|||+|...
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999987  9999999999765

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.82  E-value=1.4e-20  Score=174.68  Aligned_cols=142  Identities=13%  Similarity=0.157  Sum_probs=99.1

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccc------------hhHH-------HHHHHHHHHHHh
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK------------KNHV-------DYMKAERDILTK  171 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~------------~~~~-------~~~~~E~~~l~~  171 (355)
                      -|++..+||+|+||.||+|...      .++.||||+++......            ....       ....+|...|.+
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r  169 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADE------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA  169 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECT------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEecCEeeeCCceEEEEEECC------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence            3999999999999999999853      47889999976432110            0000       112235555665


Q ss_pred             cCCCcceecceeeecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCC
Q 018487          172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD  251 (355)
Q Consensus       172 l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~  251 (355)
                      +.+.++... ..+... ..++||||++|+.|....      ....+..++.||+.+|.+||++|||||||||.|||++++
T Consensus       170 L~~~gv~vp-~p~~~~-~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~d  241 (397)
T 4gyi_A          170 LYEEGFPVP-EPIAQS-RHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREE  241 (397)
T ss_dssp             HHHTTCSCC-CEEEEE-TTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEE
T ss_pred             HHhcCCCCC-eeeecc-CceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCC
Confidence            544433211 111111 237999999998874332      223456788999999999999999999999999999877


Q ss_pred             C----------cEEEEecCCccccC
Q 018487          252 G----------HVMLTDFGLAKEID  266 (355)
Q Consensus       252 ~----------~~kl~Dfg~a~~~~  266 (355)
                      +          .+.|+||+.+....
T Consensus       242 gd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          242 KDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             ECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             CCcccccccccceEEEEeCCcccCC
Confidence            6          38999999886544

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.54  E-value=5e-14  Score=124.91  Aligned_cols=139  Identities=12%  Similarity=0.064  Sum_probs=109.4

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecceeeecCCe
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSK  189 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~  189 (355)
                      .|++...++.|+++.||++..       .++.+++|+........   ...+.+|..+++.+. +..+.++++++...+.
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~-------~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~   84 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVG-------ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEEC-------SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             cceeEeeccCCCCCeEEEEEC-------CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCc
Confidence            699999999999999999873       24679999987532111   124778999999885 6677888888888889


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK------------------------------------  233 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~------------------------------------  233 (355)
                      .|+||||++|.+|.+..     .+......++.+++++|..||+                                    
T Consensus        85 ~~lv~e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T 3tm0_A           85 SNLLMSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEEEECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred             eEEEEEecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence            99999999999886542     1223345788899999999998                                    


Q ss_pred             -----------------------CCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          234 -----------------------CGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       234 -----------------------~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                                             ..++|+|+++.|||+++++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                   4589999999999998765567999997754

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.38  E-value=1.3e-12  Score=115.31  Aligned_cols=134  Identities=13%  Similarity=0.147  Sum_probs=96.5

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc--ceecceeeecCC
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF--IVQLRYSFQTRS  188 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~  188 (355)
                      .|.+....+.|..+.||++...      +++.+++|+.....      ...+.+|+.+++.+.+.+  +.+++.+....+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~------~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~   88 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQ------GRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAG   88 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECT------TSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS
T ss_pred             CCceEecccCCCCceEEEEecC------CCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCC
Confidence            5666554456667999998632      34569999976431      123667888888886544  455788888778


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---------------------------------
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG---------------------------------  235 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~---------------------------------  235 (355)
                      ..++||||++|.+|.  .   ....   ...++.++++.|..||+..                                 
T Consensus        89 ~~~~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (264)
T 1nd4_A           89 RDWLLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE  160 (264)
T ss_dssp             CEEEEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred             CCEEEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence            899999999998883  1   1112   2356677777788887643                                 


Q ss_pred             -------------------------CeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          236 -------------------------IVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       236 -------------------------iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                                               ++|+|++|.|||++.++.+.|+|||.+..
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                     99999999999998766667999998754

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.35  E-value=3.1e-12  Score=118.74  Aligned_cols=144  Identities=13%  Similarity=0.240  Sum_probs=105.4

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEee--cccccchhHHHHHHHHHHHHHhcCC--Ccceecceeeec
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR--KDTIIKKNHVDYMKAERDILTKVTH--PFIVQLRYSFQT  186 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~  186 (355)
                      ....++.|+.|.++.||++...       ++.+++|+..  .....  .....+.+|..+++.+..  ..+.+++.++.+
T Consensus        39 ~~~~~~~l~~G~sn~~y~v~~~-------~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~  109 (359)
T 3dxp_A           39 GPLSVEQFKGGQSNPTFKLVTP-------GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCED  109 (359)
T ss_dssp             CCCEEEECCC-CCSCEEEEECS-------SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECC
T ss_pred             CCceEEEcCCcccceEEEEEEC-------CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCC
Confidence            3445788999999999998743       3568888876  33211  112356789999999874  456777777766


Q ss_pred             C---CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------
Q 018487          187 R---SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK------------------------------  233 (355)
Q Consensus       187 ~---~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~------------------------------  233 (355)
                      .   +..|+||||++|..+.+.  ....+++.+...++.+++++|..||+                              
T Consensus       110 ~~~~g~~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (359)
T 3dxp_A          110 ESVIGRAFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYK  187 (359)
T ss_dssp             TTTTSSCEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHH
T ss_pred             CCccCCeEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHH
Confidence            5   458999999999877431  12236788888999999999999997                              


Q ss_pred             ----------------------------CCCeeccCCCCcEEecCCCc--EEEEecCCcccc
Q 018487          234 ----------------------------CGIVHRDLKPENILMDSDGH--VMLTDFGLAKEI  265 (355)
Q Consensus       234 ----------------------------~~iiHrDlkp~NILl~~~~~--~kl~Dfg~a~~~  265 (355)
                                                  ..++|+|+++.|||++.++.  +.|+||+.+...
T Consensus       188 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          188 LSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             hcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                        35899999999999987753  689999988653

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.29  E-value=3.6e-12  Score=115.57  Aligned_cols=185  Identities=17%  Similarity=0.240  Sum_probs=120.8

Q ss_pred             EeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCc--ceecceeeecCC---
Q 018487          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPF--IVQLRYSFQTRS---  188 (355)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--Iv~l~~~~~~~~---  188 (355)
                      ++.++.|....||++.          +.+++|+....     .....+.+|..+|+.+. +..  +.+++.......   
T Consensus        25 i~~~~~G~~n~v~~v~----------~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~   89 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----------RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQ   89 (304)
T ss_dssp             CCEEEECSSEEEEEST----------TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCS
T ss_pred             eEecCCCCcceEEEEC----------CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCC
Confidence            4569999999999753          23888986432     33456788999998884 333  233333333222   


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-----------------------------------  233 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~-----------------------------------  233 (355)
                      ..|+||++++|..|.....  ..++..+...++.++++.|..||+                                   
T Consensus        90 ~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (304)
T 3sg8_A           90 MSFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG  167 (304)
T ss_dssp             CSCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred             cceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence            3588999999988865432  346777888888888888888886                                   


Q ss_pred             -----------------------CCCeeccCCCCcEEecC--CCcEEEEecCCccccCcCCCCCcccccCccccchhhcc
Q 018487          234 -----------------------CGIVHRDLKPENILMDS--DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS  288 (355)
Q Consensus       234 -----------------------~~iiHrDlkp~NILl~~--~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~  288 (355)
                                             ..++|+|+++.||+++.  ++.+.|+||+.+...+.............-..|+....
T Consensus       168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~  247 (304)
T 3sg8_A          168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSK  247 (304)
T ss_dssp             HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHH
T ss_pred             ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHH
Confidence                                   13699999999999988  45688999998865432211100000000022222110


Q ss_pred             -----CC---------CCCcccHHHHHHHHHHHHcCCCCCCC
Q 018487          289 -----KG---------HNKDADWWSVGILLYEMLTGQVNIKS  316 (355)
Q Consensus       289 -----~~---------~~~~~DiwSlG~~l~elltg~~pf~~  316 (355)
                           ..         .....+.|+++.++|.+.+|..+|-.
T Consensus       248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~  289 (304)
T 3sg8_A          248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYE  289 (304)
T ss_dssp             HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred             HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence                 00         01125899999999999999887754

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.80  E-value=1.1e-07  Score=86.11  Aligned_cols=135  Identities=18%  Similarity=0.246  Sum_probs=91.7

Q ss_pred             EeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCC---cceecceeee-cCCeE
Q 018487          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP---FIVQLRYSFQ-TRSKL  190 (355)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~l~~~~~-~~~~~  190 (355)
                      ++.++.|....||++          ++.+++|+...     ......+.+|..+|+.+.+.   .|.+++.+.. ..+..
T Consensus        24 v~~l~~G~~n~v~~v----------g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~   88 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----------NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNP   88 (306)
T ss_dssp             EEEEEECSSEEEEEE----------TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCE
T ss_pred             eeecCCCcceeEEEE----------CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCce
Confidence            456889999999987          12388888532     23345688899999999752   2444555553 44567


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC------------------------------------
Q 018487          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC------------------------------------  234 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~------------------------------------  234 (355)
                      ++||||++|..+.....  ..++..+...++.++.+.|..||+.                                    
T Consensus        89 ~~v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~  166 (306)
T 3tdw_A           89 FVGYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDE  166 (306)
T ss_dssp             EEEEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCH
T ss_pred             EEEEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccch
Confidence            89999999988865321  1234455555555555555555532                                    


Q ss_pred             ------------------------CCeeccCCCCcEEecC---CCc-EEEEecCCccccC
Q 018487          235 ------------------------GIVHRDLKPENILMDS---DGH-VMLTDFGLAKEID  266 (355)
Q Consensus       235 ------------------------~iiHrDlkp~NILl~~---~~~-~kl~Dfg~a~~~~  266 (355)
                                              .++|+|+++.|||++.   ++. +.|+||+.+...+
T Consensus       167 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          167 SLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             HHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred             hhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence                                    3599999999999987   455 4899999886543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.79  E-value=8.2e-08  Score=84.94  Aligned_cols=133  Identities=17%  Similarity=0.173  Sum_probs=90.7

Q ss_pred             eeccCCcE-EEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecceeeecCCeEEEEE
Q 018487          117 VVGQGAFG-KVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLIL  194 (355)
Q Consensus       117 ~lG~G~~g-~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~  194 (355)
                      .+..|..| .||+....     ..+..+++|+....      ....+.+|..+|+.+. +--+.+++.++.+.+..|+||
T Consensus        31 ~~~~G~S~~~v~rl~~~-----~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvm   99 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGK-----PNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLT   99 (272)
T ss_dssp             EEECSSSSCEEEEEECC-----TTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             EccCCCcCCeEEEEEec-----CCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEE
Confidence            34455554 68987643     34556889986543      2345778999988885 223566778888888999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC----------------------------------------
Q 018487          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC----------------------------------------  234 (355)
Q Consensus       195 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~----------------------------------------  234 (355)
                      |+++|.++.+.....    ......++.++...|..||..                                        
T Consensus       100 e~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (272)
T 4gkh_A          100 TAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWP  175 (272)
T ss_dssp             ECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCC
T ss_pred             EeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchH
Confidence            999998776544321    112233444555555555521                                        


Q ss_pred             ------------------CCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          235 ------------------GIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       235 ------------------~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                                        .++|+|+.+.|||++.++.+-|+||+.+..
T Consensus       176 ~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          176 VEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                              168999999999998877778999998864

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.55  E-value=2.3e-07  Score=86.88  Aligned_cols=81  Identities=16%  Similarity=0.255  Sum_probs=48.8

Q ss_pred             EEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccc-cc---hhHHHHHHHHHHHHHhcCC--Ccce-ecceeee
Q 018487          113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-IK---KNHVDYMKAERDILTKVTH--PFIV-QLRYSFQ  185 (355)
Q Consensus       113 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~---~~~~~~~~~E~~~l~~l~h--~nIv-~l~~~~~  185 (355)
                      ...+.||.|..+.||++...     ..++.++||....... ..   ....+.+..|..+|+.+..  +..+ +++.+  
T Consensus        33 ~~~~~lg~G~~n~vyrv~~~-----~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--  105 (397)
T 2olc_A           33 LTCQEIGDGNLNYVFHIYDQ-----EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--  105 (397)
T ss_dssp             CEEEECCSSSSEEEEEEEC---------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--
T ss_pred             eEEEECCCCceEEEEEEEEC-----CCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--
Confidence            34678999999999999643     2356799998653221 00   1122345678888887742  3333 44433  


Q ss_pred             cCCeEEEEEeccCCC
Q 018487          186 TRSKLYLILDFINGG  200 (355)
Q Consensus       186 ~~~~~~lv~e~~~~g  200 (355)
                      +....++||||+++.
T Consensus       106 d~~~~~lvmE~l~g~  120 (397)
T 2olc_A          106 DTEMAVTVMEDLSHL  120 (397)
T ss_dssp             ETTTTEEEECCCTTS
T ss_pred             cCCccEEEEEeCCCc
Confidence            334468999999874

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.46  E-value=2.4e-06  Score=77.86  Aligned_cols=31  Identities=16%  Similarity=0.308  Sum_probs=27.9

Q ss_pred             CCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       234 ~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      ..++|+|+++.|||++.++.+.|+||+.+..
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            5799999999999998888999999998753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.43  E-value=7.1e-07  Score=82.24  Aligned_cols=91  Identities=11%  Similarity=0.143  Sum_probs=53.7

Q ss_pred             eEEEeee-ccCCcEEEEEEEEcCCCCCC-CCceEEEEEeecccccchhHHHHHHHHHHHHHhcCC---Ccceecceeeec
Q 018487          112 FEIFRVV-GQGAFGKVFQVKKKGVDDGD-SDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH---PFIVQLRYSFQT  186 (355)
Q Consensus       112 y~~~~~l-G~G~~g~V~~~~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~nIv~l~~~~~~  186 (355)
                      ....+.| +.|....+|++......++. .++.+++|+..............+.+|..+++.+..   -.+.+++.+...
T Consensus        22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~  101 (357)
T 3ats_A           22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT  101 (357)
T ss_dssp             EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred             eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence            4456788 88999999988642000000 145688898654320000001235567777777742   245566666554


Q ss_pred             C---CeEEEEEeccCCCCh
Q 018487          187 R---SKLYLILDFINGGHL  202 (355)
Q Consensus       187 ~---~~~~lv~e~~~~gsL  202 (355)
                      .   +..|+||||++|..+
T Consensus       102 ~~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          102 GDVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             STTTSSCEEEEECCCCBCC
T ss_pred             CCccCCceEEEEecCCCCh
Confidence            4   356899999998654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.38  E-value=9.5e-07  Score=83.44  Aligned_cols=78  Identities=9%  Similarity=0.089  Sum_probs=49.0

Q ss_pred             HCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCCCCcccc--cCccccchhhccCCC---CCcccHHHHHHHHHHH
Q 018487          233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG--TTEYMAPEILLSKGH---NKDADWWSVGILLYEM  307 (355)
Q Consensus       233 ~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~---~~~~DiwSlG~~l~el  307 (355)
                      ...++|+|+++.|||++.++ ++|+||+.+..............  ...|++|+......-   ....++......+|+.
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            45799999999999998776 99999998875432221111111  134666665532111   1134556778888887


Q ss_pred             HcCC
Q 018487          308 LTGQ  311 (355)
Q Consensus       308 ltg~  311 (355)
                      ++++
T Consensus       310 y~~~  313 (420)
T 2pyw_A          310 FNKR  313 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7653

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.24  E-value=1.2e-05  Score=72.61  Aligned_cols=79  Identities=11%  Similarity=0.122  Sum_probs=59.3

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC---CCcceecceeeecC
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT---HPFIVQLRYSFQTR  187 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~  187 (355)
                      ...-.+.|+.|....+|++..       .++.+++|+....      ....+..|...|+.+.   ...+.+++.+....
T Consensus        37 ~i~~~~~l~gG~~n~~y~v~~-------~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~  103 (312)
T 3jr1_A           37 FIKHKEKLYSGEMNEIWLIND-------EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ  103 (312)
T ss_dssp             CCCEEEEECCSSSSEEEEEES-------SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS
T ss_pred             ceeeeEEeCCccceeeeEEEE-------CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC
Confidence            344567899999999999872       3456888987542      2355778888888774   24577777777777


Q ss_pred             CeEEEEEeccCCCCh
Q 018487          188 SKLYLILDFINGGHL  202 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL  202 (355)
                      +..|+||||++|..+
T Consensus       104 g~~~lvme~l~G~~~  118 (312)
T 3jr1_A          104 GHSFLLLEALNKSKN  118 (312)
T ss_dssp             SEEEEEEECCCCCCC
T ss_pred             CceEEEEEeccCCCC
Confidence            889999999998754

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=98.04  E-value=1.7e-05  Score=71.77  Aligned_cols=143  Identities=16%  Similarity=0.204  Sum_probs=79.3

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc--ceeccee----
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF--IVQLRYS----  183 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~----  183 (355)
                      +...-++.|+.|....+|++...       ++.+++|+.....  ..   +.+..|..+++.+....  +.+++..    
T Consensus        22 ~~~~~~~~i~~G~~n~~~~v~~~-------~g~~vlk~~~~~~--~~---~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~   89 (322)
T 2ppq_A           22 GSLTSYKGIAEGVENSNFLLHTT-------KDPLILTLYEKRV--EK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGE   89 (322)
T ss_dssp             CCEEEEEEECC---EEEEEEEES-------SCCEEEEEECC-----C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCC
T ss_pred             CcceEeeccCCCcccceEEEEeC-------CccEEEEEeCCCC--CH---HHHHHHHHHHHHHHHCCCCCCcccCCCCCC
Confidence            45566778888999999998743       2358899886531  11   22445666666554212  2223211    


Q ss_pred             --eecCCeEEEEEeccCCCChH----H----------HHHhc--C---C----CCHHHHHH---------------HHHH
Q 018487          184 --FQTRSKLYLILDFINGGHLF----F----------HLYRQ--G---I----FREDQARF---------------YTAE  223 (355)
Q Consensus       184 --~~~~~~~~lv~e~~~~gsL~----~----------~l~~~--~---~----l~~~~~~~---------------i~~q  223 (355)
                        ....+..+++|+|++|..+.    .          .++..  .   .    ........               +...
T Consensus        90 ~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~  169 (322)
T 2ppq_A           90 LLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREE  169 (322)
T ss_dssp             SCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHH
T ss_pred             EEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHH
Confidence              12345679999999986431    0          11111  0   0    01110000               0011


Q ss_pred             HHHHHHHHHH-------CCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          224 IVSAVSHLHK-------CGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       224 l~~~L~~LH~-------~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      +...++.+..       .+++|+|+++.|||++.++.+.|+||+.+..
T Consensus       170 l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          170 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            3444555552       3699999999999998776668999998754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=98.03  E-value=2.1e-05  Score=70.58  Aligned_cols=133  Identities=15%  Similarity=0.080  Sum_probs=72.8

Q ss_pred             EeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcc-eecceeeecCCeEEEE
Q 018487          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI-VQLRYSFQTRSKLYLI  193 (355)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv  193 (355)
                      ++.|+.|....+|++           +.+++|+........    ....+|..+++.+....+ .+++...  .+.-+++
T Consensus        23 i~~l~gG~tN~~~~~-----------~~~vlR~~~~~~~~~----~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v   85 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----------GDLCLRIPGKGTEEY----INRANEAVAAREAAKAGVSPEVLHVD--PATGVMV   85 (301)
T ss_dssp             CEEEESCSSEEEEEE-----------TTEEEEEECC----C----CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEE
T ss_pred             eeEcCCcccccccee-----------eeEEEECCCCCccce----eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEE
Confidence            678999999999998           238889876432111    112347777666643223 3444433  3234789


Q ss_pred             Eecc-CCCChHHH------------------HHhcCC-C----C-HHHHHHHHHH--------------HHHHHHHHH--
Q 018487          194 LDFI-NGGHLFFH------------------LYRQGI-F----R-EDQARFYTAE--------------IVSAVSHLH--  232 (355)
Q Consensus       194 ~e~~-~~gsL~~~------------------l~~~~~-l----~-~~~~~~i~~q--------------l~~~L~~LH--  232 (355)
                      +||+ +|.++...                  ++.... +    . ...+..+...              +...+..|.  
T Consensus        86 ~e~i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  165 (301)
T 3dxq_A           86 TRYIAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSA  165 (301)
T ss_dssp             EECCTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHH
T ss_pred             EeecCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHH
Confidence            9999 66554211                  001010 1    1 1111111111              111122111  


Q ss_pred             --H----CCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          233 --K----CGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       233 --~----~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                        .    ..++|+|+.+.||+ ..++.+.|+||..+..-
T Consensus       166 l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          166 LAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             HHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             HHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence              1    13799999999999 56778999999987643

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.78  E-value=0.0004  Score=61.66  Aligned_cols=80  Identities=11%  Similarity=0.057  Sum_probs=54.2

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCC---cceecceeeec
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP---FIVQLRYSFQT  186 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~l~~~~~~  186 (355)
                      .+..-++.+|.|..+.||++...      +++.|++|+........   ...+..|...|+.+...   -+.+++.+  .
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~------DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~   83 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELA------DGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGW--D   83 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEET------TSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEE--E
T ss_pred             CCeEEEEecCCCCCeEEEEEEEC------CCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEec--c
Confidence            46778899999999999999854      46779999865443211   23467799888888532   23333433  2


Q ss_pred             CCeEEEEEeccCCCCh
Q 018487          187 RSKLYLILDFINGGHL  202 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL  202 (355)
                        .-++||||++++..
T Consensus        84 --~~~lv~e~l~~~~~   97 (288)
T 3f7w_A           84 --DRTLAMEWVDERPP   97 (288)
T ss_dssp             --TTEEEEECCCCCCC
T ss_pred             --CceEEEEeecccCC
Confidence              23789999987643

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.74  E-value=8e-05  Score=67.69  Aligned_cols=32  Identities=34%  Similarity=0.377  Sum_probs=27.5

Q ss_pred             CCCeeccCCCCcEEecCC----CcEEEEecCCcccc
Q 018487          234 CGIVHRDLKPENILMDSD----GHVMLTDFGLAKEI  265 (355)
Q Consensus       234 ~~iiHrDlkp~NILl~~~----~~~kl~Dfg~a~~~  265 (355)
                      ..++|+|+.+.|||++.+    +.+.|+||+.+..-
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            469999999999999874    68999999988653

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.73  E-value=0.00011  Score=69.37  Aligned_cols=81  Identities=15%  Similarity=0.115  Sum_probs=49.8

Q ss_pred             EEEeeeccCCcEEEEEEEEcCCCC--CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcc-eecceeeecCCe
Q 018487          113 EIFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI-VQLRYSFQTRSK  189 (355)
Q Consensus       113 ~~~~~lG~G~~g~V~~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~  189 (355)
                      ..++.|+.|....||++.......  ...++.+++|+.....  .   .+.+.+|..+++.+...++ .++++.+..   
T Consensus        76 ~~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~---  147 (429)
T 1nw1_A           76 LRISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG---  147 (429)
T ss_dssp             EEEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT---
T ss_pred             eEEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC---
Confidence            346788899999999998542110  1124678899874321  1   1234468888887753333 455555543   


Q ss_pred             EEEEEeccCCCCh
Q 018487          190 LYLILDFINGGHL  202 (355)
Q Consensus       190 ~~lv~e~~~~gsL  202 (355)
                       .+||||++|.+|
T Consensus       148 -g~v~e~l~G~~l  159 (429)
T 1nw1_A          148 -GRLEEYIPSRPL  159 (429)
T ss_dssp             -EEEECCCCEEEC
T ss_pred             -CEEEEEeCCccc
Confidence             389999987443

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.68  E-value=0.00022  Score=64.49  Aligned_cols=136  Identities=13%  Similarity=0.165  Sum_probs=75.5

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCC--cceeccee-----eecCC
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP--FIVQLRYS-----FQTRS  188 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~-----~~~~~  188 (355)
                      ..|+ |....||++...      .++.+++|+.+.... .   .+.+..|..+++.+...  .+++++..     ....+
T Consensus        32 ~~l~-g~~n~~y~v~~~------~g~~~vlK~~~~~~~-~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g  100 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE------DRRRFVVKFYRPERW-T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQG  100 (328)
T ss_dssp             EEEC-CSSSEEEEECCT------TCCCEEEEEECTTTS-C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETT
T ss_pred             Eeec-CcccceEEEEcC------CCCEEEEEEcCCCCC-C---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECC
Confidence            4566 888899987632      244689999864321 1   23455677777766421  23334332     12345


Q ss_pred             eEEEEEeccCCCChH----HH----------HHh---cC------CCCHHHH----HHHH---------------HHHHH
Q 018487          189 KLYLILDFINGGHLF----FH----------LYR---QG------IFREDQA----RFYT---------------AEIVS  226 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~----~~----------l~~---~~------~l~~~~~----~~i~---------------~ql~~  226 (355)
                      ..+++|+|++|..+.    ..          ++.   ..      .+.....    ..++               ..+-.
T Consensus       101 ~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  180 (328)
T 1zyl_A          101 FYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDE  180 (328)
T ss_dssp             EEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHH
T ss_pred             EEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHH
Confidence            678999999885431    00          111   00      1111110    0111               11111


Q ss_pred             HHHHHH-------HCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          227 AVSHLH-------KCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       227 ~L~~LH-------~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      .++.+.       ...++|+|+++.|||++ + .+.|+||+.+..
T Consensus       181 ~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          181 LIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            222332       23589999999999998 4 899999998764

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.63  E-value=0.00015  Score=67.25  Aligned_cols=146  Identities=17%  Similarity=0.145  Sum_probs=83.1

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCC--CCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc-ceecceeeec
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVD--DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF-IVQLRYSFQT  186 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~  186 (355)
                      +.++ ++.|..|-...+|++......  ....++.+++|+.....    .....+.+|..+++.+..-+ ..++++.+..
T Consensus        51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~  125 (379)
T 3feg_A           51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL----QGVDSLVLESVMFAILAERSLGPQLYGVFPE  125 (379)
T ss_dssp             GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT
T ss_pred             CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc----chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC
Confidence            3444 456777888999998853210  01134678899863321    12334557888888775322 3445555543


Q ss_pred             CCeEEEEEeccCCCChHH--------------HH---HhcC-----CC--CHHHHHHHHHHHHH----------------
Q 018487          187 RSKLYLILDFINGGHLFF--------------HL---YRQG-----IF--REDQARFYTAEIVS----------------  226 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~--------------~l---~~~~-----~l--~~~~~~~i~~ql~~----------------  226 (355)
                          .+||||++|..|..              .+   +...     ..  -+.++..+..++..                
T Consensus       126 ----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~  201 (379)
T 3feg_A          126 ----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYS  201 (379)
T ss_dssp             ----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTT
T ss_pred             ----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHH
Confidence                29999999865421              11   1110     11  23556666654422                


Q ss_pred             ---HHHHHH----H----CCCeeccCCCCcEEecCC----CcEEEEecCCccc
Q 018487          227 ---AVSHLH----K----CGIVHRDLKPENILMDSD----GHVMLTDFGLAKE  264 (355)
Q Consensus       227 ---~L~~LH----~----~~iiHrDlkp~NILl~~~----~~~kl~Dfg~a~~  264 (355)
                         .+..|.    .    ..++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       202 l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          202 LKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence               233332    2    248999999999999876    7899999998864

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.53  E-value=0.0012  Score=60.06  Aligned_cols=32  Identities=16%  Similarity=0.351  Sum_probs=28.0

Q ss_pred             CCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       234 ~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      ..++|+|+.+.||+++.++.+.|+||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            35899999999999998889999999887653

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.51  E-value=0.00021  Score=65.87  Aligned_cols=81  Identities=15%  Similarity=0.123  Sum_probs=43.6

Q ss_pred             EEeeeccCCcEEEEEEEEcCCC---CCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc-ceecceeeecCCe
Q 018487          114 IFRVVGQGAFGKVFQVKKKGVD---DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF-IVQLRYSFQTRSK  189 (355)
Q Consensus       114 ~~~~lG~G~~g~V~~~~~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~  189 (355)
                      .++.|+.|....+|++...+..   ....++.+++|+.......    ......|..+++.+...+ +.++++.+  .+ 
T Consensus        37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-  109 (369)
T 3c5i_A           37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE----LYNTISEFEVYKTMSKYKIAPQLLNTF--NG-  109 (369)
T ss_dssp             EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG----TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT-
T ss_pred             EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc----eecHHHHHHHHHHHHhcCCCCceEEec--CC-
Confidence            3567888888999998754200   0011256889987543211    111345777777765333 33555443  22 


Q ss_pred             EEEEEeccCCCCh
Q 018487          190 LYLILDFINGGHL  202 (355)
Q Consensus       190 ~~lv~e~~~~gsL  202 (355)
                       ++||||++|..+
T Consensus       110 -~~v~e~i~G~~l  121 (369)
T 3c5i_A          110 -GRIEEWLYGDPL  121 (369)
T ss_dssp             -EEEEECCCSEEC
T ss_pred             -cEEEEEecCCcC
Confidence             689999998543

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.31  E-value=0.002  Score=61.16  Aligned_cols=76  Identities=18%  Similarity=0.282  Sum_probs=47.1

Q ss_pred             EEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcc-eecceeeecCCeEEE
Q 018487          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI-VQLRYSFQTRSKLYL  192 (355)
Q Consensus       114 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~l  192 (355)
                      -++.|+.|-...+|++...+     .++.+++|+......   ..++ ..+|..+++.+...++ .++++.+. +   .+
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~-----~~~~~vLRi~g~~~~---~~id-R~~E~~vl~~L~~~gl~P~ll~~~~-~---G~  178 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMS-----KQAKYLIRLYGPKTD---EIIN-REREKKISCILYNKNIAKKIYVFFT-N---GR  178 (458)
T ss_dssp             EEEEECC--CEEEEEEEETT-----TTEEEEEEEECC-CC---SCSC-HHHHHHHHHHHTTSSSBCCEEEEET-T---EE
T ss_pred             EEEEcCCCeEeEEEEEEECC-----CCceEEEEECCCChh---hhcC-HHHHHHHHHHHHhcCCCCCEEEEeC-C---eE
Confidence            45678889999999998541     236688998754321   1111 2468888888875555 45566553 2   25


Q ss_pred             EEeccCCCCh
Q 018487          193 ILDFINGGHL  202 (355)
Q Consensus       193 v~e~~~~gsL  202 (355)
                      ||||++|..|
T Consensus       179 v~e~I~G~~l  188 (458)
T 2qg7_A          179 IEEFMDGYAL  188 (458)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEeeCCccC
Confidence            9999998544

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.79  E-value=0.0049  Score=51.95  Aligned_cols=103  Identities=18%  Similarity=0.092  Sum_probs=67.9

Q ss_pred             CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH-HCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCCCCccccc
Q 018487          200 GHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT  277 (355)
Q Consensus       200 gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH-~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt  277 (355)
                      -+|.++|... .+++|+++|.++.|.+.+|.-+- ++.-..+=+.|..|+|..+|.|.+.+ +.+.           ...
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~  100 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGE  100 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------ccc
Confidence            4788888765 57999999999999999987762 22223444557899999999988774 2111           112


Q ss_pred             CccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCC
Q 018487          278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIK  315 (355)
Q Consensus       278 ~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~  315 (355)
                      ..+.|||... ...+.+.=|||||+++|.-+-=..|=.
T Consensus       101 ~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~  137 (229)
T 2yle_A          101 PPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN  137 (229)
T ss_dssp             ------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             cCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc
Confidence            3456787753 344577889999999999886444433

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.70  E-value=0.0039  Score=58.51  Aligned_cols=82  Identities=17%  Similarity=0.150  Sum_probs=47.7

Q ss_pred             EEEeeeccCCcEEEEEEEEcCCCC--CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcc-eecceeeecCCe
Q 018487          113 EIFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI-VQLRYSFQTRSK  189 (355)
Q Consensus       113 ~~~~~lG~G~~g~V~~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~  189 (355)
                      .-++.|..|-...+|++.......  ...++.+++|+.....   ...+ ...+|..+++.+...++ .++++.+.  + 
T Consensus        73 ~~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~i-dR~~E~~~l~~L~~~gi~P~l~~~~~--~-  145 (424)
T 3mes_A           73 IEVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFY-DSKVELDVFRYLSNINIAPNIIADFP--E-  145 (424)
T ss_dssp             EEEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCC-CHHHHHHHHHHHHHTTSSCCEEEEET--T-
T ss_pred             eEEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhc-CHHHHHHHHHHHHhcCCCCCEEEEcC--C-
Confidence            345678888889999988642110  0114678999865432   1111 13457777777753233 34444332  2 


Q ss_pred             EEEEEeccCCCCh
Q 018487          190 LYLILDFINGGHL  202 (355)
Q Consensus       190 ~~lv~e~~~~gsL  202 (355)
                       ++||||++|..|
T Consensus       146 -~~I~efI~G~~l  157 (424)
T 3mes_A          146 -GRIEEFIDGEPL  157 (424)
T ss_dssp             -EEEEECCCSEEC
T ss_pred             -CEEEEEeCCccC
Confidence             789999998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=96.24  E-value=0.021  Score=53.08  Aligned_cols=29  Identities=31%  Similarity=0.518  Sum_probs=25.1

Q ss_pred             CeeccCCCCcEEe------cCCCcEEEEecCCccc
Q 018487          236 IVHRDLKPENILM------DSDGHVMLTDFGLAKE  264 (355)
Q Consensus       236 iiHrDlkp~NILl------~~~~~~kl~Dfg~a~~  264 (355)
                      ++|+|+.+.|||+      ++++.++++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999      4567899999998863

>3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A

Probab=86.94  E-value=11  Score=36.60  Aligned_cols=25  Identities=28%  Similarity=0.527  Sum_probs=22.9

Q ss_pred             ccCCCCcEEecCCCcEEEEecCCcc
Q 018487          239 RDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       239 rDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      +|=.++||||+.+|.+.=+|||.+-
T Consensus       477 gDRH~~NILld~tG~v~HIDFG~~f  501 (614)
T 3ls8_A          477 GDRHLDNLLLTKTGKLFHIDFGYIL  501 (614)
T ss_dssp             CCCCTTSEEECTTSCEEECCCSSCT
T ss_pred             cCCCCcceeEcCCCCEeeeehHHhh
Confidence            5888999999999999999999874

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=85.62  E-value=2.6  Score=35.17  Aligned_cols=117  Identities=12%  Similarity=0.135  Sum_probs=75.9

Q ss_pred             cCCCcceecceeeecCCeEEEEEeccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC
Q 018487          172 VTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS  250 (355)
Q Consensus       172 l~h~nIv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~  250 (355)
                      ..||+.+.. ..-...+.+.+.++.-+.+ ++ ..+   ..++....+.++.+|+....++  ..-+|--|.|+||+++.
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f-~~i---k~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~  114 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPF-DNI---KSFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTR  114 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCCTTSEEG-GGG---GGSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECT
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcCcccCCH-HHH---HhcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcC
Confidence            357888766 4556667777777765433 22 222   2357788888888888777443  44578889999999999


Q ss_pred             CCcEEEEecCCccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCC
Q 018487          251 DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKS  316 (355)
Q Consensus       251 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~  316 (355)
                      ++.+++.-.|+-..+                +|.     .++...=+-.+=+++..+++++..|..
T Consensus       115 ~~~p~i~~RGik~~l----------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~  159 (215)
T 4ann_A          115 DGLPIAKTRGLQNVV----------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDA  159 (215)
T ss_dssp             TSCEEESCCEETTTB----------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred             CCCEEEEEccCccCC----------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            999999877754322                111     112222233456777778888777754

>2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A*

Probab=85.40  E-value=8.7  Score=38.00  Aligned_cols=25  Identities=28%  Similarity=0.575  Sum_probs=23.2

Q ss_pred             ccCCCCcEEecCCCcEEEEecCCcc
Q 018487          239 RDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       239 rDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      +|-.++||||+.+|.+.-+|||.+-
T Consensus       551 GDRH~~NILid~tG~v~HIDFG~~f  575 (696)
T 2x6h_A          551 GDRHLDNLLLTTNGKLFHIDFGYIL  575 (696)
T ss_dssp             CCCCTTTEEECTTSCEEECCCCSCT
T ss_pred             CCCCCcceEEeCCCCEEEEeehhhh
Confidence            6889999999999999999999874

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=84.24  E-value=2.2  Score=35.76  Aligned_cols=116  Identities=13%  Similarity=0.128  Sum_probs=73.8

Q ss_pred             CCCcceecceeeecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHHCCCeeccCCCCcEEecCC
Q 018487          173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS-HLHKCGIVHRDLKPENILMDSD  251 (355)
Q Consensus       173 ~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~-~LH~~~iiHrDlkp~NILl~~~  251 (355)
                      .||++ . ...-..++.+.+.++.-+++.-+..+   ..++....+.++.+|+.... ++  ..-+|--|.|+||+++.+
T Consensus        48 ~~~~f-~-~~I~~~eD~~~i~y~~~~~~~~f~~i---~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~  120 (219)
T 4ano_A           48 VDPCI-V-RDIDVSEDEVKVVIKPPSSFLTFAAI---RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA  120 (219)
T ss_dssp             SCSSS-E-EEEEECSSEEEEEEECCTTCEEHHHH---HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred             cCCCC-C-eEEEEeCCEEEEEEEcCcccCcHHHH---HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence            57777 3 34446677788887775444333333   23677888888877766554 33  456788899999999999


Q ss_pred             CcEEEEecCCccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCC
Q 018487          252 GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKS  316 (355)
Q Consensus       252 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~  316 (355)
                      +.+++.-.|+-..+                +|..     .+...=+-.+=|++..++.++..|..
T Consensus       121 ~~p~i~hRGi~~~l----------------pP~e-----~~ee~fl~qyKali~all~~K~~Fe~  164 (219)
T 4ano_A          121 LEPFFLHVGVKESL----------------PPDE-----WDDERLLREVKATVLALTEGEYRFDE  164 (219)
T ss_dssp             CCEEESCCEETTTB----------------SSCS-----CCHHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred             CcEEEEEcCCcccC----------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            99999987754332                2211     11111223455677777777777654

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=84.06  E-value=0.064  Score=50.87  Aligned_cols=63  Identities=8%  Similarity=0.062  Sum_probs=16.0

Q ss_pred             EEEeeeccCCcEEEEEEEEcCCCCCCCCceEEE------EEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAM------KVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       113 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vav------K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      .+.++||   ||.||++.++.     ....||+      |..+... ...+....+.+|..+++.++|+|+++.+.+-
T Consensus       145 ~l~~~lG---fG~v~~g~~~~-----~~~~Vav~~~~~~K~~~~~~-~~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYK-----KHMPVLKETHDERDSTGQDG-VSEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             CSTTTSS---BCCC--------------CCBGGGC------------------------------------CBCCCEE
T ss_pred             cccccCC---chhhhcccccc-----cCCchhhhhccCcccccccc-ccccccccccccccccccccccccCCCcceE
Confidence            4456676   99999998763     1235777      6554432 2233445577788899999999999876553

>1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3

Probab=80.01  E-value=9.8  Score=33.98  Aligned_cols=135  Identities=13%  Similarity=0.167  Sum_probs=74.4

Q ss_pred             eEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceeccee--------
Q 018487          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS--------  183 (355)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~--------  183 (355)
                      ++.++..-.|..|.++.+.        .+..|+||-..      ....+.+..++...-.+.-|+..-+...        
T Consensus        71 v~~I~~s~~Gstgvff~~t--------d~~~~VVK~s~------~l~~E~l~s~LA~~LGlpiP~~Riv~~~~~E~~e~~  136 (342)
T 1cja_A           71 FKGIERSEKGTEGLFFVET--------ESGVFIVKRST------NIESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNML  136 (342)
T ss_dssp             EEEEEECCSTTSCEEEEEE--------SSCEEEEECCT------THHHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHHH
T ss_pred             eeEEEeccCCCCCeEEEEe--------CCCEEEEeCcH------HHHHHHHHHHHHHHhCCCCCCeeEEeeCcHHHHHHH
Confidence            7777888788766555444        25578888541      2233445555655556666653221100        


Q ss_pred             -----e---------ecCCeEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHH--HHHHHHHHHCC----Ce-ecc
Q 018487          184 -----F---------QTRSKLYLILDFINGGHLFFHLYR--QGIFREDQARFYTAEI--VSAVSHLHKCG----IV-HRD  240 (355)
Q Consensus       184 -----~---------~~~~~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~ql--~~~L~~LH~~~----ii-HrD  240 (355)
                           +         ...+.+.++|+|.+|..|...-..  ...+.++    .++++  +-+++.+..++    .+ +.-
T Consensus       137 ~~L~~~~~~~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~~----~~k~LG~Ii~FDi~InN~DR~Pl~W~n~  212 (342)
T 1cja_A          137 ECLAAIDKSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKS----TMQQLGSLMALDVIVNNSDRLPIAWTNE  212 (342)
T ss_dssp             HHHHHHCSSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHH----HHHHHHHHHHHHHHHTCCSSSCSSSCSC
T ss_pred             HHHHHhhhhhHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCHH----HHHhhchhheehhhhcCCccCcccccCC
Confidence                 0         012356799999997665321110  0112222    23343  23455555543    11 123


Q ss_pred             CCCCcEEecCCCc-EEEEecCCccc
Q 018487          241 LKPENILMDSDGH-VMLTDFGLAKE  264 (355)
Q Consensus       241 lkp~NILl~~~~~-~kl~Dfg~a~~  264 (355)
                      -.++|||++.++. +.++|-+++..
T Consensus       213 GN~~NIL~~~~n~~~~~IDhn~af~  237 (342)
T 1cja_A          213 GNLDNIMLSERGATVVPIDSKIIPL  237 (342)
T ss_dssp             CCGGGEEEESBTTCEEECSCCCCCC
T ss_pred             CChhheEEeCCCCeEEEEcCCcccc
Confidence            5899999987554 99999998854

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	355
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-70
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-69
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-68
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-63
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-62
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	7e-62
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-61
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-61
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	9e-61
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-60
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-60
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-59
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-59
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-58
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-58
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-58
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-57
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-56
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-56
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	7e-56
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-55
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-55
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-55
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-54
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-53
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-53
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	7e-53
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-53
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-52
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-51
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-51
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-51
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-51
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-51
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	9e-51
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-50
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	6e-50
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-49
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-49
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-49
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-49
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-48
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-48
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-48
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-48
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-48
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	7e-48
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	9e-48
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-47
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-47
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-46
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-45
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-44
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-44
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-44
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-44
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-44
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-43
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	8e-43
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-42
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-41
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	8e-33
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	9e-18

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (558), Expect = 3e-70
 Identities = 87/210 (41%), Positives = 134/210 (63%), Gaps = 8/210 (3%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
           RK  P DF+  +++G+G+F  V   ++       +   YA+K++ K  IIK+N V Y+  
Sbjct: 3   RKKRPEDFKFGKILGEGSFSTVVLAREL-----ATSREYAIKILEKRHIIKENKVPYVTR 57

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ERD+++++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEI
Sbjct: 58  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 117

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYM 281
           VSA+ +LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+NS  GT +Y+
Sbjct: 118 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           +PE+L  K   K +D W++G ++Y+++ G 
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGL 207

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (550), Expect = 3e-69
 Identities = 70/201 (34%), Positives = 118/201 (58%), Gaps = 6/201 (2%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI R +G+G FG V+  ++K      S  I A+KV+ K  + K      ++ E +I +
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREK-----QSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 61

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E+ +A+S+
Sbjct: 62  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 121

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
            H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ PE++  + 
Sbjct: 122 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRM 180

Query: 291 HNKDADWWSVGILLYEMLTGQ 311
           H++  D WS+G+L YE L G+
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGK 201

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (547), Expect = 3e-68
 Identities = 62/202 (30%), Positives = 107/202 (52%), Gaps = 9/202 (4%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE    +G G  G VF+V  K      S  + A K++  +  IK    + +  E  +L 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHK-----PSGLVMARKLIHLE--IKPAIRNQIIRELQVLH 59

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  ++  +++
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119

Query: 231 LH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           L  K  I+HRD+KP NIL++S G + L DFG++ ++ + S +NS  GT  YM+PE L   
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGT 178

Query: 290 GHNKDADWWSVGILLYEMLTGQ 311
            ++  +D WS+G+ L EM  G+
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGR 200

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 3e-63
 Identities = 63/240 (26%), Positives = 119/240 (49%), Gaps = 15/240 (6%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            D+++ + +G+GA+G+V     +      ++   A+K++     +     + +K E  I 
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNR-----VTEEAVAVKIVDMKRAVDC--PENIKKEICIN 57

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + H  +V+     +  +  YL L++ +GG LF  +       E  A+ +  ++++ V 
Sbjct: 58  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 117

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 118 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177

Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLIIFHCLFVNSLELLS 345
             +  H +  D WS GI+L  ML G++          ++   +        ++N  + + 
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS----DSCQEYSDWKEKKTYLNPWKKID 233

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 3e-62
 Identities = 67/216 (31%), Positives = 113/216 (52%), Gaps = 16/216 (7%)

Query: 104 ERKIGPGD-FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
            R + P D +EI   +G GAFGKV++ + K     ++  + A KV+       +  ++  
Sbjct: 5   TRDLNPEDFWEIIGELGDGAFGKVYKAQNK-----ETSVLAAAKVIDTK---SEEELEDY 56

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYT 221
             E DIL    HP IV+L  +F   + L+++++F  GG +   +   +    E Q +   
Sbjct: 57  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVC 116

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEY 280
            + + A+++LH   I+HRDLK  NIL   DG + L DFG++ +   +  R +S  GT  +
Sbjct: 117 KQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYW 176

Query: 281 MAPEILLS-----KGHNKDADWWSVGILLYEMLTGQ 311
           MAPE+++      + ++  AD WS+GI L EM   +
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE 212

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  198 bits (504), Expect = 7e-62
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 11/203 (5%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F   R +G G+FG V+  +        +  + A+K M             +  E   L K
Sbjct: 17  FSDLREIGHGSFGAVYFARDV-----RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP  +Q R  +      +L++++  G         +   +E +    T   +  +++L
Sbjct: 72  LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS--- 288
           H   ++HRD+K  NIL+   G V L DFG A  +     +NS  GT  +MAPE++L+   
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDE 188

Query: 289 KGHNKDADWWSVGILLYEMLTGQ 311
             ++   D WS+GI   E+   +
Sbjct: 189 GQYDGKVDVWSLGITCIELAERK 211

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  198 bits (505), Expect = 2e-61
 Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 11/204 (5%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            ++I   +G GAFG V +V ++      +   +A K +       ++  + ++ E   ++
Sbjct: 27  HYDIHEELGTGAFGVVHRVTER-----ATGNNFAAKFVMTP---HESDKETVRKEIQTMS 78

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + HP +V L  +F+  +++ +I +F++GG LF  +  +     ED+A  Y  ++   + 
Sbjct: 79  VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 138

Query: 230 HLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           H+H+   VH DLKPENI+  +     + L DFGL   +D         GT E+ APE+  
Sbjct: 139 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE 198

Query: 288 SKGHNKDADWWSVGILLYEMLTGQ 311
            K      D WSVG+L Y +L+G 
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGL 222

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  197 bits (502), Expect = 4e-61
 Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 11/205 (5%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             ++I   +G GAFG V +  +K      +  ++  K +     + K  V   K E  I+
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEK-----ATGRVFVAKFINTPYPLDKYTV---KNEISIM 80

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAV 228
            ++ HP ++ L  +F+ + ++ LIL+F++GG LF  +  +     E +   Y  +    +
Sbjct: 81  NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGL 140

Query: 229 SHLHKCGIVHRDLKPENILMDS--DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEIL 286
            H+H+  IVH D+KPENI+ ++     V + DFGLA +++          T E+ APEI+
Sbjct: 141 KHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 200

Query: 287 LSKGHNKDADWWSVGILLYEMLTGQ 311
             +      D W++G+L Y +L+G 
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGL 225

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 9e-61
 Identities = 82/203 (40%), Positives = 132/203 (65%), Gaps = 7/203 (3%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF + +++G+G+FGKVF  + K      ++  +A+K ++KD ++  + V+    E+ +L+
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFK-----KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS 57

Query: 171 KV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
               HPF+  +  +FQT+  L+ +++++NGG L +H+     F   +A FY AEI+  + 
Sbjct: 58  LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 117

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPEILLS 288
            LH  GIV+RDLK +NIL+D DGH+ + DFG+ KE     +++N+ CGT +Y+APEILL 
Sbjct: 118 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG 177

Query: 289 KGHNKDADWWSVGILLYEMLTGQ 311
           + +N   DWWS G+LLYEML GQ
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQ 200

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 5e-60
 Identities = 64/222 (28%), Positives = 108/222 (48%), Gaps = 14/222 (6%)

Query: 95  NDAELEAESERKIGPGD----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRK 150
           +D E+  +    +  GD    +  F  +GQGA G V+           +    A++ M  
Sbjct: 1   SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDV-----ATGQEVAIRQMNL 55

Query: 151 DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG 210
               KK  +     E  ++ +  +P IV    S+    +L+++++++ GG L   +    
Sbjct: 56  QQQPKKELI---INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC 112

Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESS 269
              E Q      E + A+  LH   ++HRD+K +NIL+  DG V LTDFG   +I  E S
Sbjct: 113 -MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171

Query: 270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           + ++M GT  +MAPE++  K +    D WS+GI+  EM+ G+
Sbjct: 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 6e-60
 Identities = 63/255 (24%), Positives = 110/255 (43%), Gaps = 25/255 (9%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I  G   + + +G G+FG V++ K  G          A+K++       +  +   K E 
Sbjct: 5   IPDGQITVGQRIGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQ-QLQAFKNEV 55

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIV 225
            +L K  H  I+     + T  +L ++  +  G  L+ HL+  +  F   +      +  
Sbjct: 56  GVLRKTRHVNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 114

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMA 282
             + +LH   I+HRDLK  NI +  D  V + DFGLA      S   +   + G+  +MA
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174

Query: 283 PEILLSKGHNK---DADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLIIFHCLFVN 339
           PE++  +  N     +D ++ GI+LYE++TGQ+   ++     N       ++       
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI-----NNRDQIIFMVGRGYL-- 227

Query: 340 SLELLSHFPENCPAS 354
               LS    NCP +
Sbjct: 228 -SPDLSKVRSNCPKA 241

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  191 bits (486), Expect = 3e-59
 Identities = 73/204 (35%), Positives = 116/204 (56%), Gaps = 10/204 (4%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            ++   V+G GAF +V   + K      +  + A+K + K  +  +     M+ E  +L 
Sbjct: 10  IYDFRDVLGTGAFSEVILAEDK-----RTQKLVAIKCIAKKAL--EGKEGSMENEIAVLH 62

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           K+ HP IV L   +++   LYLI+  ++GG LF  +  +G + E  A     +++ AV +
Sbjct: 63  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 122

Query: 231 LHKCGIVHRDLKPENIL---MDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           LH  GIVHRDLKPEN+L   +D D  +M++DFGL+K  D  S  ++ CGT  Y+APE+L 
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA 182

Query: 288 SKGHNKDADWWSVGILLYEMLTGQ 311
            K ++K  D WS+G++ Y +L G 
Sbjct: 183 QKPYSKAVDCWSIGVIAYILLCGY 206

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  189 bits (481), Expect = 6e-59
 Identities = 68/214 (31%), Positives = 112/214 (52%), Gaps = 18/214 (8%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK------A 164
           ++E   ++G+G    V +   K      +   YA+K++        +  +  +       
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHK-----PTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 58

Query: 165 ERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
           E DIL KV  HP I+QL+ +++T +  +L+ D +  G LF +L  +    E + R     
Sbjct: 59  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 118

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           ++  +  LHK  IVHRDLKPENIL+D D ++ LTDFG + ++D   +   +CGT  Y+AP
Sbjct: 119 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178

Query: 284 EILLS------KGHNKDADWWSVGILLYEMLTGQ 311
           EI+         G+ K+ D WS G+++Y +L G 
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (477), Expect = 2e-58
 Identities = 54/213 (25%), Positives = 109/213 (51%), Gaps = 18/213 (8%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+E+   +G G++G+  ++++K         I   K +   ++ +      + +E ++L 
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRK-----SDGKILVWKELDYGSMTEAE-KQMLVSEVNLLR 58

Query: 171 KVTHPFIVQLRYSF--QTRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEI 224
           ++ HP IV+       +T + LY+++++  GG L   + +    +    E+       ++
Sbjct: 59  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 118

Query: 225 VSAVSHLHKCG-----IVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTT 278
             A+   H+       ++HRDLKP N+ +D   +V L DFGLA+ ++ ++S + +  GT 
Sbjct: 119 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTP 178

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
            YM+PE +    +N+ +D WS+G LLYE+    
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 211

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 4e-58
 Identities = 89/207 (42%), Positives = 139/207 (67%), Gaps = 6/207 (2%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G FGKV  V++K      +   YAMK++RK+ II K+ V +   E
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREK-----ATGRYYAMKILRKEVIIAKDEVAHTVTE 55

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPE 284
           SA+ +LH   +V+RD+K EN+++D DGH+ +TDFGL KE   + +   + CGT EY+APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQ 311
           +L    + +  DWW +G+++YEM+ G+
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  190 bits (483), Expect = 4e-58
 Identities = 83/205 (40%), Positives = 124/205 (60%), Gaps = 10/205 (4%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF + R++G+G FG+V+  +K      D+  +YAMK + K  I  K        ER +L+
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKA-----DTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 59

Query: 171 KVT---HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
            V+    PFIV + Y+F T  KL  ILD +NGG L +HL + G+F E   RFY AEI+  
Sbjct: 60  LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 119

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + H+H   +V+RDLKP NIL+D  GHV ++D GLA +  +  + ++  GT  YMAPE+L 
Sbjct: 120 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQ 178

Query: 288 S-KGHNKDADWWSVGILLYEMLTGQ 311
               ++  ADW+S+G +L+++L G 
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGH 203

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  186 bits (473), Expect = 4e-57
 Identities = 85/201 (42%), Positives = 136/201 (67%), Gaps = 7/201 (3%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+I R +G G+FG+V  ++ +      +   YAMKV++K+ +++   V++   ER +L+
Sbjct: 5   DFQILRTLGTGSFGRVHLIRSR-----HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 59

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            VTHPFI+++  +FQ   ++++I+D+I GG LF  L +   F    A+FY AE+  A+ +
Sbjct: 60  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
           LH   I++RDLKPENIL+D +GH+ +TDFG AK + +   + ++CGT +Y+APE++ +K 
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTKP 177

Query: 291 HNKDADWWSVGILLYEMLTGQ 311
           +NK  DWWS GIL+YEML G 
Sbjct: 178 YNKSIDWWSFGILIYEMLAGY 198

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 1e-56
 Identities = 60/208 (28%), Positives = 109/208 (52%), Gaps = 12/208 (5%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN---HVDYMKAERD 167
            ++    +G G F  V + ++K      +   YA K ++K            + ++ E  
Sbjct: 11  YYDTGEELGSGQFAVVKKCREK-----STGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65

Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           IL ++ HP ++ L   ++ ++ + LIL+ + GG LF  L  +    E++A  +  +I++ 
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 125

Query: 228 VSHLHKCGIVHRDLKPENILMDSDG----HVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           V +LH   I H DLKPENI++         + + DFGLA +ID  +   ++ GT E++AP
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQ 311
           EI+  +    +AD WS+G++ Y +L+G 
Sbjct: 186 EIVNYEPLGLEADMWSIGVITYILLSGA 213

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 2e-56
 Identities = 51/207 (24%), Positives = 101/207 (48%), Gaps = 15/207 (7%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
            +    +G+G+F  V++         ++    A   ++   + K +     K E ++L  
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDT-----ETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKG 64

Query: 172 VTHPFIVQLRYSFQTRSK----LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           + HP IV+   S+++  K    + L+ + +  G L  +L R  + +    R +  +I+  
Sbjct: 65  LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKG 124

Query: 228 VSHLHKCG--IVHRDLKPENILMDS-DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
           +  LH     I+HRDLK +NI +    G V + D GLA  +  +S + ++ GT E+MAPE
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPE 183

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQ 311
           +   + +++  D ++ G+ + EM T +
Sbjct: 184 M-YEEKYDESVDVYAFGMCMLEMATSE 209

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  184 bits (467), Expect = 7e-56
 Identities = 90/230 (39%), Positives = 143/230 (62%), Gaps = 7/230 (3%)

Query: 82  SSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG 141
            S+   + + + +   + E  S+       F+  + +G G+FG+V  VK K     +S  
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK-----ESGN 67

Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
            YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG 
Sbjct: 68  HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127

Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           +F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG 
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF 187

Query: 262 AKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           AK +    R+ ++CGT E +APEI+LSKG+NK  DWW++G+L+YEM  G 
Sbjct: 188 AKRVK--GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 2e-55
 Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 17/207 (8%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +   + ++ + +G+G FG V     +G          A+K ++ D   +        AE 
Sbjct: 4   LNMKELKLLQTIGKGEFGDVMLGDYRG-------NKVAVKCIKNDATAQA-----FLAEA 51

Query: 167 DILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAE 223
            ++T++ H  +VQL     + +  LY++ +++  G L  +L  +G  +   D    ++ +
Sbjct: 52  SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 111

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  A+ +L     VHRDL   N+L+  D    ++DFGL KE   SS  ++     ++ AP
Sbjct: 112 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA--SSTQDTGKLPVKWTAP 169

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTG 310
           E L  K  +  +D WS GILL+E+ + 
Sbjct: 170 EALREKKFSTKSDVWSFGILLWEIYSF 196

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  179 bits (456), Expect = 4e-55
 Identities = 52/210 (24%), Positives = 106/210 (50%), Gaps = 13/210 (6%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             +E+  ++G G   +V   +             A+KV+R D     +     + E    
Sbjct: 7   DRYELGEILGFGGMSEVHLARDL-----RLHRDVAVKVLRADLARDPSFYLRFRREAQNA 61

Query: 170 TKVTHPFIVQLRYSFQTRSK----LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             + HP IV +  + +  +      Y+++++++G  L   ++ +G     +A    A+  
Sbjct: 62  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 121

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES----SRSNSMCGTTEYM 281
            A++  H+ GI+HRD+KP NI++ +   V + DFG+A+ I +S    +++ ++ GT +Y+
Sbjct: 122 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           +PE       +  +D +S+G +LYE+LTG+
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGE 211

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 7e-55
 Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 12/204 (5%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            + I   +G+G FG V +  +       S   Y  K ++     K      +K E  IL 
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVET-----SSKKTYMAKFVKV----KGTDQVLVKKEISILN 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVS 229
              H  I+ L  SF++  +L +I +FI+G  +F  +        E +   Y  ++  A+ 
Sbjct: 57  IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116

Query: 230 HLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
            LH   I H D++PENI+  +     + + +FG A+++        +    EY APE+  
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176

Query: 288 SKGHNKDADWWSVGILLYEMLTGQ 311
               +   D WS+G L+Y +L+G 
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGI 200

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 4e-54
 Identities = 112/232 (48%), Positives = 162/232 (69%), Gaps = 10/232 (4%)

Query: 87  QIQELEHE-NDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAM 145
           Q+  ++HE   A L   +E+ +G  +FE+ +V+G GA+GKVF V+K  +   D+  +YAM
Sbjct: 1   QLLTVKHELRTANLTGHAEK-VGIENFELLKVLGTGAYGKVFLVRK--ISGHDTGKLYAM 57

Query: 146 KVMRKDTIIKK-NHVDYMKAERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           KV++K TI++K    ++ + ER +L  +   PF+V L Y+FQT +KL+LILD+INGG LF
Sbjct: 58  KVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELF 117

Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK 263
            HL ++  F E + + Y  EIV A+ HLHK GI++RD+K ENIL+DS+GHV+LTDFGL+K
Sbjct: 118 THLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 177

Query: 264 EID--ESSRSNSMCGTTEYMAPEILLSK--GHNKDADWWSVGILLYEMLTGQ 311
           E    E+ R+   CGT EYMAP+I+     GH+K  DWWS+G+L+YE+LTG 
Sbjct: 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 1e-53
 Identities = 46/208 (22%), Positives = 87/208 (41%), Gaps = 8/208 (3%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           IG  D  +   +G G+FG V + +             A+K ++ D + +   +D    E 
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDA--PSGKTVSVAVKCLKPDVLSQPEAMDDFIREV 62

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIV 225
           + +  + H  +++L Y       + ++ +    G L   L   QG F       Y  ++ 
Sbjct: 63  NAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS----RSNSMCGTTEYM 281
             + +L     +HRDL   N+L+ +   V + DFGL + + ++               + 
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT 309
           APE L ++  +  +D W  G+ L+EM T
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFT 209

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 2e-53
 Identities = 48/206 (23%), Positives = 98/206 (47%), Gaps = 13/206 (6%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I P D    + +G G FG V   K +G          A+K++++ ++ +         E 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRG------QYDVAIKMIKEGSMSEDE----FIEEA 50

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIV 225
            ++  ++H  +VQL      +  +++I +++  G L  +L   +  F+  Q      ++ 
Sbjct: 51  KVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVC 110

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYMAP 283
            A+ +L     +HRDL   N L++  G V ++DFGL++ +  DE + S        +  P
Sbjct: 111 EAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170

Query: 284 EILLSKGHNKDADWWSVGILLYEMLT 309
           E+L+    +  +D W+ G+L++E+ +
Sbjct: 171 EVLMYSKFSSKSDIWAFGVLMWEIYS 196

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  174 bits (442), Expect = 7e-53
 Identities = 49/212 (23%), Positives = 95/212 (44%), Gaps = 11/212 (5%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
           ++I     +I +V+G G FG+V     K    G  +   A+K ++      +       +
Sbjct: 21  KEIDISCVKIEQVIGAGEFGEVCSGHLK--LPGKREIFVAIKTLKSGYT--EKQRRDFLS 76

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGIFREDQARFYTAE 223
           E  I+ +  HP ++ L       + + +I +F+  G L  F     G F   Q       
Sbjct: 77  EASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRG 136

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS------RSNSMCGT 277
           I + + +L     VHRDL   NIL++S+    ++DFGL++ +++ +       +      
Sbjct: 137 IAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 196

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             + APE +  +     +D WS GI+++E+++
Sbjct: 197 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 228

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 7e-53
 Identities = 56/249 (22%), Positives = 103/249 (41%), Gaps = 29/249 (11%)

Query: 89  QELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM 148
            E  + +  E E + + +    + E  +V+G GAFGKV      G+         A+K++
Sbjct: 16  NEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML 75

Query: 149 RKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           ++      +  + + +E  ++T++  H  IV L  +      +YLI ++   G L  +L 
Sbjct: 76  KEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLR 133

Query: 208 RQ-----------------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPE 244
            +                        +   +    +  ++   +  L     VHRDL   
Sbjct: 134 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193

Query: 245 NILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEILLSKGHNKDADWWSVG 301
           N+L+     V + DFGLA++I   S      +     ++MAPE L    +   +D WS G
Sbjct: 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYG 253

Query: 302 ILLYEMLTG 310
           ILL+E+ + 
Sbjct: 254 ILLWEIFSL 262

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 3e-52
 Identities = 43/207 (20%), Positives = 101/207 (48%), Gaps = 13/207 (6%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I P +    + +G G FG V            +    A+K +R+  + +++       E 
Sbjct: 2   IDPSELTFVQEIGSGQFGLVHLGYWL------NKDKVAIKTIREGAMSEED----FIEEA 51

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGIFREDQARFYTAEIV 225
           +++ K++HP +VQL      ++ + L+ +F+  G L  +   ++G+F  +       ++ 
Sbjct: 52  EVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 111

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYMAP 283
             +++L +  ++HRDL   N L+  +  + ++DFG+ + +  D+ + S       ++ +P
Sbjct: 112 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 171

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTG 310
           E+     ++  +D WS G+L++E+ + 
Sbjct: 172 EVFSFSRYSSKSDVWSFGVLMWEVFSE 198

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 2e-51
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 15/208 (7%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I      +   +GQG FG+V+     G          A+K ++  T+  +        E 
Sbjct: 14  IPRESLRLEVKLGQGCFGEVWMGTWNG------TTRVAIKTLKPGTMSPEA----FLQEA 63

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEI 224
            ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A+I
Sbjct: 64  QVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 122

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYMA 282
            S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I  +E +         ++ A
Sbjct: 123 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 182

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTG 310
           PE  L       +D WS GILL E+ T 
Sbjct: 183 PEAALYGRFTIKSDVWSFGILLTELTTK 210

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 2e-51
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 9/203 (4%)

Query: 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA--ERDILT 170
           E    +G+G F  V++ + K     +++ I A+K ++     +        A  E  +L 
Sbjct: 1   EKLDFLGEGQFATVYKARDK-----NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 55

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +++HP I+ L  +F  +S + L+ DF+             +      + Y    +  + +
Sbjct: 56  ELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEY 115

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM-CGTTEYMAPEILLS- 288
           LH+  I+HRDLKP N+L+D +G + L DFGLAK     +R+ +    T  Y APE+L   
Sbjct: 116 LHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGA 175

Query: 289 KGHNKDADWWSVGILLYEMLTGQ 311
           + +    D W+VG +L E+L   
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRV 198

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 2e-51
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 14/210 (6%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK---AER 166
             +++  ++G G FG V+   +        +   A+K + KD I     +        E 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRV-----SDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 58

Query: 167 DILTKVT--HPFIVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAE 223
            +L KV+     +++L   F+      LIL+       LF  +  +G  +E+ AR +  +
Sbjct: 59  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 118

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           ++ AV H H CG++HRD+K ENIL+D + G + L DFG    + + +      GT  Y  
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSP 177

Query: 283 PEILL-SKGHNKDADWWSVGILLYEMLTGQ 311
           PE +   + H + A  WS+GILLY+M+ G 
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 4e-51
 Identities = 39/198 (19%), Positives = 87/198 (43%), Gaps = 9/198 (4%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G G FG V +   +           A+K+++ +        D + AE +++ ++ +P
Sbjct: 13  KELGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNE-ANDPALKDELLAEANVMQQLDNP 68

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
           +IV++           L+++    G L  +L +    ++        ++   + +L +  
Sbjct: 69  YIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 127

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKEIDES----SRSNSMCGTTEYMAPEILLSKGH 291
            VHRDL   N+L+ +  +  ++DFGL+K +                 ++ APE +     
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187

Query: 292 NKDADWWSVGILLYEMLT 309
           +  +D WS G+L++E  +
Sbjct: 188 SSKSDVWSFGVLMWEAFS 205

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  169 bits (429), Expect = 6e-51
 Identities = 44/228 (19%), Positives = 96/228 (42%), Gaps = 29/228 (12%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           + E  R +G+GAFG+VFQ +  G+   +   + A+K+++++     +     + E  ++ 
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMA 71

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-------------------- 210
           +  +P IV+L         + L+ +++  G L   L                        
Sbjct: 72  EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131

Query: 211 ----IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID 266
                    +      ++ + +++L +   VHRDL   N L+  +  V + DFGL++ I 
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191

Query: 267 ESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
            +       +      +M PE +    +  ++D W+ G++L+E+ +  
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 9e-51
 Identities = 68/253 (26%), Positives = 122/253 (48%), Gaps = 26/253 (10%)

Query: 110 GDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
            D+++  +V+G G  GKV Q+  K      +   +A+K+++     ++        E ++
Sbjct: 11  DDYKVTSQVLGLGINGKVLQIFNK-----RTQEKFALKMLQDCPKARR--------EVEL 57

Query: 169 LTKVT-HPFIVQLRYSFQT----RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYT 221
             + +  P IV++   ++     R  L ++++ ++GG LF  +  +G   F E +A    
Sbjct: 58  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 117

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTT 278
             I  A+ +LH   I HRD+KPEN+L  S   +  + LTDFG AKE    +   + C T 
Sbjct: 118 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP 177

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLIIFHCLFV 338
            Y+APE+L  + ++K  D WS+G+++Y +L G     S   +A +  +   + +    F 
Sbjct: 178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237

Query: 339 NSLELLSHFPENC 351
           N     S   E  
Sbjct: 238 N--PEWSEVSEEV 248

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 2e-50
 Identities = 47/208 (22%), Positives = 95/208 (45%), Gaps = 15/208 (7%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +     ++   +G G FG+V+     G          A+K +++ ++          AE 
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYNG------HTKVAVKSLKQGSMSPDA----FLAEA 59

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFR--EDQARFYTAEI 224
           +++ ++ H  +V+L Y+  T+  +Y+I +++  G L   L      +   ++     A+I
Sbjct: 60  NLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMA 282
              ++ + +   +HRDL+  NIL+       + DFGLA+ I+++            ++ A
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 178

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTG 310
           PE +        +D WS GILL E++T 
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTH 206

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 6e-50
 Identities = 49/205 (23%), Positives = 93/205 (45%), Gaps = 15/205 (7%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            D E+    G G FG V Q   +           A+KV+++ T  +K   + M  E  I+
Sbjct: 13  ADIEL----GCGNFGSVRQGVYRMRKKQI---DVAIKVLKQGT--EKADTEEMMREAQIM 63

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAV 228
            ++ +P+IV+L    Q    L L+++   GG L   L  +              ++   +
Sbjct: 64  HQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 122

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES----SRSNSMCGTTEYMAPE 284
            +L +   VHRDL   N+L+ +  +  ++DFGL+K +       +  ++     ++ APE
Sbjct: 123 KYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 182

Query: 285 ILLSKGHNKDADWWSVGILLYEMLT 309
            +  +  +  +D WS G+ ++E L+
Sbjct: 183 CINFRKFSSRSDVWSYGVTMWEALS 207

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 1e-49
 Identities = 49/240 (20%), Positives = 99/240 (41%), Gaps = 24/240 (10%)

Query: 93  HENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDT 152
           + +  +L  + + +         + +G GAFGKV +    G+   D+    A+K+++   
Sbjct: 6   YIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA 65

Query: 153 IIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR--- 208
            +     + + +E  +L+ +  H  IV L  +        +I ++   G L   L R   
Sbjct: 66  HLT--EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 123

Query: 209 ---------------QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH 253
                          +     +    ++ ++   ++ L     +HRDL   NIL+     
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI 183

Query: 254 VMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
             + DFGLA++I   S      +     ++MAPE + +  +  ++D WS GI L+E+ + 
Sbjct: 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 1e-49
 Identities = 51/216 (23%), Positives = 94/216 (43%), Gaps = 20/216 (9%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             +E    +GQG FG+VF+ + +      +    A+K +  +   +   +  ++ E  IL
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHR-----KTGQKVALKKVLMENEKEGFPITALR-EIKIL 63

Query: 170 TKVTHPFIVQLRYSFQTRS--------KLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
             + H  +V L    +T++         +YL+ DF               F   + +   
Sbjct: 64  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 123

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-----NSMCG 276
             +++ + ++H+  I+HRD+K  N+L+  DG + L DFGLA+    +  S      +   
Sbjct: 124 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQ 311
           T  Y  PE+LL  + +    D W  G ++ EM T  
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  165 bits (418), Expect = 2e-49
 Identities = 50/208 (24%), Positives = 93/208 (44%), Gaps = 13/208 (6%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +   D  +   +G G +G+V++   K           A+K +++DT+  +        E 
Sbjct: 14  MERTDITMKHKLGGGQYGEVYEGVWK-----KYSLTVAVKTLKEDTMEVEE----FLKEA 64

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEI 224
            ++ ++ HP +VQL          Y+I +F+  G+L  +L              +   +I
Sbjct: 65  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 124

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYMA 282
            SA+ +L K   +HRDL   N L+  +  V + DFGL++ +  D  +         ++ A
Sbjct: 125 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTG 310
           PE L     +  +D W+ G+LL+E+ T 
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATY 212

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 4e-49
 Identities = 49/222 (22%), Positives = 92/222 (41%), Gaps = 22/222 (9%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
            +   D +   V+G+G FG+V + + K              + R      K+       E
Sbjct: 6   VLDWNDIKFQDVIGEGNFGQVLKARIK-----KDGLRMDAAIKRMKEYASKDDHRDFAGE 60

Query: 166 RDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--------------- 209
            ++L K+  HP I+ L  + + R  LYL +++   G+L   L +                
Sbjct: 61  LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 120

Query: 210 -GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES 268
                  Q   + A++   + +L +   +HRDL   NIL+  +    + DFGL++  +  
Sbjct: 121 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 180

Query: 269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            +         +MA E L    +  ++D WS G+LL+E+++ 
Sbjct: 181 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 222

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 1e-48
 Identities = 50/209 (23%), Positives = 95/209 (45%), Gaps = 6/209 (2%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAFG V++      +        A+K +R+ T  K N    +  
Sbjct: 4   RILKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKAN--KEILD 60

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  ++  V +P + +L     T +   +      G  L +    +          +  +I
Sbjct: 61  EAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYM 281
              +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +   +       ++M
Sbjct: 121 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTG 310
           A E +L + +   +D WS G+ ++E++T 
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTF 209

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 1e-48
 Identities = 48/210 (22%), Positives = 94/210 (44%), Gaps = 8/210 (3%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           +I P      +V+G G FG+V++   K    G  +   A+K ++      +        E
Sbjct: 3   EIHPSCVTRQKVIGAGEFGEVYKGMLKT-SSGKKEVPVAIKTLKAG--YTEKQRVDFLGE 59

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAEI 224
             I+ + +H  I++L         + +I +++  G    F   + G F   Q       I
Sbjct: 60  AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGI 119

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR----SNSMCGTTEY 280
            + + +L     VHRDL   NIL++S+    ++DFGL++ +++       ++       +
Sbjct: 120 AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            APE +  +     +D WS GI+++E++T 
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTY 209

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 2e-48
 Identities = 48/207 (23%), Positives = 96/207 (46%), Gaps = 8/207 (3%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I     E+ R +G+G FG V     +G+     +   A+ +         +  +    E 
Sbjct: 4   IQRERIELGRCIGEGQFGDVH----QGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 59

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIV 225
             + +  HP IV+L     T + +++I++    G L   L  R+          Y  ++ 
Sbjct: 60  LTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 118

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAP 283
           +A+++L     VHRD+   N+L+ S+  V L DFGL++ +++S+  +++      ++MAP
Sbjct: 119 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTG 310
           E +  +     +D W  G+ ++E+L  
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMH 205

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  162 bits (411), Expect = 3e-48
 Identities = 44/254 (17%), Positives = 95/254 (37%), Gaps = 26/254 (10%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             +++ R +G+G+FG +F+          ++   A+K   + +   +     ++ E    
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNL-----LNNQQVAIKFEPRRSDAPQ-----LRDEYRTY 54

Query: 170 TKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
             +     I  + Y  Q      L++D +              F          ++++ V
Sbjct: 55  KLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARV 114

Query: 229 SHLHKCGIVHRDLKPENILMDS-----DGHVMLTDFGLAKEIDESS--------RSNSMC 275
             +H+  +V+RD+KP+N L+          + + DFG+ K   +             ++ 
Sbjct: 115 QSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174

Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLIIFHC 335
           GT  YM+    L +  ++  D  ++G +    L G +  + ++  A      +  I    
Sbjct: 175 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK--AATNKQKYERIGEKK 232

Query: 336 LFVNSLELLSHFPE 349
                 EL + FPE
Sbjct: 233 QSTPLRELCAGFPE 246

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 5e-48
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 12/209 (5%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK--AERDI 168
            +E    +G+GA+GKVF    K  D  +     A+K +R  T  +   +  ++  A    
Sbjct: 8   QYECVAEIGEGAYGKVF----KARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 169 LTKVTHPFIVQLRYSFQT-----RSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTA 222
           L    HP +V+L            +KL L+ + ++     +     +     +  +    
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +++  +  LH   +VHRDLKP+NIL+ S G + L DFGLA+         S+  T  Y A
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 183

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           PE+LL   +    D WSVG +  EM   +
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRK 212

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 7e-48
 Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 23/212 (10%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            +   +V+G G+FG V+Q K       DS  + A+K + +D   K         E  I+ 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLC-----DSGELVAIKKVLQDKRFKNR-------ELQIMR 68

Query: 171 KVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLY---RQGIFREDQARFYT 221
           K+ H  IV+LRY F +  +      L L+LD++         +    +        + Y 
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCGTTEY 280
            ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     + S   +  Y
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 188

Query: 281 MAP-EILLSKGHNKDADWWSVGILLYEMLTGQ 311
            AP  I  +  +    D WS G +L E+L GQ
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  161 bits (408), Expect = 9e-48
 Identities = 45/258 (17%), Positives = 94/258 (36%), Gaps = 25/258 (9%)

Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK 163
           E ++G   + + R +G G+FG ++           +    A+K+        K     + 
Sbjct: 2   ELRVG-NRYRLGRKIGSGSFGDIYLGTDI-----AAGEEVAIKLECV-----KTKHPQLH 50

Query: 164 AERDILTKVTHP-FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
            E  I   +     I  +R+         ++++ +         +    F          
Sbjct: 51  IESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLAD 110

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESS--------RS 271
           +++S + ++H    +HRD+KP+N LM        V + DFGLAK+  ++          +
Sbjct: 111 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 170

Query: 272 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACNTMLLFYLI 331
            ++ GT  Y +    L    ++  D  S+G +L     G +  + ++  A      +  I
Sbjct: 171 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK--AATKRQKYERI 228

Query: 332 IFHCLFVNSLELLSHFPE 349
               +      L   +P 
Sbjct: 229 SEKKMSTPIEVLCKGYPS 246

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  160 bits (406), Expect = 1e-47
 Identities = 48/203 (23%), Positives = 96/203 (47%), Gaps = 9/203 (4%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            +     +G+G +G V++ +            +A+K +R +    +        E  IL 
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN------YGETFALKKIRLEKE-DEGIPSTTIREISILK 55

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ H  IV+L     T+ +L L+ + ++          +G      A+ +  ++++ +++
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-NSMCGTTEYMAPEILLSK 289
            H   ++HRDLKP+N+L++ +G + + DFGLA+      R       T  Y AP++L+  
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175

Query: 290 G-HNKDADWWSVGILLYEMLTGQ 311
             ++   D WSVG +  EM+ G 
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGT 198

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 6e-47
 Identities = 58/204 (28%), Positives = 103/204 (50%), Gaps = 9/204 (4%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F+    +G+G +G V++ + K      +  + A+K +R DT  +      ++ E  +L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNK-----LTGEVVALKKIRLDTETEGVPSTAIR-EISLLK 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFIN-GGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           ++ HP IV+L     T +KLYL+ +F++     F              + Y  +++  ++
Sbjct: 57  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR-SNSMCGTTEYMAPEILLS 288
             H   ++HRDLKP+N+L++++G + L DFGLA+      R       T  Y APEILL 
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176

Query: 289 KGHN-KDADWWSVGILLYEMLTGQ 311
             +     D WS+G +  EM+T +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRR 200

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 2e-46
 Identities = 49/204 (24%), Positives = 92/204 (45%), Gaps = 8/204 (3%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            +E    +G+G +G VF+ K +     ++  I A+K +R D    +        E  +L 
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNR-----ETHEIVALKRVRLDDD-DEGVPSSALREICLLK 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ H  IV+L     +  KL L+ +F +     +     G    +  + +  +++  +  
Sbjct: 57  ELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM-CGTTEYMAPEILLSK 289
            H   ++HRDLKP+N+L++ +G + L +FGLA+      R  S    T  Y  P++L   
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176

Query: 290 G-HNKDADWWSVGILLYEMLTGQV 312
             ++   D WS G +  E+     
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGR 200

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 3e-45
 Identities = 48/229 (20%), Positives = 95/229 (41%), Gaps = 15/229 (6%)

Query: 95  NDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII 154
           + A++    E ++      + R +GQG+FG V++   KGV   + +   A+K + +   +
Sbjct: 5   SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM 64

Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFR- 213
           +         E  ++ +     +V+L           +I++ +  G L  +L        
Sbjct: 65  R--ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMA 122

Query: 214 ---------EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE 264
                      +      EI   +++L+    VHRDL   N ++  D  V + DFG+ ++
Sbjct: 123 NNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 182

Query: 265 IDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           I E+    +         +M+PE L        +D WS G++L+E+ T 
Sbjct: 183 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 231

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 1e-44
 Identities = 50/235 (21%), Positives = 105/235 (44%), Gaps = 24/235 (10%)

Query: 98  ELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG--IYAMKVMRKDTIIK 155
           EL  +   ++      + + +G+GAFG+V   +  G+D    +     A+K+++ D    
Sbjct: 1   ELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-- 58

Query: 156 KNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG---- 210
           +  +  + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L  +     
Sbjct: 59  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 118

Query: 211 ------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTD 258
                                   ++   + +L     +HRDL   N+L+  D  + + D
Sbjct: 119 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 178

Query: 259 FGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           FGLA++I       ++ +     ++MAPE L  + +   +D WS G+LL+E+ T 
Sbjct: 179 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 233

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 2e-44
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 15/208 (7%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +     +G+GA+G V            +    A+K +       + +      E  IL +
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDN-----VNKVRVAIKKISPFE--HQTYCQRTLREIKILLR 62

Query: 172 VTHPFIVQLRYSFQTRS---KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
             H  I+ +    +  +      + L     G   + L +      D   ++  +I+  +
Sbjct: 63  FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGL 122

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS----NSMCGTTEYMAPE 284
            ++H   ++HRDLKP N+L+++   + + DFGLA+  D              T  Y APE
Sbjct: 123 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 285 ILLSK-GHNKDADWWSVGILLYEMLTGQ 311
           I+L+  G+ K  D WSVG +L EML+ +
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNR 210

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 3e-44
 Identities = 50/229 (21%), Positives = 98/229 (42%), Gaps = 21/229 (9%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           S+ +      ++ + +G+GAFG+V +    G+D   +    A+K++++       H   M
Sbjct: 6   SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALM 64

Query: 163 KAERDILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQG----------- 210
              + ++    H  +V L     +    L +I++F   G+L  +L  +            
Sbjct: 65  SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 124

Query: 211 -----IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI 265
                    +    Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I
Sbjct: 125 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 184

Query: 266 DESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
            +     R        ++MAPE +  + +   +D WS G+LL+E+ +  
Sbjct: 185 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 233

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  152 bits (385), Expect = 4e-44
 Identities = 49/206 (23%), Positives = 92/206 (44%), Gaps = 19/206 (9%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ R +G+G + +VF+          ++    +K      I+K      +K E  IL 
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINI-----TNNEKVVVK------ILKPVKKKKIKREIKILE 84

Query: 171 KV-THPFIVQLRYSFQTRSK--LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
            +   P I+ L    +        L+ + +N               +   RFY  EI+ A
Sbjct: 85  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKA 141

Query: 228 VSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEIL 286
           + + H  GI+HRD+KP N+++D +   + L D+GLA+        N    +  +  PE+L
Sbjct: 142 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 201

Query: 287 LS-KGHNKDADWWSVGILLYEMLTGQ 311
           +  + ++   D WS+G +L  M+  +
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRK 227

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 6e-44
 Identities = 52/231 (22%), Positives = 94/231 (40%), Gaps = 13/231 (5%)

Query: 90  ELEHENDAELEAESERKIGPGDFEIF--RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKV 147
           +L   N   ++A     IGP    +    V+G+G FG V+      +D+       A+K 
Sbjct: 5   DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVY--HGTLLDNDGKKIHCAVKS 62

Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL-RYSFQTRSKLYLILDFINGGHLF-FH 205
           + + T      V     E  I+   +HP ++ L     ++     ++L ++  G L  F 
Sbjct: 63  LNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 120

Query: 206 LYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI 265
                         +  ++   +  L     VHRDL   N ++D    V + DFGLA+++
Sbjct: 121 RNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 180

Query: 266 DESS-----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
            +                ++MA E L ++     +D WS G+LL+E++T  
Sbjct: 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 231

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 3e-43
 Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 35/224 (15%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
               +   +G+G FG+V++ K +G          A+K+       ++    + +AE    
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKWRGE-------EVAVKIFSS----REERSWFREAEIYQT 51

Query: 170 TKVTHPFIVQLRYSFQ----TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             + H  I+    +      T ++L+L+ D+   G LF +L R  +  E   +       
Sbjct: 52  VMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLA-LSTA 110

Query: 226 SAVSHLH--------KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-----RSN 272
           S ++HLH        K  I HRDLK +NIL+  +G   + D GLA   D ++       N
Sbjct: 111 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 170

Query: 273 SMCGTTEYMAPEILLSKGHNKD------ADWWSVGILLYEMLTG 310
              GT  YMAPE+L    + K       AD +++G++ +E+   
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 214

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 8e-43
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 13/208 (6%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
              +   + VG GA+G V         DG +    A+K + +     +        E  +
Sbjct: 17  RAVYRDLQPVGSGAYGAVCSAV-----DGRTGAKVAIKKLYRP-FQSELFAKRAYRELRL 70

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFI----NGGHLFFHLYRQGIFREDQARFYTAEI 224
           L  + H  ++ L   F     L    DF       G     L +     ED+ +F   ++
Sbjct: 71  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQM 130

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
           +  + ++H  GI+HRDLKP N+ ++ D  + + DFGLA++ D  S       T  Y APE
Sbjct: 131 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD--SEMTGYVVTRWYRAPE 188

Query: 285 ILLS-KGHNKDADWWSVGILLYEMLTGQ 311
           ++L+   + +  D WSVG ++ EM+TG+
Sbjct: 189 VILNWMRYTQTVDIWSVGCIMAEMITGK 216

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 2e-42
 Identities = 52/210 (24%), Positives = 93/210 (44%), Gaps = 15/210 (7%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
              ++  + +G GA G V             D   A+K + +     + H      E  +
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDA-----VLDRNVAIKKLSRP-FQNQTHAKRAYRELVL 69

Query: 169 LTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           +  V H  I+ L   F  +        +YL+++ ++                ++  +   
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLY 126

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+    S        T  Y A
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQV 312
           PE++L  G+ ++ D WSVG ++ EM+  ++
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKI 216

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 4e-41
 Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 13/208 (6%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           P  ++    VG GA+G V            +    A+K + +       H      E  +
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDT-----KTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 70

Query: 169 LTKVTHPFIVQLRYSFQTRSKL----YLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           L  + H  ++ L   F     L     + L     G    ++ +     +D  +F   +I
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
           +  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y APE
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPE 188

Query: 285 ILLSKGH-NKDADWWSVGILLYEMLTGQ 311
           I+L+  H N+  D WSVG ++ E+LTG+
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  123 bits (308), Expect = 8e-33
 Identities = 45/219 (20%), Positives = 86/219 (39%), Gaps = 22/219 (10%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI- 168
             + + R +G G F  V+  K        ++   AMK++R D +  +   D +K  + + 
Sbjct: 13  ARYILVRKLGWGHFSTVWLAKDM-----VNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 67

Query: 169 ------LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH-----LFFHLYRQGIFREDQA 217
                    +    I++L   F  +    + +  +              Y          
Sbjct: 68  DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127

Query: 218 RFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVM----LTDFGLAKEIDESSRSN 272
           +  + +++  + ++H +CGI+H D+KPEN+LM+          +    L           
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187

Query: 273 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           +   T EY +PE+LL       AD WS   L++E++TG 
Sbjct: 188 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 78.3 bits (192), Expect = 9e-18
 Identities = 28/206 (13%), Positives = 62/206 (30%), Gaps = 35/206 (16%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY-------MKAERDI 168
           +++G+G    VF    +        G   +K  +      K   +               
Sbjct: 6   KLMGEGKESAVFNCYSE------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIR 59

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFR---EDQARFYTAEIV 225
             +     + +L+     +   +       G  +   L           +        I+
Sbjct: 60  SARNEFRALQKLQGLAVPKVYAW------EGNAVLMELIDAKELYRVRVENPDEVLDMIL 113

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEI 285
             V+  +  GIVH DL   N+L+  +  + + DF  + E+ E           E +  ++
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEG-------WREILERDV 165

Query: 286 L-----LSKGHNKDADWWSVGILLYE 306
                  S+ +  + D  S    + +
Sbjct: 166 RNIITYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	355
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.71
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.38
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.23
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.65
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.55
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.48

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-56  Score=398.21  Aligned_cols=230  Identities=31%  Similarity=0.526  Sum_probs=203.5

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|++.+.||+|+||+||+|+++     .+++.||+|++.+.........+.+.+|+.+++.++|||||++++++.+++
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~   79 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREK-----QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT   79 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hhHeEEEEEEecCCCcEEEEEEEC-----CCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC
Confidence            468999999999999999999987     567889999998766555566677889999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      .+|+|||||++|+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|......
T Consensus        80 ~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          80 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             EEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            99999999999999999999899999999999999999999999999999999999999999999999999999876543


Q ss_pred             CCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHHhhhhe
Q 018487          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYLIIFHC  335 (355)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~~i~~~  335 (355)
                      . ....+||+.|||||++.+..|+.++|||||||++|||+||+.||...+....-             ....+.++|.+|
T Consensus       160 ~-~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  238 (263)
T d2j4za1         160 R-RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL  238 (263)
T ss_dssp             C-CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHH
T ss_pred             c-ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHH
Confidence            3 44568999999999999999999999999999999999999999876432211             122457788888


Q ss_pred             eeecCCCcC
Q 018487          336 LFVNSLELL  344 (355)
Q Consensus       336 l~~~~~e~~  344 (355)
                      |..+|.+++
T Consensus       239 L~~dp~~R~  247 (263)
T d2j4za1         239 LKHNPSQRP  247 (263)
T ss_dssp             TCSSGGGSC
T ss_pred             ccCCHhHCc
Confidence            888887765

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-56  Score=401.38  Aligned_cols=234  Identities=37%  Similarity=0.662  Sum_probs=203.2

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      ..+++|++++.||+|+||+||+|+++     .+++.||||++.+.........+.+.+|+++|++++|||||+++++|.+
T Consensus         5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~   79 (288)
T d1uu3a_           5 KRPEDFKFGKILGEGSFSTVVLAREL-----ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD   79 (288)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC
T ss_pred             CCCCCCEEEEEEeeCCCeEEEEEEEC-----CCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE
Confidence            34568999999999999999999987     4678899999987665555666788999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                      ++.+|+|||||+||+|.+++...+.+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+.
T Consensus        80 ~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~  159 (288)
T d1uu3a_          80 DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS  159 (288)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CCEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999998775


Q ss_pred             cCC---CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHH
Q 018487          267 ESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYL  330 (355)
Q Consensus       267 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~  330 (355)
                      ...   .....+||+.|||||++.+..|+.++|||||||++|||+||+.||...+.....             ....+.+
T Consensus       160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  239 (288)
T d1uu3a_         160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD  239 (288)
T ss_dssp             ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHH
T ss_pred             cCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHH
Confidence            332   234568999999999999999999999999999999999999999876433211             1224567


Q ss_pred             hhhheeeecCCCcCC
Q 018487          331 IIFHCLFVNSLELLS  345 (355)
Q Consensus       331 ~i~~~l~~~~~e~~~  345 (355)
                      +|.+||..+|.+++.
T Consensus       240 li~~~L~~dP~~R~t  254 (288)
T d1uu3a_         240 LVEKLLVLDATKRLG  254 (288)
T ss_dssp             HHHTTSCSSGGGSTT
T ss_pred             HHHHHccCCHhHCcC
Confidence            888999988888763

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-55  Score=402.95  Aligned_cols=233  Identities=39%  Similarity=0.724  Sum_probs=208.2

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      .-++|++++.||+|+||+||+|+++     .+++.||||++++.........+.+.+|+.+|+.++|||||+++++|.+.
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~~~~~-----~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~   77 (337)
T d1o6la_           3 TMNDFDYLKLLGKGTFGKVILVREK-----ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH   77 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS
T ss_pred             chHhcEEEEEEecCcCeEEEEEEEC-----CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc
Confidence            3468999999999999999999977     56889999999877655566677788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCc
Q 018487          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~  267 (355)
                      +.+|+|||||+||+|..++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus        78 ~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          78 DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             cccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999987643


Q ss_pred             -CCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHHhhh
Q 018487          268 -SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYLIIF  333 (355)
Q Consensus       268 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~~i~  333 (355)
                       .......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+.....             ......++|.
T Consensus       158 ~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~  237 (337)
T d1o6la_         158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLA  237 (337)
T ss_dssp             TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred             CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHH
Confidence             33456679999999999999999999999999999999999999999887543311             1224578899


Q ss_pred             heeeecCCCcCC
Q 018487          334 HCLFVNSLELLS  345 (355)
Q Consensus       334 ~~l~~~~~e~~~  345 (355)
                      +||+++|.+++.
T Consensus       238 ~~L~~dP~~R~~  249 (337)
T d1o6la_         238 GLLKKDPKQRLG  249 (337)
T ss_dssp             HHTCSSTTTSTT
T ss_pred             hhccCCchhhcc
Confidence            999999999873

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-56  Score=395.87  Aligned_cols=229  Identities=27%  Similarity=0.443  Sum_probs=194.9

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|+++++||+|+||+||+|+++     .+++.||||++.....  .+..+.+.+|+.+|++++|||||++++++.+++.
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~-----~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~   77 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNR-----VTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNI   77 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEEecCcCeEEEEEEEC-----CCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCce
Confidence            58999999999999999999987     5678899999976532  2334568899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      +|+|||||+||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+....
T Consensus        78 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          78 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             eEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            99999999999999999888889999999999999999999999999999999999999999999999999998764332


Q ss_pred             ---CCCcccccCccccchhhccCCC-CCcccHHHHHHHHHHHHcCCCCCCCchhhhh----------------hhhHHHH
Q 018487          270 ---RSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQVNIKSMQVIAC----------------NTMLLFY  329 (355)
Q Consensus       270 ---~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~elltg~~pf~~~~~~~~----------------~~~~~~~  329 (355)
                         .....+||+.|||||++.+..+ +.++|||||||++|||+||+.||........                .......
T Consensus       158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  237 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL  237 (271)
T ss_dssp             EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred             ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHH
Confidence               2455789999999999988776 5789999999999999999999976432110                1123456


Q ss_pred             HhhhheeeecCCCcCC
Q 018487          330 LIIFHCLFVNSLELLS  345 (355)
Q Consensus       330 ~~i~~~l~~~~~e~~~  345 (355)
                      ++|.+||..+|.+++.
T Consensus       238 ~li~~~L~~dP~~R~t  253 (271)
T d1nvra_         238 ALLHKILVENPSARIT  253 (271)
T ss_dssp             HHHHHHSCSSTTTSCC
T ss_pred             HHHHHHcCCChhHCcC
Confidence            7888999998888763

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-54  Score=390.94  Aligned_cols=228  Identities=27%  Similarity=0.435  Sum_probs=198.4

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|+++++||+|+||+||+|+++     .+++.||||++......   ..+.+.+|+.+|+.++|||||+++++|...+
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~-----~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   90 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDV-----ATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGD   90 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBT-----TTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             ccccEEEEEEecCcCcEEEEEEEC-----CCCCEEEEEEEecccCh---HHHHHHHHHHHHHhCCCCCEeeEeEEEEECC
Confidence            457999999999999999999976     56789999999765432   2456889999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      .+|+|||||+||+|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+...
T Consensus        91 ~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~  169 (293)
T d1yhwa1          91 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (293)
T ss_dssp             EEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence            99999999999999887755 56999999999999999999999999999999999999999999999999999877543


Q ss_pred             -CCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh----------------hhHHHHHh
Q 018487          269 -SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN----------------TMLLFYLI  331 (355)
Q Consensus       269 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~----------------~~~~~~~~  331 (355)
                       ......+||+.|||||++.+..|+.++|||||||++|+|+||+.||.+.+.....                ....+.++
T Consensus       170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  249 (293)
T d1yhwa1         170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF  249 (293)
T ss_dssp             TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHH
T ss_pred             cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHH
Confidence             3345668999999999999999999999999999999999999999875432211                12346788


Q ss_pred             hhheeeecCCCcCC
Q 018487          332 IFHCLFVNSLELLS  345 (355)
Q Consensus       332 i~~~l~~~~~e~~~  345 (355)
                      |.+||..+|.+++.
T Consensus       250 i~~~L~~dP~~R~s  263 (293)
T d1yhwa1         250 LNRCLDMDVEKRGS  263 (293)
T ss_dssp             HHHHTCSSTTTSCC
T ss_pred             HHHHccCChhHCcC
Confidence            88999999988763

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-55  Score=401.43  Aligned_cols=204  Identities=30%  Similarity=0.492  Sum_probs=183.5

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +..++|+++++||+|+||+||+|+++     .+++.||+|+++...  .....+.+.+|+.+|+.++|||||+++++|.+
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~-----~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~   75 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHK-----PSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS   75 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEET-----TTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEEC-----CCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            34568999999999999999999976     568899999997653  34445678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      .+++|+|||||+||+|.+++.+.+.+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|+.+
T Consensus        76 ~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~  155 (322)
T d1s9ja_          76 DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  155 (322)
T ss_dssp             SSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             CCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence            99999999999999999999999999999999999999999999997 59999999999999999999999999999876


Q ss_pred             CcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      .... ....+||+.|||||++.+..|+.++||||+||++|||++|+.||...+
T Consensus       156 ~~~~-~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~  207 (322)
T d1s9ja_         156 IDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  207 (322)
T ss_dssp             HHHT-C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred             CCCc-cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            4432 345789999999999999999999999999999999999999997643

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.2e-54  Score=392.66  Aligned_cols=228  Identities=38%  Similarity=0.709  Sum_probs=203.7

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|+++++||+|+||+||+|+++     .+++.||||++++.........+.+.+|+.+|+.++|||||++++++.+.+.
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   78 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSR-----HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ   78 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSE
T ss_pred             hHeEEEEEEecCcCcEEEEEEEC-----CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCe
Confidence            57999999999999999999987     5678999999987665555667788899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      +|+|||||+||+|..++.....+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+..... 
T Consensus        79 ~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-  157 (316)
T d1fota_          79 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  157 (316)
T ss_dssp             EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             eeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999876543 


Q ss_pred             CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHHhhhhee
Q 018487          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYLIIFHCL  336 (355)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~~i~~~l  336 (355)
                       ....+||+.|||||++.+..|+.++|||||||++|+|+||+.||.+.+.....             ....+.+.|.+||
T Consensus       158 -~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L  236 (316)
T d1fota_         158 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLI  236 (316)
T ss_dssp             -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred             -cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence             34578999999999999999999999999999999999999999886443211             1124577888999


Q ss_pred             eecCCCcC
Q 018487          337 FVNSLELL  344 (355)
Q Consensus       337 ~~~~~e~~  344 (355)
                      .++|.+++
T Consensus       237 ~~dp~~R~  244 (316)
T d1fota_         237 TRDLSQRL  244 (316)
T ss_dssp             CSCTTTCT
T ss_pred             hhCHHhcc
Confidence            99988875

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-54  Score=393.63  Aligned_cols=230  Identities=32%  Similarity=0.530  Sum_probs=182.9

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .+.|++.+.||+|+||+||+|+++     .+++.||||++.+.....  ..+.+.+|+.+|+.++|||||+++++|.+++
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   80 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDK-----RTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGG   80 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEET-----TTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEEEEeeccCeEEEEEEEC-----CCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            357999999999999999999977     567889999998654322  2355778999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEec---CCCcEEEEecCCcccc
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD---SDGHVMLTDFGLAKEI  265 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~---~~~~~kl~Dfg~a~~~  265 (355)
                      .+|+|||||+||+|.+++...+.+++.++..++.||+.||+|||++||+||||||+|||+.   +++.+||+|||+++..
T Consensus        81 ~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          81 HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             EEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            9999999999999999999999999999999999999999999999999999999999994   5789999999999987


Q ss_pred             CcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-----------------hhhHHH
Q 018487          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-----------------NTMLLF  328 (355)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-----------------~~~~~~  328 (355)
                      .........+||+.|||||++.+..|+.++|||||||++|||++|+.||.+......                 +....+
T Consensus       161 ~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  240 (307)
T d1a06a_         161 DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA  240 (307)
T ss_dssp             ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred             cCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHH
Confidence            666666677899999999999999999999999999999999999999987543221                 112245


Q ss_pred             HHhhhheeeecCCCcCC
Q 018487          329 YLIIFHCLFVNSLELLS  345 (355)
Q Consensus       329 ~~~i~~~l~~~~~e~~~  345 (355)
                      .++|.+||.++|.+++.
T Consensus       241 ~~li~~~L~~dP~~R~s  257 (307)
T d1a06a_         241 KDFIRHLMEKDPEKRFT  257 (307)
T ss_dssp             HHHHHHHSCSSGGGSCC
T ss_pred             HHHHHHHccCCHhHCcC
Confidence            77888999998888753

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.2e-54  Score=390.71  Aligned_cols=227  Identities=25%  Similarity=0.380  Sum_probs=199.7

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeE
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  190 (355)
                      .|+++++||+|+||+||+|+++     .+++.||||++...........+.+.+|+.+|++++|||||+++++|.+.+.+
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   90 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDV-----RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA   90 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEET-----TTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             hcEeeEEEecCCCeEEEEEEEC-----CCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEE
Confidence            4999999999999999999977     56788999999877655666677889999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCC
Q 018487          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR  270 (355)
Q Consensus       191 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~  270 (355)
                      |+|||||.+|+|..++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.....   
T Consensus        91 ~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---  167 (309)
T d1u5ra_          91 WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---  167 (309)
T ss_dssp             EEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred             EEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC---
Confidence            99999999999988888888899999999999999999999999999999999999999999999999999987543   


Q ss_pred             CCcccccCccccchhhcc---CCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh---------------hhhHHHHHhh
Q 018487          271 SNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC---------------NTMLLFYLII  332 (355)
Q Consensus       271 ~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~---------------~~~~~~~~~i  332 (355)
                      ....+||+.|||||++.+   ..|+.++|||||||++|||++|+.||.+......               .....+.++|
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li  247 (309)
T d1u5ra_         168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV  247 (309)
T ss_dssp             BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHH
T ss_pred             CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Confidence            345689999999999864   4589999999999999999999999987543221               1223567888


Q ss_pred             hheeeecCCCcCC
Q 018487          333 FHCLFVNSLELLS  345 (355)
Q Consensus       333 ~~~l~~~~~e~~~  345 (355)
                      .+||..+|.+++.
T Consensus       248 ~~~L~~dP~~Rpt  260 (309)
T d1u5ra_         248 DSCLQKIPQDRPT  260 (309)
T ss_dssp             HHHTCSSGGGSCC
T ss_pred             HHHCcCChhHCcC
Confidence            9999999888763

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.3e-54  Score=396.32  Aligned_cols=229  Identities=39%  Similarity=0.722  Sum_probs=205.0

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|+++++||+|+||+||+|+++     .+++.||||++.+.........+.+.+|+++|+.++|||||+++++|....
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~-----~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~  114 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHK-----ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS  114 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccCeEEEEEeecCcCcEEEEEEEC-----CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccc
Confidence            368999999999999999999987     567899999998765555566677889999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      .+++||||+.+|+|..++...+.+++.+++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+...
T Consensus       115 ~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999887543


Q ss_pred             CCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHHhhhhe
Q 018487          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYLIIFHC  335 (355)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~~i~~~  335 (355)
                        ....+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+.....             ....+.++|.+|
T Consensus       195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  272 (350)
T d1rdqe_         195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNL  272 (350)
T ss_dssp             --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHH
T ss_pred             --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHH
Confidence              34568999999999999999999999999999999999999999886543321             122567889999


Q ss_pred             eeecCCCcC
Q 018487          336 LFVNSLELL  344 (355)
Q Consensus       336 l~~~~~e~~  344 (355)
                      |.++|.+++
T Consensus       273 L~~dP~kR~  281 (350)
T d1rdqe_         273 LQVDLTKRF  281 (350)
T ss_dssp             SCSCTTTCT
T ss_pred             hhhCHHhcc
Confidence            999998875

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-53  Score=384.40  Aligned_cols=231  Identities=28%  Similarity=0.457  Sum_probs=202.7

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccc---hhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK---KNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      ++|++++.||+|+||+||+|+++     .+++.||||++.+.....   ....+.+.+|+.+|++++|||||+++++|.+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~-----~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~   84 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREK-----STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN   84 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             cCEEEeEEEecCCCeEEEEEEEC-----CCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            57999999999999999999987     567889999997654322   2345678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC----cEEEEecCCc
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG----HVMLTDFGLA  262 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~----~~kl~Dfg~a  262 (355)
                      .+.+|+|||||+||+|.+++...+.+++.+++.++.|++.||+|||++||+||||||+|||++.++    .+||+|||++
T Consensus        85 ~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          85 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             CCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhh
Confidence            999999999999999999999989999999999999999999999999999999999999998776    5999999999


Q ss_pred             cccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-----------------hhh
Q 018487          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-----------------NTM  325 (355)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-----------------~~~  325 (355)
                      ..+..........||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+....                 +..
T Consensus       165 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  244 (293)
T d1jksa_         165 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS  244 (293)
T ss_dssp             EECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred             hhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCC
Confidence            988766666777899999999999999999999999999999999999999987643221                 112


Q ss_pred             HHHHHhhhheeeecCCCcCC
Q 018487          326 LLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ..+.++|.+||..+|.+|+.
T Consensus       245 ~~~~~li~~~L~~dP~~R~s  264 (293)
T d1jksa_         245 ALAKDFIRRLLVKDPKKRMT  264 (293)
T ss_dssp             HHHHHHHHTTSCSSGGGSCC
T ss_pred             HHHHHHHHHHccCChhHCcC
Confidence            24567888898888888763

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-54  Score=387.46  Aligned_cols=227  Identities=30%  Similarity=0.477  Sum_probs=194.2

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      +.|+++++||+|+||+||+|+++     .+++.||||++....   ....+.+.+|+++|++++|||||++++++.+.+.
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~-----~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~   83 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNK-----ETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENN   83 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEEC-----CCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCe
Confidence            46999999999999999999987     567889999997643   2334567889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      +|+|||||+||+|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus        84 ~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~  163 (288)
T d2jfla1          84 LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  163 (288)
T ss_dssp             EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence            99999999999999987654 56999999999999999999999999999999999999999999999999999765332


Q ss_pred             -CCCCcccccCccccchhhc-----cCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh----------------hhhH
Q 018487          269 -SRSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC----------------NTML  326 (355)
Q Consensus       269 -~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~----------------~~~~  326 (355)
                       ......+||+.|||||++.     +..|+.++|||||||++|||+||+.||...+....                +...
T Consensus       164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~  243 (288)
T d2jfla1         164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS  243 (288)
T ss_dssp             HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCH
T ss_pred             cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCH
Confidence             2234568999999999984     45688999999999999999999999987543221                1123


Q ss_pred             HHHHhhhheeeecCCCcC
Q 018487          327 LFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       327 ~~~~~i~~~l~~~~~e~~  344 (355)
                      .+.++|.+||+.+|.+++
T Consensus       244 ~~~~li~~~L~~dp~~R~  261 (288)
T d2jfla1         244 NFKDFLKKCLEKNVDARW  261 (288)
T ss_dssp             HHHHHHHHHSCSSTTTSC
T ss_pred             HHHHHHHHHccCChhHCc
Confidence            557788899999888876

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-54  Score=384.62  Aligned_cols=229  Identities=24%  Similarity=0.448  Sum_probs=184.5

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec--C
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--R  187 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~  187 (355)
                      ++|++++.||+|+||+||+|+++     .+++.||||++..... .+...+.+.+|+++|++++|||||++++++.+  .
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~-----~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   77 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRK-----SDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN   77 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC---
T ss_pred             hhCEEeEEEecCCCeEEEEEEEC-----CCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCC
Confidence            57999999999999999999987     5678899999977653 34456778899999999999999999999864  4


Q ss_pred             CeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----CeeccCCCCcEEecCCCcEEEEe
Q 018487          188 SKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCG-----IVHRDLKPENILMDSDGHVMLTD  258 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~L~~LH~~~-----iiHrDlkp~NILl~~~~~~kl~D  258 (355)
                      +.+|+|||||++|+|.+++..    ...+++..++.++.||+.||.|||++|     |+||||||+|||++.++.+||+|
T Consensus        78 ~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~D  157 (269)
T d2java1          78 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD  157 (269)
T ss_dssp             -CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECC
T ss_pred             CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEee
Confidence            568999999999999998864    356999999999999999999999976     99999999999999999999999


Q ss_pred             cCCccccCcCC-CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh--------------
Q 018487          259 FGLAKEIDESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN--------------  323 (355)
Q Consensus       259 fg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~--------------  323 (355)
                      ||+++.+.... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||...+.....              
T Consensus       158 FG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~  237 (269)
T d2java1         158 FGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR  237 (269)
T ss_dssp             HHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred             ccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence            99998875433 345678999999999999999999999999999999999999999876433211              


Q ss_pred             hhHHHHHhhhheeeecCCCcC
Q 018487          324 TMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       324 ~~~~~~~~i~~~l~~~~~e~~  344 (355)
                      ....+..+|.+||..+|.+++
T Consensus       238 ~s~~l~~li~~~L~~dp~~Rp  258 (269)
T d2java1         238 YSDELNEIITRMLNLKDYHRP  258 (269)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSC
T ss_pred             cCHHHHHHHHHHcCCChhHCc
Confidence            112456777788887777765

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-53  Score=377.28  Aligned_cols=227  Identities=26%  Similarity=0.389  Sum_probs=192.1

Q ss_pred             CCe-EEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec--
Q 018487          110 GDF-EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--  186 (355)
Q Consensus       110 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--  186 (355)
                      ++| ++.++||+|+||+||+|.++     .+++.||+|++..... .....+.+.+|+++|++++|||||+++++|..  
T Consensus         8 gry~~~~~~iG~G~fg~Vy~~~~~-----~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   81 (270)
T d1t4ha_           8 GRFLKFDIEIGRGSFKTVYKGLDT-----ETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV   81 (270)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred             CCEEEeeeEEecCcCcEEEEEEEC-----CCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc
Confidence            345 77889999999999999977     4677899999977653 34456678899999999999999999999864  


Q ss_pred             --CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCcEEec-CCCcEEEEecCC
Q 018487          187 --RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMD-SDGHVMLTDFGL  261 (355)
Q Consensus       187 --~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~--iiHrDlkp~NILl~-~~~~~kl~Dfg~  261 (355)
                        ...+|+||||+++|+|.+++.....+++.+++.++.||+.||+|||+++  |+||||||+|||++ +++.+||+|||+
T Consensus        82 ~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl  161 (270)
T d1t4ha_          82 KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL  161 (270)
T ss_dssp             SSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred             ccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence              4568999999999999999999899999999999999999999999999  99999999999996 578999999999


Q ss_pred             ccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh----------------hhhh
Q 018487          262 AKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA----------------CNTM  325 (355)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~----------------~~~~  325 (355)
                      |+.... ......+||+.|||||++.+ .++.++|||||||++|||+||+.||...+...                ....
T Consensus       162 a~~~~~-~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~  239 (270)
T d1t4ha_         162 ATLKRA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI  239 (270)
T ss_dssp             GGGCCT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred             ceeccC-CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCC
Confidence            986443 33456789999999999875 59999999999999999999999997642111                0011


Q ss_pred             HHHHHhhhheeeecCCCcC
Q 018487          326 LLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~  344 (355)
                      ..+.++|.+||..+|.+++
T Consensus       240 ~~~~~li~~~l~~dp~~R~  258 (270)
T d1t4ha_         240 PEVKEIIEGCIRQNKDERY  258 (270)
T ss_dssp             HHHHHHHHHHSCSSGGGSC
T ss_pred             HHHHHHHHHHccCCHhHCc
Confidence            2467888899998888876

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.1e-53  Score=391.11  Aligned_cols=227  Identities=27%  Similarity=0.463  Sum_probs=199.2

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|+++++||+|+||+||+|+++     .+++.||||++....   ....+.+.+|+.+|++++|||||+++++|.+.+.
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~-----~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   97 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTER-----ATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE   97 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEET-----TTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTE
T ss_pred             cCeEEEEEEecCcCeEEEEEEEC-----CCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            47999999999999999999977     567899999997643   2334668899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC--CCcEEEEecCCccccC
Q 018487          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS--DGHVMLTDFGLAKEID  266 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~--~~~~kl~Dfg~a~~~~  266 (355)
                      +|+|||||+||+|.+++.. .+.+++.+++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++.+.
T Consensus        98 ~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~  177 (350)
T d1koaa2          98 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  177 (350)
T ss_dssp             EEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred             EEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence            9999999999999998854 467999999999999999999999999999999999999964  6789999999999887


Q ss_pred             cCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-----------------hhhHHHH
Q 018487          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-----------------NTMLLFY  329 (355)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-----------------~~~~~~~  329 (355)
                      ........+||+.|||||++.+..|+.++|||||||++|+|+||+.||.+.+....                 .....+.
T Consensus       178 ~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  257 (350)
T d1koaa2         178 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK  257 (350)
T ss_dssp             TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHH
T ss_pred             cccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            76666678899999999999999999999999999999999999999987543221                 1122457


Q ss_pred             HhhhheeeecCCCcC
Q 018487          330 LIIFHCLFVNSLELL  344 (355)
Q Consensus       330 ~~i~~~l~~~~~e~~  344 (355)
                      ++|.+||..+|.+++
T Consensus       258 ~li~~~L~~dP~~R~  272 (350)
T d1koaa2         258 DFIRKLLLADPNTRM  272 (350)
T ss_dssp             HHHHHHCCSSGGGSC
T ss_pred             HHHHHHccCChhHCc
Confidence            788999999988876

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-53  Score=384.74  Aligned_cols=231  Identities=36%  Similarity=0.698  Sum_probs=200.8

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHH-hcCCCcceecceeeecCC
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT-KVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~~~  188 (355)
                      ++|++++.||+|+||+||+|+++     .+++.||||++++.........+.+..|+.++. .++|||||++++++.+++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~-----~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFK-----KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEET-----TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CCeEEeeEEecCCCcEEEEEEEC-----CCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC
Confidence            58999999999999999999987     568899999998765444455555666776654 689999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      .+|+|||||++|+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        77 ~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             ceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999866433


Q ss_pred             -CCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-------------hhHHHHHhhhh
Q 018487          269 -SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-------------TMLLFYLIIFH  334 (355)
Q Consensus       269 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-------------~~~~~~~~i~~  334 (355)
                       ......+||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.+....-             ....+.++|.+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~  236 (320)
T d1xjda_         157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVK  236 (320)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence             3344568999999999999999999999999999999999999999876433211             12355778889


Q ss_pred             eeeecCCCcCC
Q 018487          335 CLFVNSLELLS  345 (355)
Q Consensus       335 ~l~~~~~e~~~  345 (355)
                      ||.++|.+++.
T Consensus       237 ~L~~dP~~R~s  247 (320)
T d1xjda_         237 LFVREPEKRLG  247 (320)
T ss_dssp             HSCSSGGGSBT
T ss_pred             hcccCCCCCcC
Confidence            99999988864

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4.6e-53  Score=391.01  Aligned_cols=228  Identities=26%  Similarity=0.442  Sum_probs=199.6

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|++++.||+|+||+||+|.++     .+++.||||++.....   ...+.+.+|+.+|++++|||||+++++|.+++.
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~  100 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEK-----ATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE  100 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred             cceEEEEEEecCCCeEEEEEEEC-----CCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            47999999999999999999976     5678999999876532   233567889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEec--CCCcEEEEecCCccccC
Q 018487          190 LYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD--SDGHVMLTDFGLAKEID  266 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~--~~~~~kl~Dfg~a~~~~  266 (355)
                      +|+|||||+||+|.+++...+ .+++.+++.|+.||+.||.|||++||+||||||+||||+  .++.+||+|||+|..+.
T Consensus       101 ~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~  180 (352)
T d1koba_         101 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  180 (352)
T ss_dssp             EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             EEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC
Confidence            999999999999988876554 699999999999999999999999999999999999997  57899999999999887


Q ss_pred             cCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-----------------hhhHHHH
Q 018487          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-----------------NTMLLFY  329 (355)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-----------------~~~~~~~  329 (355)
                      .........||+.|||||++.+..|+.++|||||||++|+|+||+.||.+.+....                 +....+.
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  260 (352)
T d1koba_         181 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK  260 (352)
T ss_dssp             TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred             CCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            76666677899999999999999999999999999999999999999988643321                 1122457


Q ss_pred             HhhhheeeecCCCcCC
Q 018487          330 LIIFHCLFVNSLELLS  345 (355)
Q Consensus       330 ~~i~~~l~~~~~e~~~  345 (355)
                      ++|.+||..+|.+++.
T Consensus       261 ~li~~~L~~dp~~R~s  276 (352)
T d1koba_         261 DFIKNLLQKEPRKRLT  276 (352)
T ss_dssp             HHHHTTSCSSGGGSCC
T ss_pred             HHHHHHccCChhHCcC
Confidence            7888999998888753

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.1e-52  Score=390.49  Aligned_cols=231  Identities=35%  Similarity=0.630  Sum_probs=197.4

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHH---HHHHHHhcCCCcceecceeee
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA---ERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~---E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      .++|+++++||+|+||.||+|+++     .+++.||||++.+...........+.+   |+.+++.++|||||+++++|.
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~-----~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~   77 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKA-----DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH   77 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEEC-----CCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE
Confidence            468999999999999999999977     567899999997654433333333333   466777888999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      ..+.+|+|||||+||+|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+
T Consensus        78 ~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          78 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             ECCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999877


Q ss_pred             CcCCCCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh----------------hhhhHHH
Q 018487          266 DESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA----------------CNTMLLF  328 (355)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~----------------~~~~~~~  328 (355)
                      .... ....+||+.|||||++.+ ..|+.++|||||||++|||+||+.||.......                ......+
T Consensus       158 ~~~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  236 (364)
T d1omwa3         158 SKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL  236 (364)
T ss_dssp             SSSC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHH
T ss_pred             CCCc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHH
Confidence            5543 445689999999999974 568999999999999999999999997643211                0122246


Q ss_pred             HHhhhheeeecCCCcCC
Q 018487          329 YLIIFHCLFVNSLELLS  345 (355)
Q Consensus       329 ~~~i~~~l~~~~~e~~~  345 (355)
                      .++|.+||.++|.+++.
T Consensus       237 ~~li~~~L~~dP~~R~t  253 (364)
T d1omwa3         237 RSLLEGLLQRDVNRRLG  253 (364)
T ss_dssp             HHHHHHHTCSSTTTSTT
T ss_pred             HHHHHHHcccCHHHhCC
Confidence            88999999999999875

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.7e-52  Score=375.91  Aligned_cols=231  Identities=23%  Similarity=0.391  Sum_probs=195.2

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|++.+.||+|+||+||+|+++     .+++.||||+++.....+....+.+.+|+++++.++|||||++++++...+
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~   80 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDL-----RLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET   80 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC
T ss_pred             cceeEEeEEEeeCCCeEEEEEEEC-----CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc
Confidence            368999999999999999999976     568899999998876666677778999999999999999999999987643


Q ss_pred             ----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          189 ----KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       189 ----~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                          .+|+||||++|++|..++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.+..
T Consensus        81 ~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          81 PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             SSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             CCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhh
Confidence                4899999999999999999999999999999999999999999999999999999999999999999999999876


Q ss_pred             cCcCC----CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-----------------h
Q 018487          265 IDESS----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-----------------N  323 (355)
Q Consensus       265 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-----------------~  323 (355)
                      .....    .....+||+.|||||++.+..++.++|||||||++|||+||+.||...+....                 +
T Consensus       161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG  240 (277)
T ss_dssp             CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSS
T ss_pred             hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccC
Confidence            53322    23456899999999999999999999999999999999999999987643321                 1


Q ss_pred             hhHHHHHhhhheeeecCCCcC
Q 018487          324 TMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       324 ~~~~~~~~i~~~l~~~~~e~~  344 (355)
                      ....+.++|.+||.++|.+++
T Consensus       241 ~s~~l~~li~~~L~~dp~~R~  261 (277)
T d1o6ya_         241 LSADLDAVVLKALAKNPENRY  261 (277)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSC
T ss_pred             CCHHHHHHHHHHccCCHhHCH
Confidence            123467888899998888875

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-53  Score=377.73  Aligned_cols=230  Identities=26%  Similarity=0.370  Sum_probs=190.1

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      |.+..++|++.++||+|+||+||+|+++        ..||||+++.... .....+.+.+|+.+|++++|||||++++++
T Consensus         3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~   73 (276)
T d1uwha_           3 WEIPDGQITVGQRIGSGSFGTVYKGKWH--------GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS   73 (276)
T ss_dssp             CBCCTTCCCCCSEEEECSSCEEEEEESS--------SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cccccccEEEEEEEeeCCCcEEEEEEEC--------CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEE
Confidence            5577889999999999999999999854        2499999976543 345567889999999999999999999987


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      .. +.+++|||||++|+|.+++... ..+++.++..++.||++||+|||++|||||||||+|||++.++.+||+|||+|+
T Consensus        74 ~~-~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~  152 (276)
T d1uwha_          74 TA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT  152 (276)
T ss_dssp             CS-SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred             ec-cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEcccccee
Confidence            54 5689999999999999999765 569999999999999999999999999999999999999999999999999998


Q ss_pred             ccCcCC---CCCcccccCccccchhhccC---CCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh---------------
Q 018487          264 EIDESS---RSNSMCGTTEYMAPEILLSK---GHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC---------------  322 (355)
Q Consensus       264 ~~~~~~---~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~---------------  322 (355)
                      ......   ......||+.|||||++.+.   .|+.++|||||||++|||+||+.||.+.+....               
T Consensus       153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~  232 (276)
T d1uwha_         153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS  232 (276)
T ss_dssp             C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGG
T ss_pred             eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcch
Confidence            764322   23456899999999999743   478999999999999999999999987532110               


Q ss_pred             ----hhhHHHHHhhhheeeecCCCcC
Q 018487          323 ----NTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       323 ----~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                          +....+..+|.+||..+|.+++
T Consensus       233 ~~~~~~~~~l~~li~~cl~~dp~~RP  258 (276)
T d1uwha_         233 KVRSNCPKAMKRLMAECLKKKRDERP  258 (276)
T ss_dssp             GSCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             hccccchHHHHHHHHHHcCCCHhHCc
Confidence                1112567888899988888875

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=7.3e-52  Score=370.93  Aligned_cols=232  Identities=30%  Similarity=0.494  Sum_probs=201.3

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccc------hhHHHHHHHHHHHHHhcC-CCcceecc
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK------KNHVDYMKAERDILTKVT-HPFIVQLR  181 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~-h~nIv~l~  181 (355)
                      .++|++.+.||+|+||+||+|+++     .+++.||||++.+.....      +...+.+.+|+.++++++ |||||+++
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~-----~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~   76 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHK-----PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK   76 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             cccCEEceEEecCcCeEEEEEEEC-----CCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence            368999999999999999999976     568899999997654322      233456888999999997 99999999


Q ss_pred             eeeecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCC
Q 018487          182 YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (355)
Q Consensus       182 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~  261 (355)
                      ++|.+++.+|+|||||+||+|.+++..++.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        77 ~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          77 DTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             eecccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCcCCCCCcccccCccccchhhcc------CCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh------------
Q 018487          262 AKEIDESSRSNSMCGTTEYMAPEILLS------KGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN------------  323 (355)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~------------  323 (355)
                      ++.+.........+||+.|+|||++.+      ..++.++||||+||++|+|+||+.||.+.+.....            
T Consensus       157 a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~  236 (277)
T d1phka_         157 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS  236 (277)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred             eeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence            998876666667789999999999863      34688999999999999999999999887533211            


Q ss_pred             -----hhHHHHHhhhheeeecCCCcCC
Q 018487          324 -----TMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       324 -----~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                           ....+.+++.+||..+|.+++.
T Consensus       237 ~~~~~~s~~~~~li~~~L~~~p~~R~s  263 (277)
T d1phka_         237 PEWDDYSDTVKDLVSRFLVVQPQKRYT  263 (277)
T ss_dssp             TTGGGSCHHHHHHHHHHCCSSGGGSCC
T ss_pred             cccccCCHHHHHHHHHHccCChhHCcC
Confidence                 1123567788888888887653

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.5e-52  Score=378.34  Aligned_cols=235  Identities=22%  Similarity=0.328  Sum_probs=188.2

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      .+..++|++.++||+|+||+||+|.++...  .....||||.+....  .....+.+.+|+.+|++++|||||++++++.
T Consensus        22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~   97 (299)
T d1jpaa_          22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPG--KREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVT   97 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             hhChhhcEEeeEEeeCCCeEEEEEEEeCCC--CEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence            455678999999999999999999987432  234468889876543  3445567889999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      ..+.+|+|||||++|+|.+++... +.+++.++..++.||++||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus        98 ~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  177 (299)
T d1jpaa_          98 KSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRF  177 (299)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             eCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceE
Confidence            999999999999999999988774 5699999999999999999999999999999999999999999999999999987


Q ss_pred             cCcCCCC------CcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------h
Q 018487          265 IDESSRS------NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------N  323 (355)
Q Consensus       265 ~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~  323 (355)
                      +......      ....||+.|||||++.+..++.++|||||||++|||+| |+.||.+......              +
T Consensus       178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  257 (299)
T d1jpaa_         178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMD  257 (299)
T ss_dssp             ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred             ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence            6443221      12457899999999999999999999999999999998 8999987643221              1


Q ss_pred             hhHHHHHhhhheeeecCCCcC
Q 018487          324 TMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       324 ~~~~~~~~i~~~l~~~~~e~~  344 (355)
                      ....+..+|.+||..+|.+++
T Consensus       258 ~~~~l~~li~~cl~~~P~~RP  278 (299)
T d1jpaa_         258 CPSALHQLMLDCWQKDRNHRP  278 (299)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSC
T ss_pred             chHHHHHHHHHHcCCCHhHCc
Confidence            123567888999999988875

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-52  Score=377.45  Aligned_cols=232  Identities=23%  Similarity=0.349  Sum_probs=196.2

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      |.+..++|++.++||+|+||+||+|.++     .+++.||||+++.+..    ..+.+.+|+++|++++|||||+++++|
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~   82 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWK-----KYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVC   82 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEG-----GGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEEC-----CCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccE
Confidence            4456678999999999999999999987     4577899999876432    245688999999999999999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                      .+++.+|+|||||++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|
T Consensus        83 ~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a  162 (287)
T d1opja_          83 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS  162 (287)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred             eeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccce
Confidence            9999999999999999999998764  46899999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCC--CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCC-chhhhh--------------hhh
Q 018487          263 KEIDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKS-MQVIAC--------------NTM  325 (355)
Q Consensus       263 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~-~~~~~~--------------~~~  325 (355)
                      +.......  .....|++.|+|||++.+..|+.++|||||||++|||++|..||.. .+....              ...
T Consensus       163 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~  242 (287)
T d1opja_         163 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP  242 (287)
T ss_dssp             TTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             eecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccch
Confidence            87654332  2334588999999999999999999999999999999997776543 322111              122


Q ss_pred             HHHHHhhhheeeecCCCcCC
Q 018487          326 LLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ..+.++|.+||..+|.+++.
T Consensus       243 ~~l~~li~~cl~~dP~~Rps  262 (287)
T d1opja_         243 EKVYELMRACWQWNPSDRPS  262 (287)
T ss_dssp             HHHHHHHHHHTCSSGGGSCC
T ss_pred             HHHHHHHHHHcCCCHhHCcC
Confidence            35678888999888888763

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-52  Score=383.72  Aligned_cols=239  Identities=25%  Similarity=0.399  Sum_probs=198.7

Q ss_pred             hcCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecce
Q 018487          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY  182 (355)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~  182 (355)
                      .|.+..++|++.++||+|+||+||+|++++.........||+|.+....  .......+.+|+.+|+++ +|||||++++
T Consensus        31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~  108 (325)
T d1rjba_          31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLG  108 (325)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence            3456678999999999999999999999876555556679999986543  233345678899999998 8999999999


Q ss_pred             eeecCCeEEEEEeccCCCChHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 018487          183 SFQTRSKLYLILDFINGGHLFFHLYRQ-----------------------GIFREDQARFYTAEIVSAVSHLHKCGIVHR  239 (355)
Q Consensus       183 ~~~~~~~~~lv~e~~~~gsL~~~l~~~-----------------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHr  239 (355)
                      ++...+.+|+|||||++|+|.+++..+                       ..+++.+++.++.||+.||+|||++|||||
T Consensus       109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR  188 (325)
T d1rjba_         109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR  188 (325)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            999999999999999999999999754                       248899999999999999999999999999


Q ss_pred             cCCCCcEEecCCCcEEEEecCCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCC
Q 018487          240 DLKPENILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIK  315 (355)
Q Consensus       240 Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~  315 (355)
                      ||||+|||++.++.+||+|||+|+.......   .....||+.|||||++.+..++.++|||||||++|||+| |+.||.
T Consensus       189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~  268 (325)
T d1rjba_         189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  268 (325)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence            9999999999999999999999987644332   234568999999999999999999999999999999998 899998


Q ss_pred             Cchhhh---------------hhhhHHHHHhhhheeeecCCCcC
Q 018487          316 SMQVIA---------------CNTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       316 ~~~~~~---------------~~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                      +.+...               ......+.++|.+||..+|.+++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RP  312 (325)
T d1rjba_         269 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP  312 (325)
T ss_dssp             TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             CCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCc
Confidence            753211               01123567888899988888865

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-52  Score=369.42  Aligned_cols=228  Identities=21%  Similarity=0.381  Sum_probs=183.6

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +.+++|+++++||+|+||+||+|.++      +++.||||+++....    ..+.+.+|+.++++++|||||++++++..
T Consensus         2 idp~~~~~~~~iG~G~fg~Vy~~~~~------~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~   71 (263)
T d1sm2a_           2 IDPSELTFVQEIGSGQFGLVHLGYWL------NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLE   71 (263)
T ss_dssp             BCCSCEEEEEEEECCSSCCEEEEEET------TTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CChHHcEEEEEEeeCCCeEEEEEEEC------CCCEEEEEEECCCcC----cHHHHHHHHHHHHhcCCCCcccccceecc
Confidence            45679999999999999999999976      345799999876432    23468889999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      ++.+|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  151 (263)
T d1sm2a_          72 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV  151 (263)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----
T ss_pred             CCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheec
Confidence            99999999999999999988765 55899999999999999999999999999999999999999999999999999876


Q ss_pred             CcCCC--CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcC-CCCCCCchhhhh--------------hhhHHH
Q 018487          266 DESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG-QVNIKSMQVIAC--------------NTMLLF  328 (355)
Q Consensus       266 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg-~~pf~~~~~~~~--------------~~~~~~  328 (355)
                      .....  .....||+.|+|||++.+..|+.++|||||||++|||+|+ +.||........              .....+
T Consensus       152 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l  231 (263)
T d1sm2a_         152 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHV  231 (263)
T ss_dssp             -------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHH
T ss_pred             cCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHH
Confidence            44332  2345789999999999999999999999999999999995 555655422111              112356


Q ss_pred             HHhhhheeeecCCCcC
Q 018487          329 YLIIFHCLFVNSLELL  344 (355)
Q Consensus       329 ~~~i~~~l~~~~~e~~  344 (355)
                      +.+|.+||..+|.+++
T Consensus       232 ~~li~~cl~~~p~~Rp  247 (263)
T d1sm2a_         232 YQIMNHCWKERPEDRP  247 (263)
T ss_dssp             HHHHHHHTCSSGGGSC
T ss_pred             HHHHHHHccCCHhHCc
Confidence            7888899998888865

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=377.10  Aligned_cols=228  Identities=23%  Similarity=0.373  Sum_probs=198.3

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|++++.||+|+||+||+|.++     .+++.||||+++....    ....+.+|+++|+.++|||||+++++|.+.+
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~-----~~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   74 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVET-----SSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESME   74 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEEecCCCeEEEEEEEC-----CCCcEEEEEEEcCCcc----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            468999999999999999999987     5678899999976532    2345778999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCC--CcEEEEecCCcccc
Q 018487          189 KLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEI  265 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~--~~~kl~Dfg~a~~~  265 (355)
                      .+|+|||||+||+|.+++...+ .+++.+++.|+.||+.||.|||++||+||||||+|||++.+  +.+||+|||+++..
T Consensus        75 ~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence            9999999999999999998765 69999999999999999999999999999999999999854  48999999999987


Q ss_pred             CcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhhh-----------------hhHHH
Q 018487          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIACN-----------------TMLLF  328 (355)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~~-----------------~~~~~  328 (355)
                      ..........+|+.|+|||.+.+..|+.++|||||||++|+|++|+.||...+....-                 ....+
T Consensus       155 ~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  234 (321)
T d1tkia_         155 KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA  234 (321)
T ss_dssp             CTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred             ccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHH
Confidence            6655556678999999999999999999999999999999999999999876432210                 11235


Q ss_pred             HHhhhheeeecCCCcCC
Q 018487          329 YLIIFHCLFVNSLELLS  345 (355)
Q Consensus       329 ~~~i~~~l~~~~~e~~~  345 (355)
                      .++|.+||..+|.+++.
T Consensus       235 ~~li~~~L~~dp~~R~s  251 (321)
T d1tkia_         235 MDFVDRLLVKERKSRMT  251 (321)
T ss_dssp             HHHHHTTSCSSGGGSCC
T ss_pred             HHHHHHHccCChhHCcC
Confidence            77888999998888764

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-52  Score=370.90  Aligned_cols=224  Identities=20%  Similarity=0.317  Sum_probs=186.8

Q ss_pred             eeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEEEEEe
Q 018487          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (355)
Q Consensus       116 ~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  195 (355)
                      ++||+|+||+||+|.++..   ..++.||||+++... .+....+.+.+|+.+|++++|||||++++++..+ ..|+|||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~---~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE   87 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMK---KVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVME   87 (277)
T ss_dssp             EEEEECSSEEEEEEEEECS---SSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEE
T ss_pred             CCcccCCCeEEEEEEEccC---CcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEE
Confidence            4799999999999987632   456789999997654 3445567789999999999999999999998654 5789999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCC----C
Q 018487          196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR----S  271 (355)
Q Consensus       196 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~----~  271 (355)
                      |+++|+|.+++.....+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.....    .
T Consensus        88 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          88 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             cCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            999999999999989999999999999999999999999999999999999999999999999999987643322    2


Q ss_pred             CcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhhHHHHHhhhhee
Q 018487          272 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTMLLFYLIIFHCL  336 (355)
Q Consensus       272 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~~~~~~~i~~~l  336 (355)
                      ....||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+....              .....+.++|.+||
T Consensus       168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl  247 (277)
T d1xbba_         168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCW  247 (277)
T ss_dssp             ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred             cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHc
Confidence            34568999999999999999999999999999999998 8999987643221              11234577888888


Q ss_pred             eecCCCcC
Q 018487          337 FVNSLELL  344 (355)
Q Consensus       337 ~~~~~e~~  344 (355)
                      ..+|.+++
T Consensus       248 ~~dp~~RP  255 (277)
T d1xbba_         248 TYDVENRP  255 (277)
T ss_dssp             CSSTTTSC
T ss_pred             CCCHhHCc
Confidence            88888865

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-51  Score=370.27  Aligned_cols=232  Identities=23%  Similarity=0.341  Sum_probs=193.5

Q ss_pred             cCCCCeEEEe-eeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          107 IGPGDFEIFR-VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       107 ~~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      +..++|.+.+ +||+|+||+||+|.++..   ..+..||||+++...  .....+.+.+|+++|++++|||||++++++.
T Consensus         5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~---~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~   79 (285)
T d1u59a_           5 LKRDNLLIADIELGCGNFGSVRQGVYRMR---KKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ   79 (285)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC------CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ecccCeEECCcEEecccCeEEEEEEEecC---CCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeec
Confidence            3446788888 499999999999987643   245679999997643  3455677899999999999999999999987


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      . +.+|+|||||++|+|.+++... ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        80 ~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~  158 (285)
T d1u59a_          80 A-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA  158 (285)
T ss_dssp             S-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             c-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhc
Confidence            5 4589999999999999987654 5699999999999999999999999999999999999999999999999999987


Q ss_pred             cCcCCC----CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhh
Q 018487          265 IDESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTM  325 (355)
Q Consensus       265 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~  325 (355)
                      +.....    .....||+.|||||++.+..++.++|||||||++|||+| |+.||........              +..
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~  238 (285)
T d1u59a_         159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP  238 (285)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCC
T ss_pred             ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCC
Confidence            644322    234568999999999999999999999999999999998 9999987643211              112


Q ss_pred             HHHHHhhhheeeecCCCcC
Q 018487          326 LLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~  344 (355)
                      ..++.+|.+||..+|.+++
T Consensus       239 ~~l~~li~~cl~~~p~~RP  257 (285)
T d1u59a_         239 PELYALMSDCWIYKWEDRP  257 (285)
T ss_dssp             HHHHHHHHHTTCSSGGGSC
T ss_pred             HHHHHHHHHHcCCCHhHCc
Confidence            2467888899988888875

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-51  Score=363.39  Aligned_cols=228  Identities=22%  Similarity=0.392  Sum_probs=196.1

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      .+++|+++++||+|+||+||+|+++      +++.||||+++.....    .+.+.+|+.++++++|||||++++++.+.
T Consensus         2 ~~~~~~~~~~iG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~   71 (258)
T d1k2pa_           2 DPKDLTFLKELGTGQFGVVKYGKWR------GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ   71 (258)
T ss_dssp             CCCCCCCCCCCCEETTEEEEEEEET------TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCS
T ss_pred             ChHHCEEeEEEecCCCeEEEEEEEC------CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeC
Confidence            4578999999999999999999975      4667999999865432    34678999999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                      +.+++||||+++|+|..++... ..+++..++.++.|+++||+|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus        72 ~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~  151 (258)
T d1k2pa_          72 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL  151 (258)
T ss_dssp             SSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCS
T ss_pred             CceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheecc
Confidence            9999999999999998886654 568999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCC--CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhhhh--------------hHHHH
Q 018487          267 ESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACNT--------------MLLFY  329 (355)
Q Consensus       267 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~~~--------------~~~~~  329 (355)
                      ....  .....||+.|+|||++.+..++.++|||||||++|||+| |+.||...+......              ...+.
T Consensus       152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~  231 (258)
T d1k2pa_         152 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY  231 (258)
T ss_dssp             SSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             CCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHH
Confidence            4332  234578999999999999999999999999999999998 899999864332111              12467


Q ss_pred             HhhhheeeecCCCcCC
Q 018487          330 LIIFHCLFVNSLELLS  345 (355)
Q Consensus       330 ~~i~~~l~~~~~e~~~  345 (355)
                      ++|.+||+.+|.+|+.
T Consensus       232 ~li~~cl~~dP~~RPt  247 (258)
T d1k2pa_         232 TIMYSCWHEKADERPT  247 (258)
T ss_dssp             HHHHHTTCSSGGGSCC
T ss_pred             HHHHHHccCCHhHCcC
Confidence            8888999998888763

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-51  Score=366.75  Aligned_cols=231  Identities=22%  Similarity=0.331  Sum_probs=191.4

Q ss_pred             hcCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceeccee
Q 018487          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (355)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~  183 (355)
                      .+.+..++|++.++||+|+||+||+|.++      +++.||||+++....    ..+.+.+|+.++++++|||||+++++
T Consensus         7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~   76 (272)
T d1qpca_           7 EWEVPRETLKLVERLGAGQFGEVWMGYYN------GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAV   76 (272)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEET------TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CeecCHHHeEEeEEEecCCCcEEEEEEEC------CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEee
Confidence            35566789999999999999999999975      356799999975432    23568899999999999999999998


Q ss_pred             eecCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCC
Q 018487          184 FQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (355)
Q Consensus       184 ~~~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~  261 (355)
                      +.+ +.+|+||||+++|+|.+++...  ..+++.++..++.||++||.|||+++|+||||||+||||+.++.+||+|||+
T Consensus        77 ~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGl  155 (272)
T d1qpca_          77 VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL  155 (272)
T ss_dssp             ECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             ecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccc
Confidence            765 5679999999999998876544  3589999999999999999999999999999999999999999999999999


Q ss_pred             ccccCcCC--CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCC-CCchhhh--------------hhh
Q 018487          262 AKEIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNI-KSMQVIA--------------CNT  324 (355)
Q Consensus       262 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf-~~~~~~~--------------~~~  324 (355)
                      |+.+....  ......||+.|||||++.+..++.++|||||||++|||+||..|+ .......              ...
T Consensus       156 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~  235 (272)
T d1qpca_         156 ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC  235 (272)
T ss_dssp             CEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred             eEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccC
Confidence            98775432  234457899999999999889999999999999999999965554 4432211              112


Q ss_pred             hHHHHHhhhheeeecCCCcCC
Q 018487          325 MLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       325 ~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ...+..+|.+||..+|.+++.
T Consensus       236 ~~~l~~li~~cl~~~P~~Rpt  256 (272)
T d1qpca_         236 PEELYQLMRLCWKERPEDRPT  256 (272)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCC
T ss_pred             hHHHHHHHHHHcCCCHhHCcC
Confidence            235678888999998888753

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-51  Score=375.84  Aligned_cols=224  Identities=29%  Similarity=0.494  Sum_probs=190.2

Q ss_pred             CCCeEEEe-eeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHh-cCCCcceecceeeec
Q 018487          109 PGDFEIFR-VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTHPFIVQLRYSFQT  186 (355)
Q Consensus       109 ~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~  186 (355)
                      .++|+++. .||+|+||+||+|+++     .+++.||||+++..        ..+.+|+.++.+ .+|||||+++++|.+
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~   76 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNK-----RTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYEN   76 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEEC-----CCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence            35899886 5999999999999976     56788999998643        235678988654 589999999999875


Q ss_pred             ----CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC---CCcEEEE
Q 018487          187 ----RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLT  257 (355)
Q Consensus       187 ----~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~---~~~~kl~  257 (355)
                          ...+|+|||||+||+|.+++..++  .+++.+++.|+.||+.||+|||++||+||||||+|||++.   ++.+||+
T Consensus        77 ~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~  156 (335)
T d2ozaa1          77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT  156 (335)
T ss_dssp             EETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred             cccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccc
Confidence                467999999999999999998753  6999999999999999999999999999999999999975   4579999


Q ss_pred             ecCCccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh----------------
Q 018487          258 DFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA----------------  321 (355)
Q Consensus       258 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~----------------  321 (355)
                      |||+|+...........+||+.|||||++.+..|+.++|||||||++|+|+||+.||.+.+...                
T Consensus       157 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~  236 (335)
T d2ozaa1         157 DFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF  236 (335)
T ss_dssp             CCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSC
T ss_pred             ccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence            9999998776666677889999999999999999999999999999999999999997653211                


Q ss_pred             -----hhhhHHHHHhhhheeeecCCCcCC
Q 018487          322 -----CNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       322 -----~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                           ......+.++|.+||..+|.+|+.
T Consensus       237 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s  265 (335)
T d2ozaa1         237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMT  265 (335)
T ss_dssp             CTTHHHHSCHHHHHHHHHHSCSSTTTSCC
T ss_pred             CCcccccCCHHHHHHHHHHccCChhHCcC
Confidence                 111224677888999998888763

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-50  Score=362.93  Aligned_cols=236  Identities=21%  Similarity=0.315  Sum_probs=188.6

Q ss_pred             CcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeee
Q 018487          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (355)
Q Consensus       106 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  185 (355)
                      .+.++.|++.++||+|+||+||+|.++.... .....||||++....  .......+.+|+++|++++|||||++++++.
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~   79 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSG-KKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS   79 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC----CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCC-EEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe
Confidence            3567789999999999999999999875432 334679999987543  3344556889999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      ..+..++||||+.++++.+.+... ..+++.++..++.|++.||+|||+++|+||||||+||||+.++.+||+|||+++.
T Consensus        80 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  159 (283)
T d1mqba_          80 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV  159 (283)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             cCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence            999999999999999998877655 5699999999999999999999999999999999999999999999999999987


Q ss_pred             cCcCCC----CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCc-hhhh--------------hhhh
Q 018487          265 IDESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSM-QVIA--------------CNTM  325 (355)
Q Consensus       265 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~-~~~~--------------~~~~  325 (355)
                      +.....    .....||+.|||||++.+..++.++|||||||++|||+||..||... ....              .+..
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  239 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP  239 (283)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCB
T ss_pred             ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhH
Confidence            643321    22346899999999999999999999999999999999976665432 1111              1122


Q ss_pred             HHHHHhhhheeeecCCCcC
Q 018487          326 LLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~  344 (355)
                      ..+..+|.+||..+|.+++
T Consensus       240 ~~l~~li~~cl~~~p~~RP  258 (283)
T d1mqba_         240 SAIYQLMMQCWQQERARRP  258 (283)
T ss_dssp             HHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHHHCcCCHhHCc
Confidence            3567888899988888765

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-51  Score=366.01  Aligned_cols=231  Identities=28%  Similarity=0.447  Sum_probs=194.8

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccch---hHHHHHHHHHHHHHhcC--CCcceeccee
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK---NHVDYMKAERDILTKVT--HPFIVQLRYS  183 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--h~nIv~l~~~  183 (355)
                      .++|++.++||+|+||+||+|+++     .+++.||||++.+......   .....+.+|+.+|++++  |||||+++++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~   77 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRV-----SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW   77 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEEC-----CCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEE
Confidence            368999999999999999999977     5678899999976543221   11223567999999997  8999999999


Q ss_pred             eecCCeEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCC-CcEEEEecCC
Q 018487          184 FQTRSKLYLILDFING-GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGL  261 (355)
Q Consensus       184 ~~~~~~~~lv~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~-~~~kl~Dfg~  261 (355)
                      |...+.+|+||||+.+ +++.+++..+..+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus        78 ~~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          78 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EeeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccc
Confidence            9999999999999976 5788888888899999999999999999999999999999999999999854 7999999999


Q ss_pred             ccccCcCCCCCcccccCccccchhhccCCC-CCcccHHHHHHHHHHHHcCCCCCCCchhhhh-------hhhHHHHHhhh
Q 018487          262 AKEIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQVNIKSMQVIAC-------NTMLLFYLIIF  333 (355)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-------~~~~~~~~~i~  333 (355)
                      |+..... .....+||+.|+|||++.+..+ +.++|||||||++|||+||+.||...+.+..       .....+.++|.
T Consensus       158 a~~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~~~~~~~~~~s~~~~~li~  236 (273)
T d1xwsa_         158 GALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIR  236 (273)
T ss_dssp             CEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHHHHHHHH
T ss_pred             ceecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHhhcccCCCCCCCHHHHHHHH
Confidence            9875443 3456789999999999987765 5678999999999999999999998654332       12335678899


Q ss_pred             heeeecCCCcCC
Q 018487          334 HCLFVNSLELLS  345 (355)
Q Consensus       334 ~~l~~~~~e~~~  345 (355)
                      +||..+|.+++.
T Consensus       237 ~~L~~dp~~R~s  248 (273)
T d1xwsa_         237 WCLALRPSDRPT  248 (273)
T ss_dssp             HHTCSSGGGSCC
T ss_pred             HHccCCHhHCcC
Confidence            999999888763

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-51  Score=369.82  Aligned_cols=200  Identities=27%  Similarity=0.437  Sum_probs=170.9

Q ss_pred             EEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccc--hhHHHHHHHHHHHHHhcCCCcceecceeeecCCeEE
Q 018487          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK--KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (355)
Q Consensus       114 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  191 (355)
                      .+++||+|+||+||+|+++     .+++.||||+++......  ....+.+.+|+.+|++++|||||+++++|..++.+|
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~   76 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDK-----NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS   76 (299)
T ss_dssp             EEEEEEEETTEEEEEEECS-----SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred             cceEeccCcCeEEEEEEEC-----CCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCcee
Confidence            5789999999999999976     567899999987654322  122346788999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC-C
Q 018487          192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-R  270 (355)
Q Consensus       192 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-~  270 (355)
                      +||||+.++++..+......+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus        77 ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~  156 (299)
T d1ua2a_          77 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA  156 (299)
T ss_dssp             EEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred             ehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence            999999998877776667789999999999999999999999999999999999999999999999999998765433 3


Q ss_pred             CCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          271 SNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       271 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      ....+||+.|+|||++.+ ..|+.++|||||||++|||+||+.||....
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~  205 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS  205 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC
Confidence            445689999999999875 467999999999999999999999998653

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.8e-50  Score=364.63  Aligned_cols=238  Identities=21%  Similarity=0.341  Sum_probs=201.6

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      ..+..++|++.++||+|+||+||+|++++..+..+++.||||++....  .....+.+.+|+.+|++++||||+++++++
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            345567899999999999999999999987777788899999987543  344566789999999999999999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQG------------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRD  240 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~~------------------------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrD  240 (355)
                      ...+..+++|||+++|+|.+++....                        .+++.++..++.|++.||+|||+++|||||
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD  165 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD  165 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence            99999999999999999999986532                        378899999999999999999999999999


Q ss_pred             CCCCcEEecCCCcEEEEecCCccccCcCC---CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCC-CCCCC
Q 018487          241 LKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ-VNIKS  316 (355)
Q Consensus       241 lkp~NILl~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~-~pf~~  316 (355)
                      |||+|||++.++.+||+|||+|+......   ......||+.|+|||++.+..|+.++|||||||++|||++|. .||..
T Consensus       166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence            99999999999999999999998664332   223467899999999999999999999999999999999996 57877


Q ss_pred             chhhhh--------------hhhHHHHHhhhheeeecCCCcC
Q 018487          317 MQVIAC--------------NTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       317 ~~~~~~--------------~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                      .+....              .....+..++.+||..+|.+++
T Consensus       246 ~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RP  287 (301)
T d1lufa_         246 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRP  287 (301)
T ss_dssp             SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             CCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCc
Confidence            644321              1223567788888888888765

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-50  Score=360.10  Aligned_cols=235  Identities=22%  Similarity=0.344  Sum_probs=184.9

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      +.+..++|++.+.||+|+||+||+|.+....  .....||||.++...  .....+.+.+|+.+|++++|||||++++++
T Consensus         2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~--~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~   77 (273)
T d1mp8a_           2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPE--NPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVI   77 (273)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC----CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CCcCHHHeEEEEEEeeCCCcEEEEEEEecCC--ceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            3456679999999999999999999986432  345568888875432  344556788999999999999999999998


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                      . .+.+|+||||+++|+|.+++... ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        78 ~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~  156 (273)
T d1mp8a_          78 T-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  156 (273)
T ss_dssp             C-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             e-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhhe
Confidence            6 46789999999999998887654 569999999999999999999999999999999999999999999999999998


Q ss_pred             ccCcCC--CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhhH
Q 018487          264 EIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTML  326 (355)
Q Consensus       264 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~~  326 (355)
                      .+....  ......||+.|+|||++.+..++.++|||||||++|||+| |..||........              +...
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~  236 (273)
T d1mp8a_         157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP  236 (273)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred             eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence            764332  2344568999999999999999999999999999999998 8999987543221              1223


Q ss_pred             HHHHhhhheeeecCCCcC
Q 018487          327 LFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       327 ~~~~~i~~~l~~~~~e~~  344 (355)
                      .+..+|.+||..+|.+++
T Consensus       237 ~~~~li~~cl~~dp~~Rp  254 (273)
T d1mp8a_         237 TLYSLMTKCWAYDPSRRP  254 (273)
T ss_dssp             HHHHHHHHHTCSSGGGSC
T ss_pred             HHHHHHHHHcCCCHhHCc
Confidence            567888888888888765

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-50  Score=363.91  Aligned_cols=239  Identities=22%  Similarity=0.374  Sum_probs=188.4

Q ss_pred             hcCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecce
Q 018487          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY  182 (355)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~  182 (355)
                      ++.+..++|++.++||+|+||.||+|.+++.....+++.||||+++...  .....+.+.+|..++.++ +|+|||.+++
T Consensus         7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~   84 (299)
T d1ywna1           7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG   84 (299)
T ss_dssp             HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence            3456678999999999999999999999877766778899999987543  233345566777777766 6899999998


Q ss_pred             eeec-CCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q 018487          183 SFQT-RSKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (355)
Q Consensus       183 ~~~~-~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~N  245 (355)
                      ++.. +..+++|||||++|+|.+++...                ..+++.++..++.||+.||.|||++||+||||||+|
T Consensus        85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~N  164 (299)
T d1ywna1          85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  164 (299)
T ss_dssp             EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccc
Confidence            8765 45789999999999999998753                248899999999999999999999999999999999


Q ss_pred             EEecCCCcEEEEecCCccccCcCC---CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcC-CCCCCCchhhh
Q 018487          246 ILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG-QVNIKSMQVIA  321 (355)
Q Consensus       246 ILl~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg-~~pf~~~~~~~  321 (355)
                      |||+.++.+||+|||+|+......   .....+||+.|||||++.+..++.++|||||||++|||+|| ..||...+...
T Consensus       165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~  244 (299)
T d1ywna1         165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  244 (299)
T ss_dssp             EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999998654332   23456799999999999999999999999999999999997 55787653211


Q ss_pred             ---------------hhhhHHHHHhhhheeeecCCCcC
Q 018487          322 ---------------CNTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       322 ---------------~~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                                     ......+.++|.+||..+|.+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp  282 (299)
T d1ywna1         245 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP  282 (299)
T ss_dssp             HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             HHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCc
Confidence                           01223567888889888888765

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-50  Score=362.05  Aligned_cols=203  Identities=28%  Similarity=0.455  Sum_probs=172.7

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|+++++||+|+||+||+|+++     .+++.||||+++.... .....+.+.+|+++|++++|||||+++++|.+++.
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~   75 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNK-----LTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK   75 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEET-----TTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             CCCEeccEEecCcCeEEEEEEEC-----CCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccc
Confidence            58999999999999999999987     5678899999976542 23344678889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcC
Q 018487          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~  268 (355)
                      +|+||||+.++.+...... ...+++.+++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus        76 ~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          76 LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             EEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             eeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC
Confidence            9999999987644433333 356999999999999999999999999999999999999999999999999999876433


Q ss_pred             -CCCCcccccCccccchhhccCC-CCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          269 -SRSNSMCGTTEYMAPEILLSKG-HNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       269 -~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                       ......+||+.|+|||++.... ++.++|||||||++|+|++|+.||...+
T Consensus       156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~  207 (298)
T d1gz8a_         156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS  207 (298)
T ss_dssp             SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC
Confidence             3344568999999999987665 5789999999999999999999998653

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-50  Score=360.62  Aligned_cols=236  Identities=21%  Similarity=0.349  Sum_probs=186.4

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  186 (355)
                      +..++|++.+.||+|+||+||+|+++...  .....||||++.++........+.+.+|+.+|++++|||||++++++.+
T Consensus         5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~--~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~   82 (273)
T d1u46a_           5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPS--GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT   82 (273)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTT--SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             EchHHeEEEEEEecCCCeEEEEEEEECCC--CcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            34568999999999999999999876432  2345799999987766566667789999999999999999999999976


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                       +..++||||+++|++.+++..+ +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus        83 -~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          83 -PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             -cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence             4678999999999998877654 56999999999999999999999999999999999999999999999999999987


Q ss_pred             CcCCC----CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh---------------hhh
Q 018487          266 DESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC---------------NTM  325 (355)
Q Consensus       266 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~---------------~~~  325 (355)
                      .....    .....|+..|+|||++.+..++.++|||||||++|||+| |+.||...+....               +..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP  241 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCccccc
Confidence            54432    233467889999999999999999999999999999998 8999987643331               112


Q ss_pred             HHHHHhhhheeeecCCCcCC
Q 018487          326 LLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ..+.++|.+||..+|.+|+.
T Consensus       242 ~~l~~li~~cl~~dp~~RPt  261 (273)
T d1u46a_         242 QDIYNVMVQCWAHKPEDRPT  261 (273)
T ss_dssp             HHHHHHHHHHTCSSGGGSCC
T ss_pred             HHHHHHHHHHcCCChhHCcC
Confidence            25577888888888888653

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-50  Score=359.22  Aligned_cols=229  Identities=24%  Similarity=0.310  Sum_probs=185.3

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      +.+..++|++.+.||+|+||+||+|.++      ..+.||||++.....    ..+.+.+|+.++++++|||||++++++
T Consensus        12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~------~~~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~   81 (285)
T d1fmka3          12 WEIPRESLRLEVKLGQGCFGEVWMGTWN------GTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVV   81 (285)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEET------TTEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             eEcCHHHEEEeeEEeeCCCeEEEEEEEC------CCCEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEE
Confidence            4455678999999999999999999976      234699999975542    235688999999999999999999998


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          185 QTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       185 ~~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                      .+ +.+|+||||+++|+|..++...  ..+++.++..++.||+.||+|||++||+||||||+||||+.++.+||+|||++
T Consensus        82 ~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla  160 (285)
T d1fmka3          82 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA  160 (285)
T ss_dssp             CS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             ec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchh
Confidence            65 5679999999999998887643  56999999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCC--CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCc-hhhh--------------hhhh
Q 018487          263 KEIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSM-QVIA--------------CNTM  325 (355)
Q Consensus       263 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~-~~~~--------------~~~~  325 (355)
                      +.+....  ......||+.|+|||++.+..++.++|||||||++|||+||..||... ....              ....
T Consensus       161 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~  240 (285)
T d1fmka3         161 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP  240 (285)
T ss_dssp             C--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSC
T ss_pred             hhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccC
Confidence            8764332  233467899999999999999999999999999999999976665443 2111              1122


Q ss_pred             HHHHHhhhheeeecCCCcC
Q 018487          326 LLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       326 ~~~~~~i~~~l~~~~~e~~  344 (355)
                      ..++.+|.+||..+|.+|+
T Consensus       241 ~~l~~li~~cl~~dP~~Rp  259 (285)
T d1fmka3         241 ESLHDLMCQCWRKEPEERP  259 (285)
T ss_dssp             HHHHHHHHHHTCSSGGGSC
T ss_pred             HHHHHHHHHHcccCHhHCc
Confidence            3568889999999988875

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-49  Score=359.73  Aligned_cols=204  Identities=27%  Similarity=0.405  Sum_probs=172.4

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc---CCCcceecceeee-
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV---THPFIVQLRYSFQ-  185 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~-  185 (355)
                      ++|+++++||+|+||+||+|+++.    ..++.||||+++....... ....+.+|+.+|+.+   +||||++++++|. 
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~----~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~   81 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLK----NGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTV   81 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT----TTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred             CCEEEEEEEecccCeEEEEEEEEC----CCCEEEEEEEEehhhccch-HHHHHHHHHHHHHHHhhcCCCCcceeeeeecc
Confidence            589999999999999999999752    2357799999976543221 122344566666555   8999999999985 


Q ss_pred             ----cCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecC
Q 018487          186 ----TRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG  260 (355)
Q Consensus       186 ----~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg  260 (355)
                          ....++++|||++++.+...... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        82 ~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          82 SRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             EECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             cccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchh
Confidence                34578999999999877544443 3568999999999999999999999999999999999999999999999999


Q ss_pred             CccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       261 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      ++............+||+.|||||++.+..|+.++|||||||++|||+||+.||...+
T Consensus       162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~  219 (305)
T d1blxa_         162 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS  219 (305)
T ss_dssp             SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             hhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC
Confidence            9987766666677889999999999999999999999999999999999999998764

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-49  Score=360.74  Aligned_cols=233  Identities=23%  Similarity=0.351  Sum_probs=188.0

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  187 (355)
                      ...+|+++++||+|+||+||+|.++.+.. .....||+|.++...  .....+.+.+|+.++++++|||||++++++.++
T Consensus         7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~   83 (317)
T d1xkka_           7 KETEFKKIKVLGSGAFGTVYKGLWIPEGE-KVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   83 (317)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECC-----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             CHHHCEEeeEEecCCCeEEEEEEEcCCCC-EEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            34679999999999999999999874321 123468888876542  334456788999999999999999999999875


Q ss_pred             CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccC
Q 018487          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~  266 (355)
                       ..+++|||+.+++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus        84 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          84 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             -SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             -CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence             567888999999998877765 569999999999999999999999999999999999999999999999999998764


Q ss_pred             cCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhh--------------hhhHHH
Q 018487          267 ESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIAC--------------NTMLLF  328 (355)
Q Consensus       267 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~--------------~~~~~~  328 (355)
                      ....   .....||+.|||||++.+..|+.++|||||||++|||+| |+.||........              .....+
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~  242 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV  242 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHH
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHH
Confidence            4332   233468999999999999999999999999999999999 8999987533221              122356


Q ss_pred             HHhhhheeeecCCCcC
Q 018487          329 YLIIFHCLFVNSLELL  344 (355)
Q Consensus       329 ~~~i~~~l~~~~~e~~  344 (355)
                      ..+|.+||..+|.+++
T Consensus       243 ~~li~~cl~~dP~~RP  258 (317)
T d1xkka_         243 YMIMVKCWMIDADSRP  258 (317)
T ss_dssp             HHHHHHHTCSSGGGSC
T ss_pred             HHHHHHhCCCChhhCc
Confidence            7888899999888875

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-49  Score=359.50  Aligned_cols=238  Identities=22%  Similarity=0.380  Sum_probs=194.7

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCC--CCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecc
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDG--DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLR  181 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~  181 (355)
                      +.+..++|++.++||+|+||.||+|++.+....  ..+..||||+++.+.  .......+.+|...+.++ +|||||+++
T Consensus         8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~   85 (299)
T d1fgka_           8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL   85 (299)
T ss_dssp             TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence            556778999999999999999999998765432  334579999997654  333456677888888888 799999999


Q ss_pred             eeeecCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q 018487          182 YSFQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (355)
Q Consensus       182 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~N  245 (355)
                      ++|.+++.+++||||+++|+|.+++..+.                .+++.++..++.||+.||+|||+++||||||||+|
T Consensus        86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N  165 (299)
T d1fgka_          86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN  165 (299)
T ss_dssp             EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence            99999999999999999999999997553                48999999999999999999999999999999999


Q ss_pred             EEecCCCcEEEEecCCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhh
Q 018487          246 ILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIA  321 (355)
Q Consensus       246 ILl~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~  321 (355)
                      ||++.++.+||+|||+++.......   .....||+.|+|||++.++.|+.++|||||||++|||+| |+.||.......
T Consensus       166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~  245 (299)
T d1fgka_         166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  245 (299)
T ss_dssp             EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence            9999999999999999987654332   344678999999999999999999999999999999998 788998764332


Q ss_pred             hh--------------hhHHHHHhhhheeeecCCCcC
Q 018487          322 CN--------------TMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       322 ~~--------------~~~~~~~~i~~~l~~~~~e~~  344 (355)
                      ..              ....+.++|.+||+.+|.+++
T Consensus       246 ~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rp  282 (299)
T d1fgka_         246 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP  282 (299)
T ss_dssp             HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSC
T ss_pred             HHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCc
Confidence            11              123567888889988888865

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-49  Score=360.04  Aligned_cols=239  Identities=23%  Similarity=0.360  Sum_probs=202.9

Q ss_pred             hcCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecce
Q 018487          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY  182 (355)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~  182 (355)
                      .|.+..++|++.++||+|+||.||+|++++..+...++.||||+++...  .......+.+|+.+++++ +|||||++++
T Consensus        17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g   94 (311)
T d1t46a_          17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLG   94 (311)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            4556678999999999999999999999877777788999999997654  334455688999999999 6999999999


Q ss_pred             eeecCCeEEEEEeccCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q 018487          183 SFQTRSKLYLILDFINGGHLFFHLYRQG------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPE  244 (355)
Q Consensus       183 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~  244 (355)
                      ++...+.+|+|||||++|+|.+++....                  .+++..+..++.||+.||+|||++|++||||||+
T Consensus        95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~  174 (311)
T d1t46a_          95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR  174 (311)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence            9999999999999999999999987543                  5899999999999999999999999999999999


Q ss_pred             cEEecCCCcEEEEecCCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhh
Q 018487          245 NILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVI  320 (355)
Q Consensus       245 NILl~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~  320 (355)
                      |||++.++.+|++|||+++.......   ....+||+.|+|||++.+..++.++|||||||++|||+| |..||......
T Consensus       175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999987654332   234678999999999999999999999999999999999 55556554221


Q ss_pred             h---------------hhhhHHHHHhhhheeeecCCCcC
Q 018487          321 A---------------CNTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       321 ~---------------~~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                      .               ......+.++|.+||..+|.+++
T Consensus       255 ~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RP  293 (311)
T d1t46a_         255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRP  293 (311)
T ss_dssp             HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred             HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCc
Confidence            1               11224567888899998888875

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.1e-49  Score=355.36  Aligned_cols=202  Identities=24%  Similarity=0.437  Sum_probs=175.8

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|+++++||+|+||+||+|+++      +++.||||++..... .....+.+.+|+.+|++++|||||+++++|...+.
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~------~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~   74 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN------YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR   74 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET------TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred             CCceeccEEecCCCcEEEEEEeC------CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc
Confidence            58999999999999999999875      467899999976543 33445678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      .|++||++.++.+..+....+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          75 LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             EEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             eeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence            99999999988887777778889999999999999999999999999999999999999999999999999998765433


Q ss_pred             C-CCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          270 R-SNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       270 ~-~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      . .....|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~  205 (286)
T d1ob3a_         155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS  205 (286)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC
Confidence            2 3455789999999998764 56899999999999999999999998754

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-49  Score=358.62  Aligned_cols=233  Identities=24%  Similarity=0.351  Sum_probs=190.4

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCcceecceeee
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQ  185 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~  185 (355)
                      +..++|++.++||+|+||+||+|.++.+   .....||||.+....  .....+.+.+|+++|+++ +|||||++++++.
T Consensus         7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~---~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~   81 (309)
T d1fvra_           7 LDWNDIKFQDVIGEGNFGQVLKARIKKD---GLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACE   81 (309)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEET---TEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred             cCHHHcEEEEEEeeCCCcEEEEEEECCC---CeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEe
Confidence            4457899999999999999999998732   122347777765432  233455688999999998 7999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEec
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD  249 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~  249 (355)
                      .++.+|+||||+++|+|.+++...                ..+++.++..++.||+.||.|||+++|+||||||+|||++
T Consensus        82 ~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~  161 (309)
T d1fvra_          82 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG  161 (309)
T ss_dssp             ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred             cCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEc
Confidence            999999999999999999998754                4689999999999999999999999999999999999999


Q ss_pred             CCCcEEEEecCCccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCC-CCCCCchhhhh------
Q 018487          250 SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ-VNIKSMQVIAC------  322 (355)
Q Consensus       250 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~-~pf~~~~~~~~------  322 (355)
                      .++.+||+|||+++............||..|+|||.+.+..++.++|||||||++|||++|. .||...+....      
T Consensus       162 ~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~  241 (309)
T d1fvra_         162 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  241 (309)
T ss_dssp             GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred             CCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence            99999999999998776655555667999999999999999999999999999999999975 57876533221      


Q ss_pred             --------hhhHHHHHhhhheeeecCCCcC
Q 018487          323 --------NTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       323 --------~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                              +....+..+|.+||..+|.+|+
T Consensus       242 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RP  271 (309)
T d1fvra_         242 GYRLEKPLNCDDEVYDLMRQCWREKPYERP  271 (309)
T ss_dssp             TCCCCCCTTBCHHHHHHHHHHTCSSGGGSC
T ss_pred             cCCCCCCccCCHHHHHHHHHHcCCChhHCc
Confidence                    1223567788888888888766

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-49  Score=349.34  Aligned_cols=226  Identities=24%  Similarity=0.439  Sum_probs=184.0

Q ss_pred             cCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceee
Q 018487          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (355)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  184 (355)
                      |.+..++|++.++||+|+||.||+|.++       ++.||||+++.+.     ..+.+.+|+.++++++|||||++++++
T Consensus         2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~   69 (262)
T d1byga_           2 WALNMKELKLLQTIGKGEFGDVMLGDYR-------GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVI   69 (262)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEET-------TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEE
T ss_pred             CccCHHHeEEeEEEecCCCeEEEEEEEC-------CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            4566678999999999999999999975       4569999996543     335688999999999999999999988


Q ss_pred             ec-CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCC
Q 018487          185 QT-RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (355)
Q Consensus       185 ~~-~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~  261 (355)
                      .+ .+.+|+||||+++|+|.+++..+.  .+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+
T Consensus        70 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~  149 (262)
T d1byga_          70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL  149 (262)
T ss_dssp             CCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred             EecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeeccccc
Confidence            54 466899999999999999987653  489999999999999999999999999999999999999999999999999


Q ss_pred             ccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHc-CCCCCCCchhhhhh--------------hhH
Q 018487          262 AKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQVNIKSMQVIACN--------------TML  326 (355)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~pf~~~~~~~~~--------------~~~  326 (355)
                      ++.....  .....+|..|+|||++.+..++.++|||||||++|||+| |+.||...+.....              ...
T Consensus       150 s~~~~~~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~  227 (262)
T d1byga_         150 TKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP  227 (262)
T ss_dssp             --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCH
T ss_pred             ceecCCC--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCH
Confidence            9876443  334568999999999999999999999999999999998 78888875433211              123


Q ss_pred             HHHHhhhheeeecCCCcC
Q 018487          327 LFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       327 ~~~~~i~~~l~~~~~e~~  344 (355)
                      .+.++|.+||..+|.+++
T Consensus       228 ~~~~li~~cl~~dP~~Rp  245 (262)
T d1byga_         228 AVYEVMKNCWHLDAAMRP  245 (262)
T ss_dssp             HHHHHHHHHTCSSGGGSC
T ss_pred             HHHHHHHHHcccCHhHCc
Confidence            567888888888888865

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=355.00  Aligned_cols=240  Identities=21%  Similarity=0.294  Sum_probs=202.7

Q ss_pred             hcCcCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceeccee
Q 018487          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (355)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~  183 (355)
                      +|.+..++|++.++||+|+||+||+|.+++..+...+..||||+++...  .......+.+|+.++++++|||||+++++
T Consensus        14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~   91 (308)
T d1p4oa_          14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGV   91 (308)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence            3567778999999999999999999998866555567789999997543  33445568899999999999999999999


Q ss_pred             eecCCeEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCc
Q 018487          184 FQTRSKLYLILDFINGGHLFFHLYRQ----------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH  253 (355)
Q Consensus       184 ~~~~~~~~lv~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~  253 (355)
                      +..+...++||||+++|+|.+++...          ..+++..+..++.|+++||.|||+++|+||||||+|||++.++.
T Consensus        92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred             EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence            99999999999999999999887643          23688999999999999999999999999999999999999999


Q ss_pred             EEEEecCCccccCcCCC---CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcC-CCCCCCchhhhh-------
Q 018487          254 VMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG-QVNIKSMQVIAC-------  322 (355)
Q Consensus       254 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg-~~pf~~~~~~~~-------  322 (355)
                      +||+|||+++.+.....   .....||+.|+|||.+.+..++.++|||||||++|||+|| +.||........       
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~  251 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG  251 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Confidence            99999999987644332   2344689999999999999999999999999999999998 577876543221       


Q ss_pred             -------hhhHHHHHhhhheeeecCCCcCC
Q 018487          323 -------NTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       323 -------~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                             .....+..+|.+||+.+|.+|+.
T Consensus       252 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPs  281 (308)
T d1p4oa_         252 GLLDKPDNCPDMLFELMRMCWQYNPKMRPS  281 (308)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCCCcccchHHHHHHHHHHcCCChhHCcC
Confidence                   11236788899999999888763

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-48  Score=356.72  Aligned_cols=196  Identities=31%  Similarity=0.485  Sum_probs=169.5

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec----
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT----  186 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----  186 (355)
                      +|+.+++||+|+||+||+|+++     .+++.||||++..+...       ..+|+.+|++++||||++++++|..    
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~   88 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLC-----DSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEK   88 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--C
T ss_pred             CcEeeeEEeeCcCeEEEEEEEC-----CCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCcc
Confidence            6999999999999999999987     56889999999765321       2369999999999999999999853    


Q ss_pred             --CCeEEEEEeccCCCChHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC-cEEEEecC
Q 018487          187 --RSKLYLILDFINGGHLFFHL---YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFG  260 (355)
Q Consensus       187 --~~~~~lv~e~~~~gsL~~~l---~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~-~~kl~Dfg  260 (355)
                        ..++|+|||||+++.+....   .....+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus        89 ~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG  168 (350)
T d1q5ka_          89 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG  168 (350)
T ss_dssp             CSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCT
T ss_pred             CCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEeccc
Confidence              34689999999876443332   3455799999999999999999999999999999999999999775 89999999


Q ss_pred             CccccCcCCCCCcccccCccccchhhcc-CCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          261 LAKEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       261 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      +++.+.........+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||...+
T Consensus       169 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~  227 (350)
T d1q5ka_         169 SAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS  227 (350)
T ss_dssp             TCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred             chhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC
Confidence            9998876666677789999999999875 568999999999999999999999998754

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-48  Score=351.94  Aligned_cols=204  Identities=25%  Similarity=0.391  Sum_probs=172.7

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec--
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--  186 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--  186 (355)
                      .++|+++++||+|+||+||+|+++     .+++.||||++..... .....+.+.+|+.+|++++||||+++++++..  
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~   82 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHR-----KTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKA   82 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEET-----TTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred             cCCEEEEEEEecCcCeEEEEEEEC-----CCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeeccc
Confidence            368999999999999999999976     5678999999876543 33344567789999999999999999998754  


Q ss_pred             ------CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecC
Q 018487          187 ------RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG  260 (355)
Q Consensus       187 ------~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg  260 (355)
                            .+.+|+||||+.++.+.........+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        83 ~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          83 SPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             --------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             ccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecc
Confidence                  45689999999988776666666789999999999999999999999999999999999999999999999999


Q ss_pred             CccccCcCC-----CCCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          261 LAKEIDESS-----RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       261 ~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      +++.+....     .....+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~  226 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT  226 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC
Confidence            998664322     23345799999999998765 68999999999999999999999998654

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-48  Score=353.84  Aligned_cols=236  Identities=46%  Similarity=0.803  Sum_probs=197.7

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeeccccc-chhHHHHHHHHHHHHHhcCC-Ccceecceeee
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-KKNHVDYMKAERDILTKVTH-PFIVQLRYSFQ  185 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~  185 (355)
                      .-++|+++++||+|+||+||+|++...  ..+++.||||++++.... +....+.+.+|+.+|++++| |||+++++++.
T Consensus        22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~   99 (322)
T d1vzoa_          22 GIENFELLKVLGTGAYGKVFLVRKISG--HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ   99 (322)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSS--TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             chhceEEEEEEecCCCeEEEEEEECcc--CCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec
Confidence            346799999999999999999987532  246789999998765432 22334557789999999976 89999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcccc
Q 018487          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (355)
Q Consensus       186 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~  265 (355)
                      +...++++|||+.+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus       100 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         100 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             cCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999876


Q ss_pred             CcC--CCCCcccccCccccchhhccC--CCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh-----------------hh
Q 018487          266 DES--SRSNSMCGTTEYMAPEILLSK--GHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC-----------------NT  324 (355)
Q Consensus       266 ~~~--~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~-----------------~~  324 (355)
                      ...  .......|++.|+|||.+.+.  .++.++|||||||+||+|+||+.||........                 ..
T Consensus       180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~  259 (322)
T d1vzoa_         180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM  259 (322)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred             cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccC
Confidence            432  233456799999999999764  468899999999999999999999977532211                 12


Q ss_pred             hHHHHHhhhheeeecCCCcCC
Q 018487          325 MLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       325 ~~~~~~~i~~~l~~~~~e~~~  345 (355)
                      ...+.+++.+||..+|.+++.
T Consensus       260 s~~~~~li~~~l~~dP~~R~s  280 (322)
T d1vzoa_         260 SALAKDLIQRLLMKDPKKRLG  280 (322)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTT
T ss_pred             CHHHHHHHHHHcccCHHHcCC
Confidence            224678899999999999863

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-47  Score=351.50  Aligned_cols=200  Identities=28%  Similarity=0.454  Sum_probs=168.5

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC-
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-  188 (355)
                      ++|+++++||+|+||+||+|.++     .+++.||||++.+..  .....+.+.+|+.+|+.++||||+++++++.... 
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~-----~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~   80 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDN-----VNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   80 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEET-----TTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             CCeEEEEEEeeccCeEEEEEEEC-----CCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence            57999999999999999999976     567889999997543  3445567889999999999999999999987543 


Q ss_pred             ----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          189 ----KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       189 ----~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                          .+|++ +++.+|+|.+++..+ .+++.+++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++..
T Consensus        81 ~~~~~~~l~-~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~  158 (345)
T d1pmea_          81 EQMKDVYLV-THLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV  158 (345)
T ss_dssp             TTCCCEEEE-EECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             cccceEEEE-EeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceee
Confidence                34555 556688999998654 689999999999999999999999999999999999999999999999999986


Q ss_pred             cCcCC----CCCcccccCccccchhhc-cCCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          265 IDESS----RSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       265 ~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      .....    .....+||+.|+|||++. +..++.++||||+||++|+|++|+.||...+
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~  217 (345)
T d1pmea_         159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH  217 (345)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence            64332    234567999999999985 4567899999999999999999999998754

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-47  Score=342.14  Aligned_cols=201  Identities=24%  Similarity=0.438  Sum_probs=180.4

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCCe
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  189 (355)
                      ++|+++++||+|+||+||+|+++     .+++.||||+++.... .....+.+.+|+.+|+.++||||++++++|.....
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   75 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNR-----ETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK   75 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEET-----TTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CCCEeeeEEecCcCeEEEEEEEC-----CCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccc
Confidence            58999999999999999999977     5678899999977653 45566788899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCC
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  269 (355)
                      .++|||++.+++|..++...+.+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.++......
T Consensus        76 ~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          76 LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             EEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             eeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            99999999999998888888899999999999999999999999999999999999999999999999999998775433


Q ss_pred             C-CCcccccCccccchhhccCC-CCCcccHHHHHHHHHHHHcCCCCCCC
Q 018487          270 R-SNSMCGTTEYMAPEILLSKG-HNKDADWWSVGILLYEMLTGQVNIKS  316 (355)
Q Consensus       270 ~-~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~elltg~~pf~~  316 (355)
                      . .....+++.|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~  204 (292)
T d1unla_         156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred             ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence            2 33456788999999988654 68999999999999999999999744

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-47  Score=351.96  Aligned_cols=200  Identities=27%  Similarity=0.467  Sum_probs=169.1

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  188 (355)
                      .++|+++++||+|+||+||+|.++     .+++.||||+++... ......+.+.+|+++|+.++|||||+++++|...+
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~-----~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~   90 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDG-----RTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE   90 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEET-----TTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred             CCcEEEEEEEecCCCeEEEEEEEC-----CCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCc
Confidence            578999999999999999999976     568899999997654 34455677889999999999999999999997654


Q ss_pred             ------eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCc
Q 018487          189 ------KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (355)
Q Consensus       189 ------~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a  262 (355)
                            ++|+||||+ +.+|..+. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+|
T Consensus        91 ~~~~~~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          91 TLDDFTDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             STTTCCCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             cccccceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccce
Confidence                  579999999 55665554 4567999999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCCCCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          263 KEIDESSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      +.....  ....+||+.|+|||++.+. .++.++||||+||++|+|++|+.||...+
T Consensus       169 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~  223 (346)
T d1cm8a_         169 RQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD  223 (346)
T ss_dssp             EECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eccCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC
Confidence            876543  3456799999999998764 56899999999999999999999998764

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-47  Score=343.48  Aligned_cols=228  Identities=21%  Similarity=0.273  Sum_probs=186.6

Q ss_pred             EEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec-CCeEEE
Q 018487          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-RSKLYL  192 (355)
Q Consensus       114 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~l  192 (355)
                      +.++||+|+||+||+|.+....  .....||||.++..  ......+.+.+|+++|++++|||||++++++.. ++..++
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~--~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l  106 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDND--GKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  106 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC------CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEE
T ss_pred             cceEEeecCCeEEEEEEEECCC--CEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEE
Confidence            3678999999999999986321  23446899998643  245556779999999999999999999999764 568999


Q ss_pred             EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCccccCcCCC-
Q 018487          193 ILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR-  270 (355)
Q Consensus       193 v~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~-  270 (355)
                      |||||++|+|.+++.... .+++..+..++.|++.||.|||+.+|+||||||+||||++++.+||+|||+++....... 
T Consensus       107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            999999999999887554 478889999999999999999999999999999999999999999999999987643322 


Q ss_pred             ----CCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhh---------------hhhhHHHHHh
Q 018487          271 ----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIA---------------CNTMLLFYLI  331 (355)
Q Consensus       271 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~---------------~~~~~~~~~~  331 (355)
                          .....||+.|+|||++.+..++.++||||||+++|||+||+.||.......               ......+..+
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~l  266 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV  266 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHH
Confidence                223468999999999999999999999999999999999888886542111               1112357888


Q ss_pred             hhheeeecCCCcCC
Q 018487          332 IFHCLFVNSLELLS  345 (355)
Q Consensus       332 i~~~l~~~~~e~~~  345 (355)
                      |.+||..+|.+|+.
T Consensus       267 i~~cl~~dP~~RPs  280 (311)
T d1r0pa_         267 MLKCWHPKAEMRPS  280 (311)
T ss_dssp             HHHHTCSSGGGSCC
T ss_pred             HHHHcCCCHhHCcC
Confidence            99999999888763

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-46  Score=348.22  Aligned_cols=200  Identities=27%  Similarity=0.443  Sum_probs=164.8

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeec---
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT---  186 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~---  186 (355)
                      ++|+++++||+|+||+||+|+++     .+++.||||+++.... .....+.+.+|+.+|++++|||||+++++|..   
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~-----~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~   90 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDA-----VLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT   90 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEET-----TTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred             CCeEEEEEeecCcCeEEEEEEEC-----CCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccc
Confidence            57999999999999999999977     5688999999987653 45556678899999999999999999999963   


Q ss_pred             ---CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          187 ---RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       187 ---~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                         ..++|+||||+.++.+ ..+  ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++
T Consensus        91 ~~~~~~~~iv~Ey~~~~l~-~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          91 LEEFQDVYLVMELMDANLC-QVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             TTTCCEEEEEEECCSEEHH-HHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             cccCceeEEEEeccchHHH-Hhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhh
Confidence               4689999999987654 444  3568999999999999999999999999999999999999999999999999998


Q ss_pred             ccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          264 EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      ...........+||+.|+|||++.+..++.++||||+||++|+|++|+.||...+
T Consensus       168 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~  222 (355)
T d2b1pa1         168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD  222 (355)
T ss_dssp             -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC
Confidence            8777666677789999999999999999999999999999999999999997654

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2e-46  Score=338.57  Aligned_cols=199  Identities=21%  Similarity=0.335  Sum_probs=172.9

Q ss_pred             CCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCC-Ccceecceeeec
Q 018487          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQLRYSFQT  186 (355)
Q Consensus       108 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~  186 (355)
                      ..++|+++++||+|+||+||+|+++     .+++.||||++......     ..+.+|++.++.+.| +||+.+++++..
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~-----~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~   72 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNL-----LNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQE   72 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEET-----TTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred             CCCceEEEEEEecCCCeEEEEEEEC-----CCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeec
Confidence            3578999999999999999999977     56789999998654321     235678889999975 899999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC-----CCcEEEEecC
Q 018487          187 RSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-----DGHVMLTDFG  260 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~-----~~~~kl~Dfg  260 (355)
                      +...|+||||+ +++|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.     ++.+||+|||
T Consensus        73 ~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG  151 (293)
T d1csna_          73 GLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG  151 (293)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred             CCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccc
Confidence            99999999999 578888887654 6999999999999999999999999999999999999964     5789999999


Q ss_pred             CccccCcCC--------CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          261 LAKEIDESS--------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       261 ~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      +|+.+....        .....+||+.|||||++.+..++.++|||||||++|||+||+.||...
T Consensus       152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~  216 (293)
T d1csna_         152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL  216 (293)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred             eeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCc
Confidence            998764321        233567999999999999999999999999999999999999999754

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.4e-46  Score=345.22  Aligned_cols=195  Identities=24%  Similarity=0.421  Sum_probs=172.0

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecceeeec-
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQT-  186 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~-  186 (355)
                      .++|+++++||+|+||+||+|+++     .+++.||||+++...      .+.+.+|+++|+.+. ||||++++++|.. 
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~  102 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINI-----TNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDP  102 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred             CcCeEEEEEEecCcCeEEEEEEEC-----CCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence            357999999999999999999976     568899999986532      345778999999996 9999999999874 


Q ss_pred             -CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCC-cEEEEecCCccc
Q 018487          187 -RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKE  264 (355)
Q Consensus       187 -~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~-~~kl~Dfg~a~~  264 (355)
                       ...+++|||||.+++|..+   .+.+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.
T Consensus       103 ~~~~~~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~  179 (328)
T d3bqca1         103 VSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  179 (328)
T ss_dssp             TTCSEEEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred             CCCceeEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeeccccccee
Confidence             4579999999999998654   34699999999999999999999999999999999999998655 699999999998


Q ss_pred             cCcCCCCCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          265 IDESSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      +.........++|+.|+|||++.+. .++.++||||+||++|+|++|+.||...
T Consensus       180 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~  233 (328)
T d3bqca1         180 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG  233 (328)
T ss_dssp             CCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             ccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence            8766666777899999999998865 5799999999999999999999999764

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-46  Score=340.19  Aligned_cols=225  Identities=18%  Similarity=0.280  Sum_probs=181.5

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCccee-cceeeecCC
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQ-LRYSFQTRS  188 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~-l~~~~~~~~  188 (355)
                      ++|+++++||+|+||+||+|+++     .+++.||||++......     +.+..|+++++.++|+|++. +.+++...+
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~-----~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~   76 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDI-----AAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGD   76 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEET-----TTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETT
T ss_pred             CEEEEeEEEeeCCCcEEEEEEEC-----CCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCC
Confidence            57999999999999999999976     46788999998764322     23667999999998776555 455567788


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecC---CCcEEEEecCCcccc
Q 018487          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEI  265 (355)
Q Consensus       189 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~---~~~~kl~Dfg~a~~~  265 (355)
                      ..++||||+.++.+.........+++..+..++.|++.||+|||++||+||||||+|||++.   +..+||+|||+|+.+
T Consensus        77 ~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          77 YNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             EEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            99999999966444434445567999999999999999999999999999999999999863   557999999999876


Q ss_pred             CcCC--------CCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCchhhhh---------------
Q 018487          266 DESS--------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSMQVIAC---------------  322 (355)
Q Consensus       266 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~~~~~~---------------  322 (355)
                      ....        .....+||+.|||||++.+..++.++|||||||++|||+||+.||........               
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  236 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred             cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence            5432        12356799999999999999999999999999999999999999976422110               


Q ss_pred             ------hhhHHHHHhhhheeeecCCCcC
Q 018487          323 ------NTMLLFYLIIFHCLFVNSLELL  344 (355)
Q Consensus       323 ------~~~~~~~~~i~~~l~~~~~e~~  344 (355)
                            +...-+..++..|+..+|.+++
T Consensus       237 ~~~~~~~~p~~~~~li~~cl~~~p~~RP  264 (299)
T d1ckia_         237 IEVLCKGYPSEFATYLNFCRSLRFDDKP  264 (299)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHHSCTTCCC
T ss_pred             hhHhccCCCHHHHHHHHHHccCChhHCc
Confidence                  1112357788999999988875

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-47  Score=342.13  Aligned_cols=224  Identities=26%  Similarity=0.384  Sum_probs=178.1

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecCC-
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-  188 (355)
                      .+|.+.++||+|+||+||+|++.       ++.||||++..+..    .......|+..+..++|||||++++++...+ 
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~-------g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~   71 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR-------GEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNG   71 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-------TEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-------CEEEEEEEECccch----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCC
Confidence            46899999999999999999864       56899999865421    1122334666667889999999999987543 


Q ss_pred             ---eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------CCCeeccCCCCcEEecCCCcEEEE
Q 018487          189 ---KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK--------CGIVHRDLKPENILMDSDGHVMLT  257 (355)
Q Consensus       189 ---~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~--------~~iiHrDlkp~NILl~~~~~~kl~  257 (355)
                         .+|+|||||++|+|.+++.+. .+++.++..++.|++.||+|||.        +||+||||||+||||+.++.+||+
T Consensus        72 ~~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~  150 (303)
T d1vjya_          72 TWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  150 (303)
T ss_dssp             SSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred             cceEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEE
Confidence               689999999999999999765 58999999999999999999996        599999999999999999999999


Q ss_pred             ecCCccccCcCC-----CCCcccccCccccchhhccCC------CCCcccHHHHHHHHHHHHcCCCCCCCchhh------
Q 018487          258 DFGLAKEIDESS-----RSNSMCGTTEYMAPEILLSKG------HNKDADWWSVGILLYEMLTGQVNIKSMQVI------  320 (355)
Q Consensus       258 Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwSlG~~l~elltg~~pf~~~~~~------  320 (355)
                      |||+++......     .....+||+.|||||++.+..      ++.++|||||||+||||+||..||......      
T Consensus       151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~  230 (303)
T d1vjya_         151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  230 (303)
T ss_dssp             CCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred             ecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh
Confidence            999998764432     234567999999999987643      567899999999999999998776331100      


Q ss_pred             -----------------------------hhhhhHHHHHhhhheeeecCCCcCC
Q 018487          321 -----------------------------ACNTMLLFYLIIFHCLFVNSLELLS  345 (355)
Q Consensus       321 -----------------------------~~~~~~~~~~~i~~~l~~~~~e~~~  345 (355)
                                                   .......+.+++.+||+.+|.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps  284 (303)
T d1vjya_         231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT  284 (303)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCC
T ss_pred             cccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcC
Confidence                                         0111223677888999998888663

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-46  Score=344.12  Aligned_cols=201  Identities=26%  Similarity=0.423  Sum_probs=169.7

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcceecceeeecC-
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-  187 (355)
                      +++|+++++||+|+||+||+|+++     .+++.||||++.+... .....+.+.+|+++|+.++|||||++++++... 
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~   90 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDT-----KTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   90 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEET-----TTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             CCCeEEEEEEecCCCeEEEEEEEC-----CCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecc
Confidence            468999999999999999999976     5688999999986543 344456688999999999999999999998633 


Q ss_pred             ----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEEEecCCcc
Q 018487          188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (355)
Q Consensus       188 ----~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~  263 (355)
                          ...+++|+|+.+|+|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+|++|||++.
T Consensus        91 ~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          91 SLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             STTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             ccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhc
Confidence                344666777789999988854 569999999999999999999999999999999999999999999999999997


Q ss_pred             ccCcCCCCCcccccCccccchhhccC-CCCCcccHHHHHHHHHHHHcCCCCCCCch
Q 018487          264 EIDESSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQVNIKSMQ  318 (355)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~pf~~~~  318 (355)
                      .....  .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+
T Consensus       170 ~~~~~--~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~  223 (348)
T d2gfsa1         170 HTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD  223 (348)
T ss_dssp             CCTGG--GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccCcc--cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC
Confidence            65433  3456789999999997765 46889999999999999999999998754

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.9e-39  Score=300.00  Aligned_cols=198  Identities=26%  Similarity=0.433  Sum_probs=160.5

Q ss_pred             CCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-----------CCcc
Q 018487          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-----------HPFI  177 (355)
Q Consensus       109 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nI  177 (355)
                      .++|+++++||+|+||+||+|+++     .+++.||||+++++.    ...+.+.+|+++++.++           |+||
T Consensus        12 ~~rY~i~~~LG~G~fg~Vy~~~~~-----~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i   82 (362)
T d1q8ya_          12 DARYILVRKLGWGHFSTVWLAKDM-----VNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHI   82 (362)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred             CCcEEEEEEEeeCCCeEEEEEEEC-----CCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence            357999999999999999999976     568899999997643    23355677888888775           4789


Q ss_pred             eecceeeec--CCeEEEEEeccCCCChHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEecCC
Q 018487          178 VQLRYSFQT--RSKLYLILDFINGGHLFFH---LYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSD  251 (355)
Q Consensus       178 v~l~~~~~~--~~~~~lv~e~~~~gsL~~~---l~~~~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDlkp~NILl~~~  251 (355)
                      +++++++..  ....+++|+++.++.....   ......+++..++.++.||+.||.|||+ +||+||||||+|||++.+
T Consensus        83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~  162 (362)
T d1q8ya_          83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV  162 (362)
T ss_dssp             CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred             EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeecc
Confidence            999988764  3456666666655433222   2233568999999999999999999997 899999999999999866


Q ss_pred             C------cEEEEecCCccccCcCCCCCcccccCccccchhhccCCCCCcccHHHHHHHHHHHHcCCCCCCCc
Q 018487          252 G------HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQVNIKSM  317 (355)
Q Consensus       252 ~------~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~pf~~~  317 (355)
                      +      .++++|||.+......  ....+||+.|+|||++.+..++.++||||+||++++|++|+.||...
T Consensus       163 ~~~~~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~  232 (362)
T d1q8ya_         163 DSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD  232 (362)
T ss_dssp             ETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             CcccccceeeEeecccccccccc--cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence            5      4999999999865443  34568999999999999999999999999999999999999999754

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=3.8e-28  Score=204.49  Aligned_cols=167  Identities=19%  Similarity=0.213  Sum_probs=122.2

Q ss_pred             eEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeeccccc---------------chhHHHHHHHHHHHHHhcCCCc
Q 018487          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII---------------KKNHVDYMKAERDILTKVTHPF  176 (355)
Q Consensus       112 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---------------~~~~~~~~~~E~~~l~~l~h~n  176 (355)
                      +.+.++||+|+||+||+|.+.      +++.||||+++.....               .........+|...+.++.|.+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~   75 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLA   75 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSS
T ss_pred             chhCCEeeeCcceEEEEEECC------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCC
Confidence            467899999999999999864      4678999987642111               0111233456888999999999


Q ss_pred             ceecceeeecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEecCCCcEEE
Q 018487          177 IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML  256 (355)
Q Consensus       177 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDlkp~NILl~~~~~~kl  256 (355)
                      ++..+++..    .+++|||+++..+.       .+.+..+..++.|++.+|.|||++||+||||||+|||++++ .++|
T Consensus        76 v~~~~~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~l  143 (191)
T d1zara2          76 VPKVYAWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWI  143 (191)
T ss_dssp             SCCEEEEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEE
T ss_pred             cceEEEecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEE
Confidence            988765532    27999999987552       24556678899999999999999999999999999999864 5999


Q ss_pred             EecCCccccCcCCCCCcccccCccccc------hhhccCCCCCcccHHHHHHHH
Q 018487          257 TDFGLAKEIDESSRSNSMCGTTEYMAP------EILLSKGHNKDADWWSVGILL  304 (355)
Q Consensus       257 ~Dfg~a~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DiwSlG~~l  304 (355)
                      +|||+|.........       .|...      +. ..+.|+.++|+||+.--+
T Consensus       144 iDFG~a~~~~~~~~~-------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         144 IDFPQSVEVGEEGWR-------EILERDVRNIITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCCTTCEETTSTTHH-------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             EECCCcccCCCCCcH-------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence            999999775433211       11111      11 236688899999986443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.71  E-value=1.1e-07  Score=81.43  Aligned_cols=139  Identities=11%  Similarity=0.059  Sum_probs=88.7

Q ss_pred             CeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCcceecceeeecCCe
Q 018487          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSK  189 (355)
Q Consensus       111 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~  189 (355)
                      .|++.+..+-++.+.||++..       .++.++||+.........   ..+.+|...++.+. +--+.+++.+...++.
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~~-------~~~~~vlk~~~~~~~~~~---~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~   84 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLVG-------ENENLYLKMTDSRYKGTT---YDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEEC-------SSCEEEEEEECGGGTTST---TCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             ceEEEEcCCCCCCCcEEEEEe-------CCCeEEEEEcCCCcccch---hhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence            677777765556679998862       355578888765432222   23556888877764 3335566777778889


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 018487          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH-------------------------------------  232 (355)
Q Consensus       190 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~L~~LH-------------------------------------  232 (355)
                      .++||++++|..+.......     .....++.++.+.+..||                                     
T Consensus        85 ~~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T d1j7la_          85 SNLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred             eEEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence            99999999997764332110     111112222333333333                                     


Q ss_pred             ----------------HC------CCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          233 ----------------KC------GIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       233 ----------------~~------~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                                      +.      .++|+|+.|.|||+++++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                            11      268999999999998776667999998764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.38  E-value=6.2e-07  Score=81.69  Aligned_cols=81  Identities=16%  Similarity=0.292  Sum_probs=47.6

Q ss_pred             EeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccc----hhHHHHHHHHHHHHHhcC-C-C-cceecceeeecC
Q 018487          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK----KNHVDYMKAERDILTKVT-H-P-FIVQLRYSFQTR  187 (355)
Q Consensus       115 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~E~~~l~~l~-h-~-nIv~l~~~~~~~  187 (355)
                      .+.||.|....||++...     ..++.++||.........    ....++...|...|+.+. + | .+.+++.+  +.
T Consensus        31 ~~eig~G~~N~vfrV~~~-----~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~  103 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQ-----EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT  103 (392)
T ss_dssp             EEECCSSSSEEEEEEEC---------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET
T ss_pred             EEEeCCCceEeEEEEEeC-----CCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cC
Confidence            567999999999999743     345678999754321110    112234556777777663 2 2 34444433  34


Q ss_pred             CeEEEEEeccCCCCh
Q 018487          188 SKLYLILDFINGGHL  202 (355)
Q Consensus       188 ~~~~lv~e~~~~gsL  202 (355)
                      ...++|||++++..+
T Consensus       104 ~~~~lvmE~L~~~~~  118 (392)
T d2pula1         104 EMAVTVMEDLSHLKI  118 (392)
T ss_dssp             TTTEEEECCCTTSEE
T ss_pred             CCCEEEEeccCCccc
Confidence            455789999987543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.23  E-value=2.8e-06  Score=72.07  Aligned_cols=136  Identities=14%  Similarity=0.136  Sum_probs=80.0

Q ss_pred             eeccCCc-EEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCC--cceecceeeecCCeEEEE
Q 018487          117 VVGQGAF-GKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP--FIVQLRYSFQTRSKLYLI  193 (355)
Q Consensus       117 ~lG~G~~-g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~~~~~~~~~lv  193 (355)
                      .+..|.. +.||++...      .+..+++|.......      ..+..|...++.+...  .+.+++.+....+..++|
T Consensus        17 ~~~~G~s~~~v~r~~~~------~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v   84 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ------GRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL   84 (255)
T ss_dssp             ECSCTTSSCEEEEEECT------TSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred             EcCCcccCCeEEEEEeC------CCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEE
Confidence            4455554 689988743      345588898654432      1255677777766432  245567777778889999


Q ss_pred             EeccCCCChHH--------------HHHhcC-------CC--CHHHHHH----HHH----------------HHHHHHHH
Q 018487          194 LDFINGGHLFF--------------HLYRQG-------IF--REDQARF----YTA----------------EIVSAVSH  230 (355)
Q Consensus       194 ~e~~~~gsL~~--------------~l~~~~-------~l--~~~~~~~----i~~----------------ql~~~L~~  230 (355)
                      |++++|.++..              .+.+-.       .+  .......    ...                .....+..
T Consensus        85 ~~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (255)
T d1nd4a_          85 LGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  164 (255)
T ss_dssp             EECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             EEeeeccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence            99999865521              111100       00  0000000    000                12223333


Q ss_pred             HHHC-------CCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          231 LHKC-------GIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       231 LH~~-------~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      +...       .++|+|+.|.|||++.+..+-|+||+.+..
T Consensus       165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            3332       279999999999998776678999998754

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.65  E-value=0.00011  Score=64.64  Aligned_cols=71  Identities=11%  Similarity=0.248  Sum_probs=43.5

Q ss_pred             CCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcc-----eec--ceeeecCCeEEEE
Q 018487          121 GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI-----VQL--RYSFQTRSKLYLI  193 (355)
Q Consensus       121 G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-----v~l--~~~~~~~~~~~lv  193 (355)
                      +-.-.||++...      +++.|++|+.+.....    .+.+..|...+..|....|     +..  -..+...+..+.+
T Consensus        33 s~EN~vy~v~~~------dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l  102 (325)
T d1zyla1          33 SYENRVYQFQDE------DRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  102 (325)
T ss_dssp             CSSSEEEEECCT------TCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             cccceeEEEEcC------CCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEE
Confidence            334789998743      4667999998765322    2345667777776642222     111  1223456678899


Q ss_pred             EeccCCCC
Q 018487          194 LDFINGGH  201 (355)
Q Consensus       194 ~e~~~~gs  201 (355)
                      +++++|..
T Consensus       103 ~~~~~G~~  110 (325)
T d1zyla1         103 FPSVGGRQ  110 (325)
T ss_dssp             EECCCCEE
T ss_pred             EeecCCcC
Confidence            99998743

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.55  E-value=0.00026  Score=61.52  Aligned_cols=146  Identities=15%  Similarity=0.200  Sum_probs=77.0

Q ss_pred             cCCCCeEEEeeeccCCcEEEEEEEEcCCCCCCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCC-----Ccceecc
Q 018487          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-----PFIVQLR  181 (355)
Q Consensus       107 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-----~nIv~l~  181 (355)
                      ..-++..-.+.|..|---+.|++...       ++.+++|++....  ...   .+..|+.++..+..     |..+...
T Consensus        15 Y~lg~~~~~~~i~~G~~N~ny~v~t~-------~g~yVLri~~~~~--~~~---~l~~~~~~l~~L~~~g~pvp~pi~~~   82 (316)
T d2ppqa1          15 YDVGSLTSYKGIAEGVENSNFLLHTT-------KDPLILTLYEKRV--EKN---DLPFFLGLMQHLAAKGLSCPLPLPRK   82 (316)
T ss_dssp             BCCCCEEEEEEECC---EEEEEEEES-------SCCEEEEEECC-----CC---HHHHHHHHHHHHHHTTCCCCCBCCBT
T ss_pred             CCCCCceEeecCCCCcccCeEEEEEC-------CCcEEEEEcCCCC--CHH---HHHHHHHHHHhhhhccccccccceec
Confidence            34567777788888988999998743       3348999986532  222   23345666665542     2222211


Q ss_pred             -e--eeecCCeEEEEEeccCCCChH--------------HHHHhc---------CCCCHHH------------------H
Q 018487          182 -Y--SFQTRSKLYLILDFINGGHLF--------------FHLYRQ---------GIFREDQ------------------A  217 (355)
Q Consensus       182 -~--~~~~~~~~~lv~e~~~~gsL~--------------~~l~~~---------~~l~~~~------------------~  217 (355)
                       +  .....+..+.++.++.+....              ..+...         .......                  .
T Consensus        83 ~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (316)
T d2ppqa1          83 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL  162 (316)
T ss_dssp             TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred             CCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhH
Confidence             1  122345566777777664321              000000         0001110                  1


Q ss_pred             HHHHHHHHHHHHHHH----HCCCeeccCCCCcEEecCCCcEEEEecCCccc
Q 018487          218 RFYTAEIVSAVSHLH----KCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (355)
Q Consensus       218 ~~i~~ql~~~L~~LH----~~~iiHrDlkp~NILl~~~~~~kl~Dfg~a~~  264 (355)
                      ...+..+...+.-..    ..|+||+|+.++||+++.+...-|+||+.+..
T Consensus       163 ~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         163 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            111122222222222    24799999999999999887778999998753

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.48  E-value=0.00025  Score=63.93  Aligned_cols=83  Identities=16%  Similarity=0.169  Sum_probs=52.1

Q ss_pred             CCeEEEeeeccCCcEEEEEEEEcCCCC--CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhcCCCcc-eecceeeec
Q 018487          110 GDFEIFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI-VQLRYSFQT  186 (355)
Q Consensus       110 ~~y~~~~~lG~G~~g~V~~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~  186 (355)
                      +++++ +.|+.|-.-.+|++.......  ....+.|.+++....    ... ....+|..+++.+.-.++ .++++++..
T Consensus        43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~----~~~-idr~~E~~i~~~ls~~gl~Pkll~~~~~  116 (395)
T d1nw1a_          43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETE-SHLVAESVIFTLLSERHLGPKLYGIFSG  116 (395)
T ss_dssp             GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCH-HHHHHHHHHHHHHHHTTSSSCEEEEETT
T ss_pred             cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc----chh-hHHHHHHHHHHHHHhCCCCCeEEEEcCC
Confidence            44554 678889999999998653221  123455777776521    112 234568888888763344 456666543


Q ss_pred             CCeEEEEEeccCCCCh
Q 018487          187 RSKLYLILDFINGGHL  202 (355)
Q Consensus       187 ~~~~~lv~e~~~~gsL  202 (355)
                          .+||||++|..+
T Consensus       117 ----g~I~efi~g~~l  128 (395)
T d1nw1a_         117 ----GRLEEYIPSRPL  128 (395)
T ss_dssp             ----EEEECCCCEEEC
T ss_pred             ----ceEEEEeccccC
Confidence                689999998544